PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Andrews, BT; Barbay, S; Townsend, J; Detamore, M; Harris, J; Tuchek, C; Nudo, RJ				Andrews, Brian T.; Barbay, Scott; Townsend, Jakob; Detamore, Michael; Harris, Janna; Tuchek, Chad; Nudo, Randolph J.			Unrepaired decompressive craniectomy worsens motor performance in a rat traumatic brain injury model	SCIENTIFIC REPORTS			English	Article							CONTROLLED CORTICAL IMPACT; BONE REGENERATION; CORTEX; DEFECT; DAMAGE	Decompressive craniectomy (DC) is often required to manage rising intracranial pressure after traumatic brain injury (TBI). Syndrome of the trephine (SoT) is a reversible neurologic condition that often occurs following DC as a result of the unrepaired skull. The purpose of the present study is to characterize neurological impairment following TBI in rats with an unrepaired craniectomy versus rats with a closed cranium. Long Evans male rats received a controlled cortical impact (CCI) over the caudal forelimb area (CFA) of the motor cortex. Immediately after CCI, rats received either a hemi-craniectomy (TBI Open Skull Group) or an immediate acrylic cranioplasty restoring cranial anatomy (TBI Closed Skull Group). Motor performance was assessed on a skilled reaching task on post-CCI weeks 1-4, 8, 12, and 16. Three weeks after the CCI injury, the TBI Closed Skull Group demonstrated improved motor performance compared to TBI Open Skull Group. The TBI Closed Skull Group continued to perform better than the TBI Open Skull Group throughout weeks 4, 8, 12 and 16. The protracted recovery of CFA motor performance demonstrated in rats with unrepaired skulls following TBI suggests this model may be beneficial for testing new therapeutic approaches to prevent SoT.	[Andrews, Brian T.] Univ Kansas, Sutherland Inst, Dept Plast & Reconstruct Surg, Med Ctr, MS 3015,3901 Rainbow Blvd, Kansas City, MS 66160 USA; [Barbay, Scott; Nudo, Randolph J.] Univ Kansas, Dept Rehabil Med, Med Ctr, Kansas City, KS USA; [Townsend, Jakob; Detamore, Michael] Univ Oklahoma, Sch Biomed Engn, Norman, OK 73019 USA; [Harris, Janna] Univ Kansas, Dept Anat & Cell Biol, Kansas City, KS USA; [Tuchek, Chad] Univ Kansas, Dept Neurosurg, Med Ctr, Kansas City, KS USA		Andrews, BT (corresponding author), Univ Kansas, Sutherland Inst, Dept Plast & Reconstruct Surg, Med Ctr, MS 3015,3901 Rainbow Blvd, Kansas City, MS 66160 USA.	bandrews@kumc.edu		Andrews, Brian/0000-0003-3994-6808	National Institute of Dental and Craniofacial Research of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R03 DE025906]	Research reported in the current publication was supported by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under award number R03 DE025906. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Andrews BT, 2020, J CRANIOFAC SURG, V31, P2364, DOI 10.1097/SCS.0000000000006777; Andrews BT, 2016, J CRANIOFAC SURG, V27, P1875, DOI 10.1097/SCS.0000000000002897; Annan M, 2015, BRIT J NEUROSURG, V29, P314, DOI 10.3109/02688697.2015.1012047; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Cushing H, 1908, ANN SURG, V47, P641, DOI 10.1097/00000658-190805000-00001; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; Farr TD, 2002, STROKE, V33, P1869, DOI 10.1161/01.STR.0000020714.48349.4E; Friess SH, 2015, J NEUROTRAUM, V32, P791, DOI 10.1089/neu.2014.3564; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Jeyaraj P, 2015, J MAXILLOFAC ORAL SU, V14, P666, DOI 10.1007/s12663-014-0673-1; Marklund N, 2016, METHODS MOL BIOL, V1462, P29, DOI 10.1007/978-1-4939-3816-2_3; Marquez-Rivas J, 2013, J NEUROSURG, V119, P1657, DOI 10.3171/2013.5.JNS131034; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Oladunjoye AO, 2013, J NEUROSURG, V118, P776, DOI 10.3171/2013.1.JNS121475; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113; Stein DG, 2007, PROG BRAIN RES, V161, P339, DOI 10.1016/S0079-6123(06)61024-8; Steiner Claudia, 2002, Eff Clin Pract, V5, P143; Szczygielski J, 2016, J NEUROTRAUM, V33, P122, DOI 10.1089/neu.2014.3835; Tarr JT, 2020, PLAST RECONSTR SURG, V145, P1486, DOI 10.1097/PRS.0000000000006836; Townsend JM, 2017, AAPS J, V19, P703, DOI 10.1208/s12248-017-0045-0; WOODHALL B, 1945, ANN SURG, V121, P649, DOI 10.1097/00000658-194505000-00009; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	29	2	2	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	DEC 17	2020	10	1							22242	10.1038/s41598-020-79155-8			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL6WA	WOS:000603258300051	33335178	Green Published, gold			2022-02-06	
J	Arun, P; Rossetti, F; DeMar, JC; Wang, Y; Batuure, AB; Wilder, DM; Gist, ID; Morris, AJ; Sabbadini, RA; Long, JSB				Arun, Peethambaran; Rossetti, Franco; DeMar, James C.; Wang, Ying; Batuure, Andrew B.; Wilder, Donna M.; Gist, Irene D.; Morris, Andrew J.; Sabbadini, Roger A.; Long, Joseph B.			Antibodies Against Lysophosphatidic Acid Protect Against Blast-Induced Ocular Injuries	FRONTIERS IN NEUROLOGY			English	Article						blast exposure; eye injury; ocular dysfunction; lysophosphatidic acid; anti-LPA antibody; rat; retina	TRAUMATIC BRAIN-INJURY; VISUAL-ACUITY; MOUSE MODEL; APOPTOSIS; RECEPTOR; DAMAGE; EYE; PATHOPHYSIOLOGY; RETINA; LPA(1)	Exposure to blast overpressure waves is implicated as the major cause of ocular injuries and resultant visual dysfunction in veterans involved in recent combat operations. No effective therapeutic strategies have been developed so far for blast-induced ocular dysfunction. Lysophosphatidic acid (LPA) is a bioactive phospholipid generated by activated platelets, astrocytes, choroidal plexus cells, and microglia and is reported to play major roles in stimulating inflammatory processes. The levels of LPA in the cerebrospinal fluid have been reported to increase acutely in patients with traumatic brain injury (TBI) as well as in a controlled cortical impact (CCI) TBI model in mice. In the present study, we have evaluated the efficacy of a single intravenous administration of a monoclonal LPA antibody (25 mg/kg) given at 1 h post-blast for protection against injuries to the retina and associated ocular dysfunctions. Our results show that a single 19 psi blast exposure significantly increased the levels of several species of LPA in blood plasma at 1 and 4 h post-blast. The anti-LPA antibody treatment significantly decreased glial cell activation and preserved neuronal cell morphology in the retina on day 8 after blast exposure. Optokinetic measurements indicated that anti-LPA antibody treatment significantly improved visual acuity in both eyes on days 2 and 6 post-blast exposure. Anti-LPA antibody treatment significantly increased rod photoreceptor and bipolar neuronal cell signaling in both eyes on day 7 post-blast exposure. These results suggest that blast exposure triggers release of LPAs, which play a major role promoting blast-induced ocular injuries, and that a single early administration of anti-LPA antibodies provides significant protection.	[Arun, Peethambaran; Rossetti, Franco; DeMar, James C.; Wang, Ying; Batuure, Andrew B.; Wilder, Donna M.; Gist, Irene D.; Long, Joseph B.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA; [Morris, Andrew J.] Univ Kentucky, Coll Med, Lexington VA Med Ctr, Div Cardiovasc Med, Lexington, KY USA; [Sabbadini, Roger A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA		Arun, P (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA.	peethambaran.arun.ctr@mail.mil			Lpath Inc. (San Diego, CA) [12-0234]; Walter Reed Army Institute of Research (Silver Spring, MD) [12-0234]	This study was funded by Lpath Inc. (San Diego, CA), through a Co-operative Research and Development Agreement (12-0234) with Walter Reed Army Institute of Research (Silver Spring, MD). Lpath, Inc., has since been acquired by Apollo Endosurgery (Austin, TX). Murine anti-LPA monoclonal antibodies (504B3) are now sold by Echelon Biosciences (Salt Lake City, UT. Product Number: Z-P200). This research benefitted from resources and facilities at the VA Medical Center in Lexington KY.	Ackerman SJ, 2016, BIOMARK MED, V10, P123, DOI 10.2217/bmm.15.93; Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; Anliker B, 2013, GLIA, V61, P2009, DOI 10.1002/glia.22572; Arun P, 2020, J NEUROTRAUM, V37, P647, DOI 10.1089/neu.2019.6591; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; Brault S, 2007, AM J PHYSIOL-REG I, V292, pR1174, DOI 10.1152/ajpregu.00619.2006; Bricker-Anthony C, 2017, OPTOMETRY VISION SCI, V94, P20, DOI 10.1097/OPX.0000000000000898; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Crack PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-37; Dacheva I, 2016, RETINA-J RET VIT DIS, V36, P2311, DOI 10.1097/IAE.0000000000001112; DeMar J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00059; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Eisenried A, 2017, PAIN, V158, P2181, DOI 10.1097/j.pain.0000000000001019; Fincher J, 2014, DEV NEUROSCI-BASEL, V36, P443, DOI 10.1159/000364858; Frugier T, 2011, CELL MOL NEUROBIOL, V31, P569, DOI 10.1007/s10571-011-9650-0; Goldshmit Y, 2012, AM J PATHOL, V181, P978, DOI 10.1016/j.ajpath.2012.06.007; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00766; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Holtsberg FW, 1998, J NEUROCHEM, V70, P66; Jiang YD, 2014, CYTOKINE, V70, P115, DOI 10.1016/j.cyto.2014.07.004; Jiang YD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-96; Kihara Y, 2015, EXP CELL RES, V333, P171, DOI 10.1016/j.yexcr.2014.11.020; Kong H, 2003, DOC OPHTHALMOL, V106, P239, DOI 10.1023/A:1022988332578; Kraemer M, 2019, J LIPID RES, V60, P1818, DOI 10.1194/jlr.M093096; Kwon JH, 2018, BBA-MOL CELL BIOL L, V1863, P1237, DOI 10.1016/j.bbalip.2018.07.015; Lemke S, 2016, OPHTHALMOLOGY, V123, P415, DOI 10.1016/j.ophtha.2015.10.003; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; Mammadova N, 2017, AM J PATHOL, V187, P1459, DOI 10.1016/j.ajpath.2017.03.005; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Prusky GT, 2002, BEHAV BRAIN RES, V136, P339, DOI 10.1016/S0166-4328(02)00126-2; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Sayas CL, 2006, MOL BIOL CELL, V17, P1834, DOI 10.1091/mbc.E05-07-0688; Shano S, 2008, NEUROCHEM INT, V52, P216, DOI 10.1016/j.neuint.2007.07.004; Srikanth M, 2018, EUR J PHARMACOL, V841, P49, DOI 10.1016/j.ejphar.2018.10.005; Steiner MR, 2000, ANN NY ACAD SCI, V905, P132; Sun Y, 2011, MOL CELLS, V31, P483, DOI 10.1007/s10059-011-1036-0; Thomas BB, 2004, J NEUROSCI METH, V138, P7, DOI 10.1016/j.jneumeth.2004.03.007; Ueda H, 2020, PAIN MANAG, V10, P43, DOI 10.2217/pmt-2019-0036; Wang HCH, 2014, MIL MED, V179, P34, DOI 10.7205/MILMED-D-13-00504; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weichel ED, 2008, CURR OPIN OPHTHALMOL, V19, P519, DOI 10.1097/ICU.0b013e3283140e98; Yang C, 2009, INVEST OPHTH VIS SCI, V50, P1290, DOI 10.1167/iovs.08-1920; Zhu YL, 2019, CURR EYE RES, V44, P770, DOI 10.1080/02713683.2019.1567791; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	51	2	2	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 15	2020	11								611816	10.3389/fneur.2020.611816			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PL3QE	WOS:000603039900001	33384658	gold, Green Published			2022-02-06	
J	McDonald, WS; Miyamoto, K; Rivera, R; Kennedy, G; Almeida, BSV; Kingsbury, MA; Chun, J				McDonald, Whitney S.; Miyamoto, Kyoko; Rivera, Richard; Kennedy, Grace; Almeida, Beatriz S. V.; Kingsbury, Marcy A.; Chun, Jerold			Altered cleavage plane orientation with increased genomic aneuploidy produced by receptor-mediated lysophosphatidic acid (LPA) signaling in mouse cerebral cortical neural progenitor cells	MOLECULAR BRAIN			English	Article						LPA; Lysophospholipid; GPCR; Neural progenitor cells; NPC; Adherens junctions; Somatic genomic mosaicism; Aneuploidy; Cleavage plane; Hydrocephalus	TRAUMATIC BRAIN-INJURY; SPINDLE ORIENTATION; CHROMOSOME SEGREGATION; GENE-EXPRESSION; DIVISIONS; NEURONS; MICE; DEATH; DIFFERENTIATION; REARRANGEMENT	The brain is composed of cells having distinct genomic DNA sequences that arise post-zygotically, known as somatic genomic mosaicism (SGM). One form of SGM is aneuploidy-the gain and/or loss of chromosomes-which is associated with mitotic spindle defects. The mitotic spindle orientation determines cleavage plane positioning and, therefore, neural progenitor cell (NPC) fate during cerebral cortical development. Here we report receptor-mediated signaling by lysophosphatidic acid (LPA) as a novel extracellular signal that influences cleavage plane orientation and produces alterations in SGM by inducing aneuploidy during murine cortical neurogenesis. LPA is a bioactive lipid whose actions are mediated by six G protein-coupled receptors, LPA(1)-LPA(6). RNAscope and qPCR assessment of all six LPA receptor genes, and exogenous LPA exposure in LPA receptor (Lpar)-null mice, revealed involvement of Lpar1 and Lpar2 in the orientation of the mitotic spindle. Lpar1 signaling increased non-vertical cleavage in vivo by disrupting cell-cell adhesion, leading to breakdown of the ependymal cell layer. In addition, genomic alterations were significantly increased after LPA exposure, through production of chromosomal aneuploidy in NPCs. These results identify LPA as a receptor-mediated signal that alters both NPC fate and genomes during cortical neurogenesis, thus representing an extracellular signaling mechanism that can produce stable genomic changes in NPCs and their progeny. Normal LPA signaling in early life could therefore influence both the developing and adult brain, whereas its pathological disruption could contribute to a range of neurological and psychiatric diseases, via long-lasting somatic genomic alterations.	[McDonald, Whitney S.; Rivera, Richard; Kennedy, Grace; Chun, Jerold] Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA; [McDonald, Whitney S.; Miyamoto, Kyoko; Rivera, Richard; Kennedy, Grace; Almeida, Beatriz S. V.; Kingsbury, Marcy A.; Chun, Jerold] Scripps Res Inst, La Jolla, CA 92037 USA		Chun, J (corresponding author), Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Chun, J (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	jchun@sbpdiscovery.org			Department of DefenseUnited States Department of Defense [W81XWH-17-1-0455]; NIAAA of the National Institutes of Health [R01AA21402]	Funding was provided by the Department of Defense W81XWH-17-1-0455 (JC) and the NIAAA of the National Institutes of Health R01AA21402 (JC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams RJ, 1996, J NEUROSCI, V16, P7610; Allen DR, 2001, GENE DEV, V15, P554, DOI 10.1101/gad.869001; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; Blaschke AJ, 1998, J COMP NEUROL, V396, P39, DOI 10.1002/(SICI)1096-9861(19980622)396:1<39::AID-CNE4>3.0.CO;2-J; Bushman DM, 2013, SEMIN CELL DEV BIOL, V24, P357, DOI 10.1016/j.semcdb.2013.02.003; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Castilla-Ortega E, 2010, NEUROBIOL LEARN MEM, V94, P73, DOI 10.1016/j.nlm.2010.04.003; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Contos JJA, 2001, GENE, V267, P243, DOI 10.1016/S0378-1119(01)00410-3; Crack PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-37; Damiani D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13509; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Dubin AE, 2010, J NEUROSCI, V30, P7300, DOI 10.1523/JNEUROSCI.6151-09.2010; Dubin AE, 1999, J NEUROSCI, V19, P1371; Estivill-Torrus G, 2008, CEREB CORTEX, V18, P938, DOI 10.1093/cercor/bhm132; Evrony GD, 2015, NEURON, V85, P49, DOI 10.1016/j.neuron.2014.12.028; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Fukushima N, 2000, DEV BIOL, V228, P6, DOI 10.1006/dbio.2000.9930; Fukushima N, 2002, MOL BIOL CELL, V13, P2692, DOI 10.1091/mbc.01-09-0465; Fukushima N, 2007, NEUROCHEM INT, V50, P302, DOI 10.1016/j.neuint.2006.09.008; Fukushima N, 2006, BRAIN RES, V1094, P65, DOI 10.1016/j.brainres.2006.04.007; Gauthier-Fisher A, 2009, NAT NEUROSCI, V12, P735, DOI 10.1038/nn.2339; Geller LN, 1999, NEUROBIOL DIS, V6, P167, DOI 10.1006/nbdi.1999.0236; Graham E, 2001, J Matern Fetal Med, V10, P258; Guizzetti M, 2008, J BIOL CHEM, V283, P31884, DOI 10.1074/jbc.M801316200; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P1170, DOI 10.1016/j.mcn.2003.09.001; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Herr KJ, 2011, P NATL ACAD SCI USA, V108, P15444, DOI 10.1073/pnas.1106129108; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Jones HC, 2004, EXP NEUROL, V190, P79, DOI 10.1016/j.expneurol.2004.06.019; Jones HC, 2001, BEHAV GENET, V31, P101, DOI 10.1023/A:1010266110762; Kaeser G, 2020, J BIOL CHEM, V295, P12786, DOI 10.1074/jbc.REV120.009192; Kaeser GE, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00390; Kaushal D, 2003, J NEUROSCI, V23, P5599; Kingsbury MA, 2006, CELL MOL LIFE SCI, V63, P2626, DOI 10.1007/s00018-006-6169-5; Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102; Kingsbury MA, 2004, J CELL BIOCHEM, V92, P1004, DOI 10.1002/jcb.20061; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Kitagawa D, 2011, J CELL SCI, V124, P3884, DOI 10.1242/jcs.089888; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; LaMonica BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2647; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee MH, 2018, NATURE, V563, P639, DOI 10.1038/s41586-018-0718-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Lummis NC, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2011; Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034; Marshall CR, 2017, NAT GENET, V49, P27, DOI 10.1038/ng.3725; Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746; Matas-Rico E, 2008, MOL CELL NEUROSCI, V39, P342, DOI 10.1016/j.mcn.2008.07.014; McConnell MJ, 2004, J NEUROSCI, V24, P8090, DOI 10.1523/JNEUROSCI.2263-04.2004; McDermott KM, 2006, PLOS BIOL, V4, P350, DOI 10.1371/journal.pbio.0040051; McDonald WS, 2018, AM J PATHOL, V188, P1779, DOI 10.1016/j.ajpath.2018.05.005; McIntyre RE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003022; Mirendil H, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.33; Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007; Nomura ML, 2010, ARCH GYNECOL OBSTET, V282, P607, DOI 10.1007/s00404-009-1254-2; Ohuchi H, 2008, DEV DYNAM, V237, P3280, DOI 10.1002/dvdy.21736; Pack SD, 2005, CELL CYCLE, V4, P1758, DOI 10.4161/cc.4.12.2153; Park R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10329; Peterson SE, 2012, J NEUROSCI, V32, P16213, DOI 10.1523/JNEUROSCI.3706-12.2012; Poulton JS, 2017, J CELL BIOL, V216, P1255, DOI 10.1083/jcb.201607022; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Rohrback S, 2018, P NATL ACAD SCI USA, V115, P10804, DOI 10.1073/pnas.1812702115; Rohrback S, 2018, DEV NEUROBIOL, V78, P1026, DOI 10.1002/dneu.22626; Rosenberg SS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004259; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Ruzo A, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156844; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Sheng LF, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-94; Suckau O, 2019, DEV DYNAM, V248, P375, DOI 10.1002/dvdy.23; Terry M, 2000, FETAL DIAGN THER, V15, P331, DOI 10.1159/000021031; Tokumura A, 2004, J CELL BIOCHEM, V92, P869, DOI 10.1002/jcb.20147; Waltereit R, 2012, FASEB J, V26, P4418, DOI 10.1096/fj.11-202317; Yang AH, 2003, J NEUROSCI, V23, P10454; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Yung YC, 2015, NEURON, V85, P669, DOI 10.1016/j.neuron.2015.01.009; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558	89	2	2	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1756-6606		MOL BRAIN	Mol. Brain	DEC 14	2020	13	1							169	10.1186/s13041-020-00709-y			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PG6AX	WOS:000599817200003	33317583	Green Published, gold			2022-02-06	
J	Radford, KA; Craven, K; McLellan, V; Sach, TH; Brindle, R; Holloway, I; Hartley, S; Bowen, A; O'Connor, R; Stevens, J; Philips, J; Walker, M; Holmes, J; McKevitt, C; Murray, J; Watkins, C; Powers, K; Shone, A; Farrin, A				Radford, Kathryn A.; Craven, Kristelle; McLellan, Vicki; Sach, Tracey H.; Brindle, Richard; Holloway, Ivana; Hartley, Suzanne; Bowen, Audrey; O'Connor, Rory; Stevens, Judith; Philips, Julie; Walker, Marion; Holmes, Jain; McKevitt, Christopher; Murray, John; Watkins, Caroline; Powers, Katie; Shone, Angela; Farrin, Amanda			An individually randomised controlled multi-centre pragmatic trial with embedded economic and process evaluations of early vocational rehabilitation compared with usual care for stroke survivors: study protocol for the RETurn to work After stroKE (RETAKE) trial	TRIALS			English	Article						Occupational therapy; Return to work; Vocational rehabilitation; Randomised controlled trial; Internal pilot; Stroke; Protocol; Economic evaluation; Process evaluation	COST-EFFECTIVENESS ANALYSIS; TRAUMATIC BRAIN-INJURY; HOSPITAL ANXIETY; VALIDITY; CONFIDENCE; DEPRESSION; EQ-5D-5L; SCALE; RATES	BackgroundReturn to work (RTW) is achieved by less than 50% of stroke survivors. The rising incidence of stroke among younger people, the UK economic forecast, and clinical drivers highlight the need for stroke survivors to receive support with RTW. However, evidence for this type of support is lacking. This randomised controlled trial (RCT) will investigate whether Early Stroke Specialist Vocational Rehabilitation (ESSVR) plus usual care (UC) (i.e. usual NHS rehabilitation) is more clinically and cost-effective for supporting post-stroke RTW, than UC alone.MethodsSeven hundred sixty stroke survivors and their carers will be recruited from approximately 20 NHS stroke services. A 5:4 allocation ratio will be employed to randomise participants to receive ESSVR plus UC, or UC alone. The individually tailored ESSVR intervention will commence within 12weeks of stroke onset and be delivered for up to 12months as necessary by trained RETAKE occupational therapists in the community, participants' homes or workplaces, and outpatient/inpatient therapy settings, via telephone, email, or SMS text message. Outcome data will be collected via self-report questionnaires administered by post or online at 3, 6, and 12months follow-up. The primary outcome will be self-reported RTW and job retention at 12months (minimum 2h/week). Secondary outcomes will include mood, function, participation, health-related quality of life, confidence, intervention compliance, health and social care resource use, and mortality. An embedded economic evaluation will estimate cost-effectiveness and cost-utility analyses from National Health Service (NHS) and Personal Social Services (PSS) perspectives. An embedded process evaluation will employ a mixed methods approach to explore ESSVR implementation, contextual factors linked to outcome variation, and factors affecting NHS roll-out.DiscussionThis article describes the protocol for a multi-centre RCT evaluating the clinical- and cost-effectiveness of an early vocational rehabilitation intervention aimed at supporting adults to return to work following a stroke. Evidence favouring the ESSVR intervention would support its roll-out in NHS settings.Trial registrationISRCTN, ISRCTN12464275. Registered on 26 February 2018.	[Radford, Kathryn A.; Craven, Kristelle; Philips, Julie; Walker, Marion; Holmes, Jain; Powers, Katie] Queens Med Ctr, Sch Med, Div Rehabil & Ageing, Nottingham NG7 2UH, England; [McLellan, Vicki; Brindle, Richard; Holloway, Ivana; Hartley, Suzanne; Farrin, Amanda] Univ Leeds, Leeds Inst Clin Trials Res, Clin Trials Res Unit CTRU, Level 11 Worsley Bldg, Leeds LS2 9JT, W Yorkshire, England; [Sach, Tracey H.] Univ East Anglia, Hlth Econ Grp, Norwich Med Sch, Room 237,Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Bowen, Audrey] Univ Manchester MAHSC, Sch Biol Sci, Div Neurosci & Expt Psychol, Manchester M13 9PL, Lancs, England; [O'Connor, Rory] Univ Leeds, Acad Dept Rehabil Med, Leeds Inst Mol Med, Leeds Gen Infirm, Level D,Martin Wing, Leeds LS1 3EX, W Yorkshire, England; [Stevens, Judith] Patient & Publ Involvement Collab, Southampton, Hants, England; [McKevitt, Christopher] Kings Coll London, Fac Life Sci & Med, Dept Populat Hlth Sci, 5th Floor Addison House,Guys Campus, London SE1 1UL, England; [Murray, John] Different Strokes, Raphael House, London IG1 1YT, England; [Watkins, Caroline] Univ Cent Lancashire, Sch Hlth, Lancashire Clin Trials Unit, Brook Bldg,Room 217, Preston PR1 2HE, Lancs, England; [Shone, Angela] Jubilee Conf Ctr, Res & Innovat, Jubilee Campus,Wollaton Rd, Nottingham NG8 1BB, England		Radford, KA (corresponding author), Queens Med Ctr, Sch Med, Div Rehabil & Ageing, Nottingham NG7 2UH, England.; Shone, A (corresponding author), Jubilee Conf Ctr, Res & Innovat, Jubilee Campus,Wollaton Rd, Nottingham NG8 1BB, England.	kate.radford@nottingham.ac.uk; angela.shone@nottingham.ac.uk	mckevitt, christopher/AAN-7271-2021; Holmes, Jain/K-2125-2016	MCKEVITT, CHRISTOPHER/0000-0002-5290-4613; Holmes, Jain/0000-0003-2465-102X; Radford, Kate/0000-0001-6246-3180; Sach, Tracey/0000-0002-8098-9220; Farrin, Amanda/0000-0002-2876-0584; Bowen, Audrey/0000-0003-4075-1215	NIHR HTA programme [15/130/11]	This article presents research funded by the NIHR HTA programme (ref: 15/130/11) (Additional file 7). The views expressed herein are those of the authors, not necessarily the NIHR, the Department of Health and Social Care, or the NHS. As part of the funding application procedure, the study underwent a full peer review with feedback incorporated within the final protocol. The funders and sponsor had no further input into the trial design, collection of data, analysis, data management, interpretation and writing up results, or the decisions concerning publication.	Aben I, 2002, PSYCHOSOMATICS, V43, P386, DOI 10.1176/appi.psy.43.5.386; Anne F, 2014, PROGRAM GRANTS APPL, V2; Arauz A, 2013, J NEUROL NEUROSUR PS, V84, P240, DOI 10.1136/jnnp-2012-303328; Balasooriya-Smeekens C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009974; Baldwin C, 2011, TOP STROKE REHABIL, V18, P562, DOI 10.1310/tsr1805-562; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; British Society of Rehabilitation Medicine (BSRM), 2003, VOC REH WAY FORW REP; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chen PY, 2016, QUAL LIFE RES, V25, P1585, DOI 10.1007/s11136-015-1196-z; Coole C, 2013, J OCCUP REHABIL, V23, P406, DOI 10.1007/s10926-012-9401-1; Corr S., 2003, BRIT J OCCUPATIONAL, V66, P186, DOI DOI 10.1177/030802260306600502; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Curtis L, 2019, UNIT COSTS HLTH SOCI; Daniel K, 2009, STROKE, V40, pE431, DOI [10.1161/STROKEAHA.108.534487, 10.1161/STROKEAHA.108.535088]; Dawson L, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000111; Department for Work and Pensions (DWP), BUILD CAP WORK UK FR; Department of Health (DH), 2007, NAT STROK STRAT DH; DH, 2012, LONG TERM COND COMP; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Faria R, 2014, PHARMACOECONOMICS, V32, P1157, DOI 10.1007/s40273-014-0193-3; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Frank AO, 2006, INT J THER REHABIL, V13, P126, DOI 10.12968/ijtr.2006.13.3.21364; Frost D., 2011, HLTH WORK INDEPENDEN; GLADMAN JRF, 1993, AGE AGEING, V22, P419, DOI 10.1093/ageing/22.6.419; Golicki D, 2015, QUAL LIFE RES, V24, P845, DOI 10.1007/s11136-014-0834-1; Grant M, 2016, THESIS; Hankey GJ, 2013, LANCET, V382, P2043, DOI 10.1016/S0140-6736(13)61688-8; Hartke RJ, 2011, TOP STROKE REHABIL, V18, P341, DOI 10.1310/tsr1804-341; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Horne J, 2016, THESIS; Horne JC, 2017, CLIN REHABIL, V31, P1529, DOI 10.1177/0269215517705424; ILMARINEN J, 1993, P FINN INST, V4, P142; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK; Lindstrom B, 2009, J REHABIL MED, V41, P714, DOI 10.2340/16501977-0423; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; National Institute for Health and Care Excellence (NICE), 2019, POS STAT US EQ 5D 5L; National Institute for Health and Care Excellence (NICE), 2019, NICEIMPACT STROK NIC; National Institute for Health and Care Excellence (NICE), 2013, STROK REH AD CLIN GU; NHS Digital, 2020, NHS OUTC FRAM 2019 2; NHS Digital, 2018, PRECR COST AN ENGL 2; NHS England, 2014, NHS 5 YEAR FORW VIEW; NHS England, 2019, NHS LONG TERM PLAN; NHS Health Research Authority, UK POL FRAM HLTH SOC; NHS Improvement, 2018, 2017 18 REF COSTS GU; Nouri F. M., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Ntsiea MV, 2015, CLIN REHABIL, V29, P663, DOI 10.1177/0269215514554241; Patel A, 2020, AGE AGEING, V49, P270, DOI 10.1093/ageing/afz162; Phillips J, 2019, BRIT J OCCUP THER, V82, P27, DOI 10.1177/0308022618791976; Phillips M, 2020, BRIT SOC REHAB MED; Ping Chan S., 2020, BANK ENGLAND WARNS S; Public Health England (PHE), 2019, HLTH MATT HLTH WORK; Public Health England (PHE), 2018, BRIEF DOC 1 INC STRO; Radford KA, 2012, BRAIN INJURY, V26, P600; Radford K, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2647; Radford KA, 2008, BRAIN IMPAIR, V9, P161, DOI 10.1375/brim.9.2.161; Royal College of Occupational Therapists (RCOT), 2020, GOOD WORK GOOD HLTH; Royal College of Occupational Therapists (RCOT), 2018, GETT MY LIF BACK OCC; Schnepf A, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00316; Sinclair Emma, 2014, Disabil Rehabil, V36, P409, DOI 10.3109/09638288.2013.793410; Stroke Association, 2019, COMPL GUID STROK EMP; Stroke Association, NHS ENGL LONG TERM P; Trexler LE, 2010, J HEAD TRAUMA REHAB, V25, P440, DOI 10.1097/HTR.0b013e3181d41139; Tyerman A, 2004, VOCATIONAL ASSESSMEN; Waddell G, 2009, MODELS SICKNESS DISA; Willan AR, 2004, HEALTH ECON, V13, P461, DOI 10.1002/hec.843; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; World Medical Association (WMA), 1996, DECL HELS WMA; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	70	2	2	2	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	DEC 9	2020	21	1							1010	10.1186/s13063-020-04883-1			17	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	PH0MR	WOS:000600118700006	33298162	gold, Green Submitted, Green Accepted, Green Published			2022-02-06	
J	Muller, M; Rossetti, AO; Zimmermann, R; Alvarez, V; Ruegg, S; Haenggi, M; Z'Graggen, WJ; Schindler, K; Zubler, F				Mueller, Michael; Rossetti, Andrea O.; Zimmermann, Rebekka; Alvarez, Vincent; Rueegg, Stephan; Haenggi, Matthias; Z'Graggen, Werner J.; Schindler, Kaspar; Zubler, Frederic			Standardized visual EEG features predict outcome in patients with acute consciousness impairment of various etiologies	CRITICAL CARE			English	Article						Electroencephalography; Prognostication; Acute consciousness impairment; Hypoxic ischemic encephalopathy; Traumatic brain injury; Random forest	TRAUMATIC BRAIN-INJURY; C-REACTIVE PROTEIN; CARDIAC-ARREST; SUBARACHNOID HEMORRHAGE; COMATOSE PATIENTS; QUANTITATIVE EEG; PROGNOSIS; PROGNOSTICATION	BackgroundEarly prognostication in patients with acute consciousness impairment is a challenging but essential task. Current prognostic guidelines vary with the underlying etiology. In particular, electroencephalography (EEG) is the most important paraclinical examination tool in patients with hypoxic ischemic encephalopathy (HIE), whereas it is not routinely used for outcome prediction in patients with traumatic brain injury (TBI).MethodData from 364 critically ill patients with acute consciousness impairment (GCS <= 11 or FOUR <= 12) of various etiologies and without recent signs of seizures from a prospective randomized trial were retrospectively analyzed. Random forest classifiers were trained using 8 visual EEG features-first alone, then in combination with clinical features-to predict survival at 6 months or favorable functional outcome (defined as cerebral performance category 1-2).ResultsThe area under the ROC curve was 0.812 for predicting survival and 0.790 for predicting favorable outcome using EEG features. Adding clinical features did not improve the overall performance of the classifier (for survival: AUC=0.806, p=0.926; for favorable outcome: AUC=0.777, p=0.844). Survival could be predicted in all etiology groups: the AUC was 0.958 for patients with HIE, 0.955 for patients with TBI and other neurosurgical diagnoses, 0.697 for patients with metabolic, inflammatory or infectious causes for consciousness impairment and 0.695 for patients with stroke. Training the classifier separately on subgroups of patients with a given etiology (and thus using less training data) leads to poorer classification performance.ConclusionsWhile prognostication was best for patients with HIE and TBI, our study demonstrates that similar EEG criteria can be used in patients with various causes of consciousness impairment, and that the size of the training set is more important than homogeneity of ACI etiology.	[Mueller, Michael; Zimmermann, Rebekka; Schindler, Kaspar; Zubler, Frederic] Univ Bern, Univ Hosp Bern, Dept Neurol, Inselspital,Sleep Wake Epilepsy Ctr, Bern, Switzerland; [Rossetti, Andrea O.] Lausanne Univ Hosp CHUV, Dept Clin Neurosci, Lausanne, Switzerland; [Rossetti, Andrea O.] Univ Lausanne, Lausanne, Switzerland; [Alvarez, Vincent] Hop Valais, Dept Neurol, Sion, Switzerland; [Rueegg, Stephan] Univ Hosp Basel, Dept Neurol, Basel, Switzerland; [Haenggi, Matthias] Univ Bern, Univ Hosp Bern, Dept Intens Care Med, Inselspital, Bern, Switzerland; [Z'Graggen, Werner J.] Univ Bern, Univ Hosp Bern, Dept Neurol, Inselspital, Bern, Switzerland; [Z'Graggen, Werner J.] Univ Bern, Univ Hosp Bern, Dept Neurosurg, Inselspital, Bern, Switzerland		Zubler, F (corresponding author), Univ Bern, Univ Hosp Bern, Dept Neurol, Inselspital,Sleep Wake Epilepsy Ctr, Bern, Switzerland.	frederic.zubler@gmail.com	Schindler, Kaspar/L-7115-2013; Haenggi, Matthias/A-8073-2008; Rossetti, Andrea/A-6712-2008	Schindler, Kaspar/0000-0002-2387-7767; Muller, Michael/0000-0002-6915-4820; Zubler, Frederic/0000-0003-0090-7297; Haenggi, Matthias/0000-0001-5845-031X; Rossetti, Andrea/0000-0002-7878-172X	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [320030_169379]	The CERTA study and this post hoc analysis were supported by the Swiss National Science Foundation (Grant 320030_169379). The funding agency had no role in study design, analysis or writing of the report.	Admiraal MM, 2017, EUR J NEUROL, V24, P245, DOI 10.1111/ene.13219; Alvarez V, 2013, CLIN NEUROPHYSIOL, V124, P204, DOI 10.1016/j.clinph.2012.06.017; Azabou E, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2104-z; Barth R, 2020, RESUSCITATION; Biau G, 2016, TEST-SPAIN, V25, P197, DOI 10.1007/s11749-016-0481-7; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Caporro M, 2019, RESUSCITATION, V138, P146, DOI 10.1016/j.resuscitation.2019.03.014; Chen C., 2004, USING RANDOM FOREST; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; De Marchis GM, 2016, NEUROLOGY, V86, P253, DOI 10.1212/WNL.0000000000002281; Di Napoli M, 2012, NEUROLOGY, V79, P690, DOI 10.1212/WNL.0b013e318264e3be; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Finnigan S, 2013, CLIN NEUROPHYSIOL, V124, P10, DOI 10.1016/j.clinph.2012.07.003; Foster KR, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-94; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Gollwitzer S, 2019, J CLIN NEUROPHYSIOL, V36, P25, DOI 10.1097/WNP.0000000000000537; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Haveman ME, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2656-6; Herta J, 2017, CLIN NEUROPHYSIOL, V128, P1524, DOI 10.1016/j.clinph.2017.04.012; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Hofmeijer J, 2015, NEUROLOGY, V85, P137, DOI 10.1212/WNL.0000000000001742; Horsting MWB, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0041-9; Jonas S, 2019, HUM BRAIN MAPP, V40, P4606, DOI 10.1002/hbm.24724; Kang XG, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0094-4; Kaplan PW, 2004, J CLIN NEUROPHYSIOL, V21, P307; Keijzer HM, 2018, RESUSCITATION, V133, P124, DOI 10.1016/j.resuscitation.2018.09.012; Koozi H, 2020, J CRIT CARE, V56, P73, DOI 10.1016/j.jcrc.2019.12.009; Lee H, 2019, CRIT CARE MED, V47, P574, DOI 10.1097/CCM.0000000000003639; Limotai C, 2019, CRIT CARE MED, V47, pE366, DOI 10.1097/CCM.0000000000003641; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Posner JB, 2019, PLUM POSNERS DIAGNOS, DOI [10.1093/med/9780190208875.001.0001, DOI 10.1093/MED/9780190208875.001.0001]; Rieke N, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-00323-1; Rossetti AO, 2020, JAMA NEUROL, V77, P1225, DOI 10.1001/jamaneurol.2020.2264; Rossetti AO, 2018, J CLIN NEUROPHYSIOL, V35, P359, DOI 10.1097/WNP.0000000000000467; Rossetti AO, 2017, CRIT CARE MED, V45, pE674, DOI 10.1097/CCM.0000000000002337; Rossetti AO, 2012, NEUROLOGY, V78, P796, DOI 10.1212/WNL.0b013e318249f6bb; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Ruijter BJ, 2019, ANN NEUROL, V86, P203, DOI 10.1002/ana.25518; Sandroni C, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2060-7; Selioutski O, 2019, J CLIN NEUROPHYSIOL, V36, P358, DOI 10.1097/WNP.0000000000000594; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sutter R, 2016, J CLIN NEUROPHYSIOL, V33, P25, DOI 10.1097/WNP.0000000000000216; Taccone FS, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2405-x; Tjepkema-Cloostermans MC, 2017, CRIT CARE MED, V45, pE789, DOI [10.1097/CCM.0000000000002528, 10.1097/CCM.0000000000002412]; Tolonen A, 2018, CLIN EEG NEUROSCI, V49, P248, DOI 10.1177/1550059417742232; Westhall E, 2016, NEUROLOGY, V86, P1482, DOI 10.1212/WNL.0000000000002462; Westhall E, 2015, CLIN NEUROPHYSIOL, V126, P2397, DOI 10.1016/j.clinph.2015.03.017; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P107, DOI 10.1136/jnnp.4.2.107; Witsch J, 2016, ANN NEUROL, V80, P46, DOI 10.1002/ana.24675; Wu O, 2009, RADIOLOGY, V252, P173, DOI 10.1148/radiol.2521081232; You WD, 2018, NEUROSCI BULL, V34, P639, DOI 10.1007/s12264-018-0241-7; Zhang Y, 2011, J CLIN NEUROPHYSIOL, V28, P497, DOI 10.1097/WNP.0b013e318231c852; Zubler F, 2018, CLIN NEUROPHYSIOL, V129, P1418, DOI 10.1016/j.clinph.2018.03.038; Zubler F, 2017, CLIN NEUROPHYSIOL, V128, P635, DOI 10.1016/j.clinph.2017.01.020; Zubler F, 2016, CLIN NEUROPHYSIOL, V127, P2942, DOI 10.1016/j.clinph.2015.08.022	58	2	2	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	DEC 7	2020	24	1							680	10.1186/s13054-020-03407-2			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PE0BM	WOS:000598038800005	33287874	Green Published, gold			2022-02-06	
J	Saikumar, J; Kim, J; Byrns, CN; Hemphill, M; Meaney, DF; Bonini, NM				Saikumar, Janani; Kim, Joshua; Byrns, China N.; Hemphill, Matthew; Meaney, David F.; Bonini, Nancy M.			Inducing different severities of traumatic brain injury in Drosophila using a piezoelectric actuator	NATURE PROTOCOLS			English	Article							IN-VIVO; MODEL; MELANOGASTER; LONGEVITY	Drosophila models have been instrumental in providing insights into molecular mechanisms of neurodegeneration, with wide application to human disease. The brain degeneration associated with traumatic brain injury (TBI) has been modeled in Drosophila using devices that inflict trauma on multiple parts of the fly body, including the head. However, the injuries produced by these models are not specific in location and are inconsistent between individual animals. We have recently developed a device that can be used to inflict controlled head injury to flies, resulting in physiological responses that are remarkably similar to those observed in humans with TBI. This protocol describes the construction, calibration and use of the Drosophila TBI (dTBI) device, a platform that employs a piezoelectric actuator to reproducibly deliver a force in order to briefly compress the fly head against a metal surface. The extent of head compression can be controlled through an electrical circuit, allowing the operator to set different levels of injury. The entire device can be assembled and calibrated in under a week. The device components and the necessary electrical tools are readily available and cost similar to$800. The dTBI device can be used to harness the power of Drosophila genetics and perform large-scale genetic or pharmacological screens, using a 7-d post-injury survival curve to identify modifiers of injury.	[Saikumar, Janani; Kim, Joshua; Bonini, Nancy M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Byrns, China N.; Bonini, Nancy M.] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Hemphill, Matthew; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Bonini, NM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.; Bonini, NM (corresponding author), Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA.; Meaney, DF (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Meaney, DF (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu; nbonini@sas.upenn.edu	Saikumar, Janani/AAE-9461-2021	Meaney, David/0000-0002-0954-4122; Saikumar, Janani/0000-0002-8930-2472; Kim, Joshua/0000-0003-4449-5028; Bonini, Nancy/0000-0003-0226-5291	predoctoral HHMI fellowship; Vagelos Molecular Life Sciences Scholars Program; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS088176, R35-NS097275]; Paul G Allen Frontiers group	We thank M. Suplick and F. Letterio from the University of Pennsylvania Machine Shop for constructing and modifying the Heisenberg fly collars. We thank F. Carranza, A. Srinivasan and A. Perlegos for critical feedback. This work was supported by a predoctoral HHMI fellowship (J.S.), the Vagelos Molecular Life Sciences Scholars Program (J.K.), funding from the NIH R35-NS097275 (N.M.B.), the Paul G Allen Frontiers group and NIH NS088176 (D.F.M.).	Angstman NB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28910-z; Baldal EA, 2005, MECH AGEING DEV, V126, P407, DOI 10.1016/j.mad.2004.09.035; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Dai JX, 2018, INT J NEUROSCI, V128, P243, DOI 10.1080/00207454.2017.1380008; Fang YS, 2012, CURR BIOL, V22, P590, DOI 10.1016/j.cub.2012.01.065; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Maheras AL, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0208-17.2017; McCutcheon V, 2017, J NEUROTRAUM, V34, P1382, DOI 10.1089/neu.2016.4497; McGurk L, 2015, GENETICS, V201, P377, DOI 10.1534/genetics.115.179457; Miansari M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47295-1; MILLER RS, 1958, ECOLOGY, V39, P118, DOI 10.2307/1929973; Neukomm LJ, 2014, P NATL ACAD SCI USA, V111, P9965, DOI 10.1073/pnas.1406230111; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Saikumar J, 2020, P NATL ACAD SCI USA, V117, P17269, DOI 10.1073/pnas.2003909117; Semenchenko GV, 2004, BIOGERONTOLOGY, V5, P17, DOI 10.1023/B:BGEN.0000017681.46326.9e; Sorensen JG, 2001, J INSECT PHYSIOL, V47, P1301, DOI 10.1016/S0022-1910(01)00119-6; Strange K, 2016, ILAR J, V57, P133, DOI 10.1093/ilar/ilw034; Sun MK, 2017, JOVE-J VIS EXP, DOI 10.3791/55602; Sunderhaus ER, 2016, JOVE-J VIS EXP, DOI 10.3791/54809; Tataroglu O, 2014, METHODS, V68, P140, DOI 10.1016/j.ymeth.2014.01.001	30	2	2	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1754-2189	1750-2799		NAT PROTOC	Nat. Protoc.	JAN	2021	16	1					263	282		10.1038/s41596-020-00415-y		DEC 2020	20	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PO2RQ	WOS:000599028300003	33277631	Green Accepted			2022-02-06	
J	DePadilla, L; Miller, GF; Jones, SE; Breiding, MJ				DePadilla, Lara; Miller, Gabrielle F.; Jones, Sherry Everett; Breiding, Matthew J.			Substance Use and Sports- or Physical Activity-Related Concussions Among High School Students	JOURNAL OF SCHOOL NURSING			English	Article; Early Access						high school; athlete health; concussion; substance use; school nurse	TRAUMATIC BRAIN-INJURY; UNITED-STATES; ALCOHOL; ADOLESCENTS; BEHAVIOR; YOUTH; PERSONALITY; CANNABIS; SLEEP	History of concussion is associated with substance use. Data from the 2017 National Youth Risk Behavior Survey (N = 14,765) were used in this study to examine associations between sports- or physical activity-related concussions and current cigarette, alcohol, and marijuana use among high school students, and whether other factors moderate those associations. In addition to having played on a sports team, potential moderators examined included persistent feelings of sadness or hopelessness, hours of sleep, and serious difficulty concentrating, remembering, or making decisions. The association between sports- or physical activity-related concussions and current cigarette, alcohol, and marijuana use was significant when controlling for sex, grade, and race/ethnicity and the potential moderators with the exception of cigarette smoking while controlling for hours of sleep. Those involved in the care of high school students after a concussion may consider assessing current cigarette, alcohol, and marijuana use.	[DePadilla, Lara] CDC, Div Overdose Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE,Mailstop S-106-8, Atlanta, GA 30341 USA; [Miller, Gabrielle F.; Breiding, Matthew J.] CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; [Jones, Sherry Everett] CDC, Div Adolescent & Sch Hlth, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30341 USA		DePadilla, L (corresponding author), CDC, Div Overdose Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE,Mailstop S-106-8, Atlanta, GA 30341 USA.	lpo9@cdc.gov					Allen S, 2016, SUBST USE MISUSE, V51, P1577, DOI 10.1080/10826084.2016.1188955; Bacon CEW, 2017, J INTERPROF CARE, V31, P725, DOI 10.1080/13561820.2017.1345873; Bierhoff J, 2019, SUBST USE MISUSE, V54, P1365, DOI 10.1080/10826084.2019.1581220; Blackwell LS, 2017, J CHILD NEUROL, V32, P327, DOI 10.1177/0883073816681351; Brener ND, 2002, J ADOLESCENT HEALTH, V31, P336, DOI 10.1016/S1054-139X(02)00339-7; Centers for Disease Control and Prevention, 2019, SYMPT TRAUM BRAIN IN; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Centers for Disease Prevention and Control, 2015, REP C MILD TRAUM BRA; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Diaz Anne L, 2013, NASN Sch Nurse, V28, P110; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Howard AL, 2019, J ABNORM CHILD PSYCH, V47, P1903, DOI 10.1007/s10802-019-00573-y; Ilie G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135860; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108167; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; JOBE JB, 1993, APPL COGNITIVE PSYCH, V7, P567, DOI 10.1002/acp.2350070703; Kann L, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6708a1; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; King K. A., 2016, J BEHAV HLTH, V5, P82, DOI DOI 10.5455/JBH.20160302022952; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mays D, 2010, AM J PREV MED, V38, P491, DOI 10.1016/j.amepre.2010.01.023; McEwan D, 2019, J RES PERS, V79, P83, DOI 10.1016/j.jrp.2019.02.006; McFarland J., 2016, 2016117 NCES US DEP; McKnight-Eily LR, 2011, PREV MED, V53, P271, DOI 10.1016/j.ypmed.2011.06.020; Mike TB, 2016, DRUG ALCOHOL DEPEN, V168, P335, DOI 10.1016/j.drugalcdep.2016.08.009; Murray RD, 2008, PEDIATRICS, V121, P1052, DOI 10.1542/peds.2008-0382; Pharo H, 2011, BEHAV NEUROSCI, V125, P970, DOI 10.1037/a0025768; Rawlins MLW, 2020, BRAIN INJURY, V34, P665, DOI 10.1080/02699052.2020.1739334; Sarmiento K, 2019, J SAFETY RES, V68, P223, DOI 10.1016/j.jsr.2018.10.010; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Veliz PT, 2015, SUBST USE MISUSE, V50, P156, DOI 10.3109/10826084.2014.962049; Weber ML, 2019, J SCH NURS, V35, P378, DOI 10.1177/1059840518774391; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005	37	2	2	2	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1059-8405	1546-8364		J SCH NURS	J. Sch. Nurs.											1059840520977319	10.1177/1059840520977319		DEC 2020	8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	PG1YM	WOS:000599538400001	33267719				2022-02-06	
J	Lannin, NA; Coulter, M; Laver, K; Hyett, N; Ratcliffe, J; Holland, AE; Callaway, L; English, C; Bragge, P; Hill, S; Unsworth, CA				Lannin, Natasha A.; Coulter, Megan; Laver, Kate; Hyett, Nerida; Ratcliffe, Julie; Holland, Anne E.; Callaway, Libby; English, Coralie; Bragge, Peter; Hill, Sophie; Unsworth, Carolyn A.			Public perspectives on acquired brain injury rehabilitation and components of care: A Citizens' Jury	HEALTH EXPECTATIONS			English	Article						consumer participation; decision making; deliberative methods; health policy; traumatic brain injury	DECISION-MAKING; HEALTH-CARE; JURIES; DELIBERATIONS; INDIVIDUALS; EXPERIENCE; FAMILIES; WANT; HOPE	Background Brain injury rehabilitation is an expensive and long-term endeavour. Very little published information or debate has underpinned policy for service delivery in Australia. Within the context of finite health budgets and the challenges associated with providing optimal care to persons with brain injuries, members of the public were asked 'What considerations are important to include in a model of care of brain injury rehabilitation?' Methods Qualitative study using the Citizen Jury method of participatory research. Twelve adult jurors from the community and seven witnesses participated including a health services funding model expert, peak body representative with lived experience of brain injury, carer of a person with a brain injury, and brain injury rehabilitation specialists. Witnesses were cross-examined by jurors over two days. Results Key themes related to the need for a model of rehabilitation to: be consumer-focused and supporting the retention of hope; be long-term; provide equitable access to services irrespective of funding source; be inclusive of family; provide advocacy; raise public awareness; and be delivered by experts in a suitable environment. A set of eight recommendations were made. Conclusion Instigating the recommendations made requires careful consideration of the need for new models of care with flexible services; family involvement; recruitment and retention of highly skilled staff; and providing consumer-focused services that prepare individuals and their carers for the long term. Patient and public contribution As jury members, the public deliberated information provided by expert witnesses (including a person with a head injury) and wrote the key recommendations.	[Lannin, Natasha A.; Unsworth, Carolyn A.] Monash Univ, Cent Clin Sch, Dept Neurosci, Clayton, Vic, Australia; [Lannin, Natasha A.; Coulter, Megan] Alfred Hlth, Occupat Therapy Dept, Melbourne, Vic, Australia; [Laver, Kate] Flinders Univ S Australia, Adelaide, SA, Australia; [Hyett, Nerida] La Trobe Univ, La Trobe Rural Hlth Sch, Melbourne, Vic, Australia; [Ratcliffe, Julie] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Adelaide, SA, Australia; [Holland, Anne E.] Monash Univ, Cent Clin Sch, Clayton, Vic, Australia; [Holland, Anne E.] Alfred Hlth, Physiotherapy Dept, Melbourne, Vic, Australia; [Callaway, Libby] Monash Univ, Clayton, Vic, Australia; [English, Coralie] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Sch Hlth Sci, Callaghan, NSW, Australia; [Bragge, Peter] Monash Univ, Monash Sustainable Dev Inst, Behav Works Australia, Clayton, Vic, Australia; [Hill, Sophie] La Trobe Univ, Ctr Hlth Commun & Participat, Melbourne, Vic, Australia; [Hill, Sophie] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia; [Unsworth, Carolyn A.] Federat Univ, Sch Hlth, Churchill, Vic, Australia; [Unsworth, Carolyn A.] Jonkoping Univ, Dept Rehabil, Jonkoping, Sweden		Lannin, NA (corresponding author), Monash Univ, Alfred Ctr, Cent Clin Sch, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	natasha.lannin@monash.edu	Lannin, Natasha A/A-4195-2013; English, Coralie/D-4591-2009; Ratcliffe, Julie/G-3169-2017	Lannin, Natasha A/0000-0002-2066-8345; English, Coralie/0000-0001-5910-7927; Holland, Anne/0000-0003-2061-845X; Bragge, Peter/0000-0003-0745-5131; Laver, Kate/0000-0003-0259-2209; Callaway, Libby/0000-0002-3127-6312; Ratcliffe, Julie/0000-0001-7365-1988; Hyett, Nerida/0000-0003-0554-1773	La Trobe University; National Heart Foundation of AustraliaNational Heart Foundation of Australia [GNT 102055, GNT 101177]	La Trobe University; National Heart Foundation of Australia, Grant/Award Number: NAL GNT 102055 and CE GNT 101177	ABELSON J, 1995, CAN MED ASSOC J, V153, P403; Abelson J, 2003, HEALTH POLICY, V66, P95, DOI 10.1016/S0168-8510(03)00048-4; Abelson J, 2003, SOC SCI MED, V57, P239, DOI 10.1016/S0277-9536(02)00343-X; Armstrong T, 2020, J CHRIST NURS, V37, P144, DOI 10.1097/CNJ.0000000000000734; Australian Department of Human Services, 2020, NAT DIS INS SCHEM ND; Australian Government Department of Health, 2019, AUSTR HLTH SYST; Bogner J, 2019, ARCH PHYS MED REHAB, V100, P1801, DOI 10.1016/j.apmr.2019.04.008; Bowers M R, 1987, J Health Care Mark, V7, P35; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Callaghan GD, 2006, PUBLIC ADMIN, V84, P583, DOI 10.1111/j.1467-9299.2006.00603.x; Campbell Danielle M, 2009, Aust New Zealand Health Policy, V6, P21, DOI 10.1186/1743-8462-6-21; Conklin A, 2015, HEALTH EXPECT, V18, P153, DOI 10.1111/hex.12038; Crotty M, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01575-y; Daniels N., 2008, SETTING LIMITS FAIRL; Elwood P, 2010, J EPIDEMIOL COMMUN H, V64, P761, DOI 10.1136/jech.2009.087767; Evans R, 2007, SOC STUD SCI, V37, P827, DOI 10.1177/0306312707076602; Hartwell J, 2016, AM SURGEON, V82, pE183; Health Queensland, GUID HLTH SERV PLANN; Holm S, 1998, BRIT MED J, V317, P1000, DOI 10.1136/bmj.317.7164.1000; Hutchison KJ, 2012, J EVAL CLIN PRACT, V18, P984, DOI 10.1111/j.1365-2753.2012.01905.x; Ibarra S, 2020, BRAIN INJURY, V34, P732, DOI 10.1080/02699052.2020.1749931; *JEFF CTR, 2004, CIT JUR HDB; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Kendall E, 1994, CITIZENS JURIES; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lehoux P, 2009, SOC SCI MED, V68, P2002, DOI 10.1016/j.socscimed.2009.03.017; Lenaghan J, 1996, BRIT MED J, V312, P1591, DOI 10.1136/bmj.312.7046.1591; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Menon D, 2007, HEALTH POLICY, V84, P220, DOI 10.1016/j.healthpol.2007.05.009; Mitton C, 2009, HEALTH POLICY, V91, P219, DOI 10.1016/j.healthpol.2009.01.005; Mosconi P, 2015, HEALTH EXPECT, V18, P1956, DOI 10.1111/hex.12261; Muus K, 2006, J HEAD TRAUMA REHAB, V21, P431, DOI 10.1097/00001199-200609000-00052; National Institute for Health and Care Excellence [NICE], DEV NICE GUID MAN; Oliver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-2; Price D, 2000, J MED ETHICS, V26, P272, DOI 10.1136/jme.26.4.272; Rowe G, 2005, SCI TECHNOL HUM VAL, V30, P251, DOI 10.1177/0162243904271724; Sabik LM, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-4; Schutz REC, 2017, J PALLIAT MED, V20, P170, DOI 10.1089/jpm.2016.0286; Scott AM, 2019, HEALTH EXPECT, V22, P537, DOI 10.1111/hex.12880; Smith G, 2000, POLIT STUD-LONDON, V48, P51, DOI 10.1111/1467-9248.00250; Street J, 2014, SOC SCI MED, V109, P1, DOI 10.1016/j.socscimed.2014.03.005; Thomas R, 2017, HEALTH EXPECT, V20, P626, DOI 10.1111/hex.12493; Turner-Stokes L, 2004, CLIN MED, V4, P10, DOI 10.7861/clinmedicine.4-1-10; Visvanathan A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222500; Wilson MG, 2020, J HEALTH SERV RES PO, V25, P59, DOI 10.1177/1355819619872221	45	2	2	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1369-6513	1369-7625		HEALTH EXPECT	Health Expect.	APR	2021	24	2					352	362		10.1111/hex.13176		DEC 2020	11	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	RT4MK	WOS:000594888200001	33264470	Green Published, gold			2022-02-06	
J	Braeckman, K; Descamps, B; Vanhove, C; Caeyenberghs, K				Braeckman, Kim; Descamps, Benedicte; Vanhove, Christian; Caeyenberghs, Karen			Exploratory relationships between cognitive improvements and training induced plasticity in hippocampus and cingulum in a rat model of mild traumatic brain injury: a diffusion MRI study	BRAIN IMAGING AND BEHAVIOR			English	Article						Mild traumatic brain injury; Diffusion MRI; Touchscreen cognitive training system; Neuroplasticity; Preclinical	REACTION-TIME-TASK; WHITE-MATTER MICROSTRUCTURE; LEARNING PAL TASK; TRANSLATIONAL ASSAYS; EXECUTIVE FUNCTION; TESTING METHOD; RODENT MODEL; REHABILITATION; MEMORY; ATTENTION	Traumatic brain injury (TBI) is a major cause of long-term cognitive deficits, even in mild TBI patients. Computerized cognitive training can help alleviate complaints and improve daily life functioning of TBI patients. However, the underlying biological mechanisms of cognitive training in TBI are not fully understood. In the present study, we utilised for the first time a touchscreen cognitive training system in a rat model of mild TBI. Moreover, we wanted to examine whether the beneficial effects of a cognitive training are task-dependent and selective in their target. Specifically, we examined the effect of two training tasks, i.e. the Paired Associate Learning (PAL) task targeting spatial memory functioning and 5-Choice Continuous Performance (5-CCP) task loading on attention and inhibition control, on the microstructural organization of the hippocampus and cingulum, respectively, using diffusion tensor imaging (DTI). Our findings revealed that the two training protocols induced similar effects on the diffusion MRI metrics. Further, in the TBI groups who received training microstructural organization in the hippocampus and cingulum improved (as denoted by increases in fractional anisotropy), while a worsening (i.e., increases in mean diffusivity and radial diffusivity) was found in the TBI control group. In addition, these alterations in diffusion MRI metrics coincided with improved performance on the training tasks in the TBI groups who received training. Our findings show the potential of DTI metrics as reliable measure to evaluate cognitive training in TBI patients and to facilitate future research investigating further improvement of cognitive training targeting deficits in spatial memory and attention.	[Braeckman, Kim; Descamps, Benedicte; Vanhove, Christian] UGent, Infin Lab, Med Imaging & Signal Proc Grp IBiTech, Blok B-5 Ingang 36,Campus UZ Gent, B-9000 Ghent, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, 470-5-02,Level 5,Bldg 470,215 Spring St, Melbourne, Vic 3000, Australia		Braeckman, K (corresponding author), UGent, Infin Lab, Med Imaging & Signal Proc Grp IBiTech, Blok B-5 Ingang 36,Campus UZ Gent, B-9000 Ghent, Belgium.	kim.braeckman@ugent.be; benedicte.descamps@ugent.be; christian.vanhove@ugent.be; karen.caeyenberghs@acu.edu.au			Fonds Wetenschappelijk OnderzoekFWO [G027815N] Funding Source: Medline		Barbelivien A, 2001, CEREB CORTEX, V11, P1056, DOI 10.1093/cercor/11.11.1056; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Bhandari J, 2016, J NEUROSCI METH, V270, P17, DOI 10.1016/j.jneumeth.2016.06.002; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Bonzano L, 2014, NEUROIMAGE, V90, P107, DOI 10.1016/j.neuroimage.2013.12.025; Braeckman K, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101669; Brayer SW, 2015, NEUROREHAB NEURAL RE, V29, P483, DOI 10.1177/1545968314550367; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Bussey TJ, 2008, LEARN MEMORY, V15, P516, DOI 10.1101/lm.987808; Campden Instruments, 2013, INSTR MAN, P1; Campden Instruments, 2011, INSTR MAN CS616 CS62, P1; Catani M, 2013, NEUROSCI BIOBEHAV R, V37, P1724, DOI 10.1016/j.neubiorev.2013.07.001; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; de Lange AMG, 2017, HUM BRAIN MAPP, V38, P5666, DOI 10.1002/hbm.23756; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Fan YT, 2015, RESTOR NEUROL NEUROS, V33, P835, DOI 10.3233/RNN-150523; Fetta J, 2017, J NEUROSCI NURS, V49, P235, DOI 10.1097/JNN.0000000000000298; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Hallock H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00537; Han K, 2018, NEUROIMAGE-CLIN, V18, P262, DOI 10.1016/j.nicl.2018.01.030; Hofstetter S, 2017, NEUROIMAGE, V155, P202, DOI 10.1016/j.neuroimage.2017.04.056; Hofstetter S, 2013, J NEUROSCI, V33, P12844, DOI 10.1523/JNEUROSCI.4520-12.2013; Hvoslef-Eide Martha, 1800, Brain Neurosci Adv, V2, DOI 10.1177/2398212818772962; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Kim CH, 2015, PSYCHOPHARMACOLOGY, V232, P3947, DOI 10.1007/s00213-015-4081-0; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Mar AC, 2013, NAT PROTOC, V8, P1985, DOI 10.1038/nprot.2013.123; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Melby-Lervag M, 2016, PERSPECT PSYCHOL SCI, V11, P512, DOI 10.1177/1745691616635612; Metzler-Baddeley C, 2017, J COGNITIVE NEUROSCI, V29, P1509, DOI 10.1162/jocn_a_01127; Minen M, 2019, HEADACHE, V59, P151, DOI 10.1111/head.13455; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Nichols JN, 2017, J NEUROTRAUM, V34, P2481, DOI 10.1089/neu.2017.4998; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Radabaugh HL, 2017, EXP NEUROL, V294, P12, DOI 10.1016/j.expneurol.2017.04.013; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Scholz J, 2015, NEUROIMAGE, V107, P182, DOI 10.1016/j.neuroimage.2014.12.003; Shepherd A, 2016, J MOL NEUROSCI, V60, P371, DOI 10.1007/s12031-016-0837-1; Shipstead Z, 2012, J APPL RES MEM COGN, V1, P185, DOI 10.1016/j.jarmac.2012.06.003; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Talpos JC, 2009, PSYCHOPHARMACOLOGY, V205, P157, DOI 10.1007/s00213-009-1526-3; Thomas RE, 2017, RESTOR NEUROL NEUROS, V35, P643, DOI 10.3233/RNN-170761; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Veraart J, 2016, MAGN RESON MED, V76, P1582, DOI 10.1002/mrm.26059; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Young JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004227; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	56	2	2	1	10	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2020	14	6					2281	2294		10.1007/s11682-019-00179-4			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OO1HQ	WOS:000587138100019	31407153				2022-02-06	
J	Buttner, F; Howell, DR; Doherty, C; Blake, C; Ryan, J; Delahunt, E				Buttner, Fionn; Howell, David R.; Doherty, Cailbhe; Blake, Catherine; Ryan, John; Delahunt, Eamonn			Headache- and Dizziness-Specific Health-Related Quality-of-Life Impairments Persist for 1 in 4 Amateur Athletes Who Cleared to Return to Sporting Activity Following Sport-Related Concussion: A Prospective Matched-Cohort Study	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						concussion; quality of life; recovery; symptoms	NECK DISABILITY INDEX; POSTTRAUMATIC MIGRAINE CHARACTERISTICS; GENERALIZED ANXIETY DISORDER; CLINICAL-OUTCOMES ASSESSMENT; TRAUMATIC BRAIN-INJURY; FATIGUE SEVERITY SCALE; PROLONGED RECOVERY; RELIABILITY; PREDICTORS; COMORBIDITY	OBJECTIVES: To prospectively investigate the recovery of athlete-reported symptoms and the condition-specific health-related quality of life (HRQoL) following sport-related concussion. DESIGN: Prospective matched-cohort study. METHODS: We recruited amateur athletes who were diagnosed with sport-related concussion by emergency department physicians. Study participants were assessed at 3 time points following sport-related concussion. At each assessment, participants completed 5 condition-specific HRQoL patient-reported outcome measures to evaluate participants' perceptions of the effects of specific concussion-related symptoms on their HRQoL. We performed log-linear analyses to assess the proportion of concussed participants with clinically impaired condition-specific HRQoL compared with the proportion of participants in the control group with clinically impaired condition-specific HRQoL. RESULTS: Fifty participants with sport-related concussion and 50 control participants matched by sex, age, and activity completed the study. Upon return to sporting activity, there was a significantly greater proportion of participants in the concussion group who perceived that headache, neck pain, and dizziness had an adverse effect on their HRQoL compared with the control group. Two weeks after return to sporting activity, there was still a significantly greater proportion of participants in the concussion group who perceived that headache (chi(2)(1) = 9.0; odds ratio [OR] = 4.4; 95% confidence interval [CI]: 1.5, 15.2; P = .003) and dizziness (chi(2)(1) = 9.5; OR = 13.5; 95% CI: 1.8, 604.9; P = .006) had an adverse effect on their HRQoL compared with the proportion of clinically impaired participants in the control group. CONCLUSION: Of concussed participants, 1 in 4 perceived that headache and dizziness had adverse effects on their HRQoL after returning to sporting activity following sport-related concussion compared with nonconcussed, control participants.	[Buttner, Fionn; Doherty, Cailbhe; Blake, Catherine; Delahunt, Eamonn] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin 4, Ireland; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado Sch Med, Dept Orthoped, Aurora, CO USA; [Howell, David R.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Ryan, John] St Vincents Univ Hosp, Emergency Dept, Dublin, Ireland; [Delahunt, Eamonn] Univ Coll Dublin, Inst Sport & Hlth, Dublin, Ireland		Buttner, F (corresponding author), Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin 4, Ireland.	fionn.cleirigh-buttner@ucdconnect.ie		Doherty, Cailbhe/0000-0002-5284-856X	Irish Research Council (Government of Ireland)	School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland. 2Sports Medicine Center, Children's Hospital Colorado, Aurora, CO. 3Department of Orthopedics, University of Colorado School of Medicine, Aurora, CO. 4The Micheli Center for Sports Injury Prevention, Waltham, MA. 5Emergency Department, St Vincent's University Hospital, Dublin, Ireland. 6Institute for Sport and Health, University College Dublin, Dublin, Ireland. The conduct of this longitudinal study was preapproved by the Human Research Ethics Committee-Life Sciences at University College Dublin. The study was funded by the Irish Research Council (Government of Ireland). The authors certify that they have no affiliations with or financial involvement in any organization or entity with a direct financial interest in the subject matter or materials discussed in the article. Address correspondence to Fionn Cle ' irigh Bu<spacing diaeresis>ttner, School of Public Health, Physiotherapy and Sports Science, University College Dublin, Belfield, Dublin 4, Ireland. E-mail:fionn.cleirigh-buttner@ucdconnect.iet Copyright (c) 2020 Journal of Orthopaedic & Sports Physical Therapy	Carr AJ, 2001, BRIT MED J, V322, P1357, DOI 10.1136/bmj.322.7298.1357; Cramer AOJ, 2016, PSYCHON B REV, V23, P640, DOI 10.3758/s13423-015-0913-5; Davidson M, 2014, BRIT J SPORT MED, V48, P792, DOI 10.1136/bjsports-2012-091704; Ebell MH, 2004, AM FAM PHYSICIAN, V69, P548; Ellis MJ, 2019, J HEAD TRAUMA REHAB, V34, P103, DOI 10.1097/HTR.0000000000000411; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Field A., 2012, DISCOVERING STAT USI; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hewlett S, 2011, ARTHRIT CARE RES, V63, pS263, DOI 10.1002/acr.20579; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V319, P1429, DOI 10.1001/jama.2018.1536; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; McCarthy MJH, 2007, EUR SPINE J, V16, P2111, DOI 10.1007/s00586-007-0503-y; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P377, DOI 10.1080/13803395.2017.1353590; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Piebes SK, 2011, J SPORT REHABIL, V20, P129, DOI 10.1123/jsr.20.1.129; Pool JJM, 2007, SPINE, V32, P3047, DOI 10.1097/BRS.0b013e31815cf75b; Register-Mihalik JK, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0724-2; Reiley Alexander S, 2017, Arch Physiother, V7, P12, DOI 10.1186/s40945-017-0040-x; Reneker Jennifer C, 2015, Inj Epidemiol, V2, P22; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Sutton M, 2019, J WOMENS HEALTH, V28, P473, DOI 10.1089/jwh.2018.7282; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Valovich TC, 2008, J ATHL TRAINING, V43, P437, DOI 10.4085/1062-6050-43.4.437; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Vos CJ, 2006, EUR SPINE J, V15, P1729, DOI 10.1007/s00586-006-0119-7; Wilcox R.R., 2012, INTRO ROBUST ESTIMAT; Wylie Glenn R, 2017, Concussion, V2, pCNC50, DOI 10.2217/cnc-2017-0003; Yang M, 2011, CEPHALALGIA, V31, P357, DOI 10.1177/0333102410379890	55	2	2	1	1	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	DEC	2020	50	12								10.2519/jospt.2020.9485			15	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation; Sport Sciences	PB5WL	WOS:000596390900007	33256513				2022-02-06	
J	Cogan, AM; Smith, B; Pape, TLB; Mallinson, T; Eapen, BC; Scholten, J				Cogan, Alison M.; Smith, Bridget; Pape, Theresa L. Bender; Mallinson, Trudy; Eapen, Blessen C.; Scholten, Joel			Self-reported Participation Restrictions Among Male and Female Veterans With Traumatic Brain Injury in Veterans Health Administration Outpatient Polytrauma Programs	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							POSTCONCUSSIVE SYMPTOMS; GENDER-DIFFERENCES; IRAQ; AFGHANISTAN; CARE; REHABILITATION; DEPLOYMENT; AWARENESS; OUTCOMES; SYSTEM	Objectives: To identify areas of most restricted self-reported participation among veterans with traumatic brain injury (TBI), explore associations among participation restriction and clinical characteristics, and examine differences in participation restrictions by sex. Design: Retrospective cross-sectional design. Setting: National VA Polytrauma System of Care outpatient settings. Participants: Veterans with a confirmed TBI event (N=6065). Interventions: Not applicable. Main Outcome Measure(s): Mayo-Portland Participation Index (M2PI), a 5-point Likert-type scale with 8 items. Total score was converted to standardized T score for analysis. Results: The sample consisted of 5679 male and 386 female veterans with >= 1 clinically confirmed TBI events (69% white; 74% with blast exposure). The M2PI items with greatest perceived restrictions were social contact, leisure, and initiation. There were no significant differences between men and women on M2PI standardized T scores. Wilcoxon rank-sum analyses showed significant differences by sex on 4 items: leisure, residence, employment, and financial management (all P<.01). In multinomial logistic regression on each item controlling for demographics, injury characteristics, and comorbidities, female veterans had significantly greater relative risk for part-time work and unemployment on the employment item and significantly less risk for impairment on the residence and financial management item. Conclusions: There was no significant difference between men and women. Veterans on M2PI standardized T scores, which masks differences in response patterns to individual items. Clinical teams should be encouraged to discuss perceived restrictions with patients and target these areas in treatment planning. Future work is needed to investigate the psychometric properties of the M2PI by biological sex. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Cogan, Alison M.; Scholten, Joel] Washington DC VA Med Ctr, Phys Med & Rehabil Serv, 50 Irving St NW, Washington, DC 20422 USA; [Smith, Bridget; Pape, Theresa L. Bender] US Dept Vet Affairs, Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare CINCCH, Hines, IL USA; [Smith, Bridget; Pape, Theresa L. Bender] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Pape, Theresa L. Bender] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Mallinson, Trudy] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Eapen, Blessen C.] VA Greater Los Angeles Hlth Care Syst, Phys Med & Rehabil Serv, Los Angeles, CA USA		Cogan, AM (corresponding author), Washington DC VA Med Ctr, Phys Med & Rehabil Serv, 50 Irving St NW, Washington, DC 20422 USA.	alison.cogan@va.gov	Cogan, Alison/AAS-3101-2021; Mallinson, Trudy/B-8392-2009	Mallinson, Trudy/0000-0002-4888-5579	Polytrauma/TBI Advanced Fellowship from the VA Office of Academic Affiliations	Dr. Cogan is supported by a Polytrauma/TBI Advanced Fellowship from the VA Office of Academic Affiliations.	Amara J, 2014, MIL MED, V179, P964, DOI 10.7205/MILMED-D-13-00559; Baldassarre M, 2015, PM&R, V7, P845, DOI 10.1016/j.pmrj.2015.03.003; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Bucher-Koenen T, 2017, J CONSUM AFF, V51, P255, DOI 10.1111/joca.12121; Chronic Conditions Data Warehouse, COND CAT; Cogan AM, 2020, PM&R, V12, P301, DOI 10.1002/pmrj.12237; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Department of Veterans Affairs, VHA HDB; Department of Veterans Affairs Veterans Health Administration, SCREEN EV POSS TRAUM; Eapen BC, 2013, CURR PHYS MED REHABI, V1, P151, DOI DOI 10.1007/S40141-013-0023-0; Elbogen EB, 2013, AM J PUBLIC HEALTH, V103, pS248, DOI 10.2105/AJPH.2013.301335; Elbogen EB, 2012, MIL MED, V177, P669, DOI 10.7205/MILMED-D-11-00388; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Ford MW, 2009, J EDUC BUS, V85, P7, DOI 10.1080/08832320903217366; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Hawkins BL, 2018, ARCH PHYS MED REHAB, V99, pS65, DOI 10.1016/j.apmr.2017.07.018; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Katz MH, 2006, STUDY DESIGN STAT AN; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Kleylamp M, 2013, SOC SCI RES, V42, P836, DOI 10.1016/j.ssresearch.2012.12.017; LEW HL, 2007, J REHABIL RES DEV, V44, pR; Lippa SM, 2018, J HEAD TRAUMA REHAB, V33, P101, DOI 10.1097/HTR.0000000000000353; Maguen S, 2012, MIL MED, V177, P797, DOI 10.7205/MILMED-D-11-00412; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; Malec JF., MANUAL MAYO PORTLAND; McCulloch K, 2015, J HEAD TRAUMA REHAB, V30, P38, DOI 10.1097/HTR.0000000000000041; McGarity S, 2017, J HEAD TRAUMA REHAB, V32, P34, DOI 10.1097/HTR.0000000000000242; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Office of Data Governance and Analytics, WOM VET REP PRES FUT; Peng C-Y, 2003, J MOD APPL STAT METH, V2, P117; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Scholten J, 2016, PROF CASE MANAG, V21, P266, DOI 10.1097/NCM.0000000000000165; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Stiers W, 2012, J REHABIL RES DEV, V49, P139, DOI 10.1682/JRRD.2010.07.0131; Trivedi AN, 2011, HEALTH AFFAIR, V30, P707, DOI 10.1377/hlthaff.2011.0074; U.S. Department of Veterans Affairs, TRAUM BRAIN INJ VET; U.S. Departments of Veterans Affairs and Defense, MAN CONC MILD TRAUM; Washington DL, 2017, HEALTH AFFAIR, V36, P1086, DOI 10.1377/hlthaff.2017.0029; Whiteneck GG, VA TRAUMATIC BRAIN I; Yue JK, 2019, NEUROL RES, V41, P609, DOI 10.1080/01616412.2019.1602312	48	2	2	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2020	101	12					2071	2079		10.1016/j.apmr.2020.06.030			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	PI8KT	WOS:000601333700003	32795563				2022-02-06	
J	Coleman, JR; Leasia, K; Douglas, IS; Hosokawa, P; Lawless, RA; Moore, EE; Pieracci, F				Coleman, Julia R.; Leasia, Kiara; Douglas, Ivor S.; Hosokawa, Patrick; Lawless, Ryan A.; Moore, Ernest E.; Pieracci, Fredric			Quantifying the expense of deferring surgical stabilization of rib fractures: Operative management of rib fractures is associated with significantly lower charges	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Meeting of the Chest-Wall-Injury-Society	APR 22-24, 2020	Denver, CO	Chest Wall Injury Soc		Surgical stabilization of rib fractures; cost analysis; flail chest; rib fractures	RANDOMIZED CONTROLLED-TRIAL; FLAIL CHEST INJURIES; FIXATION; OUTCOMES	INTRODUCTION Surgical stabilization of rib fractures (SSRF) remains a relatively controversial operation, which is often deferred because of concern about expense. The objective of this study was to determine the charges for SSRF versus medical management during index admission for rib fractures. We hypothesize that SSRF is associated with increased charge as compared with medical management. METHODS This is a retrospective chart review of a prospectively maintained database of patients with >= 3 displaced rib fractures admitted to a level 1 trauma center from 2010 to 2019. Patients who underwent SSRF (operative management [OM]) were compared with those managed medically (nonoperative management [NOM]). The total hospital charge between OM and NOM was compared with univariate analysis, followed by backward stepwise regression and mediation analysis. RESULTS Overall, 279 patients were included. The majority (75%) were male, the median age was 54 years, and the median Injury Severity Scale score (ISS) was 21. A total of 182 patients underwent OM, whereas 97 underwent NOM. Compared with NOM, OM patients had a lower ISS (18 vs. 22, p = 0.004), less traumatic brain injury (14% vs. 31%, p = 0.0006), shorter length of stay (10 vs. 14 days, p = 0.001), and decreased complications. After controlling for the differences between OM and NOM patients, OM was significantly associated with decreased charges (beta = US $35,105, p = 0.01). Four other predictors, with management, explained 30% of the variance in charge (R-2 = 0.30, p < 0.0001): scapular fracture (beta = US $471,967, p < 0.0001), ISS per unit increase (beta = US $4,139, p < 0.0001), long bone fracture (beta = US $52,176, p = 0.01), bilateral rib fractures (beta = US $34,392, p = 0.01), and Glasgow Coma Scale per unit decrease (beta = US $17,164, p < 0.0001). The difference in charge between NOM and OM management was most strongly, although only partially, mediated by length of stay. CONCLUSION Our analysis found that OM, as compared with NOM, was independently associated with decreased hospital charges. These data refute the prevailing notion that SSRF should be withheld because of concerns for increased cost.	[Coleman, Julia R.; Hosokawa, Patrick] Univ Colorado Denver, Dept Surg, 12631 & 17th Ave,Room 5402,Mail Stop C-291, Aurora, CO 80045 USA; [Leasia, Kiara; Lawless, Ryan A.; Moore, Ernest E.; Pieracci, Fredric] Ernest & Moore Shock Trauma Enter & Denver Hlth, Dept Surg, Denver, CO USA; [Douglas, Ivor S.] Denver Ilealth Med Ctr, Dept Internal Med, Denver, CO USA		Coleman, JR (corresponding author), Univ Colorado Denver, Dept Surg, 12631 & 17th Ave,Room 5402,Mail Stop C-291, Aurora, CO 80045 USA.	Julia.coleman@cuanschutz.edu	Douglas, Ivor S/AAC-6245-2021	Douglas, Ivor S/0000-0002-4541-1431			Akil A, 2019, EUR J TRAUMA EMERG S, V45, P623, DOI 10.1007/s00068-018-01062-5; Althausen PL, 2011, J ORTHOP TRAUMA, V25, P641, DOI 10.1097/BOT.0b013e318234d479; Bhatnagar A, 2012, J AM COLL SURGEONS, V215, P201, DOI 10.1016/j.jamcollsurg.2012.02.023; Buyukkarabacak YB, 2015, ACTA CHIR BELG, V115, P408; Cheema FA, 2019, AM SURGEON, V85, P474; Dehghan N, 2018, J ORTHOP TRAUMA, V32, P15, DOI 10.1097/BOT.0000000000000992; Dehghan N, 2014, J TRAUMA ACUTE CARE, V76, P462, DOI 10.1097/TA.0000000000000086; Dorman JR, 2020, INTERACT CARDIOV TH, V30, P597, DOI 10.1093/icvts/ivz317; Fitzgerald MT, 2018, AM SURGEON, V84, P680; Fokin AA, 2019, J ORTHOP TRAUMA, V33, P3, DOI 10.1097/BOT.0000000000001330; Golic DA, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00280; Hardin KS, 2019, J TRAUMA ACUTE CARE, V87, P1260, DOI 10.1097/TA.0000000000002480; Iqbal HJ, 2018, J BONE JOINT SURG AM, V100, P1298, DOI 10.2106/JBJS.17.01215; Kane ED, 2018, J AM COLL SURGEONS, V226, P961, DOI 10.1016/j.jamcollsurg.2017.11.008; Kane ED, 2017, J TRAUMA ACUTE CARE, V83, P1047, DOI 10.1097/TA.0000000000001648; Khandelwal G, 2011, INT J SURG, V9, P478, DOI 10.1016/j.ijsu.2011.06.003; Kocher GJ, 2017, EUR J CARDIO-THORAC, V51, P696, DOI 10.1093/ejcts/ezw365; Lafferty PM, 2011, J BONE JOINT SURG AM, V93A, P97, DOI 10.2106/JBJS.I.00696; Majercik S, 2015, AM J SURG, V210, P1112, DOI 10.1016/j.amjsurg.2015.08.008; Majercik S, 2015, J TRAUMA ACUTE CARE, V79, P533, DOI 10.1097/TA.0000000000000820; Marasco SF, 2013, J AM COLL SURGEONS, V216, P924, DOI 10.1016/j.jamcollsurg.2012.12.024; Michelitsch C, 2018, WORLD J SURG, V42, P3918, DOI 10.1007/s00268-018-4721-8; Mullens CL, 2019, J SURG RES, V244, P205, DOI 10.1016/j.jss.2019.06.048; Nirula R, 2006, AM SURGEON, V72, P307; Nirula R, 2009, WORLD J SURG, V33, P14, DOI 10.1007/s00268-008-9770-y; Pieracci FM, 2020, J TRAUMA ACUTE CARE, V88, P249, DOI 10.1097/TA.0000000000002559; Pieracci FM, 2019, J THORAC DIS, V11, pS1049, DOI 10.21037/jtd.2018.12.126; Pieracci FM, 2018, J TRAUMA ACUTE CARE, V84, P1, DOI 10.1097/TA.0000000000001729; Pieracci FM, 2017, INJURY, V48, P307, DOI 10.1016/j.injury.2016.11.026; Pieracci FM, 2016, J TRAUMA ACUTE CARE, V80, P187, DOI 10.1097/TA.0000000000000925; Qiu MG, 2016, INDIAN J SURG, V78, P458, DOI 10.1007/s12262-015-1409-2; SOBEL ME, 1985, SOCIOL METHODOL, P152; Sobel ME., 1982, SOCIOLOGICAL METHODO, V13, P290, DOI DOI 10.2307/270723; Su YH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216170; Tanaka H, 2001, SURG TODAY, V31, P12, DOI 10.1007/s005950170213; Uchida K, 2017, EUR J TRAUMA EMERG S, V43, P541, DOI 10.1007/s00068-016-0687-0	36	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2020	89	6					1032	1038		10.1097/TA.0000000000002922			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	OZ3WN	WOS:000594860700019	32890348				2022-02-06	
J	D'Arcy, RCN; Greene, T; Greene, D; Frehlick, Z; Fickling, SD; Campbell, N; Etheridge, T; Smith, C; Bollinger, F; Danilov, Y; Livingstone, A; Tannouri, P; Martin, P; Lakhani, B				D'Arcy, Ryan C. N.; Greene, Trevor; Greene, Debbie; Frehlick, Zack; Fickling, Shaun D.; Campbell, Natasha; Etheridge, Tori; Smith, Christopher; Bollinger, Fabio; Danilov, Yuri; Livingstone, Ashley; Tannouri, Pamela; Martin, Pauline; Lakhani, Bimal			Portable neuromodulation induces neuroplasticity to re-activate motor function recovery from brain injury: a high-density MEG case study	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Traumatic brain injury (TBI); Motor function; Neuroplasticity; Portable neuromodulation stimulator (PoNS); Translingual neurostimulation (TLNS); Magnetoencephalography (MEG); Electroencephalography (EEG); Brain vital signs; Functional connectivity; Rehabilitation	SITTING TEST; STROKE; NEUROREHABILITATION; STIMULATION; FMRI	BackgroundIn a recent high-profile case study, we used functional magnetic resonance imaging (fMRI) to monitor improvements in motor function related to neuroplasticity following rehabilitation for severe traumatic brain injury (TBI). The findings demonstrated that motor function improvements can occur years beyond current established limits. The current study extends the functional imaging investigation to characterize neuromodulation effects on neuroplasticity to further push the limits.MethodsCanadian Soldier Captain (retired) Trevor Greene (TG) survived a severe open-TBI when attacked with an axe during a 2006 combat tour in Afghanistan. TG has since continued intensive daily rehabilitation to recover motor function, experiencing an extended plateau using conventional physical therapy. To overcome this plateau, we paired translingual neurostimulation (TLNS) with the continuing rehabilitation program.ResultsCombining TLNS with rehabilitation resulted in demonstrable clinical improvements along with corresponding changes in movement evoked electro-encephalography (EEG) activity. High-density magneto-encephalography (MEG) characterized cortical activation changes in corresponding beta frequency range (27 Hz). MEG activation changes corresponded with reduced interhemispheric inhibition in the post-central gyri regions together with increased right superior/middle frontal activation suggesting large scale network level changes.ConclusionsThe findings provide valuable insight into the potential importance of non-invasive neuromodulation to enhance neuroplasticity mechanisms for recovery beyond the perceived limits of rehabilitation.	[D'Arcy, Ryan C. N.; Greene, Trevor; Greene, Debbie; Frehlick, Zack; Fickling, Shaun D.; Campbell, Natasha; Etheridge, Tori; Smith, Christopher; Bollinger, Fabio; Livingstone, Ashley; Tannouri, Pamela; Lakhani, Bimal] HealthTech Connex, Ctr Neurol Studies, 13737 96th Ave,Suite 204, Vancouver, BC V3V 0C6, Canada; [D'Arcy, Ryan C. N.; Greene, Trevor; Greene, Debbie; Frehlick, Zack; Fickling, Shaun D.; Campbell, Natasha; Etheridge, Tori; Smith, Christopher; Bollinger, Fabio; Livingstone, Ashley; Tannouri, Pamela; Martin, Pauline; Lakhani, Bimal] BrainNET, Hlth & Technol Dist, Vancouver, BC, Canada; [D'Arcy, Ryan C. N.; Fickling, Shaun D.] Simon Fraser Univ, Appl Sci & Sci, Vancouver, BC, Canada; [D'Arcy, Ryan C. N.] Univ British Columbia, Ctr Brain Hlth Radiol, Vancouver, BC, Canada; [Danilov, Yuri] Univ Wisconsin, Dept Kinesiol, Madison, WI USA; [Danilov, Yuri] Russian Acad Sci, Pavlov Inst Physiol, St Petersburg, Russia; [Martin, Pauline] NeuroMot Rehabil, Vancouver, BC, Canada		D'Arcy, RCN; Lakhani, B (corresponding author), HealthTech Connex, Ctr Neurol Studies, 13737 96th Ave,Suite 204, Vancouver, BC V3V 0C6, Canada.	ryan@healthtechconnex.com; bimal.lakhani@healthtechconnex.com			National Research Council of Canada (NRC); Natural Sciences and Engineering Research Council (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); BC Leading Edge Endowment Fund; Surrey Hospital Foundation	The work was funded by the National Research Council of Canada (NRC), the Natural Sciences and Engineering Research Council (NSERC), BC Leading Edge Endowment Fund, and the Surrey Hospital Foundation.	Bastani Andisheh, 2018, Cerebellum Ataxias, V5, P6, DOI 10.1186/s40673-018-0084-z; Belardinelli P, 2017, NEUROIMAGE-CLIN, V14, P726, DOI 10.1016/j.nicl.2017.03.005; D'Arcy RCN, 2016, J HEAD TRAUMA REHAB, V31, pE50, DOI 10.1097/HTR.0000000000000185; Danilov Y, 2015, CRANIAL NERVE NONINV; Danilov Y, 2018, NEUROMETHODS, V139, P307, DOI 10.1007/978-1-4939-8564-7_19; De Cicco V, 2018, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00130; Doidge N., 2016, BRAINS WAY HEALING R; Doidge Norman, 2007, BRAIN CHANGES ITSELF; Frehlick Z, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0538-4; Gorman SL, 2014, REHABIL RES PRACT, V2014, DOI 10.1155/2014/593280; Gorman SL, 2014, ARCH PHYS MED REHAB, V95, P2304, DOI 10.1016/j.apmr.2014.07.415; Gorman SL, 2010, J NEUROL PHYS THER, V34, P150, DOI 10.1097/NPT.0b013e3181f0065f; Greene T., 2012, MARCH FORTH INSPIRIN; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Khan F, 2017, J NEUROL, V264, P603, DOI 10.1007/s00415-016-8307-9; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kuipers P, 2014, NEUROREHABILITATION, V35, P475, DOI 10.3233/NRE-141139; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leonard Gabriel, 2017, Mult Scler J Exp Transl Clin, V3, p2055217317690561, DOI 10.1177/2055217317690561; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Lotze M, 2019, NEUROSCI BIOBEHAV R, V99, P49, DOI 10.1016/j.neubiorev.2019.01.027; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Niazi IK, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066009; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Paggiaro A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00035; Palmer JA, 2019, NEUROREHAB NEURAL RE, V33, P762, DOI 10.1177/1545968319862552; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V72, P250, DOI [10.1016/0013-4694(89)90250-2, DOI 10.1016/0013-4694(89)90250-2]; Ptito A, NEUROMODULATION TECH; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Quinn T, 2017, NEUROCRIT CARE, V27, P154, DOI 10.1007/s12028-017-0427-2; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Triccas LT, 2019, J NEUROSCI METH, V311, P318, DOI 10.1016/j.jneumeth.2018.08.009; Tyler Mitchell, 2019, Arch Rehabil Res Clin Transl, V1, P100026, DOI 10.1016/j.arrct.2019.100026; Wang TL, 2018, CORTEX, V107, P148, DOI 10.1016/j.cortex.2017.09.006; Wildenberg JC, 2011, NEUROIMAGE, V56, P2129, DOI 10.1016/j.neuroimage.2011.03.074; Wildenberg JC, 2010, BRAIN IMAGING BEHAV, V4, P199, DOI 10.1007/s11682-010-9099-7; Zhang X, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab0b82; Zhu JD, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/8481371	38	2	2	3	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1743-0003		J NEUROENG REHABIL	J. NeuroEng. Rehabil.	DEC 1	2020	17	1							158	10.1186/s12984-020-00772-5			12	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology; Rehabilitation	PB7QV	WOS:000596512100001	33261623	Green Submitted, Green Published, gold			2022-02-06	
J	Dhillon, NK; Huang, R; Mason, R; Melo, N; Margulies, DR; Ley, EJ; Barmparas, G				Dhillon, Navpreet K.; Huang, Raymond; Mason, Russell; Melo, Nicolas; Margulies, Daniel R.; Ley, Eric J.; Barmparas, Galinos			Vasopressors in traumatic brain injury: Quantifying their effect on mortality	AMERICAN JOURNAL OF SURGERY			English	Article						Cerebral perfusion pressure; Hypotension; Trauma; Traumatic brain injury; Vasopressors	PRESSURE; NOREPINEPHRINE; CATECHOLAMINES; MANAGEMENT	Background: The benefits of vasopressor (VP) use to improve clinical outcomes in traumatic brain injury (TBI) is unknown. We sought to characterize the use of VP in TBI patients and evaluate its impact on mortality. Methods: A retrospective review was conducted of all TBI patients admitted to an ICU at a Level I trauma center from January 2014 to August 2016. Patients who had any VP administered (VP+) were compared to those who did not (VP-). Results: Among the 556 patients analyzed, 83 (14.9%) received VP. The overall mortality was 9.2%, significantly higher in the VP + cohort (42.2% vs. 3.4%, p < 0.01). After adjusting for confounding factors, VP + patients had a significantly higher risk for in-hospital mortality (Adjusted Hazard Ratio: 2.77, adjusted p = 0.01). Conclusion: Although VP may be temporarily useful in avoiding secondary insult to the brain in TBI patients, their use is not associated with improved survival. (c) 2020 Elsevier Inc. All rights reserved.	[Dhillon, Navpreet K.; Huang, Raymond; Mason, Russell; Melo, Nicolas; Margulies, Daniel R.; Ley, Eric J.; Barmparas, Galinos] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Barmparas, G (corresponding author), Surg Cedars Sinai Med Ctr, FACS, Dept Surg, Div Acute Care Surg & Surg Crit Care, 8635 West 3rd St,Suite 650W, Los Angeles, CA 90048 USA.	Navpreet.Dhillon@cshs.org; Raymond.Huang@cshs.org; Russell.Mason@cshs.org; Nicolas.Melo@cshs.org; Daniel.Margulies@cshs.org; Eric.Ley@cshs.org; gbarmparas@gmail.com					Alali AS, 2017, ANN SURG, V266, P952, DOI 10.1097/SLA.0000000000002286; Allen CJ, 2018, AM SURGEON, V84, P43; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cohn SM, 2013, J TRAUMA ACUTE CARE, V75, P620, DOI 10.1097/TA.0b013e31829eff31; Dickson JM, 2018, MIL MED, V183, pE460, DOI 10.1093/milmed/usy001; Feinstein AJ, 2005, J TRAUMA, V59, P876, DOI 10.1097/01.ta.0000187654.24146.22; Feinstein AJ, 2005, J TRAUMA, V59, P882; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Huijben JA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2000-6; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Ley EJ, 2018, J TRAUMA ACUTE CARE, V84, P234, DOI 10.1097/TA.0000000000001747; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Rajani RR, 2009, AM SURGEON, V75, P1207; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Sims CA, 2019, JAMA SURG, V154, P994, DOI 10.1001/jamasurg.2019.2884; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Van Haren RM, 2013, J TRAUMA ACUTE CARE, V75, P1024, DOI 10.1097/TA.0b013e3182a99d48	23	2	2	0	1	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	DEC	2020	220	6					1498	1502		10.1016/j.amjsurg.2020.09.016			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PB8LB	WOS:000596564900026	33008617				2022-02-06	
J	Domenichiello, AF; Jensen, JR; Zamora, D; Horowitz, M; Yuan, ZX; Faurot, K; Mann, JD; Mannes, AJ; Ramsden, CE				Domenichiello, Anthony F.; Jensen, Jennifer R.; Zamora, Daisy; Horowitz, Mark; Yuan, Zhi-Xin; Faurot, Keturah; Mann, J. Douglas; Mannes, Andrew J.; Ramsden, Christopher E.			Identifying oxidized lipid mediators as prognostic biomarkers of chronic posttraumatic headache	PAIN			English	Article						Pain; Headache; Traumatic brain injury; Posttraumatic headache; Lipid mediators; Liquid chromatography tandem mass spectrometry; Oxidized lipids; Docosahexaenoic acid; Omega 3; Omega 6; Polyunsaturated fatty acids	TRAUMATIC BRAIN-INJURY; POLYUNSATURATED FATTY-ACIDS; LINOLEIC-ACID; SPINAL-CORD; TARGETED ALTERATIONS; CEREBROSPINAL-FLUID; INFLAMMATORY PAIN; DOUBLE-BLIND; DIETARY N-3; LIFE	Chronic posttraumatic headache (PTH) is among the most common and disabling sequelae of traumatic brain injury (TBI). Current PTH treatments are often only partially effective and have problematic side effects. We previously showed in a small randomized trial of patients with chronic nontraumatic headaches that manipulation of dietary fatty acids decreased headache frequency, severity, and pain medication use. Pain reduction was associated with alterations in oxylipins derived from n-3 and n-6 fatty acids, suggesting that oxylipins could potentially mediate clinical pain reduction. The objective of this study was to investigate whether circulating oxylipins measured in the acute setting after TBI could serve as prognostic biomarkers for developing chronic PTH. Participants enrolled in the Traumatic Head Injury Neuroimaging Classification Protocol provided serum within 3 days of TBI and were followed up at 90 days postinjury with a neurobehavioral symptom inventory (NSI) and satisfaction with life survey. Liquid chromatographytandem mass spectrometry methods profiled 39 oxylipins derived from n-3 docosahexaenoic acid (DHA), and n-6 arachidonic acid and linoleic acid. Statistical analyses assessed the association of oxylipins with headache severity (primary outcome, measured by headache question on NSI) as well as associations between oxylipins and total NSI or satisfaction with life survey scores. Among oxylipins, 4-hydroxy-DHA and 19,20-epoxy-docosapentaenoate (DHA derivatives) were inversely associated with headache severity, and 11-hydroxy-9-epoxy-octadecenoate (a linoleic acid derivative) was positively associated with headache severity. These findings support a potential for DHA-derived oxylipins as prognostic biomarkers for development of chronic PTH.	[Domenichiello, Anthony F.; Jensen, Jennifer R.; Zamora, Daisy; Horowitz, Mark; Yuan, Zhi-Xin; Ramsden, Christopher E.] NIA, Lipid Peroxidat Unit, Lab Clin Invest, NIH, Baltimore, MD 20892 USA; [Domenichiello, Anthony F.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Faurot, Keturah; Mann, J. Douglas] Univ N Carolina, Program Integrat Med, Dept Phys Med & Rehabil, Chapel Hill, NC 27515 USA; [Mann, J. Douglas] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27515 USA; [Mannes, Andrew J.] NIH, Dept Perioperat Med, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA; [Ramsden, Christopher E.] NIAAA, NIH, Bethesda, MD USA		Domenichiello, AF (corresponding author), NIA, Lipid Peroxidat Unit, Lab Clin Invest, 35 Convent Dr,1E-420C, Bethesda, MD 20892 USA.	anthony.domeni-chiello@nih.gov	Zamora, Daisy/ABG-5162-2021; Ramsden, Christopher/AAW-9516-2021	Zamora, Daisy/0000-0003-2114-5156; Horowitz, Mark/0000-0002-0061-8586; Ramsden, Christopher/0000-0002-4058-7630	Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	The authors wish to acknowledge the staff at Suburban Hospital and Washington Hospital Center, Investigators of the Center for Neuroscience and Regenerative Medicine THINC Study team, and participants. Support for this work included funding from Department of Defense in the Center for Neuroscience and Regenerative Medicine and the intramural programs of the National Institute on Aging and National Institute on Alcohol Abuse and Alcoholism.	Anthonymuthu TS, 2017, BBA-MOL BASIS DIS, V1863, P2601, DOI 10.1016/j.bbadis.2017.03.015; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Cezar TLC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39584-6; Chen CT, 2015, SCI REP-UK, V5, DOI 10.1038/srep15791; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; Green DP, 2016, MOL PAIN, V12, DOI 10.1177/1744806916661725; Guo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05446-2; Hargreaves KM, 2016, J DENT RES, V95, P1117, DOI 10.1177/0022034516653751; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Kaufmann I, 2009, EUR SURG RES, V43, P325, DOI 10.1159/000235870; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lewis M, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.05.014; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; Lu LH, 2020, MIL MED, V185, pE43, DOI 10.1093/milmed/usz173; Mallinckrodt CH., 2013, PREVENTING TREATING; Mann JD, 2018, PROSTAG LEUKOTR ESS, V128, P41, DOI 10.1016/j.plefa.2017.11.002; Moye LS, 2017, J NEUROSCI RES, V95, P1347, DOI 10.1002/jnr.24001; National Institutes of Health, 2020, AC CHRON PAIN SIGN N; Orr SK, 2015, CRIT CARE MED, V43, P2642, DOI 10.1097/CCM.0000000000001312; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Park CK, 2011, J NEUROSCI, V31, P18433, DOI 10.1523/JNEUROSCI.4192-11.2011; Patwardhan AM, 2010, J CLIN INVEST, V120, P1617, DOI 10.1172/JCI41678; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Piomelli D, 2014, J NEUROSCI, V34, P15184, DOI 10.1523/JNEUROSCI.3475-14.2014; Pradalier A, 2001, CEPHALALGIA, V21, P818, DOI 10.1046/j.1468-2982.2001.00240.x; Ramsden CE, 2019, PROSTAG LEUKOTR ESS, V150, P31, DOI 10.1016/j.plefa.2019.09.001; Ramsden CE, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal5241; Ramsden CE, 2016, MOL PAIN, V12, DOI 10.1177/1744806916636386; Ramsden CE, 2015, PAIN, V156, P587, DOI 10.1097/01.j.pain.0000460348.84965.47; Ramsden CE, 2013, PAIN, V154, P2441, DOI 10.1016/j.pain.2013.07.028; Ramsden CE, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-97; Rose S, 1998, LANGENBECK ARCH SURG, V383, P199, DOI 10.1007/s004230050119; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Rund KM, 2020, ANALYST, V145, P2378, DOI 10.1039/c9an01880h; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silverberg ND, 2017, CONCUSSION MILD TRAU; Soares AD, 2018, NUTR NEUROSCI, V21, P219, DOI [10.1080/1028415X.2016.1266133, 10.1080/1028415x.2016.1266133]; Solomon S, 2005, HEADACHE, V45, P53, DOI 10.1111/j.1526-4610.2005.05011.x; Sorokin AV, 2018, J INVEST DERMATOL, V138, P1518, DOI 10.1016/j.jid.2018.02.003; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Vargas BB, 2012, CURR OPIN NEUROL, V25, P284, DOI 10.1097/WCO.0b013e3283535bf5; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Wagner K, 2014, PROSTAG OTH LIPID M, V113, P2, DOI 10.1016/j.prostaglandins.2014.09.001; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; WESTCOTT JY, 1987, PROSTAGLANDINS, V34, P877, DOI 10.1016/0090-6980(87)90068-2; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yi LZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21320; Yu GF, 2013, CLIN CHIM ACTA, V421, P7, DOI 10.1016/j.cca.2013.02.030; Yuan ZX, 2018, ANAL BIOANAL CHEM, V410, P6009, DOI 10.1007/s00216-018-1222-4; Zhang LL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00412; Zimmer B, 2018, BBA-MOL CELL BIOL L, V1863, P669, DOI 10.1016/j.bbalip.2018.03.012	65	2	2	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	DEC	2020	161	12					2775	2785		10.1097/j.pain.0000000000001983			11	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; Neurosciences & Neurology	QI4QI	WOS:000618963500013	32694380	Green Accepted			2022-02-06	
J	Fraser, EE; Downing, MG; Ponsford, JL				Fraser, Elinor E.; Downing, Marina G.; Ponsford, Jennie L.			Understanding the Multidimensional Nature of Sexuality After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Depression; Rehabilitation; Sexuality	PARTICIPATION ASSESSMENT; DEPRESSION; FATIGUE; SCALE; INDIVIDUALS; VALIDATION; PREDICTORS	Objective: To investigate the association of sexuality with sociodemographic (age, sex, education), medical (injury severity, time since injury), physical (fatigue, pain, independence), neuropsychological (memory, attention, executive function), psychological (depression, anxiety, self- esteem), and social participation factors after traumatic brain injury (TBI). Design: Survey. Individuals with TBI completed measures at a mean average of 2.78 years post injury (range, 1-10.3y). Setting: All participants were community based at the time of data collection. Participants: Eighty-four individuals with TBI consecutively recruited after discharge from rehabilitation and 88 age-, sex-, and education- matched controls without TBI recruited from the general community. Interventions: Not applicable. Main Outcome Measure: Brain Injury Questionnaire of Sexuality. Results: Individuals with TBI performed significantly worse on sexuality, mood, and self-esteem measures than the control group without TBI, supporting previous findings. Research findings highlighted a range of significant correlations between sociodemographic, physical, neuropsychological, psychological, and social participation factors and sexuality outcomes after TBI. In the multiple regression model, older age, greater depression, and lower self-esteem were significant predictors of poorer sexuality post injury. Further analyses indicated that depression mediated the independent relationships between lower social participation and greater fatigue with a decline in sexuality after TBI. Conclusions: These findings support sexuality changes after TBI as a multidimensional construct, highlighting depression as a key mechanism through which other factors may affect sexual functioning. Further research is needed to target assessment and intervention services for sexuality problems after TBI. (C) 2020 by the American Congress of Rehabilitation Medicine	[Fraser, Elinor E.; Downing, Marina G.; Ponsford, Jennie L.] Monash Univ, Turner Inst Brain & Mental Hlth, Sch Psychol Sci, Melbourne, Vic, Australia; [Downing, Marina G.; Ponsford, Jennie L.] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu			Transport Accident Commission	Supported by the Transport Accident Commission.	Aloni R, 1999, BRAIN INJURY, V13, P269, DOI 10.1080/026990599121647; Annon J. S., 1974, BEHAV TREATMENT SEXU; Baldwin DS, 2001, BRIT MED BULL, V57, P81, DOI 10.1093/bmb/57.1.81; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bellamkonda E, 2014, BRAIN INJURY, V28, P1063, DOI 10.3109/02699052.2014.896473; Bivona U, 2016, BRAIN INJURY, V30, P1082, DOI 10.3109/02699052.2016.1165867; Bogner J, 2013, J HEAD TRAUMA REHAB, V28, P337, DOI 10.1097/HTR.0b013e31829af969; Burgess P.W., 1997, HAYLING BRIXTON TEST; Calabro R, 2019, BRAIN BEHAV, V9, P1; Cohen J, 1998, STAT POWER ANAL BEHA; Crowe SF, 1999, BRAIN INJURY, V13, P347; DeLamater J, 2009, CURR PSYCHIAT REP, V11, P6, DOI 10.1007/s11920-009-0002-4; Deschenes PM, 2019, SEX DISABIL, V37, P297, DOI 10.1007/s11195-019-09576-5; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Goldin Y, 2014, J HEAD TRAUMA REHAB, V29, P418, DOI 10.1097/HTR.0b013e31829cf76d; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Hanks RA, 2013, J HEAD TRAUMA REHAB, V28, P179, DOI 10.1097/HTR.0b013e31828b4fae; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Keppel CC, 2000, NEUROPSYCHOL REHABIL, V10, P15, DOI 10.1080/096020100389273; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Little R. J., 2019, STAT ANAL MISSING DA, V793; Moreno A, 2017, NEUROREHABILITATION, V41, P255, DOI 10.3233/NRE-001480; Moreno JA, 2017, NEUROREHABILITATION, V41, P281, DOI 10.3233/NRE-172201; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2013, J HEAD TRAUMA REHAB, V28, P195, DOI 10.1097/HTR.0b013e31828b4f7b; Rees PM, 2007, LANCET, V369, P512, DOI 10.1016/S0140-6736(07)60238-4; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1992, TRAIL MAKING TEST MA; Rosenberg M., 1979, CONCEIVING SELF; Rosenberg M., 1965, SOC ADOLESCENT SELF; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Schmidt M., 1996, REY AUDITORY VERBAL; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Simpson G, 2001, BRAIN IMPAIR, V2, P97, DOI DOI 10.1375/BRIM.2.2.97; Snaith R., 1994, HOSP ANXIETY DEPRESS; Stolwyk RJ, 2013, J HEAD TRAUMA REHAB, V28, P164, DOI 10.1097/HTR.0b013e31828197d1; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Verschuren JEA, 2010, J SEX RES, V47, P153, DOI 10.1080/00224491003658227; War Firdous A, 2014, Asian J Neurosurg, V9, P29, DOI 10.4103/1793-5482.131061; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	57	2	2	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2020	101	12					2080	2086		10.1016/j.apmr.2020.06.028			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	PI8KT	WOS:000601333700004	32750372				2022-02-06	
J	Houten, JK; Buksbaum, JR; Collins, MJ				Houten, John K.; Buksbaum, Joshua R.; Collins, Michael J.			Patterns of neurological deficits and recovery of postoperative C5 nerve palsy	JOURNAL OF NEUROSURGERY-SPINE			English	Article						C5 nerve palsy; cervical fusion; complications; myelomalacia; myelopathy; T2 cord change; deltoid weakness	CERVICAL-SPINE SURGERY; DISSOCIATED MOTOR LOSS; ROOT PALSY; DECOMPRESSION; LAMINOPLASTY; LAMINECTOMY; INJURY; COMPRESSION; CONCUSSION; MYELOPATHY	OBJECTIVE Paresis of the C5 nerve is a well-recognized complication of cervical spine surgery. Numerous studies have investigated its incidence and possible causes, but the specific pattern and character of neurological deficits, time course, and relationship to preoperative cord signal changes remain incompletely understood. METHODS Records of patients undergoing cervical decompressive surgery for spondylosis, disc herniation, or ossification of the longitudinal ligament, including the C4-5 level, were reviewed from a 15-year period, identifying C5 palsy cases. Data collected included age, sex, diabetes and smoking statuses, body mass index, surgical levels, approach, presence of increased cord signal intensity, and modified Japanese Orthopaedic Association (mJOA) scores. Narrative descriptions of the patterns and findings on neurological examination were reviewed, and complications were noted. The minimum follow-up requirement for the study was 12 months. RESULTS Of 642 patients who underwent cervical decompressive surgery, 18 developed C5 palsy (2.8%). The incidence was significantly lower following anterior surgery (6 of 441 [1.4%]) compared with that following cervical laminectomy and fusion (12 of 201 [6.0%]) (p < 0.001). There were 10 men and 8 women whose mean age was 66.7 years (range 54-76 years). The mean preoperative mJOA score of 11.4 improved to 15.6 at the latest follow-up examination. There were no differences between those with and without C5 palsy with regard to sex, age, number of levels treated, or preor postoperative mJOA score. Fifteen patients with palsy (83%) had signal changes/myelomalacia on preoperative T2-weighted imaging, compared with 436 of 624 (70%) patients without palsy; however, looking specifically at the C4-5 level, signal change/myelomalacia was present in 12 of 18 (67%) patients with C5 palsy, significantly higher than in the 149 of 624 (24%) patients without palsy (p < 0.00003). Paresis was unilateral in 16 (89%) and bilateral in 2 (11%) patients. All had deltoid weakness, but 15 (83%) exhibited new biceps weakness, 8 (44%) had triceps weakness, and 2 (11%) had hand intrinsic muscle weakness. The mean time until onset of palsy was 4.6 days (range 2-14 days). Two patients (11%) complained of shoulder pain preceding weakness; 3 patients (17%) had sensory loss. Recovery to grade 4/5 deltoid strength occurred in 89% of the patients. No patient had intraoperative loss of somatosensory or motor evoked potentials or abnormal intraoperative C5 electromyography activity. CONCLUSIONS Postoperative C5 nerve root dysfunction appears in a delayed fashion, is predominantly a motor deficit, and weakness is frequently appreciated in the biceps and triceps muscles in addition to the deltoid muscle. Preoperative cord signal change/myelomalacia at C4-5 was a significant risk factor. No patient had a detectable deficit in the immediate postoperative period or changes in intraoperative neuromonitoring status. Neurological recovery to at least that of grade 4/5 occurred in nearly 90% of the patients.	[Houten, John K.; Buksbaum, Joshua R.] Maimonides Hosp, Div Neurosurg, Brooklyn, NY 11219 USA; [Houten, John K.; Collins, Michael J.] Maimonides Hosp, Dept Orthoped Surg, Brooklyn, NY 11219 USA; [Houten, John K.] Hofstra Northwell Sch Med, Dept Neurosurg, Manhasset, NY USA		Houten, JK (corresponding author), Maimonides Hosp, Brooklyn, NY 11219 USA.	jkhmd@yahoo.com					Alafifi T, 2007, J NEUROIMAGING, V17, P315, DOI 10.1111/j.1552-6569.2007.00119.x; Brown JM, 2010, NEUROSURGERY, V67, pE1831, DOI 10.1227/NEU.0b013e3181f8254b; Bydon M, 2014, SPINE J, V14, P2861, DOI 10.1016/j.spinee.2014.03.040; Chiba K, 2002, SPINE, V27, P2108, DOI 10.1097/00007632-200210010-00006; Currier BL, 2012, SPINE, V37, pE328, DOI 10.1097/BRS.0b013e3182417276; Fan DP, 2002, SPINE, V27, P2499, DOI 10.1097/00007632-200211150-00014; Fassett DR, 2007, J NEUROSURG-SPINE, V7, P277, DOI 10.3171/SPI-07/09/277; Fischer I, 2016, NEURAL REGEN RES, V11, P58, DOI 10.4103/1673-5374.169634; Gandhoke G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11156; Hashimoto M, 2010, EUR SPINE J, V19, P1702, DOI 10.1007/s00586-010-1427-5; Hosono N, 2009, J BONE JOINT SURG BR, V91B, P1541, DOI 10.1302/0301-620X.91B11.22196; Houten JK, 2003, NEUROSURGERY, V52, P1081, DOI 10.1227/01.NEU.0000057746.74779.55; Imagama S, 2010, J BONE JOINT SURG BR, V92B, P393, DOI 10.1302/0301-620X.92B3.22786; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jack A, 2019, GLOB SPINE J, V9, P881, DOI 10.1177/2192568219874771; Jimenez JC, 2005, J NEUROSURG-SPINE, V3, P92, DOI 10.3171/spi.2005.3.2.0092; Jin Y, 2015, EXP NEUROL, V271, P175, DOI 10.1016/j.expneurol.2015.06.001; Katsumi K, 2012, SPINE, V37, P748, DOI 10.1097/BRS.0b013e3182326957; Klement MR, 2016, SPINE J, V16, P462, DOI 10.1016/j.spinee.2015.07.437; Kurakawa T, 2016, EUR SPINE J, V25, P2060, DOI 10.1007/s00586-016-4548-7; Levin KH, 1996, NEUROLOGY, V46, P1022, DOI 10.1212/WNL.46.4.1022; Liu T, 2010, ORTHOPEDICS, V33, P8; Liu TL, 2016, TURK NEUROSURG, V26, P280, DOI 10.5137/1019-5149.JTN.7476-12.1; Lombard FW, 2010, SEMIN CARDIOTHORAC V, V14, P102, DOI 10.1177/1089253210371519; MARZO JM, 1987, SPINE, V12, P964, DOI 10.1097/00007632-198712000-00002; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matsunaga S, 1993, SPINE, V18, P1964; Minoda Y, 2003, SPINE, V28, P1123, DOI 10.1097/00007632-200306010-00008; Nakajima H, 2020, J NEUROSURG-SPINE, V32, P592, DOI 10.3171/2019.10.SPINE19993; Nassr A, 2012, SPINE, V37, P174, DOI 10.1097/BRS.0b013e318219cfe9; O'Toole JE, 2004, SPINE, V29, pE56, DOI 10.1097/01.BRS.0000106497.62333.32; Odate S, 2013, SPINE, V38, P2184, DOI 10.1097/BRS.0000000000000019; Park P, 2007, SPINE, V32, pE640, DOI 10.1097/BRS.0b013e3181573d1d; Radcliff KE, 2014, J SPINAL DISORD TECH, V27, P86, DOI 10.1097/BSD.0b013e31824e53af; Sakaura H, 2003, SPINE, V28, P2447, DOI 10.1097/01.BRS.0000090833.96168.3F; SAUNDERS RL, 1995, NEUROSURGERY, V37, P408, DOI 10.1227/00006123-199509000-00006; SHINOMIYA K, 1994, SPINE, V19, P2501, DOI 10.1097/00007632-199411001-00002; Shiozaki T, 2009, SPINE, V34, P274, DOI 10.1097/BRS.0b013e318194e275; Shou FY, 2015, EUR SPINE J, V24, P2724, DOI 10.1007/s00586-015-4186-5; Takenaka S, 2016, BONE JOINT J, V98B, P117, DOI 10.1302/0301-620X.98B1.36042; Tanaka N, 2006, SPINE, V31, P3013, DOI 10.1097/01.brs.0000250303.17840.96; Tsuzuki N, 1996, SPINE, V21, P203, DOI 10.1097/00007632-199601150-00008; Woodroffe RW, 2020, WORLD NEUROSURG, V136, pE393, DOI 10.1016/j.wneu.2020.01.024; Yagi M, 2010, J NEUROSURG-SPINE, V12, P59, DOI 10.3171/2009.5.SPINE08940	44	2	2	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	DEC	2020	33	6					742	750		10.3171/2020.5.SPINE20514			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PB6AZ	WOS:000596402800004	32736364	Bronze			2022-02-06	
J	Iaubasarova, IR; Khailova, LS; Nazarov, PA; Rokitskaya, TI; Silachev, DN; Danilina, TI; Plotnikov, EY; Denisov, SS; Kirsanov, RS; Korshunova, GA; Kotova, EA; Zorov, DB; Antonenko, YN				Iaubasarova, I. R.; Khailova, L. S.; Nazarov, P. A.; Rokitskaya, T., I; Silachev, D. N.; Danilina, T., I; Plotnikov, E. Y.; Denisov, S. S.; Kirsanov, R. S.; Korshunova, G. A.; Kotova, E. A.; Zorov, D. B.; Antonenko, Y. N.			Linking 7-Nitrobenzo-2-oxa-1,3-diazole (NBD) to Triphenylphosphonium Yields Mitochondria-Targeted Protonophore and Antibacterial Agent	BIOCHEMISTRY-MOSCOW			English	Article						mitochondria; uncoupler; protonophore; membrane potential; respiration	FLUORESCENCE CORRELATION SPECTROSCOPY; OXIDATIVE-PHOSPHORYLATION; UNCOUPLER; MEMBRANE; CATIONS; INJURY; BRAIN; PROBE; SAFRANINE; LIPOSOMES	Appending lipophilic cations to small molecules has been widely used to produce mitochondria-targeted compounds with specific activities. In this work, we obtained a series of derivatives of the well-known fluorescent dye 7-nitrobenzo-2-oxa-1,3-diazole (NBD). According to the previous data [Denisov et al. (2014) Bioelectrochemistry, 98, 30-38], alkyl derivatives of NBD can uncouple isolated mitochondria at concentration of tens of micromoles despite a high pK(a) value (similar to 11) of the dissociating group. Here, a number of triphenylphosphonium (TPP) derivatives linked to NBD via hydrocarbon spacers of varying length (C5, C8, C10, and C12) were synthesized (mitoNBD analogues), which accumulated in the mitochondria in an energy-dependent manner. NBD-C10-TPP (C10-mitoNBD) acted as a protonophore in artificial lipid membranes (liposomes) and uncoupled isolated mitochondria at micromolar concentrations, while the derivative with a shorter linker (NBD-C5-TPP, or C5-mitoNBD) exhibited no such activities. In accordance with this data, C10-mitoNBD was significantly more efficient than C5-mitoNBD in suppressing the growth of Bacillus subtilis. C10-mitoNBD and C12-mitoNBD demonstrated the highest antibacterial activity among the investigated analogues. C10-mitoNBD also exhibited the neuroprotective effect in the rat model of traumatic brain injury.	[Iaubasarova, I. R.; Khailova, L. S.; Nazarov, P. A.; Rokitskaya, T., I; Silachev, D. N.; Danilina, T., I; Plotnikov, E. Y.; Denisov, S. S.; Kirsanov, R. S.; Korshunova, G. A.; Kotova, E. A.; Zorov, D. B.; Antonenko, Y. N.] Lomonosov Moscow State Univ, Belozersky Inst Phys Chem Biol, Moscow 119991, Russia; [Iaubasarova, I. R.] Lomonosov Moscow State Univ, Fac Chem, Moscow 119991, Russia; [Denisov, S. S.] Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, Univ Singel 50, NL-6229 ER Maastricht, Netherlands		Antonenko, YN (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Phys Chem Biol, Moscow 119991, Russia.	antonen@belozersky.msu.ru	Plotnikov, Egor Y/F-8592-2019; Zorov, Dmitry B./AAB-1738-2019; Nazarov, Pavel A/G-7885-2018; Silachev, Denis/ABE-8515-2020	Plotnikov, Egor Y/0000-0003-2838-3704; Zorov, Dmitry B./0000-0003-0863-8490; Nazarov, Pavel A/0000-0003-1857-323X; 	Russian Science FoundationRussian Science Foundation (RSF) [16-14-10025, 19-74-00015, 19-14-00173]	This work was supported by the Russian Science Foundation (project no. 16-14-10025; synthesis of Cn-mitoNBD, pKa measurements, induction of pro-ton permeability in liposomes and planar BLM, investigation of the effect of Cn-mitoNBD on the membrane potential and respiration rate, evaluation of Cn-mitoNBD accumulation in the mitochondria by using a TPP electrode, assessment of the antimicrobial activity of NBD derivatives), the Russian Science Foundation (project no. 19-74-00015; measurements of energy-dependent uptake of Cn-mitoNBD by mitochondria with the fluorescence correlation spectroscopy technique), and the Russian Science Foundation (project no. 19-14-00173; confocal microscopy of eukaryotic cells with C10-mitoNBD and investigation of C10-mitoNBD neuroprotective effect in the rat model of focal brain ischemia).	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Antonenko YN, 2016, BBA-GEN SUBJECTS, V1860, P2463, DOI 10.1016/j.bbagen.2016.07.014; Antonenko YN, 2012, J BIOENERG BIOMEMBR, V44, P453, DOI 10.1007/s10863-012-9449-9; Belosludtsev KN, 2019, BIOCHEM MOSC SUPPL S, V13, P310, DOI 10.1134/S1990747819040044; Biasutto L, 2010, BBA-BIOENERGETICS, V1797, P189, DOI 10.1016/j.bbabio.2009.10.001; Childress ES, 2018, J MED CHEM, V61, P4641, DOI 10.1021/acs.jmedchem.7b01182; Clinical and Laboratory Standards Institute (CLSI), 2012, M07A9 CLSI; Denisov SS, 2014, CHEM COMMUN, V50, P15366, DOI 10.1039/c4cc04996a; Denisov SS, 2014, BIOELECTROCHEMISTRY, V98, P30, DOI 10.1016/j.bioelechem.2014.02.002; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Desquiret V, 2006, BBA-BIOENERGETICS, V1757, P21, DOI 10.1016/j.bbabio.2005.11.005; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Firsov AM, 2015, BBA-BIOMEMBRANES, V1848, P767, DOI 10.1016/j.bbamem.2014.11.027; Gao JL, 2018, FREE RADICAL BIO MED, V124, P288, DOI 10.1016/j.freeradbiomed.2018.06.020; Geisler JG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030280; Geisler JG, 2017, ALZHEIMERS DEMENT, V13, P582, DOI 10.1016/j.jalz.2016.08.001; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Khailova LS, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1589, DOI 10.1134/S000629791512007X; Khailova LS, 2014, BBA-BIOENERGETICS, V1837, P1739, DOI 10.1016/j.bbabio.2014.07.006; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; Lardy H., 1967, METHOD ENZYMOL, V10, P94, DOI [DOI 10.1016/0076-6879(67)10018-9, 10.1016/0076-6879(67)10018-9]; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Martynov VI, 2016, ACTA NATURAE, V8, P33, DOI 10.32607/20758251-2016-8-4-33-46; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; NAGAMUNE H, 1993, BIOCHIM BIOPHYS ACTA, V1141, P231, DOI 10.1016/0005-2728(93)90047-J; Nazarov PA, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020309; Nazarov PA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00802-8; Normoyle KP, 2015, TRANSL NEUROSCI, V6, P179, DOI 10.1515/tnsci-2015-0019; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Perevoshchikova IV, 2008, BBA-BIOMEMBRANES, V1778, P2182, DOI 10.1016/j.bbamem.2008.04.008; Perevoshchikova IV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P497, DOI 10.1134/S0006297911050014; Perevoshchikova IV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P663, DOI 10.1134/S000629790906011X; Plotnikov EY, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1029, DOI 10.1134/S0006297912090106; Popova LB, 2019, BIOCHEMISTRY-MOSCOW+, V84, P1151, DOI 10.1134/S0006297919100043; Rokitskaya TI, 2019, BIOCONJUGATE CHEM, V30, P2435, DOI 10.1021/acs.bioconjchem.9b00516; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; SCHWALLER MA, 1995, J BIOL CHEM, V270, P22709, DOI 10.1074/jbc.270.39.22709; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Silachev DN, 2015, B EXP BIOL MED+, V159, P528, DOI 10.1007/s10517-015-3009-3; Silachev DN, 2014, BBA-GEN SUBJECTS, V1840, P3434, DOI 10.1016/j.bbagen.2014.09.002; STARKOV AA, 1994, FEBS LETT, V355, P305, DOI 10.1016/0014-5793(94)01211-3; Wang J, 2018, TOXICOL SCI, V161, P431, DOI 10.1093/toxsci/kfx218	44	2	2	2	6	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0006-2979	1608-3040		BIOCHEMISTRY-MOSCOW+	Biochem.-Moscow	DEC	2020	85	12-13			SI		1578	1590		10.1134/S000629792012010X			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7TX	WOS:000603320400010	33705296				2022-02-06	
J	Jung, HY; Kim, W; Kwon, HJ; Yoo, DY; Nam, SM; Hahn, KR; Yi, SS; Choi, JH; Kim, DW; Yoon, YS; Hwang, IK				Jung, Hyo Young; Kim, Woosuk; Kwon, Hyun Jung; Yoo, Dae Young; Nam, Sung Min; Hahn, Kyu Ri; Yi, Sun Shin; Choi, Jung Hoon; Kim, Dae Won; Yoon, Yeo Sung; Hwang, In Koo			Physical Stress Induced Reduction of Proliferating Cells and Differentiated Neuroblasts Is Ameliorated by Fermented Laminaria japonica Extract Treatment	MARINE DRUGS			English	Article						stress; corticosterone; fermented Laminaria japonica extract; dentate gyrus; neurogenesis	NEUROTROPHIC FACTOR; PSYCHOLOGICAL STRESS; MESSENGER-RNA; HIPPOCAMPAL NEUROGENESIS; DOWN-REGULATION; MOUSE MODEL; FEMALE RATS; BRAIN; NEURONS; MEMORY	Laminaria japonica is widely cultivated in East Asia, including South Korea. Fucoidan, a main component of L. japonica, protects neurons from neurological disorders such as ischemia and traumatic brain injury. In the present study, we examined the effects of extract from fermented L. japonica on the reduction of proliferating cells and neuroblasts in mice that were physically (with electric food shock) or psychologically (with visual, auditory and olfactory sensation) stressed with the help of a communication box. Vehicle (distilled water) or fermented L. japonica extract (50 mg/kg) were orally administered to the mice once a day for 21 days. On the 19th day of the treatment, physical and psychological stress was induced by foot shock using a communication box and thereafter for three days. Plasma corticosterone levels were significantly increased after exposure to physical stress and decreased Ki67 positive proliferating cells and doublecortin immunoreactive neuroblasts. In addition, western blot analysis demonstrated that physical stress as well as psychological stress decreased the expression levels of brain-derived neurotrophic factor (BDNF) and the number of phosphorylated cAMP response element binding protein (pCREB) positive nuclei in the dentate gyrus. Fermentation of L. japonica extract significantly increased the contents of reduced sugar and phenolic compounds. Supplementation with fermented L. japonica extract significantly ameliorated the increases of plasma corticosterone revels and decline in the proliferating cells, neuroblasts, and expression of BDNF and pCREB in the physically stressed mice. These results indicate that fermented L. japonica extract has positive effects in ameliorating the physical stress induced reduction in neurogenesis by modulating BDNF and pCREB expression in the dentate gyrus.	[Jung, Hyo Young; Kim, Woosuk; Hahn, Kyu Ri; Yoon, Yeo Sung; Hwang, In Koo] Seoul Natl Univ, Coll Vet Med, Dept Anat & Cell Biol, Seoul 08826, South Korea; [Jung, Hyo Young; Kim, Woosuk; Hahn, Kyu Ri; Yoon, Yeo Sung; Hwang, In Koo] Seoul Natl Univ, Res Inst Vet Sci, Seoul 08826, South Korea; [Kim, Woosuk] Hallym Univ, Dept Biomed Sci, Chunchon 24252, South Korea; [Kim, Woosuk] Hallym Univ, Res Inst Biosci & Biotechnol, Chunchon 24252, South Korea; [Kwon, Hyun Jung; Kim, Dae Won] Gangneung Wonju Natl Univ, Coll Dent, Res Inst Oral Sci, Dept Biochem & Mol Biol, Kangnung 25457, South Korea; [Yoo, Dae Young] Soonchunhyang Univ, Coll Med, Dept Anat, Cheonan 31151, South Korea; [Nam, Sung Min] Wonkwang Univ, Sch Med, Dept Anat, Iksan 54538, South Korea; [Nam, Sung Min] Wonkwang Univ, Inst Environm Sci, Iksan 54538, South Korea; [Yi, Sun Shin] Soonchunhyang Univ, Coll Med Sci, Dept Biomed Lab Sci, Asan 31538, South Korea; [Choi, Jung Hoon] Kangwon Natl Univ, Coll Vet Med, Dept Anat, Chunchon 24341, South Korea; [Choi, Jung Hoon] Kangwon Natl Univ, Inst Vet Sci, Chunchon 24341, South Korea		Hwang, IK (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Anat & Cell Biol, Seoul 08826, South Korea.; Hwang, IK (corresponding author), Seoul Natl Univ, Res Inst Vet Sci, Seoul 08826, South Korea.	hyoyoung@snu.ac.kr; tank3430@hallym.ac.kr; donuts25@gwnu.ac.kr; dyyoo@sch.ac.kr; namvet1@wku.ac.kr; hkinging@snu.ac.kr; admiral96@sch.ac.kr; jhchoi@kangwon.ac.kr; kimdw@gwnu.ac.kr; ysyoon@snu.ac.kr; vetmed2@snu.ac.kr		Jung, Hyo Young/0000-0001-5725-6574	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2016R1A2B4009156]; Research Institute for Veterinary Science of Seoul National University	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. NRF-2016R1A2B4009156). In addition, this study was partially supported by the Research Institute for Veterinary Science of Seoul National University.	Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; Alam MJ, 2018, J NEUROSCI, V38, P6854, DOI 10.1523/JNEUROSCI.2976-17.2018; Alghazwi M, 2019, INT J BIOL MACROMOL, V122, P255, DOI 10.1016/j.ijbiomac.2018.10.168; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barrientos RM, 2003, NEUROSCIENCE, V121, P847, DOI 10.1016/S0306-4522(03)00564-5; Bath KG, 2016, HORM BEHAV, V82, P64, DOI 10.1016/j.yhbeh.2016.04.010; Belanoff JK, 2001, J PSYCHIATR RES, V35, P127, DOI 10.1016/S0022-3956(01)00018-8; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Braun SMG, 2014, NEUROPATH APPL NEURO, V40, P3, DOI 10.1111/nan.12107; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Caltagirone C, 2012, AGING CLIN EXP RES, V24, P580, DOI 10.3275/8585; Campbell T, 2003, PHYSIOL BEHAV, V78, P495, DOI 10.1016/S0031-9384(03)00033-7; Cao YG, 2016, BIOMED PHARMACOTHER, V84, P1705, DOI 10.1016/j.biopha.2016.10.082; Cao YG, 2011, BRAIN RES BULL, V85, P396, DOI 10.1016/j.brainresbull.2011.05.002; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Cinini SM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00045; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dard RF, 2019, HIPPOCAMPUS, V29, P579, DOI 10.1002/hipo.23052; Dodiya HB, 2020, NEUROBIOL DIS, V135, DOI 10.1016/j.nbd.2018.12.012; Du Preez A, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01000-3; Endo Y, 2001, Med Sci Monit, V7, P1161; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esch T, 2002, NEUROENDOCRINOL LETT, V23, P199; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Finkbeiner S, 2000, CELL MOL LIFE SCI, V57, P394, DOI 10.1007/PL00000701; Gouveia K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56860-7; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Han Ji-Sook, 2006, Preventive Nutrition and Food Science, V11, P10; Hannan MA, 2020, MAR DRUGS, V18, DOI 10.3390/md18070347; Hannan MA, 2012, IN VITRO CELL DEV-AN, V48, P535, DOI 10.1007/s11626-012-9537-5; Harris NG, 2013, J NEUROTRAUM, V30, P1257, DOI 10.1089/neu.2012.2737; Hewitt SM, 2014, J HISTOCHEM CYTOCHEM, V62, P693, DOI 10.1369/0022155414545224; Hill AS, 2015, NEUROPSYCHOPHARMACOL, V40, P2368, DOI 10.1038/npp.2015.85; Huether G, 1999, PSYCHIAT RES, V87, P83, DOI 10.1016/S0165-1781(99)00044-X; Hwang IK, 2010, J VET MED SCI, V72, P1431, DOI 10.1292/jvms.09-0527; Israel I, 2018, CURR NEUROVASC RES, V15, P55, DOI 10.2174/1567202615666180319152007; Jafari M, 2014, EXCLI J, V13, P161; Jafari Z, 2019, NEUROBIOL AGING, V77, P66, DOI 10.1016/j.neurobiolaging.2019.01.019; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Jung HY, 2019, NEUROCHEM RES, V44, P323, DOI 10.1007/s11064-018-2678-5; Katina K, 2007, FOOD MICROBIOL, V24, P175, DOI 10.1016/j.fm.2006.07.012; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kim H, 2019, BIOMED PHARMACOTHER, V109, P1718, DOI 10.1016/j.biopha.2018.11.015; Kim IH, 2014, PHARM BIOL, V52, P335, DOI 10.3109/13880209.2013.837074; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lafenetre P, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/neuro.08.034.2009; Lee B, 2013, J NAT MED-TOKYO, V67, P534, DOI 10.1007/s11418-012-0712-5; Lee CH, 2011, NEUROCHEM RES, V36, P1767, DOI 10.1007/s11064-011-0492-4; Li GY, 2016, NEUROSCI LETT, V624, P34, DOI 10.1016/j.neulet.2016.04.039; Li MX, 2020, BIOCHEM BIOPH RES CO, V521, P318, DOI 10.1016/j.bbrc.2019.10.043; Li Q, 2005, STRESS, V8, P107, DOI 10.1080/10253890500140972; Li Q, 2013, NEURAL REGEN RES, V8, P2838, DOI 10.3969/j.issn.1673-5374.2013.30.006; Lin HTV, 2016, PROCESS BIOCHEM, V51, P1945, DOI 10.1016/j.procbio.2016.08.024; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; MARSDEN WL, 1982, J CHEM TECHNOL BIOT, V32, P1016, DOI 10.1002/jctb.5030320744; McEwen BS, 2000, NEUROCHEM RES, V25, P1219, DOI 10.1023/A:1007687911139; Ming JX, 2021, J ETHNOPHARMACOL, V265, DOI 10.1016/j.jep.2020.113302; Mohibbullah M, 2016, CELL MOL NEUROBIOL, V36, P669, DOI 10.1007/s10571-015-0247-x; Murata Y, 2017, J AFFECT DISORDERS, V209, P209, DOI 10.1016/j.jad.2016.11.046; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nam SM, 2013, EXP GERONTOL, V48, P1369, DOI 10.1016/j.exger.2013.09.002; Ning C, 2018, BIOMED ENG ONLINE, V17, DOI 10.1186/s12938-018-0477-5; Odagiri K, 2008, NEUROSCI LETT, V446, P25, DOI 10.1016/j.neulet.2008.09.028; Ondrejcak T, 2010, NEUROMOL MED, V12, P13, DOI 10.1007/s12017-009-8091-0; Otten U, 2000, ANN NY ACAD SCI, V917, P322; Pabon MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045256; Park HS, 2017, ADV APPL MICROBIOL, V100, P161, DOI 10.1016/bs.aambs.2017.03.001; Park HJ, 2016, ALGAE-SEOUL, V31, P73, DOI 10.4490/algae.2016.31.11.10; Park SK, 2019, MAR DRUGS, V17, DOI 10.3390/md17100591; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Pereira-Caixeta AR, 2018, NEUROBIOL LEARN MEM, V155, P92, DOI 10.1016/j.nlm.2018.06.014; Pinnock SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013652; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pyter LM, 2013, BRAIN BEHAV IMMUN, V30, P88, DOI 10.1016/j.bbi.2013.01.075; Rasmusson AM, 2002, NEUROPSYCHOPHARMACOL, V27, P133, DOI 10.1016/S0893-133X(02)00286-5; Reid SNS, 2018, NUTR RES PRACT, V12, P199, DOI [10.4162/nrp.2018.12.3.199, 10.4162/nrp.201]; Richetin K, 2015, BRAIN, V138, P440, DOI 10.1093/brain/awu354; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Rubin RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00742; Sasaki K, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00900; Schepers M, 2020, NEURAL REGEN RES, V15, P790, DOI 10.4103/1673-5374.268894; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Shields GS, 2019, PSYCHONEUROENDOCRINO, V106, P138, DOI 10.1016/j.psyneuen.2019.04.001; Shirosaki M, 2011, ADV FOOD NUTR RES, V64, P199, DOI 10.1016/B978-0-12-387669-0.00015-6; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Fernandez MS, 2019, BEHAV BRAIN RES, V364, P317, DOI 10.1016/j.bbr.2019.02.035; Souza RB, 2017, BASIC CLIN PHARMACOL, V120, P159, DOI 10.1111/bcpt.12669; Suri D, 2013, NEUROSCIENCE, V239, P196, DOI 10.1016/j.neuroscience.2012.08.065; Takahashi A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12811-8; Toledo-Rodriguez M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00017; Tsai CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9373; Wang FW, 2021, NAT PROD RES, V35, P5323, DOI 10.1080/14786419.2020.1753738; Wang GH, 2019, J BIOSCI BIOENG, V127, P59, DOI 10.1016/j.jbiosc.2018.06.015; Wang T, 2016, CELL MOL NEUROBIOL, V36, P1257, DOI 10.1007/s10571-015-0323-2; White BC, 1996, ANN EMERG MED, V27, P588, DOI 10.1016/S0196-0644(96)70161-0; Wu YP, 2019, NEURAL REGEN RES, V14, P298, DOI 10.4103/1673-5374.244792; Yoo DY, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1534; Zhang L, 2018, AGING DIS, V9, P590, DOI 10.14336/AD.2017.0831	100	2	2	3	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-3397		MAR DRUGS	Mar. Drugs	DEC	2020	18	12							587	10.3390/md18120587			17	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pharmacology & Pharmacy	PJ9CR	WOS:000602056500001	33255381	Green Published, gold			2022-02-06	
J	Katar, S; Ozturk, PA; Ozel, M; Arac, S; Evran, S; Cevik, S; Baran, O				Katar, Salim; Aydin Ozturk, Pinar; Ozel, Mehmet; Arac, Songul; Evran, Sevket; Cevik, Serdar; Baran, Oguz			The Use of Rotterdam CT Score for Prediction of Outcomes in Pediatric Traumatic Brain Injury Patients Admitted to Emergency Service	PEDIATRIC NEUROSURGERY			English	Article						Pediatric traumatic brain injuries; Rotterdam CT score; Glasgow coma scale	NERVE SHEATH DIAMETER	Introduction: Rotterdam CT score for prediction of outcome in traumatic brain injury is widely used for patient evaluation. The data on the assessment of pediatric traumatic brain injury patients with the Rotterdam scale in our country are still limited. In this study, we aimed to evaluate the use of the Rotterdam scale on pediatric trauma patients in our country and assess its relationship with lesion type, location and severity, trauma type, and need for surgery. Methods: A total of 229 pediatric patients admitted to the emergency service due to head trauma were included in our study. Patients were evaluated in terms of age, gender, Glasgow Coma Scale (GCS), initial and follow-up Rotterdam scale scores, length of stay, presence of other traumas, seizures, antiepileptic drug use, need for surgical necessity, and final outcome. Results: A total of 229 patients were included in the study, and the mean age of the patients was 95.8 months. Of the patients, 87 (38%) were girls and 142 (62%) were boys. Regarding GCS at the time of admission, 59% (n = 135) of the patients had mild (GCS = 13-15), 30.6% (n = 70) had moderate (GCS = 9-12), and 10.5% (n = 24) had severe (GCS < 9) head trauma. The mean Rotterdam scale score was calculated as 1.51 (ranging from 1 to 3) for mild, 2.22 (ranging from 1 to 4) for moderate, and 4.33 (ranging from 2 to 6) for severe head trauma patients. Rotterdam scale score increases significantly as the degree of head injury increases (p < 0.001). Discussion: With the adequate use of GCS and cerebral computed tomography imaging, pediatric patients with a higher risk of mortality and need for surgery can be predicted. We recommend the follow-up of pediatric traumatic brain injury patients with repeated CT scans to observe alterations in Rotterdam CT scores, which may be predictive for the need for surgery and intensive care.	[Katar, Salim] Balikesir Univ, Dept Neurosurg, Balikesir, Turkey; [Aydin Ozturk, Pinar] Univ Hlth Sci, Diyarbakir Gazi Yasargil Educ & Res Hosp, Dept Neurosurg, TR-21010 Diyarbakir, Turkey; [Ozel, Mehmet; Arac, Songul] Univ Hlth Sci, Diyarbakir Gazi Yasargil Educ & Res Hosp, Dept Emergency Med, Diyarbakir, Turkey; [Evran, Sevket] Haseki Educ & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Cevik, Serdar] Gelisim Univ, Sch Hlth Sci, Dept Phys Therapy & Rehabil, Istanbul, Turkey; [Cevik, Serdar] Mem Sisli Hosp, Dept Neurosurg, Istanbul, Turkey; [Baran, Oguz] Koc Univ Hosp, Dept Neurosurg, Istanbul, Turkey		Ozturk, PA (corresponding author), Univ Hlth Sci, Diyarbakir Gazi Yasargil Educ & Res Hosp, Dept Neurosurg, TR-21010 Diyarbakir, Turkey.	aydinpinar12@gmail.com	BARAN, Oguz/AAG-3278-2019; OZTURK, PINAR AYDIN/AAL-5274-2021; Cevik, Serdar/G-7161-2018; EVRAN, Sevket/AAG-3284-2019	OZTURK, PINAR AYDIN/0000-0002-7688-7774; Baran, Oguz/0000-0002-2345-4318			Crawford AM, 2019, J TRAUMA ACUTE CARE, V87, pS146, DOI 10.1097/TA.0000000000002256; Das SK, 2017, POL J RADIOL, V82, P240, DOI 10.12659/PJR.900196; Faheem M, 2019, PEDIATR NEUROSURG, V54, P237, DOI 10.1159/000501043; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Mikkonen ED, 2019, J NEUROSURG-PEDIATR, V24, P476, DOI 10.3171/2019.7.PEDS1983a; Miles DK, 2020, CHILD NERV SYST, V36, P1453, DOI 10.1007/s00381-020-04516-7; Ongun EA, 2018, ULUS TRAVMA ACIL CER, V24, P199, DOI 10.5505/tjtes.2017.37906; Parmontree P, 2019, J NEUROSCI RURAL PRA, V10, P582, DOI 10.1055/s-0039-1700791; Rehman L, 2019, J NEUROSCI RURAL PRA, V10, P212, DOI 10.4103/jnrp.jnrp_335_18; Talari HR, 2019, WORLD NEUROSURG, V125, pE139, DOI 10.1016/j.wneu.2018.12.221; Waqas M, 2016, J NEURORADIOLOGY, V43, P25, DOI 10.1016/j.neurad.2015.07.003	14	2	2	1	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.	DEC	2020	55	5					237	243		10.1159/000510016			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	PH6NY	WOS:000600528100001	33147582				2022-02-06	
J	Kulkarni, P; Bhosle, MR; Lu, SF; Simon, NS; Iriah, S; Brownstein, MJ; Ferris, CF				Kulkarni, Praveen; Bhosle, Mansi R.; Lu, Shi-fang; Simon, Neal S.; Iriah, Sade; Brownstein, Michael J.; Ferris, Craig F.			Evidence of early vasogenic edema following minor head impact that can be reduced with a vasopressin V1a receptor antagonist	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Diffusion weighted imaging; Apparent diffusion coefficient; Magnetic resonance imaging; Cerebellum	TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; FUNCTIONAL CONNECTIVITY; BARRIER PERMEABILITY; PROFESSIONAL BOXERS; AQP4 EXPRESSION; BLOOD; DIFFUSION; DAMAGE; V-1A	Background: Does minor head impact without signs of structural brain damage cause short-term changes in vasogenic edema as measured by an increase apparent diffusion coefficient (ADC) using diffusion weighted imaging? If so, could the increase in vasogenic edema be treated with a vasopressin V1a receptor antagonist? We hypothesized that SRX251, a highly selective V1a antagonist, would reduce vasogenic edema in response to a single minor head impact. Methods: Lightly anesthetized male rats were subjected to a sham procedure or a single hit to the forehead using a closed skull, momentum exchange model. Animals recovered in five min and were injected with saline vehicle (n = 8) or SRX251 (n = 8) at 15 min post head impact and again 7-8 hrs later. At 2 h, 6 h, and 24 h post injury, rats were anesthetized and scanned for increases in ADC, a neurological measure of vasogenic edema. Sham rats (n = 6) were exposed to anesthesia and scanned at all time points but were not hit or treated. Images were registered to and analyzed using a 3D MRI rat atlas providing site-specific data on 150 different brain areas. These brain areas were parsed into 11 major brain regions. Results: Untreated rats with brain injury showed a significant increase in global brain vasogenic edema as compared to sham and SRX251 treated rats. Edema peaked at 6 h in injured, untreated rats in three brain regions where changes in ADC were observed, but returned to sham levels by 24 h. There were regional variations in the time course of vasogenic edema and drug efficacy. Edema was significantly reduced in cerebellum and thalamus with SRX251 treatment while the basal ganglia did not show a response to treatment. Conclusion: A single minor impact to the forehead causes regional increases in vasogenic edema that peak at 6 h but return to baseline within a day in a subset of brain regions. Treatment with a selective V1a receptor antagonist can reduce much of the edema.	[Kulkarni, Praveen; Bhosle, Mansi R.; Iriah, Sade; Ferris, Craig F.] Northeastern Univ, Ctr Translat Neuroimaging, Boston, MA 02115 USA; [Lu, Shi-fang; Simon, Neal S.; Brownstein, Michael J.] Azevan Pharmaceut, Bethlehem, PA USA; [Lu, Shi-fang; Simon, Neal S.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Ferris, Craig F.] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Ferris, Craig F.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA		Ferris, CF (corresponding author), Ctr Translat NeuroImaging, 360 Huntington Ave, Boston, MA 02115 USA.	c.ferris@northeastern.edu			National Institute of Neurological Disorders and Stroke United States SBIR award [1R43NS110343]; Azevan Pharmaceuticals, Inc.	Supported in part by National Institute of Neurological Disorders and Stroke United States SBIR award 1R43NS110343 to M.J.B, (C.F. and N. G.S., co-Investigators) and Azevan Pharmaceuticals, Inc.	Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; [Anonymous], 2018, EP REH; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cai XZ, 2019, BRAIN RES, V1706, P58, DOI 10.1016/j.brainres.2018.10.033; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Cui T, 2015, CELL BIOCHEM BIOPHYS, V71, P595, DOI 10.1007/s12013-014-0239-3; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Ferris C.F., 2019, NEUROBIOL PAIN, V6, P246; Filippidis AS, 2014, J NEUROTRAUM, V31, P1258, DOI 10.1089/neu.2013.3063; Finan JD, 2019, CLIN BIOMECH, V64, P114, DOI 10.1016/j.clinbiomech.2018.01.015; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Gultekin R, 2016, INJURY, V47, P516, DOI 10.1016/j.injury.2015.10.011; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JENNETT B, 1977, LANCET, V1, P878; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jungner M, 2016, MINERVA ANESTESIOL, V82, P525; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Kozniewska E, 2008, J PHYSIOL PHARMACOL, V59, P109; Krieg SM, 2017, J NEUROTRAUM, V34, P1329, DOI 10.1089/neu.2016.4514; Krieg SM, 2015, J NEUROTRAUM, V32, P221, DOI 10.1089/neu.2013.3274; Kulkarni P, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00034; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Li W, 2016, BRAIN RES, V1646, P53, DOI 10.1016/j.brainres.2016.05.036; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Morrison TR, 2020, NEUROSCI LETT, V714, DOI 10.1016/j.neulet.2019.134565; Morrison Thomas R, 2014, Curr Top Behav Neurosci, V17, P189, DOI 10.1007/7854_2014_283; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Pascale CL, 2006, J PHYSIOL PHARMACOL, V57, P161; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; Ren HH, 2019, NEUROREPORT, V30, P605, DOI 10.1097/WNR.0000000000001213; Rossi-Mossuti F, 2016, J NEUROL SURG PART A, V77, P36, DOI 10.1055/s-0035-1563556; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Szczygielski J, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00273; Szczygielski J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00799; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Szmydynger-Chodobska J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079328; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Toth A., 2015, BRAIN NEUROTRAUMA MO; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DW, 2015, NEW ENGL J MED, V372, P1766, DOI 10.1056/NEJMc1503138; Young LJ, 1999, J NEUROENDOCRINOL, V11, P291; Yu MM, 2019, MAGN RESON IMAGING, V62, P1, DOI 10.1016/j.mri.2019.01.017; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	79	2	2	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	DEC	2020	165						218	227		10.1016/j.brainresbull.2020.10.001			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OT2IZ	WOS:000590676900004	33053434	Green Accepted			2022-02-06	
J	Liebel, SW; Van Pelt, KL; Garcia, GGP; Czerniak, LL; McCrea, MA; McAllister, TW; Broglio, SP				Liebel, Spencer W.; Van Pelt, Kathryn L.; Garcia, Gian-Gabriel P.; Czerniak, Lauren L.; McCrea, Michael A.; McAllister, Thomas W.; Broglio, Steven P.		CARE Consortium Investigators	The Relationship between Sport-Related Concussion and Sensation-Seeking	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						concussion; sensation-seeking; concussion management and care; college athletes		Sensation-seeking, or the need for novel and exciting experiences, is thought to play a role in sport-related concussion (SRC), yet much remains unknown regarding these relationships and, more importantly, how sensation-seeking influences SRC risk. The current study assessed sensation-seeking, sport contact level, and SRC history and incidence in a large sample of NCAA collegiate athletes. Data included a full study sample of 22,374 baseline evaluations and a sub-sample of 2037 incident SRC. Independent samples t-test, analysis of covariance, and hierarchical logistic regression were constructed to address study hypotheses. Results showed that (1) among participants without SRC, sensation-seeking scores were higher in athletes playing contact sports compared to those playing limited- or non-contact sports (p < 0.001, R-2 = 0.007, eta(2)(p) = 0.003); (2) in the full study sample, a one-point increase in sensation-seeking scores resulted in a 21% greater risk of prior SRC (OR = 1.212; 95% CI: 1.154-1.272), and in the incident SRC sub-sample, a 28% greater risk of prior SRC (OR = 1.278; 95% CI: 1.104-1.480); (3) a one-point increase in sensation-seeking scores resulted in a 12% greater risk of incident SRC among the full study sample; and (4) sensation-seeking did not vary as a function of incident SRC (p = 0.281, eta(2)(p) = 0.000). Our findings demonstrate the potential usefulness of considering sensation-seeking in SRC management.	[Liebel, Spencer W.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Liebel, Spencer W.; Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [Van Pelt, Kathryn L.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40504 USA; [Garcia, Gian-Gabriel P.; Czerniak, Lauren L.] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Wauwatosa, WI 53226 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA		Liebel, SW (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.; Liebel, SW (corresponding author), Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA.	spenceli@med.umich.edu; kathryn.oconnor@uky.edu; garciagg@umich.edu; czernl@umich.edu; mmccrea@mcw.edu; twmcalli@iupui.edu; broglio@umich.edu		Van Pelt, Kathryn/0000-0002-5494-2357; Czerniak, Lauren/0000-0003-4379-2004; Liebel, Spencer/0000-0002-7036-4198	Grand Alliance CARE Consortium - NCAA; Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; Department of Defense (Defense Health Program funds)	This research was funded, in part, by support from the Grand Alliance CARE Consortium, funded by the NCAA and the Department of Defense. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, USA, is the awarding and administering acquisition office. This work was supported by the O ffice of the Assistant Secretary of Defense for Health A ffairs through the Psychological Health and Traumatic Brain Injury Program under award no. W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (Defense Health Program funds).	Allen MS, 2017, HEALTH PSYCHOL, V36, P332, DOI 10.1037/hea0000371; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Beidler E, 2017, SPORT EXERC PERFORM, V6, P252, DOI 10.1037/spy0000107; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Broglio SP, 2018, HAND CLINIC, V158, P193, DOI 10.1016/B978-0-444-63954-7.00019-7; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Caspi A, 1997, J PERS SOC PSYCHOL, V73, P1052, DOI 10.1037/0022-3514.73.5.1052; Castanier C, 2010, RES Q EXERCISE SPORT, V81, P478, DOI 10.5641/027013610X13088600029418; Cross CP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02486; Dretsch MN, 2017, J NEUROTRAUM, V34, P869, DOI 10.1089/neu.2016.4480; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Glicksohn J., 2018, DEV PATHWAYS DISRUPT, P183; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Greve KW, 2001, BRAIN INJURY, V15, P255; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Hoyle RH, 2002, PERS INDIV DIFFER, V32, P401, DOI 10.1016/S0191-8869(01)00032-0; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Jack SJ, 1998, PERS INDIV DIFFER, V25, P1063, DOI 10.1016/S0191-8869(98)00081-6; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lynne-Landsman SD, 2011, J YOUTH ADOLESCENCE, V40, P48, DOI 10.1007/s10964-010-9529-2; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McEwan D, 2019, J RES PERS, V79, P83, DOI 10.1016/j.jrp.2019.02.006; Merritt VC, 2015, DEV NEUROPSYCHOL, V40, P45, DOI 10.1080/87565641.2014.979928; Mosti C, 2018, J NEUROPSYCH CLIN N, V30, P220, DOI 10.1176/appi.neuropsych.17070141; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; O?Connor KL, 2017, BRIT J SPORT MED, V51, pA33, DOI DOI 10.1136/BJSPORTS-2016-097270.84; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Primi C, 2011, TPM-TEST PSYCHOM MET, V18, P231, DOI 10.4473/TPM.18.4.3; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Saletti SR, 2017, PSICOTHEMA, V29, P133, DOI 10.7334/psicothema2016.144; Rush BK, 2004, REHABIL PSYCHOL, V49, P275, DOI 10.1037/0090-5550.49.4.275; SCHROTH ML, 1995, PERS INDIV DIFFER, V18, P219, DOI 10.1016/0191-8869(94)00144-H; Sharma L, 2014, PSYCHOL BULL, V140, P374, DOI 10.1037/a0034418; Shulman EP, 2015, J YOUTH ADOLESCENCE, V44, P1, DOI 10.1007/s10964-014-0116-9; Smith GT, 2007, ASSESSMENT, V14, P155, DOI 10.1177/1073191106295527; Spinella M, 2007, INT J NEUROSCI, V117, P359, DOI 10.1080/00207450600588881; Stephenson MT, 2003, DRUG ALCOHOL DEPEN, V72, P279, DOI 10.1016/j.drugalcdep.2003.08.003; Veliz P, 2021, SUBST ABUS, V42, P183, DOI 10.1080/08897077.2019.1671938; Wood TA, 2019, AM J PHYS MED REHAB, V98, P566, DOI 10.1097/PHM.0000000000001152; Zuckerman, 2007, SENSATION SEEKING RI; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	52	2	2	1	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	DEC	2020	21	23							9097	10.3390/ijms21239097			12	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Chemistry	PD8BA	WOS:000597902300001	33265913	Green Published, gold			2022-02-06	
J	Lu, YC; Wu, MK; Zhang, L; Zhang, CL; Lu, YY; Wu, CH				Lu, Yueh-Chien; Wu, Ming-Kung; Zhang, Li; Zhang, Cong-Liang; Lu, Ying-Yi; Wu, Chieh-Hsin			Association between suicide risk and traumatic brain injury in adults: a population based cohort study	POSTGRADUATE MEDICAL JOURNAL			English	Article							PSYCHIATRIC-DISORDERS; BEHAVIOR; ADOLESCENTS; DEPRESSION; PREVALENCE; VETERANS; IDEATION; IMPACT; IRAQ	Background Traumatic brain injury (TBI) is a major cause of death and disability worldwide, and its treatment is potentially a heavy economic burden. Suicide is another global public health problem and the second leading cause of death in young adults. Patients with TBI are known to have higher than normal rates of non-fatal deliberate self-harm, suicide and all-cause mortality. The aim of this study was to explore the association between TBI and suicide risk in a Chinese cohort. Method This study analysed data contained in the Taiwan National Health Insurance Research Database for 17 504 subjects with TBI and for 70 016 subjects without TBI matched for age and gender at a ratio of 1 to 4. Cox proportional hazard regression analysis was used to estimate subsequent suicide attempts in the TBI group. Probability of attempted suicide was determined by Kaplan-Meier method. Results The overall risk of suicide attempts was 2.23 times higher in the TBI group compared with the non-TBI group (0.98 vs 0.29 per 1000 person-years, respectively) after adjustment for covariates. Regardless of gender, age or comorbidity, the TBI group tended to have more suicide attempts, and the risk attempted suicide increased with the severity of TBI. Depression and alcohol attributed disease also increased the risk of attempted suicide in the TBI group. Conclusion Suicide is preventable if risk factors are recognised. Hence, TBI patients require special attention to minimise their risk of attempted suicide.	[Lu, Yueh-Chien] Kaohsiung Chang Gung Mem Hosp, Dept Family Med, Kaohsiung, Taiwan; [Lu, Yueh-Chien; Wu, Ming-Kung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Wu, Ming-Kung] Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Zhang, Li] Soochow Univ, Affiliated Zhangjiagang Hosp, Dept Neurosurg, Zhangjiagang, Peoples R China; [Zhang, Cong-Liang] Hebei Quyang Renji Hosp, Dept Cardiol, Quyang, Peoples R China; [Lu, Ying-Yi] Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Lu, Ying-Yi] Shu Zen Jr Coll Med & Management, Dept Nursing, Kaohsiung, Taiwan; [Lu, Ying-Yi] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Wu, Chieh-Hsin] Kaohsiung Med Univ Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan; [Wu, Chieh-Hsin] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Surg, Kaohsiung, Taiwan		Wu, CH (corresponding author), Kaohsiung Med Univ Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan.; Wu, CH (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Dept Surg, Kaohsiung, Taiwan.	wujoeys@gmail.com			Kaohsiung Medical University Hospital [KMUH105-5M17, KMUH106-6T09, KMUH108--8M23, KMU-Q108029]	This work was supported by KMUH105-5M17, KMUH106-6T09,KMUH108--8M23 and KMU-Q108029 from Kaohsiung Medical University Hospital.	Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Chi YC, 2016, J AFFECT DISORDERS, V191, P56, DOI 10.1016/j.jad.2015.11.035; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Chung KH, 2015, J CLIN SLEEP MED, V11, P542, DOI 10.5664/jcsm.4700; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; Fonda JR, 2017, AM J EPIDEMIOL, V186, P220, DOI 10.1093/aje/kwx044; Gaynes BN, 2004, ANN INTERN MED, V140, P822, DOI 10.7326/0003-4819-140-10-200405180-00015; Gvion Y, 2011, ARCH SUICIDE RES, V15, P93, DOI 10.1080/13811118.2011.565265; Hartkopp A, 1998, ARCH PHYS MED REHAB, V79, P1356, DOI 10.1016/S0003-9993(98)90227-1; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Hu LY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002800; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kolakowsky-Hayner SA, 2012, BRAIN INJURY, V26, P1328, DOI 10.3109/02699052.2012.706353; Krishnamoorthy V, 2015, J TRAUMA NURS, V22, P204, DOI 10.1097/JTN.0000000000000135; Lin HT, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1702-2; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ougrin D, 2015, J AM ACAD CHILD PSY, V54, P97, DOI 10.1016/j.jaac.2014.10.009; Roy D, 2018, PSYCHOSOMATICS, V59, P47, DOI 10.1016/j.psym.2017.07.008; Ruan XL, 2017, BRAIN INJURY, V31, P717, DOI 10.1080/02699052.2017.1282043; Saxena S, 2014, PREVENTING SUICIDE G; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tung YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129043; Turecki G, 2016, LANCET, V387, P1227, DOI 10.1016/S0140-6736(15)00234-2; Wei HT, 2016, J PEDIATR-US, V177, P292, DOI 10.1016/j.jpeds.2016.06.057; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Wu CH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8030676; Zalsman G, 2016, LANCET PSYCHIAT, V3, P646, DOI 10.1016/S2215-0366(16)30030-X	33	2	2	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0032-5473	1469-0756		POSTGRAD MED J	Postgrad. Med. J.	DEC	2020	96	1142					747	752		10.1136/postgradmedj-2019-136860			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	PR5IB	WOS:000607269100006	32015186	Green Published, hybrid			2022-02-06	
J	Nieves, MD; Furmanski, O; Doughty, ML				Nieves, Michael D.; Furmanski, Orion; Doughty, Martin L.			Host sex and transplanted human induced pluripotent stem cell phenotype interact to influence sensorimotor recovery in a mouse model of cortical contusion injury	BRAIN RESEARCH			English	Article						Neural stem cells; Traumatic brain injury; Controlled cortical impact sensorimotor; Induced pluripotent stem cells; Transplantation	TRAUMATIC BRAIN-INJURY; FUNCTIONAL MATURATION; NEURONS; GENERATION; INDUCTION; EFFICIENT; DEFICITS; REPAIR; CNS	Traumatic brain injury (TBI) is a substantial cause of disability and death worldwide. Primary head trauma triggers chronic secondary injury mechanisms in the brain that are a focus of therapeutic efforts to treat TBI. Currently, there is no successful clinical strategy to repair brain injury. Cell transplantation therapies have demonstrated promise in attenuating secondary injury mechanisms of neuronal death and dysfunction in animal models of brain injury. In this study, we used a unilateral cortical contusion injury (CCI) model of sensorimotor brain injury to examine the effects of human induced pluripotent stem cell (hiPSC) transplantation on pathology in male and female adult mice. We determined transplanted hiPSC-derived neural stem cells (NSCs) and neuroblasts but not astrocytes best tolerate the injured host environment. Surviving NSC and neuroblast cells were clustered at the site of injection within the deep layers of the cortex and underlying corpus callosum. Cell grafts extended neuritic processes that crossed the midline into the contralateral corpus callosum or continued laterally within the external capsule to enter the ipsilateral entorhinal cortex. To determine the effect of transplantation on neuropathology, we performed sensorimotor behavior testing and stereological estimation of host neurons, astrocytes, and microglia within the contused cortex. These measures did not reveal a consistent effect of transplantation on recovery post-injury. Rather the positive and negative effects of cell transplantation were dependent on the host sex, highlighting the importance of developing patient-specific approaches to treat TBI. Our study underscores the complex interactions of sex, neuroimmune responses and cell therapy in a common experimental model of TBI.	[Nieves, Michael D.; Furmanski, Orion; Doughty, Martin L.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Nieves, Michael D.; Furmanski, Orion; Doughty, Martin L.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, FE Hebert Sch Med, Bethesda, MD 20814 USA; [Nieves, Michael D.; Doughty, Martin L.] Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, FE Hebert Sch Med, Bethesda, MD 20814 USA		Doughty, ML (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.	martin.doughty@usuhs.edu			Center for Neuroscience and Regenerative Medicine (CNRM)United States Department of Defense [G170244014]	This work was supported by a grant from the Center for Neuroscience and Regenerative Medicine (CNRM, grant number G170244014). We are grateful to Amanda Fu and Laura Tucker of the Pre-Clinical Studies Core, CNRM for rodent surgical and behavioral expertise. We also thank Dennis McDaniel, Ph.D. of the Biomedical Instrumentation Center (BIC) at USUHS for assistance with stereology and microscopy services and Cara Olsen, Ph.D. of the Biostatistics Consulting Center (BCC) for statistical consultation. Lastly, we acknowledge Qiong Zhou, Ana Efthymiou, Kryslaine Radomski, Mahima Dewan, Clara Selbrede, and Nia Williams for technical assistance.	Acharya MM, 2015, STEM CELL TRANSL MED, V4, P74, DOI 10.5966/sctm.2014-0063; Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; All AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116933; Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; [Anonymous], 2015, C TRAUM BRAIN INJ US; Ballout N, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00160; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Bramble MS, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-019-0242-x; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Efthymiou A, 2014, J BIOMOL SCREEN, V19, P32, DOI 10.1177/1087057113501869; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gorris R, 2015, GLIA, V63, P2152, DOI 10.1002/glia.22882; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Jaffer H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03117; Jahn-Eimermacher A, 2011, BEHAV BRAIN RES, V221, P271, DOI 10.1016/j.bbr.2011.03.007; Khaksari M, 2018, TRANSL STROKE RES, V9, P393, DOI 10.1007/s12975-017-0588-5; Kondo T, 2014, STEM CELL REP, V3, P242, DOI 10.1016/j.stemcr.2014.05.017; Lin GQ, 2018, NEUROSCI LETT, V674, P11, DOI 10.1016/j.neulet.2018.02.064; Lischka FW, 2018, GLIA, V66, P725, DOI 10.1002/glia.23278; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Peron S, 2017, J NEUROSCI, V37, P1820, DOI 10.1523/JNEUROSCI.2936-16.2017; Rais Y, 2015, NATURE, V520, P710, DOI 10.1038/nature14369; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Sharma R, 2019, SCI TRANSL MED, V11; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Smith PF, 2016, J NEUROSCI METH, V271, P154, DOI 10.1016/j.jneumeth.2016.07.008; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Springer JE, 2018, NEURAL REGEN RES, V13, P1338, DOI 10.4103/1673-5374.235218; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Sun AX, 2016, CELL REP, V16, P1942, DOI 10.1016/j.celrep.2016.07.035; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor CJ, 2012, CELL STEM CELL, V11, P147, DOI 10.1016/j.stem.2012.07.014; Thompson LH, 2015, NEUROBIOL DIS, V79, P28, DOI 10.1016/j.nbd.2015.04.003; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Uchino H, 2002, NEUROBIOL DIS, V10, P219, DOI 10.1006/nbdi.2002.0514; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Waldron J, 2011, STEM CELLS CLONING, V4, P25, DOI 10.2147/SCCAA.S18653; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yan YP, 2013, STEM CELL TRANSL MED, V2, P862, DOI [10.5966/sctm.2013-0080, 10.5966/sctm.2013-0080erratum]; Yuan F, 2015, SCI REP-UK, V5, DOI 10.1038/srep18550; Yuan T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt224	54	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 1	2020	1748								147120	10.1016/j.brainres.2020.147120			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OC8TB	WOS:000579428000037	32926852	Bronze			2022-02-06	
J	Popiolek-Barczyk, K; Ciechanowska, A; Ciapala, K; Pawlik, K; Oggioni, M; Mercurio, D; De Simoni, MG; Mika, J				Popiolek-Barczyk, Katarzyna; Ciechanowska, Agata; Ciapala, Katarzyna; Pawlik, Katarzyna; Oggioni, Marco; Mercurio, Domenico; De Simoni, Maria-Grazia; Mika, Joanna			The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia	MOLECULAR AND CELLULAR PROBES			English	Article						CCL2; Complement system; Lectin pathway; Microglia	CHEMOATTRACTANT PROTEIN-1 MCP-1; CHEMOKINE RECEPTOR CCR2; MANNOSE-BINDING LECTIN; NEUROPATHIC PAIN; COGNITIVE IMPAIRMENTS; EMBRYONIC-DEVELOPMENT; FRACTALKINE RECEPTOR; GENE-EXPRESSION; IN-VIVO; DEFICIENCY	Traumatic brain injury (TBI) is the leading cause of death in the global population. Disturbed inflammatory processes after TBI exacerbate secondary brain injury and contribute to unfavorable outcomes. Multiple inflammatory events that accompany brain trauma, such as glial activation, chemokine release, or the initiation of the complement system cascade, have been identified as potential targets for TBI treatment. However, the participation of chemokines in the complement activation remains unknown. Our studies sought to determine the changes in the expression of the molecules involved in the CCL2/CCL7/CCL12/CCR2 pathway in the injured brain and the effect of CCL2, CCL7, and CCL12 (10, 100, and 500 ng/mL) on the classic and lectin complement pathways and inflammatory factors in microglial cell cultures. Brain injury in mice was modeled by controlled cortical impact (CCI). Our findings indicate a time-dependent upregulation of CCL2, CCL7, and CCL12 at the mRNA and protein levels within the cortex, striatum, and/or thalamus beginning 24 h after the trauma. The analysis of the expression of the receptor of the tested chemokines, CCR2, revealed its substantial upregulation within the injured brain areas mainly on the mRNA level. Using primary cortical microglial cell cultures, we observed a substantial increase in the expression of CCL2, CCL7, and CCL12 after 24 h of LPS (100 ng/mL) treatment. CCL2 stimulation of microglia increased the level of IL-1 beta mRNA but did not influence the expression of IL-18, IL-6, and IL-10. Moreover, CCL2 significantly increased the expression of Iba1, a marker of microglia activation. CCL2 and CCL12 upregulated the expression of C1qa but did not influence the expression of C1ra and C1s1 (classical pathway); moreover, CCL2 increased ficolin A expression and reduced collectin 11 expression (lectin pathway). Additionally, we observed the downregulation of pentraxin 3, a modulator of the complement cascade, after CCL2 and CCL12 treatment. We did not detect the expression of ficolin B, Mbl1, and Mbl2 in microglial cells. Our data identify CCL2 as a modulator of the classical and lectin complement pathways suggesting that CCL2 may be a promising target for pharmacological intervention after brain injury. Moreover, our study provides evidence that CCL2 and two other CCR2 ligands may play a role in the development of changes in TBI.	[Popiolek-Barczyk, Katarzyna; Ciechanowska, Agata; Ciapala, Katarzyna; Pawlik, Katarzyna; Mika, Joanna] Polish Acad Sci, Maj Inst Pharmacol, Dept Pain Pharmacol, 12 Smetna Str, PL-31343 Krakow, Poland; [Oggioni, Marco; Mercurio, Domenico; De Simoni, Maria-Grazia] Ist Ric Farmacolog Mario Negri IRCCS, Dept Neurosci, Via Mario Negri 2, I-20156 Milan, Italy		Mika, J (corresponding author), Polish Acad Sci, Maj Inst Pharmacol, Dept Pain Pharmacol, 12 Smetna Str, PL-31343 Krakow, Poland.	joamika@if-pan.krakow.pl	Mercurio, Domenico/ABH-6795-2020; De Simoni, Maria Grazia/I-6021-2012	Mercurio, Domenico/0000-0001-5101-7222; De Simoni, Maria Grazia/0000-0001-6695-5297; Mika, Joanna/0000-0003-1986-7205; Ciapala, Katarzyna/0000-0001-6147-1576; Pawlik, Katarzyna/0000-0002-8091-4974; Ciechanowska, Agata/0000-0001-5270-2758; Popiolek-Barczyk, Katarzyna/0000-0003-4366-6577; Oggioni, Marco/0000-0002-7307-8111	ERA-NET-NEURON, JTC 2016: LEAP [NEURON9-FP-044]; ational Centre for Research and Development (Narodowe Centrum Bada n i Rozwoju), Poland [ERA-NET NEURON-Cofund/1/LEAP/15/17]; Italian Ministry of Health (Ministero della Salute), Italy; Maj Institute of Pharmacology, Polish Academy of Sciences	This study was supported by ERA-NET-NEURON, JTC 2016: LEAP, NEURON9-FP-044 with the following national institutions providing grant funding: National Centre for Research and Development (Narodowe Centrum Bada ' n i Rozwoju, ERA-NET NEURON-Cofund/1/LEAP/15/17), Poland and the Italian Ministry of Health (Ministero della Salute), Italy. This study was also supported by statutory funds from the Maj Institute of Pharmacology, Polish Academy of Sciences.	Ajuebor MN, 1998, J LEUKOCYTE BIOL, V63, P108, DOI 10.1002/jlb.63.1.108; ALLES VV, 1994, BLOOD, V84, P3483; Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Bardina SV, 2015, J IMMUNOL, V195, P4306, DOI 10.4049/jimmunol.1500352; Belarbi K, 2013, CANCER RES, V73, P1201, DOI 10.1158/0008-5472.CAN-12-2989; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Biber K., 2002, CHEMOKINES NERV SYST, P289, DOI [10.1016/B978-044451002-0/50023-3, DOI 10.1016/B978-044451002-0/50023-3]; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Carson WF, 2017, CELL IMMUNOL, V314, P63, DOI 10.1016/j.cellimm.2017.02.005; Cheng JW, 2014, CYTOKINE, V69, P277, DOI 10.1016/j.cyto.2014.06.007; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; Ciechanowska A, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2020.151911; Dawes JM, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-57; De Blasio D, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X18758881; De Blasio D, 2017, J CEREBR BLOOD F MET, V37, P938, DOI 10.1177/0271678X16647397; Denk F, 2016, CELL REP, V15, P1771, DOI 10.1016/j.celrep.2016.04.063; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dubovy P, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00040; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Farber K, 2009, J NEUROSCI RES, V87, P644, DOI 10.1002/jnr.21875; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Fumagalli S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00081; Gao C, 2017, MOL NEUROBIOL, V54, P8348, DOI 10.1007/s12035-016-0318-0; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gebicke-Haerter P J, 2001, Prog Brain Res, V132, P525; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Hammond MD, 2014, J NEUROSCI, V34, P3901, DOI 10.1523/JNEUROSCI.4070-13.2014; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hu JH, 2012, NEUROSCI LETT, V517, P60, DOI 10.1016/j.neulet.2012.04.026; Huang JC, 2020, AGING DIS, V11, P1103, DOI 10.14336/AD.2019.1229; Inforzato A, 2013, SEMIN IMMUNOL, V25, P79, DOI 10.1016/j.smim.2013.05.002; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Ke BC, 2016, NEUROREPORT, V27, P849, DOI 10.1097/WNR.0000000000000625; Kiguchi N, 2012, CURR OPIN PHARMACOL, V12, P55, DOI 10.1016/j.coph.2011.10.007; Kim KS, 1996, FEBS LETT, V395, P277, DOI 10.1016/0014-5793(96)01024-1; Kwiatkowski K, 2019, CYTOKINE, V119, P202, DOI 10.1016/j.cyto.2019.03.007; Kwiatkowski K, 2018, PHARMACOL REP, V70, P821, DOI 10.1016/j.pharep.2018.01.006; Kwiatkowski K, 2017, J NEUROIMMUNE PHARM, V12, P402, DOI 10.1007/s11481-017-9729-6; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Liu SR, 2016, WIRES RNA, V7, P562, DOI 10.1002/wrna.1350; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Longobardi L, 2017, OSTEOARTHR CARTILAGE, V25, P914, DOI 10.1016/j.joca.2016.11.004; Ma YJ, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.51; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Naert G, 2011, J NEUROSCI, V31, P6208, DOI 10.1523/JNEUROSCI.0299-11.2011; Neglia L, 2020, CELL MOL IMMUNOL, V17, P218, DOI 10.1038/s41423-019-0225-1; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Orsini F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00380; Palma JP, 2004, J NEUROIMMUNOL, V149, P121, DOI 10.1016/j.jneuroim.2003.12.025; Piotrowska A, 2016, J NEUROIMMUNOL, V297, P9, DOI 10.1016/j.jneuroim.2016.04.017; Piotrowska A, 2016, NEUROPHARMACOLOGY, V108, P207, DOI 10.1016/j.neuropharm.2016.04.024; Popiolek-Barczyk K, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/3829472; Quinones MP, 2005, J MOL MED, V83, P672, DOI 10.1007/s00109-005-0637-5; Rajkovic I, 2016, J NEUROIMMUNOL, V292, P27, DOI 10.1016/j.jneuroim.2015.12.007; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Renner NA, 2011, J NEUROVIROL, V17, P146, DOI 10.1007/s13365-010-0017-y; Rodriguez-Grande B, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0227-y; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-221; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P2379, DOI 10.1167/iovs.10-6010; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Sarafi MN, 1997, J EXP MED, V185, P99, DOI 10.1084/jem.185.1.99; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Semple BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-67; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Singhal G, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00270; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Yamagami S, 1999, J LEUKOCYTE BIOL, V65, P744, DOI 10.1002/jlb.65.6.744; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Yu W, 2015, CLIN CHIM ACTA, V451, P111, DOI 10.1016/j.cca.2015.10.017; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007	93	2	2	4	5	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0890-8508			MOL CELL PROBE	Mol. Cell. Probes	DEC	2020	54								101671	10.1016/j.mcp.2020.101671			15	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Cell Biology	PD0SL	WOS:000597404800004	33160071				2022-02-06	
J	Pushchina, EV; Stukaneva, ME; Varaksin, AA				Pushchina, Evgeniya, V; Stukaneva, Maria E.; Varaksin, Anatoly A.			Hydrogen Sulfide Modulates Adult and Reparative Neurogenesis in the Cerebellum of Juvenile Masu Salmon, Oncorhynchus masou	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; adult neuronal stem cells; neuronal progenitor cells; nestin; vimentin; H2S; glutamine synthetase; cerebellum; masu salmon; adult neurogenesis	CENTRAL-NERVOUS-SYSTEM; CYSTATHIONINE BETA-SYNTHASE; GLIA-LIKE PROGENITOR; NEURAL STEM-CELLS; RADIAL GLIA; ZEBRAFISH BRAIN; TELEOST FISH; NEURONAL REGENERATION; VIMENTIN; PROLIFERATION	Fish are a convenient model for the study of reparative and post-traumatic processes of central nervous system (CNS) recovery, because the formation of new cells in their CNS continues throughout life. After a traumatic injury to the cerebellum of juvenile masu salmon, Oncorhynchus masou, the cell composition of the neurogenic zones containing neural stem cells (NSCs)/neural progenitor cells (NPCs) in the acute period (two days post-injury) changes. The presence of neuroepithelial (NE) and radial glial (RG) neuronal precursors located in the dorsal, lateral, and basal zones of the cerebellar body was shown by the immunohistochemical (IHC) labeling of glutamine synthetase (GS). Progenitors of both types are sources of neurons in the cerebellum of juvenile O. masou during constitutive growth, thus, playing an important role in CNS homeostasis and neuronal plasticity during ontogenesis. Precursors with the RG phenotype were found in the same regions of the molecular layer as part of heterogeneous constitutive neurogenic niches. The presence of neuroepithelial and radial glia GS+ cells indicates a certain proportion of embryonic and adult progenitors and, obviously, different contributions of these cells to constitutive and reparative neurogenesis in the acute post-traumatic period. Expression of nestin and vimentin was revealed in neuroepithelial cerebellar progenitors of juvenile O. masou. Patterns of granular expression of these markers were found in neurogenic niches and adjacent areas, which probably indicates the neurotrophic and proneurogenic effects of vimentin and nestin in constitutive and post-traumatic neurogenesis and a high level of constructive metabolism. No expression of vimentin and nestin was detected in the cerebellar RG of juvenile O. masou. Thus, the molecular markers of NSCs/NPCs in the cerebellum of juvenile O. masou are as follows: vimentin, nestin, and glutamine synthetase label NE cells in intact animals and in the post-traumatic period, while GS expression is present in the RG of intact animals and decreases in the acute post-traumatic period. A study of distribution of cystathionine beta-synthase (CBS) in the cerebellum of intact young O. masou showed the expression of the marker mainly in type 1 cells, corresponding to NSCs/NCPs for other molecular markers. In the post-traumatic period, the number of CBS+ cells sharply increased, which indicates the involvement of H2S in the post-traumatic response. Induction of CBS in type 3 cells indicates the involvement of H2S in the metabolism of extracellular glutamate in the cerebellum, a decrease in the production of reactive oxygen species, and also arrest of the oxidative stress development, a weakening of the toxic effects of glutamate, and a reduction in excitotoxicity. The obtained results allow us to consider H2S as a biologically active substance, the numerous known effects of which can be supplemented by participation in the processes of constitutive neurogenesis and neuronal regeneration.	[Pushchina, Evgeniya, V; Stukaneva, Maria E.; Varaksin, Anatoly A.] Russian Acad Sci, Zhirmunsky Natl Sci Ctr Marine Biol, Far Eastern Branch, Vladivostok 690041, Russia		Pushchina, EV (corresponding author), Russian Acad Sci, Zhirmunsky Natl Sci Ctr Marine Biol, Far Eastern Branch, Vladivostok 690041, Russia.	puschina@mail.ru; Stykanyova@mail.ru; anvaraksin@mail.ru	Stykanyova, Maria/AAB-8379-2019; Varaksin, Anatoliy/AAN-1585-2021; Pushchina, Evgeniya/P-9789-2015	Stukaneva, Maryia/0000-0002-0013-7942; Pushchina, Evgeniya/0000-0003-0388-3147	Russian FederationRussian Federation [MD-4318.2015.4]	This work was supported by a grant from the President of the Russian Federation (No. MD-4318.2015.4; to E.V.P. and M.E.S.).	Abe K, 1996, J NEUROSCI, V16, P1066; Adams KL, 2018, NAT NEUROSCI, V21, P9, DOI 10.1038/s41593-017-0033-9; Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Albright JE, 2016, NEUROSCI LETT, V615, P50, DOI 10.1016/j.neulet.2016.01.019; Alunni A, 2016, DEVELOPMENT, V143, P741, DOI 10.1242/dev.122796; Arochena M, 2004, J COMP NEUROL, V469, P413, DOI 10.1002/cne.11021; Barbosa Joana S, 2016, Neurogenesis (Austin), V3, pe1148101, DOI 10.1080/23262133.2016.1148101; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Bernal A, 2018, CELL MOL LIFE SCI, V75, P2177, DOI 10.1007/s00018-018-2794-z; Carmona IC, 2011, MICROSC RES TECHNIQ, V74, P148, DOI 10.1002/jemt.20884; Cerda J, 1998, EUR J CELL BIOL, V77, P175, DOI 10.1016/S0171-9335(98)80105-2; Che XR, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00392; Chen M, 2018, MOL NEUROBIOL, V55, P5478, DOI 10.1007/s12035-017-0759-0; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Dambroise E, 2017, STEM CELLS, V35, P1505, DOI 10.1002/stem.2588; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Dhaliwal J, 2011, EUR J NEUROSCI, V33, P1025, DOI 10.1111/j.1460-9568.2011.07600.x; Duncan RN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145810; ELMQUIST JK, 1994, J COMP NEUROL, V344, P283, DOI 10.1002/cne.903440209; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Galant S, 2016, DEV BIOL, V420, P120, DOI 10.1016/j.ydbio.2016.09.022; Ganz J, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019018; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Ghosh S, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5815439; Gopalakrishnan Priya, 2019, Pathophysiology, V26, P1, DOI 10.1016/j.pathophys.2018.10.005; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Grandel H, 2013, DEV GENES EVOL, V223, P131, DOI 10.1007/s00427-012-0425-5; Grupp L, 2010, J COMP NEUROL, V518, P4277, DOI 10.1002/cne.22481; Hendrickson ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018535; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Hu R, 2007, NEUROSCIENCE, V144, P1229, DOI 10.1016/j.neuroscience.2006.09.056; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Kalman M, 1998, ANAT EMBRYOL, V198, P409, DOI 10.1007/s004290050193; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kaslin J., 2013, HDB CEREBELLUM CEREB, P1441, DOI 10.1007/978-94-007-1333-8_63; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kaslin J, 2017, DEVELOPMENT, V144, P1462, DOI 10.1242/dev.144907; Kaslin J, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-9; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; KATSURA K, 1994, BIOCHEM SOC T, V22, P991, DOI 10.1042/bst0220991; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Kimura H, 2019, NEUROCHEM INT, V126, P118, DOI 10.1016/j.neuint.2019.01.027; Kimura H, 2013, NEUROCHEM INT, V63, P492, DOI 10.1016/j.neuint.2013.09.003; Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Kirkham M, 2014, STEM CELL REP, V2, P507, DOI 10.1016/j.stemcr.2014.01.018; Kizil C, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-27; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kukley M, 2008, FASEB J, V22, P2957, DOI 10.1096/fj.07-090985; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; Lepanto Paola, 2016, Neurogenesis (Austin), V3, pe1253363, DOI 10.1080/23262133.2016.1253363; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lindsey BW, 2018, PROG NEUROBIOL, V170, P99, DOI 10.1016/j.pneurobio.2018.06.004; Lindsey BW, 2014, DEV NEUROBIOL, V74, P1053, DOI 10.1002/dneu.22183; Lindsey BW, 2012, J COMP NEUROL, V520, P2275, DOI 10.1002/cne.23065; Luo YG, 2013, NEUROCHEM INT, V63, P826, DOI 10.1016/j.neuint.2013.06.004; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Mahler J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-89; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Murdoch B, 2008, J NEUROSCI, V28, P4271, DOI 10.1523/JNEUROSCI.5566-07.2008; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Paridaen JTML, 2014, EMBO REP, V15, P351, DOI 10.1002/embr.201438447; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Pushchina EV, 2019, RUSS J DEV BIOL+, V50, P59, DOI 10.1134/S106236041902005X; Pushchina EV, 2011, NEUROCHEM J+, V5, P24, DOI 10.1134/S1819712411010090; Pushchina E.V., 2017, PERIPHERAL NERVE REG, P175; Pushchina E.V., 2019, J R SCI, V1, P36; Pushchina EV, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10040222; Pushchina EV, 2020, NEURAL REGEN RES, V15, P1867, DOI 10.4103/1673-5374.280320; Pushchina EV, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10020065; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Sanchez-Farias N, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00065; Shigyo M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28293; Sinyakov MS, 2017, BRAIN RES, V1676, P28, DOI 10.1016/j.brainres.2017.09.009; Sirbulescu RF, 2015, DEV NEUROBIOL, V75, P39, DOI 10.1002/dneu.22210; Skaggs K, 2014, GLIA, V62, P2061, DOI 10.1002/glia.22726; Stukaneva ME, 2017, RUSS J DEV BIOL+, V48, P321, DOI 10.1134/S1062360417050071; TAPSCOTT SJ, 1981, NATURE, V292, P836, DOI 10.1038/292836a0; Taverna E, 2010, NEURON, V67, P906, DOI 10.1016/j.neuron.2010.08.027; Terriac E, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00106; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Wan J, 2014, CELL REP, V9, P285, DOI 10.1016/j.celrep.2014.08.048; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; Wang JF, 2014, NEUROCHEM INT, V64, P37, DOI 10.1016/j.neuint.2013.11.002; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wu LH, 2017, GLYCOCONJUGATE J, V34, P51, DOI 10.1007/s10719-016-9727-6; Zupanc GKH, 2006, J COMP PHYSIOL A, V192, P649, DOI 10.1007/s00359-006-0104-y; Zupanc GKH, 2012, NEUROSCIENCE, V210, P416, DOI 10.1016/j.neuroscience.2012.03.012; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571; Zupanc GKH, 1999, EXP NEUROL, V160, P78, DOI 10.1006/exnr.1999.7182; Zupanc GKH, 2013, CURR TOP MICROBIOL, V367, P193, DOI 10.1007/82_2012_297; Zupanc GKH, 2011, EUR J NEUROSCI, V34, P917, DOI 10.1111/j.1460-9568.2011.07854.x	100	2	2	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	DEC	2020	21	24							9638	10.3390/ijms21249638			40	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	PK9VQ	WOS:000602783400001	33348868	Green Published, gold			2022-02-06	
J	Roach, AE; Hines, C; Stafford, J; Mooney, S				Roach, Alexandra E.; Hines, Christopher; Stafford, Jane; Mooney, Scott			Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Active-Duty Service Members Improves Depressive Symptoms	JOURNAL OF ECT			English	Article						TMS; active-duty service members; noninvasive brain stimulation; transcranial magnetic stimulation; treatment-resistant depression	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; TRAUMATIC BRAIN-INJURY; MAJOR DEPRESSION; DOUBLE-BLIND; ELECTROCONVULSIVE-THERAPY; MILITARY PERSONNEL; PREFRONTAL CORTEX; SUBSTANCE USE; EFFICACY	Objectives: Current research on the efficacy of repetitive transcranial magnetic stimulation (rTMS) over left dorsolateral prefrontal cortex as a noninvasive therapy for treatment-resistant depression is largely settled science. However, little is known about its efficacy with active-duty service members (ADSMs) with major depressive disorder. In a retrospective chart review, we examined depressive symptom ratings in ADSMs seeking treatment at the US Army Outpatient Behavioral Health Service Clinic at Eisenhower Army Medical Center, Fort Gordon, Ga. Methods: We reviewed 121 consecutive outpatient charts, which yielded 61 ADSMs who completed a minimum of 20 rTMS sessions for refractory depression, and for whom both pretreatment and posttreatment depressive symptom ratings were available. Pre- and post-Patient Health Questionnaire 9 (PHQ-9) scores were subjected to a paired t test, and Reliable Change Indices were calculated to determine both reliable and clinical significance. Results: Average (SD) pretreatment and posttreatment PHQ-9 scores were 15.8 (6.2) and 12.6 (7.6), respectively. Statistically significant reduction in post-PHQ-9 was demonstrated (P < 0.001), with 69% of patients lowering their ratings and 31% demonstrating reliable change (improvement >5.64). Additionally, 20% demonstrated a reliable change that placed them in the nondysfunctional range (post-PHQ-9 <9.6), demonstrating clinical significance. Conclusions: These data confirm a course of standard rTMS to ADSMs with major depression is promising in reducing depressive symptoms. Given that success and completion rates from this clinic are similar to those reported in civilian populations (80%), rTMS may be an adequate additional treatment or augmentation strategy for refractory depression in ADSMs.	[Roach, Alexandra E.; Stafford, Jane] Univ South Carolina Aiken, Dept Psychol, Aiken, SC 29801 USA; [Hines, Christopher] Eisenhower Army Med Ctr, Outpatient Behav Hlth Serv, Ft Gordon, GA USA; [Hines, Christopher; Mooney, Scott] Augusta Univ, Dept Psychiat & Hlth Behav, Med Coll Georgia, Augusta, GA USA; [Mooney, Scott] Eisenhower Army Med Ctr, Neurosci & Rehabil Ctr, Ft Gordon, GA USA		Roach, AE (corresponding author), Univ South Carolina Aiken, 471 Univ Pkwy, Aiken, SC 29801 USA.	alexandraro@usca.edu		Hines, Christopher/0000-0003-4802-3167			[Anonymous], 2011, GUID DOC MED DEV RAD, VCenter for Devices and Radiological Health; Avery DH, 2006, BIOL PSYCHIAT, V59, P187, DOI 10.1016/j.biopsych.2005.07.003; Berlim MT, 2007, CAN J PSYCHIAT, V52, P46, DOI 10.1177/070674370705200108; Bray RM, 2007, ADDICTION, V102, P1092, DOI 10.1111/j.1360-0443.2007.01841.x; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; Bullman T, 2018, ARCH SUICIDE RES, V22, P1, DOI 10.1080/13811118.2017.1304308; Carpenter LL, 2017, BRAIN STIMUL, V10, P926, DOI 10.1016/j.brs.2017.06.003; Carpenter LL, 2012, DEPRESS ANXIETY, V29, P587, DOI 10.1002/da.21969; Contractor AA, 2015, J PSYCHIATR RES, V68, P19, DOI 10.1016/j.jpsychires.2015.05.014; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Fava M, 2003, BIOL PSYCHIAT, V53, P649, DOI 10.1016/S0006-3223(03)00231-2; Fitzgerald PB, 2003, ARCH GEN PSYCHIAT, V60, P1002, DOI 10.1001/archpsyc.60.9.1002; Gadermann AM, 2012, MIL MED, V177, P47, DOI 10.7205/MILMED-D-12-00103; George MS, 2013, CURR OPIN PSYCHIATR, V26, P13, DOI 10.1097/YCO.0b013e32835ab46d; George MS, 2010, ARCH GEN PSYCHIAT, V67, P507, DOI 10.1001/archgenpsychiatry.2010.46; George MS, 1997, AM J PSYCHIAT, V154, P1752, DOI 10.1176/ajp.154.12.1752; GEORGE MS, 1995, NEUROREPORT, V6, P1853, DOI 10.1097/00001756-199510020-00008; George MS, 2000, BIOL PSYCHIAT, V48, P962, DOI 10.1016/S0006-3223(00)01048-9; Goertz C, 2013, J ALTERN COMPLEM MED, V19, P509, DOI 10.1089/acm.2012.0108; Harel EV, 2011, WORLD J BIOL PSYCHIA, V12, P119, DOI 10.3109/15622975.2010.510893; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hunter AM, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1275; Husain MM, 2004, J CLIN PSYCHIAT, V65, P485; Isaac L, 2015, BIOL PSYCHOL, V105, P20, DOI 10.1016/j.biopsycho.2014.12.011; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kemp AH, 2008, CNS SPECTRUMS, V13, P1066, DOI 10.1017/S1092852900017120; Klein E, 1999, ARCH GEN PSYCHIAT, V56, P315, DOI 10.1001/archpsyc.56.4.315; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lande RG, 2017, GEN HOSP PSYCHIAT, V45, P99, DOI 10.1016/j.genhosppsych.2016.10.001; Lee JH, 2019, J ECT, V35, P44, DOI 10.1097/YCT.0000000000000533; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McMillan D, 2010, J AFFECT DISORDERS, V127, P122, DOI 10.1016/j.jad.2010.04.030; Nemeroff CB, 2007, J CLIN PSYCHIAT, V68, P17; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Ohayon MM, 2007, J PSYCHIAT RES, V41, P207, DOI 10.1016/j.jpsychires.2006.10.006; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; R Core Team, 2014, R LANG ENV STAT COMP; Ragen BJ, 2016, STRESS CONCEPTS COGN, P241; Reimann CA, 2018, MIL MED, V183, P396, DOI 10.1093/milmed/usx209; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Slotema CW, 2010, J CLIN PSYCHIAT, V71, P873, DOI 10.4088/JCP.08m04872gre; Spaans HP, 2013, J CLIN PSYCHIAT, V74, pE1029, DOI 10.4088/JCP.13m08538; Thase ME, 1997, J CLIN PSYCHIAT, V58, P23; Visco R, 2009, PERSPECT PSYCHIATR C, V45, P240, DOI 10.1111/j.1744-6163.2009.00227.x; Wajdik C, 2014, J ECT, V30, P320, DOI 10.1097/YCT.0000000000000096; Walter KH, 2018, CONTEMP CLIN TRIALS, V64, P152, DOI 10.1016/j.cct.2017.10.010; Yesavage JA, 2018, JAMA PSYCHIAT, V75, P884, DOI 10.1001/jamapsychiatry.2018.1483; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	50	2	2	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1095-0680	1533-4112		J ECT	J. ECT	DEC	2020	36	4					279	284		10.1097/YCT.0000000000000680			6	Behavioral Sciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychiatry	OY8EU	WOS:000594475200022	32205738	Green Published, hybrid			2022-02-06	
J	Saez, P; Duno, C; Sun, LY; Antonovaite, N; Malve, M; Tost, D; Goriely, A				Saez, P.; Duno, C.; Sun, L. Y.; Antonovaite, N.; Malve, M.; Tost, D.; Goriely, A.			Topological features dictate the mechanics of the mammalian brains	INTERNATIONAL JOURNAL OF MECHANICAL SCIENCES			English	Article						Brain shape; Animal-scale laws; Brain mechanics; Finite element method	IN-VIVO; INJURY; HEAD; MODELS; TISSUE; DEFORMATION; DAMAGE	Understanding brain mechanics is crucial in the study of pathologies involving brain deformations such as tumor, strokes, or in traumatic brain injury. Apart from the intrinsic mechanical properties of the brain tissue, the topology and geometry of the mammalian brains are particularly important for its mechanical response. We use computational methods in combination with geometric models to understand the role of these features. We find that the geometric quantifiers such as the gyrification index play a fundamental role in the overall mechanical response of the brain. We further demonstrate that topological diversity in brain models is more important than differences in mechanical properties: Topological differences modify not only the stresses and strains in the brain but also its spatial distribution. Therefore, computational brain models should always include detailed geometric information to generate accurate mechanical predictions. These results suggest that mammalian brain gyrification acts as a damping system to reduce mechanical damage in large-mass brain mammals. Our results are relevant in several areas of science and engineering related to brain mechanics, including the study of tumor growth, the understanding of brain folding, and the analysis of traumatic brain injuries.	[Saez, P.; Duno, C.] Univ Politecn Cataluna, Lab Calcul Numer LaCaN, Barcelona, Spain; [Saez, P.] Barcelona Grad Sch Math BGSMath, Barcelona, Spain; [Sun, L. Y.; Tost, D.] Univ Politecn Cataluna, Ctr Recerca Engn Biomed CREB, Barcelona, Spain; [Antonovaite, N.] Vrije Univ Amsterdam, Dept Phys & Astron, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands; [Antonovaite, N.] Vrije Univ Amsterdam, LaserLab Amsterdam, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands; [Malve, M.] Univ Zaragoza, Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Aragon Inst Engn Res I3A, Zaragoza, Spain; [Malve, M.] Univ Publ Navarra, Dept Engn, Pamplona, Spain; [Tost, D.] Inst Recerca St Joan de Deu, Barcelona, Spain; [Goriely, A.] Univ Oxford, Math Inst, Oxford, England		Saez, P (corresponding author), Univ Politcn Catalunya, Lab Clcul Numr, Jordi Girona 1-3, Barcelona 08034, Spain.	pablo.saez@upc.edu	; Saez, Pablo/O-9839-2014; Tost, Dani/H-6289-2015	Antonovaite, Nelda/0000-0001-9080-0324; Saez, Pablo/0000-0002-9253-0417; Tost, Dani/0000-0001-9619-605X	Generalitat de CatalunyaGeneralitat de CatalunyaGeneral Electric [2017-SGR-1278]; European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC grant [615170]; Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/R020205/1]; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/R020205/1] Funding Source: UKRI	P.S has been supported by the Generalitat de Catalunya under grants 2017-SGR-1278. N.A acknowledge funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC grant agreement no. [615170]. This work was supported by a Engineering and Physical Sciences Research Council grant to Alain Goriely (EP/R020205/1).	Aktas O, 2007, ARCH NEUROL-CHICAGO, V64, P185, DOI 10.1001/archneur.64.2.185; Angeli S, 2018, NEUROIMAGE-CLIN, V20, P664, DOI 10.1016/j.nicl.2018.08.032; Antonovaite N, 2018, SCI REP, V8, P1; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2015, J MECH BEHAV BIOMED; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Carlsen RW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00028; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Colella M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59471-9; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Fletcher TL, 2016, ANN BIOMED ENG, V44, P3495, DOI 10.1007/s10439-016-1666-7; FLORY PJ, 1961, T FARADAY SOC, V57, P829, DOI 10.1039/tf9615700829; Gerriets T, 2004, STROKE; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Goriely A., 2017, SPRINGER INTERDISCIP; Goriely A, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.138001; Goriely A, 2015, ADV APPL MECH, V48, P79, DOI 10.1016/bs.aams.2015.10.002; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Holland M, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.228002; Huang XN, 2019, MAGN RESON IMAGING, V59, P68, DOI 10.1016/j.mri.2019.03.009; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Johnson CL, 2018, DEV COGN NEUROS-NETH, V33, P176, DOI 10.1016/j.dcn.2017.08.010; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; KHALIL TB, 1974, INT J MECH SCI, V16, P609, DOI 10.1016/0020-7403(74)90061-7; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koser DE, 2015, BIOPHYS J, V108, P2137, DOI 10.1016/j.bpj.2015.03.039; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Lang GE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0123; Lopez-Rincon A, 2020, J NEUROSCI METH, V331, DOI 10.1016/j.jneumeth.2019.108464; Mac Donald CL, 2007, J NEUROSCI; Manger PR, 2012, J COMP NEUROL, V520, P2430, DOI 10.1002/cne.23046; Marino L, 2007, ANAT REC, V290, P694, DOI 10.1002/ar.20530; Mihai LA, 2017, J MECH PHYS SOLIDS, V106, P60, DOI 10.1016/j.jmps.2017.05.015; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Murphy MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081668; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Post A, 2014, COMPUT METHODS BIOME; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sahoo D, 2013, COMPUT METHOD BIOMEC, V16, P198, DOI 10.1080/10255842.2013.815908; Saunders RN, 2018, ANN BIOMED ENG; Sciume G, 2013, ARCH COMPUT METHOD E, V20, P327, DOI 10.1007/s11831-013-9090-8; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Su S, 2013, HUM BRAIN MAPP, V34, P1230, DOI 10.1002/hbm.21510; Systemes D. Abaqus, 2016, AN US MAN; Tallinen T, 2016, NAT PHYS; Tang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096944; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Townsend MT, 2018, ANN BIOMED ENG; Trosseille X, 1992, 36 STAPP CAR CRASH C; Trotta A, 1974, INT J MECH SCI, V16, P60925; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Walberer M, 2008, J NEUROSURG; Weickenmeier J, 2017, J ELASTICITY, V129, P197, DOI 10.1007/s10659-016-9606-1; Weickenmeier J, 2018, J MECH BEHAV BIOMED, V77, P702, DOI 10.1016/j.jmbbm.2017.08.029; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	70	2	2	2	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7403	1879-2162		INT J MECH SCI	Int. J. Mech. Sci.	DEC 1	2020	187								105914	10.1016/j.ijmecsci.2020.105914			8	Engineering, Mechanical; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mechanics	OO5BO	WOS:000587394000008		Green Submitted			2022-02-06	
J	Sturla, MI; Ricagni, IG; Ignozza, C; Rondoni, F; Bonetti, A; Ricciardi, L				Sturla, Mario, I; Ricagni, Italo G.; Ignozza, Carmela; Rondoni, Francesco; Bonetti, Antonio; Ricciardi, Lucio			Boxers' healthcare and the abolition of the headgear in amateur boxing	MEDICINA DELLO SPORT			English	Article						Boxing; Brain concussion; Sports	CONCUSSION; SPORT	The abolition of the headgear for the amateur boxer has opened a discussion on the acute brain damage of the boxer. The pros and cons the use of the headgear are analyzed and the first AIBA statistical data are presented and discussed, taken from a large number of rounds fought with and without a headgear.	[Sturla, Mario, I] World Boxing Council WBC, Commiss Med Europea EBU, Federaz Pugilist Italiana FPI, Turin, Italy; [Ricagni, Italo G.] Federaz Pugilist Italiana FPI, Turin, Italy; [Ignozza, Carmela; Rondoni, Francesco] Federaz Pugilist Italiana FPI, Fed Tech Ctr, Turin, Italy; [Bonetti, Antonio] Univ Parma, Parma, Italy; [Ricciardi, Lucio] Univ Pavia, Pavia, Italy		Ricciardi, L (corresponding author), Univ Pavia, Pavia, Italy.	lucio.ricciardi@unipv.it					Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Bartsch AJ, 2012, J NEUROSURG, V116, P1070, DOI 10.3171/2011.12.JNS111478; Carson A, 2017, J NEUROL NEUROSUR PS, V88, P462, DOI 10.1136/jnnp-2016-315510; Davis GA, 2015, NEUROSURGERY, V76, P643, DOI 10.1227/NEU.0000000000000722; Discussion on the use of headgear the in amateur boxing: rationale to remove on headgear during amateur boxing competition (AIBA), DISC US HEADG AM BOX; Faro S. H., 2006, FUNCTIONAL MRI BASIC; Francavilla G, 2013, MED SPORT, V66, P241; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, BRIT J SPORT MED, V46, P459, DOI 10.1136/bjsports-2012-091276; Pavan A, 2012, MED SPORT, V65, P289; Pearce JMS, 2008, EUR NEUROL, V59, P113, DOI 10.1159/000111872; Ricagni IG, 2015, MED SPORT, V68, P335; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Stumph J., 2017, P ANN M AM COLL SPOR; Sturla MI, 2001, MED SPORT, V54, P329; Sturla MI, 2012, MED SPORT, V65, P359; Tranchita E, 2017, MED SPORT, V70, P282, DOI 10.23736/S0025-7826.17.03179-9; Vagnozzi R, 2010, CONCUSSIONE CEREBRAL; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	21	2	2	1	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0025-7826	1827-1863		MED SPORT	Med. Sport	DEC	2020	73	4					673	680		10.23736/S0025-7826.20.03829-6			8	Medicine, General & Internal; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Sport Sciences	PF2KV	WOS:000598890700010					2022-02-06	
J	Swanson, LC; Trujillo, EA; Thiede, GH; Katzenberger, RJ; Shishkova, E; Coon, JJ; Ganetzky, B; Wassarman, DA				Swanson, Laura C.; Trujillo, Edna A.; Thiede, Gene H.; Katzenberger, Rebeccah J.; Shishkova, Evgenia; Coon, Joshua J.; Ganetzky, Barry; Wassarman, David A.			Survival Following Traumatic Brain Injury in Drosophila Is Increased by Heterozygosity for a Mutation of the NF-kappa B Innate Immune Response Transcription Factor Relish	GENETICS			English	Article						Drosophila melanogaster; innate immunity; traumatic brain injury; proteomics; gene expression	PEPTIDOGLYCAN RECOGNITION PROTEINS; ANTIMICROBIAL PEPTIDE GENES; HUMORAL STRESS-RESPONSE; CLOSED-HEAD INJURY; CEREBRAL EDEMA; IMD PATHWAYS; HOST-DEFENSE; OUTCOMES; TOLL; NEUROINFLAMMATION	Traumatic brain injury (TBI) pathologies are caused by primary and secondary injuries. Primary injuries result from physical damage to the brain, and secondary injuries arise from cellular responses to primary injuries. A characteristic cellular response is sustained activation of inflammatory pathways commonly mediated by nuclear factor-kappa B (NF-kappa B) transcription factors. Using a Drosophila melanogaster TBI model, we previously found that the main proximal transcriptional response to primary injuries is triggered by activation of Toll and Imd innate immune response pathways that engage NF-kappa B factors Dif and Relish (Rel), respectively. Here, we found by mass spectrometry that Rel protein level increased in fly heads at 4-8 hr after TBI. To investigate the necessity of Rel for secondary injuries, we generated a null allele, Rel(del), by CRISPR/Cas9 editing. When heterozygous but not homozygous, the Rel(del) mutation reduced mortality at 24 hr after TBI and increased the lifespan of injured flies. Additionally, the effect of heterozygosity for Rel(del) on mortality was modulated by genetic background and diet. To identify genes that facilitate effects of Rel(del) on TBI outcomes, we compared genome-wide mRNA expression profiles of uninjured and injured +/+, +/Rel(del), and Rel(del)/Rel(del) flies at 4 hr following TBI. Only a few genes changed expression more than twofold in +/Rel(del) flies relative to +/+ and Rel(del)/Rel(del) flies, and they were not canonical innate immune response genes. Therefore, Rel is necessary for TBI-induced secondary injuries but in complex ways involving gene dose, genetic background, diet, and possibly small changes in expression of innate immune response genes.	[Swanson, Laura C.; Thiede, Gene H.; Katzenberger, Rebeccah J.; Wassarman, David A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; [Swanson, Laura C.] Univ Wisconsin, Med Scientist Training Program, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Trujillo, Edna A.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, Coll Letters & Sci, Madison, WI 53706 USA; [Trujillo, Edna A.; Shishkova, Evgenia; Coon, Joshua J.] Univ Wisconsin, Natl Ctr Quantitat Biol Complex Syst, Madison, WI 53706 USA; [Shishkova, Evgenia; Coon, Joshua J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA; [Ganetzky, Barry] Univ Wisconsin, Dept Genet, Coll Agr & Life Sci, Madison, WI 53706 USA; [Coon, Joshua J.] Morgridge Inst Res, Madison, WI 53706 USA		Wassarman, DA (corresponding author), Univ Wisconsin, Dept Med Genet, Sch Med & Publ Hlth, Room 4262,Genet Biotechnol Bldg,425-G Henry Mall, Madison, WI 53706 USA.	dawassarman@wisc.edu		Swanson, Laura/0000-0002-9438-7546; ganetzky, barry/0000-0001-5418-7577; Trujillo, Edna Angelica/0000-0002-8551-9199; Shishkova, Evgenia/0000-0001-6097-6097	National Institutes of Health (NIH) (National Center for Quantitative Biology of Complex Systems)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RF1 NS114359, P41 GM108538]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 AG000213, T32 HG002760]	We thank members of the Boekhoff-Falk, Perouansky, Coon, and Wassarman laboratories for their insights throughout the course of this research, Stanislava Chtarbanova for providing astute comments on the manuscript, Kate O'Connor-Giles for providing CRISPR/Cas9 plasmids, the University of Wisconsin's Gene Expression Center for providing Illumina RNA library preparation, and the DNA Sequencing Facility sequencing services as well as the Bioinformatics Resource Center and Mark Berres for providing project consultation and data analysis for the RNA-seq experiments. This work was supported by the National Institutes of Health (NIH) RF1 NS114359 (to D.A.W.), P41 GM108538 (the National Center for Quantitative Biology of Complex Systems to J.J.C.), and predoctoral fellowships from NIH training grants T32 AG000213 (to L.C.S.) and T32 HG002760 (to E.A.T.). The authors of this paper declare no conflicts of interest.	Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bernini A, 2020, J CEREBR BLOOD F MET, V40, P177, DOI 10.1177/0271678X18808947; Biehs B, 2010, DEVELOPMENT, V137, P3887, DOI 10.1242/dev.055871; Bogart K., 2006, 200610 CGB, DOI [10.2506/cgbtr-200610, DOI 10.2506/CGBTR-200610]; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x; Caglayan B, 2019, MOL BIOL REP, V46, P241, DOI 10.1007/s11033-018-4465-4; Cao XL, 2018, INSECT BIOCHEM MOLEC, V103, P53, DOI 10.1016/j.ibmb.2018.10.006; Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Chinchore Y, 2012, P NATL ACAD SCI USA, V109, pE605, DOI 10.1073/pnas.1110666109; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chowdhury M, 2019, DEV COMP IMMUNOL, V95, P50, DOI 10.1016/j.dci.2019.01.017; Cinege G, 2017, INSECT BIOCHEM MOLEC, V87, P45, DOI 10.1016/j.ibmb.2017.06.006; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Deng YB, 2020, GENES DIS, V7, P253, DOI 10.1016/j.gendis.2019.05.002; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Dhankhar J, 2020, J NEUROIMMUNOL, V346, DOI 10.1016/j.jneuroim.2020.577302; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Diamond ML, 2015, EPILEPSIA, V56, P991, DOI 10.1111/epi.13100; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Eastman CL, 2020, NEUROPHARMACOLOGY, V172, DOI 10.1016/j.neuropharm.2019.107907; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Ekengren S, 2001, CURR BIOL, V11, P714, DOI 10.1016/S0960-9822(01)00203-2; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Feng Y, 2016, INT J MOL MED, V37, P921, DOI 10.3892/ijmm.2016.2495; Fischer JA, 2018, ANESTH ANALG, V126, P1979, DOI 10.1213/ANE.0000000000002906; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Ganesan S, 2011, CURR TOP MICROBIOL, V349, P25, DOI 10.1007/82_2010_107; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goto A, 2018, IMMUNITY, V49, P225, DOI 10.1016/j.immuni.2018.07.013; Goto A, 2010, J BIOL CHEM, V285, P15731, DOI 10.1074/jbc.M109.082115; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Greco T, 2016, J CEREBR BLOOD F MET, V36, P1603, DOI 10.1177/0271678X15610584; Greco T, 2013, J CHILD NEUROL, V28, P983, DOI 10.1177/0883073813487594; Gupta SC, 2020, BBA-REV CANCER, V1873, DOI 10.1016/j.bbcan.2019.188316; Hadjicharalambous MR, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5020034; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jiang HS, 2018, CELL MOL NEUROBIOL, V38, P1009, DOI 10.1007/s10571-017-0570-5; Juengst SB, 2017, EPILEPSY BEHAV, V73, P240, DOI 10.1016/j.yebeh.2017.06.001; Katzenberger RJ, 2016, G3-GENES GENOM GENET, V6, P4151, DOI 10.1534/g3.116.036194; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Katzenberger RJ, 2015, JOVE-J VIS EXP, DOI 10.3791/52905; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Kounatidis I, 2017, CELL REP, V19, P836, DOI 10.1016/j.celrep.2017.04.007; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Kurata S, 2014, DEV COMP IMMUNOL, V42, P36, DOI 10.1016/j.dci.2013.06.006; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lee DC, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01140; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lindsay SA, 2018, J INNATE IMMUN, V10, P306, DOI 10.1159/000489831; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Long XB, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01761-0; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Myllymaki H, 2014, J IMMUNOL, V192, P3455, DOI 10.4049/jimmunol.1303309; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; PARKES TL, 1993, GENOME, V36, P1007, DOI 10.1139/g93-134; Parsons B, 2016, DEV COMP IMMUNOL, V58, P95, DOI 10.1016/j.dci.2015.12.019; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Petersen AJ, 2012, FLY, V6, P169, DOI 10.4161/fly.20999; Petersen AJ, 2012, P NATL ACAD SCI USA, V109, pE656, DOI 10.1073/pnas.1110470109; Preethi P, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01528; Putnam LJ, 2019, FLY, V13, P1, DOI 10.1080/19336934.2019.1664363; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Richards AL, 2015, NAT PROTOC, V10, P701, DOI 10.1038/nprot.2015.040; Rubovitch V, 2019, J MOL NEUROSCI, V67, P613, DOI 10.1007/s12031-019-01271-6; Saikumar J, 2020, P NATL ACAD SCI USA, V117, P17269, DOI 10.1073/pnas.2003909117; Sanuki R, 2019, BRAIN BEHAV IMMUN, V80, P427, DOI 10.1016/j.bbi.2019.04.023; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Sen AK, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00175; Shah EJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00409; Shaito A, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102829; Shao XF, 2020, INT IMMUNOPHARMACOL, V79, DOI 10.1016/j.intimp.2019.106175; Shi HJ, 2019, NEUROPHARMACOLOGY, V145, P259, DOI 10.1016/j.neuropharm.2018.07.022; Shishkova E, 2018, ANAL CHEM, V90, P11503, DOI 10.1021/acs.analchem.8b02766; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sochocka M, 2017, MOL NEUROBIOL, V54, P8071, DOI 10.1007/s12035-016-0297-1; Somayaji MR, 2018, CURR NEUROPHARMACOL, V16, P484, DOI 10.2174/1570159X15666170828165711; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Swanson LC, 2020, G3-GENES GENOM GENET, V10, P3109, DOI 10.1534/g3.120.401377; Tan AA, 2009, J NEUROTRAUM, V26, P539, DOI 10.1089/neu.2008.0611; Tan LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003966; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Tanji T, 2010, P NATL ACAD SCI USA, V107, P14715, DOI 10.1073/pnas.1009473107; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Tortella FC, 2016, METHODS MOL BIOL, V1462, P735, DOI 10.1007/978-1-4939-3816-2_40; Trujillo EA, 2019, ANAL CHEM, V91, P12625, DOI 10.1021/acs.analchem.9b02979; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Wu JC, 2020, TRANSL STROKE RES, V11, P720, DOI 10.1007/s12975-019-00771-2; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang YM, 2019, J CELL BIOCHEM, V120, P17584, DOI 10.1002/jcb.29025; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zu Z., 2012, ANN CLIN LAB SCI, V42, P25	119	2	2	0	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	DEC	2020	216	4					1117	1136		10.1534/genetics.120.303776			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PD8TH	WOS:000597949900019	33109529	Bronze, Green Published			2022-02-06	
J	Tarzi, C; Aubrey, J; Rotundo, M; Armstrong, N; Saha, A; Cusimano, MD				Tarzi, Christopher; Aubrey, Jason; Rotundo, Mario; Armstrong, Nicholas; Saha, Ashirbani; Cusimano, Michael D.			Professional assessment of potential concussions in elite football tournaments	INJURY PREVENTION			English	Article						concussion; traumatic brain injury; hand injury	VIDEO ANALYSIS; IMPACT SYNDROME; INJURIES; RELIABILITY; BRAIN	Background Potential concussive events (PCEs) are a major health concern in football. Though there are protocols set in place for assessments of PCEs, there has been no evidence of adherence in major football tournaments. Methods Our research goal is to determine if PCEs in elite football are professionally assessed according to the International Conference on Concussion in Sport (ICCS) consensus statement recommendations. Identification and analysis of PCEs in the 2018 World Cup (WC) were accomplished through standardised observation of video footage by trained observers. Results were contrasted with data from the 2014 WC and 2016 Euro Cup. Our primary outcomes include frequency and professional assessment of PCEs, signs of concussions and time stopped for assessments. Findings In the 64 games of the 2018 WC, 87 PCEs (1.36 per game) were identified. Thirty-one (35.6%) PCEs were professionally assessed, resulting in the removal of three (3.5%) players from the match. Six (6.9%) PCEs showed one sign of concussion, 60 (69.0%) showed two signs, 20 (23.0%) showed three signs and 1 (1.2%) showed four or more signs. The mean time stopped for assessment was 63.3 s. No significant change in the percentage of professional assessments (mean=33.4%, 95% CI 20.7% to 46.1%) were identified across tournaments (p=0.42). Interpretation These findings demonstrate a need for adherence to concussion protocols in order to improve the brain-health of athletes. Proper enforcement of the ICCS protocols during these tournaments and promoting player health and safety can influence the officiating, coaching and playing of football worldwide by promoting player safety.	[Tarzi, Christopher; Aubrey, Jason; Rotundo, Mario; Armstrong, Nicholas; Cusimano, Michael D.] St Michaels Hosp, Neurosurg, Toronto, ON, Canada; [Tarzi, Christopher; Aubrey, Jason; Rotundo, Mario; Armstrong, Nicholas; Saha, Ashirbani; Cusimano, Michael D.] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Dept Surg, Toronto, ON M5B 1W8, Canada		Cusimano, MD (corresponding author), Univ Toronto, St Michaels Hosp, Dept Surg, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca		Armstrong, Nicholas/0000-0002-9470-9437; Tarzi, Christopher/0000-0003-0809-8391	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation	This work is supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946 and the Ontario Neurotrauma Foundation.	Abraham KJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024607; Athiviraham A, 2012, AM J SPORT MED, V40, P2808, DOI 10.1177/0363546512461754; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Cantu RC, 2016, WORLD NEUROSURG, V95, P601, DOI 10.1016/j.wneu.2016.04.056; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Cusimano MD, 2017, JAMA-J AM MED ASSOC, V317, P2548, DOI 10.1001/jama.2017.6204; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Federation Internationale de Football Association, 2014, FIF WORLD CUP REACH; Federation Internationale de Soccer Association, 2014, FIFAS MED COMM PROP; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0133-4; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Kunz M, 2007, FIFA MAGAZINE, V7, P11, DOI [10.1080/13673882.2007.9680857, DOI 10.1080/13673882.2007.9680857]; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Meeuwisse WH, 2017, BRIT J SPORT MED, V51, P873, DOI 10.1136/bjsports-2017-097569; Oehlert K, 2004, SPORTVERLETZ SPORTSC, V18, P80, DOI 10.1055/s-2004-813031; Premkumar A, 2019, JAMA NEUROL, V76, P232, DOI 10.1001/jamaneurol.2018.3462; Sport Concussion Assessment Tool - 3rd edition, 2013, BR J SPORT MED; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Union of European Football Associations (UEFA), 2019, UEFA LAUNCH CONC AW	27	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	DEC	2020	26	6					536	539		10.1136/injuryprev-2019-043397			4	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	OY4IN	WOS:000594212000006	31941757	hybrid, Green Published			2022-02-06	
J	Tuerk, C; Gagner, C; Degeilh, F; Bellerose, J; Lalonde, G; Landry-Roy, C; Seguin, M; de Beaumont, L; Gravel, J; Bernier, A; Beauchamp, MH				Tuerk, Carola; Gagner, Charlotte; Degeilh, Fanny; Bellerose, Jenny; Lalonde, Gabrielle; Landry-Roy, Catherine; Seguin, Marilou; de Beaumont, Louis; Gravel, Jocelyn; Bernier, Annie; Beauchamp, Miriam H.			Quality of life 6 and 18 months after mild traumatic brain injury in early childhood: An exploratory study of the role of genetic, environmental, injury, and child factors	BRAIN RESEARCH			English	Article						Mild traumatic brain injury; Quality of life; BDNF; Genetics; Early childhood	BDNF VAL66MET POLYMORPHISM; MUTUALLY RESPONSIVE ORIENTATION; ACTIVITY-DEPENDENT SECRETION; NEUROTROPHIC FACTOR; EXECUTIVE FUNCTION; POSTCONCUSSIVE SYMPTOMS; YOUNG-CHILDREN; RISK-FACTORS; MET ALLELE; PLASTICITY	Mild traumatic brain injury (mTBI) in early childhood is prevalent, and some children may be at risk for short- and long-term difficulties that could affect quality of life (QoL). Despite growing efforts to understand associations between potential risk factors and outcomes after injury, prognosis is elusive and lacks the inclusion of genetic variables which may convey additional predictive power. This study assessed which factors contribute to pediatric QoL 6 and 18 months post-recruitment in 159 participants (mTBI = 52; orthopedic injury [OI] = 43; typically developing controls [TDC] = 64) aged 18 to 60 months at the time of injury (M = 37.50, SD = 11.69). Family environment, injury characteristics, and child cognitive-behavioral functioning were assessed at 6 months via parent questionnaires and socio-cognitive assessment. QoL was determined using the Pediatric Quality of Life Inventory at both time points. Genetic information (Brain-derived neurotrophic factor [BDNF] genotype) was collected using saliva samples. Hierarchical regression analyses testing biological, family-environmental, injury and cognitive-behavioral factors revealed that the BDNF Val66Met polymorphism was a significant independent predictor of better QoL 6 months post-injury in the mTBI group. Lower parental distress significantly and independently predicted higher QoL 18 months after mTBI, and 6 months post-recruitment in the TDC group. At 18 months, models were non-significant for both control groups. Genetic factors involved in neuroplasticity may play an important role in recovery 6 months after mTBI and contribute to outcome via their interplay with environmental factors. Over time, family factors appear to become the primary determinants of post-mTBI outcome.	[Tuerk, Carola; Gagner, Charlotte; Degeilh, Fanny; Bellerose, Jenny; Lalonde, Gabrielle; Landry-Roy, Catherine; Seguin, Marilou; Bernier, Annie; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, POB 6128 Downtown Stn, Montreal, PQ H3C 3J7, Canada; [Gagner, Charlotte; Degeilh, Fanny; Bellerose, Jenny; Lalonde, Gabrielle; Landry-Roy, Catherine; Seguin, Marilou; Gravel, Jocelyn; Beauchamp, Miriam H.] St Justine Hosp Res Ctr, 3175 Cote St Catherine Rd, Montreal, PQ H3T 1C5, Canada; [de Beaumont, Louis] Hop Sacre Coeur, Montreal Res Ctr, 5400 Gouin Blvd West, Montreal, PQ H4J 1C5, Canada; [de Beaumont, Louis] Univ Montreal, Dept Surg, POB 6128 Downtown Stn, Montreal, PQ H3C 3J7, Canada; [Degeilh, Fanny] Ludwig Maximilians Univ Munchen, LMU Univ Hosp Munich, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Lalonde, Gabrielle] McGill Univ, Montreal Childrens Hosp, Dept Psychol, Hlth Ctr, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, POB 6128 Downtown Stn, Montreal, PQ H3C 3J7, Canada.	carola.beatrice.tuerk@umontreal.ca; charlotte.gagner@umontreal.ca; fanny.degeilh@gmail.com; jenny.bellerose@umontreal.ca; gabrielle.lalonde@umontreal.ca; catherine.landry-roy@umontreal.ca; marilou.seguin@umontreal.ca; louis.de.beaumont@umontreal.ca; graveljocelyn@hotmail.com; annie.bernier@umontreal.ca; miriam.beauchamp@umontreal.ca	Degeilh, Fanny/AAA-7445-2019	Degeilh, Fanny/0000-0002-5802-4975; Tuerk, Carola/0000-0002-0910-846X	Canadian Health Research Fund [MOP111036, 261327]; Fonds de recherche du Quebec-Nature et technologies	This work was supported by the Canadian Health Research Fund (grant number MOP111036). CT received a doctoral scholarship (grant number 261327) from the Fonds de recherche du Quebec-Nature et technologies. The funding bodies were not involved in the design of the study, the collection, analysis or interpretation of data, nor in the writing of the manuscript.	Abidin, 1995, PARENTING STRESS IND; Aksan N, 2006, DEV PSYCHOL, V42, P833, DOI 10.1037/0012-1649.42.5.833; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; [Anonymous], 1971, JAMA, V215, P277; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Bayley N., 2005, BAYLEY SCALES INFANT; Beauchamp MH, 2019, J INT NEUROPSYCH SOC, V25, P375, DOI 10.1017/S1355617719000286; Beauchamp MH, 2018, NEUROPSYCHOLOGY, V32, P495, DOI 10.1037/neu0000419; Beaudoin C., 2017, 12 WORLD C BRAIN INJ; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Bendikas EA, 2011, REHABIL PSYCHOL, V56, P374, DOI 10.1037/a0025634; Bennett E.R., 2016, TRANSLATIONAL RES TR; Biringen Z, 2000, Attach Hum Dev, V2, P188; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Brown EA, 2016, J PEDIATR PSYCHOL, V41, P244, DOI 10.1093/jpepsy/jsv090; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Casey BJ, 2009, NEUROSCIENCE, V164, P108, DOI 10.1016/j.neuroscience.2009.03.081; Centonze D, 2007, NEUROBIOL DIS, V27, P44, DOI 10.1016/j.nbd.2007.03.012; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Clark Alex, 2008, Clin Child Psychol Psychiatry, V13, P565, DOI 10.1177/1359104508090607; Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; Cowan P.A., 2003, NORMAL FAMILY PROCES, V3rd, P424, DOI DOI 10.4324/9780203428436_CHAPTER_16; De Young AC, 2014, J CHILD ADOL PSYCHOP, V24, P9, DOI 10.1089/cap.2013.0066; Degeilh F, 2018, DEV PSYCHOBIOL, V60, P1037, DOI 10.1002/dev.21786; Di Filippo M, 2008, NEUROPHARMACOLOGY, V55, P353, DOI 10.1016/j.neuropharm.2008.01.012; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Enders C. K., 2010, APPL MISSING DATA AN; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Gagner C, 2021, J NEUROTRAUM, V38, P102, DOI 10.1089/neu.2019.6936; Gagner C, 2020, J PEDIATR PSYCHOL, V45, P50, DOI 10.1093/jpepsy/jsz071; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Geyer CJ, 1992, STAT SCI, V7, P473, DOI [10.1214/ss/1177011137, DOI 10.1214/SS/1177011137]; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gorski JA, 2003, J NEUROSCI, V23, P6856; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Haartsen R, 2016, CURR OPIN BEHAV SCI, V10, P149, DOI 10.1016/j.cobeha.2016.05.015; Hagemann G, 1998, ANN NEUROL, V44, P255, DOI 10.1002/ana.410440217; Hosang GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-7; Hughes C, 2005, DEV NEUROPSYCHOL, V28, P645, DOI 10.1207/s15326942dn2802_5; Hughes C, 2011, J EXP CHILD PSYCHOL, V108, P96, DOI 10.1016/j.jecp.2010.07.012; Ivanova T, 2001, NEUROSCI LETT, V307, P21, DOI 10.1016/S0304-3940(01)01905-X; IVERSON GL, 2017, BR J SPORTS MED, V0051, DOI DOI 10.1136/BJSPORTS-2017-9; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Kochanska G, 2000, DEV PSYCHOL, V36, P220, DOI 10.1037//0012-1649.36.2.220; Kochanska G, 2008, CHILD DEV, V79, P30, DOI 10.1111/j.1467-8624.2007.01109.x; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Kurowski BG, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00481; Labrell F, 2018, BRAIN INJURY, V32, P1780, DOI 10.1080/02699052.2018.1524931; Lalonde G, 2020, J NEUROPSYCHOL, V14, P98, DOI 10.1111/jnp.12179; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Landry-Roy C, 2018, J INT NEUROPSYCH SOC, V24, P769, DOI 10.1017/S1355617718000401; Landry-Roy C, 2017, J HEAD TRAUMA REHAB, V32, pE13, DOI 10.1097/HTR.0000000000000303; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Narayanan V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158838; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Pears KC, 2003, SOC DEV, V12, P1, DOI 10.1111/1467-9507.00219; Pearson-Fuhrhop KM, 2012, CURR OPIN NEUROL, V25, P682, DOI 10.1097/WCO.0b013e32835a360a; Pearson-Fuhrhop KM, 2010, PM&R, V2, pS227, DOI 10.1016/j.pmrj.2010.09.011; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Putnam S. P., 2010, INT C INF STUD BALT; Putnam SP, 2006, J PERS ASSESS, V87, P102, DOI 10.1207/s15327752jpa8701_09; Repacholi BM, 1997, DEV PSYCHOL, V33, P12, DOI 10.1037/0012-1649.33.1.12; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Schafer JL, 1997, ANAL INCOMPLETE MULT; Seguin M, 2020, NEUROPSYCHOLOGY, V34, P375, DOI 10.1037/neu0000618; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Siironen J, 2007, STROKE, V38, P2858, DOI 10.1161/STROKEAHA.107.485441; Silhol M, 2005, NEUROSCIENCE, V132, P613, DOI 10.1016/j.neuroscience.2005.01.008; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Sophie Su Y., 2016, TRANSLATIONAL RES TR; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Taylor H, 2010, FOREIGN DIRECT INVESTMENTS FROM EMERGING MARKETS: THE CHALLENGES AHEAD, P145; TEASDALE G, 1974, LANCET, V2, P81; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tilford JM, 2007, NEUROCRIT CARE, V7, P64, DOI 10.1007/s12028-007-0037-5; Treble-Barna A, 2020, J NEUROTRAUM, V37, P1491, DOI 10.1089/neu.2019.6866; Trenchard SO, 2013, BRAIN INJURY, V27, P1217, DOI 10.3109/02699052.2013.812240; Tsai SJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00156; van der Horn HJ, 2020, J NEUROL, V267, P2497, DOI 10.1007/s00415-019-09335-8; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Vilkki J, 2008, NEUROSURGERY, V63, P198, DOI 10.1227/01.NEU.0000320382.21577.8E; Wang YJ, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0518-0; Wechsler D., 2002, WECHSLER PRESCHOOL P; Yeates KO, 2019, J NEUROTRAUM, V36, P1758, DOI 10.1089/neu.2018.6009; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zelazo PD, 2006, NAT PROTOC, V1, P297, DOI 10.1038/nprot.2006.46; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zhao MZ, 2018, J AFFECT DISORDERS, V227, P226, DOI 10.1016/j.jad.2017.10.024; [No title captured]	112	2	2	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 1	2020	1748								147061	10.1016/j.brainres.2020.147061			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OC8TB	WOS:000579428000007	32818528				2022-02-06	
J	Samuelson, KW; Engle, K; Abadjian, L; Jordan, J; Bartel, A; Talbot, M; Powers, T; Bryan, L; Benight, C				Samuelson, Kristin W.; Engle, Krista; Abadjian, Linda; Jordan, Joshua; Bartel, Alisa; Talbot, Margaret; Powers, Tyler; Bryan, Lori; Benight, Charles			Cognitive Training for Mild Traumatic Brain Injury and Posttraumatic Stress Disorder	FRONTIERS IN NEUROLOGY			English	Article						cognitive training; mild TBI; PTSD; memory; cognitive rehabilitation	MEMORY MALINGERING TOMM; RELIABLE CHANGE INDEXES; OF-THE-LITERATURE; NEUROPSYCHOLOGICAL PERFORMANCE; INCOG RECOMMENDATIONS; MISERABLE MINORITY; OEF/OIF VETERANS; PROCESSING SPEED; SERVICE MEMBERS; HEAD-INJURY	Although there is evidence of mild cognitive impairments for many individuals with mild traumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD), little research evaluating the effectiveness of cognitive training interventions has been conducted. This randomized controlled trial examined the effectiveness of a 9-h group cognitive training targeting higher-order functions, Strategic Memory Advanced Reasoning Training (SMART), compared to a 9-h psychoeducational control group in improving neurocognitive functioning in adults with mTBI and PTSD. A sample of 124 adults with histories of mild TBI (n = 117) and/or current diagnoses of PTSD (n = 84) were randomized into SMART (n = 66) or Brain Health Workshop (BHW; n = 58) and assessed at three time points: baseline, following training, and 6 months later. Participants completed a battery of neurocognitive tests, including a test of gist reasoning (a function directly targeted by SMART) as well as tests of verbal, visual, and working memory and executive functioning, functions commonly found to be mildly impaired in mTBI and PTSD. The two groups were compared on trajectories of change over time using linear mixed-effects models with restricted maximum likelihood (LMM). Contrary to our hypothesis that SMART would result in superior improvements compared to BHW, both groups displayed statistically and clinically significant improvements on measures of memory, executive functioning, and gist reasoning. Over 60% of the sample showed clinically significant improvements, indicating that gains can be found through psychoeducation alone. A longer SMART protocol may be warranted for clinical samples in order to observe gains over the comparison group.	[Samuelson, Kristin W.; Engle, Krista; Abadjian, Linda; Bartel, Alisa; Talbot, Margaret; Powers, Tyler; Bryan, Lori; Benight, Charles] Univ Colorado, Dept Psychol, Natl Inst Human Resilience, Colorado Springs, CO 80933 USA; [Jordan, Joshua] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA		Samuelson, KW (corresponding author), Univ Colorado, Dept Psychol, Natl Inst Human Resilience, Colorado Springs, CO 80933 USA.	ksamuel3@uccs.edu			Lyda Hill Foundation	This project was funded by the Lyda Hill Foundation. There are not funds available for open access publication fees from this grant or my institution or library.	Anand R, 2011, INT J GERIATR PSYCH, V26, P961, DOI 10.1002/gps.2633; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Ben-Zion Z, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00477; Benedict R., 1997, BRIEF VISUOSPATIAL M; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Boot WR, 2013, PERSPECT PSYCHOL SCI, V8, P445, DOI 10.1177/1745691613491271; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Castel AD, 2002, MEM COGNITION, V30, P1078, DOI 10.3758/BF03194325; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Chapman S.B., 2008, STRATEGIC MEMORY REA; Chapman SB, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00338; Chapman SB, 2015, CEREB CORTEX, V25, P396, DOI 10.1093/cercor/bht234; Chapman SB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00069; Chapman SB, 2008, TEST STRATEGIC LEARN; Chapman SB., 2006, BRAIN IMPAIR, V7, P223, DOI [DOI 10.1375/BRIM.7.3.223, 10.1375/brim.7.3.223]; Chen AJW, 2006, J HEAD TRAUMA REHAB, V21, P107, DOI 10.1097/00001199-200603000-00004; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Conners CK, 2016, CONNERS CONTINUOUS P; Cook L, 2015, J HEAD TRAUMA REHAB, V30, pE96; Cook LG, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00087; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; EGAN V, 1988, PERS INDIV DIFFER, V9, P179, DOI 10.1016/0191-8869(88)90046-3; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; Faul M, 2010, TRAUMATIC BRAIN INJU; Foroughi CK, 2016, P NATL ACAD SCI USA, V113, P7470, DOI 10.1073/pnas.1601243113; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Gamino JF, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00924; Gamino JF, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00188; Gardner AJ, 2020, BRAIN INJURY, V34, P224, DOI 10.1080/02699052.2019.1683894; Gronwall D, 1974, PSYCHOL EFFECTS CONC; Haber AH, 2006, CLIN NEUROPSYCHOL, V20, P524, DOI 10.1080/13854040590967595; Han K, 2020, NEUROREHAB NEURAL RE, V34, P26, DOI 10.1177/1545968319868710; Han K, 2018, NEUROIMAGE-CLIN, V18, P262, DOI 10.1016/j.nicl.2018.01.030; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hanten G, 2002, CHILD NEUROPSYCHOL, V8, P107, DOI 10.1076/chin.8.2.107.8729; Hedeker D, 1997, PSYCHOL METHODS, V2, P64, DOI 10.1037/1082-989X.2.1.64; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Institute of Medicine, 2011, COGN REH THER TRAUM; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Li J, 2015, PSYCHO-ONCOLOGY, V24, P676, DOI 10.1002/pon.3710; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Miller R. M., 2016, J MENTAL HLTH COUNSE, V38, P47, DOI [10.17744/mehc.38.1.04, DOI 10.17744/MEHC.38.1.04]; Motes MA, 2014, BRAIN COGNITION, V84, P44, DOI 10.1016/j.bandc.2013.10.007; National Center for Injury Prevention and Control, 2006, C TRAUM BRAIN INJ US; Neipert L, 2014, BRAIN INJURY, V28, P1667, DOI 10.3109/02699052.2014.947623; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Neylan TC, 2004, J TRAUMA STRESS, V17, P41, DOI 10.1023/B:JOTS.0000014675.75686.ee; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; O'Neil ME, 2019, APPL NEUROPSYCH-ADUL, V26, P247, DOI 10.1080/23279095.2017.1395334; Piantella S, 2020, ARCH CLIN NEUROPSYCH, V35, P482, DOI 10.1093/arclin/acaa012; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Rath JF, 2004, ARCH CLIN NEUROPSYCH, V19, P613, DOI 10.1016/j.acn.2003.08.006; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; RONALD MG, 1995, ARCH INTERN MED, V155, P262; Ruff RM, 1999, BRAIN INJURY, V13, P943; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; SAMPSON H, 1958, CAN J PSYCHOLOGY, V12, P179, DOI 10.1037/h0083750; Samuelson KW, 2017, J TRAUMA STRESS, V30, P521, DOI 10.1002/jts.22223; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Shoulson I, 2012, COGNITIVE REHABILITA; Siegel D. J., 2012, DEV MIND RELATIONSHI, V2nd; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stein J, 2010, DEMENT GERIATR COGN, V29, P275, DOI 10.1159/000289779; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Stein MB, 1999, J TRAUMA STRESS, V12, P527, DOI 10.1023/A:1024775222098; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teichner G, 2000, ARCH CLIN NEUROPSYCH, V15, P673; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vas AK, 2016, J APPL BIOBEHAV RES, V21, P216, DOI 10.1111/jabr.12073; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; Zalewski, 1994, Assessment, V1, P133, DOI 10.1177/1073191194001002003	111	2	2	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 26	2020	11								569005	10.3389/fneur.2020.569005			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PC2GV	WOS:000596826600001	33324318	Green Published, gold			2022-02-06	
J	Schranz, AL; Dekaban, GA; Fischer, L; Blackney, K; Barreira, C; Doherty, TJ; Fraser, DD; Brown, A; Holmes, J; Menon, RS; Bartha, R				Schranz, Amy L.; Dekaban, Gregory A.; Fischer, Lisa; Blackney, Kevin; Barreira, Christy; Doherty, Timothy J.; Fraser, Douglas D.; Brown, Arthur; Holmes, Jeff; Menon, Ravi S.; Bartha, Robert			Brain Metabolite Levels in Sedentary Women and Non-contact Athletes Differ From Contact Athletes	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						magnetic resonance spectroscopy; glutamine; concussion and sports; exercise; sub-concussive head impact; sub-concussion	PROFESSIONAL SOCCER PLAYERS; PRIMARY MOTOR CORTEX; RELAXATION-TIMES; SPORTS CONCUSSIONS; T-2 RELAXATION; SEASON; GLUTAMINE; TISSUE; QUANTIFICATION; INTEGRITY	White matter tracts are known to be susceptible to injury following concussion. The objective of this study was to determine whether contact play in sport could alter white matter metabolite levels in female varsity athletes independent of changes induced by long-term exercise. Metabolite levels were measured by single voxel proton magnetic resonance spectroscopy (MRS) in the prefrontal white matter at the beginning (In-Season) and end (Off-Season) of season in contact (N = 54, rugby players) and non-contact (N = 23, swimmers and rowers) varsity athletes. Sedentary women (N = 23) were scanned once, at a time equivalent to the Off-Season time point. Metabolite levels in non-contact athletes did not change over a season of play, or differ from age matched sedentary women except that non-contact athletes had a slightly lower myo-inositol level. The contact athletes had lower levels of myo-inositol and glutamate, and higher levels of glutamine compared to both sedentary women and non-contact athletes. Lower levels of myo-inositol in non-contact athletes compared to sedentary women indicates long-term exercise may alter glial cell profiles in these athletes. The metabolite differences observed between contact and non-contact athletes suggest that non-contact athletes should not be used as controls in studies of concussion in high-impact sports because repetitive impacts from physical contact can alter white matter metabolite level profiles. It is imperative to use athletes engaged in the same contact sport as controls to ensure a matched metabolite profile at baseline.	[Schranz, Amy L.; Menon, Ravi S.; Bartha, Robert] Western Univ, Ctr Funct & Metab Mapping, Robarts Res Inst, Dept Med Biophys, London, ON, Canada; [Dekaban, Gregory A.; Blackney, Kevin; Barreira, Christy; Brown, Arthur] Western Univ, Robarts Res Inst, Mol Med Res Labs, London, ON, Canada; [Dekaban, Gregory A.; Blackney, Kevin] Western Univ, Dept Microbiol & Immunol, London, ON, Canada; [Fischer, Lisa] Western Univ, Dept Family Med, Fowler Kennedy Sport Med Clin, London, ON, Canada; [Doherty, Timothy J.] Western Univ, Phys Med & Rehabil, London, ON, Canada; [Fraser, Douglas D.] London Hlth Sci Ctr, Paediat Crit Care Med, London, ON, Canada; [Brown, Arthur] Western Univ, Dept Anat & Cell Biol, London, ON, Canada; [Holmes, Jeff] Western Univ, Sch Occupat Therapy, London, ON, Canada		Bartha, R (corresponding author), Western Univ, Ctr Funct & Metab Mapping, Robarts Res Inst, Dept Med Biophys, London, ON, Canada.	rbartha@robarts.ca	Dekaban, Gregory/L-1987-2013; Bartha, Robert/K-3611-2013; Menon, Ravi S/K-5500-2013	Dekaban, Gregory/0000-0002-3087-4660; Bartha, Robert/0000-0002-7118-9096; Menon, Ravi S/0000-0002-7916-0263	Schulich School of Medicine and Dentistry; Canada First Research Excellence Fund (BrainsCAN); Brain Canada; CIHRCanadian Institutes of Health Research (CIHR) [FDN 148453]	This work was supported by the Schulich School of Medicine and Dentistry, the Canada First Research Excellence Fund (BrainsCAN), and Brain Canada. The acquisition of the data from the swimmers and rowers was supported by a CIHR Foundation grant (FDN 148453) to RM.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2005, GUIDELINES DATA PROC; Bari S, 2019, BRAIN IMAGING BEHAV, V13, P735, DOI 10.1007/s11682-018-9861-9; Bartha R, 1999, NMR BIOMED, V12, P205, DOI 10.1002/(SICI)1099-1492(199906)12:4<205::AID-NBM558>3.0.CO;2-1; Bartha R, 2000, MAGN RESON MED, V44, P641, DOI 10.1002/1522-2594(200010)44:4<641::AID-MRM19>3.0.CO;2-G; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bernier LP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15267-z; Chamard E, 2014, J NEUROTRAUM, V31, P339, DOI 10.1089/neu.2013.3083; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Churchill NW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00390; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Ethofer T, 2003, MAGN RESON MED, V50, P1296, DOI 10.1002/mrm.10640; Gangolli M, 2019, J NEUROTRAUM, V36, P735, DOI 10.1089/neu.2018.5700; Ganji SK, 2012, NMR BIOMED, V25, P523, DOI 10.1002/nbm.1767; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goncalves S, 2016, J NEUROSURG-SPINE, V25, P436, DOI 10.3171/2016.2.SPINE15944; Gonzales MM, 2013, BRAIN TOPOGR, V26, P126, DOI 10.1007/s10548-012-0248-8; Harris AD, 2015, J MAGN RESON IMAGING, V42, P1431, DOI 10.1002/jmri.24903; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Huang RW, 2015, BRAIN STRUCT FUNCT, V220, P625, DOI 10.1007/s00429-013-0677-5; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King DA, 2018, J SCI MED SPORT, V21, P139, DOI 10.1016/j.jsams.2017.10.026; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kreis R, 2016, MAGN RESON MED, V75, P15, DOI 10.1002/mrm.25568; Lefebvre G, 2018, J NEUROTRAUM, V35, P953, DOI 10.1089/neu.2017.5254; Lu HZ, 2005, J MAGN RESON IMAGING, V22, P13, DOI 10.1002/jmri.20356; Maddock RJ, 2016, J NEUROSCI, V36, P2449, DOI 10.1523/JNEUROSCI.3455-15.2016; Maddock RJ, 2011, NEUROIMAGE, V57, P1324, DOI 10.1016/j.neuroimage.2011.05.048; Manning KY, 2020, NEUROLOGY, V95, pE402, DOI 10.1212/WNL.0000000000009821; Manning KY, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2018.101627; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McGroarty NK, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120932306; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Panchal H, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00616; Piechnik SK, 2009, MAGN RESON MED, V61, P579, DOI 10.1002/mrm.21897; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Schranz AL, 2018, HUM BRAIN MAPP, V39, P1489, DOI 10.1002/hbm.23919; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Traber F, 2004, J MAGN RESON IMAGING, V19, P537, DOI 10.1002/jmri.20053; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Triplett, 2015, ESSENTIALS STRENGTH; Wang B, 2013, NEUROIMAGE, V65, P476, DOI 10.1016/j.neuroimage.2012.10.007; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Wong D, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.4002; Wyss PO, 2018, MAGN RESON MED, V80, P452, DOI 10.1002/mrm.27067; Zhang Y, 2016, MAGN RESON MED, V76, P725, DOI 10.1002/mrm.25922	56	2	2	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	NOV 26	2020	14								593498	10.3389/fnhum.2020.593498			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	PC2EJ	WOS:000596820200001	33324185	Green Published, gold			2022-02-06	
J	Hoffman, AN; Watson, SL; Makridis, AS; Patel, AY; Gonzalez, ST; Ferguson, L; Giza, CC; Fanselow, MS				Hoffman, Ann N.; Watson, Sonya L.; Makridis, Anna S.; Patel, Anisha Y.; Gonzalez, Sarah T.; Ferguson, Lindsay; Giza, Christopher C.; Fanselow, Michael S.			Sex Differences in Behavioral Sensitivities After Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						migraine; PTSD&#8211; post-traumatic stress disorder; traumatic brain injury; sensory sensitivity; defensive behavior; fear &amp; anxiety; sex differences	POSTTRAUMATIC-STRESS-DISORDER; EMERGENCY-DEPARTMENT VISITS; INDUCED ENHANCEMENT; ANXIETY DISORDERS; ACTIVITY RESPONSE; UNITED-STATES; ANIMAL-MODEL; BASE-LINE; FEAR; CONCUSSION	Traumatic brain injury (TBI) is associated with high rates of post-injury psychiatric and neurological comorbidities. TBI is more common in males than females despite females reporting more symptoms and longer recovery following TBI and concussion. Both pain and mental health conditions like anxiety and post-traumatic stress disorder (PTSD) are more common in women in the general population, however the dimorphic comorbidity in the TBI population is not well-understood. TBI may predispose the development of maladaptive anxiety or PTSD following a traumatic stressor, and the impact of sex on this interaction has not been investigated. We have shown that white noise is noxious to male rats following fluid percussion injury (FPI) and increases fear learning when used in auditory fear conditioning, but it is unclear whether females exhibit a similar phenotype. Adult female and male rats received either lateral FPI or sham surgery and 48 h later received behavioral training. We first investigated sex differences in response to 75 dB white noise followed by white noise-signaled fear conditioning. FPI groups exhibited defensive behavior to the white noise, which was significantly more robust in females, suggesting FPI increased auditory sensitivity. In another experiment, we asked how FPI affects contextual fear learning in females and males following unsignaled footshocks of either strong (0.9 mA) or weaker (0.5 mA) intensity. We saw that FPI led to rapid acquisition of contextual fear compared to sham. A consistent pattern of increased contextual fear after TBI was apparent in both sexes across experiments under differing conditioning protocols. Using a light gradient open field task we found that FPI females showed a defensive photophobia response to light, a novel finding supporting TBI enhanced sensory sensitivity across modalities in females. General behavioral differences among our measures were observed between sexes and discussed with respect to interpretations of TBI effects for each sex. Together our data support enhanced fear following a traumatic stressor after TBI in both sexes, where females show greater sensitivity to sensory stimuli across multiple modalities. These data demonstrate sex differences in emergent defensive phenotypes following TBI that may contribute to comorbid PTSD, anxiety, and other neurological comorbidities.	[Hoffman, Ann N.; Watson, Sonya L.; Ferguson, Lindsay; Giza, Christopher C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Neurosurg, Los Angeles, CA 90095 USA; [Hoffman, Ann N.; Watson, Sonya L.; Makridis, Anna S.; Patel, Anisha Y.; Gonzalez, Sarah T.; Fanselow, Michael S.] Univ Calif Los Angeles, Psychol, Los Angeles, CA 90095 USA; [Hoffman, Ann N.; Ferguson, Lindsay; Giza, Christopher C.] Univ Calif Los Angeles, Steve Tisch Brain SPORT Program, Los Angeles, CA 90095 USA; [Hoffman, Ann N.; Gonzalez, Sarah T.; Fanselow, Michael S.] Univ Calif Los Angeles, Staglin Ctr Brain & Behav Hlth, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Pediat, Div Neurol, Mattel Childrens Hosp, Los Angeles, CA 90024 USA; [Fanselow, Michael S.] Dept Psychiat & Biobehav Sci, Los Angeles, CA USA		Hoffman, AN (corresponding author), Univ Calif Los Angeles, Brain Injury Res Ctr, Neurosurg, Los Angeles, CA 90095 USA.; Hoffman, AN (corresponding author), Univ Calif Los Angeles, Psychol, Los Angeles, CA 90095 USA.; Hoffman, AN (corresponding author), Univ Calif Los Angeles, Steve Tisch Brain SPORT Program, Los Angeles, CA 90095 USA.; Hoffman, AN (corresponding author), Univ Calif Los Angeles, Staglin Ctr Brain & Behav Hlth, Los Angeles, CA 90095 USA.	hoffmana7@ucla.edu			UCLA Depression Grand Challenge Fellowship Fund [F32NS098694, R01MH062122]; Staglin Center for Brain & Behavioral Health; UCLA Brain Injury Research Center [1R01NS27544]; Easton Labs for Brain Injury; Center for NeuroSkills; UCLA Steve Tisch BrainSPORT	This work was supported in part by: F32NS098694: AH; R01MH062122: MF; UCLA Depression Grand Challenge Fellowship Fund: MF; Staglin Center for Brain & Behavioral Health: MF; UCLA Brain Injury Research Center; 1R01NS27544: AH and CG; Center for NeuroSkills: AH; UCLA Steve Tisch BrainSPORT: CG; Easton Labs for Brain Injury CG and LF.	Avona A, 2019, J NEUROSCI, V39, P4323, DOI 10.1523/JNEUROSCI.0364-19.2019; Baran SE, 2009, NEUROBIOL LEARN MEM, V91, P321, DOI 10.1016/j.nlm.2008.11.005; Barker JM, 2010, PHYSIOL BEHAV, V99, P82, DOI 10.1016/j.physbeh.2009.10.014; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Bekker MHJ, 2007, GENDER MED, V4, pS178, DOI 10.1016/S1550-8579(07)80057-X; Bellgowan PSF, 1996, BEHAV NEUROSCI, V110, P727; Bree D, 2020, CEPHALALGIA, V40, P748, DOI 10.1177/0333102420907597; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Carter AJ, 2013, BIOL REV, V88, P465, DOI 10.1111/brv.12007; Colon L, 2018, LEARN MEMORY, V25, P230, DOI 10.1101/lm.047159.117; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Fanselow MS, 2019, BEHAV PROCESS, V166, DOI 10.1016/j.beproc.2019.103890; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Godsil BP, 2005, LEARN BEHAV, V33, P454, DOI 10.3758/BF03193184; Godsil BR, 2004, LEARN BEHAV, V32, P299; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hagenaars MA, 2014, NEUROSCI BIOBEHAV R, V47, P165, DOI 10.1016/j.neubiorev.2014.07.021; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P177, DOI 10.1037/0735-7044.108.1.177; Hersman S, 2020, ELIFE, V9, DOI 10.7554/eLife.53803; Hoffman AN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50312-y; Hoffman AN, 2015, NEUROBIOL LEARN MEM, V120, P61, DOI 10.1016/j.nlm.2015.02.004; Hoffman AN, 2014, NEUROBIOL LEARN MEM, V112, P139, DOI 10.1016/j.nlm.2014.01.018; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Liu Katherine A., 2016, Pharmacy Pract (Granada), V14, DOI 10.18549/PharmPract.2016.01.708; MAREN S, 1994, BRAIN RES, V661, P25, DOI 10.1016/0006-8993(94)91176-2; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Notermans S L, 1967, Psychiatr Neurol Neurochir, V70, P23; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Perez-Garcia G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00176; Perusini JN, 2016, NEUROPSYCHOPHARMACOL, V41, P45, DOI 10.1038/npp.2015.224; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Riley JL, 2001, J PAIN, V2, P354, DOI 10.1054/jpai.2001.27000; Scholl JL, 2019, PHYSIOL BEHAV, V211, DOI 10.1016/j.physbeh.2019.112670; Shansky RM, 2016, J NEUROSCI, V36, P11817, DOI 10.1523/JNEUROSCI.1390-16.2016; St Ivany A, 2018, QUAL HEALTH RES, V28, P1708, DOI 10.1177/1049732318786705; Stock HS, 2001, PHYSIOL BEHAV, V72, P439, DOI 10.1016/S0031-9384(00)00426-1; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vetvik KG, 2017, LANCET NEUROL, V16, P76, DOI 10.1016/S1474-4422(16)30293-9; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wiesenfeld-Hallin Zsuzsanna, 2005, Gend Med, V2, P137, DOI 10.1016/S1550-8579(05)80042-7; Wiltgen BJ, 2001, BEHAV NEUROSCI, V115, P26, DOI 10.1037/0735-7044.115.1.26; Yoshimoto M, 2010, AM J PHYSIOL-REG I, V299, pR1114, DOI 10.1152/ajpregu.00831.2009; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	67	2	2	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 25	2020	11								553190	10.3389/fneur.2020.553190			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PB8GX	WOS:000596554100001	33324313	Green Published, gold			2022-02-06	
J	Nowell, C; Downing, M; Bragge, P; Ponsford, J				Nowell, Clare; Downing, Marina; Bragge, Peter; Ponsford, Jennie			Current practice of cognitive rehabilitation following traumatic brain injury: An international survey	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; traumatic; rehabilitation; cognition; clinician	CLINICAL-PRACTICE GUIDELINES; OF-THE-LITERATURE; INCOG RECOMMENDATIONS; MANAGEMENT; MODERATE; ADULTS; INDIVIDUALS; IMPAIRMENT; AGREEMENT; ATTENTION	Traumatic brain injury (TBI) is a global public health issue, frequently resulting in impairments in the cognitive domains of attention, information processing speed, memory, executive function, and communication. Despite the importance of rehabilitating cognitive difficulties, and the release of clinical practice guidelines (CPGs) for cognitive rehabilitation, little is known about current clinician practice. This study aimed to explore current international clinician practice of cognitive rehabilitation. One hundred and fifteen English-speaking allied health professionals, including neuropsychologists and occupational therapists, from 29 countries outside Australia, were surveyed online about their current practice and reflections on cognitive rehabilitation. Both cognitive retraining and functional compensation approaches to cognitive rehabilitation were commonly utilized. Clinicians mostly targeted deficits in attention and executive functioning with retraining interventions, whilst memory deficits were mostly targeted with compensatory interventions. Clinicians were aware of and utilized various resources for cognitive rehabilitation, including CPGs. Clinicians considered the client's social support network, client engagement and motivation in rehabilitation, multidisciplinary team collaboration, and goal setting and implementation as highly impactful factors on the success of cognitive rehabilitation interventions. Whilst practice is broadly consistent with current CPG recommendations, addressing facilitating factors can further optimize client outcomes and quality of life following TBI.	[Nowell, Clare; Downing, Marina; Ponsford, Jennie] Monsah Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia; [Nowell, Clare; Downing, Marina; Ponsford, Jennie] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Bragge, Peter] Monash Univ, Monash Sustainable Dev Inst, BehaviourWorks Australia, Melbourne, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Downing, Marina/AAX-2380-2020; Ponsford, Jennie/H-8341-2014	Downing, Marina/0000-0002-3126-6632; Bragge, Peter/0000-0003-0745-5131; Nowell, Clare/0000-0003-2263-0153; Ponsford, Jennie/0000-0003-0430-125X			Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Bayley MT, 2018, J HEAD TRAUMA REHAB, V33, P296, DOI 10.1097/HTR.0000000000000428; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Boyatzis R. E., 1998, TRANSFORMING QUALITA; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Campbell M., 2000, REHABILITATION TRAUM; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Creswell J., 2009, RES DESIGN, V3rd; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Downing M, 2019, BRAIN IMPAIR, V20, P24, DOI 10.1017/BrImp.2018.12; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Evans JJ, 2012, CURR OPIN NEUROL, V25, P651, DOI 10.1097/WCO.0b013e3283598f75; Institute of Medicine, 2011, COGN REH THER TRAUM; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; Kelly M, 2017, BRAIN IMPAIR, V18, P11, DOI 10.1017/BrImp.2016.34; KEWMAN DG, 1985, REHABIL PSYCHOL, V30, P11; Lamontagne ME, 2018, J HEAD TRAUMA REHAB, V33, P288, DOI 10.1097/HTR.0000000000000429; Lamontagne ME, 2018, J HEAD TRAUMA REHAB, V33, P306, DOI 10.1097/HTR.0000000000000430; Pagan E, 2015, BRAIN IMPAIR, V16, P173, DOI 10.1017/BrImp.2015.34; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Ponsford J, 2017, NEUROPSYCHOLOGY, V31, P921, DOI 10.1037/neu0000415; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; Sander AM, 2009, CLIN NEUROPSYCHOL, V23, P1196, DOI 10.1080/13854040902845706; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Swaine B, 2018, J HEAD TRAUMA REHAB, V33, P285, DOI 10.1097/HTR.0000000000000427; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Truchon C, 2017, BRAIN INJURY, V31, P741; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Viera AJ, 2005, FAM MED, V37, P360; Wilson B, 2009, MEMORY REHABILITATIO; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002	43	2	2	2	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	NOV 25	2020	30	10					1976	1995		10.1080/09602011.2019.1623823			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	OK4VL	WOS:000584650000005	31164047				2022-02-06	
J	Johnstone, B; Bruininks, P; Smith, EI; Yoon, DP; Cohen, D; Edman, L; Bankard, J; Witvliet, C				Johnstone, Brick; Bruininks, Patricia; Smith, Erin, I; Yoon, Dong Pil; Cohen, Daniel; Edman, Laird; Bankard, Joseph; Witvliet, Charlotte			Conceptualising spirituality and religion as psychological processes: validation of the factor structure of the BMMRS	MENTAL HEALTH RELIGION & CULTURE			English	Article						Spirituality; religion; factor analysis; BMMRS	BRIEF MULTIDIMENSIONAL MEASURE; CONGREGATIONAL SUPPORT; MENTAL-HEALTH; STRESS; INVOLVEMENT; SCIENCE	This study validated previous principal component analyses of the Brief Multidimensional Measure of Religiousness/Spirituality (BMMRS) that have been conducted with persons with diverse medical conditions and traumatic brain injuries from diverse cultures (India, US), ethnicities (African American, Caucasian, South Asian), and religions (Christian, Hindu, Muslim). Participants included 398 healthy undergraduate students who completed the BMMRS online. A principal components factor analysis identified a five factor solution accounting for 64.00% of the variance in scores, labelled as: (1) Positive Spiritual Experience; (2) Negative Spiritual Experience/Congregational Support; (3) Forgiveness; (4) Religious Practices; and (5) Positive Congregational Support. The current analysis is supportive of a conceptual framework in which the BMMRS spiritual and religious variables are best conceptualised in terms of positive/negative psychological processes including: (a) emotional connection with the divine (i.e., spirituality); (b) behavioural rituals/beliefs (i.e., religiosity); and (c) social support (i.e., congregationally based). Implications for psychoneuroimmunological research are discussed.	[Johnstone, Brick] Shepherd Ctr, Atlanta, GA 30309 USA; [Bruininks, Patricia] Whitworth Univ, Dept Psychol, Spokane, WA USA; [Smith, Erin, I] Calif Baptist Univ, Coll Behav & Social Sci, Riverside, CA USA; [Yoon, Dong Pil] Univ Missouri, Sch Social Work, Columbia, MO USA; [Cohen, Daniel] Univ Missouri, Dept Religious Studies, Columbia, MO USA; [Edman, Laird] Northwestern Coll, Dept Psychol, Orange, IA USA; [Bankard, Joseph] Northwest Nazarene Univ, Dept Philosophy, Nampa, ID USA; [Witvliet, Charlotte] Hope Coll, Dept Psychol, Holland, MI 49423 USA		Johnstone, B (corresponding author), Shepherd Ctr, Atlanta, GA 30309 USA.	Brickjohnstone47@gmail.com			Science and Christianity in Oxford Program - Templeton Religious Trust	This article was supported with funding from the Science and Christianity in Oxford Program funded by Templeton Religious Trust.	Berry JW, 2001, J COUNS PSYCHOL, V48, P447, DOI 10.1037//0022-0167.48.4.447; Campbell JD, 2010, J RELIG HEALTH, V49, P3, DOI 10.1007/s10943-008-9227-5; Capanna C, 2013, PSYCHOL RELIG SPIRIT, V5, P316, DOI 10.1037/a0033642; Cohen D, 2009, INT J PSYCHOL RELIG, V19, P121, DOI 10.1080/10508610802711335; Ellison CG, 2000, RES AGING, V22, P630, DOI 10.1177/0164027500226003; Fetzer Institute y National Institute on Aging Working Group, 1999, MULT MEAREL SPIR U; Franklin KL, 2008, TOPICS SPINAL CORD I, V14, P76, DOI DOI 10.1310/SCI1402-76; George LK, 2002, PSYCHOL INQ, V13, P190, DOI 10.1207/S15327965PLI1303_04; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Hackney CH, 2003, J SCI STUD RELIG, V42, P43, DOI 10.1111/1468-5906.t01-1-00160; Handal PJ, 2017, J RELIG HEALTH, V56, P1971, DOI 10.1007/s10943-016-0304-x; Harris KA, 2018, PSYCHOL RELIG SPIRIT, V10, P1, DOI 10.1037/rel0000134; Idler EL, 2003, RES AGING, V25, P327, DOI 10.1177/0164027503025004001; Johnstone B, 2016, J RELIG HEALTH, V55, P572, DOI 10.1007/s10943-015-0170-y; Johnstone B, 2012, J RELIG HEALTH, V51, P1017, DOI 10.1007/s10943-012-9615-8; Johnstone B, 2009, J RELIG HEALTH, V48, P146, DOI 10.1007/s10943-008-9179-9; Lutgendorf SK, 2003, BRAIN BEHAV IMMUN, V17, P225, DOI 10.1016/S0889-1591(03)00033-3; MacDonald DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117701; Neff JA, 2006, J SCI STUD RELIG, V45, P449, DOI 10.1111/j.1468-5906.2006.00318.x; Pargament K., 1997, PSYCHOL RELIG COPING; Pargament KI, 2000, FORGIVENESS, P299; Pargament KI, 1998, LAWS LIF SYMP SER, V1, P59; Pew Research Center, 2012, PEW FOR REL PUBL LIF; Piedmont RL., 2007, RES SOCIAL SCI STUDY, V17, P177; Ray O, 2004, ANN NY ACAD SCI, V1032, P35, DOI 10.1196/annals.1314.004; Ray O, 2004, AM PSYCHOL, V59, P29, DOI 10.1037/0003-066X.59.1.29; Saroglou V, 2005, J SCI STUD RELIG, V44, P323, DOI 10.1111/j.1468-5906.2005.00289.x; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Sherman AC, 2005, J BEHAV MED, V28, P359, DOI 10.1007/s10865-005-9006-7; Smith EI, 2017, BRIT J DEV PSYCHOL, V35, P76, DOI 10.1111/bjdp.12156; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Stewart C., 2006, INT J PSYCHOL RELIG, V16, P181, DOI [DOI 10.1207/S15327582IJPR1603_3, 10.1207/s15327582ijpr1603_3]; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Tarakeshwar N, 2005, MENT HEALTH RELIG CU, V8, P179, DOI 10.1080/13694670500138908; Tarakeshwar N, 2005, MENT HEALTH RELIG CU, V8, P109, DOI 10.1080/1367467042000240383; Thoresen C E, 1999, J Health Psychol, V4, P291, DOI 10.1177/135910539900400314; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Valdesolo P, 2016, EMOTION, V16, P937, DOI 10.1037/emo0000213; Witvliet C., 2011, J PSYCHOL CHRISTIANI, V30, P223; Witvliet C. V. O., 2018, POSITIVE PSYCHOL, P131; Witvliet C. V. O., 2016, FORGIVENESS HLTH SCI, DOI [10.1007/978-94-017-9993-5_4, DOI 10.1007/978-94-017-9993-5_4]; Wuthnow R, 2000, J SCI STUD RELIG, V39, P125, DOI 10.1111/0021-8294.00011	42	2	2	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1367-4676	1469-9737		MENT HEALTH RELIG CU	Ment. Health Relig. Cult.	MAR 16	2021	24	3			SI		316	332		10.1080/13674676.2020.1793311		NOV 2020	17	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	SN7YR	WOS:000591757800001					2022-02-06	
J	Berthold-Lindstedt, M; Johansson, J; Ygge, J; Borg, K				Berthold-Lindstedt, Marta; Johansson, Jan; Ygge, Jan; Borg, Kristian			How to assess visual function in acquired brain injury-Asking is not enough	BRAIN AND BEHAVIOR			English	Article						brain injuries; ocular motility disorders; stroke; traumatic brain injury; vision disorders	INSUFFICIENCY SYMPTOM SURVEY; VERGENCE FACILITY; 1ST YEAR; VISION; DYSFUNCTION; RELIABILITY; VALIDITY; STROKE; MODEL	Background Acquired brain injury affects many brain areas and causes a range of dysfunctions including vision-related issues. These issues can have negative impacts on rehabilitation progress and activities of daily life but may easily be overlooked. There is no common recommendation about how to assess visual impairments after ABI. The purpose of this study was to estimate the frequency of objectively measures oculomotor dysfunctions, and also how these findings are related to two inventories intended to support detection of visual impairment. Methods The study was cross-sectional and included 73 outpatients. In addition to the standard evaluation program, the patients went through a comprehensive optometric examination. The inventories used were the Vision Interview (VI) and the Convergence Insufficiency Symptom Survey (CISS). Results All three types of examinations showed a high proportion vision-related symptoms. Fusion vergence was the most common objectively measured finding, 83%. There were seven statistically significant associations between five VI items and five visual deficits. The strength of associations was moderate (Phi 0.261-0.487, p < .05). The sensitivity and specificity of the CISS were moderate. Conclusion We found high percentages of the patients with visual symptoms and dysfunctions. Due to the complexity of visual symptoms and functional deficits in ABI, we find it necessary to combine both symptom assessment and vision examination in order to capture visual function issues.	[Berthold-Lindstedt, Marta; Borg, Kristian] Karolinska Inst, Danderyd Univ Hosp, Dept Clin Sci, Div Rehabil Med, SE-18257 Stockholm, Sweden; [Johansson, Jan; Ygge, Jan] Karolinska Inst, Dept Clin Neurosci, Eye & Vis, Stockholm, Sweden		Berthold-Lindstedt, M (corresponding author), Karolinska Inst, Danderyd Univ Hosp, Dept Clin Sci, Div Rehabil Med, SE-18257 Stockholm, Sweden.	marta.berthold-lindstedt@ki.se			County Council of StockholmStockholm County Council; Swedish Stroke Association	The County Council of Stockholm; The Swedish Stroke Association	Antona B, 2008, OPHTHAL PHYSL OPT, V28, P475, DOI 10.1111/j.1475-1313.2008.00583.x; Berthold Lindstedt M, 2019, J REHABIL MED, V51, P499, DOI 10.2340/16501977-2570; Berthold-Lindstedt M, 2017, J REHABIL MED, V49, P327, DOI 10.2340/16501977-2218; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Cacho-Martinez Pilar, 2014, J Optom, V7, P2, DOI 10.1016/j.optom.2013.01.004; Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Conrad JS, 2017, OPTOMETRY VISION SCI, V94, P101, DOI 10.1097/OPX.0000000000000937; Gall R, 1998, OPTOMETRY VISION SCI, V75, P731, DOI 10.1097/00006324-199810000-00018; Garcia A, 2000, OPHTHAL PHYSL OPT, V20, P98, DOI 10.1016/S0275-5408(99)00034-4; Goss DA, 2011, OPTOMETRY, V82, P104, DOI 10.1016/j.optm.2010.09.011; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Kerkhoff, 2000, Am J Ophthalmol, V130, P687, DOI 10.1016/S0002-9394(00)00753-4; Merezhinskaya N, 2019, OPTOMETRY VISION SCI, V96, P542, DOI 10.1097/OPX.0000000000001407; Momeni-Moghaddam H, 2014, OPTOMETRY VISION SCI, V91, P522, DOI 10.1097/OPX.0000000000000227; Pellizzer S, 1998, OPTOMETRY VISION SCI, V75, P817, DOI 10.1097/00006324-199811000-00023; Roberts PS, 2016, J REHABIL RES DEV, V53, P693, DOI 10.1682/JRRD.2015.06.0113; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Rowe Fiona, 2016, Community Eye Health, V29, P75; Rowe F, 2016, DISABIL REHABIL, V38, P813, DOI 10.3109/09638288.2015.1061604; Rowe F, 2009, AGE AGEING, V38, P188, DOI 10.1093/ageing/afn230; Rowe FJ, 2019, EYE, V33, P1485, DOI 10.1038/s41433-019-0441-z; Rutstein RP., 1998, ANOMALIES BINOCULAR; Schuett S, 2012, BRAIN, V135, P912, DOI 10.1093/brain/awr356; SIMONS HD, 1993, OPTOMETRY VISION SCI, V70, P369, DOI 10.1097/00006324-199305000-00005; Simpson-Jones ME, 2019, DISABIL REHABIL, V41, P2206, DOI 10.1080/09638288.2018.1460407; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; WARREN M, 1993, AM J OCCUP THER, V47, P42, DOI 10.5014/ajot.47.1.42; Yekta A, 2017, STRABISMUS, V25, P5, DOI 10.1080/09273972.2016.1276937	31	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	FEB	2021	11	2							e01958	10.1002/brb3.1958		NOV 2020	8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	QK9JN	WOS:000591508800001	33230981	Green Published, gold			2022-02-06	
J	Hlavac, N; Guilhaume-Correa, F; VandeVord, PJ				Hlavac, Nora; Guilhaume-Correa, Fernanda; VandeVord, Pamela J.			Mechano-stimulation initiated by extracellular adhesion and cationic conductance pathways influence astrocyte activation	NEUROSCIENCE LETTERS			English	Article						Astrocyte; Overpressure; Focal adhesion kinase; Bioenergetics; NOX4; 3D culture		Traumatic brain injury (TBI) represents a major cause of long-term disability worldwide. Primary damage to brain tissue leads to complex secondary injury mechanisms involving inflammation, oxidative stress and cellular activation/reactivity. The molecular pathways that exacerbate brain cell dysfunction after injury are not well understood and provide challenges to developing TBI therapeutics. This study aimed to delineate mechanisms of astrocyte activation induced by mechano-stimulation, specifically involving extracellular adhesion and cationic transduction. An in vitro model was employed to investigate 2D and 3D cultures of primary astrocytes, in which cells were exposed to a single high-rate overpressure known to cause upregulation of structural and proliferative markers within 72 h of exposure. An inhibitor of focal adhesion kinase (FAK) phosphorylation, TAE226, was used to demonstrate a relationship between extracellular adhesion perturbations and structural reactivity in the novel 3D model. TAE226 mitigated upregulation of glial fibrillary acidic protein in 3D cultures by 72 h post-exposure. Alternatively, incubation with gadolinium (a cationic channel blocker) during overpressure, demonstrated a role for cationic transduction in reducing the increased levels of proliferating cell nuclear antigen that occur at 24 h post-stimulation. Furthermore, early changes in mitochondrial polarization at 15 min and in endogenous ATP levels at 4-6 h occur post-overpressure and may be linked to later changes in cell phenotype. By 24 h, there was evidence of increased amine metabolism and increased nicotinamide adenine dinucleotide phosphate oxidase (NOX4) production. The overproduction of NOX4 was counteracted by gadolinium during overpressure exposure. Altogether, the results of this study indicated that both extracellular adhesion (via FAK activation) and cationic conductance (via ion channels) contribute to early patterns of astrocyte activation following overpressure stimulation. Mechano-stimulation pathways are linked to bioenergetic and metabolic disruptions in astrocytes that influence downstream oxidative stress, aberrant proliferative capacity and structural reactivity.	[Hlavac, Nora; VandeVord, Pamela J.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Guilhaume-Correa, Fernanda] Virginia Tech, Dept Translat Biol Med & Hlth, Blacksburg, VA USA; [VandeVord, Pamela J.] Salem Vet Affairs Med Ctr, Dept Res, Salem, VA USA		VandeVord, PJ (corresponding author), 447 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	pvord@vt.edu		Guilhaume Correa, Fernanda/0000-0002-3878-5283			Abbracchio Maria P, 2006, Purinergic Signal, V2, P595, DOI 10.1007/s11302-006-9016-0; Bailey ZS, 2016, METHODS MOL BIOL, V1462, P119, DOI 10.1007/978-1-4939-3816-2_8; Benlimame N, 2005, J CELL BIOL, V171, P505, DOI 10.1083/jcb.200504124; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cheli VT, 2016, GLIA, V64, P1396, DOI 10.1002/glia.23013; Chen YX, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12781; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; De Bock M, 2014, BBA-MOL CELL RES, V1843, P2211, DOI 10.1016/j.bbamcr.2014.04.016; Di Marco E, 2016, FREE RADICAL BIO MED, V97, P556, DOI 10.1016/j.freeradbiomed.2016.07.013; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Giannone G, 2004, J BIOL CHEM, V279, P28715, DOI 10.1074/jbc.M404054200; Hlavac N, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00099; Hlavac Nora, 2015, Biomed Sci Instrum, V51, P439; Hua SZ, 2010, AM J PHYSIOL-CELL PH, V298, pC1424, DOI 10.1152/ajpcell.00503.2009; Lan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129743; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Liu B, 2014, SCI REP-UK, V4, DOI 10.1038/srep07008; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; Miller WJ, 2009, J NEUROTRAUM, V26, P789, DOI [10.1089/neu.2008.0727, 10.1089/neu.2008-0727]; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Paemeleire K, 2000, J NEUROTRAUM, V17, P345, DOI 10.1089/neu.2000.17.345; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Placone AL, 2015, BIOMATERIALS, V42, P134, DOI 10.1016/j.biomaterials.2014.11.046; Ravin R, 2019, BIOPHYS J, V117, P1167, DOI 10.1016/j.bpj.2019.07.052; Ravin R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25713; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Shi Q, 2007, MOL CARCINOGEN, V46, P488, DOI 10.1002/mc.20297; Singh A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14574-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8	40	2	2	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 20	2020	739								135405	10.1016/j.neulet.2020.135405			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PA8JC	WOS:000595874700011	32979460				2022-02-06	
J	Massaro, AN; Lee, JK; Vezina, G; Glass, P; O'Kane, A; Li, RY; Chang, T; Brady, K; Govindan, R				Massaro, An N.; Lee, Jennifer K.; Vezina, Gilbert; Glass, Penny; O'Kane, Alexandra; Li, Ruoying; Chang, Taeun; Brady, Kenneth; Govindan, Rathinaswamy			Exploratory Assessment of the Relationship Between Hemoglobin Volume Phase Index, Magnetic Resonance Imaging, and Functional Outcome in Neonates with Hypoxic-Ischemic Encephalopathy	NEUROCRITICAL CARE			English	Article						Neonatal encephalopathy; Newborn; Magnetic resonance imaging; Brain injury	CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; WHOLE-BODY HYPOTHERMIA; CEREBROVASCULAR AUTOREGULATION; SYSTEMIC HYPOTHERMIA; PERINATAL ASPHYXIA; SWINE MODEL; PRESSURE; TERM; REACTIVITY	Background/Objective Near-infrared spectroscopy (NIRS)-based measures of cerebral autoregulation (CAR) can potentially identify neonates with hypoxic-ischemic encephalopathy (HIE) who are at greatest risk of irreversible brain injury. However, modest predictive abilities have precluded previously described metrics from entering clinical care. We previously validated a novel autoregulation metric in a piglet model of induced hypotension called the hemoglobin volume phase index (HVP). The objective of this study was to evaluate the clinical ability of the HVP to predict adverse outcomes neonates with HIE. Methods This is a prospective study of neonates with HIE who underwent therapeutic hypothermia (TH) at a level 4 neonatal intensive care unit (NICU). Continuous cerebral NIRS and mean arterial blood pressure (MAP) from indwelling arterial catheters were measured during TH and through rewarming. Multivariate autoregressive process was used to calculate the coherence between MAP and the sum total of the oxy- and deoxygenated Hb densities (HbT), a surrogate measure of cerebral blood volume (CBV). The HVP was calculated as the cosine-transformed phase shift at the frequency of maximal MAP-HbT coherence. Brain injury was assessed by neonatal magnetic resonance imaging (MRI), and developmental outcomes were assessed by the Bayley Scales of Infant Development (BSID-III) at 15-30 months. The ability of the HVP to predict (a) death or severe brain injury by MRI and (b) death or significant developmental delay was assessed using logistic regression analyses. Results In total, 50 neonates with moderate or severe HIE were monitored. Median HVP was higher, representing more dysfunctional autoregulation, in infants who had adverse outcomes. After adjusting for sex and encephalopathy grade at presentation, HVP at 21-24 and 24-27 h of life predicted death or brain injury by MRI (21-24 h: OR 8.8, p = 0.037; 24-27 h: OR 31, p = 0.011) and death or developmental delay at 15-30 months (21-24 h: OR 11.8, p = 0.05; 24-27 h: OR 15, p = 0.035). Conclusions Based on this pilot study of neonates with HIE, HVP merits further study as an indicator of death or severe brain injury on neonatal MRI and neurodevelopmental delay in early childhood. Larger studies are warranted for further clinical validation of the HVP to evaluate cerebral autoregulation following HIE.	[Massaro, An N.] Childrens Natl Hosp, Div Neonatol, Washington, DC USA; [Lee, Jennifer K.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Vezina, Gilbert] Childrens Natl Hosp, Diagnost Imaging & Radiol, Washington, DC USA; [Glass, Penny] Childrens Natl Hosp, Psychol & Behav Hlth, Washington, DC USA; [O'Kane, Alexandra; Li, Ruoying; Chang, Taeun] Childrens Natl Hosp, Neurol, Washington, DC USA; [Brady, Kenneth] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Anesthesia, Chicago, IL 60611 USA; [Govindan, Rathinaswamy] Childrens Natl Hosp, Fetal & Transit Med, Washington, DC USA; [Massaro, An N.; Vezina, Gilbert; Glass, Penny; Chang, Taeun; Govindan, Rathinaswamy] George Washington Univ, Sch Med, Washington, DC 20052 USA		Massaro, AN (corresponding author), George Washington Univ, Sch Med, Washington, DC 20052 USA.	anguyenm@childrensnational.org		Li, Ruoying/0000-0002-5125-0064; Massaro, An/0000-0002-5543-6165	Clinical and Translational Science Institute at Children's National [UL1TR000075, 1KL2RR031987-01]; National Institutes of Health Intellectual and Developmental Disabilities Research Consortium [U54 HD090257]	This study was supported by the Clinical and Translational Science Institute at Children's National (UL1TR000075, 1KL2RR031987-01) and the National Institutes of Health Intellectual and Developmental Disabilities Research Consortium (U54 HD090257).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Azzopardi D, 2014, NEW ENGL J MED, V371, P140, DOI 10.1056/NEJMoa1315788; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Barbieri R, 2002, AM J PHYSIOL-REG I, V283, pR1210, DOI 10.1152/ajpregu.00127.2002; Bassan H, 2005, PEDIATR RES, V57, P35, DOI 10.1203/01.PDR.0000147576.84092.F9; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2012, J APPL PHYSIOL, V113, P1362, DOI 10.1152/japplphysiol.00853.2012; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Burton VJ, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0464-4; Chalak LF, 2017, DEV NEUROSCI-BASEL, V39, P89, DOI 10.1159/000457833; Chalak LF, 2017, SCI REP-UK, V7, DOI 10.1038/srep45958; Chavez-Valdez R, 2017, PEDIATR RES, V81, P759, DOI 10.1038/pr.2017.23; Czosnyka M, 2000, ACT NEUR S, V76, P483; de Vries LS, 2010, ARCH DIS CHILD-FETAL, V95, pF220, DOI 10.1136/adc.2008.148205; Fellman V, 1997, PEDIATR RES, V41, P599, DOI 10.1203/00006450-199705000-00001; Fraser CD, 2013, J APPL PHYSIOL, V115, P52, DOI 10.1152/japplphysiol.00068.2013; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Govindan RB, 2018, J NEUROSCI METH, V309, P147, DOI 10.1016/j.jneumeth.2018.09.003; Govindan RB, 2019, DEV NEUROSCI-BASEL, V40, P547, DOI 10.1159/000499425; Govindan RB, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00266; GREISEN G, 1992, BRAIN PATHOL, V2, P223, DOI 10.1111/j.1750-3639.1992.tb00695.x; Hoiland RL, 2016, AM J PHYSIOL-REG I, V310, pR398, DOI 10.1152/ajpregu.00270.2015; Howlett JA, 2013, PEDIATR RES, V74, P525, DOI 10.1038/pr.2013.132; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3; Kaiser JR, 2005, PEDIATR RES, V58, P931, DOI 10.1203/01.pdr.0000182180.80645.0c; Kay S. M., 1998, MODERN SPECTRAL ESTI; Kunihara T, 2001, ASAIO J, V47, P417, DOI 10.1097/00002480-200107000-00023; Larson AC, 2013, J APPL PHYSIOL, V115, P1433, DOI 10.1152/japplphysiol.00238.2013; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lee JK, 2014, RESUSCITATION, V85, P1387, DOI 10.1016/j.resuscitation.2014.07.006; Lee JK, 2011, CRIT CARE MED, V39, P2337, DOI 10.1097/CCM.0b013e318223b910; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Lee JK, 2016, DEV NEUROSCIENCE; Lingappan K, 2016, PEDIATR RES, V80, P204, DOI 10.1038/pr.2016.62; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; Massaro AN, 2014, J PERINATOL; Massaro AN, 2015, J NEUROPHYSIOL, V114, P818, DOI 10.1152/jn.00353.2015; Meek JH, 1999, ARCH DIS CHILD-FETAL, V81, pF110, DOI 10.1136/fn.81.2.F110; Nusbaum DM, 2016, NEUROL RES, V38, P196, DOI 10.1179/1743132815Y.0000000094; PRYDS O, 1990, J PEDIATR-US, V117, P119, DOI 10.1016/S0022-3476(05)72459-8; ROBERTSON CMT, 1989, J PEDIATR-US, V114, P753, DOI 10.1016/S0022-3476(89)80132-5; Samraj RS, 2015, CLIN INVEST MED, V38, pE285; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; SHANKARAN S, 1991, EARLY HUM DEV, V25, P135, DOI 10.1016/0378-3782(91)90191-5; Shankaran S, 2012, ARCH DIS CHILD-FETAL, V97, pF398, DOI 10.1136/archdischild-2011-301524; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Shellhaas RA, 2013, NEUROLOGY, V81, P249, DOI 10.1212/WNL.0b013e31829bfe41; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Sokoloff MD, 2015, PEDIATR RES, V78, P91, DOI 10.1038/pr.2015.64; Soul JS, 2007, PEDIATR RES, V61, P467, DOI 10.1203/pdr.0b013e31803237f6; Srinivasakumar P, 2013, J PEDIATR-US, V163, P465, DOI 10.1016/j.jpeds.2013.01.041; Tekes A, 2015, AM J NEURORADIOL, V36, P188, DOI 10.3174/ajnr.A4083; Tian FH, 2016, NEUROIMAGE-CLIN, V11, P124, DOI 10.1016/j.nicl.2016.01.020; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Tsuji M, 2000, PEDIATRICS, V106, P625, DOI 10.1542/peds.106.4.625; VANBEL F, 1993, PEDIATRICS, V92, P365; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	63	2	2	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2021	35	1					121	129		10.1007/s12028-020-01150-8		NOV 2020	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TJ4CL	WOS:000590940500003	33215394				2022-02-06	
J	Tatara, Y; Shimada, R; Kibayashi, K				Tatara, Yuki; Shimada, Ryo; Kibayashi, Kazuhiko			Effects of Preexisting Diabetes Mellitus on the Severity of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain contusion volume; diabetes mellitus; inflammatory cell migration; nerve function changes; traumatic brain injury	APOPTOSIS; RAT; INFLAMMATION; PREVENTION; NECROSIS; DEFICITS; INSULIN; EDEMA	Falls and traffic accidents can cause traumatic brain injury (TBI). Assessment of the injury severity is essential to determine the prognosis or the cause of death. Diabetes mellitus (DM) is a common preexisting disease in elderly adults. We hypothesized that preexisting DM exacerbates TBI secondary to prolonged inflammation. In this study, we investigated TBI-induced changes in nerve function and inflammatory cell migration to the injury site, and the extent of brain contusion in KK-Ay (DM) and C57BL/6J (non-DM) mice. A controlled cortical impact device was used to induce TBI in each mouse. The brain contusion volume was measured using magnetic resonance imaging. Nerve function changes were assessed using the following animal behavior tasks: neurological severity score (NSS), Morris water maze, forced swim test, and beam walking. Immunohistochemical examinations of brain sections were performed to assess the infiltration of neutrophils, astrocytes, microglia, and macrophages, and to detect apoptosis. These experiments were performed on post-injury days 1-90 (over five experiments/time-points in each group). Compared with non-DM mice, DM mice showed significantly greater brain contusion volume, greater deterioration in the NSS, and a higher number of neutrophils, macrophages, and apoptotic cells in the brain tissue specimens. This study indicates that the prognosis of normal mice and DM mice differs, even if they acquire a TBI of the same severity. Therefore, it is important to evaluate patients with TBI for DM and other preexisting diseases in order to provide adequate treatment or to determine the correct cause of death.	[Tatara, Yuki; Shimada, Ryo; Kibayashi, Kazuhiko] Tokyo Womens Med Univ, Dept Legal Med, Sch Med, Tokyo, Japan		Tatara, Y (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	tatara.yuki@twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215	JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP18K17420]	This work was supported by JSPS KAKENHI (grant number JP18K17420).	Abe K, 2016, NEUROL RES, V38, P358, DOI 10.1080/01616412.2015.1110402; Abou-El-Hassan H, 2017, MED HYPOTHESES, V108, P69, DOI 10.1016/j.mehy.2017.08.008; Bandte A, 2018, J NEUROSURG-PEDIATR, V22, P233, DOI 10.3171/2018.2.PEDS17714; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chen Y, 2012, ADV DRUG DELIVER REV, V64, P640, DOI 10.1016/j.addr.2011.11.010; Commons KG, 2017, ACS CHEM NEUROSCI, V8, P955, DOI 10.1021/acschemneuro.7b00042; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; International Diabetes Federation, 2019, IDF DIABETES ATLAS; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Karelina K, 2016, EUR J NEUROSCI, V43, P1034, DOI 10.1111/ejn.13194; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Kelly-Cobbs AI, 2013, AM J PHYSIOL-HEART C, V304, pH806, DOI 10.1152/ajpheart.00720.2012; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Kibayashi K, 2019, IATSS RES, V43, P71, DOI 10.1016/j.iatssr.2019.06.004; Kim E, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-83; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Li TT, 2020, BRAIN RES, V1730, DOI 10.1016/j.brainres.2020.146651; Li ZG, 2004, LIFE SCI, V76, P249, DOI 10.1016/j.lfs.2004.03.039; Lim SW, 2017, WORLD NEUROSURG, V100, P128, DOI 10.1016/j.wneu.2016.12.118; Lioupis C, 2005, J Wound Care, V14, P84; Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812; Lustenberger T, 2013, BRAIN INJURY, V27, P281, DOI 10.3109/02699052.2012.743178; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nagayach A, 2014, METAB BRAIN DIS, V29, P747, DOI 10.1007/s11011-014-9562-z; Nishimura M, 1969, EXP ANIMALS, V18, P147; Porsolt R D, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as14; Rizk NN, 2006, BRAIN RES, V1096, P204, DOI 10.1016/j.brainres.2006.04.060; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Sharma AN, 2010, PHYSIOL BEHAV, V101, P381, DOI 10.1016/j.physbeh.2010.07.002; Shijo K, 2015, BRAIN RES, V1614, P94, DOI 10.1016/j.brainres.2015.04.022; Shimada R, 2017, LEGAL MED-TOKYO, V29, P29, DOI 10.1016/j.legalmed.2017.09.004; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; Silva MT, 2011, J LEUKOCYTE BIOL, V89, P675, DOI 10.1189/jlb.0910536; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Swift ME, 2001, J INVEST DERMATOL, V117, P1027, DOI 10.1046/j.0022-202x.2001.01539.x; Takemiya T, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00202; Tureyen K, 2011, J NEUROCHEM, V116, P499, DOI 10.1111/j.1471-4159.2010.07127.x; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Warmke N, 2016, J DIABETES COMPLICAT, V30, P1643, DOI 10.1016/j.jdiacomp.2016.08.005; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038701; Zelinkova V, 2019, BRAIN INJURY, V33, P830, DOI 10.1080/02699052.2019.1605622	52	2	2	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2021	38	7					886	902		10.1089/neu.2020.7118		NOV 2020	17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RI3KN	WOS:000592936600001	32998635				2022-02-06	
J	Chen, MM; Guo, LL; Hao, J; Ni, J; Lv, QY; Xin, XY; Liao, H				Chen, Mingming; Guo, Linlu; Hao, Jie; Ni, Jie; Lv, Qunyu; Xin, Xiaoyan; Liao, Hong			p75NTR Promotes Astrocyte Proliferation in Response to Cortical Stab Wound	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article; Early Access						p75NTR; Traumatic brain injury; Astrocyte; Proliferation; Cell cycle; CDK2	TRAUMATIC BRAIN-INJURY; RECEPTOR MESSENGER-RNA; CELL-CYCLE ARREST; SCAR FORMATION; P75(NTR); ASTROGLIOSIS; EXPRESSION; DELETION; REVEALS; NEURONS	Astrogliosis after brain trauma can have a significant impact on functional recovery. However, little is known about the mechanisms underlying astrocyte proliferation and subsequent astrogliosis. In this study, we established a cortical stab wound injury mouse model and observed dramatic astrocyte activation and nerve growth factor receptor (p75NTR) upregulation near the lesion. We also found profound alterations in the cell cycle of astrocytes near the lesion, with a switch from a mitotically quiescent (G0) phase to the G2/M and S phases. However, no changes in the level of astrocyte apoptosis were observed. Cell cycle progression to the G2/M and S phases and CDK2 protein levels in response to cortical stab wound was inhibited after p75NTR knockdown in mouse astrocytes. Conversely, p75NTR overexpression in mouse astrocytes was sufficient in promoting cell cycle progression. In conclusion, our results suggested that p75NTR upregulation in astrocytes after brain injury induces cell cycle entry by promoting CDK2 expression and promoting astrocyte proliferation. Our findings provided a better understanding of astrocytic responses after cortical stab wound injury in mice.	[Chen, Mingming; Guo, Linlu; Hao, Jie; Ni, Jie; Lv, Qunyu; Liao, Hong] China Pharmaceut Univ, Jiangsu Ctr Pharmacodynam Res & Evaluat, New Drug Screening Ctr, 24 Tongjiaxiang St, Nanjing 210009, Peoples R China; [Xin, Xiaoyan] Nanjing Univ, Sch Med, Affiliated Hosp, Nanjing Drum Tower Hosp, Nanjing 210008, Peoples R China		Liao, H (corresponding author), China Pharmaceut Univ, Jiangsu Ctr Pharmacodynam Res & Evaluat, New Drug Screening Ctr, 24 Tongjiaxiang St, Nanjing 210009, Peoples R China.	chenmm@stu.cpu.edu.cn; 2270873222@qq.com; 793656891@qq.com; 535672044@qq.com; 19850853550@163.com; radchestxxy@njglyy.com; hliao@cpu.edu.cn		Qunyu, Lv/0000-0002-1608-2093; Chen, Mingming/0000-0002-9702-103X; hao, haojie/0000-0002-5374-5175	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772063, 82073831, 81572240]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20191325, CPU2018GY20, CPU2018GY13]	This study was supported by the National Natural Science Foundation of China (81772063, 82073831, 81572240), Natural Science Foundation of Jiangsu Province (BK20191325) and "Double First-Class" University plan (CPU2018GY20, CPU2018GY13).	Akiyama Y, 2014, DIFFERENTIATION, V87, P111, DOI 10.1016/j.diff.2014.01.002; Alder J, 2016, BRAIN INJURY, V30, P48, DOI 10.3109/02699052.2015.1088963; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Bethea JR, 1997, J IMMUNOL, V158, P5815; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Cragnolini AB, 2008, TRENDS NEUROSCI, V31, P99, DOI 10.1016/j.tins.2007.11.005; Cragnolini AB, 2012, DEV NEUROBIOL, V72, P766, DOI 10.1002/dneu.20981; Delbary-Gossart S, 2016, BRAIN, V139, P1762, DOI 10.1093/brain/aww074; Do H, 2013, CELL BIOL TOXICOL, V29, P365, DOI 10.1007/s10565-013-9260-3; DOU QP, 1991, P NATL ACAD SCI USA, V88, P1157, DOI 10.1073/pnas.88.4.1157; Dougherty KD, 1999, J COMP NEUROL, V407, P77, DOI 10.1002/(SICI)1096-9861(19990428)407:1<77::AID-CNE6>3.0.CO;2-S; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; Escartin C, 2007, J NEUROSCI, V27, P7094, DOI 10.1523/JNEUROSCI.0174-07.2007; Escartin C, 2019, GLIA, V67, P2221, DOI 10.1002/glia.23687; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Frade JM, 2000, TRENDS NEUROSCI, V23, P591, DOI 10.1016/S0166-2236(00)01704-5; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Hanbury R, 2002, J COMP NEUROL, V444, P291, DOI 10.1002/cne.10104; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Morillo SM, 2012, MOL CELL BIOL, V32, P2722, DOI 10.1128/MCB.00239-12; Oderfeld-Nowak B, 2003, NEUROSCIENCE, V120, P31, DOI 10.1016/S0306-4522(03)00289-6; Pajalunga D, 2008, CELL MOL LIFE SCI, V65, P8, DOI 10.1007/s00018-007-7425-z; Perez-Nievas BG, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00114; Ren YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41122; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; RUDGE JS, 1994, EUR J NEUROSCI, V6, P693, DOI 10.1111/j.1460-9568.1994.tb00981.x; Schachtrup C, 2015, NAT NEUROSCI, V18, P1077, DOI 10.1038/nn.4054; Seitz C, 1998, GENOMICS, V48, P111, DOI 10.1006/geno.1997.5161; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Takarada-Iemata M, 2014, J NEUROCHEM, V130, P374, DOI 10.1111/jnc.12729; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; VERGE VMK, 1992, J NEUROSCI, V12, P4011; Verkhratsky A, 2019, ADV EXP MED BIOL, V1175, P45, DOI 10.1007/978-981-13-9913-8_3; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2	46	2	2	2	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.												10.1007/s10571-020-01006-x		NOV 2020	14	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	OS6FN	WOS:000590257400004	33201418				2022-02-06	
J	Giarratana, AO; Zheng, C; Reddi, S; Teng, SL; Berger, D; Adler, D; Sullivan, P; Thakker-Varia, S; Alder, J				Giarratana, Anna O.; Zheng, Cynthia; Reddi, Sahithi; Teng, Shavonne L.; Berger, David; Adler, Derek; Sullivan, Patrick; Thakker-Varia, Smita; Alder, Janet			APOE4 genetic polymorphism results in impaired recovery in a repeated mild traumatic brain injury model and treatment with Bryostatin-1 improves outcomes	SCIENTIFIC REPORTS			English	Article							HUMAN APOLIPOPROTEIN E4; AMYLOID-BETA PEPTIDE; PKC-EPSILON; BEHAVIORAL DEFICITS; NEUROTROPHIC FACTOR; FLUORO-JADE; MOUSE MODEL; TNF-ALPHA; ALLELE; NEURODEGENERATION	After traumatic brain injury (TBI), some people have worse recovery than others. Single nucleotide polymorphisms (SNPs) in Apolipoprotein E (APOE) are known to increase risk for developing Alzheimer's disease, however there is controversy from human and rodent studies as to whether ApoE4 is a risk factor for worse outcomes after brain trauma. To resolve these conflicting studies we have explored the effect of the human APOE4 gene in a reproducible mouse model that mimics common human injuries. We have investigated cellular and behavioral outcomes in genetically engineered human APOE targeted replacement (TR) mice following repeated mild TBI (rmTBI) using a lateral fluid percussion injury model. Relative to injured APOE3 TR mice, injured APOE4 TR mice had more inflammation, neurodegeneration, apoptosis, p-tau, and activated microglia and less total brain-derived neurotrophic factor (BDNF) in the cortex and/or hippocampus at 1 and/or 21 days post-injury. We utilized a novel personalized approach to treating APOE4 susceptible mice by administering Bryostatin-1, which improved cellular as well as motor and cognitive behavior outcomes at 1 DPI in the APOE4 injured mice. This study demonstrates that APOE4 is a risk factor for poor outcomes after rmTBI and highlights how personalized therapeutics can be a powerful treatment option.	[Giarratana, Anna O.; Zheng, Cynthia; Reddi, Sahithi; Teng, Shavonne L.; Berger, David; Thakker-Varia, Smita; Alder, Janet] Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 683 Hoes Lane West,Res Bldg 357A, Piscataway, NJ 08854 USA; [Sullivan, Patrick] Duke Univ, Dept Med, Div Geriatr, GRECC,Durham VAMC, Durham, NC USA; [Adler, Derek] Rutgers Mol Imaging Ctr, 41 Gordon Rd,Suite D,Room 365A, Piscataway, NJ 08854 USA		Alder, J (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 683 Hoes Lane West,Res Bldg 357A, Piscataway, NJ 08854 USA.	janet.alder@rutgers.edu			New Jersey Commission on Brain Injury Research [CBIR16FEL009]	We would like to thank Chanel Reid and Sahitya Hari for their work helping us to collect data. Funding support came from the New Jersey Commission on Brain Injury Research CBIR16FEL009.	Alder J, 2016, BRAIN INJURY, V30, P48, DOI 10.3109/02699052.2015.1088963; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Allard JS, 2017, EXP GERONTOL, V87, P129, DOI 10.1016/j.exger.2016.11.001; Alvarez A, 2014, J ALZHEIMERS DIS, V42, P1347, DOI 10.3233/JAD-140849; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bennett RE, 2013, J NEUROPATH EXP NEUR, V72, P396, DOI 10.1097/NEN.0b013e31828e24ab; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Cao JQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11654-7; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; De Palma RG., 2015, BRAIN NEUROTRAUMA MO; Deng Hansen, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6030078; DiBattista AM, 2016, CURR ALZHEIMER RES, V13, P1200, DOI 10.2174/1567205013666160401115127; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Ferguson S, 2010, NEUROSCIENCE, V168, P811, DOI 10.1016/j.neuroscience.2010.01.031; Fernandez CG, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00014; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Giarratana AO, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01175; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Guo L, 2004, J MOL NEUROSCI, V23, P205, DOI 10.1385/JMN:23:3:205; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hartman R. E, APOLIPOPROTEIN E4 IN; Hong S, 2016, J NEUROTRAUM, V33, P362, DOI 10.1089/neu.2014.3860; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Ji ZS, 2006, J BIOL CHEM, V281, P2683, DOI 10.1074/jbc.M506646200; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Kollar P, 2014, PHARM BIOL, V52, P237, DOI 10.3109/13880209.2013.804100; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Liang DY, 2017, MOL PAIN, V13, DOI 10.1177/1744806917730212; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Miszczuk D., TRAUMATIC BRAIN INJU; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Muza P, 2019, NEUROSCIENCE, V404, P297, DOI 10.1016/j.neuroscience.2019.01.049; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Nelson TJ, 2017, J ALZHEIMERS DIS, V58, P521, DOI 10.3233/JAD-170161; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Neumann JT, 2015, J CEREBR BLOOD F MET, V35, P121, DOI 10.1038/jcbfm.2014.185; Nicoll JAR, 1996, NEUROPATH APPL NEURO, V22, P515, DOI 10.1111/j.1365-2990.1996.tb01128.x; Noble W, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00083; Ouyang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171976; Oyegbile TO, 2018, J CHILD NEUROL, V33, P383, DOI 10.1177/0883073818759436; Padgett CR, 2016, NEUROPSYCHOLOGY, V30, P775, DOI 10.1037/neu0000270; Pang JW, 2018, TRANSL STROKE RES, V9, P654, DOI 10.1007/s12975-018-0665-4; POIRIER J, 1991, MOL BRAIN RES, V11, P97, DOI 10.1016/0169-328X(91)90111-A; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; Sackheim AM, 2017, J SURG RES, V213, P100, DOI 10.1016/j.jss.2017.02.016; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Sen A, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0301-3; Sen A, 2015, J NEUROSCI, V35, P7538, DOI 10.1523/JNEUROSCI.0260-15.2015; Shadli RM, 2011, BRAIN INJURY, V25, P596, DOI 10.3109/02699052.2011.572947; Shi Y, 2019, J EXP MED, V216, P2546, DOI 10.1084/jem.20190980; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Sun MK, 2016, J PHARMACOL EXP THER, V357, P300, DOI 10.1124/jpet.115.231100; Sun MK, 2014, J PHARMACOL EXP THER, V349, P393, DOI 10.1124/jpet.114.214098; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Tan ZJ, 2013, STROKE, V44, P3490, DOI 10.1161/STROKEAHA.113.002411; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teng ZP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06932-3; Tesseur I, 2000, AM J PATHOL, V156, P951, DOI 10.1016/S0002-9440(10)64963-2; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Washington PM, 2016, J NEUROPATH EXP NEUR, V75, P770, DOI 10.1093/jnen/nlw049; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yellowhair TR, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00324; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Ziebell JM, 2017, NEUROSCIENCE, V359, P209, DOI 10.1016/j.neuroscience.2017.07.027; Zupanc GKH, 1998, EXP NEUROL, V152, P221, DOI 10.1006/exnr.1998.6853	97	2	2	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	NOV 16	2020	10	1							19919	10.1038/s41598-020-76849-x			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9UL	WOS:000595263800034	33199792	gold, Green Published			2022-02-06	
J	Glushakova, OY; Glushakov, AV; Yang, LK; Hayes, RL; Valadka, AB				Glushakova, Olena Y.; Glushakov, Alexander V.; Yang, Likun; Hayes, Ronald L.; Valadka, Alex B.			Intracranial Pressure Monitoring in Experimental Traumatic Brain Injury: Implications for Clinical Management	JOURNAL OF NEUROTRAUMA			English	Article						animal models; clinical studies; intracranial pressure; traumatic brain injury	CONTROLLED CORTICAL IMPACT; CEREBRAL-BLOOD-FLOW; FLUID-PERCUSSION MODEL; SEVERE HEAD-INJURY; L-ARGININE; HYPERBARIC-OXYGEN; DECOMPRESSIVE CRANIECTOMY; HEMORRHAGIC-SHOCK; MITOCHONDRIAL-FUNCTION; INDUCED HYPERTENSION	Traumatic brain injury (TBI) is often associated with long-term disability and chronic neurological sequelae. One common contributor to unfavorable outcomes is secondary brain injury, which is potentially treatable and preventable through appropriate management of patients in the neurosurgical intensive care unit. Intracranial pressure (ICP) is currently the predominant neurological-specific physiological parameter used to direct the care of severe TBI (sTBI) patients. However, recent clinical evidence has called into question the association of ICP monitoring with improved clinical outcome. The detailed cellular and molecular derangements associated with intracranial hypertension (IC-HTN) and their relationship to injury phenotype and neurological outcomes are not completely understood. Various animal models of TBI have been developed, but the clinical applicability of ICP monitoring in the pre-clinical setting has not been well-characterized. Linking basic mechanistic studies in translational TBI models with investigation of ICP monitoring that more faithfully replicates the clinical setting will provide clinical investigators with a more informed understanding of the pathophysiology of IC-HTN, thus facilitating development of improved therapies for sTBI patients.	[Glushakova, Olena Y.; Hayes, Ronald L.; Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurosurg, POB 980631, Richmond, VA 23298 USA; [Glushakov, Alexander V.] Single Breath Inc, Midlothian, VA USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, Alachua, FL USA; [Yang, Likun] 101st Hosp Chinese Peoples Liberat Army, Dept Neurosurg, Xuxi, Jiangsu, Peoples R China		Glushakova, OY (corresponding author), Virginia Commonwealth Univ, Dept Neurosurg, POB 980631, Richmond, VA 23298 USA.	olenaglushakova@gmail.com	Glushakov, Alexander V/B-5452-2008; Glushakova, Olena/AAY-1130-2021	Glushakov, Alexander V/0000-0003-2872-8960; Glushakova, Olena/0000-0002-2109-3651			Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Aiolfi A, 2018, J NEUROSURG, V128, P828, DOI 10.3171/2016.11.JNS162198; Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; Alice P, 2017, INJURY, V48, P1944, DOI 10.1016/j.injury.2017.04.033; American Association for the Surgery of Trauma, 2003, J Trauma, V54, pS235; Anderson RE, 2003, J TRAUMA, V54, P550, DOI 10.1097/01.TA.0000047049.64695.69; Armstead WM, 2010, BRAIN RES, V1330, P142, DOI 10.1016/j.brainres.2010.03.024; Atkinson JLD, 1998, J TRAUMA, V45, P941, DOI 10.1097/00005373-199811000-00016; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bedell EA, 1998, J NEUROTRAUM, V15, P985, DOI 10.1089/neu.1998.15.985; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Bragin DE, 2018, ACTA NEUROCHIR SUPPL, V126, P309, DOI 10.1007/978-3-319-65798-1_60; Bragin DE, 2016, ACTA NEUROCHIR SUPPL, V122, P25, DOI 10.1007/978-3-319-22533-3_5; Brockman EC, 2013, J CEREBR BLOOD F MET, V33, P1457, DOI 10.1038/jcbfm.2013.104; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cherian L, 2004, J NEUROTRAUM, V21, P1196; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cherian L, 2003, J PHARMACOL EXP THER, V304, P617, DOI 10.1124/JPET.102.043430; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Colgan NC, 2010, J NEUROTRAUM, V27, P1265, DOI 10.1089/neu.2009.1267; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dai XP, 2016, CRIT CARE MED, V44, pE633, DOI 10.1097/CCM.0000000000001625; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Filippidis AS, 2014, J NEUROTRAUM, V31, P1258, DOI 10.1089/neu.2013.3063; Forsyth RJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002043.pub3; Friess SH, 2015, J NEUROTRAUM, V32, P791, DOI 10.1089/neu.2014.3564; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Gabrielian L, 2011, J NEUROTRAUM, V28, P2103, DOI 10.1089/neu.2011.1785; GALINDO A, 1963, ANESTHESIOLOGY, V24, P318, DOI 10.1097/00000542-196305000-00011; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Glushakova Olena Y, 2017, Brain Circ, V3, P87, DOI 10.4103/bc.bc_27_16; Glushakova OY, 2018, HDB NEUROEMERGENCY C, P139, DOI [10.1016/B978-0-12-804064-5.00008, DOI 10.1016/B978-0-12-804064-5.00008]; GOPINATH SP, 1993, J NEUROSCI METH, V49, P11, DOI 10.1016/0165-0270(93)90104-Y; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Griebenow M, 2007, J NEUROTRAUM, V24, P1529, DOI 10.1089/neu.2007.0306; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Harary M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020465; Hawkins BE, 2013, BRAIN RES, V1496, P28, DOI 10.1016/j.brainres.2012.12.027; Hawryluk GWJ, 2016, J NEUROSURG, V125, P1217, DOI 10.3171/2015.7.JNS15809; Hayes R L, 1987, Brain Inj, V1, P93, DOI 10.3109/02699058709034449; Hertle Daniel, 2012, Acta Neurochir Suppl, V114, P383, DOI 10.1007/978-3-7091-0956-4_74; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; HOFFMAN WE, 1991, ANESTH ANALG, V73, P753; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kawoos U, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00219; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kawoos U, 2014, IEEE T BIO-MED ENG, V61, P841, DOI 10.1109/TBME.2013.2291239; Kim H, 2017, J NEUROSURG, V127, P23, DOI 10.3171/2016.7.JNS161263; Kim H, 2015, J NEUROTRAUM, V32, P1210, DOI 10.1089/neu.2014.3771; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Krieg SM, 2017, J NEUROTRAUM, V34, P1329, DOI 10.1089/neu.2016.4514; Krieg SM, 2015, J NEUROTRAUM, V32, P221, DOI 10.1089/neu.2013.3274; Kroppenstedt SN, 1999, J NEUROTRAUM, V16, P629, DOI 10.1089/neu.1999.16.629; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; Kroppenstedt SN, 1998, ACT NEUR S, V71, P114; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Lane PL, 2000, CAN J SURG, V43, P442; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laskowitz D., 2016, TRANSLATIONAL RES TR; Lazaridis C, 2019, NEUROPHARMACOLOGY, V145, P145, DOI 10.1016/j.neuropharm.2018.06.005; LEE JG, 1994, ANESTH ANALG, V79, P58; Leo P, 2016, TRANSLATIONAL RES TR; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Liu H, 2016, ONCOTARGET, V7, P62657, DOI 10.18632/oncotarget.11632; Liu S, 2015, EXP BRAIN RES, V233, P3359, DOI 10.1007/s00221-015-4405-7; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Mader MM, 2018, NEUROCRIT CARE, V29, P291, DOI 10.1007/s12028-018-0541-9; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meymandi MS, 2018, BRAIN RES BULL, V140, P169, DOI 10.1016/j.brainresbull.2018.05.001; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1973, EUR NEUROL, V10, P1, DOI 10.1159/000114256; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Navarro JC, 2012, J NEUROTRAUM, V29, P322, DOI 10.1089/neu.2011.1979; Nyanzu M, 2017, INT J MED SCI, V14, P494, DOI 10.7150/ijms.18075; Peacock SH, 2018, AACN ADV CRIT CARE, V29, P183, DOI 10.4037/aacnacc2018632; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Pesek M, 2014, NEUROSURGERY, V75, P163, DOI 10.1227/NEU.0000000000000367; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Prough DS, 2006, SHOCK, V26, P290, DOI 10.1097/01.shk.0000225405.66693.49; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Rogatsky G, 1996, J Basic Clin Physiol Pharmacol, V7, P23; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; Roh D, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0659-0; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168901; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Stalhammar D, 1987, Brain Inj, V1, P73, DOI 10.3109/02699058709034448; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; STULLKEN EH, 1975, ANESTH ANALG, V54, P494; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tan AA, 2009, J NEUROTRAUM, V26, P539, DOI 10.1089/neu.2008.0611; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Thomale UW, 2005, ACT NEUR S, V95, P429; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Thomale UW, 2004, J NEUROTRAUM, V21, P1737; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Voigt C, 2012, NEUROPATH APPL NEURO, V38, P354, DOI 10.1111/j.1365-2990.2011.01211.x; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675; You WD, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0199-9; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Yuan Q, 2013, BRAIN INJURY, V27, P664, DOI 10.3109/02699052.2013.775497; Zausinger S, 2004, NEUROSURGERY, V55, P679, DOI 10.1227/01.NEU.0000134558.28977.EE; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083; Zweckberger K, 2011, NEUROL RES, V33, P875, DOI 10.1179/1743132811Y.0000000017; Zweckberger K, 2010, NEUROSCI LETT, V470, P150, DOI 10.1016/j.neulet.2009.12.075; Zweckberger K, 2009, NEUROSCI LETT, V454, P115, DOI 10.1016/j.neulet.2009.02.014; Zwienenberg M, 1999, J NEUROTRAUM, V16, P1095, DOI 10.1089/neu.1999.16.1095	153	2	2	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2020	37	22					2401	2413		10.1089/neu.2018.6145			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	OP2MH	WOS:000587918100005	30595079				2022-02-06	
J	King, D; Hume, PA; Clark, TN; Pearce, AJ				King, D.; Hume, P. A.; Clark, T. N.; Pearce, A. J.			Use of the King-Devick test for the identification of concussion in an amateur domestic women's rugby union team over two competition seasons in New Zealand	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Women's rugby union; Sideline assessment; Concussion; Eye movement; Saccadic	SPORTS-RELATED CONCUSSION; VISUAL SCREENING TOOL; COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION; INJURIES; LEAGUE; RELIABILITY; UTILITY	Objective: To investigate the use of the King-Devick (K-D) test for sideline assessment of concussive injuries in a New Zealand amateur women's rugby union team. Design: Prospective cohort observational. Methods: All players were K-D tested during pre-season using a tablet (iPad; Apple Inc., Cupertino, CA). Differences in K-D scores and test-retest reliability were calculated for baseline test scores, baseline, and postinjury (concussion) sideline assessment and baseline and post-season testing scores for tests by year and as a combined score. Results: One training-related (0.3 per 1000 training-hrs) and nine match-related (16.1 per 1000 match-hrs) concussions were recorded. The K-D post-injury (concussion) sideline test score were significantly slower than established baseline (-4.4 [-5.8 to -3.4] s;chi(2)((1)) = 42.2; p < 0.0001; t((9)) = -4.0; p = 0.0029; d = -0.8). There was good-to-excellent reliability of the K-D test for baseline (ICC: 0.84 to 0.89), post-injury (concussion) sideline assessment (ICC: 0.82 to 0.97) and post-season evaluation (ICC: 0.79 to 0.83). Discussion: By utilising the baseline to post-injury (concussion) assessment comparisons, any player with a postinjury (concussion) assessment slowing of their K-D test time, regardless of whether the player has, or has not had a witnessed insult, should be withheld from any further participation until they are evaluated by a medical professional trained in the management of concussion. Conclusion: This study has provided additional evidence to support the use of the K-D test as a frontline method of assessing concussion with good to excellent reliability of the test for baseline, side-line assessment and postseason evaluation.	[King, D.] Auckland Univ Technol, Fac Hlth & Environm Sci, Sport Performance Res Inst New Zealand SPRINZ, Auckland, New Zealand; [King, D.; Hume, P. A.] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [King, D.] Massey Univ, Sch Sport Exercise & Nutr, Palmerston North, New Zealand; [Hume, P. A.] Auckland Univ Technol, Fac Hlth & Environm Sci, Natl Inst Stroke & Appl Neurosci NISAN, Auckland, New Zealand; [Clark, T. N.] Int Coll Management Sydney, Manly, NSW, Australia; [Pearce, A. J.] La Trobe Univ, Coll Sci Hlth & Engn, Melbourne, Vic, Australia		King, D (corresponding author), Hutt Valley Dist Hlth Board, Emergency Dept, Private Bag 31-907, Lower Hutt, New Zealand.	dking30@une.edu.au	Hume, Patria/AAN-5514-2021; Hume, Patria Anne/P-1084-2017	Hume, Patria/0000-0003-1847-8128; Hume, Patria Anne/0000-0003-1847-8128			Arca KN, 2020, NEUROLOGIST, V25, P33, DOI 10.1097/NRL.0000000000000268; Bretzin A.C., 2020, J NEUROL SCI, V416; Brooks L, 2005, INT J TECHNOL HUM IN, V1, P39, DOI 10.4018/jthi.2005100103; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; COHEN J, 1988, NEW YORK TIMES BK R, P26; Cummins C, 2020, BRIT J SPORT MED, V54, DOI 10.1136/bjsports-2019-101403; DAVIDSON RM, 1987, MED J AUSTRALIA, V147, P119, DOI 10.5694/j.1326-5377.1987.tb133299.x; DENG HS, 2020, NEUROSURGERY, DOI DOI 10.10936/NEUROS/NYAA022; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; Eddy R, 2020, CLIN J SPORT MED, V30, P239, DOI 10.1097/JSM.0000000000000586; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Galetta K., 2015, CONCUSSION, V1; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heitger M., 2008, C P IEEE ENG MED BIO; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Howitt Scott, 2016, J Can Chiropr Assoc, V60, P322; Hubbard R, 2019, BRAIN INJURY, V33, P349, DOI 10.1080/02699052.2018.1553068; Kara S, 2020, CLIN J SPORT MED, V30, P96, DOI 10.1097/JSM.0000000000000811; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Kirkwood G., 2015, BR J SPORTS MED, V49; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Legarreta AD, 2019, OPEN ACCESS J SPORTS, V10, P115, DOI 10.2147/OAJSM.S171815; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Marinides Zoe, 2015, Neurol Clin Pract, V5, P25, DOI 10.1212/CPJ.0000000000000060; Marshall SW, 2001, J ATHL TRAINING, V36, P334; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; Mujika I, 2019, INT J SPORT PHYSIOL, V14, P1013, DOI 10.1123/ijspp.2019-0514; Nguyen MQ, 2020, J NEURO-OPHTHALMOL, V40, P207, DOI 10.1097/WNO.0000000000000829; Nordahl-Hansen A, 2018, PSYCHIAT RES, V270, P801, DOI 10.1016/j.psychres.2018.10.069; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Pearce AJ, 2019, NEUROSCIENCE, V408, P272, DOI 10.1016/j.neuroscience.2019.04.019; Pearce AJ, 2018, BRAIN INJURY, V32, P498, DOI 10.1080/02699052.2018.1430376; Perinetti G., 2018, S EUR J ORTHOD DENTO, V5, P3, DOI [10.5937/sejodr5-17434, DOI 10.5937/SEJODR5-17434, 10.5937/sejodr4-1283]; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Seidman DH, 2015, J NEUROL SCI, V356, P97, DOI 10.1016/j.jns.2015.06.021; Spradley B., 2014, SPORT J, V55; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Whitehouse T, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116634075; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021	56	2	2	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	NOV 15	2020	418								117162	10.1016/j.jns.2020.117162			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OH9TD	WOS:000582930900065	33017712				2022-02-06	
J	Wallace, J; Learman, K; Moran, R; Covassin, T; Deitrick, JM; Delfin, D; Shina, J				Wallace, Jessica; Learman, Ken; Moran, Ryan; Covassin, Tracey; Deitrick, Jamie McAllister; Delfin, Danae; Shina, James			Premorbid anxiety and depression and baseline neurocognitive, ocular-motor and vestibular performance: A retrospective cohort study	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Psychological risk factor; Anxiety; Depression; Concussion; Baseline testing; Premorbid	SPORT-RELATED CONCUSSION; SEX-DIFFERENCES; RISK-FACTORS; SYMPTOMS; ASSOCIATION; RELIABILITY; SENSITIVITY; MANAGEMENT; CHILDREN; OUTCOMES	Concussion has become a growing concern among sport and healthcare practitioners. Experts continue to investigate ways to advance the quality of concussion evaluation, diagnosis and management. Psychological conditions have been reported to influence concussion assessment outcomes at baseline and post-concussion; however, little evidence has examined psychological conditions and their effect on multifaceted measures of concussion. A retrospective cohort design was employed to examine differences between those with and without a premorbid psychological condition for high school and collegiate athletes who completed a preseason baseline battery, consisting of symptom reporting, computerized neurocognitive assessment, Vestibular-Ocular Motor Screening (VOMS), and the King-Devick (KD) test. Forty athletes within the sample self-reported a diagnosed psychological risk factor, consisting of depression and/or anxiety, and each were matched with a discordant control. Controls were matched on sex, age, sport, concussion history and ocular history. Athletes with psychological conditions reported higher symptom severity and had worse visual motor speed than controls. There were no differences between groups on other neurocognitive domains, VOMS, or KD. These results suggest that vestibular-ocular tools may be more consistent or less likely to vary between those with and without a premorbid psychological diagnosis, adding value to tools such as the KD and VOMS.	[Wallace, Jessica; Shina, James] Youngstown State Univ, Kinesiol & Sport Sci Dept, 1 Univ Plaza,307 Beeghly Ctr, Youngstown, OH 44555 USA; [Learman, Ken] Youngstown State Univ, Dept Phys Therapy, 1 Univ Plaza,Cushwa Hall B307, Youngstown, OH 44555 USA; [Wallace, Jessica; Moran, Ryan; Delfin, Danae] Univ Alabama, Dept Hlth Sci, Athlet Training, 270 Kilgore Lane,Capital Hall, Tuscaloosa, AL 35487 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, 105 IM Sports Circle, E Lansing, MI 48824 USA; [Deitrick, Jamie McAllister] Coastal Carolina Univ, Dept Kinesiol, Conway, SC 29528 USA; [Wallace, Jessica] Univ Alabama, 270 Kilgore Lane,2106 Capital Hall, Tuscaloosa, AL 35487 USA		Delfin, D (corresponding author), Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane,2121 Capital Hall, Tuscaloosa, AL 35487 USA.	Jswallace1@ua.edu; klearman@ysu.edu; rnmoran@ches.ua.edu; covassin@msu.edu; jdeitrick@coastal.edu; ddelfin@crimson.ua.edu					Albanese BJ, 2017, PSYCHIAT RES, V252, P242, DOI 10.1016/j.psychres.2017.01.099; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Brett BL, 2016, ARCH CLIN NEUROPSYCH, V31, P904, DOI 10.1093/arclin/acw055; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cicerone KD, 1997, BRAIN INJURY, V11, P643, DOI 10.1080/026990597123197; Clugston JR, 2019, J ATHL TRAINING, V54, P1247, DOI 10.4085/1062-6050-455-18; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; Elbin RJ, 2019, J ATHL TRAINING, V54, P939, DOI 10.4085/1062-6050-347-18; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Guerriero RM, 2018, J CHILD NEUROL, V33, P168, DOI 10.1177/0883073817749655; Health N.I.o.M, 2019, ANXIETY DISORDERS; Health N.I.o.M. Depression, 2019, DEPRESSION; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Irwin DE, 2010, QUAL LIFE RES, V19, P595, DOI 10.1007/s11136-010-9619-3; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lariviere K, 2019, J SPORTS MED HINDAWI; Matthews K, 2008, J AFFECT DISORDERS, V111, P113, DOI 10.1016/j.jad.2008.02.003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moran R, 2017, J NEUROL SCI, V383, P101, DOI 10.1016/j.jns.2017.10.039; Moran RN, 2021, APPL NEUROPSYCH-CHIL, V10, P276, DOI 10.1080/21622965.2019.1683453; Moran RN, 2019, J NEUROSURG-PEDIATR, V23, P465, DOI 10.3171/2018.10.PEDS18425; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Scheiman M, 2011, OPTOMETRY VISION SCI, V88, P1343, DOI 10.1097/OPX.0b013e31822f4d7c; Seifert T, 2018, HAND CLINIC, V158, P119, DOI 10.1016/B978-0-444-63954-7.00012-4; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Trinh LN, 2020, AM J SPORT MED, V48, P1516, DOI 10.1177/0363546519882626; Tsourtos G, 2002, PSYCHOL MED, V32, P259, DOI 10.1017/S0033291701005001; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Weber ML, 2018, AM J SPORT MED, V46, P1742, DOI 10.1177/0363546518765145; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yengo-Kahn AM, 2015, PHYSICIAN SPORTSMED, V43, P227, DOI 10.1080/00913847.2015.1071638	45	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	NOV 15	2020	418								117110	10.1016/j.jns.2020.117110			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OH9TD	WOS:000582930900031	32882438				2022-02-06	
J	Hammond, FM; Perkins, SM; Corrigan, JD; Nakase-Richardson, R; Brown, AW; O'Neil-Pirozzi, TM; Zasler, ND; Greenwald, BD				Hammond, Flora M.; Perkins, Susan M.; Corrigan, John D.; Nakase-Richardson, Risa; Brown, Allen W.; O'Neil-Pirozzi, Therese M.; Zasler, Nathan D.; Greenwald, Brian D.			Functional Change from Five to Fifteen Years after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injuries; cognition; disabled persons; function; prognosis; rehabilitation outcome	GLOBAL OUTCOME TRAJECTORIES; DISABILITY RATING-SCALE; LONG-TERM RECOVERY; NATIONAL INSTITUTE; LONGITUDINAL DESCRIPTION; GALVESTON ORIENTATION; MODERATE; INDIVIDUALS; PREDICTORS; COGNITION	Few studies have assessed the long-term functional outcomes of traumatic brain injury (TBI) in large, well-characterized samples. Using the Traumatic Brain Injury Model Systems cohort, this study assessed the maintenance of independence between years 5 and 15 post-injury and risk factors for decline. The study sample included 1381 persons with TBI who received inpatient rehabilitation, survived to 15 years post-injury, and were available for data collection at 5 or 10 years and 15 years post-injury. The Functional Independence Measure (FIM) and Disability Rating Scale (DRS) were used to measure functional outcomes. The majority of participants had no changes during the 10-year time frame. For FIM, only 4.4% showed decline in Self-Care, 4.9% declined in Mobility, and 5.9% declined in Cognition. Overall, 10.4% showed decline in one or more FIM subscales. Decline was detected by DRS Level of Function (24% with >1-point change) and Employability (6% with >1-point change). Predictors of decline factors across all measures were age >25 years and, across most measures, having less than or equal to a high school education. Additional predictors of FIM decline included male sex (FIM Mobility and Self-Care) and longer rehabilitation length of stay (FIM Mobility and Cognition). In contrast to studies reporting change in the first 5 years post-TBI inpatient rehabilitation, a majority of those who survive to 15 years do not experience functional decline. Aging and cognitive reserve appear to be more important drivers of loss of function than original severity of the injury. Interventions to identify those at risk for decline may be needed to maintain or enhance functional status as persons age with a TBI.	[Hammond, Flora M.] Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Perkins, Susan M.] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Polytrauma TBI Rehabil, Mental Hlth & Behav Sci & Def & Vet Brain Injury, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Div Pulm & Sleep Med, Tampa, FL 33620 USA; [Brown, Allen W.] Mayo Clin, Coll Med & Sci, Dept Phys Med & Rehabil, Rochester, MN USA; [O'Neil-Pirozzi, Therese M.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [Zasler, Nathan D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Greenwald, Brian D.] Dept Phys Med & Rehabil, Edison, NJ USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	Flora.hammond@rhin.com			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR): Indiana University School of Medicine [90DRTB0002]; Ohio State UniversityOhio State University [90DP0040]; Mayo Clinic [90DPTB0012]; JFK-Johnson Rehabilitation Institute [90DPTB0014]; Center within the Administration for Community Living (ACL); Department of Health and Human Services (HHS); Spaulding/Harvard [90DPTB0011]; Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research)	The contents of this publication were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR): Indiana University School of Medicine grant numbers (grant no. 90DRTB0002); Ohio State University (grant no. 90DP0040); Spaulding/Harvard (90DPTB0011); Mayo Clinic (grant no. 90DPTB0012); JFK-Johnson Rehabilitation Institute (90DPTB0014); a Center within the Administration for Community Living (ACL); and the Department of Health and Human Services (HHS).; The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research).	Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Forslund MV, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00219; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Krellman JW, 2014, ARCH PHYS MED REHAB, V95, P633, DOI 10.1016/j.apmr.2013.10.016; Kumar RG, 2020, J HEAD TRAUMA REHAB, V35, pE372, DOI 10.1097/HTR.0000000000000572; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lu J, 2018, J NEUROTRAUM, V35, P1596, DOI 10.1089/neu.2017.5299; Malec JF, 2019, J HEAD TRAUMA REHAB, V34, pE24, DOI 10.1097/HTR.0000000000000459; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; O'Neil-Pirozzi TM, 2019, BRAIN INJURY, V33, P1308, DOI 10.1080/02699052.2019.1641620; Pretz C, 2020, J HEAD TRAUMA REHAB, V35, P140, DOI 10.1097/HTR.0000000000000506; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2478, DOI 10.1016/j.apmr.2013.06.019; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Richter S, 2019, J NEUROTRAUM, V36, P2743, DOI 10.1089/neu.2018.6216; Schwartz CE, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0297-0	37	2	2	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2021	38	7					858	869		10.1089/neu.2020.7287		NOV 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	RI3KN	WOS:000592673400001	32907468				2022-02-06	
J	Maruta, J; Mallott, JM; Sulioti, G; Ghajar, J; Palacios, EM; Mukherjee, P				Maruta, Jun; Mallott, Jacob M.; Sulioti, Gary; Ghajar, Jamshid; Palacios, Eva M.; Mukherjee, Pratik			Concussion Disrupts Normal Brain White Matter Microstructural Symmetry	FRONTIERS IN NEUROLOGY			English	Article						acute concussion; bilateral homolog; diffusion tensor imaging (DTI); mild traumatic brain injury (mTBI); magnetic resonance imaging (MRI)	VOXELWISE ANALYSIS; ROBUST	Injuries and illnesses can alter the normal bilateral symmetry of the brain, and determining the extent of this disruption may be useful in characterizing the pathology. One way of quantifying brain symmetry is in terms of bilateral correlation of diffusion tensor metrics between homologous white matter tracts. With this approach, we hypothesized that the brains of patients with a concussion are more asymmetrical than those of healthy individuals without a history of a concussion. We scanned the brains of 35 normal individuals and 15 emergency department patients with a recent concussion. Fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) were determined for regions of interest (ROI) defined by a standard white-matter atlas that included 21 bilateral ROIs. For each ROI pair, bilateral correlation coefficients were calculated and compared between the two subject groups. A symmetry index, defined as the ratio between the difference and the sum of bilateral measures, was also calculated for each ROI pair and compared between the groups. We found that in normal subjects, the extent of symmetry varied among regions and individuals, and at least subtle forms of structural lateralization were common across regions. In patients, higher asymmetry was found overall as well as in the corticospinal tract specifically. Results indicate that a concussion can manifest in brain asymmetry that deviates from a normal state. The clinical utility of characterizing post-concussion pathology as abnormal brain asymmetry merits further exploration.	[Maruta, Jun] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Maruta, Jun] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Maruta, Jun; Ghajar, Jamshid] Brain Trauma Fdn, New York, NY 10036 USA; [Mallott, Jacob M.; Sulioti, Gary; Palacios, Eva M.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Sulioti, Gary] Duke Univ, Sch Med, Durham, NC USA; [Ghajar, Jamshid] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Mukherjee, Pratik] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA		Maruta, J (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.; Maruta, J (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA.; Maruta, J (corresponding author), Brain Trauma Fdn, New York, NY 10036 USA.	jun.maruta@mssm.edu	Maruta, Jun/I-3790-2019	Maruta, Jun/0000-0002-5054-6605	U.S. Department of DefenseUnited States Department of Defense [contractsW911QY-12-C-0005 andW911QY-14-C-0086]	This work was supported by U.S. Department of Defense contractsW911QY-12-C-0005 andW911QY-14-C-0086.	Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; HOLM S, 1979, SCAND J STAT, V6, P65; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Lerma-Usabiaga G, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116048; Mallott JM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00518; MARUTA J, 2018, FRONT NEUROL, V0009; Maruta J, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00640; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Myers L., 2006, ENCY STAT SCI; Presson N, 2015, MIL MED, V180, P109, DOI 10.7205/MILMED-D-14-00413; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Vakhtin AA, 2020, J NEUROTRAUM, V37, P373, DOI 10.1089/neu.2019.6487; Wahl M, 2010, NEUROIMAGE, V51, P531, DOI 10.1016/j.neuroimage.2010.02.072; Yang FPG, 2011, P INT SOC MAG RESON, V19, P346	20	2	2	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 12	2020	11								548220	10.3389/fneur.2020.548220			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OV6ZJ	WOS:000592355000001	33262738	Green Published, gold			2022-02-06	
J	Brett, BL; Koch, KM; Muftuler, LT; Budde, M; McCrea, MA; Meier, TB				Brett, Benjamin L.; Koch, Kevin M.; Muftuler, L. Tugan; Budde, Matthew; McCrea, Michael A.; Meier, Timothy B.			Association of Head Impact Exposure with White Matter Macrostructure and Microstructure Metrics	JOURNAL OF NEUROTRAUMA			English	Article						concussion; diffusion kurtosis imaging; diffusion tensor imaging; quantitative susceptibility mapping; repetitive head impacts	CHRONIC TRAUMATIC ENCEPHALOPATHY; DIFFUSION TENSOR; HIGH-SCHOOL; TRACT ABNORMALITIES; FOOTBALL PLAYERS; SINGLE SEASON; BRAIN; CONCUSSION; SUSCEPTIBILITY; MRI	Prior studies have reported white matter abnormalities associated with a history of cumulative concussion and/or repetitive head impacts (RHI) in contact sport athletes. Growing evidence suggests these abnormalities may begin as more subtle changes earlier in life in active younger athletes. We investigated the relationship between prior concussion and contact sport exposure with multi-modal white matter microstructure and macrostructure using magnetic resonance imaging. High school and collegiate athletes (n = 121) completed up to four evaluations involving neuroimaging. Linear mixed-effects models examined associations of years of contact sport exposure (i.e., RHI proxy) and prior concussion across multiple metrics of white matter, including total white matter volume, diffusion tensor imaging (DTI) metrics, diffusion kurtosis imaging (DKI) metrics, and quantitative susceptibility mapping (QSM). A significant inverse association between cumulative years of contact sport exposure and QSM was observed, F(1, 237.77) = 4.67, p = 0.032. Cumulative contact sport exposure was also associated with decreased radial diffusivity, F(1, 114.56) = 5.81, p = 0.018, as well as elevated fractional anisotropy, F(1, 115.32) = 5.40, p = 0.022, and radial kurtosis, F(1, 113.45) = 4.03, p = 0.047. In contrast, macroscopic white matter volume was not significantly associated with cumulative contact sport exposure (p > 0.05). Concussion history was not significantly associated with QSM, DTI, DKI, or white matter volume (all, p > 0.05). Cumulative contact sport exposure is associated with subtle differences in white matter microstructure, but not gross white matter macrostructure, in young active athletes. Longitudinal follow-up is required to assess the progression of these findings to determine their contribution to potential adverse effects later in life.	[Brett, Benjamin L.; Muftuler, L. Tugan; Budde, Matthew; McCrea, Michael A.; Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; Koch, Kevin M.; Muftuler, L. Tugan; Budde, Matthew; McCrea, Michael A.; Meier, Timothy B.] Med Coll Wisconsin, Ctr Neurotrauma Res, Milwaukee, WI 53226 USA; [Koch, Kevin M.; Muftuler, L. Tugan] Med Coll Wisconsin, Dept Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Koch, Kevin M.] Med Coll Wisconsin, Ctr Imaging Res, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA		Brett, BL (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	bbrett@mcw.edu	Koch, Kevin/AAD-6403-2021; Muftuler, L. Tugan/AAG-7539-2021		Department of Defense Broad Agency Announcement for Extramural Medical Research [W81XWH-14-1-0561]; National Institute of Neurological Disorders and Stroke under the National Institutes of Health [L30 NS113158]; National Institute of Neurological Disorders and Stroke of the NIH [R01NS102225]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436]	This research was supported by the Department of Defense Broad Agency Announcement for Extramural Medical Research through award number W81XWH-14-1-0561. BLB acknowledges support from the National Institute of Neurological Disorders and Stroke under the National Institutes of Health under the award NO L30 NS113158. TBM acknowledges support from the National Institute of Neurological Disorders and Stroke of the NIH under award number R01NS102225. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The REDCap electronic database used for this project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, Award Number UL1TR001436. This research was completed in part with computational resources and technical support provided by the Research Computing Center at the Medical College of Wisconsin.	Ahlgren A, 2016, NMR BIOMED, V29, P640, DOI 10.1002/nbm.3505; Alosco ML, 2020, NEUROLOGY, V95, pE793, DOI 10.1212/WNL.0000000000010040; Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; Alosco ML, 2020, BRAIN IMAGING BEHAV, V14, P1419, DOI 10.1007/s11682-019-00060-4; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Braeckman K, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101669; Brett B.L., 2019, SPORTS HEALTH; Brett BL, 2020, BRAIN BEHAV IMMUN, V89, P380, DOI 10.1016/j.bbi.2020.07.024; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Caballero MAA, 2018, BRAIN, V141, P3065, DOI 10.1093/brain/awy229; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Clark MD, 2018, RADIOLOGY, V286, P975, DOI 10.1148/radiol.2017170539; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Foss KDB, 2019, CLIN J SPORT MED, V29, P442, DOI 10.1097/JSM.0000000000000753; Gong NJ, 2018, NEUROBIOL DIS, V119, P79, DOI 10.1016/j.nbd.2018.07.020; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Jang I, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101930; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Koch KM, 2018, AM J NEURORADIOL, V39, P1215, DOI 10.3174/ajnr.A5692; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Lee JB, 2018, DEV NEUROSCI-BASEL, V40, P358, DOI 10.1159/000494134; Lepage C, 2019, BRAIN IMAGING BEHAV, V13, P725, DOI 10.1007/s11682-018-9895-z; Li W, 2014, HUM BRAIN MAPP, V35, P2698, DOI 10.1002/hbm.22360; Liu J, 2012, NEUROIMAGE, V59, P2560, DOI 10.1016/j.neuroimage.2011.08.082; Ly M, 2014, HUM BRAIN MAPP, V35, P2044, DOI 10.1002/hbm.22311; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; Mayo CD, 2017, NEUROIMAGE-CLIN, V13, P330, DOI 10.1016/j.nicl.2016.12.012; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mori S, 2005, MRI ATLAS HUMAN WHIT; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Myer GD, 2019, BRIT J SPORT MED, V53, P1539, DOI 10.1136/bjsports-2018-099571; Nilsson KJ, 2019, SPORTS HEALTH, V11, P507, DOI 10.1177/1941738119865264; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; Peckham ME, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2087-9; Puzo C, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0521-0; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Sepehrband F, 2019, NEUROIMAGE, V197, P243, DOI 10.1016/j.neuroimage.2019.04.070; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Soni N, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00153; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Thrane AS, 2014, TRENDS NEUROSCI, V37, P620, DOI 10.1016/j.tins.2014.08.010; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Vaas M, 2018, TRANSL STROKE RES, V9, P426, DOI 10.1007/s12975-017-0591-x; Vieni C, 2020, NEUROIMAGE, V204, DOI 10.1016/j.neuroimage.2019.116228; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; Weber AM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00575; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859	79	2	2	3	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2021	38	4					474	484		10.1089/neu.2020.7376		NOV 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QC1FI	WOS:000591088900001	33003979				2022-02-06	
J	Morrow, EL; Hereford, AP; Covington, NV; Duff, MC				Morrow, Emily L.; Hereford, Amanda P.; Covington, Natalie V.; Duff, Melissa C.			Traumatic brain injury in the acute care setting: assessment and management practices of speech-language pathologists	BRAIN INJURY			English	Article						Traumatic brain injury; speech-language pathology; acute care; cognitive-communication	KNOWLEDGE; OUTCOMES; PATIENT	Primary Objective To characterize current knowledge, beliefs, confidence, and practice patterns of acute care speech-language pathologists (SLPs) in assessing and managing cognitive-communication disorders following traumatic brain injury (TBI). Research Design We developed an online survey to learn more about current TBI knowledge and practice patterns of acute care SLPs, with the goal of establishing a baseline upon which changes in SLP training and practice standards may be measured. Methods and Procedures We distributed the survey to 1800 SLPs in 18 states via postal mail, in addition to posting it to relevant online groups. One hundred and eighty-two practicing acute care SLPs responded to the survey. Main Outcomes and Results Respondents were highly variable in their training and knowledge about TBI, their beliefs about cognitive-communication rehabilitation, and their practice patterns in assessing, managing, and communicating about TBI during the acute stage of injury. Conclusions These results highlight the need for more consistent training about cognitive-communication deficits during and after graduate school, as well as the development of sensitive, specific, and standardized assessment tools, education protocols, and shared language for describing patients with TBI along the continuum of care.	[Morrow, Emily L.; Hereford, Amanda P.; Covington, Natalie V.; Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37232 USA		Morrow, EL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37232 USA.	Emily.l.morrow@vanderbilt.edu		Covington, Natalie/0000-0002-0016-2654; Morrow, Emily/0000-0003-4629-2283			Armstrong E, 2003, ADV SPEECH LANGUAGE, V5, P137, DOI DOI 10.1080/14417040510001669171; Centers for Disease Control and Prevention, 2019, TBI GET THE FACTS; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Covington NV, AM J SPEECH LANGUAGE; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Duffy J, 2010, APHASIA CARE ACUTE H; Ferdagotis G, 2015, J SPEECH LANG HEAR R, V58, P377; Frank EM, 1997, J CHILDRENS COMMUNIC, V18, P49, DOI 10.1177/152574019701800206; Hagen C, 1972, RANCHO LOS AMIGOS LE; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McGrane SA, 2000, BRAIN INJURY, V14, P975; Riedeman S, 2018, AM J SPEECH-LANG PAT, V27, P181, DOI 10.1044/2017_AJSLP-17-0011; Rigon A, 2020, J CLIN EXP NEUROPSYC, V42, P14, DOI 10.1080/13803395.2019.1659755; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Vogel AP, 2010, J EVAL CLIN PRACT, V16, P1183, DOI 10.1111/j.1365-2753.2009.01291.x; Wilson SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192773	21	2	2	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 14	2020	34	12					1590	1609		10.1080/02699052.2020.1766114		NOV 2020	20	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OU7LB	WOS:000587531300001	33164599				2022-02-06	
J	Karr, JE; Iverson, GL; Williams, MW; Huang, SJ; Yang, CC				Karr, Justin E.; Iverson, Grant L.; Williams, Michael W.; Huang, Sheng-Jean; Yang, Chi-Cheng			Complicated versus uncomplicated mild traumatic brain injuries: A comparison of psychological, cognitive, and post-concussion symptom outcomes	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Brain concussion; neuropsychological tests; post-concussion syndrome; mental health; anxiety; depression; Taiwan	SPORTS-RELATED CONCUSSION; NEUROPSYCHOLOGICAL OUTCOMES; PREDICTION; RECOVERY; CT; ABNORMALITIES; ASSOCIATION; MODERATE; IMPACT; MEMORY	Introduction A complicated mild traumatic brain injury (MTBI) is defined as mild by all clinical severity indicators but is complicated due to a traumatic intracranial abnormality visible on neuroimaging. Researchers have reported mixed findings regarding whether neuropsychological and functional outcomes following complicated MTBI are worse than, or similar to, outcomes following uncomplicated MTBI. This study examined patients referred from a Taiwanese emergency department to a neurosurgical outpatient clinic. Participants with complicated MTBI, uncomplicated MTBI, and those who did not undergo head computed tomography (CT) were compared on psychological, neuropsychological, and post-concussion symptom outcomes within 21 days of injury. Method Participants with complicated MTBI (n = 42), uncomplicated MTBI (n = 77), and no head CT (n = 172) completed the Paced Auditory Serial Attention Test, Taiwanese Word Sequence Learning Test, a semantic Verbal Fluency Test, the Checklist of Post-Concussion Symptoms, and the Beck Depression and Anxiety Inventories. Results No significant differences were observed between groups on any measure. For individual post-concussion symptoms, dizziness, anxiety, and attention difficulty were endorsed more often after uncomplicated MTBIs, but these group differences were not significant after controlling for multiple comparisons. Conclusions Participants with complicated MTBIs did not have worse acute or subacute outcomes than participants with uncomplicated MTBIs or no head CT. These results are consistent with many studies finding comparable outcomes between those with complicated and uncomplicated MTBIs. This study is limited by small sample size and minimal information on intracranial abnormalities, broadly categorizing groups based on positive or negative neuroimaging as opposed to specific lesion types and locations.	[Karr, Justin E.] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] Home Base, Charlestown, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Williams, Michael W.] Univ Houston, Dept Psychol, Houston, TX USA; [Huang, Sheng-Jean] Taipei City Hosp, Taipei, Taiwan; [Yang, Chi-Cheng] Natl Chengchi Univ, Dept Psychol, Taipei, Taiwan; [Yang, Chi-Cheng] Taipei City Hosp, Holist Mental Hlth Ctr, Taipei, Taiwan		Yang, CC (corresponding author), Natl Chengchi Univ, Dept Psychol, Taipei, Taiwan.	yangyang@nccu.edu.tw		Karr, Justin/0000-0003-3653-332X; YANG, CHI CHENG/0000-0002-4544-3978; Iverson, Grant/0000-0001-7348-9570	Ministry of Science and Technology in TaiwanMinistry of Science and Technology, Taiwan [MOST 108-2410-H-004-087-, MOST 108-2918-I-004-003-]	Dr. Yang reports that this study was supported by the Ministry of Science and Technology in Taiwan (MOST 108-2410-H-004-087-and MOST 108-2918-I-004-003-). Dr. Iverson acknowledges unrestricted philanthropic support from the Heinz Family Foundation and the Spaulding Research Institute.	Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Chen C. Y., 2012, THESIS; Chen HY, 2000, BECK DEPRESSION INVE; Chen W-C, 2014, THESIS; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook NE, 2020, J DEV BEHAV PEDIATR, V41, P571, DOI 10.1097/DBP.0000000000000808; Dagher JH, 2013, BRAIN INJURY, V27, P189, DOI 10.3109/02699052.2012.729288; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; de Koning ME, 2017, BRAIN INJURY, V31, P1102, DOI 10.1080/02699052.2017.1296193; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Frenette LC, 2019, BRAIN INJURY, V33, P189, DOI 10.1080/02699052.2018.1542506; Gardner JE, 2019, NEUROSURGERY, V85, pE842, DOI 10.1093/neuros/nyz140; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hellstrom T, 2017, BRAIN INJURY, V31, P674, DOI 10.1080/02699052.2017.1283537; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Holthe OO, 2019, J HEAD TRAUMA REHAB, V34, pE45, DOI 10.1097/HTR.0000000000000463; Hua M.-S., 1986, WORD SEQUENCE UNPUB; Hua MS, 1997, NEUROPSYCHOLOGY, V11, P156, DOI 10.1037/0894-4105.11.1.156; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Karr JE, 2020, J NEUROTRAUM, V37, P1183, DOI 10.1089/neu.2019.6834; Karr JE, 2020, BRAIN INJURY, V34, P26, DOI 10.1080/02699052.2019.1669825; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Kumar RG, 2014, AM J PHYS MED REHAB, V93, P687, DOI 10.1097/PHM.0000000000000077; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levin H. S., 1983, PACED AUDITORY UNPUB; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lin JW, 2008, ACT NEUR S, V101, P113; Lin YC, 2000, BECK ANXIETY INVENTO; Liu M.Y., 2013, THESIS; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Puvanachandra P, 2009, PAK J NEUROL SCI, V4, P27; QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Steward K, 2018, J HEAD TRAUMA REHABI, V33, pE18; Steward KA, 2016, NEUROLOGY, V87, P1052, DOI 10.1212/WNL.0000000000003079; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Su BY, 2017, BRAIN INJURY, V31, P601, DOI 10.1080/02699052.2016.1267800; Tayim FM, 2016, J CLIN EXP NEUROPSYC, V38, P1005, DOI 10.1080/13803395.2016.1182968; Tomczak M, 2014, TRENDS SPORT SCI, V21, P19, DOI DOI 10.7326/0003-4819-159-3-201308060-00005; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Veeramuthu V, 2017, WORLD NEUROSURG, V97, P416, DOI 10.1016/j.wneu.2016.10.041; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343; Yuen KM, 2016, APPL NEUROPSYCH-ADUL, V23, P322, DOI 10.1080/23279095.2015.1057638; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	65	2	2	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	NOV 25	2020	42	10					1049	1058		10.1080/13803395.2020.1841118		NOV 2020	10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	PE7ND	WOS:000587534500001	33161877				2022-02-06	
J	Jung, TY; Katase, A; Wagatsuma, M; Fujii, T; Jung, Y; Jeng, B; Chaparro, G				Jung, Taeyou; Katase, Ai; Wagatsuma, Mayumi; Fujii, Takuto; Jung, Youngok; Jeng, Brenda; Chaparro, Gioella			The influence of concurrent cognitive tasks on motor performance in people with traumatic brain injury: a pilot study	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article; Early Access						Gait; traumatic brain injury; cognitive tasks; dual tasks	HEALTHY OLDER-ADULTS; DUAL-TASK; PARKINSONS-DISEASE; GAIT; WALKING; INTERFERENCE; ADOLESCENTS; IMPAIRMENT; CONCUSSION; COMPLEXITY	Background: Performing dual-tasks is often required for completing activities of daily living. Limited research investigated the effects of dual-tasking on gait in people with Traumatic Brain Injury (TBI). Purpose: To investigate the effects of cognitive tasks on gait in people with TBI Methods: Seven individuals with TBI and nine controls completed walking under three conditions; usual walking, walking with questions and answers, and walking with word generation while 3D motion analysis system captured gait. Results: Significant group x condition interactions were found in which TBI group showed greater changes in speed (p < .01), cadence (p = .07), and ankle kinematics (p = .03) as cognitive task became more complex from usual walking to walking with word generation. TBI group decreased speed (p = .02), stride length (p = .01), and hip kinematics (p = .03) as concurrent task became more complex. The control showed decreases in speed (p = .01), stride length (p = .01), and joint kinematics in the hip (p = .03) and knee (p = .01) as the complexity of concurrent cognitive task increased. Conclusion: People with TBI have greater difficulty walking with a cognitive task and show greater compromises in gait performance as the task complexity increases when compared to those without TBI. Clinicians should consider the use of progression in cognitive tasks for dual-task gait training.	[Jung, Taeyou; Katase, Ai; Wagatsuma, Mayumi; Fujii, Takuto] Calif State Univ Northridge, Ctr Achievement, Dept Kinesiol, Northridge, CA USA; [Jung, Youngok] Calif State Univ Long Beach, Dept Family & Consumer Sci, Coll Hlth & Human Serv, Long Beach, CA 90840 USA; [Jeng, Brenda] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL USA; [Chaparro, Gioella] Calif State Univ Dominguez Hills, Dept Kinesiol, Carson, CA 90747 USA		Jung, TY (corresponding author), Calif State Univ Northridge, Ctr Achievement, Dept Kinesiol, Northridge, CA USA.	taeyou.jung@csun.edu					Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Beauchet O, 2005, J MOTOR BEHAV, V37, P259; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Beauchet Olivier, 2006, Psychol Neuropsychiatr Vieil, V4, P215; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bowen A, 2001, AGE AGEING, V30, P319, DOI 10.1093/ageing/30.4.319; Clark DJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00246; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Haggard P, 2000, J NEUROL NEUROSUR PS, V69, P479, DOI 10.1136/jnnp.69.4.479; Hausdorff JM, 2008, J GERONTOL A-BIOL, V63, P1335, DOI 10.1093/gerona/63.12.1335; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Kahneman D., 1973, ATTENTION EFFORT; Lin MIB, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00092; Maciel MA, 2014, PSICOL-REFLEX CRIT, V27, P351, DOI 10.1590/1678-7153.201427216; Maclean LM, 2017, GAIT POSTURE, V53, P139, DOI 10.1016/j.gaitpost.2017.01.018; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Montero-Odasso M, 2012, ARCH PHYS MED REHAB, V93, P293, DOI 10.1016/j.apmr.2011.08.026; Motl RW, 2014, GAIT POSTURE, V39, P870, DOI 10.1016/j.gaitpost.2013.11.023; Muir SW, 2012, GAIT POSTURE, V35, P96, DOI 10.1016/j.gaitpost.2011.08.014; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Patel P, 2014, NEUROSCIENCE, V260, P140, DOI 10.1016/j.neuroscience.2013.12.016; Plummer-D'Amato P, 2008, GAIT POSTURE, V27, P683, DOI 10.1016/j.gaitpost.2007.09.001; Rahman RAA, 2018, REHABIL RES PRACT, V2018, DOI 10.1155/2018/2071726; Rochester L, 2004, ARCH PHYS MED REHAB, V85, P1578, DOI 10.1016/j.apmr.2004.01.025; Simoni D, 2013, CLIN BIOMECH, V28, P692, DOI 10.1016/j.clinbiomech.2013.05.011; Wajda DA, 2013, J NEUROL SCI, V335, P160, DOI 10.1016/j.jns.2013.09.021; Wild LB, 2013, J NEUROL, V260, P580, DOI 10.1007/s00415-012-6683-3; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x	37	2	2	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.												10.1080/09593985.2020.1840681		NOV 2020	8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	OO7PC	WOS:000587566400001	33164609				2022-02-06	
J	Nowak, MK; Ejima, K; Quinn, PD; Bazarian, JJ; Mickleborough, TD; Harezlak, J; Newman, SD; Kawata, K				Nowak, Madeleine K.; Ejima, Keisuke; Quinn, Patrick D.; Bazarian, Jeffrey J.; Mickleborough, Timothy D.; Harezlak, Jaroslaw; Newman, Sharlene D.; Kawata, Keisuke			ADHD May Associate With Reduced Tolerance to Acute Subconcussive Head Impacts: A Pilot Case-Control Intervention Study	JOURNAL OF ATTENTION DISORDERS			English	Article						ADHD; adult ADHD; cognitive functioning; head trauma; case-control study; concussion; soccer; football		Objective: To test our hypothesis that individuals with ADHD would exhibit reduced resiliency to subconcussive head impacts induced by ten soccer headings. Method: We conducted a case-control intervention study in 51 adults (20.6 +/- 1.7 years old). Cognitive assessment, using ImPACT, and plasma levels of neurofilament-light (NF-L), Tau, glial-fibrillary-acidic protein (GFAP), and ubiquitin-C-terminal hydrolase-L1 (UCH-L1) were measured. Results: Ten controlled soccer headings demonstrated ADHD-specific transient declines in verbal memory function. Ten headings also blunted learning effects in visual memory function in the ADHD group while the non-ADHD counterparts improved both verbal and visual memory functions even after ten headings. Blood biomarker levels of the ADHD group were sensitive to the stress induced by ten headings, where plasma GFAP and UCH-L1 levels acutely increased after 10 headings. Variance in ADHD-specific verbal memory decline was correlated with increased levels of plasma GFAP in the ADHD group. Conclusions: These data suggest that ADHD may reduce brain tolerance to repetitive subconcussive head impacts.	[Nowak, Madeleine K.; Mickleborough, Timothy D.; Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Bloomington, IN USA; [Ejima, Keisuke; Harezlak, Jaroslaw] Indiana Univ, Dept Epidemiol & Biostat, Bloomington, IN USA; [Quinn, Patrick D.] Indiana Univ, Dept Appl Hlth, Bloomington, IN USA; [Bazarian, Jeffrey J.] Univ Rochester, Med Ctr, Dept Emergency Med, Rochester, NY 14627 USA; [Newman, Sharlene D.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Kawata, Keisuke] Indiana Univ, Program Neurosci, Bloomington, IN USA		Kawata, K (corresponding author), Indiana Univ, Sch Publ Hlth, Dept Kinesiol, 1025 E 7th St, Bloomington, IN 47405 USA.	kkawata@indiana.edu	Harezlak, Jaroslaw/P-8557-2014	Harezlak, Jaroslaw/0000-0002-3070-7686; Mickleborough, Timothy/0000-0002-5118-268X; Kawata, Keisuke/0000-0003-4135-9311	Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health [ISCBIRF 0019939]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R21NS116548]; National Institute on Drug Abuse of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R00DA040727]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported from a Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health (to K Kawata: ISCBIRF 0019939) and the National Institute of Neurological Disorders and Stroke (to K Kawata and S Newman: 1R21NS116548). P. Quinn is supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number R00DA040727.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Babbs C F, 2001, ScientificWorldJournal, V1, P281; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Bevilacqua ZW, 2019, JOVE-J VIS EXP, DOI 10.3791/59381; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Broglio SP, 2018, CLIN J SPORT MED, V28, P130, DOI 10.1097/JSM.0000000000000420; Cassidy D., 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097699, DOI 10.1136/BJSPORTS-2017-097699]; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P842; Den Heijer AE, 2017, J NEURAL TRANSM, V124, pS3, DOI 10.1007/s00702-016-1593-7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Epstein JN, 2013, NEUROPSYCHIATRY-LOND, V3, P455, DOI 10.2217/npy.13.59; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Halperin JM, 2011, NEUROSCI BIOBEHAV R, V35, P621, DOI 10.1016/j.neubiorev.2010.07.006; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Iaccarino MA, 2018, NEUROL-CLIN PRACT, V8, P403, DOI 10.1212/CPJ.0000000000000525; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Joseph J, 2020, J BUS ETHICS, V164, P349, DOI 10.1007/s10551-018-4065-1; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kashon ML, 2004, J ALZHEIMERS DIS, V6, P595; Kawata K, 2018, J NEUROTRAUM, V35, P260, DOI 10.1089/neu.2017.5376; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Liou YJ, 2018, J ADOLESCENT HEALTH, V63, P233, DOI 10.1016/j.jadohealth.2018.02.012; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Manderino L, 2018, CLIN J SPORT MED, V28, P111, DOI 10.1097/JSM.0000000000000433; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Nowak MK, 2020, JAMA OPHTHALMOL, V138, P350, DOI 10.1001/jamaophthalmol.2019.6128; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Poysophon P, 2018, SPORTS HEALTH, V10, P317, DOI 10.1177/1941738117751387; Reynolds B.B., 2015, J NEUROSURG, P1, DOI [10.3171/2015.5.JNS15573, DOI 10.3171/2015.5.JNS15573]; Rodrigues AC, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00209; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Strauss SB, 2021, BRAIN IMAGING BEHAV, V15, P882, DOI 10.1007/s11682-020-00297-4; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Wallace C, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000433; Wilhelmsson U, 2019, BIOL CHEM, V400, P1147, DOI 10.1515/hsz-2019-0199; Wirsching A, 2019, J NEUROTRAUM, V36, P548, DOI 10.1089/neu.2018.5836; Zonner SW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00327; Zonner SW, 2019, JAMA OPHTHALMOL, V137, P265, DOI 10.1001/jamaophthalmol.2018.6193	52	2	2	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1087-0547	1557-1246		J ATTEN DISORD	J. Atten. Disord.	JAN	2022	26	1					125	139	1087054720969977	10.1177/1087054720969977		NOV 2020	15	Psychology, Developmental; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	XF7ZB	WOS:000623425900001	33161816	Green Accepted			2022-02-06	
J	Vita, SM; Grayson, BE; Grill, RJ				Vita, Sydney M.; Grayson, Bernadette E.; Grill, Raymond J.			Acute damage to the blood-brain barrier and perineuronal net integrity in a clinically-relevant of rat model traumatic brain	NEUROREPORT			English	Article						blood-brain barrier; diffuse injury; traumatic brain injury; perineuronal nets	ACTIVATED MICROGLIA; OXIDATIVE STRESS; INJURY; PERMEABILITY; EPIDEMIOLOGY	Closed-head, frontal impacts in which the brain undergoes both lateral and rotational acceleration comprise the majority of human traumatic brain injury (TBI). Here, we utilize a clinically relevant model to examine the effects of a single concussion on aspects of brain integrity: the blood-brain barrier, the perineuronal nets (PNNs), and diffuse axonal injury. Adult, male Sprague-Dawley rats received either a frontal, closed-head concussive TBI, or no injury and were evaluated at 1- or 7-day post-injury. Using immunolabeling for albumin, we observed a significant increase in the permeability of the blood-brain barrier at 1-, but not 7-day post-injury. Breakdown of the PNN, as measured by the binding of wisteria floribunda, was observed at 1-day post-injury in the dorsal, lateral, and ventral cortices. This difference was resolved at 7-day. Finally, axonal injury was identified at both 1- and 7-day post-injury. This preclinical model of closed-head, frontal TBI presents a useful tool with which to understand better the acute pathophysiology of a single, frontal TBI.	[Vita, Sydney M.; Grayson, Bernadette E.; Grill, Raymond J.] Univ MS, Dept Neurobiol & Anat Sci, Med Ctr, Jackson, MS USA		Grayson, BE (corresponding author), Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, 2500 North State St, Jackson, MS 39216 USA.	bgrayson@umc.edu		Vita, Sydney/0000-0002-8413-1782	University of Texas Health Science Center; US Department of DefenseUnited States Department of Defense [SC150037, SC140017, 150016]	Our thanks to Dr. Pramod Dash at the University of Texas Health Science Center for financial support with the silver staining.; This work was supported by the US Department of Defense under Grant SC150037; Grant SC140017; and Grant 150016.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Angelov DN, 1998, J NEUROSCI, V18, P6218; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bozzelli PL, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5735789; Cabungcal JH, 2013, P NATL ACAD SCI USA, V110, P9130, DOI 10.1073/pnas.1300454110; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Centers for Disease Control and Prevention, 2015, CDCS REP C TRAUM BRA; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Faralli A, 2016, BRAIN STRUCT FUNCT, V221, P3193, DOI 10.1007/s00429-015-1095-7; Fawcett JW, 2019, NAT REV NEUROSCI, V20, P451, DOI 10.1038/s41583-019-0196-3; Feng JF, 2012, BRAIN RES, V1469, P144, DOI 10.1016/j.brainres.2012.06.021; Fowke TM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36083-y; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; HARTIG W, 1992, NEUROREPORT, V3, P869; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974; Li W, 2016, BRAIN RES, V1646, P53, DOI 10.1016/j.brainres.2016.05.036; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Numminen HJ, 2011, EUR J NEUROL, V18, P460, DOI 10.1111/j.1468-1331.2010.03179.x; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00404; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Yao LP, 2018, CONTRAST MEDIA MOL I, DOI 10.1155/2018/7628037	39	2	2	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	NOV 4	2020	31	16					1167	1174		10.1097/WNR.0000000000001531			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NX3OK	WOS:000575621400008	32991524				2022-02-06	
J	Woo, PYM; Ho, JWK; Ko, NMW; Li, RPT; Jian, L; Chu, ACH; Kwan, MCL; Chan, Y; Wong, AKS; Wong, HT; Chan, KY; Kwok, JCK				Woo, Peter Y. M.; Ho, Joanna W. K.; Ko, Natalie M. W.; Li, Ronald P. T.; Jian, Leo; Chu, Alberto C. H.; Kwan, Marco C. L.; Chan, Yung; Wong, Alain K. S.; Wong, Hoi-Tung; Chan, Kwong-Yau; Kwok, John C. K.			Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage	BMC NEUROLOGY			English	Article						Aneurysmal subarachnoid hemorrhage; Neuroprotection; Delayed cerebral ischemia	PEPTIDERGIC DRUG CEREBROLYSIN; DELAYED CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; FUNCTIONAL RECOVERY; NEUROPROTECTIVE TREATMENT; ALZHEIMERS-DISEASE; CLINICAL-TRIALS; STROKE; VASOSPASM; MULTICENTER	Background: There are limited neuroprotective treatment options for patients with aneurysmal subarachnoid hemorrhage (SAH). Cerebrolysin, a brain-specific proposed pleiotropic neuroprotective agent, has been suggested to improve global functional outcomes in ischemic stroke. We investigated the efficacy, safety and feasibility of administering Cerebrolysin for SAH patients. Methods: This was a prospective, randomized, double-blind, placebo-controlled, single-center, parallel-group pilot study. Fifty patients received either daily Cerebrolysin (30 ml/day) or a placebo (saline) for 14 days (25 patients per study group). The primary endpoint was a favorable Extended Glasgow Outcome Scale (GOSE) of 5 to 8 (moderate disability to good recovery) at six-months. Secondary endpoints included the modified Ranking Scale (mRS), the Montreal Cognitive Assessment (MOCA) score, occurrence of adverse effects and the occurrence of delayed cerebral ischemia (DCI). Results: No severe adverse effects or mortality attributable to Cerebrolysin were observed. No significant difference was detected in the proportion of patients with favorable six-month GOSE in either study group (odds ratio (OR): 1.49; 95% confidence interval (CI): 0.43-5.17). Secondary functional outcome measures for favorable six-month recovery i.e. a mRS of 0 to 3 (OR: 3.45; 95% CI 0.79-15.01) were comparable for both groups. Similarly, there was no difference in MOCA neurocognitive performance (p-value: 0.75) and in the incidence of DCI (OR: 0.85 95% CI: 0.28-2.59). Conclusions: Use of Cerebrolysin in addition to standard-of-care management of aneurysmal SAH is safe, well tolerated and feasible. However, the neutral results of this trial suggest that it does not improve the six-month global functional performance of patients.	[Woo, Peter Y. M.; Ho, Joanna W. K.; Ko, Natalie M. W.; Li, Ronald P. T.; Jian, Leo; Chu, Alberto C. H.; Kwan, Marco C. L.; Chan, Yung; Wong, Alain K. S.; Wong, Hoi-Tung; Chan, Kwong-Yau; Kwok, John C. K.] Kwong Wah Hosp, Dept Neurosurg, Room CS11-01,11th Floor,25 Waterloo Rd, Hong Kong, Peoples R China		Woo, PYM (corresponding author), Kwong Wah Hosp, Dept Neurosurg, Room CS11-01,11th Floor,25 Waterloo Rd, Hong Kong, Peoples R China.	wym307@ha.org.hk		Woo, Peter Yat Ming/0000-0002-7345-7904			Al-Mufti F, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17431; Alvarez XA, 2011, EUR J NEUROL, V18, P59, DOI 10.1111/j.1468-1331.2010.03092.x; Amiri-Nikpour MR, 2014, NEUROPSYCH DIS TREAT, V10, P2299, DOI 10.2147/NDT.S75304; Andersen CR, 2019, NEUROCRIT CARE, V30, P534, DOI 10.1007/s12028-018-0566-0; Ayer R, 2010, TURK NEUROSURG, V20, P159, DOI 10.5137/1019-5149.JTN.2714-09.0; BASKYS A, 1994, PHARMACOL BIOCHEM BE, V49, P1105, DOI 10.1016/0091-3057(94)90272-0; Bornstein NM, 2018, NEUROL SCI, V39, P629, DOI 10.1007/s10072-017-3214-0; Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711; Catalin B, 2018, CNS NEUROL DISORD-DR, V17, P299, DOI 10.2174/1871527317666180425124340; Chang WH, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0553-z; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008900.pub2; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Chu Alberto Chi Ho, 2015, Acta Neurochir Suppl, V120, P303, DOI 10.1007/978-3-319-04981-6_51; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Doppler E, 2008, ACTA NEUROPATHOL, V116, P425, DOI 10.1007/s00401-008-0407-x; Egge A, 2001, NEUROSURGERY, V49, P593, DOI 10.1097/00006123-200109000-00012; Fischer U, 2006, ACTA NEUROL SCAND, V113, P108, DOI 10.1111/j.1600-0404.2005.00551.x; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Gauthier S, 2015, DEMENT GERIATR COGN, V39, P332, DOI 10.1159/000377672; Gharagozli K, 2017, J Med Life, V10, P153; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Guan X, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01245; Guekht A, 2017, NEUROL SCI, V38, P1761, DOI 10.1007/s10072-017-3037-z; Gutmann B, 2002, NEUROTOX RES, V4, P59, DOI 10.1080/10298420290007637; Hanson LR, 2009, AM J NEUROPROTEC NEU, V1, P62; Hartbauer M, 2001, J NEURAL TRANSM, V108, P459, DOI 10.1007/s007020170067; Hartbauer M, 2001, J NEURAL TRANSM, V108, P581, DOI 10.1007/s007020170058; Heiss W. D, 2012, J STROKE CEREBROVASC, V3, P630, DOI DOI 10.1161/STROKEAHA.111.628537; HIJDRA A, 1990, STROKE, V21, P1156, DOI 10.1161/01.STR.21.8.1156; Ilodigwe D, 2013, J NEUROSURG, V118, P3, DOI 10.3171/2012.9.JNS111383; Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413; Kassell NF, 1996, J NEUROSURG, V84, P221, DOI 10.3171/jns.1996.84.2.0221; Khalili H, 2017, CLIN NEUROL NEUROSUR, V152, P34, DOI 10.1016/j.clineuro.2016.11.011; Khan AU, 2015, CLIN NEUROL NEUROSUR, V133, P55, DOI 10.1016/j.clineuro.2015.03.006; Kirkpatrick PJ, 2014, LANCET NEUROL, V13, P666, DOI 10.1016/S1474-4422(14)70084-5; Ladurner G, 2005, J NEURAL TRANSM, V112, P415, DOI 10.1007/s00702-004-0248-2; Lang W, 2013, INT J STROKE, V8, P95, DOI 10.1111/j.1747-4949.2012.00901.x; Lantigua H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1036-0; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Molyneux Andrew J, 1800, Lancet, V366, P809; Muresanu DF, 2016, STROKE, V47, P151, DOI 10.1161/STROKEAHA.115.009416; Onose G, 2009, J Med Life, V2, P350; Park YK, 2018, ADV THER, V35, P2224, DOI 10.1007/s12325-018-0832-8; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; Poon W, 2020, NEUROL SCI, V41, P281, DOI 10.1007/s10072-019-04053-5; Ren J, 2007, RESTOR NEUROL NEUROS, V25, P25; Riley C, 2006, J NEURAL TRANSM, V113, P103, DOI 10.1007/s00702-005-0302-8; Rinkel G J, 2002, Cochrane Database Syst Rev, pCD000277; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Sano Hirotoshi, 2016, Surg Neurol Int, V7, pS502, DOI 10.4103/2152-7806.187491; Schauer E, 2006, J NEURAL TRANSM, V113, P855, DOI 10.1007/s00702-005-0384-3; Schmidt JM, 2008, J NEUROSURG, V109, P1052, DOI 10.3171/JNS.2008.109.12.1052; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Shamalov NA, 2010, ZH NEVROL PSIKHIATR, V110, P34; Sim J, 2012, J CLIN EPIDEMIOL, V65, P301, DOI 10.1016/j.jclinepi.2011.07.011; Skvortsova VI, 2004, ZH NEVROPATOL PSIKH, P51; Stallard N, 2012, STAT MED, V31, P1031, DOI 10.1002/sim.4357; Stienen MN, 2019, NEUROCRIT CARE, V30, P102, DOI 10.1007/s12028-019-00737-0; Suarez JI, 2019, NEUROCRIT CARE, V30, P4, DOI 10.1007/s12028-019-00723-6; Tuttolomondo A, 2015, EXPERT REV NEUROTHER, V15, P1271, DOI 10.1586/14737175.2015.1101345; Uyttenboogaart M, 2005, STROKE, V36, P1984, DOI 10.1161/01.STR.0000177872.87960.61; van den Bergh WM, 2006, STROKE, V37, P2326, DOI 10.1161/01.STR.0000236841.16055.0f; van Donkelaar CE, 2017, J NEUROSURG, V126, P52, DOI 10.3171/2016.1.JNS152136; Velat GJ, 2011, WORLD NEUROSURG, V76, P446, DOI 10.1016/j.wneu.2011.02.030; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Wang ZF, 2017, DRUG DES DEV THER, V11, P1273, DOI 10.2147/DDDT.S124273; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wong GKC, 2013, J NEUROL NEUROSUR PS, V84, P1054, DOI 10.1136/jnnp-2012-304517; Wong GKC, 2010, STROKE, V41, P921, DOI 10.1161/STROKEAHA.109.571125; Woo PYM, 2017, J NEUROINTERV SURG, V9, P1118, DOI 10.1136/neurintsurg-2016-012576; Wostrack M, 2013, ACTA NEUROCHIR, V155, P579, DOI 10.1007/s00701-013-1634-z; Xue LX, 2016, EXP THER MED, V11, P2015, DOI 10.3892/etm.2016.3139; Yang Y, 2016, NEUROCHEM RES, V41, P748, DOI 10.1007/s11064-015-1745-4; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zhang DF, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4191670; Zhang L, 2019, J NEUROL SCI, V398, P22, DOI 10.1016/j.jns.2019.01.017; Zhang L, 2013, STROKE, V44, P1965, DOI 10.1161/STROKEAHA.111.000831; Ziganshina LE, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007026.pub5; Zwienenberg-Lee M, 2008, STROKE, V39, P1759, DOI 10.1161/STROKEAHA.107.502666	84	2	2	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	NOV 3	2020	20	1							401	10.1186/s12883-020-01908-9			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OR6CT	WOS:000589556900001	33143640	gold, Green Submitted, Green Published			2022-02-06	
J	Doroszkiewicz, C; Gold, D; Green, R; Tartaglia, MC; Ma, J; Tator, CH				Doroszkiewicz, Corinne; Gold, David; Green, Robin; Tartaglia, Maria Carmela; Ma, Jin; Tator, Charles H.			Anxiety, Depression, and Quality of Life: A Long-Term Follow-Up Study of Patients with Persisting Concussion Symptoms	JOURNAL OF NEUROTRAUMA			English	Article						anxiety; DASS-42; depression; post-concussion syndrome; quality of life; WHOQOL-BREF	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSION SYNDROME; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; PREDICTORS; ASSOCIATION; RISK; POSTINJURY; SCALES	Persisting concussion symptoms (PCS) can last for months, years, or indefinitely and affect a considerable number of concussion patients. The objectives of this study were to evaluate the prevalence of clinical symptoms of anxiety and depression and the relationship between PCS and quality of life in patients examined at the Canadian Concussion Centre. The Depression and Anxiety Stress Scale-42 (DASS-42) and the World Health Organization Quality of Life Assessment-BREF (WHOQOL-BREF) were sent to 526 adult patients diagnosed with PCS. Median with interquartile range follow-up time was 5 (4-7) years. Of the 105 respondents, 35.2% displayed mild or greater symptoms of anxiety, depression, or both. Importantly, the number of previous concussions was correlated with elevations on the DASS-42 Anxiety (p = 0.030) and Depression (p = 0.018) subscale scores, suggesting an acquired cause of symptoms. Patients with clinical elevations of depression, anxiety, or both exhibited poorer mean WHOQOL-BREF scores in each domain (p < 0.001) compared to those who scored in the normal range on the DASS-42. These findings indicate that depression and anxiety in PCS can endure for years and are associated with diminished quality of life. Consequently, depression and anxiety should be identified and treated early in PCS populations in order to optimize recovery. Although the underlying etiology of depression and anxiety cannot be ascertained with certainty in the present study, the association between depression and anxiety and the number of concussions may indicate an organic explanation. In the future, quality-of-life measures should be incorporated into treatment and research in PCS to improve intervention strategies and enhance understanding of the trajectory of recovery in this population.	[Doroszkiewicz, Corinne; Green, Robin; Tartaglia, Maria Carmela; Tator, Charles H.] Canadian Concuss Ctr, Toronto, ON, Canada; [Gold, David] Univ Hlth Network, Toronto Western Hosp, Krembil Neurosci Network, Neuropsychol Clin, Toronto, ON, Canada; [Tator, Charles H.] Univ Hlth Network, Div Neurosurg, Toronto Western Hosp, Toronto, ON, Canada; [Tartaglia, Maria Carmela] Univ Hlth Network, Toronto Western Hosp, Div Neurol, Toronto, ON, Canada; [Green, Robin] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Ma, Jin] Univ Hlth Network, Biostat Res Unit, Toronto, ON, Canada		Tator, CH (corresponding author), Univ Hlth Network, TWH, 399 Bathurst St,Room 4W-433, Toronto, ON M5T 2S8, Canada.	charles.tator@uhn.ca		Gold, David/0000-0002-9802-0362	Canadian Concussion Center; Toronto General and Toronto Western Hospital Foundation	This study was funded by the Canadian Concussion Center, which is funded by the Toronto General and Toronto Western Hospital Foundation. The Toronto General and Toronto Western Hospital Foundation had no role in the design of this study and collection, analysis, interpretation of data, and writing of the manuscript.	Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Allen J, 2014, INT REV PSYCHIATR, V26, P392, DOI 10.3109/09540261.2014.928270; Altemus M, 2014, FRONT NEUROENDOCRIN, V35, P320, DOI 10.1016/j.yfrne.2014.05.004; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Ansari Ahmed, 2014, Asian J Neurosurg, V9, P182, DOI 10.4103/1793-5482.146597; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Balakrishnan Buveinthiran, 2019, Asian J Neurosurg, V14, P201, DOI 10.4103/ajns.AJNS_49_18; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Chisholm D, 2016, LANCET PSYCHIAT, V3, P415, DOI 10.1016/S2215-0366(16)30024-4; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Dwyer B, 2018, HAND CLINIC, V158, P163, DOI 10.1016/B978-0-444-63954-7.00017-3; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Fisher LB, 2019, CURR CLIN PSYCHIAT, P87, DOI 10.1007/978-3-319-97241-1_7; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz Kevin M, 2015, Handb Clin Neurol, V127, P157, DOI 10.1016/B978-0-444-52892-6.00010-6; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Parkitny L, 2010, J PHYSIOTHER, V56, P204, DOI 10.1016/S1836-9553(10)70030-8; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Reddy RP, 2017, INDIAN J PSYCHOL MED, V39, P32, DOI 10.4103/0253-7176.198940; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; van Ierssel J, 2018, QUAL LIFE RES, V27, P3071, DOI 10.1007/s11136-018-1939-8; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662; World Health Organization, 1992, ICD 10 CLASSIFICATIO; World Health Organization, 1996, WHOQOL BREF INTR ADM	51	2	2	3	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2021	38	4					493	505		10.1089/neu.2020.7313		NOV 2020	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	QC1FI	WOS:000586689600001	32962513	hybrid			2022-02-06	
J	Adams, SA; Turner, AP; Richards, H; Hutchinson, PJ				Adams, Stephanie A.; Turner, Anthony P.; Richards, Hugh; Hutchinson, Peter J.			Concussion in Motorsport? Experience, Knowledge, Attitudes, and Priorities of Medical Personnel and Drivers	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; motor sports; motorsport; stakeholders; knowledge; attitudes	EDUCATION; PLAYERS; COACHES; CARE	Objective: To assess concussion experiences, knowledge, and attitudes of motorsport medical personnel and drivers and to determine priority areas regarding concussion within the sport. Design: Sequential mixed-method design. Part 1: stakeholder interviews; part 2: cross-sectional online survey. Setting: United Kingdom. Participants: Part 1: key motorsport stakeholders (N = 8); part 2: motorsport medical personnel and drivers (N = 209) representing amateur and/or professional 4-wheeled motorsport. Main Outcome Measures: Concussion experience, knowledge, attitudes, and perceived priority areas. Results: Thirty-one percent of surveyed drivers (age = 37.91 +/- 13.49 years: 89% male) reported suffering from concussion in motorsport. Eighty-seven percent of surveyed medical personnel (age = 48.60 +/- 10.68 years: 74% male) reported experience with concussed drivers, and 34% reported feeling pressured to clear a driver with concussion. Gaps in knowledge and misperceptions about concussion were reported in both groups, and disparity between concussion attitudes emerged between drivers and medical personnel. Application of assessment and management procedures varied between medical personnel and there was evidence motorsport policy and concussion guidelines may not be directly followed. According to both medical personnel (77%) and drivers (85%), "education and training" is the top priority area for the sport. Conclusions: There is clear evidence of concussions in motorsport, but accurate knowledge about this injury is missing. Concussion education and training for all drivers and medical personnel is required. Additional investigations into concussion attitudes are advised to complement and advance simple educational initiatives. Further investigation is also required to determine how to best support motorsport medical personnel, and general practitioners, who hold significant responsibility in guiding drivers from diagnosis to return to racing, and to support the effective implementation of policy.	[Adams, Stephanie A.; Turner, Anthony P.; Richards, Hugh] Univ Edinburgh, Moray House Sch Educ, Inst Sport PE & Hlth Sci, Holyrood Rd, Edinburgh EH8 8AQ, Midlothian, Scotland; [Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Acad Div Neurosurg, Cambridge, England		Adams, SA (corresponding author), Univ Edinburgh, Moray House Sch Educ, Inst Sport PE & Hlth Sci, Holyrood Rd, Edinburgh EH8 8AQ, Midlothian, Scotland.	stephanie.adams@ed.ac.uk		Hutchinson, Peter/0000-0002-2796-1835	University of Edinburgh Principal's Career Development Scholarship; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390, G1002277, G0601025, G0502030] Funding Source: UKRI	P. J. Hutchinson is the Chief Medical Officer for the FIA Formula One British Grand Prix at Silverstone. S. A. Adams is supported by a University of Edinburgh Principal's Career Development Scholarship. The remaining authors report no conflicts of interest.	Boffano P, 2011, J CRANIOFAC SURG, V22, P2053, DOI 10.1097/SCS.0b013e318231988d; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Burke MJ, 2012, CAN J NEUROL SCI, V39, P763, DOI 10.1017/S0317167100015584; Creswell J.W., 2013, RES DESIGN QUALITATI; Cutler M, 2016, INT J MOT SPORT MED, V9, P10; Deakin ND, 2017, CONCUSSION, V2, P43; Deakin ND, 2017, J CONCUSSION, V1, P1; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; FIA, 2017, MEMB; Fraas MR, 2015, IRISH J MED SCI, V184, P425, DOI 10.1007/s11845-014-1137-9; Gabbe B, 2003, J SCI MED SPORT, V6, P231, DOI 10.1016/S1440-2440(03)80259-1; Haider Mohammad N, 2017, Concussion, V2, pCNC40, DOI 10.2217/cnc-2017-0001; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry N., 2007, MOTORSPORT GOING GLO; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Lavigne M, 2017, ARCH DIS CHILD, V102, P748, DOI 10.1136/archdischild-2016-312284; Mann A., 2017, BRIT J SPORT MED, V51, pA53; Mann A, 2017, CAN FAM PHYSICIAN, V63, P460; Mathema P, 2016, CLIN J SPORT MED, V26, P320, DOI 10.1097/JSM.0000000000000256; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; Miller Kristina O, 2016, Concussion, V1, pCNC16, DOI 10.2217/cnc-2016-0004; Minoyama O, 2004, BRIT J SPORT MED, V38, P613, DOI 10.1136/bjsm.2003.007674; Montano DE, 2015, THEORY REASONED ACTI; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Mountjoy M, 2017, BRIT J SPORT MED, V52, P54; MSA, 2016, RUL CHANG; Noble J, 2016, F1 VOTES HALO INTRO; Olvey S., 2015, INT J MOTOR SPORT ME, P36; Owusu-Addo E, 2015, INT J HEALTH PROMOT, V53, P291, DOI 10.1080/14635240.2015.1030033; Petty Richard E., 2012, ATTITUDES INSIGHTS N; Phillips T., 2017, BRIT J SPORT MED, V51, pA49.1, DOI [10.1136/bjsports-2016-097270.126, DOI 10.1136/BJSPORTS-2016-097270.126]; Phillipson J, 2012, J ENVIRON MANAGE, V95, P56, DOI 10.1016/j.jenvman.2011.10.005; Potkanowicz ES, 2013, SPORTS MED, V43, P565, DOI 10.1007/s40279-013-0040-2; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Reiman S, 2017, DARIO FRANCHITTI DIS; Ridge H, 2017, MSA MAGAZINE; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Ross F, 2004, INT J NURS STUD, V41, P547, DOI 10.1016/j.ijnurstu.2003.12.008; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Sparkes AC, 1998, SPORT PSYCHOL, V12, P363, DOI 10.1123/tsp.12.4.363; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009	47	2	2	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2020	30	6					568	577		10.1097/JSM.0000000000000647			10	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	OP0UO	WOS:000587794700018	30113965	Green Submitted			2022-02-06	
J	Bath, PM; Woodhouse, LJ; Suntrup-Krueger, S; Likar, R; Koestenberger, M; Warusevitane, A; Herzog, J; Schuttler, M; Ragab, S; Everton, L; Ledl, C; Walther, E; Saltuari, L; Pucks-Faes, E; Bocksrucker, C; Vosko, M; De Broux, J; Haase, CG; Raginis-Zborowska, A; Mistry, S; Hamdy, S; Dziewas, R				Bath, Philip M.; Woodhouse, Lisa J.; Suntrup-Krueger, Sonja; Likar, Rudolf; Koestenberger, Markus; Warusevitane, Anushka; Herzog, Juergen; Schuttler, Michael; Ragab, Suzanne; Everton, Lisa; Ledl, Christian; Walther, Ernst; Saltuari, Leopold; Pucks-Faes, Elke; Bocksrucker, Christof; Vosko, Milan; de Broux, Johanna; Haase, Claus G.; Raginis-Zborowska, Alicja; Mistry, Satish; Hamdy, Shaheen; Dziewas, Rainer		PHADER Investigators	Pharyngeal electrical stimulation for neurogenic dysphagia following stroke, traumatic brain injury or other causes: Main results from the PHADER cohort study	ECLINICALMEDICINE			English	Article						Decannulation; Dysphagia; Pharyngeal electrical stimulation; Stroke; Traumatic brain injury; Ventilation		Background: Neurogenic dysphagia is common and has no definitive treatment. We assessed whether pharyngeal electrical stimulation (PES) is associated with reduced dysphagia. Methods: The PHAryngeal electrical stimulation for treatment of neurogenic Dysphagia European Registry (PHADER) was a prospective single-arm observational cohort study. Participants were recruited with neurogenic dysphagia (comprising five groups - stroke not needing ventilation; stroke needing ventilation; ventilation acquired; traumatic brain injury; other neurological causes). PES was administered once daily for three days. The primary outcome was the validated dysphagia severity rating scale (DSRS, score best-worst 0-12) at 3 months. Findings: Of 255 enrolled patients from 14 centres in Austria, Germany and UK, 10 failed screening. At baseline, mean (standard deviation) or median [interquartile range]: age 68 (14) years, male 71%, DSRS 11.4 (1.7), time from onset to treatment 32 [44] days; age, time and DSRS differed between diagnostic groups. Insertion of PES catheters was successfully inserted in 239/245 (98%) participants, and was typically easy taking 11.8 min. 9 participants withdrew before the end of treatment. DSRS improved significantly in all dysphagia groups, difference in means (95% confidence intervals, CI) from 0 to 3 months: stroke (n = 79) -6.7 (-7.8, -5.5), ventilated stroke (n = 98) -6.5 (-7.6, -5.5); ventilation acquired (n = 35) -6.6 (-8.4, -4.8); traumatic brain injury (n = 24) -4.5 (-6.6, -2.4). The results for DSRS were mirrored for instrumentally assessed penetration aspiration scale scores. DSRS improved in both supratentorial and infratentorial stroke, with no difference between them (p = 0.32). In previously ventilated participants with tracheotomy, DSRS improved more in participants who could be decannulated (n = 66) -7.5 (-8.6, -6.5) versus not decannulated (n = 33) -2.1 (-3.2, -1.0) (p<0.001). 74 serious adverse events (SAE) occurred in 60 participants with pneumonia (9.2%) the most frequent SAE. Interpretation: In patients with neurogenic dysphagia, PES was safe and associated with reduced measures of dysphagia and penetration/aspiration. (C) 2020 The Author(s). Published by Elsevier Ltd.	[Bath, Philip M.; Woodhouse, Lisa J.; Everton, Lisa] Univ Nottingham, Div Clin Neurosci, Stroke Trials Unit, Nottingham NG5 1PB, England; [Bath, Philip M.] Nottingham Univ Hosp NHS Trust, Stroke, Nottingham NG5 1PB, England; [Suntrup-Krueger, Sonja; Dziewas, Rainer] Univ Hosp Munster, Dept Neurol, Bldg A1,Albert Schweitzer Campus 1, D-48149 Munster, Germany; [Likar, Rudolf; Koestenberger, Markus] Klinikum Klagenfurt Worthersee, Dept Anaesthesiol & Intens Care Med, Klagenfurt, Austria; [Warusevitane, Anushka] Univ Hosp North Midlands NHS Trust, Royal Stoke Univ Hosp, Stroke Res, Parish Bldg,1st Floor,Newcastle Rd, Stoke On Trent ST4 6QG, Staffs, England; [Herzog, Juergen] Schon Klin Munchen Schwabing, Clin Neurol Rehabil & Early Rehabil, Parzivalpl 4, D-80804 Munich, Germany; [Schuttler, Michael] Schon Klin Bad Staffelstein, Ctr Neurol, Kurpk 11, D-96231 Bad Staffelstein, Germany; [Ragab, Suzanne] Poole Hosp NHS Fdn Trust, Dept Stroke, Philip Arnold Unit, Ground Floor,Longfleet Rd, Poole BH15 2JB, Dorset, England; [Everton, Lisa] Nottinghamshire Healthcare NHS Fdn Trust, Speech & Language Therapy, Nottingham NG3 6AA, England; [Ledl, Christian] Schon Klin Bad Aibling, Specialist Clin Neurol Neurol Rehabil & Alzheimer, Kolbermoorer Str 72, D-83043 Bad Aibling, Germany; [Walther, Ernst] Schon Klin Hamburg Eilbek, Clin Neurol & Neurorehabil, Hamburg, Germany; [Saltuari, Leopold; Pucks-Faes, Elke] Tiroler Landesrankenanstalten GmbH LkH Hochzirl, Dept Neurol, O Landeskrankenhaus Hochzirl Natters, A-6170 Zirl Hochzirl, Austria; [Bocksrucker, Christof] Konventhosp Barmherzige Bruder Linz, Dept Neurol, Seilerstatte 2, A-4021 Linz, Austria; [Vosko, Milan] Kepler Univ Klinikum, Dept Neurol 2, Med Campus 3,Krankenhausstr 9, A-4020 Linz, Austria; [de Broux, Johanna] Alexianer Krefeld GmbH, Clin Neurol, Diessemer Bruch 81, D-47805 Krefeld, Germany; [Haase, Claus G.] Lehrkrankenhaus Univ Essen Duisburg, Evangel Kliniken Gelsenkirchen, Clin Neurol & Neurophysiol, Munckelstr 27, D-45879 Gelsenkirchen, Germany; [Raginis-Zborowska, Alicja; Mistry, Satish; Hamdy, Shaheen] Phagenesis Ltd, Dept Clin Res, Manchester M15 6SE, Lancs, England; [Hamdy, Shaheen] Univ Manchester, Fac Biol Med & Hlth, Ctr Gastrointestinal Sci, Manchester M6 8HD, Lancs, England; [Hamdy, Shaheen] Manchester Acad Hlth Sci Ctr, Manchester M6 8HD, Lancs, England		Bath, PM (corresponding author), Univ Nottingham, Div Clin Neurosci, Stroke Trials Unit, Nottingham NG5 1PB, England.	philip.bath@nottingham.ac.uk	Kostenberger, Markus/AAL-1020-2020; Bath, Philip/F-9020-2011	Kostenberger, Markus/0000-0002-7205-6818; Everton, Lisa F/0000-0001-5106-4395; Bath, Philip/0000-0003-2734-5132	Phagenesis Ltd.	Phagenesis Ltd.	Bath PM, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000323.pub3; Bath PM, 2016, STROKE, V47, P1562, DOI 10.1161/STROKEAHA.115.012455; Cohen D, 2016, P IEEE RAD C, P1; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Dziewas R, 2020, EUR J NEUROL, V27, pE46, DOI 10.1111/ene.14367; Dziewas R, 2018, LANCET NEUROL; Everton LF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64208-9; Hamdy S, 1998, J PHYSIOL-LONDON, V506, P857, DOI 10.1111/j.1469-7793.1998.857bv.x; Jayasekeran V, 2010, GASTROENTEROLOGY, V138, P1737, DOI 10.1053/j.gastro.2010.01.052; Koestenberger M, 2019, NEUROCRIT CARE; Muhle Paul, 2017, Neurosignals, V25, P74, DOI 10.1159/000482002; Restivo DA, 2018, MED DEVICES-EVID RES, V11, P21, DOI 10.2147/MDER.S122287; Restivo DA, 2013, BRAIN STIMUL, V6, P418, DOI 10.1016/j.brs.2012.09.001; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Scutt P, 2015, STROKE RES TREAT, V2015, DOI 10.1155/2015/429053; Suntrup S, 2015, INTENS CARE MED, V41, P1629, DOI 10.1007/s00134-015-3897-8; Vasant DH, 2016, NEUROREHAB NEURAL RE, V30, P866, DOI 10.1177/1545968316639129; Woodhouse LJ, 2017, TRANSL STROKE RES	18	2	2	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2589-5370		ECLINICALMEDICINE	EClinicalMedicine	NOV	2020	28								100608	10.1016/j.eclinm.2020.100608			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV5WP	WOS:000645903100029	33294818	Green Published, gold			2022-02-06	
J	Brickell, TA; Cotner, BA; French, LM; Carlozzi, NE; O'Connor, DR; Nakase-Richardson, R; Lange, RT				Brickell, Tracey A.; Cotner, Bridget A.; French, Louis M.; Carlozzi, Noelle E.; O'Connor, Danielle R.; Nakase-Richardson, Risa; Lange, Rael T.			Severity of Military Traumatic Brain Injury Influences Caregiver Health-Related Quality of Life	REHABILITATION PSYCHOLOGY			English	Article						military caregiver; health-related quality of life; service member and veteran; traumatic brain injury; military family functioning	US SERVICE MEMBERS; FAMILY-MEMBERS; SOCIAL SUPPORT; MENTAL-HEALTH; VETERANS; BURDEN; IMPACT; CARE; TBI; INTERVENTION	Purpose/Objective: To examine the influence of traumatic brain injury (1131) severity on the health-related quality of life of caregivers providing care to service members/veterans (SMV) following a TBI. Research Method/Design: Thirty caregivers (90.0% female; 70.0% spouse; age: M = 39.5 years, SD = 10.7) of SMVs who sustained a mild. moderate, severe, or penetrating TBI were recruited from Walter Reed National Military Medical Center and via community outreach to participate in one of six focus groups. Caregivers were classified into 3 TBI severity/caregiver groups: (a) moderate/severe/penetrating TBI caregiver group (n = 11); (b) mild TBI caregiver group (n = 10); and (c) equivocal TBI caregiver group (n = 9). Thematic analysis using a constant comparative approach was conducted with qualitative analysis software to identify common themes across the 3 severity/caregiver groups. Results: Eleven themes emerged: no time for self/needs last (83.3%), poor physical health (80.0%), increased stress/anxiety (76.7%). social isolation/loneliness (66.7%). lack of access to services (50.0%), impact on family life (46.7%), sleep issues (46.7%), finances/employment (36.7%), depression (30.0%), exhaustion (30.0%), and anger (16.7%). Exploratory pairwise comparisons revealed a higher proportion of the moderate/severe/penetrating TBI group endorsed 7 of the 11 themes (no time for self/needs last. increased stress/anxiety, impact on family life, sleep issues, finances/employment, exhaustion, anger, and increased stress/anxiety) compared with the other 2 groups. Conclusions/Implications: It is important that caregivers of SMVs receive long-term support in their caregiving and parenting roles. Further work is required to understand the challenges caregivers experience in accessing services they need and how to effectively meet their needs across the care continuum.	[Brickell, Tracey A.; French, Louis M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 51,Room 1502B,4954 North Palmer Rd, Bethesda, MD 20889 USA; [Brickell, Tracey A.; French, Louis M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bldg 51,Room 1502B,4954 North Palmer Rd, Bethesda, MD 20889 USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Cotner, Bridget A.; O'Connor, Danielle R.] James A Haley Vet Hosp, Rehabil Outcomes Res Sect, Tampa, FL 33612 USA; [Cotner, Bridget A.; O'Connor, Danielle R.] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; [Cotner, Bridget A.] Univ S Florida, Dept Anthropol, Tampa, FL 33620 USA; [Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth Behav Sci, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Pulm & Sleep Med, Tampa, FL 33620 USA; [Lange, Rael T.] Univ British Columbia, Fac Med, Vancouver, BC, Canada		Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 51,Room 1502B,4954 North Palmer Rd, Bethesda, MD 20889 USA.; Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bldg 51,Room 1502B,4954 North Palmer Rd, Bethesda, MD 20889 USA.	tbrickell@dvbic.org		french, louis/0000-0002-9451-0604	Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs; National Institutes of Health (NIH) National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658]; James A. Haley Veterans' HospitalUS Department of Veterans Affairs	This material is based upon work primarily supported by the Defense and Veterans Brain Injury Center (DVBIC), with support also from the National Institutes of Health (NIH) National Institute of Nursing Research (R01NR013658) and the James A. Haley Veterans' Hospital. The authors would like to express gratitude to the caregivers for their time and commitment each year to participating in the 15-Year Longitudinal TBI Study (Sec721 NDAA FY2007) by the Defense and Veterans Brain Injury Center (DVBIC). A special thank you to the community organizations who offer their time and services to publicize the study to the caregiver community. The authors would like to acknowledge the efforts of the larger team of research managers, coordinators, associates, and assistants who contributed to the project. The views expressed in article are those of the author(s) and do not reflect the official policy of the Department of Army, Navy, Air Force, Department of Defense, Department of Veteran Affairs, or U.S. Government. The identification of specific products, scientific instrumentation, or organizations is considered an integral part of the scientific endeavor and does not constitute endorsement or implied endorsement on the part of the author, Department of Defense, or any component agency. No conflicts of interest were declared.	[Anonymous], 2013, INSTR DEV VAL SCI ST; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Brickell TA, 2019, REHABIL PSYCHOL, V64, P307, DOI 10.1037/rep0000272; Brickell TA, 2019, REHABIL PSYCHOL, V64, P72, DOI 10.1037/rep0000249; Brickell TA, 2018, BRAIN INJURY, V32, P1541, DOI 10.1080/02699052.2018.1503328; Brickell TA, 2018, CLIN CHILD PSYCHOL P, V23, P425, DOI 10.1177/1359104517740405; Brickell TA, 2018, J HEAD TRAUMA REHAB, V33, P133, DOI 10.1097/HTR.0000000000000384; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS110, DOI 10.1016/j.apmr.2018.06.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS94, DOI 10.1016/j.apmr.2018.05.021; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS102, DOI 10.1016/j.apmr.2018.05.020; Carlozzi NE, 2018, J HEAD TRAUMA REHAB, V33, P342, DOI 10.1097/HTR.0000000000000373; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catanzaro M., 1988, NURSING RES THEORY P, P437; Chandra A, 2010, J ADOLESCENT HEALTH, V46, P218, DOI 10.1016/j.jadohealth.2009.10.009; Cozza SJ, 2013, CLIN CHILD FAM PSYCH, V16, P311, DOI 10.1007/s10567-013-0141-3; Doser K, 2016, BRAIN INJURY, V30, P334, DOI 10.3109/02699052.2015.1114143; Dreer LE, 2019, ARCH PHYS MED REHAB, V100, pS76, DOI 10.1016/j.apmr.2018.12.027; Eaton KM, 2008, MIL MED, V173, P1051, DOI 10.7205/MILMED.173.11.1051; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; French L. M., 2012, NEUROPSYCHOLOGICAL A, P127; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Friedemann-Sanchez G, 2008, REHABIL NURS, V33, P206, DOI 10.1002/j.2048-7940.2008.tb00229.x; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Glaser B., 1967, DISCOVERY GROUNDED T; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Griffin J.M., 2014, MILITARY DEPLOYMENT, P259, DOI [10.1007/978-1-4614-8712-8_14, DOI 10.1007/978-1-4614-8712-8_14]; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hewitt-Taylor J, 2001, Nurs Stand, V15, P39; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; HUBERMAN AM, 2002, QUALITATIVE RES COMP, DOI DOI 10.4135/9781412986274; Iverson G. L., 2016, BRAIN INJURY MED PRI, P470; Iverson G. L., 2016, MILD TRAUMATIC BRAIN; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Kidd PS, 2000, QUAL HEALTH RES, V10, P293, DOI 10.1177/104973200129118453; Kisala Pamela A, 2010, J Appl Meas, V11, P315; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Lange R. T., J TRAUMATIC STRESS; Lange RT, 2020, NEUROPSYCHOL REHABIL, V30, P1762, DOI 10.1080/09602011.2019.1604385; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Leong P., 2010, J VIRTUAL WORLDS RES, V3, P3; Lester P, 2016, J AM ACAD CHILD PSY, V55, P14, DOI 10.1016/j.jaac.2015.10.009; Lester P, 2012, AM J PUBLIC HEALTH, V102, pS48, DOI 10.2105/AJPH.2010.300088; Lincoln Y.S., 1985, INT J INTERCULT REL, V9, P438, DOI [10.1016/0147-1767(85)90062-8, DOI 10.1016/0147-1767(85)90062-8]; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Malec JF, 2017, BRAIN INJURY, V31, P1235, DOI 10.1080/02699052.2016.1274778; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Miles M., 2020, QUALITATIVE DATA ANA, V4th ed.; Monk JK, 2017, J MARITAL FAM THER, V43, P448, DOI 10.1111/jmft.12230; Moriarty H, 2018, J FAM NURS, V24, P184, DOI 10.1177/1074840718773470; Ramchand R., 2014, HIDDEN HEROES AM MIL; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Saltzman WR, 2016, FAM PROCESS, V55, P633, DOI 10.1111/famp.12238; Stevens LF, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/185941; Tanielian T., 2013, MILITARY CAREGIVERS, DOI [10.7249/RR244, DOI 10.7249/RR244]; Van Houtven CH., 2016, SHORT TERM IMPACTS V; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; Wallace CA, 1998, BRAIN INJURY, V12, P483, DOI 10.1080/02699052.1998.11910751	68	2	2	0	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2020	65	4					377	389		10.1037/rep0000306			13	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	OW5SF	WOS:000592945400006	31971431	Green Accepted, Bronze			2022-02-06	
J	Duda, S; Meyer, L; Musienko, E; Hartig, S; Meyer, T; Fette, M; Wessling, H				Duda, Sven; Meyer, Lisa; Musienko, Eugen; Hartig, Sascha; Meyer, Tobias; Fette, Marc; Wessling, Heinrich			The Manufacturing of 3D Printed models for the Neurotraumatological Education of Military Surgeons	MILITARY MEDICINE			English	Article								Introduction When deployed abroad, military surgeons frequently have to deal with casualties involving head trauma. The emergency treatments, as well as craniotomies, are often performed by non-neurosurgeons qualified with basic neurotraumatological skills. Previous neurotrauma courses for education of non-neurosurgeons in Germany teach surgical emergency skills but do not include the training of skills needed to successfully utilize imaging in surgical planning, which is of importance for the safety and success of the treatment. To overcome these limitations, 3D printed models of neurotrauma cases were fabricated for application in the training of non-neurosurgeons. Materials and Methods Five models of actual neurotrauma cases from our neurosurgical department were segmented from CT scans and 3D printed using multi-part fused deposition modeling. Model quality was assessed with respect to the representation of predefined anatomical landmarks. The models were then fixed to a wooden mount with a central light source and covered by a latex mask for skin simulation. Surgical planning by means of craniometric measurements on the basis of available CT scans of the corresponding patients was then applied to the model. Results The 3D printed models precisely represented the cranium, the lesion, and anatomical landmarks, which are taken into consideration during surgical planning. Surface covering with washable latex masks ensured sufficient masking of the now non-noticeable lesion within the semi-translucent skull. Surgical planning was performed using washable marker drawings. When lighted, the otherwise non-visible lesion within the semi-translucent 3D printed craniums became visible and facilitated immediate success control for the course participants. Conclusion The presented method provided a way to fabricate precise 3D models of neurotrauma cases, which are suitable to teach the application of medical imaging in surgical planning. For further benefit analysis, the application of the presented education tool needs to be investigated within a neurotrauma course.	[Duda, Sven; Meyer, Lisa; Wessling, Heinrich] Hosp German Armed Forces, Dept Neurosurg, Lange Str 38, D-26655 Westerstede, Germany; [Musienko, Eugen; Hartig, Sascha; Meyer, Tobias; Fette, Marc] Helmut Schmidt Univ, Lab Mfg Technol, Univ German Armed Forces, Holstenhofweg 85, D-22043 Hamburg, Germany		Duda, S (corresponding author), Hosp German Armed Forces, Dept Neurosurg, Lange Str 38, D-26655 Westerstede, Germany.			Hartig, Sascha/0000-0003-2186-322X	German Federal Ministry of Defence [SoFo 03K8-S-13 1922]	This research was financially supported by the German Federal Ministry of Defence (SoFo 03K8-S-13 1922).	Hoencamp R, 2014, INJURY, V45, P1028, DOI 10.1016/j.injury.2014.02.012; Keene DD, 2016, J ROY ARMY MED CORPS, V162, P355, DOI 10.1136/jramc-2015-000490; Kuno J, 2017, ORTHOPADIE UNFALLCHI, V5, P24; Lichtenberger JP, 2018, MIL MED, V183, P73, DOI 10.1093/milmed/usx142; Lobel DA, 2013, NEUROSURGERY, V73, P57, DOI 10.1227/NEU.0000000000000116; Martin JA, 1997, BRIT J SURG, V84, P273, DOI 10.1046/j.1365-2168.1997.02502.x; Pieper DR, 2002, NEUROSURG FOCUS, V12, P1, DOI [10.3171/foc.2002.12.5.7, DOI 10.3171/FOC.2002.12.5.7]; Roberts SAG, 2016, BRIT J NEUROSURG, V30, P529, DOI 10.1080/02688697.2016.1208807; Schweizer MA, 2019, MILITARY MED RES, V6, DOI 10.1186/s40779-019-0197-6; Teff RJ, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1017; Willy C, 2019, UNFALLCHIRURG, V122, P418, DOI 10.1007/s00113-019-0647-3; Yiasemidou M, 2018, IRISH J MED SCI, V187, P827, DOI 10.1007/s11845-017-1704-y	12	2	2	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2020	185	11-12					E2013	E2019		10.1093/milmed/usaa183			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PQ9JH	WOS:000606857200016	33377497	Bronze			2022-02-06	
J	Elder, AJS; Nilson, CJ; Elder, CL				Elder, Amanda J. Sinclair; Nilson, Collin J.; Elder, Craig L.			Analysis of 4 Years of Injury in Professional Rodeo	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						injury frequency; injury density; injury risk; Professional Rodeo	SPORTS	Objective: To analyze injury frequency, density, location, type, mechanism of injury (MOI), activity phase of injury, and injury risk in professional rodeo. Design: Retrospective epidemiological review. Setting: Professional Rodeo Cowboys Association sanctioned rodeos from 2011 to 2014. Participants: Professional Rodeo Cowboys Association competitors competing in bull riding, bareback riding, saddle bronc riding, team roping, tie-down roping, and steer wrestling. Main Outcome Measures: Injury reports were documented by sports medicine personnel. Variables assessed include event, frequency, density, location, type, MOI, activity phase of injury, and injury density. Results: A total of 2305 injuries from 139,098 competitor exposures (CEs) were reported, demonstrating overall injury density of 16.6 injuries per 1000 CEs (95% confidence interval, 0.016-0.017) and overall risk of injury of 1.69%. Rough stock riders accounted for 88.7% of all injuries. Bull riders, bareback riders, and saddle bronc riders demonstrated injury densities of 48.2, 41.1, and 23.2 injuries per 1000 CEs, respectively. Most injuries (62.9%) were sustained by collisions with the ground or animal, or being stomped on by the animal. Contusions, sprains, and concussions were the most frequent injury types (23.1%, 13.6%, and 11.6%, respectively). Neurological components, knees, and shoulders were the most injured body parts (13.4%, 11.1%, and 11.0%, respectively). Most injuries (36.8%) occurred during or immediately after the dismount. Conclusions: Rough stock events have the greatest risk of injury in professional rodeo, whereas steer wrestling has the greatest risk of injury for timed event athletes. Medical professionals should use these findings to implement prevention programming where possible.	[Elder, Amanda J. Sinclair; Nilson, Collin J.; Elder, Craig L.] Univ Colorado Colorado Springs, Dept Hlth Sci, 1420 Austin Bluffs Pkwy, Colorado Springs, CO 80918 USA		Elder, AJS (corresponding author), Univ Colorado Colorado Springs, Dept Hlth Sci, 1420 Austin Bluffs Pkwy, Colorado Springs, CO 80918 USA.	aelder@uccs.edu					Brandenburg MA, 2007, INT SPORTMED J, V8, P78; Butterwick DJ, 2011, CLIN J SPORT MED, V21, P243, DOI 10.1097/JSM.0b013e318218acdd; Butterwick DJ, 2003, PHYSICIAN SPORTSMED, V31, P37, DOI 10.3810/psm.2003.06.407; Butterwick DJ, 2002, CLIN J SPORT MED, V12, P30, DOI 10.1097/00042752-200201000-00009; Butterwick DJ, 2002, AM J SPORT MED, V30, P193, DOI 10.1177/03635465020300020801; FLECK SJ, 1986, SPORTS MED, V3, P61, DOI 10.2165/00007256-198603010-00006; MEYERS MC, 1990, AM J SPORT MED, V18, P87, DOI 10.1177/036354659001800114; National Collegiate Athletic Association, NCAA INJ SURV SYST I; Professional Rodeo Cowboys Association, BEC PRCA COWB; Sinclair AJ, 2009, CLIN J SPORT MED, V19, P383, DOI 10.1097/JSM.0b013e3181b625e4	10	2	2	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2020	30	6					591	597		10.1097/JSM.0000000000000654			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	OP0UO	WOS:000587794700021	30169344				2022-02-06	
J	Greenslade, KJ; Stuart, JEB; Richardson, JD; Dalton, SG; Ramage, AE				Greenslade, Kathryn J.; Stuart, Jade E. B.; Richardson, Jessica D.; Dalton, Sarah Grace; Ramage, Amy E.			Macrostructural Analyses of Cinderella Narratives in a Large Nonclinical Sample	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DISCOURSE PRODUCTION; MEASURING GOODNESS; STORY NARRATIVES; MAIN CONCEPTS; ADULTS; APHASIABANK; RELIABILITY; LANGUAGE; MILD	Purpose: Macrostructural narrative analyses are important clinical measures, revealing age-related declines and disorderrelated impairments in the accuracy, completeness, logical sequencing, and organization of content. The current study aims to provide preliminary data on typical aging and psychometric evidence supporting multilevel Main Concept, Sequencing, and Story Grammar (MSSG) analyses that capture these aspects of narratives. Method: Transcripts of Cinderella narratives for 92 healthy control participants stratified across four age brackets from the online database AphasiaBank were coded by Richardson and Dalton (2016) for main concept (MC) analysis. In the current study, MSSG analyses were completed for (a) logical sequencing, independently and in combination with MC accuracy and completeness (MC + sequencing), and (b) story grammar organization (i.e., inclusion of episodic components and complexity of episodes). Interrater agreement (99%100%) revealed highly reliable scoring. Results: Descriptive statistics for the typically aging sample are presented for sequencing, MC + sequencing, total episodic components, and episodic complexity. Scores for participants over 60 years of age were lower (poorer) than scores for those 20-59 years of age, supporting the construct validity of score use for identifying age-related declines in performance. Conclusions: This study's novel MSSG analyses of narrative production efficiently assess the logical sequencing and story grammar organization of content in healthy controls. Preliminary reliability and validity evidence support the use of all scores to measure age-related changes in narrative macrostructure. Data from this typically aging sample provide a foundation for future research and clinical assessment aimed at quantifying narrative deficits in adults with communication disorders.	[Greenslade, Kathryn J.; Stuart, Jade E. B.; Ramage, Amy E.] Univ New Hampshire, Dept Commun Sci & Disorders, Durham, NH 03824 USA; [Richardson, Jessica D.] Univ New Mexico, Dept Speech & Hearing Sci, Albuquerque, NM 87131 USA; [Dalton, Sarah Grace] Marquette Univ, Dept Speech Pathol & Audiol, Milwaukee, WI 53233 USA; [Ramage, Amy E.] Univ New Hampshire, Interdisciplinary Program Neurosci & Behav, Durham, NH 03824 USA		Greenslade, KJ (corresponding author), Univ New Hampshire, Dept Commun Sci & Disorders, Durham, NH 03824 USA.	kathryn.greenslade@unh.edu	Ramage, Amy/S-9227-2018	Ramage, Amy/0000-0001-8554-555X	National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089]	J. D. Richardson's research was supported by an Institutional Development Award from the National Institute of General Medical Sciences (P20GM109089). We would like to thank Michelle LaCroix for her assistance in coding transcripts and her attention to detail and Melanie Pond for her assistance with data entry. We also thank the creators of AphasiaBank (NIDCD R01-DC008524) for developing a repository for researchers to share their data and the Capilouto, Richardson, and Wright laboratories and their participants for sharing the Cinderella transcripts used in this research.	Canfield AR, 2016, J SPEECH LANG HEAR R, V59, P533, DOI 10.1044/2015_JSLHR-L-15-0022; Cannizzaro MS, 2013, J PSYCHOLINGUIST RES, V42, P527, DOI 10.1007/s10936-012-9231-5; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Capilouto G, 2005, J COMMUN DISORD, V38, P431, DOI 10.1016/j.jcomdis.2005.03.005; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Dalton SGH, 2020, SEMIN SPEECH LANG, V41, P32, DOI 10.1055/s-0039-3400990; Elbourn E, 2019, BRAIN INJURY, V33, P143, DOI 10.1080/02699052.2018.1539246; Fergadiotis G, 2011, APHASIOLOGY, V25, P1261, DOI 10.1080/02687038.2011.606974; Forbes MM, 2012, SEMIN SPEECH LANG, V33, P217, DOI 10.1055/s-0032-1320041; Fromm D, 2017, AM J SPEECH-LANG PAT, V26, P762, DOI 10.1044/2016_AJSLP-16-0071; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; Gillam SL, 2017, COMMUN DISORD Q, V38, P96, DOI 10.1177/1525740116651442; Grimes N., 2005, WALT DISNEYS CINDERE; Hameister I, 2018, LANG COGN NEUROSCI, V33, P1296, DOI 10.1080/23273798.2018.1497801; Heilmann J, 2010, AM J SPEECH-LANG PAT, V19, P154, DOI 10.1044/1058-0360(2009/08-0024); Dalton SGH, 2019, AM J SPEECH-LANG PAT, V28, P293, DOI 10.1044/2018_AJSLP-17-0166; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kazdin A., 1982, SINGLE CASE RES DESI; Kong APH, 2009, J COMMUN DISORD, V42, P442, DOI 10.1016/j.jcomdis.2009.06.002; Kreutzer J, 2017, ENCY CLIN NEUROPSYCH, P1; Laerd Statistics, TEST NORM SPSS STAT; Le K, 2012, AM J SPEECH-LANG PAT, V21, pS115, DOI 10.1044/1058-0360(2012/11-0114); Le K, 2011, APHASIOLOGY, V25, P748, DOI 10.1080/02687038.2010.539696; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); Lindsey A, 2019, AM J SPEECH-LANG PAT, V28, P330, DOI 10.1044/2018_AJSLP-17-0151; MacWhinney B, 2011, APHASIOLOGY, V25, P1286, DOI 10.1080/02687038.2011.589893; Marini A, 2005, J PSYCHOLINGUIST RES, V34, P439, DOI 10.1007/s10936-005-6203-z; Marini A, 2017, J NEUROLINGUIST, V44, P91, DOI 10.1016/j.jneuroling.2017.03.005; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; NICHOLAS LE, 1995, J SPEECH HEAR RES, V38, P146, DOI 10.1044/jshr.3801.145; NICHOLAS LE, 1993, CLIN APHASIOL, V21, P87; Paul R., 1995, LANGUAGE DISORDERS I; Pinto TCC, 2019, INT PSYCHOGERIATR, V31, P491, DOI 10.1017/S1041610218001370; Richardson J. D., 2014, STORY GRAMMAR ANAL P; Richardson JD, 2016, APHASIOLOGY, V30, P45, DOI 10.1080/02687038.2015.1057891; ROTH FP, 1986, J SPEECH HEAR DISORD, V51, P8, DOI 10.1044/jshd.5101.08; Stark JA, 2010, APHASIOLOGY, V24, P709, DOI 10.1080/02687030903524729; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Wright HH, 2005, APHASIOLOGY, V19, P263, DOI 10.1080/02687030444000732	41	2	2	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2020	29	4					1923	1936		10.1044/2020_AJSLP-19-00151			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	OU0CU	WOS:000591205400011	32924890	Green Submitted, Green Published			2022-02-06	
J	Hanks, RA; Boileau, NR; Norman, AL; Nakase-Richardson, R; Mariouw, KH; Carlozzi, NE				Hanks, Robin A.; Boileau, Nicholas R.; Norman, Andria L.; Nakase-Richardson, Risa; Mariouw, Kyr Hudson; Carlozzi, Noelle E.			Spirituality and Outcomes in Caregivers of Persons With Traumatic Brain Injury (TBI)	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; brain injuries; caregivers; rehabilitation; spirituality	QUALITY-OF-LIFE; SOCIAL SUPPORT; HEALTH; INDIVIDUALS; FAMILY; RELATIVES; BURDEN; PREDICTORS; DEPRESSION; SATISFACTION	Purpose/Objective: Spiritual well-being has been associated with better quality of life outcomes in caregivers, but the associations among the care recipient's functional status, the caregiver's spiritual well-being. and the caregiver's health-related quality of life (HRQOL) is unknown. Research Method/ Design: The study examined the Spiritual Well-Being Scale in caregivers of persons with traumatic brain injury (TBI; n = 335). Participants completed measures from the Patient-Reported Outcomes Measurement Information System, the Quality of Life in Caregivers of TBI, and the Caregiver Appraisal Scale. The Mayo-Portland Adaptability Inventory-4 (MPAI-4) measured care recipient's functional status. The association between religious well-being and existential well-being and HRQOL were examined with Pearson correlation coefficients. Multiple linear regressions examined the interaction between caregiver well-being and care recipient functional status on HRQOL outcomes accounting for demographic variables. Results: Less favorable caregiver HRQOL was associated with military affiliation, male status. spousal caregiver relationship, and White race. MPAI-4 was moderately associated with all HRQOL subdomains. For spiritual well-being. existential well-being was moderately correlated with 9 of 16 HRQOL subdomains in comparison to religious well-being that demonstrated small correlations with 3 of 16 subdomains. MPAI-4 had negative effects on HRQOL regardless of spiritual well-being with higher existential well-being reducing the negative impact of the care recipient's functional impairment on HRQOL for significant HRQOL interactions. Conclusions/Implications: Interventions that encourage development and maintenance of life purpose and meaning, in caregivers of persons with 'FBI, and less so, spirituality, might have beneficial effects on HRQOL when the person with injury has more functional limitations.	[Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Sch Med, Detroit, MI 48201 USA; [Hanks, Robin A.; Norman, Andria L.; Mariouw, Kyr Hudson] Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Detroit, MI USA; [Boileau, Nicholas R.; Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Polytrauma Div, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Sleep & Pulm Div, Tampa, FL 33620 USA		Hanks, RA (corresponding author), ABPP, Dept Rehabil Psychol & Neuropsychol, Rehabil Inst Michigan, 261 Mack Blvd,Suite 555, Detroit, MI 48201 USA.	rhanks@wayne.edu	Boileau, Nicholas/V-4832-2019	Boileau, Nicholas/0000-0002-4056-4404	National Institutes of Health (NIH), National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; Veterans Health Administration Central Office Veterans Affairs TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015]	Work on this article was supported by Grant R01NR013658 from the National Institutes of Health (NIH), National Institute of Nursing Research. Funding from the National Center for Advancing Translational Sciences (UL1TR000433) provided support for data collection. This research is sponsored by Veterans Health Administration Central Office Veterans Affairs TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center within the Defense Health Agency. We thank the investigators and research associates/coordinators who worked on the study, the study participants, and organizations who supported recruitment efforts. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Campbell JD, 2010, J RELIG HEALTH, V49, P3, DOI 10.1007/s10943-008-9227-5; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS110, DOI 10.1016/j.apmr.2018.06.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS43, DOI 10.1016/j.apmr.2018.06.025; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS85, DOI 10.1016/j.apmr.2018.05.034; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS31, DOI 10.1016/j.apmr.2018.05.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS22, DOI 10.1016/j.apmr.2018.05.027; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS94, DOI 10.1016/j.apmr.2018.05.021; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS102, DOI 10.1016/j.apmr.2018.05.020; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Edmondson D, 2008, PSYCHO-ONCOL, V17, P161, DOI 10.1002/pon.1197; ELLISON CG, 1994, J SCI STUD RELIG, V33, P46, DOI 10.2307/1386636; ELLISON CW, 1983, J PSYCHOL THEOL, V11, P330, DOI 10.1177/009164718301100406; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; Folkman S., 1984, STRESS; Gulin SL, 2014, FAM SYST HEALTH, V32, P53, DOI 10.1037/a0032623; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kilpatrick SD, 1999, REHABIL PSYCHOL, V44, P388, DOI 10.1037/0090-5550.44.4.388; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Koenig HG., 2013, APA HDB PSYCHOL RELI, V2, P275; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Malec J., 2005, MAYO PORTLAND ADAPTA; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Nanda U, 1998, EVAL HEALTH PROF, V21, P179, DOI 10.1177/016327879802100204; Nightingale Marcie C, 2003, DEMENTIA, V2, P379, DOI DOI 10.1177/147130120; Norup A, 2013, AUST J REHABIL COUNS, V19, P71, DOI 10.1017/jrc.2013.12; Norup A, 2012, BRAIN INJURY, V26, P1192, DOI 10.3109/02699052.2012.672790; Norup A, 2011, NEUROPSYCHOL REHABIL, V21, P306, DOI 10.1080/09602011.2011.558766; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; PALOUTZIAN RF, 1982, LONELINESS SOURCEBOO, P00224; Riley BB, 1998, ARCH PHYS MED REHAB, V79, P258, DOI 10.1016/S0003-9993(98)90004-1; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; SAS Institute Inc, 2013, SAS 9 4 LANG REF CON; Shah A. A, 2001, CLIN GERONTOLOGIST, V24, P127, DOI DOI 10.1300/J018V24N03_11; Silva J, 2011, BRAIN IMPAIR, V12, P93, DOI 10.1375/brim.12.2.93; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Waldron-Perrine B, 2011, REHABIL PSYCHOL, V56, P107, DOI 10.1037/a0023552; West S. G., 1991, MULTIPLE REGRESSION	60	2	2	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2020	65	4					347	359		10.1037/rep0000304			13	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	OW5SF	WOS:000592945400004	31916806	Bronze, Green Accepted			2022-02-06	
J	He, JC; Russell, T; Qiu, XC; Hao, F; Kyle, M; Chin, L; Zhao, LR				He, Junchi; Russell, Thomas; Qiu, Xuecheng; Hao, Fei; Kyle, Michele; Chin, Lawrence; Zhao, Li-Ru			The contribution of stem cell factor and granulocyte colony-stimulating factor in reducing neurodegeneration and promoting neurostructure network reorganization after traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Stem cell factor; Granulocyte colony-stimulating factor; Neurodegeneration; Neural network reorganization; Functional recovery	HEMATOPOIETIC GROWTH-FACTORS; CONTROLLED CORTICAL IMPACT; WHITE-MATTER DAMAGE; FACTOR G-CSF; BONE-MARROW; AXON REORGANIZATION; FUNCTIONAL RECOVERY; DENTATE GYRUS; MEMORY; IMPAIRMENT	Traumatic brain injury (TBI) is a major cause of death and disability in young adults worldwide. TBI-induced long-term cognitive deficits represent a growing clinical problem. Stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF) are involved in neuroprotection and neuronal plasticity. However, the knowledge concerning reparative efficacy of SCF + G-CSF treatment in post-acute TBI recovery remains incomplete. This study aims to determine the efficacy of SCF + G-CSF on post-acute TBI recovery in young adult mice. The controlled cortical impact model of TBI was used for inducing a severe damage in the motor cortex of the right hemisphere in 8-week-old male C57BL mice. SCF + G-CSF treatment was initiated 3 weeks after induction of TBI. Severe TBI led to persistent motor functional deficits (Rota-Rod test) and impaired spatial learning function (water maze test). SCF + G-CSF treatment significantly improved the severe TBI-impaired spatial learning function 6 weeks after treatment. TBI also caused significant increases of Fluoro-Jade C positive degenerating neurons in bilateral frontal cortex, striatum and hippocampus, and significant reductions in MAP2(+) apical dendrites and overgrowth of SMI312+ axons in peri-TBI cavity frontal cortex and in the ipsilateral hippocampal CA1 at 24 weeks post-TBI. SCF + G-CSF treatment significantly reduced TBI-induced neurodegeneration in the contralateral frontal cortex and hippocampal CA1, increased MAP2(+) apical dendrites in the peri-TBI cavity frontal cortex, and prevented TBI-induced axonal overgrowth in both the peri-TBI cavity frontal cortex and ipsilateral hippocampal CA1.These findings reveal a novel pathology of axonal overgrowth after severe TBI and demonstrate a therapeutic potential of SCF + G-CSF in ameliorating severe TBI-induced long-term neuronal pathology, neurostructural network malformation, and impairments in spatial learning.	[He, Junchi; Russell, Thomas; Qiu, Xuecheng; Hao, Fei; Kyle, Michele; Chin, Lawrence; Zhao, Li-Ru] SUNY Upstate Med Univ, Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA		Zhao, LR (corresponding author), SUNY Upstate Med Univ, Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA.	ZHAOL@upstate.edu			Merit Review Award from the United States Department of Veterans Affairs Rehabilitation Research & Development Service [I01RX002125]	This study was supported by Merit Review Award (I01RX002125) from the United States Department of Veterans Affairs Rehabilitation Research & Development Service.	Alhourani A, 2016, J NEUROPHYSIOL, V116, P1840, DOI 10.1152/jn.00513.2016; Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Buckmaster PS, 1999, J NEUROPHYSIOL, V81, P712, DOI 10.1152/jn.1999.81.2.712; Buckmaster PS, 1997, J NEUROPHYSIOL, V77, P2685, DOI 10.1152/jn.1997.77.5.2685; Caracciolo L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04445-9; Carlson SW, 2018, J NEUROTRAUM, V35, P1467, DOI 10.1089/neu.2017.5374; CARNAHAN JF, 1994, J NEUROSCI, V14, P1433, DOI 10.1523/JNEUROSCI.14-03-01433.1994; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Cui LL, 2016, ASN NEURO, V8, DOI 10.1177/1759091416655010; Cui LL, 2015, EXP NEUROL, V263, P17, DOI 10.1016/j.expneurol.2014.08.026; Cui LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064684; Dhandapani KM, 2005, J NEUROCHEM, V95, P9, DOI 10.1111/j.1471-4159.2005.03319.x; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Ge XT, 2018, J NEUROSCI METH, V308, P162, DOI 10.1016/j.jneumeth.2018.07.021; Giacino JTC, 2016, REHABILITATION ACCES; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HIRATA T, 1993, DEVELOPMENT, V119, P49; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Katafuchi T, 2000, LEARN MEMORY, V7, P383, DOI 10.1101/lm.33900; Kawada H, 2006, CIRCULATION, V113, P701, DOI 10.1161/CIRCULATIONAHA.105.563668; Kerchner GA, 2012, NEUROIMAGE, V63, P194, DOI 10.1016/j.neuroimage.2012.06.048; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MCNIECE IK, 1995, J LEUKOCYTE BIOL, V58, P14, DOI 10.1002/jlb.58.1.14; Missault S, 2019, J NEUROTRAUM, V36, P768, DOI 10.1089/neu.2018.5704; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Piao Chun-Shu, 2012, Exp Transl Stroke Med, V4, P25, DOI 10.1186/2040-7378-4-25; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Qiu XC, 2020, EXP NEUROL, V330, DOI 10.1016/j.expneurol.2020.113335; Rich MC, 2016, NEUROSCI LETT, V617, P188, DOI 10.1016/j.neulet.2016.02.025; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Sehara Y, 2007, J NEUROSCI RES, V85, P2167, DOI 10.1002/jnr.21341; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Six I, 2003, EUR J PHARMACOL, V458, P327, DOI 10.1016/S0014-2999(02)02785-1; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Spratling M W, 2002, Behav Cogn Neurosci Rev, V1, P219, DOI 10.1177/1534582302001003003; Su Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075562; Toshkezi G., 2018, J NEUROSURG, P1; Toshkezi G, 2018, J NEUROSURG, V129, P1286, DOI 10.3171/2017.7.JNS17878; Toth ZE, 2008, BLOOD, V111, P5544, DOI 10.1182/blood-2007-10-119073; Tsitsopoulos PP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00599; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; Witcher K.G., 2018, GLIA; Yen TL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041100; Zhang S, 2009, J NEUROSCI RES, V87, P1135, DOI 10.1002/jnr.21941; Zhao L.R., 2018, PROG NEUROBIOL; Zhao LR, 2007, STROKE, V38, P2804, DOI 10.1161/STROKEAHA.107.486217; Zhao LR, 2007, STROKE, V38, P2584, DOI 10.1161/STROKEAHA.106.476457; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4	62	2	2	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 1	2020	1746								147000	10.1016/j.brainres.2020.147000			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NL4NJ	WOS:000567394400001	32579949				2022-02-06	
J	Hennessy, MJ; Marshman, LAG; delle Baite, L; McLellan, J				Hennessy, M. J.; Marshman, L. A. G.; delle Baite, L.; McLellan, J.			Optimizing and simplifying post-traumatic amnesia testing after moderate-severe traumatic brain injury despite common confounders in routine practice	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Post-traumatic amnesia; Opioids		The duration of post-traumatic amnesia (PTA) following traumatic brain injury (TBI) is a key diagnostic and outcome indicator. However, concerningly, different PTA paradigms record different PTA durations: some over-estimate, others under-estimate, PTA. Thus, a compromise is implied. The potential effect of in-hospital confounders including opioids is unknown. Three clinical groups were prospectively recruited. Group-1: in-patients with moderate-severe-TBI (MS-TBI), considered likely 'in-PTA'. Group- 2: patients rehabilitating after recent MS-TBI, considered 'out-of-PTA'. Group-3: orthopaedic in- patients without TBI undergoing elective surgery. Only Groups 1813 were taking opioids. All were administered the Westmead Post-traumatic Amnesia Scale (WPTAS) and the Galveston Orientation and Amnesia Test (GOAT). Results were obtained in n = 56 (Group-1:n = 18, Group-2:n = 13 and Group-3: n = 25). On WPTAS, Groups 183 scored similarly, but significantly lower than, Group-2 (chi(2) = 8.2, P = 0.017). Contrariwise, on GOAT, Group-1 scored significantly lower than Groups 2&3 (chi(2) = 23.99, P < 0.001): however, no patient scored GOAT <75. WPTAS showed moderate sensitivity (72%) but poor specificity (40%) in distinguishing Group-1 from Groups 2&3. Contrariwise, GOAT showed 100% specificity but 0% sensitivity. WPTAS 'day of week' and 'pictures' combined with GOAT 'transport medium to hospital', 'anterograde amnesia' and 'retrograde amnesia' maximized sensitivity (100%), specificity (85-88%), PPV (77-83%) and NPV (100%) in distinguishing Group-1 from Groups 2&3. Conclusions: Confounders including opioids likely affected WPTAS overall, but not GOAT specificity. A merger, whereby WPTAS sensitivity augmented GOAT specificity, was therefore sought. Favourable items from WPTAS (4/12) and GOAT (3/10) together optimized, and yet simplified, PTA testing; despite preva- lent clinical confounders. Less, not more, 'PTA' items would benefit both patients and staff alike. Crown Copyright (C) 2020 Published by Elsevier Ltd. All rights reserved.	[Hennessy, M. J.] Charles Darwin Univ, Dept Psychol, Darwin, NT 0810, Australia; [Hennessy, M. J.] James Cook Univ Singapore, Dept Psychol, Singapore 387380, Singapore; [Marshman, L. A. G.] Townsville Hosp, Dept Neurosurg, Townsville, Qld 4810, Australia; [Marshman, L. A. G.] James Cook Univ, Sch Med & Dent, Townsville, Qld 4810, Australia; [delle Baite, L.; McLellan, J.] James Cook Univ, Dept Psychol, Townsville, Qld 4810, Australia		Marshman, LAG (corresponding author), Townsville Hosp, Dept Neurosurg, Townsville, Qld 4810, Australia.	l.a.g.marshman@btinternet.com					[Anonymous], 1942, Proc R Soc Med, V35, P601; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Cohen J., 2013, STAT POWER ANAL BEHA; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marshman LAG, 2018, WORLD NEUROSURG, V110, pE830, DOI 10.1016/j.wneu.2017.11.131; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McCarter RJ, 2007, BRAIN INJURY, V21, P1393, DOI 10.1080/02699050701793793; McLellan J, 2017, J CLIN NEUROSCI, V44, P184, DOI 10.1016/j.jocn.2017.06.027; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Ross PE, 2015, ARCH PHYS MED REHAB, V96, P440, DOI 10.1016/j.apmr.2014.09.027; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Symonds CP, 1943, LANCET, V1, P7; Symonds CP, 1935, LANCET, V1, P486; Symonds CP, 1937, P ROY SOC MED, V30, P34; Symonds CP, 1935, LANCET, V226, P1217, DOI [10.1016/S0140-6736(00)47408-8, DOI 10.1016/S0140-6736(00)47408-8]; Symonds CP, INJURIES SKULL BRAIN; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tate R.L., 2000, BRAIN IMPAIR, V1, P116, DOI [10.1375/brim.1.2.116, DOI 10.1375/BRIM.1.2.116]; TEASDALE G, 1974, LANCET, V2, P81; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359	22	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2020	81						37	42		10.1016/j.jocn.2020.09.030			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PC7AG	WOS:000597149000008	33222946				2022-02-06	
J	Howell, DR; Bonnette, S; Diekfuss, JA; Grooms, DR; Myer, GD; Wilson, JC; Meehan, WP				Howell, David R.; Bonnette, Scott; Diekfuss, Jed A.; Grooms, Dustin R.; Myer, Gregory D.; Wilson, Julie C.; Meehan, William P.			Dual-Task Gait Stability after Concussion and Subsequent Injury: An Exploratory Investigation	SENSORS			English	Article						mild traumatic brain injury; adolescent; pediatric; locomotion; postural stability; inertial measurement units; accelerometers	RECURRENCE QUANTIFICATION; TANDEM GAIT; BIOFEEDBACK; RISK; ASSOCIATION; VARIABILITY; FEEDBACK; BALANCE	Persistent gait alterations can occur after concussion and may underlie future musculoskeletal injury risk. We compared dual-task gait stability measures among adolescents who did/did not sustain a subsequent injury post-concussion, and uninjured controls. Forty-seven athletes completed a dual-task gait evaluation. One year later, they reported sport-related injuries and sport participation volumes. There were three groups: concussion participants who sustained a sport-related injury (n = 8; age =15.4 +/- 3.5 years; 63% female), concussion participants who did not sustain a sport-related injury (n = 24; 14.0 +/- 2.6 years; 46% female), and controls (n = 15; 14.2 +/- 1.9 years; 53% female). Using cross-recurrence quantification, we quantified dual-task gait stability using diagonal line length, trapping time, percent determinism, and laminarity. The three groups reported similar levels of sports participation (11.8 +/- 5.8 vs. 8.6 +/- 4.4 vs. 10.9 +/- 4.3 hours/week; p = 0.37). The concussion/subsequent injury group walked slower (0.76 +/- 0.14 vs. 0.65 +/- 0.13 m/s; p = 0.008) and demonstrated higher diagonal line length (0.67 +/- 0.08 vs. 0.58 +/- 0.05; p = 0.02) and trapping time (5.3 +/- 1.5 vs. 3.8 +/- 0.6; p = 0.006) than uninjured controls. Dual-task diagonal line length (hazard ratio =1.95, 95% CI = 1.05-3.60), trapping time (hazard ratio = 1.66, 95% CI = 1.09-2.52), and walking speed (hazard ratio = 0.01, 95% CI = 0.00-0.51) were associated with subsequent injury. Dual-task gait stability measures can identify altered movement that persists despite clinical concussion recovery and is associated with future injury risk.	[Howell, David R.; Wilson, Julie C.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA; [Howell, David R.; Wilson, Julie C.] Univ Colorado Sch Med, Dept Orthoped, Aurora, CO 80045 USA; [Howell, David R.; Myer, Gregory D.; Meehan, William P.] Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA; [Bonnette, Scott; Diekfuss, Jed A.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, SPORT Ctr, Div Sports Med, Cincinnati, OH 45219 USA; [Grooms, Dustin R.] Ohio Univ, Grover Ctr, Ohio Musculoskeletal & Neurol Inst, Athens, OH 45701 USA; [Grooms, Dustin R.] Ohio Univ, Coll Hlth Sci & Profess, Grover Ctr, Sch Rehabil & Commun Sci,Div Phys Therapy, Athens, OH 45701 USA; [Grooms, Dustin R.] Ohio Univ, Coll Hlth Sci & Profess, Grover Ctr, Sch Appl Hlth Sci & Wellness,Div Athlet Training, Athens, OH 45701 USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45219 USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Orthopaed Surg, Cincinnati, OH 45219 USA; [Wilson, Julie C.] Univ Colorado, Div Pediat, Sch Med, Aurora, CO 80045 USA; [Meehan, William P.] Boston Childrens Hosp, Div Sports Med, Boston, MA 02115 USA; [Meehan, William P.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P.] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA 02115 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA.; Howell, DR (corresponding author), Univ Colorado Sch Med, Dept Orthoped, Aurora, CO 80045 USA.; Howell, DR (corresponding author), Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA.	david.howell@cuanschutz.edu; Scott.Bonnette@cchmc.org; Jed.Diekfuss@cchmc.org; groomsd@ohio.edu; Greg.Myer@cchmc.org; julie.wilson@childrenscolorado.org; william.meehan@childrens.harvard.edu	Grooms, Dustin/AAO-8917-2021; Myer, Gregory/H-6572-2016	Grooms, Dustin/0000-0001-6102-8224; Myer, Gregory/0000-0002-9983-8422; Diekfuss, Jed/0000-0003-3835-363X; Bonnette, Scott/0000-0002-4002-6286; Howell, David/0000-0002-2955-0191; Wilson, Julie/0000-0002-6834-6257	IC Design Education Center	The EDA Tool was supported by the IC Design Education Center.	Bisi MC, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0159-0; Bonnette S, 2020, NEUROSCI LETT, V729, DOI 10.1016/j.neulet.2020.134975; Bonnette S, 2018, EXP BRAIN RES, V236, P2691, DOI 10.1007/s00221-018-5328-x; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Caudron S, 2014, NEUROPHYSIOL CLIN, V44, P77, DOI 10.1016/j.neucli.2013.10.134; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Dozza M, 2005, ARCH PHYS MED REHAB, V86, P1401, DOI 10.1016/j.apmr.2004.12.036; Dozza Marco, 2005, J Neuroeng Rehabil, V2, P13, DOI 10.1186/1743-0003-2-13; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Gabbe BJ, 2003, BRIT J SPORT MED, V37, P545, DOI 10.1136/bjsm.37.6.545; Guy Jeffrey A, 2016, Prim Care Companion CNS Disord, V18, DOI 10.4088/PCC.16m01937; Howell DR, 2020, J ORTHOP SPORT PHYS, V50, P438, DOI 10.2519/jospt.2020.9133; Howell DR, 2019, J ATHL TRAINING, V54, P1254, DOI 10.4085/1062-6050-525-18; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2021, CLIN J SPORT MED, V31, P133, DOI 10.1097/JSM.0000000000000722; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2018, GAIT POSTURE, V62, P291, DOI 10.1016/j.gaitpost.2018.03.038; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kennel MB, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026209; Kiefer AW, 2015, NONLIN DYNAM PSYCHOL, V19, P489; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Labini FS, 2012, GAIT POSTURE, V35, P48, DOI 10.1016/j.gaitpost.2011.08.004; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; Marwan N, 2002, PHYS LETT A, V302, P299, DOI 10.1016/S0375-9601(02)01170-2; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Mirelman A, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-35; Oldham JR, 2020, MED SCI SPORT EXER, V52, P2279, DOI 10.1249/MSS.0000000000002385; Pataky Z, 2009, ARCH PHYS MED REHAB, V90, P1435, DOI 10.1016/j.apmr.2009.02.011; Read PJ, 2016, SPORTS MED, V46, P1059, DOI 10.1007/s40279-016-0479-z; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; Rhea C. K., 2014, GAIT BIOMETRICS BASI, P17; Riva F, 2014, COMPUT BIOL MED, V50, P9, DOI 10.1016/j.compbiomed.2014.04.001; RIZZI M, 2016, SCI REP UK; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; Shockley K, 2002, PHYS LETT A, V305, P59, DOI 10.1016/S0375-9601(02)01411-1; Soon Kok-Soon, 2011, Proceedings of the 2011 International Conference on System Science and Engineering (ICSSE), P675, DOI 10.1109/ICSSE.2011.5961988; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Valdes BA, 2017, ARCH PHYS MED REHAB, V98, P1932, DOI 10.1016/j.apmr.2017.03.034; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; White SC, 2005, ARCH PHYS MED REHAB, V86, P1958, DOI 10.1016/j.apmr.2005.04.010; Wilkerson GB, 2017, CURR SPORT MED REP, V16, P419, DOI 10.1249/JSR.0000000000000430; Zbilut JP, 1998, PHYS LETT A, V246, P122, DOI 10.1016/S0375-9601(98)00457-5	54	2	2	1	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	NOV	2020	20	21							6297	10.3390/s20216297			13	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	OR2VS	WOS:000589333600001	33167407	Green Published, gold			2022-02-06	
J	Johnson, MA; Nishijima, DK; Kuppermann, N				Johnson, M. Austin; Nishijima, Daniel K.; Kuppermann, Nathan			The Association of Glasgow Coma Scale Score With Clinically Important Traumatic Brain Injuries in Children	PEDIATRIC EMERGENCY CARE			English	Article						traumatic brain injury; brain trauma; Glasgow Coma Scale; neurosurgery	MORTALITY	Objective An accurate understanding of the incidence of clinically important traumatic brain injuries (ciTBIs) based on presenting Glasgow Coma Scale (GCS) scores in pediatric patients is required to formulate a pretest probability of disease to guide testing and treatment. Our objective was to determine the prevalence of ciTBI and neurosurgical intervention for each GCS score (range 3-15) in children presenting after blunt head trauma. Methods This was a secondary analysis of prospectively collected observational data from 25 pediatric emergency departments in the Pediatric Emergency Care Applied Research Network. Patients younger than 18 years with nontrivial blunt head injury were included. Results A total of 43,379 children with complete GCS scores were included in the analysis. Seven hundred sixty-three children had ciTBIs (1.8%) and 200 underwent neurosurgery (0.5%). Children with GCS scores of 4 had the highest incidence of ciTBI (21/22, 95.5%) and neurosurgical intervention (16/22, 72.2%). A nearly linear decrease in the prevalence of ciTBI from a GCS score of 4 to a score of 15 was observed (R = 0.92). Of 1341 children, 107 (8.0%) presenting with GCS scores of 14 were found to have ciTBIs and 17 (1.3%) underwent neurosurgical intervention. Conclusions A nearly linear relationship exists between the initial GCS score and ciTBI in children with blunt head trauma. The highest prevalence of ciTBI and neurosurgical intervention occurred in children with GCS scores of 4. Children presenting with GCS scores of 14 had a nonnegligible prevalence of ciTBI. These findings are critical to providers caring for children with blunt head trauma to accurately formulate pretest probabilities of ciTBI.	[Johnson, M. Austin; Nishijima, Daniel K.; Kuppermann, Nathan] Univ Calif Davis Hlth, Dept Emergency Med, Sacramento, CA USA		Johnson, MA (corresponding author), 4150 V St,Suite 2100, Sacramento, CA 95817 USA.	ausjohnson@ucdavis.edu			National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108964]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000002, TL1 TR000133]	M.A.J. is the recipient of a training grant from the National Heart, Lung and Blood Institute (K12HL108964). This project was partly supported by the National Center for Advancing Translational Sciences, National Institutes of Health (Grant Numbers UL1 TR000002 and TL1 TR000133).	American College of Surgeons, RESOURCES OPTIMAL CA; Amini Rachid, 2011, J Emerg Trauma Shock, V4, P12, DOI 10.4103/0974-2700.76824; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Dreyfus J, 2016, J PEDIATR SURG, V51, P1693, DOI 10.1016/j.jpedsurg.2016.04.005; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Matis G, 2008, ACTA NEUROL BELG, V108, P75; McCoy CE, 2013, WEST J EMERG MED, V14, P69, DOI 10.5811/westjem.2013.1.15981; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Sathya C, 2015, JAMA SURG, V150, P874, DOI 10.1001/jamasurg.2015.1121; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Wang NE, 2013, J TRAUMA ACUTE CARE, V75, P704, DOI 10.1097/TA.0b013e31829a0a65; Webman RB, 2016, JAMA PEDIATR, V170, P780, DOI 10.1001/jamapediatrics.2016.0805; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	16	2	2	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	NOV	2020	36	11					E610	E613		10.1097/PEC.0000000000001701			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	OR4WE	WOS:000589471800014	32484321				2022-02-06	
J	Katyal, N; Singh, I; Narula, N; Idiculla, PS; Premkumar, K; Beary, JM; Nattanmai, P; Newey, CR				Katyal, Nakul; Singh, Ishpreet; Narula, Naureen; Idiculla, Pretty Sara; Premkumar, Keerthivaas; Beary, Jonathan M.; Nattanmai, Premkumar; Newey, Christopher R.			Continuous Electroencephalography (CEEG) in Neurological Critical Care Units (NCCU): A Review	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Continuous electroencephalography (CEEG); EEG; Critical care; Nonconvulsive seizure; Intensive care	NONCONVULSIVE STATUS EPILEPTICUS; COMPRESSED SPECTRAL ARRAY; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; PERIODIC EEG PATTERNS; CARDIAC-ARREST; QUANTITATIVE EEG; THERAPEUTIC HYPOTHERMIA; PROGNOSTIC VALUE; ILL PATIENTS		[Katyal, Nakul; Singh, Ishpreet; Idiculla, Pretty Sara; Nattanmai, Premkumar] Univ Missouri, Dept Neurol, 5 Hosp Dr,CE 540, Columbia, MO USA; [Narula, Naureen] Staten Isl Univ Hosp, Dept Pulm Crit Care Med, 475 Seaview Ave, Staten Isl, NY 10305 USA; [Premkumar, Keerthivaas] Univ Missouri, Dept Biol Sci, Columbia, MO 65211 USA; [Beary, Jonathan M.] AT Still Univ, Dept Neurobehav Sci, Kirksville, MO 63501 USA; [Newey, Christopher R.] Cleveland Clin, Cerebrovasc Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA		Idiculla, PS (corresponding author), 202 Grasmere Dr, Staten Isl, NY 10305 USA.	katyal.nakul@gmail.com; ishpreet2k8@gmail.com; drnaureennarula@gmail.com; sarahidiculla.psi@gmail.com; keerthivaaspremkumar@mail.missouri.edu; Jonbeary@gmail.com; Nattanmaip@health.missouri.edu; Crnewey@gmail.com	Idiculla, Pretty Sara/AAJ-4229-2020	Idiculla, Pretty Sara/0000-0002-6563-0009; Katyal, Nakul/0000-0003-0249-1707			Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2011, NEUROCRIT CARE, V15, P70, DOI 10.1007/s12028-010-9380-z; Alvarez V, 2013, CRIT CARE, V17, DOI 10.1186/cc12879; ALVING J, 1979, ELECTROEN CLIN NEURO, V47, P95, DOI 10.1016/0013-4694(79)90036-1; Andresen JM, 2014, CRIT CARE MED, V42, P2244, DOI 10.1097/CCM.0000000000000522; Bassetti C, 1996, J NEUROL NEUROSUR PS, V61, P610, DOI 10.1136/jnnp.61.6.610; Benbadis SR, 2010, EPILEPSIA, V51, P2338, DOI 10.1111/j.1528-1167.2010.02683.x; BEREK K, 1995, STROKE, V26, P543, DOI 10.1161/01.STR.26.4.543; BERGEN DC, 1994, INT J ARTIF ORGANS, V17, P247, DOI 10.1177/039139889401700501; Berkhoff M, 2000, CLIN NEUROPHYSIOL, V111, P297, DOI 10.1016/S1388-2457(99)00246-1; Binnie C.D., 2000, BMJ-BRIT MED J, V4, P265; Boesebeck F, 2010, ACTA NEUROL SCAND, V122, P189, DOI 10.1111/j.1600-0404.2009.01287.x; Bosco E, 2011, CRIT CARE, V15, DOI 10.1186/cc10315; BRICOLO A, 1978, ELECTROEN CLIN NEURO, V45, P211, DOI 10.1016/0013-4694(78)90005-6; Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; Carrera E, 2008, ARCH NEUROL-CHICAGO, V65, P1612, DOI 10.1001/archneur.65.12.1612; Chen R, 1996, CRIT CARE MED, V24, P672, DOI 10.1097/00003246-199604000-00020; CHOKROVERTY S, 1975, NEUROLOGY, V25, P655, DOI 10.1212/WNL.25.7.655; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Cloostermans MC, 2012, CRIT CARE MED, V40, P2867, DOI 10.1097/CCM.0b013e31825b94f0; Coeytaux A, 2000, NEUROLOGY, V55, P693, DOI 10.1212/WNL.55.5.693; Crepeau AZ, 2014, RESUSCITATION, V85, P785, DOI 10.1016/j.resuscitation.2014.01.019; Crepeau AZ, 2013, NEUROLOGY, V80, P339, DOI 10.1212/WNL.0b013e31827f089d; Cronberg T, 2011, NEUROLOGY, V77, P623, DOI 10.1212/WNL.0b013e31822a276d; Daubin C, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-35; De Herdt V, 2011, NEUROLOGY, V77, P1794, DOI 10.1212/WNL.0b013e31823648a6; DeGiorgio CM, 1999, NEUROLOGY, V52, P746, DOI 10.1212/WNL.52.4.746; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Dennis LJ, 2002, NEUROSURGERY, V51, P1136, DOI 10.1097/00006123-200211000-00006; Diedler J, 2010, CEREBROVASC DIS, V29, P162, DOI 10.1159/000262313; Drislane FW, 2000, EPILEPSY BEHAV, V1, P301, DOI 10.1006/ebeh.2000.0100; Elf K, 2019, ACTA NEUROCHIR, V161, P1835, DOI 10.1007/s00701-019-03982-6; Emmady P.D., 2020, ABNORMAL WAVEFORMS; Finnigan S, 2016, CLIN NEUROPHYSIOL, V127, P1452, DOI 10.1016/j.clinph.2015.07.014; Florea B, 2017, SEIZURE-EUR J EPILEP, V48, P33, DOI 10.1016/j.seizure.2017.03.018; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; Gavvala J, 2014, EPILEPSIA, V55, P1864, DOI 10.1111/epi.12809; Gilad R., 2009, DRUGS AGING, V29, P533; Gilmore EJ, 2015, INTENS CARE MED, V41, P686, DOI 10.1007/s00134-015-3709-1; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; Helbok R, 2013, EPILEPSIA, V54, P57, DOI 10.1111/epi.12279; Hirsch L.J., 2005, JOINT ANN M AM CLIN; Hirsch Lawrence J, 2004, Am J Electroneurodiagnostic Technol, V44, P137; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; Hirsch LJ, 2004, J CLIN NEUROPHYSIOL, V21, P332; Hirsch LJ, 2004, EPILEPSIA, V45, P109, DOI 10.1111/j.0013-9580.2004.38103.x; HOCKADAY JM, 1965, ELECTROEN CLIN NEURO, V18, P575, DOI 10.1016/0013-4694(65)90075-1; Hocker S, 2016, JAMA NEUROL, V73, P1201, DOI 10.1001/jamaneurol.2016.1572; Husain AM, 2003, J NEUROL NEUROSUR PS, V74, P189, DOI 10.1136/jnnp.74.2.189; Inamasu J, 2016, J CLIN NEUROSCI, V33, P142, DOI 10.1016/j.jocn.2016.03.035; Jaitly R, 1997, J CLIN NEUROPHYSIOL, V14, P326, DOI 10.1097/00004691-199707000-00005; Jette N., 2004, EPILEPSIA, V45, P245; Jette Nathalie, 2005, Curr Neurol Neurosci Rep, V5, P312, DOI 10.1007/s11910-005-0077-1; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Johnson EL, 2018, J CLIN NEUROPHYSIOL, V35, P229, DOI 10.1097/WNP.0000000000000434; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P14, DOI 10.1097/00004691-199901000-00002; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; Kanda Paulo Afonso de Medeiros, 2009, Dement. neuropsychol., V3, P195, DOI 10.1590/S1980-57642009DN30300004; Kaplan Peter W, 2006, Am J Electroneurodiagnostic Technol, V46, P81; Kaplan PW, 2007, EPILEPSIA, V48, P39, DOI 10.1111/j.1528-1167.2007.01345.x; Karakis I, 2010, J CLIN NEUROPHYSIOL, V27, P100, DOI 10.1097/WNP.0b013e3181d649e4; Katyal N, 2017, CASE REP NEUROL MED, V2017, DOI 10.1155/2017/4742026; Kawai M, 2011, J CLIN NEUROPHYSIOL, V28, P483, DOI 10.1097/WNP.0b013e318231bfef; Kennedy J, 2013, EPILEPSIA, V54, P50, DOI 10.1111/epi.12444; Kennedy JD, 2012, CURR NEUROL NEUROSCI, V12, P419, DOI 10.1007/s11910-012-0289-0; Kilbride RD, 2009, ARCH NEUROL-CHICAGO, V66, P723, DOI 10.1001/archneurol.2009.100; Kim K, 2017, J CLIN NEUROPHYSIOL, V34, P381, DOI 10.1097/WNP.0000000000000375; Knake S, 2001, EPILEPSIA, V42, P714, DOI 10.1046/j.1528-1157.2001.01101.x; Koren J, 2015, EPILEPSY BEHAV, V49, P286, DOI 10.1016/j.yebeh.2015.04.044; Kull LL, 2005, J CLIN NEUROPHYSIOL, V22, P107, DOI 10.1097/01.WNP.0000158361.24544.2D; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; Lahti AM, 2017, NEUROLOGY, V88, P2169, DOI 10.1212/WNL.0000000000004009; Lawn ND, 2000, CLIN NEUROPHYSIOL, V111, P2125, DOI 10.1016/S1388-2457(00)00466-1; LEMMI H, 1973, J NEUROL NEUROSUR PS, V36, P997, DOI 10.1136/jnnp.36.6.997; Little AS, 2007, J NEUROSURG, V106, P805, DOI 10.3171/jns.2007.106.5.805; Lossius MI, 2005, EPILEPSIA, V46, P1246, DOI 10.1111/j.1528-1167.2005.57904.x; Mani R, 2012, J CLIN NEUROPHYSIOL, V29, P203, DOI 10.1097/WNP.0b013e3182570f83; McCoy B, 2011, EPILEPSIA, V52, P1973, DOI 10.1111/j.1528-1167.2011.03291.x; Mirski MA, 2008, CRIT CARE CLIN, V24, P115, DOI 10.1016/j.ccc.2007.11.005; MOLLER M, 1978, ACTA MED SCAND, V203, P31; MORILLO LE, 1983, ARCH NEUROL-CHICAGO, V40, P287, DOI 10.1001/archneur.1983.04050050055007; Muraja-Murro A, 2015, EPILEPSY BEHAV, V49, P245, DOI 10.1016/j.yebeh.2015.04.041; Narayanan JT, 2007, EPILEPSIA, V48, P900, DOI 10.1111/j.1528-1167.2007.01099.x; Newey CR, 2013, NEUROCRIT CARE, V18, P261, DOI 10.1007/s12028-011-9650-4; Newey C.R., 2017, UNPUB; Newey CR, 2017, J CLIN NEUROPHYSIOL, V34, P365, DOI 10.1097/WNP.0000000000000370; Newey CR, 2017, CRIT CARE RES PRACT, V2017, DOI 10.1155/2017/2504058; Newey CR, 2017, CASE REP NEUROL MED, V2017, DOI 10.1155/2017/9131579; Nitzschke R, 2011, J CLIN MONIT COMPUT, V25, P329, DOI 10.1007/s10877-011-9312-2; O'Rourke D, 2016, NEUROCRIT CARE, V24, P233, DOI 10.1007/s12028-015-0151-8; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Pandian JD, 2004, ARCH NEUROL-CHICAGO, V61, P1090, DOI 10.1001/archneur.61.7.1090; Pitkanen A, 2016, LANCET NEUROL, V15, P185, DOI 10.1016/S1474-4422(15)00248-3; PRIVITERA M, 1994, EPILEPSY RES, V18, P155, DOI 10.1016/0920-1211(94)90008-6; Rathakrishnan R, 2011, NEUROCRIT CARE, V14, P152, DOI 10.1007/s12028-010-9495-2; RIVIEREZ M, 1991, ACTA NEUROCHIR, V110, P17, DOI 10.1007/BF01402042; Rodriguez Ruiz A, 2017, JAMA NEUROL, V74, P181, DOI DOI 10.1001/jamaneurol.2016.4990; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Rossetti AO, 2012, NEUROLOGY, V78, P796, DOI 10.1212/WNL.0b013e318249f6bb; Rossetti AO, 2010, CRIT CARE, V14, DOI 10.1186/cc9276; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; ROTHSTEIN TL, 1991, ELECTROEN CLIN NEURO, V79, P101, DOI 10.1016/0013-4694(91)90046-7; Rundgren M, 2006, INTENS CARE MED, V32, P836, DOI 10.1007/s00134-006-0178-6; Rundgren M, 2010, CRIT CARE MED, V38, P1838, DOI 10.1097/CCM.0b013e3181eaa1e7; Sandroni C, 1995, Eur J Emerg Med, V2, P33, DOI 10.1097/00063110-199503000-00008; Scheuer ML, 2002, EPILEPSIA, V43, P114, DOI 10.1046/j.1528-1157.43.s.3.7.x; SCOLLOLAVIZZARI G, 1987, EUR NEUROL, V26, P161, DOI 10.1159/000116329; Shafi MM, 2012, NEUROLOGY, V79, P1796, DOI 10.1212/WNL.0b013e3182703fbc; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Sheorajpanday RVA, 2011, CLIN NEUROPHYSIOL, V122, P884, DOI 10.1016/j.clinph.2010.08.020; Sheorajpanday RVA, 2010, CLIN NEUROPHYSIOL, V121, P1719, DOI 10.1016/j.clinph.2009.10.037; SORENSEN K, 1978, J NEUROL NEUROSUR PS, V41, P840, DOI 10.1136/jnnp.41.9.840; Stecker MM, 2016, J CLIN NEUROPHYSIOL, V33, P324, DOI 10.1097/WNP.0000000000000322; Sutter R, 2013, CRIT CARE MED, V41, P1124, DOI 10.1097/CCM.0b013e318275882f; Swisher CB, 2015, J CLIN NEUROPHYSIOL, V32, P324, DOI 10.1097/WNP.0000000000000144; Synek V M, 1990, Clin Exp Neurol, V27, P99; Synek V M, 1989, Clin Exp Neurol, V26, P119; SYNEK VM, 1989, CLIN ELECTROENCEPHAL, V20, P141, DOI 10.1177/155005948902000211; Tanaka T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136200; Tiainen M, 2007, STROKE, V38, P2303, DOI 10.1161/STROKEAHA.107.483867; Tjepkema-Cloostermans MC, 2015, CRIT CARE MED, V43, P159, DOI 10.1097/CCM.0000000000000626; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; van Putten MJAM, 2004, STROKE, V35, P2489, DOI 10.1161/01.STR.0000144649.49861.1d; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; Vulliemoz S, 2009, J CLIN NEUROPHYSIOL, V26, P236, DOI 10.1097/WNP.0b013e3181af1c95; Walker MC, 2003, J NEUROL, V250, P401, DOI 10.1007/s00415-003-1042-z; Wasterlain C.G., 1993, EPILEPSIA S1, pS37; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; Wennervirta JE, 2009, CRIT CARE MED, V37, P2427, DOI 10.1097/CCM.0b013e3181a0ff84; YAMASHITA S, 1995, INTERNAL MED, V34, P71, DOI 10.2169/internalmedicine.34.71; Yoo JY, 2014, JAMA NEUROL, V71, P454, DOI 10.1001/jamaneurol.2013.6238; Young GB, 2017, HAND CLINIC, V140, P107, DOI 10.1016/B978-0-444-63600-3.00007-6; Young GB, 2009, NEUROCRIT CARE, V11, P411, DOI 10.1007/s12028-009-9248-2; Young GB, 2005, NEUROCRIT CARE, V2, P159, DOI 10.1385/NCC:2:2:159; Young GB, 1996, NEUROLOGY, V47, P83; Zacharaki Evangelia I, 2016, Brain Inform, V3, P73, DOI 10.1007/s40708-016-0044-4; Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88	151	2	2	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2020	198								106145	10.1016/j.clineuro.2020.106145			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OO4JG	WOS:000587346400033	32823186				2022-02-06	
J	Khan, DZ; Placek, MM; Smielewski, P; Budohoski, KP; Anwar, F; Hutchinson, PJA; Bance, M; Czosnyka, M; Helmy, A				Khan, Danyal Z.; Placek, Michal M.; Smielewski, Peter; Budohoski, Karol P.; Anwar, Fahim; Hutchinson, Peter J. A.; Bance, Manohar; Czosnyka, Marek; Helmy, Adel			Robotic Semi-Automated Transcranial Doppler Assessment of Cerebrovascular Autoregulation in Post-Concussion Syndrome: Methodological Considerations	NEUROTRAUMA REPORTS			English	Article						brain concussion; cerebral blood flow; cerebrovascular circulation; post-concussion syndrome; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; REACTIVITY; QUESTIONNAIRE; VALIDATION; BIOMARKERS; DIAGNOSIS; SCALE; SF-36	Post-concussion syndrome (PCS) refers to a constellation of physical, cognitive, and emotional symptoms after traumatic brain injury (TBI). Despite its incidence and impact, the underlying mechanisms of PCS are unclear. We hypothesized that impaired cerebral autoregulation (CA) is a contributor. In this article, we present our protocol for non-invasively assessing CA in patients with TBI and PCS in a real-world clinical setting. A prospective, observational study was integrated into outpatient clinics at a tertiary neurosurgical center. Data points included: demographics, symptom profile (Post-Concussion Symptom Scale [PCSS]) and neuropsychological assessment (Cambridge Neuropsychological Test Automated-Battery [CANTAB]). Cerebrovascular metrics (nMxa co-efficient and the transient hyperaemic-response ratio [THRR]) were collected using transcranial Doppler (TCD), finger plethysmography, and bespoke software (ICM+). Twelve participants were initially recruited but 2 were excluded after unsuccessful insonation of the middle cerebral artery (MCA); 10 participants (5 patients with TBI, 5 healthy controls) were included in the analysis (median age 26.5 years, male to female ratio: 7:3). Median PCSS scores were 6/126 for the TBI patient sub-groups. Median CANTAB percentiles were 78 (healthy controls) and 25 (TBI). nMxa was calculated for 90% of included patients, whereas THRR was calculated for 50%. Median study time was 127.5 min and feedback (n = 6) highlighted the perceived acceptability of the study. This pilot study has demonstrated a reproducible assessment of PCS and CA metrics (non-invasively) in a real-world setting. This protocol is feasible and is acceptable to participants. By scaling this methodology, we hope to test whether CA changes are correlated with symptomatic PCS in patients post-TBI.	[Khan, Danyal Z.; Budohoski, Karol P.; Hutchinson, Peter J. A.; Helmy, Adel] Univ Cambridge, Div Neurosurg, Cambridge CB2 0QQ, England; [Bance, Manohar] Univ Cambridge, Dept ENT, Cambridge, England; [Bance, Manohar] Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England; [Placek, Michal M.; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Dept Clin Neurosci, Brain Phys Lab, Cambridge, England; [Placek, Michal M.] Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wroclaw, Poland; [Anwar, Fahim] Cambridge Univ Hosp NHS Fdn Trust, Dept Neurorehabil, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Khan, DZ (corresponding author), Univ Cambridge, Div Neurosurg, Cambridge CB2 0QQ, England.; Khan, DZ (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England.	danyal.khan@nhs.net		Khan, Danyal Zaman/0000-0001-9213-2550	National Institute of Health Research (NIHR) Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Research Professorship; Royal College of Surgeons (RCS) of England	A.H., P.S., and M.C. are supported by the National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre. P.J.A.H. is funded by the NIHR Research Professorship and the Royal College of Surgeons (RCS) of England.	Albalawi T, 2017, J NEUROTRAUM, V34, P2700, DOI 10.1089/neu.2017.5060; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Bance ML, 1998, LARYNGOSCOPE, V108, P610, DOI 10.1097/00005537-199804000-00027; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Cambridge Cognition, CAMBR NEUR TEST AUT; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Churchill NW, 2019, J NEUROTRAUM, V36, P1518, DOI 10.1089/neu.2018.6024; COMEROTA AJ, 1995, J VASC SURG, V21, P90, DOI 10.1016/S0741-5214(95)70247-4; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Dannenbaum E, 2011, J VESTIBUL RES-EQUIL, V21, P153, DOI 10.3233/VES-2011-0412; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; GARRATT AM, 1993, BRIT MED J, V306, P1440, DOI 10.1136/bmj.306.6890.1440; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lavinio A, 2007, STROKE, V38, P402, DOI 10.1161/01.STR.0000254551.92209.5c; Lee JO, 2018, HUM BRAIN MAPP, V39, P3340, DOI 10.1002/hbm.24080; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marzo SJ, 2004, LARYNGOSCOPE, V114, P1720, DOI 10.1097/00005537-200410000-00008; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; National Institute for Health and Care Excellence, 2017, HEAD INJ ASS EARL MA; Nicoletto Heather A, 2009, Am J Electroneurodiagnostic Technol, V49, P14; Piechnik S, 1998, ACT NEUR S, V71, P269; Piechnik SK, 1999, ANESTH ANALG, V89, P944, DOI 10.1097/00000539-199910000-00023; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Serrador JM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-119; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Smielewski P, 1997, J NEUROSURG, V86, P773, DOI 10.3171/jns.1997.86.5.0773; Smielewski P, 1996, STROKE, V27, P2197, DOI 10.1161/01.STR.27.12.2197; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wijnhoud AD, 2008, ULTRASOUND MED BIOL, V34, P923, DOI 10.1016/j.ultrasmedbio.2007.11.022; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zeiler FA, 2018, CRIT ULTRASOUND J, V10, DOI 10.1186/s13089-018-0097-0; Zeiler FA, 2018, ACTA NEUROCHIR, V160, P2149, DOI 10.1007/s00701-018-3687-5	48	2	2	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	NOV 1	2020	1	1					218	231		10.1089/neur.2020.0021			14	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WU7FW	WOS:000716708100008	33274347	Green Submitted, hybrid, Green Published			2022-02-06	
J	Lang, SS; Valeri, A; Zhang, BQ; Storm, PB; Heuer, GG; Leavesley, L; Bellah, R; Kim, CT; Griffis, H; Kilbaugh, TJ; Huh, JW				Lang, Shih-Shan; Valeri, Amber; Zhang, Bingqing; Storm, Phillip B.; Heuer, Gregory G.; Leavesley, Lauren; Bellah, Richard; Kim, Chong Tae; Griffis, Heather; Kilbaugh, Todd J.; Huh, Jimmy W.			Head of bed elevation in pediatric patients with severe traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						head of bed elevation; cerebral perfusion pressure; intracranial pressure; pediatric; traumatic brain injury; trauma; neuromonitoring; neurocritical care	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; BODY POSITION; HYPERTENSION; ULTRASOUND; MANAGEMENT; VALIDITY; UPDATE; SCALE; VEINS	OBJECTIVE Head of bed (HOB) elevation to 30 degrees after severe traumatic brain injury (TBI) has become standard positioning across all age groups. This maneuver is thought to minimize the risk of elevated ICP in the hopes of decreasing cerebral blood and fluid volume and increasing cerebral venous outflow with improvement in jugular venous drainage. However, HOB elevation is based on adult population data due to a current paucity of pediatric TBI studies regarding HOB management. In this prospective study of pediatric patients with severe TBI, the authors investigated the role of different head positions on intracranial pressure (ICP), cerebral perfusion pressure (CPP), and cerebral venous outflow through the internal jugular veins (IJVs) on postinjury days 2 and 3 because these time periods are considered the peak risk for intracranial hypertension. METHODS Patients younger than <= 8 years with a Glasgow Coma Scale score 8 after severe TBI were prospectively recruited at a single quaternary pediatric intensive care unit. All patients had an ICP monitor placed, and no other neurosurgical procedure was performed. On the 2nd and 3rd days postinjury, the degree of HOB elevation was varied between 0 degrees (head-flat or horizontal), 10 degrees, 20 degrees, 30 degrees, 40 degrees, and 50 degrees while ICP, CPP, and bilateral IJV blood flows were recorded. RESULTS Eighteen pediatric patients with severe TBI were analyzed. On each postinjury day, 13 of the 18 patients had at least 1 optimal HOB position (the position that simultaneously demonstrated the lowest ICP and the highest CPP). Six patients on each postinjury day had 30 degrees as the optimal HOB position, with only 2 being the same patient on both postinjury days. On postinjury day 2, 3 patients had more than 1 optimal HOB position, while 5 patients did not have an optimal position. On postinjury day 3, 2 patients had more than 1 optimal HOB position while 5 patients did not have an optimal position. Interestingly, 0 degrees (head-flat or horizontal) was the optimal HOB position in 2 patients on postinjury day 2 and 3 patients on postinjury day 3. The optimal HOB position demonstrated lower right IJV blood flow than a nonoptimal position on both postinjury days 2 (p = 0.0023) and 3 (p = 0.0033). There was no significant difference between optimal and nonoptimal HOB positions in the left IJV blood flow. CONCLUSIONS In pediatric patients with severe TBI, the authors demonstrated that the optimal HOB position (which decreases ICP and improves CPP) is not always at 30 degrees. Instead, the optimal HOB should be individualized for each pediatric TBI patient on a daily basis.	[Lang, Shih-Shan; Storm, Phillip B.; Heuer, Gregory G.] Univ Penn, Childrens Hosp Philadelphia, Div Neurosurg, Dept Neurosurg,Perelman Sch Med, Philadelphia, PA 19104 USA; [Lang, Shih-Shan; Storm, Phillip B.; Heuer, Gregory G.] Childrens Hosp Philadelphia, Ctr Data Driven Discovery Biomed, Philadelphia, PA 19104 USA; [Valeri, Amber] Philadelphia Coll Osteopath Med, Dept Neurosurg, Philadelphia, PA USA; [Zhang, Bingqing; Griffis, Heather] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Healthcare Analyt Unit, Philadelphia, PA 19104 USA; [Leavesley, Lauren; Kilbaugh, Todd J.; Huh, Jimmy W.] Univ Penn, Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bellah, Richard] Univ Penn, Childrens Hosp Philadelphia, Dept Radiol & Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kim, Chong Tae] Univ Penn, Childrens Hosp Philadelphia, Dept Phys Med & Rehabil & Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA		Lang, SS (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	shihshan.lang@uphs.upenn.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [M01-RR00240]	This investigation was supported (in part) by the Public Health Services Research Grant M01-RR00240 from the National Institutes of Health (J.W.H.).	Adelson PD, 2003, PEDIAT CRIT CARE M S; Agbeko RS, 2012, PEDIATR CRIT CARE ME, V13, pE39, DOI 10.1097/PCC.0b013e31820ac2ad; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bos MJ, 2016, J CLIN ANESTH, V32, P65, DOI 10.1016/j.jclinane.2015.12.034; Bruce D A, 1977, Adv Pediatr, V24, P233; Cormio M, 2001, J NEUROSURG ANESTH, V13, P250, DOI 10.1097/00008506-200107000-00014; Czyzewska D, 2015, J ULTRASON, V15, P267, DOI 10.15557/JoU.2015.0023; Czyzewska D, 2015, J CLIN ANESTH, V27, P129, DOI 10.1016/j.jclinane.2014.09.010; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; DURWARD QJ, 1983, J NEUROSURG, V59, P938, DOI 10.3171/jns.1983.59.6.0938; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KENNING JA, 1981, SURG NEUROL, V15, P148, DOI 10.1016/0090-3019(81)90037-9; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LIPE HP, 1980, HEART LUNG, V9, P1031; Lovell AT, 2000, ANESTH ANALG, V90, P372, DOI 10.1097/00000539-200002000-00025; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; Meixensberger J, 1997, NEUROL RES, V19, P249, DOI 10.1080/01616412.1997.11740808; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; ROPPER AH, 1982, NEUROLOGY, V32, P1288, DOI 10.1212/WNL.32.11.1288; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; Schulz-Stubner S, 2006, EUR J ANAESTH, V23, P177, DOI 10.1017/S0265021505232118; SHAPIRO HM, 1975, ANESTHESIOLOGY, V43, P445, DOI 10.1097/00000542-197510000-00010; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Winkelman C, 2000, Am J Crit Care, V9, P373; WOISCHNECK D, 1992, J NEUROSURG, V77, P651	35	2	2	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2020	26	5					465	475		10.3171/2020.4.PEDS20102			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	OI1OU	WOS:000583057700001	32679558	Bronze			2022-02-06	
J	Park, MK; Choi, BY; Kho, AR; Lee, SH; Hong, DK; Jeong, JH; Kang, DH; Kang, BS; Suh, SW				Park, Min Kyu; Choi, Bo Young; Kho, A. Ra; Lee, Song Hee; Hong, Dae Ki; Jeong, Jeong Hyun; Kang, Dong Hyeon; Kang, Beom Seok; Suh, Sang Won			Effects of Transient Receptor Potential Cation 5 (TRPC5) Inhibitor, NU6027, on Hippocampal Neuronal Death after Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; zinc; NU6027; transient receptor potential cation channel 5; neuronal death	OXIDATIVE STRESS; ZINC; CHANNEL; CONTRIBUTES; HYPOTHERMIA; SUPEROXIDE; PREVENTION; DEFICITS; SEIZURE; RELEASE	Traumatic brain injury (TBI) can cause physical, cognitive, social, and behavioral changes that can lead to permanent disability or death. After primary brain injury, translocated free zinc can accumulate in neurons and lead to secondary events such as oxidative stress, inflammation, edema, swelling, and cognitive impairment. Under pathological conditions, such as ischemia and TBI, excessive zinc release, and accumulation occurs in neurons. Based on previous research, it hypothesized that calcium as well as zinc would be influx into the TRPC5 channel. Therefore, we hypothesized that the suppression of TRPC5 would prevent neuronal cell death by reducing the influx of zinc and calcium. To test our hypothesis, we used a TBI animal model. After the TBI, we immediately injected NU6027 (1 mg/kg, intraperitoneal), TRPC5 inhibitor, and then sacrificed animals 24 h later. We conducted Fluoro-Jade B (FJB) staining to confirm the presence of degenerating neurons in the hippocampal cornus ammonis 3 (CA3). After the TBI, the degenerating neuronal cell count was decreased in the NU6027-treated group compared with the vehicle-treated group. Our findings suggest that the suppression of TRPC5 can open a new therapeutic window for a reduction of the neuronal death that may occur after TBI.	[Park, Min Kyu; Choi, Bo Young; Kho, A. Ra; Lee, Song Hee; Hong, Dae Ki; Jeong, Jeong Hyun; Kang, Beom Seok; Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, Chunchon 24252, South Korea; [Kang, Dong Hyeon] Hallym Univ, Coll Med, Dept Med Sci, Chunchon 24252, Kangwon Do, South Korea		Suh, SW (corresponding author), Hallym Univ, Coll Med, Dept Physiol, Chunchon 24252, South Korea.	bagmingyu50@gmail.com; bychoi@hallym.ac.kr; rnlduadkfk136@hallym.ac.kr; sshlee@hallym.ac.kr; zxnm01220@gmail.com; jd1422@hanmail.net; ehdgus6312@gmail.com; ttiger1993@gmail.com; swsuh@hallym.ac.kr		Hong, Dae-Ki/0000-0003-3769-3456; Hong, Dae Ki/0000-0002-8937-1064	National Research Foundation of Korea (NRF)National Research Foundation of Korea [NRF-2019R1A2C4004912, NRF-2017M3C7A1028937, 2020R1A2C2008480]; Hallym University Research Fund [HRF-201901-008]	This study was supported by funding from the National Research Foundation of Korea (NRF; NRF-2019R1A2C4004912 to BC; NRF-2017M3C7A1028937 and 2020R1A2C2008480 to SS). This work was also supported by the Hallym University Research Fund (HRF-201901-008).	Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Alawi KM, 2017, ANN RHEUM DIS, V76, P252, DOI 10.1136/annrheumdis-2015-208886; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Arris CE, 2000, J MED CHEM, V43, P2797, DOI 10.1021/jm990628o; Bouron A, 2015, PFLUG ARCH EUR J PHY, V467, P1143, DOI 10.1007/s00424-014-1590-3; Broker-Lai J, 2017, EMBO J, V36, P2770, DOI 10.15252/embj.201696369; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Choi BY, 2019, TRANSL RES, V207, P1, DOI 10.1016/j.trsl.2019.01.002; Choi BY, 2018, BIOL PHARM BULL, V41, P1001, DOI 10.1248/bpb.b17-00937; Choi BY, 2016, AMINO ACIDS, V48, P1619, DOI 10.1007/s00726-016-2221-4; Choi BY, 2014, J TRACE ELEM MED BIO, V28, P474, DOI 10.1016/j.jtemb.2014.07.007; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; Guzman SJ, 2016, SCIENCE, V353, P1117, DOI 10.1126/science.aaf1836; He ZH, 2012, J NEUROSCI, V32, P9383, DOI 10.1523/JNEUROSCI.6363-11.2012; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hong C, 2015, BRAIN, V138, P3030, DOI 10.1093/brain/awv188; Hong DK, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120231; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Hwang JJ, 2008, J NEUROSCI, V28, P3114, DOI 10.1523/JNEUROSCI.0199-08.2008; Jagt TAV, 2009, NEUROSCIENCE, V159, P104, DOI 10.1016/j.neuroscience.2008.11.052; Kang BS, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124232; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Kho AR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051420; Kim JH, 2013, BRAIN RES, V1499, P163, DOI 10.1016/j.brainres.2013.01.007; Krishnamurthy K., 2016, TRAUMATIC BRAIN INJU; Lecona E, 2018, NAT REV CANCER, V18, P586, DOI 10.1038/s41568-018-0034-3; Lee S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-8; Lee SH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122510; Lee SH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103087; Li MS, 2017, AM J PHYSIOL-CELL PH, V312, pC47, DOI 10.1152/ajpcell.00208.2016; Ma MW, 2018, REDOX BIOL, V16, P285, DOI 10.1016/j.redox.2018.03.005; Marmarou A, 2003, ACT NEUR S, V86, P7; Noh KM, 1999, J NEUROCHEM, V72, P1609, DOI 10.1046/j.1471-4159.1999.721609.x; Noh KM, 2000, J NEUROSCI, V20; Ovesen J, 2001, BONE, V29, P565, DOI 10.1016/S8756-3282(01)00616-0; Park SE, 2019, MOL NEUROBIOL, V56, P2822, DOI 10.1007/s12035-018-1258-7; Pavlova V, 2018, ENDOCR METAB IMMUNE, V18, P502, DOI 10.2174/1871530318666180423121833; Phelan KD, 2013, MOL PHARMACOL, V83, P429, DOI 10.1124/mol.112.082271; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Roohani N, 2013, J RES MED SCI, V18, P144; Salgado VL, 2017, J PESTIC SCI, V42, P1, DOI 10.1584/jpestics.D16-104; Senzai Y, 2019, NEUROSCI RES, V140, P43, DOI 10.1016/j.neures.2018.11.003; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; Tarafdar A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123824; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Won SJ, 2012, J NEUROTRAUM, V29, P1401, DOI 10.1089/neu.2011.2228; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yauger YJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1430-7; Zheng F, 2017, ADV EXP MED BIOL, V976, P123, DOI 10.1007/978-94-024-1088-4_11; Zhu L, 2009, BRAIN RES, V1289, P96, DOI 10.1016/j.brainres.2009.07.015; Zhu YF, 2019, J BIOL CHEM, V294, P28, DOI 10.1074/jbc.RA118.005392	63	2	2	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	NOV	2020	21	21							8256	10.3390/ijms21218256			18	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	OQ7MI	WOS:000588962200001	33158109	gold, Green Published			2022-02-06	
J	Peltonen, K; Launes, J; Koskinen, S; Vartiainen, M; Pajunen, S; Pertab, J; Laitala, T; Hokkanen, L				Peltonen, Kati; Launes, Jyrki; Koskinen, Sanna; Vartiainen, Matti; Pajunen, Sara; Pertab, Jon; Laitala, Tiina; Hokkanen, Laura			On-field signs of concussion predict deficits in cognitive functioning: Loss of consciousness, amnesia, and vacant look	TRANSLATIONAL SPORTS MEDICINE			English	Article						exercise-induced damage; injury	SPORT-RELATED CONCUSSION; TEST-RETEST RELIABILITY; HIGH-SCHOOL; NEUROPSYCHOLOGICAL IMPACT; ONLINE VERSION; VIDEO ANALYSIS; RECOVERY; COLLEGIATE; EPIDEMIOLOGY; SPECIFICITY	The usefulness of on-field signs in predicting concussion outcome is under debate. We studied the prevalence of these signs and analyzed the predictive value for post-injury cognitive recovery in Finnish elite-level youth ice hockey players. Of the 570 consecutive athletes, 52 were concussed during seasons 2015-2017. After exclusion criterion analysis included 34 hockey players (14-20 years-old). Follow-up assessment was performed seven days post-injury and compared with pre-injury baseline. Cognitive performance was assessed using the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT (R)) battery. Hierarchical regression analyses were conducted to examine the relationship between on-field signs of concussion and the post-injury change in cognitive performance. The findings indicated that on-field loss of consciousness, amnesia, and vacant look were associated with larger decrements in cognition. Loss of consciousness accounted for 22% of the variance in verbal memory scores; amnesia accounted for 15% of the variance in verbal memory scores, and the presence of vacant look accounted for 9% of the variance in visual memory performance. The presence of loss of consciousness, amnesia, or vacant look is risk factors for longer recovery times and predict the need for extended cognitive follow-up.	[Peltonen, Kati; Launes, Jyrki; Koskinen, Sanna; Vartiainen, Matti; Pajunen, Sara; Hokkanen, Laura] Univ Helsinki, Dept Psychol & Logoped, POB 21, FIN-00014 Helsinki, Finland; [Pertab, Jon] Intermt Med Ctr, Neurosci Inst, Murray, UT USA; [Laitala, Tiina] Univ Turku, Inst Biomed, Turku, Finland		Peltonen, K (corresponding author), Univ Helsinki, Dept Psychol & Logoped, POB 21, FIN-00014 Helsinki, Finland.	kati.peltonen@helsinki.fi		Koskinen, Sanna/0000-0002-3453-5084	Ministry of Social Affairs and Health Finland [201510103]; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science [00190810]	The Ministry of Social Affairs and Health Finland, Grant/Award Number: 201510103; the Finnish Cultural Foundation, Grant/Award Number: 00190810	Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Echemendia RJ, 2020, ARCH CLIN NEUROPSYCH, V35, P240, DOI 10.1093/arclin/acz077; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Echlin P. S., 2010, NEUROSURG FOCUS, V29, P1, DOI DOI 10.3171/2010.9FOCUS10187; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0117-9; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0093-0; Gardner AJ, 2017, INT J SPORTS MED, V38, P71, DOI 10.1055/s-0042-116072; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Johnson LSM, 2011, CMAJ, V183, P905; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrea M, 2012, CLIN NEUROPSYCHOL, V26, P1, DOI 10.1080/13854046.2012.658678; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Peltonen K, 2019, CHILD NEUROPSYCHOL, V25, P336, DOI 10.1080/09297049.2018.1474865; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	45	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2573-8488		TRANSL SPORTS MED	Transl. Sports Med.	NOV	2020	3	6					565	573		10.1002/tsm2.179			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	RY0OW	WOS:000647615700005		Green Published, hybrid			2022-02-06	
J	Plumblee, L; Williams, R; Vane, D; Zhang, JW; Jensen, A; Naik-Mathuria, B; Evans, L; Streck, CJ				Plumblee, Leah; Williams, Regan; Vane, Dennis; Zhang, Jingwen; Jensen, Aaron; Naik-Mathuria, Bindi; Evans, Lauren; Streck, Christian J.			Isolated low-grade solid organ injuries in children following blunt abdominal trauma: Is it time to consider discharge from the emergency department?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	50th Annual Meeting of the Western-Trauma-Association	FEB 23-28, 2020	Sun Valley, ID	Western Trauma Assoc		Solid organ injury; pediatric; trauma; blunt abdominal trauma	ABBREVIATED BEDREST PROTOCOL; EVIDENCE-BASED GUIDELINES; VERY-LOW RISK; LIVER-INJURY; ISOLATED SPLEEN; NONOPERATIVE MANAGEMENT; PROSPECTIVE VALIDATION; IDENTIFYING CHILDREN	INTRODUCTION Acute intervention (AI) for solid organ injury (SOI) is rare in hemodynamically stable children. Pediatric guidelines recommend admission with follow-up laboratories, even for low-grade injuries. METHODS Data sets from two large multicenter prospective observational studies were used to analyze a cohort of children (age, <17 years) with grade I to III SOI following blunt abdominal trauma. Children with hollow viscus injuries were excluded. Patients were divided into (a) those with or without other major injuries (OMIs) (traumatic brain injury, hemothorax or pneumothorax, pelvic fracture, urgent orthopedic or neurosurgical operations) and (b) with grade I or II versus grade III injuries. Outcomes included AIs (transfusion, angiography, abdominal operation) and disposition (admission unit and length of stay). RESULTS There were 14,232 children enrolled in the two studies, and 791 patients had a SOI (5.6%). After excluding patients with hollow viscus injuries and higher-grade SOIs, 517 patients with a grade I to III SOI were included, and 262 of these had no OMI. Among patients with no OMI, none of 148 patients with grade I or II SOI underwent AI, while only 3 of 114 patients with grade III injuries underwent AI (3 transfusions/1 angioembolization). All three had hemoperitoneum; two of three had an additional organ with a grade II injury. Among grade I and II SOIs with no OMI, 28 (18.9%) of 148 were admitted to an intensive care unit, 110 (74.3%) of 148 to floor, and 7 (4.7%) of 148 discharged home from emergency department; median length of stay 2 days. Among grade III SOIs with no OMI, 38 (33.3%) of 114 were admitted to an intensive care unit and 61.4% to the floor; median length of stay was 4 days. Among 255 patients with a grade I to III SOI and other major organ system injuries, 31 (12.2%) underwent AI. CONCLUSION No patient with a grade I and II SOI and no OMI following blunt abdominal trauma received intervention, suggesting that patients with low-grade SOI without OMIs could be safely observed and discharged from the emergency department.	[Plumblee, Leah; Vane, Dennis; Zhang, Jingwen; Streck, Christian J.] Med Univ South Carolina, Dept Surg, Div Pediat Surg, Charleston, SC 29425 USA; [Williams, Regan] Univ Tennessee, Ctr Hlth Sci, Childrens Fdn Res Inst, Le Bonheur Childrens Hosp,Div Pediat Surg, Memphis, TN 38163 USA; [Jensen, Aaron] Univ Calif San Francisco, Benioff Childrens Hosp Oakland, Div Pediat Surg, Oakland, CA USA; [Naik-Mathuria, Bindi; Evans, Lauren] Baylor Coll Med, Dept Surg, Div Pediat Surg, Houston, TX 77030 USA		Plumblee, L (corresponding author), Med Univ South Carolina, Charleston, SC 29425 USA.	nunezl@musc.edu; rfwillia@uthsc.edu; vaned@musc.edu; zhajin@musc.edu; aaron.jensen@ucsf.edu; bjnaikma@texaschildrens.org; lauren.evans@ucsf.edu; streck@musc.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [LP: NIH T32 HL007260]	Research reported in this publication was supported by the National Institute of Health (LP: NIH T32 HL007260).	Acker SN, 2015, J TRAUMA ACUTE CARE, V79, P991, DOI 10.1097/TA.0000000000000791; Arbra CA, 2018, J TRAUMA ACUTE CARE, V85, P71, DOI 10.1097/TA.0000000000001933; Arbra CA, 2017, J TRAUMA ACUTE CARE, V83, P597, DOI 10.1097/TA.0000000000001533; Bond SJ, 1996, ANN SURG, V223, P286, DOI 10.1097/00000658-199603000-00009; Calder BW, 2017, J TRAUMA ACUTE CARE, V83, P218, DOI 10.1097/TA.0000000000001546; Dodgion CM, 2014, J PEDIATR SURG, V49, P1004, DOI 10.1016/j.jpedsurg.2014.01.041; Eubanks JW, 2003, J PEDIATR SURG, V38, P363, DOI 10.1053/jpsu.2003.50109; Gates RL, 2019, J PEDIATR SURG, V54, P1519, DOI 10.1016/j.jpedsurg.2019.01.012; Golden J, 2015, J TRAUMA ACUTE CARE, V79, P555, DOI 10.1097/TA.0000000000000806; Graziano KD, 2014, J PEDIATR SURG, V49, P198, DOI 10.1016/j.jpedsurg.2013.09.053; Holmes JF, 2013, ANN EMERG MED, V62, P107, DOI 10.1016/j.annemergmed.2012.11.009; Linnaus Maria E, 2017, J Trauma Acute Care Surg, V82, P672, DOI 10.1097/TA.0000000000001375; Mcvay MR, 2008, J PEDIATR SURG, V43, P1072, DOI 10.1016/j.jpedsurg.2008.02.031; Notrica DM, 2018, J PEDIATR SURG, V53, P339, DOI 10.1016/j.jpedsurg.2017.10.005; Notrica DM, 2015, J TRAUMA ACUTE CARE, V79, P683, DOI 10.1097/TA.0000000000000808; Peter SD, 2008, J PEDIATR SURG, V43, P191, DOI 10.1016/j.jpedsurg.2007.09.042; St Peter SD, 2013, J PEDIATR SURG, V48, P2437, DOI 10.1016/j.jpedsurg.2013.08.018; St Peter SD, 2011, J PEDIATR SURG, V46, P173, DOI 10.1016/j.jpedsurg.2010.09.079; Streck CJ, 2017, J AM COLL SURGEONS, V224, P449, DOI 10.1016/j.jamcollsurg.2016.12.041; Stylianos S, 2002, J PEDIATR SURG, V37, P453, DOI 10.1053/jpsu.2002.30860; Stylianos S, 2000, J PEDIATR SURG, V35, P164, DOI 10.1016/S0022-3468(00)90003-4; Vogel AM, 2019, PEDIATR SURG INT, V35, P479, DOI 10.1007/s00383-018-4417-z; Wisner DH, 2015, J TRAUMA ACUTE CARE, V79, P206, DOI 10.1097/TA.0000000000000731; Yen K, 2013, ACAD EMERG MED, V20, DOI 10.1111/acem.12132	24	2	2	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2020	89	5					887	893		10.1097/TA.0000000000002899			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	OM5WX	WOS:000586095800017	32769952				2022-02-06	
J	Roberts, AL; Taylor, HA; Whittington, AJ; Zafonte, RD; Speizer, FE; Pascual-Leone, A; Baggish, A; Weisskopf, MG				Roberts, Andrea L.; Taylor, Herman A., Jr.; Whittington, Alicia J.; Zafonte, Ross D.; Speizer, Frank E.; Pascual-Leone, Alvaro; Baggish, Aaron; Weisskopf, Marc G.			Race in association with physical and mental health among former professional American-style football players: findings from the Football Players Health Study	ANNALS OF EPIDEMIOLOGY			English	Article						Anxiety; Cognitive function; Depression; Health disparities; Pain; Physical function; Professional football; Race	QUALITY-OF-LIFE; PERCEIVED DISCRIMINATION; RECURRENT CONCUSSION; WEIGHT CHANGE; ITEM BANK; MORTALITY; BIAS; CARE; DEPRESSION; DISORDERS	Purpose: Race differences in health are pervasive in the United States. American-style football players are a racially diverse group with social status and other benefits that may reduce health disparities. Whether race disparities in health exist among former professional football players, and whether they differ by era of play, is unknown. Methods: We examined the association of self-reported race with health outcomes (e.g., physical and cognitive function, pain, depression, and anxiety), among 3747 participants in the Football Players Health Study, comprising former National Football League players who played since 1960. We conducted analyses stratified by age. Results: Black players had increased risk of all five adverse health outcomes versus white players (risk ratio range = 1.36 to 1.89). Native Hawaiians and men of other races had greater risk of all health outcomes except impaired physical functioning, compared with white players (risk ratio range = 1.25 to 1.64). No clear patterns were observed by era of play. In general, race disparities were not accounted for by health-related exposures during playing years. Adjustment for current BMI somewhat attenuated associations. Conclusions: Social and economic advantages of playing professional football did not appear to equalize race disparities in health. (C) 2020 The Authors. Published by Elsevier Inc.	[Roberts, Andrea L.; Speizer, Frank E.; Weisskopf, Marc G.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Taylor, Herman A., Jr.] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Whittington, Alicia J.] Harvard Med Sch, Football Players Hlth Study, Boston, MA 02115 USA; [Zafonte, Ross D.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Pascual-Leone, Alvaro] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Baggish, Aaron] Massachusetts Gen Hosp, Cardiovasc Performance Program, Heart Ctr, Boston, MA 02114 USA		Roberts, AL (corresponding author), Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	aroberts@hsph.harvard.edu		Whittington, Alicia/0000-0001-5075-3033; Roberts, Andrea/0000-0001-5023-4399	National Football League Players Association (NFLPA)	This work was supported by the National Football League Players Association (NFLPA). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; [Anonymous], 2020, HIDD GAM SPORTS; Barnes LL, 2008, AM J PUBLIC HEALTH, V98, P1241, DOI 10.2105/AJPH.2007.114397; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Chen JM, 2018, J EXP SOC PSYCHOL, V78, P43, DOI 10.1016/j.jesp.2018.05.002; Cozier YC, 2009, ANN EPIDEMIOL, V19, P379, DOI 10.1016/j.annepidem.2009.01.008; Dubay LC, 2012, INT J HEALTH SERV, V42, P607, DOI 10.2190/HS.42.4.c; Duru N.J., 2007, VIRGINIA SPORTS ENTE, V7, P179; Fine JT, 1999, JAMA-J AM MED ASSOC, V282, P2136, DOI 10.1001/jama.282.22.2136; Frank E, 2000, AM J PREV MED, V19, P155, DOI 10.1016/S0749-3797(00)00201-4; Gee GC, 2007, SOC SCI MED, V64, P1984, DOI 10.1016/j.socscimed.2007.02.013; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; HealthMeasures, TRANSF HLTH IS MEAS; Ho AK, 2011, J PERS SOC PSYCHOL, V100, P492, DOI 10.1037/a0021562; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Krosch AR, 2013, J EXP SOC PSYCHOL, V49, P1196, DOI 10.1016/j.jesp.2013.05.009; Lapchick R., 2015, 2015 RACIAL GENDER R; Lapchick RE, 2005, 2004 RACIAL GENDER R; LaVeist TA, 2005, J URBAN HEALTH, V82, pIII26, DOI 10.1093/jurban/jti061; Lawler T, 2012, ANN EPIDEMIOL, V22, P406, DOI 10.1016/j.annepidem.2012.04.009; Marcelin JR, 2019, J INFECT DIS, V220, pS62, DOI 10.1093/infdis/jiz214; National Football League, EL RUL; National Institute on Alcohol Abuse and Alcoholism, 2018, DRINK LEV DEF; Okifuji A, 2015, J PAIN RES, V8, P399, DOI 10.2147/JPR.S55598; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Plummer F, 2016, GEN HOSP PSYCHIAT, V39, P24, DOI 10.1016/j.genhosppsych.2015.11.005; Rohal, 2015, MULTIRACIAL AM PROUD, V98, P109; Rose M, 2008, J CLIN EPIDEMIOL, V61, P17, DOI 10.1016/j.jclinepi.2006.06.025; Shavers VL, 2012, AM J PUBLIC HEALTH, V102, P953, DOI 10.2105/AJPH.2012.300773; Weir DR., 2009, NATL FOOTBALL LEAGUE; Williams DR, 2008, AM J PUBLIC HEALTH, V98, pS29, DOI 10.2105/AJPH.98.Supplement_1.S29; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; Zafonte R, 2019, AM J IND MED, V62, P643, DOI 10.1002/ajim.22991	35	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1047-2797	1873-2585		ANN EPIDEMIOL	Ann. Epidemiol.	NOV	2020	51						48	+		10.1016/j.annepidem.2020.07.013			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	OG1TI	WOS:000581675000008	32738401	hybrid			2022-02-06	
J	Rotolo, T; Lengefeld, M				Rotolo, Thomas; Lengefeld, Michael			Clearing the cobwebs: An analysis of the timing of youth concussion legislation in US states	SOCIAL SCIENCE & MEDICINE			English	Article						Institutional medicalization; Contested illnesses; Concussion legislation; Youth sport	CHRONIC TRAUMATIC ENCEPHALOPATHY; SOCIAL-MOVEMENTS; UNITED-STATES; HEALTH; RISK; ILLNESSES; DIFFUSION; DIAGNOSIS; SYMPTOMS; HISTORY	After decades of ignoring head injury in youth sports, U.S. states passed youth concussion legislation with stipulations about when athletes can return to play. Why were some states slower to pass laws than others? We consider this question through the lens of institutional medicalization, where medically informed policies are enacted. Our study recognizes the uneven nature of policy enactment across time and space with event history methods. We explore the influence of high school sport participation and other variables on the timing of legislation in all fifty states, 2007-2014. States with more high school football participation, as well as states with a strong college football presence, passed concussion laws later. Conversely, states with stronger orientations toward gender egalitarianism adopted laws sooner. These factors reflect sources of receptivity and resistance that underlie the process of institutional medicalization. Our approach offers one of the few quantitative studies of institutional medicalization and provides a template for future quantitative research in this area.	[Rotolo, Thomas] Washington State Univ, Dept Sociol, 100 Dairy Rd, Pullman, WA 99164 USA; [Lengefeld, Michael] Goucher Coll, Ctr People Polit & Markets, Baltimore, MD 21204 USA		Rotolo, T (corresponding author), Washington State Univ, Dept Sociol, 100 Dairy Rd, Pullman, WA 99164 USA.	rotolo@wsu.edu					Allison PD, 1995, SURVIVAL ANAL USING; Bachynski K., 2019, NO GAME BOYS PLAY HI; Bachynski KE, 2018, INJURY PREV, V24, P180, DOI 10.1136/injuryprev-2017-042404; Beal, 2019, SOCIOLOGY N AM SPORT; BEST J, 1987, SOC PROBL, V34, P101, DOI 10.1525/sp.1987.34.2.03a00010; Birkland Thomas A., 1998, J PUBLIC POLICY, V18, P53, DOI 10.1017/S0143814X98000038; Brady E., 2017, US TODAY; Brandt AllanM., 2007, CIGARETTE CENTURY RI; Brown P, 2004, SOCIOL HEALTH ILL, V26, P50, DOI 10.1111/j.1467-9566.2004.00378.x; Brown P, 2012, CONTESTED ILLNESSES: CITIZENS, SCIENCE, AND HEALTH SOCIAL MOVEMENTS, P1; BROWN P, 1995, J HEALTH SOC BEHAV, V35, P34, DOI 10.2307/2626956; Brown P., 2007, TOXIC EXPOSURES CONT; Brown P., 1997, NO SAFE PLACE TOXIC; Casper ST, 2018, HEADACHE, V58, P795, DOI 10.1111/head.13288; Centers for Disease Control Prevention, 2015, IMPL RET PLAY LEARN; Chadiha J., 2009, HEED CRY TOUGH GUYS; Ciciurkaite G, 2019, PUBLIC HEALTH REP, V134, P141, DOI 10.1177/0033354918813102; Cleves M., 2008, INTRO SURVIVAL ANAL; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Conrad P, 1997, SOC PROBL, V44, P139, DOI 10.1525/sp.1997.44.2.03x0219k; CONRAD P, 1992, ANNU REV SOCIOL, V18, P209, DOI 10.1146/annurev.so.18.080192.001233; Conrad P., 2007, MED SOC TRANSFORMATI; Conrad Peter., 2010, DEVIANCE MED BADNESS; Cunningham M, 2008, SOC SCI RES, V37, P254, DOI 10.1016/j.ssresearch.2007.01.003; DIMAGGIO PJ, 1983, AM SOCIOL REV, V48, P147, DOI 10.2307/2095101; Dokshin FA, 2016, AM SOCIOL REV, V81, P921, DOI 10.1177/0003122416663929; Dumit J, 2006, SOC SCI MED, V62, P577, DOI 10.1016/j.socscimed.2005.06.018; Everson D., 2008, WALL ST J; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Finkel AM, 2019, HUM ECOL RISK ASSESS, V25, P564, DOI 10.1080/10807039.2018.1456899; Goldberg D, 2020, ROUT RES SPORT EXERC, P78; Grattet R, 1998, AM SOCIOL REV, V63, P286, DOI 10.2307/2657328; Greco M, 2012, SOC SCI MED, V75, P2362, DOI 10.1016/j.socscimed.2012.09.010; Heck J F, 1996, J Athl Train, V31, P31; HILGARTNER S, 1988, AM J SOCIOL, V94, P53, DOI 10.1086/228951; JEZIORSKI RM, 1994, IMPORTANCE SCH SPORT; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kenen RH, 1996, SOC SCI MED, V42, P1545, DOI 10.1016/0277-9536(95)00248-0; Kim S, 2017, J LEG ASP SPORT, V27, P162, DOI [10.1123/jlas. 2016-0007, DOI 10.1123/JLAS.2016-0007]; Klawiter M., 2002, HIST TECHNOL, V18, P309, DOI [10.1080/0734151022000023785, DOI 10.1080/0734151022000023785]; Kreager DA, 2007, AM SOCIOL REV, V72, P705, DOI 10.1177/000312240707200503; Kucera K.L., 2017, ANN SURVEY FOOTBALL; Legislature Nebraska, 2019, HIST NEBR UN; Loimer H, 1996, AM J PUBLIC HEALTH, V86, P101, DOI 10.2105/AJPH.86.1.101; Lowrey K.M., 2014, STATE EXPERIENCES IM; Lowrey KM., 2015, J BUS TECHNOL LAW, V10, P61; LUPTON D, 1993, INT J HEALTH SERV, V23, P425, DOI 10.2190/16AY-E2GC-DFLD-51X2; Malcolm D., 2017, SPORT MED HLTH MED S; Malcolm D., 2020, CONCUSSION CRISIS SP; Malcolm D, 2020, ROUT RES SPORT EXERC, P23; Mickool S., 2012, SEATTLE MAGAZINE; Moloney ME, 2019, SSM-POPUL HLTH, V8, DOI 10.1016/j.ssmph.2019.100388; Moore LR, 2014, SOC SCI MED, V105, P76, DOI 10.1016/j.socscimed.2014.01.009; MOST BA, 1980, AM POLIT SCI REV, V74, P932, DOI 10.2307/1954314; National Federation of High School Associations, 2020, 2018 2019 HIGH SCH A; NFL Player Health & Safety, 2016, PUSH CONC PROT ALL 5; Nixon H. L. II, 1992, Journal of Sport and Social Issues, V16, P127, DOI 10.1177/019372359201600208; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pennington B., 2017, NY TIMES; Preidt R., 2017, WHICH HIGH SCH SPORT; ROSS HL, 1984, ANNU REV SOCIOL, V10, P21; Rossi-Hansberg E., 2012, SPATIAL DIFFUSION TE; Sage G. H., 2016, SOCIOLOGY N AM SPORT; Shor E, 2017, SOC PROBL, V64, P106, DOI 10.1093/socpro/spw028; Shu XL, 2018, SOC FORCES, V96, P1243, DOI 10.1093/sf/sox090; Smith C., 2017, NEW STUDY SHOWS GIRL; Stata Corp L.L.C., 2017, STAT SURV AN REF MAN, V15; Steil JP, 2014, AM J SOCIOL, V119, P1104, DOI 10.1086/675301; Today U.S.A., 2018, TODAY US; WEED FJ, 1990, SOCIOL QUART, V31, P459, DOI 10.1111/j.1533-8525.1990.tb00339.x; WEED FJ, 1991, SOC FORCES, V69, P851, DOI 10.2307/2579478; Weinreb M., 2014, ROLLING STONE; Wilco D., 2019, COLL FOOTBALL TEAMS; YOUNG K, 1994, SOCIOL SPORT J, V11, P175, DOI 10.1123/ssj.11.2.175; Young K., 2004, SPORTING BODIES DAMA, V2; Zevestoski S, 2004, SOC SCI MED, V58, P161, DOI 10.1016/S0277-9536(03)00157-6	77	2	2	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536	1873-5347		SOC SCI MED	Soc. Sci. Med.	NOV	2020	265								113491	10.1016/j.socscimed.2020.113491			8	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	PR5VC	WOS:000607303000027	33162197				2022-02-06	
J	Schumacher, DJ; Martini, A; Sobolewski, B; Carraccio, C; Holmboe, E; Busari, J; Poynter, S; van der Vleuten, C; Lingard, L				Schumacher, Daniel J.; Martini, Abigail; Sobolewski, Brad; Carraccio, Carol; Holmboe, Eric; Busari, Jamiu; Poynter, Sue; van der Vleuten, Cees; Lingard, Lorelei			Use of Resident-Sensitive Quality Measure Data in Entrustment Decision Making: A Qualitative Study of Clinical Competency Committee Members at One Pediatric Residency	ACADEMIC MEDICINE			English	Article							IMPLEMENTATION; WORK	Purpose Resident-sensitive quality measures (RSQMs) are quality measures that are likely performed by an individual resident and are important to care quality for a given illness of interest. This study sought to explore how individual clinical competency committee (CCC) members interpret, use, and prioritize RSQMs alongside traditional assessment data when making a summative entrustment decision. Method In this constructivist grounded theory study, 19 members of the pediatric residency CCC at Cincinnati Children's Hospital Medical Center were purposively and theoretically sampled between February and July 2019. Participants were provided a deidentified resident assessment portfolio with traditional assessment data (milestone and/or entrustable professional activity ratings as well as narrative comments from 5 rotations) and RSQM performance data for 3 acute, common diagnoses in the pediatric emergency department (asthma, bronchiolitis, and closed head injury) from the emergency medicine rotation. Data collection consisted of 2 phases: ( 1) observation and think out loud while participants reviewed the portfolio and (2) semistructured interviews to probe participants' reviews. Analysis moved from close readings to coding and theme development, followed by the creation of a model illustrating theme interaction. Data collection and analysis were iterative. Results Five dimensions for how participants interpret, use, and prioritize RSQMs were identified: (1) ability to orient to RSQMs: confusing to self-explanatory, (2) propensity to use RSQMs: reluctant to enthusiastic, (3) RSQM interpretation: requires contextualization to self-evident, (4) RSQMs for assessment decisions: not sticky to sticky, and (5) expectations for residents: potentially unfair to fair to use RSQMs. The interactions among these dimensions generated 3 RSQM data user profiles: eager incorporation, willing incorporation, and disinclined incorporation. Conclusions Participants used RSQMs to varying extents in their review of resident data and found such data helpful to varying degrees, supporting the inclusion of RSQMs as resident assessment data for CCC review.	[Schumacher, Daniel J.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Schumacher, Daniel J.; Sobolewski, Brad; Poynter, Sue] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Martini, Abigail] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45226 USA; [Sobolewski, Brad; Poynter, Sue] Cincinnati Childrens Hosp Med Ctr, Pediat, Cincinnati, OH 45229 USA; [Carraccio, Carol] Amer Board Pediat Inc, Competency Based Assessment, Chapel Hill, NC USA; [Holmboe, Eric] Accreditat Council Grad Med Educ, Milestones Dev & Evaluat, Chicago, IL USA; [Busari, Jamiu] Maastricht Univ, Med Educ, Maastricht, Netherlands; [van der Vleuten, Cees] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Educ Dev & Res, Educ, Maastricht, Netherlands; [van der Vleuten, Cees] Maastricht Univ, Sch Hlth Profess Educ, Maastricht, Netherlands; [Lingard, Lorelei] Western Univ, Schulich Sch Med & Dent, Dept Med, London, ON, Canada; [Lingard, Lorelei] Western Univ, Schulich Sch Med & Dent, Ctr Educ Res & Innovat, London, ON, Canada		Schumacher, DJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45226 USA.	daniel.schumacher@cchmc.org	Busari, Jamiu/C-9425-2018	Busari, Jamiu/0000-0002-8616-5564	Division of Emergency Medicine at Cincinnati Children's Hospital Medical Center	This study was funded by the Division of Emergency Medicine at Cincinnati Children's Hospital Medical Center.	American Board of Pediatrics, ENTR PROF ACT GEN PE; Apramian T, 2018, ANN SURG, V268, P385, DOI 10.1097/SLA.0000000000002284; Arora VM, 2018, ACAD MED, V93, P833, DOI 10.1097/ACM.0000000000002209; Chahine S, 2018, ACAD MED, V93, P829, DOI 10.1097/ACM.0000000000002217; Chahine S, 2017, PERSPECT MED EDUC, V6, P192, DOI 10.1007/s40037-017-0357-x; Charmaz K., 2014, CONSTRUCTING GROUNDE, V2nd edition; Donato AA, 2016, J COMMUNITY HOSP INT, V6, DOI 10.3402/jchimp.v6.33533; French Judith C, 2014, J Surg Educ, V71, pe22, DOI 10.1016/j.jsurg.2014.04.005; Friedman KA, 2016, MED EDUC ONLINE, V21, DOI 10.3402/meo.v21.29838; Hauer Karen E, 2016, J Grad Med Educ, V8, P156, DOI 10.4300/JGME-D-15-00144.1; Hauer KE, 2015, ACAD MED, V90, P1084, DOI 10.1097/ACM.0000000000000736; Hauer Karen E, 2013, J Grad Med Educ, V5, P54, DOI 10.4300/JGME-D-12-00060.1; Hong Robert, 2015, J Grad Med Educ, V7, P496, DOI 10.4300/JGME-D-15-00131.1; Jaffe Rebecca, 2017, J Grad Med Educ, V9, P381, DOI 10.4300/JGME-D-16-00752.1; Johna Samir, 2015, Perm J, V19, P61, DOI 10.7812/TPP/15-041; Kalet AL, 2010, ACAD MED, V85, P844, DOI 10.1097/ACM.0b013e3181d734a5; Ketteler ER, 2014, J SURG EDUC, V71, P36, DOI 10.1016/j.jsurg.2013.09.012; Kinnear B, 2018, MED TEACH, V40, P1110, DOI 10.1080/0142159X.2018.1474191; Lau BD, 2015, JAMA SURG, V150, P813, DOI 10.1001/jamasurg.2015.0891; Mink RB, 2018, ACAD MED, V93, P1668, DOI 10.1097/ACM.0000000000002353; Mink RB, 2018, ACAD MED, V93, P283, DOI 10.1097/ACM.0000000000001820; Mount Cristin A, 2014, J Grad Med Educ, V6, P551, DOI 10.4300/JGME-D-13-00365.1; Nasca TJ, 2012, NEW ENGL J MED, V366, P1051, DOI 10.1056/NEJMsr1200117; Pack R, 2019, MED EDUC, V53, P723, DOI 10.1111/medu.13884; Paradis E, 2017, MED EDUC, V51, P31, DOI 10.1111/medu.13122; Pool AO, 2018, ADV HEALTH SCI EDUC, V23, P275, DOI 10.1007/s10459-017-9793-y; Promes Susan B, 2014, J Grad Med Educ, V6, P163, DOI 10.4300/JGME-D-13-00444.1; Rogers EM, 1962, DIFFUSION INNOVATION; Ross FJ, 2016, J CLIN ANESTH, V32, P17, DOI 10.1016/j.jclinane.2015.12.026; Schumacher DJ, 2020, ACAD MED, V95, P1256, DOI 10.1097/ACM.0000000000003242; Schumacher DJ, 2020, ACAD MED, V95, P1248, DOI 10.1097/ACM.0000000000003147; Schumacher DJ, 2019, ACAD PEDIATR, V19, P177, DOI 10.1016/j.acap.2018.09.013; Schumacher DJ, 2018, ACAD MED, V93, P1071, DOI 10.1097/ACM.0000000000002093; Schumacher DJ, 2018, MED TEACH, V40, P70, DOI 10.1080/0142159X.2017.1394576; Schumacher DJ, 2014, ACAD PEDIATR, V14, P436, DOI 10.1016/j.acap.2014.06.003; Shumway Nathan M, 2015, J Grad Med Educ, V7, P101, DOI 10.4300/JGME-D-14-00283.1; Sklansky DJ, 2017, MED SCI EDUC, V27, P417, DOI [10.1007/s40670-016-0363, DOI 10.1007/S40670-016-0363]; Smirnova A, 2019, ACAD MED, V94, P671, DOI 10.1097/ACM.0000000000002620; Stroud L, 2011, ACAD MED, V86, pS9, DOI 10.1097/ACM.0b013e31822a729d; Warm Eric J, 2019, J Grad Med Educ, V11, P143, DOI 10.4300/JGME-D-19-00162.1; Watling C, 2012, MED EDUC, V46, P192, DOI 10.1111/j.1365-2923.2011.04126.x; Weinstein DF, 2018, ACAD MED, V93, P975, DOI 10.1097/ACM.0000000000002244	42	2	2	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-2446	1938-808X		ACAD MED	Acad. Med.	NOV	2020	95	11					1726	1735		10.1097/ACM.0000000000003435			10	Education, Scientific Disciplines; Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Education & Educational Research; Health Care Sciences & Services	OH7GR	WOS:000582762900055	32324637	Bronze			2022-02-06	
J	Subramanian, K; Utriainen, D; Ramasamy, DP; Sethi, SK; Schweser, F; Beaver, J; Hagemeier, J; Weinstock-Guttman, B; Rajagovindan, R; Zivadinov, R; Haacke, EM				Subramanian, Karthikeyan; Utriainen, David; Ramasamy, Deepa P.; Sethi, Sean K.; Schweser, Ferdinand; Beaver, John; Hagemeier, Jesper; Weinstock-Guttman, Bianca; Rajagovindan, Rajasimhan; Zivadinov, Robert; Haacke, Ewart Mark			Longitudinal Magnetic Resonance Imaging of Cerebral Microbleeds in Multiple Sclerosis Patients	DIAGNOSTICS			English	Article						multiple sclerosis; cerebral microbleeds; susceptibility mapping; susceptibility weighted imaging	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; MRI; PREVALENCE; DISEASE	We hypothesized that cerebral microbleeds (CMBs) in multiple sclerosis (MS) patients will be detected with higher prevalence compared to healthy controls (HC) and that quantitative susceptibility mapping (QSM) will help remove false positives seen in susceptibility weighted imaging (SWI). A cohort of 100 relapsing remitting MS subjects scanned at 3T were used to validate a set of CMB detection guidelines specifically using QSM. A second longitudinal cohort of 112 MS and 25 HCs, also acquired at 3T, was reviewed across two time points. Both cohorts were imaged with SWI and fluid attenuated inversion recovery. Fourteen subjects in the first cohort (14%, 95% CI 8-21%) and twenty-one subjects in the second cohort (18.7%, 95% CI 11-27%) had at least one CMB. The combined information from SWI and QSM allowed us to discern stable CMBs and new CMBs from potential mimics and evaluate changes over time. The longitudinal results demonstrated that longer disease duration increased the chance to develop new CMBs. Higher age was also associated with increased CMB prevalence for MS and HC. We observed that MS subjects developed new CMBs between time points, indicating the need for longitudinal quantitative imaging of CMBs.	[Subramanian, Karthikeyan; Sethi, Sean K.; Haacke, Ewart Mark] Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA; [Utriainen, David; Sethi, Sean K.; Haacke, Ewart Mark] Magnet Resonance Innovat Inc, Bingham Farms, MI 48025 USA; [Utriainen, David; Sethi, Sean K.; Haacke, Ewart Mark] SpinTech Inc, Bingham Farms, MI 48025 USA; [Ramasamy, Deepa P.; Schweser, Ferdinand; Hagemeier, Jesper; Zivadinov, Robert] SUNY Buffalo, Univ Buffalo, Jacobs Sch Med & Biomed Sci, Ffalo Neuroimaging Anal Ctr,Dept Neurol, Buffalo, NY 14203 USA; [Schweser, Ferdinand; Zivadinov, Robert] SUNY Buffalo, Univ Buffalo, Clin & Translat Sci Inst, Translat Imaging Ctr, Buffalo, NY 14203 USA; [Beaver, John; Rajagovindan, Rajasimhan] Abbvie Inc, Translat Imaging, N Chicago, IL 60085 USA; [Weinstock-Guttman, Bianca] SUNY Buffalo, Univ Buffalo, Jacobs Sch Med & Biomed Sci, Jacobs Multiple Sclerosis Ctr,Dept Neurol, Buffalo, NY 14202 USA		Subramanian, K (corresponding author), Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA.	karthik.mri@wayne.edu; david@spintechimaging.com; dramasamy@bnac.net; sethisea@wayne.edu; schweser@buffalo.edu; john.beaver@abbvie.com; jhagemeier@bnac.net; BWeinstockGuttman@kaleidahealth.org; rajasimhan@gmail.com; rzivadinov@bnac.net; nmrimaging@aol.com	Schweser, Ferdinand/Q-6932-2019	Schweser, Ferdinand/0000-0003-0399-9211	AbbVie, Inc.AbbVie; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]	This study was funded by AbbVie, Inc. Cohort 2 was funded by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR001412. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Ayaz M, 2010, J MAGN RESON IMAGING, V31, P142, DOI 10.1002/jmri.22001; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Buch S, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3551; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Cordonnier C, 2006, NEUROLOGY, V66, P1356, DOI 10.1212/01.wnl.0000210535.20297.ae; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Cordonnier C, 2011, BRAIN, V134, P335, DOI 10.1093/brain/awq321; Eisele P, 2016, MULT SCLER RELAT DIS, V7, P61, DOI 10.1016/j.msard.2016.03.010; Fan YH, 2003, STROKE, V34, P2459, DOI 10.1161/01.STR.0000090841.90286.81; Goos JDC, 2010, NEUROLOGY, V74, P1954, DOI 10.1212/WNL.0b013e3181e396ea; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregoire SM, 2012, CEREBROVASC DIS, V33, P430, DOI 10.1159/000336237; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Gregoire SM, 2010, STROKE, V41, P184, DOI 10.1161/STROKEAHA.109.568469; Haacke EM, 2007, AM J NEURORADIOL, V28, P316; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Haller S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167743; Ham JH, 2014, J NEUROL, V261, P1628, DOI 10.1007/s00415-014-7403-y; Jeerakathil T, 2004, STROKE, V35, P1831, DOI 10.1161/01.STR.0000131809.35202.1b; Jeon SB, 2014, NEUROSURGERY, V74, P176, DOI 10.1227/NEU.0000000000000244; Kato H, 2002, STROKE, V33, P1536, DOI 10.1161/01.STR.0000018012.65108.86; Lee SH, 2009, NEUROLOGY, V72, P171, DOI 10.1212/01.wnl.0000339060.11702.dd; Liu SF, 2019, NEUROIMAGE, V198, P271, DOI 10.1016/j.neuroimage.2019.05.046; Lupo JM, 2012, INT J RADIAT ONCOL, V82, pE493, DOI 10.1016/j.ijrobp.2011.05.046; Marrie RA, 2010, NEUROLOGY, V74, P1041, DOI 10.1212/WNL.0b013e3181d6b125; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Pacurar EE, 2016, NEUROIMAGE, V124, P1220, DOI 10.1016/j.neuroimage.2015.04.066; Poels MMF, 2011, STROKE, V42, P656, DOI 10.1161/STROKEAHA.110.607184; Roob G, 1999, NEUROLOGY, V52, P991, DOI 10.1212/WNL.52.5.991; Shoamanesh A, 2011, CEREBROVASC DIS, V32, P528, DOI 10.1159/000331466; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Tang J, 2013, MAGN RESON MED, V69, P1396, DOI 10.1002/mrm.24384; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Tsushima Y, 2002, NEURORADIOLOGY, V44, P31, DOI 10.1007/s002340100649; Van der Flier WM, 2012, EXP GERONTOL, V47, P853, DOI 10.1016/j.exger.2012.07.007; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Williams R, 2012, J NEUROCHEM, V120, P7, DOI 10.1111/j.1471-4159.2011.07536.x; Zivadinov R, 2016, RADIOLOGY, V281, P884, DOI 10.1148/radiol.2016160060	41	2	2	2	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	NOV	2020	10	11							942	10.3390/diagnostics10110942			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OW4IU	WOS:000592853300001	33198313	gold, Green Published			2022-02-06	
J	Sun, ZY; Wu, L; Liu, ZX; Zhong, WM; Kou, ZF; Liu, JF				Sun, Zhongyi; Wu, Lin; Liu, Zhixiong; Zhong, Weiming; Kou, Zhifeng; Liu, Jinfang			Optimizing accuracy of freehand cannulation of the ipsilateral ventricle for intracranial pressure monitoring in patients with brain trauma	QUANTITATIVE IMAGING IN MEDICINE AND SURGERY			English	Article						Traumatic brain injury (TBI); intracranial pressure (ICP); ventricular cannulation; surgical simulation	DRAIN PLACEMENT; VENTRICULOSTOMY PLACEMENT; HEMORRHAGIC COMPLICATIONS; CATHETER PLACEMENT; CT; NEURONAVIGATION; EFFICACY; TRAJECTORIES; GUIDELINES; MANAGEMENT	Background: Intracranial pressure (ICP) monitoring in traumatic brain injury (TBI) usually requires the placement of a catheter into the ipsilateral ventricle. This surgical procedure is commonly performed via a freehand method using surface anatomical landmarks as guides. The current accuracy of the catheter placement remains relatively low and even lower among TBI patients. This study was undertaken to optimize the freehand ventricular cannulation to increase the accuracy for TBI. The authors hypothesized that an optimal surgical plan of cannulation should give an operator the greatest degrees of freedom, which could be measured as the range of operation angle, range of catheter placement depth, and size of the target area. Methods: An imaging simulation was first performed using the computed tomography (CT) images of 47 adult patients with normal brain anatomy. On the reconstructed 3D head model, four different coronal planes of ventricular cannulation were identified: a 4-cm anterior, a 2-cm anterior, a standard (central), and a 2-cm posterior plane. The degrees of freedom during the cannulation procedure were determined, including the relevant angles, lengths of cannulation, cross-sectional area, and bounding rectangle of the lateral ventricle. Next, a retrospective assessment was performed on the CT scans of another 111 patients with TBI who underwent freehand ventricular cannulation for ICP monitoring. Postoperative measurements were also performed based on CT images to calculate the accuracy and safety of catheter placement between coronal planes in practice. Results: Our simulation results showed that the 2-cm anterior plane had more extensive degrees of freedom for ventricular cannulation, in terms of length of catheter trajectory (7% longer, P<0.001), crosssectional area of the lateral ventricle (14% larger, P=0.046), and length of the lateral ventricle (17% wider, P<0.001) than that of the standard plane, while both the 4-cm anterior and 2-cm posterior planes did not offer advantages over the standard plane in these ways. The mean length range of catheter trajectory in the 2-cm anterior plane was 41 to 58 mm. Retrospective assessment of TBI patients with ICP monitor placement also confirmed our simulation data. It showed that the accuracy of ipsilateral ventricle cannulation in the 2-cm anterior plane was 70.6%, which was a significant increase from 42.9% in the standard plane (P=0.007). Conclusions: Our imaging simulation and retrospective study demonstrate that different coronal planes could provide different degrees of freedom for cannulation, the 2-cm anterior plane has the greatest degrees of freedom in terms of larger target area and greater length range of the trajectory. The optimized surgical plan in this manner could improve cannulation accuracy and benefit a significant number of TBI patients.	[Sun, Zhongyi; Liu, Zhixiong; Zhong, Weiming; Liu, Jinfang] Cent South Univ, Xiangya Hosp, Dept Neurosurg, 87 Xiangya St, Changsha 410008, Peoples R China; [Wu, Lin] Wayne State Univ, Dept Ophthalmol & Anat & Cell Biol, Detroit, MI USA; [Kou, Zhifeng] Wayne State Univ, Dept Biomed Engn, 818 W Hancock St, Detroit, MI 48201 USA; [Kou, Zhifeng] Wayne State Univ, Dept Radiol, 818 W Hancock St, Detroit, MI 48201 USA		Liu, JF (corresponding author), Cent South Univ, Xiangya Hosp, Dept Neurosurg, 87 Xiangya St, Changsha 410008, Peoples R China.; Kou, ZF (corresponding author), Wayne State Univ, Dept Biomed Engn, 818 W Hancock St, Detroit, MI 48201 USA.; Kou, ZF (corresponding author), Wayne State Univ, Dept Radiol, 818 W Hancock St, Detroit, MI 48201 USA.	zhifeng_kou@wayne.edu; jinfang_liu@csu.edu.cn			Xiangya medical big data Foundation	The research was supported by a grant from the Xiangya medical big data Foundation.	Abdoh MG, 2012, ACTA NEUROCHIR, V154, P153, DOI 10.1007/s00701-011-1136-9; AlAzri A, 2017, ACTA NEUROCHIR, V159, P1399, DOI 10.1007/s00701-017-3201-5; Ann JM, 2016, J KOREAN NEUROSURG S, V59, P322, DOI 10.3340/jkns.2016.59.3.322; Bauer DF, 2011, NEUROSURGERY, V69, P255, DOI 10.1227/NEU.0b013e31821a45ba; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; BOGDAHN U, 1992, NEUROSURGERY, V31, P898, DOI 10.1227/00006123-199211000-00011; Brean A, 2006, J Clin Monit Comput, V20, P411, DOI 10.1007/s10877-006-9047-7; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cinalli G, 2005, EXPERT REV MED DEVIC, V2, P351, DOI 10.1586/17434440.2.3.351; Dupont S, 2013, NEUROL RES, V35, P103, DOI 10.1179/1743132812Y.0000000121; Ehtisham A, 2009, NEUROCRIT CARE, V10, P241, DOI 10.1007/s12028-008-9097-4; Fichtner J, 2018, WORLD NEUROSURG, V109, pE24, DOI 10.1016/j.wneu.2017.09.091; Fiorella D, 2014, J NEUROINTERV SURG, V6, P457, DOI 10.1136/neurintsurg-2013-010856; Foreman PM, 2015, CLIN NEUROL NEUROSUR, V128, P94, DOI 10.1016/j.clineuro.2014.09.026; Ganau M, 2019, QUANT IMAG MED SURG, V9, P350, DOI 10.21037/qims.2019.03.06; Hayhurst C, 2010, J NEUROSURG, V113, P1273, DOI 10.3171/2010.3.JNS091237; Hsieh CT, 2011, ACTA NEUROL BELG, V111, P22; Huyette DR, 2008, J NEUROSURG, V108, P88, DOI 10.3171/JNS/2008/108/01/0088; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Kirkman MA, 2017, J NEUROSURG, V126, P304, DOI 10.3171/2016.1.JNS152263; Krotz M, 2004, EUR RADIOL, V14, P227, DOI 10.1007/s00330-003-2134-y; Lind CRP, 2008, J CLIN NEUROSCI, V15, P886, DOI 10.1016/j.jocn.2007.05.013; Liu H, 2015, WORLD NEUROSURG, V83, P794, DOI 10.1016/j.wneu.2014.12.040; Lollis SS, 2008, J NEUROSURG, V108, P269, DOI 10.3171/JNS/2008/108/2/0269; Muirhead WR, 2012, BRIT J NEUROSURG, V26, P710, DOI 10.3109/02688697.2012.671973; Nowacki A, 2018, OPER NEUROSURG, V15, P66, DOI 10.1093/ons/opx175; O'Leary ST, 2000, J NEUROSURG, V92, P801, DOI 10.3171/jns.2000.92.5.0801; O'Neill BR, 2008, SURG NEUROL, V70, P268, DOI 10.1016/j.surneu.2007.05.007; PARAMORE CG, 1994, ACTA NEUROCHIR, V127, P79, DOI 10.1007/BF01808552; Patil V, 2015, STEREOT FUNCT NEUROS, V93, P50, DOI 10.1159/000368906; Raabe C, 2018, J NEUROSURG, V128, P1250, DOI 10.3171/2016.11.JNS161765; Rehman T, 2013, WORLD NEUROSURG, V80, P173, DOI 10.1016/j.wneu.2012.12.012; Robertson FC, 2017, J NEUROSURG, V127, P532, DOI 10.3171/2016.8.JNS16538; Sabarudin A, 2014, QUANT IMAGING MED SU, V4, P282, DOI 10.3978/j.issn.2223-4292.2014.07.10; Saladino A, 2009, NEUROCRIT CARE, V10, P248, DOI 10.1007/s12028-008-9154-z; Sarrafzadeh A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-478; Srinivasan VM, 2014, J NEUROSURG, V120, P228, DOI 10.3171/2013.6.JNS121577; Theodosopoulos PV, 2001, CAN J NEUROL SCI, V28, P56; Toma AK, 2009, NEUROSURGERY, V65, P1197, DOI 10.1227/01.NEU.0000356973.39913.0B; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Wang DF, 2015, QUANT IMAG MED SURG, V5, P640, DOI 10.3978/j.issn.2223-4292.2015.10.03; Wilson MP, 2019, J NEUROSURG, V130, P1692, DOI 10.3171/2018.2.JNS172962; Woernle CM, 2011, NEUROL MED-CHIR, V51, P180, DOI 10.2176/nmc.51.180; Woo H, 2013, J CLIN NEUROSCI, V20, P1754, DOI 10.1016/j.jocn.2013.01.025; Zhang Z, 2019, CURR OPIN ANESTHESIO, V32, P568, DOI 10.1097/ACO.0000000000000764	46	2	2	1	2	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2223-4292	2223-4306		QUANT IMAG MED SURG	Quant. Imaging Med. Surg.	NOV	2020	10	11					2144	2156		10.21037/qims-20-128			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	NT7GS	WOS:000573105100007	33139994	Green Published, gold			2022-02-06	
J	Witcher, KG; Dziabis, JE; Bray, CE; Gordillo, AJ; Kumar, JE; Eiferman, DS; Godbout, JP; Kokiko-Cochran, ON				Witcher, Kristina G.; Dziabis, Julia E.; Bray, Chelsea E.; Gordillo, Alan J.; Kumar, Julia E.; Eiferman, Daniel S.; Godbout, Jonathan P.; Kokiko-Cochran, Olga N.			Comparison between midline and lateral fluid percussion injury in mice reveals prolonged but divergent cortical neuroinflammation	BRAIN RESEARCH			English	Article						Traumatic brain injury; Fluid percussion injury; Neuroinflammation; Microglia	TRAUMATIC BRAIN-INJURY; MODEL; ACTIVATION; DISRUPTION	Animal models are critical for determining the mechanisms mediating traumatic brain injury-induced (TBI) neuropathology. Fluid percussion injury (FPI) is a widely used model of brain injury typically applied either midline or parasagittally (lateral). Midline FPI induces a diffuse TBI, while lateral FPI induces both focal cortical injury (ipsilateral hemisphere) and diffuse injury (contralateral hemisphere). Nonetheless, discrete differences in neuroinflammation and neuropathology between these two versions of FPI remain unclear. The purpose of this study was to compare acute (4-72 h) and subacute (7 days) neuroinflammatory responses between midline and lateral FPI. Midline FPI resulted in longer righting reflex times than lateral FPI. At acute time points, the inflammatory responses to the two different injuries were similar. For instance, there was evidence of monocytes and cytokine mRNA expression in the brain with both injuries acutely. Midline FPI had the highest proportion of brain monocytes and highest IL-1 beta/TNF alpha mRNA expression 24 h later. NanoString nCounter analysis 7 days post-injury revealed robust and prolonged expression of inflammatory-related genes in the cortex after midline FPI compared to lateral FPI; however, Iba-1 cortical immunoreactivity was increased with lateral FPI. Thus, midline and lateral FPI caused similar cortical neuroinflammatory responses acutely and mRNA expression of inflammatory genes was detectable in the brain 7 days later. The primary divergence was that inflammatory gene expression was greater and more diverse subacutely after midline FPI. These results provide novel insight to variations between midline and lateral FPI, which may recapitulate unique temporal pathogenesis.	[Witcher, Kristina G.; Dziabis, Julia E.; Bray, Chelsea E.; Gordillo, Alan J.; Kumar, Julia E.; Godbout, Jonathan P.; Kokiko-Cochran, Olga N.] Ohio State Univ, Dept Neurosci, 333 W 10th Ave, Columbus, OH 43210 USA; [Eiferman, Daniel S.] Ohio State Univ, Dept Surg, 395 W 12th Ave, Columbus, OH 43210 USA; [Godbout, Jonathan P.; Kokiko-Cochran, Olga N.] Ohio State Univ, Ctr Brain & Spinal Cord Repair, 460 W 12th Ave, Columbus, OH 43210 USA; [Witcher, Kristina G.; Dziabis, Julia E.; Bray, Chelsea E.; Gordillo, Alan J.; Kumar, Julia E.; Godbout, Jonathan P.; Kokiko-Cochran, Olga N.] Ohio State Univ, Inst Behav Med Res, 460 Med Ctr Dr, Columbus, OH 43210 USA		Kokiko-Cochran, ON (corresponding author), Ohio State Univ, 257 IBMR Bldg,460 Med Ctr Dr, Columbus, OH 43210 USA.	Olga.Kokiko-Cochran@osumc.edu		Horwood, Chelsea/0000-0002-4838-3536	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56-NS-090311]; College of Medicine Dean's Discovery Grant from the OSU Center for Brain and Spinal Cord Repair; Chronic Brain Injury Pilot Award; P30 Core grant [NINDS P30-NS-045758]; National Institute of Dental and Craniofacial Research Training Grant [T32-DE-01-4320]; Ohio State University Presidential FellowshipOhio State University; Ohio State's Secondyear Transformational Experience Program Fellowship	This research was supported by an NINDS R56-NS-090311 (to JPG), a College of Medicine Dean's Discovery Grant (to JPG), funding from the OSU Center for Brain and Spinal Cord Repair (to JPG), and a Chronic Brain Injury Pilot Award (to OKC). In addition, this work was supported by a P30 Core grant (NINDS P30-NS-045758). KGW was supported by a National Institute of Dental and Craniofacial Research Training Grant (T32-DE-01-4320) and an Ohio State University Presidential Fellowship. JED was supported by Ohio State's Secondyear Transformational Experience Program Fellowship. The authors thank Zoe Tapp for assistance with histology, John Velasquez for surgical assistance, as well as the Chronic Brain Injury Discovery Themes Initiative at The Ohio State University.	Bachstetter AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149451; Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Faul M, 2010, TRAUMATIC BRAIN INJU; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kokiko-Cochran ON, 2018, J NEUROTRAUM, V35, P73, DOI 10.1089/neu.2017.5203; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyeth BG, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00217; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Schurman LD, 2017, NEUROSCI LETT, V653, P31, DOI 10.1016/j.neulet.2017.05.032; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523	23	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 1	2020	1746								146987	10.1016/j.brainres.2020.146987			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NK4WQ	WOS:000566733300011	32592739	Green Accepted			2022-02-06	
J	Zhai, XL; Li, JY; Li, LY; Sun, Y; Zhang, XN; Xue, Y; Lv, JX; Gao, Y; Li, SX; Yan, W; Yin, SM; Xiao, ZY				Zhai, Xiuli; Li, Jinying; Li, Liya; Sun, Ye; Zhang, Xiaonan; Xue, Ying; Lv, Jiaxin; Gao, Ye; Li, Shouxin; Yan, Wei; Yin, Shengming; Xiao, Zhaoyang			L-lactate preconditioning promotes plasticity-related proteins expression and reduces neurological deficits by potentiating GPR81 signaling in rat traumatic brain injury model	BRAIN RESEARCH			English	Article						Traumatic brain injury; L-lactate; Neurological function recovery; GPR81	INTRACRANIAL HYPERTENSIVE EPISODES; MONOCARBOXYLATE TRANSPORTER MCT2; GROWTH-ASSOCIATED PROTEIN; COGNITIVE DEFICITS; NERVOUS-SYSTEM; SODIUM LACTATE; CYCLOSPORINE-A; RECEPTOR; ACID; BDNF	Currently, there is no efficacious pharmacological treatment for traumatic brain injury (TBI). Previous studies revealed that L-lactate preconditioning has shown rich neuroprotective effects against cerebral ischemia, and therefore has the potential to improve neurological outcomes after TBI. L-lactate played a neuroprotective role by activating GPR81 in diseases of the central nervous system (CNS) such as TBI and cerebral ischemia. In this study we investigated the effects of L-lactate preconditioning on TBI and explored the underlying mechanisms. In this study, the mNSS test revealed that L-lactate preconditioning alleviates the neurological deficit caused by TBI in rats. L-lactate preconditioning significantly increased the expression of GPR81, PSD95, GAP43, BDNF, and MCT2 24 h after TBI in the cortex and hippocampus compared with the sham group. Taken together, these data suggested that L-lactate preconditioning is an effective method with which to recover neurological function after TBI. This reveals the mechanism of L-lactate preconditioning on TBI and provides a potential therapeutic method for TBI in humans.	[Zhai, Xiuli; Li, Jinying; Li, Liya; Sun, Ye; Gao, Ye; Li, Shouxin; Xiao, Zhaoyang] Dalian Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Dalian 116027, Peoples R China; [Zhang, Xiaonan; Xue, Ying; Yan, Wei; Yin, Shengming] Dalian Med Univ, Dept Physiol, Dalian 116044, Peoples R China; [Lv, Jiaxin] Dalian Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Dalian 116011, Peoples R China		Xiao, ZY (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Dalian 116027, Peoples R China.; Yin, SM (corresponding author), Dalian Med Univ, Dept Physiol, Dalian 116044, Peoples R China.	dlshengmingd@163.com; xiaozhaoy2012@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471373]; Liaoning Provincial Natural Science Foundation [2014023007]	This work was supported by the National Natural Science Foundation of China (81471373) and Liaoning Provincial Natural Science Foundation (2014023007)	ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; AIGNER L, 1993, J CELL BIOL, V123, P417, DOI 10.1083/jcb.123.2.417; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Bergersen L, 2001, EXP BRAIN RES, V136, P523, DOI 10.1007/s002210000600; Bergersen LH, 2005, CEREB CORTEX, V15, P361, DOI 10.1093/cercor/bhh138; Bergersen LH, 2015, J CEREBR BLOOD F MET, V35, P176, DOI 10.1038/jcbfm.2014.206; Berthet C, 2012, CEREBROVASC DIS, V34, P329, DOI 10.1159/000343657; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; Bliss TM, 2004, J NEUROSCI, V24, P6202, DOI 10.1523/JNEUROSCI.0805-04.2004; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Carre E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00146; Cavaliere G, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00509; Darwazeh R, 2018, WORLD NEUROSURG, V116, pE329, DOI 10.1016/j.wneu.2018.04.202; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; GARCIA CK, 1994, CELL, V76, P865, DOI 10.1016/0092-8674(94)90361-1; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gladden LB, 2008, MED SCI SPORT EXER, V40, P475, DOI [10.1249/mss.0b013e31816154c9, 10.1249/MSS.0b013e31816154c9]; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Horn T, 2013, NEUROCHEM INT, V62, P251, DOI 10.1016/j.neuint.2012.12.017; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Lauritzen KH, 2014, CEREB CORTEX, V24, P2784, DOI 10.1093/cercor/bht136; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lerch MM, 2014, GASTROENTEROLOGY, V146, P1602, DOI 10.1053/j.gastro.2014.04.025; Li LY, 2017, BEHAV BRAIN RES, V326, P322, DOI 10.1016/j.bbr.2017.03.021; Li TT, 2020, BRAIN RES, V1730, DOI 10.1016/j.brainres.2020.146651; Li ZZ, 2014, J NEUROL SCI, V338, P112, DOI 10.1016/j.jns.2013.12.027; Liu CL, 2012, J PHARMACOL EXP THER, V341, P794, DOI 10.1124/jpet.112.192799; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; LoPachin RM, 1997, TOXICOL APPL PHARM, V143, P233, DOI 10.1006/taap.1997.8106; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Morland C, 2015, J NEUROSCI RES, V93, P1045, DOI 10.1002/jnr.23593; Mosienko V, 2015, J CEREBR BLOOD F MET, V35, P1069, DOI 10.1038/jcbfm.2015.77; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Peterson MJ, 2019, J GERONTOL A-BIOL, V74, P299, DOI 10.1093/gerona/gly122; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pierre K, 2009, EUR J NEUROSCI, V29, P1951, DOI 10.1111/j.1460-9568.2009.06756.x; Rafiki A, 2003, NEUROSCIENCE, V122, P677, DOI 10.1016/j.neuroscience.2003.08.040; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Robinet C, 2010, J CEREBR BLOOD F MET, V30, P286, DOI 10.1038/jcbfm.2009.208; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00114; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Schurr A, 2001, BRAIN RES, V895, P268, DOI 10.1016/S0006-8993(01)02082-0; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; Schwedt TJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00615; Seifert B, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4145708; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Singh K, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3764; Su WS, 2017, BRAIN STIMUL, V10, P1032, DOI 10.1016/j.brs.2017.09.003; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Vaynman S, 2006, NEUROSCIENCE, V139, P1221, DOI 10.1016/j.neuroscience.2006.01.062; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Won SJ, 2012, J CEREBR BLOOD F MET, V32, P1086, DOI 10.1038/jcbfm.2012.30; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; Yang JY, 2014, P NATL ACAD SCI USA, V111, P12228, DOI 10.1073/pnas.1322912111; Yin R, 2020, J PHARM PHARMACOL, V72, P539, DOI 10.1111/jphp.13233; Yu WZ, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.929; Zhou J, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00231; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2	69	2	3	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 1	2020	1746								146945	10.1016/j.brainres.2020.146945			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NK4WQ	WOS:000566733300008	32531223				2022-02-06	
J	Zhang, J; Wang, HL; Li, YP; Zhang, HZ; Dong, L				Zhang, Jun; Wang, Haili; Li, Yuping; Zhang, Hengzhu; Dong, Lun			The efficacy of progesterone 1 mg kg(-1) every 12 hours over 5 days in moderate-to-severe traumatic brain injury: A meta-analysis of randomized controlled trials	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Good functional outcome; Meta-analysis; Mortality; Progesterone; Traumatic brain injury	DIFFUSE AXONAL INJURY; CLINICAL-TRIAL; EXPRESSION; INFLAMMATION	Objective: The objective of this meta-analysis was to assess the efficacy of progesterone (PG) at 1.0 mg kg(-1) once every 12 h for 5 consecutive days in patients with moderate-to-severe (Glasgow Coma Score [GCS] 3-12) traumatic brain injury (TBI). Methods: The Cochrane Library, OvidSP, Web of Science, PubMed, CNKI, WFSD, and VIP databases were systematically searched from inception to May 1, 2020. The quality of included studies was evaluated using the bias risk assessment tool from the Cochrane systematic evaluator manual 5.1.0. A pooled analysis of relevant data was conducted using RevMan 5.3 software. The primary outcome was good functional outcome (GFO), and the secondary outcome was mortality. Subgroup analysis was performed to explore the impact of time, administration route, type of injury, and GCS on outcome measures. Results: A total of 7 randomized controlled trials involving 504 participants were included in this meta-analysis. The findings indicated a statistically significant difference in terms of GFO (RR, 1.48; 95 % confidence interval [CI], 1.25-1.76; P < 0.00001) and mortality (RR, 0.66; 95 % CI, 0.44-0.84; P = 0.002) between the PG and control groups. Subgroup analyses demonstrated that administration route was an important influencing factor for improving GFO in the PG group, and administration route and follow-up time were important for reducing mortality in the PG group. Conclusions: We conclude that PG, at a dose of 1.0 mg kg(-1) via intramuscular injection every 12h for 5 consecutive days, could significantly improve GFO (1 month, 3 months, 6 months, and 12 months) and reduce the medium-term (3-month and 6-month) mortality rate. Larger studies are needed to support our findings.	[Zhang, Jun; Wang, Haili] Dalian Med Univ, Dept Clin Med, Dalian, Liaoning, Peoples R China; [Li, Yuping; Zhang, Hengzhu; Dong, Lun] Yangzhou Univ, Dept Neurosurg, Clin Med Coll, 98 Nantong Westrd, Yangzhou 225001, Jiangsu, Peoples R China		Dong, L (corresponding author), Yangzhou Univ, Dept Neurosurg, Clin Med Coll, 98 Nantong Westrd, Yangzhou 225001, Jiangsu, Peoples R China.	lundongu571@163.com	; Li, Yuping/C-4122-2014	zhang, jun/0000-0002-7869-2807; Li, Yuping/0000-0002-4527-2582	Jiangsu Province Key Experiments of Basic and Clinical Translation of Non-coding RNA [201902]; Jiangsu Province Natural Science FoundationNatural Science Foundation of Jiangsu Province [BK20190241]; Jiangsu Provincial Key Medical Talents Program [QNRC2016326]	This study was supported by the Jiangsu Province Key Experiments of Basic and Clinical Translation of Non-coding RNA (201902); Jiangsu Province Natural Science Foundation (BK20190241); and Jiangsu Provincial Key Medical Talents Program (QNRC2016326).	Aboukhabar HA, 2017, RES OPIN ANESTH INTE, V4, P84; Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; BITRAN D, 1995, J NEUROENDOCRINOL, V7, P171, DOI 10.1111/j.1365-2826.1995.tb00744.x; Chen H.H., 2019, CHINA PHARMACY, V30, P253, DOI DOI 10.6039/j.issn.1001-0408.2019.02.23; Coughlan T, 2005, J NEUROCHEM, V93, P932, DOI 10.1111/j.1471-4159.2005.03068.x; Espinoza TR, 2011, J HEAD TRAUMA REHAB, V26, P497, DOI 10.1097/HTR.0b013e31823088fa; Garling RJ, 2018, NEURAL REGEN RES, V13, P434, DOI 10.4103/1673-5374.228725; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Lengel D, 2020, EXP NEUROL, V330, DOI 10.1016/j.expneurol.2020.113329; Ma JP, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub4; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mofid B, 2016, INT IMMUNOPHARMACOL, V32, P103, DOI 10.1016/j.intimp.2016.01.015; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Patet C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0638-5; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pozzato I, 2019, AUST NZ J PUBL HEAL, V43, P382, DOI 10.1111/1753-6405.12878; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Sinha S, 2017, NEUROL INDIA, V65, P1304, DOI 10.4103/0028-3886.217973; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Soltani Z, 2017, BRAIN INJURY, V31, P16, DOI 10.1080/02699052.2016.1213421; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Wang H, 2016, ACM T DES AUTOMAT EL, V22, DOI 10.1145/2891409; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xydakis MS, 2015, NEW ENGL J MED, V372, P1765, DOI 10.1056/NEJMc1503138; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yu P, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12362; Zhang M, 2017, NEUROCRIT CARE, V26, P292, DOI 10.1007/s12028-016-0342-y	39	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2020	198								106131	10.1016/j.clineuro.2020.106131			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OO4JG	WOS:000587346400023	32823183				2022-02-06	
J	Hu, Y; Seker, B; Exner, C; Zhang, JP; Plesnila, N; Schwarzmaier, SM				Hu, Yue; Seker, Burcu; Exner, Carina; Zhang, Junping; Plesnila, Nikolaus; Schwarzmaier, Susanne M.			Longitudinal Characterization of Blood-Brain Barrier Permeability after Experimental Traumatic Brain Injury by In Vivo 2-Photon Microscopy	JOURNAL OF NEUROTRAUMA			English	Article						blood&#8211; brain barrier; in vivo; traumatic brain injury; 2-photon microscopy vasogenic brain edema	CONTROLLED CORTICAL IMPACT; CEREBRAL EDEMA; HEAD-INJURY; MODEL; DISRUPTION; CONTUSION; BREAKDOWN; RAT; PATHOPHYSIOLOGY; DYSFUNCTION	Vasogenic brain edema (VBE) formation remains an important factor determining the fate of patients with traumatic brain injury (TBI). The spatial and temporal development of VBE, however, remains poorly understood because of the lack of sufficiently sensitive measurement techniques. To close this knowledge gap, we directly visualized the full time course of vascular leakage after TBI by in vivo 2-photon microscopy (2-PM). Male C57BL/6 mice (n = 6/group, 6-8 weeks old) were assigned randomly to sham operation or brain trauma by controlled cortical impact. A cranial window was prepared, and tetramethylrhodamine-dextran (TMRM, MW 40,000 Da) was injected intravenously to visualize blood plasma 4 h, 24 h, 48 h, 72 h, or seven days after surgery or trauma. Three regions with increasing distance to the primary contusion were investigated up to a depth of 300 mu m by 2-PM. No TMRM extravasation was detected in sham-operated mice, while already 4 h after TBI vascular leakage was significantly increased (p < 0.05 vs. sham) and reached its maximum at 48 h after injury. Vascular leakage was most pronounced in the vicinity of the contusion. The rate of extravasation showed a biphasic pattern, peaking 4 h and 48-72 h after trauma. Taken together, longitudinal quantification of vascular leakage after TBI in vivo demonstrates that VBE formation after TBI develops in a biphasic manner suggestive of acute and delayed mechanisms. Further studies using the currently developed dynamic in vivo imaging modalities are needed to investigate these mechanisms and potential therapeutic strategies in more detail.	[Hu, Yue; Seker, Burcu; Exner, Carina; Plesnila, Nikolaus; Schwarzmaier, Susanne M.] Ludwig Maximilians Univ LMU, Inst Stroke & Dementia Res ISD, Munich Med Ctr, Munich, Germany; [Schwarzmaier, Susanne M.] Ludwig Maximilians Univ LMU, Dept Anesthesiol, Munich Med Ctr, Munich, Germany; [Hu, Yue; Zhang, Junping] Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Tianjin, Peoples R China; [Hu, Yue; Seker, Burcu; Exner, Carina; Plesnila, Nikolaus; Schwarzmaier, Susanne M.] Cluster Syst Neurol SyNergy, Munich, Germany		Plesnila, N (corresponding author), Inst Stroke & Dementia Res, Feodor Lynen Str 17, D-81377 Munich, Germany.	nikolaus.plesnila@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy of the Munich Cluster for Systems NeurologyGerman Research Foundation (DFG) [EXC 2145 SyNergy, 390857198]	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy - ID 390857198).	Adelson PD, 1998, ACT NEUR S, V71, P104; Allt G, 1997, BRAIN RES REV, V24, P67, DOI 10.1016/S0165-0173(97)00011-8; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Gerzanich V, 2019, J NEUROTRAUM, V36, P1060, DOI 10.1089/neu.2018.5986; Guerin CJ, 2001, NEUROSCIENCE, V103, P873, DOI 10.1016/S0306-4522(01)00015-X; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Helmchen F, 2009, FRONT NEUROSCI, P37; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jha RM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0912-9; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Klohs J, 2009, J NEUROSCI METH, V180, P126, DOI 10.1016/j.jneumeth.2009.03.002; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Lukaszewicz AC, 2011, CURR OPIN ANESTHESIO, V24, P138, DOI 10.1097/ACO.0b013e32834458af; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; MAYHAN WG, 1985, AM J PHYSIOL, V248, pH712, DOI 10.1152/ajpheart.1985.248.5.H712; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Prager O, 2010, NEUROIMAGE, V49, P337, DOI 10.1016/j.neuroimage.2009.08.009; Ren ZT, 2019, NEUROSCIENCE, V423, P177, DOI 10.1016/j.neuroscience.2019.10.017; Reyes-Aldasoro CC, 2008, MICROCIRCULATION, V15, P65, DOI 10.1080/10739680701436350; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rosas-Hernandez H, 2018, MOL NEUROBIOL, V55, P258, DOI 10.1007/s12035-017-0738-5; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Saunders NR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3339/fnins.2015.00385, 10.3389/fnins.2015.00385]; Schwarzmaier SM, 2015, J NEUROTRAUM, V32, P990, DOI 10.1089/neu.2014.3775; Schwarzmaier SM, 2015, J NEUROTRAUM, V32, P731, DOI 10.1089/neu.2014.3650; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shen Q, 2016, METHODS MOL BIOL, V1462, P645, DOI 10.1007/978-1-4939-3816-2_35; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Soares HD, 1995, J NEUROSCI, V15, P8223; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; WAHL M, 1985, INT J MICROCIRC, V4, P3; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Yu MM, 2019, MAGN RESON IMAGING, V62, P1, DOI 10.1016/j.mri.2019.01.017; Zlotnik A, 2012, J NEUROSURG ANESTH, V24, P30, DOI 10.1097/ANA.0b013e318232deaa; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	66	2	2	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2021	38	4					399	410		10.1089/neu.2020.7271		OCT 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QC1FI	WOS:000586283200001	33012249				2022-02-06	
J	Zarshenas, S; Couture, M; Bier, N; Giroux, S; Pigot, H; Dawson, D; Nalder, E; Gagnon-Roy, M; Le Dorze, G; Poncet, F; McKenna, S; Zabjek, K; Bottari, C				Zarshenas, Sareh; Couture, Melanie; Bier, Nathalie; Giroux, Sylvain; Pigot, Helene; Dawson, Deirdre; Nalder, Emily; Gagnon-Roy, Mireille; Le Dorze, Guylaine; Poncet, Frederique; McKenna, Suzanne; Zabjek, Karl; Bottari, Carolina		Canadian Traumatic Brain Injury Re	Potential advantages, barriers, and facilitators of implementing a cognitive orthosis for cooking for individuals with traumatic brain injury: the healthcare providers' perspective	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article; Early Access						Traumatic brain injury; assistive technology; implementation; activities of daily living; cognitive rehabilitation	ASSISTIVE TECHNOLOGY; DECISION-MAKING; REHABILITATION; PEOPLE; PERFORMANCE; ACCEPTANCE; ADULTS	Purpose Considering the key role of health care providers in integrating assistive technologies into clinical settings (e.g., in/outpatient rehabilitation) and home, this study explored the care providers' perspectives on benefits, barriers and facilitators to the implementation of the Cognitive Orthosis for coOking (COOK) for adults with traumatic brain injury (TBI) within clinical contexts and homes. Methods Using a qualitative descriptive approach, semi-structured individual interviews and focus groups were carried out with experienced care providers of adults with TBI (n = 30) in Ontario-Canada. Qualitative analysis based on the Miles et al approach was used. Results According to the participants, COOK could potentially be used with individuals with cognitive impairments (TBI and non-TBI) to increase safety and independence in meal preparation and support healthcare providers. However, limited access to funding, clients' lack of motivation/knowledge, and the severity of their cognitive and motor impairments were perceived as potential barriers. Facilitators to the use of COOK include training sessions, availability of private/provincial financing, and comprehensive assessments by a clinical team prior to use. Conclusions Health care providers' perspectives will help develop implementation strategies to facilitate the adoption of COOK within homes and clinical contexts for individuals with TBI and improve the next version of this technology.	[Zarshenas, Sareh; Bier, Nathalie; Gagnon-Roy, Mireille; Bottari, Carolina] Univ Montreal, Sch Rehabil, Occupat Therapy Program, Montreal, PQ, Canada; [Zarshenas, Sareh; Gagnon-Roy, Mireille; Le Dorze, Guylaine; Bottari, Carolina] Inst univ readaptat deficience phys Montreal CIUS, Ctr Interdisciplinary Res Rehabil Greater Montrea, Ctr Sud De Ille De Montreal, Montreal, PQ, Canada; [Couture, Melanie] Ctr Res & Expertise Social Gerontol, Cote St Luc, PQ, Canada; [Bier, Nathalie] Inst univ geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Giroux, Sylvain; Pigot, Helene] Univ Sherbrooke, DOMUS Lab, Montreal, PQ, Canada; [Dawson, Deirdre; Nalder, Emily] Univ Toronto, Occupat Sci & Occupat Therapy Dept, Toronto, ON, Canada; [Dawson, Deirdre] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Dawson, Deirdre] Baycrest Hlth Sci, Rotman Res Inst, Toronto, ON, Canada; [Dawson, Deirdre] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Nalder, Emily] March Dimes Canada, Toronto, ON, Canada; [Le Dorze, Guylaine] Univ Montreal, Sch Speech Language Pathol & Audiol, Montreal, PQ, Canada; [Poncet, Frederique] Lethbridge Layton Mackay Rehab Ctr, Montreal, PQ, Canada; [Poncet, Frederique] Univ Montreal, Optometry Dept, Montreal, PQ, Canada; [Poncet, Frederique; McKenna, Suzanne] Champlain Local Hlth Integrat Network LHIN, Ottawa, ON, Canada; [Zabjek, Karl] Univ Toronto, Phys Therapy Dept, Toronto, ON, Canada		Bottari, C (corresponding author), 7077 Ave Parc, Montreal, PQ H3N 1X7, Canada.	carolina.bottari@umontreal.ca		Nalder, Emily/0000-0001-9612-9420; Giroux, Sylvain/0000-0003-0602-5957; Bier, Nathalie/0000-0002-2940-694X; Gagnon-Roy, Mireille/0000-0001-9668-7289			[Anonymous], 2001, INT CLASS FUNCT DIS; [Anonymous], 2019, POPULATION DISTRIBUT; Bottari C, 2010, ARCH PHYS MED REHAB, V91, P734, DOI 10.1016/j.apmr.2009.12.023; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Boudreault A, 2016, INT CONF INTEL ENVIR, P230, DOI 10.1109/IE.2016.52; Brunner M, 2017, BRAIN INJURY, V31, P1028, DOI 10.1080/02699052.2017.1292429; Ceccacci S, 2015, P 4 INT C SMART SYST; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chen CC, 2011, AM J PHYS MED REHAB, V90, P415, DOI 10.1097/PHM.0b013e318214f5d8; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Christodoulakis C, 2017, P ACM CASCON C CASCO; Chu Y, 2014, DISABIL REHABIL-ASSI, V9, P279, DOI 10.3109/17483107.2013.823631; Cruz D., 2016, OPEN J OCCUP THER, V4, P10, DOI [10.15453/2168-6408.1166, DOI 10.15453/2168-6408.1166]; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Dubuc E, 2019, AUST OCCUP THER J, V66, P720, DOI 10.1111/1440-1630.12611; Durocher E, 2019, ETHICS BEHAV, V29, P172, DOI 10.1080/10508422.2017.1396461; Ficocelli M, 2012, ASSIST TECHNOL, V24, P246, DOI 10.1080/10400435.2012.659834; Gagnon-Roy M, 2020, ASSIST TECHNOL, DOI 10.1080/10400435.2020.1809552; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Giroux S, 2015, P AAAI 2015 SPRING S, P1; Godbout L, 2005, BRAIN INJURY, V19, P337, DOI 10.1080/02699050400005093; Harrison AL, 2017, DISABIL REHABIL, V39, P2071, DOI 10.1080/09638288.2016.1217081; Jamieson M, 2020, DISABIL REHABIL-ASSI, V15, P453, DOI 10.1080/17483107.2019.1594402; Jamwal R, 2017, BRIT J OCCUP THER, V80, P89, DOI 10.1177/0308022616678634; Kettlewell J, 2019, CLIN REHABIL, V33, P1705, DOI 10.1177/0269215519865774; Leopold A, 2015, NEUROREHABILITATION, V37, P359, DOI 10.3233/NRE-151267; Liu LL, 2015, DISABIL REHABIL, V37, P447, DOI 10.3109/09638288.2014.923529; Malec JF, 2017, BRAIN INJURY, V31, P1235, DOI 10.1080/02699052.2016.1274778; Mandich A., 2004, ENABLING OCCUPATION; Marikyan D, 2019, TECHNOL FORECAST SOC, V138, P139, DOI 10.1016/j.techfore.2018.08.015; Martin D, 2018, LANCET, V391, P1718, DOI 10.1016/S0140-6736(18)30181-8; McGrath C, 2017, BRIT J OCCUP THER, V80, P123, DOI 10.1177/0308022616667959; Mihailidis A, 2004, NEUROPSYCHOL REHABIL, V14, P135, DOI 10.1080/09602010343000156; Mihailidis Alex, 2008, BMC Geriatr, V8, P28, DOI 10.1186/1471-2318-8-28; Miles M., 2020, QUALITATIVE DATA ANA, V4th ed.; Ownsworth T, 2017, NEUROREHAB NEURAL RE, V31, P1072, DOI 10.1177/1545968317740635; Oyesanya TO, 2019, ASSIST TECHNOL, DOI 10.1080/10400435.2019.1612798; Peckham A, 2018, RAPID REV, V4; Pinard S, 2021, DISABIL REHABIL-ASSI, V16, P687, DOI 10.1080/17483107.2019.1696898; Public Health Agency of Canada National Population Health Study of Neurological Conditions (Canada)., 2014, MAPP CONN UND NEUR C; Radomski MV, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020776; Saborowski M, 2015, TECHNOL FORECAST SOC, V93, P133, DOI 10.1016/j.techfore.2014.05.006; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Swaine B, 2018, DISABIL REHABIL, V40, P697, DOI 10.1080/09638288.2016.1262911; Thordardottir B, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9196729; Turner A, 2015, BRIT J OCCUP THER, V78, P739, DOI 10.1177/0308022615601443; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434; World Health Organization, 2017, GLOB PRIOR RES AG IM; Zarshenas S, 2019, ARCH PHYS MED REHAB, V100, P1274, DOI 10.1016/j.apmr.2018.11.023	50	2	2	1	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.												10.1080/17483107.2020.1833093		OCT 2020	10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	OT4FH	WOS:000590803700001	33151098				2022-02-06	
J	Dehbozorgi, A; Mousavi-Roknabadi, RS; Hosseini-Marvast, SR; Sharifi, M; Sadegh, R; Farahmand, F; Damghani, F				Dehbozorgi, Afsaneh; Mousavi-Roknabadi, Razieh Sadat; Hosseini-Marvast, Seyed Rouhollah; Sharifi, Mehrdad; Sadegh, Robab; Farahmand, Faramarz; Damghani, Fatemeh			Diagnosing skull fracture in children with closed head injury using point-of-care ultrasound vs. computed tomography scan	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						Closed head injury; Traumatic brain injuries; Skull fracture; Ultrasonography; Emergency department	TRAUMA	Diagnostic and therapeutic interventions in children for traumatic brain injury, which is known as the most important complication in trauma, require special attention. This study aimed to evaluate the accuracy of point-of-care ultrasound (POCUS) in diagnosing skull fracture in children with closed head injury in comparison with computed tomography (CT) scan. The current prospective cross-sectional study was conducted on children (0-14 years old), who were referred to the emergency department of a general teaching hospital in Shiraz, southern Iran (January-March 2018), with close head injury and were suspected of bone fracture. The participants were selected using a convenience sampling. The results of POCUS performed by emergency medicine (EM) residents were compared with the results of CT scan, which was reported by radiologists and considered a gold standard. Then, diagnostic tests were calculated. A total of 168 children were enrolled, with the mean +/- standard deviation age of 6.21 +/- 3.99. The most affected areas in the skull were the frontal (34.5%) and occipital areas (33.3%). POCUS had a sensitivity and specificity of 81.8% (95%CI, 48.2-97.7%) and 100% (95%CI, 97.7-100%), respectively. Positive and negative predictive values were 100% and 98.7%, with an accuracy of 98.8% in comparison with CT scan in the diagnosis of skull fracture. Conclusion: The results showed that POCUS with a portable ultrasonography machine, performed by the EM's physicians, have high diagnostic precision and can be considered a tool in the management of patients with closed head injury. What is Known: Some studies have investigated the accuracy of ultrasound in diagnosing skull bone fractures in children with closed head injury, but before conducting this survey, no definite evidence recommended POCUS for skull fracture in children with closed head trauma in the ED. What is New: POCUS with a portable ultrasonography machine, performed by the EM's physicians, has high diagnostic precision and can be considered a tool in the management of patients with closed head injury.	[Dehbozorgi, Afsaneh; Mousavi-Roknabadi, Razieh Sadat; Hosseini-Marvast, Seyed Rouhollah; Sharifi, Mehrdad; Sadegh, Robab; Farahmand, Faramarz; Damghani, Fatemeh] Shiraz Univ Med Sci, Fac Med, Emergency Med Dept, Shiraz, Iran; [Hosseini-Marvast, Seyed Rouhollah] Shiraz Univ Med Sci, Namazi Hosp, Fac Med, Emergency Med Dept, Shiraz 7193711351, Iran		Hosseini-Marvast, SR (corresponding author), Shiraz Univ Med Sci, Fac Med, Emergency Med Dept, Shiraz, Iran.; Hosseini-Marvast, SR (corresponding author), Shiraz Univ Med Sci, Namazi Hosp, Fac Med, Emergency Med Dept, Shiraz 7193711351, Iran.	dehbozorgia@sums.ac.ir; mousavi_razieh@sums.ac.ir; hoseinimr@sums.ac.ir; m_sharifi@sums.ac.ir; sadeghrobab@yahoo.com; frama1347@yahoo.com; dr.f.damghani@gmail.com	Mousavi-Roknabadi, Razieh Sadat/S-4319-2019; Dehbozorgi, Afsaneh/U-1346-2019; Sharifi, Mehrdad/Z-1891-2018	Mousavi-Roknabadi, Razieh Sadat/0000-0001-9483-8848; Dehbozorgi, Afsaneh/0000-0002-0230-5196; Sharifi, Mehrdad/0000-0002-1391-1968; Hosseini-Marvast, Seyed Rouhollah/0000-0001-6325-6327	Shiraz University of Medical Sciences [94.01.01.10718]	The present article was extracted from the thesis written by Seyed Rouhollah Hosseini-Marvast in fulfillment of the requirements for certification as a specialist in EM, which was supported by Shiraz University of Medical Sciences (grant No. 94.01.01.10718). The authors wish to thank Mr. H. Argasi at the Research Consultation Center (RCC), as well as Parisa Chamanpara for statistical assistance at Center for Development of Clinical Research of Namazi Teaching Hospital.	Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; ARKIN CF, 1990, JAMA-J AM MED ASSOC, V263, P275, DOI 10.1001/jama.263.2.275; Behnood HR, 2017, TRAUMA MON, V22, DOI 10.5812/traumamon.35997; Bishai D, 2006, HEALTH ECON, V15, P65, DOI 10.1002/hec.1020; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brooks T, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e01010; Conforto I, 2016, TINTINALLIS EMERGENC, P903; Gordon I, 2021, PEDIATR EMERG CARE, V37, pE1701, DOI 10.1097/PEC.0000000000001958; Hall EJ, 2002, PEDIATR RADIOL, V32, P700, DOI 10.1007/S00247-002-0774-8; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Lee Bruce, 2005, NeuroRx, V2, P372; Marin J, 2011, CLIN PEDIATR EMERG M, V12, P53, DOI 10.1016/j.cpem.2010.12.006; Marin JR, 2016, CRIT ULTRASOUND J, V8, DOI 10.1186/s13089-016-0049-5; Masaeli M, 2019, ARCH ACAD EMERG MED, V7; McGrath A., 2020, PEDIAT SKULL FRACTUR; Muhammad Gul, 2017, J Ayub Med Coll Abbottabad, V29, P311; Munoz-Sanchez MA, 2009, BRAIN INJURY, V23, P39, DOI 10.1080/02699050802590346; Parri N, 2018, J PEDIATR-US, V196, P230, DOI 10.1016/j.jpeds.2017.12.057; Rabiner JE, 2013, PEDIATRICS, V131, pE1757, DOI 10.1542/peds.2012-3921; Riera A, 2012, PEDIATR EMERG CARE, V28, P420, DOI 10.1097/PEC.0b013e318252da3b; Saadat S, 2011, ULUS TRAVMA ACIL CER, V17, P149, DOI 10.5505/tjtes.2011.26043; Shokoohi H, 2015, OPEN ACCESS EMERG M, V7, P1, DOI 10.2147/OAEM.S50360; Trenchs V, 2009, EUR J EMERG MED, V16, P150, DOI 10.1097/MEJ.0b013e328321b7b5; Weinberg ER, 2010, INJURY, V41, P862, DOI 10.1016/j.injury.2010.04.020	24	2	2	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	FEB	2021	180	2					477	484		10.1007/s00431-020-03851-w		OCT 2020	8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	PT7YY	WOS:000584915100002	33118087	Green Published, Bronze			2022-02-06	
J	Rowson, S; Campolettano, ET; Duma, SM; Stemper, B; Shah, A; Harezlak, J; Riggen, L; Mihalik, JP; Brooks, A; Cameron, KL; Svoboda, SJ; Houston, MN; McAllister, T; Broglio, S; McCrea, M				Rowson, Steven; Campolettano, Eamon T.; Duma, Stefan M.; Stemper, Brian; Shah, Alok; Harezlak, Jaroslaw; Riggen, Larry; Mihalik, Jason P.; Brooks, Alison; Cameron, Kenneth L.; Svoboda, Steven J.; Houston, Megan N.; McAllister, Thomas; Broglio, Steven; McCrea, Michael			Concussion Risk Between Individual Football Players: Survival Analysis of Recurrent Events and Non-events	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Biomechanics; Rotational; Angular; Injury; Risk function; Sensors; NCAA-DOD CARE Consortium	HEAD IMPACT EXPOSURE; BIOMECHANICS; VALIDATION; KINEMATICS; MAGNITUDE; SEVERITY; CURVES	Concussion tolerance and head impact exposure are highly variable among football players. Recent findings highlight that head impact data analyses need to be performed at the subject level. In this paper, we describe a method of characterizing concussion risk between individuals using a new survival analysis technique developed with real-world head impact data in mind. Our approach addresses the limitations and challenges seen in previous risk analyses of football head impact data. Specifically, this demonstrative analysis appropriately models risk for a combination of left-censored recurrent events (concussions) and right-censored recurrent non-events (head impacts without concussion). Furthermore, the analysis accounts for uneven impact sampling between players. In brief, we propose using the Consistent Threshold method to develop subject-specific risk curves and then determine average risk point estimates between subjects at injurious magnitude values. We describe an approach for selecting an optimal cumulative distribution function to model risk between subjects by minimizing injury prediction error. We illustrate that small differences in distribution fit can result in large predictive errors. Given the vast amounts of on-field data researchers are collecting across sports, this approach can be applied to develop population-specific risk curves that can ultimately inform interventions that reduce concussion incidence	[Rowson, Steven; Campolettano, Eamon T.; Duma, Stefan M.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Stemper, Brian; Shah, Alok; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Harezlak, Jaroslaw] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Riggen, Larry] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Mihalik, Jason P.] Univ North Carolina Chapel Hill, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Brooks, Alison] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped, Madison, WI USA; [Cameron, Kenneth L.; Svoboda, Steven J.; Houston, Megan N.] US Mil Acad, Keller Army Community Hosp, Dept Orthopaed Surg, West Point, NY 10996 USA; [Cameron, Kenneth L.] US Air Force Acad, Dept Sports Med, Colorado Springs, CO 80840 USA; [McAllister, Thomas] Indiana Sch Med, Dept Psychiat, Indianapolis, IN USA; [Broglio, Steven] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA		Rowson, S (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	srowson@vt.edu	Rowson, Steven/B-1270-2012; Harezlak, Jaroslaw/P-8557-2014	Rowson, Steven/0000-0002-3227-0596; Harezlak, Jaroslaw/0000-0002-3070-7686	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DoD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This investigation was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DoD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (DHP funds.)	Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Beusenberg MC., 2000, P INT RES C BIOM IMP; Bland ML, 2020, ANN BIOMED ENG, V48, P47, DOI 10.1007/s10439-019-02330-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Campolettano ET, 2020, ANN BIOMED ENG, V48, P92, DOI 10.1007/s10439-019-02382-2; Campolettano ET, 2019, ANN BIOMED ENG, V47, P2086, DOI 10.1007/s10439-019-02309-x; Campos EC, 2020, ANIMAL, V14, P1777, DOI 10.1017/S1751731120000488; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Domenico L. D, 2003, SAE TECHNICAL PAPER, VSAE 2003-01-1362; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Ghazi K, 2019, SCI REP-UK, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Kent R. W., 2004, SAE TECHNICAL PAPER, VSAE 2004-01-0317; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mertz HJ, 1997, SAE TECHNICAL PAPER; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman J. A, 1986, P INT IRCOBI C 1986; Nusholtz G, 1999, SAE T, P1179; Ommaya A. K, 1985, BIOMECHANICS HEAD IN; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Press J. N, 2016, CLIN J SPORT MED; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2019, ANN BIOMED ENG, V47, P2048, DOI 10.1007/s10439-019-02329-7; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stemper B. D, 2018, ANN BIOMED ENG, P1; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Yoganandan N, 2016, J BIOMECH, V49, P3260, DOI 10.1016/j.jbiomech.2016.08.002; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	49	2	2	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2020	48	11			SI		2626	2638		10.1007/s10439-020-02675-x		OCT 2020	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PB5UI	WOS:000584846100001	33113020				2022-02-06	
J	Botchway, EN; Knight, S; Muscara, F; Greenham, M; D'Cruz, K; Bonyhady, B; Anderson, V; Scheinberg, A				Botchway, Edith N.; Knight, Sarah; Muscara, Frank; Greenham, Mardee; D'Cruz, Kate; Bonyhady, Bruce; Anderson, Vicki; Scheinberg, Adam			Rehabilitation models of care for children and youth living with traumatic brain and/or spinal cord injuries: A focus on family-centred care, psychosocial wellbeing, and transitions	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Traumatic brain injury; Traumatic spinal cord injury; Rehabilitation; Model of care; Children; Youth	OUTCOMES; PARENTS; NEEDS; EXPERIENCES; DISTRESS; IMPACT	To describe current rehabilitation models of care and programmes, in Australia and internationally, related to family-centred care, psychosocial support, and transitions used for children and youth who have sustained major traumatic brain and/or spinal cord injuries. Fourteen services were interviewed, including eight medical rehabilitation services, three community-based rehabilitation services, two insurance services, and one state-wide education service provider. Semi-structured interviews were transcribed and analysed using qualitative content analysis in NVivo. Compared to the number of services supporting children and youth with traumatic brain injury, a very limited number supported those with spinal cord injury. Although valued and often included in the model of care, family-centred care was rarely systematically evaluated by the services. Most services provided psychosocial and transition support to children and youth, and their families in the short-term post-injury, but not in the long-term. Several challenges also hindered the smooth delivery of these support services, including poor communication between service providers. These findings show that services aimed to provide the best possible care to these children and youth, and their families; guided by rehabilitation models of care. However, challenges persist with regards to delivering family-centred care, coordinating return to school, and providing long-term support for psychosocial problems and transition.	[Botchway, Edith N.; Knight, Sarah; Muscara, Frank; Greenham, Mardee; Anderson, Vicki; Scheinberg, Adam] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Botchway, Edith N.; Knight, Sarah; Muscara, Frank; Anderson, Vicki; Scheinberg, Adam] Royal Childrens Hosp, Parkville, Vic, Australia; [Botchway, Edith N.; Knight, Sarah; Muscara, Frank; Anderson, Vicki; Scheinberg, Adam] Univ Melbourne, Parkville, Vic, Australia; [Knight, Sarah; Muscara, Frank; Scheinberg, Adam] Victorian Paediat Rehabil Serv, Parkville, Vic, Australia; [D'Cruz, Kate] La Trobe Univ, Sch Allied Hlth Human Serv & Sport, Coll Sci Hlth & Engn, Dept Occupat Therapy Social Work & Social Policy, Melbourne, Vic, Australia; [Bonyhady, Bruce] Melbourne Disabil Inst, Melbourne, Vic, Australia; [Scheinberg, Adam] Monash Univ, Dept Paediat, Melbourne, Vic, Australia		Knight, S (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.; Knight, S (corresponding author), Royal Childrens Hosp, Parkville, Vic, Australia.; Knight, S (corresponding author), Univ Melbourne, Parkville, Vic, Australia.	sarah.knight@mcri.edu.au	Greenham, Mardee/AAR-1711-2020; D'Cruz, Kate/ABC-7970-2021; Knight, Sarah/AAZ-8515-2020	D'Cruz, Kate/0000-0002-5155-1350; Knight, Sarah/0000-0002-9908-2231; Botchway, Edith N/0000-0002-0075-3382	Victorian Government's Operational Infrastructure Support Programme	This work was commissioned by the Transport and Accident Commission in Victoria (Australia) and was supported by the Victorian Government's Operational Infrastructure Support Programme. We would like to acknowledge the members of the Study Steering Committee for their expertise and contribution to establishing and designing this project, and in interpretation of the data: Professor Bruce Bonyhady, Tessa de Vries, Dr. Jason Thompson, and Professor Louise Harms from the University of Melbourne (Australia); Nick Rushworth from Brain Injury Australia; Dianne Lucas from Spinal Cord Injuries Australia; Dr. Emma Tavender from the Murdoch Children's Research Institute (Australia); and David Bowen. Special thanks to Lyndie Freestone, Eliza Fitzpatrick, and Dr. Beth Costa of the Transport and Accident Commission (Victoria, Australia). Most importantly, we would like to acknowledge the steering committee members with lived experience of TBI or SCI: Jessica Pellow, Kajol Aegle, Rebekka Nies, and Joanne Liparota. Nethmie Gamage and Bernadette Lam (student interns at MCRI) are appreciated for their contribution to data cleaning and entry. We also thank Kate Paton and Taylor Jenkin for their advice on qualitative research methods, as well as Renata Winkler and Taylor Jenkin for assistance with the piloting of the interview guide for the CBR and MR services. We wish to thank the informants from the national (Australian) and international services who participated in this study. Service names have been withheld to maintain the confidentiality of informants/participants.	Akhtar M, 2012, J PEDIATR REHAB MED, V5, P301, DOI 10.3233/PRM-2012-00226; Anderson CJ, 2003, DEV MED CHILD NEUROL, V45, P129, DOI 10.1017/S0012162203000239; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Barnard-Brak L, 2017, MATERN CHILD HLTH J, V21, P1073, DOI 10.1007/s10995-016-2203-x; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chan J, 2009, ADV MENT HEALTH, V8, P155, DOI 10.5172/jamh.8.2.155; Chavez-Arana C, 2018, BRAIN INJURY, V32, P276, DOI 10.1080/02699052.2017.1394491; Cunningham BJ, 2014, DEV MED CHILD NEUROL, V56, P445, DOI 10.1111/dmcn.12347; Davidson P, 2006, AUST J ADV NURS, V23, P47; DeSanto-Madeya S, 2009, NURS SCI QUART, V22, P57, DOI 10.1177/0894318408327295; Eren S, 2014, SOCIAL CARE NEURODIS, V5, P135, DOI [10.1108/SCN-06-2013-0022, DOI 10.1108/SCN-06-2013-0022]; Gan C, 2019, BRAIN INJURY, V33, P623, DOI 10.1080/02699052.2019.1566836; Glaser B., 1967, DISCOVERY GROUNDED T; King G, 1999, J PEDIATR PSYCHOL, V24, P41, DOI 10.1093/jpepsy/24.1.41; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Kuo DZ, 2012, MATERN CHILD HLTH J, V16, P297, DOI 10.1007/s10995-011-0751-7; Lakhani A, 2017, BRAIN INJURY, V31, P1718, DOI 10.1080/02699052.2017.1374468; Law M, 2003, CHILD CARE HLTH DEV, V29, P357, DOI 10.1046/j.1365-2214.2003.00351.x; Liamputtong P., 2013, QUALITATIVE RES METH, V4; Majid M.A.A., 2017, INT J ACAD RES BUSIN, V7, P1073, DOI [10.6007/IJARBSS/v7-i4/2916, DOI 10.6007/IJARBSS/V7-I4/2916]; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; QSR International Pty Ltd, 2018, NVIVO VERS 12; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Robson T., 2005, BRAIN IMPAIR, V6, P45, DOI [10.1375/brim.6.1.45.65477, DOI 10.1375/BRIM.6.1.45.65477]; Rosenbaum P., 1998, PHYS OCCUP THER PEDI, V18, P1, DOI [DOI 10.1080/J006v18n01_01, 10.1080/J006v18n01_01]; Rumrill P, 2016, J HEAD TRAUMA REHAB, V31, P288, DOI 10.1097/HTR.0000000000000186; Russell LT, 2018, J FAM NURS, V24, P29, DOI 10.1177/1074840717745520; Ryan G.W., 2000, HDB QUALITATIVE RES, V2nd ed.; Sandford PR, 1999, ARCH PHYS MED REHAB, V80, P885, DOI 10.1016/S0003-9993(99)90078-3; Schrieff-elson L. E., 2017, TXB PEDIAT NEUROSURG; Scratch SE, 2020, DEV NEUROREHABIL, V23, P359, DOI 10.1080/17518423.2019.1687600; Shields L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004811.pub2; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Swift EE, 2003, J DEV BEHAV PEDIATR, V24, P24, DOI 10.1097/00004703-200302000-00007; Tabish S. A., 2015, EMERGEN MED, V5, P1, DOI [10.4172/2165-7548.10000229, DOI 10.4172/2165-7548.10000229]; Thompson LA, 2009, PEDIATRICS S4, V124, pS420; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Uhl T, 2013, JOGNN-J OBST GYN NEO, V42, P121, DOI 10.1111/1552-6909.12001; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wehman P, 2014, NEUROREHABILITATION, V34, P365, DOI 10.3233/NRE-131029	47	2	2	2	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2020.1833945		OCT 2020	23	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	OH9VX	WOS:000582938100001	33108961				2022-02-06	
J	Luo, JN; Wu, X; Liu, HX; Cui, WX; Guo, W; Guo, K; Guo, H; Tao, K; Li, F; Shi, YW; Feng, DY; Yan, H; Gao, GD; Qu, Y				Luo, Jianing; Wu, Xun; Liu, Haixiao; Cui, Wenxing; Guo, Wei; Guo, Kang; Guo, Hao; Tao, Kai; Li, Fei; Shi, Yingwu; Feng, Dayun; Yan, Hao; Gao, Guodong; Qu, Yan			Antagonism of Protease-Activated Receptor 4 Protects Against Traumatic Brain Injury by Suppressing Neuroinflammation via Inhibition of Tab2/NF-kappa B Signaling	NEUROSCIENCE BULLETIN			English	Article						Protease-activated receptors; BMS; Traumatic brain injury; Inflammation; Astrocyte; Tab2	NF-KAPPA-B; UP-REGULATION; THROMBIN; PLATELET; CELLS; MODEL; MAINTENANCE; DISRUPTION; EXPRESSION; RESPONSES	Traumatic brain injury (TBI) triggers the activation of the endogenous coagulation mechanism, and a large amount of thrombin is released to curb uncontrollable bleeding through thrombin receptors, also known as protease-activated receptors (PARs). However, thrombin is one of the most critical factors in secondary brain injury. Thus, the PARs may be effective targets against hemorrhagic brain injury. Since the PAR1 antagonist has an increased bleeding risk in clinical practice, PAR4 blockade has been suggested as a more promising treatment. Here, we explored the expression pattern of PAR4 in the brain of mice after TBI, and explored the effect and possible mechanism of BMS-986120 (BMS), a novel selective and reversible PAR4 antagonist on secondary brain injury. Treatment with BMS protected against TBI in mice. mRNA-seq analysis, Western blot, and qRT-PCR verification in vitro showed that BMS significantly inhibited thrombin-induced inflammation in astrocytes, and suggested that the Tab2/ERK/NF-kappa B signaling pathway plays a key role in this process. Our findings provide reliable evidence that blocking PAR4 is a safe and effective intervention for TBI, and suggest that BMS has a potential clinical application in the management of TBI.	[Luo, Jianing; Wu, Xun; Liu, Haixiao; Cui, Wenxing; Guo, Wei; Guo, Kang; Guo, Hao; Tao, Kai; Li, Fei; Shi, Yingwu; Feng, Dayun; Gao, Guodong; Qu, Yan] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710038, Peoples R China; [Yan, Hao] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710038, Peoples R China		Gao, GD; Qu, Y (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710038, Peoples R China.	gguodong@fmmu.edu.cn; yanqu0123@fmmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81630027, 81571215]; Chang Jiang Scholar Program of China	This work was supported by grants from the National Natural Science Foundation of China (81630027, 81571215), and the Chang Jiang Scholar Program of China.	Alluri H, 2018, METHODS MOL BIOL, V1717, P37, DOI 10.1007/978-1-4939-7526-6_4; An CR, 2016, TRANSL STROKE RES, V7, P512, DOI 10.1007/s12975-016-0483-5; Bai LY, 2016, NEUROSCI BULL, V32, P27, DOI 10.1007/s12264-015-0007-4; Chen LM, 2017, NEUROSCI BULL, V33, P264, DOI 10.1007/s12264-016-0084-z; Chen PP, 2019, BIOORGAN MED CHEM, V27, P116, DOI 10.1016/j.bmc.2018.11.024; Chiu PJS, 1997, EUR J PHARMACOL, V321, P129, DOI 10.1016/S0014-2999(96)00931-4; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; CONNOLLY TM, 1994, THROMB HAEMOSTASIS, V72, P627; De Palma RG., 2015, BRAIN NEUROTRAUMA MO; Deng P, 2016, STEM CELL REP, V6, P456, DOI 10.1016/j.stemcr.2016.02.006; Derian CK, 2003, J PHARMACOL EXP THER, V304, P855, DOI 10.1124/jpet.102.042663; Hamilton JR, 2004, J THROMB HAEMOST, V2, P1429, DOI 10.1111/j.1538-7836.2004.00783.x; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; He JC, 2018, NEUROBIOL DIS, V117, P114, DOI 10.1016/j.nbd.2018.06.003; Ius T, 2018, NEURO-ONCOLOGY, V20, P776, DOI 10.1093/neuonc/nox234; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Kong XD, 2014, NEUROSCI BULL, V30, P903, DOI 10.1007/s12264-014-1481-9; Lee M, 2012, STROKE, V43, P3189, DOI 10.1161/STROKEAHA.112.670604; Li YJ, 2015, NEUROSCI BULL, V31, P755, DOI 10.1007/s12264-015-1532-2; Lin HL, 2013, PHARMACOL REV, V65, P1198, DOI 10.1124/pr.111.004747; Lindblad C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00015; Liu KL, 2016, MOL NUTR FOOD RES, V60, P430, DOI 10.1002/mnfr.201500178; Luaute J, 2016, ANN PHYS REHABIL MED, V59, P58, DOI 10.1016/j.rehab.2015.11.001; Mao YY, 2010, J CEREBR BLOOD F MET, V30, P1044, DOI 10.1038/jcbfm.2009.283; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Moschonas IC, 2017, PLATELETS, V28, P812, DOI 10.1080/09537104.2017.1282607; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Patel YM, 2014, J THROMB HAEMOST, V12, P716, DOI 10.1111/jth.12539; Patricio ES, 2015, J INVEST DERMATOL, V135, P2484, DOI 10.1038/jid.2015.183; Petzold T, 2020, CIRC RES, V126, P486, DOI 10.1161/CIRCRESAHA.119.315099; Piao CS, 2019, J CEREBR BLOOD F MET, V39, P58, DOI 10.1177/0271678X17742792; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Thibeault PE, 2020, J BIOL CHEM, V295, P2520, DOI 10.1074/jbc.RA119.011461; Wen WD, 2014, BIOORG MED CHEM LETT, V24, P4708, DOI 10.1016/j.bmcl.2014.08.021; Wilson SJ, 2018, ARTERIOSCL THROM VAS, V38, P448, DOI 10.1161/ATVBAHA.117.310104; Wong PC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf5294; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Wu JC, 2020, TRANSL STROKE RES, V11, P720, DOI 10.1007/s12975-019-00771-2; Wu K, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1428-1; Xi Y, 2018, BBA-MOL BASIS DIS, V1864, P2859, DOI 10.1016/j.bbadis.2018.05.018; Xu HY, 2020, AM J SPORT MED, V48, P197, DOI 10.1177/0363546519886120; Yang LJ, 2018, CELL PHYSIOL BIOCHEM, V46, P2532, DOI 10.1159/000489659; Yuan JW, 2020, CELL MOL NEUROBIOL, V40, P511, DOI 10.1007/s10571-019-00749-6; Zeng KW, 2015, J CELL BIOCHEM, V116, P1286, DOI 10.1002/jcb.25084; Zhang Q, 2013, BRAIN RES BULL, V99, P132, DOI 10.1016/j.brainresbull.2013.10.008; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0	49	2	2	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1673-7067	1995-8218		NEUROSCI BULL	Neurosci. Bull.	FEB	2021	37	2					242	254		10.1007/s12264-020-00601-8		OCT 2020	13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QE6OT	WOS:000584623300001	33111257				2022-02-06	
J	Wang, GM; Xue, H; Guo, ZJ; Yu, JL				Wang, Guang-Ming; Xue, Hang; Guo, Zhen-Jie; Yu, Jin-Lu			Cerebral infarct secondary to traumatic internal carotid artery dissection	WORLD JOURNAL OF CLINICAL CASES			English	Article						Internal carotid artery dissection; Brain infarction; Treatment; Prognosis	BLUNT CEREBROVASCULAR INJURIES; MANAGEMENT; DIAGNOSIS	BACKGROUND Traumatic internal carotid artery dissection (TICAD) is rare and can result in severe neurological disability and even death. No consensus regarding its diagnostic screening and management has been established. AIM To investigate the clinical presentation, imaging features, diagnostic workup, and treatment of TICAD. METHODS In this retrospective case series, emergency admissions for TICAD due to closed head injury were analyzed. The demographic, clinical, and radiographic data were retrieved from patient charts and the picture archiving and communication system. RESULTS Six patients (five males and one female, age range of 43-62 years, mean age of 52.67 years) presented with TICAD. Traffic accidents (4/6) were the most frequent cause of TICAD. The clinical presentation was always related to brain hypoperfusion. Imaging examination revealed dissection of the affected artery and corresponding brain infarction. All the patients were definitively diagnosed with TICAD. One patient was treated conservatively, one patient underwent anticoagulant therapy, two patients were given both antiplatelet and anticoagulant drugs, and two patients underwent decompressive craniectomy. One patient fully recovered, while three patients were disabled at follow-up. Two patients died of refractory brain infarction. CONCLUSION TICAD can cause catastrophic outcomes and even refractory brain hernia. Early and efficient diagnosis of TICAD is essential for initiating appropriate treatment. The treatment of TICAD is challenging and variable and is based on clinician discretion on a case-by-case basis.	[Wang, Guang-Ming; Xue, Hang; Guo, Zhen-Jie; Yu, Jin-Lu] First Hosp Jilin Univ, Dept Neurosurg, 71 Xinmin Ave, Changchun 130021, Jilin, Peoples R China		Yu, JL (corresponding author), First Hosp Jilin Univ, Dept Neurosurg, 71 Xinmin Ave, Changchun 130021, Jilin, Peoples R China.	jIyu@jlu.edu.cn		Yu, Jinlu/0000-0003-2329-7946			Almandoz JED, 2010, RADIOLOGY, V254, P236, DOI 10.1148/radiol.09090693; Bajko Z, 2018, J CRIT CARE MED, V4, P23, DOI [10.1515/jccm-2018-0003, 10.2478/jccm-2018-0003]; Bajko Z, 2016, J CRIT CARE MED, V2, P135, DOI 10.1515/jccm-2016-0021; Ben Hassen W, 2014, DIAGN INTERV IMAG, V95, P1151, DOI 10.1016/j.diii.2014.10.003; Benedict WJ, 2007, J NEUROL SCI, V256, P94, DOI 10.1016/j.jns.2007.02.016; Berne JD, 2010, J VASC SURG, V51, P57, DOI 10.1016/j.jvs.2009.08.071; Bouzat P, 2010, INTENS CARE MED, V36, P1514, DOI 10.1007/s00134-010-1919-0; Cohen JE, 2005, STROKE, V36, pE45, DOI 10.1161/01.STR.0000158910.08024.7f; Cohen JE, 2012, J TRAUMA ACUTE CARE, V72, P216, DOI 10.1097/TA.0b013e31823f630a; Cronlein M, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0153-1; Dandamudi VS, 2013, J NEUROIMAGING, V23, P429, DOI 10.1111/j.1552-6569.2012.00706.x; Daou B, 2017, NEUROSURGERY, V80, P368, DOI 10.1093/neuros/nyw086; DAVIS JW, 1990, J TRAUMA, V30, P1514, DOI 10.1097/00005373-199012000-00013; Debette S, 2009, LANCET NEUROL, V8, P668, DOI 10.1016/S1474-4422(09)70084-5; Delgado F, 2005, CEREBROVASC DIS, V19, P136, DOI 10.1159/000083243; Engelter ST, 2000, EUR NEUROL, V44, P199, DOI 10.1159/000008236; Esnault P, 2017, J NEUROSURG, V127, P16, DOI 10.3171/2016.4.JNS152600; Foreman PM, 2017, CEREBROVASC DIS EXTR, V7, P72, DOI 10.1159/000455391; Furtner M, 2006, CLIN J SPORT MED, V16, P76, DOI 10.1097/01.jsm.0000173267.84112.a0; Giossi A, 2014, NEUROLOGY, V83, P2032, DOI 10.1212/WNL.0000000000001030; Griessenauer CJ, 2016, J NEUROSURG, V124, P305, DOI 10.3171/2015.1.JNS142840; Jacobson LE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0040-7; Kowalski RG, 2017, STROKE, V48, P1802, DOI 10.1161/STROKEAHA.117.017327; KRAJEWSKI LP, 1980, ANN SURG, V191, P341, DOI 10.1097/00000658-198003000-00014; Kurre W, 2016, NEURORADIOLOGY, V58, P1167, DOI 10.1007/s00234-016-1757-z; Lohrer L, 2012, EUR SPINE J, V21, P837, DOI 10.1007/s00586-011-2009-x; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Misra S, 2016, J ORAL MAXIL SURG, V74, P123, DOI 10.1016/j.joms.2015.09.013; Ramchand P, 2018, J STROKE CEREBROVASC, V27, P438, DOI 10.1016/j.jstrokecerebrovasdis.2017.09.065; Robertson JJ, 2017, EMERG MED CLIN N AM, V35, P727, DOI 10.1016/j.emc.2017.06.006; Shindo T, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.104307; Sporns PB, 2019, CLIN NEURORADIOL, V29, P269, DOI 10.1007/s00062-018-0666-4; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tveita Ingrid Aune, 2017, J Med Case Rep, V11, P148, DOI 10.1186/s13256-017-1316-1; Vadikolias K, 2009, J CLIN ULTRASOUND, V37, P221, DOI 10.1002/jcu.20556; Vertinsky AT, 2008, AM J NEURORADIOL, V29, P1753, DOI 10.3174/ajnr.A1189; Zhou W, 2007, J VASC SURG, V46, P1044, DOI 10.1016/j.jvs.2007.06.026	38	2	3	0	1	BAISHIDENG PUBLISHING GROUP INC	PLEASANTON	7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES	2307-8960			WORLD J CLIN CASES	World J. Clin. Cases	OCT 26	2020	8	20					4773	4784		10.12998/wjcc.v8.i20.4773			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OY0RA	WOS:000593960300010	33195645	Green Published, gold			2022-02-06	
J	Loder, RT; Palma, S; Smith, M				Loder, Randall T.; Palma, Samantha; Smith, Maddie			Injury Patterns and Demographics in Child and Adolescent Assault Victims Presenting to US Emergency Departments	INTERNATIONAL JOURNAL OF PEDIATRICS			English	Article							SEXUAL ASSAULT; UNITED-STATES; VIOLENCE; LEVEL	Objective. To correlate injury patterns with patient demographics in child and adolescent assault victims. Methods. The National Electronic Injury Surveillance System-All Injury Program data for the years 2005 through 2015 was used. Injuries due to assault were identified and analyzed with SUDAAN 11.0.01 (TM) software to account for the weighted, stratified nature of the data. Results. There were an estimated 4,407,009 ED visits for assault in patients <= 19 years of age. With increasing age, the percentage of females decreased. Sexual assaults were more common in females (87.4%), and robbery/burglary was more common in males (79.8%). When the perpetrator was a spouse/partner, the assault victim was most commonly female (88.8%), and when a stranger, the assault victim was most commonly male (71.5%). With increasing age, the percentage of sexual assaults decreased while the reason for the assault being unknown increased. The assault occurred in the home in 59.6% of those <= 4 years of age, decreasing to 18.7% in those 15 to 19 years of age. The anatomic location was the head/neck in 32.8% of those <= 4 years of age, increasing to 60.6% in those 15-19 years old. Those <= 4 years old had the highest hospital admission rate (8.3%). The main diagnoses were concussion (3.0%), contusion/abrasion (33.3%), fracture (11.5%), laceration (11.5%), internal organ injury (11.5%), puncture (2.8%), and strain/sprain (20.7%). The number of assaults from 2005 to 2015 decreased for all age groups except for those <= 4 years old. Conclusions. These data provide a comprehensive overview of child and adolescent assault victims presenting to the ED in the USA and can be used as background data for further study. The decreasing numbers of assaults over the 11 years of the study are encouraging, and challenges still exist in decreasing the number for those <= 4 years old.	[Loder, Randall T.; Palma, Samantha; Smith, Maddie] Indiana Univ, Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA		Loder, RT (corresponding author), Indiana Univ, Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA.	rloder@iupui.edu		Loder, Randall/0000-0003-1217-0528; Palma, Samantha/0000-0002-6344-9708; Smith, Madeline/0000-0003-4003-6588	Garceau Professorship Endowment; Rapp Pediatric Orthopaedic Research Fund, Riley Children's Foundation	This study was supported in part by the Garceau Professorship Endowment and Rapp Pediatric Orthopaedic Research Fund, Riley Children's Foundation.	ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; Barmparas G, 2017, INT J SURG, V43, P137, DOI 10.1016/j.ijsu.2017.05.068; De Jong A R, 1983, Child Abuse Negl, V7, P155, DOI 10.1016/0145-2134(83)90067-4; Eveleth PB, 1990, WORLDWIDE VARIATION; Feldhaus KM, 2000, ANN EMERG MED, V36, P23, DOI 10.1067/mem.2000.107660; Fisher BS, 2003, CRIM JUSTICE BEHAV, V30, P6, DOI 10.1177/0093854802239161; Gebran SG, 2019, J CRANIOFAC SURG, V30, P2189, DOI 10.1097/SCS.0000000000005789; Gise R, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-018-1024-7; Herbert HK, 2012, J TRAUMA ACUTE CARE, V73, P168, DOI 10.1097/TA.0b013e31824d67c3; HOPKINS RS, 1989, AM J PREV MED, V5, P104, DOI 10.1016/S0749-3797(18)31112-7; Kalesan B, 2016, MATERN CHILD HLTH J, V20, P1082, DOI 10.1007/s10995-015-1894-8; Larsen ML, 2015, BJOG-INT J OBSTET GY, V122, P577, DOI 10.1111/1471-0528.13093; Loder RT, 2020, J FORENSIC LEG MED, V69, DOI 10.1016/j.jflm.2019.101887; Mollen CJ, 2003, PEDIATR EMERG CARE, V19, P379, DOI 10.1097/01.pec.0000101577.65509.95; Rennison C. M., 2002, 194530 NCJ US DEP JU; Sumner SA, 2015, JAMA-J AM MED ASSOC, V314, P478, DOI 10.1001/jama.2015.8371; Tjaden P., 2000, 183781 NCJ NAT DEP J; Tjaden P., 2000, 183781 NCJ NAT DEP J; United States Department of Health and Human Services Centers for Disease Control and Prevention US Consumer Product Safety Commission National Electronic Injury Surveillance System All Injury Program, 2015, NAT EL INJ SURV SYST; Vulliamy P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023114; Wainwright DJ, 2019, J CRANIOFAC SURG, V30, P1970, DOI 10.1097/SCS.0000000000005613; Walthall JDH, 2018, PEDIATR EMERG CARE, V34, P69, DOI 10.1097/PEC.0000000000000807; Wolitzky-Taylor KB, 2011, J AM COLL HEALTH, V59, P582, DOI 10.1080/07448481.2010.515634	23	2	2	1	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-9740	1687-9759		INT J PEDIAT	Int. J. Pediatr.	OCT 24	2020	2020								8169030	10.1155/2020/8169030			13	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	OT7MK	WOS:000591025600001	33163081	Green Published, gold			2022-02-06	
J	Huibregtse, ME; Nowak, MK; Kim, JE; Kalbfell, RM; Koppineni, A; Ejima, K; Kawata, K				Huibregtse, Megan E.; Nowak, Madeleine K.; Kim, Joseph E.; Kalbfell, Rachel M.; Koppineni, Alekhya; Ejima, Keisuke; Kawata, Keisuke			Does acute soccer heading cause an increase in plasma S100B? A randomized controlled trial	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; S-100 PROTEIN MEASUREMENTS; NEURON-SPECIFIC ENOLASE; SERUM-LEVELS; BIOCHEMICAL MARKERS; CEREBROSPINAL-FLUID; TISSUE DAMAGE; ELITE PLAYERS; ICE HOCKEY; BIOMARKERS	The purpose of this study was to test the effect of subconcussive head impacts on acute changes in plasma S100B. In this randomized controlled trial, 79 healthy adult soccer players were randomly assigned to either the heading (n = 41) or kicking-control groups (n = 38). The heading group executed 10 headers with soccer balls projected at a speed of 25 mph, whereas the kicking-control group performed 10 kicks. Plasma samples were obtained at pre-, 0h post-, 2h post- and 24h post-intervention and measured for S100B. The primary hypothesis was that there would be a significant group difference (group-by-time interaction) in plasma S100B at 2h post-intervention. Secondary hypotheses included (1) no significant group differences in plasma S100B concentrations at 0h post- and 24h post-intervention; (2) a significant within-group increase in S100B concentrations in the heading group at 2h post-intervention compared to pre-intervention; and (3) no significant within-group changes in plasma S100B in the kicking-control group. Data from 68 subjects were available for analysis (heading n = 37, kicking n = 31). There were no differences in S100B concentrations between heading and kicking groups over time, as evidenced by nonsignificant group-by-time interaction at 2h post-intervention (B = 2.20, 95%CI [-22.22, 26.63], p = 0.86) and at all the other time points (0h post: B = -11.05, 95%CI [-35.37, 13.28], p = 0.38; 24h post: B = 16.11, 95%CI [-8.29, 40.51], p = 0.20). Part of the secondary outcome, the heading group showed elevation in plasma S100B concentrations at 24h post-intervention compared to pre-heading baseline (B = 19.57, 95%CI [3.13, 36.02], p = 0.02), whereas all other within-group comparisons in both remained nonsignificant. The data suggest that 10 bouts of acute controlled soccer headings do not elevate S100B concentrations up to 24-hour post-heading. Further dose-response studies with longer follow-up time points may help determine thresholds of acute soccer heading exposure that are related to astrocyte activation. The protocol was registered under ClinicalTrials.gov (; retrospectively registered.).	[Huibregtse, Megan E.; Nowak, Madeleine K.; Kim, Joseph E.; Kalbfell, Rachel M.; Koppineni, Alekhya; Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA; [Ejima, Keisuke] Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth Bloomington, Bloomington, IN USA; [Kawata, Keisuke] Indiana Univ, Coll Arts & Sci, Program Neurosci, Bloomington, IN 47405 USA		Kawata, K (corresponding author), Indiana Univ, Dept Kinesiol, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA.; Kawata, K (corresponding author), Indiana Univ, Coll Arts & Sci, Program Neurosci, Bloomington, IN 47405 USA.	kkawata@indiana.edu		Kawata, Keisuke/0000-0003-4135-9311	Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health [ISCBIRF 0019939]; IU School of Public Health faculty research grant program [FRGP: 2246237]	This work was partly supported from the Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health (KK; ISCBIRF 0019939; https://www.in.gov/isdh/23657.htm) and IU School of Public Health faculty research grant program (KK; FRGP: 2246237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; [Anonymous], 2008, FORDHAM J CORP FIN L, V13, P511; [Anonymous], 2019, INTEL 64 IA 32 ARCHI, V3; Arora P, 2019, INDIAN J PSYCHIAT, V61, P70, DOI 10.4103/psychiatry.IndianJPsychiatry_391_16; Babbs C F, 2001, ScientificWorldJournal, V1, P281; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bevilacqua ZW, 2019, JOVE-J VIS EXP, DOI 10.3791/59381; Bevilacqua ZW, 2019, JOVE-J VIS EXP, V146, pe59381; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Dietrich MO, 2003, CAN J APPL PHYSIOL, V28, P710, DOI 10.1139/h03-054; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gannon JM, 2020, PSYCHIAT QUART, V91, P137, DOI 10.1007/s11126-019-09687-4; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Hatpio R, 2004, CLIN BIOCHEM, V37, P512, DOI 10.1016/j.clinbiochem.2004.05.012; Huang M, 2010, WORLD J EMERG MED, V1, P22; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Janigro D, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00528; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Keary TA, 2008, EXP AGING RES, V34, P101, DOI 10.1080/03610730701876920; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lindblad C, 2020, J NEUROTRAUM, V37, P1381, DOI 10.1089/neu.2019.6741; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; NCAA-Research, 2017, EST PROB COMP COLL A; Nowak MK, 2020, JAMA OPHTHALMOL, V138, P350, DOI 10.1001/jamaophthalmol.2019.6128; O'Connell B, 2018, CLIN J SPORT MED, V28, P561, DOI 10.1097/JSM.0000000000000478; Oris C, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0037; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Piata Wspolna Grupa Robocza Europejskiego Towarzystwa Kardiologicznego i Innych Towarzystw Naukowych ds, 2012, KARDIOL POL, V70, P1, DOI DOI 10.1227/NEU.0B013E31823021B2; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rogatzki MJ, 2018, SCAND J MED SCI SPOR, V28, P2505, DOI 10.1111/sms.13297; Rogatzki MJ, 2016, INT J IMMUNOPATH PH, V29, P450, DOI 10.1177/0394632016657091; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Saunders TD, 2020, CLIN BIOMECH, V74, P14, DOI 10.1016/j.clinbiomech.2020.02.003; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schroeter ML, 2002, NEUROREPORT, V13, P1675, DOI 10.1097/00001756-200209160-00021; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Stalnacke BM, 2008, BIOMARK INSIGHTS, V3, P87; Steiner J, 2008, NEUROSCIENCE, V154, P496, DOI 10.1016/j.neuroscience.2008.03.060; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Straume-Naesheim TM, 2008, NEUROSURGERY, V62, P1297, DOI 10.1227/01.neu.0000333301.34189.3d; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Wirsching A, 2019, J NEUROTRAUM, V36, P548, DOI 10.1089/neu.2018.5836; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zonner SW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00327	71	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0239507	10.1371/journal.pone.0239507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	WOS:000586649400052	33096545	Green Published, gold			2022-02-06	
J	Moll, A; Lara, M; Pomar, J; Orozco, M; Frontera, G; Llompart-Pou, JA; Moratinos, L; Gonzalez, V; Ibanez, J; Perez-Barcena, J				Moll, Apolonia; Lara, Monica; Pomar, Jaume; Orozco, Monica; Frontera, Guiem; Llompart-Pou, Juan A.; Moratinos, Lesmes; Gonzalez, Victor; Ibanez, Javier; Perez-Barcena, Jon			Effects of dexamethasone in traumatic brain injury patients with pericontusional vasogenic edema A prospective-observational DTI-MRI study	MEDICINE			English	Article						brain contusions; dexamethasone; diffusion tensor imaging; pericontusional edema; traumatic brain injury	CEREBRAL EDEMA; DIFFUSION	Cerebral edema is a frequent and serious complication in traumatic brain injury (TBI) patients. The objective is to study the effect of dexamethasone in patients with brain contusions, and to assess its effect on the vasogenic component of the pericontusional edema. Prospective-observational study to quantify, using magnetic resonance imaging, the volume of the edema before and after 10 days of dexamethasone in patients with brain contusions. Using diffusion tensor imaging, we have examined the effect of dexamethasone on fractional anisotropy (FA) and apparent diffusion coefficient (ADC). To assess changes, the pre- and post-treatment values for each patient were compared using a paired-samples Student t test. We included 30 TBI patients, 15 in each group. The volume of the vasogenic edema in the group of patients treated with dexamethasone decreased from 22 to 19 mL and this decrease was statistically significant (P < .05). Nevertheless, in the non-steroids group the volume of the vasogenic edema increased from 11 to 15 mL. There was a significant decrease in the ADC value (from 1.78-1.59; P < .05); and a significant increase in the FA value (0.09-0.11; P < .05) in the patients treated with dexamethasone. Using diffusion tensor imaging we have shown in a selected group of TBI patients with vasogenic pericontusional edema, a reduction of edema volume, a decrease in the ADC and an increase in the FA after treatment with dexamethasone. However, we have no data if such results are beneficial in terms of improving functional outcome.	[Moll, Apolonia; Orozco, Monica] Son Espases Hosp, Radiol Dept, Palma de Mallorca, Spain; [Lara, Monica; Moratinos, Lesmes; Gonzalez, Victor; Ibanez, Javier] Son Espases Hosp, Neurosurg Dept, Palma de Mallorca, Spain; [Pomar, Jaume] Res Inst Hlth IDISBA, Neuropsychol & Cognit Res Grp, Palma De Mallorca, Spain; [Pomar, Jaume] IUNICS UIB, Palma De Mallorca, Spain; [Frontera, Guiem] Son Espases Hosp, Res Inst Hlth IDISBA, Palma de Mallorca, Spain; [Llompart-Pou, Juan A.; Perez-Barcena, Jon] Son Espases Hosp, Intens Care Dept, Carretera Valldemossa 79, Palma de Mallorca 07120, Islas Baleares, Spain		Perez-Barcena, J (corresponding author), Son Espases Hosp, Intens Care Dept, Carretera Valldemossa 79, Palma de Mallorca 07120, Islas Baleares, Spain.	juan.perez@ssib.es		Ibanez, Javier/0000-0003-3735-8332			Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bastin ME, 2006, AM J NEURORADIOL, V27, P402; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; EBISU T, 1993, JMRI-J MAGN RESON IM, V3, P863, DOI 10.1002/jmri.1880030612; Edwards P, 2005, LANCET, V365, P1957; Emich S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-6; Gomes JA, 2005, CRIT CARE MED, V33, P1214, DOI 10.1097/01.CCM.0000166389.85273.38; Grassi DC, 2018, ARQ NEURO-PSIQUIAT, V76, P189, DOI [10.1590/0004-282X20180007, 10.1590/0004-282x20180007]; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kolias AG, 2018, TRIALS, V19, DOI 10.1186/s13063-018-3050-4; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Reynolds J.E.F, 1996, MARTINDALE EXTRA PHA, V31st ed; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sinha S, 2004, J NEUROL NEUROSUR PS, V75, P1632, DOI 10.1136/jnnp.2003.028647; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	23	2	2	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	OCT 23	2020	99	43							e22879	10.1097/MD.0000000000022879			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OP6IA	WOS:000588186800106	33120830	gold, Green Published			2022-02-06	
J	Barlow, KM; Kirk, V; Brooks, B; Esser, MJ; Yeates, KO; Zemek, R; Kirton, A; Mikrogianakis, A; MacMaster, F; Nettel-Aguirre, A; Hutchison, J; Turley, B; Cameron, C; Hill, M; Boyd, R; Dewey, D				Barlow, Karen Maria; Kirk, Valerie; Brooks, Brian; Esser, Michael Joachim; Yeates, Keith Owen; Zemek, Roger; Kirton, Adam; Mikrogianakis, Angelo; MacMaster, Frank; Nettel-Aguirre, Alberto; Hutchison, James; Turley, Brenda; Cameron, Candice; Hill, Michael; Boyd, Roslyn; Dewey, Deborah			Efficacy of Melatonin for Sleep Disturbance in Children with Persistent Post-Concussion Symptoms: Secondary Analysis of a Randomized Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						clinical trial; head trauma; pediatric brain injury; rehabilitation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; RELEASE MELATONIN; DISORDERS; SAFETY; INTERVENTION; ADOLESCENTS; PARAMETERS; INVENTORY; EXCRETION; PATTERNS	Sleep disturbances are commonly reported in children with persistent post-concussion symptoms (PPCS). Melatonin treatment is often recommended, yet supporting evidence is scarce. We aimed to evaluate the efficacy of treatment with melatonin for sleep disturbance in youth with PPCS following mild traumatic brain injury (mTBI). This article is a secondary analysis of a clinical trial of melatonin compared with placebo to treat PPCS. Youth (8-18 years of age) with PPCS and significant sleep-related problems (SRPs) at 4-6 weeks post-injury were eligible. Exclusion criteria: significant medical/psychiatric history; previous concussion/mTBI within 3 months. Treatment groups were: placebo, melatonin 3 mg, or melatonin 10 mg. Primary outcome was change in SRPs measured using the Post-Concussion Symptom Inventory (PCSI) after 2 weeks of treatment. Secondary outcomes included change in actigraphy sleep efficiency, duration, onset latency, and wake-after-sleep-onset. Behavior was measured using Behaviour Assessment for Children (2nd edition). Seventy-two participants (mean age 14.0, standard deviation [SD] = 2.6) years; 60% female) with PPCS and significant sleep disturbance were included in the secondary analysis: placebo (n = 22); melatonin 3 mg (n = 25); melatonin 10 mg (n = 25). Sixty-four participants had actigraphy data. SRPs decreased across all groups over time with a significant effect of melatonin 3 mg (3.7; 95% confidence interval [CI]: 2.1, 5.4) compared with placebo (7.4; 95% CI: 4.2, 10.6) and melatonin 10 mg (6.4; 95% CI: 3.6, 9.2). Sleep duration increased in the melatonin 3 mg (43 min; 95% CI: 6, 93) and melatonin 10 mg groups (55 min; 95% CI: 5, 104) compared with placebo. A per protocol analysis demonstrated improved sleep efficiency in the melatonin 10 mg group (p = 0.029). No serious adverse events were reported. Depressive symptoms significantly decreased with melatonin 3 mg (-4.7; 95% CI: -9.2, -.2) but not with melatonin 10 mg (-1.4, 95% CI: -5.9, 3.2) treatment compared with placebo. Changes in cognition or behavior were otherwise not significantly different between treatment groups. Short-term melatonin is a well-tolerated treatment for sleep disturbance in youth with PPCS following mTBI. In this context, it may also be associated with a reduction in depressive symptoms.	[Barlow, Karen Maria] Univ Queensland, Child Hlth Res Ctr, Fac Med & Biomed Sci, South Brisbane, Qld, Australia; [Barlow, Karen Maria; Kirk, Valerie; Kirton, Adam; Nettel-Aguirre, Alberto; Dewey, Deborah] Univ Calgary, Cumming Sch Med, Dept Paediat, Calgary, AB, Canada; [Hill, Michael] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian; Turley, Brenda] Alberta Childrens Prov Gen Hosp, Dept Pediat Clin Neurosci & Psychol, Calgary, AB, Canada; [Brooks, Brian; Turley, Brenda] Univ Calgary, Calgary, AB, Canada; [Esser, Michael Joachim] Univ Calgary, Fac Med, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [MacMaster, Frank] Univ Calgary, Dept Psychiat & Pediat, Calgary, AB, Canada; [Zemek, Roger] Childrens Hosp Eastern Ontario, Clin Res Unit, Ottawa, ON, Canada; [Mikrogianakis, Angelo] McMaster Childrens Hosp, Hamilton, ON, Canada; [Hutchison, James] Hosp Sick Children, Crit Care Med & Pediat, Toronto, ON, Canada; [Cameron, Candice] Alberta Hlth Serv, Res Pharm, Calgary, AB, Canada; [Boyd, Roslyn] Univ Queensland, Childrens Hlth Res Ctr, South Brisbane, Qld, Australia		Barlow, KM (corresponding author), Univ Queenslands Childrens Hlth Res Ctr, Acquired Brain Injury Children Res Program, Level 6,62 Graham St, South Brisbane, Qld 4101, Australia.	kbarlow@uq.edu.au	Nettel-Aguirre, Alberto/ABB-9412-2021; Boyd, Roslyn N/A-4498-2011; Yeates, Keith/AAJ-4223-2020; Mikrogianakis, Angelo/AAW-5929-2021; Hill, Michael D/C-9073-2012; Barlow, Karen/C-1323-2014	Boyd, Roslyn N/0000-0002-4919-5975; Mikrogianakis, Angelo/0000-0002-8854-0620; Hill, Michael D/0000-0002-6269-1543; MacMaster, Frank/0000-0002-7159-7583; Dewey, Deborah/0000-0002-1323-5832; Nettel-Aguirre, Alberto/0000-0001-6604-0652; Barlow, Karen/0000-0003-2612-8507	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [293375]; Alberta Children's Hospital Research Institute; University of Calgary [10006634]; Motor Accident Insurance Commission, Queensland, Australia [61278]	All phases of the research were funded by Canadian Institutes of Health Research (CIHR) grant number 293375, the Alberta Children's Hospital Research Institute, and the University of Calgary (10006634). Dr. Barlow acknowledges funding from the Motor Accident Insurance Commission, Queensland, Australia (61278).	Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; Andersen LPH, 2016, CLIN DRUG INVEST, V36, P169, DOI 10.1007/s40261-015-0368-5; Barlow KM, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-2812; Barlow KM, 2020, PEDIATR NEUROL, V105, P27, DOI 10.1016/j.pediatrneurol.2019.11.006; Barlow KM, 2019, J NEUROTRAUM, V36, P523, DOI 10.1089/neu.2018.5752; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Benloucif S, 2008, J CLIN SLEEP MED, V4, P66; Botchway EN, 2019, J HEAD TRAUMA REHAB, V34, P241, DOI 10.1097/HTR.0000000000000446; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Brooks BL, 2019, J NEUROTRAUM, V36, P2391, DOI 10.1089/neu.2018.6257; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Cortesi F, 2012, J SLEEP RES, V21, P700, DOI 10.1111/j.1365-2869.2012.01021.x; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Dodge NN, 2001, J CHILD NEUROL, V16, P581, DOI 10.2310/7010.2001.16810; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Ferracioli-Oda E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063773; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Griefahn B, 2003, J PINEAL RES, V34, P26, DOI 10.1034/j.1600-079X.2003.02931.x; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Grima NA, 2017, CURR OPIN PULM MED, V23, P493, DOI 10.1097/MCP.0000000000000429; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Gringas P, 2017, J AM ACAD CHILD PSY, V56, P948, DOI 10.1016/j.jaac.2017.09.414; Harpsoe NG, 2015, EUR J CLIN PHARMACOL, V71, P901, DOI 10.1007/s00228-015-1873-4; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Kennaway DJ, 2015, J PAEDIATR CHILD H, V51, P584, DOI 10.1111/jpc.12840; Klante G, 1997, J PINEAL RES, V23, P191, DOI 10.1111/j.1600-079X.1997.tb00354.x; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Landgraf JM, 1996, CHILD HLTH QUESTIONN; Landry-Roy C, 2018, J INT NEUROPSYCH SOC, V24, P769, DOI 10.1017/S1355617718000401; Lequerica A, 2015, ARCH PHYS MED REHAB, V96, P1802, DOI 10.1016/j.apmr.2015.05.011; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McMullan CJ, 2013, JAMA-J AM MED ASSOC, V309, P1388, DOI 10.1001/jama.2013.2710; Mrazik M, 2016, ARCH CLIN NEUROPSYCH, V31, P297, DOI 10.1093/arclin/acw013; Nguyen S, 2018, DISABIL REHABIL, V40, P1906, DOI 10.1080/09638288.2017.1315461; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; NOWAK R, 1987, CLIN ENDOCRINOL, V27, P445, DOI 10.1111/j.1365-2265.1987.tb01172.x; Pinto SM, 2017, PM&R, V9, P847, DOI 10.1016/j.pmrj.2016.12.009; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Short MA, 2013, NAT SCI SLEEP, V5, P23, DOI 10.2147/NSS.S38369; Stocker RPJ, 2017, ARCH CLIN NEUROPSYCH, V32, P349, DOI 10.1093/arclin/acx003; Tham SW, 2019, BRAIN INJURY, V33, P1413, DOI 10.1080/02699052.2019.1643921; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Tomfohr-Madsen L, 2020, J HEAD TRAUMA REHAB, V35, pE103, DOI 10.1097/HTR.0000000000000504; Waldhauser F, 1998, EXP GERONTOL, V33, P759, DOI 10.1016/S0531-5565(98)00054-0; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Witt-Enderby PA, 2003, LIFE SCI, V72, P2183, DOI 10.1016/S0024-3205(03)00098-5	57	2	2	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					950	959		10.1089/neu.2020.7154		OCT 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000583923100001	32988292				2022-02-06	
J	Dalla Mora, A; Di Sieno, L; Behera, A; Taroni, P; Contini, D; Torricelli, A; Pifferi, A				Dalla Mora, Alberto; Di Sieno, Laura; Behera, Anurag; Taroni, Paola; Contini, Davide; Torricelli, Alessandro; Pifferi, Antonio			The SiPM revolution in time-domain diffuse optics	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Time-domain diffuse optics; Silicon photomultiplier; Single-photon avalanche diode; Photon scattering; Near-infrared spectroscopy; Time-correlated single-photon counting	SILICON PHOTOMULTIPLIER; SPECTROSCOPY; PENETRATION; PERFORMANCE; DEPTH	Time-domain diffuse optics is a powerful non-invasive, non-ionizing and label-free technique based on the use of picosecond pulsed laser light to probe highly scattering media like biological tissues down to a depth of few centimeters to obtain functional and compositional information. This technique is opening new perspectives in various fields spanning from oncology (e.g. characterization of breast or thyroid lesions, etc.) to neurology (e.g. diagnosis and monitoring of traumatic brain injuries, functional brain imaging, etc.), as well as in non-biomedical fields (e.g. characterization of fruits, wood, etc.). Time-domain diffuse optics is nowadays undergoing fascinating technology advancements, permitting for the first time the design of low-cost compact/wearable high performance systems. This revolution has been made possible also taking advantage from Silicon PhotoMultiplier (SiPM) progresses, originally driven by other applications, since time-domain diffuse optics is highly demanding in terms of performance, in particular requiring single-photon detectors with large collection area, high fill-factor, high single-photon timing resolution, low power dissipation and compact high-throughput front-end electronics. This work will review the recent advancements introduced by SiPMs in time-domain diffuse optics, mostly thanks to the support of different running EU H2020 projects (e.g. SOLUS -G.A.731877-, LUCA -G.A.688303-, BITMAP -G.A.675332-, ATTRACT -G.A.777222-, Laserlab-Europe -G.A.654148-), showing their present performances in this field, the inherent advantages that allowed the design of innovative diffuse optical imaging systems, as well as highlighting their present limitations in order to push forward the research towards the perfect SiPM for time-domain diffuse optics.	[Dalla Mora, Alberto; Di Sieno, Laura; Behera, Anurag; Taroni, Paola; Contini, Davide; Torricelli, Alessandro; Pifferi, Antonio] Politecn Milan, Dipartimento Fis, Piazza Leonardo Vinci 32, I-20133 Milan, Italy; [Taroni, Paola; Torricelli, Alessandro; Pifferi, Antonio] CNR, Ist Foton & Nanotecnol, Piazza Leonardo Vinci 32, I-20133 Milan, Italy		Dalla Mora, A (corresponding author), Politecn Milan, Dipartimento Fis, Piazza Leonardo Vinci 32, I-20133 Milan, Italy.	alberto.dallamora@polimi.it	Di Sieno, Laura/J-3509-2016		ECEuropean CommissionEuropean Commission Joint Research Centre [731877, 688303, 675332, 777222, 654148]	The research leading to these results has received partial funding from the EC's H2020 Framework Programme under grant agreement No 731877 (SOLUS), No 688303 (LUCA), No 675332 (BITMAP), No 777222 (ATTRACT) and No. 654148 (Laserlab-Europe). SOLUS and LUCA are initiatives of the Photonics Public Private Partnership (www.photonics21.org).	Alerstam E, 2012, OPT LETT, V37, P2877, DOI 10.1364/OL.37.002877; ANDERSSONENGELS S, 1993, OPT LETT, V18, P1697, DOI 10.1364/OL.18.001697; Bargigia I, 2013, J NEAR INFRARED SPEC, V21, P259, DOI 10.1255/jnirs.1068; Becker W., 2005, ADV TIME CORRELATED; Behera A, 2018, BIOMED OPT EXPRESS, V9, P5524, DOI 10.1364/BOE.9.005524; Bruzzone L., 2019, 2019 IEEE CUST INT C, P1; Buttafava M., 2017, IEEE PHOTONICS J, V9, P1, DOI [10.1109/JPHOT.2016.2632061, DOI 10.1109/JPHOT.2016.2632061]; Buttafava M, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4893385; Contini D., 2007, P SOC PHOTO-OPT INS, V6629, P1; Contini D, 2015, J PHYS D APPL PHYS, V48, DOI 10.1088/0022-3727/48/4/045401; Corten L, 2020, PHYS OCCUP THER PEDI, V40, P192, DOI 10.1080/01942638.2019.1647329; D'Andrea C, 2012, APPL OPTICS, V51, P7858, DOI 10.1364/AO.51.007858; Dalla Mora A, 2015, J APPL PHYS, V117, DOI 10.1063/1.4915332; Dalla Mora A., 2012, APPL PHYS LETT, V100, P1; Dalla Mora A, 2015, OPT EXPRESS, V23, P13937, DOI 10.1364/OE.23.013937; Dalla Mora A, 2015, BIOMED OPT EXPRESS, V6, P1749, DOI 10.1364/BOE.6.001749; Dalla Mora A, 2010, IEEE J SEL TOP QUANT, V16, P1023, DOI 10.1109/JSTQE.2009.2035823; Del Bianco S, 2002, PHYS MED BIOL, V47, P4131, DOI 10.1088/0031-9155/47/23/301; Di Sieno L., 2016, J BIOMED OPT, V21, P1; Di Sieno L, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.8.085004; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Dutton N. A. W., 2015, IEEE INT SOL STAT CI, V11, P1; Eggebrecht AT, 2014, NAT PHOTONICS, V8, P448, DOI 10.1038/nphoton.2014.107; Farina A., APPL SCI, V7, P1; Ferocino E, 2018, BIOMED OPT EXPRESS, V9, P755, DOI 10.1364/BOE.9.000755; Ferrari M, 2012, J NEAR INFRARED SPEC, V20, P1, DOI 10.1255/jnirs.973; Fujisaka S, 2016, ADV EXP MED BIOL, V876, P427, DOI 10.1007/978-1-4939-3023-4_54; Grosenick D, 2015, SPRINGER SER FLUORES, V15, P343, DOI 10.1007/4243_2014_74; Grosenick D, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.091311; Gulinatti A, 2005, ELECTRON LETT, V41, P272, DOI 10.1049/el:20047445; Hebden JC, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P503, DOI 10.1109/ISBI.2012.6235595; Itzler MA, 2007, J MOD OPTIC, V54, P283, DOI 10.1080/09500340600792291; Jiang XD, 2009, PROC SPIE, V7320, DOI 10.1117/12.818681; Kacprzak M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2743964; Khoptyar D, 2013, OPT EXPRESS, V21, P20941, DOI 10.1364/OE.21.020941; Krstajic N, 2015, OPT LETT, V40, P4305, DOI 10.1364/OL.40.004305; Lanka P., 2018, P SOC PHOTO-OPT INS, V10685, P1; Lindensmith CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147700; Markovic B, 2013, IEEE T CIRCUITS-I, V60, P557, DOI 10.1109/TCSI.2012.2215737; Martelli F., 2016, SCI REP, V6, P1, DOI DOI 10.1038/SREP27057; Martinenghi E, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4954968; Martinenghi E, 2015, IEEE PHOTONICS J, V7, DOI 10.1109/JPHOT.2015.2456070; Mazurenka M, 2013, BIOMED OPT EXPRESS, V4, P2257, DOI 10.1364/BOE.4.002257; Ohmae E, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804931; Pifferi A, 2005, APPL OPTICS, V44, P2104, DOI 10.1364/AO.44.002104; Pifferi A., 2016, J BIOMEDICAL OPTICS, V21, P1; Pifferi A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.138101; Puszka A, 2015, BIOMED OPT EXPRESS, V6, P1, DOI 10.1364/BOE.6.000001; Re R, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.4.045004; Renna M, 2019, IEEE J SEL TOP QUANT, V25, DOI 10.1109/JSTQE.2018.2863570; Saha S, 2018, IEEE PHOTONIC TECH L, V30, P1515, DOI 10.1109/LPT.2018.2854272; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Sekar S. Konugolu Venkata, 2017, J BIOMED OPT, V22, P1; Sekar SKV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27684-8; Sekar SKV, 2017, BIOPHYS CHEM, V229, P130, DOI 10.1016/j.bpc.2017.07.004; Sekar SKV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168426; Sekar SKV, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2015.2506613; Selb J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852553; Steinbrink J, 2001, PHYS MED BIOL, V46, P879, DOI 10.1088/0031-9155/46/3/320; Taroni P., 2018, DIAGN IMAGING EUR, V34, P20; Taroni P, 2009, OPT EXPRESS, V17, P15932, DOI 10.1364/OE.17.015932; Torricelli A., 2005, PHYS REV LETT, V95, P1; Torricelli A, 2008, SENS INSTRUM FOOD QU, V2, P82, DOI DOI 10.1007/S11694-008-9036-2; Torricelli A, 2015, CHEM ENGINEER TRANS, V44, P43, DOI 10.3303/CET1544008; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106; Tosi A, 2011, IEEE PHOTONICS J, V3, P31, DOI 10.1109/JPHOT.2010.2100037; Tyndall D, 2012, IEEE T BIOMED CIRC S, V6, P562, DOI 10.1109/TBCAS.2012.2222639; Wabnitz H., 2014, J BIOMED OPT, V19, P1; Wabnitz H, 2010, ADV EXP MED BIOL, V662, P143, DOI 10.1007/978-1-4419-1241-1_20; Wilson RH, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.3.030901; Yamamoto Y, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9010039; YODH A, 1995, PHYS TODAY, V48, P34, DOI 10.1063/1.881445; Zhang J, 2015, LIGHT-SCI APPL, V4, DOI 10.1038/lsa.2015.59; Zouaoui J, 2017, BIOMED OPT EXPRESS, V8, P4772, DOI 10.1364/BOE.8.004772	74	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	OCT 21	2020	978								164411	10.1016/j.nima.2020.164411			7	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Nuclear; Physics, Particles & Fields	Science Citation Index Expanded (SCI-EXPANDED)	Instruments & Instrumentation; Nuclear Science & Technology; Physics	NA8OF	WOS:000560076700003					2022-02-06	
J	Mikolic, A; Polinder, S; Steyerberg, EW; Helmrich, IRAR; Giacino, JT; Maas, AIR; van der Naalt, J; Voormolen, DC; von Steinbuchel, N; Wilson, L; Lingsma, HF; van Klaveren, D				Mikolic, Ana; Polinder, Suzanne; Steyerberg, Ewout W.; Retel Helmrich, Isabel R. A.; Giacino, Joseph T.; Maas, Andrew I. R.; van der Naalt, Joukje; Voormolen, Daphne C.; von Steinbuechel, Nicole; Wilson, Lindsay; Lingsma, Hester F.; van Klaveren, David		CENTER TBI Study Pa	Prediction of Global Functional Outcome and Post-Concussive Symptoms after Mild Traumatic Brain Injury: External Validation of Prognostic Models in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study	JOURNAL OF NEUROTRAUMA			English	Article						external validation; Glasgow Outcome Scale Extended; mild traumatic brain injury; post-concussive symptoms; prognostic model	RISK-FACTORS; HEAD-INJURY; RECOVERY; CARE; QUESTIONNAIRE; EPIDEMIOLOGY; PREVALENCE; PREVENTION; BIOMARKERS; GUIDELINES	The majority of traumatic brain injuries (TBIs) are categorized as mild, according to a baseline Glasgow Coma Scale (GCS) score of 13-15. Prognostic models that were developed to predict functional outcome and persistent post-concussive symptoms (PPCS) after mild TBI have rarely been externally validated. We aimed to externally validate models predicting 3-12-month Glasgow Outcome Scale Extended (GOSE) or PPCS in adults with mild TBI. We analyzed data from the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) project, which included 2862 adults with mild TBI, with 6-month GOSE available for 2374 and Rivermead Post-Concussion Symptoms Questionnaire (RPQ) results available for 1605 participants. Model performance was evaluated based on calibration (graphically and characterized by slope and intercept) and discrimination (C-index). We validated five published models for 6-month GOSE and three for 6-month PPCS scores. The models used different cutoffs for outcome and some included symptoms measured 2 weeks post-injury. Discriminative ability varied substantially (C-index between 0.58 and 0.79). The models developed in the Corticosteroid Randomisation After Significant Head Injury (CRASH) trial for prediction of GOSE <5 discriminated best (C-index 0.78 and 0.79), but were poorly calibrated. The best performing models for PPCS included 2-week symptoms (C-index 0.75 and 0.76). In conclusion, none of the prognostic models for early prediction of GOSE and PPCS has both good calibration and discrimination in persons with mild TBI. In future studies, prognostic models should be tailored to the population with mild TBI, predicting relevant end-points based on readily available predictors.	[Mikolic, Ana; Polinder, Suzanne; Steyerberg, Ewout W.; Retel Helmrich, Isabel R. A.; Voormolen, Daphne C.; Lingsma, Hester F.; van Klaveren, David] Erasmus MC, Univ Med Ctr, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Cambridge, MA USA; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Antwerp, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Antwerp, Belgium; [van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [von Steinbuechel, Nicole] Georg August Univ, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling, Scotland; [van Klaveren, David] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Predict Analyt & Comparat Effectiveness Ctr, Boston, MA 02111 USA		Mikolic, A (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.mikolic@erasmusmc.nl	Sahuquillo, Juan/B-3577-2008; Vande Vyvere, Thijs/AAB-5180-2022; Giacino, Joseph/AAF-1952-2021; Posti, Jussi P./Y-2908-2019; Castano-Leon, Ana M/ABF-6322-2020; Raj, Rahul/K-7693-2012; Gomez, Pedro/E-2411-2014	Sahuquillo, Juan/0000-0003-0713-5875; Vande Vyvere, Thijs/0000-0003-4032-5443; Giacino, Joseph/0000-0002-7916-9698; Posti, Jussi P./0000-0002-5925-5193; Castano-Leon, Ana M/0000-0002-7918-5049; Coles, Jonathan/0000-0003-4013-679X; Rossi, Sandra/0000-0002-9963-8121; Van Essen, Thomas/0000-0003-4657-5283; Newcombe, Virginia/0000-0001-6044-9035; Dark, Paul/0000-0003-3309-0164; van der Naalt, Joukje/0000-0001-9873-2418; Sakowitz, Oliver/0000-0003-3248-6335; Raj, Rahul/0000-0003-4243-9591; Zeiler, Frederick/0000-0003-1737-0510; Gomez, Pedro/0000-0002-4185-5238; Sanchez-Porras, Renan/0000-0002-9084-8114; Stewart, William/0000-0003-2199-2582; Radoi, Andreea/0000-0002-0677-3544; Kondziella, Daniel/0000-0001-5562-9808	European Union 7th Framework programme (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Neurotrauma Sciences (USA)	The authors Mikolic, Polinder, Steyerberg, Retel Helmrich, Maas, Voormolen, Steinbuechel, Wilson, and Lingsma were supported by the European Union 7th Framework programme (EC grant 602150). Additional support was obtained from the Hannelore Kohl Stiftung (Germany), OneMind (USA), Integra LifeSciences Corporation (USA), and Neurotrauma Sciences (USA).	Acquadro C, 2008, VALUE HEALTH, V11, P509, DOI 10.1111/j.1524-4733.2007.00292.x; Andelic N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/2678081; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; Booker J, 2019, BRAIN INJURY, V33, P1158, DOI 10.1080/02699052.2019.1629626; Booker James, 2019, Br J Neurosurg, V33, P367, DOI 10.1080/02688697.2019.1598542; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Buuren S., 2011, J STAT SOFTW, V45, DOI [DOI 10.18637/JSS.V045.I03, 10.18637/jss.v045.i03]; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Hellstrom T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00125; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson G, 2007, BRAIN INJURY MED PRI; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Plass AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210138; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Teymoori A, 2020, J AFFECT DISORDERS, V262, P278, DOI 10.1016/j.jad.2019.10.035; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Van Calster B, 2016, J CLIN EPIDEMIOL, V74, P167, DOI 10.1016/j.jclinepi.2015.12.005; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van Klaveren D, 2016, STAT MED, V35, P4136, DOI 10.1002/sim.6997; Van Praag DLG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231857; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343; Yue JK, 2018, NEUROL RES, V40, P972, DOI 10.1080/01616412.2018.1505416; Yue JK, 2017, BRAIN INJURY, V31, P1820, DOI 10.1080/02699052.2017.1351000; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	68	2	2	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2021	38	2					196	209		10.1089/neu.2020.7074		OCT 2020	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PP0TL	WOS:000581637600001	32977737	Green Submitted, Green Published, hybrid			2022-02-06	
J	Morin, A; Mouzon, B; Ferguson, S; Paris, D; Browning, M; Stewart, W; Mullan, M; Crawford, F				Morin, Alexander; Mouzon, Benoit; Ferguson, Scott; Paris, Daniel; Browning, Mackenzie; Stewart, William; Mullan, Mike; Crawford, Fiona			Nilvadipine suppresses inflammation via inhibition of P-SYK and restores spatial memory deficits in a mouse model of repetitive mild TBI	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article							TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; TAU	Repeated exposure to mild TBI (mTBI) has been linked to an increased risk of Alzheimer's disease (AD), chronic traumatic encephalopathy (CTE) and other neurodegenerative diseases. Some pathological features typically observed in AD have been found in postmortem brains of TBI and CTE, hence treatments tested for AD have a potential to be effective against r-mTBI outcomes. Neuroinflammation may present a possible answer due to its central role both in acute brain injury and in chronic degenerative-like disorders. Our previous studies have shown that drug nilvadipine, acting as an inhibitor of spleen tyrosine kinase (SYK), is effective at reducing inflammation, tau hyperphosphorylation and amyloid production in AD mouse models. To demonstrate the effect of nilvadipine in the absence of age-related variables, we introduced the same treatment to young r-mTBI mice. We further investigate therapeutic mechanisms of nilvadipine using its racemic properties. Both enantiomers, (+)-nilvadipine and (-)-nilvadipine, can lower SYK activity, whereas (+)-nilvadipine is also a potent L-type calcium channel blocker (CCB) and shown to be anti-hypertensive. All r-mTBI mice exhibited increased neuroinflammation and impaired cognitive performance and motor functions. Treatment with racemic nilvadipine mitigated the TBI-induced inflammatory response and significantly improved spatial memory, whereas (-)-enantiomer decreased microgliosis and improved spatial memory but failed to reduce the astroglial response to as much as the racemate. These results suggest the therapeutic potential of SYK inhibition that is enhanced when combined with the CCB effect, which indicate a therapeutic advantage of multi-action drugs for r-mTBI.	[Morin, Alexander; Mouzon, Benoit; Ferguson, Scott; Paris, Daniel; Browning, Mackenzie; Mullan, Mike; Crawford, Fiona] Roskamp Inst, Sarasota, FL 34243 USA; [Morin, Alexander; Mouzon, Benoit; Ferguson, Scott; Paris, Daniel; Mullan, Mike; Crawford, Fiona] Open Univ, Milton Keynes, Bucks, England; [Morin, Alexander; Mouzon, Benoit; Ferguson, Scott; Paris, Daniel; Crawford, Fiona] James A Haley Vet Adm, Tampa, FL 33637 USA; [Stewart, William] Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland		Morin, A (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.; Morin, A (corresponding author), Open Univ, Milton Keynes, Bucks, England.; Morin, A (corresponding author), James A Haley Vet Adm, Tampa, FL 33637 USA.	amorin@roskampinstitute.net		Morin, Alexander/0000-0002-2895-985X; Stewart, William/0000-0003-2199-2582	Department of Veterans Affairs VA MeritUS Department of Veterans Affairs [I01RX002334]; Roskamp Institute	This work was supported by the Department of Veterans Affairs VA Merit [I01RX002334 (PI: F. Crawford)] and by the Roskamp Institute. The contents do not represent the views of the Department of Veterans Affairs, or the United States Government.	Abdullah L, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00149; Bachmeier C, 2011, EUR J PHARMACOL, V659, P124, DOI 10.1016/j.ejphar.2011.03.048; BROGDEN RN, 1995, DRUG AGING, V6, P150, DOI 10.2165/00002512-199506020-00007; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hanyu H, 2007, INT J GERIATR PSYCH, V22, P1264, DOI 10.1002/gps.1851; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kennelly SP, 2011, INT J GERIATR PSYCH, V26, P1038, DOI 10.1002/gps.2638; Lawlor B, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002660; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Mckee AC, 2018, HDB CLIN NEUROL, V25, P350; MITCHELL AS, 2018, BRAIN NEUROSCI ADV, V2, P1, DOI DOI 10.1177/2398212818757098; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Morin A, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00292; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Paris D, 2004, BRAIN RES, V999, P53, DOI 10.1016/j.brainres.2003.11.061; Paris D, 2014, J BIOL CHEM, V289, P33927, DOI 10.1074/jbc.M114.608091; Paris D, 2011, MOL MED, V17, P149, DOI 10.2119/molmed.2010.00180; Peters J, 2015, THER ADV CHRONIC DIS, V6, P160, DOI 10.1177/2040622315582353; Schweig JE, 2019, J BIOL CHEM, V294, P13378, DOI 10.1074/jbc.RA119.008033; Schweig JE, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0472-2; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tateno A, 2015, GEN HOSP PSYCHIAT, V37, DOI 10.1016/j.genhosppsych.2014.09.016; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Xu GZ, 2013, BRAIN RES BULL, V99, P41, DOI 10.1016/j.brainresbull.2013.09.011	35	2	2	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	OCT 19	2020	8	1							166	10.1186/s40478-020-01045-x			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OL1NL	WOS:000585108400001	33076989	Green Accepted, Green Published, gold			2022-02-06	
J	Auger, J; Markel, J; Pecoski, DD; Leiva-Molano, N; Talavage, TM; Leverenz, L; Shen, FC; Nauman, EA				Auger, Joshua; Markel, Justin; Pecoski, Dimitri D.; Leiva-Molano, Nicolas; Talavage, Thomas M.; Leverenz, Larry; Shen, Francis; Nauman, Eric A.			Factors affecting peak impact force during soccer headers and implications for the mitigation of head injuries	PLOS ONE			English	Article							HIGH-SCHOOL; UNITED-STATES; CONCUSSIONS; FOOTBALL; PERFORMANCE; PLAYERS	It has been documented that up to 22% of all soccer injuries are concussions. This is in part due to players purposely using their head to direct the ball during play. To provide a more complete understanding of head trauma in soccer athletes, this study characterized the effects of four soccer ball characteristics (size, inflation pressure, mass, velocity) on the resulting peak impact force as it relates to the potential for incurring neurophysiological changes. A total of six hundred trials were performed on size 4 and 5 soccer balls as well as a novel lightweight soccer ball. Impact force was measured with a force plate and ball velocity was determined using motion capture. These data were used, in conjunction with dimensional analysis to relate impact force to ball size, mass, velocity, and pressure. Reasonable reductions in allowable ball parameters resulted in a 19.7% decrease in peak impact force. Adjustments to ball parameters could reduce a high cumulative peak translational acceleration soccer athlete down into a previously defined safer low loading range. In addition, it was noted that water absorption by soccer balls can result in masses that substantially increase impact force and quickly surpass the NCAA weight limit for game play. Additional research is required to determine whether varying soccer ball characteristics will enable soccer players to avoid persistent neurophysiological deficits or what additional interventions may be necessary and the legal implications of these data are discussed.	[Auger, Joshua; Markel, Justin; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Pecoski, Dimitri D.; Leiva-Molano, Nicolas; Talavage, Thomas M.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Leverenz, Larry; Nauman, Eric A.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Shen, Francis] Univ Minnesota, Sch Law, Minneapolis, MN 55455 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Nauman, EA (corresponding author), Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA.; Nauman, EA (corresponding author), Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA.; Nauman, EA (corresponding author), Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA.	enauman@purdue.edu		Auger, Joshua/0000-0003-4281-8591; Leiva-Molano, Nicolas/0000-0002-8734-8813; Talavage, Thomas/0000-0003-4977-6398			Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Andres K, 2016, NCAA 2016 2017 MENS; [Anonymous], 2016, MATLAB VERS R2016B; [Anonymous], **NON-TRADITIONAL**; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barenblatt G. I., 2003, CAMBRIDGE TEXTS APPL; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2003, J ATHL TRAINING, V38, P220; com F, 2007, COM F FIFA BIG COUNT; COTTER SC, 1974, J ROY STAT SOC B MET, V36, P267; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Elbin RJ, 2015, RES SPORTS MED, V23, P203, DOI 10.1080/15438627.2015.1005293; FIFA, 2015, LAWS GAM 2015 2016; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koizumi A, 2014, PROCEDIA ENGINEER, V72, P423, DOI 10.1016/j.proeng.2014.06.074; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Schuff MM, 2013, J MATH BIOL, V67, P1307, DOI 10.1007/s00285-012-0544-7; Soccer USY, 2017, RUL GAM; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, BRAIN IMAGING BEHAV; Taha Z, 2015, SADHANA-ACAD P ENG S, V40, P1567, DOI 10.1007/s12046-015-0383-5; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512	36	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240162	10.1371/journal.pone.0240162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	WOS:000585918300021	33064732	gold, Green Published			2022-02-06	
J	Fleischmann, C; Shohami, E; Trembovler, V; Heled, Y; Horowitz, M				Fleischmann, Chen; Shohami, Esther; Trembovler, Victoria; Heled, Yuval; Horowitz, Michal			Cognitive Effects of Astaxanthin Pretreatment on Recovery From Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						astaxanthin; traumatic brain injury (TBI); cognitive tests; neurological severity score (NSS); Y maze; object recognition test (ORT); nutritional supplementation Astaxanthin pretreatment and TBI recovery	CLOSED-HEAD INJURY; DISODIUM DISUCCINATE ASTAXANTHIN; POSTTRAUMATIC-STRESS-DISORDER; IMPROVES FUNCTIONAL RECOVERY; NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS; CEREBRAL-ISCHEMIA; MEMORY DEFICITS; GENE-EXPRESSION; DOUBLE-BLIND	Traumatic brain injury (TBI), caused by mechanical impact to the brain, is a leading cause of death and disability among young adults, with slow and often incomplete recovery. Preemptive treatment strategies may increase the injury resilience of high-risk populations such as soldiers and athletes. In this work, the xanthophyll carotenoid Astaxanthin was examined as a potential nutritional preconditioning method in mice (sabra strain) to increase their resilience prior to TBI in a closed head injury (CHI) model. The effect of Astaxanthin pretreatment on heat shock protein (HSP) dynamics and functional outcome after CHI was explored by gavage or free eating (in pellet form) for 2 weeks before CHI. Assessment of neuromotor function by the neurological severity score (NSS) revealed significant improvement in the Astaxanthin gavage-treated group (100 mg/kg, ATX) during recovery compared to the gavage-treated olive oil group (OIL), beginning at 24 h post-CHI and lasting throughout 28 days (p < 0.007). Astaxanthin pretreatment in pellet form produced a smaller improvement in NSS vs. posttreatment at 7 days post-CHI (p < 0.05). Cognitive and behavioral evaluation using the novel object recognition test (ORT) and the Y Maze test revealed an advantage for Astaxanthin administration via free eating vs. standard chow during recovery post-CHI (ORT at 3 days, p < 0.035; improvement in Y Maze score from 2 to 29 days, p < 0.02). HSP profile and anxiety (open field test) were not significantly affected by Astaxanthin. In conclusion, astaxanthin pretreatment may contribute to improved recovery post-TBI in mice and is influenced by the form of administration.	[Fleischmann, Chen] IDF Med Corps, Inst Mil Physiol, Tel Hashomer, Israel; [Fleischmann, Chen; Heled, Yuval] Sheba Med Ctr, Heller Inst Med Res, Ramat Gan, Israel; [Fleischmann, Chen; Horowitz, Michal] Hebrew Univ Jerusalem, Lab Environm Physiol, Jerusalem, Israel; [Shohami, Esther; Trembovler, Victoria] Hebrew Univ Jerusalem, Inst Drug Res, Dept Pharmacol, Jerusalem, Israel; [Heled, Yuval] Kibbutzim Coll, Tel Aviv, Israel		Fleischmann, C (corresponding author), IDF Med Corps, Inst Mil Physiol, Tel Hashomer, Israel.; Fleischmann, C (corresponding author), Sheba Med Ctr, Heller Inst Med Res, Ramat Gan, Israel.; Fleischmann, C (corresponding author), Hebrew Univ Jerusalem, Lab Environm Physiol, Jerusalem, Israel.	Chen.fleischmann@sheba.health.gov.il			Israel Defense Forces (IDF) Medical Corps; Directorate of Defense Research & Development Israeli Ministry of Defense (IMOD DDRD) [4440518389, 4440772172]	Research reported in this publication was supported by the Israel Defense Forces (IDF) Medical Corps and Directorate of Defense Research & Development Israeli Ministry of Defense (IMOD DDR&D), grant numbers 4440518389 and 4440772172.	Adluri RS, 2013, CELL BIOCHEM BIOPHYS, V67, P281, DOI 10.1007/s12013-011-9300-7; Aoi W, 2003, ANTIOXID REDOX SIGN, V5, P139, DOI 10.1089/152308603321223630; Asmaro K, 2013, CURR DRUG TARGETS, V14, P74, DOI 10.2174/138945013804806505; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Barringer Nick, 2012, J Spec Oper Med, V12, P5; BeitYannai E, 1996, BRAIN RES, V717, P22, DOI 10.1016/0006-8993(95)01492-6; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Brendler T, 2019, PHYTOTHER RES, V33, P3090, DOI 10.1002/ptr.6514; Chang Y, 2018, NEUROCHEM INT, V116, P85, DOI 10.1016/j.neuint.2018.02.008; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Choi HD, 2011, BRIT J NUTR, V105, P220, DOI 10.1017/S0007114510003454; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Comhaire FH, 2005, ASIAN J ANDROL, V7, P257, DOI 10.1111/j.1745-7262.2005.00047.x; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; Council NR, 2010, GUIDE CARE USE LAB A; Curek GD, 2010, TOXICOLOGY, V267, P147, DOI 10.1016/j.tox.2009.11.003; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dukay B, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00920; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Duveau V, 2007, NEUROBIOL DIS, V26, P385, DOI 10.1016/j.nbd.2007.01.007; Ekpe L, 2018, J MOL PATHOPHYSIOL, V7, P1, DOI DOI 10.5455/jmp.20180627120817; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fakhri S, 2018, BRAIN RES BULL, V143, P217, DOI 10.1016/j.brainresbull.2018.09.011; Fassett RG, 2011, MAR DRUGS, V9, P447, DOI 10.3390/md9030447; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Galasso C., 2018, MAR DRUGS, V16; Gite S, 2019, NUTR NEUROSCI, V22, P551, DOI 10.1080/1028415X.2017.1418728; Gross GJ, 2005, MOL CELL BIOCHEM, V272, P221, DOI 10.1007/s11010-005-7555-2; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hu SL, 2010, NEUROL RES, V32, P173, DOI 10.1179/174313209X414524; Hussein G, 2005, BIOL PHARM BULL, V28, P47, DOI 10.1248/bpb.28.47; Ikeda Y, 2008, J NEUROCHEM, V107, P1730, DOI 10.1111/j.1471-4159.2008.05743.x; Ikeuchi M, 2006, BIOL PHARM BULL, V29, P2106, DOI 10.1248/bpb.29.2106; Jadhav V, 2009, STROKE, V40, P3139, DOI 10.1161/STROKEAHA.109.549774; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Ji XR, 2017, BRAIN RES, V1659, P88, DOI 10.1016/j.brainres.2016.12.031; Kamath BS, 2008, EUR J PHARMACOL, V590, P387, DOI 10.1016/j.ejphar.2008.06.042; Katagiri M, 2012, J CLIN BIOCHEM NUTR, V51, P102, DOI 10.3164/jcbn.D-11-00017; Kidd P, 2011, ALTERN MED REV, V16, P355; Kim JH, 2010, FOOD CHEM TOXICOL, V48, P1741, DOI 10.1016/j.fct.2010.04.002; Lai YC, 2004, J NEUROTRAUM, V21, P229, DOI 10.1089/089771504322972022; Lauver DA, 2005, J PHARMACOL EXP THER, V314, P686, DOI 10.1124/jpet.105.087114; Lee DH, 2010, J CLIN BIOCHEM NUTR, V47, P121, DOI 10.3164/jcbn.10-29; Levy A, 2009, J NEUROTRAUM, V26, P1521, DOI 10.1089/neu.2008.0746; Lin XT, 2017, EUR J PHARMACOL, V806, P43, DOI 10.1016/j.ejphar.2017.04.008; Liraz-Zaltsman S, 2016, J MOL NEUROSCI, V60, P46, DOI 10.1007/s12031-016-0786-8; Lockwood SF, 2006, LIFE SCI, V79, P162, DOI 10.1016/j.lfs.2005.12.052; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Lu YP, 2010, BRAIN RES, V1360, P40, DOI 10.1016/j.brainres.2010.09.016; Maloyan A, 2005, PHYSIOL GENOMICS, V23, P79, DOI 10.1152/physiolgenomics.00279.2004; Manabe Y, 2018, BIOSCI BIOTECH BIOCH, V82, P1433, DOI 10.1080/09168451.2018.1459467; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Meehan A, 2019, UNDERSEA HYPERBAR M, V46, P271; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Moojen VKM, 2012, BRAIN RES, V1466, P82, DOI 10.1016/j.brainres.2012.05.041; Moussaieff A, 2008, J CEREBR BLOOD F MET, V28, P1341, DOI 10.1038/jcbfm.2008.28; Namekawa T, 2010, REPROD DOMEST ANIM, V45, pe387, DOI 10.1111/j.1439-0531.2010.01584.x; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Pan L, 2017, BRAIN RES BULL, V130, P211, DOI 10.1016/j.brainresbull.2017.01.024; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; Pittet JF, 2002, J TRAUMA, V52, P611, DOI 10.1097/00005373-200204000-00001; Rejdak R, 2001, POL J PHARMACOL, V53, P73; Santhanam P, 2019, UNDERSEA HYPERBAR M, V46, P261; Seidberg NA, 2003, J NEUROCHEM, V84, P514, DOI 10.1046/j.1471-4159.2003.01547.x; Shein NA, 2007, PROG BRAIN RES, V161, P353, DOI 10.1016/S0079-6123(06)61025-X; Shein NA, 2011, MOL MED, V17, P448, DOI 10.2119/molmed.2011.00038; Shen H, 2009, FASEB J, V23, P1958, DOI 10.1096/fj.08-123281; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Somero GN, 2020, J EXP ZOOL PART A, V333, P379, DOI 10.1002/jez.2344; Song XD, 2011, BIOL PHARM BULL, V34, P839, DOI 10.1248/bpb.34.839; Su ZJ, 2009, J NEUROTRAUM, V26, P1695, DOI 10.1089/neu.2008.0519; Takizawa Y, 2011, EUR J DRUG METAB PH, V35, P89, DOI 10.1007/s13318-010-0020-y; Trembovler V, 1999, J INTERF CYTOK RES, V19, P791, DOI 10.1089/107999099313640; Tripathi DN, 2008, TOXICOLOGY, V248, P96, DOI 10.1016/j.tox.2008.03.015; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Umschwief G, 2010, J CEREBR BLOOD F MET, V30, P616, DOI 10.1038/jcbfm.2009.234; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang YB, 2019, ACTA HISTOCHEM, V121, P56, DOI 10.1016/j.acthis.2018.10.014; Wei IH, 2008, J CHEM NEUROANAT, V35, P123, DOI 10.1016/j.jchemneu.2007.08.008; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Yamada M, 2011, J ETHNOPHARMACOL, V135, P737, DOI 10.1016/j.jep.2011.04.010; Yuan JP, 2011, MOL NUTR FOOD RES, V55, P150, DOI 10.1002/mnfr.201000414; Zazryn TR, 2008, NEUROL CLIN, V26, P257, DOI 10.1016/j.ncl.2007.11.004; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; Zhang XY, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/1269738; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	101	2	3	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 15	2020	11								999	10.3389/fneur.2020.00999			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OK6NQ	WOS:000584765200001	33178093	gold, Green Published			2022-02-06	
J	Kawa, L; Arborelius, UP; Hokfelt, T; Risling, M				Kawa, Lizan; Arborelius, Ulf P.; Hokfelt, Tomas; Risling, Marten			Sex-Specific Differences in Rodents Following a Single Primary Blast Exposure: Focus on the Monoamine and Galanin Systems	FRONTIERS IN NEUROLOGY			English	Article						anxiety; post concussive disorder; post traumatic stress disorder (PSTD); serotonin; neuropeptide; locus caeruleus; dorsal raphe (DR); noradrenaline	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; HYDROXYLASE MESSENGER-RNA; CHRONIC RESTRAINT STRESS; TYROSINE-HYDROXYLASE; GENDER-DIFFERENCES; IMMOBILIZATION STRESS; GENE-EXPRESSION; RAT; MILD	Most blast-induced traumatic brain injuries (bTBI) are mild in severity and culpable for the lingering and persistent neuropsychological complaints in affected individuals. There is evidence that the prevalence of symptoms post-exposure may be sex-specific. Our laboratory has focused on changes in the monoamine and the neuropeptide, galanin, systems in male rodents following primary bTBI. In this study, we aimed to replicate these findings in female rodents. Brainstem sections from the locus coeruleus (LC) and dorsal raphe nuclei (DRN) were processed for in situ hybridisation at 1 and 7 days post-bTBI. We investigated changes in the transcripts for tyrosine hydroxylase (TH), tryptophan hydroxylase two (TPH2) and galanin. Like in males, we found a transient increase in TH transcript levels bilaterally in the female LC. Changes in TPH2 mRNA were more pronounced and extensive in the DRN of females compared to males. Galanin mRNA was increased bilaterally in the LC and DRN, although this increase was not apparent until day 7 in the LC. Serum analysis revealed an increase in corticosterone, but only in exposed females. These changes occurred without any visible signs of white matter injury, cell death, or blood-brain barrier breakdown. Taken together, in the apparent absence of visible structural damage to the brain, the monoamine and galanin systems, two key players in emotional regulation, are activated deferentially in males and females following primary blast exposure. These similarities and differences should be considered when developing and evaluating diagnostic and therapeutic interventions for bTBI.	[Kawa, Lizan; Arborelius, Ulf P.; Hokfelt, Tomas; Risling, Marten] Karolinska Inst, Dept Neurosci, Solna, Sweden		Kawa, L (corresponding author), Karolinska Inst, Dept Neurosci, Solna, Sweden.	lizan.kawa@ki.se			Swedish Armed Forces RD; Swedish Research CouncilSwedish Research CouncilEuropean Commission [04X-2887]; Karolinska Institutet Funds	This work was supported by the Swedish Armed Forces R&D (MR), the Swedish Research Council (04X-2887) (TH), and Karolinska Institutet Funds (MR and TH). The valuable contribution of Jenny Gustavsson is gratefully acknowledged.	Agoston DV, 2019, J NEUROTRAUM, V36, P1724, DOI 10.1089/neu.2018.6261; Barde S, 2016, P NATL ACAD SCI USA, V113, pE8472, DOI 10.1073/pnas.1617824113; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Branchek TA, 2000, TRENDS PHARMACOL SCI, V21, P109, DOI 10.1016/S0165-6147(00)01446-2; Bremner JD, 1996, SYNAPSE, V23, P28, DOI 10.1002/(SICI)1098-2396(199605)23:1<28::AID-SYN4>3.0.CO;2-J; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chamas F, 1999, NEUROSCI LETT, V267, P157, DOI 10.1016/S0304-3940(99)00340-7; Chamas FM, 2004, BIOL PSYCHIAT, V55, P278, DOI 10.1016/S0006-3223(03)00788-1; Chang MS, 2000, NEUROSCIENCE, V101, P131, DOI 10.1016/S0306-4522(00)00352-3; CLEMEDSON CJ, 1956, ACTA PHYSIOL SCAND, V37, P202; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Crum-Cianflone NF, 2014, EPIDEMIOL REV, V36, P5, DOI 10.1093/epirev/mxt005; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Davidsson J, 2019, NEUROMETHODS, V149, P151, DOI 10.1007/978-1-4939-9711-4_8; Dayan P, 2009, ANNU REV NEUROSCI, V32, P95, DOI 10.1146/annurev.neuro.051508.135607; DEAKIN J F W, 1991, Journal of Psychopharmacology, V5, P305, DOI 10.1177/026988119100500414; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Donner N, 2009, NEUROSCIENCE, V163, P705, DOI 10.1016/j.neuroscience.2009.06.046; Estanislau C, 2011, BEHAV PROCESS, V86, P46, DOI 10.1016/j.beproc.2010.08.008; Free KE, 2017, EXP NEUROL, V296, P62, DOI 10.1016/j.expneurol.2017.07.004; Fuxe K., 1991, GALANIN NEW MULTIFUN, P221, DOI DOI 10.1007/978-1-349-12664-4_16; GABRIEL SM, 1992, PEPTIDES, V13, P801, DOI 10.1016/0196-9781(92)90190-E; Goddard AW, 2010, DEPRESS ANXIETY, V27, P339, DOI 10.1002/da.20642; Goenjian AK, 2012, J AFFECT DISORDERS, V140, P244, DOI 10.1016/j.jad.2012.02.015; Graeff FG, 1996, PHARMACOL BIOCHEM BE, V54, P129, DOI 10.1016/0091-3057(95)02135-3; GRIMA B, 1987, NATURE, V326, P707, DOI 10.1038/326707a0; Gunther M, 2015, ACTA NEUROCHIR, V157, P649, DOI 10.1007/s00701-014-2331-2; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Haskell SG, 2011, WOMEN HEALTH ISS, V21, P92, DOI 10.1016/j.whi.2010.08.001; Hiroi R, 2011, NEUROSCIENCE, V176, P120, DOI 10.1016/j.neuroscience.2010.12.019; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hokfelt T, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00106; Holmes A., 2006, CNS & Neurological Disorders-Drug Targets, V5, P225, DOI 10.2174/187152706776359600; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Jackson CE, 2016, J TRAUMA STRESS, V29, P309, DOI 10.1002/jts.22110; JACOBS BL, 1991, PHARMACOL REV, V43, P563; Jacobsen JPR, 2012, PHILOS T R SOC B, V367, P2444, DOI 10.1098/rstb.2012.0109; Jadid KD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00811; Kamarck KN, 2016, BRIT J SPORTS MED; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; KAPLAN LM, 1988, P NATL ACAD SCI USA, V85, P7408, DOI 10.1073/pnas.85.19.7408; Kawa L, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00479; Kawa L, 2016, EXP NEUROL, V279, P159, DOI 10.1016/j.expneurol.2016.02.019; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Keszler G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226228; Khoshbouei H, 2002, PHARMACOL BIOCHEM BE, V71, P407, DOI 10.1016/S0091-3057(01)00683-9; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; KORF J, 1973, NEUROPHARMACOLOGY, V12, P933, DOI 10.1016/0028-3908(73)90024-5; Kuteeva E, 2010, EXPERIENTIA SUPPL, V102, P163, DOI 10.1007/978-3-0346-0228-0_12; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lang R, 2015, PHARMACOL REV, V67, P118, DOI 10.1124/pr.112.006536; Ling G, 2015, Handb Clin Neurol, V127, P173, DOI 10.1016/B978-0-444-52892-6.00011-8; Linzer M, 1996, AM J MED, V101, P526, DOI 10.1016/S0002-9343(96)00275-6; Lu Xiaoying, 2007, CNS & Neurological Disorders-Drug Targets, V6, P183, DOI 10.2174/187152707780619335; Maes M, 1995, PSYCHOPHARMACOLOGY 4; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Mann JJ, 1999, NEUROPSYCHOPHARMACOL, V21, pS99, DOI 10.1038/sj.npp.1395364; MCMAHON A, 1992, J NEUROCHEM, V58, P2124, DOI 10.1111/j.1471-4159.1992.tb10954.x; MELANDER T, 1986, NEUROSCIENCE, V19, P223, DOI 10.1016/0306-4522(86)90017-5; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Park CR, 2008, LEARN MEMORY, V15, P271, DOI 10.1101/lm.721108; Paxinos G, 2007, RAT BRAIN STREOTAXIC, V6th; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Risling M, 2019, J INTERN MED, V285, P594, DOI 10.1111/joim.12909; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rosenfield S, 2000, GENDER DIMENSIONS SE; Russell AL, 2018, ENDOCRINOLOGY, V159, P2363, DOI 10.1210/en.2018-00203; Schatzberg AF, 1995, PSYCHOPHARMACOLOGY 4; Sciolino NR, 2015, NEUROPHARMACOLOGY, V89, P255, DOI 10.1016/j.neuropharm.2014.09.029; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Sweerts BW, 2000, BRAIN RES, V873, P318, DOI 10.1016/S0006-8993(00)02558-0; Sweerts BW, 1999, MOL BRAIN RES, V69, P113, DOI 10.1016/S0169-328X(99)00095-9; Thompson JM, 2008, CAN FAM PHYSICIAN, V54, P1549; Toth ZE, 2008, J NEUROCHEM, V104, P653, DOI 10.1111/j.1471-4159.2007.05069.x; Tseng JY, 1997, MOL BRAIN RES, V50, P100, DOI 10.1016/S0169-328X(97)00164-2; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; VRONTAKIS ME, 1987, J BIOL CHEM, V262, P16755; Waider J, 2011, PSYCHONEUROENDOCRINO, V36, P393, DOI 10.1016/j.psyneuen.2010.12.012; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Waters SM, 2000, NEUROSCIENCE, V95, P265; Watts S, 2019, J ROY ARMY MED CORPS, V165, P38, DOI 10.1136/jramc-2018-000956; Weinshenker D, 2016, BRAIN RES, V1641, P320, DOI 10.1016/j.brainres.2015.11.025; WHO, 2013, GENDER DISPARITIES M; Xing YL, 2013, NEUROCHEM INT, V63, P570, DOI 10.1016/j.neuint.2013.09.019	101	2	2	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 15	2020	11								540144	10.3389/fneur.2020.540144			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OL8ZF	WOS:000585619800001	33178100	Green Published, gold			2022-02-06	
J	Meabon, JS; Cook, DG; Yagi, M; Terry, GE; Cross, DJ; Muzi, M; Pagulayan, KF; Logsdon, AF; Schindler, AG; Ghai, V; Wang, K; Fallen, S; Zhou, Y; Kim, TK; Lee, I; Banks, WA; Carlson, ES; Mayer, C; Hendrickson, RC; Raskind, MA; Marshall, DA; Perl, DP; Keene, CD; Peskind, ER				Meabon, James S.; Cook, David G.; Yagi, Mayumi; Terry, Garth E.; Cross, Donna J.; Muzi, Mark; Pagulayan, Kathleen F.; Logsdon, Aric F.; Schindler, Abigail G.; Ghai, Vikas; Wang, Kai; Fallen, Shannon; Zhou, Yong; Kim, Taek-Kyun; Lee, Inyoul; Banks, William A.; Carlson, Erik S.; Mayer, Cynthia; Hendrickson, Rebecca C.; Raskind, Murray A.; Marshall, Desiree A.; Perl, Daniel P.; Keene, C. Dirk; Peskind, Elaine R.			Chronic elevation of plasma vascular endothelial growth factor-A (VEGF-A) is associated with a history of blast exposure	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Neurotrauma; Neurovascular; Vascular; Angiogenic; Neurovascular unit; Endothelial	TRAUMATIC BRAIN-INJURY; SERUM; CEREBELLUM; VETERANS; TAU; PERMEABILITY; ACTIVATION; MECHANISMS; EXPRESSION; SYMPTOMS	Mounting evidence points to the significance of neurovascular-related dysfunction in veterans with blast-related mTBI, which is also associated with reduced [F-18]-fluorodeoxyglucose (FDG) uptake. The goal of this study was to determine whether plasma VEGF-A is altered in veterans with blast-related mTBI and address whether VEGF-A levels correlate with FDG uptake in the cerebellum, a brain region that is vulnerable to blast-related injury 72 veterans with blast-related mTBI (mTBI) and 24 deployed control (DC) veterans with no lifetime history of TBI were studied. Plasma VEGF-A was significantly elevated in mTBIs compared to DCs. Plasma VEGF-A levels in mTBIs were significantly negatively correlated with FDG uptake in cerebellum. In addition, performance on a Stroop color/word interference task was inversely correlated with plasma VEGF-A levels in blast mTBI veterans. Finally, we observed aberrant perivascular VEGF-A immunoreactivity in postmortem cerebellar tissue and not cortical or hippocampal tissues from blast mTBI veterans. These findings add to the limited number of plasma proteins that are chronically elevated in veterans with a history of blast exposure associated with mTBI. It is likely the elevated VEGF-A levels are from peripheral sources. Nonetheless, increasing plasma VEGF-A concentrations correlated with chronically decreased cerebellar glucose metabolism and poorer performance on tasks involving cognitive inhibition and set shifting. These results strengthen an emerging view that cognitive complaints and functional brain deficits caused by blast exposure are associated with chronic blood-brain barrier injury and prolonged recovery in affected regions.	[Meabon, James S.; Terry, Garth E.; Pagulayan, Kathleen F.; Mayer, Cynthia; Hendrickson, Rebecca C.; Raskind, Murray A.; Peskind, Elaine R.] Vet Affairs VA Northwest Mental Illness Res Educ, Seattle, WA USA; [Meabon, James S.; Terry, Garth E.; Pagulayan, Kathleen F.; Schindler, Abigail G.; Carlson, Erik S.; Hendrickson, Rebecca C.; Raskind, Murray A.; Peskind, Elaine R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Cook, David G.; Yagi, Mayumi; Logsdon, Aric F.; Schindler, Abigail G.; Banks, William A.; Carlson, Erik S.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr GRECC, Seattle, WA USA; [Cook, David G.; Logsdon, Aric F.; Banks, William A.] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA USA; [Cook, David G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Cross, Donna J.] Univ Utah, Dept Radiol, Salt Lake City, UT 84132 USA; [Terry, Garth E.; Muzi, Mark] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Ghai, Vikas; Wang, Kai; Fallen, Shannon; Zhou, Yong; Kim, Taek-Kyun; Lee, Inyoul] Inst Syst Biol, Seattle, WA USA; [Marshall, Desiree A.; Keene, C. Dirk] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Perl, Daniel P.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Sch Med, Dept Pathol, Bethesda, MD USA		Peskind, ER (corresponding author), Vet Affairs VA Northwest MIRECC, 1660 S Columbian Way, Seattle, WA 98108 USA.	peskind@uw.edu	Terry, Garth/AAI-2749-2021; Carlson, Erik/V-9170-2019; Banks, William A/K-1330-2017; Pagulayan, Kati/AAR-9225-2020	Carlson, Erik/0000-0002-6662-7856; Banks, William A/0000-0002-0496-3619; 	Department of Veterans Affairs Rehabilitation Research and Development Service Merit Review GrantUS Department of Veterans Affairs [IO1 RX001612]; Department of Research and Development Medical Research Service [I01 BX002311-05]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG046619, U01HL126496-02, R56HL133887, U01CA213330, R01DA040395]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG052354]; VA Puget Sound Health Care System Seed GrantUS Department of Veterans Affairs; NIA Alzheimer's Disease Research Center [AG005136]; Friends of Alzheimer's Research Endowment; Nancy and Buster Alvord Endowment; Department of DefenseUnited States Department of Defense [W81XWH-16-1-0301, W911NF-17-2-0086, DTRA HDTRA1-13-C-0055]; VA CSRD [CX-001787];  [R50CA211270];  [IK2 BX003258-01A1]	This work was supported by research grants from the Departments of Veterans Affairs Rehabilitation Research and Development Service Merit Review Grant IO1 RX001612 (Peskind) and Research and Development Medical Research Service I01 BX002311-05 (Cook); NIH R01AG046619 (Banks); NIA T32AG052354 (Logsdon); VA Puget Sound Health Care System Seed Grant (Meabon); NIA Alzheimer's Disease Research Center AG005136 (Keene, Marshall); Friends of Alzheimer's Research Endowment (Peskind); Nancy and Buster Alvord Endowment (Keene); Department of Defense W81XWH-16-1-0301 (Wang), W911NF-17-2-0086 (Wang), DTRA HDTRA1-13-C-0055 (Wang); NIH U01HL126496-02 (Wang), R56HL133887 (Wang), U01CA213330 (Wang) and R01DA040395 (Wang); R50CA211270 (Muzi); IK2 BX003258-01A1 (Schindler); VA CSR&D CX-001787 (Terry).	Abutarboush R, 2019, J NEUROTRAUM, V36, P3138, DOI 10.1089/neu.2019.6423; Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Audenaert K, 2001, NUCL MED COMMUN, V22, P135, DOI 10.1097/00006231-200102000-00004; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; BERSE B, 1992, MOL BIOL CELL, V3, P211, DOI 10.1091/mbc.3.2.211; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Boer K, 2008, ACTA NEUROPATHOL, V115, P683, DOI 10.1007/s00401-008-0354-6; Braga-Neto P, 2012, CEREBELLUM, V11, P549, DOI 10.1007/s12311-011-0318-6; Buchsbaum MS, 2015, J NEUROTRAUM, V32, P1736, DOI 10.1089/neu.2014.3660; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 1997, Vojnosanit Pregl, V54, P91; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cesca F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125259; Cetin A, 2019, FOLIA MORPHOL, V78, P684, DOI 10.5603/FM.a2019.0029; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; de Almodovar CR, 2010, J NEUROSCI, V30, P15052, DOI 10.1523/JNEUROSCI.0477-10.2010; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Delis Kramer K.E., 2001, DELIS KAPLAN EXECUTI; Della Rosa PA, 2014, NEUROINFORMATICS, V12, P575, DOI 10.1007/s12021-014-9235-4; Dickstein DL, 2021, MOL PSYCHIATR, V26, P5940, DOI 10.1038/s41380-020-0674-z; Edwards KA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00091; Egervari K, 2016, GLIA, V64, P440, DOI 10.1002/glia.22939; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Ghai V, 2020, J NEUROTRAUM, V37, P1418, DOI 10.1089/neu.2019.6826; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Heinzelmann M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00198; Huang L, 2013, NEUROSCI LETT, V550, P60, DOI 10.1016/j.neulet.2013.06.031; Hubbard WB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5175249; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hudson N, 2014, DEV CELL, V30, P541, DOI 10.1016/j.devcel.2014.06.027; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lejbman N, 2016, BRAIN INJURY, V30, P1436, DOI 10.1080/02699052.2016.1219054; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Logsdon AF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66113-7; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Mateo I, 2007, ACTA NEUROL SCAND, V116, P56, DOI 10.1111/j.1600-0404.2006.00775.x; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McDonald JH., 2014, HDB BIOL STAT; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Michinaga S, 2018, J NEUROTRAUM, V35, P1481, DOI 10.1089/neu.2017.5421; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; MURTHY JMK, 1979, J NEUROSURG, V50, P260, DOI 10.3171/jns.1979.50.2.0260; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nonaka H, 2002, ACTA NEUROPATHOL, V104, P608, DOI 10.1007/s00401-002-0592-y; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Ozevren H, 2018, FOLIA MORPHOL, V77, P642, DOI 10.5603/FM.a2018.0029; Pagulayan KF, 2020, BRAIN IMAGING BEHAV, V14, P949, DOI 10.1007/s11682-018-9987-9; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Peskind ER, 2005, ALZ DIS ASSOC DIS, V19, P220, DOI 10.1097/01.wad.0000194014.43575.fd; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rentiya Z, 2017, NEUROPSYCHOLOGIA, V107, P25, DOI 10.1016/j.neuropsychologia.2017.10.036; Rigau V, 2007, BRAIN, V130, P1942, DOI 10.1093/brain/awm118; Robinson ME, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101651; Roth I.P., 2005, BEHAV RATING INVENTO; Ryan-Gonzalez C, 2019, J NEUROTRAUM, V36, P1584, DOI 10.1089/neu.2017.5590; Sajja Venkata Siva Sai S, 2012, Biomed Sci Instrum, V48, P374; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Sentilhes L, 2010, J NEUROPATH EXP NEUR, V69, P111, DOI 10.1097/NEN.0b013e3181ccc9a9; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Stefanini MO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000622; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Su JJ, 2006, J NEUROL SCI, V243, P21, DOI 10.1016/j.jns.2005.11.006; Takeuchi H, 2012, NEUROIMAGE, V59, P2899, DOI 10.1016/j.neuroimage.2011.09.064; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang ZY, 2020, J NEUROTRAUM, V37, P1221, DOI 10.1089/neu.2019.6742; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yu S, 2016, CLIN CHIM ACTA, V453, P154, DOI 10.1016/j.cca.2015.12.018; Zhang JB, 2016, EUR J NEUROL, V23, P1337, DOI 10.1111/ene.13030; Zhong P, 1999, J ENDOUROL, V13, P611, DOI 10.1089/end.1999.13.611; Zhong P, 2001, ULTRASOUND MED BIOL, V27, P119, DOI 10.1016/S0301-5629(00)00322-7	96	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	OCT 15	2020	417								117049	10.1016/j.jns.2020.117049			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NP6HG	WOS:000570274600008	32758764	Green Accepted			2022-02-06	
J	Murphy, EK; Iacono, D; Pan, HN; Grimes, JB; Parks, S; Raiciulescu, S; Leonessa, F; Perl, DP				Murphy, Erin K.; Iacono, Diego; Pan, Hongna; Grimes, Jamie B.; Parks, Steven; Raiciulescu, Sorana; Leonessa, Fabio; Perl, Daniel P.			Explosive-driven double-blast exposure: molecular, histopathological, and behavioral consequences	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; ALPHA-II-SPECTRIN; CEREBRAL-ARTERY OCCLUSION; TIME-DEPENDENT CHANGES; SPINAL-CORD CONTUSION; CLOSED-HEAD-INJURY; CEREBROSPINAL-FLUID; BIOMARKER LEVELS; AXONAL INJURY; RODENT MODEL	Traumatic brain injury generated by blast may induce long-term neurological and psychiatric sequelae. We aimed to identify molecular, histopathological, and behavioral changes in rats 2 weeks after explosive-driven double-blast exposure. Rats received two 30-psi (similar to 207-kPa) blasts 24 h apart or were handled identically without blast. All rats were behaviorally assessed over 2 weeks. At Day 15, rats were euthanized, and brains removed. Brains were dissected into frontal cortex, hippocampus, cerebellum, and brainstem. Western blotting was performed to measure levels of total-Tau, phosphorylated-Tau (pTau), amyloid precursor protein (APP), GFAP, Iba1, alpha II-spectrin, and spectrin breakdown products (SBDP). Kinases and phosphatases, correlated with tau phosphorylation were also measured. Immunohistochemistry for pTau, APP, GFAP, and Iba1 was performed. pTau protein level was greater in the hippocampus, cerebellum, and brainstem and APP protein level was greater in cerebellum of blast vs control rats (p<0.05). GFAP, Iba1, alpha II-spectrin, and SBDP remained unchanged. No immunohistochemical or neurobehavioral changes were observed. The dissociation between increased pTau and APP in different regions in the absence of neurobehavioral changes 2 weeks after double blast exposure is a relevant finding, consistent with human data showing that battlefield blasts might be associated with molecular changes before signs of neurological and psychiatric disorders manifest.	[Murphy, Erin K.; Iacono, Diego; Perl, Daniel P.] Uniformed Serv Univ USU, DoD USU Brain Tissue Repository & Neuropathol Cor, Bethesda, MD 20814 USA; [Murphy, Erin K.; Iacono, Diego; Pan, Hongna; Leonessa, Fabio] Henry M Jackson Fdn HJF Adv Mil Med, Bethesda, MD 20817 USA; [Murphy, Erin K.; Iacono, Diego; Pan, Hongna; Grimes, Jamie B.; Leonessa, Fabio] Uniformed Serv Univ USU, F Edward Hebert Sch Med, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Murphy, Erin K.; Iacono, Diego; Perl, Daniel P.] Uniformed Serv Univ USU, F Edward Hebert Sch Med, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Iacono, Diego] NINDS, Neurodegenerat Clin, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Parks, Steven] ORA Inc, 315 Baldwin Ave, Marion, NC 28752 USA; [Raiciulescu, Sorana] Uniformed Serv Univ USU, F Edward Hebert Sch Med, Dept Prevent Med & Biostat, Biostat Consulting Ctr, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Pan, Hongna] Uniformed Serv Univ USU, Dept Biochem, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Iacono, D (corresponding author), Uniformed Serv Univ USU, DoD USU Brain Tissue Repository & Neuropathol Cor, Bethesda, MD 20814 USA.; Iacono, D (corresponding author), Henry M Jackson Fdn HJF Adv Mil Med, Bethesda, MD 20817 USA.; Iacono, D (corresponding author), Uniformed Serv Univ USU, F Edward Hebert Sch Med, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Iacono, D (corresponding author), Uniformed Serv Univ USU, F Edward Hebert Sch Med, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Iacono, D (corresponding author), NINDS, Neurodegenerat Clin, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	diego.iacono.ctr@usuhs.edu			DoD/USU Brain Tissue Repository and Neuropathology Core; TAU [308049-4.01-60855]; Defense Advanced Research Projects AgencyUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [G192310115]	This study was supported by: DoD/USU Brain Tissue Repository and Neuropathology Core, TAU Project award #: 308049-4.01-60855 and Defense Advanced Research Projects Agency, Project award #: G192310115.	Abbotts R, 2007, J R Army Med Corps, V153, P119; Agoston DV, 2017, J NEUROTRAUM, V34, pS44, DOI 10.1089/neu.2017.5317; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Catafau AM, 2016, J NUCL MED, V57, P1740, DOI 10.2967/jnumed.115.171652; Cernak Ibolja, 2017, Concussion, V2, pCNC42, DOI 10.2217/cnc-2017-0006; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Engel C., 2019, P FIND EXP REC 7 DEP; Feng K, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00179; Feng Q, 2005, NEUROSCI LETT, V388, P13, DOI 10.1016/j.neulet.2005.06.022; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Hernandez A, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0408-1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang E, 2013, BRAIN RES, V1529, P125, DOI 10.1016/j.brainres.2013.06.042; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Jacobs HIL, 2018, BRAIN, V141, P37, DOI 10.1093/brain/awx194; Kawa L, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00479; Kirsch JH, 2002, CONTEMP TOP LAB ANIM, V41, P9; Konan LM, 2019, J NEUROTRAUM, V36, P2117, DOI 10.1089/neu.2018.6260; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Lucke-Wold BP, 2016, J NEUROSURG, V124, P687, DOI 10.3171/2015.3.JNS141802; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Okawa Y, 2003, FEBS LETT, V535, P183, DOI 10.1016/S0014-5793(02)03883-8; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Paxinos G., 2014, PAXINOS WATSONS RAT, VSeventh; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Robinson ME, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101651; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sosa MAG, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0483-z; Stuhmiller J, 1990, DAMD1785C5238 US ARM; TUPPER DE, 1980, ACTA NEUROBIOL EXP, V40, P999; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Verma SK, 2015, NMR BIOMED, V28, P1069, DOI 10.1002/nbm.3351; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Wang H, 2018, NEUROPATHOLOGY, V38, P484, DOI 10.1111/neup.12509; Wang YS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00413; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Yanagisawa M, 1999, FEBS LETT, V461, P329, DOI 10.1016/S0014-5793(99)01480-5; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025	73	2	2	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	OCT 15	2020	10	1							17446	10.1038/s41598-020-74296-2			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OH6ML	WOS:000582705900060	33060648	gold, Green Published			2022-02-06	
J	Xiong, JH; Gao, YL; Li, XT; Li, K; Li, QF; Shen, J; Han, ZY; Zhang, JN				Xiong, Jianhua; Gao, Yalong; Li, Xiaotian; Li, Kai; Li, Qifeng; Shen, Jun; Han, Zhenying; Zhang, Jianning			Losartan Treatment Could Improve the Outcome of TBI Mice	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; blood brain barrier; endoplasmic reticulum stress; neuroinflammation; angiotensin II type 1 receptors blockage; tight junction proteins; losartan	BLOOD-BRAIN-BARRIER; II TYPE-1 RECEPTOR; ANGIOTENSIN-II; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; RENIN-ANGIOTENSIN; RAT MODEL; INJURY; PATHWAY; INFLAMMATION	Traumatic brain injury frequently leads to serious mortality and physical disability, yet effective treatments remains insufficient. TBI always leads to a series of secondary brain injuries including neuronal apoptosis, continuous inflammation, endoplasmic reticulum stress, and disruption of the blood-brain barrier. Sartans that block angiotensin II type 1 receptors are strongly neuroprotective, neurorestorative and anti-inflammatory. However, whether losartan, a FDA-approved and widely used drug for regulating blood pressure, is beneficial for improving the prognosis of TBI need more evidence. Through a controlled cortical impact injury mice model, we confirmed that losartan treatment could ameliorate CCI-induced secondary brain injury. We found that losartan treatment decreased brain lesion volume, neuronal apoptosis and ER stress protein ATF4 and eIF2 alpha. Moreover, our results showed that losartan also improved neurological and motor function. It is worth pointing out that losartan increased the expression of tight junction proteins ZO-1 and alleviated brain edema and blood brain barrier leakage. Additionally, losartan inhibited pro-inflammatory factor TNF-alpha and improve anti-inflammatory factor IL-10. Taken together, our data demonstrated that losartan could improve the prognosis of TBI and may be a promising therapeutic method for mitigating TBI.	[Xiong, Jianhua; Gao, Yalong; Li, Xiaotian; Li, Kai; Li, Qifeng; Shen, Jun; Han, Zhenying; Zhang, Jianning] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China		Xiong, JH; Zhang, JN (corresponding author), Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China.	doctorxiong@hotmail.com; profzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81330029]	This work was supported by grants from the National Natural Science Foundation of China (grant no.81330029).	Abdel-Fattah MM, 2018, N-S ARCH PHARMACOL, V391, P1003, DOI 10.1007/s00210-018-1523-3; Abdul-Muneer PM, 2018, MOL NEUROBIOL, V55, P5901, DOI 10.1007/s12035-017-0812-z; Al-Mufti F, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17431; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Benicky J, 2011, NEUROPSYCHOPHARMACOL, V36, P857, DOI 10.1038/npp.2010.225; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Bhat SA, 2018, MOL NEUROBIOL, V55, P5282, DOI 10.1007/s12035-017-0754-5; Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9; Chen W, 2020, J TISSUE ENG REGEN M, V14, P412, DOI 10.1002/term.3002; Elkahloun AG, 2019, MOL NEUROBIOL, V56, P3193, DOI 10.1007/s12035-018-1300-9; Friedman A, 2014, EXPERT REV NEUROTHER, V14, P1365, DOI 10.1586/14737175.2014.972945; Gan Y, 2014, P NATL ACAD SCI USA, V111, P2704, DOI 10.1073/pnas.1315943111; Gao WW, 2018, EXP NEUROL, V307, P99, DOI 10.1016/j.expneurol.2018.06.001; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Hirooka Y, 2006, HYPERTENS RES, V29, P49, DOI 10.1291/hypres.29.49; Ito H, 2001, J HYPERTENS, V19, P591, DOI 10.1097/00004872-200103001-00011; Jindal A, 2017, NEUROCHEM INT, V111, P3, DOI 10.1016/j.neuint.2016.12.004; Khaksari M, 2018, IRAN J BASIC MED SCI, V21, P615, DOI 10.22038/IJBMS.2018.26586.6512; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Leversha S, 2019, HYPERTENSION, V74, P896, DOI 10.1161/HYPERTENSIONAHA.119.12937; Li T, 2018, PHARMAZIE, V73, P585, DOI 10.1691/ph.2018.8592; LI ZH, 1993, BRAIN RES BULL, V30, P33, DOI 10.1016/0361-9230(93)90036-B; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Miyoshi M, 2008, EUR J NEUROSCI, V27, P343, DOI 10.1111/j.1460-9568.2007.06014.x; Mogi M, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/169649; Moulder JE, 2011, RADIAT RES, V175, P29, DOI 10.1667/RR2400.1; Nakka VP, 2016, MOL NEUROBIOL, V53, P532, DOI 10.1007/s12035-014-9029-6; Phillips MI, 2008, J MOL MED, V86, P715, DOI 10.1007/s00109-008-0331-5; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rueckschloss U, 2002, ARTERIOSCL THROM VAS, V22, P1845, DOI 10.1161/01.ATV.0000035392.38687.65; Mikusic NLR, 2018, METABOLISM, V85, P271, DOI 10.1016/j.metabol.2018.04.010; Saavedra JM, 2011, PSYCHONEUROENDOCRINO, V36, P1, DOI 10.1016/j.psyneuen.2010.10.001; Sadoshima J, 2002, CIRC RES, V90, P754, DOI 10.1161/01.RES.0000016843.82450.8C; Salmani H, 2018, LIFE SCI, V203, P161, DOI 10.1016/j.lfs.2018.04.033; Serlin Y, 2015, SEMIN CELL DEV BIOL, V38, P2, DOI 10.1016/j.semcdb.2015.01.002; Shen J, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01133; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Smeda JS, 2018, VASC PHARMACOL, V111, P26, DOI 10.1016/j.vph.2018.08.006; Sumners C, 2013, CLIN EXP PHARMACOL P, V40, P580, DOI 10.1111/1440-1681.12137; Sun DD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00193; Sun H, 2019, BRAIN RES BULL, V149, P251, DOI 10.1016/j.brainresbull.2019.05.002; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Teixido-Tura G, 2018, J AM COLL CARDIOL, V72, P1613, DOI 10.1016/j.jacc.2018.07.052; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Torika N, 2018, CNS NEUROSCI THER, V24, P231, DOI 10.1111/cns.12802; VILLAPOL S, 2015, BRAIN 11, V0138; Villapol S, 2015, AM J HYPERTENS, V28, P289, DOI 10.1093/ajh/hpu197; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang ZF, 2020, BIOCHEM PHARMACOL, V171, DOI 10.1016/j.bcp.2019.113674; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Wu L, 2013, NEUROSCI LETT, V548, P50, DOI 10.1016/j.neulet.2013.06.008; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Xu Y, 2015, BRAIN BEHAV IMMUN, V50, P298, DOI 10.1016/j.bbi.2015.07.015; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Zhang TL, 2012, CNS NEUROSCI THER, V18, P981, DOI 10.1111/cns.12015	58	2	2	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 15	2020	11								992	10.3389/fneur.2020.00992			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OK7BY	WOS:000584802400001	33178092	gold, Green Published			2022-02-06	
J	Harper, KA; Butler, EC; Hacker, ML; Naik, A; Eoff, BR; Phibbs, FT; Isaacs, DA; Gallion, SJ; Thomas, EP; Scott, JL; Ploucher, S; Meystedt, JC; McLeod, ME; Charles, PD				Harper, Kelly A.; Butler, Emily C.; Hacker, Mallory L.; Naik, Aaditi; Eoff, Bryan R.; Phibbs, Fenna T.; Isaacs, David A.; Gallion, Stephen J.; Thomas, Esmeralda P.; Scott, Jim L.; Ploucher, Shelby; Meystedt, Jacqueline C.; McLeod, Megan E.; Charles, Philip David			A comparative evaluation of telehealth and direct assessment when screening for spasticity in residents of two long-term care facilities	CLINICAL REHABILITATION			English	Article						Telehealth; teleneurology; spasticity	RELIABILITY; AGREEMENT; KAPPA	Objective: To evaluate the performance of telehealth as a screening tool for spasticity compared to direct patient assessment in the long-term care setting. Design: Cross-sectional, observational study. Setting: Two long-term care facilities: a 140-bed veterans' home and a 44-bed state home for individuals with intellectual and developmental disabilities. Subjects: Sixty-one adult residents of two long-term care facilities (aged 70.1 +/- 16.2 years) were included in this analysis. Spasticity was identified in 43% of subjects (Modified Ashworth Scale rating mode = 2). Contributing diagnoses included traumatic brain injury, spinal cord injury, birth trauma, stroke, cerebral palsy, and multiple sclerosis. Main measures: Movement disorders neurologists conducted in-person examinations to determine whether spasticity was present (reference standard) and also evaluated subjects with spasticity using the Modified Ashworth Scale. Telehealth screening examinations, facilitated by a bedside nurse, were conducted remotely by two teleneurologists using a three-question screening tool. Telehealth screening determinations of spasticity were compared to the reference standard determination to calculate sensitivity, specificity, and the area under the curve (AUC) in receiver operating characteristics. Teleneurologist agreement was evaluated using Cohen's kappa. Results: Teleneurologist 1 had a specificity of 89% and sensitivity of 65% to identify the likely presence of spasticity (n = 61; AUC = 0.770). Teleneurologist 2 showed 100% specificity and 82% sensitivity (n = 16; AUC = 0.909). There was almost perfect agreement between the two examiners at 94% (kappa = 0.875, 95% CI: 0.640-1.000). Conclusion: Telehealth may provide a useful, efficient method of identifying residents of long-term care facilities that likely need referral for spasticity evaluation.	[Harper, Kelly A.; Hacker, Mallory L.; Eoff, Bryan R.; Phibbs, Fenna T.; Isaacs, David A.; Gallion, Stephen J.; Meystedt, Jacqueline C.; Charles, Philip David] Vanderbilt Univ, Med Ctr, Dept Neurol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Butler, Emily C.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hacker, Mallory L.] Vanderbilt Univ, Med Ctr, Dept Phys Med & Rehabil, 221 Kirkland Hall, Nashville, TN 37235 USA; [Naik, Aaditi] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Thomas, Esmeralda P.; Scott, Jim L.] Middle Tennessee Homes, Tennesse Dept Intellectual & Dev Disabil, Nashville, TN USA; [Ploucher, Shelby] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA; [McLeod, Megan E.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA		Harper, KA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, 1121 21st Ave South,Suite A-1106 MCN, Nashville, TN 37232 USA.	kelly.a.harper@vumc.org		McLeod, Megan/0000-0002-6290-5310; Naik, Aaditi/0000-0003-2662-4025; Harper, Kelly/0000-0003-4504-6232	Allergan FoundationAbbVieAllergan; AllerganAbbVieAllergan; IpsenIpsen; MedtronicMedtronic; Merz; PharmaDexcel Pharma; Voyager	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by a grant from the Allergan Foundation, a 501(c)(3) charitable organization. Vanderbilt University receives income from grants or contracts Allergan, Ipsen, Medtronic, Merz, Pharma Two B, and Voyager for research or educational programs led by P.D.C. P.D.C. receives income from Allergan, Ipsen, Revance, and USWorldMeds for consulting services.	FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Gill CE, 2020, J AM MED DIR ASSOC, V21, P1361; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Hacker ML, 2020, CLIN INTERV AGING, V15, P655, DOI 10.2147/CIA.S248602; Harper K, 2019, RURAL REMOTE HEALTH, V19, DOI [10.22605/RRH4743, 10.22605/rrh4743]; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Meseguer-Henarejos AB, 2018, EUR J PHYS REHAB MED, V54, P576, DOI 10.23736/S1973-9087.17.04796-7; Thompson AJ, 2005, J NEUROL NEUROSUR PS, V11, P215; Turchan M, 2017, INT J NEUROL NEUROTH, V3, P2	10	2	2	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	APR	2021	35	4					589	594	0269215520963845	10.1177/0269215520963845		OCT 2020	6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	RJ8MU	WOS:000578594700001	33040604				2022-02-06	
J	Sicard, V; Simard, A; Moore, RD; Ellemberg, D				Sicard, Veronik; Simard, Alexe; Moore, Robert Davis; Ellemberg, Dave			Practice effect associated with the serial administration of the switch task and its implications in the assessment of sports-related concussion	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Learning effect; cognitive testing; injury management; brain injury	EXECUTIVE FUNCTION; TEST-PERFORMANCE; RECOVERY; SPECIFICITY; RELIABILITY; SENSITIVITY; ATTENTION; TRACKING; BATTERY; HISTORY	In the context of return to play assessment following a sports concussion, athletes may have to complete a cognitive task several times within days. The current longitudinal study aimed to examine the practice effect associated with the serial administration of the switch task. We hypothesized that the practice effect would be the greatest between the first and second assessments and that a plateau would be obtained by the third assessment. Forty healthy university students completed the switch task four times at an interval of 48-hour, with half of them doing version A on all visits (AA group), while the others alternated between A and B every other assessment (AB group). For response accuracy, performance generally improved from V1 to V2, and from V2 to V3 (ps <=.001), irrespective of group. For reaction time, a significant interaction of Visit x Group was observed. Specifically, AA group performance improved from V1 to V2, and from V2 to V3, while the AB group only improved from V2 to V3 (ps <=.01). Performance improved over the first three assessments and stabilized with no statistically significant change between the third and fourth testing sessions. Although the use of an alternative version has helped reduce the practice effect, it did not help in eliminating it. The current results highlight the need for further examination of the practice effect and its implication in clinical decision-making. Clinicians working in the sports concussion field must take the practice effect into account when they use the switch task for serial testing.	[Sicard, Veronik; Simard, Alexe; Ellemberg, Dave] Univ Montreal, Sch Kinesiol & Exercise Sci, Montreal, PQ H3T 1J4, Canada; [Sicard, Veronik; Ellemberg, Dave] Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada; [Moore, Robert Davis] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA		Sicard, V (corresponding author), Univ Montreal, Sch Kinesiol & Exercise Sci, Montreal, PQ H3T 1J4, Canada.	veronik.sicard@gmail.com		Sicard, Veronik/0000-0003-2452-934X	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CIHR MOP-102608]	This research was supported by a grant from the Canadian Institutes of Health Research (CIHR MOP-102608) to Dave Ellemberg.	Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Bailey CM, 2009, J HEAD TRAUMA REHAB, V24, P123, DOI 10.1097/HTR.0b013e31819c1caa; Bartels C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-118; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Beglinger LJ, 2005, ARCH CLIN NEUROPSYCH, V20, P517, DOI 10.1016/j.acn.2004.12.003; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Bruggemans EF, 1997, J CLIN EXP NEUROPSYC, V19, P543, DOI 10.1080/01688639708403743; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; Cohen J., 2013, STAT POWER ANAL BEHA; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Duff K, 2001, ARCH CLIN NEUROPSYCH, V16, P461; Ellemberg D., 2020, TRANSLATIONAL J AM C, V5, P1, DOI DOI 10.1249/TJX.0000000000000130; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Hughes MM, 2014, BEHAV RES METHODS, V46, P702, DOI 10.3758/s13428-013-0411-5; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McCaffrey R. J., 2013, PRACTITIONERS GUIDE; McCaffrey RJ, 1995, NEUROPSYCHOL REV, V5, P203, DOI 10.1007/BF02214762; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Sicard V, 2019, CLIN J SPORT MED, V29, P62, DOI 10.1097/JSM.0000000000000492; Sparrow E, 1999, CONNERS ADULT ADHD R; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wesnes K, 2002, LANCET NEUROL, V1, P473, DOI 10.1016/S1474-4422(02)00236-3	41	2	2	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT 20	2020	42	9					965	973		10.1080/13803395.2020.1828836		OCT 2020	9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	OI6AX	WOS:000579157900001	33043799				2022-02-06	
J	Quinn, DK; Upston, J; Jones, T; Brandt, E; Story-Remer, J; Fratzke, V; Wilson, JK; Rieger, R; Hunter, MA; Gill, D; Richardson, JD; Campbell, R; Clark, VP; Yeo, RAA; Shuttleworth, CW; Mayer, AR				Quinn, Davin K.; Upston, Joel; Jones, Thomas; Brandt, Emma; Story-Remer, Jacqueline; Fratzke, Violet; Wilson, J. Kevin; Rieger, Rebecca; Hunter, Michael A.; Gill, Darbi; Richardson, Jessica D.; Campbell, Richard; Clark, Vincent P.; Yeo, Ronald A.; Shuttleworth, Claude William; Mayer, Andrew R.			Cerebral Perfusion Effects of Cognitive Training and Transcranial Direct Current Stimulation in Mild-Moderate TBI	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; cognitive training; cerebral perfusion; pCASL; transcranial direct current stimulation	TRAUMATIC BRAIN-INJURY; DORSOLATERAL PREFRONTAL CORTEX; SPIN-LABELING PERFUSION; BLOOD-FLOW ALTERATIONS; MAGNETIC STIMULATION; MEMORY; TDCS; ASSOCIATIONS; CONSEQUENCES; INDIVIDUALS	Background:Persistent post-traumatic symptoms (PPS) after traumatic brain injury (TBI) can lead to significant chronic functional impairment. Pseudocontinuous arterial spin labeling (pCASL) has been used in multiple studies to explore changes in cerebral blood flow (CBF) that may result in acute and chronic TBI, and is a promising neuroimaging modality for assessing response to therapies. Methods:Twenty-four subjects with chronic mild-moderate TBI (mmTBI) were enrolled in a pilot study of 10 days of computerized executive function training combined with active or sham anodal transcranial direct current stimulation (tDCS) for treatment of cognitive PPS. Behavioral surveys, neuropsychological testing, and magnetic resonance imaging (MRI) with pCASL sequences to assess global and regional CBF were obtained before and after the training protocol. Results:Robust improvements in depression, anxiety, complex attention, and executive function were seen in both active and sham groups between the baseline and post-treatment visits. Global CBF decreased over time, with differences in regional CBF noted in the right inferior frontal gyrus (IFG). Active stimulation was associated with static or increased CBF in the right IFG, whereas sham was associated with reduced CBF. Neuropsychological performance and behavioral symptoms were not associated with changes in CBF. Discussion:The current study suggests a complex picture between mmTBI, cerebral perfusion, and recovery. Changes in CBF may result from physiologic effect of the intervention, compensatory neural mechanisms, or confounding factors. Limitations include a small sample size and heterogenous injury sample, but these findings suggest promising directions for future studies of cognitive training paradigms in mmTBI.	[Quinn, Davin K.; Upston, Joel; Jones, Thomas; Campbell, Richard] Univ New Mexico, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA; [Brandt, Emma; Fratzke, Violet; Wilson, J. Kevin; Rieger, Rebecca; Gill, Darbi; Campbell, Richard; Yeo, Ronald A.; Shuttleworth, Claude William] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA; [Story-Remer, Jacqueline; Fratzke, Violet] Chicago Med Sch, Chicago, IL USA; [Hunter, Michael A.] Naval Hlth Res Ctr, San Diego, CA USA; [Richardson, Jessica D.] Univ New Mexico, Dept Speech & Hearing Sci, Albuquerque, NM 87131 USA; [Clark, Vincent P.; Yeo, Ronald A.] Univ New Mexico, Dept Psychol, Albuquerque, NM USA; [Clark, Vincent P.; Mayer, Andrew R.] Mind Res Network, Albuquerque, NM USA		Quinn, DK (corresponding author), Univ New Mexico, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA.	dquinn@salud.unm.edu	Clark, Vincent P/B-3343-2010	Clark, Vincent P/0000-0002-9151-2102	University of New Mexico (UNM) Center for Brain Recovery and Repair, COBRE NIH/NIGMS [5P20 GM109089-01A1]	University of New Mexico (UNM) Center for Brain Recovery and Repair, COBRE NIH/NIGMS 5P20 GM109089-01A1, PI: CS.	Almeida JRC, 2018, MAGN RESON IMAGING, V45, P26, DOI 10.1016/j.mri.2017.09.004; Andre Jalal B, 2015, Top Magn Reson Imaging, V24, P275, DOI 10.1097/RMR.0000000000000065; Antal A, 2014, HUM BRAIN MAPP, V35, P3750, DOI 10.1002/hbm.22434; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Belkonen S., 2011, ENCY CLIN NEUROPSYCH; Bikson M, 2016, BRAIN STIMUL, V9, P641, DOI 10.1016/j.brs.2016.06.004; Bragina OA, 2018, ADV EXP MED BIOL, V1072, P27, DOI 10.1007/978-3-319-91287-5_5; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Brooks BL, 2019, BRAIN INJURY, V33, P233, DOI 10.1080/02699052.2018.1540798; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Caplan B, 2011, ENCY CLIN NEUROPSYCH; Churchill NW, 2019, J NEUROTRAUM, V36, P1518, DOI 10.1089/neu.2018.6024; Clark AL, 2017, NEUROIMAGE-CLIN, V14, P308, DOI 10.1016/j.nicl.2016.12.017; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Clark VP, 2012, NEUROIMAGE, V59, P117, DOI 10.1016/j.neuroimage.2010.11.036; Clark VP, 2011, NEUROSCI LETT, V500, P67, DOI 10.1016/j.neulet.2011.05.244; Coffman BA, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-108; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cunillera T, 2016, NEUROIMAGE, V140, P66, DOI 10.1016/j.neuroimage.2015.11.044; Dhaliwal SK, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00119; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dmochowski JP, 2013, NEUROIMAGE, V75, P12, DOI 10.1016/j.neuroimage.2013.02.049; Doron KW, 2012, P NATL ACAD SCI USA, V109, P18661, DOI 10.1073/pnas.1216402109; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Douglas DB, 2018, NEUROIMAG CLIN N AM, V28, P55, DOI 10.1016/j.nic.2017.09.002; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Giglia G, 2014, FUNCT NEUROL, V29, P189, DOI 10.11138/FNeur/2014.29.3.189; Haller S, 2016, RADIOLOGY, V281, P337, DOI 10.1148/radiol.2016150789; Hamer J, 2020, J NEUROTRAUM, V37, P1197, DOI 10.1089/neu.2019.6800; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Han KW, 2018, HUM BRAIN MAPP, V39, P2955, DOI 10.1002/hbm.24052; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Jaeggi SM, 2003, NEUROIMAGE, V19, P210, DOI 10.1016/S1053-8119(03)00098-3; Jang H, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.4.045007; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kito S, 2008, NEUROPSYCHOBIOLOGY, V58, P29, DOI 10.1159/000154477; Kito S, 2011, PSYCHIAT CLIN NEUROS, V65, P175, DOI 10.1111/j.1440-1819.2010.02183.x; Kramer JH, 2014, J INT NEUROPSYCH SOC, V20, P11, DOI 10.1017/S1355617713001094; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Linden SC, 2014, MED HIST, V58, P519, DOI 10.1017/mdh.2014.51; Lipszyc J, 2014, ARCH CLIN NEUROPSYCH, V29, P289, DOI 10.1093/arclin/acu004; Mayer AR, 2019, HUM BRAIN MAPP, V40, P5370, DOI 10.1002/hbm.24778; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Mielke D, 2013, NEUROL RES, V35, P1029, DOI 10.1179/1743132813Y.0000000248; Min SK, 1997, PSYCHOSOM MED, V59, P236, DOI 10.1097/00006842-199705000-00005; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Newsome MR, 2012, INT J DEV NEUROSCI, V30, P255, DOI 10.1016/j.ijdevneu.2011.10.008; O'Neil-Pirozzi TM, 2017, INT J NEUROSCI, V127, P592, DOI 10.1080/00207454.2016.1216415; Pearson, 2009, ADV CLIN SOL WAIS 4; Phillips AA, 2016, J CEREBR BLOOD F MET, V36, P647, DOI 10.1177/0271678X15617954; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; R Core Team, 2013, LANGUAGE ENV STAT CO, DOI DOI 11/44679/INDEX.HTM; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Richard NM, 2018, NEUROPSYCHOLOGY, V32, P541, DOI 10.1037/neu0000442; Sacco K., 2016, FRONT BEHAV NEUROSCI, V10; Sankar SB, 2019, NEUROBIOL DIS, V124, P544, DOI 10.1016/j.nbd.2018.12.018; Seibt O, 2015, BRAIN STIMUL, V8, P590, DOI 10.1016/j.brs.2015.01.401; Sharma A, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00042; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Stagg CJ, 2013, J NEUROSCI, V33, P11425, DOI 10.1523/JNEUROSCI.3887-12.2013; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Talairach J., 1988, COPLANAR STEREOTAXIC; Teneback CC, 1999, J NEUROPSYCH CLIN N, V11, P426; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; Trofimov AO, 2018, ADV EXP MED BIOL, V1072, P59, DOI 10.1007/978-3-319-91287-5_10; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wang Z, 2005, MAGN RESON MED, V54, P732, DOI 10.1002/mrm.20574; Weathers FW, 2013, POSTTRAUMATIC STRESS; Wechsler, 1997, WECHSLER ADULT INTEL; Wright J, 2011, ENCY CLIN NEUROPSYCH; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zheng X, 2011, NEUROIMAGE, V58, P26, DOI 10.1016/j.neuroimage.2011.06.018	90	2	2	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 7	2020	11								545174	10.3389/fneur.2020.545174			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OD4ON	WOS:000579831900001	33117255	Green Published, gold			2022-02-06	
J	Vogel, DDS; Ortiz-Villatoro, NN; de Freitas, L; Aimbire, F; Scorza, FA; Albertini, R; Scorza, CA				Vogel, Debora D. S.; Ortiz-Villatoro, Nancy N.; de Freitas, Leandro; Aimbire, Flavio; Scorza, Fulvio A.; Albertini, Regiane; Scorza, Carla A.			Repetitive transcranial photobiomodulation but not long-term omega-3 intake reduces epileptiform discharges in rats with stroke-induced epilepsy	JOURNAL OF BIOPHOTONICS			English	Article						epilepsy; omega-3; photobiomodulation; stroke	TRAUMATIC BRAIN-INJURY; SEIZURES; THERAPY	Epilepsy is a yet under-recognized consequence after a stroke and nearly 30% of cases are pharmacoresistant. There is an unmet need for therapeutic interventions during epileptogenesis for better long-term disease outcomes. Transcranial photobiomodulation (PBM) and omega-3 (omega-3) dietary supplementation are two approaches that have been shown promising neuroprotective effects after brain injuries. Here, we studied the PBM treatment or omega-3 diet during epileptogenesis in long-term recurrent spontaneous abnormal electrical discharges after stroke. Wistar rats received repetitive 780 nm-laser in the scalp or oral diet with omega-3 for 2-months after photothrombotic stroke. EEG recordings were performed 60 days after treatment end. PBM but not omega-3 reduced both electrographic seizure duration and spikes number in the ipsilateral and contralateral cortices and ventral posteromedial thalamic nucleus. Conclusively, PBM reduced epileptiform discharges in stroke-induced epilepsy. Our results suggest the PBM as a therapeutic approach for stroke-induced epileptogenesis to minimize long-term disease outcomes.	[Vogel, Debora D. S.; Ortiz-Villatoro, Nancy N.; de Freitas, Leandro; Scorza, Fulvio A.; Scorza, Carla A.] Univ Fed Sao Paulo UNIFESP, Dept Neurol & Neurocirurgia, Escola Paulista Med EPM, Disciplina Neurociencia, Sao Paulo, Brazil; [Aimbire, Flavio] Univ Fed Sao Paulo UNIFESP, Dept Ciencia & Tecnol, Programa Posgrad Med Translac, Sao Paulo, Brazil; [Albertini, Regiane] Univ Fed Sao Paulo UNIFESP, Dept Ciencia & Tecnol, Programa Posgrad Ciencia Movimento Humano & Reabi, i, Sao Paulo, Brazil		Aimbire, F (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Ciencia & Tecnol, Programa Posgrad Med Translac, Sao Paulo, Brazil.	flavio.aimbire@unifesp.br	Aimbire, Flavio/E-6193-2012	Aimbire, Flavio/0000-0002-4290-541X; ALBERTINI, REGIANE/0000-0002-4143-0387	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [302583/2017-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/10286-7]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Grant/Award Number: 302583/2017-3; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES), Grant/Award Number: Finance Code 001; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Grant/Award Number: 2016/10286-7	Belayev L, 2018, MOL NEUROBIOL, V55, P7090, DOI 10.1007/s12035-018-1136-3; Bentes C, 2017, J NEUROL, V264, P1978, DOI 10.1007/s00415-017-8586-9; Feyissa AM, 2019, EUR J NEUROL, V26, P18, DOI 10.1111/ene.13813; Frigerio F, 2018, BRAIN, V141, P3130, DOI 10.1093/brain/awy247; Hamblin MR, 2018, J NEUROSCI RES, V96, P731, DOI 10.1002/jnr.24190; Kharlamov EA, 2003, EPILEPSY RES, V56, P185, DOI 10.1016/j.eplepsyres.2003.09.005; Klein P, 2020, NEUROPHARMACOLOGY, V168, DOI 10.1016/j.neuropharm.2019.107762; Nejm MB, 2015, METAB BRAIN DIS, V30, P903, DOI 10.1007/s11011-015-9666-0; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Pitkanen A, 2015, COLD SPRING HARB PER, V5, P10, DOI DOI 10.1101/CSHPERSPECT.A022822; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Xuan WJ, 2016, J BIOPHOTONICS, V9, P1263, DOI 10.1002/jbio.201500336; Yang LD, 2018, EXP NEUROL, V299, P86, DOI 10.1016/j.expneurol.2017.10.013; Zivin JA, 2014, INT J STROKE, V9, P950, DOI 10.1111/j.1747-4949.2012.00896.x	14	2	2	0	1	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1864-063X	1864-0648		J BIOPHOTONICS	J. Biophotonics	JAN	2021	14	1							e202000287	10.1002/jbio.202000287		OCT 2020	5	Biochemical Research Methods; Biophysics; Optics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Optics	PQ4GE	WOS:000575808600001	32888387				2022-02-06	
J	Alisafaei, F; Gong, Z; Johnson, VE; Dolle, JP; Smith, DH; Shenoy, VB				Alisafaei, Farid; Gong, Ze; Johnson, Victoria E.; Dolle, Jean-Pierre; Smith, Douglas H.; Shenoy, Vivek B.			Mechanisms of Local Stress Amplification in Axons near the Gray-White Matter Interface	BIOPHYSICAL JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; TAU PROTEINS; DAMAGE; MICROTUBULES; TISSUE; BIOMECHANICS; ELASTICITY; CRITERION; PATHOLOGY	Diffuse axonal injury is a primary neuropathological feature of concussion and is thought to greatly contribute to the classical symptoms of decreased processing speed and memory dysfunction. Although previous studies have investigated the injury biomechanics at the micro- and mesoscale of concussion, few have addressed the multiscale transmission of mechanical loading at thresholds that can induce diffuse axonal injury. Because it has been recognized that axonal pathology is commonly found at anatomic interfaces across all severities of traumatic brain injury, we combined computational, analytical, and experimental approaches to investigate the potential mechanical vulnerability of axons that span the gray-white tissue interface. Our computational models predict that material heterogeneities at the gray-white interface lead to a highly nonuniform distribution of stress in axons, which was most amplified in axonal regions near the interface. This mechanism was confirmed using an analytical model of an individual fiber in a strained bimaterial interface. Comparisons of these collective data with histopathological evaluation of a swine model of concussion demonstrated a notably similar pattern of axonal damage adjacent to the gray-white interface. The results suggest that the tissue property mismatch at the gray-white matter interface places axons crossing this region at greater risk of mechanical damage during brain tissue deformation from traumatic brain injury.	[Alisafaei, Farid; Gong, Ze; Shenoy, Vivek B.] Univ Penn, Sch Engn & Appl Sci, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Alisafaei, Farid; Gong, Ze; Shenoy, Vivek B.] Univ Penn, Ctr Engn Mechanobiol, Philadelphia, PA 19104 USA; [Johnson, Victoria E.; Dolle, Jean-Pierre; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Penn Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA		Shenoy, VB (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.; Shenoy, VB (corresponding author), Univ Penn, Ctr Engn Mechanobiol, Philadelphia, PA 19104 USA.	vshenoy@seas.upenn.edu	Shenoy, Vivek/ABD-5075-2021; Gong, Ze/V-1194-2019	Gong, Ze/0000-0003-0172-0563	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32-NS-043126, R01-EB021293, R01-NS092398]; NSF Center for Engineering Mechanobiology [CMMI-154857]; NIH through the Paul G. Allen Family Foundation	F.A. thankfully acknowledges NIH grant T32-NS-043126. We also gratefully acknowledge support from the NSF Center for Engineering Mechanobiology (CMMI-154857), and also from the NIH through the Paul G. Allen Family Foundation and NIH grants R01-EB021293 and R01-NS092398.	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alisafaei F, 2019, P NATL ACAD SCI USA, V116, P13200, DOI 10.1073/pnas.1902035116; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; Biot M.A, 1937, J APPL MECH A, P1; Brito JP, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00015; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Chan DD, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040230; Cignoni P., 2008, MESHLAB OPEN SOURCE, DOI 10.2312/LocalChapterEvents/ItalChap/ItalianChapConf2008/129-136.; Datar A, 2019, BIOPHYS J, V117, P880, DOI 10.1016/j.bpj.2019.07.046; Dillard DA, 2018, SOFT MATTER, V14, P3669, DOI 10.1039/c7sm02062g; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Gong Z, 2019, SOFT MATTER, V15, P166, DOI 10.1039/c8sm01747f; Haralick R.M, 1992, COMPUTER ROBOT VISIO; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; KREMKAU FW, 1981, J ACOUST SOC AM, V70, P29, DOI 10.1121/1.386578; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Meaney DF, 2015, HDB CLIN NEUROLOGY, P105; MILLER AKH, 1980, NEUROPATH APPL NEURO, V6, P119, DOI 10.1111/j.1365-2990.1980.tb00283.x; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Shakiba D, 2020, ACS NANO, V14, P7868, DOI 10.1021/acsnano.9b09941; Shao XY, 2019, BIOPHYS J, V117, P193, DOI 10.1016/j.bpj.2019.06.011; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Spedden E, 2013, INT J MOL SCI, V14, P16124, DOI 10.3390/ijms140816124; Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005; Swanson LW, 2016, ANNU REV NEUROSCI, V39, P197, DOI 10.1146/annurev-neuro-071714-033954; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Weickenmeier J, 2017, J MECH BEHAV BIOMED, V76, P119, DOI 10.1016/j.jmbbm.2017.04.017; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1	63	2	2	4	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	OCT 6	2020	119	7					1290	1300		10.1016/j.bpj.2020.08.024			11	Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics	OC7UL	WOS:000579362900008	33027609	Bronze, Green Published			2022-02-06	
J	Mansour, A; Loggini, A; El Ammar, F; Ginat, D; Awad, IA; Lazaridis, C; Kramer, C; Vasenina, V; Polster, SP; Huang, AN; Perez, HO; Das, P; Horowitz, PM; Zakrison, T; Hampton, D; Rogers, SO; Goldenberg, FD				Mansour, Ali; Loggini, Andrea; El Ammar, Faten; Ginat, Daniel; Awad, Issam A.; Lazaridis, Christos; Kramer, Christopher; Vasenina, Valentina; Polster, Sean P.; Huang, Anna; Perez, Henry Olivera; Das, Paramita; Horowitz, Peleg M.; Zakrison, Tanya; Hampton, David; Rogers, Selwyn O.; Goldenberg, Fernando D.			Cerebrovascular Complications in Early Survivors of Civilian Penetrating Brain Injury	NEUROCRITICAL CARE			English	Article						Cerebrovascular injury; Penetrating brain injury; Neurotrauma	TRAUMATIC INTRACRANIAL ANEURYSMS; ARTERIAL INJURIES; HEAD; ANGIOGRAPHY; DIAGNOSIS	Background This study investigates the presence of cerebrovascular injuries in a large sample of civilian penetrating brain injury (PBI) patients, determining the prevalence, radiographic characteristics, and impact on short-term outcome. Methods We retrospectively reviewed patients with PBI admitted to our institution over a 2-year period. Computed tomography head scans, computer tomography angiograms and venograms of the intracranial vessels were evaluated to determine the wound trajectory, intracranial injury characteristics, and presence of arterial (AI) and venous sinus (VSI) injuries. Demographics, clinical presentation, and treatment were also reviewed. Discharge disposition was used as surrogate of short-term outcome. Results Seventy-two patients were included in the study. The mechanism of injury was gunshot wounds in 71 patients and stab wound in one. Forty-one of the 72 patients (60%) had at least one vascular injury. Twenty-six out of 72 patients suffered an AI (36%), mostly pseudoaneurysms and occlusions, involving the anterior and middle cerebral arteries. Of the 72 patients included, 45 had dedicated computed tomography venograms, and of those 22 had VSI (49%), mainly manifesting as superior sagittal sinus occlusion. In a multivariable regression model, intraventricular hemorrhage at presentation was associated with AI (OR 9.9,p = 0.004). The same was not true for VSI. Conclusion Acute traumatic cerebrovascular injury is a prevalent complication in civilian PBI, frequently involving both the arterial and venous sinus systems. Although some radiographic features might be associated with presence of vascular injury, assessment of the intracranial vasculature in the acute phase of all PBI is essential for early diagnosis. Treatment of vascular injury remains variable depending on local practice.	[Mansour, Ali; Loggini, Andrea; El Ammar, Faten; Lazaridis, Christos; Kramer, Christopher; Goldenberg, Fernando D.] Univ Chicago Med & Biol Sci, Dept Neurol, Neurosci Intens Care Unit, Neurocrit Care, 5841 S Maryland Ave,MC 2030, Chicago, IL 60637 USA; [Ginat, Daniel] Univ Chicago Med & Biol Sci, Dept Radiol, Sect Neuroradiol, Chicago, IL 60637 USA; [Mansour, Ali; Awad, Issam A.; Lazaridis, Christos; Kramer, Christopher; Vasenina, Valentina; Polster, Sean P.; Das, Paramita; Horowitz, Peleg M.; Goldenberg, Fernando D.] Univ Chicago Med & Biol Sci, Dept Surg, Sect Neurosurg, Chicago, IL 60637 USA; [Huang, Anna; Perez, Henry Olivera] Univ Chicago Med & Biol Sci, Pritzker Sch Med, Chicago, IL 60637 USA; [Zakrison, Tanya; Hampton, David; Rogers, Selwyn O.] Univ Chicago Med & Biol Sci, Dept Surg, Sect Trauma & Acute Care Surg, Chicago, IL 60637 USA		Mansour, A (corresponding author), Univ Chicago Med & Biol Sci, Dept Neurol, Neurosci Intens Care Unit, Neurocrit Care, 5841 S Maryland Ave,MC 2030, Chicago, IL 60637 USA.; Mansour, A (corresponding author), Univ Chicago Med & Biol Sci, Dept Surg, Sect Neurosurg, Chicago, IL 60637 USA.	ali.mansour@uchospitals.edu	, Ali/ABE-6372-2021	, Ali/0000-0002-2658-074X; Loggini, Andrea/0000-0001-5479-9442; Hampton, David/0000-0002-9870-0835	Department of Neurology; Department of Surgery, Sections of Neurosurgery and Trauma at the University of Chicago; Department of Radiology, Section of Neuroradiology	We wish to acknowledge the support of the Department of Neurology, the Department of Radiology, Section of Neuroradiology, and the Department of Surgery, Sections of Neurosurgery and Trauma at the University of Chicago.	AARABI B, 1995, NEUROSURG CLIN N AM, V6, P775; AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; ACHRAM M, 1980, BRIT J RADIOL, V53, P1144, DOI 10.1259/0007-1285-53-636-1144; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; [Anonymous], 2001, J TRAUMA, V51, pS26; BANK WO, 1978, AM J ROENTGENOL, V130, P975, DOI 10.2214/ajr.130.5.975; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BENZEL EC, 1991, NEUROSURGERY, V29, P67, DOI 10.1227/00006123-199107000-00011; Bodanapally UK, 2015, J NEUROSURG, V122, P219, DOI 10.3171/2014.9.JNS14679; Bodanapally UK, 2014, J NEUROSURG, V121, P1275, DOI 10.3171/2014.7.JNS132688; Bodanapally UK, 2014, NEURORADIOL J, V27, P138, DOI 10.15274/NRJ-2014-10024; Chedid MK, 2001, J NEUROSURG, V94, P637, DOI 10.3171/jns.2001.94.4.0637; Hachemi M, 2007, CHILD NERV SYST, V23, P283, DOI 10.1007/s00381-006-0269-2; HADDAD FS, 1991, NEUROSURGERY, V28, P1; Hemphill JC, 1999, CRIT CARE CLIN, V15, P811, DOI 10.1016/S0749-0704(05)70089-0; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Horowitz MB, 1999, SURG NEUROL, V51, P31, DOI 10.1016/S0090-3019(98)00029-9; JAKOBSSON KE, 1984, ACTA NEUROCHIR, V71, P91, DOI 10.1007/BF01401153; JINKINS JR, 1992, AM J ROENTGENOL, V159, P365, DOI 10.2214/ajr.159.2.1632358; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; Larson P S, 2000, Neurosurg Focus, V8, pe4; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; Loggini A, 2020, J CRIT CARE, V56, P159, DOI 10.1016/j.jcrc.2019.12.026; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; SHALLAT RF, 1981, NEUROSURGERY, V8, P569, DOI 10.1227/00006123-198105000-00010	26	2	2	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2021	34	3					918	926		10.1007/s12028-020-01106-y		OCT 2020	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN4OZ	WOS:000575724500002	33025542				2022-02-06	
J	Archer, B; Azios, JH; Gulick, N; Tetnowski, J				Archer, Brent; Azios, Jamie H.; Gulick, Nora; Tetnowski, Jennifer			Facilitating participation in conversation groups for aphasia	APHASIOLOGY			English	Article						Aphasia groups; conversation analysis; participation	TRAUMATIC BRAIN-INJURY; SUPPORTED CONVERSATION; QUALITATIVE RESEARCH; PATIENT INTERACTION; GROUP-THERAPY; TURN-TAKING; COMMUNICATION; PEOPLE; ORGANIZATION; SEQUENCES	Background Although facilitated group conversations for aphasia are a popular practice within contemporary clinical aphasiology, only a small number of published studies have shed some light on how interaction occurs in this setting. One aspect of aphasia group conversation that has been mentioned in the literature but that has not yet been the focus of intensive study is participation management. Facilitators report that finding ways to help people with verbal language impairments participate in conversation is one of the central challenges faced by the clinicians and volunteers who lead these groups. However, thus far, no in-depth, interactionally-oriented research on how facilitators support group members with limited expressive language abilities exists. Aims The aim of this study was to investigate how facilitators support people with non-fluent aphasia during group conversation. Method/procedures We applied conversation analysis (CA) to nine video recordings of conversation groups involving people with aphasia. These videos were recorded at three sites in North America (three sites X three recordings). Each of the sessions we analysed were facilitated by experienced facilitators: Catina at Site 1, Cooper at Site 2 and Lyra at Site 3. Results/outcomes Our analysis revealed that facilitators and group members constructed two types of sequences that supported participation by people with non-fluent aphasia (PwNFA) namely floor transfers and question-answer series. Floor transfers established a shared group focus on a specific PwNFA while question-answer series furnished PwNFA opportunities to contribute several relevant, consecutive turns to the conversation. Conclusions The sequences we identified appeared to be designed to promote meaningful conversational participation by group members with verbal output difficulties. The behaviours that facilitators and group members engage in during these sessions could plausibly be used in other settings and suggest foci for future studies of aphasia groups.	[Archer, Brent; Gulick, Nora] Bowling Green State Univ, Dept Commun Sci & Disorders, Bowling Green, OH 43403 USA; [Azios, Jamie H.] Lamar Univ, Dept Speech & Hearing Sci, Beaumont, TX 77710 USA; [Tetnowski, Jennifer] Univ Oklahoma, Hlth Sci Ctr, Dept Commun Sci & Disorders, Norman, OK 73019 USA		Archer, B (corresponding author), Bowling Green State Univ, Dept Commun Sci & Disorders, Bowling Green, OH 43403 USA.	barcher@bgsu.edu					Antaki C, 2012, DISCOURSE STUD, V14, P531, DOI 10.1177/1461445612454074; Archer B., 2016, THESIS; Archer B., 2017, AM SPEECH LANG HEAR; Archer B, 2019, APHASIOLOGY, V33, P1248, DOI 10.1080/02687038.2019.1630596; Archer B, 2018, APHASIOLOGY, V32, P394, DOI 10.1080/02687038.2017.1413705; Auer P, 2018, ADV INTERACT STUD, V10, P197, DOI 10.1075/ais.10.09aue; Azios JH, 2018, APHASIOLOGY, V32, P944, DOI 10.1080/02687038.2018.1466106; Barnes S., 2011, THESIS; Beeke S, 2007, APHASIOLOGY, V21, P256, DOI 10.1080/02687030600911344; Beeke Suzanne, 2007, Seminars in Speech and Language, V28, P136, DOI 10.1055/s-2007-970571; Bernstein-Ellis E, 2007, GROUP TREATMENT NEUR, P71; Coelho C. A., 1993, P 21 CLIN APH C DEST; Damico J, 2015, APHASIOLOGY, V29, P400, DOI 10.1080/02687038.2014.945388; Damico JS, 2003, AM J SPEECH-LANG PAT, V12, P131, DOI 10.1044/1058-0360(2003/060); Damico JS, 1999, APHASIOLOGY, V13, P667, DOI 10.1080/026870399401777; Denman A, 2011, DISABIL REHABIL, V33, P243, DOI 10.3109/09638288.2010.511686; Elman R., 2010, SIG 2 PERSPECTIVES N, V20, P120, DOI [10.1044/nnsld20.4.120, DOI 10.1044/nnsld20.4.120]; Elman RJ, 1999, J SPEECH LANG HEAR R, V42, P411, DOI 10.1044/jslhr.4202.411; Enfield N., 2006, ROOTS HUMAN SOCIALIT; Frankel T, 2007, APHASIOLOGY, V21, P1039, DOI 10.1080/02687030701198395; Goffman E., 1979, SEMIOTICA, V25, P1, DOI DOI 10.1515/SEMI.1979.25.1-2.1; Goodwin, 2004, J LINGUIST ANTHROPOL, V14, P151, DOI DOI 10.1525/JLIN.2004.14.2.151; Goodwin C, 2000, J PRAGMATICS, V32, P1489, DOI 10.1016/S0378-2166(99)00096-X; GOODWIN C, 1990, ANNU REV ANTHROPOL, V19, P283, DOI 10.1146/annurev.an.19.100190.001435; Goodwin C., 2003, CONVERSATION BRAIN D, P90; Goodwin C, 2007, DISCOURSE SOC, V18, P53, DOI 10.1177/0957926507069457; Goodwin C, 2010, STUD DISCOURSE GRAMM, V23, P373; Gordon C, 2009, J ADV NURS, V65, P544, DOI 10.1111/j.1365-2648.2008.04917.x; Heeschen C, 1999, APHASIOLOGY, V13, P365, DOI 10.1080/026870399402145; Heeschen C., 2003, CONVERSATION BRAIN D, P231; Hepburn A, 2014, RES LANG SOC INTERAC, V47, P239, DOI 10.1080/08351813.2014.925661; Hoen B, 1997, APHASIOLOGY, V11, P681, DOI 10.1080/02687039708249415; Horton S, 2016, APHASIOLOGY, V30, P629, DOI 10.1080/02687038.2014.1000819; Hutchby I., 2008, CONVERSATION ANAL, V2nd edn.; Jefferson G, 1989, CONVERSATION INTERDI, P166; Jefferson G., 2004, CONVERSATION ANAL ST, P13, DOI [10.1075/pbns.125.02jef, DOI 10.1080/13613320902995475]; Jensen LR, 2015, APHASIOLOGY, V29, P57, DOI 10.1080/02687038.2014.955708; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan A., 1993, APHASIA TREATMENT WO, P199; Kendon A., 1990, CONDUCTING INTERACTI; Laakso M, 1999, APHASIOLOGY, V13, P345, DOI 10.1080/026870399402136; Lee J. B., 2019, AM J SPEECH-LANG PAT, V29, DOI [10.1044/2019_AJSLP-19-0078, DOI 10.1044/2019_AJSLP-19-0078]; Lerner GH, 2003, LANG SOC, V32, P177, DOI 10.1017/S004740450332202X; MACLAY H, 1959, WORD, V15, P19, DOI 10.1080/00437956.1959.11659682; MAYNARD DW, 1984, SOC PSYCHOL QUART, V47, P301, DOI 10.2307/3033633; Maynard DW, 2005, MED EDUC, V39, P428, DOI 10.1111/j.1365-2929.2005.02111.x; Merriam S.B., 2009, QUALITATIVE RES GUID, V4th ed.; Oelschlaeger M.L., 2003, CONVERSATION BRAIN D, P211; ORLETTI F, 1989, INT J SOCIOL LANG, P75; Perakyla A., 2007, BLACKWELL ENCY SOCIO; Quirk Rodney, 2010, COMPREHENSIVE GRAMMA; Ross A, 2006, APHASIOLOGY, V20, P427, DOI 10.1080/02687030500532786; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Schegloff E. A., 1990, CONVERSATIONAL ORG I, P51; SCHEGLOFF EA, 1977, LANGUAGE, V53, P361, DOI 10.2307/413107; Schegloff EA, 1998, SOC RES, V65, P535; Sherratt S, 2016, APHASIOLOGY, V30, P1039, DOI 10.1080/02687038.2015.1092495; Simmons-Mackie N., 2001, LANGUAGE INTERVENTIO, V235, P279; Simmons-Mackie N, 2007, TOP LANG DISORD, V27, P5, DOI 10.1097/00011363-200701000-00003; Simmons-Mackie Nina, 2011, Seminars in Speech and Language, V32, P203, DOI 10.1055/s-0031-1286175; Simmons-Mackie Nina, 2009, Seminars in Speech and Language, V30, P18, DOI 10.1055/s-0028-1104531; Simmons-Mackie NN, 2007, APHASIOLOGY, V21, P39, DOI 10.1080/02687030600798287; Simmons-Mackie NN, 2005, APHASIOLOGY, V19, P583, DOI 10.1080/02687030444000408; SINYOR D, 1986, STROKE, V17, P1102, DOI 10.1161/01.STR.17.6.1102; Stivers T, 2010, J PRAGMATICS, V42, P2620, DOI 10.1016/j.pragma.2010.04.002; Stivers T, 2010, RES LANG SOC INTERAC, V43, P3, DOI 10.1080/08351810903471258; Strauss A B, 1967, Rehabil Rec, V8, P30; Tetnowski JA, 2003, AM J SPEECH-LANG PAT, V12, P155, DOI 10.1044/1058-0360(2003/062); Tompkins CA, 2006, APHASIOLOGY, V20, P684, DOI 10.1080/02687030500334076; Travers M, 2006, LAW SOCIAL INQUIRY, V31, P447, DOI 10.1111/j.1747-4469.2006.00017.x; van der Gaag A, 2005, CLIN REHABIL, V19, P372, DOI 10.1191/0269215505cr785oa; Vickers CP, 2010, APHASIOLOGY, V24, P902, DOI 10.1080/02687030903438532; WERTZ RT, 1981, J SPEECH HEAR RES, V24, P580, DOI 10.1044/jshr.2404.580; Whitworth A., 1997, CONVERSATION ANAL PR; Wilkinson R, 2011, INT J SPEECH-LANG PA, V13, P74, DOI 10.3109/17549507.2011.551140; Wilkinson R, 2010, APHASIOLOGY, V24, P869, DOI 10.1080/02687030903501958; Worrall L. E., 2000, NEUROGENIC COMMUNICA, P162	77	2	2	1	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	JUN 3	2021	35	6					764	782		10.1080/02687038.2020.1812030		OCT 2020	19	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	SK5LG	WOS:000575228100001					2022-02-06	
J	Ahmad, S; Orellana, A; Kohler, I; Frolich, L; de Rojas, I; Gil, S; Boada, M; Hernandez, I; Hausner, L; Bakker, MHM; Cabrera-Socorro, A; Amin, N; Ramirez, A; Ruiz, A; Hankemeier, T; Van Duijn, CM				Ahmad, Shahzad; Orellana, Adelina; Kohler, Isabelle; Froelich, Lutz; de Rojas, Itziar; Gil, Silvia; Boada, Merce; Hernandez, Isabel; Hausner, Lucrezia; Bakker, Margot H. M.; Cabrera-Socorro, Alfredo; Amin, Najaf; Ramirez, Alfredo; Ruiz, Agustin; Hankemeier, Thomas; Van Duijn, Cornelia M.			Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer's disease	ALZHEIMERS RESEARCH & THERAPY			English	Article						Lysophosphatidic acids; Pro-inflammatory phospholipids; Signaling lipids; CSF biomarkers; Alzheimer's disease; MCI	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; VASCULAR DEMENTIA; MOLECULAR-CLONING; LIPID MEDIATORS; LPA RECEPTORS; TAU; BETA-AMYLOID(1-42)	Background Lysophosphatidic acids (LPAs) are bioactive signaling phospholipids that have been implicated in Alzheimer's disease (AD). It is largely unknown whether LPAs are associated with AD pathology and progression from mild cognitive impairment (MCI) to AD. Methods The current study was performed on cerebrospinal fluid (CSF) and plasma samples of 182 MCI patients from two independent cohorts. We profiled LPA-derived metabolites using liquid chromatography-mass spectrometry. We evaluated the association of LPAs with CSF biomarkers of AD, A beta-42,p-tau, and total tau levels overall and stratified byAPOEgenotype and with MCI to AD progression. Results Five LPAs (C16:0, C16:1, C22:4, C22:6, and isomer-LPA C22:5) showed significant positive association with CSF biomarkers of AD, A beta-42,p-tau, and total tau, while LPA C14:0 and C20:1 associated only with A beta-42 and alkyl-LPA C18:1, and LPA C20:1 associated with tau pathology biomarkers. Association of cyclic-LPA C16:0 and two LPAs (C20:4, C22:4) with A beta-42 levels was found only in APOE epsilon 4 carriers. Furthermore, LPA C16:0 and C16:1 also showed association with MCI to AD dementia progression, but results did not replicate in an independent cohort. Conclusions Our findings provide evidence that LPAs may contribute to early AD pathogenesis. Future studies are needed to determine whether LPAs play a role in upstream of AD pathology or are downstream markers of neurodegeneration.	[Ahmad, Shahzad; Amin, Najaf; Hankemeier, Thomas; Van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Orellana, Adelina; de Rojas, Itziar; Gil, Silvia; Boada, Merce; Hernandez, Isabel; Ruiz, Agustin] Aplicades Univ Int Catalunya, Inst Catala Neurociencies, Res Ctr, Barcelona, Spain; [Orellana, Adelina; de Rojas, Itziar; Gil, Silvia; Boada, Merce; Hernandez, Isabel; Ruiz, Agustin] Aplicades Univ Int Catalunya, Inst Catala Neurociencies, Memory Clin Fundacio ACE, Barcelona, Spain; [Orellana, Adelina; de Rojas, Itziar; Gil, Silvia; Boada, Merce; Hernandez, Isabel; Ruiz, Agustin] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Kohler, Isabelle; Hankemeier, Thomas] Leiden Univ, Leiden Acad Ctr Drug Res, Div Syst Biomed & Pharmacol, Leiden, Netherlands; [Froelich, Lutz; Hausner, Lucrezia] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Geriatr Psychiat, D-68159 Mannheim, Germany; [Hausner, Lucrezia] Heidelberg Univ, Med Fac Mannheim, Inst Cognit & Clin Neurosci, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Bakker, Margot H. M.] AbbVie Deutschland GmbH & Co KG, Discovery Res, Knollstr, D-67061 Ludwigshafen, Germany; [Cabrera-Socorro, Alfredo] Janssen Pharmaceut NV, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Ramirez, Alfredo] Univ Bonn, Dept Neurodegenerat Dis & Geriatr Psychiat, Bonn, Germany; [Ramirez, Alfredo] Univ Cologne, Med Fac, Dept Psychiat & Psychotherapy, Div Neurogenet & Mol Psychiat, Cologne, Germany; [Van Duijn, Cornelia M.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England		Ahmad, S; Hankemeier, T; Van Duijn, CM (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	s.ahmad@erasmusmc.nl; hankemeier@lacdr.leidenuniv.nl; Cornelia.vanDuijn@ndph.ox.ac.uk	Hankemeier, Thomas/V-5407-2019; Ramirez, Alfredo/S-5126-2019	Hankemeier, Thomas/0000-0001-7871-2073; Ramirez, Alfredo/0000-0003-4991-763X; Ahmad, Shahzad/0000-0002-8658-3790; Kohler, Isabelle/0000-0002-3629-1597; de Rojas, Itziar/0000-0002-2148-381X; Van Duijn, Cornelia/0000-0002-2374-9204	ADAPTED: Alzheimer's Disease Apolipoprotein Pathology for Treatment Elucidation and Development consortium from the Innovative Medicines Initiative 2 Joint Undertaking [115975]; European Union's Horizon 2020 research and innovation programme; European Federation of Pharmaceutical Industries and Associations; JPND EADB grant (German Federal Ministry of Education and Research) [BMBF: 01ED1619A]; European Union/EFPIA Innovative Medicines Initiative Joint Undertaking ADAPTED project [115975]; European Union/EFPIA Innovative Medicines Initiative Joint Undertaking MOPEAD project [115985]; ISCIII (Instituto de Salud Carlos III)-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER- "Una manera de Hacer Europa")European Commission;  [PI13/02434];  [PI16/01861];  [PI17/01474]	This study was funded by the ADAPTED: Alzheimer's Disease Apolipoprotein Pathology for Treatment Elucidation and Development consortium which has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115975. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations. Part of this work was supported by the JPND EADB grant (German Federal Ministry of Education and Research, BMBF: 01ED1619A).; We acknowledge all patients participating in this study from Fundacio ACE and Heidelberg-Mannheim memory clinic. We also want to thank the investigators from the Fundacio ACE Barcelona Alzheimer Treatment and Research Center, for their close collaboration and continuous intellectual input. We are grateful to Laura Montrreal for her exceptional technical support. A.R. and M.B. receive support from the European Union/EFPIA Innovative Medicines Initiative Joint Undertaking ADAPTED and MOPEAD projects (Grants No. 115975 and 115985, respectively). M.B., S.G., and A.R. are also supported by national grants PI13/02434, PI16/01861, and PI17/01474. Accion Estrategica en Salud is integrated into the Spanish National R + D + I Plan and funded by ISCIII (Instituto de Salud Carlos III)-Subdireccion General de Evaluacion and the Fondo Europeo de Desarrollo Regional (FEDER- "Una manera de Hacer Europa").	Aikawa S, 2015, J BIOCHEM, V157, P81, DOI 10.1093/jb/mvu077; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Anliker B, 2013, GLIA, V61, P2009, DOI 10.1002/glia.22572; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Armati PJ, 2013, J NEUROL SCI, V333, P68, DOI 10.1016/j.jns.2013.01.018; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Bandoh K, 2000, FEBS LETT, V478, P159, DOI 10.1016/S0014-5793(00)01827-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boada M, 2014, ALZHEIMERS DEMENT, V10, P409, DOI 10.1016/j.jalz.2013.03.006; Cho HJ, 2019, J GINSENG RES, V43, P209, DOI 10.1016/j.jgr.2017.11.006; de Leeuw Francisca A, 2017, Alzheimers Dement (Amst), V8, P196, DOI 10.1016/j.dadm.2017.07.006; Draczynska-Lusiak B, 1998, MOL CHEM NEUROPATHOL, V33, P139, DOI 10.1007/BF02870187; Edition F, 2013, AM PSYCHIAT ASS; Frisardi V, 2011, PROG LIPID RES, V50, P313, DOI 10.1016/j.plipres.2011.06.001; Garcia-Morales V, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002153; Halliday G, 2017, DIAGNOSIS MANAGEMENT; Hampel H, 2004, MOL PSYCHIATR, V9, P705, DOI 10.1038/sj.mp.4001473; Hayakawa K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45742-7; Holtsberg FW, 1998, J NEUROSCI RES, V53, P685, DOI 10.1002/(SICI)1097-4547(19980915)53:6<685::AID-JNR7>3.0.CO;2-1; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Im DS, 2000, MOL PHARMACOL, V57, P753, DOI 10.1124/mol.57.4.753; Kaerst L, 2013, J NEUROL, V260, P2722, DOI 10.1007/s00415-013-7047-3; Keller JN, 1997, J NEUROCHEM, V69, P1073; Liu Q, 2014, NEUROSCI BULL, V30, P331, DOI 10.1007/s12264-013-1410-3; McDonald WS, 2018, AM J PATHOL, V188, P1779, DOI 10.1016/j.ajpath.2018.05.005; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mesulam MM, 2003, ANN NEUROL, V54, pS11, DOI 10.1002/ana.10569; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949, DOI 10.1074/jbc.270.22.12949; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Ramesh S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071827; Reitan RM, 2004, ARCH CLIN NEUROPSYCH, V19, P281, DOI 10.1016/S0887-6177(03)00042-8; Robinson R, 2015, PLOS BIOL, V13, pe1002154; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Sayas CL, 2002, BBA-MOL CELL BIOL L, V1582, P144, DOI 10.1016/S1388-1981(02)00149-X; Schilling T, 2004, EUR J NEUROSCI, V19, P1469, DOI 10.1111/j.1460-9568.2004.03265.x; Schilling T, 2002, NEUROSCIENCE, V109, P827, DOI 10.1016/S0306-4522(01)00534-6; Schoeman JC, 2018, ANAL BIOANAL CHEM, V410, P2551, DOI 10.1007/s00216-018-0912-2; Shi J, 2013, BBA-MOL BASIS DIS, V1832, P29, DOI 10.1016/j.bbadis.2012.09.010; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sun YX, 2003, DEMENT GERIATR COGN, V16, P136, DOI 10.1159/000071001; Sunderland T, 2004, BIOL PSYCHIAT, V56, P670, DOI 10.1016/j.biopsych.2004.07.021; Takeda A, 2015, TRANSL CANCER RES, V4, P537, DOI 10.3978/j.issn.2218-676X.2015.09.03; Uranbileg B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52999-5; van der Lee SJ, 2018, ALZHEIMERS DEMENT, V14, P707, DOI 10.1016/j.jalz.2017.11.012; van der Lee SJ, 2018, LANCET NEUROL, V17, P434, DOI [10.1016/s1474-4422(18)30053-X, 10.1016/S1474-4422(18)30053-X]; Vanderstichele H, 2008, BIOMARKERS EARLY DIA; Vanderstichele H, 2012, ALZHEIMERS DEMENT, V8, P65, DOI 10.1016/j.jalz.2011.07.004; Varma VR, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002482; WALTON D, 1958, J MENT SCI, V104, P1111, DOI 10.1192/bjp.104.437.1111; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yoshida K, 2003, CIRCULATION, V108, P1746, DOI 10.1161/01.CIR.0000089374.35455.F3; Yukiura H, 2011, J BIOL CHEM, V286, P43972, DOI 10.1074/jbc.M111.301093; Yung YC, 2015, NEURON, V85, P669, DOI 10.1016/j.neuron.2015.01.009	59	2	2	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1758-9193		ALZHEIMERS RES THER	Alzheimers Res. Ther.	OCT 2	2020	12	1							124	10.1186/s13195-020-00680-9			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NZ2RX	WOS:000576945000002	33008436	Green Published, gold			2022-02-06	
J	Charoensareerat, T; Bhurayanontachai, R; Sitaruno, S; Navasakulpong, A; Boonpeng, A; Lerkiatbundit, S; Pattharachayakul, S				Charoensareerat, Taniya; Bhurayanontachai, Rungsun; Sitaruno, Sirima; Navasakulpong, Asma; Boonpeng, Apinya; Lerkiatbundit, Sanguan; Pattharachayakul, Sutthiporn			Efficacy and Safety of Enteral Erythromycin Estolate in Combination With Intravenous Metoclopramide vs Intravenous Metoclopramide Monotherapy in Mechanically Ventilated Patients With Enteral Feeding Intolerance: A Randomized, Double-Blind, Controlled Pilot Study	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article						erythromycin estolate; feeding intolerance; gastric residual volume; mechanical ventilation; metoclopramide	CRITICALLY-ILL PATIENTS; RESIDUAL GASTRIC VOLUME; TRAUMATIC BRAIN-INJURY; RISK-FACTORS; NUTRITION; THERAPY; PHARMACOKINETICS; PREVALENCE; TOLERANCE; CARE	Background In this pilot study, we aimed to determine the efficacy and safety of enteral erythromycin estolate in combination with intravenous metoclopramide compared to intravenous metoclopramide monotherapy in mechanically ventilated patients with enteral feeding intolerance. Methods This randomized, double-blind, controlled pilot study included 35 mechanically ventilated patients with feeding intolerance who were randomly assigned to receive 10-mg metoclopramide intravenously every 6-8 hours in combination with 250-mg enteral erythromycin estolate (study group) or placebo every 6 hours for 7 days. The primary outcome was an administered-to-target energy ratio of >= 80% at 48 hours, indicating a successful feeding. Secondary, prespecified outcomes were daily average gastric residual volume (GRV), total energy intake, administered-to-target energy ratio, hospital length of stay, in-hospital mortality, and 28-day mortality. Results The rate of successful feeding was not significantly different between the study and placebo groups (47.1% and 61.1%, respectively;P= .51). The average daily GRV was significantly lower in the study group than in the placebo group (beta = 91.58 [95% Wald CI, -164.35 to -18.8]), determined by generalized estimating equation. Other secondary outcomes were comparable, and the incidence of adverse events was not significantly different between the 2 groups. One common complication was cardiac arrhythmia, which was mostly self-terminated. Conclusion Although the combination therapy of enteral erythromycin estolate and intravenous metoclopramide reduced GRV, the successful feeding rate and other patient-specific outcomes did not improve in mechanically ventilated patients with feeding intolerance.	[Charoensareerat, Taniya] Siam Univ, Fac Pharm, Bangkok, Thailand; [Bhurayanontachai, Rungsun] Prince Songkla Univ, Div Internal Med, Crit Care Med Unit, Fac Med, Hat Yai, Songkhla, Thailand; [Sitaruno, Sirima] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Hat Yai, Thailand; [Navasakulpong, Asma] Prince Songkla Univ, Div Internal Med, Resp & Resp Crit Care Med Unit, Fac Med, Hat Yai, Thailand; [Boonpeng, Apinya] Univ Phayao, Sch Pharmaceut Sci, Phayao, Thailand; [Lerkiatbundit, Sanguan] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Pharm Adm, Hat Yai, Thailand; [Pattharachayakul, Sutthiporn] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Hat Yai, Thailand		Bhurayanontachai, R (corresponding author), Prince Songkla Univ, Div Internal Med, Crit Care Med Unit, Fac Med, Hat Yai, Songkhla, Thailand.	rungsun2346@gmail.com	navasakulpong, asma/ABA-1258-2021; Bhurayanontachai, Rungsun/L-3562-2017	Bhurayanontachai, Rungsun/0000-0002-3352-5060; Charoensareerat, Taniya/0000-0002-1100-2162; Boonpeng, Apinya/0000-0002-6169-0039	Siam University; Research Administration and Service and Faculty of Pharmaceutical Sciences, Prince of Songkla University; Seven Stars Pharmaceutical Co Ltd.	This study was funded by Siam University and the Research Administration and Service and Faculty of Pharmaceutical Sciences, Prince of Songkla University. The placebo was sponsored by the Seven Stars Pharmaceutical Co Ltd. The funding source had no role in the study design; collection, analysis, and interpretation of data; writing of the article; or the decision to submit the article for publication.	Blaser AR, 2014, ACTA ANAESTH SCAND, V58, P914, DOI 10.1111/aas.12302; CATNACH SM, 1992, GUT, V33, P397, DOI 10.1136/gut.33.3.397; CROTEAU D, 1988, ANTIMICROB AGENTS CH, V32, P561, DOI 10.1128/AAC.32.4.561; Deane A, 2007, WORLD J GASTROENTERO, V13, P3909, DOI 10.3748/wjg.v13.i29.3909; Elke G, 2013, JAMA-J AM MED ASSOC, V309, P2090, DOI 10.1001/jama.2013.4090; Gungabissoon U, 2015, JPEN-PARENTER ENTER, V39, P441, DOI 10.1177/0148607114526450; HART GK, 1988, JPEN-PARENTER ENTER, V12, P465, DOI 10.1177/0148607188012005465; Heyland DK, 2011, CRIT CARE MED, V39, P2619, DOI 10.1097/CCM.0b013e318226641d; HOUIN G, 1980, J INT MED RES, V8, P9; Koda-Kimble MA, 2009, APPL THERAPEUTICS CL, V9th; Landry C, 1996, ALIMENT PHARM THERAP, V10, P967, DOI 10.1046/j.1365-2036.1996.75247000.x; Lewis K, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1441-z; MacLaren R, 2008, JPEN-PARENTER ENTER, V32, P412, DOI 10.1177/0148607108319803; Makar JK, 2016, SAUDI J ANAESTH, V10, P308, DOI 10.4103/1658-354X.174902; Mentec H, 2001, CRIT CARE MED, V29, P1955, DOI 10.1097/00003246-200110000-00018; Mishra A, 1999, CHEST, V115, P983, DOI 10.1378/chest.115.4.983; Nguyen NQ, 2007, CRIT CARE MED, V35, P2561, DOI 10.1097/01.CCM.0000286397.04815.B1; Nguyen NQ, 2007, CRIT CARE, V11, DOI 10.1186/cc5685; Nguyen NQ, 2007, CRIT CARE MED, V35, P483, DOI 10.1097/01.CCM.0000253410.36492.E9; Nguyen NQ, 2013, INTENS CARE MED, V39, P1238, DOI 10.1007/s00134-013-2881-4; Nguyen NQ, 2011, CRIT CARE MED, V39, P868, DOI 10.1097/CCM.0b013e318206d57b; NILSEN OG, 1987, J ANTIMICROB CHEMOTH, V20, P81, DOI 10.1093/jac/20.suppl_B.81; Pinto TF, 2012, BRAIN INJURY, V26, P1113, DOI 10.3109/02699052.2012.666369; Reignier J, 2013, JAMA-J AM MED ASSOC, V309, P249, DOI 10.1001/jama.2012.196377; Ritz MA, 2005, INTENS CARE MED, V31, P949, DOI 10.1007/s00134-005-2663-8; Singer P, 2019, CLIN NUTR, V38, P48, DOI 10.1016/j.clnu.2018.08.037; Sioson MS, 2018, CLIN NUTR ESPEN, V24, P156, DOI 10.1016/j.clnesp.2017.11.008; Suita K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133664; Taylor BE, 2016, CRIT CARE MED, V44, P390, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; van der Meer YG, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0502-4; Veldkamp MW, 2001, EUR HEART J, V22, P955, DOI 10.1053/euhj.2000.2499	31	2	2	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-6071	1941-2444		JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	AUG	2021	45	6					1309	1318		10.1002/jpen.2013		OCT 2020	10	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	UL2SO	WOS:000574465200001	32895971				2022-02-06	
J	Harrois, A; Anstey, JR; van der Jagt, M; Taccone, FS; Udy, AA; Citerio, G; Duranteau, J; Ichai, C; Badenes, R; Prowle, JR; Ercole, A; Oddo, M; Schneider, A; Wolf, S; Helbok, R; Nelson, DW; Cooper, DJ; Bellomo, R				Harrois, Anatole; Anstey, James R.; van der Jagt, Mathieu; Taccone, Fabio S.; Udy, Andrew A.; Citerio, Giuseppe; Duranteau, Jacques; Ichai, Carole; Badenes, Rafael; Prowle, John R.; Ercole, Ari; Oddo, Mauro; Schneider, Antoine; Wolf, Stefan; Helbok, Raimund; Nelson, David W.; Cooper, D. Jamie; Bellomo, Rinaldo		TBI Collaborative	Variability in Serum Sodium Concentration and Prognostic Significance in Severe Traumatic Brain Injury: A Multicenter Observational Study	NEUROCRITICAL CARE			English	Article						Sodium variability; Traumatic brain injury; Hypernatremia; Hyponatremia; Osmotherapy	INTENSIVE-CARE-UNIT; DIABETES-INSIPIDUS; HYPONATREMIA; HYPERNATREMIA; RISK; CONSEQUENCES; DEATH	Background/Objective Dysnatremia is common in severe traumatic brain injury (TBI) patients and may contribute to mortality. However, serum sodium variability has not been studied in TBI patients. We hypothesized that such variability would be independently associated with mortality. Methods We collected 6-hourly serum sodium levels for the first 7 days of ICU admission from 240 severe TBI patients in 14 neurotrauma ICUs in Europe and Australia. We evaluated the association between daily serum sodium standard deviation (dNa(SD)), an index of variability, and 28-day mortality. Results Patients were 46 +/- 19 years of age with a median initial GCS of 6 [4-8]. Overall hospital mortality was 28%. Hypernatremia and hyponatremia occurred in 64% and 24% of patients, respectively. Over the first 7 days in ICU, serum sodium standard deviation was 2.8 [2.0-3.9] mmol/L. Maximum daily serum sodium standard deviation (dNa(SD)) occurred at a median of 2 [1-4] days after admission. There was a significant progressive decrease in dNa(SD)over the first 7 days (coefficient - 0.15 95% CI [- 0.18 to - 0.12],p < 0.001). After adjusting for baseline TBI severity, diabetes insipidus, the use of osmotherapy, the occurrence of hypernatremia, and hyponatremia and center, dNa(SD)was significantly independently associated with 28-day mortality (HR 1.27 95% CI (1.01-1.61),p = 0.048). Conclusions Our study demonstrates that daily serum sodium variability is an independent predictor of 28-day mortality in severe TBI patients. Further prospective investigations are necessary to confirm the significance of sodium variability in larger cohorts of TBI patients and test whether attenuating such variability confers outcome benefits to such patients.	[Harrois, Anatole; Anstey, James R.; Bellomo, Rinaldo] Royal Melbourne Hosp, Intens Care Unit, Level 5,B Block, Parkville, Vic 3050, Australia; [Harrois, Anatole; Duranteau, Jacques] Paris Sud Univ, Dept Anesthesia & Surg Intens Care, CHU Bicetre, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France; [van der Jagt, Mathieu] Erasmus MC Univ Med Ctr, Dept Intens Care Adults, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands; [van der Jagt, Mathieu] Erasmus MC Univ Med Ctr, Dept Intens Care Adults, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Taccone, Fabio S.] Univ Libre Bruxelles, Dept Intens Care, Erasme Hosp, Route Lennik 808, B-1070 Brussels, Belgium; [Udy, Andrew A.; Cooper, D. Jamie] Alfred Hosp, Intens Care Unit, Main Ward Block,Level 1,Commercial Rd, Melbourne, Vic 3004, Australia; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Neurointens Care, San Gerardo Hosp,ASST Monza, Monza, Italy; [Ichai, Carole] Univ Cote Azur, Ctr Hosp Univ Nice, Serv Reanimat Polyvalente, Hop Pasteur 2, 30 Voie Romaine, F-06000 Nice, France; [Badenes, Rafael] Univ Valencia, Dept Anesthesiol & Surg Trauma Intens Care, Hosp Clin Univ Valencia, Dept Surg, Valencia, Spain; [Prowle, John R.] Barts Hlth NHS Trust, Adult Crit Care Unit, Royal London Hosp, Whitechapel Rd, London E1 1BB, England; [Ercole, Ari] Cambridge Univ Hosp NHS Fdn Trust, Neurosci & Trauma Crit Care Unit, Cambridge, England; [Oddo, Mauro; Schneider, Antoine] Univ Lausanne, Dept Med Surg Intens Care Med, Fac Biol & Med, Ctr Hosp Univ Vaudois CHUV, CH-1011 Lausanne, Switzerland; [Wolf, Stefan] Charite, Dept Neurosurg, Neuro Intens Care Unit 102i, Campus Charite Mitte CCM,Charitepl 1, D-10117 Berlin, Germany; [Helbok, Raimund] Med Univ Innsbruck, Neurocrit Care Unit, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria; [Nelson, David W.] Karolinska Inst, Sect Perioperat Med & Intens Care, Dept Physiol & Pharmacol, S-17176 Stockholm, Sweden; [Udy, Andrew A.; Cooper, D. Jamie; Bellomo, Rinaldo] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Preventat Med, ANZIC RC,Dept Epidemiol & Prevent Med, Level 3,553 St Kilda Rd, Melbourne, Vic 3004, Australia; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, 145 Studley Rd, Melbourne, Vic, Australia; [Bellomo, Rinaldo] Univ Melbourne, Ctr Integrated Crit Care, Sch Med, Melbourne, Vic, Australia		Harrois, A (corresponding author), Paris Sud Univ, Dept Anesthesia & Surg Intens Care, CHU Bicetre, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.	harroisanatole@yahoo.fr	Ercole, Ari/B-6288-2009; Helbok, Raimund/AAA-8361-2021; Prowle, John/D-5014-2009; Schneider, Antoine/L-2480-2019; van der Jagt, Mathieu/G-1905-2017	Ercole, Ari/0000-0001-8350-8093; Prowle, John/0000-0002-5002-2721; Schneider, Antoine/0000-0003-0576-7094; van der Jagt, Mathieu/0000-0003-2566-8325; Nelson, David/0000-0003-2530-8207; Badenes, Rafael/0000-0001-7017-0150; Harrois, Anatole/0000-0002-5098-4656			Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Anstey JR, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6399; Asehnoune K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1918-4; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Harrois A, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0574-z; Harrois A, 2019, CRIT CARE CLIN, V35, P187, DOI 10.1016/j.ccc.2018.11.001; Human T, 2017, NEUROCRIT CARE, V27, P242, DOI 10.1007/s12028-016-0343-x; Huque MH, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0615-6; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P221, DOI 10.1007/978-3-211-98811-4_41; Kleindienst A, 2016, J NEUROTRAUM, V33, P615, DOI 10.1089/neu.2015.3981; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Li M, 2013, INJURY, V44, P1213, DOI 10.1016/j.injury.2012.05.021; Lohani S, 2011, WORLD NEUROSURG, V76, P355, DOI 10.1016/j.wneu.2011.03.042; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; MELTON JE, 1987, AM J PHYSIOL, V252, pF661, DOI 10.1152/ajprenal.1987.252.4.F661; Meng XF, 2016, J NEUROSURG ANESTH, V28, P21, DOI 10.1097/ANA.0000000000000192; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Sakr Y, 2013, CRIT CARE MED, V41, P133, DOI 10.1097/CCM.0b013e318265f576; Sen S, 2017, BURNS TRAUMA, V5, DOI 10.1186/s41038-017-0098-4; Shintani AK, 2009, CRIT CARE MED, V37, P2939, DOI 10.1097/CCM.0b013e3181b7fbbb; Stelfox HT, 2010, CAN J ANAESTH, V57, P650, DOI 10.1007/s12630-010-9309-1; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; Sterns RH, 2015, NEW ENGL J MED, V372, P55, DOI 10.1056/NEJMra1404489; Vedantam A, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17418; Verbalis JG, 2010, NEUROSCIENCE, V168, P862, DOI 10.1016/j.neuroscience.2010.03.042; Wells DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11678; Ye XL, 2019, AM J NEPHROL, V49, P1, DOI 10.1159/000495354; Yumoto T, 2015, ACTA MED OKAYAMA, V69, P213	30	2	2	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2021	34	3					899	907		10.1007/s12028-020-01118-8		OCT 2020	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN4OZ	WOS:000574729000001	33009658	Green Submitted			2022-02-06	
J	Annen, J; Mertel, I; Xu, R; Chatelle, C; Lesenfants, D; Ortner, R; Bonin, EAC; Guger, C; Laureys, S; Muller, F				Annen, Jitka; Mertel, Isabella; Xu, Ren; Chatelle, Camille; Lesenfants, Damien; Ortner, Rupert; Bonin, Estelle A. C.; Guger, Christoph; Laureys, Steven; Mueller, Friedemann			Auditory and Somatosensory P3 Are Complementary for the Assessment of Patients with Disorders of Consciousness	BRAIN SCIENCES			English	Article						multisensory stimulation; P3; vibrotactile; auditory evoked potentials; disorders of consciousness	BRAIN-COMPUTER INTERFACE; COMA RECOVERY SCALE; VEGETATIVE STATE; OWN NAME; DIAGNOSIS; AWARENESS	The evaluation of the level of consciousness in patients with disorders of consciousness (DOC) is primarily based on behavioural assessments. Patients with unresponsive wakefulness syndrome (UWS) do not show any sign of awareness of their environment, while minimally conscious state (MCS) patients show reproducible but fluctuating signs of awareness. Some patients, although with remaining cognitive abilities, are not able to exhibit overt voluntary responses at the bedside and may be misdiagnosed as UWS. Several studies investigated functional neuroimaging and neurophysiology as an additional tool to evaluate the level of consciousness and to detect covert command following in DOC. Most of these studies are based on auditory stimulation, neglecting patients suffering from decreased or absent hearing abilities. In the present study, we aim to assess the response to a P3-based paradigm in 40 patients with DOC and 12 healthy participants using auditory (AEP) and vibrotactile (VTP) stimulation. To this end, an EEG-based brain-computer interface was used at DOC patient's bedside. We compared the significance of the P3 performance (i.e., the interpretation of significance of the evoked P3 response) as obtained by 'direct processing' (i.e., theoretical-based significance threshold) and 'offline processing' (i.e., permutation-based single subject level threshold). We evaluated whether the P3 performances were dependent on clinical variables such as diagnosis (UWS and MCS), aetiology and time since injury. Last we tested the dependency of AEP and VTP performances at the single subject level. Direct processing tends to overestimate P3 performance. We did not find any difference in the presence of a P3 performance according to the level of consciousness (UWS vs. MCS) or the aetiology (traumatic vs. non-traumatic brain injury). The performance achieved at the AEP paradigm was independent from what was achieved at the VTP paradigm, indicating that some patients performed better on the AEP task while others performed better on the VTP task. Our results support the importance of using multimodal approaches in the assessment of DOC patients in order to optimise the evaluation of patient's abilities.	[Annen, Jitka; Chatelle, Camille; Bonin, Estelle A. C.; Laureys, Steven] Univ Liege, Coma Sci Grp, GIGA Consciousness, B-4000 Liege, Belgium; [Annen, Jitka; Chatelle, Camille; Bonin, Estelle A. C.; Laureys, Steven] Univ Hosp Liege, Ctr Cerveau C2, B-4000 Liege, Belgium; [Mertel, Isabella; Mueller, Friedemann] Schoen Klin Bad Aibling, D-83043 Bad Aibling, Germany; [Mertel, Isabella] Univ Tubingen, Dept Clin Psychol, D-72074 Tubingen, Germany; [Xu, Ren; Guger, Christoph] Guger Technol OG, A-8020 Graz, Austria; [Xu, Ren] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Lab NeuroImaging Coma & Consciousness, Boston, MA 02114 USA; [Lesenfants, Damien; Bonin, Estelle A. C.] Katholieke Univ Leuven, Dept Neurosci, Expt Otorinolaryngol, B-3000 Leuven, Belgium; [Ortner, Rupert] gtec Med Engn, Barcelona 08038, Spain; [Guger, Christoph] gtec Med Engn GmbH, A-4521 Schiedlberg, Austria		Annen, J (corresponding author), Univ Liege, Coma Sci Grp, GIGA Consciousness, B-4000 Liege, Belgium.; Annen, J (corresponding author), Univ Hosp Liege, Ctr Cerveau C2, B-4000 Liege, Belgium.	jitka.annen@uliege.be; isabella.mertel@gmail.com; xu@gtec.at; camillechatelle@gmail.com; Damien.Lesenfants@uliege.be; ortner@gtec.at; estelle.bonin@uliege.be; guger@gtec.at; Steven.Laureys@uliege.be; Fmueller@Schoen-Kliniken.de	Laureys, Steven/AAN-2097-2021; Annen, Jitka/ABH-5297-2020; Xu, Ren/O-5479-2017; Laureys, Steven/A-3349-2011	Laureys, Steven/0000-0002-3096-3807; Annen, Jitka/0000-0002-7459-4345; BONIN, Estelle/0000-0002-5120-2767	University Hospital of Liege; Belgian National Funds for Scientific Research (FRS-FNRS)Fonds de la Recherche Scientifique - FNRS; European Union's Horizon 2020 Framework Programme for Research and Innovation [945539]; European Space Agency (ESA)European Space Agency; Belgian Federal Science Policy Office (BELSPO)Belgian Federal Science Policy Office; Fondazione Europea di Ricerca Biomedica; Bial FoundationBial Foundation; Mind Science Foundation; European CommissionEuropean CommissionEuropean Commission Joint Research Centre; fund Generet; King Baudouin Foundation; DOCMA project [EU-H2020-MSCA-RISE-778234]	The study was supported by the University and University Hospital of Liege, the Belgian National Funds for Scientific Research (FRS-FNRS), the European Union's Horizon 2020 Framework Programme for Research and Innovation under the Specific Grant Agreement No. 945539 (Human Brain Project SGA3), the European Space Agency (ESA) and the Belgian Federal Science Policy Office (BELSPO) in the framework of the PRODEX Programme, "Fondazione Europea di Ricerca Biomedica", the Bial Foundation, the Mind Science Foundation and the European Commission, the fund Generet, the King Baudouin Foundation, DOCMA project [EU-H2020-MSCA-RISE-778234]. RX and CC are Marie Sklodowska-Curie fellows (H2020-MSCA-IF-2016-MoveAGAIN-752620 and H2020-MSCA-IF-2016-ADOC-752686). SL is research director at FRS-FNRS.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Annen J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00370; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Chatelle C, 2018, CLIN NEUROPHYSIOL, V129, P1519, DOI 10.1016/j.clinph.2018.04.747; Chennu S, 2013, NEUROIMAGE-CLIN, V3, P450, DOI 10.1016/j.nicl.2013.10.008; Chennu S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00065; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Curley WH, 2018, BRAIN, V141, P1404, DOI 10.1093/brain/awy070; Di Perri C, 2016, LANCET NEUROL, V15, P1115, DOI 10.1016/S1474-4422(16)30205-8; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Faugeras F, 2012, NEUROPSYCHOLOGIA, V50, P403, DOI 10.1016/j.neuropsychologia.2011.12.015; Fossati M.C.B., 2018, ANN PHYS REHABIL MED, V61, pe267, DOI [10.1016/j.rehab.2018.05.623, DOI 10.1016/J.REHAB.2018.05.623]; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gosseries O, 2014, BRAIN INJURY, V28, P1141, DOI 10.3109/02699052.2014.920522; Guger C, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00423; Guger C, 2017, FRONT NEUROSCI-SWITZ, V11, P1, DOI 10.3389/fnins.2017.00251; Jox RJ, 2012, LANCET NEUROL, V11, P732, DOI 10.1016/S1474-4422(12)70154-0; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kempny AM, 2018, NEUROIMAGE-CLIN, V19, P311, DOI 10.1016/j.nicl.2018.04.027; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kotchoubey B, 2018, CLIN NEUROPHYSIOL, V129, P1785, DOI 10.1016/j.clinph.2018.03.049; Langner R, 2012, HUM BRAIN MAPP, V33, P398, DOI 10.1002/hbm.21220; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lugo ZR, 2014, CLIN EEG NEUROSCI, V45, P14, DOI 10.1177/1550059413505533; Lule D, 2013, CLIN NEUROPHYSIOL, V124, P101, DOI 10.1016/j.clinph.2012.04.030; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nichols T.E., 2001, HUM BRAIN MAPP, V25, P887; Noirhomme Q, 2014, NEUROIMAGE-CLIN, V4, P687, DOI 10.1016/j.nicl.2014.04.004; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pan JH, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056007; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Piarulli A, 2016, J NEUROL, V263, P1746, DOI 10.1007/s00415-016-8196-y; Pokorny C, 2013, ARTIF INTELL MED, V59, P81, DOI 10.1016/j.artmed.2013.07.003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; R Core Team, 2012, R LANG ENV STAT COMP; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, NEUROCASE, V15, P271, DOI 10.1080/13554790902724904; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Thibaut A, 2015, EUR J PHYS REHAB MED, V51, P389; Tzovara A, 2016, ANN NEUROL, V79, P748, DOI 10.1002/ana.24622; Wangshan H., 2015, BMC MED, V13; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Yin EW, 2016, INT J NEURAL SYST, V26, DOI 10.1142/S0129065716500015	49	2	2	2	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	OCT	2020	10	10							748	10.3390/brainsci10100748			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OJ6QB	WOS:000584082200001	33080842	Green Published, gold			2022-02-06	
J	Avedesian, JM; Covassin, T; Dufek, JS				Avedesian, Jason M.; Covassin, Tracey; Dufek, Janet S.			Landing Biomechanics in Adolescent Athletes With and Without a History of Sports-Related Concussion	JOURNAL OF APPLIED BIOMECHANICS			English	Article						ACL; musculoskeletal injury; drop landing	EXTREMITY MUSCULOSKELETAL INJURY; HIGH-SCHOOL; EXECUTIVE FUNCTION; ASSOCIATION; RISK; STIFFNESS; FOOTBALL; YOUTH; SEX; DORSIFLEXION	Recent evidence suggests previously concussed athletes are at greater risk for lower-extremity (LE) injuries than are controls. However, little is known regarding the influence of sports-related concussion (SRC) on landing biomechanics that may provide a mechanistic rationale for LE injury risk. The purpose of this investigation was to examine LE drop-landing biomechanics in adolescent athletes with and without a previous SRC history. Participants included 10 adolescent athletes with an SRC history and 11 controls from multiple sports. Three-dimensional kinematic and kinetic data associated with LE injury risk were analyzed across 5 trials for 30- and 60-cm landing heights. Multivariate analyses indicated group differences in landing patterns from the 30- (P = .041) and 60-cm (P = .015) landing heights. Follow-up analyses indicated that concussed adolescent athletes demonstrated significantly less ankle dorsiflexion and knee flexion versus controls when performing drop landings. Our findings suggest that previously concussed adolescent athletes complete drop-landing maneuvers with ankle and knee joint kinematic patterns that suggest greater risk for LE injury. While limitations such as sport variety and explicit LE injury history are present, the results of this study provide a possible biomechanical rationale for the association between SRC and LE injury risk.	[Avedesian, Jason M.; Dufek, Janet S.] Univ Nevada Las Vegas, Dept Kinesiol & Nutr Sci, Las Vegas, NV 89154 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA		Avedesian, JM (corresponding author), Univ Nevada Las Vegas, Dept Kinesiol & Nutr Sci, Las Vegas, NV 89154 USA.	jason.avedesian@unlv.edu	Dufek, Janet/AAF-7477-2021				Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; DEVITA P, 1992, MED SCI SPORT EXER, V24, P108; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Eagle SR, 2018, CLIN J SPORT MED, DOI 10.1097/JSM.0000000000000731; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Houston MN, 2018, BRAIN INJURY, V32, P1353, DOI 10.1080/02699052.2018.1512718; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Ireland ML, 2002, ORTHOP CLIN N AM, V33, P637, DOI 10.1016/S0030-5898(02)00028-7; James CR, 2007, J SPORT SCI MED, V6, P126; Kardouni JR, 2018, J ORTHOP SPORT PHYS, V48, P533, DOI 10.2519/jospt.2018.8053; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Lapointe AP, 2018, INT J PSYCHOPHYSIOL, V132, P93, DOI 10.1016/j.ijpsycho.2017.08.003; Lax ID, 2015, BRAIN INJURY, V29, P1409, DOI 10.3109/02699052.2015.1043344; Leppanen M, 2017, AM J SPORT MED, V45, P386, DOI 10.1177/0363546516665810; Lima YL, 2018, PHYS THER SPORT, V29, P61, DOI 10.1016/j.ptsp.2017.07.003; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Malloy P, 2015, KNEE SURG SPORT TR A, V23, P3550, DOI 10.1007/s00167-014-3222-z; Maquirriain J, 2012, INT J SPORTS MED, V33, P567, DOI 10.1055/s-0032-1304644; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGowan AL, 2018, NEUROPSYCHOLOGY, V32, P564, DOI 10.1037/neu0000475; Nordin AD, 2017, J SPORT SCI, V35, P1858, DOI 10.1080/02640414.2016.1240876; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Powers CM, 2010, J ORTHOP SPORT PHYS, V40, P42, DOI 10.2519/jospt.2010.3337; Quatman CE, 2009, BRIT J SPORT MED, V43, P328, DOI 10.1136/bjsm.2009.059139; Roewer BD, 2014, BRIT J SPORT MED, V48, P464, DOI 10.1136/bjsports-2012-091398; Sigward SM, 2008, J ORTHOP SPORT PHYS, V38, P661, DOI 10.2519/jospt.2008.2695; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Swanik C, 2015, J ATHL TRAINING, V50, P1100, DOI 10.4085/1062-6050-50.10.08; Watsford ML, 2010, AM J SPORT MED, V38, P2058, DOI 10.1177/0363546510370197; Westermann RW, 2016, AM J SPORT MED, V44, P3230, DOI 10.1177/0363546516659290	43	2	2	0	4	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	OCT	2020	36	5					313	318		10.1123/jab.2020-0034			6	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	NY1BR	WOS:000576134000007	32736340				2022-02-06	
J	Boness, CL; Korucuoglu, O; Ellingson, JM; Merrill, AM; McDowell, YE; Trela, CJ; Sher, KJ; Piasecki, TM; Kerns, JG				Boness, Cassandra L.; Korucuoglu, Ozlem; Ellingson, Jarrod M.; Merrill, Anne M.; McDowell, Yoanna E.; Trela, Constantine J.; Sher, Kenneth J.; Piasecki, Thomas M.; Kerns, John G.			Twenty-First Birthday Drinking: Extreme-Drinking Episodes and White Matter Microstructural Changes in the Fornix and Corpus Callosum	EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY			English	Article						diffusion tensor imaging (DTI); binge drinking; emerging adulthood; white matter; 21st birthday drinking	TRAUMATIC BRAIN-INJURY; BINGE DRINKING; HIPPOCAMPAL VOLUME; DIFFUSION; INTEGRITY; ADOLESCENTS; MILD; AGE; 21ST; DEGRADATION	The 21st birthday celebration is characterized by extreme alcohol consumption. Accumulating evidence suggests that high-dose bingeing is related to structural brain changes and cognitive deficits. This is particularly problematic in the transition from adolescence to adulthood when the brain is still maturing, elevating the brain's sensitivity to the acute effects of alcohol intoxication. Heavy drinking is associated with reduced structural integrity in the hippocampus and corpus callosum and is accompanied by cognitive deficits. However, there is little research examining changes in the human brain related to discrete heavy-drinking episodes. The present study investigated whether alcohol exposure during a 21st birthday celebration would result in changes to white matter microstructure by utilizing diffusion tensor imaging measures and a quasi-experimental design. By examining structural changes in the brain from pre- to postcelebration within subjects (N = 49) prospectively, we were able to more directly observe brain changes following an extreme-drinking episode. Region of interest analyses demonstrated increased fractional anisotropy in the posterior fornix (p = .0001) and in the body of the corpus callosum (p = .0029) from pre- to postbirthday celebration. These results suggest acute white matter damage to the fornix and corpus callosum following an extreme-drinking episode, which is especially problematic during continued neurodevelopment. Therefore, 21st birthday drinking may be considered an important target event for preventing acute brain injury in young adults.	[Boness, Cassandra L.; McDowell, Yoanna E.; Sher, Kenneth J.; Piasecki, Thomas M.; Kerns, John G.] Univ Missouri, Dept Psychol Sci, Psychol Bldg,200 South Seventh St, Columbia, MO 65211 USA; [Korucuoglu, Ozlem] Washington Univ, Dept Psychiat, Sch Med, St Louis, MO 63130 USA; [Ellingson, Jarrod M.] Univ Colorado, Dept Psychiat, Sch Med, Boulder, CO 80309 USA; [Merrill, Anne M.] Kansas City Vet Adm Med Ctr, Kansas City, MO USA; [Trela, Constantine J.] Family Ctr, Ellicott City, MD USA		Boness, CL (corresponding author), Univ Missouri, Dept Psychol Sci, Psychol Bldg,200 South Seventh St, Columbia, MO 65211 USA.	clmkdb@mail.missouri.edu	Ellingson, Jarrod/AAF-8440-2021	Boness, Cassandra/0000-0001-8734-193X; Piasecki, Thomas/0000-0002-2793-2049; McDowell, Yoanna/0000-0003-3766-9165	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AA13526, F31AA026177, K05AA017242, R21AA019492]	The present study was supported by the NIH Grants T32AA13526 and F31AA026177 to Cassandra L. Boness, K05AA017242 to Kenneth J. Sher, and R21AA019492 to John G. Kerns. These funding sources had no other involvement other than financial support. All authors contributed to the manuscript in a significant way, and all authors have read and approved the final manuscript. A portion of this data was previously disseminated at the Research Society on Alcoholism's annual conference. A preprint of this article has been posted online at PsyArXiv and can be accessed at the following link: https://psyarxiv.com/c8tyv.	Anderson K., 2010, CHANGE YOUR DRINKING; Arnone D, 2006, NEUROPSYCHOBIOLOGY, V54, P107, DOI 10.1159/000096992; Babor TF, 2000, J STUD ALCOHOL, V61, P55, DOI 10.15288/jsa.2000.61.55; Bava S, 2013, ALCOHOL CLIN EXP RES, V37, pE181, DOI 10.1111/j.1530-0277.2012.01920.x; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bracken MB, 2009, J ROY SOC MED, V102, P120, DOI 10.1258/jrsm.2008.08k033; Brown MW, 2010, HIPPOCAMPUS, V20, P1228, DOI 10.1002/hipo.20858; Cardenas VA, 2013, NEUROIMAGE-CLIN, V2, P804, DOI 10.1016/j.nicl.2013.06.002; Chen DQ, 2015, STEREOT FUNCT NEUROS, V93, P151, DOI 10.1159/000368442; Chumin EJ, 2019, ALCOHOL CLIN EXP RES, V43, P1170, DOI 10.1111/acer.14048; Cooper R. A., 1983, DATA MODELS STAT ANA; Correas A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31293; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; De Bellis MD, 2000, AM J PSYCHIAT, V157, P737, DOI 10.1176/appi.ajp.157.5.737; De Bellis MD, 2008, ALCOHOL CLIN EXP RES, V32, P395, DOI 10.1111/j.1530-0277.2007.00603.x; Fabri M, 2014, WORLD J RADIOL, V6, P895, DOI 10.4329/wjr.v6.i12.895; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Hartley DE, 2004, PHARMACOL BIOCHEM BE, V78, P611, DOI 10.1016/j.pbb.2004.04.027; Hermens DF, 2013, CORTEX, V49, P3, DOI 10.1016/j.cortex.2012.05.021; Jackson O, 2004, NEUROIMAGE, V21, P456, DOI 10.1016/j.neuroimage.2003.09.050; Jacob T., 1998, MODIFIED LIFET UNPUB; Jacobus J, 2013, PSYCHOL ADDICT BEHAV, V27, P431, DOI 10.1037/a0028235; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kaskutas LA, 2008, J STUD ALCOHOL DRUGS, V69, P605, DOI 10.15288/jsad.2008.69.605; Kochunov P, 2014, SCHIZOPHRENIA BULL, V40, P721, DOI 10.1093/schbul/sbu070; Kohno M, 2019, PHARMACOL BIOCHEM BE, V179, P34, DOI 10.1016/j.pbb.2019.01.007; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lewis MA, 2009, ADDICTION, V104, P760, DOI 10.1111/j.1360-0443.2009.02518.x; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; MATTHEWS DB, 1979, ADDICT BEHAV, V4, P55, DOI 10.1016/0306-4603(79)90021-2; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McQueeny T, 2009, ALCOHOL CLIN EXP RES, V33, P1278, DOI 10.1111/j.1530-0277.2009.00953.x; Miller ET, 2002, PSYCHOL ADDICT BEHAV, V16, P56, DOI 10.1037//0893-164X.16.1.56; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Muller-Oehring EM, 2009, ALCOHOL CLIN EXP RES, V33, P477, DOI 10.1111/j.1530-0277.2008.00858.x; Nagel BJ, 2005, PSYCHIAT RES-NEUROIM, V139, P181, DOI 10.1016/j.pscychresns.2005.05.008; Nahum L, 2015, BRAIN TOPOGR, V28, P760, DOI 10.1007/s10548-014-0391-5; National Institute on Alcohol Abuse and Alcoholism, 2018, UND DANG ALC OV; Neighbors C, 2012, J CONSULT CLIN PSYCH, V80, P850, DOI 10.1037/a0029480; Penning Renske, 2010, Curr Drug Abuse Rev, V3, P68; Perea RD, 2018, NEUROIMAGE-CLIN, V19, P331, DOI 10.1016/j.nicl.2018.04.029; Petit G, 2014, ALCOHOL ALCOHOLISM, V49, P198, DOI 10.1093/alcalc/agt172; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pfefferbaum A, 2005, NEUROPSYCHOPHARMACOL, V30, P423, DOI 10.1038/sj.npp.1300623; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Pfefferbaum A, 2005, NEUROIMAGE, V26, P891, DOI 10.1016/j.neuroimage.2005.02.034; Pfefferbaum A, 2006, NEUROBIOL AGING, V27, P994, DOI 10.1016/j.neurobiolaging.2005.05.007; Pfefferbaum A, 2014, LANCET PSYCHIAT, V1, P202, DOI 10.1016/S2215-0366(14)70301-3; Rourke L.N., 1999, DIAGNOSTIC INTERVIEW; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutledge PC, 2008, J CONSULT CLIN PSYCH, V76, P511, DOI 10.1037/0022-006X.76.3.511; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Slutske WS, 2004, J ABNORM PSYCHOL, V113, P530, DOI 10.1037/0021-843X.113.4.530; Smith KW, 2017, ADDICT BIOL, V22, P490, DOI 10.1111/adb.12332; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Sobell LC, 1992, MEASURING ALCOHOL CO, P41, DOI 10.1007/978-1-4612-0357-5_3; Squeglia Lindsay M, 2014, Handb Clin Neurol, V125, P501, DOI 10.1016/B978-0-444-62619-6.00028-8; Squeglia LM, 2011, ALCOHOL CLIN EXP RES, V35, P1831, DOI 10.1111/j.1530-0277.2011.01527.x; Stappenbeck C. A., 2007, BIRTHDAY CELEB UNPUB; Tapert SF, 2001, ALCOHOL CLIN EXP RES, V25, P236, DOI 10.1097/00000374-200102000-00012; Vetreno RP, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00200; Vetreno RP, 2016, ADDICT BIOL, V21, P939, DOI 10.1111/adb.12232; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Zahr NM, 2017, ALCOHOL RES-CURR REV, V38, P183	68	2	2	0	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1064-1297	1936-2293		EXP CLIN PSYCHOPHARM	Exp. Clin. Psychopharmacol.	OCT	2020	28	5					553	566		10.1037/pha0000336			14	Psychology, Biological; Psychology, Clinical; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pharmacology & Pharmacy; Psychiatry	OE3OC	WOS:000580443000005	31789553	Green Accepted, Bronze			2022-02-06	
J	Brunner, R; Bizzini, M; Niedermann, K; Maffiuletti, NA				Brunner, Romana; Bizzini, Mario; Niedermann, Karin; Maffiuletti, Nicola A.			Epidemiology of Traumatic and Overuse Injuries in Swiss Professional Male Ice Hockey Players	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						traumatic injuries; overuse injuries; epidemiology; ice hockey	SYSTEMATIC VIDEO ANALYSIS; GROIN INJURIES; LEAGUE NHL; CONCUSSIONS; VALIDATION	Background: Ice hockey injury patterns in Europe were last evaluated in the 1990s. Purpose: The aim of this study was to assess the frequency, type, location, and incidence of traumatic injuries, as well as the prevalence and relative effect of overuse injuries in professional male ice hockey players. Study Design: Descriptive epidemiology study. Methods: Traumatic injuries were assessed using a standardized injury report form over a 1-year period (including the preparatory phase and season). The Oslo Sports Trauma Research Centre Overuse Injury Questionnaire was used to determine overall and substantial overuse injuries and their relative effect on ice hockey players. Results: Five Swiss National League teams participated in the study. From a total of 321 recorded injuries, 179 led to time loss from sport. The game-related time-loss injury incidence during the season was 88.6/1000 player-game hours.Time-loss injuries affected mainly the hip/groin/thigh region (23%), followed by the head (17%). Most time-loss injuries were classified as muscle strains (24%), followed by concussions (18%). The most common injury mechanism involved collision with an opponent's body (31%), and right forward players (23%) were most likely to report a game-related injury. Most injuries (27%) occurred within the defending zone along the boards. The average prevalence rates of all overuse and substantial overuse injuries were 49% and 13%, respectively. The hip/groin displayed the highest average prevalence for all overuse problems (16%), translating to the highest relative effect. Conclusion: Muscle strains and concussions were the most frequent time-loss injuries in Swiss professional ice hockey players. The hip/groin was the most affected region for both traumatic and overuse injuries.	[Brunner, Romana; Bizzini, Mario; Niedermann, Karin; Maffiuletti, Nicola A.] Schulthess Clin, Human Performance Lab, Lengghalde 6, CH-8008 Zurich, Switzerland; [Niedermann, Karin] Zurich Univ Appl Sci, Sch Hlth Profess, Inst Physiotherapy, Winterthur, Switzerland		Brunner, R (corresponding author), Schulthess Clin, Human Performance Lab, Lengghalde 6, CH-8008 Zurich, Switzerland.	romana.brunner@kws.ch			Zurich Insurance Company; AOSSM	This study was supported in part by the Zurich Insurance Company. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; BIASCA N, 1995, UNFALLCHIRURG, V98, P283; Brown RA, 2008, CLIN J SPORT MED, V18, P221, DOI 10.1097/JSM.0b013e318172831a; Clarsen B, 2015, SCAND J MED SCI SPOR, V25, P323, DOI 10.1111/sms.12223; Clarsen B, 2013, BRIT J SPORT MED, V47, P495, DOI 10.1136/bjsports-2012-091524; Dupont G, 2010, AM J SPORT MED, V38, P1752, DOI 10.1177/0363546510361236; Elattar O, 2016, SPORTS HEALTH, V8, P313, DOI 10.1177/1941738116653711; Emery CA, 1999, CLIN J SPORT MED, V9, P151, DOI 10.1097/00042752-199907000-00006; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Griffin DR, 2016, BRIT J SPORT MED, V50, P1169, DOI 10.1136/bjsports-2016-096743; Hirschmuller A, 2017, BRIT J SPORT MED, V51, P260, DOI 10.1136/bjsports-2016-096669; Holmich P, 2007, BRIT J SPORT MED, V41, P247, DOI 10.1136/bjsm.2006.033373; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Izraelski Jason, 2014, J Can Chiropr Assoc, V58, P346; Leppanen M, 2019, BRIT J SPORT MED, V53, P165, DOI 10.1136/bjsports-2018-099218; LORENTZON R, 1988, AM J SPORT MED, V16, P392, DOI 10.1177/036354658801600415; McKay CD, 2014, BRIT J SPORT MED, V48, P57, DOI 10.1136/bjsports-2013-092860; Molsa J, 2000, AM J SPORT MED, V28, P322; Molsa J, 1997, AM J SPORT MED, V25, P495, DOI 10.1177/036354659702500412; PATTERSSON M, 1993, BRIT J SPORT MED, V27, P251, DOI 10.1136/bjsm.27.4.251; Polites SF, 2014, PEDIATRICS, V133, pE1601, DOI 10.1542/peds.2013-3628; Stull JD, 2011, AM J SPORT MED, V39, p29S, DOI 10.1177/0363546511414012; Timpka T, 2014, BRIT J SPORT MED, V48, P483, DOI 10.1136/bjsports-2013-093241; Tuominen M, 2015, BRIT J SPORT MED, V49, P30, DOI 10.1136/bjsports-2014-093688; Tyler TF, 2002, AM J SPORT MED, V30, P680, DOI 10.1177/03635465020300050801; Tyler TF, 2010, SPORTS HEALTH, V2, P231, DOI 10.1177/1941738110366820; Weir A, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094869; Worner T, 2020, KNEE SURG SPORT TR A, V28, P2302, DOI 10.1007/s00167-019-05787-7	31	2	3	1	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	OCT	2020	8	10							2325967120964720	10.1177/2325967120964720			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	OL5DO	WOS:000585360700001	33178879	gold, Green Published			2022-02-06	
J	Chandran, A; Nedimyer, AK; Kerr, ZY; O'Neal, C; Mensch, J; Yeargin, SW				Chandran, Avinash; Nedimyer, Aliza K.; Kerr, Zachary Y.; O'Neal, Cathleen; Mensch, James; Yeargin, Susan W.			Concussion Knowledge, Attitudes, and Self-Reporting Intentions in Youth Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						middle school athletes; mild traumatic brain injuries; high school athletes; sport	SPORT-RELATED CONCUSSION; FOOTBALL PLAYERS; SCHOOL; HEALTH; EPIDEMIOLOGY; SYMPTOMS; INJURY; DISPARITIES; URBAN; RISK	Context: Although it has been suggested that developmental and sociological factors play a role in concussion reporting, the empirical evidence related to this is limited. Objective: To examine the influences of sex, school level, school location, concussion-reporting history, and socioeconomic status on concussion-related knowledge, attitudes, and reporting intentions among middle school and high school athletes. Design: Cross-sectional study. Setting: Master students and High School athletes attending pre-participation examinations (PPEs) were asked to complete paper-based surveys. Patients or Other Participants: Overall, 541 athletes representing 18 sports returned fully completed surveys. Main Outcome Measure(s): Outcomes were concussion-related knowledge, perceived seriousness, positive feelings about reporting, and self-reporting intentions. We examined group differences in these outcomes across levels of the explanatory variables of sex, school level (middle school versus high school), school location (urban versus rural), concussion self-reporting history (yes or no), and socioeconomic status (free or reduced-price lunch versus no free or reduced-price lunch) using Wilcoxon rank sum tests. Then we used multivariable ordinal logistic regression models to identify predictors of higher score levels for each outcome. Odds ratio (OR) estimates with 95% confidence intervals (CIs) excluding 1.00 were deemed significant. Results: Odds of higher levels of knowledge were higher in urban versus rural school student-athletes (ORAdjusted = 1.81; 95% CI = 1.03, 3.17), and lower in student-athletes on free or reduced-price lunch versus those not on free or reduced-price lunch (ORAdjusted = 0.52; 95% CI = 0.36, 0.77). Similarly, odds of higher levels of seriousness were lower in male versus female student-athletes (ORAdjusted = 0.48; 95% CI = 0.32, 0.72). Further, odds of higher levels of self-reporting intentions were lower among male versus female student-athletes (ORAdjusted = 0.53; 95% CI = 0.37, 0.75). Conclusions: Developmental and sociological factors were differentially associated with concussion-related knowledge, attitudes, and self-reporting intentions. These results can inform medical providers, parents, and coaches with regard to context-specific clinical assessments of concussion symptoms.	[Chandran, Avinash; Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Nedimyer, Aliza K.] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC 27599 USA; [Chandran, Avinash; Nedimyer, Aliza K.; Kerr, Zachary Y.] Univ N Carolina, Matthew Gfeller Sport Related TBI Res Ctr, Chapel Hill, NC 27599 USA; [O'Neal, Cathleen; Mensch, James; Yeargin, Susan W.] Univ South Carolina, Dept Exercise Sci, Columbia, SC 29208 USA		Chandran, A (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related TBI Res Ctr, Chapel Hill, NC 27599 USA.	avinashc@email.unc.edu					Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Aikens NL, 2008, J EDUC PSYCHOL, V100, P235, DOI 10.1037/0022-0663.100.2.235; Baugh CM, 2017, J NEUROTRAUM, V34, P790, DOI 10.1089/neu.2016.4585; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckingham J, 2013, AUST J EDUC, V57, P190, DOI 10.1177/0004944113495500; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Day SE, 2016, J SCHOOL HEALTH, V86, P204, DOI 10.1111/josh.12371; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Johnson ME, 2006, ADM POLICY MENT HLTH, V33, P504, DOI 10.1007/s10488-005-0001-7; Kerr Zachary Y, 2018, Inj Epidemiol, V5, P28, DOI 10.1186/s40621-018-0158-7; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Lininger M, 2017, ATHLETIC TRAIN SPORT, V9, P71, DOI DOI 10.3928/19425864-20161116-01; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; Meehan WP, 2006, AM J SPORTS MED, V39, P2304; Monheit AC, 2000, MED CARE RES REV, V57, P11; Morgan PL, 2009, J ABNORM CHILD PSYCH, V37, P401, DOI 10.1007/s10802-008-9279-8; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Stokols D, 1996, AM J HEALTH PROMOT, V10, P247, DOI 10.4278/0890-1171-10.4.247; Taylor ME, 2017, J SCH NURS, V33, P73, DOI 10.1177/1059840515619683; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056	37	2	2	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT	2020	55	10					1027	1034		10.4085/1062-6050-232-19			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	OH5SX	WOS:000582645900003	33032324	Green Published, gold			2022-02-06	
J	Czorlich, P; Mader, MMD; Emami, P; Westphal, M; Lefering, R; Hoffmann, M				Czorlich, Patrick; Mader, Marius Marc-Daniel; Emami, Pedram; Westphal, Manfred; Lefering, Rolf; Hoffmann, Michael			Operative versus non-operative treatment of traumatic brain injuries in patients 80 years of age or older	NEUROSURGICAL REVIEW			English	Article						Traumatic brain injury; Elderly; Geriatric; Mortality; Age; Outcome; Surgery	COMA SCALE SCORE; DECOMPRESSIVE CRANIECTOMY; ELDERLY-PATIENTS; HEAD-INJURY; EPIDEMIOLOGY; MORTALITY; OUTCOMES; CARE; INTENSITY; IMPACT	Traumatic brain injury (TBI) in older adults is an increasing issue in modern medicine. Nevertheless, it remains unclear which patients presenting with TBI and 80 years of age or older benefit from an operative treatment. The aim of this study was to explore the effect of an operative treatment in isolated TBI patients >= 80 years of age. Data were derived from the TraumaRegister DGU(R)from 2002 to 2016. Inclusion criteria were >= 80 years of age, an Abbreviated Injury Scale(Head)(AIS) >= 3, and an AIS(Non-Head)<= 1. The cohort was split in operatively and non-operatively treated patients, and outcome was assessed at discharge using the Glasgow Outcome Scale (GOS). A favorable outcome was defined as a GOS of 4 or 5. A total of 1.693 patients (431 operatively and 1.262 non-operatively treated patients) were analyzed. Mortality rate was 54.4% (687 patients) in the non-operative group and 49.4% in the operative group. Simultaneously, there were more patients discharged with a GOS 2 (persistent vegetative state) in the operative group (7.9%, 34 patients) than in the non-operative group (1.0%, 13 patients). An analysis of the operatively treated patients showed an association between a higher mortality risk and brainstem hemorrhage (p = 0.04), fixed pupils (p = 0.001), initial intubation (p = 0.03), and an AIS(Head)of 5/6 (p = 0.03). Patients 80 years of age or older seem to benefit from an operative treatment regarding mortality rate. However, there has been a higher rate of a poor neurological outcome particularly with regard to persistent vegetative state in the operative treatment group at discharge.	[Czorlich, Patrick; Mader, Marius Marc-Daniel; Emami, Pedram; Westphal, Manfred] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Martinistr 52, D-20246 Hamburg, Germany; [Lefering, Rolf] Witten Herdecke Univ, Inst Res Operat Med IFOM, Ostmerheimer Str 200, D-51109 Cologne, Germany; [Hoffmann, Michael] Schon Klin Neustadt, Clin Orthoped, Kiebitzberg 10, D-23730 Neustadt, Germany		Czorlich, P (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Martinistr 52, D-20246 Hamburg, Germany.	p.czorlich@uke.de		Czorlich, Patrick/0000-0003-0865-241X; Mader, Marius/0000-0002-7467-9672			Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Bus S, 2019, BRIT J NEUROSURG, V33, P51, DOI 10.1080/02688697.2018.1522418; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Haasper C, 2010, UNFALLCHIRURG, V113, P366, DOI 10.1007/s00113-010-1778-8; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1975, LANCET, V1, P480; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Lilley EJ, 2016, J TRAUMA ACUTE CARE, V80, P998, DOI 10.1097/TA.0000000000001028; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenfeld JV, 2015, INJURY, V46, P1703, DOI 10.1016/j.injury.2015.07.037; ROSENORN J, 1978, J NEUROSURG, V48, P345, DOI 10.3171/jns.1978.48.3.0345; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Schumacher R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0801-7; Stein DM, 2018, J TRAUMA ACUTE CARE, V85, P788, DOI 10.1097/TA.0000000000001910; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Wan XY, 2016, WORLD NEUROSURG, V89, P147, DOI 10.1016/j.wneu.2016.01.084; Wutzler S, 2015, INJURY, V46, P1706, DOI 10.1016/j.injury.2015.02.013	33	2	2	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	OCT	2020	43	5					1305	1314		10.1007/s10143-019-01159-4			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NS7ZB	WOS:000572475000007	31414197				2022-02-06	
J	Dismuke-Greer, C; Hirsch, S; Carlson, K; Pogoda, T; Nakase-Richardson, R; Bhatnagar, S; Eapen, B; Troyanskaya, M; Miles, S; Nolen, T; Walker, WC				Dismuke-Greer, Clara; Hirsch, Shawn; Carlson, Kathleen; Pogoda, Terri; Nakase-Richardson, Risa; Bhatnagar, Saurabha; Eapen, Blessen; Troyanskaya, Maya; Miles, Shannon; Nolen, Tracy; Walker, William C.			Health Services Utilization, Health Care Costs, and Diagnoses by Mild Traumatic Brain Injury Exposure: A Chronic Effects of Neurotrauma Consortium Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							MILITARY	Objective: To compare Veterans Health Administration (VHA) diagnoses, health services utilization, and costs by mild traumatic brain injury (mTBI) group (blast-related [BR] mTBI vs non-blast-related [NBR] mTBI vs no mTBI) among Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF)/Operation New Dawn (OND) veterans in the Chronic Effects of Neurotrauma Consortium multicenter observational study. Design: Prospective cohort study. Setting: Four Veterans Affairs Medical Centers. Participants: OEF/OIF/OND veterans (N = 472) who used Veterans Affairs Medical Centers services between 2002-2017. Interventions: Not applicable. Lifetime mTBI history was assessed via semistructured interviews. Main Outcome Measures: VHA diagnoses, health services utilization, and costs. Results: Relative to NBR mTBI and no mTBI, veterans with BR mTBI were more likely to be male, have greater combat, and have controlled and uncontrolled detonations exposures (median BR, 15.0 vs NBR, 3.0 vs no mTBI, 3.0). They also had higher prevalence of headache, posttraumatic stress disorder, and anxiety diagnoses. Veterans with BR had the highest site-adjusted mean annual VHA utilization (26.31 visits; 95% confidence interval [CI], 26.01-26.61) relative to NBR (20.43 visits; 95% CI, 20.15-20.71) and no mTBI (16.62 visits; 95% CI, 16.21-17.04) and highest site adjusted mean annual VHA outpatient costs ($6480; 95% CI, $5842-$7187) relative to NBR ($4901; 95% CI, $4392-$5468) and no mTBI ($4069; 95% CI, $3404$4864). Conclusions: Veterans with BR mTBI had higher exposure to combat and detonation. BR was associated with greater prevalence of select diagnoses and higher health services utilization and costs relative to NBR and no mTBI. The role of health care needs from mTBI polytrauma, other deployment-related exposures, and VHA access warrants future research. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Dismuke-Greer, Clara] VA Palo Alto Healthcare Syst, Hlth Econ Resource Ctr HERC, Palo Alto, CA USA; [Dismuke-Greer, Clara] Med Univ South Carolina, Charleston, SC 29425 USA; [Hirsch, Shawn; Nolen, Tracy] RTI Int, Res Triangle Pk, NC USA; [Carlson, Kathleen] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, Portland, OR USA; [Carlson, Kathleen] Oregon Hlth & Sci Univ, OHSU PSU Sch Publ Hlth, Portland, OR 97201 USA; [Pogoda, Terri] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, Terri] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, MHBS, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Univ S Florida, Morsani Coll Med, Div Sleep & Pulm Med, Tampa, FL 33620 USA; [Bhatnagar, Saurabha] Harvard Med Sch, Hlth Qual Safety & Value, Dept Vet Affairs, Boston, MA 02115 USA; [Bhatnagar, Saurabha] United Healthcare, Boston, MA USA; [Eapen, Blessen] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Troyanskaya, Maya] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Troyanskaya, Maya] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Miles, Shannon] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Miles, Shannon] Univ S Florida, Dept Psychiat & Behav Neurosci, Morsani Coll Med, Tampa, FL 33620 USA; [Walker, William C.] Virginia Commonwealth Univ, Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA		Dismuke-Greer, C (corresponding author), VA Palo Alto Hlth Care Syst VAPAHCS, Hlth Econ Resource Ctr, 795 Willow Rd,152 MPD, Menlo Pk, CA 94025 USA.	Clara.dismuke@va.gov	Miles, Shannon/AAS-2173-2021	Miles, Shannon/0000-0001-8925-1321; , Clara/0000-0002-3645-0068; Hirsch, Shawn/0000-0001-6280-9559; Nolen, Tracy/0000-0003-2512-343X	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma ConsortiumUS Department of Veterans Affairs [W81XWH-13-2-0095]	Supported by the U.S. Army Medical Research and Materiel Command and from the U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma Consortium (award no. W81XWH-13-2-0095). The U.S. Army Medical Research Acquisition Activity, 820 Chandler St, Fort Detrick, MD 21702-5014, is the awarding and administering acquisition office. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the U.S. Government, or the U.S. Department of Veterans Affairs, and no official endorsement should be inferred.	[Anonymous], DOD WORLDW NUMB TBI; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Carlson KF, 2010, J REHABIL RES DEV, V47, P689, DOI 10.1682/JRRD.2009.08.0118; Cifu DX, 2013, ETHNICITY, V137, P22; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Defense and Veterans Brain Injury Center (DVBIC), TBI MIL; Department of Homeland Security, NEWS TERR COMM CRIS; Department of Veterans Affairs/Department of Defense, VA DOD CLIN PRACT GU; Eggleston B, 2019, BRAIN INJURY, V33, P1602, DOI 10.1080/02699052.2019.1655793; Greer N, 2016, PREVALENCE EPIDEMIOL; Health Economics Resource Center, AV COST; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; Kehle-Forbes SM, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000227; Kurz CF, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0445-y; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Smyth GK, 1996, P 2 AUSTR JAP WORKSH; Taylor B., FISCAL YEAR 2014 VA; Taylor BC, FISCAL YEAR 2012 VA; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; US Bureau of Labor Statistics, CPI INFL CALC; US Department of Veterans Affairs, VA INF COMP INFR VIN; US Department of Veterans Affairs, VA INF RES CTR VIREC; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Yoon J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2504-9	26	2	2	1	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2020	101	10					1720	1730		10.1016/j.apmr.2020.06.008			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	NX5ZF	WOS:000575788300007	32653582				2022-02-06	
J	Evans, LP; Boehme, N; Wu, S; Burghardt, EL; Akurathi, A; Todd, BP; Newell, EA; Ferguson, PJ; Mahajan, VB; Dutca, LM; Harper, MM; Bassuk, AG				Evans, Lucy P.; Boehme, Nickolas; Wu, Shu; Burghardt, Elliot L.; Akurathi, Abhigna; Todd, Brittany P.; Newell, Elizabeth A.; Ferguson, Polly J.; Mahajan, Vinit B.; Dutca, Laura M.; Harper, Matthew M.; Bassuk, Alexander G.			Sex Does Not Influence Visual Outcomes After Blast-Mediated Traumatic Brain Injury but IL-1 Pathway Mutations Confer Partial Rescue	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						blast; IL-1; retina; sex; visual function; TBI	GANGLION-CELLS; INFLAMMATION; DAMAGE; MODEL; IRAQ; EYE; PREVENTION; IL-1-BETA; RECEPTOR; MICE	PURPOSE. In a mouse model of blast-mediated traumatic brain injury (bTBI), interleukin1 (IL-1)-pathway components were tested as potential therapeutic targets for bTBI-mediated retinal ganglion cell (RGC) dysfunction. Sex was also evaluated as a variable for RGC outcomes post-bTBI. METHODS. Male and female mice with null mutations in genes encoding IL-1 alpha, IL-1 beta, or IL-1RI were compared to C57BL/6J wild-type (WT) mice after exposure to three 20-psi blast waves given at an interblast interval of 1 hour or to mice receiving sham injury. To determine if genetic blockade of IL-1 alpha, IL-1 beta, or IL-1RI could prevent damage to RGCs, the function and structure of these cells were evaluated by pattern electroretinogram and optical coherence tomography, respectively, 5 weeks following blast or sham exposure. RGC survival was also quantitatively assessed via immunohistochemical staining of BRN3A at the completion of the study. RESULTS. Our results showed that male and female WT mice had a similar response to blast-induced retinal injury. Generally, constitutive deletion of IL-1 alpha, IL-1 beta, or IL-1RI did not provide full protection from the effects of bTBI on visual outcomes; however, injured WT mice had significantly worse visual outcomes compared to the injured genetic knockout mice. CONCLUSIONS. Sex does not affect RGC outcomes after bTBI. The genetic studies suggest that deletion of these IL-1 pathway components confers some protection, but global deletion from birth did not result in a complete rescue.	[Evans, Lucy P.; Wu, Shu; Todd, Brittany P.; Newell, Elizabeth A.; Ferguson, Polly J.; Bassuk, Alexander G.] Univ Iowa, Dept Pediat, 200 Hawkins Dr, Iowa City, IA 52242 USA; [Evans, Lucy P.; Burghardt, Elliot L.; Todd, Brittany P.] Univ Iowa, Med Scientist Training Program, Iowa City, IA 52242 USA; [Boehme, Nickolas; Akurathi, Abhigna; Dutca, Laura M.; Harper, Matthew M.] Iowa City VA Hlth Care Syst Ctr Prevent & Treatme, 601 Highway 6 West, Iowa City, IA 52242 USA; [Burghardt, Elliot L.] Univ Iowa, Dept Biostat, Iowa City, IA 52242 USA; [Mahajan, Vinit B.] Stanford Univ, Sch Med, Dept Ophthalmol, Omics Lab,Byers Eye Inst, Palo Alto, CA 94304 USA; [Mahajan, Vinit B.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Dutca, Laura M.; Harper, Matthew M.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA		Bassuk, AG (corresponding author), Univ Iowa, Dept Pediat, 200 Hawkins Dr, Iowa City, IA 52242 USA.; Harper, MM (corresponding author), Iowa City VA Hlth Care Syst Ctr Prevent & Treatme, 601 Highway 6 West, Iowa City, IA 52242 USA.	matthew-harper@uiowa.edu; alexander-bassuk@uiowa.edu		Bassuk, Alexander/0000-0002-4067-2157; Harper, Matthew/0000-0003-3395-2406	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EY026877, R01EY024665, R01EY025225, R01EY024698, R21AG050437, P30EY026877]; NIH National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [F30 EY031245-01]; NIH National Institute of Arthritis and Musculoskeletal and Skin DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR059703]; NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS098590]; Department of Veterans AffairsUS Department of Veterans Affairs [RX000952]; Department of DefenseUnited States Department of Defense [W81XWH-14-1-0583]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Iowa City Center for the Prevention and Treatment of Visual Loss; U.S. Department of Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [IK2-RX002003]	Supported by grants from the National Institutes of Health (NIH) (R01EY026877, R01EY024665, R01EY025225, R01EY024698, R21AG050437, and P30EY026877 to VBM); NIH National Eye Institute (F30 EY031245-01 to LPE); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR059703 to AGB and PJF); NIH National Institute of Neurological Disorders and Stroke (R01NS098590 to AGB and PJF); Department of Veterans Affairs (RX000952 to MMH); and Department of Defense (W81XWH-14-1-0583 to MMH). It is also supported by Research to Prevent Blindness (VBM), Iowa City Center for the Prevention and Treatment of Visual Loss (MMH), and Career Development/Capacity Building Award IK2-RX002003 from the U.S. Department of Veterans Affairs Rehabilitation Research and Development Service (LMD).	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Bricker-Anthony C, 2016, J OCUL PHARMACOL TH, V32, P286, DOI 10.1089/jop.2015.0104; Cho RI, 2009, J TRAUMA, V67, P516, DOI 10.1097/TA.0b013e3181a5f08d; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Das M, 2019, REV NEUROSCIENCE, V30, P305, DOI 10.1515/revneuro-2018-0015; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Evans LP, 2020, J NEUROTRAUM, V37, P1463, DOI 10.1089/neu.2019.6725; Evans LP, 2018, ANN CLIN TRANSL NEUR, V5, P240, DOI 10.1002/acn3.523; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI [10.1146/annurev.pharmtox.44.101802.121453, 10.2165/00003088-200948030-00001]; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P4159, DOI 10.1167/iovs.19-27565; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; McCarthy MM, 2015, HORM BEHAV, V76, P3, DOI 10.1016/j.yhbeh.2015.04.013; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mead B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109305; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Mohan K, 2012, VET OPHTHALMOL, V15, P94, DOI 10.1111/j.1463-5224.2012.01034.x; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Struebing FL, 2018, J NEUROTRAUM, V35, P118, DOI 10.1089/neu.2017.5104; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016	38	2	2	0	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	OCT	2020	61	12							7	10.1167/iovs.61.12.7			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	OR2IJ	WOS:000589298400025	33030508	Green Published, gold			2022-02-06	
J	Fu, SL; Zhu, LN; Yin, HH; Jiang, Y; Zhu, JC				Fu Shao-li; Zhu Li-na; Yin Hua-hua; Jiang Yan; Zhu Jing-ci			Da-Cheng-Qi Decoction Combined withLactobacillus AcidophilusImproves Gastrointestinal Function of Traumatic Brain-Injured Model Mice	CHINESE JOURNAL OF INTEGRATIVE MEDICINE			English	Article						traumatic brain-injury; Da-Cheng-Qi Decoction; Lactobacillus acidophilus; intestinal mucosal barrier; gastrointestinal motility	SMOOTH-MUSCLE-CELLS; INTERSTITIAL-CELLS; BARRIER FUNCTION; DACHENGQI DECOCTION; CAJAL; RATS; ISCHEMIA; NETWORK; TRACT	Objective To investigate the effects of Da-Cheng-Qi Decoction (DCQD, combined withLactobacillus acidophilus(LA) on the recovery of gastrointestinal (GI) function in traumatic brain-injured (TBI) mice. Methods A total of 150 male C57BL/6 mice were randomly divided into sham-injury, normal saline (NS), DCQD (0.4 mL/day), LA (> 1 x 10(10)cfu/day LA), DCQD+LA (LA administration at the same dosage after 4 h of feeding DCQD), and 1/2 DCQD+LA groups (LA administration at the same dosage after 4 h of feeding 1/2 DCQD dose) by a random number table, 5-8 mice in each group. The sever TBI model was constructed according to Feeney's enhanced gravitational forces of free falling. On days 1, 3, and 7 post-TBI, plasma diamine oxidase (DAO) and D-lactic acid levels were assessed by enzyme-linked immunosorbent assay (ELISA). Occludin expression in the intestinal epithelium was assessed by Western blot analysis. Transmission electron microscopy (TEM) was used to observe the morphological changes in the network structure of interstitial cells of Cajal (ICC) and change of enteric nervous system-ICC-smooth muscle cell (ENS-ICC-SMC). Immunofluorescence staining was used to detect changes in the network structure of the ICC. Results Compared with the NS group, occludin expression in the DCQD+LA group significantly increased on Day 1, 3, and 7 post-TBI (PP<0.01). The concentration of DAO significantly decreased in the LA, DCQD, and DCQD+LA groups on Day 3 and 7, whilst the D-lactate concentrations in the LA and 1/2 DCQD+LA groups decreased on Day 1 and 3 post-injury(PP<0.01). The NS group experienced a great damage on the ENS-ICC-SMC network morphology and ICC network structure, and all treatment groups had some improvements, among which the DCQD+LA group presented relatively intact network morphology. Conclusions DCQD combined with LA treatment could effectively repair the intestinal mucosal barrier and improve GI motility in mice after TBI. The combination of DCQD and LA was more effective than their respective monotherapies.	[Fu Shao-li; Zhu Li-na; Yin Hua-hua; Jiang Yan; Zhu Jing-ci] Third Mil Med Univ, Sch Nursing, Dept Nursing, Chongqing 400038, Peoples R China; [Fu Shao-li] Chongqing Tradit Chinese Med Hosp, Dept Orthoped, Chongqing 400021, Peoples R China		Zhu, JC (corresponding author), Third Mil Med Univ, Sch Nursing, Dept Nursing, Chongqing 400038, Peoples R China.	zhujingci@163.com					Balzan S, 2007, J GASTROEN HEPATOL, V22, P464, DOI 10.1111/j.1440-1746.2007.04933.x; Barrenetxe J, 2006, An Sist Sanit Navar, V29, P337; Dickerson RN, 2009, JPEN-PARENTER ENTER, V33, P646, DOI 10.1177/0148607109335307; [方欢 Fang Huan], 2013, [中华创伤杂志, Chinese Journal of Trauma], V29, P165; Gao X, 2012, WORLD J GASTROENTERO, V20, P2882; Gong HL, 2012, CHIN J INTEGR MED, V18, P708, DOI 10.1007/s11655-012-1205-9; Gosain A, 2005, J BURN CARE REHABIL, V26, P85, DOI 10.1097/01.BCR.0000150212.21651.79; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Li L, 2011, INT J PATHOL SCI CLI, V31, P193; Li N, 2015, HUBEI J TRADIT CHIN, P7; Mei F, 2009, VIRCHOWS ARCH, V454, P401, DOI 10.1007/s00428-009-0739-5; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Moriyama K, 2006, TOXICOLOGY, V217, P233, DOI 10.1016/j.tox.2005.09.017; Persborn M, 2013, ALIMENT PHARM THER, V38, P772, DOI 10.1111/apt.12451; Qi Qing-hui, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P21; Qi QH, 2010, CHIN J INTEGR MED, V16, P422, DOI 10.1007/s11655-010-0539-4; Qian QL, 2011, PROCED EARTH PLAN SC, V2, P327, DOI 10.1016/j.proeps.2011.09.051; Sapin V, 2006, CLIN CHEM LAB MED, V44, P492, DOI 10.1515/CCLM.2006.086; Sindhu KN, 2014, CLIN INFECT DIS, V1, P9; Suzuki S, 2010, NEUROGASTROENT MOTIL, V22, P585, DOI 10.1111/j.1365-2982.2009.01444.x; Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang B, 2010, NEUROGASTROENT MOTIL, V22, P98, DOI 10.1111/j.1365-2982.2009.01384.x; Wang Y, 2014, CHIN ARCH TRADIT CHI, V32, P159; Xie M, 2013, J DALIAN MED U CHIN, V35, P520; Yu XY, 2011, NUTRITION, V27, P100, DOI 10.1016/j.nut.2010.01.010; Zhang D, 2012, J LIAONING U TRADIT, V14, P58; Zhang SuoFei, 2013, Chongqing Medicine, V42, P1486; Zhang Y, 2012, HEBEI MED J CHIN, V34, P3069; Zhang YingQian, 2007, China Journal of Traditional Chinese Medicine and Pharmacy, V22, P843; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	31	2	3	1	12	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1672-0415	1993-0402		CHIN J INTEGR MED	Chin. J. Integr. Med.	OCT	2020	26	10					762	768		10.1007/s11655-019-3036-4			7	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	NY1UA	WOS:000576182100006	31446576				2022-02-06	
J	Le, TMT; Oleck, NC; Liu, FC; Halsey, JN; Hoppe, IC; Lee, ES; Granick, MS				Le, Thuy-My T.; Oleck, Nicholas C.; Liu, Farrah C.; Halsey, Jordan N.; Hoppe, Ian C.; Lee, Edward S.; Granick, Mark S.			Motor Vehicle Collision Injuries: An Analysis of Facial Fractures in the Urban Pediatric Population	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Craniofacial; facial fracture; motor vehicle collisions; reconstructive surgery	TRAUMA; MANAGEMENT; PATTERNS; CHILDREN	Purpose: Motor vehicle collisions (MVC) are a leading cause of unintentional death and injury in the US pediatric population. Compliance with prevention measures such as seatbelts and child safety seats varies considerably with patient demographics. In this study, the authors examine facial fracture secondary to MVC in an urban pediatric population. Methods: A retrospective chart review was performed of all facial fractures as a result of MVC in the pediatric population in a level 1 trauma center in an urban environment (University Hospital in Newark, NJ). Patient demographics were collected, as well as location of fractures, concomitant injuries, and surgical management strategies. Results: Seventy-five patients met inclusion criteria for the authors' study. Mean age was 14 years old. Common fracture sites included orbital, mandible, nasal bone, and frontal sinus. Patients were more likely to incur fracture of the zygoma, orbit, nasal bone, frontal sinus, and nasoorbitoethmoid (NOE) if involved in an MVC compared to all other etiologies. Common concomitant injuries included traumatic brain injury, intracranial hemorrhage, and skull and long bone fractures. Open reduction and internal fixation with titanium plates was the most common surgical procedure indicated. Conclusion: Motor vehicle collisions related injury has significant health implications in the urban pediatric population. Orbital, zygoma, and nasal facial fractures and TBI are injuries commonly associated with MVC. The facial fractures are likely due to lack of proper utilization of safety equipment and airbags. Development of effective prevention techniques relies heavily on analysis of injury patterns and management strategies.	[Le, Thuy-My T.; Oleck, Nicholas C.; Liu, Farrah C.; Halsey, Jordan N.; Lee, Edward S.; Granick, Mark S.] Rutgers New Jersey Med Sch, Dept Surg, Div Plast & Reconstruct Surg, 140 Bergen St Ste E1640, Newark, NJ 07103 USA; [Hoppe, Ian C.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA		Granick, MS (corresponding author), Rutgers New Jersey Med Sch, Dept Surg, Div Plast & Reconstruct Surg, 140 Bergen St Ste E1640, Newark, NJ 07103 USA.	mgranickmd@rutgers.edu					Al-Jazaeri A, 2012, ANN SAUDI MED, V32, P502, DOI 10.5144/0256-4947.2012.502; Braun TL, 2017, SEMIN PLAST SURG, V31, P118, DOI 10.1055/s-0037-1601380; Centers for Disease Control and Prevention, CHILD PASS SAF; Chao MT, 2009, CRANIOMAX TRAUM REC, V2, P103, DOI 10.1055/s-0029-1215873; Dastur CK, 2017, STROKE VASC NEUROL, V2, P21, DOI 10.1136/svn-2016-000047; Greenspan AI, 2010, J SAFETY RES, V41, P183, DOI 10.1016/j.jsr.2010.03.001; Hyman DA, 2016, JAMA FACIAL PLAST SU, V18, P455, DOI 10.1001/jamafacial.2016.0733; Ji So Young, 2016, Arch Craniofac Surg, V17, P206, DOI 10.7181/acfs.2016.17.4.206; Juul Niels, 2008, Ugeskr Laeger, V170, P2337; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Miller AF, 2018, PEDIATR EMERG CARE, V34, P21, DOI 10.1097/PEC.0000000000001306; Munante-Cardenas JL, 2011, J CRANIOFAC SURG, V22, P1251, DOI 10.1097/SCS.0b013e31821c696c; Murphy RX, 2000, PLAST RECONSTR SURG, V105, P516, DOI 10.1097/00006534-200002000-00005; National Highway Traffic Safety Administration, STAT TAK REC; Neligan PC, 2013, PLASTIC SURG, V3; New York City Department of Transportation, PED SAF STUD ACT PLA; Newgard CD, 2005, PEDIATRICS, V115, P1579, DOI 10.1542/peds.2004-0555; Peltola EM, 2014, EMERG RADIOL, V21, P165, DOI 10.1007/s10140-013-1173-1; Schachar RJ, 2015, J CAN ACAD CHILD ADO, V24, P100; WALLIS A, 1988, LARYNGOSCOPE, V98, P593	20	2	2	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	OCT	2020	31	7					1910	1913		10.1097/SCS.0000000000006671			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	OP6EB	WOS:000588176500045	32649563				2022-02-06	
J	Li, YD; Zhao, M; Wei, QX; Yu, J; Chen, J; Chen, DY; Wang, JB				Li, Yadong; Zhao, Ming; Wei, Qiuxu; Yu, Jie; Chen, Jian; Chen, Deyong; Wang, Junbo			Wireless Passive Intracranial Pressure Sensor Based on Vacuum Packaging	IEEE SENSORS JOURNAL			English	Article						Capacitors; Temperature sensors; Glass; Resonant frequency; Wireless sensor networks; Wireless communication; Intracranial pressure (ICP); wireless passive pressure sensor; vacuum packaging; in-vivo test	SILICON; INJURY	This paper presents a wireless passive pressure sensor based on a pressure-sensitive capacitor specifically designed to monitor intracranial pressure (ICP) in patients with traumatic brain injuries. It is crucial that temperature will affect the accuracy of pressure detection. To improve temperature stability, the capacitor is composed of an SOI wafer as the sensing element and a glass cap for vacuum packaging. To realize reliable vacuum packaging, it is vital to transfer the electrical signal out of the vacuum cavity. The experimental results show that the proposed sensor demonstrated averaged pressure sensitivity and averaged temperature sensitivity of 0.5803 Hz/kPa and 0.024 Hz/degrees C. Additionally, the in-vivo test in the animal show that the proposed sensor has the similar detection effect with the commercial wired sensor, and naturally has the advantage of reducing the risk of infection, which further validated the feasibility and effectiveness of the wireless passive ICP monitoring system.	[Li, Yadong; Wei, Qiuxu; Yu, Jie; Chen, Jian; Chen, Deyong; Wang, Junbo] Chinese Acad Sci, Aerosp Informat Res Inst, State Key Lab Transducer Technol, Beijing 100190, Peoples R China; [Li, Yadong; Wei, Qiuxu; Yu, Jie; Chen, Jian; Chen, Deyong; Wang, Junbo] Univ Chinese Acad Sci, Sch Elect Elect & Commun Engn, Beijing 100049, Peoples R China; [Zhao, Ming] Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Med Ctr 4, Beijing 100043, Peoples R China		Wang, JB (corresponding author), Chinese Acad Sci, Aerosp Informat Res Inst, State Key Lab Transducer Technol, Beijing 100190, Peoples R China.	liyadong16@mails.ucas.ac.cn; jbwang@mail.ie.ac.cn		, Yadong/0000-0003-2708-3101; wei, qiu xu/0000-0003-1201-6432	National Key Research and Development Program [2016YFC0301801]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61825107, U1930206]	This work was supported in part by the National Key Research and Development Program under Grant 2016YFC0301801 and in part by the National Natural Science Foundation of China under Grant 61825107 and Grant U1930206.	Behfar MH, 2016, IEEE ENG MED BIO, P1950, DOI 10.1109/EMBC.2016.7591105; Chavan AV, 2001, J MICROELECTROMECH S, V10, P580, DOI 10.1109/84.967381; Cocuzza M, 2008, J VAC SCI TECHNOL B, V26, P541, DOI 10.1116/1.2870221; COZMA A, 1995, J MICROMECH MICROENG, V5, P98, DOI 10.1088/0960-1317/5/2/010; Hu AP, 2016, IEEE J EM SEL TOP P, V4, P273, DOI 10.1109/JESTPE.2015.2489226; Kawoos U., 2009, EMBEDDED WIRELESS IN; Kawoos U, 2008, IEEE T MICROW THEORY, V56, P2356, DOI 10.1109/TMTT.2008.2004253; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Khan MWA, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON ELECTROMAGNETICS IN ADVANCED APPLICATIONS (ICEAA), P383, DOI 10.1109/ICEAA.2015.7297141; Khan MWA, 2016, IEEE MICROW WIREL CO, V26, P549, DOI 10.1109/LMWC.2016.2574836; Lee HY, 2015, SENSOR ACTUAT A-PHYS, V221, P104, DOI 10.1016/j.sna.2014.11.002; Liu QM, 2013, SENSOR ACTUAT A-PHYS, V201, P241, DOI 10.1016/j.sna.2013.07.013; Meng X, 2013, IEEE T MICROW THEORY, V61, P316, DOI 10.1109/TMTT.2012.2224361; Moradi E, 2014, 2014 IEEE RFID TECHNOLOGY AND APPLICATIONS CONFERENCE (RFID-TA), P145, DOI 10.1109/RFID-TA.2014.6934217; Pang C, 2008, SENSOR ACTUAT A-PHYS, V147, P672, DOI 10.1016/j.sna.2008.06.001; Ramesh VJ, 2018, NEUROSURGERY, V82, pE143, DOI 10.1093/neuros/nyy029; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Vogeli B, 2000, WEAR, V238, P20, DOI 10.1016/S0043-1648(99)00336-1; Wei QX, 2019, MICROSYST TECHNOL, V25, P3437, DOI 10.1007/s00542-019-04336-z	20	2	2	4	16	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1530-437X	1558-1748		IEEE SENS J	IEEE Sens. J.	OCT 1	2020	20	19					11247	11255		10.1109/JSEN.2020.2998786			9	Engineering, Electrical & Electronic; Instruments & Instrumentation; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Instruments & Instrumentation; Physics	OH7WT	WOS:000582804900023					2022-02-06	
J	Liou, JH; Chang, YL; Lee, HT; Wu, MF; Hou, YC; Liou, WS				Liou, Jaw-Horng; Chang, Yen-Lin; Lee, Hsu-Tung; Wu, Ming-Fen; Hou, Yu-Chi; Liou, Wen-Shyong			Preventing epilepsy after traumatic brain injury: A propensity score analysis	JOURNAL OF THE CHINESE MEDICAL ASSOCIATION			English	Article						Anticonvulsants; Brain injuries; traumatic; Epilepsy; post-traumatic	POSTTRAUMATIC EPILEPSY; SEIZURE PROPHYLAXIS; RISK-FACTORS; LEVETIRACETAM; PHENYTOIN; EPIDEMIOLOGY; MORTALITY	Background: Due to the potential consequences of post-traumatic epilepsy (PTE) exacerbating secondary injury following traumatic brain injury (TBI), the use of antiepileptic drugs (AEDs) is an accepted option for seizure prophylaxis. However, there is only a paucity of data that can be found regarding outcomes surrounding the use of AEDs. The purpose of this retrospective study is to evaluate whether the prophylactic administration of AEDs significantly decreased the incidence of PTE, when considering the severity of TBI. Methods: All trauma patients who had been newly diagnosed with TBI from January 1, 2010 to December 31, 2017 were retrospectively analyzed. Statistical comparisons were made using the chi-square test, Mann-WhitneyUtest, and Cox regression modeling. After excluding any exposed subjects with no appropriate match, patients who had received AED prophylaxis were matched by propensity score with those who did not receive AEDs. All of the TBI populations were followed up until June 30, 2018. Results: We identified 1316 patients who met the inclusion and exclusion criteria in our matched cohort through their propensity scores, where 138 patients had been receiving prophylactic AEDs and 138 patients had not. Baseline characteristics were similar in gender, age, Glasgow Coma Scale (GCS) scores, and risk factors of PTE including skull fracture, chronic alcoholism, subdural hematoma, epidural hematoma, and intracerebral hematoma. After adjusting for those risk factors, the relative incidence of seizure was not statistically significant in either of the groups (p= 0.566). Conclusion: In our cohort analysis, AED prophylaxis was ineffective in preventing seizures, as the rate of seizures was similar whether patients had been receiving the drugs or not. We therefore concluded that the benefits of routine prophylactic anticonvulsant therapy in patients with TBI need to be re-evaluated.	[Liou, Jaw-Horng; Chang, Yen-Lin; Wu, Ming-Fen; Liou, Wen-Shyong] Taichung Vet Gen Hosp, Dept Pharm, 1650 Taiwan Blvd Sect 4, Taichung 407, Taiwan; [Liou, Jaw-Horng; Hou, Yu-Chi; Liou, Wen-Shyong] China Med Univ, Sch Pharm, Taichung, Taiwan; [Lee, Hsu-Tung] Taichung Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taichung, Taiwan; [Lee, Hsu-Tung] Taichung Vet Gen Hosp, Canc Prevent & Control Ctr, Taichung, Taiwan		Liou, WS (corresponding author), Taichung Vet Gen Hosp, Dept Pharm, 1650 Taiwan Blvd Sect 4, Taichung 407, Taiwan.	wlschna.liou@gmail.com					Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Flanagan SR, 2015, ARCH PHYS MED REHAB, V96, P1753, DOI 10.1016/j.apmr.2015.07.001; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gabriel WM, 2014, ANN PHARMACOTHER, V48, P1440, DOI 10.1177/1060028014549013; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hazama A, 2018, CUREUS, V10, DOI 10.7759/cureus.2674; Hesdorffer DC, 2011, NEUROLOGY, V76, P23, DOI 10.1212/WNL.0b013e318204a36a; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Lee YJ, 2013, CNS DRUGS, V27, P753, DOI 10.1007/s40263-013-0094-6; Liao KH, 2016, J CHIN MED ASSOC, V79, P58, DOI 10.1016/j.jcma.2015.10.002; Lin WJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040589; Ma CY, 2010, CHIN J TRAUMATOL, V13, P293, DOI 10.3760/cma.j.issn.1008-1275.2010.05.008; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MCQUEEN JK, 1983, J NEUROL NEUROSUR PS, V46, P899, DOI 10.1136/jnnp.46.10.899; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Sperling MR, 2004, CNS SPECTRUMS, V9, P98, DOI 10.1017/S1092852900008464; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Wilson CD, 2018, WORLD NEUROSURG, V110, pE901, DOI 10.1016/j.wneu.2017.11.116; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	32	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1726-4901	1728-7731		J CHIN MED ASSOC	J. Chin. Med. Assoc.	OCT	2020	83	10					950	955		10.1097/JCMA.0000000000000414			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NX3ND	WOS:000575618100014	32858550	Green Published, hybrid			2022-02-06	
J	Lumba-Brown, A; Lee, MO; Brown, I; Cornwell, J; Dannenberg, B; Fang, A; Ghazi-Askar, M; Grant, G; Imler, D; Khanna, K; Lowe, J; Wang, E; Wintermark, M				Lumba-Brown, Angela; Lee, Moon O.; Brown, Ian; Cornwell, Jordan; Dannenberg, Bernard; Fang, Andrea; Ghazi-Askar, Marjan; Grant, Gerald; Imler, Daniel; Khanna, Kajal; Lowe, Jason; Wang, Ewen; Wintermark, Max			Emergency department implementation of abbreviated magnetic resonance imaging for pediatric traumatic brain injury	JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN			English	Article						head injury; pediatrics; traumatic brain injury; trauma	COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; MRI PROTOCOL; CHILDREN; CT; SEQUENCE; RISK	Pediatric head injury is a common presenting complaint in the emergency department (ED), often requiring neuroimaging or ED observation for diagnosis. However, the traditional diagnostic neuroimaging modality, head computed tomography (CT), is associated with radiation exposure while prolonged ED observation impacts patient flow and resource utilization. Recent scientific literature supports abbreviated, or focused and shorter, brain magnetic resonance imaging (MRI) as a feasible and accurate diagnostic alternative to CT for traumatic brain injury. However, this is a relatively new application and its use is not widespread. The aims of this review are to describe the science and applications of abbreviated brain MRI and report a model protocol's development and ED implementation in the evaluation of children with head injury for replication in other institutions.	[Lumba-Brown, Angela; Lee, Moon O.; Brown, Ian; Cornwell, Jordan; Dannenberg, Bernard; Fang, Andrea; Ghazi-Askar, Marjan; Imler, Daniel; Khanna, Kajal; Lowe, Jason; Wang, Ewen] Stanford Univ, Dept Emergency Med, Stanford, CA 94303 USA; [Grant, Gerald] Stanford Univ, Dept Neurosurg, Stanford, CA 94303 USA; [Wintermark, Max] Stanford Univ, Dept Radiol, Stanford, CA 94303 USA		Lumba-Brown, A (corresponding author), Stanford Univ, Dept Emergency Med, Stanford, CA 94303 USA.	alumba@stanford.edu		Cornwell, Jordan/0000-0003-0538-5272; /0000-0001-8924-6477; Lumba-Brown, Angela/0000-0002-9102-8791			Ahmad R, 2018, PEDIATR RADIOL, V48, P37, DOI 10.1007/s00247-017-3987-6; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Bakker MF, 2019, NEW ENGL J MED, V381, P2091, DOI 10.1056/NEJMoa1903986; Canellas R, 2019, RADIOGRAPHICS, V39, P744, DOI 10.1148/rg.2019180123; Dremmen MHG, 2017, AM J NEURORADIOL, V38, P2187, DOI 10.3174/ajnr.A5405; Frush DP, 2008, PEDIATR RADIOL, V38, pS629, DOI 10.1007/s00247-008-1006-7; Hales S, 2016, B WORLD HEALTH ORGAN, V94, P58, DOI 10.2471/BLT.15.167585; Harvey SC, 2016, J AM COLL RADIOL, V13, P374, DOI [10.1016/j.jacr.2015.08.015, 10.1016/j.jacr.2016.09.031]; Imler D, 2017, ACAD EMERG MED, V24, P569, DOI 10.1111/acem.13180; Itri JN, 2015, RADIOGRAPHICS, V35, P1835, DOI 10.1148/rg.2015150110; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lindberg DM, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0419; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; National Institute of Biomedical Imaging and Bioengineering, MAGN RES IM MRI; Newman Beverley, 2011, Pediatr Radiol, V41 Suppl 2, P453, DOI 10.1007/s00247-011-2154-8; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pooler BD, 2019, AM J ROENTGENOL, V213, P90, DOI 10.2214/AJR.18.20947; Powell BJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0209-1; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Slovis TL, 2003, PEDIATRICS, V112, P971, DOI 10.1542/peds.112.4.971; Subhas N, 2017, AM J ROENTGENOL, V208, pW146, DOI 10.2214/AJR.16.17041; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson EM, 2014, J NEUROSURG-PEDIATR, V13, P636, DOI 10.3171/2014.2.PEDS13567; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Trofimova A, 2019, AM J ROENTGENOL, V212, P1348, DOI 10.2214/AJR.18.20439; Young JY, 2016, EMERG RADIOL, V23, P325, DOI 10.1007/s10140-016-1392-3	30	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2688-1152		JACEP OPEN	J. Am. Coll. Emerg. Phys. Open	OCT	2020	1	5					994	999		10.1002/emp2.12055			6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	RZ6GP	WOS:000648695300044	33145550	Green Published, gold			2022-02-06	
J	Mahumane, GD; Kumar, P; Pillay, V; Choonara, YE				Mahumane, Gillian D.; Kumar, Pradeep; Pillay, Viness; Choonara, Yahya E.			Repositioning N-Acetylcysteine (NAC): NAC-Loaded Electrospun Drug Delivery Scaffolding for Potential Neural Tissue Engineering Application	PHARMACEUTICS			English	Article						nanofibers; electrospinning; drug delivery; N-acetylcysteine; scaffold; drug release; Poly(D; L-lactide-co-glycolide (PLGA)	ANTIOXIDANT THERAPY; PLGA NANOFIBERS; BRAIN; NEUROTRAUMA; RELEASE; SYSTEM; TRIALS; INJURY; ACID	Traumatic brain injury (TBI) presents a serious challenge for modern medicine due to the poor regenerative capabilities of the brain, complex pathophysiology, and lack of effective treatment for TBI to date. Tissue-engineered scaffolds have shown some experimental success in vivo; unfortunately, none have yielded consummate results of clinical efficacy. N-acetylcysteine has shown neuroprotective potential. To this end, we developed a N-acetylcysteine (NAC)-loaded poly(lactic-co-glycolic acid) (PLGA) electrospun system for potential neural tissue application for TBI. Scanning electron microscopy showed nanofiber diameters ranging 72-542 nm and 124-592 nm for NAC-free and NAC-loaded PLGA nanofibers, respectively. NAC loading was obtained at 28%, and drug entrapment efficacy was obtained at 84%. A biphasic NAC release pattern that featured an initial burst release (13.9%) stage and a later sustained release stage was noted, thus enabling the prolonged replenishing of NAC and drastically improving cell viability and proliferation. This was evidenced by a significantly higher cell viability and proliferation on NAC-loaded nanofibers for rat pheochromocytoma (PC12) and human glioblastoma multiform (A172) cell lines in comparison to PLGA-only nanofibers. The increased cell viability and cell proliferation on NAC-loaded nanofiber substantiates for the repositioning of NAC as a pharmacological agent in neural tissue regeneration applications.	[Mahumane, Gillian D.; Kumar, Pradeep; Pillay, Viness; Choonara, Yahya E.] Univ Witwatersrand, Fac Hlth Sci, Sch Therapeut Sci, Wits Adv Drug Delivery Platform Res Unit,Dept Pha, 7 York Rd, ZA-2193 Johannesburg, South Africa		Choonara, YE (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Therapeut Sci, Wits Adv Drug Delivery Platform Res Unit,Dept Pha, 7 York Rd, ZA-2193 Johannesburg, South Africa.	gillian.mahumane@wits.ac.za; pradeep.kumar@wits.ac.za; viness.pillay@wits.ac.za; yahya.choonara@wits.ac.za	Choonara, Yahya E./B-2955-2013; Kumar, Pradeep/C-9424-2013	Choonara, Yahya E./0000-0002-3889-1529; Kumar, Pradeep/0000-0002-8640-4350; Pillay, Viness/0000-0002-8119-3347; mahumane, gillian/0000-0002-1734-3689	National Research Foundation (NRF) of South AfricaNational Research Foundation - South Africa; South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the Bongani Mayosi NationalHealth Scholars Program from the Public Health Enhancement Fund/South African National Department of Health; South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the Bongani Mayosi NationalHealth Scholars Program from the SIR Grant; University of theWitwatersrand, Johannesburg	The work was funded by the National Research Foundation (NRF) of South Africa; the South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the Bongani Mayosi NationalHealth Scholars Program from funding received from the Public Health Enhancement Fund/South African National Department of Health and the SIR Grant; and the University of theWitwatersrand, Johannesburg.	Ahmaditabar P, 2017, J CELL BIOCHEM, V118, P4203, DOI 10.1002/jcb.26070; Amariei N, 2017, IOP CONF SER-MAT SCI, V209, DOI 10.1088/1757-899X/209/1/012092; [Anonymous], 1099352009 ISO; Bharadwaj VN, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700668; Blasi Paolo, 2019, Journal of Pharmaceutical Investigation, V49, P337, DOI 10.1007/s40005-019-00453-z; Bobo D, 2016, PHARM RES-DORDR, V33, P2373, DOI 10.1007/s11095-016-1958-5; Braghirolli DI, 2014, J BIOMED MATER RES B, V102, P700, DOI 10.1002/jbm.b.33049; Brown P., 2007, NANOFIBERS NANOTECHN; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Chen WQ, 2012, J COLLOID INTERF SCI, V371, P144, DOI 10.1016/j.jcis.2011.12.052; Clark RSB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180280; Desai KGH, 2008, PHARM RES, V25, P586, DOI 10.1007/s11095-007-9430-1; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI [10.1517/14728220802517901, 10.1517/14728220802517901 ]; Ershad M., 2020, N ACETYLCYSTEINE STA; Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x; Feng XR, 2019, J CONTROL RELEASE, V302, P19, DOI 10.1016/j.jconrel.2019.03.020; Fouad H, 2013, INT J ELECTROCHEM SC, V8, P2293; Fu Y, 2010, EXPERT OPIN DRUG DEL, V7, P429, DOI 10.1517/17425241003602259; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Gnanasekar S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41693-1; Hara Y, 2017, JPAD-J PREV ALZHEIM, V4, P201, DOI 10.14283/jpad.2017.22; He LM, 2010, ACTA BIOMATER, V6, P2960, DOI 10.1016/j.actbio.2010.02.039; He YY, 2020, J MOL NEUROSCI, V70, P340, DOI 10.1007/s12031-019-01417-6; Heard KJ, 2008, NEW ENGL J MED, V359, P285, DOI 10.1056/NEJMct0708278; Hoffer BJ, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0377-1; Katz M, 2015, PARKINSONISM RELAT D, V21, P500, DOI 10.1016/j.parkreldis.2015.02.020; Khadka P, 2014, ASIAN J PHARM SCI, V9, P304, DOI 10.1016/j.ajps.2014.05.005; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Kim JI, 2016, SCI REP-UK, V6, DOI 10.1038/srep23761; Kim Y, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00456; Kimizuka N, 2008, ADV POLYM SCI, V219, P1, DOI 10.1007/12_2008_170; Lamade AM, 2019, NEUROPHARMACOLOGY, V145, P209, DOI 10.1016/j.neuropharm.2018.07.014; Lancheros R, 2018, J NANOTECHNOL, V2018, DOI 10.1155/2018/3620373; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042; Lee J, 2008, TISSUE ENG PART B-RE, V14, P61, DOI 10.1089/teb.2007.0150; Leung V, 2011, POLYM ADVAN TECHNOL, V22, P350, DOI 10.1002/pat.1813; Mahumane GD, 2018, BIOMATER SCI-UK, V6, P2812, DOI 10.1039/c8bm00422f; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Pettikiriarachchi JTS, 2010, AUST J CHEM, V63, P1143, DOI 10.1071/CH10159; Picquart M, 1998, CHEM PHYS, V228, P279, DOI 10.1016/S0301-0104(97)00337-6; Pillay V, 2013, J NANOMATER, V2013, DOI 10.1155/2013/789289; Ramazani F, 2016, INT J PHARMACEUT, V499, P358, DOI 10.1016/j.ijpharm.2016.01.020; Ramburrun P, 2019, BIOMED MATER, V14, DOI 10.1088/1748-605X/ab453c; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sedaghati T, 2015, NEURAL REGEN RES, V10, P1191, DOI 10.4103/1673-5374.162678; Shen YF, 2014, COPD, V11, P351, DOI 10.3109/15412555.2013.858315; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Stukel JM, 2016, TISSUE ENG PART B-RE, V22, P173, DOI [10.1089/ten.teb.2015.0380, 10.1089/ten.TEB.2015.0380]; Subramanian A, 2012, ANN BIOMED ENG, V40, P2098, DOI 10.1007/s10439-012-0592-6; Wang LM, 2016, LECT NOTES COMPUT SC, V9912, P20, DOI 10.1007/978-3-319-46484-8_2; Wu YB, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181748; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; You Y, 2006, J APPL POLYM SCI, V99, P1214, DOI 10.1002/app.22602; Zhang L., 2018, BIORXIV PREPRINT, DOI [10.1101/261438, DOI 10.1101/261438]; Zhou L, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/5024175; Zhou ZH, 2008, DES MONOMERS POLYM, V11, P447, DOI 10.1163/156855508X328149; Zhu YJ, 2019, INT J NANOMED, V14, P787, DOI 10.2147/IJN.S183233	63	2	2	5	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1999-4923		PHARMACEUTICS	Pharmaceutics	OCT	2020	12	10							934	10.3390/pharmaceutics12100934			19	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	OL6DB	WOS:000585427000001	33007830	Green Published, gold			2022-02-06	
J	Manivannan, S; Harari, B; Muzaffar, M; Elalfy, O; Hettipathirannahelage, S; James, Z; Sharouf, F; Ormonde, C; Alsaqati, M; Gray, W; Zaben, M				Manivannan, Susruta; Harari, Balkis; Muzaffar, Maryam; Elalfy, Omar; Hettipathirannahelage, Sameera; James, Zoe; Sharouf, Feras; Ormonde, Chloe; Alsaqati, Mouhamed; Gray, William; Zaben, Malik			Glycyrrhizin Blocks the Detrimental Effects of HMGB1 on Cortical Neurogenesis after Traumatic Neuronal Injury	BRAIN SCIENCES			English	Article						traumatic brain injury; neurogenesis; HMGB1; neuroinflammation	GROUP BOX 1; BRAIN-INJURY; IN-VITRO; MICROGLIAL ACTIVATION; NEURITE OUTGROWTH; CEREBRAL-ISCHEMIA; GENE-EXPRESSION; RECEPTOR; PROTEIN; CELLS	Despite medical advances, neurological recovery after severe traumatic brain injury (TBI) remains poor. Elevated levels of high mobility group box protein-1 (HMGB1) are associated with poor outcomes; likely via interaction with receptors for advanced-glycation-end-products (RAGE). We examined the hypothesis that HMGB1 post-TBI is anti-neurogenic and whether this is pharmacologically reversible. Post-natal rat cortical mixed neuro-glial cell cultures were subjected to needle-scratch injury and examined for HMGB1-activation/neuroinflammation. HMGB1-related genes/networks were examined using genome-wide RNA-seq studies in cortical perilesional tissue samples from adult mice. Post-natal rat cortical neural stem/progenitor cell cultures were generated to quantify effects of injury-condition medium (ICM) on neurogenesis with/without RAGE antagonist glycyrrhizin. Needle-injury upregulated TNF-alpha/NOS-2 mRNA-expressions at 6 h, increased proportions of activated microglia, and caused neuronal loss at 24 h. Transcriptome analysis revealed activation of HMGB1 pathway genes/canonical pathways in vivo at 24 h. A 50% increase in HMGB1 protein expression, and nuclear-to-cytoplasmic translocation of HMGB1 in neurons and microglia at 24 h post-injury was demonstrated in vitro. ICM reduced total numbers/proportions of neuronal cells, but reversed by 0.5 mu M glycyrrhizin. HMGB1 is activated following in vivo post mechanical injury, and glycyrrhizin alleviates detrimental effects of ICM on cortical neurogenesis. Our findings highlight glycyrrhizin as a potential therapeutic agent post-TBI.	[Manivannan, Susruta; Harari, Balkis; Muzaffar, Maryam; Elalfy, Omar; Hettipathirannahelage, Sameera; James, Zoe; Sharouf, Feras; Ormonde, Chloe; Alsaqati, Mouhamed; Gray, William; Zaben, Malik] Neurosci & Mental Hlth Res Inst, Hadyn Ellis Bldg, Cardiff CF24 4HQ, Wales; [Sharouf, Feras; Alsaqati, Mouhamed; Gray, William; Zaben, Malik] Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci DPMCN, Cardiff CF24 4HQ, Wales		Zaben, M (corresponding author), Neurosci & Mental Hlth Res Inst, Hadyn Ellis Bldg, Cardiff CF24 4HQ, Wales.; Zaben, M (corresponding author), Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci DPMCN, Cardiff CF24 4HQ, Wales.	manivannansusruta@gmail.com; HarariB@cardiff.ac.uk; MuzaffarMA@cardiff.ac.uk; omarelalfy@me.com; sameera_he@hotmail.co.uk; zoz364@googlemail.com; SharoufFH@cardiff.ac.uk; OrmondeCE@cardiff.ac.uk; alsaqatim@cardiff.ac.uk; graywp@cardiff.ac.uk; ZabenM@cardiff.ac.uk	; Alsaqati, Mouhamed/F-7704-2016	Hettipathirannahelage, Sameera/0000-0002-9585-7407; Ormonde, Chloe/0000-0002-4432-0693; Zaben, Malik/0000-0002-7446-4532; Alsaqati, Mouhamed/0000-0001-8276-8854	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/L010305/1] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [514823] Funding Source: Medline; Royal College of Surgeons of England [514374] Funding Source: Medline; Rhiannon Jade-Smith Trust [AL11330011] Funding Source: Medline		Ahmed AI, 2012, J NEUROTRAUM, V29, P828, DOI 10.1089/neu.2011.1923; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Borsini A, 2015, TRENDS NEUROSCI, V38, P145, DOI 10.1016/j.tins.2014.12.006; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Cho S, 2001, GLIA, V33, P324, DOI 10.1002/1098-1136(20010315)33:4<324::AID-GLIA1031>3.0.CO;2-M; DeBoussard CN, 2017, CLIN REHABIL, V31, P555, DOI 10.1177/0269215516652184; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drapeau J, 2017, BRAIN INJURY, V31, P221, DOI 10.1080/02699052.2016.1208846; Ernst A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002045; FaberElman A, 1996, J CLIN INVEST, V97, P162, DOI 10.1172/JCI118385; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Fink MP, 2007, CRIT CARE, V11, DOI 10.1186/cc6088; Gao HM, 2011, J NEUROSCI, V31, P1081, DOI 10.1523/JNEUROSCI.3732-10.2011; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gauley J, 2009, AUTOIMMUNITY, V42, P299, DOI 10.1080/08916930902831522; Ghawami H, 2017, APPL NEUROPSYCH-ADUL, V24, P299, DOI 10.1080/23279095.2016.1157078; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Gu XJ, 2014, CHIN J TRAUMATOL, V17, P1, DOI 10.3760/cma.j.issn.1008-1275.2014.01.001; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kigerl KA, 2018, BRAIN BEHAV IMMUN, V72, P22, DOI 10.1016/j.bbi.2017.11.018; Kim JB, 2008, J NEUROSCI RES, V86, P1125, DOI 10.1002/jnr.21555; Kim SW, 2011, NEUROTOX RES, V20, P159, DOI 10.1007/s12640-010-9231-x; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lewis FD, 2017, NEUROREHABILITATION, V40, P401, DOI 10.3233/NRE-161427; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Nemirovich-Danchenko NM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00588; Nishio T, 2005, NEUROSCIENCE, V132, P87, DOI 10.1016/j.neuroscience.2004.12.028; Ohnishi M, 2014, NEUROCHEM INT, V75, P32, DOI 10.1016/j.neuint.2014.05.007; Okuma Y, 2014, NEUROPHARMACOLOGY, V85, P18, DOI 10.1016/j.neuropharm.2014.05.007; Reyes A, 2013, P NATL ACAD SCI USA, V110, P15377, DOI 10.1073/pnas.1307202110; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; SAHA B, 2012, FRONT CELL NEUROSCI, V6; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shi YB, 2018, MOL MED REP, V17, P5125, DOI 10.3892/mmr.2018.8485; Simon DW, 2018, J NEUROTRAUM, V35, P130, DOI 10.1089/neu.2017.5093; Srikrishna G, 2002, J NEUROCHEM, V80, P998, DOI 10.1046/j.0022-3042.2002.00796.x; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Sun XJ, 2018, EXP CELL RES, V369, P112, DOI 10.1016/j.yexcr.2018.05.012; Takizawa T, 2017, J CEREBR BLOOD F MET, V37, P890, DOI 10.1177/0271678X16647398; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Xue X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22672-4; Yang HN, 2010, P NATL ACAD SCI USA, V107, P12611, DOI 10.1073/pnas.1006542107; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070306; Zaben M, 2009, STEM CELLS, V27, P2539, DOI 10.1002/stem.184; Zhao CS, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01632.x; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	71	2	2	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	OCT	2020	10	10							760	10.3390/brainsci10100760			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OJ7VH	WOS:000584163400001	33096930	Green Published, Green Accepted, gold			2022-02-06	
J	Martin, AK; Petersen, AJ; Sesma, HW; Koolmo, MB; Ingram, KM; Slifko, KB; Nguyen, VN; Doss, RC; Linabery, AM				Martin, Alexia K.; Petersen, Ashley J.; Sesma, Heather W.; Koolmo, Mary B.; Ingram, Katherine M.; Slifko, Katie B.; Nguyen, Victoria N.; Doss, Robert C.; Linabery, Amy M.			Concussion symptomology and recovery in children and adolescents with pre-existing anxiety	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TRAUMATIC BRAIN-INJURY; TRAJECTORIES; VALIDITY; SPORT	Objective To examine pre-existing anxiety disorders as a risk factor for increased concussion symptomology and prolonged recovery in children and adolescents. Methods In this retrospective cohort study, we abstracted medical record data for 637 children/adolescents (5-17 years) presenting to three tertiary concussion clinics between April 2018 and March 2019. Primary outcomes were mean concussion symptom and vision symptom severity scores measured at clinic visits. Linear mixed-effects regression models were employed to investigate differences in average symptom load, vision symptom score and symptom recovery trajectories across anxiety strata, adjusted for random effects (time), age and sex. Secondary outcomes, time to concussion symptom recovery and time to return to academics and sports, respectively, were examined via log-rank tests and multivariable Cox regression. Results Among 637 eligible concussion patients, 155 (24%) reported pre-existing anxiety. On average, patients with anxiety reported an additional 2.64 (95% CI 1.84 to 3.44) concussion symptoms and 7.45 (95% CI 5.22 to 9.68) higher vision symptom severity scores throughout recovery versus those without, after adjusting for age and sex. There was no evidence that concussion or vision symptom trajectories varied over time between those with/without anxiety after accounting for baseline dissimilarities in symptom scores (all p(interaction) > 0.05). Anxiety was significantly associated with delayed symptom recovery (adjusted HR 3.34, 95% CI 2.18 to 5.12), return to school (adjusted HR 2.01, 95% CI 1.59 to 2.53) and return to physical activity (adjusted HR 1.88, 95% CI 1.49 to 2.37). Conclusions Pre-existing anxiety disorders were associated with more severe symptomology and prolonged recovery after concussion in children and adolescents. These results can be referenced by providers to manage patients' recovery expectations.	[Martin, Alexia K.; Sesma, Heather W.; Koolmo, Mary B.; Ingram, Katherine M.; Slifko, Katie B.; Nguyen, Victoria N.; Doss, Robert C.; Linabery, Amy M.] Childrens Minnesota, Neurosci Inst, Minneapolis, MN 55404 USA; [Martin, Alexia K.; Linabery, Amy M.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; [Petersen, Ashley J.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Doss, Robert C.] Minnesota Epilepsy Grp PA, St Paul, MN USA		Linabery, AM (corresponding author), Childrens Minnesota, Neurosci Inst, Minneapolis, MN 55404 USA.	amy.linabery@childrensmn.org		Linabery, Amy/0000-0002-6081-3121			Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Faul M, 2010, TRAUMATIC BRAIN INJU; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GC M, 2006, ACUTE CONCUSSION EVA; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GRAYSON DA, 1987, AM J EPIDEMIOL, V126, P546, DOI 10.1093/oxfordjournals.aje.a114687; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Howell DR, 2019, J NEUROSURG-PEDIATR, V24, P54, DOI 10.3171/2018.11.PEDS18626; Ibrahim JG, 2009, TEST-SPAIN, V18, P1, DOI 10.1007/s11749-009-0138-x; Institute of Medicine (IOM) and National Research Council (NRC), 2014, SPORTS RELATED CONCU; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lovell MR, 1996, EVALUATION PROFESSIO; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; MCCRACKEN LM, 1993, CLIN J PAIN, V9, P253, DOI 10.1097/00002508-199312000-00006; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Merikangas Kathleen Ries, 2009, Dialogues Clin Neurosci, V11, P7; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Romeu-Mejia R, 2019, CURR REV MUSCULOSKE, V12, P105, DOI 10.1007/s12178-019-09536-8; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Salim S, 2012, ADV PROTEIN CHEM STR, V88, P1, DOI 10.1016/B978-0-12-398314-5.00001-5; Scheiman M, 2011, SLACK INCORPORATED; VanderWeele TJ, 2019, EUR J EPIDEMIOL, V34, pCP3, DOI 10.1007/s10654-019-00494-6; Wieronska J.M., 2011, ANXIETY DISORDERS; Williams R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004649; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	39	2	2	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	OCT	2020	91	10					1060	1066		10.1136/jnnp-2020-323137			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	NU8WD	WOS:000573917200013	32788258				2022-02-06	
J	Nkoana, W; Williams, H; Steenkamp, N; Clasby, B; Knowler, H; Schrieff, L				Nkoana, Winnie; Williams, Huw; Steenkamp, Nina; Clasby, Betony; Knowler, Helen; Schrieff, Leigh			Understanding the educational needs of young offenders: A prevalence study of traumatic brain injury and learning disabilities	INTERNATIONAL JOURNAL OF EDUCATIONAL DEVELOPMENT			English	Article						Learning disabilities; South Africa; Traumatic brain injuries; Young offenders; Neurodevelopmental disabilities	JUVENILE-OFFENDERS; NEURODEVELOPMENTAL DISORDERS; PRISON-INMATES; DETENTION; CHILDREN; VIOLENT; HEALTH; IQ; DELINQUENCY; ADOLESCENTS	Offenders in custody are often disadvantaged in terms of education. Research shows that providing and improving education in custody can help reduce the possibility of recidivism and high crime rates in young offenders. Among various factors that can impact on youth's ability to engage effectively with education in custody, prevalence rates of neurodisabilities such as learning disabilities and traumatic brain injuries (TBI) remain high. Young offenders with neurodisabilities may present with various developmental, cognitive, intellectual, social functioning, language and communication deficits, that may impact on learner-teacher relationships and learning acquisition. For the purpose of this paper, we focused on learning disabilities and TBI given high prevalence rates for these neurodisabilities reported in the literature. We also report on general intellectual functioning given the association with specific learning disabilities. Despite contextual vulnerabilities, there is a dearth of literature on neurodisabilities and its associated impact on education for young offenders in South Africa. Our study sample included young offenders (n = 25) and controls (n = 56), aged 14-21 years. Measures of alcohol (AUDIT), substance use (MAP), learning disabilities and TBIs (CHAT), general intellectual functioning (WASI-II), and depression (BDI-II) were included for offenders and controls. Results show significant differences in TBI, alcohol use, substance use, and reported possible learning disabilities, with higher scores and rates for these factors, indicating poorer outcomes, in the young offender as compared to the control group. The young offender group also had significantly lower and therefore poorer verbal IQ (VIQ) scores than the control group. The results for VIQ were upheld even when the significant difference in age (young offenders were on average 5 years older) was controlled for. Results of this nature can potentially be used to inform rehabilitative efforts in our local youth centres for offenders in the hope of screening for various developmental and acquired neuro-disabilities so that rehabilitation strategies may be even more targeted for those with special education needs in of an already vulnerable population. Such results may also inform the schooling structures within such centres by providing profiles needs of offenders in custody based on screenings of neurodisabilities.	[Nkoana, Winnie; Steenkamp, Nina; Schrieff, Leigh] Univ Cape Town, Dept Psychol, ACSENT Lab, Cape Town, South Africa; [Williams, Huw] Univ Exeter, Ctr Clin Neuropsychol Res, Exeter, Devon, England; [Clasby, Betony] Univ Sheffield, Dept Sociol Studies, Sheffield, S Yorkshire, England; [Clasby, Betony] Murdoch Childrens Res Inst, Dept Neuropsychol, Melbourne, Vic, Australia; [Knowler, Helen] Univ Exeter, Grad Sch Educ, Exeter, Devon, England		Schrieff, L (corresponding author), Univ Cape Town, Appl Cognit Sci & Expt Neuropsychol Team ACSENT, 3 11 Dept Psychol, ZA-7707 Cape Town, South Africa.	leigh.schrieff-elson@uct.ac.za	Clasby, Betony/ABC-4657-2020	Clasby, Betony/0000-0001-7104-4308; Steenkamp, nina/0000-0003-1491-1596	National Research Foundation Thuthuka Grant (South Africa) [TTK170418227316]; MRC Confidence in Global Mental Health: Trauma and Adverse Childhood Experiences Springboard (TrACES) (United Kingdom) [MC_PC_MR/R019991/1]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_PC_MR/R019991/1] Funding Source: UKRI	National Research Foundation Thuthuka Grant (TTK170418227316, South Africa) and the MRC Confidence in Global Mental Health: Trauma and Adverse Childhood Experiences Springboard (TrACES) grant (MC_PC_MR/R019991/1, United Kingdom).	Allely CS, 2016, BRAIN INJURY, V30, P1161, DOI 10.1080/02699052.2016.1191674; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anderson SAS, 2016, CHILD YOUTH SERV REV, V65, P195, DOI 10.1016/j.childyouth.2016.04.004; Babor T.F., 2001, AUDIT THE ALCOHOL US; Ball C, 2000, BRIT J CRIMINOL, V40, P594, DOI 10.1093/bjc/40.4.594; Billstedt E, 2017, PSYCHIAT RES, V252, P234, DOI 10.1016/j.psychres.2017.03.004; Borschmann R, 2020, LANCET PUBLIC HEALTH, V5, pE114, DOI 10.1016/S2468-2667(19)30217-8; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Burny E, 2012, J LEARN DISABIL-US, V45, P351, DOI 10.1177/0022219411407773; Chitsabesan P, 2015, J HEAD TRAUMA REHAB, V30, P106, DOI 10.1097/HTR.0000000000000129; Chitsabesan P, 2014, J FORENSIC PSYCHI PS, V25, P1, DOI 10.1080/14789949.2014.882387; Chitsabesan P, 2007, J CHILD SERV, V2, P4, DOI 10.1108/17466660200700032; Chitsabesan P, 2012, EUR CHILD ADOLES PSY, V21, P339, DOI 10.1007/s00787-012-0266-9; Clasby B, 2020, DISABIL REHABIL, V42, P2412, DOI 10.1080/09638288.2019.1635214; Cobb E., 2011, PRISON SERV J, P43; Collin-Smyth S., 2018, FRAMEWORK YOUNG PEOP; Crabbe MJC, 2016, J PEDAGOG DEV, V6; Cruise KR, 2011, LEARN INDIVID DIFFER, V21, P30, DOI 10.1016/j.lindif.2010.11.004; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Einat T, 2008, INT J OFFENDER THER, V52, P416, DOI 10.1177/0306624X07307352; Evans MK, 2015, DEVIANT BEHAV, V36, P200, DOI 10.1080/01639625.2014.924361; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Forsyth CJ, 2014, CRIM JUSTICE STUD, V27, P149, DOI 10.1080/1478601X.2013.844463; Geib CF, 2011, LEARN INDIVID DIFFER, V21, P3, DOI 10.1016/j.lindif.2010.05.002; Gladstone M, 2014, SEMIN PEDIATR NEUROL, V21, P50, DOI 10.1016/j.spen.2014.01.002; Hall I., 2000, ADV PSYCHIAT TREATME, V6, P278; Hawkins KA, 2002, ARCH CLIN NEUROPSYCH, V17, P49, DOI 10.1016/S0887-6177(00)00099-8; Hughes N, 2017, J CHILD PSYCHOL PSYC, V58, P1106, DOI 10.1111/jcpp.12791; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Jimenez JE, 2003, J LEARN DISABIL-US, V36, P15, DOI 10.1177/00222194030360010301; JUEL C, 1988, J EDUC PSYCHOL, V80, P437, DOI 10.1037/0022-0663.80.4.437; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Lanskey C, 2015, INT J INCLUSIVE EDUC, V19, P568, DOI 10.1080/13603116.2014.961675; Loza W, 2007, J INTERPERS VIOLENCE, V22, P1144, DOI 10.1177/0886260507303730; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Machin S, 2011, ECON J, V121, P463, DOI 10.1111/j.1468-0297.2011.02430.x; Mallett CA, 2014, CHILD SCH, V36, P147, DOI 10.1093/cs/cdu010; Maniadaki Katerina., 2011, PSYCHOLOGY, V2, P53, DOI [10.4236/psych.2011.21009, DOI 10.4236/PSYCH.2011.21009]; Marsden J, 1998, ADDICTION, V93, P1857, DOI 10.1046/j.1360-0443.1998.9312185711.x; McCarthy J, 2015, J INTELLECT DISABIL, V6, P102, DOI 10.1108/JIDOB-08-2015-0018; McCrimmon A. W., 2012, J PSYCHOEDUCATIONAL, V31, P337, DOI DOI 10.1177/0734282912467756; Mobius M., 2017, S AFRICA KEY ISSUES; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Morris KA, 2006, DISABIL SOC, V21, P613, DOI 10.1080/09687590600918339; Mounce L., 2012, NOBODY MADE CONNECTI; National Research Council, 2001, JUVENILE CRIME JUVEN, DOI [10.17226/9747, DOI 10.17226/9747]; O'Rourke S., 2020, DEV COGNITIVE EMOTIO; Pullen P.C., 2017, HDB SPECIAL ED, V2nd, P286; Rogers L, 2014, LOND REV EDUC, V12, P184, DOI 10.18546/LRE.12.2.04; Romer D, 2017, DEV COGN NEUROS-NETH, V27, P19, DOI 10.1016/j.dcn.2017.07.007; Rucklidge JJ, 2013, CRIME DELINQUENCY, V59, P1263, DOI 10.1177/0011128709336945; de Ribera OS, 2019, AGGRESS VIOLENT BEH, V49, DOI 10.1016/j.avb.2019.07.001; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schrieff-Elson L.E., 2017, INT HDB NEUROPSYCHOL; Sentenac M, 2019, DEV MED CHILD NEUROL, V61, P226, DOI 10.1111/dmcn.14014; Shafi AA, 2019, J EDUC STUDENTS PLAC, V24, P323, DOI 10.1080/10824669.2019.1613897; Shelton D., 2006, J CORRECT HEALTH CAR, V12, P36, DOI DOI 10.1177/1078345806287573; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; SIEGEL LS, 1989, J LEARN DISABIL-US, V22, P469, DOI 10.1177/002221948902200803; Snow PC, 2008, CHILD SOC, V22, P16, DOI 10.1111/j.1099-0860.2006.00076.x; Snowling M.J., 2000, CRIM BEHAV MENT HEAL, V10, P229, DOI [10.1002/cbm.362, DOI 10.1002/CBM.362]; Souverein FA, 2016, J INTERPERS VIOLENCE, V31, P1859, DOI 10.1177/0886260515570748; Statistics S.A., 2014, 030159 STAT SA, P1; Statistics South Africa, 2018, VICT CRIM SURV; Susan Y, 2014, AIMS PUBLIC HEALTH, V1, P33, DOI 10.3934/publichealth.2014.1.33; van de Mortel TF, 2008, AUST J ADV NURS, V25, P40; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Wechsler D., 2011, WECHSLER ABBREVIATED; White J., 2019, IMPROVING ED CONNECT; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Williams WH, 2015, J HEAD TRAUMA REHAB, V30, P69, DOI 10.1097/HTR.0000000000000134; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Young S, 2018, PSYCHIAT RES, V261, P109, DOI 10.1016/j.psychres.2017.12.036	74	2	2	4	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0738-0593	1873-4871		INT J EDUC DEV	Int. J. Educ. Dev.	OCT	2020	78								102261	10.1016/j.ijedudev.2020.102261			8	Education & Educational Research	Social Science Citation Index (SSCI)	Education & Educational Research	NU0BO	WOS:000573305600019					2022-02-06	
J	Otallah, SI				Otallah, Scott, I			Psychogenic Gait Disorder Complicating Recovery After Concussion: A Case Series	PEDIATRIC NEUROLOGY			English	Article						Psychogenic gait; Functional gait disorder; Concussion; Conversion disorder; Persistent post-concussion symptoms; PPCS; Gait; Mild traumatic brain injury	MOVEMENT-DISORDERS; CHILDREN	Background: Gait impairment is common after concussion. "Dizziness" is associated with prolonged recovery after concussion. Most often each of these symptoms is considered to be of vestibular origin. However, whether or not there are psychological etiologies of gait instability that complicate concussion recovery has been less fully explored. Methods: A chart review was performed of all patients seen between 2017 and 2019 in a weekly pediatric traumatic brain injury clinic. Results: Of eighty-four patients with traumatic brain injury, five were found to have developed a classic psychogenic gait. All were adolescents at the time of diagnosis. Recognition of this complication led to modification/initiation of physical therapy and/or mental health intervention and eventual resolution for all patients. Conclusion: Although uncommon, psychogenic gait disorders may complicate concussion recovery in adolescents likely at a higher rate than their occurrence in the general population. This association has not been previously reported. Accurate diagnosis of psychogenic gait likely improves outcomes in this subset of patients with concussion. (C) 2020 Elsevier Inc. All rights reserved.	[Otallah, Scott, I] Wake Forest Baptist Hlth, Winston Salem, NC 27157 USA; [Otallah, Scott, I] Wake Forest Pediat TBI Clin, Winston Salem, NC USA; [Otallah, Scott, I] Wake Forest Child Neurol Residency, Winston Salem, NC USA		Otallah, SI (corresponding author), Wake Forest Baptist Hlth, Wake Forest Child Neurol Residency, JT9,Med Ctr Blvd, Winston Salem, NC 27157 USA.	sotallah@wakehealth.edu					Adams Caitlin, 2018, Pract Neurol, V18, P323, DOI 10.1136/practneurol-2017-001835; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Ferrara J, 2008, MOVEMENT DISORD, V23, P1875, DOI 10.1002/mds.22220; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Kirsch DB, 2004, PEDIATR NEUROL, V30, P1, DOI 10.1016/j.pediatrneurol.2003.07.001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Ryu JH, 2010, J MOV DISORD, V3, P15, DOI 10.14802/jmd.10004; Schwingenschuh P, 2008, MOVEMENT DISORD, V23, P1882, DOI 10.1002/mds.22280; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; STICKLER GB, 1989, CLIN PEDIATR, V28, P12, DOI 10.1177/000992288902800103	15	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	OCT	2020	111						1	3		10.1016/j.pediatrneurol.2020.05.005			3	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	NU1ZI	WOS:000573440100002	32951647				2022-02-06	
J	Rahaman, MM; Fang, WQ; Fawzi, AL; Wan, Y; Kesari, H				Rahaman, Mohammad Masiur; Fang, Wenqiang; Fawzi, Alice Lux; Wan, Yang; Kesari, Haneesh			An accelerometer-only algorithm for determining the acceleration field of a rigid body, with application in studying the mechanics of mild traumatic brain injury	JOURNAL OF THE MECHANICS AND PHYSICS OF SOLIDS			English	Article						Acceleration field; Tri-axial accelerometers; Angular velocity; Orientation tensor; mTBI	HEAD IMPACT KINEMATICS; ANGULAR-ACCELERATION; AXONAL DAMAGE; GYROSCOPE; VELOCITY; DESIGN; SYSTEM; MODEL	We present an algorithm for determining the acceleration field of a rigid body using measurements from four tri-axial accelerometers. The acceleration field is an important quantity in bio-mechanics problems, especially in the study of mild traumatic brain injury (mTBI). The in vivo strains in the brain, which are hypothesized to closely correlate with brain injury, are generally not directly accessible outside of a laboratory setting. However, they can be estimated on knowing the head's acceleration field. In contrast to other techniques, the proposed algorithm uses data exclusively from accelerometers, rather than from a combination of accelerometers and gyroscopes. For that reason, the proposed accelerometer only (AO) algorithm does not involve any numerical differentiation of data, which is known to greatly amplify measurement noise. For applications where only the magnitude of the acceleration vector is of interest, the algorithm is straightforward, computationally efficient and does not require computation of angular velocity or orientation. When both the magnitude and direction of acceleration are of interest, the proposed algorithm involves the calculation of the angular velocity and orientation as intermediate steps. In addition to helping understand the mechanics of mTBI, the AO-algorithm may find widespread use in several bio-mechanical applications, gyroscope-free inertial navigation units, ballistic platform guidance, and platform control. (C) 2020 Elsevier Ltd. All rights reserved.	[Rahaman, Mohammad Masiur; Fang, Wenqiang; Wan, Yang; Kesari, Haneesh] Brown Univ, Sch Engn, 184 Hope St, Providence, RI 02912 USA; [Fawzi, Alice Lux] Brown Univ, Inst Mol & Nanoscale Innovat, 184 Hope St, Providence, RI 02912 USA		Kesari, H (corresponding author), Brown Univ, Sch Engn, 184 Hope St, Providence, RI 02912 USA.	haneesh_kesari@brown.edu			Panther Program; Office of Naval ResearchOffice of Naval Research [N0 0 0141812494]	The authors gratefully acknowledge support from the Panther Program and the Office of Naval Research (Dr. Timothy Bentley) under grant N0 0 0141812494.	Allen M.P., 2017, COMPUTER SIMULATION; Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Alonso FJ, 2005, J BIOMECH, V38, P1085, DOI 10.1016/j.jbiomech.2004.05.031; Analog Devices, 2009, 3 AXIS 2G 4G 8G 16G; Analog Devices, 2009, SMALL LOW POWER 3 AX; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bibbona E, 2008, METROLOGIA, V45, pS117, DOI 10.1088/0026-1394/45/6/S17; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; BRITTING KR, 1971, INERTIAL NAVIGATION; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cardou P, 2008, MULTIBODY SYST DYN, V19, P383, DOI 10.1007/s11044-007-9096-9; Chan DD, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040230; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Dimian M., 2014, NOISE DRIVEN PHENOME; Franck JA, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4030942; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Genin J, 1997, J DYN SYST-T ASME, V119, P474, DOI 10.1115/1.2801281; Goldstein H, 2002, CLASSICAL MECH; Gomez AD, 2019, IEEE T BIO-MED ENG, V66, P1456, DOI 10.1109/TBME.2018.2874591; HALMOS PR, 1942, FINITE DIMENSIONAL V; Jog C., 2015, CONTINUUM MECH VOLUM; Khial PP, 2018, NAT PHOTONICS, V12, P671, DOI 10.1038/s41566-018-0266-5; Kolmogorov A., 1975, INTRO REAL ANAL, V100; Kreyszig Erwin, 1978, INTRO FUNCTIONAL ANA, V1; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Landau L. D., 1978, COURSE THEORETICAL P, V1; Langlois J.A., 2004, TECHNICAL REPORT; Liu CJ, 2014, SENSOR ACTUAT A-PHYS, V214, P175, DOI 10.1016/j.sna.2014.04.033; Madgwick SOH, 2013, MECHATRONICS, V23, P518, DOI 10.1016/j.mechatronics.2013.04.003; Marsden J.E., 2013, INTRO MECH SYMMETRY, V17; Maruskin J.M., 2012, INTRO DYNAMICAL SYST; National Center for Injury Prevention and Control (US), 2003, TECHNICAL REPORT; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; O'Reilly O. M., 2008, INTERMEDIATE DYNAMIC; Oliva W.M., 2004, GEOMETRIC MECH; Ovaska SJ, 1998, IEEE IMTC P, P875, DOI 10.1109/IMTC.1998.676850; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Park M, 2006, J INTELL ROBOT SYST, V46, P27, DOI 10.1007/s10846-006-9037-5; Rogers M.J., 1997, TECHNICAL REPORT; Sackfield A., 2013, MECH ELASTIC CONTACT; Tan CW, 2005, IEEE T INSTRUM MEAS, V54, P2520, DOI 10.1109/TIM.2005.858129; Terze Z, 2015, J COMPUT NONLIN DYN, V10, DOI 10.1115/1.4028671; Titterton David, 2004, STRAPDOWN INERTIAL N, V17; Truesdell C., 2004, NONLINEAR FIELD THEO; Wanner G., 2006, GEOMETRIC NUMERICAL, V31; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Zou T, 2018, J APPL MECH-T ASME, V85, DOI 10.1115/1.4039435; Zou T, 2014, J APPL MECH-T ASME, V81, DOI 10.1115/1.4028405	51	2	2	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-5096	1873-4782		J MECH PHYS SOLIDS	J. Mech. Phys. Solids	OCT	2020	143								104014	10.1016/j.jmps.2020.104014			21	Materials Science, Multidisciplinary; Mechanics; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Mechanics; Physics	OS6DD	WOS:000590251200004		Bronze, Green Submitted			2022-02-06	
J	Rosenberg, A; Mukeshimana, L; Uwamahoro, A; Dworkin, M; Nsengimana, V; Kankindi, E; Niyonsaba, M; Uwitonze, JM; Kabagema, I; Dushime, T; Jayaraman, S				Rosenberg, Ashley; Mukeshimana, Leoncie; Uwamahoro, Alphosine; Dworkin, Myles; Nsengimana, Vizir; Kankindi, Eugenie; Niyonsaba, Mediatrice; Uwitonze, Jean Marie; Kabagema, Ignace; Dushime, Theophile; Jayaraman, Sudha			The Initial Prehospital Management of Traumatic Brain Injuries in Kigali, Rwanda	PREHOSPITAL AND DISASTER MEDICINE			English	Article						ambulance; developing countries; Rwanda; traffic accident; traumatic brain injury	MORTALITY; PREVALENCE; CARE	Introduction: Traumatic brain injuries (TBIs) are an important cause of mortality and disability around the world. Early intervention and stabilization are necessary to obtain optimal outcomes, yet little is written on the topic in low- and middle-income countries (LMICs). The aim is to provide a descriptive analysis of patients with TBI treated by Service d'Aide Medicale Urgente (SAMU), the prehospital ambulance service in Kigali, Rwanda. Hypothesis/Problem: What is the incidence and nature of TBI seen on the ambulance in Kigali, Rwanda? Methods: A retrospective descriptive analysis was performed using SAMU records captured on an electronic database from December 2012 through May 2016. Variables included demographic information, injury characteristics, and interventional data. Results: Patients with TBIs accounted for 18.0% (n = 2,012) of all SAMU cases. The incidence of TBIs in Kigali was 234 crashes per 100,000 people. The mean age was 30.5 (SD = 11.5) years and 81.5% (n = 1,615) were men. The most common mechanisms were road traffic incidents (RTIs; 78.5%, n = 1,535), assault (10.7%, n=216), and falls (7.8%, n=156). Most patients experienced mild TBI (Glasgow Coma Score [GCS] >= 13; 83.5%, n = 1,625). The most common interventions were provision of pain medications (71.0%, n = 1,429), placement of a cervical collar (53.6%, n = 1,079), and administration of intravenous fluids (48.7%, n = 979). In total, TBIs were involved in 67.0% of all mortalities seen by SAMU. Conclusion: Currently, TBIs represent a large burden of disease managed in the prehospital setting of Kigali, Rwanda. These injuries are most often caused by RTIs and were observed in 67% of mortalities seen by SAMU. Rwanda has implemented several initiatives to reduce the incidence of TBIs with a specific emphasis on road safety. Further efforts are needed to better prevent these injuries. Countries seeking to develop prehospital care capacity should train providers to manage patients with TBIs.	[Rosenberg, Ashley; Jayaraman, Sudha] Virginia Commonwealth Univ, Sch Med, Dept Surg, Div Acute Care Surg, Richmond, VA USA; [Mukeshimana, Leoncie; Uwamahoro, Alphosine; Kankindi, Eugenie; Niyonsaba, Mediatrice; Uwitonze, Jean Marie; Kabagema, Ignace; Dushime, Theophile] Rwanda Minist Hlth, Serv Aide Med Urgence, Kigali, Rwanda; [Dworkin, Myles] Thomas Jefferson Univ, Sch Med, Philadelphia, PA 19107 USA; [Nsengimana, Vizir] Univ Teaching Hosp Kigali, Dept Emergency Med, Kigali, Rwanda; [Jayaraman, Sudha] Virginia Commonwealth Univ, Program Global Surg, VCU Hlth, Dept Surg, Richmond, VA USA		Rosenberg, A (corresponding author), VCU Dept Surg, 1200 East Broad St,POB 980135, Richmond, VA 23298 USA.	Ashley.Rosenberg@vcuhealth.org		UWITONZE, Jean Marie/0000-0002-2222-3323	National Institutes of Health (NIH; Bethesda, Maryland USA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21:1R21TW010439-02]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20: 1P20CA210284-01A]; Rotary Foundation (Evanston, Illinois USA) [GG1749568]	None of the authors have any conflicts of interest. This work was supported by the National Institutes of Health (NIH; Bethesda, Maryland USA) R21:1R21TW010439-02, NIH P20: 1P20CA210284-01A, and Rotary Foundation (Evanston, Illinois USA) Global Grant #GG1749568.	Ackaah W, 2010, TRAFFIC INJ PREV, V11, P522, DOI 10.1080/15389588.2010.489198; Boniface R, 2017, PAN AFR MED J, V26, P40; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Brown H, 2007, B WORLD HEALTH ORGAN, V85, P425; Chowdhury T, 2014, SAUDI J ANAESTH, V8, P114, DOI 10.4103/1658-354X.125971; Committee of The National Association of Emergency Medical Technicians in Cooperation with The Committee on Trauma of The American College of Surgeons, 2010, PREHOSPITAL TRAUMA L, V7; Dewan M.C., 2018, J NEUROSURG; Enumah S, 2016, PREHOSP DISASTER MED, V31, P614, DOI 10.1017/S1049023X16000807; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kim WC, 2016, WORLD J SURG, V40, P6, DOI 10.1007/s00268-015-3258-3; Krebs E, 2017, WORLD NEUROSURG, V102, P571, DOI 10.1016/j.wneu.2017.03.001; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; National Institute of Statistics Rwanda, SIZ RES POP; Nnadi MON, 2014, AFRICAN J MED HLTH S, V13, P51; Oginni Fadekemi O, 2007, Traffic Inj Prev, V8, P137, DOI 10.1080/15389580601058472; Qureshi JS, 2013, INT J SURG, V11, P265, DOI 10.1016/j.ijsu.2013.01.011; Scott JW, 2017, INJURY, V48, P1376, DOI 10.1016/j.injury.2017.03.050; Sobuwa Simpiwe, 2013, S Afr Med J, V103, P644, DOI 10.7196/samj.7035; Stassen W, 2014, SAMJ S AFR MED J, V104, P424, DOI [10.7196/SAMJ.7494, 10.7196/samj.7494]; TEASDALE G, 1974, LANCET, V2, P81; Terceros-Almanza LJ, 2017, MED INTENSIVA, V41, P532, DOI 10.1016/j.medin.2016.10.016; The World Bank, POP DENS PEOPL SQ KM; Ubelacker S., 2018, STAR; Weeks SR, 2016, INJURY, V47, P125, DOI 10.1016/j.injury.2015.07.004; WHO, 2019, ORLD REP ROAD TRAFF; World Bank, 2019, LEV URB RWAND EC TRA; World Health Organization, ROAD TRAFF INJ; ZUIDEMA GD, 1977, J NEUROSURG, V46, P135, DOI 10.3171/jns.1977.46.2.0135	28	2	2	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1049-023X	1945-1938		PREHOSP DISASTER MED	Prehospital Disaster Med.	OCT	2020	35	5					533	537	PII S1049023X20000813	10.1017/S1049023X20000813			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	NK8HH	WOS:000566971400011	32600486				2022-02-06	
J	Scallan, NJ; Keene, DD; Breeze, J; Hodgetts, TJ; Mahoney, PF				Scallan, Nicholas James; Keene, D. D.; Breeze, J.; Hodgetts, T. J.; Mahoney, P. F.			Extending existing recommended military casualty evacuation timelines will likely increase morbidity and mortality: a UK consensus statement	BMJ MILITARY HEALTH			English	Article						trauma management; health services administration &amp; management; organisation of health services; surgery	DAMAGE CONTROL RESUSCITATION; TRAUMA PATIENTS; PERFORMANCE IMPROVEMENT; SHORT HISTORY; TRANSFUSION; PLASMA; AFGHANISTAN; MANAGEMENT; DEATH; RATIO	Introduction Future conflicts may have limited use of aviation-based prehospital emergency care for evacuation. This will increase the likelihood of extended evacuation timelines and an extended hold at a forward hospital care facility following the completion of damage control surgery or acute medical interventions. Methods A three-round Delphi Study was undertaken using a panel comprising 44 experts from the UK armed forces including clinicians, logisticians, medical planners and commanders. The panel was asked to consider the effect of an extended hold at Deployed Hospital Care (Forward) from the current 2-hour timeline to +4, +8, +12 and +24 hours on a broad range of clinical and logistical issues. Where 75% of respondents had the same opinion, consensus was accepted. Areas where consensus could not be achieved were used to identify future research priorities. Results Consensus was reached that increasing timelines would increase the personnel, logistics and equipment support required to provide clinical care. There is a tipping point with a prolonged hold over 8 hours, after which the greatest number of clinical concerns emerge. Additional specialties of surgeons other than general and orthopaedic surgeons will likely be required with holds over 24 hours, and robust telemedicine would not negate this requirement. Conclusions Retaining acute medical emergencies at 4 hours, and head injuries was considered a particular risk. This could potentially be mitigated by an increased forward capacity of some elements of medical care and availability of a CT scanner and intracranial pressure monitoring at over 12 hours. Any efforts to mitigate the effects of prolonged timelines will come at the expense of an increased logistical burden and a reduction in mobility. Ultimately the true effect of prolonged timelines can only be answered by close audit and analysis of clinical outcomes during future operations with an extended hold.	[Scallan, Nicholas James; Keene, D. D.; Mahoney, P. F.] Royal Ctr Def Med, Acad Dept Mil Anaesthesia & Crit Care, Birmingham B15 2WB, W Midlands, England; [Scallan, Nicholas James] Army Med Serv, Med Regiment, Preston, Lancs, England; [Breeze, J.] Royal Ctr Def Med, Dept Maxillofacial Surg, Birmingham, W Midlands, England; [Hodgetts, T. J.] Army Med Serv, Andover, MA USA		Keene, DD (corresponding author), Royal Ctr Def Med, Acad Dept Mil Anaesthesia & Crit Care, Birmingham B15 2WB, W Midlands, England.	damian.keene@uhb.nhs.uk		Breeze, John/0000-0002-2352-1365			Allcock EC, 2011, J ROY ARMY MED CORPS, V157, P365, DOI 10.1136/jramc-157-04-03; Apodaca A, 2013, J TRAUMA ACUTE CARE, V75, pS157, DOI 10.1097/TA.0b013e318299da3e; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Boulton AJ, 2018, EMERG MED J, V35, P449, DOI 10.1136/emermed-2018-207523; Breeze J, 2018, J ROY ARMY MED CORPS, V164, P133, DOI 10.1136/jramc-2017-000881; Breeze J, 2016, J ROY ARMY MED CORPS, V162, P284, DOI 10.1136/jramc-2015-000431; Bricknell M, 2019, J ROY ARMY MED CORPS, V165, P173, DOI 10.1136/jramc-2018-000993; Bricknell M, 2019, J ROY ARMY MED CORPS, V165, P176, DOI 10.1136/jramc-2018-000994; Bricknell M, 2014, J ROY ARMY MED CORPS, V160, P64, DOI 10.1136/jramc-2013-000228; Bricknell MC, 2011, J ROY ARMY MED CORPS, V157, pS444, DOI DOI 10.1136/JRAMC-157-4S-07; Bricknell MC, 2011, J ROY ARMY MED CORPS, V157, pS453, DOI [10.1136/jramc-157-4s-09, DOI 10.1136/JRAMC-157-4S-09]; Campbell K, 2021, BMJ MILITARY HEALTH, V167, P18, DOI 10.1136/jramc-2019-001228; Cap AP, 2018, MIL MED, V183, P44, DOI 10.1093/milmed/usy120; Chapman MP, 2015, SHOCK, V44, P63, DOI 10.1097/SHK.0000000000000376; Daniel Y, 2016, J ROY ARMY MED CORPS, V162, P419, DOI 10.1136/jramc-2016-000628; Davenport RA, 2016, CURR OPIN ANESTHESIO, V29, P212, DOI 10.1097/ACO.0000000000000295; Dickinson A, 2016, J ROY ARMY MED CORPS, V162, P400, DOI 10.1136/jramc-2016-000669; Eder P, 2018, METHODS INF MED, V57; Forsyth RJ, COCHRANE DATABASE SY, V29; Gay DAT, 2011, J ROY ARMY MED CORPS, V157, pS289, DOI 10.1136/jramc-157-03s-06; Hodgetts TJ, 2006, EMERG MED J, V23, P745, DOI 10.1136/emj.2006.039610; Hodgetts TJ, 2012, J ROY ARMY MED CORPS, V158, P162, DOI 10.1136/jramc-158-03-04; Hodgetts T J, 2007, J R Army Med Corps, V153, P299; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Horne ST, 2015, J ROY ARMY MED CORPS, V161, P90, DOI 10.1136/jramc-2014-000275; Howard JT, 2019, JAMA SURG, V154, P600, DOI 10.1001/jamasurg.2019.0151; Hume D, 2015, TIMELINES DELPHI STU; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Keene DD, 2016, J ROY ARMY MED CORPS, V162, P355, DOI 10.1136/jramc-2015-000490; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Lane I, 2017, MIL MED, V182, P32, DOI 10.7205/MILMED-D-16-00264; Lee C, 2007, EMERG MED J, V24, P130, DOI 10.1136/emj.2006.041384; Likert R., 1932, ARCHIV PSYCHOL; Linstone H.A, 1975, DELPHI METHOD; Marsden MER, 2016, J ROY ARMY MED CORPS, V162, P373, DOI 10.1136/jramc-2015-000521; Mercer S, 2014, J ROY ARMY MED CORPS, V160, P105, DOI 10.1136/jramc-2013-000205; Midwinter M J, 2009, J R Army Med Corps, V155, P323; Ministry of Defence, 2011, JOINT DOCTR PUBL, V4-03; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; National Institute for Health and Care Excellence, 2016, NICE GUID; Nato Standardisation Office, 2019, N ATL TREATY ORGAN, V3-7, P3; NATO Standardisation Office, 2006, ALL JOINT MED SUPP D; Nato Standardisation Office; Ministry of Defence, 2015, ALL JOINT DOCTR MED; Naumann DN, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019627; OReilly D, 2008, J ROY ARMY MED CORPS, V154, P257, DOI [10.1136/jramc-154-04-12, DOI 10.1136/JRAMC-154-04-12]; Penn-Barwell JG, 2015, J TRAUMA ACUTE CARE, V78, P1014, DOI 10.1097/TA.0000000000000580; Rehn M, 2019, SHOCK, V51, P284, DOI 10.1097/SHK.0000000000001166; Sailliol A, 2013, TRANSFUSION, V53, p65S, DOI 10.1111/trf.12038; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Smith M, 2021, BMJ MILITARY HEALTH, V167, P93, DOI 10.1136/jramc-2019-001224; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Supreme Headquarters Allied Powers Europe, 2010, ALL COMM OP DIR MED; Tai N, 2008, J R Army Med Corps, V154, P14; Tai N R M, 2009, J R Army Med Corps, V155, P253; Taller J, 2008, J TRAUMA, V65, P595, DOI 10.1097/TA.0b013e31818234aa; Ulschak F.L., 1983, HUMAN RESOURCE DEV T; Vanderspurt CK, 2018, TRANSFUSION, V59; Vassallo D, 2015, J ROY ARMY MED CORPS, V161, P355, DOI 10.1136/jramc-2015-000465; Vassallo D, 2015, J ROY ARMY MED CORPS, V161, P160, DOI 10.1136/jramc-2015-000437; Winstanley M, 2019, J ROY ARMY MED CORPS, V165, P405, DOI 10.1136/jramc-2018-001031; Yeguiayan JM, 2012, CRIT CARE, V16, DOI 10.1186/cc11375	62	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2633-3767	2633-3775		BMJ MILITARY HEALTH	BMJ Military Health	OCT	2020	166	5					287	293		10.1136/bmjmilitary-2020-001517			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OJ4GM	WOS:000583922100003	32665423	Bronze			2022-02-06	
J	Tylicka, M; Matuszczak, E; Hermanowicz, A; Debek, W; Karpinska, M; Kaminska, J; Koper-Lenkiewicz, OM				Tylicka, Marzena; Matuszczak, Ewa; Hermanowicz, Adam; Debek, Wojciech; Karpinska, Maria; Kaminska, Joanna; Koper-Lenkiewicz, Olga Martyna			BDNF and IL-8, But Not UCHL-1 and IL-11, Are Markers of Brain Injury in Children Caused by Mild Head Trauma	BRAIN SCIENCES			English	Article						mild head trauma; brain-derived neurotrophic factor (BDNF); interleukin-8 (IL-8); interleukin-11 (IL-11); ubiquitin C-terminal hydrolase L1 (UCHL-1)	CEREBROSPINAL-FLUID; NEUROTROPHIC FACTOR; PROTEASOME ACTIVITY; TERMINAL HYDROLASE; FACTOR EXPRESSION; SERUM; NEUROINFLAMMATION; INTERLEUKIN-8; CONCUSSION; PLASMA	The aim of the study was to check whether the plasma levels of brain-derived neurotrophic factor (BDNF), interleukin-8 (IL-8), interleukin-11 (IL-11) and ubiquitin C-terminal hydrolase L1 (UCHL-1) change in children with mild head trauma (N = 29) compared to controls (N = 13). Protein concentration in children with mild head trauma (12 children with mild concussion without loss of consciousness and 17 children with severe concussion and loss of consciousness) and the control group were measured by means of the Enzyme-Linked Immunosorbent Assay (ELISA) method. IL-8 and BDNF concentration was statistically higher in the group of children with mild head trauma (9.89 pg/mL and 2798.00 pg/mL, respectively) compared to the control group (7.52 pg/mL and 1163.20 pg/mL, respectively). BDNF concentration was significantly higher in children with severe concussion and loss of consciousness (3826.00 pg/mL) than in the control group. None of the tested proteins differed significantly between children with mild concussion without loss of consciousness and children with severe concussion and loss of consciousness. BDNF and IL-8 may be sensitive markers of brain response to mild head trauma in children. The lack of statistical differences for BDNF and IL-8 between children with mild or severe concussion could indicate that their elevated levels may not result from significant structural brain damage but rather reflect a functional disturbance.	[Tylicka, Marzena; Karpinska, Maria] Med Univ Bialystok, Dept Biophys, Mickiewicza 2a, PL-15089 Bialystok, Poland; [Matuszczak, Ewa; Hermanowicz, Adam; Debek, Wojciech] Med Univ Bialystok, Dept Pediat Surg & Urol, Waszyngtona 17, PL-15274 Bialystok, Poland; [Kaminska, Joanna; Koper-Lenkiewicz, Olga Martyna] Med Univ Bialystok, Dept Clin Lab Diagnost, Waszyngtona 15A, PL-15269 Bialystok, Poland		Tylicka, M (corresponding author), Med Univ Bialystok, Dept Biophys, Mickiewicza 2a, PL-15089 Bialystok, Poland.; Koper-Lenkiewicz, OM (corresponding author), Med Univ Bialystok, Dept Clin Lab Diagnost, Waszyngtona 15A, PL-15269 Bialystok, Poland.	marzena.tylicka@umb.edu.pl; ewamat@tlen.pl; ahermanowicz@wp.pl; wdebek@umwb.edu.pl; karpm@umb.edu.pl; joanna.kaminska@umb.edu.pl; o.koper@wp.pl	Koper-Lenkiewicz, Olga/N-8901-2019; Kaminska, Joanna/ABH-7067-2020; Matuszczak, Ewa/T-3497-2018; Karpinska, Maria/T-6399-2018; Hermanowicz, Adam/T-3500-2018; Debek, Wojciech/S-8168-2018	Koper-Lenkiewicz, Olga/0000-0001-5199-2773; Kaminska, Joanna/0000-0002-2986-4852; Matuszczak, Ewa/0000-0003-2425-9589; Karpinska, Maria/0000-0002-5002-2799; Hermanowicz, Adam/0000-0002-5723-6941; Debek, Wojciech/0000-0001-6023-8510			Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Borovcanin M., 2018, SERB J EXP CLIN RES, V108, P110, DOI [10.1515/sjecr-2017-0031, DOI 10.1515/SJECR-2017-0031]; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Cacialli P, 2018, NEURAL REGEN RES, V13, P941, DOI 10.4103/1673-5374.233430; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Coelho A, 2019, CURR NEUROPHARMACOL, V17, P1021, DOI 10.2174/1570159X17666190617095844; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Golabek-Dropiewska K, 2018, CENT EUR J IMMUNOL, V43, P42, DOI 10.5114/ceji.2018.74872; Ito Y, 2000, NEUROCHEM RES, V25, P1113, DOI 10.1023/A:1007674113440; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Keefe KM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030548; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Koper OM, 2018, IRISH J MED SCI, V187, P767, DOI 10.1007/s11845-017-1695-8; Koper-Lenkiewicz OM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238406; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; LONGO FM, 1984, EXP NEUROL, V84, P207, DOI 10.1016/0014-4886(84)90016-5; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Matuszczak E, 2018, J INVEST SURG, V31, P136, DOI 10.1080/08941939.2017.1282559; Matuszczak E, 2017, ADV MED SCI-POLAND, V62, P83, DOI 10.1016/j.advms.2016.07.004; Matuszczak E, 2015, ADV MED SCI-POLAND, V60, P253, DOI 10.1016/j.advms.2015.04.005; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Minnone G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051028; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Nadir Haider M., 2019, TRAUMATIC BRAIN INJU; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Sandvik U, 2012, NEUROSURGERY, V70, P840, DOI 10.1227/NEU.0b013e318236a809; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Singh S., 2019, J CELL MOL PHARM, V7, P105; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Tabakman R, 2004, PROG BRAIN RES, V146, P387; Toliczenko-Bernatowicz D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191806; Tylicka M, 2014, CHILD NERV SYST, V30, P1191, DOI 10.1007/s00381-014-2409-4; Weremijewicz A, 2018, BURNS, V44, P931, DOI 10.1016/j.burns.2017.12.001; Werhane Madeleine L, 2017, Concussion, V2, pCNC30, DOI 10.2217/cnc-2016-0022; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	48	2	2	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	OCT	2020	10	10							665	10.3390/brainsci10100665			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OJ8GC	WOS:000584191500001	32987792	Green Published, gold			2022-02-06	
J	van Wijk, RPJ; van Dijck, JTJM; Timmers, M; van Veen, E; Citerio, G; Lingsma, HF; Maas, AIR; Menon, DK; Peul, WC; Stocchetti, N; Kompanje, EJO; Akerlund, C; Amrein, K; Andelic, N; Andreassen, L; Anke, A; Antoni, A; Audibert, G; Azouvi, P; Azzolini, ML; Bartels, R; Barzo, P; Beauvais, R; Beer, R; Bellander, BM; Belli, A; Benali, H; Berardino, M; Beretta, L; Blaabjerg, M; Bragge, P; Brazinova, A; Brinck, V; Brooker, J; Brorsson, C; Buki, A; Bullinger, M; Cabeleira, M; Caccioppola, A; Calappi, E; Calvi, MR; Cameron, P; Lozano, GC; Carbonara, M; Cavallo, S; Chevallard, G; Chieregato, A; Ceyisakar, I; Coburn, M; Coles, J; Cooper, JD; Correia, M; Covic, A; Curry, N; Czeiter, E; Czosnyka, M; Dahyot-Fizelier, C; Dark, P; Dawes, H; De Keyser, V; Degos, V; Della Corte, F; den Boogert, H; Depreitere, B; Dilvesi, D; Dixit, A; Donoghue, E; Dreier, J; Duliere, GL; Ercole, A; Esser, P; Ezer, E; Fabricius, M; Feigin, VL; Foks, K; Frisvold, S; Furmanov, A; Gagliardo, P; Galanaud, D; Gantner, D; Gao, GY; George, P; Ghuysen, A; Giga, L; Glocker, B; Golubovic, J; Gomez, PA; Gratz, J; Gravesteijn, B; Grossi, F; Gruen, RL; Gupta, D; Haagsma, JA; Haitsma, I; Helbok, R; Helseth, E; Horton, L; Huijben, J; Hutchinson, PJ; Jacobs, B; Jankowski, S; Jarrett, M; Jiang, JY; Johnson, F; Jones, K; Karan, M; Kolias, AG; Kompanje, E; Kondziella, D; Koraropoulos, E; Koskinen, LO; Kovacs, N; Kowark, A; Lagares, A; Lanyon, L; Laureys, S; Lecky, F; Ledoux, D; Lefering, R; Legrand, V; Lejeune, A; Levi, L; Lightfoot, R; Lingsma, H; Castano-Leon, AM; Maegele, M; Majdan, M; Manara, A; Manley, G; Martino, C; Marechal, H; Mattern, J; McMahon, C; Melegh, B; Menon, D; Menovsky, T; Misset, B; Mulazzi, D; Muraleedharan, V; Murray, L; Negru, A; Nelson, D; Newcombe, V; Nieboer, D; Nyiradi, J; Olubukola, O; Oresic, M; Ortolano, F; Palotie, A; Parizel, PM; Payen, JF; Perera, N; Perlbarg, V; Persona, P; Peul, W; Piippo-Karjalainen, A; Pirinen, M; Ples, H; Polinder, S; Pomposo, I; Posti, JP; Puybasset, L; Radoi, A; Ragauskas, A; Raj, R; Rambadagalla, M; Rhodes, J; Richardson, S; Richter, S; Ripatti, S; Rocka, S; Roe, C; Roise, O; Rosand, J; Rosenfeld, JV; Rosenlund, C; Rosenthal, G; Rossaint, R; Rossi, S; Rueckert, D; Rusnak, M; Sahuquillo, J; Sakowitz, O; Sanchez-Porras, R; Sandor, J; Schafer, N; Schmidt, S; Schoechl, H; Schoonman, G; Schou, RF; Schwendenwein, E; Sewalt, C; Skandsen, T; Smielewski, P; Sorinola, A; Stamatakis, E; Stanworth, S; Stevens, R; Stewart, W; Steyerberg, EW; Sundstrom, N; Synnot, A; Takala, R; Tamas, V; Tamosuitis, T; Taylor, MS; Te Ao, B; Tenovuo, O; Theadom, A; Thomas, M; Tibboel, D; Tolias, C; Trapani, T; Tudora, CM; Vajkoczy, P; Vallance, S; Valeinis, E; Vamos, Z; Van der Steen, G; van der Naalt, J; van Essen, TA; Van Hecke, W; van Heugten, C; Van Praag, D; Vande Vyvere, T; Vargiolu, A; Vega, E; Velt, K; Verheyden, J; Vespa, PM; Vik, A; Vilcinis, R; Volovici, V; von Steinbuchel, N; Voormolen, D; Vulekovic, P; Wang, KKW; Wiegers, E; Williams, G; Wilson, L; Winzeck, S; Wolf, S; Yang, ZH; Ylen, P; Younsi, A; Zeiler, FA; Zelinkova, V; Ziverte, A; Zoerle, T				van Wijk, Roel P. J.; van Dijck, Jeroen T. J. M.; Timmers, Marjolein; van Veen, Ernest; Citerio, Giuseppe; Lingsma, Hester F.; Maas, Andrew I. R.; Menon, David K.; Peul, Wilco C.; Stocchetti, Nino; Kompanje, Erwin J. O.; Akerlund, Cecilia; Amrein, Krisztina; Andelic, Nada; Andreassen, Lasse; Anke, Audny; Antoni, Anna; Audibert, Gerard; Azouvi, Philippe; Azzolini, Maria Luisa; Bartels, Ronald; Barzo, Pal; Beauvais, Romuald; Beer, Ronny; Bellander, Bo-Michael; Belli, Antonio; Benali, Habib; Berardino, Maurizio; Beretta, Luigi; Blaabjerg, Morten; Bragge, Peter; Brazinova, Alexandra; Brinck, Vibeke; Brooker, Joanne; Brorsson, Camilla; Buki, Andras; Bullinger, Monika; Cabeleira, Manuel; Caccioppola, Alessio; Calappi, Emiliana; Calvi, Maria Rosa; Cameron, Peter; Lozano, Guillermo Carbayo; Carbonara, Marco; Cavallo, Simona; Chevallard, Giorgio; Chieregato, Arturo; Ceyisakar, Iris; Coburn, Mark; Coles, Jonathan; Cooper, Jamie D.; Correia, Marta; Covic, Amra; Curry, Nicola; Czeiter, Endre; Czosnyka, Marek; Dahyot-Fizelier, Claire; Dark, Paul; Dawes, Helen; De Keyser, Veronique; Degos, Vincent; Della Corte, Francesco; den Boogert, Hugo; Depreitere, Bart; Dilvesi, Dula; Dixit, Abhishek; Donoghue, Emma; Dreier, Jens; Duliere, Guy-Loup; Ercole, Ari; Esser, Patrick; Ezer, Erzsebet; Fabricius, Martin; Feigin, Valery L.; Foks, Kelly; Frisvold, Shirin; Furmanov, Alex; Gagliardo, Pablo; Galanaud, Damien; Gantner, Dashiell; Gao, Guoyi; George, Pradeep; Ghuysen, Alexandre; Giga, Lelde; Glocker, Ben; Golubovic, Jagos; Gomez, Pedro A.; Gratz, Johannes; Gravesteijn, Benjamin; Grossi, Francesca; Gruen, Russell L.; Gupta, Deepak; Haagsma, Juanita A.; Haitsma, Iain; Helbok, Raimund; Helseth, Eirik; Horton, Lindsay; Huijben, Jilske; Hutchinson, Peter J.; Jacobs, Bram; Jankowski, Stefan; Jarrett, Mike; Jiang, Ji-Yao; Johnson, Faye; Jones, Kelly; Karan, Mladen; Kolias, Angelos G.; Kompanje, Erwin; Kondziella, Daniel; Koraropoulos, Evgenios; Koskinen, Lars-Owe; Kovacs, Noemi; Kowark, Ana; Lagares, Alfonso; Lanyon, Linda; Laureys, Steven; Lecky, Fiona; Ledoux, Didier; Lefering, Rolf; Legrand, Valerie; Lejeune, Aurelie; Levi, Leon; Lightfoot, Roger; Lingsma, Hester; Castano-Leon, Ana M.; Maegele, Marc; Majdan, Marek; Manara, Alex; Manley, Geoffrey; Martino, Costanza; Marechal, Hugues; Mattern, Julia; McMahon, Catherine; Melegh, Bela; Menon, David; Menovsky, Tomas; Misset, Benoit; Mulazzi, Davide; Muraleedharan, Visakh; Murray, Lynnette; Negru, Ancuta; Nelson, David; Newcombe, Virginia; Nieboer, Daan; Nyiradi, Jozsef; Olubukola, Otesile; Oresic, Matej; Ortolano, Fabrizio; Palotie, Aarno; Parizel, Paul M.; Payen, Jean-Francois; Perera, Natascha; Perlbarg, Vincent; Persona, Paolo; Peul, Wilco; Piippo-Karjalainen, Anna; Pirinen, Matti; Ples, Horia; Polinder, Suzanne; Pomposo, Inigo; Posti, Jussi P.; Puybasset, Louis; Radoi, Andreea; Ragauskas, Arminas; Raj, Rahul; Rambadagalla, Malinka; Rhodes, Jonathan; Richardson, Sylvia; Richter, Sophie; Ripatti, Samuli; Rocka, Saulius; Roe, Cecilie; Roise, Olav; Rosand, Jonathan; Rosenfeld, Jeffrey, V; Rosenlund, Christina; Rosenthal, Guy; Rossaint, Rolf; Rossi, Sandra; Rueckert, Daniel; Rusnak, Martin; Sahuquillo, Juan; Sakowitz, Oliver; Sanchez-Porras, Renan; Sandor, Janos; Schaefer, Nadine; Schmidt, Silke; Schoechl, Herbert; Schoonman, Guus; Schou, Rico Frederik; Schwendenwein, Elisabeth; Sewalt, Charlie; Skandsen, Toril; Smielewski, Peter; Sorinola, Abayomi; Stamatakis, Emmanuel; Stanworth, Simon; Stevens, Robert; Stewart, William; Steyerberg, Ewout W.; Sundstrom, Nina; Synnot, Anneliese; Takala, Riikka; Tamas, Viktoria; Tamosuitis, Tomas; Taylor, Mark Steven; Te Ao, Braden; Tenovuo, Olli; Theadom, Alice; Thomas, Matt; Tibboel, Dick; Tolias, Christos; Trapani, Tony; Tudora, Cristina Maria; Vajkoczy, Peter; Vallance, Shirley; Valeinis, Egils; Vamos, Zoltan; Van der Steen, Gregory; van der Naalt, Joukje; van Essen, Thomas A.; Van Hecke, Wim; van Heugten, Caroline; Van Praag, Dominique; Vande Vyvere, Thijs; Vargiolu, Alessia; Vega, Emmanuel; Velt, Kimberley; Verheyden, Jan; Vespa, Paul M.; Vik, Anne; Vilcinis, Rimantas; Volovici, Victor; von Steinbuchel, Nicole; Voormolen, Daphne; Vulekovic, Petar; Wang, Kevin K. W.; Wiegers, Eveline; Williams, Guy; Wilson, Lindsay; Winzeck, Stefan; Wolf, Stefan; Yang, Zhihui; Ylen, Peter; Younsi, Alexander; Zeiler, Frederick A.; Zelinkova, Veronika; Ziverte, Agate; Zoerle, Tommaso		CENTER-TB1 Investigators	Informed consent procedures in patients with an acute inability to provide informed consent: Policy and practice in the CENTER-TBI study	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Informed consent; European Union; Ethics	TRAUMATIC BRAIN-INJURY; SURROGATE DECISION-MAKERS; DEFERRED CONSENT; RESUSCITATION RESEARCH; CAPACITY ASSESSMENT; PROXY CONSENT; MULTICENTER; OUTCOMES	Purpose: Enrolling traumatic brain injury (731) patients with an inability to provide informed consent in research is challenging. Alternatives to patient consent are not sufficiently embedded in European and national legislation, which allows procedural variation and bias. We aimed to quantify variations in informed consent policy and practice. Methods: Variation was explored in the CENTER-TBI study. Policies were reported by using a questionnaire and national legislation. Data on used informed consent procedures were available for 4498 patients from 57 centres across 17 European countries. Results: Variation in the use of informed consent procedures was found between and within EU member states. Proxy informed consent (N = 1377;64%) was the most frequently used type of consent in the ICU, followed by patient informed consent (N 426;20%) and deferred consent (N 334;16%). Deferred consent was only actively used in 15 centres (26%), although it was considered valid in 47 centres (82%). Conclusions: Alternatives to patient consent are essential for TBI research. While there seems to be concordance amongst national legislations, there is regional variability in institutional practices with respect to the use of different informed consent procedures. Variation could be caused by several reasons, including inconsistencies in clear legislation or knowledge of such legislation amongst researchers. (C) 2020 Published by Elsevier Inc.	[van Wijk, Roel P. J.; van Dijck, Jeroen T. J. M.; Peul, Wilco C.] Univ Neurosurg Ctr Holland, LUMC, HMC, Leiden, Netherlands; [van Wijk, Roel P. J.; van Dijck, Jeroen T. J. M.; Peul, Wilco C.] HAGA, The Hague, Netherlands; [Timmers, Marjolein; van Veen, Ernest; Kompanje, Erwin J. O.] Erasmus MC, Dept Intens Care, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [van Veen, Ernest; Lingsma, Hester F.] Erasmus MC, Univ Med Ctr Rotterdam, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] San Gerardo Hosp, ASST, Monza, Italy; [Maas, Andrew I. R.; De Keyser, Veronique; Menovsky, Tomas; Van der Steen, Gregory] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Antwerp, Belgium; [Menon, David K.] Univ Cambridge, Dept Anaesthesia, Cambridge, England; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Stocchetti, Nino] Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [Kompanje, Erwin J. O.] Erasmus MC, Dept Med Eth & Philosophy Med, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [Akerlund, Cecilia; Nelson, David] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [Amrein, Krisztina; Nyiradi, Jozsef] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Div Surg & Clin Neurosci, Oslo, Norway; [Andelic, Nada] Univ Oslo, Oslo, Norway; [Andreassen, Lasse] Univ Hosp Northern Norway, Dept Neurosurg, Tromso, Norway; [Anke, Audny] Univ Hosp Northern Norway, Dept Phys Med & Rehabil, Tromso, Norway; [Antoni, Anna; Schwendenwein, Elisabeth] Med Univ Vienna, Trauma Surg, Vienna, Austria; [Audibert, Gerard] Univ Hosp Nancy, Dept Anesthesiol & Intens Care, Nancy, France; [Azouvi, Philippe] Hop Paris, Raymond Poincare Hosp, Paris, France; [Azzolini, Maria Luisa; Beretta, Luigi; Calvi, Maria Rosa] S Raffaele Univ Hosp, Dept Anesthesiol & Intens Care, Milan, Italy; [Bartels, Ronald; den Boogert, Hugo] Radboud Univ Nijmegen, Dept Neurosurg, Med Ctr, Nijmegen, Netherlands; [Barzo, Pal] Univ Szeged, Dept Neurosurg, Szeged, Hungary; [Beauvais, Romuald; Perera, Natascha] ARTTIC, Int Projects Management, Munich, Germany; [Beer, Ronny; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Innsbruck, Austria; [Bellander, Bo-Michael] Karolinska Univ Hosp, Dept Neurosurg & Anesthesia & Intens Care Med, Stockholm, Sweden; [Belli, Antonio] NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Benali, Habib; Degos, Vincent; Galanaud, Damien; Perlbarg, Vincent] Hop Paris, Anesthesie Reanimat, Paris, France; [Berardino, Maurizio; Cavallo, Simona] AOU Citta Salute & Sci Torino Orthoped & Trauma C, Dept Anesthesia & ICU, Turin, Italy; [Blaabjerg, Morten] Odense Univ Hosp, Dept Neurol, Odense, Denmark; [Bragge, Peter] Monash Univ, Monash Sustainabil Inst, BehaviourWorks Australia, Clayton, Vic, Australia; [Brazinova, Alexandra; Majdan, Marek; Taylor, Mark Steven; Zelinkova, Veronika] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava, Slovakia; [Brinck, Vibeke; Jarrett, Mike] Quesgen Syst Inc, Burlingame, CA USA; [Brooker, Joanne; Donoghue, Emma; Synnot, Anneliese] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Brorsson, Camilla] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Buki, Andras; Czeiter, Endre] Univ Pecs, Janos Szentagothai Res Ctr, Med Sch, Dept Neurosurg,Hungary & Neurotrauma Res Grp, Pecs, Hungary; [Bullinger, Monika] Univ Klinikum Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Cabeleira, Manuel; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg,Brain Phys Lab, Cambridge, England; [Caccioppola, Alessio; Calappi, Emiliana; Carbonara, Marco; Mulazzi, Davide; Ortolano, Fabrizio; Zoerle, Tommaso] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuro ICU, Milan, Italy; [Cameron, Peter; Gantner, Dashiell; Murray, Lynnette; Trapani, Tony; Vallance, Shirley] Monash Univ, ANZIC Res Ctr, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Lozano, Guillermo Carbayo; Pomposo, Inigo] Hosp Cruces, Dept Neurosurg, Bilbao, Spain; [Chevallard, Giorgio; Chieregato, Arturo] Osped Niguarda Ca Granda, NeuroIntens Care, Milan, Italy; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Citerio, Giuseppe; Vargiolu, Alessia] ASST Monza, NeuroIntens Care, Monza, Italy; [Ceyisakar, Iris; Gravesteijn, Benjamin; Haagsma, Juanita A.; Huijben, Jilske; Lingsma, Hester; Nieboer, Daan; Polinder, Suzanne; Sewalt, Charlie; Steyerberg, Ewout W.; Velt, Kimberley; Voormolen, Daphne; Wiegers, Eveline] Erasmus MC, Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Coburn, Mark; Kowark, Ana; Rossaint, Rolf] Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany; [Coles, Jonathan] Cambridge Univ Hosp NHS Fdn Trust, Dept Anesthesia & Neurointens Care, Cambridge, England; [Cooper, Jamie D.] Monash Univ, Sch Publ Hlth & PM, Melbourne, Vic, Australia; [Cooper, Jamie D.] Alfred Hosp, Melbourne, Vic, Australia; [Correia, Marta] Radiol MRI Dept, MRC Cognit & Brain Sci Unit, Cambridge, England; [Covic, Amra; von Steinbuchel, Nicole] Univ Med Gottingen, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Curry, Nicola; Stanworth, Simon] Oxford Univ Hosp NHS Trust, Oxford, England; [Dahyot-Fizelier, Claire] CHU Poitiers, Intens Care Unit, Potiers, France; [Dark, Paul] Univ Manchester, Salford Royal Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, Crit Care Directorate, Salford, Lancs, England; [Dawes, Helen; Esser, Patrick; van Heugten, Caroline] Oxford Brookes Univ, Fac Hlth & Life Sci, Movement Sci Grp, Oxford, England; [De Keyser, Veronique; Menovsky, Tomas; Van der Steen, Gregory] Univ Antwerp, Edegem, Belgium; [Della Corte, Francesco; Grossi, Francesca] Maggiore Carita Hosp, Dept Anesthesia & Intens Care, Novara, Italy; [Depreitere, Bart] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium; [Dilvesi, Dula; Golubovic, Jagos; Karan, Mladen; Vulekovic, Petar] Univ Novi Sad, Fac Med, Clin Ctr Vojvodina, Dept Neurosurg, Novi Sad, Serbia; [Dixit, Abhishek; Ercole, Ari; Koraropoulos, Evgenios; Menon, David; Newcombe, Virginia; Richter, Sophie; Stamatakis, Emmanuel; Williams, Guy; Winzeck, Stefan; Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Dreier, Jens] Charite Univ Med Berlin, Freie Univ Berlin, Humboldt Univ Berlin, Ctr Stroke Res Berlin,Berlin Inst Hlth, Berlin, Germany; [Duliere, Guy-Loup; Marechal, Hugues] CHR Citadelle, Intens Care Unit, Liege, Belgium; [Ezer, Erzsebet; Vamos, Zoltan] Univ Pecs, Dept Anaesthesiol & Intens Therapy, Pecs, Hungary; [Fabricius, Martin; Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Neurol, Copenhagen, Denmark; [Fabricius, Martin; Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Clin Neurophysiol, Copenhagen, Denmark; [Fabricius, Martin; Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Neuroanesthesiol, Copenhagen, Denmark; [Feigin, Valery L.; Jones, Kelly; Te Ao, Braden; Theadom, Alice] Auckland Univ Technol, Fac Hlth & Environm Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Foks, Kelly] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Frisvold, Shirin] Univ Hosp Northern Norway, Dept Anesthesiol & Intens Care, Tromso, Norway; [Furmanov, Alex; Rosenthal, Guy] Hadassah Hebrew Univ, Dept Neurosurg, Med Ctr, Jerusalem, Israel; [Gagliardo, Pablo] Fdn Inst Valenciano Neurorrehabil FIVAN, Valencia, Spain; [Gao, Guoyi; Jiang, Ji-Yao] Shanghai Jiao Tong Univ, Shanghai Renji Hosp, Dept Neurosurg, Sch Med, Shanghai, Peoples R China; [George, Pradeep; Lanyon, Linda; Muraleedharan, Visakh] Karolinska Inst, INCF Int Neuroinformat Coordinating Facil, Stockholm, Sweden; [Ghuysen, Alexandre] CHU, Emergency Dept, Liege, Belgium; [Giga, Lelde; Valeinis, Egils; Ziverte, Agate] Pauls Stradins Clin Univ Hosp, Neurosurg Clin, Riga, Latvia; [Glocker, Ben; Rueckert, Daniel] Imperial Coll London, Dept Comp, London, England; [Gomez, Pedro A.; Lagares, Alfonso; Castano-Leon, Ana M.] Hosp Univ 12 Octubre, Dept Neurosurg, Madrid, Spain; [Gratz, Johannes] Med Univ Vienna, Dept Anesthesia Crit Care & Pain Med, Vienna, Austria; [Gruen, Russell L.] Australian Natl Univ, Coll Hlth & Med, Canberra, ACT, Australia; [Gupta, Deepak] All India Inst Med Sci, Neurosci Ctr, Dept Neurosurg, New Delhi 110029, India; [Gupta, Deepak] All India Inst Med Sci, JPN Apex Trauma Ctr, New Delhi 110029, India; [Haitsma, Iain; Volovici, Victor] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Horton, Lindsay; Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling, Scotland; [Hutchinson, Peter J.; Kolias, Angelos G.] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Hutchinson, Peter J.; Kolias, Angelos G.] Univ Cambridge, Cambridge, England; [Jacobs, Bram; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Jankowski, Stefan] Sheffield Teaching Hosp NHS Fdn Trust, Neurointens Care, Sheffield, S Yorkshire, England; [Johnson, Faye] Salford Royal Hosp NHS Fdn Trust Acute Res Delive, Salford, Lancs, England; [Kompanje, Erwin] Erasmus MC, Dept Intens Care, Dept Eth & Philosophy Med, Rotterdam, Netherlands; [Koskinen, Lars-Owe] Umea Univ, Dept Clin Neurosci, Neurosurg, Umea, Sweden; [Kovacs, Noemi] Univ Pecs, Hungarian Brain Res Program, Pecs, Hungary; [Laureys, Steven; Ledoux, Didier; Misset, Benoit] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Lecky, Fiona; Olubukola, Otesile] Univ Sheffield, Hlth Serv Res Sect, Ctr Urgent & Emergency Care Res CURE, Sch Hlth & Related Res ScHARR, Salford, Lancs, England; [Lecky, Fiona] Salford Royal Hosp, Emergency Dept, Salford, Lancs, England; [Lefering, Rolf; Schaefer, Nadine] Witten Herdecke Univ, Inst Res Operat Med IFOM, Cologne, Germany; [Legrand, Valerie] Icon, VP Global Project Management CNS, Paris, France; [Lejeune, Aurelie; Vega, Emmanuel] Lille Univ Hosp, Dept Anesthesiol Intens Care, Lille, France; [Levi, Leon] Rambam Med Ctr, Dept Neurosurg, Haifa, Israel; [Lightfoot, Roger] Univ Hosp Southhampton NHS Trust, Dept Anesthesiol & Intens Care, Southampton, England; [Maegele, Marc] Witten Herdecke Univ, Cologne Merheim Med Ctr CMMC, Dept Traumatol Orthoped Surg & Sportmed, Cologne, Germany; [Manara, Alex; Thomas, Matt] Southmead Hosp, Intens Care Unit, Bristol, Avon, England; [Manley, Geoffrey] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Martino, Costanza] Osped Gen Provinciale M Bufalini, Dept Anesthesia & Intens Care, Cesena, Italy; [Mattern, Julia; Sakowitz, Oliver; Younsi, Alexander] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany; [McMahon, Catherine] Walton Ctr NHS Fdn Trust, Dept Neurosurg, Liverpool, Merseyside, England; [Melegh, Bela] Univ Pecs, Dept Med Genet, Pecs, Hungary; [Negru, Ancuta; Ples, Horia; Tudora, Cristina Maria] Emergency Cty Hosp Timisoara, Dept Neurosurg, Timisoara, Romania; [Oresic, Matej] Orebro Univ, Sch Med Sci, Orebro, Sweden; [Palotie, Aarno; Pirinen, Matti; Ripatti, Samuli] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat,Dept Neurol, Dept Med Psychiat & Neurodev Genet Unit, Analyt & Translat Genet Unit, Boston, MA USA; [Palotie, Aarno] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Parizel, Paul M.] Univ Antwerp, Dept Radiol, Edegem, Belgium; [Payen, Jean-Francois] Univ Hosp Grenoble, Dept Anesthesiol & Intens Care, Grenoble, France; [Persona, Paolo; Rossi, Sandra] Azienda Osped Univ Padova, Dept Anesthesia & Intens Care, Padua, Italy; [Peul, Wilco; van Essen, Thomas A.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Piippo-Karjalainen, Anna; Raj, Rahul] Univ Helsinki, Dept Neurosurg, Cent Hosp, Helsinki, Finland; [Posti, Jussi P.; Tenovuo, Olli] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku, Finland; [Posti, Jussi P.; Tenovuo, Olli] Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland; [Posti, Jussi P.; Takala, Riikka; Tenovuo, Olli] Univ Turku, Turku, Finland; [Puybasset, Louis] Hop Paris, Pitie Salpetriere Teaching Hosp, Dept Anesthesiol & Crit Care, Paris, France; [Puybasset, Louis] Univ Paris 06, Paris, France; [Radoi, Andreea; Sahuquillo, Juan] Vall dHebron Res Inst, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain; [Ragauskas, Arminas; Rocka, Saulius] Kaunas Univ Technol, Dept Neurosurg, Vilnius, Lithuania; [Ragauskas, Arminas; Rocka, Saulius] Vilnius Univ, Vilnius, Lithuania; [Rambadagalla, Malinka] Rezekne Hosp, Dept Neurosurg, Rezekne, Latvia; [Rhodes, Jonathan] Univ Edinburgh, Dept Anaesthesia Crit Care & Pain Med NHS Lothian, Edinburgh, Midlothian, Scotland; [Richardson, Sylvia] Cambridge Inst Publ Hlth, MRC Biostat Unit, Cambridge, England; [Roe, Cecilie] Univ Oslo, Dept Phys Med & Rehabil, Oslo Univ Hosp, Oslo, Norway; [Roise, Olav] Oslo Univ Hosp, Div Orthoped, Oslo, Norway; [Roise, Olav] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Rosand, Jonathan] Broad Inst, Cambridge, MA USA; [Rosand, Jonathan] Harvard Med Sch, Boston, MA 02115 USA; [Rosand, Jonathan] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Rosenfeld, Jeffrey, V] Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Rosenlund, Christina] Odense Univ Hosp, Dept Neurosurg, Odense, Denmark; [Rusnak, Martin] Int Neurotrauma Res Org, Vienna, Austria; [Sakowitz, Oliver; Sanchez-Porras, Renan] Klinikum Ludwigsburg, Klin Neurochirurg, Ludwigsburg, Germany; [Sandor, Janos] Univ Debrecen, Dept Prevent Med, Div Biostat & Epidemiol, Debrecen, Hungary; [Schmidt, Silke] Ernst Moritz Arndt Univ Greifswald, Dept Hlth & Prevent, Greifswald, Germany; [Schoechl, Herbert] AUVA Trauma Hosp, Dept Anaesthesiol & Intens Care, Salzburg, Austria; [Schoonman, Guus] Elisabeth TweeSteden Ziekenhuis, Dept Neurol, Tilburg, Netherlands; [Schou, Rico Frederik; Vik, Anne] Odense Univ Hosp, Dept Neuroanesthesia & Neurointens Care, Odense, Denmark; [Skandsen, Toril] Norwegian Univ Sci & Technol, NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Skandsen, Toril] Trondheim Reg & Univ Hosp, Dept Phys Med & Rehabil, St Olavs Hosp, Trondheim, Norway; [Sorinola, Abayomi; Tamas, Viktoria] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Stevens, Robert] Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, Baltimore, MD USA; [Stewart, William] Univ Glasgow, Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow, Lanark, Scotland; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Dept Biomed Data Sci, Leiden, Netherlands; [Stocchetti, Nino] Milan Univ, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Neurosci ICU, Milan, Italy; [Sundstrom, Nina] Umea Univ, Dept Radiat Sci, Biomed Engn, Umea, Sweden; [Synnot, Anneliese] La Trobe Univ, Sch Psychol & Publ Hlth, Ctr Hlth Commun & Participat, Cochrane Consumers & Commun Review Grp, Melbourne, Vic, Australia; [Takala, Riikka] Turku Univ Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Tamosuitis, Tomas; Vilcinis, Rimantas] Kaunas Univ Hlth Sci, Dept Neurosurg, Kaunas, Lithuania; [Tibboel, Dick] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Intens Care, Rotterdam, Netherlands; [Tibboel, Dick] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat Surg, Rotterdam, Netherlands; [Tolias, Christos] Kings Coll London, Dept Neurosurg, London, England; [Vajkoczy, Peter] Charite Univ Med Berlin, Neurol Neurochirurg & Psychiat, Berlin, Germany; [Van Hecke, Wim; Vande Vyvere, Thijs; Verheyden, Jan] IcoMetrix NV, Leuven, Belgium; [Van Praag, Dominique] Antwerp Univ Hosp, Psychol Dept, Edegem, Belgium; [Vespa, Paul M.] Univ Calif Los Angeles, Director Neurocrit Care, Los Angeles, CA USA; [Vik, Anne] Trondheim Reg & Univ Hosp, Dept Neurosurg, St Olavs Hosp, Trondheim, Norway; [Wang, Kevin K. W.; Yang, Zhihui] Univ Florida, Dept Emergency Med, Gainesville, FL USA; [Wolf, Stefan] Univ Med Berlin, Freie Univ Berlin, Humboldt Univ Berlin, Berlin Inst Hlth,Dept Neurosurg, Berlin, Germany; [Ylen, Peter] VTT Tech Res Ctr, Tampere, Finland; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Peul, Wilco; van Essen, Thomas A.] Med Ctr Haaglanden, Dept Neurosurg, The Hague, Netherlands		Kompanje, EJO (corresponding author), Erasmus MC, Dept Intens Care Med, Univ Med Ctr, POB 2040, NL-3000 CA Rotterdam, Netherlands.; Kompanje, EJO (corresponding author), Erasmus MC Univ Med Ctr, Dept Intens Care Med, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.j.o.kompanje@erasmusmc.nl	Posti, Jussi P./Y-2908-2019; Ledoux, Didier/ABA-8401-2021; Stamatakis, Emmanuel/C-4958-2009; van Dijck, Jeroen/AAM-4123-2021; Volovici, Victor/AAZ-8901-2020; Helbok, Raimund/AAA-8361-2021; Brazinova, Alexandra/C-4265-2016; Sahuquillo, Juan/B-3577-2008; Lagares, Alfonso/B-2969-2011; Cooper, D. James/G-7961-2013; Della Corte, Francesco/ABI-7646-2020; Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021; Vande Vyvere, Thijs/AAB-5180-2022; Belli, Antonio/I-3799-2015; Ercole, Ari/B-6288-2009; Castano-Leon, Ana M/ABF-6322-2020; Oresic, Matej/K-7673-2016; Gomez, Pedro/E-2411-2014; Raj, Rahul/K-7693-2012	Posti, Jussi P./0000-0002-5925-5193; Ledoux, Didier/0000-0002-9314-6564; Stamatakis, Emmanuel/0000-0001-7323-3225; van Dijck, Jeroen/0000-0002-9893-632X; Volovici, Victor/0000-0002-5798-5360; Brazinova, Alexandra/0000-0003-0625-256X; Sahuquillo, Juan/0000-0003-0713-5875; Lagares, Alfonso/0000-0003-3996-0554; Cooper, D. James/0000-0002-5872-9051; Della Corte, Francesco/0000-0003-1736-2318; Laureys, Steven/0000-0002-3096-3807; Vande Vyvere, Thijs/0000-0003-4032-5443; Belli, Antonio/0000-0002-3211-9933; Ercole, Ari/0000-0001-8350-8093; Castano-Leon, Ana M/0000-0002-7918-5049; Oresic, Matej/0000-0002-2856-9165; Sanchez-Porras, Renan/0000-0002-9084-8114; Coles, Jonathan/0000-0003-4013-679X; Sakowitz, Oliver/0000-0003-3248-6335; Stewart, William/0000-0003-2199-2582; Radoi, Andreea/0000-0002-0677-3544; Nelson, David/0000-0003-2530-8207; Gomez, Pedro/0000-0002-4185-5238; Parizel, Paul M./0000-0002-0221-2854; Raj, Rahul/0000-0003-4243-9591; Rossi, Sandra/0000-0002-9963-8121; Newcombe, Virginia/0000-0001-6044-9035; Gratz, Johannes/0000-0001-8717-0544; Dark, Paul/0000-0003-3309-0164; Van Essen, Thomas/0000-0003-4657-5283; Kondziella, Daniel/0000-0001-5562-9808; Kolias, Angelos/0000-0003-3992-0587; Zeiler, Frederick/0000-0003-1737-0510; van der Naalt, Joukje/0000-0001-9873-2418; Bragge, Peter/0000-0003-0745-5131	European Union 7th Framework program (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); National Institute for Health Research (UK)National Institute for Health Research (NIHR)	CENTER-TBI was supported by the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). David K. Menon was supported by a Senior Investigator Award from the National Institute for Health Research (UK).	ABRAMSON NS, 1986, JAMA-J AM MED ASSOC, V255, P2466, DOI 10.1001/jama.255.18.2466; [Anonymous], 1996, Fed Regist, V61, P51498; [Anonymous], 1997, 164 ETS; AssociationWM, 2018, DECL HELS ETH PRINC; Barrett KA, 2012, INTENS CARE MED, V38, P1616, DOI 10.1007/s00134-012-2625-x; Burns KEA, 2013, AM J RESP CRIT CARE, V187, P1212, DOI 10.1164/rccm.201208-1537OC; Chico V, 2018, BRIT MED BULL, V128, P109, DOI 10.1093/bmb/ldy038; Ciroldi M, 2007, INTENS CARE MED, V33, P807, DOI 10.1007/s00134-007-0582-6; Clarke N, 2019, IRISH J MED SCI, V188, P1129, DOI 10.1007/s11845-019-01980-2; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Duffett M, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.12.009; Ecarnot F, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.04.42; Eltorki M, 2013, ACAD EMERG MED, V20, P822, DOI 10.1111/acem.12180; Feng KL, 2014, STROKE, V45, pE229, DOI 10.1161/STROKEAHA.114.006395; Gigon F, 2013, INTENS CARE MED, V39, P1282, DOI 10.1007/s00134-013-2908-x; Grady C, 2017, NEW ENGL J MED, V376, P856, DOI 10.1056/NEJMra1603773; Hall DE, 2012, CAN MED ASSOC J, V184, P533, DOI 10.1503/cmaj.112120; Honarmand K, 2018, J INTENSIVE CARE MED, V33, P475, DOI 10.1177/0885066616680772; Jansen TG, 2009, CRIT CARE MED, V37, pS65, DOI 10.1097/CCM.0b013e3181920851; Johnson-Greene D, 2010, J HEAD TRAUMA REHAB, V25, P145, DOI 10.1097/HTR.0b013e3181d8287d; Kompanje EJO, 2014, INTENS CARE MED, V40, P496, DOI 10.1007/s00134-014-3243-6; Long Bronwyn, 2011, J Trauma Nurs, V18, P204, DOI 10.1097/JTN.0b013e31823a453a; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mirr M P, 1991, AACN Clin Issues Crit Care Nurs, V2, P242; Newman JT, 2012, CRIT CARE MED, V40, P2590, DOI 10.1097/CCM.0b013e318258ff19; Rumbold JMM, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7108; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Shamy MCF, 2019, STROKE, V50, P1017, DOI 10.1161/STROKEAHA.118.024096; Shepherd V, 2019, AGE AGEING, V48, P903, DOI 10.1093/ageing/afz115; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Timmers M, 2019, MED LAW REV, V27, P59, DOI 10.1093/medlaw/fwy023; Tisherman SA, 2008, CIRCULATION, V118, P1585, DOI 10.1161/CIRCULATIONAHA.107.764084; Topolovec-Vranic J, 2014, CAN RESPIR J, V21, P293, DOI 10.1155/2014/719270; UN, 2019, STAND COUNTR AR COD; van Belle G, 2015, RESUSCITATION, V91, P76, DOI 10.1016/j.resuscitation.2014.11.029; van Veen EB, 2018, EUR J CANCER, V104, P70, DOI 10.1016/j.ejca.2018.09.032; Woolfall K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008522; Wrigley A, 2007, J MED ETHICS, V33, P527, DOI 10.1136/jme.2006.019711	38	2	2	4	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	OCT	2020	59						6	15		10.1016/j.jcrc.2020.05.004			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OF2BF	WOS:000581019400002	32485440	Green Published, Green Accepted			2022-02-06	
J	Wu, SCJ; Jenkins, LM; Apple, AC; Petersen, J; Xiao, FR; Wang, L; Yang, FPG				Wu, Shun-Chin Jim; Jenkins, Lisanne M.; Apple, Alexandra C.; Petersen, Julie; Xiao, Furen; Wang, Lei; Yang, Fan-pei Gloria			Longitudinal fMRI task reveals neural plasticity in default mode network with disrupted executive-default coupling and selective attention after traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Executive function; Machine learning; Multivariate; Plasticity; Working memory	WORKING-MEMORY; PREFRONTAL CORTEX; BIASED COMPETITION; SALIENCE NETWORK; SUPPRESSION; REHABILITATION; CONNECTIVITY; INDIVIDUALS; ENHANCEMENT; RELIABILITY	Executive dysfunctions are common in individuals with Traumatic Brain Injury (TBI). However, change in functional neural coupling of default and executive networks in the post-acute phase (>= 1 month after injury) patients over time has yet to be understood. During a 5-week observation period, we examined changes in the goal-oriented executive function networks in 20 TBI participants, using a face/scene matching 1-back fMRI task (Chen et al.2011). We conducted multivariate pattern analysis to assess working memory and visual selective attention, followed by a repeat-measures ANOVA to examine longitudinal changes, with a cluster FDR atp = .001. Results showed that task accuracy significantly improved after follow-up. Significantly increased activity patterns over time were observed in the right dorsolateral prefrontal cortex and right insula. Decreased activity patterns were seen in the left posterior cingulate cortex (PCC), bilateral precuneus, right inferior occipital gyrus and right temporo-occipital junction. Improvement in task accuracy correlated with decreased activity patterns in the PCC (r = -0.478,p = 0.031) and temporo-occipital junction (r = -0.592,p = 0.006), which were interpreted as neural plastic changes. However, we did not observe the default mode network (DMN)-executive network decoupling during task performance that is found in other studies. These results suggest that fMRI of attentional task performance could serve as a potential biomarker for neural plasticity of selective attention in TBI patients in the post-acute phase.	[Wu, Shun-Chin Jim] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Jenkins, Lisanne M.; Apple, Alexandra C.; Petersen, Julie; Wang, Lei] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Xiao, Furen] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Yang, Fan-pei Gloria] Natl Tsinghua Univ, Ctr Cognit & Mind Sci, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan		Yang, FPG (corresponding author), Natl Tsinghua Univ, Ctr Cognit & Mind Sci, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.	hbmyang@gmail.com	Jenkins, Lisanne M/S-2898-2018	Jenkins, Lisanne M/0000-0002-1241-1662; Xiao, Furen/0000-0001-9683-3979	Taiwan Ministry of Science and Technology [NSC 103-2420-H-007-004-MY2]	This work was supported by a grant from the Taiwan Ministry of Science and Technology (NSC 103-2420-H-007-004-MY2) to Fanpei Gloria Yang.	ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Aerts H, 2016, BRAIN, V139, P3063, DOI 10.1093/brain/aww194; Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; Baldauf D, 2014, SCIENCE, V344, P424, DOI 10.1126/science.1247003; Beck DM, 2007, J VISION, V7, DOI 10.1167/7.2.19; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Cerf M, 2010, NATURE, V467, P1104, DOI 10.1038/nature09510; Chadick JZ, 2011, NAT NEUROSCI, V14, P830, DOI 10.1038/nn.2823; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Cohen EH, 2015, CEREB CORTEX, V25, P1080, DOI 10.1093/cercor/bht303; Couperus JW, 2010, BRAIN RES, V1359, P155, DOI 10.1016/j.brainres.2010.08.076; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Fonville L, 2015, CEREB CORTEX, V25, P4828, DOI 10.1093/cercor/bhv181; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Hayden BY, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00018; Haynes JD, 2015, NEURON, V87, P257, DOI 10.1016/j.neuron.2015.05.025; Hebart MN, 2015, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00088; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Koolschijn PCMP, 2011, J NEUROSCI, V31, P4204, DOI 10.1523/JNEUROSCI.6415-10.2011; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Liang X, 2016, CEREB CORTEX, V26, P1501, DOI 10.1093/cercor/bhu316; Lin JW, 2008, ACT NEUR S, V101, P113; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; Mattfeld AT, 2016, NEUROIMAGE-CLIN, V10, P274, DOI 10.1016/j.nicl.2015.12.003; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Miller BT, 2011, J COGNITIVE NEUROSCI, V23, P1, DOI 10.1162/jocn.2010.21516; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Peters JC, 2012, J NEUROSCI, V32, P17003, DOI 10.1523/JNEUROSCI.0591-12.2012; Reddy L, 2009, P NATL ACAD SCI USA, V106, P21447, DOI 10.1073/pnas.0907330106; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Seiss E, 2009, CLIN NEUROPHYSIOL, V120, P1087, DOI 10.1016/j.clinph.2009.03.016; Shi HY, 2014, J NEUROSURG, V121, P1323, DOI 10.3171/2014.8.JNS131526; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Strappini F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13921-z; van der Horn HJ, 2016, BRAIN IMAGING BEHAV, V10, P1243, DOI 10.1007/s11682-015-9489-y; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Woo CW, 2017, NAT NEUROSCI, V20, P365, DOI 10.1038/nn.4478; Yoon JH, 2006, NEUROIMAGE, V29, P1117, DOI 10.1016/j.neuroimage.2005.08.024; Zanto TP, 2014, NEUROIMAGE, V84, P443, DOI 10.1016/j.neuroimage.2013.08.063	58	2	2	1	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	OCT	2020	14	5					1638	1650		10.1007/s11682-019-00094-8			13	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OC9YM	WOS:000579512100031	30937828				2022-02-06	
J	Yuen, K; Bingham, K; Tayer-Shifman, OE; Touma, Z				Yuen, Kimberley; Bingham, Kathleen; Tayer-Shifman, Oshrat E.; Touma, Zahi			Measures of Cognition in Rheumatic Diseases	ARTHRITIS CARE & RESEARCH			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; VERBAL-LEARNING TEST; ASSESSMENT METRICS ANAM; TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; NORMATIVE DATA; NEUROPSYCHIATRIC SYNDROMES; NEUROCOGNITIVE IMPAIRMENT; RETEST RELIABILITY; BATTERY		[Yuen, Kimberley] Queens Univ, Sch Med, Kingston, ON, Canada; [Bingham, Kathleen; Touma, Zahi] Univ Toronto, Toronto, ON, Canada; [Tayer-Shifman, Oshrat E.] Meir Med Ctr, Kefar Sava, Israel; [Touma, Zahi] Toronto Lupus Clin, Ctr Prognosis Rheumat Dis, Toronto, ON, Canada		Touma, Z (corresponding author), Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, EW,1-412,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	Zahi.Touma@uhn.ca	Touma, Zahi/ABE-7431-2021	Touma, Zahi/0000-0001-5177-2076; Yuen, Kimberley/0000-0003-4252-2627			Abeare CA, 2010, CLIN J PAIN, V26, P683, DOI 10.1097/AJP.0b013e3181ed1762; Adhikari T, 2011, LUPUS, V20, P1142, DOI 10.1177/0961203311405374; Al Rayes H, 2018, SEMIN ARTHRITIS RHEU, V48, P240, DOI 10.1016/j.semarthrit.2018.02.007; Antonchak MA, 2011, J RHEUMATOL, V38, P1020, DOI 10.3899/jrheum.100560; Barry D, 2008, APPL NEUROPSYCHOL, V15, P97, DOI 10.1080/09084280802083863; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benton AL, 1994, MULTILINGUAL APHASIA; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Brown SC, 2002, PAIN, V96, P279, DOI 10.1016/S0304-3959(01)00457-2; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Bunker L, 2017, INT J GERIATR PSYCH, V32, P991, DOI 10.1002/gps.4558; Cavaco S, 2013, ARCH CLIN NEUROPSYCH, V28, P262, DOI 10.1093/arclin/act001; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Chalhoub NE, 2019, LUPUS, V28, P51, DOI 10.1177/0961203318815299; Chelune GJ, 1986, ADV CLIN NEUROPSYCHO, V3, P95, DOI [10.1007/978-1-4613-2211-5_4, DOI 10.1007/978-1-4613-2211-5_4]; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; Delis D.C., 2008, CALIFORNIA VERBAL LE; Dretsch M, 2015, APPL NEUROPSYCH-ADUL, V22, P304, DOI 10.1080/23279095.2014.926454; Duff K, 2014, CLIN NEUROPSYCHOL, V28, P714, DOI 10.1080/13854046.2014.920923; ENGEL L, 2018, ARTHRITIS RHEUMAT S9, V70; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Farmer K, 2001, HEADACHE, V41, P377, DOI 10.1046/j.1526-4610.2001.111006377.x; Golden CJ, 1978, STROOP COLOR WORD TE; Gonzalez LA, 2009, LUPUS, V18, P822, DOI 10.1177/0961203309104392; HANLY JG, 1994, J RHEUMATOL, V21, P1825; Hanly JG, 2005, J RHEUMATOL, V32, P1459; Hanly JG, 1997, ARTHRITIS RHEUM, V40, P1542, DOI 10.1002/art.1780400825; Hanly JG, 2010, ARTHRITIS RHEUM-US, V62, P1478, DOI 10.1002/art.27404; Haran FJ, 2016, J HEAD TRAUMA REHAB, V31, P329, DOI 10.1097/HTR.0000000000000172; Harrison JE, 2000, BRIT J CLIN PSYCHOL, V39, P181, DOI 10.1348/014466500163202; Holliday SL, 2003, LUPUS, V12, P697, DOI 10.1191/0961203303lu442oa; Jaeger J, 2018, J CLIN PSYCHOPHARM, V38, P513, DOI 10.1097/JCP.0000000000000941; Julian LJ, 2012, ARTHRIT CARE RES, V64, P448, DOI 10.1002/acr.21566; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kozora E, 2004, ARTHRIT RHEUM-ARTHR, V51, P810, DOI 10.1002/art.20692; Kwan A., 2017, CURR TREAT OPT RHEUM, V3, P308, DOI [DOI 10.1007/S40674-017-0079-6, 10.1007/s40674-017-0079-6]; Levinson D, 2005, ARCH CLIN NEUROPSYCH, V20, P403, DOI 10.1016/j.acn.2004.09.001; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Lowe M, 2007, ARCH CLIN NEUROPSYCH, V22, pS89, DOI 10.1016/j.acn.2006.10.010; Luggen ME, 2016, CLIN RHEUMATOL, V35, P93, DOI 10.1007/s10067-015-3114-8; Manzo C, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9040085; McDiarmid Melissa A, 2002, Mil Med, V167, P123; Meade T, 2018, ARTHRIT CARE RES, V70, P39, DOI 10.1002/acr.23243; Mikdashi J, 2007, LUPUS, V16, P418, DOI 10.1177/0961203307079044; Nantes SG, 2017, J RHEUMATOL, V44, P1583, DOI 10.3899/jrheum.161125; O'Neil-Pirozzi TM, 2012, BRAIN INJURY, V26, P1425, DOI 10.3109/02699052.2012.694561; Panopalis P, 2007, ARTHRIT RHEUM-ARTHR, V57, P1453, DOI 10.1002/art.23090; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Petri M, 2011, SEMIN ARTHRITIS RHEU, V41, P194, DOI 10.1016/j.semarthrit.2011.02.005; Petri M, 2010, J RHEUMATOL, V37, P2032, DOI 10.3899/jrheum.091366; Pincus T, 1996, ARTHRITIS RHEUM, V39, pS261; Poyurovsky M, 2003, EUR NEUROPSYCHOPHARM, V13, P123, DOI 10.1016/S0924-977X(02)00155-4; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A., 1993, CLIN NEUROPSYCHOL, V7, P4; Rice V. J., 2011, AUTOMATED NEUROPSYCH; Roebuck-Spencer TM, 2006, ARTHRIT RHEUM-ARTHR, V55, P434, DOI 10.1002/art.21992; Ross TP, 2007, ARCH CLIN NEUROPSYCH, V22, P475, DOI 10.1016/j.acn.2007.01.026; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P153, DOI 10.1016/S0887-6177(01)00192-5; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Scarpina F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00557; Schmand B, 2008, Tijdschr Gerontol Geriatr, V39, P64; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Shin SY, 2012, ARTHRIT CARE RES, V64, P1144, DOI 10.1002/acr.21683; Short P, 2007, ARCH CLIN NEUROPSYCH, V22, pS63, DOI 10.1016/j.acn.2006.10.012; Sullivan M.J., 1990, CAN J REHABIL, V4, P99, DOI 10.1097/JNN.0000000000000314; Tayer-Shifman OE, 2019, ARTHRITIS CARE RES H; Teo R, 2020, RHEUMATOLOGY OXFORD; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Touma Z, 2020, ARTHRITIS CARE RES H; Touma Z, 2018, ARTHRITIS RHEUM S10, V70; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Vincent AS, 2018, CLIN NEUROPSYCHOL, V32, P479, DOI 10.1080/13854046.2017.1368716; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Waterloo K, 2002, RHEUMATOLOGY, V41, P411, DOI 10.1093/rheumatology/41.4.411; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa; Wilken JA, 2007, ARCH CLIN NEUROPSYCH, V22, pS127, DOI 10.1016/j.acn.2006.10.007; Woodhouse J, 2013, CLIN NEUROPSYCHOL, V27, P376, DOI 10.1080/13854046.2012.762427; Woods SP, 2005, ASSESSMENT, V12, P96, DOI 10.1177/1073191104270342; Xie SS, 2015, HEART LUNG, V44, P387, DOI 10.1016/j.hrtlng.2015.07.002; Zgaljardic D J, 2001, Appl Neuropsychol, V8, P218, DOI 10.1207/S15324826AN0804_4	91	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2151-464X	2151-4658		ARTHRIT CARE RES	Arthritis Care Res.	OCT	2020	72			10			660	675		10.1002/acr.24364			16	Rheumatology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rheumatology	OH2MP	WOS:000582403700033	33091255				2022-02-06	
J	Zhang, YL; Chopp, M; Zhang, Y; Zhang, ZG; Lu, M; Zhang, TL; Wu, KHH; Zhang, L; Mahmood, A; Xiong, Y				Zhang, Yanlu; Chopp, Michael; Zhang, Yi; Zhang, Zheng Gang; Lu, Mei; Zhang, Talan; Wu, Kuan-Han H.; Zhang, Li; Mahmood, Asim; Xiong, Ye			Randomized controlled trial of Cerebrolysin's effects on long-term histological outcomes and functional recovery in rats with moderate closed head injury	JOURNAL OF NEUROSURGERY			English	Article						amyloid precursor protein; Cerebrolysin; cognitive function; moderate closed head injury; neuroblast; neurogenesis; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; ALZHEIMERS-DISEASE; TRANSGENIC MODEL; BEHAVIORAL TASKS; NEUROGENESIS; STROKE; SEVERITY; EFFICACY	OBJECTIVE The authors previously demonstrated that Cerebrolysin is effective for treatment of mild closed head injury (CHI) when administered 4 hours after injury. The aim of this study was to determine Cerebrolysin's effects on functional and histological outcomes in rats subjected to moderate CHI. METHODS In this randomized, blinded, and vehicle-controlled preclinical trial, male adult Wistar rats subjected to moderate CHI received either Cerebrolysin treatment at a dose of 2.5 ml/kg (n = 13) or vehicle (saline, n = 13) intraperitoneally administered daily for 10 days, starting at 4 hours after injury. Animals were subjected to cognitive and sensorimotor functional tests at multiple time points, and they were killed 3 months after injury. The brains were processed for analyses of neuronal cell loss, amyloid precursor protein, axonal damage, and neurogenesis. RESULTS Compared with rats treated with vehicle (saline), rats treated with Cerebrolysin had significantly increased numbers of neuroblasts and newborn mature neurons in the dentate gyrus (DG) and attenuated amyloid precursor protein accumulation and axonal damage in various brain regions, as well as decreased neuronal loss in the DG and cornu ammonis 3 (CA3) region of the hippocampus (p < 0.05). Global testing using generalized estimating equations showed a significant beneficial effect of Cerebrolysin treatment on sensorimotor functional outcomes from 1 day to 3 months after injury compared to that of saline treatment (p < 0.05). Compared with vehicle-treated rats, Cerebrolysin-treated rats showed significantly and robustly improved long-term (up to 3 months) cognitive functional recovery, as measured by social interaction, Morris water maze, novel object recognition, and odor recognition tests. In the Cerebrolysin-treated rats there were significant correlations between multiple histological outcomes and functional recovery evident 3 months after moderate CHI, as indicated by Pearson partial correlation analyses. CONCLUSIONS The authors' findings demonstrate that Cerebrolysin treatment significantly improves long-term functional and histological outcomes in rats with moderate CHI, with functional outcomes significantly correlated with histological indices of neuroplasticity and neuroprotection. These data indicate that Cerebrolysin may be useful for the treatment of moderate CHI.	[Zhang, Yanlu; Mahmood, Asim; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael; Zhang, Yi; Zhang, Zheng Gang; Zhang, Li] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Lu, Mei; Zhang, Talan; Wu, Kuan-Han H.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Xiong, Y (corresponding author), Henry Ford Hlth Syst, Detroit, MI 48202 USA.				EVER Neuro Pharma GmbH	This work was funded by EVER Neuro Pharma GmbH. The authors disclose receipt of the following financial support for the research, authorship, and/or publication of this article. Dr. Chopp received travel support and honoraria from EVER Neuro Pharma GmbH for presenting data at scientific meetings. EVER Neuro Pharma GmbH also provided financial support to Dr. Chopp for travel to meetings supported by EVER Neuro Pharma GmbH. Dr. Mei Lu and Ms. Talan Zhang received some salary support provided by EVER Neuro Pharma GmbH for statistical analyses. Drs. Yanlu Zhang and Ye Xiong had a percentage of salary support provided from a nonrestricted research contract with EVER Neuro Pharma GmbH.	Alvarez XA, 2011, EUR J NEUROL, V18, P59, DOI 10.1111/j.1468-1331.2010.03092.x; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; BASKYS A, 1994, PHARMACOL BIOCHEM BE, V49, P1105, DOI 10.1016/0091-3057(94)90272-0; Bengoetxea Xabier, 2015, Front Biosci (Schol Ed), V7, P10; Bornstein N, 2012, DRUG TODAY, V48, P43, DOI 10.1358/dot.2012.48(Suppl.A).1739723; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Ghaffarpasand F, 2019, NEUROPSYCH DIS TREAT, V15, P127, DOI 10.2147/NDT.S186865; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Muresanu DF, 2015, CNS NEUROL DISORD-DR, V14, P587, DOI 10.2174/1871527314666150430162531; Onose G, 2009, J Med Life, V2, P350; Orman JA, 2012, J TRAUMA ACUTE CARE, V73, pS496, DOI 10.1097/TA.0b013e318275473c; Poon W, 2015, J NEUROTRAUM, V32, P571, DOI 10.1089/neu.2014.3558; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; TROJANOWSKI JQ, 1993, BRAIN PATHOL, V3, P45, DOI 10.1111/j.1750-3639.1993.tb00725.x; Ubhi K, 2009, ACTA NEUROPATHOL, V117, P699, DOI 10.1007/s00401-009-0505-4; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zhang L, 2016, INT J STROKE, V11, P347, DOI 10.1177/1747493015625645; Zhang L, 2013, STROKE, V44, P1965, DOI 10.1161/STROKEAHA.111.000831; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang YL, 2018, J NEUROSURG, V129, P1295, DOI 10.3171/2017.6.JNS171007; Zhang YL, 2019, NEUROREHAB NEURAL RE, V33, P15, DOI 10.1177/1545968318809916; Zhang YL, 2017, J NEUROSURG, V126, P782, DOI 10.3171/2016.3.JNS152699; Zhang YL, 2015, J NEUROSURG, V122, P843, DOI 10.3171/2014.11.JNS14271; Zhang YL, 2013, J NEUROSURG, V118, P1343, DOI 10.3171/2013.3.JNS122061; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	43	2	2	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2020	133	4					1072	1082		10.3171/2019.6.JNS191027			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OM5UM	WOS:000586089500018	31491768				2022-02-06	
J	Zhong, XL; Shan, AJ; Xu, JZ; Liang, J; Long, Y; Du, B				Zhong, Xianliang; Shan, Aijun; Xu, Jianzhong; Liang, Jian; Long, Ying; Du, Bo			Hyperbaric oxygen for severe traumatic brain injury: a randomized trial	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						Hyperbaric oxygen therapy; brain injury; recovery; randomized trial; neurological function; cognitive function	CRANIOCEREBRAL INJURY; CLINICAL-RESEARCH; THERAPY; ANGIOGENESIS	Objective The present study aimed to explore the effects of hyperbaric oxygen therapy on the prognosis and neurological function of patients with severe traumatic brain injury. Methods A prospective study was carried out in 88 patients diagnosed with severe brain injury at our hospital and they were enrolled as research participants and randomly assigned to control and experimental groups (n = 44 per group) using a random number table method. Both groups underwent routine treatment. Patients in the experimental group were administered hyperbaric oxygen therapy approximately 1 week after admission when their vital signs had stabilized. Results No significant intergroup differences were observed in the Glasgow Coma Scale (GCS) and U.S. National Institutes of Health Stroke Scale (NIHSS) scores before treatment. However, after oxygen treatment, compared with the control group, the experimental group showed higher GCS and lower NIHSS scores. The GCS score at admission, tracheotomy status, and first hyperbaric oxygen therapy duration were independent prognostic factors in patients with severe traumatic brain injury. Conclusion Hyperbaric oxygen therapy may promote recovery of neurological function and improve the cognitive function and prognosis of patients with severe traumatic brain injury.	[Zhong, Xianliang; Shan, Aijun; Xu, Jianzhong; Du, Bo] Southern Univ Sci & Technol, Jinan Univ, Affiliated Hosp 1,Dept Emergency, Shenzhen Peoples Hosp,Clin Med Coll 2, 1017 Dongmen North Rd, Shenzhen 518020, Guangdong, Peoples R China; [Liang, Jian] Southern Univ Sci & Technol, Jinan Univ, Affiliated Hosp 1,Dept Neurosurg, Shenzhen Peoples Hosp,Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China; [Long, Ying] Southern Univ Sci & Technol, Jinan Univ, Affiliated Hosp 1,Dept Hyperbar Oxygen, Shenzhen Peoples Hosp,Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China		Du, B (corresponding author), Southern Univ Sci & Technol, Jinan Univ, Affiliated Hosp 1,Dept Emergency, Shenzhen Peoples Hosp,Clin Med Coll 2, 1017 Dongmen North Rd, Shenzhen 518020, Guangdong, Peoples R China.	bodoyx@163.com			Guangdong Natural Science FoundationNational Natural Science Foundation of Guangdong Province [2020A1515010289]; Clinical Research Project of Shenzhen Health and Family Planning Commission [SZLY2018007]; Shenzhen People's Hospital Young and Middle-aged Research Funds Cultivation Fund [SYKYPY201923]; Shenzhen Key Medical Discipline Construction Fund (Shenzhen Key Medical Discipline 2020-2024)	This study was funded by Guangdong Natural Science Foundation (No.2020A1515010289); Clinical Research Project of Shenzhen Health and Family Planning Commission (No. SZLY2018007); Shenzhen People's Hospital Young and Middle-aged Research Funds Cultivation Fund (No. SYKYPY201923) and Shenzhen Key Medical Discipline Construction Fund (Shenzhen Key Medical Discipline 2020-2024).	Benincasa JC, 2019, CELL BIOL INT, V43, P136, DOI 10.1002/cbin.11070; Cao YX, 2015, CELL BIOCHEM BIOPHYS, V71, P199, DOI 10.1007/s12013-014-0185-0; Chinda JY, 2014, AFR J PAEDIAT SURG, V10, P358; Daly MC, 2010, WOUNDS, V22, P1; Eshete A, 2018, ETHIOP J HEALTH SCI, V28, P323, DOI 10.4314/ejhs.v28i3.10; Geng FY, 2016, NEUROIMMUNOMODULAT, V23, P122, DOI 10.1159/000445689; Hadanny A, 2015, RESTOR NEUROL NEUROS, V33, P471, DOI 10.3233/RNN-150517; Harch PG, 2017, MED GAS RES, V7, P156, DOI 10.4103/2045-9912.215745; Huang Q, 2017, EUR REV MED PHARMACO, V21, P88; Huang Qi-bing, 2013, Zhonghua Yi Xue Za Zhi, V93, P1788; Lim SW, 2017, WORLD NEUROSURG, V100, P128, DOI 10.1016/j.wneu.2016.12.118; Mcdonagh M, 2011, ARCH PHYS MED REHAB, V92, P1519; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Montecorboli U, 2015, INT J DEV BIOL, V59, P461, DOI 10.1387/ijdb.150280dr; Naess H, 2016, ACTA NEUROL SCAND, V133, P415, DOI 10.1111/ane.12477; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Shandley S, 2017, UNDERSEA HYPERBAR M, V44, P257; Tal S, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00508; Tan Min, 2013, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V25, P627, DOI 10.3760/cma.j.issn.2095-4352.2013.10.012; Tu Xiao-Hua, 2010, Zhongguo Zhen Jiu, V30, P974; Wang F, 2016, NEUROL SCI, V37, P693, DOI 10.1007/s10072-015-2460-2; Wang Li, 2012, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V24, P670; Xu LJ, 2016, PAK J PHARM SCI, V29, P273; Yang YK, 2017, NEUROREPORT, V28, P1232, DOI 10.1097/WNR.0000000000000901; Zhang WC, 2010, J EMERG MED, V39, P151, DOI 10.1016/j.jemermed.2008.01.027; Zweckberger K, 2008, LARYNGO RHINO OTOL, V87, P121, DOI 10.1055/s-2007-995478	27	2	2	2	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	OCT	2020	48	10							0300060520939824	10.1177/0300060520939824			12	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	OG8RW	WOS:000582145100001	33050752	gold, Green Published			2022-02-06	
J	Begemann, M; Leon, M; van der Horn, HJ; van der Naalt, J; Sommer, I				Begemann, Marieke; Leon, Mikela; van der Horn, Harm Jan; van der Naalt, Joukje; Sommer, Iris			Drugs with anti-inflammatory effects to improve outcome of traumatic brain injury: a meta-analysis	SCIENTIFIC REPORTS			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; HEAD-INJURY; INFLAMMATORY RESPONSE; FUNCTIONAL RECOVERY; CLINICAL-TRIAL; DOUBLE-BLIND; CRASH TRIAL; PROGESTERONE; NEUROPROTECTION; CYCLOSPORINE	Outcome after traumatic brain injury (TBI) varies largely and degree of immune activation is an important determinant factor. This meta-analysis evaluates the efficacy of drugs with anti-inflammatory properties in improving neurological and functional outcome. The systematic search following PRISMA guidelines resulted in 15 randomized placebo-controlled trials (3734 patients), evaluating progesterone, erythropoietin and cyclosporine. The meta-analysis (15 studies) showed that TBI patients receiving a drug with anti-inflammatory effects had a higher chance of a favorable outcome compared to those receiving placebo (RR = 1.15; 95% CI 1.01-1.32, p = 0.041). However, publication bias was indicated together with heterogeneity (I-2 = 76.59%). Stratified analysis showed that positive effects were mainly observed in patients receiving this treatment within 8 h after injury. Subanalyses by drug type showed efficacy for progesterone (8 studies, RR 1.22; 95% CI 1.01-1.47, p = 0.040), again heterogeneity was high (I-2 = 62.92%) and publication bias could not be ruled out. The positive effect of progesterone covaried with younger age and was mainly observed when administered intramuscularly and not intravenously. Erythropoietin (4 studies, RR 1.20; p = 0.110; I-2 = 76.59%) and cyclosporine (3 studies, RR 0.75; p = 0.189, I-2 = 0%) did not show favorable significant effects. While negative findings for erythropoietin may reflect insufficient power, cyclosporine did not show better outcome at all. Current results do not allow firm conclusions on the efficacy of drugs with anti-inflammatory properties in TBI patients. Included trials showed heterogeneity in methodological and sample parameters. At present, only progesterone showed positive results and early administration via intramuscular administration may be most effective, especially in young people. The anti-inflammatory component of progesterone is relatively weak and other mechanisms than mitigating overall immune response may be more important.	[Begemann, Marieke; Leon, Mikela; Sommer, Iris] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, Sect Cognit Neurosci, Anton Deusinglaan 2, NL-9713 AW Groningen, Netherlands; [van der Horn, Harm Jan; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands		Begemann, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, Sect Cognit Neurosci, Anton Deusinglaan 2, NL-9713 AW Groningen, Netherlands.	m.j.h.begemann@umcg.nl		Sommer, Iris/0000-0001-5597-3262; van der Naalt, Joukje/0000-0001-9873-2418	Dutch Brain Foundation (Hersenstichting) [PZ 2017.01.2]	This work was supported by the Dutch Brain Foundation (Hersenstichting, number PZ 2017.01.2, 2017), received by Prof. Dr. Sommer and Dr. Begemann. We thank the authors that replied to e-mail requests for additional data or further clarification of their results.	Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Aminmansour Bahram, 2014, Adv Biomed Res, V3, P35, DOI 10.4103/2277-9175.125031; Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; Bai XF, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009532; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Blumbergs P. C., 2005, HEAD INJURY PATHOPHY, P41; Borenstein M., 2009, INTRO META ANAL; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Cifu D., 2010, TRAUMATIC BRAIN INJU; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Gantner DC, 2018, ANN SURG, V267, P585, DOI 10.1097/SLA.0000000000002142; Goldstein FC, 2017, J NEUROTRAUM, V34, P115, DOI 10.1089/neu.2015.4313; Gregson B, 1999, BRIT MED J, V319, P578, DOI 10.1136/bmj.319.7209.578; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Joseph B, 2018, J NEUROSCI RES, V96, P589, DOI 10.1002/jnr.24132; Kawakami M, 2000, BIOCHEM BIOPH RES CO, V279, P293, DOI 10.1006/bbrc.2000.3926; Lee J, 2019, AM J EMERG MED, V37, P1101, DOI 10.1016/j.ajem.2018.08.072; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li ZM, 2016, CLIN NEUROL NEUROSUR, V150, P80, DOI 10.1016/j.clineuro.2016.09.001; Lin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13442; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Pahl A, 2002, J PHARMACOL EXP THER, V301, P738, DOI 10.1124/jpet.301.2.738; Pan ZY, 2019, DRUG DES DEV THER, V13, P265, DOI 10.2147/DDDT.S192633; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sanchez-Aguilar M, 2013, J NEUROSURG, V118, P669, DOI 10.3171/2012.12.JNS121084; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; SINHA S, 2016, BRAIN INJURY, V30, P687; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Soltani Z, 2017, BRAIN INJURY, V31, P16, DOI 10.1080/02699052.2016.1213421; Sommer IE, 2014, SCHIZOPHRENIA BULL, V40, P181, DOI 10.1093/schbul/sbt139; Stein DG, 2011, PM&R, V3, pS100, DOI 10.1016/j.pmrj.2011.03.010; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yadav S, 2019, J PHARMACOL EXP THER, V370, P843, DOI 10.1124/jpet.118.254672; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhou ZW, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.827	59	2	2	1	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	SEP 30	2020	10	1							16179	10.1038/s41598-020-73227-5			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NZ6KB	WOS:000577213600021	32999392	Green Published, gold			2022-02-06	
J	Maerlender, A; Masterson, CJ; Norris, R; Hinthorne, A				Maerlender, Arthur; Masterson, Caitlin J.; Norris, Rex; Hinthorne, Adam			Validating Tackle Mechanics in American Football: Improving Safety and Performance	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion prevention; Tackle kinematics; American football; Head impact exposure (HIE); Defensive performance	HEAD IMPACT EXPOSURE; PROFESSIONAL RUGBY UNION; HIGH-SCHOOL; VIDEO ANALYSIS; INJURIES; EPIDEMIOLOGY; CONCUSSION	Research has helped to understand the risks of injuries of tackling in American football and rugby; however, approaches to teaching and analysis are not well-documented. Shoulder-led tackling has been proposed as a safer approach to tackling even though data on the effectiveness for safety and defensive performance is limited. Additionally, some have argued that safety and effectiveness are incompatible. The purpose of the study was to validate a specific sequence of tackling actions as a tool for teaching safer and more effective tackling skills. Results suggested tackle scores help predict presence of head contact, and that higher tackle scores were associated with reductions in Yards After Contact (YAC). Eight hundred and thirty-two (832) American high school football tackles were rated using a 12-element rating system. Estimated Structural Equation Modeling (ESEM) was employed to identify the factor structure of the elements with three factors identified: Track, Engage, and Finish. ANOVA, along with logistic and linear equation models were run to determine relationships between tackle scores and outcomes. Tackle scores predicted head-contact category (binary logistic regression accuracy = .76). Yards after contact (YAC) were significantly reduced [Finish factor: MANOVAF(3, 828) = 105.825,p< .001]. Construct and predictive validity were demonstrated and show that these tackle elements provide valid foci for teaching better tackling as well as analyzing both teaching effectiveness and performance.	[Maerlender, Arthur] Univ Nebraska, UNL, Ctr Brain Biol & Behav, East Stadium, Lincoln, NE 68588 USA; [Masterson, Caitlin J.] People Data Clar LLC, Springfield, MO USA; [Masterson, Caitlin J.] Univ Cent Arkansas, Dept Psychol, Conway, AR USA; [Norris, Rex; Hinthorne, Adam] Atavus Football Performance Co, Seattle, WA USA		Maerlender, A (corresponding author), Univ Nebraska, UNL, Ctr Brain Biol & Behav, East Stadium, Lincoln, NE 68588 USA.	amaerlender2@unl.edu					Alois J, 2019, AM J SPORT MED, V47, P3498, DOI 10.1177/0363546519882034; Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Boateng GO, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00149; Borman WC, 1986, PERFORMANCE ASSESSME, P100; Brown TA., 2015, CONFIRMATORY FACTOR, V2; Burger N, 2019, J SPORT SCI, V37, P74, DOI 10.1080/02640414.2018.1482590; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Carey L, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0182-3; Carroll P., 2014, SEAHAWKS HEAD COACH; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Davidow D, 2018, J SCI MED SPORT, V21, P1025, DOI 10.1016/j.jsams.2018.04.003; Gellner RA, 2020, P I MECH ENG P-J SPO, V234, P257, DOI 10.1177/1754337120911497; Hendricks S, 2018, STRENGTH COND J, V40, P44, DOI 10.1519/SSC.0000000000000400; Horstemeyer MF, 2019, ANN BIOMED ENG, V47, P1873, DOI 10.1007/s10439-019-02294-1; Kerr ZY, 2018, HEALTH PROMOT PRACT, V19, P184, DOI 10.1177/1524839917700398; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Stockwell DW, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120902714; Tucker R., 2017, BRIT J SPORT MED, V51, P398, DOI [10.1136/bjsports-2016-097372.291, DOI 10.1136/BJSPORTS-2016-097372.291]; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; USA Football, 2017, HEADS FOOTB	29	2	2	1	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2020	48	11			SI		2691	2700		10.1007/s10439-020-02625-7		SEP 2020	10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PB5UI	WOS:000574063200001	33000449	Green Published			2022-02-06	
J	Sokol-Randell, D; Rotundo, MP; Tierney, G; Deasy, C; Cusimano, MD				Sokol-Randell, Darek; Rotundo, Mario Pasquale; Tierney, Gregory; Deasy, Conor; Cusimano, Michael D.			Frequent but limited assessment of potentially concussed players in Gaelic Football: an opportunity to learn from other sports	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Concussion assessment; Sport-related concussion; Video incident analysis		Background Sport-related concussion (SRC) is a potential issue within Gaelic Football. Therefore, it is essential that concussion management guidelines are adhered to. Hypothesis/purpose The aim of this study is to determine if potential concussive events (PCEs) in the Gaelic Athletic Association (GAA) National Football League (NFL) are assessed in accordance with GAA concussion guidelines and compare this to other sports. Methods A descriptive video analysis approach was undertaken to identify PCEs throughout two seasons of play. Subsequent assessment, return to play (RTP) decisions, and signs of concussion were evaluated. Results A total of 242 PCEs were identified over 111 matches. Most PCEs (87.2%,n= 211) were assessed by medical personnel. However, 187 (88.6%) of assessments were under 2 min in duration. Of the 211 players assessed, 189 (78.1%) returned to play after on-pitch assessment, and 12 (5.0%) were removed following a PCE. Sixty-one (25.2%) players sustaining a PCE demonstrated one or more signs of concussion, of which 9 (14.8%) were removed from play. Conclusion In the GAA NFL, PCEs are often briefly assessed but rarely result in player removal. Introduction of video incident analysis and concussion substitutions, as in other sports, may reduce the long-term burden of SRC on Gaelic Football players.	[Sokol-Randell, Darek; Rotundo, Mario Pasquale; Deasy, Conor] Univ Coll, Univ Coll Cork, Sch Med, Brookfield Hlth Sci Complex, Cork T12 YN60, Ireland; [Sokol-Randell, Darek; Rotundo, Mario Pasquale; Deasy, Conor] Emergency Innovat Res Network, Cork, Ireland; [Tierney, Gregory] Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; [Deasy, Conor] Cork Univ Hosp, Emergency Dept, Cork, Ireland; [Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada		Sokol-Randell, D (corresponding author), Univ Coll, Univ Coll Cork, Sch Med, Brookfield Hlth Sci Complex, Cork T12 YN60, Ireland.; Sokol-Randell, D (corresponding author), Emergency Innovat Res Network, Cork, Ireland.	117105165@umail.ucc.ie; injuryprevention@smh.ca		Rotundo, Mario/0000-0002-7516-1023; Sokol-Randell, Darek/0000-0002-6751-5645; Tierney, Gregory/0000-0002-4666-4473			Armstrong N, 2019, INJ PREV; Comper P, 2016, NHL CONCUSSION EVALU, P1; Cusimano MD, 2013, PLOS ONE; Davis G, 2016, J SCI MED SPORT; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Echemendia RJ., 2017, BR J SPORTS MED; Gaelic Athletic Association, 2018, CONC MAN GUID GAEL G; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner AJ, 2018, SPORT MED OPEN; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Koerte IK, 2021, BRAIN IMAGING BEHAV, V15, P576, DOI 10.1007/s11682-020-00370-y; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kontos AP, 2012, AM J SPORTS MED; Landis J. R., 1977, BIOMETRICS; Ly N., 2015, RULES GAELIC FOOTBAL; Mack C, 2019, J ATHL TRAIN; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; McLendon LA, 2016, PEDIAT NEUROL; Meeuwisse WH, 2017, BRIT J SPORT MED, V51, P873, DOI 10.1136/bjsports-2017-097569; National Football League Operations, 2020, SID FUT; National Football League Operations, 2020, ATC SPOTTERS; O'Connor S, 2019, SPORTS HEALTH, V11, P498, DOI 10.1177/1941738119875978; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Patricios J, 2014, CURR SPORTS MED REP; Sullivan L., 2017, INT J ADOLESC MED HL, V29, P1, DOI [10.1515/ijamh-2015-0084, DOI 10.1515/IJAMH-2015-0084, 10.1515/ijamh-2017-3001]; Tarzi C, 2020, PROFESSIONAL ASSESSM, V91, P1; World Rugby, 2015, HEAD INJ ASS PROT	29	2	2	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	MAY	2021	190	2					787	792		10.1007/s11845-020-02390-5		SEP 2020	6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN7GU	WOS:000574068100002	32997230	Green Accepted			2022-02-06	
J	Stielper, ZF; Fucich, EA; Middleton, JW; Hillard, CJ; Edwards, S; Molina, PE; Gilpin, NW				Stielper, Zachary F.; Fucich, Elizabeth A.; Middleton, Jason W.; Hillard, Cecilia J.; Edwards, Scott; Molina, Patricia E.; Gilpin, Nicholas W.			Traumatic Brain Injury and Alcohol Drinking Alter Basolateral Amygdala Endocannabinoids in Female Rats	JOURNAL OF NEUROTRAUMA			English	Article						2-arachidonoylglycerol; anandamide; anxiety; electrophysiology; fluid percussion	ESTROUS-CYCLE; SEX-DIFFERENCES; PSYCHIATRIC-DISORDERS; INHIBITION; ETHANOL; EXPOSURE; STRESS; ANXIETY; NEUROINFLAMMATION; CONSUMPTION	Traumatic brain injury (TBI) affects approximately 3 million Americans yearly and increases vulnerability to developing psychiatric comorbidities. Alcohol use disorder (AUD) is the most prevalent psychiatric diagnosis preceding injury and TBI may increase subsequent alcohol use. The basolateral amygdala (BLA) is a limbic structure commonly affected by TBI that is implicated in anxiety and AUD. Endocannabinoids (eCBs) regulate synaptic activity in the BLA, and BLA eCB modulation alters anxiety-like behavior and stress reactivity. Previous work from our laboratories showed that systemic eCB degradation inhibition ameliorates TBI-induced increases in anxiety-like behavior and motivation to respond for alcohol in male rats. Here, we used a lateral fluid percussion model to test moderate TBI effects on anxiety-like behavior, alcohol drinking, and eCB levels and cell signaling in BLA, as well as the effect of alcohol drinking on anxiety-like behavior and the BLA eCB system, in female rats. Our results show that TBI does not promote escalation of operant alcohol self-administration or increase anxiety-like behavior in female rats. In the BLA, TBI and alcohol drinking alter tissue amounts of 2-arachidonoylglycerol (2-AG) andN-arachidonoylethanolamine (anandamide; AEA) 1 h post-injury, and 2-AG levels remain low 11 days post-injury. Eleven days after injury, BLA pyramidal neurons were hyperexcitable, but measures of synaptic transmission and eCB signaling were unchanged. These data show that TBI impacts BLA 2-AG tissue levels, that this effect is modified by alcohol drinking, and also that TBI increases BLA cell excitability.	[Stielper, Zachary F.; Fucich, Elizabeth A.; Edwards, Scott; Molina, Patricia E.; Gilpin, Nicholas W.] Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA USA; [Stielper, Zachary F.; Fucich, Elizabeth A.; Middleton, Jason W.; Edwards, Scott; Molina, Patricia E.; Gilpin, Nicholas W.] Louisiana State Univ, Hlth Sci Ctr, Alcohol & Drug Abuse Ctr Excellence, New Orleans, LA USA; [Middleton, Jason W.] Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA USA; [Fucich, Elizabeth A.] Tulane Univ, Neurosci Program, New Orleans, LA 70118 USA; [Hillard, Cecilia J.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Gilpin, Nicholas W.] Southeast Louisiana VA Healthcare Syst, New Orleans, LA USA		Gilpin, NW (corresponding author), LSUHSC New Orleans, 1901 Perdido St,Room 7205, New Orleans, LA 70112 USA.	ngilpi@lsuhsc.edu	Molina, Patricia E./AAK-9814-2021	Molina, Patricia E./0000-0002-3598-384X	National Institute on Alcohol Abuse and Alcoholism (NIAAA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32 AA007577]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F30AA026468-01A1, F32 AA026779, R01AA025792-01A1, R01AA026531-01]; Louisiana State University Health Sciences Center-New Orleans Department of Physiology	Support for this study was provided by National Institute on Alcohol Abuse and Alcoholism (NIAAA) training grant T32 AA007577, NIAAA fellowship award F30AA026468-01A1, NIAAA fellowship award F32 AA026779, NIAAA research grant R01AA025792-01A1, NIAAA research grant R01AA026531-01, and funds from the Louisiana State University Health Sciences Center-New Orleans Department of Physiology.	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beaulieu-Bonneau S, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000341; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Brigode W, 2019, J SURG RES, V244, P196, DOI 10.1016/j.jss.2019.06.043; Buczynski MW, 2010, BRIT J PHARMACOL, V160, P423, DOI 10.1111/j.1476-5381.2010.00787.x; Cavener VS, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00479; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Christensen J., 2019, J NEUROTRAUM, V37, P283; de Guglielmo G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09183-0; Di S, 2016, J NEUROSCI, V36, P8461, DOI 10.1523/JNEUROSCI.2279-15.2016; Epstein EL, 2019, PSYCHIAT RES, V274, P105, DOI 10.1016/j.psychres.2019.01.097; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Fernandes C, 1999, PHARMACOL BIOCHEM BE, V64, P731, DOI 10.1016/S0091-3057(99)00139-2; Ferrer B, 2007, BIOCHEM J, V404, P97, DOI 10.1042/BJ20061898; Folkes OM, 2020, J CLIN INVEST, V130, P1728, DOI 10.1172/JCI131752; Ford MM, 2002, ALCOHOL CLIN EXP RES, V26, P635, DOI 10.1097/00000374-200205000-00007; Forster G., 2012, AMYGDALA A DISCRETE; Frye CA, 2000, PHARMACOL BIOCHEM BE, V67, P587, DOI 10.1016/S0091-3057(00)00392-0; Fucich EA, 2020, J NEUROPHYSIOL, V123, P707, DOI 10.1152/jn.00570.2019; Fucich EA, 2019, J NEUROTRAUM, V36, P1847, DOI 10.1089/neu.2018.5854; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gilpin NW, 2015, BIOL PSYCHIAT, V77, P859, DOI 10.1016/j.biopsych.2014.09.008; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gray JM, 2015, J NEUROSCI, V35, P3879, DOI 10.1523/JNEUROSCI.2737-14.2015; Hill MN, 2009, NEUROPSYCHOPHARMACOL, V34, P2733, DOI 10.1038/npp.2009.114; Hillard CJ, 2015, INT REV NEUROBIOL, V125, P1, DOI 10.1016/bs.irn.2015.10.001; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Kalinin S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1184-7; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kulkarni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125748; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Ma Cheng, 2019, Chin Neurosurg J, V5, P24, DOI 10.1186/s41016-019-0173-8; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McGinnis MM, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0132-19.2019; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morena M, 2016, NEUROPSYCHOPHARMACOL, V41, P80, DOI 10.1038/npp.2015.166; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Perra S, 2008, ALCOHOL CLIN EXP RES, V32, P443, DOI 10.1111/j.1530-0277.2007.00588.x; Priddy BM, 2017, PHARMACOL BIOCHEM BE, V152, P61, DOI 10.1016/j.pbb.2016.08.001; RAINNIE DG, 1993, J NEUROPHYSIOL, V69, P1350, DOI 10.1152/jn.1993.69.4.1350; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Riebe CJN, 2010, PSYCHONEUROENDOCRINO, V35, P1265, DOI 10.1016/j.psyneuen.2010.02.008; Roberts AJ, 1998, ALCOHOL CLIN EXP RES, V22, P1564, DOI 10.1111/j.1530-0277.1998.tb03950.x; Robinson SL, 2016, NEUROPHARMACOLOGY, V108, P474, DOI 10.1016/j.neuropharm.2015.12.005; Rubio M, 2007, NEUROSCI LETT, V421, P270, DOI 10.1016/j.neulet.2007.05.052; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Sayin A, 2014, PHARMACOL BIOCHEM BE, V124, P180, DOI 10.1016/j.pbb.2014.06.002; Scheenen ME, 2016, J NEUROTRAUM, V33, P339, DOI 10.1089/neu.2015.3926; Schreiber AL, 2017, NEUROPHARMACOLOGY, V113, P323, DOI 10.1016/j.neuropharm.2016.05.008; Serrano A, 2012, ALCOHOL CLIN EXP RES, V36, P984, DOI 10.1111/j.1530-0277.2011.01686.x; Sharp BM, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.161; Stamatakis AM, 2014, NEUROPHARMACOLOGY, V76, P320, DOI 10.1016/j.neuropharm.2013.05.046; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Talani G, 2015, ALCOHOL, V49, P781, DOI 10.1016/j.alcohol.2015.08.006; Teng SX, 2015, BRAIN BEHAV IMMUN, V45, P145, DOI 10.1016/j.bbi.2014.11.006; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Varodayan FP, 2017, ADDICT BIOL, V22, P766, DOI 10.1111/adb.12369; Viader A, 2016, ELIFE, V5, DOI 10.7554/eLife.12345; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Weera MM, 2020, NEUROPHARMACOLOGY, V166, DOI 10.1016/j.neuropharm.2020.107979; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wilde EA, 2019, J NEUROTRAUM, V36, P3164, DOI 10.1089/neu.2019.6377; Wilkerson JL, 2016, BRIT J PHARMACOL, V173, P1678, DOI 10.1111/bph.13469; Wilkerson JL, 2017, J PHARMACOL EXP THER, V363, P394, DOI 10.1124/jpet.117.243808; Wrase J, 2008, AM J PSYCHIAT, V165, P1179, DOI 10.1176/appi.ajp.2008.07121877	81	2	2	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2021	38	4					422	434		10.1089/neu.2020.7175		SEP 2020	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QC1FI	WOS:000575392800001	32838651				2022-02-06	
J	Amato, I; Nanev, A; Piantella, S; Wilson, KE; Bicknell, R; Heckenberg, R; Horan, B; Maruff, P; Wright, B				Amato, Isabella; Nanev, Aleshia; Piantella, Stefan; Wilson, Kira-Elise; Bicknell, Rowena; Heckenberg, Rachael; Horan, Ben; Maruff, Paul; Wright, Bradley			Assessing the utility of a virtual-reality neuropsychological test battery, 'CONVIRT', in detecting alcohol-induced cognitive impairment	BEHAVIOR RESEARCH METHODS			English	Article						Decision-making; Attention; Saccade; Concussion; Jockeys; Virtual reality	SACCADIC EYE-MOVEMENTS; TRAUMATIC BRAIN-INJURY; IDENTIFICATION TEST; INTOXICATION; RELIABILITY; PERFORMANCE; ACCURACY; PURSUIT	New technologies such as virtual reality (VR) and eye-tracking software have paved the way for more sophisticated and ecologically valid measures of cognitive function. Testing the sensitivity and reliability of such measurements in response to acute alcohol intoxication provides a first step in establishing how these measures may operate in relation to cognitive impairments observed post-concussion. Healthy young adults (N= 54, M = 20.65, SD = 2.06, 30 females) completed the CONVIRT test battery (manual simple and choice reaction-time and saccade reaction-time) at three breath alcohol concentration (BrAC) levels: 0.00%(T1), 0.05%(T2), 0.08%(T3). Participants consumed alcoholic beverages at 30-min intervals, with BrAC monitored at 15-min intervals using a breathalyser. All three CONVIRT measures were sensitive to changes in cognitive performance induced by alcohol at BrAC levels at or exceeding 0.05%. A composite measure was also sensitive to alcohol intoxication (Cohen'sd= .85 at BrAC = 0.05%;d= 1.20 at BrAC = 0.08%). Strong test-retest reliability was observed (allr< .80), with no gender differences noted. CONVIRT measures were reliable and detected dose-dependent changes in alcohol-induced cognitive impairment. Potentially, the ecologically valid measures may assist in better quantifying the effects of conditions such as concussion, on cognitive performance.	[Amato, Isabella; Nanev, Aleshia; Piantella, Stefan; Wilson, Kira-Elise; Bicknell, Rowena; Heckenberg, Rachael; Wright, Bradley] La Trobe Univ, Psychol & Counselling, Bundoora Campus, Bundoora, Vic, Australia; [Horan, Ben] Deakin Univ, Fac Sci & Technol, Sch Engn, Melbourne, Vic, Australia; [Maruff, Paul] CogState Ltd, Melbourne, Vic, Australia		Wright, B (corresponding author), La Trobe Univ, Psychol & Counselling, Bundoora Campus, Bundoora, Vic, Australia.	b.wright@latrobe.edu.au	Maruff, Paul/ABA-1673-2020; Maruff, Paul/AAD-2454-2021	Maruff, Paul/0000-0002-6947-9537; Wright, Bradley/0000-0002-6428-9128; Wilson, Kira-Elise/0000-0002-7614-9368			Blekher T, 2002, ALCOHOL CLIN EXP RES, V26, P232, DOI 10.1097/00000374-200202000-00011; Cash C, 2015, J PSYCHOPHARMACOL, V29, P436, DOI 10.1177/0269881115570080; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Cohen J, 1998, STAT POWER ANAL BEHA; de Xivry JJO, 2007, J PHYSIOL-LONDON, V584, P11, DOI 10.1113/jphysiol.2007.139881; Dry MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050977; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; HOLM S, 1979, SCAND J STAT, V6, P65; Horan B, 2020, BMC PSYCHOL, V8, DOI 10.1186/s40359-020-00429-x; Howett D, 2019, BRAIN, V142, P1751, DOI 10.1093/brain/awz116; Jongen S, 2016, ACCIDENT ANAL PREV, V89, P31, DOI 10.1016/j.aap.2016.01.001; King AC, 2004, J STUD ALCOHOL, V65, P27, DOI 10.15288/jsa.2004.65.27; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Maruff P, 2005, J SLEEP RES, V14, P21, DOI 10.1111/j.1365-2869.2004.00438.x; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mullen SJ, 2014, CAN J NEUROL SCI, V41, P58, DOI 10.1017/S0317167100016279; Ramat S, 2007, BRAIN, V130, P10, DOI 10.1093/brain/awl309; Reppert TR, 2015, J NEUROSCI, V35, P15369, DOI 10.1523/JNEUROSCI.2621-15.2015; Roche DJO, 2010, PSYCHOPHARMACOLOGY, V212, P33, DOI 10.1007/s00213-010-1906-8; Salomoni P, 2017, J MULTIMODAL USER IN, V11, P173, DOI 10.1007/s12193-016-0236-5; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schechtman E, 2011, ACCIDENT ANAL PREV, V43, P2188, DOI 10.1016/j.aap.2011.06.013; Selin KH, 2003, ALCOHOL CLIN EXP RES, V27, P1428, DOI 10.1097/01.ALC.0000085633.23230.4A; Shields AL, 2003, EDUC PSYCHOL MEAS, V63, P404, DOI 10.1177/0013164403063003004; Smith T, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/032001; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; Sorbello JG, 2018, PEERJ, V6, DOI 10.7717/peerj.4418; TaBrAChnick B. G., 2013, USING MULTIVARIATE S; Taghdiri F, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000286; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; Vassallo S, 2002, CLIN EXP OPHTHALMOL, V30, P208, DOI 10.1046/j.1442-9071.2002.00518.x; Vorstius C, 2008, PSYCHOPHARMACOLOGY, V196, P201, DOI 10.1007/s00213-007-0954-1; Vorstius C, 2012, J PSYCHOPHARMACOL, V26, P262, DOI 10.1177/0269881111400645; Wegner AJ, 1999, PSYCHOPHARMACOLOGY, V146, P24, DOI 10.1007/s002130051084; Wiener JM, 2019, BEHAV RES METHODS, V52, P1; Zuba D, 2008, FORENSIC SCI INT, V178, pE29, DOI 10.1016/j.forsciint.2008.03.002	39	2	2	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1554-351X	1554-3528		BEHAV RES METHODS	Behav. Res. Methods	JUN	2021	53	3					1115	1123		10.3758/s13428-020-01485-2		SEP 2020	9	Psychology, Mathematical; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	SW6DP	WOS:000573496700003	32989723	Bronze			2022-02-06	
J	Csaba, Z; Vitalis, T; Charriaut-Marlangue, C; Margaill, I; Coqueran, B; Leger, PL; Parente, I; Jacquens, A; Titomanlio, L; Constans, C; Demene, C; Santin, MD; Lehericy, S; Perriere, N; Glacial, F; Auvin, S; Tanter, M; Ghersi-Egea, JF; Adle-Biassette, H; Aubry, JF; Gressens, P; Dournaud, P				Csaba, Z.; Vitalis, T.; Charriaut-Marlangue, C.; Margaill, I.; Coqueran, B.; Leger, P. -L.; Parente, I.; Jacquens, A.; Titomanlio, L.; Constans, C.; Demene, C.; Santin, M. D.; Lehericy, S.; Perriere, N.; Glacial, F.; Auvin, S.; Tanter, M.; Ghersi-Egea, J. -F.; Adle-Biassette, H.; Aubry, J. -F.; Gressens, P.; Dournaud, P.			A simple novel approach for detecting blood-brain barrier permeability using GPCR internalization	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						blood-brain barrier; cerebral cortex; magnetic resonance imaging (MRI)-guided focused ultrasound; neurodevelopment; neurological diseases; neurovascular unit; stroke; traumatic brain injury	IN-VIVO; ARCUATE NUCLEUS; RAT-BRAIN; IMMUNOHISTOCHEMICAL LOCALIZATION; SOMATOSTATIN RECEPTORS; SST2A RECEPTOR; HYPOTHALAMUS; BREAKDOWN; DISEASE; DYSFUNCTION	Aims Impairment of blood-brain barrier (BBB) is involved in numerous neurological diseases from developmental to aging stages. Reliable imaging of increased BBB permeability is therefore crucial for basic research and preclinical studies. Today, the analysis of extravasation of exogenous dyes is the principal method to study BBB leakage. However, these procedures are challenging to apply in pups and embryos and may appear difficult to interpret. Here we introduce a novel approach based on agonist-induced internalization of a neuronal G protein-coupled receptor widely distributed in the mammalian brain, the somatostatin receptor type 2 (SST2). Methods The clinically approved SST2 agonist octreotide (1 kDa), when injected intraperitoneally does not cross an intact BBB. At sites of BBB permeability, however, OCT extravasates and induces SST2 internalization from the neuronal membrane into perinuclear compartments. This allows an unambiguous localization of increased BBB permeability by classical immunohistochemical procedures using specific antibodies against the receptor. Results We first validated our approach in sensory circumventricular organs which display permissive vascular permeability. Through SST2 internalization, we next monitored BBB opening induced by magnetic resonance imaging-guided focused ultrasound in murine cerebral cortex. Finally, we proved that after intraperitoneal agonist injection in pregnant mice, SST2 receptor internalization permits analysis of BBB integrity in embryos during brain development. Conclusions This approach provides an alternative and simple manner to assess BBB dysfunction and development in different physiological and pathological conditions.	[Csaba, Z.; Vitalis, T.; Charriaut-Marlangue, C.; Leger, P. -L.; Parente, I.; Jacquens, A.; Titomanlio, L.; Auvin, S.; Adle-Biassette, H.; Gressens, P.; Dournaud, P.] Univ Paris, NeuroDiderot, Inserm U1141, Paris, France; [Margaill, I.; Coqueran, B.] Univ Paris, Res Team Pharmacol Cerebral Circulat EA4475, Fac Pharm Paris, Paris, France; [Constans, C.; Demene, C.; Tanter, M.; Aubry, J. -F.] Univ Paris, Inst Langevin, ESPCI Paris, PSL Res Univ,CNRS UMR7587,Inserm U979,Inserm Tech, Paris, France; [Santin, M. D.; Lehericy, S.] UPMC Univ Paris 06, Brain & Spine Inst ICM, Ctr NeuroImaging Res CENIR, Sorbonne Paris Cite,Inserm U1127,CNRS UMR 7225, Paris, France; [Perriere, N.; Glacial, F.] Brain & Spine Inst ICM, BrainPlotting, Paris, France; [Ghersi-Egea, J. -F.] Univ Lyon 1, Fluid Team, Lyon Neurosci Res Ctr, Inserm U1028,CNRS UMR5292, Villeurbanne, France; [Adle-Biassette, H.] Hop Lariboisiere, APHP, Serv Anat & Cytol Pathol, Paris, France		Dournaud, P (corresponding author), Hop Robert Debre, Inserm NeuroDiderot U1141, 48 Blvd Serurier, F-75019 Paris, France.	pascal.dournaud@inserm.fr	Aubry, Jean-Francois/I-8491-2016; Auvin, Stephane/AAB-7824-2021; Vitalis, Tania/K-8485-2017	Aubry, Jean-Francois/0000-0003-2644-3945; Auvin, Stephane/0000-0003-3874-9749; Vitalis, Tania/0000-0002-5531-3771	Inserm, Paris Diderot University, La Fondation pour la Recherche sur le Cerveau; PremUP Foundation; Seventh Framework Program of the European UnionEuropean Commission [HEALTH-F2-2009-241778/Neurobid]; Bettencourt Schueller Foundation; 'Agence Nationale de la Recherche' under the program 'Future Investments'French National Research Agency (ANR) [ANR-10-EQPX-15]	This work was supported by Inserm, Paris Diderot University, La Fondation pour la Recherche sur le Cerveau, the PremUP Foundation, the Seventh Framework Program of the European Union Grant Agreement HEALTH-F2-2009-241778/Neurobid, the Bettencourt Schueller Foundation and the 'Agence Nationale de la Recherche' under the program 'Future Investments' with the reference ANR-10-EQPX-15. We thank Joanna Droesbeke and Nad~ege Sarrazin from the PHENOPARC Platform for their help with animal injections. The authors thank Dr Johan Pallud (Professor of neurosurgery at Paris Descartes University, Neurosurgeon at Sainte-Anne Hospital center, Paris, France) for providing fresh human brain sample from a patient suffering from oligodendroglioma.	Abbruscato TJ, 1997, J PHARMACOL EXP THER, V280, P402; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; BANKS WA, 1990, P NATL ACAD SCI USA, V87, P6762, DOI 10.1073/pnas.87.17.6762; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; CARON P, 1995, NEW ENGL J MED, V333, P601, DOI 10.1056/NEJM199508313330918; Chhor V, 2017, BRAIN BEHAV IMMUN, V63, P197, DOI 10.1016/j.bbi.2016.11.001; Ciofi P, 2011, NEUROSCI LETT, V487, P187, DOI 10.1016/j.neulet.2010.10.019; Csaba Z, 2005, J NEUROPATH EXP NEUR, V64, P956, DOI 10.1097/01.jnen.0000186923.50215.50; Csaba Z, 2003, ENDOCRINOLOGY, V144, P1564, DOI 10.1210/en.2002-221090; Csaba Z, 2002, J COMP NEUROL, V454, P192, DOI 10.1002/cne.10430; Csaba Z, 2001, MOL CELL NEUROSCI, V17, P646, DOI 10.1006/mcne.2000.0958; Csaba Z, 2007, TRAFFIC, V8, P820, DOI 10.1111/j.1600-0854.2007.00580.x; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; De Bundel D, 2015, J NEUROSCI, V35, P11960, DOI 10.1523/JNEUROSCI.0476-15.2015; Dournaud P, 1996, J NEUROSCI, V16, P4468; Duerrschmid C, 2017, NAT MED, V23, P1444, DOI 10.1038/nm.4432; Ek CJ, 2015, J CEREBR BLOOD F MET, V35, P818, DOI 10.1038/jcbfm.2014.255; Erickson MA, 2018, PHARMACOL REV, V70, P278, DOI 10.1124/pr.117.014647; Faouzi M, 2007, ENDOCRINOLOGY, V148, P5414, DOI 10.1210/en.2007-0655; Fassnacht M, 2001, CLIN ENDOCRINOL, V55, P411, DOI 10.1046/j.1365-2265.2001.01304.x; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Fischer T, 2008, J CLIN ENDOCR METAB, V93, P4519, DOI 10.1210/jc.2008-1063; Gelot A, 2009, DEV NEUROSCI-BASEL, V31, P459, DOI 10.1159/000232564; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Gunther T, 2018, PHARMACOL REV, V70, P763, DOI 10.1124/pr.117.015388; Helboe L, 1997, MOL BRAIN RES, V49, P82, DOI 10.1016/S0169-328X(97)00127-7; Helboe L, 1999, J COMP NEUROL, V405, P247; Hoffmann A, 2011, TRANSL STROKE RES, V2, P106, DOI 10.1007/s12975-010-0049-x; Hsu YC, 2014, J CEREBR BLOOD F MET, V34, P668, DOI 10.1038/jcbfm.2013.244; JAEHDE U, 1994, PHARMACEUT RES, V11, P442, DOI 10.1023/A:1018929508018; Jiang X, 2017, PROG NEUROGIBOL; Kaur C, 2017, HISTOL HISTOPATHOL, V32, P879, DOI 10.14670/HH-11-881; Kim KS, 2018, NAT REV NEUROSCI, V19, P185, DOI 10.1038/nrn.2018.8; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Langlet F, 2013, CELL METAB, V17, P607, DOI 10.1016/j.cmet.2013.03.004; Le Verche V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005509; Leger PL, 2016, STROKE, V47, P3048, DOI 10.1161/STROKEAHA.116.015095; Leinenga G, 2016, NAT REV NEUROL, V12, P161, DOI 10.1038/nrneurol.2016.13; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Luo HL, 2018, MOL PHARMACEUT, V15, P2528, DOI 10.1021/acs.molpharmaceut.8b00018; Ma QY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071356; Magnin R, 2015, J THER ULTRASOUND, V3, DOI 10.1186/s40349-015-0044-5; MARBACH P, 1992, METABOLISM, V41, P7, DOI 10.1016/0026-0495(92)90024-5; Menard C, 2017, NAT NEUROSCI, V20, P1752, DOI 10.1038/s41593-017-0010-3; Meng Y, 2017, J THER ULTRASOUND, V5, DOI 10.1186/s40349-017-0105-z; Merzin M, 2008, THESIS U TARTU ESTON; Moretti R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00040; Nahirney PC, 2016, J CEREBR BLOOD F MET, V36, P413, DOI 10.1177/0271678X15608396; Najjar S, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00083; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-142; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Rapoport SI, 2000, CELL MOL NEUROBIOL, V20, P217, DOI 10.1023/A:1007049806660; Reyes TM, 2002, J NEUROSCI, V22, P5091, DOI 10.1523/JNEUROSCI.22-12-05091.2002; Rudolph MD, 2018, NAT NEUROSCI, V21, P765, DOI 10.1038/s41593-018-0128-y; Saunders NR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3339/fnins.2015.00385, 10.3389/fnins.2015.00385]; Saunders NR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00404; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schindler M, 1997, NEUROSCIENCE, V76, P225; Sohet F, 2015, J CELL BIOL, V208, P703, DOI 10.1083/jcb.201410131; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Theoharides TC, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.77; Thoss VS, 1996, N-S ARCH PHARMACOL, V353, P648; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Tsze DS, 2011, EMERG MED INT, V2011, DOI 10.1155/2011/734506; Weckbecker G, 2003, NAT REV DRUG DISCOV, V2, P999, DOI 10.1038/nrd1255; Wunder A, 2012, EPILEPSIA, V53, P14, DOI 10.1111/j.1528-1167.2012.03698.x; Yang SM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00902	69	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	FEB	2021	47	2					297	315		10.1111/nan.12665		SEP 2020	19	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	QC5HZ	WOS:000572810600001	32898926	hybrid, Green Published			2022-02-06	
J	Devi, Y; Khan, S; Rana, P; Deepak; Dhandapani, M; Ghai, S; Gopichandran, L; Dhandapani, S				Devi, Yashodha; Khan, Sahiba; Rana, Priyanka; Deepak; Dhandapani, Manju; Ghai, Sandhya; Gopichandran, Lakshmanan; Dhandapani, Sivashanmugam			Cognitive, Behavioral, and Functional Impairments among Traumatic Brain Injury Survivors: Impact on Caregiver Burden	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						traumatic brain injury; caregiver burden; disability rating scale; behavioral changes; outpatient department; rapport disability rating scale	INTRACRANIAL TUMORS; DISABILITY; PREVALENCE; PREDICTORS; DEPRESSION; TRENDS; COMA	Background The burden of cognitive, behavioral, and functional impairments after traumatic brain injury (TBI) is still not highlighted much, but its impact on caregivers is socio-economically relevant. The objectives of the study were to assess cognitive, behavioral, and functional impairments in patients of TBI and its impact on caregiver burden. Materials and Methods A descriptive cross-sectional study was conducted using a total enumeration sampling technique. Mini-mental status examination, neuropsychiatric inventory and Rappaport's disability rating scale were used to assess patients' cognitive, behavioral, and functional impairments, respectively. Zarit Caregiver Burden Scale was executed to quantify the caregiver burden. Results Fifty patients of TBI and their caregivers were enrolled. Among these, 24% had moderate cognitive impairments. Among behavioral symptoms, 40% had agitation, 24% had depression, 18% had anxiety, and 16% had irritability. Moderate functional disability was reported by 18% of the patients, while 2% reported severe functional disability. Moderate to severe caregiver burden was reported by 8% of caregivers. Patients' behavioral (r = 0.507, p < 0.001), functional (r= 0.473, p= 0.001), and cognitive (r= -0.438, p= 0.001) impairments had significant correlations with caregiver burden. Conclusion Patients develop cognitive, behavioral, and functional disability after TBI. The caregiver burden increases significantly with cognitive dysfunction, behavioral symptoms, and impaired functional status of patients. Therefore, appropriate support is to be provided to caregivers as well as patients.	[Devi, Yashodha] Indraprastha Apollo Hosp, Dept Nursing, Delhi, India; [Khan, Sahiba; Rana, Priyanka] Post Grad Inst Med Educ & Res, Dept Nursing, Chandigarh, India; [Deepak] ESIC Model Hosp, Dept Nursing, Ludhiana, Punjab, India; [Dhandapani, Manju; Ghai, Sandhya] Post Grad Inst Med Educ & Res, Natl Inst Nursing Educ, Sect 12, Chandigarh 160012, India; [Gopichandran, Lakshmanan] All India Inst Med Sci AIIMS, Coll Nursing, New Delhi, India; [Dhandapani, Sivashanmugam] Post Grad Inst Med Educ & Res, Dept Neurosurg, Chandigarh, India		Dhandapani, M (corresponding author), Post Grad Inst Med Educ & Res, Natl Inst Nursing Educ, Sect 12, Chandigarh 160012, India.	manjuseban@gmail.com		Dhandapani, Manju/0000-0003-3351-3841			Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; BAHLOULI E, 2016, ANN PHYS REHABIL MED, V0059, pE 136; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Boudokhane S, 2016, ANN PHYS REHABIL M S, V59S, pe134, DOI DOI 10.1016/j.rehab.2016.07.301; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; de Guise E, 2005, CAN J NEUROL SCI, V32, P186, DOI 10.1017/S0317167100003954; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Dhandapani M, 2017, ANN NEUROSCI, V24, P105, DOI 10.1159/000475899; Dhandapani M, 2016, CONTEMP NURSE, V52, P477, DOI 10.1080/10376178.2016.1222240; Dhandapani Manju, 2016, Surg Neurol Int, V7, pS190, DOI 10.4103/2152-7806.179229; Dhandapani S S, 2012, Asian J Neurosurg, V7, P17, DOI 10.4103/1793-5482.95690; Dhandapani S, 2018, NEUROSURG REV, V41, P513, DOI 10.1007/s10143-017-0880-6; Dhandapani S, 2015, NEUROL INDIA, V63, P531, DOI 10.4103/0028-3886.162026; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Grover Sandeep, 2015, Ind Psychiatry J, V24, P5, DOI 10.4103/0972-6748.160907; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lequerica AH, 2017, NEUROPSYCHOL REHABIL, V27, P1019, DOI 10.1080/09602011.2016.1231120; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahak C, 2018, J NEUROSCI RURAL PRA, V9, P461, DOI 10.4103/jnrp.jnrp_25_18; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Mbakile-Mahlanza L, 2017, DISABIL REHABIL, V39, P559, DOI 10.3109/09638288.2016.1152605; Mukherjee KK, 2015, ACTA NEUROCHIR, V157, P305, DOI 10.1007/s00701-014-2296-1; Neumann Dawn, 2015, Arch Phys Med Rehabil, V96, P179, DOI 10.1016/j.apmr.2013.06.003; Pinquart M, 2004, AGING MENT HEALTH, V8, P438, DOI 10.1080/13607860410001725036; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Sherwood Paula R, 2004, Int J Palliat Nurs, V10, P67; Sherwood PR, 2006, RES NURS HEALTH, V29, P105, DOI 10.1002/nur.20116; Sherwood PR, 2004, INT J PALLIAT NURS, V10, P75; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thakur D, 2019, CLIN J ONCOL NURS, V23, P315, DOI 10.1188/19.CJON.315-323; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	42	2	2	1	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	OCT	2020	11	04					629	635		10.1055/s-0040-1716777		SEP 2020	7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	OI1FX	WOS:000572647800001	33144802	gold, Green Published			2022-02-06	
J	Bland, ML; McNally, C; Cicchino, JB; Zuby, DS; Mueller, BC; McCarthy, ML; Newgard, CD; Kulie, PE; Arnold, BN; Rowson, S				Bland, Megan L.; McNally, Craig; Cicchino, Jessica B.; Zuby, David S.; Mueller, Becky C.; McCarthy, Melissa L.; Newgard, Craig D.; Kulie, Paige E.; Arnold, Brittany N.; Rowson, Steven			Laboratory Reconstructions of Bicycle Helmet Damage: Investigation of Cyclist Head Impacts Using Oblique Impacts and Computed Tomography	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Head injury; Concussion; Biomechanics; Oblique impact; Accident reconstruction	REAL-WORLD; HYBRID-III; INJURIES	Although head injuries are common in cycling, exact conditions associated with cyclist head impacts are difficult to determine. Previous studies have attempted to reverse engineer cyclist head impacts by reconstructing bicycle helmet residual damage, but they have been limited by simplified damage assessment and testing. The present study seeks to enhance knowledge of cyclist head impact conditions by reconstructing helmet damage using advanced impact testing and damage quantification techniques. Damage to 18 helmets from cyclists treated in emergency departments was quantified using computed tomography and reconstructed using oblique impacts. Damage metrics were related to normal and tangential velocities from impact tests as well as peak linear accelerations (PLA) and peak rotational velocities (PRV) using case-specific regression models. Models then allowed original impact conditions and kinematics to be estimated for each case. Helmets were most frequently damaged at the front and sides, often near the rim. Concussion was the most common, non-superficial head injury. Normal velocity and PLA distributions were similar to previous studies, with median values of 3.4 m/s and 102.5 g. Associated tangential velocity and PRV medians were 3.8 m/s and 22.3 rad/s. Results can inform future oblique impact testing conditions, enabling improved helmet evaluation and design.	[Bland, Megan L.; McNally, Craig; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, 343 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA; [Cicchino, Jessica B.; Zuby, David S.; Mueller, Becky C.] Insurance Inst Highway Safety, 988 Dairy Rd, Ruckersville, VA 22968 USA; [McCarthy, Melissa L.] George Washington Univ, Milken Inst Sch Publ Hlth, 950 New Hampshire Ave NW, Washington, DC 20052 USA; [Newgard, Craig D.; Arnold, Brittany N.] Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, Dept Emergency Med, 3181 SW Jackson Pk Rd,CR-114, Portland, OR 97239 USA; [Kulie, Paige E.] George Washington Univ, Med Ctr, Dept Emergency Med, 2120 L St NW,Suite 450, Washington, DC 20037 USA		Bland, ML (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, 343 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	mbland27@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	Insurance Institute for Highway Safety (IIHS); Virginia Tech Institute for Critical Technology and Applied Science (ICTAS)	The authors would like to thank the Insurance Institute for Highway Safety (IIHS) and the Virginia Tech Institute for Critical Technology and Applied Science (ICTAS) for their funding and support, the Virginia-Maryland College of Veterinary Medicine for CT scanner use, Materialise application engineers for aiding in the software-based analysis, Kamil Narayan for managing data collection at Oregon Health and Science University, and all research assistants who enrolled and interviewed patients for the study.	Association Governors Highway Safety Association, 2017, RIGHT ROAD UND ADDR; Bland M.L., 2018, P IRCOBI C ATH GREEC; Bland ML, 2020, ANN BIOMED ENG, V48, P47, DOI 10.1007/s10439-019-02330-0; Bland ML, 2018, TRAFFIC INJ PREV, V19, pS158, DOI 10.1080/15389588.2017.1388915; Bonin SJ, 2017, ANN BIOMED ENG, V45, P656, DOI 10.1007/s10439-016-1712-5; Bonugli E, 2015, BIOMEDICAL ENG, P78; Bourdet N, 2014, INT J CRASHWORTHINES, V19, P222, DOI 10.1080/13588265.2013.805293; Chinn B., 2001, COST 327 MOTORCYCLE; Ciccino J. B., 2019, NOT ALL PROTECTED BI; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; DeMarco AL, 2020, ANN BIOMED ENG, V48, P58, DOI 10.1007/s10439-019-02422-x; ECE, 1999, R2205 ECE; Eckersley C. P., 2017, P IRCOBI C ANTW BELG, P685; Gennarelli T, 1971, P 15 STAPP CAR CRASH; Ghajari M, 2013, ACCIDENT ANAL PREV, V50, P263, DOI 10.1016/j.aap.2012.04.016; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Loftis K. L., 2011, P 48 RMBS C DENV COL; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Mills NJ, 2010, INT J CRASHWORTHINES, V15, P331, DOI 10.1080/13588260903251000; Milne G, 2014, INT J CRASHWORTHINES, V19, P323, DOI 10.1080/13588265.2013.859470; Olivier J, 2017, TRAFFIC INJ PREV, V18, P755, DOI 10.1080/15389588.2017.1298748; Peng Y, 2012, SAFETY SCI, V50, P1749, DOI 10.1016/j.ssci.2012.03.005; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sances A, 2002, BIOMED SCI INSTRUM, V38, P459; Sanford T, 2015, JAMA-J AM MED ASSOC, V314, P947, DOI 10.1001/jama.2015.8295; SMITH TA, 1994, ACCIDENT ANAL PREV, V26, P795, DOI 10.1016/0001-4575(94)90055-8; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5	33	2	2	2	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2020	48	12					2783	2795		10.1007/s10439-020-02620-y		SEP 2020	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	PD4VU	WOS:000572622100002	32974755				2022-02-06	
J	Gabrieli, D; Schumm, SN; Vigilante, NF; Parvesse, B; Meaney, DF				Gabrieli, David; Schumm, Samantha N.; Vigilante, Nicholas F.; Parvesse, Brandon; Meaney, David F.			Neurodegeneration exposes firing rate dependent effects on oscillation dynamics in computational neural networks	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; DIFFUSE AXONAL INJURY; VISUAL-CORTEX; FUNCTIONAL CONNECTIVITY; COGNITIVE IMPAIRMENT; SYNAPTIC PLASTICITY; RECEPTIVE-FIELD; INFLAMMATION; INTERNEURONS	Traumatic brain injury (TBI) can lead to neurodegeneration in the injured circuitry, either through primary structural damage to the neuron or secondary effects that disrupt key cellular processes. Moreover, traumatic injuries can preferentially impact subpopulations of neurons, but the functional network effects of these targeted degeneration profiles remain unclear. Although isolating the consequences of complex injury dynamics and long-term recovery of the circuit can be difficult to control experimentally, computational networks can be a powerful tool to analyze the consequences of injury. Here, we use the Izhikevich spiking neuron model to create networks representative of cortical tissue. After an initial settling period with spike-timing-dependent plasticity (STDP), networks developed rhythmic oscillations similar to those seenin vivo. As neurons were sequentially removed from the network, population activity rate and oscillation dynamics were significantly reduced. In a successive period of network restructuring with STDP, network activity levels returned to baseline for some injury levels and oscillation dynamics significantly improved. We next explored the role that specific neurons have in the creation and termination of oscillation dynamics. We determined that oscillations initiate from activation of low firing rate neurons with limited structural inputs. To terminate oscillations, high activity excitatory neurons with strong input connectivity activate downstream inhibitory circuitry. Finally, we confirm the excitatory neuron population role through targeted neurodegeneration. These results suggest targeted neurodegeneration can play a key role in the oscillation dynamics after injury.	[Gabrieli, David; Schumm, Samantha N.; Vigilante, Nicholas F.; Parvesse, Brandon; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Meaney, DF (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Meaney, DF (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Meaney, David/0000-0002-0954-4122; Vigilante, Nicholas/0000-0003-0540-4816; Schumm, Samantha/0000-0003-4399-5362	Paul G. Allen Family Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS088176]	Paul G. Allen Family Foundation: received by DM, https://www.pgafamilyfoundation.org/National Institutes of Health, received by DM, grant number RO1 NS088176, https://www.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alonso JM, 2001, J NEUROSCIENCE, V21; [Anonymous], 2013, NEUROLOGY S3, V80, pS1, DOI 10.1212/WNL.06013e3182872e90; [Anonymous], 2017, EUR J TRANSL MYOL, V27, p7X; [Anonymous], 2008, DTSCH ARZTEBL, V105, pC301; [Anonymous], 2017, MMWR-MORBID MORTAL W, V66, P1; Atlan LS, 2019, J NEUROTRAUM, V36, P2558, DOI 10.1089/neu.2017.5574; Barth BB, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9090428; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bozer ALH, 2017, J INTEGR NEUROSCI, V16, P107, DOI 10.3233/JIN-170011; Brette R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004114; Briggs Farran, 2005, Thalamus & Related Systems, V3, P133, DOI 10.1017/S1472928807000131; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Cavdar S, 2014, NEUROSCI BULL, V30, P451, DOI 10.1007/s12264-013-1402-3; Clayton MS, 2015, TRENDS COGN SCI, V19, P188, DOI 10.1016/j.tics.2015.02.004; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crone JS, 2018, J NEUROSCI RES, V96, P671, DOI 10.1002/jnr.24115; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Dayan P, 2001, THEORETICAL NEUROSCI; Effenberger F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004420; Erdos Paul, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.1109/ICSMC.2006.384625; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Ferrario CR, 2013, J NEUROPHYSIOL, V110, P131, DOI 10.1152/jn.01011.2012; FERSTER D, 1992, J NEUROSCI, V12, P1262; Folweiler KA, 2018, J NEUROTRAUM, V35, P1304, DOI 10.1089/neu.2017.5350; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Gilbert N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197419; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Hanslmayr S, 2016, TRENDS NEUROSCI, V39, P16, DOI 10.1016/j.tins.2015.11.004; Hausser M, 2001, CURR BIOL, V11, pR10, DOI 10.1016/S0960-9822(00)00034-8; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lu JT, 2007, J NEUROSCI, V27, P9711, DOI 10.1523/JNEUROSCI.2513-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mac Donald CL, 2007, EXPT NEUROLOGY, V205; Maller JJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37905-9; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Mao HJ, 2013, J NEUROTRAUM, V30, P1521, DOI 10.1089/neu.2012.2520; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Nicolelis M. A., 2007, METHODS NEURAL ENSEM; OTIS TS, 1992, J NEUROPHYSIOL, V67, P227, DOI 10.1152/jn.1992.67.1.227; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Pelkey KA, 2017, PHYSIOL REV, V97, P1619, DOI 10.1152/physrev.00007.2017; Radnikow G, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00001; Rodrigues FA, 2016, PHYS REP, V610, P1, DOI 10.1016/j.physrep.2015.10.008; Roeper J, 2013, TRENDS NEUROSCI, V36, P336, DOI 10.1016/j.tins.2013.03.003; Saigal Rajiv, 2014, Neurosurgery, V75 Suppl 4, pS149, DOI 10.1227/NEU.0000000000000497; Schumm SN, 2020, FRONT COMPUT NEUROSC, V14, DOI 10.3389/fncom.2020.00018; Schwab Karen A, 2015, Handb Clin Neurol, V128, P649, DOI 10.1016/B978-0-444-63521-1.00040-6; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Soriano J, 2008, P NATL ACAD SCI USA, V105, P13758, DOI 10.1073/pnas.0707492105; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stephens JA, 2018, DEV NEUROREHABIL, V21, P423, DOI 10.1080/17518423.2017.1338777; Stoelzel CR, 2008, J NEUROSCI, V28, P5018, DOI 10.1523/JNEUROSCI.4726-07.2008; SWADLOW HA, 1985, J NEUROPHYSIOL, V54, P168, DOI 10.1152/jn.1985.54.1.168; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.026; van der Horn HJ, 2016, BRAIN IMAGING BEHAV, V10, P1243, DOI 10.1007/s11682-015-9489-y; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Vogel EW, 2017, J NEUROTRAUM, V34, P1063, DOI 10.1089/neu.2016.4578; Volman V, 2011, P NATL ACAD SCI USA, V108, P15402, DOI 10.1073/pnas.1112066108; Wang HL, 2006, ASIAN AUSTRAL J ANIM, V19; Wiles L, 2017, SCI REP-UK, V7, DOI 10.1038/srep44006; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; WOODSON W, 1989, J COMP NEUROL, V280, P254, DOI 10.1002/cne.902800207; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329; 2018, ADV MICROELECTRON MA, V45, P1	95	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0234749	10.1371/journal.pone.0234749			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX4NF	WOS:000575688700055	32966291	Green Published, gold, Green Submitted			2022-02-06	
J	Ruf, M; Pitzen, T; Meyer, C; Drumm, J				Ruf, Michael; Pitzen, Tobias; Meyer, Carolin; Drumm, Joerg			Atlantoaxial Rotatory Dislocation: Delayed Diagnose Will Result in More Invasive Treatment Options	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						atlantoaxial dislocation; atlantoaxial luxation; Grisel's syndrome; spinal trauma in children; atlantoaxial fusion	FIXATION; SUBLUXATION; REDUCTION; FUSION; SCREW	Purpose The atlantoaxial joint represents the most mobile joint complex within the spine, secured by ligaments and capsules. Integrity of the atlantoaxial joint is crucial with respect to the mobility of the head and the upper spine. Atlantoaxial rotatory dislocation is the most common type of injury within this joint in children and is characterized by a typical position of the head (cock robin position). Nevertheless, this type of injury is frequently overlooked. The purpose of the current study was threefold. First, the characteristics of the patients with atlantoaxial dislocation were identified. Next, we checked if the time to treatment did influence the type of treatment. Finally, we checked if the age of the child at the time of treatment influenced the type of treatment. Methods Forty-four children, who were treated consecutively due to atlantoaxial dislocation at a single spine center between September 1993 and October 2018, are analyzed retrospectively regarding age, sex, symptoms, etiology, time to diagnosis, time to treatment, and outcome. Results Forty-four children (30 girls, mean age 8.9 years) were included in the study. The cock robin head position was found in all of them, but neurological deficits were not found in any of them. In 21 patients, dislocation was caused by previous infection (Grisel's syndrome), whereas in 19 patients, dislocation was due to minor trauma. In 4 cases, etiology remained unknown. Mean time to sufficient treatment was 178 days. Eighteen patients received closed reduction and immobilization after 57 days at mean. Open reduction followed by temporary fixation was done in 12 patients after a mean time gap of 188 days. Bony atlantoaxial fusion was necessary in 14 children, who were diagnosed after 319 days on average. Invasiveness of treatment was dependent on the time delay between development of dislocation and treatment; a significant difference was found between invasiveness of treatment and time to treatment (Kruskal-Wallis test, p <0,05). Moreover, older children were treated significantly more often with fusion than younger ones ( <chi>(2) , p =0,002). Conclusion Young girls are predisposed to incur an atlantoaxial rotatory dislocation, which usually occurs due to minor trauma or infection. The cock robin position is characteristic, but neurological deficits are not common. There is a need for early and sufficient treatment because delayed treatment necessitates more invasive treatment, thus leading to a complete loss of function of the most mobile joint within the spine. Finally, older children are predisposed to more invasive treatment strategies.	[Ruf, Michael; Pitzen, Tobias; Drumm, Joerg] SRH Klinikum Karlsbad Langensteinbach, Ctr Spine Surg Orthoped & Traumatol, Karlsbad, Germany; [Meyer, Carolin] Univ Hosp Cologne, Dept Orthoped & Trauma Surg, Cologne, Germany		Ruf, M (corresponding author), SRH Klinikum Karlsbad Langensteinbach, Guttmannstr 1, D-76307 Karlsbad, Germany.	michael.ruf@kkl.srh.de					Bell C., 1830, NERVOUS SYSTEM HUMAN, P403; Glotzbecker MP, 2014, J PEDIATR ORTHOPED, V34, P490, DOI 10.1097/BPO.0000000000000128; GOEL A, 1994, ACTA NEUROCHIR, V129, P47, DOI 10.1007/BF01400872; Goto S, 1998, SPINE, V23, P1485, DOI 10.1097/00007632-199807010-00010; Harms J, 2001, SPINE, V26, P2467, DOI 10.1097/00007632-200111150-00014; Jeszenszky D, 2018, CLIN SPINE SURG, V31, pE252, DOI 10.1097/BSD.0000000000000563; Kim HJ, 2013, CURR OPIN PEDIATR, V25, P72, DOI 10.1097/MOP.0b013e32835bd4cf; Lopez AJ, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.1.FOCUS14807; Luck JF, 2013, SPINE, V38, pE1, DOI 10.1097/BRS.0b013e3182793873; Pitzen T, 2013, J NEUROSURG-SPINE, V19, P688, DOI 10.3171/2013.8.SPINE1349; Powell EC, 2017, PEDIATR EMERG CARE, V33, P86, DOI 10.1097/PEC.0000000000001023; Subach BR, 1998, SPINE, V23, P2174, DOI 10.1097/00007632-199810150-00006; Weisskopf M, 2005, EUR SPINE J, V14, P61, DOI 10.1007/s00586-004-0772-7	13	2	2	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	JAN	2021	82	01					1	8		10.1055/s-0040-1712940		SEP 2020	8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PO5EU	WOS:000572113300003	32968997				2022-02-06	
J	Wijenberg, MLM; Hicks, AJ; Downing, MG; van Heugten, CM; Stapert, SZ; Ponsford, JL				Wijenberg, Melloney L. M.; Hicks, Amelia J.; Downing, Marina G.; van Heugten, Caroline M.; Stapert, Sven Z.; Ponsford, Jennie L.			Relevance of the Fear-Avoidance Model for Chronic Disability after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						chronic disability; chronic phase; fear-avoidance model; traumatic brain injury	LOW-BACK-PAIN; TAMPA SCALE; PSYCHOMETRIC PROPERTIES; HOSPITAL ANXIETY; HEAD-INJURY; SYMPTOMS; KINESIOPHOBIA; DEPRESSION; SEVERITY; QUESTIONNAIRE	Previous studies convincingly suggest that the biopsychosocial fear-avoidance model (FAM) may be of added value in understanding chronic disability after traumatic brain injury (TBI). In this model, persistent symptoms occur as a result of catastrophizing and fear-avoidance regarding initial symptoms, leading to depression, reduced mental activity, and greater disability in daily functioning. This study examined the FAM in a large English-speaking TBI sample. A cross-sectional study was conducted in 117 individuals with complicated mild, moderate, or severe TBI at 1-5 years post-injury. Participants completed questionnaires assessing personal, injury-related, and psychological characteristics. Reliability, correlational, and regression analyses were performed. Main outcome measures of chronic disability were depression, disuse (e.g., fewer mental activities), and functional disability. The results revealed that all correlations suggested by the FAM were significant. Catastrophizing thoughts were positively associated with TBI-related symptoms and fear-avoidance thoughts. Main outcome measures were positively associated with fear-avoidance thoughts and TBI-related symptoms. Further, variables in the FAM were of additive value to personal, injury-related, and psychological variables in understanding chronic disability after TBI. The separate regression analyses for depression, fewer mental activities, and disability revealed "fear-avoidance thoughts" as the only consistent variable. In conclusion, this study shows the association of the FAM with chronic disability after TBI, which has implications for assessment and future management of the FAM in TBI in English-speaking countries. Longitudinal studies are warranted to further investigate and refine the model.	[Wijenberg, Melloney L. M.; van Heugten, Caroline M.; Stapert, Sven Z.] Maastricht Univ, Sch Mental Hlth & Neurosci, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Wijenberg, Melloney L. M.; van Heugten, Caroline M.] Limburg Brain Injury Ctr, Maastricht, Netherlands; [Hicks, Amelia J.; Downing, Marina G.; Ponsford, Jennie L.] Monash Univ, Turner Inst Brain & Mental Hlth, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Stapert, Sven Z.] Zuyderland Med Ctr, Dept Clin & Med Psychol, Sittard Geleen, Netherlands		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Monash Epworth Rehabil Res Ctr, 18 Innovat Walk, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu					Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; Cima RFF, 2011, EAR HEARING, V32, P634, DOI 10.1097/AUD.0b013e31821106dd; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Goubert L, 2004, CLIN J PAIN, V20, P103, DOI 10.1097/00002508-200403000-00007; Greenberg J, 2020, PSYCHOSOMATICS, V61, P49, DOI 10.1016/j.psym.2019.09.004; Greenwald BND, 2009, MT SINAI J MED, V76, P182, DOI 10.1002/msj.20103; Hosmer D W, 2013, APPL LOGISTIC REGRES, V398; Houben RMA, 2005, J BEHAV MED, V28, P415, DOI 10.1007/s10865-005-9011-x; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kline P., 2013, HDB PSYCHOL TESTING; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Mallery P, 2003, SPSS WINDOWS STEP ST; Martelli MF, 1999, ARCH CLIN NEUROPSYCH, V14, P804, DOI 10.1016/S0887-6177(99)80356-4; Nieto R, 2009, EUR J PAIN, V13, P518, DOI 10.1016/j.ejpain.2008.06.005; Nijs J, 2013, CLIN RHEUMATOL, V32, P1121, DOI 10.1007/s10067-013-2277-4; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Nucci Massimo, 2012, Aging Clin Exp Res, V24, P218, DOI 10.3275/7800; Ponsford J., 2016, INNOVATIONS FUTURE D, P182; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Roelofs J, 2004, EUR J PAIN, V8, P495, DOI 10.1016/j.ejpain.2003.11.016; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Scheenen M.E., 2016, J NEUROTRAUM, V34, P31; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Silberstein Morry, 2002, Neurosurg Focus, V13, pecp2, DOI 10.3171/foc.2002.13.1.6; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Snell DL, 2020, J NEUROTRAUM, V37, P1566, DOI 10.1089/neu.2019.6729; Spence M, 2005, PSYCHOL MED, V35, P583, DOI 10.1017/S0033291704003484; Steiner WA, 2002, PHYS THER, V82, P1098, DOI 10.1093/ptj/82.11.1098; Tabachnick B.G., 2007, USING MULTIVARIATE S, V5; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Todd D., 1998, COGNIPHOBIA SCALE C, pdomain; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Velthuis MJ, 2012, ARCH PHYS MED REHAB, V93, P332, DOI 10.1016/j.apmr.2011.08.014; Vlaeyen JWS, 2016, PAIN, V157, P1588, DOI 10.1097/j.pain.0000000000000574; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Wijenberg MLM, 2016, J BEHAV MED, V39, P815, DOI 10.1007/s10865-016-9749-3; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wood, 2017, NEUROBEHAVIOURAL DIS, P167; Woods MP, 2008, PAIN, V136, P271, DOI 10.1016/j.pain.2007.06.037; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	2	2	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2020	37	24					2639	2646		10.1089/neu.2020.7135		SEP 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PF0CR	WOS:000574497400001	32842860	Green Submitted			2022-02-06	
J	Greer, K; Basso, EKG; Kelly, C; Cash, A; Kowalski, E; Cerna, S; Ocampo, CT; Wang, X; Theus, MH				Greer, Kisha; Basso, Erwin Kristobal Gudenschwager; Kelly, Colin; Cash, Alison; Kowalski, Elizabeth; Cerna, Steven; Ocampo, Collin Tanchanco; Wang, Xia; Theus, Michelle H.			Abrogation of atypical neurogenesis and vascular-derived EphA4 prevents repeated mild TBI-induced learning and memory impairments	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; ADULT HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; MOUSE MODEL; STEM-CELLS; C-FOS; NICHE; CONSEQUENCES; NEURONS; DIFFERENTIATION	Brain injury resulting from repeated mild traumatic insult is associated with cognitive dysfunction and other chronic co-morbidities. The current study tested the effects of aberrant neurogenesis in a mouse model of repeated mild traumatic brain injury (rmTBI). Using Barnes Maze analysis, we found a significant reduction in spatial learning and memory at 24 days post-rmTBI compared to repeated sham (rSham) injury. Cell fate analysis showed a greater number of BrdU-labeled cells which co-expressed Prox-1 in the DG of rmTBI-injured mice which coincided with enhanced cFos expression for neuronal activity. We then selectively ablated dividing neural progenitor cells using a 7-day continuous infusion of Ara-C prior to rSham or rmTBI. This resulted in attenuation of cFos and BrdU-labeled cell changes and prevented associated learning and memory deficits. We further showed this phenotype was ameliorated in EphA4f.(/f)/Tie2-Cre knockout compared to EphA4f.(/f) wild type mice, which coincided with altered mRNA transcript levels of MCP-1, Cx43 and TGF beta. These findings demonstrate that cognitive decline is associated with an increased presence of immature neurons and gene expression changes in the DG following rmTBI. Our data also suggests that vascular EphA4-mediated neurogenic remodeling adversely affects learning and memory behavior in response to repeated insult.	[Greer, Kisha; Theus, Michelle H.] Virginia Tech, Grad Program Translat Biol Med & Hlth, Blacksburg, VA 24061 USA; [Basso, Erwin Kristobal Gudenschwager; Kelly, Colin; Cash, Alison; Kowalski, Elizabeth; Cerna, Steven; Ocampo, Collin Tanchanco; Wang, Xia; Theus, Michelle H.] Virginia Tech, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Theus, Michelle H.] Virginia Maryland Coll Vet Med, Ctr Regenerat Med, Blacksburg, VA 24061 USA; [Theus, Michelle H.] Virginia Tech, Ctr Engineered Hlth, Blacksburg, VA 24061 USA		Theus, MH (corresponding author), Virginia Tech, Grad Program Translat Biol Med & Hlth, Blacksburg, VA 24061 USA.; Theus, MH (corresponding author), Virginia Tech, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.; Theus, MH (corresponding author), Virginia Maryland Coll Vet Med, Ctr Regenerat Med, Blacksburg, VA 24061 USA.; Theus, MH (corresponding author), Virginia Tech, Ctr Engineered Hlth, Blacksburg, VA 24061 USA.	mtheus@vt.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096281, R01NS092681]; Center for Engineered Health; Institute for Critical Technology and Science (JFA award); Initiative for Maximizing Student Development (IMSD)	This work was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, R01NS096281 (MHT) and Diversity Supplement to R01NS092681 (KMG). We thank Dr. Gregorio Valdez for the FGF2 primers. We recognize The Center for Engineered Health, The Institute for Critical Technology and Science (JFA award, MHT) and the Initiative for Maximizing Student Development (IMSD) for support (KMG).	Antonius D, 2014, J NEUROPSYCH CLIN N, V26, P313, DOI 10.1176/appi.neuropsych.13090201; Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Brickler TR, 2018, J NEUROSCI, V38, P9618, DOI 10.1523/JNEUROSCI.0914-18.2018; Cameron MC, 2011, J COMP NEUROL, V519, P2175, DOI 10.1002/cne.22623; Coulthard MG, 2012, AM J PATHOL, V181, P1493, DOI 10.1016/j.ajpath.2012.06.043; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dixon KJ, 2015, J NEUROTRAUM, V32, P753, DOI 10.1089/neu.2014.3390; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Feng L, 2017, MOL MED REP, V15, P37, DOI 10.3892/mmr.2016.6017; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gusel'nikova VV, 2015, ACTA NATURAE, V7, P42, DOI 10.32607/20758251-2015-7-2-42-47; Hara Y, 2010, STEM CELLS, V28, P974, DOI 10.1002/stem.427; Holzmann J, 2015, DEV NEUROBIOL, V75, P1352, DOI 10.1002/dneu.22289; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Cuartero MI, 2019, J CLIN INVEST, V129, P1536, DOI 10.1172/JCI120412; Kang WF, 2015, J NEUROSCI, V35, P10217, DOI 10.1523/JNEUROSCI.1469-15.2015; Kawashima T, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00037; Kowalski EA, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1605-2; Laussu J, 2014, CELL ADHES MIGR, V8, P349, DOI 10.4161/19336918.2014.969990; Lee E, 2009, BMB REP, V42, P239, DOI 10.5483/BMBRep.2009.42.5.239; Licht T, 2015, MECH DEVELOP, V138, P56, DOI 10.1016/j.mod.2015.06.001; Lieberwirth C, 2016, BRAIN RES, V1644, P127, DOI 10.1016/j.brainres.2016.05.015; Liebmann M, 2013, NEUROSCI LETT, V545, P40, DOI 10.1016/j.neulet.2013.04.013; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Miao H, 2012, SEMIN CELL DEV BIOL, V23, P16, DOI 10.1016/j.semcdb.2011.10.013; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Myers CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068208; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Niv F, 2012, STROKE, V43, P2468, DOI 10.1161/STROKEAHA.112.660977; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Okyere B, 2020, J CLIN INVEST, V130, P1024, DOI 10.1172/JCI131493; Okyere B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159930; Ottone C, 2015, CELL CYCLE, V14, P2222, DOI 10.1080/15384101.2015.1049785; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pineda JR, 2013, EMBO MOL MED, V5, P548, DOI 10.1002/emmm.201202197; Robinson C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1347987; Rozental R, 1998, J NEUROSCI, V18, P1753; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Shors TJ, 2008, CELL STEM CELL, V3, P253, DOI 10.1016/j.stem.2008.08.010; Shu Y, 2016, MOL NEUROBIOL, V53, P561, DOI 10.1007/s12035-014-9020-2; Sultan S, 2010, FASEB J, V24, P2355, DOI 10.1096/fj.09-151456; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Sun GJ, 2015, P NATL ACAD SCI USA, V112, P9484, DOI 10.1073/pnas.1508545112; TAKEMOTO O, 1995, STROKE, V26, P1639, DOI 10.1161/01.STR.26.9.1639; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Upton M, 2015, BIOCHEM PHARMACOL, V97, P558, DOI 10.1016/j.bcp.2015.06.015; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Woitke F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183463; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang JH, 1997, MOL BRAIN RES, V47, P202, DOI 10.1016/S0169-328X(97)00051-X; Zhang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/727542; Zhu K, 2018, EPILEPSY RES, V142, P1, DOI 10.1016/j.eplepsyres.2018.03.004	68	2	2	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	SEP 21	2020	10	1							15374	10.1038/s41598-020-72380-1			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU6PO	WOS:000573764600012	32958852	Green Published, gold			2022-02-06	
J	Lin, XJ; Liu, RX; Li, CY; Yi, XQ; Fu, B; Walker, MJ; Xu, XM; Sun, G; Lin, CH				Lin, Xiao-Jing; Liu, Ruoxu; Li, Chenyi; Yi, Xueqing; Fu, Bo; Walker, M. J.; Xu, Xiao-Ming; Sun, Gang; Lin, Cheng-Hsien			Melatonin ameliorates spatial memory and motor deficits via preserving the integrity of cortical and hippocampal dendritic spine morphology in mice with neurotrauma	INFLAMMOPHARMACOLOGY			English	Article						Melatonin; IL-1 beta; IL-6; TNF-alpha; IL-10; IL-8; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DOUBLECORTIN EXPRESSION	We aimed to elucidate the role of cortical and hippocampal dendritic spines on neurological deficits associated with hippocampal microgliosis, hippocampal neurogenesis, and neuroinflammation in mice with cortical compact impact (CCI) injury. In the present study, we found that CCI reduced spatial memory mean latency (10 s. vs 50 s) and motor dysfunction (130 s. vs 150 s.) in mice, as determined by Morris water maze and rotarod test, respectively. Golgi staining of cortical pyramidal neurons revealed that, compared to the controls, the CCI group treated with vehicle solution had significantly lower values of dendritic order (or dendritic branch number) (4.0 vs 6.2), total spine length (400 mu m vs 620 mu m) and spine density (40 spines/mu m vs 60 spines/mu m), but had significantly higher values of dendritic beading (40 beadings/mm vs 20 beadings/mm). Additionally, Sholl analysis showed that, compared to controls, the CCI + NS group mice had significantly lower values of dendritic intersections (1.0 vs 2.0). Immunofluorescence assay also revealed that, compared to controls, the CCI + NS group mice had significantly higher values of the newly formed hippocampal cells (1250/mm(2)vs 1000/mm(2)) but significantly lower values of dendritic order (2.0 branch # vs 4.2 branch #), total spine length (180 mu m vs 320 mu m) and intersection (1.0 vs 3.0). The CCI + NS group mice further showed significantly higher numbers of microglia in the dentate gyrus of the hippocampus and higher concentrations of pro-inflammatory cytokines in the cerebrospinal fluids. All the CCI-induced spatial memory (40 s) and motor (150 s) dysfunction, deranged dendritic and spine morphology of cortical pyramidal neurons or hippocampal newly formed cells, hippocampal microgliosis, and central neuroinflammation were all significantly reduced by melatonin administration during post-CCI. Simultaneously, melatonin therapy caused an enhancement in the compensatory hippocampal neurogenesis and neurotrophic growth factors (e.g., doublecortin-1) and compensatory central anti-inflammatory cytokines. Our results indicate that melatonin attenuates the spatial memory and motor deficits via the modification of cortical and hippocampal dendritic spine morphology, hippocampal microgliosis and neurogenesis, and neuroinflammation in mice with traumatic brain injury.	[Lin, Xiao-Jing] 960th Hosp Joint Logist Support Force PLA, Trauma & Orthoped Inst Chinese PLA, Dept Spinal Cord Injury & Repair, Jinan, Shandong, Peoples R China; [Lin, Xiao-Jing; Liu, Ruoxu; Li, Chenyi; Fu, Bo] Acad Mil Med Sci, Inst Mil Cognit & Brain Sci, Beijing 100850, Peoples R China; [Yi, Xueqing; Sun, Gang] 960th Hosp Joint Logist Support Force PLA, Dept Med Imaging, Jinan, Shandong, Peoples R China; [Walker, M. J.; Xu, Xiao-Ming] Indiana Univ Sch Med, Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN 46202 USA; [Walker, M. J.; Xu, Xiao-Ming] Indiana Univ Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA; [Walker, M. J.; Xu, Xiao-Ming] Indiana Univ Sch Med, Goodman & Campbell Brain & Spine, Indianapolis, IN 46202 USA; [Walker, M. J.; Xu, Xiao-Ming] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Lin, Cheng-Hsien] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Lin, Cheng-Hsien] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan		Sun, G (corresponding author), 960th Hosp Joint Logist Support Force PLA, Dept Med Imaging, Jinan, Shandong, Peoples R China.; Lin, CH (corresponding author), Mackay Med Coll, Dept Med, New Taipei, Taiwan.; Lin, CH (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	cjr.sungang@vip.163.com; davidlin@mmc.edu.tw			Ministry of Science and Technology of the Republic of ChinaMinistry of Science and Technology, China [MOST 108-2314-B-715-001]; Mackay Memorial Hospital [MMH-MM-10807]; Mackay Medical College [1081A01]; Innovation Project in Military Medicine Research, PLA, P.R. China [19QNP087]; Foundation of the Director of the 960th Hospital, Joint Logistics Force of PLA [2018ZX03]; Logistics Research Program of PLA [CJN13J004]	This work was supported by the Ministry of Science and Technology of the Republic of China (MOST 108-2314-B-715-001), Mackay Memorial Hospital (MMH-MM-10807) and Mackay Medical College (1081A01) to Chen-Chia Tsai and Cheng-Hsien Lin and the Innovation Project in Military Medicine Research, PLA, P.R. China (19QNP087), Foundation of the Director of the 960th Hospital, Joint Logistics Force of PLA (2018ZX03) and Logistics Research Program of PLA (CJN13J004) to Xiaojing Lin, Ruoxu Liu, and Gang Sun.	Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Barlow KM, 2019, J NEUROTRAUM, V36, P523, DOI 10.1089/neu.2018.5752; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Campolo M, 2013, J ENDOCRINOL, V217, P291, DOI 10.1530/JOE-13-0022; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Cheng XP, 2012, J PHARMACOL SCI, V119, P177, DOI 10.1254/jphs.11183FP; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0867-9; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dehghan F, 2018, INFLAMMOPHARMACOLOGY, V26, P1017, DOI 10.1007/s10787-017-0417-1; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Ito T, 2007, J THROMB HAEMOST, V5, P109, DOI 10.1111/j.1538-7836.2006.02255.x; Jilg A, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12553; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Khakpai F, 2013, EXCLI J, V12, P41; Kirwan CB, 2005, NEUROBIOL LEARN MEM, V83, P65, DOI 10.1016/j.nlm.2004.08.001; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Naseem Mehar, 2014, ScientificWorldJournal, V2014, P586270, DOI 10.1155/2014/586270; Paxinos G, 1982, MOUSE BRAIN STEREOTA; Figueredo LZP, 2008, BRAIN RES BULL, V77, P71, DOI 10.1016/j.brainresbull.2008.05.008; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1159/000025480; SHOLL DA, 1953, J ANAT, V87, P387; Solas M, 2015, CURR PHARM DESIGN, V21, P4960, DOI 10.2174/1381612821666150914121149; Thorajak P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070686; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977	32	2	3	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0925-4692	1568-5608		INFLAMMOPHARMACOLOGY	Inflammopharmacology	DEC	2020	28	6					1553	1566		10.1007/s10787-020-00750-2		SEP 2020	14	Immunology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy; Toxicology	OE5OE	WOS:000571690400001	32959092				2022-02-06	
J	Liu, B; Zhang, G; Cui, SK; Du, GL				Liu, Bin; Zhang, Gang; Cui, Shukun; Du, Guoliang			Inhibition of RNF6 alleviates traumatic brain injury by suppressing STAT3 signaling in rats	BRAIN AND BEHAVIOR			English	Article						JAK-STAT3 signaling pathway; ring finger protein 6; SH2-containing tyrosine phosphatase-1 (SHP-1); traumatic brain injury	NF-KAPPA-B; TBI; NEUROINFLAMMATION; ACTIVATION; PATHWAY; JAK2/STAT3; KNOCKDOWN; BLOCKADE	Background Traumatic brain injury (TBI) has ranked as one of the leading causes of disability and death in the world. The neuroinflammation mediated by signal transducer and activator of transcription 3 (STAT3) signaling during the progression of TBI leads to long-term neurodegeneration. Ring finger protein 6 (RNF-6) is an E3 ubiquitin ligase and can regulate the activity of STAT3 signaling pathway by targeting its inhibitors. However, the mechanism underlying this process in TBI remains poorly understood. Methods In this research, cortical impact injury was used to construct the TBI rat model. Western blot assay was performed to evaluate the protein levels of RNF6, Src homology 2 domain-containing protein tyrosine phosphatase 1 (SHP-1), and STAT3/pSTAT3. QRT-PCR assay was performed to assess the RNA levels of RNF6 and other cytokines. The neural function of TBI rats was estimated by modified Neurological Severity Scores test. Results The expression of RNF-6 was up-regulated in the brain tissues of TBI rats. Down-regulation of RNF6 alleviated the symptoms and improved the neural recovery postinjury in TBI rats. Inhibition of RNF6 suppressed the cerebral inflammation by up-regulating the protein level of SHP-1 and down-regulating the phosphorylation level of STAT3. Conclusion Inhibition of RNF6 alleviated TBI by suppressing the STAT3 signaling in TBI rats.	[Liu, Bin; Zhang, Gang; Cui, Shukun; Du, Guoliang] Cangzhou Cent Hosp, Dept Neurosurg 6, Xinhua West Rd, Cangzhou 061000, Hebei, Peoples R China		Liu, B (corresponding author), Cangzhou Cent Hosp, Dept Neurosurg 6, Xinhua West Rd, Cangzhou 061000, Hebei, Peoples R China.	tjmulb2010@163.com					Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Beldi-Ferchiou A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174835; Bhat SA, 2016, MOL NEUROBIOL, V53, P6950, DOI 10.1007/s12035-015-9584-5; Bomyea J, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000278; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Choi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067891; Ciccia AH, 2018, NEUROREHABILITATION, V42, P331, DOI 10.3233/NRE-172384; Cui DM, 2017, CNS NEUROSCI THER, V23, P106, DOI 10.1111/cns.12633; David D, 2013, BBA-REV CANCER, V1835, P119, DOI 10.1016/j.bbcan.2012.11.003; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Donnelly JE, 2017, CHILD NERV SYST, V33, P1735, DOI 10.1007/s00381-017-3523-x; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gong P, 2019, EUR J PHARMACOL, V854, P289, DOI 10.1016/j.ejphar.2019.04.028; Huang ZM, 2018, ONCOTARGETS THER, V11, P6579, DOI 10.2147/OTT.S174846; Jiang Ziyun, 2020, STEMEDICINE, V1, pE59, DOI [DOI 10.37175/STEMEDICINE.V1I3.59, 10.37175/stemedicine.v1i3.59]; Li J, 2015, AM J EMERG MED, V33, P1191, DOI 10.1016/j.ajem.2015.05.023; Liu L, 2018, CANCER RES, V78, P1958, DOI 10.1158/0008-5472.CAN-17-2683; Macdonald DHC, 1999, GENOMICS, V58, P94, DOI 10.1006/geno.1999.5802; Marshall CA, 2019, BRAIN INJURY, V33, P255, DOI 10.1080/02699052.2018.1553308; Miles SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184265; Noggle CA, 2010, APPL NEUROPSYCHOL, V17, P123, DOI 10.1080/09084281003709009; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Pink AE, 2021, NEUROPSYCHOL REHABIL, V31, P479, DOI 10.1080/09602011.2019.1706585; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Saleem MZ, 2020, ONCOTARGETS THER, V13, P435, DOI 10.2147/OTT.S228702; Shi S, 2016, J ALZHEIMERS DIS, V50, P859, DOI 10.3233/JAD-150963; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Xu X, 2016, J BIOL CHEM, V291, P9617, DOI 10.1074/jbc.M115.701979; Yu CI, 2020, NEUROTOX RES, V38, P163, DOI 10.1007/s12640-020-00197-x; Zaninotto Ana Luiza, 2019, Dement. neuropsychol., V13, P172, DOI 10.1590/1980-57642018dn13-020005; Zeng KW, 2014, PHYTOMEDICINE, V21, P298, DOI 10.1016/j.phymed.2013.08.016; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001; Zheng TT, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1697-5; Zhou KC, 2019, PHYTOMEDICINE, V59, DOI 10.1016/j.phymed.2019.152922; Zong SH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/786947	36	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	DEC	2020	10	12							e01847	10.1002/brb3.1847		SEP 2020	8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	PL3RK	WOS:000571247300001	32955171	Green Published, gold			2022-02-06	
J	Adams, JW; Alosco, ML; Mez, J; Alvarez, VE; Huber, BR; Tripodis, Y; Adler, CH; Kubilius, C; Cormier, KA; Mathais, R; Nicks, R; Kelley, HJ; Saltiel, N; Uretsky, M; Nair, E; Aytan, N; Cherry, JD; Nowinski, CJ; Kowall, NW; Goldstein, LE; Dwyer, B; Katz, DI; Cantu, RC; Stern, RA; McKee, AC; Stein, TD				Adams, Jason W.; Alosco, Michael L.; Mez, Jesse; Alvarez, Victor E.; Huber, Bertrand R.; Tripodis, Yorghos; Adler, Charles H.; Kubilius, Carol; Cormier, Kerry A.; Mathais, Rebecca; Nicks, Raymond; Kelley, Hunter J.; Saltiel, Nicole; Uretsky, Madeline; Nair, Evan; Aytan, Nurgul; Cherry, Jonathan D.; Nowinski, Christopher J.; Kowall, Neil W.; Goldstein, Lee E.; Dwyer, Brigid; Katz, Douglas I.; Cantu, Robert C.; Stern, Robert A.; McKee, Ann C.; Stein, Thor D.			Association of probable REM sleep behavior disorder with pathology and years of contact sports play in chronic traumatic encephalopathy	ACTA NEUROPATHOLOGICA			English	Article						Chronic traumatic encephalopathy; REM sleep behavior disorder; Lewy body disease; Repetitive head impacts; Contact sports	NEURODEGENERATIVE DISEASE; PARKINSON DISEASE; NEUROPATHOLOGIC ASSESSMENT; COGNITIVE IMPAIRMENT; NATIONAL INSTITUTE; INCREASES RISK; BRAIN-INJURY; DEMENTIA; SYSTEM; DEGENERATION	Probable rapid eye movement (REM) sleep behavior disorder (pRBD) is a synucleinopathy-associated parasomnia in which loss of REM sleep muscle atonia results in motor behavior during REM sleep, including dream enactment. Traumatic brain injury is independently associated with increased risk of pRBD and Lewy body disease, and both pRBD and Lewy body disease are often observed in chronic traumatic encephalopathy (CTE). However, the frequency and pathological substrate of pRBD in CTE have not been formally studied and remain unknown. Of the total sample of 247 men, age at death of 63.1 +/- 18.8 years (mean +/- SD), 80 [32%] were determined by informant report to have symptoms of pRBD. These participants had played more years of contact sports (18.3 +/- 11.4) than those without pRBD (15.1 +/- 6.5;P = 0.02) and had an increased frequency of Lewy body disease (26/80 [33%] vs 28/167 [17%],P = 0.005). Of the 80 participants with pRBD, 54 [68%] did not have Lewy body disease; these participants were more likely to have neurofibrillary tangles and pretangles in the dorsal and median raphe (41 of 49 [84%] non-LBD participants with pRBD symptoms vs 90 of 136 [66%] non-LBD participants without pRBD symptoms,P = 0.02), brainstem nuclei with sleep regulatory function. Binary logistic regression modeling in the total study sample showed that pRBD in CTE was associated with dorsal and median raphe nuclei neurofibrillary tangles (OR = 3.96, 95% CI [1.43, 10.96],P = 0.008), Lewy body pathology (OR = 2.36, 95% CI [1.18, 4.72],P = 0.02), and years of contact sports participation (OR = 1.04, 95% CI [1.00, 1.08],P = 0.04). Overall, pRBD in CTE is associated with increased years of contact sports participation and may be attributable to Lewy body and brainstem tau pathologies.	[Adams, Jason W.; Alosco, Michael L.; Mez, Jesse; Alvarez, Victor E.; Huber, Bertrand R.; Tripodis, Yorghos; Kubilius, Carol; Cormier, Kerry A.; Mathais, Rebecca; Nicks, Raymond; Kelley, Hunter J.; Saltiel, Nicole; Uretsky, Madeline; Nair, Evan; Aytan, Nurgul; Cherry, Jonathan D.; Nowinski, Christopher J.; Kowall, Neil W.; Goldstein, Lee E.; Stern, Robert A.; McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Adams, Jason W.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Alosco, Michael L.; Mez, Jesse; Alvarez, Victor E.; Aytan, Nurgul; Cherry, Jonathan D.; Kowall, Neil W.; Dwyer, Brigid; Katz, Douglas I.; Stern, Robert A.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Alvarez, Victor E.; Huber, Bertrand R.; Cormier, Kerry A.; Kowall, Neil W.; McKee, Ann C.; Stein, Thor D.] VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Adler, Charles H.] Mayo Clin, Parkinsons Dis & Movement Disorders Ctr, Dept Neurol, Scottsdale, AZ USA; [Cormier, Kerry A.; McKee, Ann C.; Stein, Thor D.] Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA; [Nowinski, Christopher J.; Cantu, Robert C.] Concuss Legacy Fdn, Boston, MA USA; [Goldstein, Lee E.; McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Dwyer, Brigid; Katz, Douglas I.] Braintree Rehabil Hosp, Brain Injury Program, Braintree, MA USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA USA		Stein, TD (corresponding author), Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA.; Stein, TD (corresponding author), VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA.; Stein, TD (corresponding author), Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA.; Stein, TD (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA.	tdstein@bu.edu	, Bob/ABA-8507-2020; Adler, Charles/ABD-5276-2021	Uretsky, Madeline/0000-0002-7604-3619	Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award [I01-CX001038]; Alzheimer's AssociationAlzheimer's Association [NIRG-305779, NIRG-362697]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5T32GM007198]; National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG054156, R56AG057768, RF1AG057768, K23AG046377]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS115266, U01NS086659, K23NS102399]; National Institute of Aging Boston University AD Center [P30AG13846, 0572063345-5]; Department of Defense Peer Reviewed Alzheimer's Research Program (PRARP) [13267017]; Concussion Legacy Foundation; Andlinger Foundation; WWE; Veterans Affairs Biorepository [BX002466]	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award (I01-CX001038); Veterans Affairs Biorepository (BX002466); Alzheimer's Association (NIRG-305779, NIRG-362697); National Institute of General Medical Sciences (5T32GM007198); National Institute of Aging (RF1AG054156, R56AG057768, RF1AG057768, K23AG046377); National Institute of Neurological Disorders and Stroke (U54NS115266, U01NS086659, K23NS102399); National Institute of Aging Boston University AD Center (P30AG13846; supplement 0572063345-5); Department of Defense Peer Reviewed Alzheimer's Research Program (PRARP #13267017); and the Concussion Legacy Foundation. This work was also supported by unrestricted gifts from the Andlinger Foundation and WWE.	Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Adler CH, 2014, NEUROLOGY, V83, P406, DOI 10.1212/WNL.0000000000000641; Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7; Benarroch EE, 2007, ACTA NEUROPATHOL, V114, P213, DOI 10.1007/s00401-007-0260-3; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Boeve B, 2003, NEUROLOGY, V61, P40, DOI 10.1212/01.WNL.0000073619.94467.B0; Boeve BF, 2007, BRAIN, V130, P2770, DOI 10.1093/brain/awm056; Boeve BF, 2013, SLEEP MED, V14, P754, DOI 10.1016/j.sleep.2012.10.015; Boeve BF, 2001, MOVEMENT DISORD, V16, P622, DOI 10.1002/mds.1120; Boeve BF, 2013, J CLIN SLEEP MED, V9, P471, DOI 10.5664/jcsm.2670; Boeve BF, 2013, LANCET NEUROL, V12, P469, DOI 10.1016/S1474-4422(13)70054-1; Boeve BF, 2011, SLEEP MED, V12, P445, DOI 10.1016/j.sleep.2010.12.009; Boeve BF, 2010, ANN NY ACAD SCI, V1184, P15, DOI 10.1111/j.1749-6632.2009.05115.x; Boot BP, 2012, ANN NEUROL, V71, P49, DOI 10.1002/ana.22655; Campbell G, 2011, J BIOPHARM STAT, V21, P180, DOI 10.1080/10543406.2011.550094; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dauvilliers Y, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0016-5; Ferman TJ, 2011, NEUROLOGY, V77, P875, DOI 10.1212/WNL.0b013e31822c9148; Garcia SV, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02761-0; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Haba-Rubio J, 2018, SLEEP, V41, DOI 10.1093/sleep/zsx197; HALLIDAY GM, 1990, ANN NEUROL, V27, P373, DOI 10.1002/ana.410270405; HALLIDAY GM, 1990, BRAIN RES, V510, P104, DOI 10.1016/0006-8993(90)90733-R; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Iranzo A, 2005, SLEEP, V28, P203, DOI 10.1093/sleep/28.2.203; Iranzo A, 2013, LANCET NEUROL, V12, P443, DOI 10.1016/S1474-4422(13)70056-5; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935; Kimura K, 2000, NEUROLOGY, V55, P894, DOI 10.1212/WNL.55.6.894; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Koga S, 2015, NEUROLOGY, V85, P404, DOI 10.1212/WNL.0000000000001807; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Krohn L, 2020, ANN NEUROL, V87, P584, DOI 10.1002/ana.25687; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; McKenna D, 2017, MOVEMENT DISORD, V32, P636, DOI 10.1002/mds.27003; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Monti JM, 2011, SLEEP MED REV, V15, P269, DOI 10.1016/j.smrv.2010.11.003; Monti JM, 2010, SLEEP MED REV, V14, P319, DOI 10.1016/j.smrv.2009.10.003; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Nitz D, 1997, AM J PHYSIOL-REG I, V273, pR451, DOI 10.1152/ajpregu.1997.273.1.R451; PAULUS W, 1991, J NEUROPATH EXP NEUR, V50, P743, DOI 10.1097/00005072-199111000-00006; Postuma RB, 2012, BRAIN, V135, P1860, DOI 10.1093/brain/aws093; Postuma RB, 2012, NEUROLOGY, V79, P248; Postuma RB, 2015, MOVEMENT DISORD, V30, P1413, DOI 10.1002/mds.26347; Postuma Ronald B, 2012, Mov Disord, V27, P913, DOI 10.1002/mds.25037; Postuma RB, 2012, MOVEMENT DISORD, V27, P720, DOI 10.1002/mds.24939; SCHENCK CH, 1987, JAMA-J AM MED ASSOC, V257, P1786, DOI 10.1001/jama.257.13.1786; SCHENCK CH, 1986, SLEEP, V9, P293, DOI 10.1093/sleep/9.2.293; Shprecher DR, 2018, PARKINSONISM RELAT D, V55, P92, DOI 10.1016/j.parkreldis.2018.05.020; Siegel JM., 2017, PRINCIPLES PRACTICE, P78, DOI [10.1016/B978-0-323-24288-2.00008-8, DOI 10.1016/B978-0-323-24288-2.00008-8]; St Louis EK, 2017, MOVEMENT DISORD, V32, P645, DOI 10.1002/mds.27018; St Louis EK, 2014, NEUROLOGY, V83, P1871, DOI 10.1212/WNL.0000000000000978; Standring OJ, 2019, ACTA NEUROPATHOL, V138, P401, DOI 10.1007/s00401-019-02031-x; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tippmann-Peikert M, 2006, NEUROLOGY, V66, P1277, DOI 10.1212/01.wnl.0000208518.72660.ff; Ursin Reidun, 2008, P3, DOI 10.1007/978-3-7643-8561-3_1; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9	72	2	2	3	9	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	DEC	2020	140	6					851	862		10.1007/s00401-020-02206-x		SEP 2020	12	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	OS2BW	WOS:000570037100001	32939646	Green Accepted			2022-02-06	
J	Krueger, EM; Finneran, MM; Smith, M				Krueger, Evan M.; Finneran, Megan M.; Smith, Michelle			Management Strategies and Outcomes of Hemorrhagic Traumatic Brain Injury on Oral Anticoagulants	CUREUS			English	Article						traumatic brain injury; anticoagulation; antiplatelet; intracranial hemorrhage	PLATELET TRANSFUSION; ANTIPLATELET; STROKE; CARE	Introduction: Traumatic brain injury (TBI) is common, and the frequency of patients taking oral anticoagulants is increasing. However the optimal initial triage, management, and long term care plans of hemorrhagic TBI patients taking oral anticoagulants is not clear. Objectives: To determine the usage pattern of reversal agents for hemorrhagic TBI patients taking oral anticoagulants, and examine their characteristics and outcomes as compared to hemorrhagic TBI patients not taking these medications. Methods: This was a single-center, retrospective, observational study. Included were adults with trauma categorization and traumatic intracranial hemorrhage (ICH) between April 1, 2017 and December 31, 2019. Patient age, type of ICH, initial Glasgow Coma Scale (GCS) score, oral anticoagulant prescribed pre-injury, anticoagulation reversal agent given, and hospital discharge disposition were recorded. Results: For the entire sample size (n=111), the mean age and GCS were 71.6 years old and 13.8, respectively. Compared to patients not taking oral anticoagulants, patients taking oral anticoagulants were older (76.7 years old versus 69.1; p<0.01), had similar GCS scores (13.7 versus 13.9; p=0.69), had fewer subarachnoid hemorrhages (18.9% versus 37.8%; p=0.04), were less likely to discharge home (48.6% versus 73.0%; p=0.01), and had similar incidence of mortality (13.5% versus 6.7%; p=0.30). A total of 14/37 (37.8%) patients taking oral anticoagulants received reversal agents in the emergency department. Compared to patients taking oral anticoagulants and not given reversal agents, patients taking oral anticoagulants and given reversal agents had similar ages (78.8 years old versus 75.4; p=0.41), had similar GCS scores (12.9 versus 14.1; p=0.17), had similar ICH types (all p=1.0), were less likely to discharge home (48.6% versus 73.0%; p=0.01), and had higher incidence of mortality (28.6% versus 4.2%; p=0.05). Conclusions: This limited data set did not show improved outcomes by giving reversal agents to hemorrhagic TBI patients taking oral anticoagulants. However, until more robust data is available, judicious use of reversal agents in this high-risk patient population should remain common practice.	[Krueger, Evan M.; Finneran, Megan M.] Carle Fdn Hosp, Dept Neurosurg, Normal, IL 61801 USA; [Smith, Michelle] OSF Hlth Care, Dept Trauma, Bloomington, IL USA		Krueger, EM (corresponding author), Carle Fdn Hosp, Dept Neurosurg, Normal, IL 61801 USA.	dr.evankrueger@gmail.com					Babu MA, 2019, NEUROSURGERY, V84, P977, DOI 10.1093/neuros/nyy354; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Centers for Disease Control and Prevention, 2010, DAT STAT WISQARS COS; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Frontera JA, 2020, J THROMB THROMBOLYS, V49, P121, DOI 10.1007/s11239-019-01973-z; Hawryluk GWJ, 2010, J THROMB HAEMOST, V8, P1500, DOI 10.1111/j.1538-7836.2010.03882.x; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Jehan F, 2019, J SURG RES, V236, P224, DOI 10.1016/j.jss.2018.11.050; Kerr K, 2016, CLIN NEUROL NEUROSUR, V140, P85, DOI 10.1016/j.clineuro.2015.11.012; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Krueger EM, 2019, CUREUS, V11, DOI 10.7759/cureus.5982; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Ogunlade J, 2018, CLIN NEUROL NEUROSUR, V174, P163, DOI 10.1016/j.clineuro.2018.09.021; Prexl O, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0487-0; Puckett Y, 2018, CUREUS, V10, DOI 10.7759/cureus.2920; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Xu Yan, 2013, CMAJ Open, V1, pE115, DOI 10.9778/cmajo.20130032	18	2	2	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	SEP 17	2020	12	9							e10508	10.7759/cureus.10508			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NP2ZT	WOS:000570050000010	33094049	gold, Green Published			2022-02-06	
J	Norup, A; Kruse, M; Soendergaard, PL; Rasmussen, KW; Biering-Sorensen, F				Norup, Anne; Kruse, Marie; Soendergaard, Pernille Langer; Rasmussen, Katrine Winther; Biering-Sorensen, Fin			Socioeconomic Consequences of Traumatic Brain Injury: A Danish Nationwide Register-Based Study	JOURNAL OF NEUROTRAUMA			English	Article						divorce; employment; health care costs; register-based study; socioeconomic status; traumatic brain injury	RELATIONSHIP STABILITY; MARITAL STABILITY; EMPLOYMENT; PREDICTORS; DISABILITY; MODERATE; COST; EPIDEMIOLOGY; TRAJECTORIES; INDIVIDUALS	This study examined if acquiring a traumatic brain injury (TBI) increases utilization of health care costs, increases risk of job loss for the patient and the closest relatives, and increases the risk of divorce 1 to 5 years following the injury. The study was conducted as a Danish national population-based register study with follow-up. Participants included a cohort of patients with TBI (n = 18,328) admitted to a hospital or treated in an emergency room (ER) and a matching control group (n = 89,155). For both the TBI group and the matching controls, relatives were identified, using national registers (TBI relatives:n = 25,708 and control relatives:n = 135,325). The outcome measures were utilization of health care costs (including hospital services, use of general practitioner and practicing specialists, and prescribed medication), risk of job loss, and risk of divorce among the TBI group and the control group and their relatives. Patients with TBI had significantly increased health care costs at baseline (i.e., the year before the injury) and during the following 4 years. Further, TBI relatives had a significantly higher utilization of health care costs the first and the third year after injury. The TBI group had a significant increased risk of job loss (odds ratio [OR] = 2.88; confidence interval [CI]: 2.70-3.07) and divorce (OR = 1.44; CI: 1.27-1.64) during the first 3 years following injury. In conclusion, the TBI group had significantly higher utilization of health care costs, both pre-morbidly and post-injury. Further, increased risk of job loss and divorce were found, emphasizing that the socioeconomic consequences of TBI last for years post-injury.	[Norup, Anne; Soendergaard, Pernille Langer; Rasmussen, Katrine Winther] Univ Copenhagen, Dept Neurorehabil, TBI Unit, Rigshosp, Copenhagen, Denmark; [Biering-Sorensen, Fin] Univ Copenhagen, Clin Spinal Cord Injury, Rigshosp, Copenhagen, Denmark; [Norup, Anne; Soendergaard, Pernille Langer; Rasmussen, Katrine Winther] Univ Southern Denmark, Dept Psychol, Odense, Denmark; [Kruse, Marie] Univ Southern Denmark, DaCHE Danish Ctr Hlth Econ, Odense, Denmark; [Biering-Sorensen, Fin] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark		Norup, A (corresponding author), Univ Copenhagen, Dept Neurorehabil, TBI Unit, Rigshosp, Kettegard Alle 30, DK-2650 Hvidovre, Denmark.	anne.norup@regionh.dk	; Soendergaard, Pernille Langer/C-6149-2019	Norup, Anne/0000-0002-5598-6116; Soendergaard, Pernille Langer/0000-0002-5347-8898	Danish Victims Foundation	Danish Victims Foundation.	Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Ankjaer-Jensen Anni, 2006, Health Care Manag Sci, V9, P259, DOI 10.1007/s10729-006-9093-1; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Dahm J, 2015, BRAIN INJURY, V29, P1539, DOI 10.3109/02699052.2015.1075141; Danish Health Authority, 2011, FORL REH ERHV; Danmarks Nationalbank, 2020, EXCH RAT; Denmark Ministry of Health, 2017, HEALTHC DENM OV; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Forslund MV, 2014, NEUROREHABILITATION, V34, P781, DOI 10.3233/NRE-141084; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Garcia-Altes A, 2012, NEUROEPIDEMIOLOGY, V39, P103, DOI 10.1159/000338297; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Howe EI, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01051; Hu JH, 2013, J NEUROTRAUM, V30, P1755, DOI 10.1089/neu.2013.2857; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kruse M, 2015, INJURY PREV, V21, pE4, DOI 10.1136/injuryprev-2013-040757; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nalder E, 2012, J REHABIL MED, V44, P837, DOI 10.2340/16501977-1033; Norup A, 2018, REV IBEROAM NEUROPSI, V1, P17; Norup A, 2015, ARCH PHYS MED REHAB, V96, P56, DOI 10.1016/j.apmr.2014.08.009; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Odgaard L, 2018, ACTA NEUROL SCAND, V137, P44, DOI 10.1111/ane.12806; Odgaard L, 2017, BRAIN INJURY, V31, P1298, DOI 10.1080/02699052.2017.1312017; Odgaard L, 2017, J HEAD TRAUMA REHAB, V32, pE57, DOI 10.1097/HTR.0000000000000239; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Sigurdardottir S., 2018, NEUROPSYCHOL REHABIL, P281; Statistics Denmark, 2020, DAN POP REG; Stevens LF, 2017, J HEAD TRAUMA REHAB, V32, P234, DOI 10.1097/HTR.0000000000000324; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, 2018, DAN REG EV MARG DREA, P1; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; World Health Organization, 2020, NEUROTRAUMA	57	2	2	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2020	37	24					2694	2702		10.1089/neu.2020.7064		SEP 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PF0CR	WOS:000572148500001	32808586	Green Submitted			2022-02-06	
J	Ahmed, S; Gorman, GH; Susi, A; Robertson, BD; Collen, JF; Hisle-Gorman, EJ				Ahmed, Saira; Gorman, Gregory H.; Susi, Apryl; Robertson, Brian D.; Collen, Jacob F.; Hisle-Gorman, Elizabeth J.			Impact of parental injury on adolescent sleep	JOURNAL OF CLINICAL SLEEP MEDICINE			English	Article						adolescent; sleep; parents; posttraumatic stress disorders; brain injuries; wounds and injuries; military family; family health	BRAIN-INJURY; CHILDREN; PREVALENCE; DISORDERS; HEALTH; DISTURBANCES; DIFFICULTIES; INSOMNIA; ILLNESS; CARE	Study Objectives: The aim of this study was to determine the impact of serious parental injury on adolescent sleep disorder diagnoses, outpatient care, and medication use. Methods: U.S. military personnel who sustained a serious injury and were parents of adolescents aged 10-18 years were identified. Included adolescents were enrolled in the Military Health System for 2 years before their parent's injury and 2 years after the injury. We used logistic regression clustered by adolescents to compare the odds of having a sleep diagnosis and negative binomial regression analysis clustered by adolescents to compare outpatient sleep disorder visits and sleep medication days before and after parental injury. Results: There were 96,318 parents seriously injured during 2004-2014 who had 117,577 children aged 10-18 years in 2002-2016. Approximately 2% of adolescents had a sleep disorder diagnosis, both before and after their parent's injury or illness. Outpatient sleep disorder visits increased 36% after a parent's injury (incidence rate ratio 1.36 [1.24-1.50]), with a twofold increase in insomnia visits (incidence rate ratio 2.35 [2.08-2.64]). Increases in sleep visits were most pronounced in adolescents of parents with traumatic brain injury, comorbid traumatic brain injury and posttraumatic stress disorder, battle injury, and those who were medically discharged from the military. The number of adolescents using sleep medications increased, but sleep medication days did not increase. Conclusions: Adolescents in our study used more outpatient medical care for sleep disorders; sleep medication use increased after parental injury. Sleep disorders should be considered in the care of adolescents with injured parents.	[Ahmed, Saira] Brooke Army Med Ctr, Dept Pediat, Div Adolescent Med, Joint Base San Antonio F, TX USA; [Gorman, Gregory H.] Def Hlth Agcy, Falls Church, VA USA; [Susi, Apryl; Hisle-Gorman, Elizabeth J.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD USA; [Robertson, Brian D.; Collen, Jacob F.] Walter Reed Natl Mil Med Ctr, Dept Pulm Crit Care & Sleep Med, Bethesda, MD USA; [Collen, Jacob F.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD USA		Ahmed, S (corresponding author), Brooke Army Med Ctr, Dept Pediat, Div Adolescent Med, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 USA.	saira.ahmed.mil@mail.mil					[Anonymous], 2010, Medical Surveillance Monthly Report, V17, P12; [Anonymous], 2010, Medical Surveillance Monthly Report, V17, P8; Aslan S, 2002, SLEEP, V25, P677, DOI 10.1093/sleep/25.6.666; Brown LK, 2012, CURR OPIN PULM MED, V18, P541, DOI 10.1097/MCP.0b013e3283596740; Caldwell JA, 2019, SLEEP, V42, P1; Caldwell JA, 2017, J SLEEP RES, V26, P665, DOI 10.1111/jsr.12543; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; De Judicibus MA, 2004, ADOLESCENCE, V39, P551; Duke Naomi N, 2018, Glob Pediatr Health, V5, p2333794X18769555, DOI 10.1177/2333794X18769555; Dunne L, 2016, SLEEP BREATH, V20, P1277, DOI 10.1007/s11325-016-1365-5; El-Sheikh M, 2012, J CHILD PSYCHOL PSYC, V53, P806, DOI 10.1111/j.1469-7610.2012.02530.x; Fuligni AJ, 2015, J ADOLESCENT HEALTH, V56, P244, DOI 10.1016/j.jadohealth.2014.09.013; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Gorman LA, 2010, PSYCHIAT QUART, V81, P1, DOI 10.1007/s11126-009-9116-4; Gregory AM, 2006, SLEEP, V29, P1063, DOI 10.1093/sleep/29.8.1063; Hagenauer MH, 2009, DEV NEUROSCI-BASEL, V31, P276, DOI 10.1159/000216538; Harris Gardiner, 2005, NY TIMES; Hisle-Gorman E, 2019, HEALTH AFFAIR, V38, P1358, DOI 10.1377/hlthaff.2019.00276; Hisle-Gorman E, 2015, J AM ACAD CHILD PSY, V54, P294, DOI 10.1016/j.jaac.2014.12.017; Johnson EO, 2006, PEDIATRICS, V117, pE247, DOI 10.1542/peds.2004-2629; Kass LJ, 2006, PEDIATR REV, V27, P455, DOI 10.1542/pir.27-12-455; Le TD, 2018, JAMA SURG, V153, P800, DOI 10.1001/jamasurg.2018.1166; Malow BA, 2016, PEDIATRICS, V137, pS98, DOI 10.1542/peds.2015-2851H; Mc Elroy S, 2014, CHILD ABUSE NEGLECT, V38, P65, DOI 10.1016/j.chiabu.2013.07.017; McCoy BM, 2014, ANN EPIDEMIOL, V24, P629, DOI 10.1016/j.annepidem.2014.05.010; Meltzer LJ, 2010, PEDIATRICS, V125, pE1410, DOI 10.1542/peds.2009-2725; Mukherjee S, 2015, AM J RESP CRIT CARE, V191, P1450, DOI 10.1164/rccm.201504-0767ST; National Council on Disability, 2009, INV WOUNDS SERV SERV; National Sleep Foundation, 2000, AD SLEEP NEEDS PATT; National Sleep Foundation, 2006, 2006 SLEEP AM POLL H; Nelson W., 2019, NELSON TXB PEDIAT; Niemela M, 2014, GEN HOSP PSYCHIAT, V36, P337, DOI 10.1016/j.genhosppsych.2013.12.012; Niemela M, 2012, INT J CANCER, V131, P2117, DOI 10.1002/ijc.27466; Ohayon MM, 2000, J AM ACAD CHILD PSY, V39, P1549, DOI 10.1097/00004583-200012000-00019; Owens JA, 2005, J DEV BEHAV PEDIATR, V26, P312, DOI 10.1097/00004703-200508000-00011; Owens JA, 2005, J CLIN SLEEP MED, V1, P49; Owens JA, 2009, CHILD ADOL PSYCH CL, V18, P1001, DOI 10.1016/j.chc.2009.04.009; Pagel JF, 2007, J CLIN SLEEP MED, V3, P19; Park S, 2016, LARYNGOSCOPE, V126, P1241, DOI 10.1002/lary.25934; Rivara FP, 2014, PEDIATRICS, V134, pE88, DOI 10.1542/peds.2013-3273; Rolland JS, 1999, J FAM THER, V21, P242, DOI 10.1111/1467-6427.00118; Rumble ME, 2015, PSYCHIAT CLIN N AM, V38, P743, DOI 10.1016/j.psc.2015.07.006; Smaldone A, 2007, PEDIATRICS, V119, pS29, DOI 10.1542/peds.2006-2089F; Stojanovski SD, 2007, SLEEP, V30, P1013, DOI 10.1093/sleep/30.8.1013; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Telzer EH, 2015, DEV COGN NEUROS-NETH, V14, P16, DOI 10.1016/j.dcn.2015.05.007; Tiar AMV, 2015, BRAIN INJURY, V29, P1005, DOI 10.3109/02699052.2014.976272; van de Port IGL, 2007, J REHABIL MED, V39, P703, DOI 10.2340/16501977-0109; Vignau J, 1997, J ADOLESCENT HEALTH, V21, P343, DOI 10.1016/S1054-139X(97)00109-2; Williams SG, 2015, SLEEP BREATH, V19, P175, DOI 10.1007/s11325-014-0984-y; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351	51	2	2	0	0	AMER ACAD SLEEP MEDICINE	DARIEN	2510 N FRONTAGE RD, DARIEN, IL 60561 USA	1550-9389	1550-9397		J CLIN SLEEP MED	J. Clin. Sleep Med.	SEP 15	2020	16	9					1437	1444		10.5664/jcsm.8514			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PE0OS	WOS:000598073400004	32336323	Green Published, Bronze			2022-02-06	
J	Severo, L; Godinho, D; Machado, F; Hartmann, D; Fighera, MR; Soares, FA; Furian, AF; Oliveira, MS; Royes, LF				Severo, Leandro; Godinho, Douglas; Machado, Felipe; Hartmann, Diane; Fighera, Michele Rechia; Soares, Felix Alexandre; Furian, Ana Flavia; Oliveira, Mauro Schneider; Royes, Luiz Fernando			The role of mitochondrial bioenergetics and oxidative stress in depressive behavior in recurrent concussion model in mice	LIFE SCIENCES			English	Article						Recurrent concussion; Depression; Mitochondrial bioenergetics; Hippocampus	TRAUMATIC BRAIN-INJURY; TIME-COURSE; EXERCISE; DYSFUNCTION; NITRATION; DEFICITS; OUTCOMES; PATHWAY; DAMAGE; RATS	Traumatic brain injury (TBI) is a public health problem in which even though 80 to 90% of cases are considered mild, usually starts a sequence of neurological disorders that can last a considerable time. Most of the research of this injury has been focused on oxidative stress and functional deficits; however, mechanisms that underlie the development of neuropsychiatric disorders remain little researched. Due to this, the present authors decided to investigate whether recurrent concussion protocols alter depressive-like phenotype behavior, and whether mitochondria play an indispensable role in this behavior or not. The experimental data revealed, for the first time, that the present protocol of recurrent concussions (4, 7, and 10 injuries) in mice did not alter immobility time during tail suspension tests (TSTs), but decreased hippocampal mitochondrial respiration and increased expression of proteins such as nuclear factor erythroid 2-related factor 2 (Nrf2) and superoxide (SOD2). This experimental data suggests that bioenergetic changes elicited by recurrent concussion did not induce depressive like behavior, but activated the transcription factor of responsive antioxidant elements (ARE) that delay or prevent secondary cascades in this neurological disease.	[Severo, Leandro; Godinho, Douglas; Fighera, Michele Rechia; Royes, Luiz Fernando] Univ Fed Santa Maria, Bioquim Toxicol, Programa Posgrad Ciencias Biol, BR-97105900 Santa Maria, RS, Brazil; [Severo, Leandro; Godinho, Douglas; Machado, Felipe; Fighera, Michele Rechia; Royes, Luiz Fernando] Univ Fed Santa Maria, Lab Bioquim Exercicio, BR-97105900 Santa Maria, RS, Brazil; [Hartmann, Diane; Soares, Felix Alexandre] Univ Fed Santa Maria, Dept Bioquim & Biol Mol, Ctr Ciencias Nat & Exatas, BR-97105900 Santa Maria, RS, Brazil; [Furian, Ana Flavia; Oliveira, Mauro Schneider] Univ Fed Santa Maria, Programa Posgrad Farmacol, Ctr Ciencias Saude, BR-97105900 Santa Maria, RS, Brazil		Royes, LF (corresponding author), Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Dept Metodos & Tecn Desport, BR-97105900 Santa Maria, RS, Brazil.	leandrosevero55@gmail.com; nandoroyes@yahoo.com.br		Fighera, Michele/0000-0002-3111-7530	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [307382/2017-6]	The present work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grants: 307382/2017-6). All authors have read and approved the final manuscript.	Alfieri A, 2011, J PHYSIOL-LONDON, V589, P4125, DOI 10.1113/jphysiol.2011.210294; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Arulsamy A, 2019, BEHAV BRAIN RES, V365, P66, DOI 10.1016/j.bbr.2019.02.045; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bolanos JP, 2016, J NEUROCHEM, V139, P115, DOI 10.1111/jnc.13486; Boveris A, 2008, FREE RADICAL BIO MED, V44, P224, DOI 10.1016/j.freeradbiomed.2007.08.015; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; Choi JE, 2018, MOL CELL PROTEOMICS, V17, P1803, DOI 10.1074/mcp.RA118.000835; de Carvalho NR, 2017, TOXICOL RES-UK, V6, P526, DOI 10.1039/c7tx00072c; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fiorin FD, 2016, J NEUROTRAUM, V33, P1317, DOI 10.1089/neu.2015.4068; Fisar Z., 2017, PROTOCOLS HIGH RESOL; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Funck VR, 2014, EPILEPSY RES, V108, P1705, DOI 10.1016/j.eplepsyres.2014.09.025; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Goncalves DF, 2019, NEUROTOXICOLOGY, V70, P1, DOI 10.1016/j.neuro.2018.10.005; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Ku BM, 2006, NEUROSCI LETT, V405, P168, DOI 10.1016/j.neulet.2006.06.052; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Miller MW, 2014, MOL PSYCHIATR, V19, P1156, DOI 10.1038/mp.2014.111; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Toldy A, 2005, BRAIN RES BULL, V65, P487, DOI 10.1016/j.brainresbull.2005.02.028; de Castro MRT, 2017, J PHYSIOL-LONDON, V595, P6023, DOI 10.1113/JP273933; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	48	2	2	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	SEP 15	2020	257								117991	10.1016/j.lfs.2020.117991			6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	NN3RY	WOS:000568709700011	32569782				2022-02-06	
J	Spasiano, A; Barbarino, C; Marangone, A; Orso, D; Trillo, G; Giacomello, R; Bove, T; Della Rocca, G				Spasiano, Alessandra; Barbarino, Cristina; Marangone, Anna; Orso, Daniele; Trillo, Giulio; Giacomello, Roberta; Bove, Tiziana; Della Rocca, Giorgio			Early thromboelastography in acute traumatic coagulopathy: an observational study focusing on pre-hospital trauma care	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Trauma-associated coagulopathy; Thromboelastography; Fibrinolysis; Trauma; Coagulation disorder; TEG	COAGULATION; MORTALITY; THROMBELASTOGRAPHY; HYPOTHERMIA; DEFINITION; HEMORRHAGE; DIAGNOSIS; DEATHS; INJURY	Background Major brain injury and uncontrolled blood loss remain the primary causes of early trauma-related mortality. One-quarter to one-third of trauma patients exhibit trauma-induced coagulopathy (TIC). Thromboelastometry (ROTEM) and thrombelastography (TEG) are valuable alternatives to standard coagulation testing, providing a more comprehensive overview of the coagulation process. Purpose Evaluating thromboelastographic profile, the incidence of fibrinolysis (defined as Ly30 > 3%) in severe trauma patients, and factors influencing pathological coagulation pattern. Methods Prospective observational 2 years cohort study on severe trauma patients assisted by Helicopter Emergency Medical System (HEMS) and Level 1 Trauma Center, in a tertiary referral University Hospital. Results Eighty three patients were enrolled, mean NISS (new injury severity score) 36 (+/- 13). MeanRvalue decreased from 7.25 (+/- 2.6) to 6.19 (+/- 2.5) min (p < 0.03); 48 (60%) patients had a reduction inRfromT(0)toT(1). In NISS 25-40 and NISS > 40 groups, changes inRvalue increased their significance (p = 0.04 andp < 0.03, respectively). Pathological TEG was found in 71 (88.8%) patients atT(0)and 74 (92.5%) atT(1). Hypercoagulation was present in 57 (71.3%) patients atT(0,)and in 66(82.5%) atT(1). 9 (11.3%) patients had hyperfibrinolysis atT(0), 7 (8.8%) patients atT(1). Prevalence of StO(2) < 75% atT(0)was greater in patients whose TEG worsened (7 patients, 46.7%) against whose TEG remained stable or improved (8 patients, 17.4%) fromT(0)toT(1)(p = 0.02). 48 (57.8%) patients received < 1000 mL of fluids, while 35 (42.2%) received >= 1000 mL. The first group had fewer patients with hypercoagulation (20, 41.6%) than the second (6, 17.6%) atT(1)(p < 0.03). No differences were found for same TEG pattern atT(0), nor other TEG pattern. Conclusion Our population is representative of a non-hemorrhagic severe injury subgroup. Almost all of our trauma population had coagulation abnormalities immediately after the trauma; pro-coagulant changes were the most represented regardless of the severity of injury. NISS appears to affect onlyRparameter on TEG. Hyperfibrinolysis has been found in a low percentage of patients. Hypoperfusion parameters do not help to identify patients with ongoing coagulation impairment. Small volume resuscitation and mild hypotermia does not affect coagulation, at least in the early post-traumatic phase.	[Spasiano, Alessandra; Barbarino, Cristina; Marangone, Anna; Orso, Daniele; Bove, Tiziana; Della Rocca, Giorgio] Univ Udine, Anesthesiol & Intens Care Med, Dept Med, ASUFC Udine, Ple Santa Maria della Misericordia 15, I-33100 Udine, Italy; [Trillo, Giulio] ASUFC Udine, HEMS Div, Dept Anesthesia & Intens Care Med, I-33100 Udine, Italy; [Giacomello, Roberta] Univ Udine, ASUFC Udine, Dept Lab Med, Inst Clin Pathol, I-33100 Udine, Italy		Marangone, A (corresponding author), Univ Udine, Anesthesiol & Intens Care Med, Dept Med, ASUFC Udine, Ple Santa Maria della Misericordia 15, I-33100 Udine, Italy.	8annamarangone8@gmail.com	Bove, Tiziana/AAC-2109-2022; Orso, Daniele/O-8398-2017	Orso, Daniele/0000-0001-7136-0343; Reis, AlessanRSS/0000-0001-8486-7469; Marangone, Anna/0000-0002-2369-8937	Universita degli Studi di Udine within the CRUI-CARE Agreement	Open access funding provided by Universita degli Studi di Udine within the CRUI-CARE Agreement. No funding has been used for this study.	Attia J, 2001, ARCH INTERN MED, V161, P1268, DOI 10.1001/archinte.161.10.1268; Berlot G, 2012, HEMOCOAGULATIVE PROB, P30; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Burggraf M, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0038-1; Cannon WB, 1918, J AMER MED ASSOC, V70, P618; Carroll RC, 2009, TRANSL RES, V154, P34, DOI 10.1016/j.trsl.2009.04.001; Chapman MP, 2013, J TRAUMA ACUTE CARE, V75, P961, DOI 10.1097/TA.0b013e3182aa9c9f; Cotton BA, 2011, J TRAUMA, V71, P407, DOI 10.1097/TA.0b013e31821e1bf0; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Eddy VA, 2000, SURG CLIN N AM, V80, P845, DOI 10.1016/S0039-6109(05)70099-2; Flood P, 2015, STOELTINGS PHARM PHY, P620; Gall LS, 2017, SEMIN THROMB HEMOST, V43, P224, DOI 10.1055/s-0036-1598001; Gando S, 2002, THROMB HAEMOSTASIS, V88, P943, DOI 10.1055/s-0037-1613338; Gonzalez E, 2017, CRIT CARE CLIN, V33, P119, DOI 10.1016/j.ccc.2016.09.002; Hagemo JS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0823-y; Hagemo JS, 2013, INJURY, V44, P600, DOI 10.1016/j.injury.2012.11.016; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Johansson PI, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-45; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Kauvar DS, 2005, CRIT CARE, V9, P1, DOI 10.1186/cc3779; Levi M, 2007, CRIT CARE MED, V35, P2191, DOI 10.1097/01.CCM.0000281468.94108.4B; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Martini WZ, 2009, J TRAUMA, V67, P202, DOI 10.1097/TA.0b013e3181a602a7; Moore EE, 2017, TRAUMA, P224; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Peltan ID, 2015, CRIT CARE MED, V43, P1429, DOI 10.1097/CCM.0000000000000981; Rizoli S, 2016, MIL MED, V181, P117, DOI 10.7205/MILMED-D-15-00166; Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schlimp CJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12816; Schochl H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-15; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Sumislawski JJ, 2019, AM J SURG, V217, P1037, DOI 10.1016/j.amjsurg.2019.01.014; Tauber H, 2011, BRIT J ANAESTH, V107, P378, DOI 10.1093/bja/aer158; Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC	39	2	2	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-020-01493-z		SEP 2020	9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	NO1XI	WOS:000569279300001	32929548	hybrid			2022-02-06	
J	Cameron, KV; Ponsford, JL; Stolwyk, RJ				Cameron, Kate V.; Ponsford, Jennie L.; Stolwyk, Renerus J.			Do stroke survivors agree with their clinicians on the extent of their post-stroke activity limitation and participation restriction?	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Awareness; Insight; Stroke; Rehabilitation; Disability	TRAUMATIC BRAIN-INJURY; PORTLAND ADAPTABILITY INVENTORY; FUNCTIONAL INDEPENDENCE MEASURE; SELF-AWARENESS; PSYCHOMETRIC PROPERTIES; IMPAIRED AWARENESS; RATING-SCALE; ANOSOGNOSIA; REHABILITATION; DEFICITS	This study aimed to examine discrepancies in the reporting of post-stroke functioning between stroke survivors and their clinicians across various disability domains and across current and predicted functioning. Fifty sub-acute stroke survivors (AgeM = 70.30SD = 15.80, 56% female) and their occupational therapist independently completed three measures assessing activity limitations (cognitive, physical, instrumental) and participation restrictions. Assessments were made of current functioning and predicted functioning at three months' post-discharge. Compared to physical functioning, appraisal discrepancies were more pronounced for cognitive functioning, instrumental activity limitation, and participation restriction. Discrepancies were more pronounced for current, as opposed to predicted, cognitive functioning (Z = -4.21,p < .001) and instrumental activity limitation (Z = -4.00,p < .001). Conversely, discrepancies in participation restriction were greatest for predicted functioning (Z = -4.03,p < .001). Follow-up (n = 39) showed that, compared to survivors' predictions, clinicians' predictions were more closely aligned with actual stroke survivor functioning at three months' post-discharge (as rated by a close other). These findings suggest appraisal discrepancy varies across disability domains and time reference points, with cognitive and complex functional activities being particularly discrepant between stroke survivors and clinicians. Furthermore, clinicians may hold more realistic expectations of short-term functional recovery.	[Cameron, Kate V.; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Univ, Sch Psychol Sci, Monash Inst Cognit & Clin Neurosci, 18 Innovat Walk,Clayton Campus, Melbourne, Vic 3800, Australia; [Cameron, Kate V.; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Stolwyk, RJ (corresponding author), Monash Univ, Sch Psychol Sci, Monash Inst Cognit & Clin Neurosci, 18 Innovat Walk,Clayton Campus, Melbourne, Vic 3800, Australia.	rene.stolwyk@monash.edu	Ponsford, Jennie/H-8341-2014	Ponsford, Jennie/0000-0003-0430-125X; Stolwyk, Renerus/0000-0002-4975-3332			Baier B, 2015, BRAIN STRUCT FUNCT, V220, P1855, DOI 10.1007/s00429-014-0753-5; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Barrett AM, 2014, BRAIN INJURY, V28, P1328, DOI 10.3109/02699052.2014.915984; Barskova T, 2006, BRAIN INJURY, V20, P1431, DOI 10.1080/02699050600976317; Besharati S, 2016, BRAIN, V139, P971, DOI 10.1093/brain/awv390; Boosman H, 2014, BRAIN INJURY, V28, P959, DOI 10.3109/02699052.2014.888763; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Dai CY, 2014, EUR J NEUROL, V21, P797, DOI 10.1111/ene.12413; Daving Y, 2001, CLIN REHABIL, V15, P301, DOI 10.1191/026921501669986659; Doig E., 2015, REHABILITATION GOAL, P181; Ekstam L, 2007, AM J OCCUP THER, V61, P503, DOI 10.5014/ajot.61.5.503; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hartman-Maeir A, 2003, DISABIL REHABIL, V25, P35, DOI 10.1080/0963828021000007897; Hartman-Maeir A, 2002, J REHABIL MED, V34, P158, DOI 10.1080/16501970213236; Kortte K, 2009, CURR NEUROL NEUROSCI, V9, P459, DOI 10.1007/s11910-009-0068-8; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Langer KG, 2008, COGN BEHAV NEUROL, V21, P206, DOI 10.1097/WNN.0b013e3181864a4b; Malec J. F., 2003, MANUAL MAYO PORTLAND; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P2271, DOI 10.1016/j.apmr.2012.06.013; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Marcel AJ, 2004, CORTEX, V40, P19, DOI 10.1016/S0010-9452(08)70919-5; Markova IS, 2006, NEUROPSYCHOL REHABIL, V16, P439, DOI 10.1080/09602010500373396; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Nurmi ME, 2014, CORTEX, V61, P43, DOI 10.1016/j.cortex.2014.04.008; Orfei MD, 2007, BRAIN, V130, P3075, DOI 10.1093/brain/awm106; Orfei MD, 2009, CEREBROVASC DIS, V27, P280, DOI 10.1159/000199466; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Scobbie L, 2011, CLIN REHABIL, V25, P468, DOI 10.1177/0269215510389198; Seltzer B, 2001, NEUROPSY NEUROPSY BE, V14, P122; Sevy S, 2004, COMPR PSYCHIAT, V45, P16, DOI 10.1016/j.comppsych.2003.09.002; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Smeets SMJ, 2012, J HEAD TRAUMA REHAB, V27, P433, DOI 10.1097/HTR.0b013e3182242f98; Smith PM, 1996, ARCH PHYS MED REHAB, V77, P431, DOI 10.1016/S0003-9993(96)90029-5; Starkstein SE, 2010, CAN J PSYCHIAT, V55, P355, DOI 10.1177/070674371005500604; Vocat R, 2010, BRAIN, V133, P3578, DOI 10.1093/brain/awq297; Vossel S, 2013, CORTEX, V49, P1782, DOI 10.1016/j.cortex.2012.12.011; World Health Organization, 2007, INT CLASS FUNCT DIS	47	2	2	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	SEP 13	2020	30	8					1430	1448		10.1080/09602011.2019.1586734			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MT6UM	WOS:000555107800002	30874467				2022-02-06	
J	Lindner, A; Rass, V; Ianosi, BA; Schiefecker, AJ; Kofler, M; Rhomberg, P; Pfausler, B; Beer, R; Schmutzhard, E; Thome, C; Helbok, R				Lindner, Anna; Rass, Verena; Ianosi, Bogdan-Andrei; Schiefecker, Alois J.; Kofler, Mario; Rhomberg, Paul; Pfausler, Bettina; Beer, Ronny; Schmutzhard, Erich; Thome, Claudius; Helbok, Raimund			The Importance of P(bt)O(2)Probe Location for Data Interpretation in Patients with Intracerebral Hemorrhage	NEUROCRITICAL CARE			English	Article						Intracerebral hemorrhage; Neuromonitoring parameter; Critical care; Neurology	TISSUE OXYGEN-TENSION; HEALTH-CARE PROFESSIONALS; TRAUMATIC BRAIN-INJURY; NEUROCRITICAL CARE; CEREBRAL AUTOREGULATION; ISCHEMIA; OPTIMIZATION; PREDICTION; GUIDELINES; MANAGEMENT	Background/objective Monitoring of brain tissue oxygen tension (PbtO2) provides insight into brain pathophysiology after intracerebral hemorrhage (ICH). Integration of probe location is recommended to optimize data interpretation. So far, little is known about the importance of P(bt)O(2)catheter location in ICH patients. Methods We prospectively included 40 ICH patients after hematoma evacuation (HE) who required PbtO2-monitoring. PbtO2-probe location was evaluated in all head computed tomography (CT) scans within the first 6 days after HE and defined as location in thehealthy brain tissueorperilesionalwhen the catheter tip was located within 1 cm of a focal lesion (hypodense or hyperdense). Generalized estimating equations were used to investigate levels of P(bt)O(2)in relation to different probe locations. Results Patients were 60 [51-66] years old and had a median ICH-volume of 47 [29-60] mL. Neuromonitoring probes remained for a median of 6 [2-11] days. PbtO2-probes were located in healthy brain tissue in 18/40 (45%) patients and in perilesional brain tissue in 22/40 (55%) patients. In the acute phase after HE (0-72 h), P(bt)O(2)levels were significantly lower (21 +/- 12 mmHg vs. 29 +/- 10 mmHg,p = 0.010) and brain tissue hypoxia (BTH) was more common in the perilesional area as compared to healthy brain tissue (46% vs. 19%, adjOR 4.0, 95% CI 1.54-10.58,p = 0.005). Episodes of BTH significantly decreased over time in patients with probes in perilesional location (p = 0.001) but remained stable in normal appearing area (p = 0.485). A significant association between BTH and poor functional outcome was only found when probes were located in the perilesional brain tissue (adjOR 6.6, 95% CI 1.3-33.8,p = 0.023). Conclusions In the acute phase, BTH was more common in the perilesional area compared to healthy brain tissue. The improvement of BTH in the perilesional area over time may be the result of targeted treatment interventions and tissue regeneration. Due to the localized measurement of invasive neuromonitoring devices, integration of probe location in the clinical management of ICH patients and in research protocols seems mandatory.	[Lindner, Anna; Rass, Verena; Ianosi, Bogdan-Andrei; Schiefecker, Alois J.; Kofler, Mario; Pfausler, Bettina; Beer, Ronny; Schmutzhard, Erich; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Anichstr 35, A-6020 Innsbruck, Austria; [Rhomberg, Paul] Med Univ Innsbruck, Dept Neuroradiol, Anichstr 35, A-6020 Innsbruck, Austria; [Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Anichstr 35, A-6020 Innsbruck, Austria; [Ianosi, Bogdan-Andrei] UMIT Univ Hlth Sci Med Informat & Technol, Inst Med Informat, Eduard Wallnoefer Zentrum 1, A-6060 Hall In Tirol, Austria		Helbok, R (corresponding author), Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Anichstr 35, A-6020 Innsbruck, Austria.	raimund.helbok@tirol-kliniken.at	Helbok, Raimund/AAA-8361-2021; Rass, Verena/AAR-1731-2021	Rass, Verena/0000-0002-4241-5891; Schmutzhard, Erich/0000-0003-3295-7491	University of Innsbruck; Medical University of Innsbruck; Austrian Science Fund (FWF)Austrian Science Fund (FWF) [KLI 375]; Austrian Science Fund (FWF)Austrian Science Fund (FWF)	Open access funding provided by University of Innsbruck and Medical University of Innsbruck. This study has received funding from the Austrian Science Fund (FWF) under Project Number KLI 375 (to RB). The authors declare that there is no conflict of interest. Dr. Beer reports grants from Austrian Science Fund (FWF), during the conduct of the study; grants from Austrian Science Fund (FWF), outside the submitted work. Dr. Thome reports grants and personal fees from BrainLab, grants and personal fees from DePuySynthes, grants and personal fees from Intrinsic Therapeutics, grants from TETEC AG, personal fees from Aesculap, grants and personal fees from Signus Medizintechnik, grants and personal fees from Medtronic, grants and personal fees from Icotec AG, grants and personal fees from Edge Therapeutics, grants from BITPharma, outside the submitted work.	Alizadeh AM, 2014, BASIC CLIN PHARMACOL, V115, P297, DOI 10.1111/bcpt.12210; Balbi M, 2017, J CEREBR BLOOD F MET, V37, P3625, DOI 10.1177/0271678X16686595; Chesnut R, 2020, SEATTL INT SEV TRAUM; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; De Georgia MA, 2015, J INTENSIVE CARE MED, V30, P473, DOI 10.1177/0885066614529254; Dornbos D, 2016, NEUROL RES, V38, P491, DOI 10.1080/01616412.2016.1187831; Gaasch M, 2018, CRIT CARE MED, V46, P774, DOI 10.1097/CCM.0000000000003016; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; Haitsma Iain K, 2002, Curr Opin Crit Care, V8, P115, DOI 10.1097/00075198-200204000-00005; Hawryluk GWJ, 2016, J NEUROSURG, V125, P1217, DOI 10.3171/2015.7.JNS15809; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hemphill JC, 2005, NEUROCRIT CARE, V3, P260, DOI 10.1385/NCC:3:3:260; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; Kirkman Matthew A, 2016, Anesthesiol Clin, V34, P537, DOI 10.1016/j.anclin.2016.04.007; Ko SB, 2011, STROKE, V42, P3087, DOI 10.1161/STROKEAHA.111.623165; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; Morgalla Matthias H, 2012, Acta Neurochir Suppl, V114, P169, DOI 10.1007/978-3-7091-0956-4_32; Mulvey JM, 2004, NEUROCRIT CARE, V1, P391, DOI 10.1385/NCC:1:3:391; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Rass V, 2019, NEUROCRIT CARE; Rivera Lara Lucia, 2018, Continuum (Minneap Minn), V24, P1776, DOI 10.1212/CON.0000000000000671; Rose JC, 2006, CURR OPIN CRIT CARE, V12, P97, DOI 10.1097/01.ccx.0000216574.26686.e9; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Schiefecker AJ, 2015, NEUROCRIT CARE, V22, P293, DOI 10.1007/s12028-014-0050-4; Siddique MS, 2002, J NEUROSURG, V96, P736, DOI 10.3171/jns.2002.96.4.0736; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Tobieson L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39499-2; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wang E, 2008, ACTA NEUROCHIR SUPPL, V102, P335, DOI 10.1007/978-3-211-85578-2_64; Witsch J, 2017, JAMA NEUROL, V74, P299, DOI 10.1001/jamaneurol.2016.5325	36	2	2	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2021	34	3					804	813		10.1007/s12028-020-01089-w		SEP 2020	10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN4OZ	WOS:000568470100001	32918157	hybrid, Green Published			2022-02-06	
J	Peterson, RK; Williams, T; Dlamini, N; Westmacott, R				Peterson, Rachel K.; Williams, Tricia; Dlamini, Nomazulu; Westmacott, Robyn			Parent experiences and developmental outcomes following neonatal stroke	CLINICAL NEUROPSYCHOLOGIST			English	Article						Neonatal stroke; parent mental health; pediatric; neuropsychology; caregivers	TRAUMATIC BRAIN-INJURY; ARTERIAL ISCHEMIC-STROKE; QUALITY-OF-LIFE; BEHAVIOR PROBLEMS; COGNITIVE OUTCOMES; CHILDREN; DISTRESS; STRESS; INTERVENTIONS; COMMUNICATION	Objective Parents of children with neonatal stroke offer critical insight into potential avenues to direct neuropsychological care from the time of diagnosis through the early years. The aims of this study were to (1) describe what parents remember about early prognostic discussions with the medical team and (2) to examine the relationships between initial prognoses and the child's current neurodevelopmental status and parents' mental health.Method:Thirty parents of children with neonatal stroke completed the Depression Anxiety Stress Scales (DASS) and Parent Experiences Questionnaire (PEQ). The children of these parents were also seen for neurodevelopmental/neuropsychological assessments.Results:Parents recalled discussions with the medical team about motor, language, cognitive, and academic outcomes, with fewer discussions about the impact of neonatal stroke on their child's social skills, behavior, attention, mental health, and adaptive functioning. Many parents recalled poor initial prognoses following their child's diagnosis, with better than expected outcomes 3 years later. Parent self-reported depression, anxiety, and stress were associated with higher ratings of externalizing symptoms in their child. There were no significant correlations between parent mental health and their perception of their child's internalizing symptoms, neurodevelopmental functioning, or any of the child's medical/demographic factors.Conclusions:This study highlights the role of the neuropsychologist in the child's care in educating families and monitoring outcomes, emphasizes mental health support for parents of children with a history of neonatal stroke, and reiterates how environmental factors outside of the neonatal stroke itself can impact the child's functioning.	[Peterson, Rachel K.] Kennedy Krieger Inst, Dept Neuropsychol, 1750 E Fairmount Ave, Baltimore, MD 21231 USA; [Williams, Tricia; Westmacott, Robyn] Hosp Sick Children, Dept Psychol, Toronto, ON, Canada; [Dlamini, Nomazulu] Hosp Sick Children, Dept Neurol, Toronto, ON, Canada		Peterson, RK (corresponding author), Kennedy Krieger Inst, Dept Neuropsychol, 1750 E Fairmount Ave, Baltimore, MD 21231 USA.	PetersonR@KennedyKrieger.org		Peterson, Rachel/0000-0001-9544-9000			Achenbach TM., 1999, USE PSYCHOL TESTING, P429; Anderson PJ, 2017, CLIN NEUROPSYCHOL, V31, P371, DOI 10.1080/13854046.2016.1216518; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Basu AP, 2014, DEV MED CHILD NEUROL, V56, P516, DOI 10.1111/dmcn.12407; Bayley N., 2005, BAYLEY SCALES INFANT; Bemister TB, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0397-5; Bemister TB, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-182; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Chi TC, 2002, J ABNORM CHILD PSYCH, V30, P387, DOI 10.1023/A:1015770025043; Cousino MK, 2013, J PEDIATR PSYCHOL, V38, P809, DOI 10.1093/jpepsy/jst049; Crnic K, 2004, INFANT YOUNG CHILD, V17, P223, DOI 10.1097/00001163-200407000-00004; Davis E, 2012, CHILD CARE HLTH DEV, V38, P553, DOI 10.1111/j.1365-2214.2011.01267.x; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; deVeber GA, 2017, PEDIATR NEUROL, V69, P58, DOI 10.1016/j.pediatrneurol.2017.01.016; Dunbar M. J., 2020, STROKE S1, V51; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fuentes A, 2016, CHILD NEUROPSYCHOL, V22, P1, DOI 10.1080/09297049.2014.969694; Ganesan V, 2000, DEV MED CHILD NEUROL, V42, P455, DOI 10.1017/S0012162200000852; Hoare P, 1998, J INTELL DISABIL RES, V42, P218, DOI 10.1046/j.1365-2788.1998.00134.x; Jacomb I, 2018, CHILD NEUROPSYCHOL, V24, P287, DOI 10.1080/09297049.2016.1265102; Khamis V, 2007, SOC SCI MED, V64, P850, DOI 10.1016/j.socscimed.2006.10.022; Kirton A, 2013, STROKE, V44, P3265, DOI 10.1161/STROKEAHA.113.000739; Kitchen L, 2012, STROKE, V43, P1602, DOI 10.1161/STROKEAHA.111.639583; Kolk A, 2011, PEDIATR NEUROL, V44, P101, DOI 10.1016/j.pediatrneurol.2010.08.012; Levine SC, 2005, BRAIN COGNITION, V59, P114, DOI 10.1016/j.bandc.2005.05.008; Lieneman CC, 2017, PSYCHOL RES BEHAV MA, V10, P239, DOI 10.2147/PRBM.S91200; LOVIBOND SH, 1993, PSYCHOL FDN MONOGRAP; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Mineyko A, 2011, J CHILD NEUROL, V26, P1154, DOI 10.1177/0883073811408312; Mullins LL, 2007, J PEDIATR PSYCHOL, V32, P973, DOI 10.1093/jpepsy/jsm044; Peterson RK, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27287; Racine E, 2017, DEV MED CHILD NEUROL, V59, P125, DOI 10.1111/dmcn.13343; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Singer GHS, 2007, MENT RETARD DEV D R, V13, P357, DOI 10.1002/mrdd.20175; Soufi S, 2017, EUR J PAEDIATR NEURO, V21, P542, DOI 10.1016/j.ejpn.2017.01.007; Studer M, 2014, NEUROLOGY, V82, P784, DOI 10.1212/WNL.0000000000000162; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Treutler CM, 2003, J ABNORM CHILD PSYCH, V31, P13, DOI 10.1023/A:1021765114434; Tsze DS, 2011, EMERG MED INT, V2011, DOI 10.1155/2011/734506; Vonneilich N, 2016, DISABIL REHABIL, V38, P761, DOI 10.3109/09638288.2015.1060267; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wechsler D., 2012, WECHSLER PRESCHOOL P; Wechsler D., 2014, WECHSLER INTELLIGENC, V5th; Westmacott R, 2018, NEUROPSYCHOLOGICAL CONDITIONS ACROSS THE LIFESPAN, P244; Westmacott R, 2018, DEV NEUROPSYCHOL, V43, P708, DOI 10.1080/87565641.2018.1522538; Westmacott R, 2010, DEV MED CHILD NEUROL, V52, P386, DOI 10.1111/j.1469-8749.2009.03403.x; Westmacott R, 2009, STROKE, V40, P2012, DOI 10.1161/STROKEAHA.108.533976; Williams TS, 2018, BRAIN INJURY, V32, P1386, DOI 10.1080/02699052.2018.1495844	52	2	2	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 4	2021	35	5			SI		973	987		10.1080/13854046.2020.1815855		SEP 2020	15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	SV7PS	WOS:000568937200001	32924802				2022-02-06	
J	Sandalic, D; Craig, A; Arora, M; Pozzato, I; Simpson, G; Gopinath, B; Kaur, J; Shetty, S; Weber, G; Cameron, I; Tran, Y; Middleton, J				Sandalic, Danielle; Craig, Ashley; Arora, Mohit; Pozzato, Ilaria; Simpson, Grahame; Gopinath, Bamini; Kaur, Jasbeer; Shetty, Sachin; Weber, Gerard; Cameron, Ian; Tran, Yvonne; Middleton, James			A prospective cohort study investigating contributors to mild cognitive impairment in adults with spinal cord injury: study protocol	BMC NEUROLOGY			English	Article						Brain injuries; Cognition disorders; Cognitive dysfunction; Mild cognitive impairment; Mood disorder; Nervous system injury; Spinal cord injuries	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; PSYCHOMETRIC PROPERTIES; ANTICHOLINERGIC BURDEN; SELF-EFFICACY; RISK-FACTORS; VALIDITY; REHABILITATION; DEPRESSION; PEOPLE	Background Studies report rates of mild cognitive impairment (MCI) in spinal cord injury (SCI) range between 10 and 60%. This broad estimate of MCI in SCI is most likely a result of: (i) inconsistent operationalization of MCI; (ii) heterogeneity among individuals with SCI; (iii) failure to account for MCI subtypes, thereby adding to the heterogeneity of samples; and, (iv) poor control for traumatic brain injury (TBI) that obscures differentiation of MCI attributable to TBI versus other factors. There is a paucity of longitudinal studies following the course of MCI in SCI, and none that account for multiple predictors of MCI, including interactions among predictors. Methods An inception cohort longitudinal study will assess approximately 100 individuals aged 17-80 years with acute SCI, with measures taken at three timepoints (baseline, 3 months post-baseline, and 12 months post-injury). Data relevant to medical care received within the first 24-48 h of presentation to the emergency department will be analysed, as will measures of cognition, injury characteristics, medical history, personal factors, psychological status, psychosocial functioning, and quality of life. Latent class mixture modelling will determine trajectories for the primary outcome of interest, cognitive functioning and its subtypes, and secondary outcomes of interest such as depression. Multiple regression analyses will identify predictors of MCI and its subtypes. Discussion The prospective design will reveal change in cognitive functioning across time and unveil different outcome trajectories; thus addressing the lack of knowledge on trajectories of MCI and MCI subtypes in SCI. Through subtyping MCI, we hope to yield groups of cognitively impaired individuals with SCI that are potentially more homogenous and thereby stable and predictable. This is the first study to capture emergency department and acute care diagnostic evidence of mild TBI, which has been poorly controlled in previous studies. Our study will also be the first to distinguish the contribution of TBI from other factors to the development of MCI in individuals with SCI.	[Sandalic, Danielle; Craig, Ashley; Arora, Mohit; Pozzato, Ilaria; Simpson, Grahame; Gopinath, Bamini; Cameron, Ian; Middleton, James] Univ Sydney, Royal North Shore Hosp, John Walsh Ctr Rehabil Res, Kolling Inst,Northern Clin Sch,Fac Med & Hlth, St Leonards, NSW 2065, Australia; [Sandalic, Danielle; Kaur, Jasbeer] Royal North Shore Hosp, St Leonards, NSW 2065, Australia; [Shetty, Sachin] Prince Wales Hosp, Randwick, NSW 2031, Australia; [Weber, Gerard] Royal Rehab, Ryde, NSW 2112, Australia; [Tran, Yvonne] Macquarie Univ, Australian Inst Hlth Innovat, N Ryde, NSW 2113, Australia		Sandalic, D (corresponding author), Univ Sydney, Royal North Shore Hosp, John Walsh Ctr Rehabil Res, Kolling Inst,Northern Clin Sch,Fac Med & Hlth, St Leonards, NSW 2065, Australia.; Sandalic, D (corresponding author), Royal North Shore Hosp, St Leonards, NSW 2065, Australia.	danielle.sandalic@health.nsw.gov.au	Arora, Mohit/D-3373-2015	Arora, Mohit/0000-0003-1024-3682; Sandalic, Danielle/0000-0001-9540-5024; Simpson, Grahame/0000-0001-8156-9060; Tran, Yvonne/0000-0002-1741-4205	icare Foundation in NSW, Australia	The study is being funded by the icare Foundation in NSW, Australia. The icare Foundation competitively peer reviewed the study in 2019. The icare Foundation does not take a direct responsibility in any of the following; study design, data collection, data analysis, drafting of the manuscript, or decision to publish.	Alizadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00282; American Psychiatric A American Psychiatric A Force D.S.M.T, 2013, DIAGNOSTIC STAT MANU; Anton HA, 2017, SPINAL CORD, V55, P94, DOI 10.1038/sc.2016.102; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Buysse D J, 1989, Psychiatry Res, V28, P193; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Carriere I, 2009, ARCH INTERN MED, V169, P1317, DOI 10.1001/archinternmed.2009.229; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chiaravalloti ND, 2020, J SPINAL CORD MED, V43, P88, DOI 10.1080/10790268.2018.1543103; Coupland CAC, 2019, JAMA INTERN MED, V179, P1084, DOI 10.1001/jamainternmed.2019.0677; Craig A, 2016, SCREENING COGNITIVE; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; Craig A, 2015, ARCH PHYS MED REHAB, V96, P1426, DOI 10.1016/j.apmr.2015.02.027; Craig A, 2012, J PSYCHOSOM RES, V73, P205, DOI 10.1016/j.jpsychores.2012.07.005; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Giannoccaro MP, 2013, SLEEP MED REV, V17, P399, DOI 10.1016/j.smrv.2012.12.005; Grant LI, 2012, REHABIL RES PRACT, V2012; Grassner L, 2016, THER ADV NEUROL DISO, V9, P85, DOI 10.1177/1756285615621687; Green AR, 2018, DRUG AGING, V35, P223, DOI 10.1007/s40266-018-0522-x; Hadjipavlou G, 2016, BJA EDUC, V16, P264, DOI 10.1093/bjaed/mkv073; Han JW, 2012, ALZHEIMERS DEMENT, V8, P553, DOI 10.1016/j.jalz.2011.08.007; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hughes TF, 2013, INT PSYCHOGERIATR, V25, P587, DOI 10.1017/S1041610212002086; Hughes TF, 2011, CURR OPIN PSYCHIATR, V24, P237, DOI 10.1097/YCO.0b013e328344696b; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Jak AJ, 2009, AM J GERIAT PSYCHIAT, V17, P368, DOI 10.1097/JGP.0b013e31819431d5; Jensen MP, 2009, REHABIL PSYCHOL, V54, P323, DOI 10.1037/a0016345; Kaifeng L, 2008, INT J BIOSTAT, V4; Kalpakjian CZ, 2007, J SPINAL CORD MED, V30, P131, DOI 10.1080/10790268.2007.11753924; Karlsson T., P1; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Krassioukov, 2015, CURRENT PHYS MED REH, V3, P197; Krassioukov A, 2009, RESP PHYSIOL NEUROBI, V169, P157, DOI 10.1016/j.resp.2009.08.003; Krebs J, 2018, SPINAL CORD, V56, P22, DOI 10.1038/sc.2017.94; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee GJ, 2012, BIOL PSYCHIAT, V71, P814, DOI 10.1016/j.biopsych.2011.12.024; Lerdal A, 2014, ENCY QUALITY LIFE WE, P2218; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Marvanova Marketa, 2016, Ment Health Clin, V6, P201, DOI 10.9740/mhc.2016.07.201; McDonald SD, 2018, REHABIL PSYCHOL, V63, P372, DOI 10.1037/rep0000230; Middleton JW, 2003, REHABIL PSYCHOL, V48, P281, DOI 10.1037/0090-5550.48.4.281; Molina B, 2018, SPINAL CORD, V56, P796, DOI 10.1038/s41393-018-0076-0; Mollayeva T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017165; Monteiro, 2010, ALCOHOL SMOKING SUBS; New PW, 2007, J SPINAL CORD MED, V30, P225, DOI 10.1080/10790268.2007.11753930; Nightingale TE, 2020, PHYSIOL BEHAV, V213, DOI 10.1016/j.physbeh.2019.112742; Nott Melissa T, 2014, Top Spinal Cord Inj Rehabil, V20, P225, DOI 10.1310/sci2003-225; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Petersen Ronald C, 2016, Continuum (Minneap Minn), V22, P404, DOI 10.1212/CON.0000000000000313; Phillips AA, 2017, J NEUROTRAUM, V34, P1283, DOI 10.1089/neu.2016.4751; Phillips AA, 2014, J CEREBR BLOOD F MET, V34, P794, DOI 10.1038/jcbfm.2014.3; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Price M, 2016, PSYCHIAT RES, V239, P124, DOI 10.1016/j.psychres.2016.03.014; Rapp SR, 2010, ALZ DIS ASSOC DIS, V24, P248, DOI 10.1097/WAD.0b013e3181d715d5; Richard E, 2013, JAMA NEUROL, V70, P383, DOI 10.1001/jamaneurol.2013.603; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Sachdeva R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102464; Sachdeva R, 2018, NEUROLOGY, V91, P611, DOI 10.1212/WNL.0000000000006244; Sajkov D, 1998, SPINAL CORD, V36, P231, DOI 10.1038/sj.sc.3100563; Sakel M, 2015, BRAIN INJURY, V29, P1426, DOI 10.3109/02699052.2015.1060358; Salahudeen MS, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0029-9; Salyer J, 2019, J HEART LUNG TRANSPL, V38, pS299, DOI 10.1016/j.healun.2019.01.751; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Schembri R, 2017, SLEEP, V40; Schinka JA, 2010, AM J GERIAT PSYCHIAT, V18, P684, DOI 10.1097/JGP.0b013e3181e56d5a; Shaukat A, 2014, DRUG AGING, V31, P749, DOI 10.1007/s40266-014-0204-2; Shem Kazuko, 2018, Spinal Cord Ser Cases, V4, P9, DOI 10.1038/s41394-018-0038-y; Shnek ZM, 1997, ANN BEHAV MED, V19, P287, DOI 10.1007/BF02892293; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Strubreither W, 1997, SPINAL CORD, V35, P487, DOI 10.1038/sj.sc.3100495; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Thompson C, 2015, J SPINAL CORD MED, V38, P214, DOI 10.1179/2045772314Y.0000000233; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Tun CG, 1997, REHABIL PSYCHOL, V42, P163, DOI 10.1037/0090-5550.42.3.163; Vaishnavi S, 2007, PSYCHIAT RES, V152, P293, DOI 10.1016/j.psychres.2007.01.006; Walterfang M, 2006, AUST NZ J PSYCHIAT, V40, P995, DOI 10.1111/j.1440-1614.2006.01923.x; Wang YC, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1401-y; Wecht JM, 2013, J SPINAL CORD MED, V36, P74, DOI 10.1179/2045772312Y.0000000056; Widerstrom-Noga E, 2014, SPINAL CORD, V52, P282, DOI 10.1038/sc.2014.4; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Wortzel HS, 2015, J AM ACAD PSYCHIATRY, V43, P499; Yang YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175335; Yen YC, 2004, INT J GERIATR PSYCH, V19, P564, DOI 10.1002/gps.1131; Zuromski KL, 2019, DEPRESS ANXIETY, V36, P790, DOI 10.1002/da.22942	98	2	2	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	SEP 11	2020	20	1							341	10.1186/s12883-020-01899-7			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NR7DR	WOS:000571721900001	32917161	Green Published, gold			2022-02-06	
J	Scott, RA; Rabinstein, AA				Scott, Rachael A.; Rabinstein, Alejandro A.			Paroxysmal Sympathetic Hyperactivity	SEMINARS IN NEUROLOGY			English	Article						paroxysmal sympathetic hyperactivity; dysautonomia; autonomic storms; hypertension; tachycardia	TRAUMATIC BRAIN-INJURY; AUTONOMIC DYSREGULATION; DYSAUTONOMIA; GABAPENTIN; MANAGEMENT	Paroxysmal sympathetic hyperactivity (PSH) is a relatively common, but often unrecognized, complication of acute diffuse or multifocal brain diseases, most frequently encountered in young comatose patients with severe traumatic brain injury. It is presumed to be caused by loss of cortical inhibitory modulation of diencephalic and brain stem centers and possible additional maladaptive changes in the spinal cord that combine to produce exaggerated sympathetic responses to stimulation. The syndrome consists of repeated sudden episodes of tachycardia, tachypnea, hypertension, sweating, and sometimes fever and dystonic posturing. The diagnosis is clinical. Treatment includes reducing any external stimulation that can trigger the episodes, and starting abortive (e.g., intravenous morphine) and preventive medications (e.g., gabapentin, propranolol, clonidine). Prompt and adequate treatment of PSH may reduce the likelihood of secondary complications, such as dehydration, weight loss and malnutrition, and muscle contractures.	[Scott, Rachael A.] Mayo Clin, Dept Pharm, Rochester, MN USA; [Rabinstein, Alejandro A.] Mayo Clin, Dept Neurol, 200 First St SW, Rochester, MN 55905 USA		Rabinstein, AA (corresponding author), Mayo Clin, Dept Neurol, 200 First St SW, Rochester, MN 55905 USA.	rabinstein.alejandro@mayo.edu					Godoy DA, 2018, NEUROCRIT CARE, V29, P358, DOI 10.1007/s12028-017-0463-y; Alofisan TO, 2019, PEDIATR CRIT CARE ME, V20, P252, DOI 10.1097/PCC.0000000000001811; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2009, AM J PHYS MED REHAB, V88, P615, DOI 10.1097/PHM.0b013e3181aeab96; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Caldwell SB, 2014, BRAIN INJURY, V28, P370, DOI 10.3109/02699052.2013.865265; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Fernandez-Ortega JF, 2011, J NEUROTRAUM, V28, P1327, DOI 10.1089/neu.2010.1722; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Hinson HE, 2017, J HEAD TRAUMA REHAB, V32, pE50, DOI 10.1097/HTR.0000000000000271; Hinson HE, 2015, BRAIN INJURY, V29, P455, DOI 10.3109/02699052.2014.995229; Huang P, 2009, J NEUROL, V256, P276, DOI 10.1007/s00415-009-0957-4; Hughes JD, 2014, NEUROCRIT CARE, V20, P454, DOI 10.1007/s12028-013-9877-3; Laxe S, 2013, BRAIN INJURY, V27, P1383, DOI 10.3109/02699052.2013.823648; Lump D, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0494-0; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Mathew MJ, 2016, ACTA NEUROCHIR, V158, P2047, DOI 10.1007/s00701-016-2934-x; Mehta NM, 2008, JPEN-PARENTER ENTER, V32, P281, DOI 10.1177/0148607108316196; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Mittal MK, 2016, NEUROCRIT CARE, V24, P240, DOI 10.1007/s12028-015-0196-8; Morinaga Y, 2019, DRUG DISCOV THER, V13, P168, DOI 10.5582/ddt.2019.01038; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Pozzi M, 2015, J HEAD TRAUMA REHAB, V30, P357, DOI 10.1097/HTR.0000000000000084; Pucks-Faes E, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1124; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Rose MA, 2002, ANAESTHESIA, V57, P451, DOI 10.1046/j.0003-2409.2001.02399.x; Samuel S, 2018, BRAIN INJURY, V32, P1115, DOI 10.1080/02699052.2018.1482002; Thomas A, 2019, AM J PHYS MED REHAB, V98, P65, DOI 10.1097/PHM.0000000000000990; van Eijck MM, 2019, J CRIT CARE, V49, P110, DOI 10.1016/j.jcrc.2018.10.018	37	2	3	1	5	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	OCT	2020	40	05					485	491		10.1055/s-0040-1713845		SEP 2020	7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OK1PU	WOS:000567528500004	32906174				2022-02-06	
J	Forner, D; Noel, CW; Guttman, MP; Haas, B; Enepekides, D; Rigby, MH; Nathens, AB; Eskander, A				Forner, David; Noel, Christopher W.; Guttman, Matthew P.; Haas, Barbara; Enepekides, Danny; Rigby, Matthew H.; Nathens, Avery B.; Eskander, Antoine			Blunt Versus Penetrating Neck Trauma: A Retrospective Cohort Study	LARYNGOSCOPE			English	Article						Neck; trauma; laryngology; trauma; broncho-esophagology; neck trauma; survival; penetrating trauma; blunt trauma	LENGTH-OF-STAY; CERVICAL-SPINE INJURIES; FACIAL FRACTURES; INTRACRANIAL INJURY; AMERICAN-COLLEGE; BRAIN-INJURY; MORTALITY; MANAGEMENT; OUTCOMES; RISK	Objectives/Hypothesis Despite being common, neck injuries have received relatively little attention for important quality of care metrics. This study sought to determine the association between blunt and penetrating neck injuries on mortality and length of stay, and to identify additional patient and hospital-level characteristics that impact these outcomes. Study Design Retrospective cohort study utilizing the American College of Surgeons Trauma Quality Improvement Program database. Methods Adult patients (>= 18) who sustained traumatic injuries involving the soft tissues of the neck between 2012 and 2016 were eligible. Multiple imputation was used to account for missing data. Logistic regression and negative binomial models were used to analyze 1) in-hospital mortality and 2) length of stay respectively while adjusting for potential confounders and accounting for clustering at the hospital level. Results In a cohort of 20,285 patients, the crude mortality rate was lower in those sustaining blunt neck injuries compared to penetrating injuries (4.9% vs. 6.0%,P < .01), while length of hospital stay was similar (median 9.9 vs. 10.2,P= 0.06). In adjusted analysis, blunt neck injuries were associated with a reduced odds of mortality during hospital admission (odds ratio: 0.66, 95% confidence intervals [0.564, 0.788]), as well as significant reductions in length of stay (rate ratio: 0.92, 95% confidence intervals [0.880, 0.954]). Conclusions Blunt neck injuries are associated with lower mortality and length of stay compared to penetrating injuries. Areas of future study have been identified, including elucidation of processes of care in specific organs of injury. Level of Evidence: Level 3Laryngoscope, 2020	[Forner, David; Rigby, Matthew H.] Dalhousie Univ, Div Otolaryngol Head & Neck Surg, Halifax, NS, Canada; [Forner, David; Noel, Christopher W.; Guttman, Matthew P.; Haas, Barbara; Enepekides, Danny; Nathens, Avery B.; Eskander, Antoine] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Noel, Christopher W.; Enepekides, Danny; Eskander, Antoine] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Guttman, Matthew P.; Haas, Barbara; Nathens, Avery B.] Univ Toronto, Dept Surg, Div Gen Surg, Toronto, ON, Canada; [Haas, Barbara; Nathens, Avery B.] Sunnybrook Hlth Sci Ctr, Dept Surg, Div Gen Surg, Toronto, ON, Canada; [Haas, Barbara] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada; [Enepekides, Danny; Eskander, Antoine] Sunnybrook Hlth Sci Ctr, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada		Eskander, A (corresponding author), Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave,Room T2 047, Toronto, ON M4N 3M5, Canada.	antoine.eskander@mail.utoronto.ca	Noel, Christopher W/AAD-7101-2022; Noel, Christopher W/ABA-6528-2021	Noel, Christopher W/0000-0002-6625-0809; Guttman, Matthew/0000-0001-6985-6403; Forner, David/0000-0002-1014-3545			Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Alao T, 2019, NECK TRAUMA; Allareddy V, 2011, J ORAL MAXIL SURG, V69, P2613, DOI 10.1016/j.joms.2011.02.057; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Back CPN, 2007, J PLAST RECONSTR AES, V60, P146, DOI 10.1016/j.bjps.2006.01.032; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bellamy JL, 2013, J CRANIOFAC SURG, V24, P1922, DOI 10.1097/SCS.0b013e3182a30544; BOLLEN KA, 1985, SOCIOL METHOD RES, V13, P510, DOI 10.1177/0049124185013004004; Boulanger L, 2007, AM SURGEON, V73, P1269; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Bruijns SR, 2013, J TRAUMA ACUTE CARE, V74, P1432, DOI 10.1097/TA.0b013e31829246c7; Evans C, 2018, EMERG MED CLIN N AM, V36, P181, DOI 10.1016/j.emc.2017.08.013; Freeman Jenny, 2006, J Health Serv Res Policy, V11, P101, DOI 10.1258/135581906776318857; George RL, 2003, J TRAUMA, V54, P464, DOI 10.1097/01.TA.0000051939.95039.E6; Glance LG, 2011, ARCH SURG-CHICAGO, V146, P794, DOI 10.1001/archsurg.2011.41; Gomez David, 2014, CMAJ Open, V2, pE176, DOI 10.9778/cmajo.20140007; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Haider AH, 2014, J TRAUMA ACUTE CARE, V76, P1061, DOI 10.1097/TA.0000000000000182; Hardin J.W, 2005, ENCY STAT BEHAV SCI; Harris MB, 2010, J BONE JOINT SURG AM, V92A, P567, DOI 10.2106/JBJS.I.00003; Harris R, 2012, ANN ROY COLL SURG, V94, P240, DOI 10.1308/003588412X13171221590052; Hashmi ZG, 2018, JAMA SURG, V153, P852, DOI 10.1001/jamasurg.2018.0483; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Hurrell MJL, 2014, INT J ORAL MAX SURG, V43, P944, DOI 10.1016/j.ijom.2014.03.003; Husum Hans, 2002, Prehosp Disaster Med, V17, P27; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; Ingraham AM, 2010, ANN SURG, V252, P358, DOI 10.1097/SLA.0b013e3181e623bf; Jackson AP, 2005, SPINE, V30, P1524, DOI 10.1097/01.brs.0000167822.75063.8c; Jewett BS, 1999, ARCH OTOLARYNGOL, V125, P877, DOI 10.1001/archotol.125.8.877; Kendall JL, 1998, EMERG MED CLIN N AM, V16, P85, DOI 10.1016/S0733-8627(05)70350-3; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; Lucas CE, 2001, J TRAUMA, V51, P1122, DOI 10.1097/00005373-200112000-00018; Mahmoodie M, 2012, ARCH TRAUMA RES, V1, P14, DOI 10.5812/atr.5308; Mendelsohn AH, 2011, LARYNGOSCOPE, V121, P2122, DOI 10.1002/lary.22163; Nash JJ, 2010, LARYNGOSCOPE, V120, P1397, DOI 10.1002/lary.20943; Newell MA, 2007, J AM COLL SURGEONS, V204, P1056, DOI 10.1016/j.jamcollsurg.2006.12.042; Newgard CD, 2013, J AM COLL SURGEONS, V216, P147, DOI 10.1016/j.jamcollsurg.2012.08.017; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Palmer C, 2007, ANN P ASS ADV AUT ME; Rezvan PH, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0022-1; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Santana MJ, 2012, J TRAUMA ACUTE CARE, V72, P1298, DOI 10.1097/TA.0b013e318246584c; Sethi RKV, 2014, OTOLARYNG HEAD NECK, V151, P776, DOI 10.1177/0194599814546112; Shafi S, 2008, J TRAUMA, V64, P599, DOI 10.1097/TA.0b013e31816533f9; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; SPIVAK JM, 1994, SPINE, V19, P2302, DOI 10.1097/00007632-199410150-00009; Taheri PA, 2000, J AM COLL SURGEONS, V191, P123, DOI 10.1016/S1072-7515(00)00352-5; Tatum JM, 2020, J INVEST SURG, V33, P896, DOI 10.1080/08941939.2019.1576810; Thombs BD, 2007, ANN SURG, V245, P629, DOI 10.1097/01.sla.0000250422.36168.67; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yang D, 2012, SAS GLOB FOR; Zorn CJW, 2001, AM J POLIT SCI, V45, P470, DOI 10.2307/2669353	56	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	APR	2021	131	4					E1109	E1116		10.1002/lary.29088		SEP 2020	8	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Otorhinolaryngology	QU0KJ	WOS:000566534700001	32894596				2022-02-06	
J	Xiang, XJ; Sun, LZ; Xu, CB; Xie, Y; Pan, MY; Ran, J; Hu, Y; Nong, BX; Shen, Q; Huang, H; Huang, SH; Yu, YZ				Xiang, Xun-Jie; Sun, Liu-Zhong; Xu, Cai-Bang; Xie, Yong; Pan, Ming-Yan; Ran, Jiang; Hu, Yang; Nong, Bang-Xie; Shen, Qu; Huang, Hua; Huang, Sheng-Hui; Yu, Yan-Zhong			The clinical effect of vagus nerve stimulation in the treatment of patients with a minimally conscious state	JOURNAL OF NEURORESTORATOLOGY			English	Article						disorders of consciousness; vegetative state; minimally conscious state; vagus nerve stimulation	PLACEBO-CONTROLLED TRIAL; TRAUMATIC BRAIN-INJURY; HARNESSING PLASTICITY; DISORDERS; AMANTADINE; ZOLPIDEM; EPILEPSY; NETWORK	Objective: Vagus nerve stimulation (VNS) has recently been used in neurorehabilitation and the recovery of consciousness based on its effects on cortical plasticity. The aim of this study was to examine the therapeutic effects of VNS on patients with a minimally conscious state (MCS). Methods: All patients included in the study were assessed more than 5 months after injury and were receiving regular rehabilitation at our hospital from August 2018 to October 2019. Ten patients diagnosed with MCS by Coma Recovery Scale-Revised (CRS-R) test who underwent VNS surgery were enrolled. The scores on CRS-R evaluation at baseline (before VNS implantation) and 1, 3, and 6 months after VNS treatment were recorded. The stimulation parameters were chosen according to a previous study. All clinical rehabilitation protocols remained unchanged during the study. Furthermore, safety was assessed by analyzing treatment-emergent adverse events (TEAEs). Results: No significant improvement in the total CRS-R scores at the end of the 1-month follow-up was observed (p > 0.05). After 3 months of stimulation, a significant difference (p = 0.0078) was observed in the total CRS-R scores compared with the baseline. After 6 months of VNS treatment, CRS-R assessments showed a continuous significant improvement (p = 0.0039); one patient emerged from the MCS and recovered functional communication and object use. Interestingly, one item of CRS-R scores on visual domain was sensitive to VNS treatment (p = 0.0039). Furthermore, no serious adverse event occurred throughout the study. Conclusion: This exploratory study provides preliminary evidence suggesting that VNS is a safe and effective tool for consciousness recovery in patients with MCS.	[Xiang, Xun-Jie; Sun, Liu-Zhong; Xu, Cai-Bang; Xie, Yong; Pan, Ming-Yan; Ran, Jiang; Hu, Yang; Nong, Bang-Xie; Shen, Qu; Huang, Hua; Huang, Sheng-Hui; Yu, Yan-Zhong] Guangxi Jiangbin Hosp, Neurosurg Dept, Nanning 530021, Guangxi, Peoples R China		Xiang, XJ (corresponding author), Guangxi Jiangbin Hosp, Neurosurg Dept, Nanning 530021, Guangxi, Peoples R China.	xxjsun@163.com; 247984643@qq.com; 65045725@qq.com; a_sol@163.com; 446220945@qq.com; 18860054785@163.com; 286644549@qq.com; 1019071818@qq.com; 56203831@qq.com; 974236096@qq.com; 22739831@qq.com					Aaronson ST, 2017, AM J PSYCHIAT, V174, P640, DOI 10.1176/appi.ajp.2017.16010034; Abbate Carlo, 2014, Front Hum Neurosci, V8, P616, DOI 10.3389/fnhum.2014.00616; Bagary M, 2011, BEHAV NEUROL, V24, P75, DOI [10.3233/BEN-2011-0319, 10.1155/2011/464018]; Bai Y, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00473; Bourdillon P, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00223; Cao JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189518; Chen SS, 2018, NEUROSCIENCE, V382, P115, DOI 10.1016/j.neuroscience.2018.04.039; Childs JE, 2015, JOVE-J VIS EXP, DOI 10.3791/53032; Corazzol M, 2017, CURR BIOL, V27, pR994, DOI 10.1016/j.cub.2017.07.060; Cui Y, 2018, NEUROIMAGE-CLIN, V20, P260, DOI 10.1016/j.nicl.2018.07.025; Dong XY, 2018, NEURAL REGEN RES, V13, P244, DOI 10.4103/1673-5374.226395; Engineer ND, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00280; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gosseries O, 2014, CURR PHARM DESIGN, V20, P4167; Hachem LD, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.6.FOCUS18216; Haddad AR, 2019, NEUROMODULATION, V22, P373, DOI 10.1111/ner.12944; Hakon J, 2020, NEUROMODULATION, V23, P859, DOI 10.1111/ner.13148; Hays SA, 2016, NEUROTHERAPEUTICS, V13, P382, DOI 10.1007/s13311-015-0417-z; Hays SA, 2013, PROG BRAIN RES, V207, P275, DOI 10.1016/B978-0-444-63327-9.00010-2; Hodelin-Tablada R, 2016, MEDICC REV, V18, P43, DOI 10.37757/MR2016.V18.N4.9; Kilgard MP, 2012, TRENDS NEUROSCI, V35, P715, DOI 10.1016/j.tins.2012.09.002; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Liang ZH, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01511; Lozano AM, 2011, NEW ENGL J MED, V364, P1367, DOI 10.1056/NEJMcibr1100496; Malow BA, 2001, NEUROLOGY, V57, P879, DOI 10.1212/WNL.57.5.879; Martinez-Vargas D, 2009, BEHAV BRAIN RES, V205, P45, DOI 10.1016/j.bbr.2009.06.029; Meyers EC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13695-0; Meyers EC, 2018, STROKE, V49, P710, DOI 10.1161/STROKEAHA.117.019202; Moreno DR, 2010, NEUROLOGY, V75, P1871, DOI 10.1212/WNL.0b013e3181feb259; Naccache L, 2018, BRAIN, V141, P949, DOI 10.1093/brain/awx324; Noe E, 2020, BRAIN STIMUL, V13, P427, DOI 10.1016/j.brs.2019.12.005; Padua L, 2019, CURR OPIN NEUROL, V32, P844, DOI 10.1097/WCO.0000000000000747; Pape TLB, 2015, NEUROREHAB NEURAL RE, V29, P537, DOI 10.1177/1545968314554626; Rizzo P, 2003, SLEEP, V26, P607, DOI 10.1093/sleep/26.5.607; Rodenkirch C, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/ab6b84; Saleem GT, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029967; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Thibaut A, 2019, LANCET NEUROL, V18, P600, DOI 10.1016/S1474-4422(19)30031-6; Wang Y, 2020, INT J NEUROSCI, V130, P662, DOI 10.1080/00207454.2019.1702543; Whyte J, 2014, AM J PHYS MED REHAB, V93, P101, DOI 10.1097/PHM.0000000000000069; Wojtecki L, 2014, CORTEX, V60, P94, DOI 10.1016/j.cortex.2014.09.007; Xie H, 2020, EPILEPSY RES, V159, DOI 10.1016/j.eplepsyres.2019.106246; Yu YT, 2017, BRAIN STIMUL, V10, P328, DOI 10.1016/j.brs.2016.12.004	48	2	2	2	4	TSINGHUA UNIV PRESS	BEIJING	B605D, XUE YAN BUILDING, BEIJING, 100084, PEOPLES R CHINA	2324-2426			J NEURORESTORATOLOGY	J. NEURORESSTORATOLOGY	SEP 5	2020	8	3					160	171		10.26599/JNR.2020.9040016			12	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	OH5IM	WOS:000582616500005		gold			2022-02-06	
J	O'Brien, NF; Reuter-Rice, K; Wainwright, MS; Kaplan, SL; Appavu, B; Erklauer, JC; Ghosh, S; Kirschen, M; Kozak, B; Lidsky, K; Lovett, ME; Mehollin-Ray, AR; Miles, DK; Press, CA; Simon, DW; Tasker, RC; LaRovere, KL				O'Brien, Nicole Fortier; Reuter-Rice, Karin; Wainwright, Mark S.; Kaplan, Summer L.; Appavu, Brian; Erklauer, Jennifer C.; Ghosh, Suman; Kirschen, Matthew; Kozak, Brandi; Lidsky, Karen; Lovett, Marlina Elizabeth; Mehollin-Ray, Amy R.; Miles, Darryl K.; Press, Craig A.; Simon, Dennis W.; Tasker, Robert C.; LaRovere, Kerri Lynn			Practice Recommendations for Transcranial Doppler Ultrasonography in Critically Ill Children in the Pediatric Intensive Care Unit: A Multidisciplinary Expert Consensus Statement	JOURNAL OF PEDIATRIC INTENSIVE CARE			English	Article						transcranial doppler ultrasound; pediatric critical care; practice recommendations; protocol; pediatric intensive care unit	BLOOD-FLOW VELOCITY; TRAUMATIC BRAIN-INJURY; EXTRACORPOREAL MEMBRANE-OXYGENATION; IMPAIRED CEREBRAL AUTOREGULATION; TO-LEFT SHUNT; CIRCULATORY ARREST; CEREBROVASCULAR RESPONSE; INTRACRANIAL-PRESSURE; NEUROCRITICAL CARE; DELPHI TECHNIQUE	Transcranial Doppler ultrasonography (TCD) is being used in many pediatric intensive care units (PICUs) to aid in the diagnosis and monitoring of children with known or suspected pathophysiological changes to cerebral hemodynamics. Standardized approaches to scanning protocols, interpretation, and documentation of TCD examinations in this setting are lacking. A panel of multidisciplinary clinicians with expertise in the use of TCD in the PICU undertook a three-round modified Delphi process to reach unanimous agreement on 34 statements and then create practice recommendations for TCD use in the PICU. Use of these recommendations will help to ensure that high quality TCD images are captured, interpreted, and reported using standard nomenclature. Furthermore, use will aid in ensuring reproducible and meaningful study results between TCD practitioners and across PICUs.	[O'Brien, Nicole Fortier; Lovett, Marlina Elizabeth] Ohio State Univ, Dept Pediat, Div Crit Care Med, Nationwide Childrens Hosp, 700 Childrens Dr, Columbus, OH 43502 USA; [Reuter-Rice, Karin] Duke Univ, Dept Pediat, Div Pediat Crit Care, Sch Med,Sch Nursing,Duke Univ Duke Inst Brain Sci, Durham, NC 27706 USA; [Wainwright, Mark S.] Univ Washington, Seattle Childrens Hosp, Dept Neurol, Seattle, WA 98195 USA; [Kaplan, Summer L.] Univ Penn, Dept Radiol, Perelman Sch Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Appavu, Brian] Univ Arizona, Dept Pediat, Div Crit Care Med, Barrow Neurol Inst,Phoenix Childrens Hosp,Coll Me, Phoenix, AZ USA; [Erklauer, Jennifer C.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Div Crit Care Med & Neurol, Houston, TX 77030 USA; [Ghosh, Suman] Univ Florida, Coll Med, Dept Pediat, Div Pediat Neurol, Gainesville, FL USA; [Kirschen, Matthew] Univ Penn, Perelman Sch Med, Dept Anesthesiol, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kirschen, Matthew] Univ Penn, Perelman Sch Med, Dept Crit Care Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kozak, Brandi] Childrens Hosp Philadelphia, Ultrasound Div, Dept Radiol, Ctr Pediat Contrast Ultrasound, Philadelphia, PA 19104 USA; [Lidsky, Karen] Univ Florida, Dept Pediat, Div Pediat Crit Care, Wolfson Childrens Hosp, Jacksonville, FL USA; [Mehollin-Ray, Amy R.] Texas Childrens Hosp, Baylor Coll Med, Dept Radiol, EB Singleton Dept Pediat Radiol, Houston, TX 77030 USA; [Miles, Darryl K.] UT Southwestern Med Ctr, Dept Pediat, Div Crit Care, Dallas, TX USA; [Press, Craig A.] Univ Colorado, Sect Child Neurol, Dept Pediat, Childrens Hosp Colorado, Aurora, CO USA; [Simon, Dennis W.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Tasker, Robert C.] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol & Anesthesiol, Boston, MA 02115 USA; [Tasker, Robert C.] Harvard Med Sch, Boston Childrens Hosp, Dept Crit Care & Pain Med, Boston, MA 02115 USA; [LaRovere, Kerri Lynn] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA		O'Brien, NF (corresponding author), Ohio State Univ, Dept Pediat, Div Crit Care Med, Nationwide Childrens Hosp, 700 Childrens Dr, Columbus, OH 43502 USA.	Nicole.obrien@nationwidechildrens.org	Appavu, Brian L/AAE-7180-2021	Kirschen, Matthew/0000-0003-3585-2687; Wainwright, Mark/0000-0002-4736-7462; Kozak, Brandi/0000-0001-8222-3934; Appavu, Brian/0000-0002-5396-2559			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Abecasis F, 2018, CHILD NERV SYST, V34, P1465, DOI 10.1007/s00381-018-3877-8; ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; ADAMS RJ, 1998, NEW ENGL J MED, V339, P5, DOI [DOI 10.1056/NEJM199807023390102, 10.1056/NEJM199807023390102]; Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Alexandrov AV, 2012, J NEUROIMAGING, V22, P215, DOI 10.1111/j.1552-6569.2010.00523.x; [Anonymous], GUID VASC TEST; Bennett C, 2012, GASTROENTEROLOGY, V143, P336, DOI 10.1053/j.gastro.2012.04.032; Blanco P, 2018, J ULTRASOUND, V21, P1, DOI 10.1007/s40477-018-0282-9; BODE H, 1988, ARCH DIS CHILD, V63, P606, DOI 10.1136/adc.63.6.606; Bulas D, 2005, PEDIATR RADIOL, V35, P235, DOI 10.1007/s00247-005-1417-7; Bulas DI, 2000, PEDIATR RADIOL, V30, P733, DOI 10.1007/s002470000317; Bulas DI., 2009, ULTRASOUND CLIN, V4, P533; Calleja S, 2007, NEUROLOGIA, V22, P441; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Cheatham SL, 2018, PEDIATR CARDIOL, V39, P837, DOI 10.1007/s00246-018-1836-5; Cheng HH, 2014, ANN THORAC SURG, V98, P125, DOI 10.1016/j.athoracsur.2014.03.035; Consensus Group on Transcranial Doppler in Diagnosis of Brain Death, 2014, Rev Bras Ter Intensiva, V26, P240; Ducharme-Crevier L, 2016, PEDIATR NEUROL, V65, P52, DOI 10.1016/j.pediatrneurol.2016.08.027; Ducrocq X, 1998, J NEUROL SCI, V159, P145, DOI 10.1016/S0022-510X(98)00158-0; Fanelli A, 2019, J NEUROSURG-PEDIATR, V24, P509, DOI 10.3171/2019.5.PEDS19178; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; GOH D, 1993, ARCH DIS CHILD, V68, P111, DOI 10.1136/adc.68.1.111; Graefe A, 2011, INT J FORECASTING, V27, P183, DOI 10.1016/j.ijforecast.2010.05.004; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; HILLIER SC, 1991, ANESTH ANALG, V72, P723; Holey EA, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-52; Itoh S, 2011, CARDIOL YOUNG, V21, P182, DOI 10.1017/S1047951110001733; Kalanuria A, 2013, NEUROSURG CLIN N AM, V24, P441, DOI 10.1016/j.nec.2013.02.005; Kasim S.A., 2012, PRACT ASSESS RES EVA, V17, P1, DOI DOI 10.7275/G48Q-JE05; Kussman BD, 2007, J THORAC CARDIOV SUR, V133, P648, DOI 10.1016/j.jtcvs.2006.09.034; LaRovere K L, 2019, PEDIATR CRIT CARE ME, V21, P67; LaRovere KL, 2016, J NEUROTRAUM, V33, P2105, DOI 10.1089/neu.2015.4344; LaRovere KL, 2015, J ULTRAS MED, V34, P2121, DOI 10.7863/ultra.15.02016; LaRovere KL, 2015, CURR OPIN PEDIATR, V27, P712, DOI 10.1097/MOP.0000000000000282; Lau VI, 2017, CRIT ULTRASOUND J, V9, DOI 10.1186/s13089-017-0077-9; Leliefeld PH, 2009, ULTRASOUND MED BIOL, V35, P1601, DOI 10.1016/j.ultrasmedbio.2009.04.024; Lin JJ, 2015, RESUSCITATION, V89, P182, DOI 10.1016/j.resuscitation.2015.01.029; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Lovett ME, 2020, CHILD NERV SYST, V36, P993, DOI 10.1007/s00381-019-04431-6; Lovett ME, 2018, RESUSCITATION, V126, P191, DOI 10.1016/j.resuscitation.2018.02.005; Lowe LH, 2005, AM J NEURORADIOL, V26, P1698; Lowe LH, 2005, PEDIATR RADIOL, V35, P54, DOI 10.1007/s00247-004-1257-x; Ma L, 2014, PEDIATR CRIT CARE ME, V15, P742, DOI 10.1097/PCC.0000000000000197; Marteau, 1998, HEALTH TECHNOL ASSES, V2, pI, DOI DOI 10.3310/hta2030; Meshkat B, 2014, J HOSP ADM, V3, P1, DOI [10.5430/jha.v3n4p1, DOI 10.5430/JHA.V3N4P1]; Meyer PG, 2005, CHILD NERV SYST, V21, P133, DOI 10.1007/s00381-004-1016-1; Misrahi S, 2020, J RADIOL NURS, V39, P39; Nedelmann M, 2009, STROKE, V40, P3238, DOI 10.1161/STROKEAHA.109.555169; O'Brien NF, 2019, PEDIATR CRIT CARE ME, V20, P178, DOI 10.1097/PCC.0000000000001778; O'Brien NF, 2015, J NEUROSURG-PEDIATR, V16, P420, DOI 10.3171/2015.3.PEDS14521; O'Brien NF, 2013, PEDIATR CRIT CARE ME, V14, pE126, DOI 10.1097/PCC.0b013e3182712d62; O'Brien NF, 2018, J PEDIATR-US, V203, P116, DOI 10.1016/j.jpeds.2018.07.075; O'Brien NF, 2018, CHILD NERV SYST, V34, P663, DOI 10.1007/s00381-017-3693-6; O'Brien NF, 2015, CHILD NERV SYST, V31, P2269, DOI 10.1007/s00381-015-2873-5; Perkovic-Benedik M, 2013, EUR J PEDIATR, V172, P239, DOI 10.1007/s00431-012-1875-5; Perkovic-Benedik M, 2011, ARCH DIS CHILD, V96, P461, DOI 10.1136/adc.2010.203992; Philip S, 2009, CRIT CARE MED, V37, P2973, DOI 10.1097/CCM.0b013e3181a963f6; Polito Angelo, 2006, Cardiovasc Ultrasound, V4, P47, DOI 10.1186/1476-7120-4-47; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Rasulo EA, 2008, EUR J ANAESTH, V25, P167, DOI 10.1017/S0265021507003341; Reuter-Rice K, 2018, BIOL RES NURS, V20, P566, DOI 10.1177/1099800418785982; Reuter-Rice Karin, 2017, J Radiol Nurs, V36, P3, DOI 10.1016/j.jradnu.2016.11.003; Rilinger JF, 2017, J STROKE CEREBROVASC, V26, P2336, DOI 10.1016/j.jstrokecerebrovasdis.2017.05.022; Robba C, 2020, CHILD NERV SYST, V36, P117, DOI 10.1007/s00381-019-04235-8; Saqqur M, 2007, CRIT CARE MED, V35, pS216, DOI 10.1097/01.CCM.0000260633.66384.FB; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Sviri GE, 2006, NEUROSURGERY, V59, P360, DOI 10.1227/01.NEU.0000223502.93013.6E; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; Tsivgoulis G, 2009, CURR NEUROL NEUROSCI, V9, P46, DOI 10.1007/s11910-009-0008-7; Melo JRT, 2011, CHILD NERV SYST, V27, P979, DOI 10.1007/s00381-010-1367-8; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Verlhac S, 2011, PEDIATR RADIOL, V41, pS153, DOI 10.1007/s00247-011-2038-y; Wallace S, 2015, CARDIOL YOUNG, V25, P237, DOI 10.1017/S1047951113002072; Wood L, 2013, J ONCOL PRACT, V9, pE262, DOI 10.1200/JOP.2012.000870	81	2	2	1	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2146-4618	2146-4626		J PEDIATR INTENSIVE	J. Pediatr. Intensive Care	JUN	2021	10	02					133	142		10.1055/s-0040-1715128		SEP 2020	10	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	RN9VX	WOS:000565886700002	33884214				2022-02-06	
J	Zheng, F; Zhou, YT; Li, PF; Hu, E; Li, T; Tang, T; Luo, JK; Zhang, W; Ding, CS; Wang, Y				Zheng, Fei; Zhou, Yan-Tao; Li, Peng-Fei; Hu, En; Li, Teng; Tang, Tao; Luo, Jie-Kun; Zhang, Wei; Ding, Chang-Song; Wang, Yang			Metabolomics Analysis of Hippocampus and Cortex in a Rat Model of Traumatic Brain Injury in the Subacute Phase	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury; hippocampus and cortex; metabolomics; LC-MS; MS; subacute phase	URIC-ACID; ENERGY DEPLETION; SYSTEMS BIOLOGY; PATHOPHYSIOLOGY; IMPAIRMENT; BIOMARKERS; ISCHEMIA; EFFICACY; STRESS	Traumatic brain injury (TBI) is a complex and serious disease as its multifaceted pathophysiological mechanisms remain vague. The molecular changes of hippocampal and cortical dysfunction in the process of TBI are poorly understood, especially their chronic effects on metabolic profiles. Here we utilize metabolomics-based liquid chromatography coupled with tandem mass spectrometry coupled with bioinformatics method to assess the perturbation of brain metabolism in rat hippocampus and cortex on day 7. The results revealed a signature panel which consisted of 13 identified metabolites to facilitate targeted interventions for subacute TBI discrimination. Purine metabolism change in cortical tissue and taurine and hypotaurine metabolism change in hippocampal tissue were detected. Furthermore, the associations between the metabolite markers and the perturbed pathways were analyzed based on databases: 64 enzyme and one pathway were evolved in TBI. The findings represented significant profiling changes and provided unique metabolite-protein information in a rat model of TBI following the subacute phase. This study may inspire scientists and doctors to further their studies and provide potential therapy targets for clinical interventions.	[Zheng, Fei; Zhou, Yan-Tao] Hunan Univ, Coll Elect & Informat Engn, Changsha, Peoples R China; [Li, Peng-Fei; Hu, En; Li, Teng; Tang, Tao; Luo, Jie-Kun; Wang, Yang] Cent South Univ, Inst Integrated Tradit Chinese & Western Med, Xiangya Hosp, Lab Ethnopharmacol, Changsha, Peoples R China; [Zhang, Wei] Hunan Univ Chinese Med, Coll Integrated Tradit Chinese & Western Med, Changsha, Peoples R China; [Ding, Chang-Song] Hunan Univ Chinese Med, Sch Informat, Changsha, Peoples R China		Wang, Y (corresponding author), Cent South Univ, Inst Integrated Tradit Chinese & Western Med, Xiangya Hosp, Lab Ethnopharmacol, Changsha, Peoples R China.; Zhang, W (corresponding author), Hunan Univ Chinese Med, Coll Integrated Tradit Chinese & Western Med, Changsha, Peoples R China.; Ding, CS (corresponding author), Hunan Univ Chinese Med, Sch Informat, Changsha, Peoples R China.	zhangwei1979@hnucm.edu.cn; dingcs1975@hnucm.edu.cn; wangyang_xy87@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673719, 61472126]; Hunan Provincial Natural Science Foundation of ChinaNatural Science Foundation of Hunan Province [2019JJ30042]; Outstanding Youth Fund of Hunan Natural Science [2020JJ2024]; Natural Science Foundation of Hunan ProvinceNatural Science Foundation of Hunan Province [2018JJ2301]	This work was supported by the National Natural Science Foundation of China (Nos. 81673719 and 61472126), the Hunan Provincial Natural Science Foundation of China (No. 2019JJ30042), the Outstanding Youth Fund of Hunan Natural Science (No. 2020JJ2024), and Natural Science Foundation of Hunan Province (No. 2018JJ2301).	Al-Majed AA, 2006, CLIN EXP PHARMACOL P, V33, P725, DOI 10.1111/j.1440-1681.2006.04425.x; Arulsamy A, 2019, BEHAV BRAIN RES, V365, P66, DOI 10.1016/j.bbr.2019.02.045; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Bivona G, 2018, CENT EUR J IMMUNOL, V43, P331, DOI 10.5114/ceji.2018.80053; Boone DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06341-6; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chaikuad A, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-42; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chitturi J, 2018, NEUROCHEM INT, V120, P75, DOI 10.1016/j.neuint.2018.08.003; Cui CM, 2017, CELL PHYSIOL BIOCHEM, V42, P1888, DOI 10.1159/000479571; Dash PK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00036; Dickens AM, 2018, J NEUROTRAUM, V35, P2673, DOI 10.1089/neu.2017.5272; Dolezal T, 2005, PLOS BIOL, V3, P1213, DOI 10.1371/journal.pbio.0030201; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Faden AI, 2011, ANN NEUROL, V70, P345, DOI 10.1002/ana.22555; Farkhondeh T, 2018, DOSE-RESPONSE, V16, DOI 10.1177/1559325818761455; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Fontaine M, 2018, MOL GENET METAB, V123, P441, DOI 10.1016/j.ymgme.2018.02.005; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Grone BP, 2016, SCI REP-UK, V6, DOI 10.1038/srep30507; Han SQ, 2019, PROG NEURO-PSYCHOPH, V94, DOI 10.1016/j.pnpbp.2019.109665; Hanlon LA, 2019, EXP NEUROL, V316, P39, DOI 10.1016/j.expneurol.2019.04.004; Janssen HJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-7; Johnson RJ, 2009, J COMP PHYSIOL B, V179, P67, DOI 10.1007/s00360-008-0291-7; Kempuraj D, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00054; Kerner J, 2014, J BIOL CHEM, V289, P10223, DOI 10.1074/jbc.M113.524314; Kunisawa K, 2017, EUR J PHARMACOL, V796, P122, DOI 10.1016/j.ejphar.2016.12.007; Li J, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/1897316; Liao WT, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01950; Lichtman JW, 2014, NAT NEUROSCI, V17, P1448, DOI 10.1038/nn.3837; Lieblein-Boff JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136904; Lin ZY, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0792-6; LIU CL, 2017, MAR DRUGS, V0015; Liu H, 2018, INT J MED SCI, V15, P1072, DOI 10.7150/ijms.25799; Lommen A, 2007, ANAL CHIM ACTA, V584, P43, DOI 10.1016/j.aca.2006.11.018; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mallah Khalil, 2019, Mol Cell Proteomics, V18, P1669, DOI 10.1074/mcp.RA119.001604; McGuire JL, 2019, MOL NEUROBIOL, V56, P2908, DOI 10.1007/s12035-018-1276-5; Mechanick JI, 1997, ARCH PHYS MED REHAB, V78, P692, DOI 10.1016/S0003-9993(97)90075-7; Molinari C, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2843121; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Ojuka E, 2016, AM J PHYSIOL-ENDOC M, V310, pE715, DOI 10.1152/ajpendo.00475.2015; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Prieto R, 2011, BRAIN RES, V1404, P39, DOI 10.1016/j.brainres.2011.06.006; Sakuragawa T, 2010, J CLIN BIOCHEM NUTR, V46, P126, DOI 10.3164/jcbn.09-91; Sapiurka M, 2016, HIPPOCAMPUS, V26, P1515, DOI 10.1002/hipo.22652; Shao YP, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-018-0304-2; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Shui S., 2018, J PHARM BIOMED ANAL, V156, P221; Tayag EC, 1996, BRAIN RES, V733, P287, DOI 10.1016/0006-8993(96)00669-5; Terranova JI, 2019, BEHAV BRAIN RES, V372, DOI 10.1016/j.bbr.2019.112035; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; van de Kerkhof PCM, 2002, BRIT J DERMATOL, V146, P414, DOI 10.1046/j.1365-2133.2002.04567.x; Vasilopoulou CG, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00183; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Vijayakumar N, 2019, CORTEX, V117, P336, DOI 10.1016/j.cortex.2019.04.024; Wang Yifeng, 2018, Gene Expression, V18, P187, DOI 10.3727/105221618X15277685544442; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolahan SM, 2015, BRAIN NEUROTRAUMA MO; Wu J, 2008, NEUROREPORT, V19, P333, DOI 10.1097/WNR.0b013e3282f50c90; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yang TM, 2014, HIPPOCAMPUS, V24, P1102, DOI 10.1002/hipo.22294; Yi L., 2016, SCI REP, V17; Yi Y, 2018, MOL NEUROBIOL, V55, P2454, DOI 10.1007/s12035-017-0504-8; Yun Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190194; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang ZQ, 2010, METHODS MOL BIOL, V662, P317, DOI 10.1007/978-1-60761-800-3_16; Zheng F, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1520	73	2	2	5	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	SEP 4	2020	14								876	10.3389/fnins.2020.00876			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NS4UQ	WOS:000572258800001	33013291	gold, Green Published			2022-02-06	
J	Zusman, BE; Kochanek, PM; Bailey, ZS; Leung, LY; Vagni, VA; Okonkwo, DO; Puccio, AM; Shutter, LA; Janesko-Feldman, KL; Gilsdorf, JS; Shear, DA; Jha, RM				Zusman, Benjamin E.; Kochanek, Patrick M.; Bailey, Zachary S.; Leung, Lai Yee; Vagni, Vincent A.; Okonkwo, David O.; Puccio, Ava M.; Shutter, Lori A.; Janesko-Feldman, Keri L.; Gilsdorf, Janice S.; Shear, Deborah A.; Jha, Ruchira M.			Multifaceted Benefit of Whole Blood Versus Lactated Ringer's Resuscitation After Traumatic Brain Injury and Hemorrhagic Shock in Mice	NEUROCRITICAL CARE			English	Article						Brain injuries; Traumatic; Shock; Hemorrhagic; Multiple trauma; Resuscitation	ACUTE HEAD-INJURY; FLUID RESUSCITATION; INTRACRANIAL-PRESSURE; OXYGEN-TENSION; CEREBRAL EDEMA; TRANSFUSION; PLASMA; SALINE; OUTCOMES; THERAPY	Background Despite increasing use in hemorrhagic shock (HS), whole blood (WB) resuscitation for polytrauma with traumatic brain injury (TBI) is largely unexplored. Current TBI guidelines recommend crystalloid for prehospital resuscitation. Although WB outperforms lactated Ringer's (LR) in increasing mean arterial pressure (MAP) in TBI + HS models, effects on brain tissue oxygenation (PbtO(2)), and optimal MAP remain undefined. Methods C57BL/6 mice (n = 72) underwent controlled cortical impact followed by HS (MAP = 25-27 mmHg). Ipsilateral hippocampal PbtO(2)(n = 40) was measured by microelectrode. Mice were assigned to four groups (n = 18/group) for "prehospital" resuscitation (90 min) with LR or autologous WB, and target MAPs of 60 or 70 mmHg (LR60, WB60, LR70, WB70). Additional LR (10 ml/kg) was bolused every 5 min for MAP below target. Results LR requirements in WB60(7.2 +/- 5.0 mL/kg) and WB70(28.3 +/- 9.6 mL/kg) were markedly lower than in LR60(132.8 +/- 5.8 mL/kg) or LR70(152.2 +/- 4.8 mL/kg; allp < 0.001). WB(70)MAP (72.5 +/- 2.9 mmHg) was higher than LR70(59.8 +/- 4.0 mmHg,p < 0.001). WB(60)MAP (68.7 +/- 4.6 mmHg) was higher than LR60(53.5 +/- 3.2 mmHg,p < 0.001). PbtO(2)was higher in WB60(43.8 +/- 11.6 mmHg) vs either LR60(25.9 +/- 13.0 mmHg,p = 0.04) or LR70(24.1 +/- 8.1 mmHg,p = 0.001). PbtO(2)in WB70(40.7 +/- 8.8 mmHg) was higher than in LR70(p = 0.007). Despite higher MAP in WB(70)vs WB60(p = .002), PbtO(2)was similar. Conclusion WB resuscitation after TBI + HS results in robust improvements in brain oxygenation while minimizing fluid volume when compared to standard LR resuscitation. WB resuscitation may allow for a lower prehospital MAP without compromising brain oxygenation when compared to LR resuscitation. Further studies evaluating the effects of these physiologic benefits on outcome after TBI with HS are warranted, to eventually inform clinical trials.	[Zusman, Benjamin E.] Univ Pittsburgh, Sch Med, Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA; [Zusman, Benjamin E.] Univ Pittsburgh, Inst Clin Res Educ, Pittsburgh, PA USA; [Zusman, Benjamin E.; Kochanek, Patrick M.; Jha, Ruchira M.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] UPMC, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Kochanek, Patrick M.; Vagni, Vincent A.; Shutter, Lori A.; Janesko-Feldman, Keri L.; Jha, Ruchira M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.; Vagni, Vincent A.; Janesko-Feldman, Keri L.; Jha, Ruchira M.] John G Rangos Res Ctr, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Okonkwo, David O.; Puccio, Ava M.; Jha, Ruchira M.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Bailey, Zachary S.; Leung, Lai Yee; Gilsdorf, Janice S.; Shear, Deborah A.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, Silver Spring, MD USA; [Leung, Lai Yee] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Jha, Ruchira M.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA		Jha, RM (corresponding author), Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA 15260 USA.; Jha, RM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.; Jha, RM (corresponding author), John G Rangos Res Ctr, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA.; Jha, RM (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA.; Jha, RM (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA.	ruchirajha@gmail.com	Shutter, Lori A/G-2957-2013		US Department of DefenseUnited States Department of Defense [W81XWH-17-C-0064]; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS101036]; University of Pittsburgh Clinical Scientist Training Program; University of Pittsburgh Deans Faculty Advancement Award	This work was funded by the US Department of Defense contract W81XWH-17-C-0064. Other sources of support include NIH NINDS (K23NS101036; to R.M.J.), the University of Pittsburgh Clinical Scientist Training Program (B.E.Z) and the University of Pittsburgh Deans Faculty Advancement Award (to R.M.J.). RMJ serves on the scientific advisory board for Biogen Inc and is a paid consultant for Biogen Inc.	Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Barsha G, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0110-x; Bell MJ, 2017, CHILD NERV SYST, V33, P1663, DOI 10.1007/s00381-017-3530-y; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bohman LE, 2011, NEUROCRIT CARE, V14, P361, DOI 10.1007/s12028-011-9526-7; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1993, ACTA NEUROCHIR, P34; Brockman EC, 2017, J NEUROTRAUM, V34, P1337, DOI 10.1089/neu.2016.4656; Butler FK, 2017, WILD ENVIRON MED, V28, pS74, DOI 10.1016/j.wem.2016.12.007; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang R, 2017, CRIT CARE CLIN, V33, P15, DOI 10.1016/j.ccc.2016.08.007; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DeSimone RA, 2018, TRANSFUSION, V58, P1333, DOI 10.1111/trf.14619; Dunbar NM, 2018, TRANSFUSION, V58, P1348, DOI 10.1111/trf.14547; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; EINTREI C, 1986, ACTA ANAESTH SCAND, V30, P194, DOI 10.1111/j.1399-6576.1986.tb02395.x; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145; Hawryluk GWJ, 2016, J NEUROSURG, V125, P1217, DOI 10.3171/2015.7.JNS15809; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Hernandez MC, 2017, J TRAUMA ACUTE CARE, V83, P398, DOI 10.1097/TA.0000000000001581; Hirschi R, 2018, J NEUROSURG, V131, P993; Hussmann B, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0221-x; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jammula S, 2018, J SURG RES, V232, P553, DOI 10.1016/j.jss.2018.07.046; Jha RM, 2018, J NEUROTRAUM, V35, P2125, DOI 10.1089/neu.2016.4696; Jungner M, 2011, CRIT CARE MED, V39, P135, DOI 10.1097/CCM.0b013e3181fb7c94; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Ko A, 2017, AM SURGEON, V83, P1447; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Lin C-M, 2015, BIOMED RES INT, V2015; LUERSSEN TG, 1995, PEDIATR NEUROSURG, V23, P34, DOI 10.1159/000120933; Lyons DG, 2016, ELIFE, V5, DOI 10.7554/eLife.12024; Maegele M, 2019, DTSCH ARZTEBL INT, V116, P167, DOI 10.3238/arztebl.2019.0167; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; Pivalizza EG, 2018, ANESTH ANALG, V127, P157, DOI 10.1213/ANE.0000000000003427; Pulliam KE, 2020, J TRAUMA ACUTE CARE, V89, P665, DOI 10.1097/TA.0000000000002839; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Reddy GD, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0379-9; Repine TB, 2006, J TRAUMA, V60, pS59, DOI 10.1097/01.ta.0000219013.64168.b2; Riskin DJ, 2009, J AM COLL SURGEONS, V209, P198, DOI 10.1016/j.jamcollsurg.2009.04.016; Rowell SE, 2016, J NEUROTRAUM, V33, P1054, DOI 10.1089/neu.2014.3478; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Schreiber MA, 2015, J TRAUMA ACUTE CARE, V78, P687, DOI 10.1097/TA.0000000000000600; Seheult JN, 2018, TRANSFUSION, V58, P1838, DOI 10.1111/trf.14779; Seheult JN, 2018, TRANSFUSION, V58, P2280, DOI 10.1111/trf.14771; Sekhon MS, 2011, J CRIT CARE, V26, P357, DOI 10.1016/j.jcrc.2010.12.001; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Tisherman SA, 2015, ANN SURG, V261, P586, DOI 10.1097/SLA.0000000000000837; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Weymouth W, 2019, J EMERG MED, V56, P491, DOI 10.1016/j.jemermed.2019.01.024; Wise R, 2017, WORLD J SURG, V41, P1170, DOI 10.1007/s00268-016-3865-7; Zehtabchi S, 2009, ACAD EMERG MED, V16, P371, DOI 10.1111/j.1553-2712.2009.00386.x	69	2	2	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2021	34	3					781	794		10.1007/s12028-020-01084-1		SEP 2020	14	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN4OZ	WOS:000566081700001	32886294				2022-02-06	
J	Chen, G; Gao, C; Yan, YA; Wang, T; Luo, CL; Zhang, MY; Chen, XP; Tao, LY				Chen, Guang; Gao, Cheng; Yan, Ya'nan; Wang, Tao; Luo, Chengliang; Zhang, Mingyang; Chen, Xiping; Tao, Luyang			Inhibiting ER Stress Weakens Neuronal Pyroptosis in a Mouse Acute Hemorrhagic Stroke Model	MOLECULAR NEUROBIOLOGY			English	Article						Intracerebral hemorrhage; Endoplasmic reticulum stress; Pyroptosis; Interleukin-13; Programmed cell death	TAUROURSODEOXYCHOLIC ACID; CELL-DEATH; INTERLEUKIN-13; EXPRESSION; APOPTOSIS; INJURY; CONTRIBUTES; MICROGLIA; CYTOKINE; PROTECTS	Intracerebral hemorrhage (ICH) is a form of stroke, characterized by high morbidity and mortality and currently lacks specific therapy. ICH leads to endoplasmic reticulum (ER) stress, which can induce neurological impairment through crosstalk with programmed cell death (PCD). Pyroptosis, a newly discovered form of PCD, has received attention because of its close relationship with some certain diseases, such as traumatic brain injury and ischemic and hemorrhagic stroke. However, the relationship between ER stress and pyroptosis in ICH remains unclear. In this study, we investigated the role of ER stress in evoking neuronal pyroptosis and related mechanisms in a mouse ICH model. We used tauroursodeoxycholic acid (TUDCA) to inhibit ER stress and observed that TUDCA reduces neuronal pyroptosis and has a neuroprotective role. We explored the potential mechanisms underlying the regulation of neuronal pyroptosis by ER stress through testing the expression of interleukin-13 (IL-13). We found that ER stress inhibition alleviates neuronal pyroptosis through decreasing the expression of IL-13 after ICH. In summary, this study revealed that IL-13 is involved in ER stress-induced neuronal pyroptosis after ICH, pointing to IL-13 as a novel therapeutic target for ICH treatment.	[Chen, Guang; Gao, Cheng; Yan, Ya'nan; Wang, Tao; Luo, Chengliang; Zhang, Mingyang; Chen, Xiping; Tao, Luyang] Soochow Univ, Sch Med, Dept Forens Med, 178 East Ganjiang Rd, Suzhou 215213, Peoples R China		Chen, XP; Tao, LY (corresponding author), Soochow Univ, Sch Med, Dept Forens Med, 178 East Ganjiang Rd, Suzhou 215213, Peoples R China.	xipingchen@suda.edu.cn; taoluyang@suda.edu.cn			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81530062, 81871536, 81971800]; PAPD	This work was supported by the Natural Science Foundation of China (Grant no. 81530062, 81871536, and 81971800) and PAPD.	An SJ, 2017, J STROKE, V19, P3, DOI 10.5853/jos.2016.00864; Ansari MA, 2015, J NEUROL SCI, V357, P41, DOI 10.1016/j.jns.2015.06.062; Arensdorf AM, 2013, J CELL SCI, V126, P4026, DOI 10.1242/jcs.130757; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Bluthe RM, 2001, NEUROREPORT, V12, P3979, DOI 10.1097/00001756-200112210-00025; Chen XN, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3462530; Colak A, 2008, J CLIN NEUROSCI, V15, P665, DOI 10.1016/j.jocn.2007.06.002; Delmotte P, 2015, CAN J PHYSIOL PHARM, V93, P97, DOI 10.1139/cjpp-2014-0361; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Fouillet A, 2012, AUTOPHAGY, V8, P915, DOI 10.4161/auto.19716; Gao Y, 2017, MOL NEUROBIOL, V54, P3879, DOI 10.1007/s12035-016-9947-6; Gaspar JM, 2013, NEUROSCIENCE, V253, P380, DOI 10.1016/j.neuroscience.2013.08.053; He WT, 2015, CELL RES, V25, P1285, DOI DOI 10.1038/cr.2015.139; Kuramatsu JB, 2013, J NEURAL TRANSM, V120, pS35, DOI 10.1007/s00702-013-1040-y; Lebeaupin C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.248; Leonard WJ, 2000, J ALLERGY CLIN IMMUN, V105, P877, DOI 10.1067/mai.2000.106899; Lin X, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3706047; Liu F, 2015, DRUG DISCOV THER, V9, P38, DOI 10.5582/ddt.2015.01008; Ma QY, 2014, ANN NEUROL, V75, P209, DOI 10.1002/ana.24070; Massaro AN, 2018, J PEDIATR-US, V194, P67, DOI 10.1016/j.jpeds.2017.10.060; Meng CJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00111; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Morrison BE, 2012, J IMMUNOL, V189, P5498, DOI 10.4049/jimmunol.1102150; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Nakka VP, 2016, MOL NEUROBIOL, V53, P532, DOI 10.1007/s12035-014-9029-6; Niu MM, 2017, TRANSL NEUROSCI, V8, P37, DOI 10.1515/tnsci-2017-0008; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Park KW, 2009, J IMMUNOL, V183, P4666, DOI 10.4049/jimmunol.0803392; Pastuszak-Lewandoska D, 2018, MOL DIAGN THER, V22, P621, DOI 10.1007/s40291-018-0355-7; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; Seyfizadeh N, 2015, ACTA MICROBIOL IMM H, V62, P341, DOI 10.1556/030.62.2015.4.2; Shi FS, 2015, LIFE SCI, V135, P9, DOI 10.1016/j.lfs.2015.05.011; Song LM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00063; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tsujii S, 2015, EUR J PHARMACOL, V746, P301, DOI 10.1016/j.ejphar.2014.09.023; Wang ZF, 2019, NEUROBIOL LEARN MEM, V161, P12, DOI 10.1016/j.nlm.2019.03.002; Yadav MC, 2007, GLIA, V55, P1385, DOI 10.1002/glia.20544; Yang JR, 2014, AM J PHYSIOL-RENAL, V306, pF75, DOI 10.1152/ajprenal.00117.2013; Yang MS, 2006, J IMMUNOL, V177, P1323, DOI 10.4049/jimmunol.177.2.1323; Ziai Wendy C, 2018, Continuum (Minneap Minn), V24, P1603, DOI 10.1212/CON.0000000000000672	40	2	2	4	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2020	57	12					5324	5335		10.1007/s12035-020-02097-9		SEP 2020	12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NX8NH	WOS:000565831800002	32880859				2022-02-06	
J	Analytis, P; Warren, N; Ponsford, J				Analytis, Penelope; Warren, Narelle; Ponsford, Jennie			The sibling relationship after acquired brain injury (ABI): perspectives of siblings with ABI and uninjured siblings	BRAIN INJURY			English	Article						Acquired brain injury; sibling relationships; family; siblings	ADULT SIBLINGS; CHILDREN; ADJUSTMENT	Primary Objective: This study explored the sibling relationship across the lifespan after acquired brain injury (ABI). Research Design: A qualitative approach was used to explore the perspectives of siblings with ABI and uninjured siblings. Methods and Procedures: Semi-structured interviews with 19 siblings with ABI and 20 uninjured siblings (aged 6-61 years) were analyzed using reflexive thematic analysis. Main Outcomes and Results: Four themes were identified: Living with ABI; Being normal siblings; Being part of a family; Experiencing social stigma of ABI. ABI was a traumatic event which differentiated siblings but increased understanding helped accommodate its impact. This impact was experienced within perceptions of typical sibling relationships as involving closeness and conflict. The family context shaped relationships, with parents mediating across the lifespan, while siblings' partners and children contributed to adult sibling relationships. Finally, social stigma led to distance but also protectiveness between siblings. Conclusions: The sibling relationship was experienced as a continually evolving source of closeness and conflict within the family context. ABI enhanced preexisting dynamics and created new dynamics, shaped by social attitudes toward ABI. Increased understanding of ABI supported closer relationships, highlighting a need for psychoeducational interventions across the lifespan.	[Analytis, Penelope; Ponsford, Jennie] Monash Univ, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Analytis, Penelope; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Brain Injury & Rehabil Program, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia; [Warren, Narelle] Monash Univ, Fac Arts, Sch Social Sci, Melbourne, Vic, Australia		Analytis, P (corresponding author), Ground Floor,185-187 Hoddle St, Richmond, Vic 3121, Australia.	penelope.analytis@monash.edu	; Ponsford, Jennie/H-8341-2014	Warren, Narelle/0000-0003-2623-4078; Analytis, Penelope/0000-0001-5252-9916; Ponsford, Jennie/0000-0003-0430-125X	Australian Government Research Training Program (RTP) ScholarshipAustralian GovernmentDepartment of Industry, Innovation and Science	Author PA received support through an Australian Government Research Training Program (RTP) Scholarship.	Avieli H, 2019, QUAL HEALTH RES, V29, P1739, DOI 10.1177/1049732319837228; Borgers N., 2000, BMS, V66, P60, DOI [10.1177/075910630006600106, DOI 10.1177/075910630006600106]; Boylan AM, 2009, J EARLY CHILD RES, V7, P264, DOI 10.1177/1476718X09336970; Braun V., 2019, HDB RES METHODS HLTH; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Braun V, 2019, LANCET PSYCHIAT, V6, P720, DOI 10.1016/S2215-0366(19)30296-2; Burbidge J, 2014, FAM RELAT, V63, P148, DOI 10.1111/fare.12047; Bursnall S, 2018, REHABIL PSYCHOL, V63, P447, DOI 10.1037/rep0000225; Cicirelli V.G., 1995, SIBLING RELATIONSHIP; Cox MJ, 1997, ANNU REV PSYCHOL, V48, P243, DOI 10.1146/annurev.psych.48.1.243; Degeneffe CE, 2013, J APPL REHABIL COUNS, V44; Degeneffe CE, 2016, J SOC WORK DISABIL R, V15, P332, DOI 10.1080/1536710X.2016.1220881; Degeneffe CE, 2010, BRAIN INJURY, V24, P1416, DOI 10.3109/02699052.2010.514317; Dew A, 2014, DISABIL REHABIL, V36, P756, DOI 10.3109/09638288.2013.816786; Gill D. J., 2000, REHABILITATION NURSI, V25, P48, DOI [10.1002/j.2048-7940.2000.tb01862.x, DOI 10.1002/J.2048-7940.2000.TB01862.X]; GOETTING A, 1986, J MARRIAGE FAM, V48, P703, DOI 10.2307/352563; Kramer J, 2013, INTELLECT DEV DISAB, V51, P482, DOI 10.1352/1934-9556-51.6.482; Lyons A.C., 2006, HLTH PSYCHOL CRITICA; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; McMahon MA, 2001, J HEAD TRAUMA REHAB, V16, P587, DOI 10.1097/00001199-200112000-00006; Meltzer A, 2016, DISABIL SOC, V31, P17, DOI 10.1080/09687599.2015.1127212; Morse JM, 2015, QUAL HEALTH RES, V25, P587, DOI 10.1177/1049732315576699; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [10.1097/00001199-199303000-00010, DOI 10.1097/00001199-199303000-00010]; Petalas MA, 2015, J CHILD FAM STUD, V24, P38, DOI 10.1007/s10826-013-9811-5; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; QSR International, 2018, NVIVO QUAL DAT AN SO; Sambuco M, 2012, J HEAD TRAUMA REHAB, V27, P413, DOI 10.1097/HTR.0b013e3182274162; Serdity C, 2012, CHILD SOC, V26, P37, DOI 10.1111/j.1099-0860.2010.00320.x; Sk?ldberg, 2017, REFLEXIVE METHODOLOG; Slota N, 2003, DISABIL STUD Q, V23; Stoneman Z, 2005, MENT RETARD, V43, P339; Terry G., 2017, SAGE HDB QUALITATIVE, V2; Tyerman E, 2018, DISABIL REHABIL; Varpio L, 2017, MED EDUC, V51, P40, DOI 10.1111/medu.13124; Ha VS, 2016, GLOB PUBLIC HEALTH, V11, P546, DOI 10.1080/17441692.2016.1165721; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; White N., 2017, WHY SIBLINGS MATTER; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302	38	2	2	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 18	2020	34	11					1504	1512		10.1080/02699052.2020.1809708		SEP 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NR9QK	WOS:000565237300001	32866049				2022-02-06	
J	Anderson, TN; Hinson, HE; Dewey, EN; Rick, EA; Schreiber, MA; Rowell, SE				Anderson, Taylor N.; Hinson, Holly E.; Dewey, Elizabeth N.; Rick, Elizabeth A.; Schreiber, Martin A.; Rowell, Susan E.			Early Tranexamic Acid Administration After Traumatic Brain Injury Is Associated With Reduced Syndecan-1 and Angiopoietin-2 in Patients With Traumatic Intracranial Hemorrhage	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						angiopoietin-2; brain injuries; cell adhesion molecules; craniocerebral trauma; endothelium; extracellular matrix proteins; glycocalyx; intracranial hemorrhages; syndecan-1; tranexamic acid; traumatic	VASCULAR-RESPONSE; EXPRESSION; THROMBOSPONDIN-2; COAGULOPATHY; INFLAMMATION; ACTIVATION; MODEL	Objective: To evaluate the effect of early tranexamic acid (TXA) administration on circulating markers of endotheliopathy. Setting: Twenty trauma centers in the United States and Canada. Participants: Patients with moderate-to-severe traumatic brain injury (TBI) (MS-TBI) and intracranial hemorrhage who were not in shock (systolic blood pressure >= 90 mm Hg). Design: TXA (2 g) or placebo administered prior to hospital arrival, less than 2 hours postinjury. Blood samples and head computed tomographic scan collected upon arrival. Plasma markers measured using Luminex analyte platform. Differences in median marker levels evaluated usingttests performed on log-transformed variables. Comparison groups were TXA versus placebo and less than 45 minutes versus 45 minutes or more from time of injury to treatment administration. Main Measures: Plasma levels of angiopoietin-1, angiopoietin-2, syndecan-1, thrombomodulin, thrombospondin-2, intercellular adhesion molecule 1, vascular adhesion molecule 1. Results: Demographics and Injury Severity Score were similar between the placebo (n= 129) and TXA (n= 158) groups. Levels of syndecan-1 were lower in the TXA group (median [interquartile range or IQR] = 254.6 pg/mL [200.7-322.0] vs 272.4 pg/mL [219.7-373.1],P= .05. Patients who received TXA less than 45 minutes postinjury had significantly lower levels of angiopoietin-2 (median [IQR] = 144.3 pg/mL [94.0-174.3] vs 154.6 pg/mL [110.4-209.8],P= .05). No differences were observed in remaining markers. Conclusions: TXA may inhibit early upregulation of syndecan-1 and angiopoietin-2 in patients with MS-TBI, suggesting attenuation of protease-mediated vascular glycocalyx breakdown. The findings of this exploratory analysis should be considered preliminary and require confirmation in future studies.	[Anderson, Taylor N.] Oregon Hlth & Sci Univ, Traumat Brain Injury Res Grp, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Hinson, Holly E.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; [Dewey, Elizabeth N.; Rick, Elizabeth A.; Schreiber, Martin A.; Rowell, Susan E.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97239 USA; [Schreiber, Martin A.] Oregon Hlth & Sci Univ, Div Trauma Crit Care & Acute Care Surg, Portland, OR 97239 USA; [Rowell, Susan E.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA		Anderson, TN (corresponding author), Oregon Hlth & Sci Univ, Traumat Brain Injury Res Grp, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	andertay@ohsu.edu	Hinson, Holly/Q-2268-2019	Hinson, Holly/0000-0003-1598-9782; Anderson, Taylor/0000-0002-8608-8343	NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1RO1HL126585-01, GRANT11652928]; Department of Defense ERMSUnited States Department of Defense [13335004]	This work was funded by grants awarded to the following authors: Susan E. Rowell, MD, MCR, Blood Based Biomarkers of Injury and Outcome in the Prehospital TXA for TBI Trial (source: NHLBI 1RO1HL126585-01, Grants.gov GRANT11652928); Susan E. Rowell, MD, MCR, Martin A. Schreiber, MD, Prehospital Tranexamic Acid Use for Traumatic Brain Injury (source: Department of Defense ERMS#13335004; Resuscitations Outcome Consortium).	Akwii RG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050471; Albert Venencia, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6010005; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Bodewes TCF, 2017, FASEB J, V31, P109, DOI 10.1096/fj.201600501R; Boldt J, 2000, CRIT CARE MED, V28, P445, DOI 10.1097/00003246-200002000-00026; Chan DYC, 2019, WORLD NEUROSURG, V125, pE665, DOI 10.1016/j.wneu.2019.01.145; Diebel ME, 2018, J TRAUMA ACUTE CARE, V84, P75, DOI 10.1097/TA.0000000000001726; Dore-Duffy P, 2007, NEUROL RES, V29, P395, DOI 10.1179/016164107X204729; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Gu H, 2016, INT NEUROUROL J, V20, P288, DOI 10.5213/inj.1632692.346; Hatefi M, 2017, WORLD NEUROSURG, V97, P70, DOI 10.1016/j.wneu.2016.09.080; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Haywood-Watson RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023530; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Kolarova H, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/694312; Lei J, 2012, CHIN J TRAUMATOL, V15, P17, DOI 10.3760/cma.j.issn.1008-1275.2012.01.004; Michinaga S, 2020, J NEUROCHEM, V154, P330, DOI 10.1111/jnc.14957; Moxon JV, 2019, J CEREBR BLOOD F MET, V39, P2343, DOI 10.1177/0271678X19876876; Navarro-Sobrino M, 2011, ATHEROSCLEROSIS, V216, P205, DOI 10.1016/j.atherosclerosis.2011.01.030; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Peng ZL, 2016, J TRAUMA ACUTE CARE, V81, P358, DOI 10.1097/TA.0000000000001056; Risdall JE, 2014, NEUROMOL MED, V16, P606, DOI 10.1007/s12017-014-8313-y; Roberts I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI [10.3310/HTA17100, 10.3310/hta17100]; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Rodriguez EG, 2017, J AM COLL SURGEONS, V225, P419, DOI 10.1016/j.jamcollsurg.2017.05.012; Saharinen P, 2017, NAT REV DRUG DISCOV, V16, P635, DOI 10.1038/nrd.2016.278; Shiraishi A, 2017, BRIT J SURG, V104, P710, DOI 10.1002/bjs.10497; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tian WM, 2011, AM J PATHOL, V179, P860, DOI 10.1016/j.ajpath.2011.05.002; Uchimido R, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2292-6; Wang Y, 2018, INT J CLIN EXP PATHO, V11, P3267; Yang AL, 2012, J NEUROL SCI, V323, P141, DOI 10.1016/j.jns.2012.09.002; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023; Zhou HJ, 2010, J NEUROSURG, V113, P820, DOI 10.3171/2010.1.JNS09637	35	2	2	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2020	35	5			SI		317	323		10.1097/HTR.0000000000000619			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NP5SO	WOS:000570236100004	32881765	Green Accepted			2022-02-06	
J	Biederman, J; Fried, R; DiSalvo, M; Driscoll, H; Green, A; Biederman, I; Woodworth, KY; Faraone, SV				Biederman, Joseph; Fried, Ronna; DiSalvo, Maura; Driscoll, Haley; Green, Allison; Biederman, Itai; Woodworth, K. Yvonne; Faraone, Stephen V.			A novel digital health intervention to improve patient engagement to stimulants in adult ADHD in the primary care setting: Preliminary findings from an open label study	PSYCHIATRY RESEARCH			English	Article						SMS; Texting; Psychiatry; ADHD	DEFICIT-HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; CHILDREN; OUTCOMES; MEDICATION; RISK; METAANALYSIS; COMORBIDITY; PREVALENCE	Aims: We piloted the effectiveness and acceptability of a novel text messaging-based (SMS) digital health intervention aimed at addressing the previously documented poor rate of patient engagement in stimulant treatment in the primary care setting. Methods: 117 adults ages 18-55 from primary care and psychiatric practices who were prescribed a stimulant medication for ADHD treatment received the SMS intervention. Comparators were age-, race-, and sex-matched patients from the same health care organization's electronic medical record who had been prescribed stimulant medications over a similar time period. Using documented prescription records, we determined whether patients had timely prescription refills. Results: Ninety-six percent (N = 112) of participants completed our a priori metric of patient engagement consisting of 37 days of the SMS program. Eighty-one percent of participants refilled their index prescriptions in a timely manner compared to only 36% of patients receiving treatment as usual (OR=7.54, 95% CI: 4.46, 12.77; p<0.001). We found no significant interaction between prescribing source (non-psychiatry vs. psychiatry) and intervention group (SMS vs. treatment as usual). Conclusions: These data suggest that an ADHD-centric, digital health intervention using text messaging significantly improves patient engagement in stimulant treatment in adults with ADHD.	[Biederman, Joseph; Fried, Ronna; DiSalvo, Maura; Driscoll, Haley; Green, Allison; Biederman, Itai; Woodworth, K. Yvonne] Massachusetts Gen Hosp, Clin & Res Programs Pediat Psychopharmacol & Adul, Boston, MA 02114 USA; [Biederman, Joseph; Fried, Ronna] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA		Biederman, J (corresponding author), Massachusetts Gen Hosp, Yawkey 6A, Boston, MA 02114 USA.	jbiederman@partners.org			Shire/Takeda, Lexington, MA, USA	This work was funded by a research grant from Shire/Takeda, Lexington, MA, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Adler L.A., 2007, J ATTEN DISORD; Adler LD, 2010, POSTGRAD MED, V122, P184, DOI 10.3810/pgm.2010.01.2112; [Anonymous], 2017, STAT STAT SOFTW REL; Barbaresi WJ, 2007, J DEV BEHAV PEDIATR, V28, P274, DOI 10.1097/DBP.0b013e3180cabc28; Barkley RA, 2002, J CLIN PSYCHIAT, V63, P10; Biederman J, 2006, PSYCHOL MED, V36, P167, DOI 10.1017/S0033291705006410; Biederman J, 2004, J CLIN PSYCHIAT, V65, P3; Biederman J., 2019, PSYCHIAT SERV, DOI [10.1176/appi.ps.201800515.appips201800515, DOI 10.1176/APPI.PS.201800515.APPIPS201800515]; Biederman J, 2008, J CLIN PSYCHIAT, V69, P1217, DOI 10.4088/JCP.v69n0803; Biederman Joseph, 2006, MedGenMed, V8, P12; Biederman J, 2019, J CLIN PSYCHOPHARM, V39, P351, DOI 10.1097/JCP.0000000000001055; Boland H, 2020, J PSYCHIATR RES, V123, P21, DOI 10.1016/j.jpsychires.2020.01.006; Charach A, 2004, J AM ACAD CHILD PSY, V43, P559, DOI 10.1097/00004583-200405000-00009; Chen Q, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204516; Connor DF, 2002, J AM ACAD CHILD PSY, V41, P253, DOI 10.1097/00004583-200203000-00004; Cortese S., 2015, AM J PSYCHIAT, DOI [10.1176/appi.ajp.2015.15020266.appiajp201515020266., DOI 10.1176/APPI.AJP.2015.15020266.APPIAJP201515020266]; Cox D.J., 2011, CURR PSYCHIAT REP, DOI [10.1007/s11920-011-0216-0, DOI 10.1007/S11920-011-0216-0.]; Dalsgaard S, 2015, LANCET PSYCHIAT, V2, P702, DOI 10.1016/S2215-0366(15)00271-0; Dalsgaard S, 2015, LANCET, V385, P2190, DOI 10.1016/S0140-6736(14)61684-6; Dalsgaard S, 2014, J HEALTH ECON, V37, P137, DOI 10.1016/j.jhealeco.2014.05.005; Faraone Stephen V, 2007, J Atten Disord, V11, P157, DOI 10.1177/1087054706295663; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Faraone SV, 2000, BIOL PSYCHIAT, V48, P9, DOI 10.1016/S0006-3223(00)00889-1; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; GLATT SJ, 2007, PSYCHOL MED, P3; Hibbard JH, 2013, HEALTH AFFAIR, V32, P207, DOI 10.1377/hlthaff.2012.1061; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Loe IM, 2007, AMBUL PEDIATR, V7, P82, DOI 10.1016/j.ambp.2006.05.005; Mannuzza S, 2008, PSYCHIAT RES, V160, P237, DOI 10.1016/j.psychres.2007.11.003; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Mohr-Jensen C, 2019, J AM ACAD CHILD PSY, V58, P443, DOI 10.1016/j.jaac.2018.11.016; Olfson M, 2007, J MANAGE CARE PHARM, V13, P570, DOI 10.18553/jmcp.2007.13.7.570; Quinn PD, 2017, AM J PSYCHIAT, V174, P877, DOI 10.1176/appi.ajp.2017.16060686; Reinhardt MC, 2013, J PEDIAT-BRAZIL, V89, P124, DOI 10.1016/j.jped.2013.03.015; Roy A, 2017, J AM ACAD CHILD PSY, V56, P687, DOI 10.1016/j.jaac.2017.05.020; Spencer AE, 2016, J CLIN PSYCHIAT, V77, P72, DOI 10.4088/JCP.14r09479; Spencer TJ, 2014, J NERV MENT DIS, V202, P725, DOI 10.1097/NMD.0000000000000191; Spencer TJ, 2013, J CLIN PSYCHIAT, V74, P902, DOI 10.4088/JCP.12r08287; Sun SH, 2019, JAMA PSYCHIAT, V76, P1141, DOI 10.1001/jamapsychiatry.2019.1944; Wilens TE, 2011, J AM ACAD CHILD PSY, V50, P543, DOI 10.1016/j.jaac.2011.01.021; Yegian JM, 2013, HEALTH AFFAIR, V32, P328, DOI 10.1377/hlthaff.2012.1077	44	2	2	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	SEP	2020	291								113158	10.1016/j.psychres.2020.113158			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	NK6VL	WOS:000566872600025	32559669				2022-02-06	
J	Corwin, DJ; Master, CL; Grady, MF; Zonfrillo, MR				Corwin, Daniel J.; Master, Christina L.; Grady, Matthew F.; Zonfrillo, Mark R.			The Economic Burden of Pediatric Postconcussive Syndrome	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; postconcussive syndrome; visio-vestibular therapy; economic cost		Objective: To estimate the direct costs of pediatric postconcussive syndrome (PCS). Design: Retrospective cohort study. Setting: Subspecialty sports medicine clinics of a large pediatric tertiary care network in the United States. Patients: One hundred fifty-four patients aged 5 to 18 years with PCS, evaluated between 2010 and 2011. Assessment of Independent Variables: Direct costs included visits to sports medicine clinic, visio-vestibular therapy, homebound education, subspecialist referral, and prescription-only medications (amantadine and amitriptyline), all measured beginning at 28 days after injury. Main Outcome Measures: Postconcussive syndrome was defined as persistence beyond 28 days from injury. Results: The cost incurred by each PCS patient for sports medicine visits was $1575, for visio-vestibular therapy was $985, for homebound tutoring was $55, for prescription medications was $22, and for subspecialist referral was $120, totaling $3557 per patient, with a 95% confidence interval range of $2886 to $4257. Conclusions: Given the high economic costs of PCS determined in this study, therapies that mitigate this syndrome may have the potential to be cost-effective and even cost saving.	[Corwin, Daniel J.] Childrens Hosp Philadelphia, Div Emergency Med, Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Corwin, Daniel J.; Master, Christina L.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Master, Christina L.; Grady, Matthew F.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Hasbro Childrens Hosp, Dept Emergency Med, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Hasbro Childrens Hosp, Dept Pediat, Providence, RI 02912 USA		Corwin, DJ (corresponding author), Childrens Hosp Philadelphia, Div Emergency Med, Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	corwind@email.chop.edu					Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bourgeois FT, 2014, PEDIATRICS, V134, P539, DOI 10.1542/peds.2014-1278; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; Collins Christy L, 2014, Inj Epidemiol, V1, P13; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220	9	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2020	30	5					E154	E155		10.1097/JSM.0000000000000732			2	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NX9CH	WOS:000575999300010	31219930				2022-02-06	
J	Curtis, K; Nahidi, S; Gabbe, B; Vallmuur, K; Martin, K; Shaban, RZ; Christey, G				Curtis, Kate; Nahidi, Shizar; Gabbe, Belinda; Vallmuur, Kirsten; Martin, Katherine; Shaban, Ramon Z.; Christey, Grant			Identifying the priority challenges in trauma care delivery for Australian and New Zealand trauma clinicians	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Injury; Clinical practice; Trauma systems and management; Practice challenges; Translation	QUALITY	Introduction: Injury is a leading cause of death and disability world-wide. Little is known about the day-to-day challenges the trauma clinicians face in their practice that they feel could be improved through an increased evidence base. This study explored and ranked the trauma clinical practice research priorities of trauma care professionals across Australia and New Zealand. Methods: A modified-Delphi study was conducted between September 2019 and January 2020. The study employed two rounds of online survey of trauma professionals from relevant Australia and New Zealand professional organisations using snowballing method. Participants were asked to rank the importance of 29 recommendations, each corresponding to a key challenge in trauma care delivery. Decisions on the priorities of the challenges were determined by a consensus of >70% of respondents ranking the challenge as important or very important. Results: One hundred and fifty-five participants completed Round One, and 106 participants completed Round Two. A total of 15 recommendations reached >70% in Round One. Nine recommendations also reached >70% consensus in Round Two. Recommendations ranked highest were 'Caring for elderly trauma patients', 'Identifying and validating key performance indicators for trauma system benchmarking and improvement', and 'Management of traumatic brain injury'. Conclusion: This study identified the priority areas for trauma research as determined by clinician ranking of the most important for informing and improving their practice. Addressing these areas generates potential to improve the quality and safety of trauma care in Australian and New Zealand. Crown Copyright (C) 2020 Published by Elsevier Ltd. All rights reserved.	[Curtis, Kate; Nahidi, Shizar; Vallmuur, Kirsten; Shaban, Ramon Z.] Univ Sydney, Susan Wakil Sch Nursing & Midwifery, Fac Med & Hlth, Sydney, NSW, Australia; [Curtis, Kate; Martin, Katherine; Christey, Grant] Royal Australasian Coll Surg, Trauma Qual Improvement Subcomm, Melbourne, Vic, Australia; [Curtis, Kate; Gabbe, Belinda; Martin, Katherine; Christey, Grant] Australasian Trauma Soc, Crows Nest, Australia; [Curtis, Kate; Vallmuur, Kirsten; Christey, Grant] Australian Trauma Qual Improvement Program AusTQI, Melbourne, Vic, Australia; [Curtis, Kate] Illawarra Shoalhaven Local Hlth Dist, Warrawong, Australia; [Curtis, Kate] Univ Wollongong, Fac Sci Med & Hlth, Wollongong, NSW, Australia; [Gabbe, Belinda] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Vallmuur, Kirsten] Queensland Univ Technol, Australian Ctr Hlth Serv Innovat, Fac Hlth, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia; [Vallmuur, Kirsten] Queensland Hlth, Metro North Hosp & Hlth Serv, Royal Brisbane & Womens Hosp, Jamieson Trauma Inst, Brisbane, Qld, Australia; [Shaban, Ramon Z.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Camperdown, NSW, Australia; [Shaban, Ramon Z.; Christey, Grant] Western Sydney Local Hlth Dist, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia; [Shaban, Ramon Z.; Christey, Grant] Western Sydney Local Hlth Dist, Directorate Nursing Midwifery & Clin Governance, Westmead, NSW, Australia; [Christey, Grant] Waikato Dist Hlth Board, Hamilton, New Zealand; [Christey, Grant] Univ Auckland, Waikato Clin Sch, Auckland, New Zealand		Curtis, K (corresponding author), Univ Sydney, Susan Wakil Sch Nursing & Midwifery, Fac Med & Hlth, Sydney, NSW, Australia.; Curtis, K (corresponding author), Royal Australasian Coll Surg, Trauma Qual Improvement Subcomm, Melbourne, Vic, Australia.; Curtis, K (corresponding author), Australasian Trauma Soc, Crows Nest, Australia.; Curtis, K (corresponding author), Australian Trauma Qual Improvement Program AusTQI, Melbourne, Vic, Australia.; Curtis, K (corresponding author), Illawarra Shoalhaven Local Hlth Dist, Warrawong, Australia.; Curtis, K (corresponding author), Univ Wollongong, Fac Sci Med & Hlth, Wollongong, NSW, Australia.	kate.curtis1@health.nsw.gov.au	Vallmuur, Kirsten/AAL-9526-2021	Vallmuur, Kirsten/0000-0002-3760-0822; Gabbe, Belinda/0000-0001-7096-7688; Shaban, Ramon/0000-0002-5203-0557; Curtis, Kate/0000-0002-3746-0348; Nahidi, Shizar/0000-0003-0443-4626			[Anonymous], 2019, JOINT RESP RACS AIPN; Australasian College of Road Safety (ACRS) Australian Injury Prevention Network (AIPN) Royal Australasian College of Surgeons (RACS), 2015, 2015 ACRS AIPN RACS; Australian Institute of Health and Welfare, 2018, AUSTR HLTH 2018 BRIE; Australian Institute of Health and Welfare, 2018, OLD AUSTR GLANC; Australian Trauma Quality Improvement (AusTQIP) collaboration, 2019, AUSTR NZ TRAUM REG M; Bate P., 2008, ORG QUALITY IMPROVEM; Beck B, 2018, BJS OPEN, V2, P310, DOI 10.1002/bjs5.80; Benner P., 2010, ED NURSES CALL RADIC; Bobrovitz N, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-45; Browne LR, 2016, PREHOSP EMERG CARE, V20, P311, DOI 10.3109/10903127.2015.1102997; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Considine J, 2018, AUSTRALAS EMERG CARE, V21, P43, DOI 10.1016/j.auec.2018.03.001; Curtis K, 2020, AUSTR INJURY; Curtis K, 2019, AUSTR AUSTRALAS EMER, DOI [10.1016/j.auec.2019.09.004., DOI 10.1016/J.AUEC.2019.09.004]; Curtis K, 2020, INJURY, V51, P1183, DOI 10.1016/j.injury.2020.01.003; Deane HC, 2018, EMERG MED J, V35, P39, DOI 10.1136/emermed-2017-206727; George N, 2020, J PALLIAT MED, V23, P401, DOI 10.1089/jpm.2018.0632; Gravel K, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-16; Gruen RL, 2012, BRIT J SURG, V99, P97, DOI 10.1002/bjs.7754; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Jamieson Trauma Institute (JTI) Royal Australasian College of Surgeons (RACS) Queensland Trauma Committee Australasian Injury Prevention Network (AIPN), 2019, RESP AUSTR COMP CONS; Jones S, 2019, ARCH DIS CHILD, V104, P366, DOI 10.1136/archdischild-2018-315636; Kitson AL, 2009, J ADV NURS, V65, P217, DOI 10.1111/j.1365-2648.2008.04864.x; Kourouche S, 2018, INJURY, V49, P1008, DOI 10.1016/j.injury.2018.03.037; Lecky F, 2012, BEHALF IFEM QUALITY; Lecky F, 2014, EMERG MED J, V31, P926, DOI 10.1136/emermed-2013-203000; Leonard E, 2014, ANZ J SURG, V84, P523, DOI 10.1111/ans.12381; MCKENNA HP, 1994, J ADV NURS, V19, P1221, DOI 10.1111/j.1365-2648.1994.tb01207.x; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; NSW Agency for Clinical Innovation, 2018, MAJ TRAUM NSW 2016 1; NSW institute of trauma and injury management, 2016, TRAUM PAT OUTC EV QU; Reay H, 2014, J INTENSIVE CARE SOC, V15, P288; Schmitz E, 2019, J SURG EDUC, V76, P700, DOI 10.1016/j.jsurg.2018.10.009; SEDGWICK P, 2013, BMJ BRIT MED J, V0347, DOI DOI 10.1136/BMJ.F7511; Stelfox HT, 2012, J TRAUMA ACUTE CARE, V72, P962, DOI 10.1097/TA.0b013e31824a7bd8; Straus SE, 2009, CAN MED ASSOC J, V181, P165, DOI 10.1503/cmaj.081229; Thom O, 2014, EMERG MED AUSTRALAS, V26, P28, DOI 10.1111/1742-6723.12186; Titler M., 2008, PATIENT SAFETY QUALI; [No title captured]	40	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2020	51	9					2053	2058		10.1016/j.injury.2020.07.033			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	NL7XH	WOS:000567623100018	32698960				2022-02-06	
J	Datoc, A; Horne, K; Golden, C				Datoc, Alison; Horne, Kirsten; Golden, Charles			Sport-related concussion and risk for suicide in athletes	AGGRESSION AND VIOLENT BEHAVIOR			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; FOOTBALL LEAGUE PLAYERS; BRAIN-INJURY; DEPRESSION; PREVALENCE; SYMPTOMS; MILITARY; OUTCOMES; PEOPLE; ISSUES	Recently, negative consequences associated with sport-related concussion (SRC) have received increased attention in both the media and literature. A specific negative consequence that has received widespread attention is the possible association between SRC and suicide. While the connection between concussion and suicide has been reported by various sources in the media, the scientific evidence is severely limited and has reported inconsistent findings. Due to the lack of clarity regarding the relationship between SRC and suicide in athletes, the present review explored the current knowledge on this topic.	[Datoc, Alison; Horne, Kirsten; Golden, Charles] Nova Southeastern Univ, Ft Lauderdale, FL 33314 USA		Datoc, A (corresponding author), Nova Southeastern Univ, Ft Lauderdale, FL 33314 USA.	ad1995@mynsu.nova.edu					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Armstrong S, 2009, J AM COLL HEALTH, V57, P521, DOI 10.3200/JACH.57.5.521-526; Baron DA, 2013, CLINICAL SPORTS PSYCHIATRY: AN INTERNATIONAL PERSPECTIVE, P89; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Cato MA, 2004, J INT NEUROPSYCH SOC, V10, P453, DOI 10.1017/S1355617704103123; Center for Behavioral Health Statistics and Quality, 2015, HHD PUBL; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Eames P., 1990, TREATMENT BEHAV DISO; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Etzel EF, 2006, J STUD AFF RES PRACT, V43, P518, DOI 10.2202/0027-6014.1682; Filley CM, 2019, J NEUROPSYCH CLIN N, V31, P170, DOI 10.1176/appi.neuropsych.18100223; Fralick M, 2019, JAMA NEUROL, V76, P144, DOI 10.1001/jamaneurol.2018.3487; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hammond T, 2013, CLIN J SPORT MED, V23, P273, DOI 10.1097/JSM.0b013e318287b870; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KLONOFF PS, 1995, J HEAD TRAUMA REHAB, V10, P16, DOI 10.1097/00001199-199512000-00005; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Maniar S., 2005, NCAA NEWS, V42, P20; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Mann JJ, 2002, ANN INTERN MED, V136, P302, DOI 10.7326/0003-4819-136-4-200202190-00010; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckee AC, 2019, JAMA OPHTHALMOL, V137, P270, DOI 10.1001/jamaophthalmol.2018.6199; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Morgan W.P., 2000, BASIC APPL SCI SPORT; Moser RS, 2019, ARCH CLIN NEUROPSYCH, V34, P50, DOI 10.1093/arclin/acy007; Mufson EJ, 2016, BRAIN INJURY, V30, P1399, DOI 10.1080/02699052.2016.1219058; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Ott S., 2019, 7 ANN SPORTS NEUR SO; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Proctor SL, 2010, J CLIN SPORT PSYCHOL, V4, P204, DOI 10.1123/jcsp.4.3.204; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; SMITH AM, 1994, J ATHL TRAINING, V29, P337; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Storch E. A., 2005, J SPORT BEHAV, V28, P86; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; VAUHKONEN K., 1959, ACTA PSYCHIAT NEUROL SCAND SUPPL, V34, P90, DOI 10.1111/j.1600-0447.1959.tb08309.x; Vos BC, 2018, CLIN J SPORT MED, V28, P91, DOI 10.1097/JSM.0000000000000432; Webner D, 2016, BRAIN INJURY, V30, P1718, DOI 10.1080/02699052.2016.1202451; Weir K., 2019, MONITOR PSYCHOL; Wolanin A, 2015, CURR SPORT MED REP, V14, P56, DOI 10.1249/JSR.0000000000000123; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499	64	2	2	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-1789	1873-6335		AGGRESS VIOLENT BEH	Aggress. Violent Behav.	SEP-OCT	2020	54				SI				101413	10.1016/j.avb.2020.101413			9	Criminology & Penology; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Criminology & Penology; Psychology	NW4NE	WOS:000574984400006					2022-02-06	
J	De Luca, R; Maggio, MG; Naro, A; Portaro, S; Cannavo, A; Calabro, RS				De Luca, Rosaria; Maggio, Maria Grazia; Naro, Antonino; Portaro, Simona; Cannavo, Antonino; Calabro, Rocco Salvatore			Can patients with severe traumatic brain injury be trained with cognitive telerehabilitation? An inpatient feasibility and usability study	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Severe TBI; Tele-training; Feasibility; Usability; Innovation technology	REHABILITATION; EPIDEMIOLOGY; TELEMEDICINE; MOTIVATION; EXTENSION; AUTOCITE; THERAPY; MODEL	Traumatic Brain Injury (TBI) is the most common cause of long-term disability and death among young adults. Innovation technology, with regard to telerehabilitation, may be of help in managing these frail patients. The aim of the study is to evaluate whether TBI patients and caregivers are able to properly use a Tele-rehabilitation device during hospitalization. Ten TBI subjects (5 males and 5 females; mean age of 45.7 +/- 14.4 years), and their caregivers (6 males and 4 females; mean age of 43.7 +/- 13.5 years) were consecutively recruited in this preliminary study. After 3 meetings with the telemedicine operators aimed to provide both patients and caregivers with the basic information for the proper use of the device, patients were submitted to 6 training sessions, provided 3 times per week for two weeks, each session lasting about one hour. The telerehabilitation simulation was carried out using the tele-cockpit station and the VRRS-Tablet, used either in the patient's room or in the institute's Family Room. The motivation during training was positive, as per the Intrinsic Motivation Inventory score: 202.6 for patients and 216 for caregivers. Participants also presented positive usability scores, as per the System Usability Scale score: 68 for patients and 69 for caregivers. Our feasibility and usability study supports the idea that in-patients with severe TBI could benefit from cognitive telerehabilitation performed in the pre-discharge phase, in order to get a higher level of adherence to the home tele-treatment and potentially better outcomes. (C) 2020 Elsevier Ltd. All rights reserved.	[De Luca, Rosaria; Maggio, Maria Grazia; Naro, Antonino; Portaro, Simona; Cannavo, Antonino; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonin Pulejo, SS 113, I-98124 Messina, Italy		Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonin Pulejo, SS 113, I-98124 Messina, Italy.	salbro77@tiscali.it	Maggio, Maria Grazia/ABA-1852-2020	/0000-0003-0757-2389			Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Aprile I, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9245357; Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Bangor A, 2009, J USABILITY STUD, V4, P114; Bashshur RL, 2002, TELEMED J E-HEALTH, V8, P5, DOI 10.1089/15305620252933365; Bendixen RM, 2008, REHABIL NURS, V33, P215, DOI 10.1002/j.2048-7940.2008.tb00230.x; Bramanti A, 2018, EUR J NEUROL, V25, pE6, DOI 10.1111/ene.13477; Bramanti Alessia, 2018, Innov Clin Neurosci, V15, P11; Brennan DM, 2008, J TELEMED TELECARE, V14, P55, DOI 10.1258/jtt.2007.007040; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burridge JH, 2010, CURR OPIN NEUROL, V23, P671, DOI 10.1097/WCO.0b013e3283402af5; Calabr RS, 2018, MEDICINE, V97; De Cola MC, 2017, INQUIRY-J HEALTH CAR, V54, DOI 10.1177/0046958017713708; De Cola MC, 2020, GERIATR NURS S, VS0197-4572, P30055; De Luca R, 2018, NEUROPSYCHOL REHABIL, V28, P879, DOI 10.1080/09602011.2016.1211937; De Luca R, 2016, AGING CLIN EXP RES, V28, P753, DOI 10.1007/s40520-015-0463-8; De Tanti A, 2015, EUR J PHYS REHAB MED, V51, P89; Diamond BJ, 2003, NEUROREHABILITATION, V18, P171; Eicher C, 2019, ASSIST TECHNOL, V31, P25, DOI 10.1080/10400435.2017.1352051; Girard P., 2007, J REHABILITATION RES, V44, P1; Golant SM, 2017, J AGING STUD, V42, P56, DOI 10.1016/j.jaging.2017.07.003; Grahn B, 2000, DISABIL REHABIL, V22, P639, DOI 10.1080/096382800445443; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Holden MK, 2005, PRESENCE-VIRTUAL AUG, V14, P214, DOI 10.1162/1054746053967058; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Latella D, 2018, J CLIN NEUROSCI, V58, P1, DOI 10.1016/j.jocn.2018.09.030; Lum PS, 2004, J REHABIL RES DEV, V41, P249, DOI 10.1682/JRRD.2003.06.0092; Maggio MG, 2018, APPL NURS RES, V41, P11, DOI 10.1016/j.apnr.2018.03.005; Maresca G, 2019, J TELEMED TELECARE, V25, P318, DOI 10.1177/1357633X17753057; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; Nijenhuis SM, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0080-y; Ozkan Tuncay F, PERSPECTIVES PSYCHIA; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Resquin F, 2016, MED ENG PHYS, V38, P1279, DOI 10.1016/j.medengphy.2016.09.001; Rogerson L, 2020, DISABIL REHABIL-ASSI, V15, P148, DOI 10.1080/17483107.2018.1541103; Rosen E., 2001, TELEMED TODAY; Rosso G, 2018, COMPUT BIOL MED, V95, P288, DOI 10.1016/j.compbiomed.2017.08.009; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; Salem R, 2020, J PALLIAT MED, V23, P1594, DOI 10.1089/jpm.2020.0002; Sivan M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-163; Sogut C., 2017, Turkish Journal of Public Health, V15, P37, DOI 10.20518/tjph.326797; Taub E, 2005, STROKE, V36, P1301, DOI 10.1161/01.STR.0000166043.27545.e8; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624	43	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2020	79						246	250		10.1016/j.jocn.2020.07.063			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OG5ML	WOS:000581927800048	33070905				2022-02-06	
J	Elsamadicy, AA; Koo, AB; Lee, V; David, WB; Zogg, CK; Kundishora, AJ; Hong, CS; DeSpenza, T; Reeve, BC; DiLuna, M; Kahle, KT				Elsamadicy, Aladine A.; Koo, Andrew B.; Lee, Victor; David, Wyatt B.; Zogg, Cheryl K.; Kundishora, Adam J.; Hong, Christopher S.; DeSpenza, Tyrone; Reeve, Benjamin C.; DiLuna, Michael; Kahle, Kristopher T.			Risk Factors for the Development of Post-Traumatic Hydrocephalus in Children	WORLD NEUROSURGERY			English	Article						Pediatrics; Posttraumatic hydrocephalus; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; OUTCOMES; DEFINITION	OBJECTIVE: The aim of this study was to investigate the national impact of demographic, hospital, and inpatient risk factors on posttraumatic hydrocephalus (PTH) development in pediatric patients who presented to the emergency department after a traumatic brain injury (TBI). - METHODS: The Nationwide Emergency Department Sample database 2010-2014 was queried. Patients (<21 years old) with a primary diagnosis of TBI and subsequent secondary diagnosis of PTH were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification coding system. RESULTS: We identified 1,244,087 patients who sustained TBI, of whom 930 (0.07%) developed PTH. The rates of subdural hemorrhage and subarachnoid hemorrhage were both significantly higher for the PTH cohort. On multivariate regression, age 6-10 years (odds ratio [OR], 0.6; 95% confidence interval [CI], 0.38-0.93; P = 0.022), 11-15 years (OR, 0.32; 95% CI, 0.21-0.48; P < 0.0001), and 16-20 years (OR, 0.24; 95% CI, 0.15-0.37; P < 0.0001) were independently associated with decreased risk of developing hydrocephalus, compared with ages 0-5 years. Extended loss of consciousness with baseline return and extended loss of consciousness without baseline return were independently associated with increased risk of developing hydrocephalus. Respiratory complication (OR, 28.35; 95% CI, 15.75-51.05; P < 0.0001), hemorrhage (OR, 37.12; 95% CI, 4.79-287.58; P = 0.0001), thromboembolic (OR, 8.57; 95% CI, 1.31-56.19; P = 0.025), and neurologic complication (OR, 64.64; 95% CI, 1.39-3010.2; P = 0.033) were all independently associated with increased risk of developing hydrocephalus. - CONCLUSIONS: Our study using the Nationwide Emergency Department Sample database shows that various demographic, hospital, and clinical risk factors are associated with the development of hydrocephalus after traumatic brain injury.	[Elsamadicy, Aladine A.; Koo, Andrew B.; Lee, Victor; David, Wyatt B.; Zogg, Cheryl K.; Kundishora, Adam J.; Hong, Christopher S.; DeSpenza, Tyrone; Reeve, Benjamin C.; DiLuna, Michael; Kahle, Kristopher T.] Yale Univ, Dept Neurosurg, Sch Med, New Haven, CT 06510 USA		Kahle, KT (corresponding author), Yale Univ, Dept Neurosurg, Sch Med, New Haven, CT 06510 USA.	kristopher.kahle@yale.edu			NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001863] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F30 AG066371] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM007205] Funding Source: Medline		Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Ballard DW, 2019, ANN EMERG MED, V73, P440, DOI 10.1016/j.annemergmed.2018.11.011; Beck B, 2018, J NEUROTRAUM, V35, P1021, DOI 10.1089/neu.2017.5287; Bertsimas D, 2019, JAMA PEDIATR, V173, P648, DOI 10.1001/jamapediatrics.2019.1068; Bonow RH, 2018, NEUROSURGERY, V83, P732, DOI 10.1093/neuros/nyx470; Chen H, 2017, METAB BRAIN DIS, V32, P1427, DOI 10.1007/s11011-017-0008-2; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Licata C, 2001, J Neurosurg Sci, V45, P141; Linnemann M, 2014, NEUROREHABILITATION, V35, P755, DOI 10.3233/NRE-141160; Mannix R, 2019, SEMIN PEDIATR NEUROL, V30, P35, DOI 10.1016/j.spen.2019.03.006; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Pervez M, 2018, NEUROIMAG CLIN N AM, V28, P1, DOI 10.1016/j.nic.2017.09.010; Peterson AB, 2019, SURVEILLANCE REPORT; Rumalla K, 2018, PEDIATR NEUROL, V80, P70, DOI 10.1016/j.pediatrneurol.2017.11.015; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478	23	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2020	141						E105	E111		10.1016/j.wneu.2020.04.216			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NG9RY	WOS:000564320300005	32389871	Green Accepted			2022-02-06	
J	Garcia, A; Reljic, T; Pogoda, TK; Kenney, K; Agyemang, A; Troyanskaya, M; Belanger, HG; Wilde, EA; Walker, WC; Nakase-Richardson, R				Garcia, Amanda; Reljic, Tea; Pogoda, Terri K.; Kenney, Kimbra; Agyemang, Amma; Troyanskaya, Maya; Belanger, Heather G.; Wilde, Elisabeth A.; Walker, William C.; Nakase-Richardson, Risa			Obstructive Sleep Apnea Risk Is Associated with Cognitive Impairment after Controlling for Mild Traumatic Brain Injury History: A Chronic Effects of Neurotrauma Consortium Study	JOURNAL OF NEUROTRAUMA			English	Article						chronic effects; cognition; mild traumatic brain injury; military; mTBI; neurotrauma; obstructive sleep apnea; OSA	EDITION CVLT-II; NEUROPSYCHOLOGICAL OUTCOMES; SYMPTOMS; METAANALYSIS; INDIVIDUALS; RECOVERY; INSOMNIA; QUESTIONNAIRE; RELIABILITY; DEPRIVATION	The contribution of sleep disturbance to persistent cognitive symptoms following a mild traumatic brain injury (mTBI) remains unclear. Obstructive sleep apnea (OSA) is very common, yet its relationship between risk factors for developing OSA and cognitive performance in those with history of mTBI has not been investigated. The current study examined OSA risk levels and its association with cognitive performance in 391 combat-exposed, post-911 veterans and service members (median age = 37 years) enrolled in the Chronic Effects of Neurotrauma Consortium (CENC) prospective multi-center study. Participants included those with and without mTBI (n = 326 and 65, respectively). When using clinical cut-offs, those with history of mTBI were more likely to be categorized as high risk for OSA (mTBI positive = 65% vs. mTBI negative = 51%). After adjustment for TBI status and demographic variables, increased OSA risk was significantly associated with worse performance on measures of complex processing speed and executive functioning (Wechsler Adult Intelligence Scale Fourth EditionCoding, Trail Making Test, part B) and greater symptom burden (Neurobehavioral Symptom Inventory). Thus, OSA, a modifiable behavioral health factor, likely contributes to cognitive performance following mTBI. Accordingly, OSA serves as a potential point of intervention to improve clinical and cognitive outcomes after injury.	[Garcia, Amanda; Nakase-Richardson, Risa] James A Haley VA Hosp, Def & Vet Brain Injury Ctr, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Garcia, Amanda; Nakase-Richardson, Risa] James A Haley VA Hosp, Mental Hlth & Behav Sci, Tampa, FL USA; [Reljic, Tea] Univ S Florida, Morsani Coll Med, Tampa, FL 33620 USA; [Belanger, Heather G.] Univ S Florida, Dept Psychol & Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Sleep & Pulm Div, Tampa, FL 33620 USA; [Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Kenney, Kimbra] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Kenney, Kimbra] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD USA; [Agyemang, Amma; Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Troyanskaya, Maya; Wilde, Elisabeth A.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Troyanskaya, Maya] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Belanger, Heather G.] United States Special Operat Command, Tampa, FL USA; [Wilde, Elisabeth A.] George E Wahlen VA Salt Lake City Healthcare Syst, Salt Lake City, UT USA; [Wilde, Elisabeth A.] Univ Utah, Dept Neurol, TBI & Concuss, Salt Lake City, UT USA		Garcia, A (corresponding author), James A Haley VA Hosp, Def & Vet Brain Injury Ctr, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	amanda.garcia3@va.gov	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146	VHA Central Office VA TBI Model Systems Program of Research/DHA Contracting Office (CO-NCR) [W91YTZ-13-C-0015/HT0014-19-C-0004, HT0014]; U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma ConsortiumUS Department of Veterans Affairs [W81XWH-13-2-0095]; 9Line LLC	This work was prepared under Contract W91YTZ-13-C-0015/HT0014-19-C-0004 with VHA Central Office VA TBI Model Systems Program of Research/DHA Contracting Office (CO-NCR) HT0014 and, therefore, is defined as U.S. Government work under Title 17 U.S.C.x101. Per Title 17 U.S.C.x105, copyright protection is not available for any work of the U.S. Government. For more information, please contactdha.DVBICinfo@mail.mil.This material is also based upon work supported by the U.S. Army Medical Research and Material Command and from the U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma Consortium under Award No. W81XWH-13-2-0095. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Further support was provided by 9Line LLC.	Alexander M, 2016, SLEEP, V39, P1399, DOI 10.5665/sleep.5972; Asken BM, 2016, NEUROPSYCHOL REV, V26, P340, DOI 10.1007/s11065-016-9327-z; Bacyinski A, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00101; Beebe DW, 2003, SLEEP, V26, P298, DOI 10.1093/sleep/26.3.298; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Bliwise DL, 2013, CURR TREAT OPTION NE, V15, P669, DOI 10.1007/s11940-013-0262-5; Boespflug EL, 2018, BIOL PSYCHIAT, V83, P328, DOI 10.1016/j.biopsych.2017.11.031; Bucks RS, 2013, RESPIROLOGY, V18, P61, DOI 10.1111/j.1440-1843.2012.02255.x; Buysse D J, 1989, Psychiatry Res, V28, P193; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Castronovo V, 2014, SLEEP, V37, P1465, DOI 10.5665/sleep.3994; Chirinos DA, 2017, J BEHAV MED, V40, P955, DOI 10.1007/s10865-017-9869-4; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Chung F, 2016, CHEST, V149, P631, DOI 10.1378/chest.15-0903; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Defense and Veterans Brain Injury Center (DVBIC), 2020, DOD WORLDW TBI NUMB; DeJong J, 2010, J CLIN EXP NEUROPSYC, V32, P953, DOI 10.1080/13803391003645640; Delis D.C., 2000, CALIFORNIA VERBAL LE; Department of Veterans Affairs & Department of Defense ., 2019, VA DOD CLIN PRACT GU; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Eckert DJ, 2007, CHEST, V131, P595, DOI 10.1378/chest.06.2287; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fultz NE, 2019, SCIENCE, V366, P628, DOI 10.1126/science.aax5440; Gale SD, 2004, J INT NEUROPSYCH SOC, V10, P60; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Ho BL, 2018, J NEUROL, V265, P1643, DOI 10.1007/s00415-018-8895-7; Holster JL, 2017, J HEAD TRAUMA REHAB, V32, P25, DOI 10.1097/HTR.0000000000000237; IBM Corp, IBM SPSS STAT WIND V; Innes CRH, 2015, SLEEP, V38, P699, DOI 10.5665/sleep.4658; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kerner NA, 2016, AM J GERIAT PSYCHIAT, V24, P496, DOI 10.1016/j.jagp.2016.01.134; Kim H, 2013, SLEEP, V36, P709, DOI 10.5665/sleep.2632; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lentino Cynthia V, 2013, US Army Med Dep J, P98; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McDermott CM, 2003, J NEUROSCI, V23, P9687; Mendelsohn AR, 2013, REJUV RES, V16, P518, DOI 10.1089/rej.2013.1530; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Miller NL, 2011, BEHAV SLEEP MED, V9, P53, DOI 10.1080/15402002.2011.533994; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Nakase-Richardson R., 2020, CHEST; Nakase-Richardson R, 2020, ARCH PHYS MED REHAB, V101, P283, DOI 10.1016/j.apmr.2019.09.019; Olaithe M, 2018, SLEEP MED REV, V38, P39, DOI 10.1016/j.smrv.2017.03.005; Pan YY, 2015, CHINESE MED J-PEKING, V128, P2365, DOI 10.4103/0366-6999.163385; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Reitan R, 1985, HALSTEAD REITAN NEUR; Reuter H, 2018, CLIN RES CARDIOL, V107, P1071, DOI 10.1007/s00392-018-1282-7; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Sassani A, 2004, SLEEP, V27, P453, DOI 10.1093/sleep/27.3.453; Shi YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40000; Sjosten N, 2009, CHEST, V136, P130, DOI 10.1378/chest.08-2201; Sun BL, 2018, PROG NEUROBIOL, V163, P118, DOI 10.1016/j.pneurobio.2017.08.007; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; Troxel W.M., 2015, RAND HLTH Q, V5, P19; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P413, DOI 10.1037/rep0000174; U.S. Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker JM, 2016, UNDERSEA HYPERBAR M, V43, P549; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Wallace A, 2013, SLEEP, V36, P203, DOI 10.5665/sleep.2374; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Wechsler D., 2008, WECHSLER ADULT INTEL, VVol. 22, P498; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Young T, 1997, SLEEP, V20, P608, DOI 10.1093/sleep/20.8.608; Zhang Q, 2013, SLEEP, V36, P651, DOI 10.5665/sleep.2620; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	80	2	2	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2020	37	23					2517	2527		10.1089/neu.2019.6916		SEP 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PC0XQ	WOS:000568362400001	32709212	hybrid, Green Published			2022-02-06	
J	Gu, F; Parada, I; Yang, T; Longo, FM; Prince, DA				Gu, Feng; Parada, Isabel; Yang, Tao; Longo, Frank M.; Prince, David A.			Partial Activation of TrkB Receptors Corrects Interneuronal Calcium Channel Dysfunction and Reduces Epileptogenic Activity in Neocortex following Injury	CEREBRAL CORTEX			English	Article						calcium channel; cortical injury; epileptogenesis; interneuron; TrkB	EXCITATORY SYNAPTIC-TRANSMISSION; FAST-SPIKING INTERNEURONS; MEDIATE GABA RELEASE; NEUROTROPHIC FACTOR; N-TYPE; P/Q-TYPE; CA2+ CHANNELS; RAT MODEL; INHIBITION; BDNF	Decreased GABAergic inhibition due to dysfunction of inhibitory interneurons plays an important role in post-traumatic epileptogenesis. Reduced N-current Ca2+ channel function in GABAergic terminals contributes to interneuronal abnormalities and neural circuit hyperexcitability in the partial neocortical isolation (undercut, UC) model of post-traumatic epileptogenesis. Because brain-derived neurotrophic factor (BDNF) supports the development and maintenance of interneurons, we hypothesized that the activation of BDNF tropomyosin kinase B (TrkB) receptors by a small molecule, TrkB partial agonist, PTX BD4-3 (BD), would correct N channel abnormalities and enhance inhibitory synaptic transmission in UC cortex. Immunocytochemistry (ICC) and western blots were used to quantify N- and P/Q-type channels. We recorded evoked (e)IPSCs and responses to N and P/Q channel blockers to determine the effects of BD on channel function. Field potential recordings were used to determine the effects of BD on circuit hyperexcitability. Chronic BD treatment 1) upregulated N and P/Q channel immunoreactivity in GABAergic terminals; 2) increased the effects of N or P/Q channel blockade on evoked inhibitory postsynaptic currents (eIPSCs); 3) increased GABA release probability and the frequency of sIPSCs; and 4) reduced the incidence of epileptiform discharges in UC cortex. The results suggest that chronic TrkB activation is a promising approach for rescuing injury-induced calcium channel abnormalities in inhibitory terminals, thereby improving interneuronal function and suppressing circuit hyperexcitability.	[Gu, Feng; Parada, Isabel; Yang, Tao; Longo, Frank M.; Prince, David A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Room M016, Stanford, CA 94305 USA		Prince, DA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Room M016, Stanford, CA 94305 USA.	daprince@stanford.edu			National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS082644, NS039579]; Jean Perkins Foundation	National Institutes of Neurological Disorders and Stroke (NS082644 and NS039579 to D.A.P.) and the Jean Perkins Foundation (F.M.L.).	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Baldelli P, 2005, J NEUROSCI, V25, P3358, DOI 10.1523/JNEUROSCI.4227-04.2005; Baldelli P, 2002, EUR J NEUROSCI, V16, P2297, DOI 10.1046/j.1460-9568.2002.02313.x; Baldelli P, 2000, EUR J NEUROSCI, V12, P4017, DOI 10.1046/j.1460-9568.2000.00305.x; Beuckmann CT, 2003, J NEUROSCI, V23, P6793; Bolton MM, 2000, J NEUROSCI, V20, P3221, DOI 10.1523/JNEUROSCI.20-09-03221.2000; Bomben VC, 2016, J NEUROSCI, V36, P405, DOI 10.1523/JNEUROSCI.2555-15.2016; Cai ZX, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2016.00129; Carmignoto G, 1997, J PHYSIOL-LONDON, V498, P153, DOI 10.1113/jphysiol.1997.sp021848; CHAPLEAU CA, 2012, NEURAL PLAST, V2012, DOI DOI 10.1155/2012/578057; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chauvette S, 2016, J NEUROSCI METH, V260, P185, DOI 10.1016/j.jneumeth.2015.08.030; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Croll SD, 1999, NEUROSCIENCE, V93, P1491, DOI 10.1016/S0306-4522(99)00296-1; DeFelipe J, 1999, BRAIN, V122, P1807, DOI 10.1093/brain/122.10.1807; Eftekhari S, 2016, BASIC CLIN NEUROSCI, V7, P115, DOI 10.15412/J.BCN.03070205; Elmariah SB, 2004, J NEUROSCI, V24, P2380, DOI 10.1523/JNEUROSCI.4112-03.2004; Faria LC, 2012, NEUROBIOL DIS, V45, P821, DOI 10.1016/j.nbd.2011.11.006; Faria LC, 2010, J NEUROPHYSIOL, V104, P280, DOI 10.1152/jn.00351.2010; Gambardella A, 2014, PROG BRAIN RES, V213, P87, DOI 10.1016/B978-0-444-63326-2.00004-1; Gill R, 2013, EUR J NEUROSCI, V38, P3554, DOI 10.1111/ejn.12367; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Graber KD, 1999, ANN NEUROL, V46, P234, DOI 10.1002/1531-8249(199908)46:2<234::AID-ANA13>3.0.CO;2-Q; Graber KD, 2006, MODELS OF SEIZURES AND EPILEPSY, P477, DOI 10.1016/B978-012088554-1/50040-2; Gu B, 2015, NEURON, V88, P484, DOI 10.1016/j.neuron.2015.09.032; Gu F, 2018, NEUROBIOL DIS, V113, P45, DOI 10.1016/j.nbd.2018.01.018; Gu F, 2017, NEUROBIOL DIS, V108, P100, DOI 10.1016/j.nbd.2017.08.008; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Jin X, 2003, J NEUROSCI, V23, P5662; Kang SK, 2015, EUR J NEUROSCI, V42, P2792, DOI 10.1111/ejn.13094; Karson MA, 2009, J NEUROSCI, V29, P4140, DOI 10.1523/JNEUROSCI.5264-08.2009; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Lee SY, 2011, J NEUROSCI, V31, P10993, DOI 10.1523/JNEUROSCI.1970-11.2011; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Liu GM, 2013, NEURON, V79, P31, DOI 10.1016/j.neuron.2013.04.027; Ma YY, 2012, NEUROBIOL DIS, V47, P102, DOI 10.1016/j.nbd.2012.03.027; Marty S, 1997, TRENDS NEUROSCI, V20, P198, DOI 10.1016/S0166-2236(96)01026-0; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Noebels JL, 2012, CDDEJASPERS BASIC ME; Obrietan K, 2002, J NEUROPHYSIOL, V88, P1005, DOI 10.1152/jn.2002.88.2.1005; Paradiso B, 2009, P NATL ACAD SCI USA, V106, P7191, DOI 10.1073/pnas.0810710106; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Ping XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158231; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; Prince DA, 2016, PROG BRAIN RES, V226, P209, DOI 10.1016/bs.pbr.2016.03.013; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Reibel S, 2003, HIPPOCAMPUS, V13, P557, DOI 10.1002/hipo.10110; Reid CA, 2003, TRENDS NEUROSCI, V26, P683, DOI 10.1016/j.tins.2003.10.003; Rieckhof GE, 2003, J BIOL CHEM, V278, P41099, DOI 10.1074/jbc.M306417200; Rossignol E, 2013, ANN NEUROL, V74, P209, DOI 10.1002/ana.23913; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Salin P, 1995, J NEUROSCI, V15, P8234; Salin PA, 1996, J NEUROPHYSIOL, V75, P1589, DOI 10.1152/jn.1996.75.4.1589; TSIEN RW, 1995, TRENDS NEUROSCI, V18, P52; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; Uematsu M, 2008, CEREB CORTEX, V18, P315, DOI 10.1093/cercor/bhm056; Yamada MK, 2002, J NEUROSCI, V22, P7580; Zaitsev AV, 2007, J NEUROPHYSIOL, V97, P3567, DOI 10.1152/jn.01293.2006; Zhang W, 2009, J NEUROSCI, V29, P7846, DOI 10.1523/JNEUROSCI.6199-08.2009; Zhu WJ, 2001, ANN NEUROL, V50, P188, DOI 10.1002/ana.1074	67	2	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	SEP	2020	30	9					5180	5189		10.1093/cercor/bhz254			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OF1SQ	WOS:000580997100031	32488246	Green Published, hybrid			2022-02-06	
J	Jones, K; Theadom, A; Prah, P; Starkey, N; Barker-Collo, S; Ameratunga, S; Feigin, VL				Jones, Kelly; Theadom, Alice; Prah, Philip; Starkey, Nicola; Barker-Collo, Suzanne; Ameratunga, Shanthi; Feigin, Valery L.		BIONIC Study	Changes over time in family members of adults with mild traumatic brain injury	BRAIN IMPAIRMENT			English	Article						Family members; health; mild traumatic brain injury; outcomes; sleep	QUALITY-OF-LIFE; SF-36 HEALTH SURVEY; BURDEN 1 YEAR; CAREGIVER BURDEN; SOCIAL SUPPORT; NEW-ZEALAND; GENDER-DIFFERENCES; PARENT PERSPECTIVES; PERCEIVED BURDEN; MENTAL-HEALTH	Objective: The impact of traumatic brain injury (TBI) extends beyond the person who was injured. Family caregivers of adults with moderate to severe TBI frequently report increased burden, stress and depression. Few studies have examined the well-being of family members in the mild TBI population despite the latter representing up to 95% of all TBIs. Methods: Five areas of well-being were examined in 99 family members (including parents, partners, siblings, other relatives, adult children, friends or neighbours) of adults (aged >= 16 years) with mild TBI. At 6- and 12-month post-injury, family members completed the Bakas Caregiver Outcomes Scale, Short Form-36 Health Survey, EQ-5D-3L, Hospital Anxiety and Depression Scale and the Pittsburgh Sleep Quality Index. Outcomes and change over time and associated factors were examined. Results: At 6 months, group mean scores for health-related quality of life for mental and physical components and overall health status were similar to the New Zealand (NZ) population. Mean scores for sleep, anxiety and depression were below clinically significant thresholds. From 6 to 12 months, there were significant improvements in Bakas Caregiver Outcomes Scale scores by 2.61 (95% confidence interval: 0.72-4.49), health-related quality of life (mental component) and EQ-5D-3L overall health (P= 0.01). Minimally clinically important differences were observed in overall health, anxiety, health-related quality of life and depression at 12 months. Female family members reported significant improvements in physical health over time, and more positive life changes were reported by those caring for males with TBI. Conclusions: The findings suggest diminished burden over time for family members of adults with mild TBI.	[Jones, Kelly; Theadom, Alice; Prah, Philip; Feigin, Valery L.] Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Publ Hlth & Psychosocial Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Div Arts Law Psychol & Social Sci, Sch Psychol, Hamilton, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Tamaki Campus, Auckland, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Fac Med & Hlth Sci, Auckland, New Zealand		Jones, K (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Publ Hlth & Psychosocial Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand.	kelly.jones@aut.ac.nz	Jones, Kelly/G-4127-2015	Jones, Kelly/0000-0001-5692-653X; Starkey, Nicola/0000-0002-4370-8186	Health Research Council of NZ (HRC) [09/063A, 13/408]	This work was supported by the Health Research Council of NZ (HRC grant numbers 09/063A, 13/408).	Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Anderson M, 2017, BRAIN INJURY, V31, P815; Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2012, JUST LABOUR, V19, P22; [Anonymous], 1995, 1995 NAT HLTH SURV S; Ao BT, 2015, NEUROEPIDEMIOLOGY, V44, P255, DOI 10.1159/000431043; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Armstrong Kira, 2002, Pediatr Rehabil, V5, P149, DOI 10.1080/1363849021000039353; Bakas T, 2006, NURS RES, V55, P346, DOI 10.1097/00006199-200609000-00007; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Berglund E, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0309-2; Bhandari NJ, 2013, J CARDIOPULM REHABIL, V33, P123, DOI 10.1097/HCR.0b013e31828254d4; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CHWALISZ K, 1992, REHABIL PSYCHOL, V37, P189, DOI 10.1037/h0079103; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Delmonico R, 2017, ARCH PHYSMED REHAB, V98, pe96, DOI DOI 10.1016/J.APMR.2017.08.309; Doser K, 2016, BRAIN INJURY, V30, P334, DOI 10.3109/02699052.2015.1114143; Elder H, 2012, AUSTRALAS PSYCHIATRY, V20, P20, DOI 10.1177/1039856211430147; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hasson-Ohayon I, 2015, PALLIAT SUPPORT CARE, V13, P527, DOI 10.1017/S1478951513000242; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hughes CM, 2009, ACUPUNCT MED, V27, P163, DOI 10.1136/aim.2009.000760; Jansen P, 2008, HE RITENGA WHAKAARO; Katz S, 2005, BRAIN INJURY, V19, P59, DOI 10.1080/02699050410001719970; Kobusingye, 2001, INJURY SURVEILLANCE; Konigs M, 2016, EUR J NEUROL, V23, P21, DOI 10.1111/ene.12719; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lerdal A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009345; Li QP, 2013, EUR J ONCOL NURS, V17, P578, DOI 10.1016/j.ejon.2013.01.007; Liu WH, 2015, Int J Nurs Sci, V2, P231, DOI 10.1016/j.ijnss.2015.07.001; Luo N, 2010, MED CARE, V48, P365, DOI 10.1097/MLR.0b013e3181c162a2; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Marie D, 2008, SOC POLICY J NZ, P126; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Martin CD, 2000, J FAM ISSUES, V21, P986, DOI 10.1177/019251300021008003; *MIN HLTH, 1999, TAK PULS 1996 97 NZ; Minney MJ, 2019, BRAIN INJURY, V33, P168, DOI 10.1080/02699052.2018.1540794; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Morris KC, 2001, BRAIN INJURY, V15, P239, DOI 10.1080/02699050010004068; Mystakidou K, 2013, EUR J CANCER CARE, V22, P188, DOI 10.1111/ecc.12012; Nakken N, 2017, INT J CHRONIC OBSTR, V12, P95, DOI 10.2147/COPD.S118871; Nonterah CW, 2013, BRAIN INJURY, V27, P1287, DOI 10.3109/02699052.2013.812243; Norup A, 2013, AUST J REHABIL COUNS, V19, P71, DOI 10.1017/jrc.2013.12; Oakley-Brown M. A., 2006, RAU HINENGARO; Omachi TA, 2011, ARTHRIT CARE RES, V63, pS287, DOI 10.1002/acr.20544; Parag V, 2008, CEREBROVASC DIS, V25, P548, DOI 10.1159/000131673; Powell JM, 2017, J HEAD TRAUMA REHAB, V32, pE33, DOI 10.1097/HTR.0000000000000219; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Qutub K, 2014, AMYOTROPH LAT SCL FR, V15, P292, DOI 10.3109/21678421.2014.886699; Rumpold T, 2016, SUPPORT CARE CANCER, V24, P1975, DOI 10.1007/s00520-015-2987-z; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Schrank B, 2016, PSYCHO-ONCOLOGY, V25, P808, DOI 10.1002/pon.4005; Scott KM, 1999, AUST NZ J PUBL HEAL, V23, P401, DOI 10.1111/j.1467-842X.1999.tb01282.x; Scott KM, 2000, SOC SCI MED, V51, P1655, DOI 10.1016/S0277-9536(00)00083-6; Sharma N, 2016, WORLD J PSYCHIATR, V6, P7, DOI 10.5498/wjp.v6.i1.7; Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961; Society of gynecologic oncologist clinical practice guideline, 1998, HUNTINGTON, V12, P455; StatCorp, 2015, STAT STAT SOFTW REL; Statistics New Zealand, 2017, NAT ETHN POP PROJ; Szende A, 2014, SELF REPORTED POPULA; The EuroQol Group, 2004, MEASURING SELF REPOR; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Wadhwa D, 2013, PSYCHO-ONCOLOGY, V22, P403, DOI 10.1002/pon.2104; Wang HM, 2012, QUAL LIFE RES, V21, P155, DOI 10.1007/s11136-011-9915-6; Ware J.E., 1993, SF 36 HLTH SURVEY MA; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zhang F., 2009, CHINA J PHARM EC, V6, P5; Zhou L., 2012, PRACTICAL PREVENTIVE, V19, P644; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	93	2	2	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2020	21	2					154	172	PII S1443964619000275	10.1017/BrImp.2019.27			19	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	OA1UW	WOS:000577580500002		Green Accepted			2022-02-06	
J	Kamboj, AK; Chounthirath, T; Hodges, NL; Smith, GA				Kamboj, Amrit K.; Chounthirath, Thitphalak; Hodges, Nichole L.; Smith, Gary A.			Nonfatal Pediatric Injuries Associated With Consumer Products and Sports and Recreational Activities in the United States	PEDIATRIC EMERGENCY CARE			English	Article						consumer products; National Electronic Injury Surveillance System; unintentional injuries	US EMERGENCY-DEPARTMENTS; TRAUMATIC BRAIN-INJURIES; CHILDREN; EPIDEMIOLOGY; TRENDS; COSTS	Objective The aim of this study was to investigate the epidemiology of nonfatal consumer product- and sports and recreational activity-related injuries among US children. Methods National Electronic Injury Surveillance System data regarding children younger than 18 years who were treated in US emergency departments (EDs) for nonfatal consumer product- or sports and recreational activity-related injuries were analyzed. Results From 1990 through 2012, an estimated 121,489,024 (95% confidence interval, 104,226,323-138,751,726) children younger than 18 years were treated in US EDs for nonfatal injuries meeting study criteria, yielding an average of 5,282,131 children annually, or 74.12 injuries per 1000 children. During 1990 to 2005, the overall annual injury rate decreased by 14.0% (P< 0.001), followed by an increase of 7.3% (P= 0.157) during 2005 to 2012. The concussion/closed head injury rate increased by 199.3% (P< 0.001) from 1996 to 2012. Injury rates were highest among children 0 to 4 years old and lowest among children 5 to 9 years old. Sports and recreational activities accounted for 46.5% of all injuries. Falls (40.2%) and "struck-by" (22.6%) were the leading mechanisms of injury, and 62.3% of all injuries were among boys. Injuries often occurred to the head/neck (37.8%) or upper extremities (31.9%), were frequently diagnosed as lacerations (29.0%) or soft tissue injuries (21.0%), and 2.7% were admitted to the hospital. Conclusions On average, a child was treated in a US ED for a nonfatal consumer product- or sports and recreational activity-related injury every 6 seconds. Although injury rates decreased early in the study period, there was a nonsignificant increasing trend from 2005 to 2012. Multilevel injury prevention efforts are recommended.	[Kamboj, Amrit K.; Chounthirath, Thitphalak; Hodges, Nichole L.; Smith, Gary A.] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Columbus, OH USA; [Kamboj, Amrit K.; Hodges, Nichole L.; Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Smith, Gary A.] Child Injury Prevent Alliance, Columbus, OH USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org	Michaels, Nichole/AAJ-5943-2021	Michaels, Nichole/0000-0003-2618-6440	Samuel J. RoesslerMemorial Scholarship from theMedical Student Research Scholarship Program at The Ohio State University College of Medicine	A.K.K. received the Samuel J. RoesslerMemorial Scholarship from theMedical Student Research Scholarship Program at The Ohio State University College of Medicine while he worked on this study.	Ameen ZS, 2017, J PEDIATR-US, V186, P124, DOI 10.1016/j.jpeds.2017.03.049; Bayt DR, 2016, INJURY PREV, V22, P361, DOI 10.1136/injuryprev-2015-041757; Borse Nagesh N., 2012, Morbidity and Mortality Weekly Report, V61, P830; Borse NN, 2008, CDC CHILDHOOD INJURY; Buzas David, 2014, ORTHOPEDIC J SPORTS, V2, P1; Centers for Disease Control and Prevention, 2015, SPORTS CONC POL LAWS; Centers for Disease Control and Prevention, 2015, WEB BAS INJ STAT QUE; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P736; Centers for Disease Control Prevention, 2012, NAT ACT PLAN CHILD I; Chen Allison J, 2014, R I Med J (2013), V97, P44; Chen WS, 2013, ACAD EMERG MED, V20, P570, DOI 10.1111/acem.12146; Cheng TA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2721; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; D'Souza AL, 2008, PEDIATRICS, V121, pE1696, DOI 10.1542/peds.2007-2555; Danseco ER, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e27; De Roo AC, 2013, PEDIATRICS, V132, P267, DOI 10.1542/peds.2013-1086; Dellinger A, 2019, AM J LIFESTYLE MED, V13, P7, DOI 10.1177/1559827617696297; Florence C, 2015, MMWR-MORBID MORTAL W, V64, P1078, DOI 10.15585/mmwr.mm6438a5; Fowler E, 2016, ACAD PEDIATR, V16, P726, DOI 10.1016/j.acap.2016.07.002; Gage BE, 2012, ACAD EMERG MED, V19, P378, DOI 10.1111/j.1553-2712.2012.01315.x; Gaw CE, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2503; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; HADDON W, 1972, J TRAUM, V12, P193, DOI 10.1097/00005373-197203000-00002; Haring RS, 2015, BRAIN INJURY, V29, P989, DOI 10.3109/02699052.2015.1033014; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Kamboj A, 2017, CLIN PEDIATR, V56, P545, DOI 10.1177/0009922816664064; Lallier M, 1999, J PEDIATR SURG, V34, P1060, DOI 10.1016/S0022-3468(99)90564-X; Lawrence BA, 2015, INJURY PREV, V21, P23, DOI 10.1136/injuryprev-2014-041220; Naranje SM, 2016, J PEDIATR ORTHOPED, V36, pE45, DOI 10.1097/BPO.0000000000000595; Ootes Daan, 2012, Hand (N Y), V7, P18, DOI 10.1007/s11552-011-9383-z; Schroeder T., 2001, NEISS SAMPLE DESIGN; Shields WC, 2015, INJURY PREV, V21, P296, DOI 10.1136/injuryprev-2015-041559; US Census Bureau, 2011, USEST00INTALLDATA US; US Census Bureau, 2004, USENT90INT07 US CENS; US Census Bureau, 2012, NCEST2011ALLDATA US; US Consumer Product Safety Commission, 2013, 2013 ANN REP PRES C; US Consumer Product Safety Commission, 2017, NAT EL INJ SURV SYST	38	2	2	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	SEP	2020	36	9					E485	E493		10.1097/PEC.0000000000001778			9	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Pediatrics	NP5HV	WOS:000570208100011	30829840				2022-02-06	
J	Kim, HK; Leigh, JH; Lee, YS; Choi, Y; Kim, Y; Kim, JE; Cho, WS; Seo, HG; Oh, BM				Kim, Han-Kyoul; Leigh, Ja-Ho; Lee, Ye Seol; Choi, Yoonjeong; Kim, Yoon; Kim, Jeong Eun; Cho, Won-Sang; Seo, Han Gil; Oh, Byung-Mo			Decreasing Incidence and Mortality in Traumatic Brain Injury in Korea, 2008-2017: A Population-Based Longitudinal Study	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury; longitudinal study; epidemiology; incidence; mortality	EPIDEMIOLOGY; OUTCOMES; OLDER	Traumatic brain injury (TBI), a global public health concern, may lead to death and major disability. While various short-term, small-sample, and cross-sectional studies on TBI have been conducted in South Korea, there is a lack of clarity on the nationwide longitudinal TBI trends in the country. This retrospective study investigated the epidemiological TBI trends in South Korea, using a population-based dataset of the National Health Insurance (2008-2017). The crude and age adjusted TBI incidence and mortality values were calculated and stratified by age, sex, and TBI diagnosis. The age-adjusted incidence per 100,000 people increased until 2010 and showed a decreasing trend (475.8 cases in 2017) thereafter; however, a continuously decreasing age-adjusted mortality trend was observed (42.9 cases in 2008, 11.3 in 2017). The crude incidence rate increased continually in those aged >70 years across all the TBI diagnostic categories. The mortality per 100,000 people was significantly higher among participants aged >= 70 years than in the other age groups. We observed changing trends in the TBI incidence, with a continuously decreasing overall incidence and a rapidly increasing incidence and high mortality values in older adults. Our findings highlight the importance of active TBI prevention in elderly people.	[Kim, Han-Kyoul; Leigh, Ja-Ho; Lee, Ye Seol; Choi, Yoonjeong; Seo, Han Gil; Oh, Byung-Mo] Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul 03080, South Korea; [Kim, Han-Kyoul; Lee, Ye Seol; Choi, Yoonjeong; Oh, Byung-Mo] Natl Traff Injury Rehabil Hosp, Natl Traff Injury Rehabil Res Inst, Yang Pyeong 12564, South Korea; [Leigh, Ja-Ho] Workers Compensat & Welf Incheon Hosp, Dept Rehabil Med, Incheon 21417, South Korea; [Kim, Yoon] Seoul Natl Univ, Dept Hlth Policy & Management, Coll Med, Seoul 03080, South Korea; [Kim, Yoon] Seoul Natl Univ, Med Res Ctr, Inst Hlth Policy & Management, Seoul 03080, South Korea; [Kim, Jeong Eun; Cho, Won-Sang] Seoul Natl Univ, Dept Neurosurg, Coll Med, Seoul 03080, South Korea; [Seo, Han Gil; Oh, Byung-Mo] Seoul Natl Univ, Dept Rehabil Med, Coll Med, Seoul 03080, South Korea; [Oh, Byung-Mo] Seoul Natl Univ, Inst Aging, Seoul 03080, South Korea; [Oh, Byung-Mo] Seoul Natl Univ, Neurosci Res Inst, Coll Med, Seoul 03080, South Korea		Oh, BM (corresponding author), Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul 03080, South Korea.; Oh, BM (corresponding author), Natl Traff Injury Rehabil Hosp, Natl Traff Injury Rehabil Res Inst, Yang Pyeong 12564, South Korea.; Oh, BM (corresponding author), Seoul Natl Univ, Dept Rehabil Med, Coll Med, Seoul 03080, South Korea.; Oh, BM (corresponding author), Seoul Natl Univ, Inst Aging, Seoul 03080, South Korea.; Oh, BM (corresponding author), Seoul Natl Univ, Neurosci Res Inst, Coll Med, Seoul 03080, South Korea.	collkhk@gmail.com; jaho.leigh@gmail.com; yeseol.lee127@gmail.com; yoonjeong_choi@naver.com; yoonkim@snu.ac.kr; eunkim@snu.ac.kr; nsdrcho@gmail.com; hgseo80@gmail.com; moya1@snu.ac.kr		KIM, Han-Kyoul/0000-0003-2102-8363; Choi, Yoonjeong/0000-0002-5722-9215; leigh, Ja-Ho/0000-0003-0465-6392; Seo, Han Gil/0000-0001-6904-7542; Lee, Ye Seol/0000-0002-4167-5296; Cho, Won-Sang/0000-0002-3345-8718; Oh, Byung-Mo/0000-0001-9353-7541	Ministry of Land, Infrastructure and Transport Research Fund [07-2020-5030]	This work was supported by a grant from the Ministry of Land, Infrastructure and Transport Research Fund (grant number 07-2020-5030). The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; Asim Mohammad, 2014, J Emerg Trauma Shock, V7, P88, DOI 10.4103/0974-2700.130878; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Choi DH, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e290; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eom KS, 2019, J KOREAN NEUROSURG S, V62, P243, DOI 10.3340/jkns.2018.0017; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Gebregziabher M, 2018, SOC SCI MED, V211, P198, DOI 10.1016/j.socscimed.2018.06.020; Hsu IL, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112457; Jeong HW, 2017, J KOREAN NEUROSURG S, V60, P710, DOI 10.3340/jkns.2016.1010.001; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kim E, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091318; Kim JS, 2019, J KOREAN NEUROSURG S, V62, P232, DOI [10.3340/jkns.2018.0037, 10.3340/jkns.2016.0506.007]; Korea Research Institute for Local Administration, RES STRENGTH SAF ED; Leigh JH, 2020, SPINAL CORD, V58, P939, DOI 10.1038/s41393-020-0475-x; Mason Christine Narad, 2013, Pediatr Nurs, V39, P267; Mateu NC, 2020, SCAND J PUBLIC HEALT, V48, P331, DOI 10.1177/1403494819852826; Milos V, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-40; Nishtala PS, 2014, PHARMACOEPIDEM DR S, V23, P753, DOI 10.1002/pds.3624; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pozzato I, 2019, AUST NZ J PUBL HEAL, V43, P382, DOI 10.1111/1753-6405.12878; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Song SY, 2016, J KOREAN NEUROSURG S, V59, P485, DOI 10.3340/jkns.2016.59.5.485; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Teo DB, 2018, INTERN MED J, V48, P1048, DOI 10.1111/imj.13794; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001	41	2	2	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	SEP	2020	17	17							6197	10.3390/ijerph17176197			12	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	NO8SK	WOS:000569757400001	32859061	Green Published, gold			2022-02-06	
J	Lai, CQ; Ibrahim, H; Abd Hamid, AI; Abdullah, JM				Lai, Chi Qin; Ibrahim, Haidi; Abd Hamid, Aini Ismafairus; Abdullah, Jafri Malin			Classification of Non-Severe Traumatic Brain Injury from Resting-State EEG Signal Using LSTM Network with ECOC-SVM	SENSORS			English	Article						deep-learning; electroencephalogram; error-correcting output coding; long short term memory network; machine-learning; resting-state; support vector machine; traumatic brain injury	ELECTRICAL-ACTIVITY; EVOKED-POTENTIALS; CONCUSSION; BIOMARKER; ERROR; IDENTIFICATION; DISTURBANCES; PREDICTION; MODERATE	Traumatic brain injury (TBI) is one of the common injuries when the human head receives an impact due to an accident or fall and is one of the most frequently submitted insurance claims. However, it is often always misused when individuals attempt an insurance fraud claim by providing false medical conditions. Therefore, there is a need for an instant brain condition classification system. This study presents a novel classification architecture that can classify non-severe TBI patients and healthy subjects employing resting-state electroencephalogram (EEG) as the input, solving the immobility issue of the computed tomography (CT) scan and magnetic resonance imaging (MRI). The proposed architecture makes use of long short term memory (LSTM) and error-correcting output coding support vector machine (ECOC-SVM) to perform multiclass classification. The pre-processed EEG time series are supplied to the network by each time step, where important information from the previous time step will be remembered by the LSTM cell. Activations from the LSTM cell is used to train an ECOC-SVM. The temporal advantages of the EEG were amplified and able to achieve a classification accuracy of 100%. The proposed method was compared to existing works in the literature, and it is shown that the proposed method is superior in terms of classification accuracy, sensitivity, specificity, and precision.	[Lai, Chi Qin; Ibrahim, Haidi] Univ Sains Malaysia, Sch Elect & Elect Engn, Engn Campus, Nibong Tebal 14300, Penang, Malaysia; [Abd Hamid, Aini Ismafairus; Abdullah, Jafri Malin] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Brain & Behav Cluster, Hlth Campus,Jalan Raja Perempuan Zainab 2, Kota Baharu 16150, Kelantan, Malaysia		Ibrahim, H (corresponding author), Univ Sains Malaysia, Sch Elect & Elect Engn, Engn Campus, Nibong Tebal 14300, Penang, Malaysia.	chiqinlai@student.usm.my; haidi_ibrahim@ieee.org; aini_ismafairus@usm.my; jafrimalin@usm.my	Ibrahim, Haidi/B-3131-2011; Abdullah, J/C-2828-2011; Abd Hamid, Aini Ismafairus/B-1413-2018	Ibrahim, Haidi/0000-0002-6401-1791; Abdullah, J/0000-0002-0258-7410; Abd Hamid, Aini Ismafairus/0000-0002-6809-8433; lai, chi qin/0000-0002-2513-6620	Ministry of Higher Education (MoHE), Malaysia, via the Trans-disciplinary Research Grant Scheme (TRGS) [203/PELECT/6768002]	This research was funded by the Ministry of Higher Education (MoHE), Malaysia, via the Trans-disciplinary Research Grant Scheme (TRGS) with grant number 203/PELECT/6768002.	Abdelhameed AM, 2018, IEEE INT NEW CIRC, P139, DOI 10.1109/NEWCAS.2018.8585542; Adhikari B, 2018, PROCEEDINGS ON 2018 IEEE 3RD INTERNATIONAL CONFERENCE ON COMPUTING, COMMUNICATION AND SECURITY (ICCCS), P218, DOI 10.1109/CCCS.2018.8586823; Albert B, 2016, PROCEDIA COMPUT SCI, V96, P703, DOI 10.1016/j.procs.2016.08.253; Aliyu I, 2019, 2019 3RD INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS, METAHEURISTICS & SWARM INTELLIGENCE (ISMSI 2019), P50, DOI 10.1145/3325773.3325785; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Ay B, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1345-y; Ayyagari SSDP, 2015, IEEE ENG MED BIO, P3775, DOI 10.1109/EMBC.2015.7319215; Baloglu UB, 2019, J MECH MED BIOL, V19, DOI 10.1142/S0219519419400050; BASAR E, 1976, BIOL CYBERN, V25, P27; Bengio Yoshua, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P437, DOI 10.1007/978-3-642-35289-8_26; Cao C, 2008, IEEE T NEUR SYS REH, V16, P327, DOI 10.1109/TNSRE.2008.918422; Cao CS, 2018, GENOM PROTEOM BIOINF, V16, P17, DOI 10.1016/j.gpb.2017.07.003; Cheng J, 2021, IEEE J BIOMED HEALTH, V25, P453, DOI 10.1109/JBHI.2020.2995767; Daoud H., 2018, P 2018 IEEE BIOM CIR, P1; Davidson PR, 2005, P ANN INT IEEE EMBS, P5754, DOI 10.1109/IEMBS.2005.1615795; Deng YN, 2018, LECT NOTES COMPUT SC, V11304, P622, DOI 10.1007/978-3-030-04212-7_55; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.2307/2335441; Escalera S, 2009, PATTERN RECOGN LETT, V30, P285, DOI 10.1016/j.patrec.2008.10.002; Fisher JAN, 2016, IEEE T NEUR SYS REH, V24, P1003, DOI 10.1109/TNSRE.2016.2529663; Gers FA, 2000, NEURAL COMPUT, V12, P2451, DOI 10.1162/089976600300015015; Golik P, 2013, INTERSPEECH, P1755; Golmohammadi M, 2018, 2018 17TH IEEE INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA), P745, DOI 10.1109/ICMLA.2018.00118; Graves A, 2012, STUD COMPUT INTELL, V385, P37; Guyon I., 2017, ADV NEURAL INFORM PR, V30, P4148; Hanley D, 2018, J NEUROTRAUM, V35, P41, DOI 10.1089/neu.2017.5004; Hanley D, 2017, ACAD EMERG MED, V24, P617, DOI 10.1111/acem.13175; Hine G. E., 2017, P 2017 INT C BIOM SP, P1, DOI DOI 10.23919/BIOSIG.2017.8053519; Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI 10.1162/neco.1997.9.8.1735; Hofmann SM, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND VIRTUAL REALITY (AIVR), P128, DOI 10.1109/AIVR.2018.00026; Hussein R, 2019, CLIN NEUROPHYSIOL, V130, P25, DOI 10.1016/j.clinph.2018.10.010; Ianof Jéssica Natuline, 2017, Dement. neuropsychol., V11, P3, DOI 10.1590/1980-57642016dn11-010002; Ibrahim A, 2012, PAN AFR MED J, V12; Jacquin A, 2018, COMPUT BIOL MED, V102, P95, DOI 10.1016/j.compbiomed.2018.09.011; Jeevan R.K., 2019, P 1 INT C INN INF CO, P1; Jie Zhou, 2018, 2018 Chinese Control And Decision Conference (CCDC), P5600, DOI 10.1109/CCDC.2018.8408108; Jones W, 2017, EMERG TOP LIFE SCI, V1, P257, DOI 10.1042/ETLS20160025; Keskar N. S., 2016, ARXIV160904836 CORR; Kuhn M., 2013, APPL PREDICTIVE MODE, V26; Lai CQ, 2019, PROCEEDINGS OF 2019 2ND INTERNATIONAL CONFERENCE ON ELECTRONICS AND ELECTRICAL ENGINEERING TECHNOLOGY (EEET 2019), P99, DOI 10.1145/3362752.3362758; Lai CPY, 2019, 2019 7TH INTERNATIONAL CONFERENCE ON SMART COMPUTING & COMMUNICATIONS (ICSCC), P260; Lassey M., 1997, HLTH CARE SYSTEMS WO; Lee Bruce, 2005, NeuroRx, V2, P372; Lewine JD, 2019, J CLIN NEUROPHYSIOL, V36, P298, DOI 10.1097/WNP.0000000000000588; Li MG, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION (ICMA), P584, DOI 10.1109/ICMA.2017.8015882; Li MG, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, P1971, DOI 10.1109/ICMA.2016.7558868; Li Y, 2021, IEEE T AFFECT COMPUT, V12, P494, DOI 10.1109/TAFFC.2018.2885474; Li Z., 2018, INTERNET MULTIMEDIA; Liu J., 2018, ADV MULTIMEDIA INFOR; Liu LZ, 2016, IEEE INT C BIOINFORM, P497, DOI 10.1109/BIBM.2016.7822568; Liu Y, 2018, 2018 14TH INTERNATIONAL CONFERENCE ON MOBILE AD-HOC AND SENSOR NETWORKS (MSN 2018), P134, DOI 10.1109/MSN.2018.000-6; Luschi C., 2018, ARXIV180407612; Ma X, 2018, CHINA FOUNDRY, V15, P167, DOI 10.1007/s41230-018-7211-6; Ma Xuelin, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P1903, DOI 10.1109/EMBC.2018.8512590; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mao W., 2018, BRAIN INFORM; McBride J, 2013, IEEE T BIO-MED ENG, V60, P90, DOI 10.1109/TBME.2012.2223698; McNerney MW, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0187-y; Michielli N, 2019, COMPUT BIOL MED, V106, P71, DOI 10.1016/j.compbiomed.2019.01.013; Murphy K.P, 2013, MACHINE LEARNING PRO; Ngoya PS, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.99.9736; O'Neil B, 2012, WEST J EMERG MED, V13, P394, DOI 10.5811/westjem.2011.12.6815; Oppenheim A.V, 2009, DISCRETE TIME SIGNAL; Ortega P., 2006, P 2006 INT C DAT MIN, P224; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Ravi D, 2017, IEEE J BIOMED HEALTH, V21, P4, DOI 10.1109/JBHI.2016.2636665; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Saleh K., P 2017 IEEE 20 INT C, P1, DOI 10.1109/itsc.2017.8317835; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Shen Y., 2017, INTELLIGENCE SCI BIG; Shi P., 2019, COMPUTER SUPPORTED C; Soleymani M, 2016, IEEE T AFFECT COMPUT, V7, P17, DOI 10.1109/TAFFC.2015.2436926; Supratak A, 2017, IEEE T NEUR SYS REH, V25, P1998, DOI 10.1109/TNSRE.2017.2721116; Tan L, 2013, INT SYM CODE GENER, P12; Tang H., 2017, NEURAL INFORM PROCES; Tayeb Z, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19010210; Thornton KE., 2014, CONCUSSIONS ATHLETIC, P345; Tolonen A, 2018, CLIN EEG NEUROSCI, V49, P248, DOI 10.1177/1550059417742232; van den Brink RL, 2018, NEUROIMAGE-CLIN, V17, P43, DOI 10.1016/j.nicl.2017.10.003; Vishwanath M, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20072027; Wang H., 2018, BIOINSPIRED COMPUTIN; Wang P, 2018, IEEE T NEUR SYS REH, V26, P2086, DOI 10.1109/TNSRE.2018.2876129; Yadav NK, 2015, BRAIN INJURY, V29, P352, DOI 10.3109/02699052.2014.979229; Yan RQ, 2006, IEEE T INSTRUM MEAS, V55, P2320, DOI 10.1109/TIM.2006.887042; Yang S, 2018, PATTERN ANAL APPL, V21, P105, DOI 10.1007/s10044-016-0569-4; Zemouri R, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9081526	92	2	2	3	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	SEP	2020	20	18							5234	10.3390/s20185234			21	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	OE1JT	WOS:000580296500001	32937801	gold, Green Published			2022-02-06	
J	Lee, KC; Naik, K; Wu, BW; Karlis, V; Chuang, SK; Eisig, SB				Lee, Kevin C.; Naik, Keyur; Wu, Brendan W.; Karlis, Vasiliki; Chuang, Sung-Kiang; Eisig, Sidney B.			Are Motorized Scooters Associated With More Severe Craniomaxillofacial Injuries?	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article								Purpose: The purpose of the present study was to compare the severity of craniomaxillofacial injuries between accidents involving motorized and nonmotorized standup scooters. Materials and Methods: This is a 20-year cross-sectional study of the National Electronic Injury Surveillance System. Injuries from powered and unpowered standup scooters were included in this study if they involved the head, face, eyeball, mouth, or ear. Study predictors were obtained from both patient and injury characteristics. The study outcome was the probability of hospital admission from the emergency department. A multiple logistic regression model was created to model the probability of admission using all significant univariate predictors. Results: A total of 11,916 records were included in the present study, of which 9.5% involved motorized scooters. The proportion of motorized injuries more than tripled from 2014 (5.8%) to 2018 (22.1%). Motorized injuries occurred more often in older individuals (24.0 vs 8.5 years; P < .01). A greater proportion of motorized injuries involved the head (55.0 vs 36.9%; P < .01) and resulted in concussion (11.5 vs 5.6%; P < .01), fractures (6.7 vs 2.0%; P < .01), and other nonspecified internal organ injuries (31.1 vs 19.6%; P < .01). Motorized scooter injuries had more than triple the admission rate compared to nonmotorized injuries (13.9 vs 3.7%; P < .01). After controlling for potential confounders, injuries from motorized scooters still had double the odds of hospital admission (odds ratio, 2.03; P < .01). Conclusions: Motorized standup scooters appear to cause more severe injuries than conventional nonmotorized scooters. The recent growth of rentable electric scooters may pose a future public health concern. Ride-sharing companies should ensure that customers are capable of safely and responsibly operating these vehicles. (C) 2020 American Association of Oral and Maxillofacial Surgeons	[Lee, Kevin C.] Columbia Univ, Irving Med Ctr, Div Oral & Maxillofacial Surg, NewYork Presbyterian, 630 W 168th St, New York, NY 10032 USA; [Naik, Keyur; Wu, Brendan W.; Karlis, Vasiliki] NYU, Dept Oral & Maxillofacial Surg, Langone Med Ctr, New York, NY USA; [Naik, Keyur; Wu, Brendan W.; Karlis, Vasiliki] Bellevue Hosp Ctr, New York, NY 10016 USA; [Chuang, Sung-Kiang] Univ Penn Hlth Syst, Dept Oral & Maxillofacial Surg, Philadelphia, PA USA; [Chuang, Sung-Kiang] Brockton Oral & Maxillofacial Surg Inc, Brockton, MA USA; [Chuang, Sung-Kiang] Good Samaritan Hosp, Dept Oral & Maxillofacial Surg, Brockton, MA USA; [Eisig, Sidney B.] Columbia Univ, Irving Med Ctr, Div Oral & Maxillofacial Surg, Craniofacial Surg,NewYork Presbyterian, New York, NY USA		Lee, KC (corresponding author), Columbia Univ, Irving Med Ctr, Div Oral & Maxillofacial Surg, NewYork Presbyterian, 630 W 168th St, New York, NY 10032 USA.	kcl2136@cumc.columbia.edu					Aizpuru M, 2019, AM J EMERG MED, V37, P1133, DOI 10.1016/j.ajem.2019.03.049; [Anonymous], FAST CAN EL SCOOT ES; Braun TL, 2017, SEMIN PLAST SURG, V31, P118, DOI 10.1055/s-0037-1601380; DiMaggio CJ, 2020, INJURY PREV, V26, P524, DOI 10.1136/injuryprev-2019-043418; Jewett A, 2016, J SAFETY RES, V59, P1, DOI 10.1016/j.jsr.2016.09.001; McIlvain C, 2019, AM J EMERG MED, V37, P472, DOI 10.1016/j.ajem.2018.06.022; National Association of City Transportation Officials, 2018, SHAR MICR US 2018; National Electronic Injury Surveillance System, 2019, NEISS COD MAN; Puzio TJ, 2020, TRAFFIC INJ PREV, V21, P175, DOI 10.1080/15389588.2019.1709176; Trivedi B, 2019, J ORAL MAXIL SURG, V77, P2292, DOI 10.1016/j.joms.2019.07.014; UNAGI, COMPR GUID EL SCOOT; Wu BW, 2020, J ORAL MAXILLOFAC SU	12	2	2	2	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	SEP	2020	78	9					1583	1589		10.1016/j.joms.2020.04.035			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	NK9HA	WOS:000567038500022	32473916				2022-02-06	
J	Leskovan, JJ; Patel, PD; Pederson, JM; Moore, A; Afaneh, A; Brown, LR				Leskovan, John J.; Patel, Puja D.; Pederson, John M.; Moore, Aaron; Afaneh, Amer; Brown, Laura R.			The effects of alcohol and marijuana on survival after severe traumatic brain injury: A retrospective cohort study	ANNALS OF MEDICINE AND SURGERY			English	Article						Abbreviated injury scale; Alcohol consumption; Logistic models; Marijuana; Tetrahydrocannabinol; Traumatic brain injury	OUTCOMES	Background: Alcohol (ETOH) and marijuana (THC) use have previously shown to improve outcomes after Traumatic Brain Injury (TBI). However, whether TBI severity impacts outcomes among patients tested positive for both ETOH and THC remains unclear. Materials and methods: A retrospective review from the Northern Ohio Regional Trauma Registry, which includes deidentified data from six regional hospitals, including three Level 1 and three Level 3 trauma centers, was performed to assess adult ( > 18 years) patients with severe TBI (head Abbreviated Injury Score >= 3) between January 2012 and December 2018 having an alcohol and drug toxicology screen and data regarding outcome at discharge. Patients were divided into two groups: 1) patients with a negative ETOH and drug test, and 2) patients positive for ETOH + THC. Mortality at discharge was the primary outcome measure and multiple logistic regression was used to assess predictors of mortality at discharge. Results: A total of 854 (median age: 51 years [range: 18-72]; 34.4% female [294/854]) patients were included. On multiple logistic regression, age (p = 0.003), days in intensive care unit (ICU) (p < 0.001), Glasgow Coma Scale (GCS) (p < 0.001), Injury Severity Score (ISS) (p < 0.001), length of stay (LOS) (p < 0.001), and days on ventilator support (p = 0.032) were significant predictors of mortality at discharge. Blood alcohol content (BAC), cause of TBI, drug class, and sex were not significant predictors of mortality at discharge. Conclusions: After severe TBI, positive THC and BAC screening did not predict mortality at discharge after controlling for confounding variables, indicating no survival benefit for patients with severe TBI.	[Leskovan, John J.; Moore, Aaron; Afaneh, Amer] Mercy St Vincent Med Ctr, Dept Trauma Surg, 2213 Cherry St, Toledo, OH 43608 USA; [Patel, Puja D.; Pederson, John M.] Super Med Experts, Minneapolis, MN USA; [Brown, Laura R.] MetroHlth Med Ctr, Dept Surg, Cleveland, OH USA		Leskovan, JJ (corresponding author), Mercy St Vincent Med Ctr, Dept Trauma Surg, 2213 Cherry St, Toledo, OH 43608 USA.	jjleskovan@mercy.com		Patel, Puja/0000-0002-6659-9744; Pederson, John/0000-0003-2551-4828			Agha R, 2019, INT J SURG, V72, P156, DOI 10.1016/j.ijsu.2019.11.002; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; DiGiorgio AM, 2020, WORLD NEUROSURG, V135, DOI 10.1016/j.wneu.2019.12.095; Goodwin RS, 2008, J ANAL TOXICOL, V32, P562, DOI 10.1093/jat/32.8.562; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; HERON M, 2010, DEATHS LEADING CAUSE; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; KODDE DA, 1986, ECONOMETRICA, V54, P1243, DOI 10.2307/1912331; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; McKight P. E, 2010, CORSINI ENCY PSYCHOL, DOI DOI 10.1002/9780470479216.CORPSY0491; Mohseni S, 2016, BRAIN INJURY, V30, P1256, DOI 10.1080/02699052.2016.1183823; Nguyen BM, 2014, AM SURGEON, V80, P979; Petridou E.T., 2017, ANTONOPOULOS INJURY; Prabhakaran K, 2017, J SURG RES, V219, P66, DOI 10.1016/j.jss.2017.05.103; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; Wei G, 2017, NEUROIMMUNOMODULAT, V24, P348, DOI 10.1159/000487998; Zhu H, 2016, J ADDICT MED, V10, P429, DOI 10.1097/ADM.0000000000000256	21	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2049-0801			ANN MED SURG	Ann. Med. Surg.	SEP	2020	57						201	204		10.1016/j.amsu.2020.07.031			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NP4FF	WOS:000570132300001	32793339	Green Published, gold			2022-02-06	
J	Liberta, TA; Kagiwada, M; Ho, K; Spat-Lemus, J; Voelbel, G; Kohn, A; Perrine, K; Josephs, L; McLean, EA; Sacks-Zimmerman, A				Liberta, Taylor A.; Kagiwada, Michiru; Ho, Kaylee; Spat-Lemus, Jessica; Voelbel, Gerald; Kohn, Aviva; Perrine, Kenneth; Josephs, Lawrence; McLean, Erin A.; Sacks-Zimmerman, Amanda			An investigation of Cogmed working memory training for neurological surgery patients	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						CWMT; Cognitive rehabilitation; Mood; Neurosurgery; Working memory	COMPUTERIZED COGNITIVE REHABILITATION; TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; FUNCTIONAL ASSESSMENT; ATTENTION; CANCER; DEFICITS; THERAPY; ADHD; RELIABILITY	Objective: Cognitive dysfunction is prevalent amongst individuals who have undergone neurosurgical intervention, significantly impacting daily functioning and quality of life. The aim of this pilot study was to investigate the impact of Cogmed Working Memory Training (CWMT), a five-week, home-based, computerized cognitive rehabilitation intervention, within a neurosurgical population. Method: Thirty adult participants who underwent neurosurgical intervention, regardless of etiology, were included in this study. Participants were administered a neuropsychological battery at three time points postneurosurgical intervention: (a) at baseline, prior to engaging in CWMT; (b) within two weeks of completing the training; and (c) after three months of completing the training. Results: Following CWMT, participants demonstrated significant improvement on measures of attention, working memory, processing speed, verbal learning, and memory. In addition, participants reported significant improvement in quality of life (i.e., physical, social, emotional, and functional well-being), mood (i.e., anxiety and depression), and neurobehavioral functioning (i.e., apathy).	[Josephs, Lawrence] Adelphi Univ, Garden City, NY 21402 USA; [Kagiwada, Michiru; Voelbel, Gerald] NYU, New York, NY 10003 USA; [Liberta, Taylor A.; Ho, Kaylee; Spat-Lemus, Jessica; Kohn, Aviva; Perrine, Kenneth; Sacks-Zimmerman, Amanda] Weill Cornell Med, New York, NY USA; [McLean, Erin A.] Hofstra Univ, Hempstead, NY 11550 USA		Liberta, TA (corresponding author), 525 East 68th St,Starr Pavilion 651, New York, NY 10065 USA.	Tliberta1@gmail.com					Abdi H., 2007, KENDALL RANK CORRELA; Akerlund E, 2013, BRAIN INJURY, V27, P1649, DOI 10.3109/02699052.2013.830195; Allen PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094844; Anderson-Hanley C, 2003, J INT NEUROPSYCH SOC, V9, P967, DOI 10.1017/S1355617703970019; [Anonymous], 2016, COGMED WORKING MEMOR; Barr W, 2016, EPILEPSY CURR, V16, P87, DOI 10.5698/1535-7511-16.2.87; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1993, BECK ANXIETY INVENTO; Berg JL, 2016, CLIN NEUROPSYCHOL, V30, P547, DOI 10.1080/13854046.2016.1186224; Bergo E, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3041824; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Bondi MW, 2014, J ALZHEIMERS DIS, V42, P275, DOI 10.3233/JAD-140276; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; Brehmer Y, 2011, NEUROIMAGE, V58, P1110, DOI 10.1016/j.neuroimage.2011.06.079; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Chacko A, 2014, J CHILD PSYCHOL PSYC, V55, P247, DOI 10.1111/jcpp.12146; Chu YT, 2012, J PSYCHOEDUC ASSESS, V30, P520, DOI 10.1177/0734282912442868; Cicerone KD, 1999, J HEAD TRAUMA REHAB, V14, P316, DOI 10.1097/00001199-199906000-00011; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; CRAWFORD JR, 1989, J CLIN EXP NEUROPSYC, V11, P975, DOI 10.1080/01688638908400950; Cummings G., 2012, UNDERSTANDING NEW ST; Edwards JD, 2002, GERONTOLOGY, V48, P329, DOI 10.1159/000065259; Estevis E, 2012, CLIN NEUROPSYCHOL, V26, P239, DOI 10.1080/13854046.2012.659219; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher IH, 2016, CNS SPECTRUMS, V21, P258, DOI 10.1017/S1092852916000171; Flodgren G, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002098.pub2; Gehring K, 2009, J CLIN ONCOL, V27, P3712, DOI 10.1200/JCO.2008.20.5765; Goldstein G, 1989, CLIN NEUROPSYCHOL, V3, P265, DOI DOI 10.1080/13854048908404088; Grace J, 2001, FRSBE FRONTAL SYSTEM; Gray JM, 1992, NEUROPSYCHOL REHABIL, V2, P97, DOI DOI 10.1080/09602019208401399; Gray SA, 2012, J CHILD PSYCHOL PSYC, V53, P1277, DOI 10.1111/j.1469-7610.2012.02592.x; Gropper RJ, 2014, J ATTEN DISORD, V18, P331, DOI 10.1177/1087054713516490; Hardy KK, 2013, PSYCHO-ONCOLOGY, V22, P1856, DOI 10.1002/pon.3222; Hassler MR, 2010, J NEURO-ONCOL, V97, P109, DOI 10.1007/s11060-009-0006-2; Helmstaedter C, 2003, ANN NEUROL, V54, P425, DOI 10.1002/ana.10692; Hildebrandt H, 2006, J NEUROL, V253, P512, DOI 10.1007/s00415-006-0013-6; Hillis AE, 2000, J NEUROL NEUROSUR PS, V69, P608, DOI 10.1136/jnnp.69.5.608; Jaeggi SM, 2011, P NATL ACAD SCI USA, V108, P10081, DOI 10.1073/pnas.1103228108; Jak AJ, 2016, J INT NEUROPSYCH SOC, V22, P937, DOI 10.1017/S1355617716000199; Jak AJ, 2013, NEUROPSYCHOL REV, V23, P13, DOI 10.1007/s11065-013-9226-5; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Lebowitz MS, 2012, J REHABIL RES DEV, V49, P1547, DOI 10.1682/JRRD.2011.07.0133; Lemay S, 2004, CLIN NEUROPSYCHOL, V18, P284, DOI 10.1080/13854040490501718; Locke Dona E C, 2008, J Support Oncol, V6, P383; LONGSTRETH WT, 1993, NEUROLOGY, V43, P712, DOI 10.1212/WNL.43.4.712; Loring D. W., 2015, INS DICT NEUROPSYCHO; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Maschio M, 2015, J NEURO-ONCOL, V125, P419, DOI 10.1007/s11060-015-1933-8; Medalia A, 2009, NEUROPSYCHOL REV, V19, P353, DOI 10.1007/s11065-009-9097-y; MITRUSHINA M, 1991, J CLIN PSYCHOL, V47, P790, DOI 10.1002/1097-4679(199111)47:6<790::AID-JCLP2270470610>3.0.CO;2-C; NIEMANN H, 1990, J CONSULT CLIN PSYCH, V58, P811, DOI 10.1037/0022-006X.58.6.811; Niemeier JP, 2013, REHABIL PSYCHOL, V58, P51, DOI 10.1037/a0031612; Noice H, 2004, J AGING HEALTH, V16, P562, DOI 10.1177/0898264304265819; Pearson Assessment, 2009, PEARSON ASSESSMENT T; Peng YH, 2015, NEUROPSYCH DIS TREAT, V11, P1685, DOI 10.2147/NDT.S85288; Peterson KA, 2016, BRIT J NEUROSURG, V30, P38, DOI 10.3109/02688697.2015.1029429; Raskin S., 2011, NEUROPLASTICITY REHA; Riva D, 2011, NEUROL SCI, V32, P307, DOI 10.1007/s10072-011-0779-x; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Roughan L, 2011, LEARN INDIVID DIFFER, V21, P759, DOI 10.1016/j.lindif.2011.07.011; Salinsky MC, 2001, J INT NEUROPSYCH SOC, V7, P597, DOI 10.1017/S1355617701755075; Schmidt M., 1996, REY AUDITORY VERBAL; Schretlen D., 1997, BRIEF TEST ATTENTION; Schuurs A, 2013, PSYCHO-ONCOLOGY, V22, P1043, DOI 10.1002/pon.3102; Silver JM, 2015, NEUROREHABILITATION, V36, P463, DOI 10.3233/NRE-151234; Snow W. G., 1988, INT NEUR SOC NEW ORL; Sohlberg M., 2001, COGNITIVE REHABILITA; Spencer-Smith M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119522; Taphoorn MJB, 2004, LANCET NEUROL, V3, P159, DOI 10.1016/S1474-4422(04)00680-5; Thavarajah N, 2014, SUPPORT CARE CANCER, V22, P1017, DOI 10.1007/s00520-013-2060-8; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Tucha O, 2000, NEUROSURGERY, V47, P324, DOI 10.1097/00006123-200008000-00011; van den Burg W, 1999, ARCH CLIN NEUROPSYCH, V14, P545, DOI 10.1016/S0887-6177(98)00042-0; Vance David E, 2007, J Neurosci Nurs, V39, P226; Wechsler D., 2008, WAIS 4 TECHNICAL INT, DOI [10.3109/02699052.2013.775484, DOI 10.3109/02699052.2013.775484]; WEITZNER MA, 1995, CANCER, V75, P1151, DOI 10.1002/1097-0142(19950301)75:5<1151::AID-CNCR2820750515>3.0.CO;2-Q; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Witt JA, 2012, J NEUROL, V259, P1727, DOI 10.1007/s00415-012-6526-2; Wolfson, 1993, HALSTEAD REITAN NEUR; Wolinsky FD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061624; Yang S, 2014, ANN REHABIL MED-ARM, V38, P726, DOI 10.5535/arm.2014.38.6.726; Yoo C, 2015, J PHYS THER SCI, V27, P2487, DOI 10.1589/jpts.27.2487; Zickefoose S, 2013, BRAIN INJURY, V27, P707, DOI 10.3109/02699052.2013.775484; Zucchella C, 2013, J NEURO-ONCOL, V114, P93, DOI 10.1007/s11060-013-1153-z; Zucchella C, 2013, J NEURO-ONCOL, V112, P455, DOI 10.1007/s11060-013-1076-8	94	2	2	8	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	SEP	2020	21								100786	10.1016/j.inat.2020.100786			10	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	LZ8WU	WOS:000541501800016		gold			2022-02-06	
J	Malek, AJ; Robinson, BD; Hitt, AR; Shaver, CN; Tharakan, B; Isbell, CL				Malek, Adil J.; Robinson, Bobby D.; Hitt, Angie R.; Shaver, Courtney N.; Tharakan, Binu; Isbell, Claire L.			Doxycycline improves traumatic brain injury outcomes in a murine survival model	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	33rd Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 14-18, 2020	Orlando, FL	Eastern Assoc Surg Trauma		Traumatic brain injury; doxycycline; blood-brain barrier; secondary injury	CORTICAL IMPACT MODEL; HEAD-INJURY; BARRIER; BLOOD; MATRIX-METALLOPROTEINASE-9; PROPRANOLOL; INHIBITION; DISRUPTION; MOVEMENT; PATTERNS	BACKGROUND Traumatic brain injury (TBI) has significant morbidity and cost implications. Primary treatment modalities aim to decrease intracranial pressure; however, therapies targeting the underlying pathophysiology of a TBI are limited. The TBI-induced microvascular leak and secondary injury are largely due to proteolysis of the blood-brain barrier (BBB) by matrix metalloproteinase-9. We previously observed doxycycline's inhibitory affinity on matrix metalloproteinase-9 resulting in preserved BBB integrity in nonsurvival murine studies. This study sought to determine the effect of doxycycline on functional motor and behavioral outcomes in the setting of a TBI murine survival model. METHODS C57BL/6J mice were assigned to a sham, TBI, or TBI with doxycycline arm. A moderate TBI was induced utilizing a controlled cortical impactor. The TBI with doxycycline cohort received a dose of doxycycline (20 mg/kg) 2 hours after injury and every 12 hours until postoperative day (POD) 6. All mice underwent preoperative testing for weight, modified neurological severity score, wire grip, and ataxia analysis (DigiGait). Postoperative testing was performed on POD 1, POD 3, and POD 6 for the same measures. SAS 9.4 was used for comparative analysis. RESULTS Fifteen sham mice, 15 TBI mice, and 10 TBI with doxycycline mice were studied. Mice treated with doxycycline had significantly improved modified neurological severity score and wire grip scores at POD 1 (allp< 0.05). Mice treated with doxycycline had significantly improved ataxia scores by POD 3 and POD 6 (allp< 0.05). There was no significant difference in rate of weight change between the three groups. CONCLUSION Mice treated with doxycycline following TBI demonstrated improved behavioral and motor function suggesting doxycycline's role in preserving murine BBB integrity. Examining the role of doxycycline in human TBIs is warranted given the relative universal accessibility, affordability, and safety profile of doxycycline.	[Malek, Adil J.; Robinson, Bobby D.; Isbell, Claire L.] Texas A&M Hth Sci Ctr, Dept Surg, Temple, TX USA; [Hitt, Angie R.] Baylor Scott & White Res Inst, Res Regulatory Affairs, Temple, TX USA; [Shaver, Courtney N.] Baylor Scott & White Res Inst, Dept Biostat, Temple, TX USA; [Tharakan, Binu] Morehouse Sch Med, Dept Surg, Atlanta, GA 30310 USA		Isbell, CL (corresponding author), Baylor Scott & White Med Ctr, 2401 South 31st St, Temple, TX 76508 USA.	claire.isbell@bswhealth.org		Malek, Adil/0000-0003-4243-4512	Eastern Association for the Surgery of Trauma (EAST) research committee	We would like to thank Sharon DeMorrow and Stephanie Grant for their assistance with DigiGait training and utilization. We would also like to thank Cheryl Galindo for her assistance maintaining our laboratory and study animals in concordance with the ARRIVE guidelines as well as assisting with mNSS and wire grip testing. We would like to thank Harry Papaconstantinou, Jason Huang, and Jennifer Thomas for facilitating the execution of the study. Finally, we would like to thank The Eastern Association for the Surgery of Trauma (EAST) research committee for assisting in creative development, providing mentorship, and supporting this study through the EAST Trauma Research Scholarship.	Alluri H, 2018, METHODS MOL BIOL, V1717, P37, DOI 10.1007/978-1-4939-7526-6_4; Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bhamidipati CM, 2012, SURGERY, V152, P238, DOI 10.1016/j.surg.2012.02.010; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Dekker SE, 2018, J NEUROSCI RES, V96, P711, DOI 10.1002/jnr.24125; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Field EF, 1997, BEHAV NEUROSCI, V111, P808, DOI 10.1037/0735-7044.111.4.808; Genet GF, 2018, J TRAUMA ACUTE CARE, V84, P89, DOI 10.1097/TA.0000000000001708; Grant Stephanie, 2018, Gene Expression, V18, P171, DOI 10.3727/105221618X15287315176503; Guilfoyle MR, 2015, J NEUROTRAUM, V32, P1553, DOI 10.1089/neu.2014.3764; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Jackson SJ, 2017, LAB ANIM-UK, V51, P160, DOI 10.1177/0023677216653984; Johnson C, 2011, DEV COGN NEUROS-NETH, V1, P540, DOI 10.1016/j.dcn.2011.05.008; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Lokhandwala A, 2018, J AM COLL SURGEONS, V227, pS272, DOI 10.1016/j.jamcollsurg.2018.07.561; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; MIKLYAEVA EI, 1995, BRAIN RES, V681, P23, DOI 10.1016/0006-8993(95)00277-W; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Rigor RR, 2012, AM J PHYSIOL-CELL PH, V302, pC1513, DOI 10.1152/ajpcell.00371.2011; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Sawant DA, 2013, J SURG RES, V184, P628, DOI 10.1016/j.jss.2013.04.079; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Sousa N, 2006, GENES BRAIN BEHAV, V5, P5, DOI 10.1111/j.1601-183X.2006.00228.x; Stagg HW, 2013, J TRAUMA ACUTE CARE, V75, P1040, DOI 10.1097/TA.0b013e3182aa9c79; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Tharakan B, 2012, SHOCK, V37, P306, DOI 10.1097/SHK.0b013e318240b564; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; Vandooren J, 2014, PROG BRAIN RES, V214, P193, DOI 10.1016/B978-0-444-63486-3.00009-8; Wang ZH, 2012, J MOL NEUROSCI, V47, P89, DOI 10.1007/s12031-011-9689-x; WHISHAW IQ, 1992, BEHAV BRAIN RES, V47, P59, DOI 10.1016/S0166-4328(05)80252-9; Wiggins-Dohlvik K, 2014, AM J SURG, V208, P954, DOI 10.1016/j.amjsurg.2014.08.014; Zeeshan M, 2019, J TRAUMA ACUTE CARE, V87, P1140, DOI 10.1097/TA.0000000000002484; Zhang S, 2016, NEUROCHEM INT, V96, P46, DOI 10.1016/j.neuint.2016.02.013; Zhao S, 2018, NANOMATERIALS, V8, P1	45	2	2	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2020	89	3					435	440		10.1097/TA.0000000000002801			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	NQ7RJ	WOS:000571066500015	32467458				2022-02-06	
J	Mayer, I; Sverdrup, E; Gauss, T; Moyer, JD; Wager, S; Josse, J				Mayer, Imke; Sverdrup, Erik; Gauss, Tobias; Moyer, Jean-Denis; Wager, Stefan; Josse, Julie			DOUBLY ROBUST TREATMENT EFFECT ESTIMATION WITH MISSING ATTRIBUTES	ANNALS OF APPLIED STATISTICS			English	Article						Missing data; causal inference; potential outcomes; observational data; propensity score estimation; incomplete confounders; major trauma; public health	PROPENSITY SCORE; INFERENCE; IMPUTATION; HEMORRHAGE	Missing attributes are ubiquitous in causal inference, as they are in most applied statistical work. In this paper we consider various sets of assumptions under which causal inference is possible despite missing attributes and discuss corresponding approaches to average treatment effect estimation, including generalized propensity score methods and multiple imputation. Across an extensive simulation study, we show that no single method systematically outperforms others. We find, however, that doubly robust modifications of standard methods for average treatment effect estimation with missing data repeatedly perform better than their nondoubly robust baselines; for example, doubly robust generalized propensity score methods beat inverse-weighting with the generalized propensity score. This finding is reinforced in an analysis of an observational study on the effect on mortality of tranexamic acid administration among patients with traumatic brain injury in the context of critical care management. Here, doubly robust estimators recover confidence intervals that are consistent with evidence from randomized trials, whereas nondoubly robust estimators do not.	[Mayer, Imke] Ecole Hautes Etud Sci Sociales, Ctr Anal & Math Sociales, Paris, France; [Sverdrup, Erik; Wager, Stefan] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; [Gauss, Tobias; Moyer, Jean-Denis] Beaujon Hosp, Dept Anesthesia & Intens Care, Clichy, France; [Josse, Julie] Inst Polytech Paris, Ecole Polytech, Ctr Math Appl, Paris, France		Mayer, I (corresponding author), Ecole Hautes Etud Sci Sociales, Ctr Anal & Math Sociales, Paris, France.	imke.mayer@ehess.fr; erikcs@stanfonrd.edu; tgauss@protonmail.com; jean-denis.moyer@aphp.fr; swager@stanford.edu; julie.josse@polytechnique.edu	Mayer, Imke/ABC-7352-2021		EHESS PhD fellowship	We thank Jean-Pierre Nadal for fruitful discussion, Helen Blake and Julie Tibshirani for their suggestions for the simulation study and the Delphi expert committee for the medical insight and advice on traumatic brain injury and hemorrhagic shock. We acknowledge funding from the EHESS PhD fellowship.	Abadie A, 2016, ECONOMETRICA, V84, P781, DOI 10.3982/ECTA11293; ATHEY S., 2019, OBSERVATIONAL STUDIE, V5; ATHEY S., 2017, ARXIV170202896; Athey S, 2019, ANN STAT, V47, P1148, DOI 10.1214/18-AOS1709; Athey S, 2018, J R STAT SOC B, V80, P597, DOI 10.1111/rssb.12268; Blake HA, 2020, BIOMETRICAL J, V62, P428, DOI 10.1002/bimj.201900041; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Buuren, 2018, FLEXIBLE IMPUTATION; Candes EJ, 2010, P IEEE, V98, P925, DOI 10.1109/JPROC.2009.2035722; CAP A. P., 2019, LANCET; Carpenter JR, 2013, MULTIPLE IMPUTATION, V1st; Chernozhukov V, 2018, ECONOMET J, V21, pC1, DOI 10.1111/ectj.12097; Crump RK, 2009, BIOMETRIKA, V96, P187, DOI 10.1093/biomet/asn055; D'Agostino RB, 2000, J AM STAT ASSOC, V95, P749, DOI 10.2307/2669455; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Farrell MH, 2015, J ECONOMETRICS, V189, P1, DOI 10.1016/j.jeconom.2015.06.017; Hastie T., 2015, SOFTIMPUTE MATRIX CO; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Hirano K, 2003, ECONOMETRICA, V71, P1161, DOI 10.1111/1468-0262.00442; Imbens GW, 2015, CAUSAL INFERENCE FOR STATISTICS, SOCIAL, AND BIOMEDICAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1017/CBO9781139025751; Imbens GW, 2004, REV ECON STAT, V86, P4, DOI 10.1162/003465304323023651; JIANG W., 2019, MISAEM LOGISTIC REGR; Jiang W, 2020, COMPUT STAT DATA AN, V145, DOI 10.1016/j.csda.2019.106907; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Josse J., 2019, CONSISTENCY SUPERVIS; Kallus N., 2018, ADV NEURAL INFORM PR, V31, P6921; Kingma D.P., 2014, 2 INT C LEARN REPR I; Kitagawa T, 2018, ECONOMETRICA, V86, P591, DOI 10.3982/ECTA13288; Lederer DJ, 2019, ANN AM THORAC SOC, V16, P22, DOI 10.1513/AnnalsATS.201808-564PS; Leyrat C, 2019, STAT METHODS MED RES, V28, P3, DOI 10.1177/0962280217713032; Li F, 2018, J AM STAT ASSOC, V113, P390, DOI 10.1080/01621459.2016.1260466; Little R. J. A, 2002, TECHNOMETRICS, V45, P364, DOI [DOI 10.1002/9781119013563, 10.1002/9781119013563]; Luedtke AR, 2016, ANN STAT, V44, P713, DOI 10.1214/15-AOS1384; Mattei A, 2009, STAT METHOD APPL-GER, V18, P257, DOI 10.1007/s10260-007-0086-0; MAYER I., 2020, DOUBLY ROBUST TREA S, DOI [10.1214/20-AOAS1356SUPPA, DOI 10.1214/20-AOAS1356SUPPA]; Pearl J, 1995, BIOMETRIKA, V82, P669, DOI 10.1093/biomet/82.4.669; Qu YM, 2009, STAT MED, V28, P1402, DOI 10.1002/sim.3549; R Core Team, 2020, R LANG ENV STAT COMP; RICHARDSON T. S., 2013, TECHNICAL REPORT; Robins JM, 2000, BIOMETRIKA, V87, P113, DOI 10.1093/biomet/87.1.113; ROBINS JM, 1994, J AM STAT ASSOC, V89, P846, DOI 10.2307/2290910; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin D.B, 1978, P SURV RES METH SECT; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Rubin DB., 1987, MULTIPLE IMPUTATION; Rubin Donald B., 2004, MULTIPLE IMPUTATION; SCHAFER J. L., 1997, MONOGRAPHS STAT APPL, V72; Scornet E, 2015, ANN STAT, V43, P1716, DOI 10.1214/15-AOS1321; Seaman S, 2014, COMMUN STAT-THEOR M, V43, P3499, DOI 10.1080/03610926.2012.700371; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Tibshirani Julie, 2020, CRAN; Twala BETH, 2008, PATTERN RECOGN LETT, V29, P950, DOI 10.1016/j.patrec.2008.01.010; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wager S., 2015, ARXIV150306388; Yang S, 2019, BIOMETRIKA, V106, P875, DOI 10.1093/biomet/asz048; Zhao YQ, 2012, J AM STAT ASSOC, V107, P1106, DOI 10.1080/01621459.2012.695674; Zubizarreta JR, 2012, J AM STAT ASSOC, V107, P1360, DOI 10.1080/01621459.2012.703874	62	2	2	3	11	INST MATHEMATICAL STATISTICS	CLEVELAND	3163 SOMERSET DR, CLEVELAND, OH 44122 USA	1932-6157			ANN APPL STAT	Ann. Appl. Stat.	SEP	2020	14	3					1409	1431		10.1214/20-AOAS1356			23	Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Mathematics	NT9MH	WOS:000573263200016		Green Submitted			2022-02-06	
J	Mazzeo, S; Silverberg, C; Oommen, T; Moya, D; Angelo, N; Zwibel, H; Mancini, J; Leder, A; Yao, SC				Mazzeo, Samantha; Silverberg, Craig; Oommen, Tiffany; Moya, Diane; Angelo, Nicole; Zwibel, Hallie; Mancini, Jayme; Leder, Adena; Yao, Sheldon C.			Effects of Osteopathic Manipulative Treatment on Sleep Quality in Student Athletes After Concussion: A Pilot Study	JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION			English	Article						concussion; insomnia; OMT; osteopathic manipulation; osteopathic medicine; sleep	TRAUMATIC BRAIN-INJURY; UNITED-STATES; DISTURBANCES; EPIDEMIOLOGY; INSOMNIA; MASSAGE; SPORT	Context: Impaired sleep quality is among many symptoms observed in patients with a concussion and may predispose a patient to a prolonged recovery course and a later return to their daily activities. Studies have suggested that osteopathic manipulative treatment (OMT) may play a role in improving sleep quality. Objective: To investigate how OMT may play a role in the management and overall healing process in patients with a concussion by improving sleep quality. Methods: Data were collected from a randomized, controlled study on OMT and concussion (of which this study represents 1 arm) to investigate the effects of OMT vs concussion education counseling on sleep quality in student athletes with a concussion. Student athletes with no medical history of neurodegenerative disease who presented to the New York Institute of Technology College of Osteopathic Medicine Academic Healthcare Center with a concussion following a sport-related injury were enrolled in the study. Participants received OMT intervention or standard counseling on how to care for a concussion during their first and second visits. Participants rated their symptoms, including sleep quality, on the validated scale Sport Concussion Assessment Tool 5th Edition at 3 consecutive visits during 1 week. The mean sleep quality score within and between the OMT and education groups before each of 2 interventions and at the third visit were compared and analyzed using the Mann-Whitney U test. Results: Thirty participants were enrolled in the study. Total symptom data showed a stronger, significant correlation with sleep scores than with other symptoms. Participants receiving OMT (n=16) reported overall 80% and 76% improvement in sleep quality from pre-OMT values to their second and third visits, respectively. Participants who had an educational intervention (n=14) reported a 36% and 46% improvement from pre-OMT values to their second and third visits, respectively. Conclusion: The beneficial relationship trend between OMT and sleep quality in patients with a concussion was not statistically significant. Owing to the limitations of this study, further research with a larger population and sham control participants is warranted.	[Zwibel, Hallie] New York Inst Technol, Dept Family Med, Coll Osteopath Med, Old Westbury, NY 11568 USA; [Mancini, Jayme; Leder, Adena; Yao, Sheldon C.] New York Inst Technol, Dept Osteopath Manipulat Med, Coll Osteopath Med, POB 8000 Northern Blvd,Serota Bldg Room 127, Old Westbury, NY 11568 USA; [Mazzeo, Samantha; Silverberg, Craig; Oommen, Tiffany; Moya, Diane; Angelo, Nicole] New York Inst Technol, Coll Osteopath Med, Old Westbury, NY 11568 USA		Yao, SC (corresponding author), New York Inst Technol, Dept Osteopath Manipulat Med, Coll Osteopath Med, POB 8000 Northern Blvd,Serota Bldg Room 127, Old Westbury, NY 11568 USA.	sheldon.yao@nyit.edu					Alhola Paula, 2007, Neuropsychiatr Dis Treat, V3, P553; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Azad Nahid, 2003, Can J Clin Pharmacol, V10, P89; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Burm FV, 2017, BRIT J SPORT MED, V51, P400, DOI [10.1136/bjsports-2016-097372.296, DOI 10.1136/BJSPORTS-2016-097372.296]; Castillo I, 2016, J AM OSTEOPATH ASSOC, V116, P178, DOI 10.7556/jaoa.2016.034; Cutler MJ, 2005, J ALTERN COMPLEM MED, V11, P103, DOI 10.1089/acm.2005.11.103; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Ettlinger H, 2005, OSTEOPATHIC APPROACH, P109; Evans RW, ACUTE MILD TRAUMATIC; Guernsey DT, 2016, J AM OSTEOPATH ASSOC, V116, pE13, DOI 10.7556/jaoa.2016.036; Hachul H, 2011, CLINICS, V66, P343, DOI 10.1590/S1807-59322011000200026; Hitscherich K, 2016, J AM OSTEOPATH ASSOC, V116, P170, DOI 10.7556/jaoa.2016.033; Huard Y., 2005, P INT RES C OST PED, P32; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; King HH, 2018, FDN OSTEOPATHIC MED, P885; Ko YL, 2014, MIDWIFERY, V30, P60, DOI 10.1016/j.midw.2012.11.005; Laker SR, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0510-3; Lim MM, SLEEP WAKE DISORDERS; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCallister A, 2016, J AM OSTEOPATH ASSOC, V116, P810, DOI 10.7556/jaoa.2016.157; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; PATEL KG, 2018, J AM OSTEOPATH ASSOC, V118, P403, DOI DOI 10.7556/JA0A.2018.061; Sarris J, 2011, SLEEP MED REV, V15, P99, DOI 10.1016/j.smrv.2010.04.001; Schwartzberg L, 2020, J AM OSTEOPATH ASSOC, V120, P601, DOI 10.7556/jaoa.2020.098; Venter R, 2012, S AFR J RES SPORT PH, V34; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Warren C, 2018, J AM OSTEOPATH ASSOC, V118, pE41, DOI 10.7556/jaoa.2018.088; Yao SC, 2020, J AM OSTEOPATH ASSOC, V120, P607, DOI 10.7556/jaoa.2020.099; Zwibel H, 2018, J AM OSTEOPATH ASSOC, V118, P655, DOI 10.7556/jaoa.2018.144	33	2	2	1	3	AMER OSTEOPATHIC ASSN	CHICAGO	142 EAST ONTARIO STREET, CHICAGO, IL 60611-2864 USA	0098-6151	1945-1997		J AM OSTEOPATH ASSOC	J. Am. Osteopath. Assoc.	SEP	2020	120	9					615	622		10.7556/jaoa.2020.100			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NU8WU	WOS:000573918900010	32780797	Bronze			2022-02-06	
J	Muller, SV; Klein, T				Mueller, Sandra Verena; Klein, Tilmann			Summary of the S2e Guideline "Diagnosis and Therapy of executive Dysfunctions in neurological Diseases" (AWMF-030/125)	ZEITSCHRIFT FUR NEUROPSYCHOLOGIE			German	Article							TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; MULTIPLE ERRANDS TEST; WORKING-MEMORY; COGNITIVE REHABILITATION; PARKINSONS-DISEASE; IMPAIRED AWARENESS; ATTENTION; SCLEROSIS; STROKE		[Mueller, Sandra Verena] Ostfalia Hsch Angew Wissensch, Fak Soziale Arbeit, Salzdahlumer Str 46-48, D-38302 Wolfenbuttel, Germany		Muller, SV (corresponding author), Ostfalia Hsch Angew Wissensch, Fak Soziale Arbeit, Salzdahlumer Str 46-48, D-38302 Wolfenbuttel, Germany.	s-v.mueller@ostfalia.de					Angelucci Francesco, 2015, Front Hum Neurosci, V9, P130, DOI 10.3389/fnhum.2015.00130; Barnes JJM, 2011, BIOL PSYCHIAT, V69, pE127, DOI 10.1016/j.biopsych.2010.12.040; Bartolo M, 2015, J NEUROL SCI, V349, P117, DOI 10.1016/j.jns.2014.12.039; Bartsch T, 2015, NEUROSCIENCE, V309, P1, DOI 10.1016/j.neuroscience.2015.07.084; Bertens D, 2015, J INT NEUROPSYCH SOC, V21, P639, DOI 10.1017/S1355617715000764; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; Burgess P.W., 2004, THEORY METHODOLOGY F, P81; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; De Giglio L, 2015, NEUROREHAB NEURAL RE, V29, P453, DOI 10.1177/1545968314554623; Dougall D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009221.pub2; Emslie H, 2007, NEUROPSYCHOL REHABIL, V17, P567, DOI 10.1080/09602010701381933; Engvig A, 2012, HUM BRAIN MAPP, V33, P2390, DOI 10.1002/hbm.21370; Fink F, 2010, MULT SCLER J, V16, P1148, DOI 10.1177/1352458510375440; Fish J, 2008, J INT NEUROPSYCH SOC, V14, P154, DOI 10.1017/S1355617708080120; Flavia M, 2010, J NEUROL SCI, V288, P101, DOI 10.1016/j.jns.2009.09.024; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; Gunstad J, 2008, J GERIATR PSYCH NEUR, V21, P166, DOI 10.1177/0891988708316860; Hancock LM, 2015, J CLIN EXP NEUROPSYC, V37, P113, DOI 10.1080/13803395.2014.989818; Hanssen KT, 2016, ACTA NEUROL SCAND, V133, P30, DOI 10.1111/ane.12420; Hildebrandt H, 2007, RESTOR NEUROL NEUROS, V25, P33; Hyndman D, 2003, DISABIL REHABIL, V25, P817, DOI 10.1080/0963828031000122221; Jacoby M, 2013, IEEE T NEUR SYS REH, V21, P182, DOI 10.1109/TNSRE.2012.2235184; Johansson B, 2012, SCAND J OCCUP THER, V19, P176, DOI 10.3109/11038128.2011.603352; Khan F, 2008, J NEUROL NEUROSUR PS, V79, P1230, DOI 10.1136/jnnp.2007.133777; Kohleis K., 2011, NEUROLOGICAL REHABIL, V17, P71; Kopp B, 2008, NERVENARZT, V79, P143, DOI 10.1007/s00115-007-2319-8; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Kreutzer J., 1999, NEUROREHABILITATION, P609; Leung IHK, 2015, NEUROLOGY, V85, P1843, DOI 10.1212/WNL.0000000000002145; Lin ZC, 2014, J INT MED RES, V42, P659, DOI 10.1177/0300060513505809; Liu KPY, 2014, ARCH PHYS MED REHAB, V95, P1262, DOI 10.1016/j.apmr.2014.03.018; Liu-Ambrose T, 2015, J STROKE CEREBROVASC, V24, P130, DOI 10.1016/j.jstrokecerebrovasdis.2014.08.012; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Matthes-von Cramon G., 2006, KOGNITIVE NEUROLOGIC, P168; Mattioli F, 2010, NEUROL SCI, V31, P271, DOI 10.1007/s10072-010-0373-7; Mattioli F, 2011, NEUROL SCI, V32, P83, DOI 10.1007/s10072-010-0412-4; Merten T, 2011, FORTSCHR NEUROL PSYC, V79, P102, DOI 10.1055/s-0029-1245731; Miniussi C, 2008, BRAIN STIMUL, V1, P326, DOI 10.1016/j.brs.2008.07.002; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Muller SV, 2016, FORTSCHR NEUROL PSYC, V84, P542, DOI 10.1055/s-0042-114870; Muller S.V., 2019, LEITLINIEN DIAGNOSTI; Narushima K, 2007, BRIT J PSYCHIAT, V190, P260, DOI 10.1192/bjp.bp.106.025064; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Okai D, 2013, NEUROLOGY, V80, P792, DOI 10.1212/WNL.0b013e3182840678; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Page SJ, 2015, ARCH PHYS MED REHAB, V96, pS89, DOI 10.1016/j.apmr.2014.09.019; Pena J, 2014, NEUROLOGY, V83, P2167, DOI 10.1212/WNL.0000000000001043; Petrelli A, 2014, PARKINSONISM RELAT D, V20, P1196, DOI 10.1016/j.parkreldis.2014.08.023; Poulin V., 2015, DISABILITY REHABILIT, V39, P1; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Radomski MV, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020776; Raspelli S, 2011, STUD HEALTH TECHNOL, V167, P92, DOI 10.3233/978-1-60750-766-6-92; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; Richter KM, 2015, NEUROREHAB NEURAL RE, V29, P33, DOI 10.1177/1545968314527352; Robbins TW, 2007, CEREB CORTEX, V17, pI151, DOI 10.1093/cercor/bhm066; Rosti-Otajarvi EM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009131.pub3; Schale A., 2009, LEHRBUCH KLIN NEUROP, P341; Schellig D., 2009, HDB NEUROPSYCHOLOGIS, V1; Schmitt FA, 2010, CNS NEUROSCI THER, V16, P330, DOI 10.1111/j.1755-5949.2010.00182.x; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stanton Biba R, 2016, Pract Neurol, V16, P42, DOI 10.1136/practneurol-2015-001232; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2006, J INT NEUROPSYCH SOC, V12, P261, DOI 10.1017/S1355617706060358; Takeuchi H, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00681; Thone-Otto A, 2018, PERSONLICHKEITS VERH; Tornas S, 2016, J INT NEUROPSYCH SOC, V22, P436, DOI 10.1017/S1355617715001344; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Vinogradov S, 2009, BIOL PSYCHIAT, V66, P549, DOI 10.1016/j.biopsych.2009.02.017; Visser MM, 2016, STROKE, V47, P135, DOI 10.1161/STROKEAHA.115.010961; Vogt A, 2008, NEUROL REHABILITATIO, V14, P93; Vogt A, 2009, RESTOR NEUROL NEUROS, V27, P225, DOI 10.3233/RNN-2009-0473; Weicker J, 2016, NEUROPSYCHOLOGY, V30, P190, DOI 10.1037/neu0000227; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Zoccolotti P, 2011, EUR J PHYS REHAB MED, V47, P123; Zygouris S, 2017, J ALZHEIMERS DIS, V56, P619, DOI 10.3233/JAD-160518	88	2	2	2	3	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1016-264X	1664-2902		Z NEUROPSYCHOL	Z. Neuropsychol.	SEP	2020	31	3					135	147		10.1024/1016-264X/a000300			13	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	NI1NS	WOS:000565125200004					2022-02-06	
J	Mummareddy, N; Brett, BL; Yengo-Kahn, AM; Solomon, GS; Zuckerman, SL				Mummareddy, Nishit; Brett, Benjamin L.; Yengo-Kahn, Aaron M.; Solomon, Gary S.; Zuckerman, Scott L.			Sway Balance Mobile Application: Reliability, Acclimation, and Baseline Administration	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						balance; Sway Balance Mobile Application; baseline; postural stability; reliability	SPORT-RELATED CONCUSSION; ERROR SCORING SYSTEM; HIGH-SCHOOL; POSTURAL STABILITY; NORMATIVE DATA; SYMPTOMS; PERFORMANCE; STATEMENT; DIAGNOSIS; INJURIES	Objectives: To describe historic baseline session administration practices, to assess the utility of a practice trial (an acclimation trial) before the official balance session, and to examine the within-session reliability of the Sway Balance Mobile Application (SBMA). Design: Retrospective observational study. Setting: Middle schools, high schools, and colleges across the United States. Participants: More than 17 000 student-athletes were included in the Sway Medical database with 7968 individuals meeting this study's inclusion criteria. Independent Variables: The Sway Medical database included the following subject characteristics for each student-athlete: age, sex, weight, and height. Main Outcome Measures: Balance assessment score generated by the SBMA. Results: Variable administration practices with significant differences between baseline session averages across methods were found. Individuals who performed an acclimation trial had a significantly higher baseline session average than those who did not. Within-session reliability estimates were in the low to adequate range (r = 0.53-0.78), with higher estimates found for 2 consecutive baseline tests (r = 0.75-0.78). Conclusions: For maximum clinical utility, a standardized protocol for postural control baseline acquisition is necessary. Acclimation trial should be administered before a baseline session to minimize variability, especially with only 1 to 2 baseline tests. The highest reliability was observed across 2 consecutive baseline tests within the same baseline session. We suggest obtaining baseline balance measurements with an acclimation trial followed by a baseline session with 2 baseline tests. Prospective studies are required for validation.	[Mummareddy, Nishit; Brett, Benjamin L.; Yengo-Kahn, Aaron M.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Vanderbilt Sports Concuss Ctr, Sch Med, Nashville, TN 37212 USA; [Brett, Benjamin L.] Vet Affairs Connecticut Healthcare Syst, Dept Psychol, West Haven, CT USA; [Brett, Benjamin L.] Univ Memphis, Dept Counseling Educ Psychol & Res, Memphis, TN 38152 USA; [Yengo-Kahn, Aaron M.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA.	scott.zuckerman@vanderbilt.edu					Amick R.Z., 2015, J MOB TECHNOL MED, V4, P40, DOI [10.7309/jmtm.4.2.6, DOI 10.7309/JMTM.4.2.6]; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Anderson SL, 2019, CLIN J SPORT MED, V29, P413, DOI 10.1097/JSM.0000000000000545; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Clark Richard C, 2010, N Am J Sports Phys Ther, V5, P122; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Dessy A, 2014, CLIN NEUROL NEUROSUR, V122, P59, DOI 10.1016/j.clineuro.2014.04.003; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Little CE, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0070-0; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Merritt VC, 2017, ARCH CLIN NEUROPSYCH, V32, P168, DOI 10.1093/arclin/acw090; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Odom Mitchell J, 2016, J Surg Orthop Adv, V25, P93; Patterson J.A., 2014, INT J ATHL THER TRAI, V19, P4, DOI [10.1123/ijatt.2013-0094, DOI 10.1123/IJATT.2013-0094]; Patterson JA, 2014, INT J SPORTS PHYS TH, V9, P135; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Ruhe A, 2014, SPORTS HEALTH, V6, P427, DOI 10.1177/1941738114541238; Slick D, 2006, PSYCHOMETRICS NEUROP, P3; Sway, SWAY SWAY FAQS 2011; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Yengo-Kahn AM, 2016, PHYSICIAN SPORTSMED, V44, P297, DOI 10.1080/00913847.2016.1200956; Zuckerman Scott L, 2016, Neurosurgery, V63 Suppl 1, P102, DOI 10.1227/NEU.0000000000001280; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	46	2	2	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2020	30	5					451	457		10.1097/JSM.0000000000000626			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NX9CH	WOS:000575999300021	29952841				2022-02-06	
J	Nakase-Richardson, R; Hoffman, JM; Magalang, U; Almeida, E; Schwartz, DJ; Drasher-Phillips, L; Ketchum, JM; Whyte, J; Bogner, J; Dismuke-Greer, CE				Nakase-Richardson, Risa; Hoffman, Jeanne M.; Magalang, Ulysses; Almeida, Emily; Schwartz, Daniel J.; Drasher-Phillips, Leah; Ketchum, Jessica M.; Whyte, John; Bogner, Jennifer; Dismuke-Greer, Clara E.			Cost-Benefit Analysis From the Payor's Perspective for Screening and Diagnosing Obstructive Sleep Apnea During Inpatient Rehabilitation for Moderate to Severe TBI	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain; Cost-benefit analysis; Polysomnography; Rehabilitation; Sleep apnea syndromes; Wounds and injuries	POSITIVE AIRWAY PRESSURE; TRAUMATIC BRAIN-INJURY; STROKE; PREDICTORS; ADHERENCE; DEPRIVATION; DISORDERS; THERAPY	Objective: To describe the cost benefit of 4 different approaches to screening for sleep apnea in a cohort of participants with moderate to severe traumatic brain injury (TBI) receiving inpatient rehabilitation from the payor's perspective. Design: A cost-benefit analysis of phased approaches to sleep apnea diagnosis. Setting: Six TBI Model System Inpatient Rehabilitation Centers. Participants: Trial data from participants (NZ214) were used in analyses (mean age 44 +/- 18y, 82% male, 75% white, with primarily motor vehicle-related injury [44%] and falls [33%] with a sample mean emergency department Glasgow Coma Scale of 8 +/- 5). Intervention: Not applicable. Main Outcome: Cost benefit. Results: At apnea-hypopnea index (AHI) >15 (34%), phased modeling approaches using screening measures (Snoring, Tired, Observed, Blood Pressure, Body Mass Index, Age, Neck Circumference, and Gender [STOPBANG] [-$5291], Multivariable Apnea Prediction Index MAPI [-$5262]) resulted in greater cost savings and benefit relative to the portable diagnostic approach (-$5210) and initial use of laboratory-quality polysomnography (-$5,011). Analyses at AHI>5 (70%) revealed the initial use of portable testing (-$6323) relative to the screening models (MAPI [-$6250], STOPBANG [-$6237) and initial assessment with polysomnography (-$5977) resulted in greater savings and cost-effectiveness. Conclusions: The high rates of sleep apnea after TBI highlight the importance of accurate diagnosis and treatment of this comorbid disorder. However, financial and practical barriers exist to obtaining an earlier diagnosis during inpatient rehabilitation hospitalization. Diagnostic cost savings are demonstrated across all phased approaches and OSA severity levels with the most cost-beneficial approach varying by incidence of OSA. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Nakase-Richardson, Risa] Univ S Florida, Mental Hlth & Behav Sci, Def & Vet Brain Injury Ctr, James A Haley Vet Hosp,Morsani Coll Med,Div Pulm, Tampa, FL USA; [Hoffman, Jeanne M.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Magalang, Ulysses] Ohio State Univ, Wexner Med Ctr, Div Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA; [Magalang, Ulysses] Ohio State Univ, Wexner Med Ctr, Res Inst, Columbus, OH 43210 USA; [Almeida, Emily; Ketchum, Jessica M.] Craig Hosp, Res Dept, Englewood, CO USA; [Schwartz, Daniel J.] Univ S Florida, Med Serv, James A Haley Vet Hosp, Morsani Coll Med,Div Pulm & Sleep Med, Tampa, FL 33620 USA; [Drasher-Phillips, Leah] Univ S Florida, James A Haley Vet Hosp, Morsani Coll Med, Res & Dev Serv,Div Pulm & Sleep Med, Tampa, FL 33620 USA; [Whyte, John] Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Elkins Pk, PA USA; [Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Div Rehabil Psychol Res & Acad Affairs, Columbus, OH 43210 USA; [Dismuke-Greer, Clara E.] Palo Alto VA Hlth Care Syst, Hlth Econ Resource Ctr HERC, Palo Alto, CA USA; [Dismuke-Greer, Clara E.] Med Univ South Carolina, Div Internal Med, Charleston, SC 29425 USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, Polytrauma TBI Rehabil, Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Risa.Richardson@va.gov			Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [CER-1511-33005]; VHA Central Office VA TBI Model Systems Program of Research; General Dynamics Information Technology from the Defense and Veterans Brain Injury Center [W91YTZ-13-C-0015, HT0014-19-C-0004]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DPTB00070, 90DP0084, 90DPTB0013-01-00, 90DPTB0008, 90DPT80004-02, 90DPTB0001]	Supported by the Patient-Centered Outcomes Research Institute (award no. CER-1511-33005); the VHA Central Office VA TBI Model Systems Program of Research; and a subcontract from General Dynamics Information Technology (no. W91YTZ-13-C-0015; HT0014-19-C-0004) from the Defense and Veterans Brain Injury Center and National Institute on Disability, Independent Living, and Rehabilitation Research (NDSC grant no. 90DPTB00070 [Craig Hospital], 90DP0084 [Craig Hospital NDSC], 90DPTB0013-01-00 [Baylor Scott & White], 90DPTB0008 [University of Washington], 90DPT80004-02 [Moss Rehabilitation], 90DPTB0001 [Ohio State University]). The statements presented in this publication are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute, its Board of Governors, or its Methodology Committee.	Aaronson JA, 2016, J CLIN SLEEP MED, V12, P533, DOI 10.5664/jcsm.5684; Amer Acad Sleep Med, 2000, SLEEP, V23, P1017; American Academy of Sleep Medicine, 2016, HIDDEN HLTH CRISIS C; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Balk E.M., 2012, AHRQ PUBLICATION; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Castronovo V, 2014, SLEEP, V37, P1465, DOI 10.5665/sleep.3994; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Flanagan SR, 2015, BRAIN INJ PROF, V12, P8; Galetke W, 2011, RESPIRATION, V82, P155, DOI 10.1159/000322838; Giacino J, 2020, ARCH PHYS MED REHABI; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1699, DOI 10.1016/j.apmr.2018.07.001; Gray AM, 2012, APPL METHODS COST EF, P9; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P82, DOI 10.1097/HTR.0000000000000230; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Khot S, 2019, STROKE, V50, P1895, DOI 10.1161/STROKEAHA.119.024795; Kim RD, 2015, SLEEP, V38, P1027, DOI 10.5665/sleep.4804; Kohler M, 2010, THORAX, V65, P829, DOI 10.1136/thx.2010.135848; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; MAISLIN G, 1995, SLEEP, V18, P158, DOI 10.1093/sleep/18.3.158; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McDermott CM, 2003, J NEUROSCI, V23, P9687; Mehrtash M, 2019, LUNG, V197, P115, DOI 10.1007/s00408-018-00193-1; Moro M, 2016, J CLIN SLEEP MED, V12, P409, DOI 10.5664/jcsm.5596; Mysliwiec V, 2015, MIL MED, V180, P475, DOI 10.7205/MILMED-D-14-00197; Nakase-Richardson R, BRAIN INJ PROF, V14, P8; Nakase-Richardson R, 2020, CHEST; Nakase-Richardson R, 2020, ARCH PHYS MED REHAB, V101, P283, DOI 10.1016/j.apmr.2019.09.019; Parra O, 2011, EUR RESPIR J, V37, P1128, DOI 10.1183/09031936.00034410; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Ryan CM, 2011, STROKE, V42, P1062, DOI 10.1161/STROKEAHA.110.597468; Schoch OD, 2014, RESPIRATION, V87, P121, DOI 10.1159/000354186; Sivertsen B, 2008, EUR RESPIR J, V32, P1497, DOI 10.1183/09031936.00044908; Sjosten N, 2009, RESP MED, V103, P1047, DOI 10.1016/j.rmed.2009.01.014; TEASDALE G, 1974, LANCET, V2, P81; Teferra Rahel A, 2014, Ann Am Thorac Soc, V11, P1064, DOI 10.1513/AnnalsATS.201404-161OC; Watson NF, 2016, J CLIN SLEEP MED, V12, P1075, DOI 10.5664/jcsm.6034; Weaver TE, 2010, INDIAN J MED RES, V131, P245; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	47	2	2	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2020	101	9					1497	1508		10.1016/j.apmr.2020.03.020			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	NT6YT	WOS:000573084400004	32376325				2022-02-06	
J	Nguyen, AS; Yang, S; Thielen, BV; Techar, K; Lorenzo, RM; Berg, C; Palmer, C; Gipson, JL; West, MA; Tignanelli, CJ				Nguyen, Arthur S.; Yang, Simon; Thielen, Brian, V; Techar, Kristina; Lorenzo, Regina M.; Berg, Cameron; Palmer, Christopher; Gipson, Jon L.; West, Michaela A.; Tignanelli, Christopher J.			Clinical Decision Support Intervention and Time to Imaging in Older Patients with Traumatic Brain Injury	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article; Proceedings Paper	105th Annual Scientific Clinical Congress of the American-College-of-Surgeons / 5th Annual Sessions of the Owen-H-Wangensteen-Scientific-Forum	OCT 27-31, 2019	San Francisco, CA	Amer Coll Surg, Owen H Wangensteen Sci Forum			GERIATRIC TRAUMA; IMPROVED SURVIVAL; AGE; PREDICTORS; HEMORRHAGE; MANAGEMENT; MORTALITY; WARFARIN; SYSTEMS	BACKGROUND: Traumatic brain injury (TBI) is the leading cause of elderly trauma admissions. Previous research identified that each minute delay to TBI diagnosis was associated with a 2% mortality increase, delaying treatment to older patients (age >70 years) who do not meet trauma activation criteria. A TBI protocol and clinical decision support intervention (CDS-I) were developed to reduce time to imaging in older patients with head trauma not meeting trauma activation criteria. STUDY DESIGN: An emergency department (ED) head CT protocol and CDS-I were developed and implemented to facilitate rapid imaging of older patients. Patients age > 70 years, with TBI and receiving anticoagulation, met inclusion criteria. The primary outcomes measure was time from ED arrival to head CT imaging comparing before (PRE: January 1, 2016 to December 31, 2016) vs after (POST: August 1, 2018 to April 3, 2019) protocol implementation. Negative binomial regression models evaluated the association of intervention on time to imaging. LOWESS (locally weighted scatterplot smoothing) was used to evaluate the association of intervention on mortality over time. RESULTS: The study examined 451 patients (269 PRE and 182 POST). Positive head CTs were seen in 78 (17.3%), and 57 of 78 (73%) patients had a Glasgow Coma Scale > 13. POST-intervention decreased time to head CT from 56 to 27 minutes (interquartile range [IQR] PRE: 32 to 93 to POST:16 to 44, p < 0.001) and POST-intervention patients had reduced hospital length of stay (incidence rate ratio [IRR] 0.83, 95% CI 0.72 to 0.86, p = 0.01). CONCLUSIONS: A significant proportion of older patients receiving anticoagulation, but not meeting trauma activation criteria, had positive CT findings. Implementation of a rapid triage protocol with CDS-I reduced time to imaging and may reduce mortality in the highest-risk populations. (C) 2020 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.	[Nguyen, Arthur S.; Yang, Simon; Thielen, Brian, V; Techar, Kristina; Lorenzo, Regina M.] Univ Minnesota, Med Sch, Minneapolis, MN USA; [Tignanelli, Christopher J.] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Tignanelli, Christopher J.] Univ Minnesota, Inst Hlth Informat, Minneapolis, MN 55455 USA; [Berg, Cameron; Palmer, Christopher] North Mem Hlth Hosp, Dept Emergency Med, Robbinsdale, MN USA; [Gipson, Jon L.; West, Michaela A.; Tignanelli, Christopher J.] North Mem Hlth Hosp, Dept Surg, Robbinsdale, MN USA		Tignanelli, CJ (corresponding author), Univ Minnesota, 420 Delaware St SE,MMC 195, Minneapolis, MN 55455 USA.	ctignane@umn.edu		Tignanelli, Christopher/0000-0002-8079-5565			Adzemovic T, 2019, J TRAUMA ACUTE CARE, V86, P952, DOI 10.1097/TA.0000000000002248; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Beeler PE, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14073; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Calland JF, 2012, J TRAUMA ACUTE CA S4, V73; Cucchiara B, 2008, STROKE, V39, P2993, DOI 10.1161/STROKEAHA.108.520668; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Goodmanson NW, 2012, SURGERY, V152, P668, DOI 10.1016/j.surg.2012.08.017; Gowing R, 2007, CAN J SURG, V50, P437; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Hashmi A, 2014, J TRAUMA ACUTE CARE, V76, P894, DOI 10.1097/TA.0b013e3182ab0763; Kucher N, 2005, NEW ENGL J MED, V352, P969, DOI 10.1056/NEJMoa041533; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McKinley BA, 2000, ARCH SURG-CHICAGO, V135, P688, DOI 10.1001/archsurg.135.6.688; Morris RS, 2020, J TRAUMA ACUTE CARE, V88, P416, DOI 10.1097/TA.0000000000002569; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Osheroff JA, 2007, J AM MED INFORM ASSN, V14, P141, DOI 10.1197/jamia.M2334; Rehn M, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-4; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; Rogers A, 2012, AM SURGEON, V78, P711; Rood E, 2005, J AM MED INFORM ASSN, V12, P172, DOI 10.1197/jamia.M1598; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Saab M, 1996, J ACCID EMERG MED, V13, P208; SCALEA TM, 1990, J TRAUMA, V30, P129, DOI 10.1097/00005373-199002000-00001; SHORTLIFFE EH, 1987, JAMA-J AM MED ASSOC, V258, P61, DOI 10.1001/jama.258.1.61; Sim I, 2001, J AM MED INFORM ASSN, V8, P527, DOI 10.1136/jamia.2001.0080527; TEASDALE G, 1974, LANCET, V2, P81; Techar K, 2019, J SURG RES, V242, P4, DOI 10.1016/j.jss.2019.04.006; Tignanelli CJ, 2020, JT COMM J QUAL PATIE, V46, P185, DOI 10.1016/j.jcjq.2019.11.007; Tignanelli CJ, 2019, JAMA SURG, V154, P74, DOI 10.1001/jamasurg.2018.4318; Tignanelli CJ, 2018, J TRAUMA ACUTE CARE, V84, P287, DOI 10.1097/TA.0000000000001745; Wright A, 2011, J AM MED INFORM ASSN, V18, P232, DOI 10.1136/amiajnl-2011-000113; Wyatt J, 1991, Proc Annu Symp Comput Appl Med Care, P3; Yaghi S, 2014, INT J NEUROSCI, V124, P890, DOI 10.3109/00207454.2014.887716	38	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	SEP	2020	231	3					361	+		10.1016/j.jamcollsurg.2020.05.023			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	NI1TW	WOS:000565141200008	32561447				2022-02-06	
J	Oldham, JR; Howell, DR; Bryk, KN; Lanois, CJ; Koerte, IK; Meehan, WP; Buckley, TA				Oldham, Jessie R.; Howell, David R.; Bryk, Kelsey N.; Lanois, Corey J.; Koerte, Inga K.; Meehan, William P., III; Buckley, Thomas A.			No differences in tandem gait performance between male and female athletes acutely post-concussion	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Gait; Balance; Mild Traumatic Brain Injury; Sex Differences	SPORTS-RELATED CONCUSSION; SEX-DIFFERENCES; HIGH-SCHOOL; EPIDEMIOLOGY; RECOVERY; BALANCE; TASK; AGE; RELIABILITY; SYMPTOMS	Objectives: To test whether 1) concussed athletes demonstrate slower tandem gait times compared to controls and 2) concussed female athletes display greater post-injury deficits than males. Design: Prospective longitudinal Method: Fifty concussed collegiate student-athletes (32% female, age = 20.18 +/- 1.27 years) completed tandem gait tests during pre-season (Time 1) and acutely (<72 hours) post-concussion (Time 2), and twenty-five controls (52% female, age = 21.08 +/- 2.22 years) completed tandem gait at two time points, 1.96 +/- 0.46 days apart. Participants completed four single-task (ST) and dual-task (DT) trials. During DT trials, they simultaneously completed a cognitive assessment. The best ST and DT times were recorded, along with cognitive accuracy, and the change score between the two assessments was calculated. A positive change in tandem gait time was indicative of worsening performance. A 2 x 2 (group*sex) ANOVA was used to examine change between pre-injury and post-injury tests for ST/DT tandem gait time and DT cognitive accuracy. Results: The change in tandem gait time from Time 1 to Time 2 was significantly higher for the concussion group relative to controls during both ST (Concussion: 1.36 +/- 2.6 seconds, Controls: -1.16 +/- 0.8 seconds, p < 0.001) and DT (Concussion: 1.70 +/- 3.8 seconds, Controls: -0.94 +/- 1.7 seconds, p = 0.002) tandem gait. There were no interactions or main effects of sex for tandem gait time or cognitive accuracy. Conclusions: There were no sex-specific differences in the change in tandem gait performance among concussed collegiate athletes or controls. However, all concussed participants, regardless of sex, performed significantly worse on tandem gait than male and female controls, who both improved between testing time points. (C) 2020 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Oldham, Jessie R.; Lanois, Corey J.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Oldham, Jessie R.; Lanois, Corey J.; Meehan, William P., III] Boston Childrens Hosp, Dept Orthoped, Div Sports Med, Boston, MA USA; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Bryk, Kelsey N.; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Bryk, Kelsey N.; Buckley, Thomas A.] Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, Newark, DE USA; [Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychomat & Psyc, Munich, Germany; [Koerte, Inga K.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat & Orthoped, Boston, MA 02115 USA		Oldham, JR (corresponding author), Boston Childrens Hosp, Dept Orthoped, Micheli Ctr Sports Injury Prevent, Div Sports Med, Waltham, MA 02453 USA.	Jessie.Oldham@childrens.harvard.edu	Koerte, Inga Katharina/AAW-3031-2021; Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100952, R41NS103698]; National Hockey League Alumni Association throughthe Corey C. Griffin Pro-Am Tournament; National Football League; Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS104371]; NCAA/DoD CARE Consortium [W81XWH14-2-0151]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01NS100952. We would like to acknowledge Melissa DiFabio, Ryan DeWolf, andAnna Brilliant for their assistance with data collection for thismanuscript. Dr. Koerte has received funding related to this research fromthe National Institute of Neurological Disorders and Stroke of theNational Institutes of Health (R01NS100952). Dr. Meehan receivesroyalties from 1) ABC-Clio publishing for the sale of his books, Kids, Sports, and Concussion: A guide for coaches and parents, and Concussions; 2) Springer International for the book Head and Neck Injuriesin Young Athlete and 3) Wolters Kluwer for working as an authorfor UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association throughthe Corey C. Griffin Pro-Am Tournament and the National Football League. Dr. Howell receives research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R03HD094560) and the National Institute of Neurological Disorders And Stroke (R01NS100952 and R41NS103698) of the National Institutes of Health. He has previously received research support from a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindALtd, and the Eastern Athletic Trainers Association Inc. Dr. Buckleyhas received funding related to this research from the NIH/NINDS(R03NS104371) and the NCAA/DoD CARE Consortium (W81XWH14-2-0151). For the remaining authors none were declared.	[Anonymous], 2013, Br J Sports Med, V47, P259; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Howell D, 2019, J ATHL TRAIN, V54; Howell D, 2018, J SCI MED SPORT; Howell D, 2020, MED SCI SPORT EXERC; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Lax I, 2015, BRAIN INF, V29, p[1409, 1409]; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Meenwisse W, 2017, BRIT J SPORT MED, P51; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Oldham JR, 2017, SPORTS HEALTH, V9, P305, DOI 10.1177/1941738116680999; Ozinga SJ, 2018, J ATHL TRAINING, V53, P636, DOI 10.4085/1062-6050-129-17; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Stolze H, 1998, GAIT POSTURE, V7, P125, DOI 10.1016/S0966-6362(97)00043-X; Sufrinko A, 2017, CLIN J SPORT MED, V27, P133; Yogev-Seligmann G, 2010, PHYS THER, V90, P177, DOI 10.2522/ptj.20090043; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	35	2	2	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	SEP	2020	23	9					814	819		10.1016/j.jsams.2020.04.003			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	MY9WW	WOS:000558774400006		Green Accepted			2022-02-06	
J	Powell, JR; Boltz, AJ; DeCicco, JP; Chandran, A; DeLellis, SM; Healy, ML; Kane, SF; Lynch, JH; Means, GE; Hackney, AC; Mihalik, JP				Powell, Jacob R.; Boltz, Adrian J.; DeCicco, Jamie P.; Chandran, Avinash; DeLellis, Stephen M.; Healy, Marshall L.; Kane, Shawn F.; Lynch, James H.; Means, Gary E.; Hackney, Anthony C.; Mihalik, Jason P.			Neuroinflammatory Biomarkers Associated With Mild Traumatic Brain Injury History in Special Operations Forces Combat Soldiers	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						blast; breacher; concussion; plasma; serum; service member; warfighter	NEURON-SPECIFIC ENOLASE; SERUM NEUROFILAMENT LIGHT; BLOOD BIOMARKERS; CONCUSSION; SYMPTOMS; MARKER; INTERLEUKIN-6; DEFICITS; RELEASE; S100B	Background: Special Operations Forces (SOF) combat soldiers are frequently exposed to blast and blunt neurotrauma, most often classified as mild traumatic brain injury (mTBI). Repetitive mTBI may increase the risk of developing long-term neurological sequelae. Identifying changes in neuroinflammatory biomarkers before chronic conditions emerge could serve as preliminary evidence of developing neuropathology. Objective: To determine the effects of mTBI history, lifetime mTBI incidence, and recency on blood biomarker concentrations of axonal protein neurofilament light (NfL), glycolytic enzyme neuron-specific enolase (NSE), astrocyte-expressed S100 calcium-binding protein B (S100B), and neurotrophic cytokine interleukin-6 (IL-6) in healthy, active duty SOF combat soldiers. Methods: Self-reported mTBI history/recency and fasted blood samples were collected in this cross-sectional study of 104 asymptomatic SOF combat soldiers. Biomarker concentrations were quantified using commercial enzyme-linked immunosorbent assays. Mann-WhitneyUand Kruskal-Wallis tests were used to compare groups. Post hoc tests with appropriate corrections were conducted as warranted. Results: Soldiers with mTBI history had higher NSE concentrations than those without (z= -2.60,P= .01). We also observed significant main effects of lifetime mTBI incidence on NSE (chi(2)(3) = 9.52,P= .02) and S100B (chi(2)(3) = 8.21,P= .04) concentrations and a significant main effect of mTBI recency on NfL concentration (chi(2)(2) = 6.02,P= .049). Conclusion: The SOF combat soldiers with mTBI history had increased NSE. Longitudinal studies in this population are needed due to between-subject heterogeneity in biomarker concentrations. The NfL concentrations in our SOF combat soldiers-regardless of mTBI history or recency-were similar to values previously reported in civilian acute TBI patients.	[Powell, Jacob R.; Boltz, Adrian J.; DeCicco, Jamie P.; Chandran, Avinash; Kane, Shawn F.; Hackney, Anthony C.; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, 2201 Stallings Evans Sports Med Ctr, Chapel Hill, NC 27599 USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [DeLellis, Stephen M.] Def Med Strategies LLC, Fayetteville, NC USA; [Healy, Marshall L.; Lynch, James H.; Means, Gary E.] US Army Special Operat Command, Ft Bragg, NC USA		Mihalik, JP (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, 2201 Stallings Evans Sports Med Ctr, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu		Powell, Jacob/0000-0002-3899-9433	United States Army Special Operations Command (USASOC); Preservation of the Force and Family Program at US Special Operations Command; Henry M. Jackson Foundation [HU0001-15-2-0053]; Uniformed Services University	This project was funded with support from the United States Army Special Operations Command (USASOC). This work was also supported by funding secured by the Preservation of the Force and Family Program at US Special Operations Command and executed as a subaward issued to The University of North Carolina at Chapel Hill by the Henry M. Jackson Foundation (grant no. HU0001-15-2-0053) under a cooperative agreement with the Uniformed Services University.	Alirezaei Z, 2020, MOL NEUROBIOL, V57, P469, DOI 10.1007/s12035-019-01698-3; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Buonora JE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00068; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Defense and Veterans Brain Injury Center (DVBIC), 2019, DOD WORLDW NUMB TBI; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Foster CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215030; Gaetani L, 2019, J NEUROL NEUROSUR PS, V90, P870, DOI 10.1136/jnnp-2018-320106; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gill J, 2018, BRAIN INJURY, V32, P1359, DOI 10.1080/02699052.2018.1471738; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Kontos Anthony P, 2015, J Trauma Acute Care Surg, V79, pS146, DOI 10.1097/TA.0000000000000667; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Loddick SA, 1998, J CEREBR BLOOD F MET, V18, P176, DOI 10.1097/00004647-199802000-00008; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; O'Connell B, 2018, BRAIN INJURY, V32, P1811, DOI 10.1080/02699052.2018.1532112; Rogatzki MJ, 2018, SCAND J MED SCI SPOR, V28, P2505, DOI 10.1111/sms.13297; Schulte S, 2014, J ATHL TRAINING, V49, P830, DOI 10.4085/1062-6050-49.3.33; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; TAPIA FJ, 1981, LANCET, V1, P808; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yee MK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070079; Zetterberg H, 2009, BRAIN INJURY, V23, P723, DOI 10.1080/02699050903120399	44	2	3	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2020	35	5			SI		300	307		10.1097/HTR.0000000000000598			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NP5SO	WOS:000570236100002	32881763	Bronze			2022-02-06	
J	Prasetyo, E; Oley, MC; Sumual, V; Faruk, M				Prasetyo, Eko; Oley, Maximillian Christian; Sumual, Vera; Faruk, Muhammad			Transorbital-penetrating intracranial injury due to a homemade metal arrow: A case report	ANNALS OF MEDICINE AND SURGERY			English	Article						Transorbital; Penetrating; Intracranial injury; Metal arrow; Case report	OF-THE-LITERATURE; BRAIN-ABSCESS; HEAD-INJURY; MANAGEMENT	A transorbital-penetrating intracranial injury (TOPI) is an unusual traumatic brain injury. This rare injury has the potential to result in serious and fatal brain damage with a high mortality rate and requires prompt multidisciplinary surgical intervention. Here, we describe an interesting case in which a patient who presented with accidental penetrating injuries of the brain was found to have a transorbital-penetrating intracranial injury (TOPI). We chose an anterior approach to the foreign body above the entrance wound for removal in a retrograde manner with fluoroscopic guidance. The patient remained well with no complications and was discharged on postoperative day 10. Reasonable diagnostic imaging, surgical planning, and careful post-surgery management can increase patients successful outcomes.	[Prasetyo, Eko; Oley, Maximillian Christian] Univ Sam Ratulangi, Fac Med, Dept Surg, Div Neurosurg, Manado, Indonesia; [Prasetyo, Eko; Oley, Maximillian Christian] RD Kandou Hosp, Dept Surg, Div Neurosurg, Manado, Indonesia; [Prasetyo, Eko; Oley, Maximillian Christian] Siloam Hosp Manado, Dept Neurosci, Manado, Indonesia; [Sumual, Vera] Univ Sam Ratulangi, Fac Med, Dept Ophthalmol, Manado, Indonesia; [Sumual, Vera] RD Kandou Hosp, Dept Ophthalmol, Manado, Indonesia; [Faruk, Muhammad] Hasanuddin Univ, Fac Med, Dept Surg, Makassar, Indonesia		Prasetyo, E (corresponding author), Jalan Malalayang Satu Barat, Manado City 95115, North Sulawesi, Indonesia.	ekoprasetyo@unsrat.ac.id; maxioley@yahoo.com; verasumual@yahoo.com; faroex8283@gmail.com		Prasetyo, Eko/0000-0002-0781-9014; Oley, Maximillian Christian/0000-0001-8317-0790; Faruk, Muhammad/0000-0002-7079-4585			Aarabi B, 2000, NEUROSURG FOCUS, V8, P1, DOI DOI 10.3171/F0C.2000.8.1.155; Agha RA, 2018, INT J SURG, V60, P132, DOI 10.1016/j.ijsu.2018.10.028; Agrawal A, 2007, PEDIATR NEUROSURG, V43, P498, DOI 10.1159/000108794; Awori J, 2017, J STROKE CEREBROVASC, V26, pE143, DOI 10.1016/j.jstrokecerebrovasdis.2017.04.004; Balasubramanian C, 2009, SURG NEUROL, V71, P238, DOI 10.1016/j.surneu.2007.07.050; Cemil B, 2009, TURK J TRAUMA EMERG, V15, P624; Esposito DP, 2009, NEUROSURG QUART, V19, P249, DOI 10.1097/WNQ.0b013e3181bd1d53; Estebanez G, 2015, CRANIOMAX TRAUM REC, V8, P356, DOI 10.1055/s-0035-1546813; Group, 2018, INT J SURG, V60, P132; Gupta OP, 2014, INDIAN J NEUROTRAUM, V11, P53, DOI 10.1016/j.ijnt.2013.12.001; Heininger AD, 2004, ANAESTHESIST, V53, P830, DOI 10.1007/s00101-004-0729-6; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Lee JH, 2000, J NEUROSURG, V93, P477, DOI 10.3171/jns.2000.93.3.0477; Lin Hung-Lin, 2007, J Chin Med Assoc, V70, P36; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Mashriqi F, 2017, CUREUS, V9, DOI 10.7759/cureus.1725; Matsuyama T, 2001, NEUROL MED-CHIR, V41, P345, DOI 10.2176/nmc.41.345; MILLER CF, 1977, SURG NEUROL, V7, P95; Modjtahedi BS, 2015, RETINA-J RET VIT DIS, V35, P95, DOI 10.1097/IAE.0000000000000271; Park SJ, 2018, J CRANIOFAC SURG, V29, pE61, DOI 10.1097/SCS.0000000000004054; Riley JP, 2017, WORLD NEUROSURG, V97, DOI 10.1016/j.wneu.2016.09.083; Schreckinger M, 2011, J NEUROSURG, V114, P53, DOI 10.3171/2010.8.JNS10301; Secer M, 2007, TURK NEUROSURG, V17, P163; Shahpurkar VV, 2008, INDIAN J OPHTHALMOL, V56, P345; Shi L, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014528; Shin TH, 2012, J KOREAN NEUROSURG S, V52, P414, DOI 10.3340/jkns.2012.52.4.414; Su YM, 2016, J SURG CASE REP, DOI 10.1093/jscr/rjw034; Sun GZ, 2016, WORLD NEUROSURG, V95, DOI 10.1016/j.wneu.2016.07.104; Taylor AG, 1997, J NEUROSURG, V87, P512, DOI 10.3171/jns.1997.87.4.0512; Temple N, 2015, J MED RADIAT SCI, V62, P122, DOI 10.1002/jmrs.101; Turbin RE, 2006, SURV OPHTHALMOL, V51, P449, DOI 10.1016/j.survophthal.2006.06.008; Wang KJ, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0076-1; Zhang DF, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2838167	34	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2049-0801			ANN MED SURG	Ann. Med. Surg.	SEP	2020	57						183	189		10.1016/j.amsu.2020.07.049			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NO4BQ	WOS:000569430900041	32774851	Green Published, gold			2022-02-06	
J	Salmi, L; Gavelli, F; Gardino, CA; Medica, D; Patrucco, F; Bellan, M; Sainaghi, PP; Vaschetto, R; Della Corte, F; Smirne, C; Benech, A; Brucoli, M; Avanzi, GC; Cantaluppi, V; Castello, LM				Salmi, Livia; Gavelli, Francesco; Gardino, Clara A.; Medica, Davide; Patrucco, Filippo; Bellan, Mattia; Sainaghi, Pier P.; Vaschetto, Rosanna; Della Corte, Francesco; Smirne, Carlo; Benech, Arnaldo; Brucoli, Matteo; Avanzi, Gian C.; Cantaluppi, Vincenzo; Castello, Luigi M.			Plasma microvesicles in patients admitted to the emergency department for mild traumatic brain injury: first clues to understand their role	MINERVA BIOTECNOLOGICA			English	Article						Prognosis; Flow cytometry; Cell-derived microparticles	CRITERIA	BACKGROUND: Mild traumatic brain injury (mTBI) represents one of the main causes of emergency department (ED) admission. Microvesicles (MVs) have been shown to play an important role in cell-to-cell communication. However, their role in mTBI needs to be clarified. METHODS: Patients admitted to the ED for mTBI, with or without minor trauma of the limbs, were enrolled. Patients with isolated minor trauma of the limbs served as control group. Five healthy volunteers were also enrolled. Blood sample was collected within 8 hours from admission and plasmatic MVs were subsequently isolated and quantified. Through flow cytometry MVs were further characterized on a subgroup of patients and controls. A 30-day follow-up phone call evaluated the presence of post-traumatic sequelae. RESULTS: One hundred and fifteen mTBI and 40 control patients were enrolled between July 2014 and March 2015. Plasma MVs size and concentration were significantly higher (P=0.0011 and P<0.0001, respectively) in mTBI patients compared to both controls and healthy volunteers. No difference was observed in terms of MVs concentration and size neither according to age, sex, anticoagulant therapy nor presence of post-traumatic sequelae. At MVs characterization, (FAS-Ligand expression was significantly higher in mTBI patients compared to controls (P=0.035). CONCLUSIONS: Both plasmatic MVs size and concentration are significantly higher in patients admitted to the ED for mTBI, compared to controls and healthy subjects.	[Salmi, Livia; Gavelli, Francesco; Gardino, Clara A.; Patrucco, Filippo; Bellan, Mattia; Sainaghi, Pier P.; Vaschetto, Rosanna; Della Corte, Francesco; Smirne, Carlo; Benech, Arnaldo; Brucoli, Matteo; Avanzi, Gian C.; Cantaluppi, Vincenzo; Castello, Luigi M.] Univ Piemonte Orientale UPO, Dept Translat Med, Via Solaroli 17, I-28100 Novara, Italy; [Gavelli, Francesco; Gardino, Clara A.; Avanzi, Gian C.; Castello, Luigi M.] Maggiore Carita Univ Hosp, Dept Emergency Med, Novara, Italy; [Medica, Davide] Univ Turin, Molinette Univ Hosp, Citta Salute & Sci, Ctr Expt Med Res CeRMS, Turin, Italy; [Patrucco, Filippo] Maggiore Carita Univ Hosp, Dept Med, Div Resp Med, Novara, Italy; [Bellan, Mattia; Sainaghi, Pier P.; Smirne, Carlo] Maggiore Carita Univ Hosp, Div Internal Med, Unit Immunorheumatol, Novara, Italy; [Bellan, Mattia; Sainaghi, Pier P.; Cantaluppi, Vincenzo] Maggiore Carita Univ Hosp, Ctr Autoimmunc & Allerg Dis CAAD, Novara, Italy; [Vaschetto, Rosanna; Della Corte, Francesco] Maggiore Carita Univ Hosp, Dept Anesthesiol & Intens Care, Novara, Italy; [Benech, Arnaldo; Brucoli, Matteo] Maggiore Carita Univ Hosp, Div Maxillofacial Surg, Novara, Italy; [Cantaluppi, Vincenzo] Maggiore Carita Univ Hosp, Nephrol & Kidney Transplantat Unit, Novara, Italy		Castello, LM (corresponding author), Univ Piemonte Orientale UPO, Dept Translat Med, Via Solaroli 17, I-28100 Novara, Italy.	luigi.castello@med.uniupo.it	Sainaghi, Pier Paolo/J-1132-2016; Castello, Luigi Mario/AAC-7344-2022; Gavelli, Francesco/AAE-6666-2019; Vaschetto, Rosanna/ABC-4671-2020; Della Corte, Francesco/ABI-7646-2020; Filippo, Patrucco/AAC-4509-2022; Medica, Davide/AAM-7691-2021; Bellan, Mattia/AAL-5472-2020	Sainaghi, Pier Paolo/0000-0001-8322-9158; Castello, Luigi Mario/0000-0001-8248-1976; Gavelli, Francesco/0000-0002-0581-245X; Vaschetto, Rosanna/0000-0003-4625-4367; Della Corte, Francesco/0000-0003-1736-2318; Medica, Davide/0000-0002-6171-8919; 			Abate MG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070695; Andrews AM, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00043; Baldira J, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-0625-5; Ballarino P, 2020, MINERVA MED, V111, P120, DOI 10.23736/S0026-4806.20.06472-1; Bellan M, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2019.102453; Bellan M, 2020, CLIN RHEUMATOL, V39, P1277, DOI 10.1007/s10067-019-04808-7; Bellan M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205070; Bergallo M, 2019, MINERVA MED; Beurton A, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2306-z; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Campion D, 2019, MINERVA BIOTECNOL, V31, P11, DOI 10.23736/S1120-4826.18.02488-6; Camussi G, 2013, BIOCHEM SOC T, V41, P283, DOI 10.1042/BST20120192; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Castello LM, 2018, BIOMARK MED, V12, P555, DOI 10.2217/bmm-2018-0041; Castello LM, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020174; Castello LM, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4049098; Caviglia GP, 2019, MINERVA BIOTECNOL, V31, P1, DOI 10.23736/S1120-4826.18.02494-1; Durazzo M, 2018, MINERVA CARDIOANGIOL, V66, P770, DOI 10.23736/S0026-4725.18.04681-9; Gavelli F, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-0644-2; Gavelli F, 2019, MINERVA PNEUMOL, V58, P109, DOI 10.23736/S0026-4954.19.01863-7; Gavelli F, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2554-y; Gavelli F, 2019, J THORAC DIS, V11, pS1528, DOI 10.21037/jtd.2019.07.10; Gavelli F, 2018, MINERVA MED, V109, P239, DOI 10.23736/S0026-4806.18.05576-3; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Hariri G, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0511-1; Harrois A, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0574-z; Marinoni C, 2019, MINERVA BIOTECNOL, V31, P100, DOI 10.23736/S1120-4826.19.02555-2; Montemezzo J, 2019, MINERVA BIOTECNOL, V31, P77, DOI 10.23736/S1120-4826.19.02557-6; Monti S, 2011, EPIDEMIOL BIOSTAT PU, V8, P49; Munivenkatappa A, 2019, J NEUROSURG SCI, V63, P525, DOI 10.23736/S0390-5616.16.03439-1; Patrucco F, 2019, MINERVA BIOTECNOL, V31, P111, DOI 10.23736/S1120-4826.19.02561-8; Patrucco F, 2018, MINERVA PNEUMOL, V57, P73, DOI 10.23736/S0026-4954.18.01824-2; Patrucco F, 2018, MINERVA PNEUMOL, V57, P121, DOI 10.23736/S0026-4954.18.01835-7; Patrucco F, 2018, PANMINERVA MED, V60, P139, DOI 10.23736/S0031-0808.18.03478-X; Patrucco F, 2018, LUNG, V196, P721, DOI 10.1007/s00408-018-0161-3; Pregernig A, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0600-1; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ribaldone DG, 2019, MINERVA BIOTECNOL, V31, P3, DOI 10.23736/S1120-4826.18.02463-1; Rosso C, 2019, MINERVA BIOTECNOL, V31, P23, DOI 10.23736/S1120-4826.18.02493-X; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salmi L, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/6156493; Shah R, 2018, NEW ENGL J MED, V379, P958, DOI 10.1056/NEJMra1704286; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Tanaka S, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0541-8; Toft K, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0548-1; Tsai MJ, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-0642-4; Vaschetto R, 2015, MINERVA ANESTESIOL, V81, P157; Vaschetto R, 2019, INTENS CARE MED, V45, P62, DOI 10.1007/s00134-018-5478-0; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299	49	2	2	0	2	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1120-4826	1827-160X		MINERVA BIOTECNOL	Minerva Biotechnol.	SEP	2020	32	3					89	94		10.23736/S1120-4826.20.02626-9			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	MT6QX	WOS:000555098500001					2022-02-06	
J	Seo, Y; Whang, K; Pyen, J; Choi, J; Kim, J; Oh, J				Seo, Yongsik; Whang, Kum; Pyen, Jinsu; Choi, Jongwook; Kim, Joneyeon; Oh, Jiwoong			Missed Skeletal Trauma Detected by Whole Body Bone Scan in Patients with Traumatic Brain Injury	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Brain injuries, Traumatic; Fractures, Bone; Radionuclide image	FRACTURES; CHILDREN; HEAD	Objective : Unclear mental state is one of the major factors contributing to diagnostic failure of occult skeletal trauma in patients with traumatic brain injury (TBI). The aim of this study was to evaluate the overlooked co-occurring skeletal trauma through whole body bone scan (WBBS) in TBI. Methods : A retrospective study of 547 TBI patients admitted between 2015 and 2017 was performed to investigate their co-occurring skeletal injuries detected by WBBS. The patients were divided into three groups based on the timing of suspecting skeletal trauma confirmed : 1) before WBBS (pre-WBBS); 2) after the routine WBBS (post-WBBS) with good mental state and no initial musculoskeletal complaints; and 3) afterthe routine WBBS with poor mental state (poor MS). The skeletal trauma detected by WBBS was classified into six skeletal categories : spine, upper and lower extremities, pelvis, chest wall, and clavicles. The skeletal injuries identified by WBBS were confirmed to be simple contusion or fractures by other imaging modalities such as X-ray or computed tomography (CT) scans. Of the six categorizations of skeletal trauma detected as hot uptake lesions in WBBS, the lesions of spine, upper and lower extremities were further statistically analyzed to calculate the incidence rates of actual fractures (AF) and actual surgery (AS) cases over the total number of hot uptake lesions in WBBS. Results : Of 547 patients with TBI, 112 patients (20.4 %) were presented with TBI alone. Four hundred and thirty-five patients with TBI had co-occurring skeletal injuries confirmed by WBBS. The incidences were as follows : chest wall (27.4%), spine (22.9%), lower extremities (20.2%), upper extremities (13.5%), pelvis (9.4%), and clavicles (6.3%). It is notable that relatively larger number of positive hot uptakes were observed in the groups of post-WBBS and poor MS. The percentage of post-WBBS group over the total hot uptake lesions in upper and lower extremities, and spines were 51.0%, 43.8%, and 41.7%, respectively, while their percentages of AS were 2.73%, 1.1%, and 0%, respectively. The percentages of poor MS group in the upper and lower extremities, and spines were 10.4%, 17.4%, and 7.8%, respectively, while their percentages of AS were 26.7%, 14.2%, and 11.1%, respectively. There was a statistical difference in the percentage of AS between the groups of post-WBBS and poor MS (p=0.000). Conclusion : WBBS is a potential diagnostic tool in understanding the skeletal conditions of patients with head injuries which may be undetected during the initial assessment.	[Seo, Yongsik; Whang, Kum; Pyen, Jinsu; Choi, Jongwook; Kim, Joneyeon] Yonsei Univ, Wonju Coll Med, Dept Neurosurg, Wonju, South Korea; [Oh, Jiwoong] Yonsei Univ, Dept Neurosurg, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea		Oh, J (corresponding author), Yonsei Univ, Dept Neurosurg, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.	nsojw@yuhs.ac		Whang, Kum/0000-0002-3701-847X; Seo, Yong Sik/0000-0002-6377-9838; Oh, Jiwoong/0000-0001-6065-4821; Kim, Jongyeon/0000-0002-9407-0127; Choi, Jongwook/0000-0003-2593-3870			BAUER GCH, 1993, CLIN ORTHOP RELAT R, P3; Brooks A, 2004, INJURY, V35, P407, DOI 10.1016/S0020-1383(03)00219-5; DEININGER HK, 1981, RADIOLOGE, V21, P35; ENDERSON BL, 1991, SURG CLIN N AM, V71, P399; FRAWLEY PA, 1995, AUST NZ J SURG, V65, P390, DOI 10.1111/j.1445-2197.1995.tb01765.x; GARLAND DE, 1981, CLIN ORTHOP RELAT R, P162; George MP, 2019, RADIOL CLIN N AM, V57, P843, DOI 10.1016/j.rcl.2019.02.009; HEINRICH SD, 1994, J BONE JOINT SURG AM, V76A, P561, DOI 10.2106/00004623-199404000-00011; HIRSHBERG A, 1994, AM J SURG, V168, P299, DOI 10.1016/S0002-9610(05)80152-7; Huang HC, 2012, EUR J TRAUMA EMERG S, V38, P319, DOI 10.1007/s00068-012-0176-z; Janjua KJ, 1998, J TRAUMA, V44, P1000, DOI 10.1097/00005373-199806000-00012; Kremli MK, 1996, INJURY, V27, P503, DOI 10.1016/0020-1383(96)00044-7; Lee KJ, 2014, ORTHOP TRAUMATOL-SUR, V100, P953, DOI 10.1016/j.otsr.2014.09.015; Lee WC, 2014, INJURY, V45, P1429, DOI 10.1016/j.injury.2014.01.017; MACKERSIE RC, 1988, J TRAUMA, V28, P1450, DOI 10.1097/00005373-198810000-00007; Mrozek S, 2013, ANN FR ANESTH, V32, P510, DOI 10.1016/j.annfar.2013.07.010; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; SCHMIDT C, 1985, RADIOLOGE, V25, P104; SOBUS KML, 1993, ARCH PHYS MED REHAB, V74, P902; Soundappan SVS, 2004, J TRAUMA, V57, P114, DOI 10.1097/01.TA.0000108992.51091.F7; Ward W G, 1991, J Orthop Trauma, V5, P308, DOI 10.1097/00005131-199109000-00009; Wei CJ, 2006, ACTA RADIOL, V47, P710, DOI 10.1080/02841850600806340; Yang DC, 2002, CLIN NUCL MED, V27, P419, DOI 10.1097/00003072-200206000-00007	23	2	2	0	0	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	SEP	2020	63	5					649	656		10.3340/jkns.2020.0171			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NJ1MU	WOS:000565809400013	32883059	Green Published, gold			2022-02-06	
J	Smith-Ryan, AE; Hirsch, KR; Saylor, HE; Gould, LM; Blue, MNM				Smith-Ryan, Abbie E.; Hirsch, Katie R.; Saylor, Hannah E.; Gould, Lacey M.; Blue, Malia N. M.			Nutritional Considerations and Strategies to Facilitate Injury Recovery and Rehabilitation	JOURNAL OF ATHLETIC TRAINING			English	Article							CREATINE MONOHYDRATE SUPPLEMENTATION; SKELETAL-MUSCLE MASS; ESSENTIAL AMINO-ACID; DOUBLE-BLIND; RESISTANCE EXERCISE; ANABOLIC RESPONSE; DIETARY-SUPPLEMENTS; PROTEIN INGESTION; OXIDATIVE STRESS; BODY-COMPOSITION	Nutritional interventions are not commonly a standard of care in rehabilitation interventions. A nutritional approach has the potential to be a low-cost, high-volume strategy that complements the existing standard of care. In this commentary, our aim is to provide an evidence-based, practical guide for athletes with injuries treated surgically or conservatively, along with healing and rehabilitation considerations. Injuries are a normal and expected part of exercise participation. Regardless of severity, an injury typically results in the athlete's short- or long-term removal from participation. Nutritional interventions may augment the recovery process and support optimal healing; therefore, incorporating nutritional strategies is important at each stage of the healing process. Preoperative nutrition and nutritional demands during rehabilitation are key factors to consider. The physiological response to wounds, immobilization, and traumatic brain injuries may be improved by optimizing macronutrient composition, caloric consumption, and nutrient timing and using select dietary supplements. Previous research supports practical nutrition recommendations to reduce surgical complications, minimize deficits after immobilization, and maximize the chance of safe return to play. These recommendations include identifying the individual's caloric requirements to ensure that energy needs are being met. A higher protein intake, with special attention to evenly distributed consumption throughout the day, will help to minimize loss of muscle and strength during immobilization. Dietary-supplement strategies may be useful when navigating the challenges of appropriate caloric intake and timing and a reduced appetite. The rehabilitation process also requires a strong nutritional plan to enhance recovery from injury. Athletic trainers, physical therapists, and other health care professionals should provide basic nutritional recommendations during rehabilitation, discuss the timing of meals with respect to therapy, and refer the patient to a registered dietitian if warranted. Because nutrition plays an essential role in injury recovery and rehabilitation, nutritional interventions should become a component of standard-of-care practice after injury. In this article, we address best practices for implementing nutritional strategies among patients with athletic injuries.	[Smith-Ryan, Abbie E.; Hirsch, Katie R.; Saylor, Hannah E.; Gould, Lacey M.] Univ N Carolina, Dept Exercise & Sport Sci, 209 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA; [Smith-Ryan, Abbie E.; Hirsch, Katie R.; Saylor, Hannah E.; Blue, Malia N. M.] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC 27599 USA; [Smith-Ryan, Abbie E.] Univ N Carolina, Dept Nutr, Gillings Sch Publ Hlth, Chapel Hill, NC 27599 USA		Smith-Ryan, AE (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 209 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA.	abbsmith@email.unc.edu		Hirsch, Katie/0000-0002-0899-0139; Gould, Lacey/0000-0002-4259-3225			Agostoni C, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2815; Ainsley Dean Philip John, 2017, Concussion, V2, pCNC34, DOI 10.2217/cnc-2016-0016; Akintoye E, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.004584; Al Moutaery K, 2003, NEUROSURGERY, V53, P704, DOI 10.1227/01.NEU.0000079487.66013.6F; Aragon AA, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0174-y; Aragon AA, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-5; Areta JL, 2013, J PHYSIOL-LONDON, V591, P2319, DOI 10.1113/jphysiol.2012.244897; BANNISTER WK, 1962, ANESTHESIOLOGY, V23, P251, DOI 10.1097/00000542-196203000-00012; Barker T, 2011, J EVID-BASED INTEGR, V16, P201, DOI 10.1177/2156587211413768; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Begtrup KM, 2017, DAN MED J, V64; Benardot D, 2016, MED SCI SPORT EXER, V48, P543; Branch JD, 2003, INT J SPORT NUTR EXE, V13, P198, DOI 10.1123/ijsnem.13.2.198; Buford TW, 2007, J INT SOC SPORT NUTR, V4, DOI 10.1186/1550-2783-4-6; Burke LM, 2019, INT J SPORT NUTR EXE, V29, P73, DOI 10.1123/ijsnem.2019-0065; Calder PC, 2009, BRIT J NUTR, V101, pS1, DOI 10.1017/S0007114509377867; Calder PC, 2013, P NUTR SOC, V72, P326, DOI 10.1017/S0029665113001031; Candow DG, 2010, J NUTR HEALTH AGING, V14, P149, DOI 10.1007/s12603-009-0224-5; Carr AC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111211; Christensen J, 2020, SYNAPSE, V74, DOI 10.1002/syn.22142; Correia CE, 2008, AM J CLIN NUTR, V88, P1272, DOI 10.3945/ajcn.2008.26352; Cribb PJ, 2006, MED SCI SPORT EXER, V38, P1918, DOI 10.1249/01.mss.0000233790.08788.3e; D'Souza AL, 2002, BRIT MED J, V324, P1361, DOI 10.1136/bmj.324.7350.1361; Dangott B, 2000, INT J SPORTS MED, V21, P13, DOI 10.1055/s-2000-8848; Davani-Davari D, 2019, FOODS, V8, DOI 10.3390/foods8030092; Demling RH, 2009, EPLASTY, V9, pE9; Deutz NEP, 2013, CLIN NUTR, V32, P704, DOI 10.1016/j.clnu.2013.02.011; Dolan E, 2019, EUR J SPORT SCI, V19, P1, DOI 10.1080/17461391.2018.1500644; Dreyer HC, 2013, J CLIN INVEST, V123, P4654, DOI 10.1172/JCI70160; Evans DC, 2014, NUTR CLIN PRACT, V29, P10, DOI 10.1177/0884533613517006; Galland L, 2010, NUTR CLIN PRACT, V25, P634, DOI 10.1177/0884533610385703; Gerber I, 2005, Eur Cell Mater, V10, P8; Gianotti L, 2010, WORLD J GASTROENTERO, V16, P167, DOI 10.3748/wjg.v16.i2.167; Gleeson M, 2012, INT J SPORT NUTR EXE, V22, P235, DOI 10.1123/ijsnem.22.4.235; Gorissen SHM, 2018, AMINO ACIDS, V50, P1685, DOI 10.1007/s00726-018-2640-5; HARLAN LC, 1990, AM J PUBLIC HEALTH, V80, P453, DOI 10.2105/AJPH.80.4.453; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Hart DW, 2001, CRIT CARE MED, V29, P1318, DOI 10.1097/00003246-200107000-00004; Havenetidis K, 2016, J ROY ARMY MED CORPS, V162, P242, DOI 10.1136/jramc-2014-000400; Hespel P, 2001, J PHYSIOL-LONDON, V536, P625, DOI 10.1111/j.1469-7793.2001.0625c.xd; Howard-Wilsher S, 2016, DISABIL HEALTH J, V9, P11, DOI 10.1016/j.dhjo.2015.08.009; Institute of Medicine, 2005, NUTR COMP RAT SHORT; Institute of Medicine  Food and Nutrition Board, 2010, DIETARY REFERENCE IN; Jager R, 2011, AMINO ACIDS, V40, P1369, DOI 10.1007/s00726-011-0874-6; Jager R, 2018, PROBIOTICS ANTIMICRO, V10, P611, DOI 10.1007/s12602-017-9354-y; Jager R, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0177-8; Jiang Q, 2014, FREE RADICAL BIO MED, V72, P76, DOI 10.1016/j.freeradbiomed.2014.03.035; Johnston APW, 2009, J STRENGTH COND RES, V23, P116, DOI 10.1519/JSC.0b013e31818efbcc; Josse AR, 2010, MED SCI SPORT EXER, V42, P1122, DOI 10.1249/MSS.0b013e3181c854f6; Jung MK, 2011, ALCOHOL CLIN EXP RES, V35, P392, DOI 10.1111/j.1530-0277.2010.01356.x; Kerksick C, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-17; Kerksick CM, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0189-4; Kreider RB, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0173-z; Layman DK, 2003, J NUTR, V133, P411, DOI 10.1093/jn/133.2.411; Layman DK, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-12; Lin E, 1998, NUTRITION, V14, P545, DOI 10.1016/S0899-9007(98)00046-X; Ljungqvist O, 2003, BRIT J SURG, V90, P400, DOI 10.1002/bjs.4066; Lucke-Wold BP, 2018, NUTR NEUROSCI, V21, P79, DOI [10.1080/1028415x.2016.1236174, 10.1080/1028415X.2016.1236174]; Maughan RJ, 2018, BRIT J SPORT MED, V52, P439, DOI 10.1136/bjsports-2018-099027; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Molfino A, 2013, AMINO ACIDS, V45, P1273, DOI 10.1007/s00726-013-1592-z; Nicastro H, 2011, AMINO ACIDS, V40, P287, DOI 10.1007/s00726-010-0636-x; Nissen SL, 2003, J APPL PHYSIOL, V94, P651, DOI 10.1152/japplphysiol.00755.2002; Nygren J, 1998, CLIN NUTR, V17, P65, DOI 10.1016/S0261-5614(98)80307-5; Nygren J, 2001, CURR OPIN CLIN NUTR, V4, P255, DOI 10.1097/00075197-200107000-00002; Olsen S, 2006, J PHYSIOL-LONDON, V573, P525, DOI 10.1113/jphysiol.2006.107359; Paddon-Jones D, 2005, AM J PHYSIOL-ENDOC M, V288, pE761, DOI 10.1152/ajpendo.00291.2004; Paddon-Jones D, 2004, J CLIN ENDOCR METAB, V89, P4351, DOI 10.1210/jc.2003-032159; Parise G, 2001, J APPL PHYSIOL, V91, P1041, DOI 10.1152/jappl.2001.91.3.1041; Parr EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088384; Phillips SM, 2012, MEAT SCI, V92, P174, DOI 10.1016/j.meatsci.2012.04.027; Rae C, 2003, P ROY SOC B-BIOL SCI, V270, P2147, DOI 10.1098/rspb.2003.2492; Raverdeau M, 2014, J IMMUNOL, V192, P2953, DOI 10.4049/jimmunol.1303245; Rayes N, 2005, AM J TRANSPLANT, V5, P125, DOI 10.1111/j.1600-6143.2004.00649.x; Reich KA, 2010, J APPL PHYSIOL, V109, P1404, DOI 10.1152/japplphysiol.00444.2010; Res PT, 2012, MED SCI SPORT EXER, V44, P1560, DOI 10.1249/MSS.0b013e31824cc363; Roberts MD, 2011, NUTRITION, V27, P659, DOI 10.1016/j.nut.2010.07.008; Schoenfeld BJ, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-53; Schricker T, 2007, CAN J ANAESTH, V54, P414, DOI 10.1007/BF03022026; Scrimgeour AG, 2014, J NEUROTRAUM, V31, P989, DOI 10.1089/neu.2013.3234; Smedley F, 2004, BRIT J SURG, V91, P983, DOI 10.1002/bjs.4578; Smith GI, 2011, CLIN SCI, V121, P267, DOI 10.1042/CS20100597; Smith-Ryan AE, 2014, MED SCI SPORT EXER, V46, P990, DOI 10.1249/MSS.0000000000000194; Sobolewski EJ, 2011, AM J LIFESTYLE MED, V5, P320, DOI 10.1177/1559827611406071; Soop M, 2004, CLIN NUTR, V23, P733, DOI 10.1016/j.clnu.2003.12.007; SOREIDE E, 1995, ACTA ANAESTH SCAND, V39, P738, DOI 10.1111/j.1399-6576.1995.tb04162.x; Stechmiller JK, 2010, NUTR CLIN PRACT, V25, P61, DOI 10.1177/0884533609358997; Stout JR, 2013, EXP GERONTOL, V48, P1303, DOI 10.1016/j.exger.2013.08.007; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Tipton KD, 2003, AM J PHYSIOL-ENDOC M, V284, pE76, DOI 10.1152/ajpendo.00234.2002; Tipton KD, 2001, AM J PHYSIOL-ENDOC M, V281, pE197, DOI 10.1152/ajpendo.2001.281.2.E197; Tipton KD, 2015, SPORTS MED, V45, pS93, DOI 10.1007/s40279-015-0398-4; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; van Vliet S, 2015, J NUTR, V145, P1981, DOI 10.3945/jn.114.204305; Wall BT, 2015, EUR J SPORT SCI, V15, P53, DOI 10.1080/17461391.2014.936326; Wall BT, 2013, J CLIN ENDOCR METAB, V98, P4872, DOI 10.1210/jc.2013-2098; Wang T, 2013, RESTOR NEUROL NEUROS, V31, P647, DOI 10.3233/RNN-130316; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Wilkinson SB, 2007, AM J CLIN NUTR, V85, P1031, DOI 10.1093/ajcn/85.4.1031; WOLFE RR, 1983, ANN SURG, V197, P163, DOI 10.1097/00000658-198302000-00007; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2014, NEUROREHAB NEURAL RE, V28, P75, DOI 10.1177/1545968313498650; Yang YF, 2012, BRIT J NUTR, V108, P1780, DOI 10.1017/S0007114511007422; Yuill KA, 2005, CLIN NUTR, V24, P32, DOI 10.1016/j.clnu.2004.06.009; Zanchi NE, 2011, AMINO ACIDS, V40, P1015, DOI 10.1007/s00726-010-0678-0; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	106	2	2	6	13	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2020	55	9					918	930		10.4085/1062-6050-550-19			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	NY4GN	WOS:000576350200007	32991705	gold, Green Published			2022-02-06	
J	Ting, CW; Lu, CH; Lan, CM; Lee, TH; Hsu, SW; Su, TM				Ting, Chun-Wei; Lu, Cheng-Hsien; Lan, Chu-Mei; Lee, Tsung-Han; Hsu, Shih-Wei; Su, Tsung-Ming			Simultaneous cranioplasty and ventriculoperitoneal shunt placement in patients with traumatic brain injury undergoing unilateral decompressive craniectomy	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Cranioplasty; Decompressive craniectomy; Hydrocephalus; Traumatic brain injury; Ventriculoperitoneal shunt	POSTTRAUMATIC HYDROCEPHALUS; INTRACRANIAL HYPERTENSION; SUBARACHNOID HEMORRHAGE; CLINICAL-FEATURES; RISK; HEMICRANIECTOMY; COMPLICATIONS; MANAGEMENT	Hydrocephalus is a common complication after decompressive craniectomy (DC) in patients with traumatic brain injury (TBI). However, the strategy of managing TBI patients with a cranial defect and hydrocephalus remains controversial. Placement of a ventriculoperitoneal shunt (VPS) in patients with a cranial defect and hydrocephalus may aggravate sinking skin flap overlying the cranial defect and result in syndrome of sinking skin flap (SSSF) that causes neurological deterioration. A retrospective analysis of 49 TBI patients who developed hydrocephalus after unilateral DC was undertaken to investigate the safety of simultaneous cranioplasty and VPS placement, and the incidence of SSSF after VPS placement. Among these patients, 17 patients underwent simultaneous cranioplasty and VPS placement, and 32 patients underwent staged cranioplasty and VPS placement. The overall complication rate was 9.3% (3/32) in staged group and 29.4% (5/17) in simultaneous group, respectively. There was no statistically significance between two study groups regarding overall complication (p = 0.11) and reoperation rate (p = 0.47). Two patients with severe brain bulging in staged group developed SSSF after placement of a nonprogrammable VPS. Our study showed that simultaneous cranioplasty and VPS placement may be safe in TBI patients with a cranial defect and hydrocephalus. However, due to the contradictory results about the safety of simultaneous cranioplasty and VPS placement in the literatures, neurosurgeons should carefully consider whether patients are suitable for such treatment. In patients planning to undergo VPS placement first, a programmable shunt may be a better choice for the possibility of SSSF after shunt placement. (C) 2020 Elsevier Ltd. All rights reserved.	[Ting, Chun-Wei; Lee, Tsung-Han; Su, Tsung-Ming] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, 123 Dapi Rd, Kaohsiung 83301, Taiwan; [Ting, Chun-Wei; Lu, Cheng-Hsien; Lee, Tsung-Han; Hsu, Shih-Wei; Su, Tsung-Ming] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Lan, Chu-Mei] Chang Jung Christian Univ, Dept Hlth Psychol, Tainan, Taiwan; [Hsu, Shih-Wei] Kaohsiung Chang Gung Mem Hosp, Dept Radiol, Kaohsiung, Taiwan		Su, TM (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, 123 Dapi Rd, Kaohsiung 83301, Taiwan.	joeting@cgmh.org.tw; chlu99@ms44.url.com.tw; cmlan@mail.cjcu.edu.tw; tsunghan927@gmail.com; hsusw@adm.cgmh.org.tw; sugaga@cgmh.org.tw					Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Annan M, 2015, BRIT J NEUROSURG, V29, P314, DOI 10.3109/02688697.2015.1012047; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Cartwright C, 2015, J CHILD NEUROL, V30, P170, DOI 10.1177/0883073814533006; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; Ganau M, 2020, J CLIN NEUROSCI, V74, P98, DOI 10.1016/j.jocn.2020.01.087; Ganau M, 2018, NEUROSURGERY, V83, pE87, DOI 10.1093/neuros/nyy205; Guresir E, 2009, J NEUROL NEUROSUR PS, V80, P799, DOI 10.1136/jnnp.2008.155630; Guresir E, 2008, NEUROSURGERY, V63, P1088, DOI 10.1227/01.NEU.0000335170.76722.B9; Han PY, 2008, J KOREAN NEUROSURG S, V43, P51, DOI 10.3340/jkns.2008.43.1.51; Heo J, 2014, J NEUROSURG, V121, P313, DOI 10.3171/2014.2.JNS131480; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; JENNETT B, 1975, LANCET, V1, P480; Jung Young Taek, 2015, Korean J Neurotrauma, V11, P93, DOI 10.13004/kjnt.2015.11.2.93; Lalou AD, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00184-6; Liao CC, 2002, J CLIN NEUROSCI, V9, P553, DOI 10.1054/jocn.2002.1116; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Meyer RM, 2017, WORLD NEUROSURG, V107, P830, DOI 10.1016/j.wneu.2017.08.034; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Nievas MNCY, 2006, NEUROL RES, V28, P139, DOI 10.1179/016164106X98008; Pachatouridis D, 2014, TURK NEUROSURG, V24, P855, DOI 10.5137/1019-5149.JTN.8871-13.1; Robles LA, 2018, WORLD NEUROSURG, V111, P99, DOI 10.1016/j.wneu.2017.12.061; Schuss P, 2015, WORLD NEUROSURG, V84, P1051, DOI 10.1016/j.wneu.2015.05.066; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2019, J CLIN NEUROSCI, V63, P62, DOI 10.1016/j.jocn.2019.02.006; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Yang XF, 2017, BRAIN INJURY, V31, P1651, DOI 10.1080/02699052.2017.1332781; Yuan Q, 2015, BRAIN INJURY, V29, P971, DOI 10.3109/02699052.2015.1004760	36	2	2	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2020	79						45	50		10.1016/j.jocn.2020.07.015			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OG5ML	WOS:000581927800008	33070916				2022-02-06	
J	Vaudreuil, R; Biondo, J; Bradt, J				Vaudreuil, Rebecca; Biondo, Jacelyn; Bradt, Joke			Music Therapy with Active-Duty Service Members: Group Protocol Description and Secondary Analysis of Protocol Evaluations	MUSIC THERAPY PERSPECTIVES			English	Article						music therapy; military; traumatic brain injury; post-traumatic stress; group protocol; evaluation	POSTTRAUMATIC-STRESS; EMOTION-REGULATION; INDIVIDUALS; PAIN	Based on the growing need for music therapy programming at military treatment facilities and clinics that specialize in the rehabilitation of service members, this article describes a music therapy group protocol and the findings of 201 post-session evaluations. In addition, we present clinical perspectives and recommendations from three music therapists who have facilitated this group protocol on four military bases across the United States. The group session outlined in the protocol is intended as an introduction to music therapy. It familiarizes service members to various music therapy experiences specifically structured to enhance feelings of safety during emotional risk-taking. In addition, the protocol functions as an initial assessment of service members' responses to the various receptive and interactive music experiences and includes psychoeducation regarding the role of music therapy in an interdisciplinary treatment model. The post-session evaluation data suggest that service members endorsed this introductory group as moderately to very helpful. Perceived benefits included the opportunity to express various emotions and increased awareness of somatic responses through music. A large number of requests for continued music therapy services following the introductory session suggest that the protocol is successful in facilitating understanding in service members regarding the potential benefits of music therapy in interdisciplinary treatment. Feedback from the music therapists indicated that the group protocol is a helpful initial experience for service members to acclimate to music therapy and for music therapists to learn about their patients' specific needs to inform subsequent treatment.	[Vaudreuil, Rebecca] Creat Forces NEA Mil Healing Arts Network, 400 7th St SW, Washington, DC 20506 USA; [Biondo, Jacelyn; Bradt, Joke] Drexel Univ, Dept Creat Arts Therapies, Philadelphia, PA USA		Vaudreuil, R (corresponding author), Creat Forces NEA Mil Healing Arts Network, 400 7th St SW, Washington, DC 20506 USA.	rebecca_vaudreuil@mail.harvard.edu	bradt, joke/C-5930-2014	bradt, joke/0000-0001-7313-9829; Vaudreuil, Rebecca/0000-0003-1108-5970	Creative Forces(R): NEA Military Healing Arts Network, an initiative of the National Endowment for the Arts (NEA); U.S. Departments of Defense and Veterans Affairs	We would like to acknowledge the men and women who bravely serve their country in the U.S. Armed Forces. The authors would also like to recognize the leadership, providers, and staff at the NICoE, Intrepid Spirit Centers, military treatment facilities, and VA hospitals. Many thanks to Hannah Bronson, MT-BC, Nathaniel McLaughlan, MA, MT-BC, and Danielle Vetro-Kalseth, MM, MT-BC, for providing insight and expertise in utilizing this protocol and evaluation. Special recognition to Julie Garrison, MA, MT-BC, Kalli Pelaccio, MT-BC, and Abigail Palmer, MT-BC for their facilitation of music therapy groups at the NICoE. This work was supported by the Creative Forces (R): NEA Military Healing Arts Network, an initiative of the National Endowment for the Arts (NEA) in partnership with the U.S. Departments of Defense and Veterans Affairs and the state and local arts agencies. This initiative serves the special needs of military patients and veterans who have been diagnosed with traumatic brain injury and psychological health conditions, as well as their families and caregivers. Administrative support for the initiative is provided by Americans for the Arts.	American Music Therapy Association, 2014, MUS THER MIL POP; Armistead-Jehle P, 2011, J COUNS DEV, V89, P81, DOI 10.1002/j.1556-6678.2011.tb00063.x; Arnsten AFT, 2015, NEUROBIOL STRESS, V1, P89, DOI 10.1016/j.ynstr.2014.10.002; Bensimon M, 2008, ART PSYCHOTHER, V35, P34, DOI 10.1016/j.aip.2007.09.002; Blanaru M, 2012, MENT ILLN, V4, P59, DOI 10.4081/mi.2012.e13; Bonn-Miller Marcel O., 2011, Cognitive Behaviour Therapy, V40, P34, DOI 10.1080/16506073.2010.525253; Bradt J, 2016, J MUSIC THER, V53, P178, DOI 10.1093/jmt/thw004; Bradt J, 2015, SUPPORT CARE CANCER, V23, P1261, DOI 10.1007/s00520-014-2478-7; Bronson H, 2018, MUSIC THER PERSPECT, V36, P195, DOI 10.1093/mtp/miy006; Cameron LD, 2018, EMOTION, V18, P465, DOI 10.1037/emo0000334; Carr C, 2012, PSYCHOL PSYCHOTHER-T, V85, P179, DOI 10.1111/j.2044-8341.2011.02026.x; de l'Etoile S. K., 2014, HDB NEUROLOGIC MUSIC, P314; Deployment Health Clinical Center (DHCC), 2017, MENT HLTH DIS PREV A; Gardiner J. C., 2014, HDB NEUROLOGIC MUSIC, P294; Gooding LF, 2019, J MUSIC THER, V56, P315, DOI 10.1093/jmt/thz010; Hegde S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00034; James M. R., 1989, MUSIC THERAPY PERSPE, V4, P28, DOI 10.1093/mtp/7.1.28; Koelsch S, 2009, ANN NY ACAD SCI, V1169, P374, DOI 10.1111/j.1749-6632.2009.04592.x; Landis-Shack Nora, 2017, Psychomusicology, V27, P334; Landon J, 2012, NEUROPSYCHOL REHABIL, V22, P391, DOI 10.1080/09602011.2011.652496; McCurry KL, 2020, BIOL PSYCHIAT-COGN N, V5, P203, DOI 10.1016/j.bpsc.2019.09.006; Moore KS, 2013, J MUSIC THER, V50, P198, DOI 10.1093/jmt/50.3.198; Pelletier CL, 2004, J MUSIC THER, V41, P192, DOI 10.1093/jmt/41.3.192; Plach T., 1980, CREATIVE USE MUSIC G; Steenkamp MM, 2020, JAMA-J AM MED ASSOC, V323, P656, DOI 10.1001/jama.2019.20825; TAYLOR DB, 1981, J MUSIC THER, V18, P62, DOI 10.1093/jmt/18.2.62; Thaut M. H., 2014, HDB NEUROLOGIC MUSIC; van der Kolk B, 2000, Dialogues Clin Neurosci, V2, P7; Vaudreuil R, 2019, DISABIL REHABIL, V41, P2333, DOI 10.1080/09638288.2018.1462412; Zoteyeva V, 2016, PSYCHOL MUSIC, V44, P307, DOI 10.1177/0305735614566841	30	2	2	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0734-6875	2053-7387		MUSIC THER PERSPECT	Music Ther. Perspect.	FAL	2020	38	2					167	177		10.1093/mtp/miaa006			11	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	PR3YF	WOS:000607173800012		hybrid			2022-02-06	
J	Xu, MJ; Wang, ZJ; Zhang, HF; Pantazis, D; Wang, HL; Li, QZ				Xu, Mengjia; Wang, Zhijiang; Zhang, Haifeng; Pantazis, Dimitrios; Wang, Huali; Li, Quanzheng			A new Graph Gaussian embedding method for analyzing the effects of cognitive training	PLOS COMPUTATIONAL BIOLOGY			English	Article							INTERVENTION; ORGANIZATION	Author summary There is still no cure and no effective drug treatment for Alzheimer's disease (AD). Hence,non-pharmacologicalcognitive intervention for patients at early stages of AD has received a lot of attention due to its non-invasive manner, safety, and scalability. Multi-domain interventions targeting memory and non-memory domains simultaneously are urgently needed for an optimal intervention effect on amnestic mild cognitive impairment (aMCI) patients. However, most of the previous multi-domain cognitive intervention studies evaluated the intervention outcomes based solely on neuropsychological assessment or simple characterization of brain anatomical structural changes. This work is the first of its kind to develop a patient-specificquantitative analysisfor the underlyingfunctionalbrain regional activity changes during the multi-domain cognitive intervention process. Specifically, we used fMRI data from 12 patients, who were trained for three months, and we developed the multi-graph unsupervised Gaussian embedding method (MG2G) to analyze these data. We obtained probabilistic changes across all the brain regions, and we found that brain regions in the default mode network and somatosensory/somatomotor hand, fronto-parietal task control, memory retrieval, and visual and dorsal attention systems had relatively large variations during the non-pharmacological training. These fundamental insights could provide effective new biomarkers for monitoring of aMCI cognitive alteration. Identifying heterogeneous cognitive impairment markers at an early stage is vital for Alzheimer's disease diagnosis. However, due to complex and uncertain brain connectivity features in the cognitive domains, it remains challenging to quantify functional brain connectomic changes during non-pharmacological interventions for amnestic mild cognitive impairment (aMCI) patients. We present aquantitativemethod for functional brain network analysis of fMRI data based on the multi-graph unsupervised Gaussian embedding method (MG2G). This neural network-based model can effectively learn low-dimensional Gaussian distributions from the original high-dimensional sparse functional brain networks, quantify uncertainties in link prediction, and discover theintrinsicdimensionality of brain networks. Using the Wasserstein distance to measure probabilistic changes, we discovered that brain regions in the default mode network and somatosensory/somatomotor hand, fronto-parietal task control, memory retrieval, and visual and dorsal attention systems had relatively large variations during non-pharmacological training, which might provide distinct biomarkers for fine-grained monitoring of aMCI cognitive alteration. An important finding of our study is the ability of the new method to capture subtle changes for individual patients before and after short-term intervention. More broadly, the MG2G method can be used in studying multiple brain disorders and injuries, e.g., in Parkinson's disease or traumatic brain injury (TBI), and hence it will be useful to the wider neuroscience community.	[Xu, Mengjia] Brown Univ, Div Appl Math, Providence, RI 02912 USA; [Xu, Mengjia; Pantazis, Dimitrios] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Wang, Zhijiang; Zhang, Haifeng; Wang, Huali] Peking Univ, Inst Mental Hlth, Hosp 6, Beijing, Peoples R China; [Wang, Zhijiang; Zhang, Haifeng; Wang, Huali] Peking Univ, Natl Clin Res Ctr Mental Disorders, Minist Hlth, Beijing, Peoples R China; [Wang, Zhijiang; Zhang, Haifeng; Wang, Huali] Peking Univ, Key Lab Mental Hlth, Minist Hlth, Beijing, Peoples R China; [Wang, Zhijiang; Zhang, Haifeng; Wang, Huali] Beijing Municipal Key Lab Translat Res Diag & Tre, Beijing, Peoples R China; [Wang, Zhijiang; Li, Quanzheng] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Wang, Zhijiang; Li, Quanzheng] Harvard Med Sch, Boston, MA 02115 USA		Wang, HL (corresponding author), Peking Univ, Inst Mental Hlth, Hosp 6, Beijing, Peoples R China.; Wang, HL (corresponding author), Peking Univ, Natl Clin Res Ctr Mental Disorders, Minist Hlth, Beijing, Peoples R China.; Wang, HL (corresponding author), Peking Univ, Key Lab Mental Hlth, Minist Hlth, Beijing, Peoples R China.; Wang, HL (corresponding author), Beijing Municipal Key Lab Translat Res Diag & Tre, Beijing, Peoples R China.; Li, QZ (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.; Li, QZ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	huali_wang@bjmu.edu.cn; li.quanzheng@mgh.harvard.edu		Li, Quanzheng/0000-0002-9651-5820; Wang, Zhijiang/0000-0003-4045-419X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 HL1163232]; Beijing Municipal Science & Technology CommissionBeijing Municipal Science & Technology Commission [Z161100000516001, D171100008217007]; J-Clinic for Machine Learning in Health award at MIT	M.X. received partial support from NIH grant U01 HL1163232; Z.W., H.Z. and H.W. were supported by Beijing Municipal Science & Technology Commission (No. Z161100000516001, D171100008217007). M.X. and D.P. were supported by a J-Clinic for Machine Learning in Health award at MIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Andrieu S, 2017, LANCET NEUROL, V16, P377, DOI 10.1016/S1474-4422(17)30040-6; [Anonymous], 2017, JLSRF, V3, pA104; Arbabshirani MR, 2014, NEUROIMAGE, V102, P294, DOI 10.1016/j.neuroimage.2014.07.045; Ashburner J., 2016, SPM12 MANUAL; Asllani M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau9403; Bengio Y, 2004, NEURAL COMPUT, V16, P2197, DOI 10.1162/0899766041732396; Benson AR, 2016, SCIENCE, V353, P163, DOI 10.1126/science.aad9029; Bojchevski A., 2017, DEEP GAUSSIAN EMBEDD; Cai HY, 2018, IEEE T KNOWL DATA EN, V30, P1616, DOI 10.1109/TKDE.2018.2807452; Cao WF, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00070; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Grover A, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P855, DOI 10.1145/2939672.2939754; Hampstead BM, 2011, NEUROREHAB NEURAL RE, V25, P210, DOI 10.1177/1545968310382424; He S., 2015, P623, DOI DOI 10.1145/2806416.2806502; Liang B, 2015, INT CONF SOFTW ENG, P894, DOI 10.1109/ICSESS.2015.7339198; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Ong SS, 2018, JAMA NEUROL, V75, P650, DOI 10.1001/jamaneurol.2018.0602; Ou MD, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1105, DOI 10.1145/2939672.2939751; Perozzi B., 2014, P 20 ACM SIGKDD INT, P701, DOI DOI 10.1145/2623330.2623732; Petersen Ronald C, 2016, Continuum (Minneap Minn), V22, P404, DOI 10.1212/CON.0000000000000313; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rizzi L, 2018, BRAIN RES, V1678, P27, DOI 10.1016/j.brainres.2017.10.008; Rosenthal G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04614-w; Valk SL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700489; van Charante EPM, 2016, LANCET, V388, P797, DOI 10.1016/S0140-6736(16)30950-3; Vilnis L., 2014, ARXIV14126623, P1; Waldemar G, 2011, NEUROEPIDEMIOLOGY, V36, P52, DOI 10.1159/000322942; Wu Zonghan, 2019, ARXIV190100596, P1; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zhang HF, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0385-x; Zhu DY, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P2827, DOI 10.1145/3219819.3220052	33	2	2	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-734X	1553-7358		PLOS COMPUT BIOL	PLoS Comput. Biol.	SEP	2020	16	9							e1008186	10.1371/journal.pcbi.1008186			21	Biochemical Research Methods; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Mathematical & Computational Biology	NU7XO	WOS:000573853000005	32941425	gold, Green Published			2022-02-06	
J	McGeary, DD; Resick, PA; Penzien, DB; Eapen, BC; Jaramillo, C; McGeary, CA; Nabity, PS; Peterson, AL; Young-McCaughan, S; Keane, TM; Reed, D; Moring, J; Sico, JJ; Pangarkar, SS; Houle, TT				McGeary, Donald D.; Resick, Patricia A.; Penzien, Donald B.; Eapen, Blessen C.; Jaramillo, Carlos; McGeary, Cindy A.; Nabity, Paul S.; Peterson, Alan L.; Young-McCaughan, Stacey; Keane, Terence M.; Reed, David; Moring, John; Sico, Jason J.; Pangarkar, Sanjog S.; Houle, Timothy T.		Consortium Alleviate PTSD	Reason to doubt the ICHD-3 7-day inclusion criterion for mild TBI-related posttraumatic headache: A nested cohort study	CEPHALALGIA			English	Article						Posttraumatic headache; survival analysis; ICHD-3 criteria; head injury	TRAUMATIC BRAIN-INJURY; STRESS-DISORDER; NATURAL-HISTORY; SELF-EFFICACY; US SOLDIERS; PAIN; DEPRESSION; SEVERITY; SLEEP	Background Posttraumatic headache is difficult to define and there is debate about the specificity of the 7-day headache onset criterion in the current definition. There is limited evidence available to guide decision making about this criterion. Method A nested cohort study of 193 treatment-seeking veterans who met criteria for persistent headache attributed to mild traumatic injury to the head, including some veterans with delayed headache onset up to 90 days post-injury, was undertaken. Survival analysis examined the proportion of participants reporting headache over time and differences in these proportions based on sex, headache phenotype, and mechanism of injury. Result 127 participants (66%; 95% CI: 59-72%) reported headache onset within 7 days of head injury and 65 (34%) reported headache onset between 8 days and 3 months after head injury. Fourteen percent of participants reported pre-existing migraine before head injury, and there was no difference in the proportion of veterans with pre-existing migraine based on headache onset. Headache onset times were not associated with sex, headache phenotype, or mechanism of injury. There were no significant differences in proportion of veterans with headache onset within 7 days of head injury based on headache phenotype (70% migraine onset within 7 days, 70% tension-type headache within 7 days, 56% cluster headache within 7 days;p >= .364). Similar findings were observed for head injury (64% blast, 60% blunt;p = .973). There were no significant differences observed between headache onset groups for psychiatric symptoms (Posttraumatic Stress Disorder Checklist forDSM-5 = 1.3, 95% CI = -27.5, 30.1; Patient Health Questionnaire-9 Item = 3.5, 95% CI = -6.3, 3.7; Generalized Anxiety Disorder Screener = 6.5, 95% CI = -2.7, 15.6). Conclusions Although most of the sample reported headache onset within 7 days of head injury, one-third experienced an onset outside of the diagnostic range. Additionally, veterans with headache onset within 7 days of head injury were not meaningfully different from those with later onset based on sex, headache phenotype, or mechanism of head injury. The ICHD-3 diagnostic criteria for 7-day headache onset should be expanded to 3 months. ClinicalTrials.gov Identifier NCT02419131	[McGeary, Donald D.; McGeary, Cindy A.; Nabity, Paul S.; Peterson, Alan L.; Young-McCaughan, Stacey; Reed, David; Moring, John] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat & Behav Sci, San Antonio, TX 78229 USA; [McGeary, Donald D.; Jaramillo, Carlos] Univ Texas Hlth Sci Ctr San Antonio, Dept Rehabil Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [McGeary, Donald D.; Jaramillo, Carlos; McGeary, Cindy A.; Nabity, Paul S.; Peterson, Alan L.; Young-McCaughan, Stacey; Moring, John] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Resick, Patricia A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Penzien, Donald B.] Wake Forest Univ, Dept Psychiat & Behav Med, Winston Salem, NC 27101 USA; [Penzien, Donald B.] Wake Forest Univ, Dept Neurol, Winston Salem, NC 27101 USA; [Eapen, Blessen C.; Pangarkar, Sanjog S.] Greater Los Angeles Vet Hlth Care Syst, Los Angeles, CA USA; [Eapen, Blessen C.; Pangarkar, Sanjog S.] Univ Calif Los Angeles, David Geffen Sch Med, Phys Med & Rehabil, Los Angeles, CA 90095 USA; [Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Keane, Terence M.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Keane, Terence M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Sico, Jason J.] Yale Sch Med, Dept Neurol, New Haven, CT USA; [Sico, Jason J.] VA Connecticut Healthcare Syst, Headache Ctr Excellence, New Haven, CT USA; [Houle, Timothy T.] Massachusetts Gen Hosp, Dept Anaesthesia, Boston, MA 02114 USA		McGeary, DD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Rehabil Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	mcgeary@uthscsa.edu	Houle, Timothy T/I-7649-2019; Penzien, Donald B/H-9693-2017	Penzien, Donald B/0000-0003-4913-7158; Reed, II, David/0000-0003-0109-5999	U.S. Department of Defense, Defense Health Program [W81XWH-13-2-0065]; U.S. Department of Defense, Psychological Health and Traumatic Brain Injury Research Program (PH/TBI RP)United States Department of Defense [W81XWH-13-2-0065]; U.S. Department of Veterans Affairs, Office of Research & Development, Clinical Science Research & Development Service [I01CX001136-01]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by Consortium to Alleviate PTSD award numbers W81XWH-13-2-0065 from the U.S. Department of Defense, Defense Health Program, Psychological Health and Traumatic Brain Injury Research Program (PH/TBI RP), and I01CX001136-01 from the U.S. Department of Veterans Affairs, Office of Research & Development, Clinical Science Research & Development Service.	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Anarte E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031587; Arbour C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-032706; Archer KR, 2012, J TRAUMA ACUTE CARE, V72, P1068, DOI 10.1097/TA.0b013e3182452df5; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Baker VB, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0943-2; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; BORGAN O, 1990, SCAND J STAT, V17, P35; Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N; Buture Alina, 2016, Anesth Pain Med, V6, pe35190, DOI 10.5812/aapm.35190; de Leeuw R, 2005, HEADACHE, V45, P1365, DOI 10.1111/j.1526-4610.2005.00269.x; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Ferroni P, 2019, CURR MED CHEM, V26, P6188, DOI 10.2174/092986732634191112142448; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; Gatchel RJ, 2014, AM PSYCHOL, V69, P119, DOI 10.1037/a0035514; Getsoian SL, 2020, BMJ OPEN, V10, pe035245; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Greene NR, 2018, HEADACHE, V58, P581, DOI 10.1111/head.13273; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Houle TT, 2006, HEADACHE, V46, P983, DOI 10.1111/j.1526-4610.2006.00470.x; Houle TT, 2017, HEADACHE, V57, P1041, DOI 10.1111/head.13137; Kliegman RM, 2017, PEDIATR CLIN N AM, V64, P1, DOI 10.1016/j.pcl.2016.08.002; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kumar RG, 2018, BRAIN INJURY, V32, P383, DOI 10.1080/02699052.2018.1427888; Labastida-Ramirez A, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01122-5; Langdon R, 2018, PEDIATR ANN, V47, pE61, DOI 10.3928/19382359-20180131-01; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; LIPTON RB, 1993, CEPHALALGIA, V13, P29, DOI 10.1177/0333102493013S1207; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Ludvigsson ML, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000018130; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; McGeary D, 2011, J CLIN PSYCHOL MED S, V18, P155, DOI 10.1007/s10880-011-9236-5; MORIN CM, 1993, PSYCHOL AGING, V8, P463, DOI 10.1037/0882-7974.8.3.463; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Peck KR, 2015, HEADACHE, V55, P1102, DOI 10.1111/head.12633; Penzien D.B., 2013, STRUCTURED DIAGNOSTI; Register-Mihalik JK, 2020, CURR PAIN HEADACHE R, V24, DOI 10.1007/s11916-020-00870-y; Roper LS, 2017, J PAIN RES, V10, P1991, DOI 10.2147/JPR.S129808; Rosenthal JF, 2013, HEADACHE, V53, P1564, DOI 10.1111/head.12200; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Stilling J, 2020, J NEUROTRAUM, V37, P312, DOI 10.1089/neu.2019.6692; Subbarao BS, 2020, POSTCRANIOTOMY HEADA; Suri P, 2019, J PAIN, V20, P97, DOI 10.1016/j.jpain.2018.08.002; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486	55	2	2	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	OCT	2020	40	11					1155	1167	0333102420953109	10.1177/0333102420953109		AUG 2020	13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NV7OO	WOS:000565263800001	32867535				2022-02-06	
J	Pierrat, B; Carroll, L; Merle, F; MacManus, DB; Gaul, R; Lally, C; Gilchrist, MD; Annaidh, AN				Pierrat, Baptiste; Carroll, Louise; Merle, Florence; MacManus, David B.; Gaul, Robert; Lally, Caitriona; Gilchrist, Michael D.; Ni Annaidh, Aisling			Mechanical Characterization and Modeling of the Porcine Cerebral Meninges	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						dura mater; mechanical properties; multiaxial testing; bulge inflation; SALS; meninges; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HUMAN DURA MATER; INTRACRANIAL-PRESSURE; TISSUE; IMPACT; EPIDEMIOLOGY; BIOMECHANICS; BEHAVIOR; MOTION; SCALP	The cerebral meninges, made up of thedura, arachnoid, andpia mater, is a tri-layer membrane that surrounds the brain and the spinal cord and has an important function in protecting the brain from injury. Understanding its mechanical behavior is important to ensure the accuracy of finite element (FE) head model simulations which are commonly used in the study of traumatic brain injury (TBI). Mechanical characterization of freshly excised porcinedura-arachnoid mater(DAM) was achieved using uniaxial tensile testing and bulge inflation testing, highlighting the dependency of the identified parameters on the testing method. Experimental data was fit to the Ogden hyperelastic material model with best fit material parameters of mu = 450 +/- 190 kPa and alpha = 16.55 +/- 3.16 for uniaxial testing, and mu = 234 +/- 193 kPa and alpha = 8.19 +/- 3.29 for bulge inflation testing. The average ultimate tensile strength of the DAM was 6.91 +/- 2.00 MPa (uniaxial), and the rupture stress at burst was 2.08 +/- 0.41 MPa (inflation). A structural analysis using small angle light scattering (SALS) revealed that while local regions of highly aligned fibers exist, globally, there is no preferred orientation of fibers and the cerebral DAM can be considered to be structurally isotropic. This confirms the results of the uniaxial mechanical testing which found that there was no statistical difference between samples tested in the longitudinal and transversal direction (p= 0.13 for mu,p= 0.87 for alpha). A finite element simulation of a craniotomy procedure following brain swelling revealed that the mechanical properties of the meninges are important for predicting accurate stress and strain fields in the brain and meninges. Indeed, a simulation using a common linear elastic representation of the meninges was compared to the present material properties (Ogden model) and the intracranial pressure was found to differ by a factor of 3. The current study has provided researchers with primary experimental data on the mechanical behavior of the meninges which will further improve the accuracy of FE head models used in TBI.	[Pierrat, Baptiste; Carroll, Louise; Merle, Florence; MacManus, David B.; Gilchrist, Michael D.; Ni Annaidh, Aisling] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Pierrat, Baptiste] Univ Jean Monnet, Univ Lyon, Ctr CIS, Mines St Etienne,INSERM U059 Sainbiose, St Etienne, France; [MacManus, David B.] Dublin City Univ, Sch Mech & Mfg Engn, Dublin, Ireland; [Gaul, Robert; Lally, Caitriona] Trinity Coll Dublin, Trinity Ctr Biomed Engn, Dublin, Ireland; [Ni Annaidh, Aisling] Univ Coll Dublin, UCD Charles Inst Dermatol, Sch Med & Med Sci, Dublin, Ireland		Annaidh, AN (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.; Annaidh, AN (corresponding author), Univ Coll Dublin, UCD Charles Inst Dermatol, Sch Med & Med Sci, Dublin, Ireland.	aisling.niannaidh@ucd.ie		Gaul, Robert/0000-0001-6693-8286; MacManus, David/0000-0003-2959-698X; Lally, Caitriona/0000-0003-4141-1685			Avril S., 2017, MAT PARAMETER IDENTI; Blaber J, 2015, EXP MECH, V55, P1105, DOI 10.1007/s11340-015-0009-1; Budday S, 2020, ARCH COMPUT METHOD E, V27, P1187, DOI 10.1007/s11831-019-09352-w; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; BYLSKI DI, 1986, J BIOMECH, V19, P19, DOI 10.1016/0021-9290(86)90105-3; Cavinato C, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00169; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chauvet D, 2010, NEUROSURG REV, V33, P287, DOI 10.1007/s10143-010-0261-x; De Kegel D, 2018, J MECH BEHAV BIOMED, V79, P122, DOI 10.1016/j.jmbbm.2017.12.023; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Faul MXL., 2010, TRAUMATIC BRAIN INJU, P2002; Frink M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/797383; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Garo A, 2007, BIORHEOLOGY, V44, P51; Gaul RT, 2017, J MECH BEHAV BIOMED, V75, P359, DOI 10.1016/j.jmbbm.2017.07.036; Gilchrist MD, 2001, INT J CRASHWORTHINES, V6, P253, DOI 10.1533/cras.2001.0176; Haimann MCJ, 1998, J ANAT, V192, P99; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S., 2007, PREDICTORS TRAUMATIC; Lang GE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0123; Lari DR, 2012, EXP EYE RES, V94, P128, DOI 10.1016/j.exer.2011.11.017; Li XG, 2016, INT J IMPACT ENG, V91, P56, DOI 10.1016/j.ijimpeng.2015.12.010; Li XG, 2017, BIOMECH MODEL MECHAN, V16, P823, DOI 10.1007/s10237-016-0855-5; Li ZG, 2011, ANN BIOMED ENG, V39, P2984, DOI 10.1007/s10439-011-0409-z; MacManus DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13727-z; MacManus DB, 2017, ACTA BIOMATER, V57, P384, DOI 10.1016/j.actbio.2017.05.022; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; Mazgajczyk E, 2012, ACTA BIOENG BIOMECH, V14, P51; MCGARVEY KA, 1984, BIOMATERIALS, V5, P109, DOI 10.1016/0142-9612(84)90011-5; Morocz IA, 2001, EXP NEUROL, V168, P96, DOI 10.1006/exnr.2000.7596; O'Leary SA, 2013, J BIOMECH, V46, P1955, DOI 10.1016/j.jbiomech.2013.05.003; Ogden R.W., 1997, NONLINEAR ELASTIC DE; Pascoletti G, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00419; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pogoda K, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/075002; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Rashid B, 2012, J MECH BEHAV BIOMED, V14, P113, DOI 10.1016/j.jmbbm.2012.04.005; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; Reddy JN, 2017, ENERGY PRINCIPLES VA; RIVLIN RS, 1951, PHILOS TR R SOC S-A, V243, P251, DOI 10.1098/rsta.1951.0004; Romo A, 2014, J BIOMECH, V47, P607, DOI 10.1016/j.jbiomech.2013.12.012; Runza M, 1999, ANESTH ANALG, V88, P1317, DOI 10.1097/00000539-199906000-00022; Syed H, 2016, P I MECH ENG H, V230, P111, DOI 10.1177/0954411915619952; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Trotta A, 2019, J MECH BEHAV BIOMED, V100, DOI 10.1016/j.jmbbm.2019.103381; Trotta A, 2018, J BIOMECH, V75, P28, DOI 10.1016/j.jbiomech.2018.05.003; Trotta A, 2018, ANN BIOMED ENG, V46, P831, DOI 10.1007/s10439-018-2003-0; van Noort R, 1981, Clin Phys Physiol Meas, V2, P197, DOI 10.1088/0143-0815/2/3/003; VANNOORT R, 1981, BIOMATERIALS, V2, P41, DOI 10.1016/0142-9612(81)90086-7; Verschueren P., 2013, J BIOMECH, V10, P23; Volino P, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1559755.1559762; Walsh DR, 2018, ACTA BIOMATER, V80, P237, DOI 10.1016/j.actbio.2018.09.004; Weickenmeier J, 2017, J ELASTICITY, V129, P197, DOI 10.1007/s10659-016-9606-1; Yang King H, 2006, Stapp Car Crash J, V50, P429	59	2	2	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	AUG 31	2020	8								801	10.3389/fbioe.2020.00801			16	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	NQ0EN	WOS:000570542100001	32984262	Green Published, gold			2022-02-06	
J	Cantu, D; Croker, D; Shacham, S; Tamir, S; Dulla, C				Cantu, David; Croker, Danielle; Shacham, Sharon; Tamir, Sharon; Dulla, Chris			In vivo KPT-350 treatment decreases cortical hyperexcitability following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; epilepsy; neuronal hyperexcitability; XPO1 inhibitors; selective inhibitors of nuclear export	NUCLEAR EXPORT; POSTTRAUMATIC EPILEPSY; HEAD-INJURY; MITOCHONDRIAL DYSFUNCTION; IMPACT; INHIBITION; ACTIVATION; EXPRESSION; EXCITATION; MEDIATORS	Primary Objective We tested whether KPT-350, a novel selective inhibitor of nuclear export, could attenuate cortical network hyperexcitability, a major risk factor for developing post-traumatic epilepsy (PTE) following traumatic brain injury (TBI). Research Design All mice in this study underwent TBI and were subsequently treated with either KPT-350 or vehicle during the post-injury latent period. Half of the animal cohort was used for electrophysiology while the other half was used for immunohistochemical analysis. Methods and Procedures TBI was induced using the controlled cortical impact (CCI) model. Cortical network activity was recorded by evoking field potentials from deep layers of the cortex and analyzed using Matlab software. Immunohistochemistry coupled with fluorescence microscopy and Image J analysis detected changes in neuronal and glial markers. Main Outcomes and Results KPT-350 attenuated TBI-associated epileptiform activity and restored disrupted input-output responses in cortical brain slices. In vivo KPT-350 treatment reduced the loss of parvalbumin-(+) GABAergic interneurons after CCI but did not significantly change CCI-induced loss of somatostatin-(+) GABAergic interneurons, nor did it reduce reactivity of GFAP and Iba1 glial markers. Conclusion KPT-350 can prevent cortical hyperexcitability and reduce the loss of parvalbumin-(+) GABAergic inhibitory neurons, making it a potential therapeutic option for preventing PTE.	[Cantu, David; Croker, Danielle; Dulla, Chris] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Shacham, Sharon; Tamir, Sharon] Karyopharm Therapeut Inc, Newton, MA USA		Dulla, C (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	chris.dulla@tufts.edu			Karyopharm Therapeutics	This work was supported by Karyopharm Therapeutics.	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Chen Y, 2006, REGUL PEPTIDES, V137, P4, DOI 10.1016/j.regpep.2006.06.016; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dulla CG, 2012, NEUROBIOL DIS; Fan L, 1995, BRAIN RES MOL BRAIN, V30, DOI [10.1016/0169-328x(94)00287-o, DOI 10.1016/0169-328X(94)00287-O]; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Guttler T, 2011, EMBO J, V30, P3457, DOI 10.1038/emboj.2011.287; Haines JD, 2015, NAT NEUROSCI, V18, P511, DOI 10.1038/nn.3953; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hightower RM, 2020, MOL THER, V28, P189, DOI 10.1016/j.ymthe.2019.08.016; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Krajewska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024341; Kudo N, 1997, J BIOL CHEM, V272, P29742, DOI 10.1074/jbc.272.47.29742; Larner SF, 2005, J NEUROCHEM, V94, P97, DOI 10.1111/j.1471-4159.2005.03172.x; Li AH, 2013, J MOL NEUROSCI, V51, P208, DOI 10.1007/s12031-013-9994-7; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Tajiri N, 2016, CNS NEUROSCI THER, V22, P306, DOI 10.1111/cns.12501; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Turner JG, 2008, CURR MED CHEM, V15, P2648, DOI 10.2174/092986708786242859; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Walker KR, 2012, J NEUROSCI, V32, P10423, DOI 10.1523/JNEUROSCI.5491-11.2012; Ward JL, 2011, J TRAUMA, V70, P1471, DOI 10.1097/TA.0b013e31821c38bd; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Yang L, 2007, J NEUROPHYSIOL, V97, P178, DOI 10.1152/jn.01374.2005	44	2	2	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 18	2020	34	11					1489	1496		10.1080/02699052.2020.1807056		AUG 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NR9QK	WOS:000563356600001	32853051				2022-02-06	
J	Hammer, E; Hetzel, S; Pfaller, A; McGuine, T				Hammer, Erin; Hetzel, Scott; Pfaller, Adam; McGuine, Tim			Longitudinal Assessment of Depressive Symptoms After Sport-Related Concussion in a Cohort of High School Athletes	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; sport; high school; depression; sex	OUTCOMES; EPIDEMIOLOGY; PREVALENCE	Background: The long-term effect of sport-related concussion on mood in adolescent athletes is largely unknown. Hypothesis: Longitudinal measures of depression will worsen acutely after sport-related concussion and improve with concussion symptom resolution. Study Design: Prospective cohort study. Level of Evidence: Level 3. Methods: A population-based sample of 2160 high school athletes from 31 urban, suburban, and rural high schools completed preseason baseline concussion symptom evaluation and Patient Health Questionnaire-9 (PHQ-9) assessments over 2 years. Athletic trainers recorded onset of sport-related concussion, and concussed athletes completed the PHQ-9 assessment within 24 to 72 hours, 7 days, date of return to sport, 3 months, 6 months, and 12 months after sport-related concussion. Scores at each time point were compared to baseline with mixed-effects models and repeated-measures analysis of variance. Sex-based differences were assessed using mixed-effect models. Results: Of the 2160 athletes enrolled in the study, 125 (5.8%; 80 males, 45 females) sustained a sport-related concussion. PHQ-9 scores worsened from baseline at 24 to 72 hours (+1.05; 95% CI, 0.26-1.84; P = 0.003) and 7 days (+0.91; 95% CI, 0.23-1.60; P = 0.006). However, PHQ-9 scores improved from baseline to date of return to sport (-1.38; 95% CI, -2.20 to -0.55; P < 0.001), 3 months (-1.08; 95% CI, -1.88 to -0.28; P = 0.003), 6 months (-1.19; 95% CI, -2.04 to -0.34; P = 0.001), and 12 months after sport-related concussion (-0.76; 95% CI, -1.43 to -0.08; P = 0.028). Female athletes reported more severe concussion symptoms 24 to 72 hours after sport-related concussion compared with male athletes (female, 20.5 [interquartile range (IQR), 10.0-36.2]; male, 9.0 [IQR, 4.0-19.5]; P = 0.003). Neither PHQ-9 scores nor change in PHQ-9 scores differed between male and female athletes at any time point. Conclusion: Sport-related concussion did not worsen longitudinal measures of depressed mood in this cohort of high school athletes.	[Hammer, Erin] Univ Wisconsin, Dept Orthoped & Rehabil, 1685 Highland Ave, Madison, WI 53705 USA; [Hammer, Erin; Pfaller, Adam; McGuine, Tim] Univ Wisconsin, Dept Family Med & Community Hlth, Madison, WI 53705 USA; [Hetzel, Scott] Univ Wisconsin, Biostat & Med Informat, Madison, WI 53705 USA		Hammer, E (corresponding author), Univ Wisconsin, Dept Orthoped & Rehabil, 1685 Highland Ave, Madison, WI 53705 USA.	ehammer@uwhealth.org					Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Costello EJ, 2006, J CHILD PSYCHOL PSYC, V47, P1263, DOI 10.1111/j.1469-7610.2006.01682.x; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Korczak DJ, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2266; Kremer P, 2014, J SCI MED SPORT, V17, P183, DOI 10.1016/j.jsams.2013.03.012; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; R Core Team, 2016, R LANG ENV STAT COMP; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Wolanin A, 2016, BRIT J SPORT MED, V50, P167, DOI 10.1136/bjsports-2015-095756; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yang MN, 2019, AM J HEALTH BEHAV, V43, P258, DOI 10.5993/AJHB.43.2.3; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	26	2	2	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN	2021	13	1					31	36	1941738120938010	10.1177/1941738120938010		AUG 2020	6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	PD7GD	WOS:000563682700001	32857687	Green Published			2022-02-06	
J	Limphaibool, N; Iwanowski, P; Kozubski, W; Swidzinski, T; Frankowska, A; Kaminska, I; Linkowska-Swidzinska, K; Sekula, A; Swidzinski, P; Maciejewska-Szaniec, Z; Maciejewska, B				Limphaibool, Nattakarn; Iwanowski, Piotr; Kozubski, Wojciech; Swidzinski, Teodor; Frankowska, Anna; Kaminska, Ilona; Linkowska-Swidzinska, Kamila; Sekula, Alicja; Swidzinski, Piotr; Maciejewska-Szaniec, Zofia; Maciejewska, Barbara			Subjective and Objective Assessments of Post-traumatic Olfactory Dysfunction	FRONTIERS IN NEUROLOGY			English	Article						olfactometry; olfactory dysfunction; olfactory evaluation; olfactory event-related potentials; traumatic brain injury	TRAUMATIC BRAIN-INJURY	Introduction:Traumatic brain injuries are the most common cause of olfactory dysfunction. Deficits in olfaction may be conductive or neurosensory in nature, with varying degrees of impairment resulting in a diminished quality of life and an increased risk for personal injury among patients. The aim of this research is to evaluate the results of the subjective and objective quantitative examinations of olfactory function in a group of patients with post-traumatic anosmia in order to predict its value in identifying olfactory deficits in clinical practice. Materials and Methods:The present study included 38 patients who reported anosmia or hyposmia caused by a traumatic head injury, and a group of 31 age- and sex-matched controls without olfactory dysfunction or prior history of head injury. The comparison of odor perception and identification of two oils (mint and anise) was assessed with the use of blast olfactometry with cortical olfactory event-related potentials. Results:Subjective olfactory tests revealed anosmia or hyposmia in 94% of patients with head injury-related olfactory dysfunction. Objective tests revealed olfactory event-related potentials from cranial nerve I produced by the stimulation with both mint and anise in 20 patients (52.6%). Olfactory event-related potentials from cranial nerve V produced by the stimulation with mint were registered in 26 patients (68.4%). The lack of any responses, from both cranial nerve I and V, was found in 12 patients (32% of cases). Conclusions:Findings from our study indicate the application of both subjective and objective examinations in the evaluation of patients with olfactory impairment. In the diagnosis of post-traumatic anosmia or hyposmia, objective examinations are particularly useful when the patients' level of cognition may be impaired or when subjects may be exaggerating their olfactory defects for a secondary gain. The diagnosis of damage to the olfactory system, specifically in the receptive part of the olfactory pathway, can be established in patients who showed reduced amplitudes or absent cortical responses in addition to absent odor identification and perception threshold in the subjective examination.	[Limphaibool, Nattakarn; Iwanowski, Piotr; Kozubski, Wojciech] Poznan Univ Med Sci, Dept Neurol, Poznan, Poland; [Swidzinski, Teodor] Poznan Univ Med Sci, Dept Biophys, Poznan, Poland; [Frankowska, Anna] Poznan Univ Med Sci, Dept Med Law Org & Management Healthcare, Poznan, Poland; [Kaminska, Ilona; Sekula, Alicja; Swidzinski, Piotr; Maciejewska, Barbara] Poznan Univ Med Sci, Dept Phoniatr & Audiol, Poznan, Poland; [Linkowska-Swidzinska, Kamila] Poznan Univ Med Sci, Dept Conservat Dent & Endodont, Poznan, Poland; [Maciejewska-Szaniec, Zofia] Poznan Univ Med Sci, Dept Temporomandibular Joint Disorders, Poznan, Poland		Limphaibool, N (corresponding author), Poznan Univ Med Sci, Dept Neurol, Poznan, Poland.	tongn.lim@gmail.com		Kozubski, Wojciech/0000-0003-2777-261X			Bakker K, 2016, BRAIN INJURY, V30, P191, DOI 10.3109/02699052.2015.1089597; Caminiti F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103151; Daramola OO, 2015, CURR OPIN OTOLARYNGO, V23, P8, DOI 10.1097/MOO.0000000000000118; Doty Richard L, 2018, World J Otorhinolaryngol Head Neck Surg, V4, P11, DOI 10.1016/j.wjorl.2018.03.001; Doty Richard L, 2015, World J Otorhinolaryngol Head Neck Surg, V1, P28, DOI 10.1016/j.wjorl.2015.09.007; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Howell Jessica, 2018, World J Otorhinolaryngol Head Neck Surg, V4, P39, DOI 10.1016/j.wjorl.2018.02.001; Huttenbrink KB, 2013, DTSCH ARZTEBL INT, V110, P1, DOI 10.3238/arztebl.2013.0001; Invitto S, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00272; Reden J, 2016, EUR ARCH OTO-RHINO-L, V273, P927, DOI 10.1007/s00405-015-3682-x; Renner B, 2012, EXP BRAIN RES, V219, P13, DOI 10.1007/s00221-012-3063-2; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Swidzinski T, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9583495; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; Upadhyay UD, 2004, OTOLARYNG CLIN N AM, V37, P1185, DOI 10.1016/j.otc.2004.05.003; Xydakis MS, 2015, NEUROLOGY, V84, P1559, DOI 10.1212/WNL.0000000000001475; Yang Jingpu, 2016, Curr Otorhinolaryngol Rep, V4, P130, DOI 10.1007/s40136-016-0120-6	20	2	2	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 26	2020	11								970	10.3389/fneur.2020.00970			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NP9RS	WOS:000570508200001	32982956	gold, Green Published			2022-02-06	
J	Miller, GF; DePadilla, L; Jones, SE; Bartholow, BN; Sarmiento, K; Breiding, MJ				Miller, Gabrielle F.; DePadilla, Lara; Jones, Sherry Everett; Bartholow, Brad N.; Sarmiento, Kelly; Breiding, Matthew J.			The Association Between Sports- or Physical Activity-Related Concussions and Suicidality Among US High School Students, 2017	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						suicide; traumatic brain injury; moderation	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; RISK; IDEATION; CHILDREN; RECOMMENDATIONS; DEPRESSION; OUTCOMES; ANXIETY; ABUSE	Background: This study examined the association between sports- or physical activity-related concussions and having seriously considered attempting suicide, made a suicide plan, or attempted suicide (ie, suicidality), and tested potential moderators of the association. Hypothesis: Risk factors such as persistent feelings of sadness or hopelessness, low academic grades, few hours of sleep, and current alcohol or marijuana use will increase the odds of suicidality among those who self-reported sports- or physical activity-related concussions, while protective factors such as physical activity and having played on a sports team will decrease the odds. Study Design: Cross-sectional study. Level of Evidence: Level 4. Methods: This study used data from the 2017 Youth Risk Behavior Survey, a biennial, school-based, nationally representative survey of US students in grade levels 9 to 12 (N = 14,765). Logistic regression models examined associations between self-reported sports- or physical activity-related concussions and suicidality among the students, and whether physical activity, having played on a sports team, persistent feelings of sadness or hopelessness, academic grades, hours of sleep, or current alcohol or marijuana use moderated those associations. Results: Sports- or physical activity-related concussions were found to be associated with suicidality. The associations remained significant in models that adjusted for demographic characteristics, and they did not appear to be moderated by physical activity, having played on sports team, academic grades, or sleep. Conclusions: Given the findings of this study and others, health care providers are advised to ask students who have experienced a concussion about their emotional well-being as part of their symptom-based assessment, using validated, age- appropriate concussion symptom scales. Comprehensively assessing students who have experienced a sports- or physical activity-related concussion for persistent feelings of sadness or hopelessness may alert providers to thoughts of suicidal ideation and will allow for earlier intervention.	[Miller, Gabrielle F.; Sarmiento, Kelly; Breiding, Matthew J.] Ctr Dis Control & Prevent, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE,Mailstop 5106-8, Atlanta, GA 30341 USA; [DePadilla, Lara] Ctr Dis Control & Prevent, Div Overdose Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; [Jones, Sherry Everett] Ctr Dis Control & Prevent, Div Adolescent & Sch Hlth, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30341 USA; [Bartholow, Brad N.] Ctr Dis Control & Prevent, Div Violence Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA		Miller, GF (corresponding author), Ctr Dis Control & Prevent, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE,Mailstop 5106-8, Atlanta, GA 30341 USA.	ygm3@cdc.gov					Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Bernert Rebecca A, 2007, Neuropsychiatr Dis Treat, V3, P735; Bethune A, 2017, ARCH SUICIDE RES, V21, P392, DOI 10.1080/13811118.2016.1199990; Brener ND, 2013, MMWR RECOMM REP, V62, P1; Brener ND, 2002, J ADOLESCENT HEALTH, V31, P336, DOI 10.1016/S1054-139X(02)00339-7; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Clacy A, 2019, MED J AUSTRALIA, V211, P247, DOI 10.5694/mja2.50319; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Fralick M, 2019, JAMA NEUROL, V76, P144, DOI 10.1001/jamaneurol.2018.3487; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Goldstein TR, 2008, J CONSULT CLIN PSYCH, V76, P84, DOI 10.1037/0022-006X.76.1.84; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Institute of Education Sciences, 2019, NAT CTR ED STAT FAST; Isaac M, 2009, CAN J PSYCHIAT, V54, P260, DOI 10.1177/070674370905400407; Kesinger MR, 2016, ARCH PHYS MED REHAB, V97, P1301, DOI 10.1016/j.apmr.2016.02.017; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Rao AL, 2018, CURR SPORT MED REP, V17, P83, DOI 10.1249/JSR.0000000000000462; Rees T, 2010, PSYCHOL SPORT EXERC, V11, P505, DOI 10.1016/j.psychsport.2010.07.002; Roberts RE, 2001, J YOUTH ADOLESCENCE, V30, P1, DOI 10.1023/A:1005230820074; Roberts RE, 2010, ARCH SUICIDE RES, V14, P66, DOI 10.1080/13811110903479078; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Stone DM, 2017, PREVENTING SUICIDE T; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID ADV CO; Wangnoo T, 2020, J NEUROTRAUM, V37, P1401, DOI 10.1089/neu.2018.5721; Wasserman D, 2015, LANCET, V385, P1536, DOI 10.1016/S0140-6736(14)61213-7; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	43	2	2	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAR	2021	13	2					187	197	1941738120939913	10.1177/1941738120939913		AUG 2020	11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	QM0ZB	WOS:000563006700001	32845815	Green Published			2022-02-06	
J	Agnafors, S; Torgerson, J; Rusner, M; Kjellstrom, AN				Agnafors, Sara; Torgerson, Jarl; Rusner, Marie; Kjellstrom, Anna Norman			Injuries in children and adolescents with psychiatric disorders	BMC PUBLIC HEALTH			English	Article						Mental health; Injuries; Maltreatment; Children	NONSUICIDAL SELF-INJURY; CHILDHOOD BEHAVIOR DISORDERS; AUTISM SPECTRUM DISORDER; MENTAL-HEALTH PROBLEMS; UNINTENTIONAL INJURY; RISK-FACTORS; PREVALENCE; PSYCHOPATHOLOGY; MALTREATMENT; ANXIETY	Background Unintentional injuries are a leading cause of morbidity and mortality in children of all ages. Prevention strategies require knowledge of risk factors, and behavior and psychiatric disorders have been suggested to influence the risk of injury during childhood. While externalizing disorders have been found to increase the risk for injuries, results are mixed regarding internalizing disorders, such as affective and anxiety conditions, and Autism Spectrum Disorders (ASD). There is a need for large scale studies relying on robust data sources. The aim of the present study was to examine the association between psychiatric disorders and injuries requiring medical attention, in a large population-based cohort of 350,000 children and adolescents in Sweden. Methods Data were obtained from the regional health care database Vega. Psychiatric diagnoses and injury diagnoses obtained during 2014-2018 for individuals aged 0-17 years in 2016 were extracted. Descriptive statistics were used to examine differences in 5-year injury prevalence between children with and without different psychiatric diagnoses. Logistic regression was used in age-stratified models to test the association between psychiatric diagnoses and injuries requiring medical attention. Results The results show an increased risk for concurrent injuries in general, but the patterns vary by age and psychiatric disorder. Externalizing disorders and anxiety conditions were associated with concurrent injuries, while individuals with ASD had a lower risk for most injuries included. Affective disorders were associated with an increased risk for wounds, concussion, complications and poisoning, while the risk for fractures was decreased. Self-inflicted injury was more common in all psychiatric conditions investigated during adolescence, except for ASD. Children and adolescents with many types of psychiatric disorders were also at increased risk for a concurrent maltreatment diagnosis. Conclusions A general pattern of increased risk for concurrent injuries in children and adolescents with most psychiatric diagnoses was found, but the associations vary by age and type of psychiatric disorder. The results add to the literature on risk factors for injuries in children and adolescents, supporting diagnosis specific patterns. Several psychiatric diagnoses were associated with a marked increase in injury risk, indicating a high burden of disease for affected individuals.	[Agnafors, Sara] Linkoping Univ, Div Childrens & Womens Hlth, BKV, Dept Biomed & Clin Sci, S-58185 Linkoping, Sweden; [Agnafors, Sara; Rusner, Marie] Sodra Alvsborgs Hosp, Dept Res, Boras, Sweden; [Torgerson, Jarl] Sahlgrens Univ Hosp, Dept Psychosis, Gothenburg, Sweden; [Rusner, Marie] Univ Gothenburg, Sahlgrenska Acad, Inst Hlth & Care Sci, Gothenburg, Sweden; [Kjellstrom, Anna Norman] Head Off, Dept Data Management & Anal, Skovde, Region Vastra G, Sweden		Agnafors, S (corresponding author), Linkoping Univ, Div Childrens & Womens Hlth, BKV, Dept Biomed & Clin Sci, S-58185 Linkoping, Sweden.; Agnafors, S (corresponding author), Sodra Alvsborgs Hosp, Dept Res, Boras, Sweden.	sara.agnafors@liu.se			Research and Development Sodra Alvsborg; Linkoping University	The study was financially supported by Research and Development Sodra Alvsborg. The funding body did not take part in any stage of planning the study, data collection, analysis, interpretation or writing the manuscript. Open access funding provided by Linkoping University.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Asbridge M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-190; Balazs J, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1620-3; BIJUR PE, 1986, AM J DIS CHILD, V140, P487, DOI 10.1001/archpedi.1986.02140190097036; Bonander C, 2016, J SAFETY RES, V58, P49, DOI 10.1016/j.jsr.2016.06.004; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Bruce B, 2007, PAED CHILD HEALT-CAN, V12, P749, DOI 10.1093/pch/12.9.749; Cavalari RNS, 2012, J PEDIATR NURS, V27, P632, DOI 10.1016/j.pedn.2011.07.013; Danseco ER, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e27; Dudani A, 2010, J DEV BEHAV PEDIATR, V31, P276, DOI 10.1097/DBP.0b013e3181da7785; Ekman R, 2005, INJURY PREV, V11, P29, DOI 10.1136/ip.2003.005074; Elliott AB, 2018, PEDIATR ANESTH, V28, P142, DOI 10.1111/pan.13298; FARMER JE, 1995, HEALTH PSYCHOL, V14, P325, DOI 10.1037/0278-6133.14.4.325; Frick PJ, 2012, ANNU REV CLIN PSYCHO, V8, P77, DOI 10.1146/annurev-clinpsy-032511-143150; Furlano RI, 2014, J DEV BEHAV PEDIATR, V35, P353, DOI 10.1097/DBP.0000000000000070; Garg N, 2014, ANN ALLERG ASTHMA IM, V112, P525, DOI 10.1016/j.anai.2014.03.006; HALPERIN JM, 1995, J CHILD PSYCHOL PSYC, V36, P1199, DOI 10.1111/j.1469-7610.1995.tb01365.x; Jaffee SR, 2017, ANNU REV CLIN PSYCHO, V13, P525, DOI 10.1146/annurev-clinpsy-032816-045005; Jernbro C, 2020, DISABIL HEALTH J, V13, DOI 10.1016/j.dhjo.2019.100841; Jokela M, 2009, J CHILD PSYCHOL PSYC, V50, P1541, DOI 10.1111/j.1469-7610.2009.02122.x; Keyes KM, 2014, PREV MED, V67, P182, DOI 10.1016/j.ypmed.2014.07.030; Louwers ECFM, 2010, ARCH DIS CHILD, V95, P214, DOI 10.1136/adc.2008.151654; Maclean MJ, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1817; Martin G, 2015, PSYCHOL MED, V45, P429, DOI 10.1017/S0033291714001615; McDermott S, 2008, J AUTISM DEV DISORD, V38, P626, DOI 10.1007/s10803-007-0426-9; McDonnell CG, 2019, J CHILD PSYCHOL PSYC, V60, P576, DOI 10.1111/jcpp.12993; Meszaros G, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1326-y; Morrongiello BA, 2008, CHILD DEV, V79, P627, DOI 10.1111/j.1467-8624.2008.01147.x; Muscatelli S, 2017, J ORTHOP TRAUMA, V31, P47, DOI 10.1097/BOT.0000000000000664; Nock MK, 2006, PSYCHIAT RES, V144, P65, DOI 10.1016/j.psychres.2006.05.010; Odelius C, 2014, NATIONELL KARTLAGGNI; Printz JN, 2019, AM J OTOLARYNG, V40, P667, DOI 10.1016/j.amjoto.2019.05.026; Raustorp A, 2015, ACTA PAEDIATR, V104, P808, DOI 10.1111/apa.13027; Reiss F, 2013, SOC SCI MED, V90, P24, DOI 10.1016/j.socscimed.2013.04.026; Rodav O, 2014, EUR PSYCHIAT, V29, P503, DOI 10.1016/j.eurpsy.2014.02.008; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Rowe R, 2007, J CHILD PSYCHOL PSYC, V48, P71, DOI 10.1111/j.1469-7610.2006.01674.x; Ruiz-Goikoetxea M, 2018, NEUROSCI BIOBEHAV R, V84, P63, DOI 10.1016/j.neubiorev.2017.11.007; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Sethi D, 2008, EUROPEAN REPORT CHIL; Stern A, 2018, CHILD ABUSE NEGLECT, V81, P274, DOI 10.1016/j.chiabu.2018.04.025; Stith SM, 2009, AGGRESS VIOLENT BEH, V14, P13, DOI 10.1016/j.avb.2006.03.006; Taylor PJ, 2018, J AFFECT DISORDERS, V227, P759, DOI 10.1016/j.jad.2017.11.073; Whitlock J, 2006, PEDIATRICS, V117, P1939, DOI 10.1542/peds.2005-2543; Zetterqvist M, 2013, J ABNORM CHILD PSYCH, V41, P759, DOI 10.1007/s10802-013-9712-5	45	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2458		BMC PUBLIC HEALTH	BMC Public Health	AUG 24	2020	20	1							1273	10.1186/s12889-020-09283-3			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	NK8OW	WOS:000566991100005	32838787	gold, Green Published			2022-02-06	
J	Schutzman, SA; Nigrovic, LE; Mannix, R				Schutzman, Sara A.; Nigrovic, Lise E.; Mannix, Rebekah			The Infant Scalp Score: A Validated Tool to Stratify Risk of Traumatic Brain Injury in Infants With Isolated Scalp Hematoma	ACADEMIC EMERGENCY MEDICINE			English	Article							HEAD-INJURY; CHILDREN; PREDICTION	Objectives The objective was to validate the previously derived Infant Scalp Score (ISS) that uses clinical signs in infants with isolated scalp hematoma (ISH) after head trauma to stratify risk for clinically important traumatic brain injury (ciTBI) or TBI on computed tomography (CT). Methods Using the publicly available Pediatric Emergency Care Applied Research Network TBI data set, we selected infants <= 1 year with GCS 14 to 15 who had ISH (defined as hematoma without other signs/symptoms of TBI). CT scans were obtained at the treating physician's discretion. We calculated ISS based on age, hematoma size, and location (range = 0-8) for each patient and calculated the sensitivity and specificity of the score for ciTBI and TBI on CT across a range of ISS cut-points. Results We included 1,289 infants <= 1 year of whom 462 (36%) had CT performed. Twelve had ciTBI and 59 had TBI on CT. An ISS cutoff >= 4 had sensitivity of 100% for ciTBI (95% confidence interval [CI] = 0.74 to 1.0) and TBI with specificity of 0.49 (95% CI = 0.46 to 0.51). An ISS cutoff of >= 5 had a sensitivity of 100% for ciTBI (95% CI = 0.74 to 1.0) and specificity of 0.68 (95% CI = 0.66 to 0.71), but missed three infants with TBI on CT (none of whom required intervention). The receiver operating characteristic curves for clinical score to detect ciTBI and TBI had areas under the curve of 0.916 and 0.807, respectively. Conclusions The ISS accurately stratified risk for ciTBI and TBI on CT in infants with ISH and is a useful tool to help guide clinical decision making.	[Schutzman, Sara A.; Nigrovic, Lise E.; Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Schutzman, Sara A.; Nigrovic, Lise E.; Mannix, Rebekah] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA		Schutzman, SA (corresponding author), Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA.; Schutzman, SA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	sara.schutzman@childrens.harvard.edu		Mannix, Rebekah/0000-0003-3608-2792; Nigrovic, Lise/0000-0002-6369-3997			Bin SS, 2010, PEDIATR EMERG CARE, V26, P633, DOI 10.1097/PEC.0b013e3181ef0440; Bressan S, 2019, ARCH DIS CHILD, V104, P664, DOI 10.1136/archdischild-2018-316066; Burns ECM, 2016, ACAD EMERG MED, V23, P576, DOI 10.1111/acem.12957; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Goodman TR, 2019, PEDIATR RADIOL, V49, P469, DOI 10.1007/s00247-018-4281-y; Gorelick MH, 2008, ACAD EMERG MED, V15, P812, DOI 10.1111/j.1553-2712.2008.00206.x; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Ide K, 2017, ACAD EMERG MED, V24, P308, DOI 10.1111/acem.13129; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Samuel M, 2002, J PEDIATR SURG, V37, P877, DOI 10.1053/jpsu.2002.32893	16	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JAN	2021	28	1					92	97		10.1111/acem.14087		AUG 2020	6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	PU8IG	WOS:000560425500001	32673432				2022-02-06	
J	Sorek, G; Gagnon, I; Schneider, K; Chevignard, M; Stern, N; Fadida, Y; Kalderon, L; Shaklai, S; Katz-Leurer, M				Sorek, Gilad; Gagnon, Isabelle; Schneider, Kathryn; Chevignard, Mathilde; Stern, Nurit; Fadida, Yahaloma; Kalderon, Liran; Shaklai, Sharon; Katz-Leurer, Michal			The integrated functions of the cardiac autonomic and vestibular/oculomotor systems in adolescents following severe traumatic brain injury and typically developing controls	BRAIN INJURY			English	Article						Cardiac autonomic control system; vestibular; oculomotor; vestibulo-sympathetic reflex; traumatic brain injury; adolescents	HEART-RATE-VARIABILITY; CONCUSSION; RELIABILITY; BALANCE; REHABILITATION; DIZZINESS; DEFICITS; MODERATE; TBI; CONSEQUENCES	Introduction The cardiac autonomic control system (CACS) is frequently impaired post-traumatic brain injury (TBI). However, the prevalence of vestibular/oculomotor impairment is less studied. These two systems interact during position change and contribute to blood-pressure regulation through the vestibulo-sympathetic reflex.Aim: To assess the CACS, the vestibular/oculomotor systems and their integrative function in adolescents post-TBI compared to typically-developing (TD) adolescents.Methods: 19 adolescents in the subacute stage following a severe TBI (14-117 days post injury) and 19 age and sex matched TD controls were recruited. Heart Rate Variability (HRV) was assessed at rest and during a modified tilt-test. A quantified version of the Vestibular/Ocular-Motor Screening (VOMS) was also administered.Results: At rest, the TBI group had higher HR and lower HRV values (p< .001). All participants with TBI demonstrated impairments in the VOMS (median of positive tests: 5 [range 2-9]) compared to only 6 out of 19 in the TD participants (median 0 [0-2]) (z = -5.34;p< .001). In response to the modified tilt test, the HRV increased significantly in the lifting period and decreased significantly once in standing only in the TBI group (z = -2.85,p= .025).Conclusion: Adolescents post severe TBI demonstrated impairments in the CACS, positive tests on the VOMS and significantly greater changes in the modified tilt test as compared to TD. Clinical trial gov. number: NCT03215082	[Sorek, Gilad; Kalderon, Liran; Katz-Leurer, Michal] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, Tel Aviv, Israel; [Gagnon, Isabelle] McGill Univ, Hlth Ctr, Montreal Childrens Hosp, Montreal, PQ, Canada; [Schneider, Kathryn] Univ Calgary, Fac Kinesiol, Sport Injury Res Prevent Ctr, Calgary, AB, Canada; [Chevignard, Mathilde] Sorbonne Univ, Lab Imagerie Biomed, LIB, Paris, France; [Chevignard, Mathilde] Sorbonne Univ, GRC, Paris, France; [Chevignard, Mathilde] St Maurice Hosp, Rehabil Unit Acquired Neurol Pathol Children, St Maurice, France; [Stern, Nurit] Alyn Childrens Hosp & Rehabil Ctr, Jerusalem, Israel; [Fadida, Yahaloma; Shaklai, Sharon] Lowenstein Rehabil Ctr Raanana, Children Rehabil Dept, Raanana, Israel		Katz-Leurer, M (corresponding author), Tel Aviv Univ, Phys Therapy Dept, Sch Hlth Profess, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	michalkz@post.tau.ac.il		Gagnon, Isabelle/0000-0003-2043-1644	Israeli Ministry of Health through the European Research Area - the Network of European Funding for Neuroscience Research (ERA-NET NEURON)	This work was supported by the Israeli Ministry of Health through the European Research Area -the Network of European Funding for Neuroscience Research (ERA-NET NEURON).	Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Biswas AK, 1999, CRIT CARE MED, V27, pA78, DOI 10.1097/00003246-199901001-00179; Brand P, 2017, CJSM, V27; Camm AJ, 1996, EUR HEART J, V17, P354; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Corwin DJ, 2018, BRAIN INJURY, V32, P794, DOI 10.1080/02699052.2018.1458150; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; Farah BQ, 2016, CLIN PHYSIOL FUNCT I, V36, P33, DOI 10.1111/cpf.12190; Franjoine Mary Rose, 2003, Pediatr Phys Ther, V15, P114, DOI 10.1097/01.PEP.0000068117.48023.18; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Gordon WA, 2000, BRAIN INJURY, V14; Gregory T, 2012, BJA EDUC, V12, P67, DOI 10.1093/bjaceaccp/mkr058; Hamel RN, 2019, SPORTS MED, V49, P1183, DOI 10.1007/s40279-019-01122-9; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Heesch CM, 2006, BRAIN RES, V1125, P46, DOI 10.1016/j.brainres.2006.09.090; Herdman SJ, 2007, VESTIBULAR REHABILIT; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kaplan D, 2010, HAREFUAH, V149; Katz-Leurer M, 2012, PHYS THERAPY CHILDRE, P679; Katz-Leurer M, 2016, BRAIN INJURY, V30, P1239, DOI 10.1080/02699052.2016.1179343; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Kerman IA, 2000, BRAIN RES BULL, V53, P11, DOI 10.1016/S0361-9230(00)00303-8; Khan F, 2016, J REHABIL MED, V48, P442, DOI 10.2340/16501977-2084; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mani R, 2018, BRAIN INJURY, V32, P1315, DOI 10.1080/02699052.2018.1483030; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCall AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00112; McCulloch KL, 2016, J NEUROL PHYS THER, V40, P269, DOI 10.1097/NPT.0000000000000145; McKinlay A, 2013, INT NEUROTRAUMA LETT; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nunan D, 2009, MED SCI SPORT EXER, V41, P243, DOI 10.1249/MSS.0b013e318184a4b1; Riberholt CG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154831; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schreihofer AM, 2005, AM J PHYSIOL-REG I, V289, pR1746, DOI 10.1152/ajpregu.00307.2005; Sharma I, 2018, CJSM, V28; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sorek G, 2018, BRAIN INJURY, V32, P770, DOI 10.1080/02699052.2018.1450993; Teasell R., 1996, AUTONOMIC NERVOUS SY; VARTIAINEN E, 1985, INT J PEDIATR OTORHI, V9, P135, DOI 10.1016/S0165-5876(85)80013-6; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Yates BJ, 2014, COMPR PHYSIOL, V4, P851, DOI 10.1002/cphy.c130041; Yates BJ, 2005, J VESTIBUL RES-EQUIL, V15; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Yudofsky S., 2011, TXB TRAUMATIC BRAIN, DOI [10.1176/appi.books.9781585624201.js01, DOI 10.1176/APPI.BOOKS.9781585624201.JS01]	59	2	2	3	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 18	2020	34	11					1480	1488		10.1080/02699052.2020.1807055		AUG 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NR9QK	WOS:000561912600001	32809873				2022-02-06	
J	Lessing, NL; Zuckerman, SL; Lazaro, A; Leech, AA; Leidinger, A; Rutabasibwa, N; Shabani, HK; Mangat, HS; Hartl, R				Lessing, Noah L.; Zuckerman, Scott L.; Lazaro, Albert; Leech, Ashley A.; Leidinger, Andreas; Rutabasibwa, Nicephorus; Shabani, Hamisi K.; Mangat, Halinder S.; Hartl, Roger			Cost-Effectiveness of Operating on Traumatic Spinal Injuries in Low-Middle Income Countries: A Preliminary Report From a Major East African Referral Center	GLOBAL SPINE JOURNAL			English	Article						Tanzania; low-middle income countries; neurotrauma; traumatic spinal cord injury; East Africa; global neurosurgery	CORD-INJURY; GLOBAL BURDEN; DISABILITY WEIGHTS; INTERVENTIONS; THRESHOLDS; MANAGEMENT; DISEASE	Study Design: Retrospective cost-effectiveness analysis. Objectives: While the incidence of traumatic spine injury (TSI) is high in low-middle income countries (LMICs), surgery is rarely possible due to cost-prohibitive implants. The objective of this study was to conduct a preliminary cost-effectiveness analysis of operative treatment of TSI patients in a LMIC setting. Methods: At a tertiary hospital in Tanzania from September 2016 to May 2019, a retrospective analysis was conducted to estimate the cost-effectiveness of operative versus nonoperative treatment of TSI. Operative treatment included decompression/stabilization. Nonoperative treatment meant 3 months of bed rest. Direct costs included imaging, operating fees, surgical implants, and length of stay. Four patient scenarios were chosen to represent the heterogeneity of spine trauma: Quadriplegic, paraplegic, neurologic improvement, and neurologically intact. Disability-adjusted-life-years (DALYs) and incremental-cost-effectiveness ratios were calculated to determine the cost per unit benefit of operative versus nonoperative treatment.Cost/DALY avertedwas the primary outcome (i.e., the amount of money required to avoid losing 1 year of healthy life). Results: A total of 270 TSI patients were included (125 operative; 145 nonoperative). Operative treatment averaged $731/patient. Nonoperative care averaged $212/patient. Comparing operative versus nonoperative treatment, the incrementalcost/DALY avertedfor each patient outcome was: quadriplegic ($112-$158/DALY averted), paraplegic ($47-$67/DALY averted), neurologic improvement ($50-$71/DALY averted), neurologically intact ($41-$58/DALY averted). Sensitivity analysis confirmed these findings without major differences. Conclusions: This preliminary cost-effectiveness analysis suggests that the upfront costs of spine trauma surgery may be offset by a reduction in disability. LMIC governments should consider conducting more spine trauma cost-effectiveness analyses and including spine trauma surgery in universal health care.	[Lessing, Noah L.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Zuckerman, Scott L.; Mangat, Halinder S.; Hartl, Roger] Weill Cornell Med, New York, NY USA; [Lazaro, Albert; Rutabasibwa, Nicephorus; Shabani, Hamisi K.] Muhimbili Orthopaed Inst, Dar Es Salaam, Tanzania; [Leech, Ashley A.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Leidinger, Andreas] Hosp Gen Cataluna, Sant Cugat Del Valles, Spain		Zuckerman, SL (corresponding author), Vanderbilt Univ, Dept Neurol Surg, Med Ctr, Med Ctr North T-4224, Nashville, TN 37212 USA.	zuckerman.scott@gmail.com		mangat, halinder/0000-0003-3426-2001; Lessing, Noah/0000-0002-3994-7977; Zuckerman, Scott/0000-0003-2951-2942; Leech, Ashley/0000-0001-6795-929X			Adeolu AA, 2014, ANN AFR MED, V13, P30, DOI 10.4103/1596-3519.126947; Ametefe MK, 2016, SPINAL CORD, V54, P1164, DOI 10.1038/sc.2016.57; Aras EL, 2016, SPINE, V41, P337, DOI 10.1097/BRS.0000000000001219; Badhiwala JH, 2019, LANCET NEUROL, V18, P24, DOI 10.1016/S1474-4422(18)30444-7; Barlow DR, 2016, SPINE, V41, P610, DOI 10.1097/BRS.0000000000001275; Bertram MY, 2016, B WORLD HEALTH ORGAN, V94, P925, DOI 10.2471/BLT.15.164418; Boakye M, 2012, J NEUROTRAUM, V29, P2220, DOI 10.1089/neu.2012.2364; Brauer CA, 2005, J BONE JOINT SURG AM, V87A, P1253, DOI 10.2106/JBJS.D.02152; Chan BCF, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.2.FOCUS17778; Choi JH, 2017, ASIAN SPINE J, V11, P908, DOI 10.4184/asj.2017.11.6.908; Emerson J, 2018, DISABILITY ADJUSTED; Furlan JC, 2016, NEUROSURGERY, V79, P418, DOI 10.1227/NEU.0000000000001314; Furlan JC, 2016, WORLD NEUROSURG, V88, P166, DOI 10.1016/j.wneu.2015.12.072; Horton S., 2017, DIS CONTROL PRIORITI, V3, P147; Hubbard ZS, 2019, J NEUROSURG-PEDIATR, V24, P306, DOI 10.3171/2019.4.PEDS18563; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kumar R, 2018, WORLD NEUROSURG, V113, pE345, DOI 10.1016/j.wneu.2018.02.033; Leech AA, 2018, VALUE HEALTH, V21, P759, DOI 10.1016/j.jval.2017.12.016; Leidinger A, 2019, J NEUROSURG-SPINE, V31, P103, DOI 10.3171/2018.12.SPINE18635; Lessing NL, 2020, SPINAL CORD, V58, P1197, DOI 10.1038/s41393-020-0474-y; Magogo J, 2021, GLOB SPINE J, V11, P89, DOI 10.1177/2192568219894956; Moradi-Lakeh M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-789; Moshi H, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1355604; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nonvignon Justice, 2018, Vaccine, V36, P7215, DOI 10.1016/j.vaccine.2017.11.080; Nwankwo OE, 2013, SPINAL CORD, V51, P448, DOI 10.1038/sc.2013.10; Rabiu Taopheeq Bamidele, 2017, Pan Afr Med J, V26, P84, DOI 10.11604/pamj.2017.26.84.8278; Rahimi-Movaghar V, 2010, SPINAL CORD, V48, P492, DOI 10.1038/sc.2009.158; Rashid Sakina Mehboob, 2017, Spinal Cord Ser Cases, V3, P17021, DOI 10.1038/scsandc.2017.21; Roberts G, 2016, WORLD J SURG, V40, P14, DOI 10.1007/s00268-015-3271-6; Robinson LA, 2017, HEALTH POLICY PLANN, V32, P141, DOI 10.1093/heapol/czw096; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sarkar S, 2019, ECLINICALMEDICINE, V10, P10, DOI 10.1016/j.eclinm.2019.04.006; Shankar Prinja, 2015, Disease control priorities, third edition: Volume 1. Essential surgery, P317; Siebenga Jan, 2007, Indian J Orthop, V41, P332, DOI 10.4103/0019-5413.36997; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163; World Bank, WORLD BANK OP DAT	40	2	2	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2192-5682	2192-5690		GLOB SPINE J	Glob. Spine J.	JAN	2022	12	1					15	23	2192568220944888	10.1177/2192568220944888		AUG 2020	9	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	XF7ZZ	WOS:000562901500001	32799677	gold			2022-02-06	
J	Walter, J; Kovalenko, O; Younsi, A; Grutza, M; Unterberg, A; Zweckberger, K				Walter, Johannes; Kovalenko, Olga; Younsi, Alexander; Grutza, Martin; Unterberg, Andreas; Zweckberger, Klaus			The CatWalk XT (R) is a valid tool for objective assessment of motor function in the acute phase after controlled cortical impact in mice	BEHAVIOURAL BRAIN RESEARCH			English	Article						CatWalk XT (R); CatWalk (R); Automated gait analysis; CCI, controlled cortical impact; TBI, traumatic brain injury; Behavioral test; Behavior; Gait; motor function	TRAUMATIC BRAIN-INJURY; GAIT ANALYSIS; DAMAGE; ABNORMALITIES; IMPAIRMENTS; GUIDELINES; RECEPTORS; RECOVERY; NEURONS; MODEL	Background: Despite multiple experimental models of traumatic brain injury (TBI) being available, objective assessment of gait and motor function in rodents remains difficult; therefore, we studied the value of the CatWalk XT (R) gait analysis as an observer independent, automated method for outcome assessment in one of the most frequently used preclinical TBI model, the controlled cortical impact (CCI), in mice. Methods: C57B1/6 mice were subjected to either right parietal CCI or a sham procedure. Functional outcome was assessed using the CatWalk XT (R) (Version 10.6) as well as the hole board test at days one, three and seven after trauma induction. Results: CCI led to diffuse, asymmetric and bilateral disturbances of both static and dynamic parameters in the CatWalk XT (R) gait analysis. The CatWalk XT (R) detected even minimal but statistically significant impairments that could not have been detected by clinical assessments. Impairments of static parameters were most pronounced within the first three days and diminished thereafter, while dynamic parameters were impaired until seven days after CCI. Fittingly, mice explored the hole board significantly less on day three trauma induction. Conclusions: The CatWalk XT (R) is a valid tool for objective assessment of motor function in the acute phase after controlled cortical impact TBI in mice. Similar to observations made in humans, CCI leads to impairments of both static and dynamic parameters of gait and motor function which persist throughout the first week after the injury.	[Walter, Johannes; Kovalenko, Olga; Younsi, Alexander; Grutza, Martin; Unterberg, Andreas; Zweckberger, Klaus] Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany		Walter, J (corresponding author), Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany.	johannes.walter@med.uni-heidelberg.de	Younsi, Alexander/AAW-7869-2020	Younsi, Alexander/0000-0002-8218-9243			Abreu TM, 2018, INT J BIOL MACROMOL, V111, P534, DOI 10.1016/j.ijbiomac.2017.12.132; Blake MG, 2013, NEUROBIOL LEARN MEM, V106, P193, DOI 10.1016/j.nlm.2013.09.001; Chaves EMC, 2018, METAB BRAIN DIS, V33, P139, DOI 10.1007/s11011-017-0139-5; Castillo-Hernandez JC, 2017, PHARMACOLOGY, V99, P268, DOI 10.1159/000457905; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen YJ, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-62; Chiang CY, 2014, J NEUROSURG, V120, P250, DOI 10.3171/2013.9.JNS13353; Cline MM, 2017, BRAIN RES, V1657, P140, DOI 10.1016/j.brainres.2016.11.027; Combs HL, 2016, J NEUROTRAUM, V33, P741, DOI 10.1089/neu.2015.4136; Cross DJ, 2015, BRAIN RES, V1618, P299, DOI 10.1016/j.brainres.2015.06.006; Crowley Samuel T, 2018, BMC Res Notes, V11, P263, DOI 10.1186/s13104-018-3374-x; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Drijkoningen D, 2015, J NEUROTRAUM, V32, P1324, DOI 10.1089/neu.2014.3787; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Guillen J, 2012, J AM ASSOC LAB ANIM, V51, P311; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Hayakawa K, 2015, J CONTROL RELEASE, V197, P1, DOI 10.1016/j.jconrel.2014.10.027; Hou JM, 2014, J NEUROTRAUM, V31, P1088, DOI 10.1089/neu.2013.3096; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Madinier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093121; Mao X, 2020, J NEUROTRAUM, V37, P1331, DOI 10.1089/neu.2019.6510; Morellini N, 2015, CEREBELLUM, V14, P23, DOI 10.1007/s12311-014-0617-9; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Patel NA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1240-3; Qin LY, 2014, J NEUROSCI, V34, P2493, DOI 10.1523/JNEUROSCI.4140-13.2014; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; Salvi J, 2014, NEUROBIOL DIS, V68, P47, DOI 10.1016/j.nbd.2014.04.005; Schonfeld LM, 2017, J NEUROTRAUM, V34, P505, DOI 10.1089/neu.2016.4440; Shin SS, 2018, BRAIN STIMUL, V11, P1306, DOI 10.1016/j.brs.2018.07.050; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Tatenhorst L, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0310-y; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Thau-Zuchman O, 2019, J NEUROTRAUM, V36, P25, DOI 10.1089/neu.2017.5579; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Tsika E, 2014, NEUROBIOL DIS, V71, P345, DOI 10.1016/j.nbd.2014.08.027; Vasudevan EVL, 2014, J NEUROL PHYS THER, V38, P172, DOI 10.1097/NPT.0000000000000049; Victorio SCS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-88; Vidal PM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92512; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yu J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020299; ZAFONTE RD, 2012, JAMA-J AM MED ASSOC, V308, P19; Zhou M, 2015, NEUROSCI LETT, V584, P184, DOI 10.1016/j.neulet.2014.10.032; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	50	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	AUG 17	2020	392								112680	10.1016/j.bbr.2020.112680			15	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	MQ1JW	WOS:000552654000005	32479852				2022-02-06	
J	Yic, CD; Prada, G; Paz, SI; Moraes, L; Pontet, JC; Lasso, ME; Biestro, A				Yic, Christian D.; Prada, Gabriel; Paz, Sergio I.; Moraes, Leandro; Pontet, Julio C.; Lasso, Marcos E.; Biestro, Alberto			Comparison of ultrasonographic versus infrared pupillary assessment	ULTRASOUND JOURNAL			English	Article						Ocular ultrasonography; Ocular ultrasound; Pupillometry; Pupillary assessment; Traumatic brain injury; Brain herniation	ULTRASOUND; PUPILLOMETRY; INJURY	Objectives: To evaluate the correlation between ultrasonographic and infrared pupillary assessments in critically ill patients, including neurocritically ill patients. Design: Prospective, observational study. Setting: Tertiary teaching hospital intensive care unit (ICU) in Montevideo, Uruguay. Patients: Twenty-six adults patients with age 18 or older admitted to the intensive care unit with and without neurologic pathology. A total of 212 pupillary measures were made between ultrasonographic pupillary assessment (UPA) and infrared pupillary assessment (IPA). Interventions: This was a study that utilized non-invasive (minimal risk) ultrasonographic and infrared pupillary assessment in patients admitted to the ICU. Time between UPA and IPA in a single patient was consistently less than 3 min. Measurements and main results: There was a strong positive association between UPA and IPA (right eye [OD]:r = de 0.926,p-value < 0.001; left eye [OS],r = 0.965,p-value < 0.001), also observed in the group of neurocritically ill patients (OD:r = 0.935,p-value < 0.001; OS:r = de 0.965,p-value < 0.001). Taking IPA as reference measure, the percent error for all subjects was 2.77% and 2.15% for OD and OS, respectively, and for neurocritically ill patients it was 3.21% and 2.44% for OD and OS, respectively. Conclusions: Ultrasonographic pupillary assessment is strongly correlated with infrared pupillary assessment in critically ill patients, including neurocritically ill patients. Ultrasonographic pupillary assessment is a quick, feasible, non-invasive method that allows accurate pupillary assessment, particularly neurologic function, in patients in whom a more precise measurement of the pupil is required or eye opening is not possible (e.g., periorbital edema due to traumatic brain injury).	[Yic, Christian D.; Moraes, Leandro; Lasso, Marcos E.; Biestro, Alberto] Hosp Clin Montevideo, Dept Crit Care Med, Montevideo, Uruguay; [Paz, Sergio I.; Pontet, Julio C.] Pasteur Hosp, Dept Crit Care Med, Montevideo, Uruguay; [Prada, Gabriel] Mayo Clin, Dept Crit Care Med, Jacksonville, FL 32224 USA		Yic, CD (corresponding author), Hosp Clin Montevideo, Dept Crit Care Med, Montevideo, Uruguay.	docyic@hotmail.com		Yic, Christian/0000-0001-8008-0909			Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chen JW, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-548; Chiao L, 2005, J TRAUMA, V58, P885, DOI 10.1097/01.TA.0000162456.37962.01; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; ELLIS CJK, 1981, BRIT J OPHTHALMOL, V65, P754, DOI 10.1136/bjo.65.11.754; FANKHAUSER F, 1989, DOC OPHTHALMOL, V73, P235, DOI 10.1007/BF00155093; Fisher Y L, 1989, Dev Ophthalmol, V18, P69; FISHER Y L, 1975, Journal of Clinical Ultrasound, V3, P219, DOI 10.1002/jcu.1870030313; Fledelius HC, 1997, ULTRASOUND MED BIOL, V23, P365, DOI 10.1016/S0301-5629(96)00213-X; Galinski M, 2013, INTENS CARE MED, V39, P2034, DOI 10.1007/s00134-013-3051-4; Harries A, 2010, AM J EMERG MED, V28, P956, DOI 10.1016/j.ajem.2009.06.026; HASEGAWA S, 1989, Nippon Ganka Gakkai Zasshi, V93, P955; HASSANI SN, 1978, RADIOLOGY, V127, P213, DOI 10.1148/127.1.213; LARSON MD, 1993, ANESTH ANALG, V76, P1072; LOWENSTEIN O, 1958, ARCH OPHTHALMOL-CHIC, V59, P352, DOI 10.1001/archopht.1958.00940040058007; Lussier BL, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0994-z; Martinez-Ricarte F, 2013, NEUROLOGIA, V28, P41, DOI 10.1016/j.nrl.2010.07.028; Phillips SS, 2019, NEUROCRIT CARE, V31, P142, DOI 10.1007/s12028-018-0645-2; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Thompson HS, 2005, J NEURO-OPHTHALMOL, V25, P44, DOI 10.1097/00041327-200503000-00012	21	2	2	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2036-3176	2524-8987		ULTRASOUND J	Ultrasound J.	AUG 14	2020	12	1							38	10.1186/s13089-020-00188-1			10	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	NA5CN	WOS:000559834600001	32794115	gold, Green Published			2022-02-06	
J	Aguilar, JM; Elleman, CB; Cassedy, AE; Minich, NM; Zhang, NH; Yeates, KO; Taylor, HG; Wade, SL				Aguilar, Jessica M.; Elleman, Chloe B.; Cassedy, Amy E.; Minich, Nori Mercuri; Zhang, Nanhua; Yeates, Keith Owen; Taylor, H. Gerry; Wade, Shari L.			Long term effects of early childhood traumatic brain injury on narrative discourse gist and psychosocial functioning	DISABILITY AND REHABILITATION			English	Article						Cognitive communication disorders; gist reasoning; social competence; everyday functioning	CLOSED-HEAD-INJURY; CHILDREN; ADOLESCENTS; COMPETENCE; PREDICTORS; RECOVERY; SKILLS; HOME; OUTCOMES	Purpose: To examine the long-term consequences of early childhood traumatic brain injury (TBI), approximately 6.8 years post-injury, on cognitive communication competency within a complex interplay of individual, contextual, and psychosocial factors. Additionally, we were interested in looking at the association of communication competence with social competence and overall functioning.Methods: 64 children with orthopedic injury, 40 children with moderate traumatic brain injury, and 14 children with severe traumatic brain injury who were between 3years and 6years 11months at injury completed a narrative discourse task and clinical measures in a single visit at a longer term follow up in early adolescence, an average of 6.8years post injury. Analyses of covariance were conducted to compare groups on the discourse task, and hierarchical linear regressions were conducted to examine the association of discourse measures with clinical measures of cognitive and psychosocial functioning.Results: Children with severe traumatic brain injury performed worse than children with moderate traumatic brain injury and orthopedic injury on all discourse indices and clinical measures. Injury severity, pragmatic skills, and socioeconomic status were associated with discourse gist. Discourse gist was the most sensitive measure of communication competence, and it was significantly associated with psychosocial outcomes independent of group.Conclusion: Children who sustain a severe traumatic brain injury in early childhood are at risk for long-term cognitive communication impairments that may be related to a complex interplay of injury, individual, and social factors.Implications for rehabilitationThe assessment and treatment of cognitive communication impairments after traumatic brain injury are complex and require consideration of individual, contextual, and psychosocial factors.Discourse, in general, and gist reasoning specifically, is a sensitive measure for detecting cognitive communication competence several years after pediatric traumatic brain injury.Treatments to address gist reasoning deficits may support improvements in global and social functioning.	[Aguilar, Jessica M.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Elleman, Chloe B.] Univ Cincinnati, Cincinnati, OH USA; [Cassedy, Amy E.; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Minich, Nori Mercuri] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Minich, Nori Mercuri; Taylor, H. Gerry] Univ Hosp Cleveland, Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Yeates, Keith Owen] Univ Calgary, Dept Pediat & Clin Neurosci, Calgary, AB, Canada; [Taylor, H. Gerry] Nationwide Childrens Hosp Res Inst, Columbus, OH USA; [Taylor, H. Gerry] Ohio State Univ, Columbus, OH 43210 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Aguilar, JM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	jessica.aguilar@cchmc.org	Yeates, Keith/AAJ-4223-2020	Zhang, Nanhua/0000-0001-5796-3404	National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; State of Ohio Emergency Medical Services; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]	This publication was supported by grant R01 HD42729 from the National Institute of Child Health and Human Development (NICHD) and Trauma Research grants from the State of Ohio Emergency Medical Services. Additional support was provided through Grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health.	Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; BRADLEY RH, 1984, DEV PSYCHOL, V20, P315, DOI 10.1037/0012-1649.20.2.315; Bradley RH, 2000, J RES ADOLESCENCE, V10, P247, DOI 10.1207/SJRA1003_1; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Carrow-Woolfolk E, 2000, COMPREHENSIVE ASSESS; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Cermak CA, 2019, J HEAD TRAUMA REHAB, V34, pE13, DOI 10.1097/HTR.0000000000000419; Chapman SB, 2013, DISCOURSE STUD, V15, P519, DOI 10.1177/1461445613501444; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P36, DOI 10.1097/00001199-199510000-00006; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; College of Audiologists and Speech-Language Pathologists of Ontario, 2002, PREF PRACT GUID COGN; Cook LG, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00087; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Freund J, 1994, COGNITIVE COMMUNICAT; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); Hodges K, 1998, J BEHAV HEALTH SER R, V25, P325, DOI 10.1007/BF02287471; Hodges K., 1996, J CHILD FAM STUD, V5, P445, DOI [10.1007/BF02233865, DOI 10.1007/BF02233865]; Hung AH, 2017, J DEV BEHAV PEDIATR, V38, P49, DOI 10.1097/DBP.0000000000000366; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; Le K., 2011, ASHA LEADER, V16, P18, DOI [10.1044/leader.FTR4.16022011.18, DOI 10.1044/LEADER.FTR4.16022011.18, DOI 10.1044/leader.FTR4.16022011.18]; Lundine JP, 2018, AM J SPEECH-LANG PAT, V27, P247, DOI 10.1044/2017_AJSLP-16-0131; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Merrell KW, 2001, PSYCHOL SCHOOLS, V38, P313, DOI 10.1002/pits.1021; Merrell KW, 2002, EUGENE; Moran C, 2012, LANG SPEECH HEAR SER, V43, P264, DOI 10.1044/0161-1461(2011/10-0114); PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Totsika Vasiliki, 2004, Child Adolesc Ment Health, V9, P25, DOI 10.1046/j.1475-357X.2003.00073.x; Turkstra LS, 2015, DEV MED CHILD NEUROL, V57, P217, DOI 10.1111/dmcn.12600; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Walz NC, 2012, J NEUROPSYCHOL, V6, P143, DOI 10.1111/j.1748-6653.2011.02020.x; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447	54	2	2	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	AUG 13	2020	42	17			SI		2383	2392		10.1080/09638288.2019.1594397			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	NJ2JX	WOS:000565872800001	30978116	Green Accepted			2022-02-06	
J	Ostberg, A; Ledig, C; Katila, A; Maanpaa, HR; Posti, JP; Takala, R; Tallus, J; Glocker, B; Rueckert, D; Tenovuo, O				Ostberg, Anna; Ledig, Christian; Katila, Ari; Maanpaa, Henna-Riikka; Posti, Jussi P.; Takala, Riikka; Tallus, Jussi; Glocker, Ben; Rueckert, Daniel; Tenovuo, Olli			Volume Change in Frontal Cholinergic Structures After Traumatic Brain Injury and Cognitive Outcome	FRONTIERS IN NEUROLOGY			English	Article						cholinergic system; traumatic brain injury; atlas based volumetric MRI analysis; structural MRI; cognitive testing	HEAD-INJURY; ATTENTION PERFORMANCE; SUSTAINED ATTENTION; DIFFUSION-TENSOR; CHRONIC SEQUELS; DONEPEZIL; MILD; RIVASTIGMINE; MODERATE; ATROPHY	The cholinergic nuclei in the basal forebrain innervate frontal cortical structures regulating attention. Our aim was to investigate if cognitive test results measuring attention relate to the longitudinal volume change of cholinergically innervated structures following traumatic brain injury (TBI). During the prospective, observational TBIcare project patients with all severities of TBI (n= 114) and controls with acute orthopedic injuries (n= 17) were recruited. Head MRI was obtained in both acute (mean 2 weeks post-injury) and late (mean 8 months) time points. T1-weighted 3D MR images were analyzed with an automatic segmentation method to evaluate longitudinal, structural brain volume change. The cognitive outcome was assessed with the Cambridge Neuropsychological Test Automated Battery (CANTAB). Analyses included 16 frontal cortical structures, of which four showed a significant correlation between post-traumatic volume change and the CANTAB test results. The strongest correlation was found between the volume loss of the supplementary motor cortex and motor screening task results (R-sq 0.16,p< 0.0001), where poorer test results correlated with greater atrophy. Of the measured sum structures, greater cortical gray matter atrophy rate showed a significant correlation with the poorer CANTAB test results. TBI caused volume loss of frontal cortical structures that are heavily innervated by cholinergic neurons is associated with neuropsychological test results measuring attention.	[Ostberg, Anna; Posti, Jussi P.; Tenovuo, Olli] Turku Univ Hosp, Div Clin Neurosci, Turku Brain Injury Ctr, Turku, Finland; [Ostberg, Anna; Maanpaa, Henna-Riikka; Posti, Jussi P.; Tallus, Jussi; Tenovuo, Olli] Univ Turku, Inst Clin Med, Dept Neurol, Turku, Finland; [Ostberg, Anna; Maanpaa, Henna-Riikka; Posti, Jussi P.] Turku Univ Hosp, Dept Neurosurg, Neuroctr, Turku, Finland; [Ledig, Christian; Glocker, Ben; Rueckert, Daniel] Imperial Coll London, Dept Comp, London, England; [Katila, Ari; Takala, Riikka] Turku Univ Hosp, Dept Perioperat Serv Intens Care & Pain Med, Turku, Finland		Ostberg, A (corresponding author), Turku Univ Hosp, Div Clin Neurosci, Turku Brain Injury Ctr, Turku, Finland.; Ostberg, A (corresponding author), Univ Turku, Inst Clin Med, Dept Neurol, Turku, Finland.; Ostberg, A (corresponding author), Turku Univ Hosp, Dept Neurosurg, Neuroctr, Turku, Finland.	aesuom@utu.fi	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193	European Commission under the 7th Framework Programme [FP7-270259-TBIcare]; Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Government's Special Financial Transfer tied to academic research in Health Sciences (Finland); Alfred Kordelin Foundation; TYKS Foundation	This work was partially funded by the European Commission under the 7th Framework Programme (FP7-270259-TBIcare), the Academy of Finland (Grant No. #17379, JP) Government's Special Financial Transfer tied to academic research in Health Sciences (Finland) (JP), Alfred Kordelin Foundation (AO), and TYKS Foundation (AO).	Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bentley P, 2011, PROG NEUROBIOL, V94, P360, DOI 10.1016/j.pneurobio.2011.06.002; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bozzali M, 2006, NEUROIMAGE, V33, P286, DOI 10.1016/j.neuroimage.2006.06.044; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gill TM, 2000, J NEUROSCI, V20, P4745, DOI 10.1523/JNEUROSCI.20-12-04745.2000; Heckemann RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129211; Heckemann RA, 2011, NEUROIMAGE, V56, P2024, DOI 10.1016/j.neuroimage.2011.03.014; Himmelheber AM, 2000, COGNITIVE BRAIN RES, V9, P313, DOI 10.1016/S0926-6410(00)00012-4; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hong JH, 2012, J HEAD TRAUMA REHAB, V27, P172, DOI 10.1097/HTR.0b013e318217192d; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kim YW, 2009, CLIN NEUROPHARMACOL, V32, P63, DOI 10.1097/WNF.0b013e31816f1bc1; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kuo MF, 2007, J NEUROSCI, V27, P14442, DOI 10.1523/JNEUROSCI.4104-07.2007; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Ledig C, 2014, 2014 IEEE 11 INT S B; Ledig C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29295-9; Ledig C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188152; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; ostberg A, THESIS; Ostberg A, 2018, J HEAD TRAUMA REHAB, V33, P25, DOI 10.1097/HTR.0000000000000279; Rosier AM, 1999, EUR J NEUROSCI, V11, P3701, DOI 10.1046/j.1460-9568.1999.00784.x; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Tenovuo O, 2009, BRAIN INJURY, V23, P548, DOI 10.1080/02699050902926275; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; 2003, J NEUROPSYCH CLIN N, V15, P383	56	2	2	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 13	2020	11								832	10.3389/fneur.2020.00832			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NJ7ML	WOS:000566227200001	32903569	gold, Green Published			2022-02-06	
J	Polich, G; Gray, S; Tran, D; Morales-Quezada, L; Glenn, M				Polich, Ginger; Gray, Sarah; Duc Tran; Morales-Quezada, Leon; Glenn, Mel			Comparing focused attention meditation to meditation with mobile neurofeedback for persistent symptoms after mild-moderate traumatic brain injury: a pilot study	BRAIN INJURY			English	Article						Traumatic brain injury; meditation; neurofeedback; anxiety; depression	STRESS REDUCTION; MINDFULNESS; BIOFEEDBACK; AWARENESS; EXERCISE; LIFE; EEG	Primary Objective This study evaluated whether a meditation practice incorporating mobile neurofeedback (mNF) offers any advantage over a more traditional form of focused attention (FA) meditation in managing persistent symptoms after traumatic brain injury (TBI) (clinicaltrials.gov NCT02615535). Research Design Pilot randomized clinical trial, exploring feasibility of mNF in TBI. Methods and Procedures Participants included adults with chronic mood and/or cognitive complaints following mild-moderate TBI. Subjects practiced either FA (n = 10) or mNF (n = 10) meditation 12 minutes daily for 6 weeks. Pre-post intervention difference on the Neurobehavioral Symptom Inventory (NSI) was the primary outcome variable. Secondary outcomes included the Beck Anxiety Inventory (BAI), Beck Depression Inventory-II (BDI-II), amongst other scales and neurocognitive tests. Main Outcomes and Results No significant pre-post between-group differences were found on the NSI (p= .838) nor other assessments. In an exploratory analysis combining FA and mNF data, meditation was associated with significant improvements on the NSI (p= .04), BAI (p= .012) and BDI (p= .037). Conclusions Meditating with neurofeedback does not appear to provide an advantage over meditating on one's own for chronic post-TBI symptoms. Further research on home-based meditation following TBI, whether self-directed or technologically facilitated, is warranted.	[Polich, Ginger; Gray, Sarah; Morales-Quezada, Leon; Glenn, Mel] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Charlestown, MA 02129 USA; [Duc Tran] Loma Linda Univ, Dept Phys Med & Rehabil, Loma Linda, CA 92350 USA		Polich, G (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Charlestown, MA 02129 USA.	ginger.polich@mgh.harvard.edu					Adams ZW, 2018, HEALTH PSYCHOL, V37, P850, DOI 10.1037/hea0000584; Adler-Neal AL, 2017, CURRENT RHEUMATOLOGY; Anderson ND, 2007, MINDFULNESS BASED ST, V463; Arbabi-Kalati F, 2015, HEALTH SCOPE, V4; Aupperless A, 2018, TRIBLIVE; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Barnes Vernon A, 2013, Mil Med, V178, pe836, DOI 10.7205/MILMED-D-12-00426; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bedard M, 2005, J COGN REHABIL, V23; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bhayee Sheffy, 2016, BMC Psychol, V4, P60; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; CDC, 2015, C TRAUM BRAIN INJ US; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Clarke Tainya C, 2015, Natl Health Stat Report, P1; Cole MA, 2015, MIL MED, V180, P956, DOI 10.7205/MILMED-D-14-00581; Coulon SM, 2016, AM J PREV MED, V51, P95, DOI 10.1016/j.amepre.2016.01.026; Crosswell A. D., 2018, J OCCUP HEALTH, V24, P127; de Bruin EI, 2016, MINDFULNESS, V7, P1182, DOI 10.1007/s12671-016-0561-5; Economides M, 2018, MINDFULNESS, V9, P1584, DOI 10.1007/s12671-018-0905-4; Feldman G, 2007, J PSYCHOPATHOL BEHAV, V29, P177, DOI 10.1007/s10862-006-9035-8; Glenn M, 2018, ESSENTIALS PHYS MED; Goyal M, 2014, JAMA INT MED, V174; Gray SN, 2017, MED ACUPUNCT, V29, P215, DOI 10.1089/acu.2017.1220; Hiroe T, 2005, PSYCHIAT RES, V135, P229, DOI 10.1016/j.psychres.2004.03.014; Hofmann SG, 2017, PSYCHIAT CLIN N AM, V40; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jensen MP, 2018, INT J CLIN EXP HYPN, V66; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Johansson B, 2015, MINDFULNESS, V6, P227, DOI 10.1007/s12671-013-0249-z; Kaptchuk TJ, 2018, PERSPECT BIOL MED, V61, P311, DOI 10.1353/pbm.2018.0045; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lilliecreutz EK, 2017, EUR J PHYSIOTHER, V19, P229, DOI 10.1080/21679169.2017.1337220; Lloyd A, 2018, MINDFULNESS, V9, P673, DOI 10.1007/s12671-017-0813-z; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MacCoon DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097551; McHugh L, 2013, BRAIN INJ, V27; O'Neil M E., 2013, COMPLICATIONS MILD T, P1; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Polich G, 2018, J NEUROTRAUM, V35, P1205, DOI 10.1089/neu.2017.5506; Ricard M, 2014, SCI AM, V311, P39; Rosenzweig S, 2010, J PSYCHOSOM RES, V68, P29, DOI 10.1016/j.jpsychores.2009.03.010; Semple RJ, 2010, MINDFULNESS, V1, P121, DOI [DOI 10.1007/S12671-010-0017-2, 10.1007/s12671-010-0017-2]; Shonin E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00194; Singh N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/406261; Upchurch DM, 2019, J WOMENS HEALTH, V28, P135, DOI 10.1089/jwh.2018.7178; van Lutterveld R, 2017, NEUROIMAGE, V151, P117, DOI 10.1016/j.neuroimage.2016.02.047; Vitoula K, 2018, PAIN THER, V7, P1, DOI 10.1007/s40122-018-0099-4; Wahbeh H.N, 2014, OPEN MED J, V1; Wilson Jeff, 2014, MINDFUL AM MEDITATIO; Zernicke KA, 2013, INT J BEHAV MED, V20, P385, DOI 10.1007/s12529-012-9241-6	52	2	2	2	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 23	2020	34	10					1408	1415		10.1080/02699052.2020.1802781		AUG 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NI5TJ	WOS:000558957400001	32783645				2022-02-06	
J	Sarmiento, K; Miller, GF; Jones, SE				Sarmiento, Kelly; Miller, Gabrielle F.; Jones, Sherry Everett			Sports- or Physical Activity-Related Concussions and Feelings of Sadness or Hopelessness Among US High School Students: Results From the 2017 Youth Behavior Risk Survey	JOURNAL OF SCHOOL NURSING			English	Article; Early Access						concussion; sport; sadness; hopeless; student; mental health	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; LONGITUDINAL TRAJECTORIES; DEPRESSION; CHILDREN; OUTCOMES; EPIDEMIOLOGY; ADOLESCENTS; MODERATE; SUPPORT	For this study, we explored the association between high school students' reported history of sport- or physical activity-related concussions and persistent feelings of sadness or hopelessness. Data from the 2017 nationalYouth Risk Behavior Survey(YRBS;N= 14,765) was used for this analysis. YRBS is administered to high school students throughout the country every 2 years. Findings from this study demonstrate that the prevalence of persistent feelings of sadness or hopelessness was 36.4% among students who reported sustaining one or more concussions. Compared to students who did not report having sustained a concussion, the odds of persistent feelings of sadness or hopelessness were significantly higher among students who had sustained one or more concussions (AOR = 1.41). These findings support the need for continued efforts by school nurses and other health care providers to identify students with a history of concussion and assess their mental health needs.	[Sarmiento, Kelly; Miller, Gabrielle F.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Prevent, Atlanta, GA 30333 USA; [Jones, Sherry Everett] Ctr Dis Control & Prevent, Div Adolescent & Sch Hlth, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA		Sarmiento, K (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Prevent, Atlanta, GA 30333 USA.	ksarmiento@cdc.gov					Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; [Anonymous], 2019, NASN Sch Nurse, V34, P62, DOI 10.1177/1942602X18814249; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Brener ND, 2013, MMWR RECOMM REP, V62, P1; Brener ND, 2002, J ADOLESCENT HEALTH, V31, P336, DOI 10.1016/S1054-139X(02)00339-7; Brent DA, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0862-y; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; Centers for Disease Control and Prevention, 2017, WHAT IS CONC; Chandran A, 2020, RES SPORTS MED, V28, P42, DOI 10.1080/15438627.2019.1590834; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Curry AE, 2019, J PEDIATR-US, V210, P13, DOI 10.1016/j.jpeds.2019.04.001; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Fazel M, 2014, LANCET PSYCHIAT, V1, P377, DOI 10.1016/S2215-0366(14)70312-8; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Institute of Education Sciences, 2019, FAST FACTS; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Moser RS, 2017, DEV NEUROPSYCHOL, V42, P276, DOI 10.1080/87565641.2017.1334785; National Institute of Neurological Disorders and Stroke, 2002, TRAUM BRAIN INJ HOP; Riglin L, 2013, J ADOLESCENCE, V36, P507, DOI 10.1016/j.adolescence.2013.03.002; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Stein E, 2017, BRAIN INJURY, V31, P1736, DOI 10.1080/02699052.2017.1380843; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yang MN, 2019, AM J HEALTH BEHAV, V43, P258, DOI 10.5993/AJHB.43.2.3; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zatzick DF, 2011, PSYCHIAT SERV, V62, P264, DOI 10.1176/ps.62.3.pss6203_0264	44	2	2	2	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1059-8405	1546-8364		J SCH NURS	J. Sch. Nurs.											1059840520945389	10.1177/1059840520945389		AUG 2020	7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	NA0OT	WOS:000559520200001	32787613				2022-02-06	
J	Gooden, JR; Cox, CA; Petersen, V; Curtis, A; Manning, V; Lubman, DI				Gooden, James R.; Cox, Catherine A.; Petersen, Vanessa; Curtis, Ashlee; Manning, Victoria; Lubman, Dan, I			Characterisation of presentations to a community-based specialist addiction neuropsychology service: Cognitive profiles, diagnoses and comorbidities	DRUG AND ALCOHOL REVIEW			English	Article						neuropsychology; addiction; acquired brain injury; drugs and alcohol; cognition	SUBSTANCE-USE DISORDERS; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; NORMATIVE DATA; ABUSE; STIGMA; AGE	Introduction and Aims Cognitive impairment is a common feature of individuals with substance-use disorders. However, research tends to exclude highly complex clinical cases, limiting the generalisability of findings for 'real-world' populations. The objective of this study was to examine the complexities associated with addiction, substance use and cognitive impairment through the characterisation of client presentations to a newly established specialised addiction neuropsychology service. Design and Methods Retrospective case file audit. Neuropsychological assessment reports for consenting clients over a 4-year period were de-identified and reviewed. Cognitive domains assessed included attention, processing speed, working memory, intellectual functioning, memory and executive functioning. Results Of the 200 case files examined, the majority were male clients, with 11 years or lower of education and a history of daily substance use, with 30% continuing to use daily. Seventy-one percent had a formal mental health diagnosis and 41% had reported a history of trauma. The most prevalent cognitive impairments were observed in complex attention (50%) and memory (40%). New diagnoses were conveyed in 25% of cases, comprising acquired brain injury (16%) and neurodevelopmental disabilities (9%). Discussion and Conclusions It is common for clients with substance use histories referred to an addiction neuropsychology service to present with complex histories including psychosocial difficulties, comorbid mental health and medical issues and cognitive impairment. As such, careful diagnostic formulations are required when multiple factors may contribute to cognitive deficits. This study highlights the importance of a state-wide specialist addiction neuropsychology service in supporting diagnostic clarification and informing relevant treatment approaches.	[Gooden, James R.; Cox, Catherine A.; Petersen, Vanessa; Manning, Victoria; Lubman, Dan, I] Eastern Hlth, Turning Point, Melbourne, Vic, Australia; [Gooden, James R.] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia; [Curtis, Ashlee] Deakin Univ, Ctr Drug Use Addict & Antisocial Behav Res, Sch Psychol, Geelong, Vic, Australia; [Manning, Victoria; Lubman, Dan, I] Monash Univ, Monash Addict Res Ctr, Eastern Hlth Clin Sch, Melbourne, Vic, Australia		Gooden, JR (corresponding author), Turning Point, 110 Church St, Richmond, Vic 3121, Australia.	jamesg@turningpoint.org.au		Lubman, Dan/0000-0002-6747-1937; Gooden, James/0000-0001-6835-9528			Australian Bureau of Statistics, 2001, AUSTR SOC TRENDS 200; Australian Curriculum Assessment and Reporting Authority, 2016, YEAR 12 CERT RAT GEO; Australian Institute of Health and Welfare, 2017, NAT DRUG START HOUS; Bates ME, 2006, PSYCHOL ADDICT BEHAV, V20, P241, DOI 10.1037/0893-164X.20.3.241; Batey RG, 2015, ADDICTION MED PRINCI; Birtel MD, 2017, PSYCHIAT RES, V252, P1, DOI 10.1016/j.psychres.2017.01.097; Braun M, 2011, COGN BEHAV NEUROL, V24, P107, DOI 10.1097/WNN.0b013e3182351289; Brown PJ, 1999, PSYCHOL ADDICT BEHAV, V13, P115, DOI 10.1037/0893-164X.13.2.115; Broyd SJ, 2016, BIOL PSYCHIAT, V79, P557, DOI 10.1016/j.biopsych.2015.12.002; Chadwell, 2016, J ALCOHOL DRUG EDUC, V60, P55; Chilcoat HD, 2003, TRAUMA AND SUBSTANCE ABUSE: CAUSES, CONSEQUENCES, AND TREATMENT OF COMORBID DISORDERS, P9, DOI 10.1037/10460-001; Delis D.C., 2000, CALIFORNIA VERBAL LE; Desfosses M, 2014, AUST PSYCHOL, V49, P287, DOI 10.1111/ap.12071; Gould F, 2012, J PSYCHIATR RES, V46, P500, DOI 10.1016/j.jpsychires.2012.01.005; Hart CL, 2012, NEUROPSYCHOPHARMACOL, V37, P586, DOI 10.1038/npp.2011.276; Jackson M., 2011, CORRECTIONS RES PAPE; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; McHugo GJ, 2017, J HEAD TRAUMA REHAB, V32, pE65, DOI 10.1097/HTR.0000000000000249; MEYERS J, 1995, MEYERS SCORING SYSTE; Mills KL, 2006, AM J PSYCHIAT, V163, P652, DOI 10.1176/appi.ajp.163.4.652; Morisano D, 2014, NORD STUD ALCOHOL DR, V31, P5, DOI 10.2478/nsad-2014-0002; Parolin M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00887; Potvin S, 2018, ADDICT BEHAV, V80, P154, DOI 10.1016/j.addbeh.2018.01.021; RACP, 2019, EARL CHILDH IMP EARL; Reitan R, 1988, HALSTEAD REITAN NEUR; Roberts NP, 2015, CLIN PSYCHOL REV, V38, P25, DOI 10.1016/j.cpr.2015.02.007; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; Schmidt M., 1996, REY AUDITORY VERBAL; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stavro K, 2013, ADDICT BIOL, V18, P203, DOI 10.1111/j.1369-1600.2011.00418.x; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Troyer AK, 2006, AGING NEUROPSYCHOL C, V13, P20, DOI 10.1080/138255890968187; van Boekel LC, 2013, DRUG ALCOHOL DEPEN, V131, P23, DOI 10.1016/j.drugalcdep.2013.02.018; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Wechsler, 2008, WAIS 4 ADM SCORING M; Wechsler D., 2008, WMS 4 ADM SCORING MA	38	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0959-5236	1465-3362		DRUG ALCOHOL REV	Drug Alcohol Rev.	JAN	2021	40	1					83	92		10.1111/dar.13135		AUG 2020	10	Substance Abuse	Social Science Citation Index (SSCI)	Substance Abuse	PR8BJ	WOS:000558589200001	32789930				2022-02-06	
J	Lefebvre, G; Guay, S; Chamard, E; Theaud, G; de Guise, E; Bacon, BA; Descoteaux, M; De Beaumont, L; Theoret, H				Lefebvre, Genevieve; Guay, Samuel; Chamard, Emilie; Theaud, Guillaume; de Guise, Elaine; Bacon, Benoit Antoine; Descoteaux, Maxime; De Beaumont, Louis; Theoret, Hugo			Diffusion Tensor Imaging in Contact and Non-Contact University-Level Sport Athletes	JOURNAL OF NEUROTRAUMA			English	Article						brain imaging; diffusion-weighted imaging; physical activity; sport-related concussion; subconcussive	WHITE-MATTER INTEGRITY; HEAD IMPACT EXPOSURE; PHYSICAL-ACTIVITY; AEROBIC FITNESS; FOOTBALL PLAYERS; CORPUS-CALLOSUM; HEALTH-BENEFITS; SEX-DIFFERENCES; SINGLE SEASON; MENTAL-HEALTH	Subconcussive hits to the head and physical fitness both have been associated with alterations in white matter (WM) microstructure in partly overlapping areas of the brain. The aim of the present study was to determine whether WM damage associated with repeated exposure to subconcussive hits to the head in university level contact sports athletes is modulated by high levels of fitness. To this end, 72 students were recruited: 24 athletes practicing a varsity contact sport (A-CS), 24 athletes practicing a varsity non-contact sport (A-NCS), and 24 healthy non-athletes (NA). Participants underwent a magnetic resonance imaging session that included diffusion-weighted imaging. Between-groups, statistical analyses were performed with diffusion tensor imaging measures extracted by tractometry of sections of the corpus callosum and the corticospinal tract. Most significant effects were found in A-NCS who exhibited higher fractional anisotropy (FA) values than A-CS in almost all segments of the corpus callosum and in the corticospinal tract. The A-NCS also showed higher FA compared with NA in the anterior regions of the corpus callosum and the corticospinal tracts. No group difference was found between the A-CS and the NA groups. These data suggest that repeated subconcussive hits to the head lead to anisotropic changes in the WM that may counteract the beneficial effects associated with high levels of fitness.	[Lefebvre, Genevieve; Guay, Samuel; Chamard, Emilie; de Guise, Elaine; Theoret, Hugo] Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada; [De Beaumont, Louis] Univ Montreal, Dept Surg, Montreal, PQ, Canada; [Theaud, Guillaume; Descoteaux, Maxime] Univ Sherbrooke, Sherbrooke Connect Imaging Lab SCIL, Sherbrooke, PQ, Canada; [Bacon, Benoit Antoine] Carleton Univ, Dept Psychol, Ottawa, ON, Canada; [Theoret, Hugo] CHU St Justine, Res Ctr, Montreal, PQ, Canada		Theoret, H (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	hugo.theoret@umontreal.ca		Theoret, Hugo/0000-0002-7458-8797; Guay, Samuel/0000-0001-6990-839X	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This work was supported by a grant from the Canadian Institutes of Health Research.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bell JA, 2018, J AM COLL CARDIOL, V72, P3142, DOI 10.1016/j.jacc.2018.09.066; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Bigler ED, 2018, INT J PSYCHOPHYSIOL, V132, P105, DOI 10.1016/j.ijpsycho.2017.09.006; Borja MJ, 2018, NEUROIMAG CLIN N AM, V28, P117, DOI 10.1016/j.nic.2017.09.009; Brickenkamp R, 2003, D2 TEST ATTENTION MA; Buckley J, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/Mhum.2014.00747, 10.3389/fnhum.2014.00747, 10.3389/fnhum.2014.00584]; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chaddock-Heyman L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00950; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Churchill NW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00390; Colby JB, 2012, NEUROIMAGE, V59, P3227, DOI 10.1016/j.neuroimage.2011.11.004; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cousineau M, 2017, NEUROIMAGE-CLIN, V16, P222, DOI 10.1016/j.nicl.2017.07.020; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Degens H, 2019, EUR J APPL PHYSIOL, V119, P1377, DOI 10.1007/s00421-019-04128-3; Delis D.C., 2001, DELIS KAPLAN D KEFS; Di Tommaso P, 2017, NAT BIOTECHNOL, V35, P316, DOI 10.1038/nbt.3820; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Dinoff A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163037; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; El-Sayes J, 2019, NEUROSCIENTIST, V25, P65, DOI 10.1177/1073858418771538; Feter N, 2018, SCI SPORT, V33, P8, DOI 10.1016/j.scispo.2017.06.009; Fletcher JL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124131; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Garyfallidis E, 2018, NEUROIMAGE, V170, P283, DOI 10.1016/j.neuroimage.2017.07.015; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; Gogliettino AR, 2016, DRUG ALCOHOL DEPEN, V162, P26, DOI 10.1016/j.drugalcdep.2016.02.015; Gonzales MM, 2013, BRAIN TOPOGR, V26, P126, DOI 10.1007/s10548-012-0248-8; Guberman GI, 2020, BRAIN STRUCT FUNCT, V225, P441, DOI 10.1007/s00429-019-02002-8; Hanggi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124222; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Huang T, 2014, SCAND J MED SCI SPOR, V24, P1, DOI 10.1111/sms.12069; Hutchison MG, 2018, INT J PSYCHOPHYSIOL, V132, P55, DOI 10.1016/j.ijpsycho.2017.11.006; King DA, 2018, J SCI MED SPORT, V21, P139, DOI 10.1016/j.jsams.2017.10.026; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Krityakiarana W, 2010, INT J NEUROSCI, V120, P280, DOI 10.3109/00207450903222741; Kurtzer GM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177459; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Lao Y, 2015, PROC SPIE, V9287, DOI 10.1117/12.2072600; Lebel C, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3778; Lefebvre G, 2018, J NEUROTRAUM, V35, P953, DOI 10.1089/neu.2017.5254; Lenth RV., 2018, PACKAGE EMMEANS ESTI; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lubans D, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1642; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marks BL, 2011, BRIT J SPORT MED, V45, P1208, DOI 10.1136/bjsm.2009.068114; Marks BL, 2007, ANN NY ACAD SCI, V1097, P171, DOI 10.1196/annals.1379.022; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027628; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Meyers JE., 1995, REY COMPLEX FIGURE T; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nakata H, 2010, BRAIN RES REV, V62, P197, DOI 10.1016/j.brainresrev.2009.11.006; Oberlin LE, 2016, NEUROIMAGE, V131, P91, DOI 10.1016/j.neuroimage.2015.09.053; Opel N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49301-y; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Pinheiro J., 2020, NLME LINEAR NONLINEA; Puterman E, 2017, HEALTH PSYCHOL, V36, P1186, DOI 10.1037/hea0000532; Raichlen DA, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00610; RCoreTeam, 2020, R LANG ENV STAT COMP; Repple J, 2018, PSYCHONEUROENDOCRINO, V91, P179, DOI 10.1016/j.psyneuen.2018.03.007; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Rubin TG, 2018, RADIOLOGY, V289, P478, DOI 10.1148/radiol.2018180217; RUFF RM, 1996, RUFF 2 7 SELECTIVE A; Sampaio-Baptista C, 2017, NEURON, V96, P1239, DOI 10.1016/j.neuron.2017.11.026; Saraulli D, 2017, CURR NEUROPHARMACOL, V15, P519, DOI 10.2174/1570159X14666160412150223; Schneider DK, 2019, J NEUROTRAUM, V36, P2831, DOI 10.1089/neu.2019.6398; Scilpy, 2019, SHERBROOKE CONNECTIV; Sexton CE, 2016, NEUROIMAGE, V131, P81, DOI 10.1016/j.neuroimage.2015.09.071; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith A., 1982, SYMBOL DIGIT MODALIT; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Stillman CM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00626; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Theaud G, 2020, NEUROIMAGE, V218, DOI 10.1016/j.neuroimage.2020.116889; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI 10.1139/H11-010; Tremblay S, 2018, INT J PSYCHOPHYSIOL, V132, P167, DOI 10.1016/j.ijpsycho.2017.09.005; Tseng BY, 2013, NEUROIMAGE, V82, P510, DOI 10.1016/j.neuroimage.2013.06.011; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Wang B, 2013, NEUROIMAGE, V65, P476, DOI 10.1016/j.neuroimage.2012.10.007; Warburton DER, 2017, CURR OPIN CARDIOL, V32, P541, DOI 10.1097/HCO.0000000000000437; Wei GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028309; White T., 1996, COLOR TRAILS TEST PR; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Zheng J, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0506-8	105	2	2	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2021	38	5					529	537		10.1089/neu.2020.7170		AUG 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	QP9GR	WOS:000558942200001	32640880				2022-02-06	
J	Martini, DN; Parrington, L; Stuart, S; Fino, PC; King, LA				Martini, Douglas N.; Parrington, Lucy; Stuart, Samuel; Fino, Peter C.; King, Laurie A.			Gait Performance in People with Symptomatic, Chronic Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						concussion; gait domains; long term; persisting symptoms; wearable sensors	DUAL-TASK GAIT; SERVICE MEMBERS; POSTCONCUSSIVE SYMPTOMS; EXECUTIVE DYSFUNCTION; COGNITIVE IMPAIRMENT; CONCUSSION; VARIABILITY; SINGLE; RISK; REHABILITATION	There is a dearth of knowledge about how symptom severity affects gait in the chronic (>3 months) mild traumatic brain injury (mTBI) population despite up to 53% of people reporting persisting symptoms after mTBI. The aim of this investigation was to determine whether gait is affected in a symptomatic, chronic mTBI group and to assess the relationship between gait performance and symptom severity on the Neurobehavioral Symptom Inventory (NSI). Gait was assessed under single- and dual-task conditions using five inertial sensors in 57 control subjects and 65 persons with chronic mTBI (1.0 year from mTBI). The single- and dual-task gait domains of Pace, Rhythm, Variability, and Turning were calculated from individual gait characteristics. Dual-task cost (DTC) was calculated for each domain. The mTBI group walked (domain z-score mean difference, single-task = 0.70; dual-task = 0.71) and turned (z-score mean difference, single-task = 0.69; dual-task = 0.70) slower (p < 0.001) under both gait conditions, with less rhythm under dual-task gait (z-score difference = 0.21;p = 0.001). DTC was not different between groups. Higher NSI somatic subscore was related to higher single- and dual-task gait variability as well as slower dual-task pace and turning (p < 0.01). Persons with chronic mTBI and persistent symptoms exhibited altered gait, particularly under dual-task, and worse gait performance related to greater symptom severity. Future gait research in chronic mTBI should assess the possible underlying physiological mechanisms for persistent symptoms and gait deficits.	[Martini, Douglas N.; Parrington, Lucy; Stuart, Samuel; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, 3181 Southwest Sam Jackson Pk Rd,L105, Portland, OR 97239 USA; [Martini, Douglas N.; Parrington, Lucy; Stuart, Samuel; King, Laurie A.] Vet Affairs Portland Healthcare Syst, Portland, OR USA; [Stuart, Samuel] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne, Tyne & Wear, England; [Fino, Peter C.] Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT USA		Martini, DN (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 Southwest Sam Jackson Pk Rd,L105, Portland, OR 97239 USA.	dmartini@umass.edu	Stuart, Samuel/I-6449-2019	Stuart, Samuel/0000-0001-6846-9372; Parrington, Lucy/0000-0001-8507-9974	 [W81XWH-15-0620]	This study was supported by the Assistant Secretary of Defense for Health Affairs under the Award Number W81XWH-15-0620. All interpretations and opinions are those of the author and are not necessarily endorsed by the Department of Defense.	Assal F, 2010, SWISS ARCH NEUROL PS, V161, P195; Bayot M, 2018, NEUROPHYSIOL CLIN, V48, P361, DOI 10.1016/j.neucli.2018.10.003; Bernstein N.., 1966, COORDINATION REGULAT; Bryant MS, 2011, NEUROL RES, V33, P959, DOI 10.1179/1743132811Y.0000000044; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Callisaya ML, 2011, AGE AGEING, V40, P481, DOI 10.1093/ageing/afr055; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark DJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00246; Cohen J, 1977, STAT POWER ANAL BEHA; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Demakakos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068632; Findling O, 2011, GAIT POSTURE, V34, P473, DOI 10.1016/j.gaitpost.2011.06.021; Fino PC, 2018, J NEUROTRAUM, V35, P1167, DOI 10.1089/neu.2017.5231; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0812-7; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Frenkel-Toledo Silvi, 2005, J Neuroeng Rehabil, V2, P23, DOI 10.1186/1743-0003-2-23; Gilat M, 2017, NEUROIMAGE, V152, P207, DOI 10.1016/j.neuroimage.2017.02.073; Hausdorff JM, 2003, J GERIATR PSYCH NEUR, V16, P53, DOI 10.1177/0891988702250580; Helbostad JL, 2007, J GERONTOL A-BIOL, V62, P1010, DOI 10.1093/gerona/62.9.1010; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lord S, 2013, MOVEMENT DISORD, V28, P1534, DOI 10.1002/mds.25545; Lord S, 2013, J GERONTOL A-BIOL, V68, P820, DOI 10.1093/gerona/gls255; Mac Donald CL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6676; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mancini M, 2015, NEUROREHABILITATION, V37, P3, DOI 10.3233/NRE-151236; Manor B, 2020, ANN NEUROL, V87, P75, DOI 10.1002/ana.25638; Martini DN, 2016, GAIT POSTURE, V49, P264, DOI 10.1016/j.gaitpost.2016.06.028; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Michalak J, 2009, PSYCHOSOM MED, V71, P580, DOI 10.1097/PSY.0b013e3181a2515c; Montero-Odasso M, 2012, ARCH PHYS MED REHAB, V93, P293, DOI 10.1016/j.apmr.2011.08.026; Moore SA, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0341-z; Morris R, 2019, PARKINSONISM RELAT D, V69, P104, DOI 10.1016/j.parkreldis.2019.06.014; Morris R, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab4023; Morrison S, 2016, J AM MED DIR ASSOC, V17, P402, DOI 10.1016/j.jamda.2015.12.013; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Pape MM, 2020, MIL MED, V185, P428, DOI 10.1093/milmed/usz265; Pape MM, 2016, J HEAD TRAUMA REHAB, V31, P339, DOI 10.1097/HTR.0000000000000179; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patience J, 2019, AM J GERIAT PSYCHIAT, V27, P1375, DOI 10.1016/j.jagp.2019.07.007; Robitaille N, 2017, DISABIL REHABIL-ASSI, V12, P758, DOI 10.1080/17483107.2016.1229048; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; SHOR RE, 1975, J GEN PSYCHOL, V93, P281; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Stuart S, 2020, J NEUROTRAUM, V37, P139, DOI 10.1089/neu.2019.6450; Stuart S, 2020, HUM MOVEMENT SCI, V69, DOI 10.1016/j.humov.2019.102557; Takei Y, 1997, EXP BRAIN RES, V115, P361, DOI 10.1007/PL00005705; Takei Y, 1996, BRAIN RES BULL, V40, P491, DOI 10.1016/0361-9230(96)00147-5; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Vandenbossche J, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00356; Verghese J, 2008, J AM GERIATR SOC, V56, P1244, DOI 10.1111/j.1532-5415.2008.01758.x; Verghese J, 2007, J NEUROL NEUROSUR PS, V78, P929, DOI 10.1136/jnnp.2006.106914; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	66	2	2	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2021	38	2					218	224		10.1089/neu.2020.6986		AUG 2020	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PP0TL	WOS:000558942700001	32495691	Green Accepted			2022-02-06	
J	Rinaldi, A; Stewart-Willis, JJ; Scarisbrick, D; Proctor-Weber, Z				Rinaldi, Anthony; Stewart-Willis, Jada J.; Scarisbrick, David; Proctor-Weber, Zoe			Clinical utility of the TOMMe10 scoring criteria for detecting suboptimal effort in an mTBI veteran sample	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						mTBI; performance validity; assessment	TRAUMATIC BRAIN-INJURY; TRIAL 1; PERFORMANCE; ERRORS; RATES	In the context of diminishing reimbursement and patient access demands, researchers continually refine performance validity measures (PVMs) to maximize efficiency while maintaining confidence in obtained data. This is particularly true for high PVM failure populations (e.g., mTBI patients). The TOMMe10 (number of errors on first 10 TOMM items) is one method this study utilized for classifying PVM performance as pass/fail (fail defined as failure on 2 of 6 PVM scores, pass defined as 0/1 failures). The present study hypothesized that the TOMMe10 would have equitable sensitivity/specificity for identifying non-credible cognitive performance among veterans with mTBI compared to previous research findings and commonly used performance validity measures (e.g., TOMM or WMT). Data were analyzed from 54 veterans assigned to a pass and fail group based on their performance across six recognized PVMs. Results revealed pass/fail groups were not significantly different regarding age, educational, or racial background. ROC analyses found the TOMMe10 demonstrated excellent discriminability (AUC = .803 +/-.128), indicating that the TOMMe10 could have clinical utility within an mTBI veteran sample, particularly in conjunction with a second PVM. Specific population limitations are discussed. Additional research should elucidate this measure's performance with additional populations, including non-veteran mTBI, dementia, moderate-severe TBI, and inpatient populations.	[Rinaldi, Anthony] Gaylord Specialty Healthcare, Dept Psychol, Wallingford, CT 06492 USA; [Stewart-Willis, Jada J.; Proctor-Weber, Zoe] CW Bill Young Bay Pines VAHCS, Dept Psychol, Bay Pines, FL USA; [Scarisbrick, David] West Virginia Sch Med, WVU Dept Behav Med & Psychiat, WVU Dept Neurosci, Morgantown, VA USA		Rinaldi, A (corresponding author), Gaylord Specialty Healthcare, 50 Gaylord Farm Rd, Wallingford, CT 06492 USA.	Anrinaldi@gaylord.org					Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bujang MA, 2016, J CLIN DIAGN RES, V10, pYE1, DOI 10.7860/JCDR/2016/18129.8744; Denning J., 2014, ARCH CLIN NEUROPSYCH, V27; Denning JH, 2021, APPL NEUROPSYCH-ADUL, V28, P35, DOI 10.1080/23279095.2019.1588122; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Grabyan JM, 2018, CLIN NEUROPSYCHOL, V32, P468, DOI 10.1080/13854046.2017.1368715; Green P., 1996, WORD MEMORY TEST USE; Greher MR, 2017, J PSYCHIATR PRACT, V23, P134, DOI 10.1097/PRA.0000000000000218; Gunner JH, 2012, ARCH CLIN NEUROPSYCH, V27, P1, DOI 10.1093/arclin/acr089; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Kansagara D., 2013, COMPLICATIONS MILD T; Kirkham R, 2013, UBICOMP'13: PROCEEDINGS OF THE 2013 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P73, DOI 10.1145/2493432.2493468; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Loughan AR, 2016, CHILD NEUROPSYCHOL, V22, P707, DOI 10.1080/09297049.2015.1020774; Martin PK, 2020, CLIN NEUROPSYCHOL, V34, P88, DOI 10.1080/13854046.2019.1637027; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730	28	2	2	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2020.1803870		AUG 2020	7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	MY5WO	WOS:000558487500001	32780587				2022-02-06	
J	Nguyen, JC; Back, SJ; Barrera, CA; Patel, M; Nguyen, MK; Hong, SJ; Sankar, WN				Nguyen, Jie C.; Back, Susan J.; Barrera, Christian A.; Patel, Maya; Nguyen, Michael K.; Hong, Shijie; Sankar, Wudbhav N.			Developmental dysplasia of the hip: can contrast-enhanced MRI predict the development of avascular necrosis following surgery?	SKELETAL RADIOLOGY			English	Article						AVN; DDH; Hip dysplasia; Infant; MRI; Osteonecrosis; Reduction; Spica	CLOSED REDUCTION; CONGENITAL DISLOCATION; PAVLIK HARNESS; FEMORAL-HEAD; OSSIFIC NUCLEUS; ABDUCTION; CHILDREN; FAILURE; GROWTH; AGE	Objective To investigate the performance of contrast-enhanced MRI for predicting avascular necrosis (AVN) of the treated femoral head after surgical reduction for developmental dysplasia of the hip (DDH) using qualitative and quantitative methods. Methods and materials This IRB-approved, HIPAA compliant retrospective study included 47 children who underwent same-day contrast-enhanced MRI following unilateral surgical hip reduction between April 2009 and June 2018. Blinded to the clinical outcome, 3 reviewers (2 pediatric radiologists and 1 pediatric orthopedist) independently categorized the enhancement pattern of the treated femoral head. Signal intensities, measured using regions of interest (ROI), were compared between treated and untreated hips and percent enhancements were compared between hips that developed and did not develop AVN. Post-reduction radiographs were evaluated using Salter's criteria for AVN and Kalmachi and MacEwen's classification for growth disturbance. Non-parametric tests and Fisher exact test were used to compare enhancement values between AVN and non-AVN hips. Bonferroni correction was used for multiple comparisons. Results Ten (21%) out of the 47 children (7 boys and 40 girls; mean age 9.0 +/- 4.7 months) developed AVN. Age at surgical reduction was significantly higher (p = 0.03) for hips that developed AVN. No significant differences were found in gender (p = 0.61), laterality (p = 0.46), surgical approach (p = 0.08), history of pre-operative bracing (p = 0.72), abduction angle (p = 0.18-0.44), enhancement pattern (p = 0.66-0.76), or percent enhancement (p = 0.41-0.88) between AVN and non-AVN groups. Conclusion Neither enhancement pattern nor percent enhancement predicted AVN, suggesting that post-reduction conventional MRI does not accurately distinguish between reversible and permanent vascular injury.	[Nguyen, Jie C.; Back, Susan J.; Barrera, Christian A.; Nguyen, Michael K.; Hong, Shijie] Childrens Hosp Philadelphia, Dept Radiol, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Nguyen, Jie C.; Back, Susan J.; Sankar, Wudbhav N.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Patel, Maya] Rowan Univ, Cooper Med Sch, Camden, NJ USA; [Sankar, Wudbhav N.] Childrens Hosp Philadelphia, Div Orthoped Surg, Philadelphia, PA 19104 USA		Nguyen, JC (corresponding author), Childrens Hosp Philadelphia, Dept Radiol, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Nguyen, JC (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	nguyenj6@email.chop.edu		Nguyen, Michael/0000-0003-2322-5782; Barrera, Christian/0000-0002-5029-4743			American College of Radiology, 2019, ACR APPR CRIT DEV DY; [Anonymous], 2014, DET NAN MAN PED DEV; Bedoya MA, 2014, AM J ROENTGENOL, V203, pW440, DOI 10.2214/AJR.13.12341; BROUGHAM DI, 1990, J BONE JOINT SURG BR, V72, P557, DOI 10.1302/0301-620X.72B4.2380203; DeFrancesco CJ, 2017, J CHILD ORTHOP, V11, P277, DOI 10.1302/1863-2548.11.170038; Gornitzky AL, 2016, CLIN ORTHOP RELAT R, V474, P1153, DOI 10.1007/s11999-015-4387-6; Haruno LS, 2019, J PEDIATR ORTHOP B, V28, P424, DOI 10.1097/BPB.0000000000000606; Haruno LS, 2019, J PEDIAT ORTHOP B; Homer CJ, 2000, PEDIATRICS, V105, P896; Jaramillo D, 1996, AM J ROENTGENOL, V166, P879, DOI 10.2214/ajr.166.4.8610567; Jaramillo D, 1998, AM J ROENTGENOL, V170, P1633, DOI 10.2214/ajr.170.6.9609187; KALAMCHI A, 1980, J BONE JOINT SURG AM, V62, P876, DOI 10.2106/00004623-198062060-00002; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee MC, 2006, ORTHOP CLIN N AM, V37, P119, DOI 10.1016/j.ocl.2005.12.001; Luhmann SJ, 1998, J BONE JOINT SURG AM, V80A, P1719, DOI 10.2106/00004623-199812000-00001; Luhmann SJ, 2003, J BONE JOINT SURG AM, V85A, P239, DOI 10.2106/00004623-200302000-00009; Nguyen JC, 2017, RADIOGRAPHICS, V37, P1791, DOI 10.1148/rg.2017170029; Nguyen S, 2019, J SEX MED, V16, pS94, DOI 10.1016/j.jsxm.2019.01.197; Novais EN, 2016, CLIN ORTHOP RELAT R, V474, P1847, DOI 10.1007/s11999-016-4776-5; Novais EN, 2016, CLIN ORTHOP RELAT R, V474, P1166, DOI 10.1007/s11999-015-4590-5; Patel H, 2001, CAN MED ASSOC J, V164, P1669; Patel H, 2001, CMAJ, V164, P81153; Pellerito J, 2018, J ULTRAS MED, V37, pE1, DOI 10.1002/jum.14829; Roposch A, 2011, CLIN ORTHOP RELAT R, V469, P2838, DOI 10.1007/s11999-011-1801-6; Roposch A, 2009, J BONE JOINT SURG AM, V91A, P911, DOI 10.2106/JBJS.H.00096; SALTER RB, 1969, CAN J SURG, V12, P44; Sankar WN, 2019, J PEDIATR ORTHOPED, V39, P111, DOI 10.1097/BPO.0000000000000895; Sankar WN, 2015, J BONE JOINT SURG AM, V97A, P292, DOI 10.2106/JBJS.N.00707; Segal LS, 1999, J PEDIATR ORTHOPED, V19, P177, DOI 10.1097/00004694-199903000-00008; Shin CH, 2016, J BONE JOINT SURG AM, V98, P952, DOI 10.2106/JBJS.15.00992; Shipman SA, 2006, PEDIATRICS, V117, pE557, DOI 10.1542/peds.2005-1597; THOMAS IH, 1989, J PEDIATR ORTHOPED, V9, P525, DOI 10.1097/01241398-198909010-00005; Tiderius C, 2009, J PEDIATR ORTHOPED, V29, P14, DOI 10.1097/BPO.0b013e3181926c40; Ucar DH, 2004, J PEDIATR ORTHOP B, V13, P70, DOI 10.1097/01202412-200403000-00002; Wenger D, 2013, ACTA ORTHOP, V84, P483, DOI 10.3109/17453674.2013.850009; Xu M, 2013, J PEDIATR ORTHOP B, V22, P179, DOI 10.1097/BPB.0b013e32835f1f7a	36	2	2	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0364-2348	1432-2161		SKELETAL RADIOL	Skeletal Radiol.	FEB	2021	50	2					389	397		10.1007/s00256-020-03572-z		AUG 2020	9	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	PF2DT	WOS:000557324800001	32772128				2022-02-06	
J	Aidinoff, E; Elkayam, K; Oximitny, A; Groswasser, Z; Gelernter, I; Catz, A				Aidinoff, Elena; Elkayam, Keren; Oximitny, Ana; Groswasser, Zeev; Gelernter, Ilana; Catz, Amiram			Consciousness recovery after various periods in vegetative state	BRAIN INJURY			English	Article						Unawareness; brain injury; time to recovery of consciousness	SEVERE BRAIN-INJURY	Background Recent studies suggest that late recovery from vegetative state (VS) is more prevalent today than previously thought. This study examined the decline in the rate of recovery from VS with time after admission to rehabilitation, and established a new time frame, in which the odds of recovery from VS remain substantial. Methods Data of 206 patients with VS after traumatic and non-traumatic brain injuries (TBI and NTBI), who were treated at the Loewenstein Rehabilitation Hospital (LRH), in Raanana, Israel, between 2003 and 2015, and described in a previous publication, were further analysed. Rate of recovery from VS was monitored at several time points after admission to intensive care and consciousness rehabilitation (ICCR). Results The odds of consciousness recovery were at least 54% at admission to ICCR, and 48%, 33%, 19%, and 7% at 3, 6, 9, and 12 months after admission, respectively. Conclusions The rate of recovery from VS decreases significantly with time, but contrary to previous consensus, 6-12 months after admission to ICCR, the odds of recovery from VS after TBI and NTBI remain substantial.	[Aidinoff, Elena; Elkayam, Keren; Oximitny, Ana; Groswasser, Zeev; Catz, Amiram] Loewenstein Hosp & Rehabil Ctr, Intens Care & Consciousness Rehabil Dept, IL-4355840 Raanana, Israel; [Aidinoff, Elena; Groswasser, Zeev; Gelernter, Ilana; Catz, Amiram] Tel Aviv Univ, Intens Care & Consciousness Rehabil Dept, Tel Aviv, Israel		Aidinoff, E (corresponding author), Loewenstein Hosp & Rehabil Ctr, Intens Care & Consciousness Rehabil Dept, IL-4355840 Raanana, Israel.	aidinofe@clalit.org.il		Catz, Amiram/0000-0002-7879-2015	Loewenstein Rehabilitation Hospital	The study was supported by a research fund of Loewenstein Rehabilitation Hospital.	Aidinoff E, 2018, BRAIN INJURY, V32, P297, DOI 10.1080/02699052.2017.1418535; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Avesani R, 2006, BRAIN INJURY, V20, P333, DOI 10.1080/02699050500487605; Baricich A, 2017, FUNCT NEUROL, V32, P131; Bender A, 2015, DTSCH ARZTEBL INT, V112, P235, DOI 10.3238/arztebl.2015.0235; Christensen AL, 1994, BRAIN INJURY NEUROPS; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Faran S, 2006, J NEUROL NEUROSUR PS, V77, P998, DOI 10.1136/jnnp.2005.076554; Krimchansky BZ, 2006, ISR MED ASSOC J, V8, P819; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Whyte J, 2009, PROG BRAIN RES, V177; Yelden K, 2018, DISABIL REHABIL, V40, P2433, DOI 10.1080/09638288.2017.1339209	13	2	2	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 28	2020	34	9					1253	1256		10.1080/02699052.2020.1800093		AUG 2020	4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ND6FI	WOS:000556092900001	32757790				2022-02-06	
J	Mealings, M; Douglas, J; Olver, J				Mealings, Margaret; Douglas, Jacinta; Olver, John			Is it me or the injury: Students' perspectives on adjusting to life after traumatic brain injury through participation in study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Adjustment; Students; Insider Perspectives; Participation	SELF-IDENTITY; REHABILITATION; POSTSECONDARY; PEOPLE; IMPACT; TBI; ENGAGEMENT; EXPERIENCE; CHILDREN; WORKING	Following traumatic brain injury (TBI), participating in education often provides a pathway for returning to a student's pre-injury life. In this paper, we explore themes related to adjustment and identity that emerged from students' reflections about their study journey. The data for this project are drawn from a longitudinal, predominantly qualitative investigation. Twelve students (aged: 17-32 years) completed up to three in-depth interviews over a period of 4-15 months, capturing a total of 30 time points. Data were analysed using grounded theory methods. A significant theme of "Is it Me or is it the Injury?" emerged from the context of students' descriptions of self, "Me" and thoughts about their injury, "The Injury." This emergent theme was indicative of the complex processes involved in adjusting and reshaping identity that arose from students' participation in education. The concepts identified in this research suggest that clinicians and educators must adopt a comprehensive, holistic and flexible approach to supporting students that can be adapted to reflect the individual and dynamic processes involved.	[Mealings, Margaret; Douglas, Jacinta] La Trobe Univ, Coll Sci Hlth & Engn, Bundoora, Vic, Australia; [Mealings, Margaret; Olver, John] Epworth Healthcare, Richmond, Australia; [Douglas, Jacinta] Summer Fdn, Box Hill, Vic, Australia; [Olver, John] Epworth Monash Rehabil Med Unit, Richmond, Australia		Mealings, M (corresponding author), Epworth Rehabil, Commun Integrat Team, 89 Bridge Rd, Richmond, Vic 3121, Australia.	margaret.mealings@epworth.org.au		Douglas, Jacinta/0000-0003-0940-6624; Olver, John/0000-0001-7069-1191; Mealings, Margaret/0000-0001-8264-275X	Epworth Healthcare; Victorian Brain Injury Recovery Association/East Kew Branch of the Community Bendigo Bank Research Scholarship	This research was supported by scholarships awarded to the first author by Epworth Healthcare and Victorian Brain Injury Recovery Association/East Kew Branch of the Community Bendigo Bank Research Scholarship.	[Anonymous], 2011, NVIVO VERS 10; Arnett J. J, 2014, EMERGING ADULTHOOD W, V2nd, DOI [10.1093/acprof:oso/9780199929382.001.0001, DOI 10.1093/ACPROF:OSO/9780199929382.001.0001]; Beadle EJ, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000158; Canto AI, 2014, EDUC PSYCHOL PRACT, V30, P88, DOI 10.1080/02667363.2014.883498; Carnicelli S, 2017, DIGITAL LEISURE CULTURES: CRITICAL PERSPECTIVES, P1; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Charmaz K., 2014, BROKERAGE CLOSURE IN; Charmaz K., 2014, CONSTRUCTING GROUNDE, V2nd edition; Coetzer R, 2009, CNS SPECTRUMS, V14, P632, DOI 10.1017/S1092852900023877; Corbin J.M., 1998, BASICS QUALITATIVE R; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Douglas J., 2015, RETHINKING REHABILIT, P136; Douglas J., 2011, SOCIAL CURE IDENTITY; Douglas J, 2015, INT J SPEECH-LANG PA, V17, P199, DOI 10.3109/17549507.2015.1016113; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Dryer R, 2016, INT J DISABIL DEV ED, V63, P419, DOI 10.1080/1034912X.2015.1130217; Ellis-Hill C., 2018, AUSTR SOC STUD BRAIN; Ellis-Hill C, 2008, DISABIL REHABIL, V30, P150, DOI 10.1080/09638280701195462; Ennals P, 2015, J MENT HEALTH, V24, P111, DOI 10.3109/09638237.2015.1019052; Erentaite R, 2018, J YOUTH ADOLESCENCE, V47, P760, DOI 10.1007/s10964-017-0806-1; Faul M, 2010, TRAUMATIC BRAIN INJU; Gelech J, 2019, NEUROPSYCHOL REHABIL, V29, P456, DOI 10.1080/09602011.2017.1308872; Gelech JM, 2011, QUAL HEALTH RES, V21, P62, DOI 10.1177/1049732310377454; Gracey F., 2011, SOCIAL CURE IDENTITY; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hartman LR, 2015, GLOB QUALIT NURS RES, V2, DOI 10.1177/2333393615614307; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kayes N., 2018, AUSTR SOC STUD BRAIN; Kroger J, 2010, J ADOLESCENCE, V33, P683, DOI 10.1016/j.adolescence.2009.11.002; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lorenz LS, 2010, SOCIOL HEALTH ILL, V32, P862, DOI 10.1111/j.1467-9566.2010.01244.x; Marks G., 2008, 55 LSAY; Martin R, 2015, DISABIL REHABIL, V37, P1234, DOI 10.3109/09638288.2014.961653; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2016, BRAIN INJURY, V30, P1656, DOI 10.1080/02699052.2016.1201592; Mealings M, 2017, INT J SPEECH-LANG PA, V19, P441, DOI 10.1080/17549507.2016.1221453; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Medved MI, 2008, QUAL HEALTH RES, V18, P469, DOI 10.1177/1049732308315731; Minichiello V., 2004, HDB RES METHODS NURS, P59; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nardone A, 2015, NEUROREHABILITATION, V37, P459, DOI 10.3233/NRE-151274; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Shadden B., 2008, NEUROGENIC COMMUNICA; Stagg K, 2019, DISABIL REHABIL, V41, P489, DOI 10.1080/09638288.2017.1396366; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Thomas EJ, 2014, QUAL HEALTH RES, V24, P1033, DOI 10.1177/1049732314542809; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2018, NEUROREHABILITATION, V42, P269, DOI 10.3233/NRE-172383; Willmott C, 2014, J HEAD TRAUMA REHAB, V29, P248, DOI 10.1097/HTR.0000000000000014; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	58	2	2	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	AUG 8	2020	30	7					1255	1276		10.1080/09602011.2019.1574231			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MH9SO	WOS:000547060000003	30729892				2022-02-06	
J	Cardim, D; Czosnyka, M; Chandrapatham, K; Badenes, R; Bertuccio, A; Di Noto, A; Donnelly, J; Pelosi, P; Ball, L; Hutchinson, PJ; Robba, C				Cardim, Danilo; Czosnyka, Marek; Chandrapatham, Karthikka; Badenes, Rafael; Bertuccio, Alessandro; Di Noto, Anna; Donnelly, Joseph; Pelosi, Paolo; Ball, Lorenzo; Hutchinson, Peter J.; Robba, Chiara			Effects of Age and Sex on Optic Nerve Sheath Diameter in Healthy Volunteers and Patients With Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						optic nerve sheath diameter; ultrasonography; traumatic brain injury; intracranial pressure; healthy volunteers	INTRACRANIAL-PRESSURE; SONOGRAPHIC ASSESSMENT; DECOMPRESSIVE CRANIECTOMY; ULTRASONOGRAPHY; RELIABILITY; THRESHOLDS; MORTALITY; ADULT	The measurement of optic nerve sheath diameter (ONSD) has been reported as a non-invasive marker for intracranial pressure (ICP). Nevertheless, it is uncertain whether possible ONSD differences occur with age and sex in healthy and brain-injured populations. The aim of this study was to investigate the effects of sex and age on ONSD in healthy volunteers and patients with traumatic brain injury. We prospectively included 122 healthy adult volunteers (Galliera Hospital, Genova, Italy), and compared age/sex dependence of ONSD to 95 adult patients (Addenbrooke's Hospital, Cambridge, UK) with severe traumatic brain injury (TBI) requiring intubation and invasive ICP monitoring. The two groups were stratified for sex and age. Age was divided into 3 subgroups: (1) young adults: 18-44 years; (2) middle-aged adults: 45-64 years; (3) old adults: >65 years. In healthy volunteers, ONSD was significantly different between males and females [median (interquartile range): 4.2 (3.9-4.6) mm vs. 4.1 (3.6-4.2) mm (p= 0.01), respectively] and was correlated with age (R = 0.50,p< 0.0001). ONSD was significantly increased in group 3 compared to groups 2 and 1, indicating that ONSD values are higher in elderly subjects. In TBI patients, no differences in ONSD were found for sex and the correlation between ONSD and age was non-significant (R = 0.13,p= 0.20). ONSD increases with age and is significantly larger for males in healthy volunteers but not in TBI patients. Different ONSD cut-off values need not be age- or sex-adjusted for the assessment of increased ICP in TBI patients.	[Cardim, Danilo; Czosnyka, Marek; Donnelly, Joseph; Robba, Chiara] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Lab,Div Neurosurg, Cambridge, England; [Cardim, Danilo] Texas Hlth Presbyterian Hosp Dallas, Inst Exercise & Environm Med, Dallas, TX USA; [Cardim, Danilo] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Chandrapatham, Karthikka; Pelosi, Paolo; Ball, Lorenzo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Badenes, Rafael] Univ Valencia Hosp Clin, Anesthesiol & Surg Trauma Intens Care, Valencia, Spain; [Bertuccio, Alessandro] S Cesare Arrigo Antonio Biagio, Dept Neurosurg, Alessandria, Italy; [Di Noto, Anna; Pelosi, Paolo; Ball, Lorenzo; Robba, Chiara] Univ Genoa, San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Anaesthesia & Intens Care, Genoa, Italy; [Donnelly, Joseph] Univ Auckland, Dept Anesthesiol, Auckland, New Zealand; [Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England		Robba, C (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Lab,Div Neurosurg, Cambridge, England.; Robba, C (corresponding author), Univ Genoa, San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Anaesthesia & Intens Care, Genoa, Italy.	kiarobba@gmail.com	Cardim, Danilo Augusto/B-8447-2012; Ball, Lorenzo/AAC-2786-2019; Donnelly, Joseph/E-9235-2018	Cardim, Danilo Augusto/0000-0002-9261-1321; Ball, Lorenzo/0000-0002-3876-4730; Donnelly, Joseph/0000-0002-6502-8069; Badenes, Rafael/0000-0001-7017-0150	NIHR Brain Injury Healthcare Technology Co-operative, Cambridge, UK; Woolf Fisher Scholarship (NZ); Cambridge Commonwealth; European & International Trust Scholarship; University of CambridgeUniversity of Cambridge; NIHRNational Institute for Health Research (NIHR)	NIHR Brain Injury Healthcare Technology Co-operative, Cambridge, UK, provided financial support in the form of equipment funding forDC andMC. JD was supported by a Woolf Fisher Scholarship (NZ). Cambridge Commonwealth, European & International Trust Scholarship, University of Cambridge provided financial support in the form of Scholarship funding for DC. PH was supported by the NIHR (Research Professorship, Cambridge BRC and NIHR Research Group on Global Neurotrauma). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amini A, 2013, AM J EMERG MED, V31, P236, DOI 10.1016/j.ajem.2012.06.025; Anas I, 2014, MALAYS J MED SCI, V21, P24; Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Ballantyne J, 1999, CLIN RADIOL, V54, P740, DOI 10.1016/S0009-9260(99)91176-5; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Caffery TS, 2014, AM J EMERG MED, V32, P1513, DOI 10.1016/j.ajem.2014.09.014; Chen H, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0361-x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; del Saz-Saucedo P, 2016, J NEUROL SCI, V361, P122, DOI 10.1016/j.jns.2015.12.032; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Goeres P, 2016, J CRIT CARE, V31, P168, DOI 10.1016/j.jcrc.2015.10.009; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jeon JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183170; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; Kim D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41332; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Liu DC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0964-5; Lochner P, 2014, AM J NEURORADIOL, V35, P2371, DOI 10.3174/ajnr.A4051; Lochner P, 2016, J ULTRASOUND, V19, P41, DOI 10.1007/s40477-014-0144-z; Maude RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081013; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Rajajee V, 2012, CRIT CARE, V16, DOI [10.1186/cc11336, 10.1186/CC11336]; Robba C, 2016, ACTA NEUROL SCAND, V134, P4, DOI 10.1111/ane.12527; Robba C, 2019, INTENS CARE MED, V45, P1842, DOI 10.1007/s00134-019-05769-w; Robba C, 2018, INTENS CARE MED, V44, P1284, DOI 10.1007/s00134-018-5305-7; Robba C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002356; Sartoretti T, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00199; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Stocchetti N, 2018, INTENS CARE MED, V44, P1321, DOI 10.1007/s00134-018-5251-4; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wang LJ, 2016, ULTRASOUND MED BIOL, V42, P683, DOI 10.1016/j.ultrasmedbio.2015.11.020	38	2	2	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 7	2020	11								764	10.3389/fneur.2020.00764			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NF5AN	WOS:000563309000001	32849220	Green Published, gold			2022-02-06	
J	Canhos, LL; Chen, MX; Falk, S; Popper, B; Straub, T; Gotz, M; Sirko, S				Canhos, Luisa Lange; Chen, Muxin; Falk, Sven; Popper, Bastian; Straub, Tobias; Goetz, Magdalena; Sirko, Swetlana			Repetitive injury and absence of monocytes promote astrocyte self-renewal and neurological recovery	GLIA			English	Article						astrocyte topology; cognitive disfunction; inflammation; reactive gliosis; self-renew; TBI	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRAUMATIC BRAIN-INJURY; FOCAL LASER-LESIONS; EXTRACELLULAR-MATRIX; REACTIVE ASTROCYTES; CEREBRAL-CORTEX; NEURAL STEM; CORTICAL PLASTICITY; CLONAL EXPANSION; CELLS	Unlike microglia and NG2 glia, astrocytes are incapable of migrating to sites of injury in the posttraumatic cerebral cortex, instead relying on proliferation to replenish their numbers and distribution in the affected region. However, neither the spectrum of their proliferative repertoire nor their postinjury distribution has been examined in vivo. Using a combination of different thymidine analogs and clonal analysis in a model of repetitive traumatic brain injury, we show for the first time that astrocytes that are quiescent following an initial injury can be coerced to proliferate after a repeated insult in the cerebral cortex grey matter. Interestingly, this process is promoted by invasion of monocytes to the injury site, as their genetic ablation (using CCR2(-/-)mice) increased the number of repetitively dividing astrocytes at the expense of newly proliferating astrocytes in repeatedly injured parenchyma. These differences profoundly affected both the distribution of astrocytes and recovery period for posttraumatic behavior deficits suggesting key roles of astrocyte self-renewal in brain repair after injury.	[Canhos, Luisa Lange; Chen, Muxin; Falk, Sven; Goetz, Magdalena; Sirko, Swetlana] Ludwig Maximilians Univ Munchen, Biomed Ctr, Physiol Genom, Munich, Germany; [Canhos, Luisa Lange; Falk, Sven; Goetz, Magdalena; Sirko, Swetlana] Helmholtz Zentrum Munich, Inst Stem Cell Res, Neuherberg, Germany; [Canhos, Luisa Lange] Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci GSN LMU, Munich, Germany; [Popper, Bastian] Ludwig Maximilians Univ Munchen, Biomed Ctr, Core Facil Anim Models, Munich, Germany; [Straub, Tobias] Ludwig Maximilians Univ Munchen, Biomed Ctr, Core Facil Bioinformat, Munich, Germany; [Goetz, Magdalena] Excellence Cluster Syst Neurol SyNergy, Munich, Germany; [Falk, Sven] Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, Erlangen, Germany		Gotz, M; Sirko, S (corresponding author), LMU, Biomed Ctr, Physiol Genom, Munich, Germany.	magdalena.goetz@helmholtz-muenchen.de; swetlana.sirko@med.uni-muenchen.de	Straub, Tobias/B-2023-2009	Straub, Tobias/0000-0002-0547-0453; Falk, Sven/0000-0003-4194-9274; Sirko, Swetlana/0000-0001-5950-616X	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB870]; Micronet grant within the ERANet NEURON program [FKZ: 01EW1705B]; Synergy Excellence Cluster and the Priority Program [1757]; Projekt DEAL; Priority Program 1757	Deutsche Forschungsgemeinschaft, Grant/Award Number: SFB870; Priority Program 1757 and the Micronet grant within the ERANet NEURON program, Grant/Award Number: FKZ: 01EW1705B; Synergy Excellence Cluster and the Priority Program, Grant/Award Number: 1757; Open access funding enabled and organized by Projekt DEAL.	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Bailey KR, 2009, FRONT NEUROSCI, P77; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barker JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063692; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Bayraktar OA, 2020, NAT NEUROSCI, V23, P500, DOI 10.1038/s41593-020-0602-1; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Belarbi K, 2013, CANCER RES, V73, P1201, DOI 10.1158/0008-5472.CAN-12-2989; Ben Haim L, 2017, NAT REV NEUROSCI, V18, P31, DOI [10.1038/nrn.2016.159, 10.1038/nm.2016.159]; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bylicky MA, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6501031; Calzolari F, 2015, NAT NEUROSCI, V18, P490, DOI 10.1038/nn.3963; Chai H, 2017, NEURON, V95, P531, DOI 10.1016/j.neuron.2017.06.029; Chandrasekar A, 2019, CEREB CORTEX, V29, P2701, DOI 10.1093/cercor/bhy139; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P1425, DOI 10.1038/jcbfm.2014.120; Clark D, 2020, AGING CELL, V19, DOI 10.1111/acel.13112; Clark RAF, 2008, J INVEST DERMATOL, V128, P1354, DOI 10.1038/jid.2008.75; Cramer SC, 2008, CURR OPIN NEUROL, V21, P76, DOI 10.1097/WCO.0b013e3282f36cb6; Dallerac G, 2016, PROG NEUROBIOL, V144, P48, DOI 10.1016/j.pneurobio.2016.01.003; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Dimou L, 2014, PHYSIOL REV, V94, P709, DOI 10.1152/physrev.00036.2013; DOMANN R, 1993, NEUROSCI LETT, V155, P69, DOI 10.1016/0304-3940(93)90675-B; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Faiz M, 2015, CELL STEM CELL, V17, P624, DOI 10.1016/j.stem.2015.08.002; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Frik J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745294; Gotz M, 2015, GLIA, V63, P1452, DOI 10.1002/glia.22850; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Heimann G, 2019, METHODS MOL BIOL, V1938, P277, DOI 10.1007/978-1-4939-9068-9_20; Heimann G, 2017, CEREB CORTEX, V27, P4213, DOI 10.1093/cercor/bhx112; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004286; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Huemmeke M, 2004, J PHYSIOL-LONDON, V559, P875, DOI 10.1113/jphysiol.2004.069534; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Imbrosci B, 2010, J PHYSIOL-LONDON, V588, P4695, DOI 10.1113/jphysiol.2010.198192; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; Ito U, 2006, STROKE, V37, P2134, DOI 10.1161/01.STR.0000231875.96714.b1; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jahn HM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00310; Jakel S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00024; Jukkola P, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-70; Khakh BS, 2019, ANNU REV NEUROSCI, V42, P187, DOI 10.1146/annurev-neuro-070918-050443; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Kjell J, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00032; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; Komitova M, 2009, J COMP NEUROL, V512, P702, DOI 10.1002/cne.21917; Lanjakornsiripan D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03940-3; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; Liu BH, 2017, J NEUROSCI RES, V95, P2126, DOI 10.1002/jnr.24140; Liu CY, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00193; Luhmann H J, 1996, Epilepsy Res Suppl, V12, P119; Martin-Lopez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074039; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Morel L, 2019, GLIA, V67, P171, DOI 10.1002/glia.23545; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nahmani M, 2014, NEUROSCIENCE, V283, P4, DOI 10.1016/j.neuroscience.2014.04.029; Nishiyama A, 2016, BRAIN RES, V1638, P116, DOI 10.1016/j.brainres.2015.08.013; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Ouyang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171976; Overman JJ, 2014, NEUROSCIENTIST, V20, P15, DOI 10.1177/1073858413491146; Palpagama TH, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00258; Pekny M, 2019, NEUROSCI LETT, V689, P45, DOI 10.1016/j.neulet.2018.07.021; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Popper B, 2018, NEUROBIOL LEARN MEM, V150, P107, DOI 10.1016/j.nlm.2018.02.027; Qu M, 1998, NEUROSCIENCE, V85, P29, DOI 10.1016/S0306-4522(97)00656-8; Robel S, 2016, NAT NEUROSCI, V19, P28, DOI 10.1038/nn.4184; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rodgers RJ, 1997, BRAZ J MED BIOL RES, V30, P289, DOI 10.1590/S0100-879X1997000300002; Roll L, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00219; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Santello M, 2019, NAT NEUROSCI, V22, P154, DOI 10.1038/s41593-018-0325-8; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Siracusa R, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01114; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sun W, 2017, J NEUROSCI, V37, P4493, DOI 10.1523/JNEUROSCI.3199-16.2017; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takata N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002525; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Toledo-Rodriguez M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00017; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Van Den Herrewegen Y, 2019, NEUROCHEM RES, V44, P600, DOI 10.1007/s11064-018-2610-z; van Dijk BJ, 2016, BBA-MOL BASIS DIS, V1862, P492, DOI 10.1016/j.bbadis.2015.10.013; Verkhratsky A, 2019, NEUROSCI LETT, V689, P1, DOI 10.1016/j.neulet.2018.07.026; Verkhratsky A, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0428; Verkhratsky A, 2014, CELL TISSUE RES, V357, P493, DOI 10.1007/s00441-014-1814-z; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Westergard T, 2020, NEUROCHEM RES, V45, P1298, DOI 10.1007/s11064-020-02959-7; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Wilhelmsson U, 2019, BIOL CHEM, V400, P1147, DOI 10.1515/hsz-2019-0199; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	112	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	JAN	2021	69	1					165	181		10.1002/glia.23893		AUG 2020	17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OR4XJ	WOS:000563864400001	32744730	hybrid			2022-02-06	
J	Tallapragada, M; Cranmer, GA				Tallapragada, Meghnaa; Cranmer, Gregory A.			Media Narratives About Concussions: Effects on Parents' Intention to Inform Their Children About Concussions	COMMUNICATION & SPORT			English	Article; Early Access						concussion; parents; football; narratives	SCHOOL FOOTBALL PLAYERS; NEGATIVE AFFECT; RISK; YOUTH; EDUCATION; COMMUNICATION; PREVENTION; KNOWLEDGE; ATTITUDES; DECISION	This study examined the effects of media narratives about concussions on parent's intentions to inform their children about concussions. A randomized experiment of 600 parents whose children play football in middle school or high school were presented with one of the five narrative conditions or the control condition (where parents read a brochure). Results indicate that parents who read the narrative shared from the perspective of a high school football player, a parent, a coach, and a Center for Disease Control and Prevention researcher induced negative emotions, and those exposed to the narratives from the perspective of a high school football player and a parent also experienced a sense of identification and thereby reduced counterargument. Negative emotions and a reduced counterargument influenced intentions of these parents to inform their children of the dangers and risks of playing football and prompted them to read information on sports-related concussions. The results of this study have implications for communities and organizations seeking to motivate parents to engage in informative conversations with their children about the dangers and risks associated with playing football including concussions.	[Tallapragada, Meghnaa] Temple Univ, Dept Advertising & Publ Relat, Klein Coll Media & Commun, Philadelphia, PA 19122 USA; [Cranmer, Gregory A.] Clemson Univ, Dept Commun, Clemson, SC 29631 USA		Tallapragada, M (corresponding author), Temple Univ, Dept Advertising & Publ Relat, Klein Coll Media & Commun, Philadelphia, PA 19122 USA.	meghnaa.tallapragada@temple.edu		Tallapragada, Meghnaa/0000-0003-1472-9129			Allen JA, 2015, AM J HEALTH PROMOT, V30, pE71, DOI 10.4278/ajhp.130510-LIT-237; [Anonymous], 2019, FACT SHEET HIGH SCH; Bell T.R., 2019, CTE MEDIA NFL FRAMIN; Belson K., 2017, NY TIMES; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Blinde E. M., 1985, International Review for the Sociology of Sport, V20, P87, DOI 10.1177/101269028502000108; BODENHAUSEN GV, 1994, EUR J SOC PSYCHOL, V24, P45, DOI 10.1002/ejsp.2420240104; Boneau RD, 2020, COMMUN SPORT, V8, P26, DOI 10.1177/2167479518816104; BOSTER FJ, 1984, ANN INT COMMUNICATIO, V8, P330, DOI [DOI 10.1080/23808985.1984.11678581, DOI 10.1080/23808985.1984]; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Brossard D, 2007, INT J PUBLIC OPIN R, V19, P24, DOI 10.1093/ijpor/edl003; Butterworth M, 2016, SOUTH COMMUN J, V81, P92, DOI 10.1080/1041794X.2015.1100211; Butterworth ML, 2017, ROUTL RES SPORT CULT, P139; Cantu R., 2012, CONCUSSIONS OUR KIDS; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Center for Disease Control and Prevention, 2019, FACT SHEET HIGH SCH; Center for Disease Control and Prevention, 2010, FACTS CONC BRAIN INJ; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Coakley J, 1993, Exerc Sport Sci Rev, V21, P169; Cohen J., 2001, MASS COMMUNICATION S, V4, P245, DOI [10.1207/S15327825MCS0403_01, DOI 10.1207/S15327825MCS0403_01]; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Cranmer G.A., 2019, ATHLETIC COACHING CO; Cranmer GA, 2018, WESTERN J COMM, V82, P631, DOI 10.1080/10570314.2018.1441431; Cranmer GA, 2018, INT J SPORT COMMUN, V11, P241, DOI 10.1123/ijsc.2017-0120; Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davison KK, 2006, RES Q EXERCISE SPORT, V77, P23, DOI 10.5641/027013606X13080769703722; Dixon MA, 2008, SOCIOL SPORT J, V25, P538, DOI 10.1123/ssj.25.4.538; Djupe PA, 2010, J SCI STUD RELIG, V49, P73, DOI 10.1111/j.1468-5906.2009.01493.x; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Eccles J., 1991, J APPL SPORT PSYCHOL, V3, P7, DOI [10.1080/10413209108406432, DOI 10.1080/10413209108406432]; Edwards C, 2013, COMPUT HUM BEHAV, V29, pA12, DOI 10.1016/j.chb.2012.12.034; Fishbein M, 2003, COMMUN THEOR, V13, P164, DOI 10.1111/j.1468-2885.2003.tb00287.x; Fraser-Thomas J, 2008, J APPL SPORT PSYCHOL, V20, P318, DOI 10.1080/10413200802163549; Fredricks JA, 2005, J YOUTH ADOLESCENCE, V34, P507, DOI 10.1007/s10964-005-8933-5; Gault BA, 2000, COGNITION EMOTION, V14, P495, DOI 10.1080/026999300402772; Goethals ER, 2019, PEDIATR DIABETES, V20, P1025, DOI 10.1111/pedi.12901; Green MC, 2006, J COMMUN, V56, pS163, DOI 10.1111/j.1460-2466.2006.00288.x; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Haase N, 2015, J HEALTH COMMUN, V20, P920, DOI 10.1080/10810730.2015.1018605; Hyman M., 2012, MOST EXPENSIVE GAME; Hyman M, 2009, IT HURTS AM OBSESSIO; Kelley B., 2013, HEY DATA DATA SWING; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kim SJ, 2014, J HEALTH COMMUN, V19, P692, DOI 10.1080/10810730.2013.837550; Knollman-Porter K, 2018, AM J SPEECH-LANG PAT, V27, P778, DOI 10.1044/2018_AJSLP-17-0108; Kreuter MW, 2007, ANN BEHAV MED, V33, P221, DOI 10.1007/BF02879904; Krieger JL, 2013, HEALTH COMMUN, V28, P683, DOI 10.1080/10410236.2012.762827; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Kroshus E, 2019, J HEALTH COMMUN, V24, P770, DOI 10.1080/10810730.2019.1668512; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lippmann Walter, 1922, PUBLIC OPINION; Liu BF, 2020, J APPL COMMUN RES, V48, P328, DOI 10.1080/00909882.2020.1756377; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lyons BA, 2019, PUBLIC UNDERST SCI, V28, P320, DOI 10.1177/0963662518821017; MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990; McCrea HJ, 2013, SPORTS HEALTH, V5, P160, DOI 10.1177/1941738112462203; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McPherson B. D., 1981, Handbook of social science of sport., P246; Messner M. A., 1992, MENS FRIENDSHIPS, V2, P215, DOI 10.4135/9781483325736.n12; Moyer-Guse E, 2008, COMMUN THEOR, V18, P407, DOI 10.1111/j.1468-2885.2008.00328.x; Moyer-Guse E, 2012, J COMMUN, V62, P1010, DOI 10.1111/j.1460-2466.2012.01680.x; Moyer-Guse E, 2010, HUM COMMUN RES, V36, P26, DOI 10.1111/j.1468-2958.2009.01367.x; Muth Christopher C, 2018, JAMA, V319, P840, DOI 10.1001/jama.2018.0436; Nabi R.L., 2002, PERSUASION HDB DEV T, P289; Nabi RL, 2007, COMMUN MONOGR, V74, P29, DOI 10.1080/03637750701196896; Nabi RL, 2015, MEDIA PSYCHOL, V18, P137, DOI 10.1080/15213269.2014.912585; *NAT CANC I, 2008, TOB CONTR MON US DEP, V19; National Cancer Institute, 2008, NIH PUB; National Federation of State High School Associations, 2017, HIGH SCH PART INCR 2; Neppl TK, 2016, J RES ADOLESCENCE, V26, P538, DOI 10.1111/jora.12212; Niederdeppe J, 2019, HEALTH COMMUN, V34, P825, DOI 10.1080/10410236.2018.1437526; Niederdeppe J, 2014, HEALTH COMMUN, V29, P431, DOI 10.1080/10410236.2012.761805; Niederdeppe J, 2011, HUM COMMUN RES, V37, DOI 10.1111/j.1468-2958.2011.01409.x; Nowinski C, 2006, HEAD GAMES FOOTBALLS; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parsai M, 2009, YOUTH SOC, V40, P353, DOI 10.1177/0044118X08318117; Petty R., 1986, COMMUNICATION PERSUA, DOI DOI 10.1016/S0065-2601(08)60214-2; Poortinga W, 2003, RISK ANAL, V23, P961, DOI 10.1111/1539-6924.00373; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Riesch SK, 2006, J SPEC PEDIATR NURS, V11, P41, DOI 10.1111/j.1744-6155.2006.00042.x; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Ruston SW, 2019, COMMUN SPORT, V7, P529, DOI 10.1177/2167479518786709; Sage GH, 1980, J SPORT SOC ISSUES, V4, P1, DOI [10.1177/019372358000400201, DOI 10.1177/019372358000400201]; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Sangalang A, 2019, J COMMUN, V69, P298, DOI 10.1093/joc/jqz014; Scheufele DA, 2013, P NATL ACAD SCI USA, V110, P14040, DOI 10.1073/pnas.1213275110; Schwartz G.E., 1980, MOTIV EMOTION, V4, P175, DOI [DOI 10.1007/BF00995197, 10.1007/BF00995197]; Scott R., 2015, CONCUSSION; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Slovic P, 2007, JUDGM DECIS MAK, V2, P79; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stevenson KT, 2019, ENVIRON EDUC RES, V25, P832, DOI 10.1080/13504622.2016.1177712; Sturgis P, 2004, PUBLIC UNDERST SCI, V13, P55, DOI 10.1177/0963662504042690; Tracy M., 2015, NY TIMES; Vanderhoven E, 2016, J PRIM PREV, V37, P247, DOI 10.1007/s10935-016-0420-0; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WEISS MR, 1992, QUEST, V44, P138, DOI 10.1080/00336297.1992.10484048; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328; Woolger C., 1993, Journal of Sport Behavior, V16, P171; Wright K., 2000, COMMUN Q, V48, P44, DOI [DOI 10.1080/01463370009385579, 10.1080/01463370009385579]; Wuerth S, 2004, PSYCHOL SPORT EXERC, V5, P21, DOI 10.1016/S1469-0292(02)00047-X	107	2	2	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport											2167479520944549	10.1177/2167479520944549		AUG 2020	24	Communication; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Communication; Social Sciences - Other Topics	MU2BH	WOS:000555476600001					2022-02-06	
J	Alves, JL; Mendes, J; Leitao, R; Silva, AP; Pinto, AM				Alves, Jose Luis; Mendes, Joao; Leitao, Ricardo; Silva, Ana Paula; Pinto, Anabela Mota			A multi-staged neuropeptide response to traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Brain trauma; Neurogenic inflammation; Neuropeptide Y; Substance P	SUBSTANCE-P; MOUSE MODEL; Y LEVELS; INFLAMMATION; SYSTEM; PROLIFERATION; DEGENERATION; SERUM	Purpose As the most abundant neuropeptides in Central Nervous System, Substance P and Neuropeptide Y are arguably involved in the response to brain trauma. This study aims to characterize a new concept of multi-staged neuropeptide response to TBI. Methods This study assessed Substance P, Neuropeptide Y, S100B, standard inflammatory parameters and ionic disturbance in TBI victims, with and without intracranial lesions, and healthy controls. In the group with intracranial lesions, blood samples were drawn until 6 h after initial trauma, at 48 h and 7 days post-TBI. Results An early increase in Substance P (mean 613.463 +/- 49.055 SE 6 h post-TBI with brain contusions vs. 441.441 +/- 22.572 SE pg/dL control group) is evident. Concerning TBI without intraparenchymatous lesions, an increase in substance P is also present (825.60 +/- 23.690 SE pg/dL). Following an initial increase and subsequent fall in NPY levels (45.997 +/- 4.96 SE 6 h post-TBI vs. 32.395 +/- 4.056 SE 48 h post-TBI vs. 19.700 +/- 1.462 SE pg/mL control group), a late increase in NPY is obvious (43.268 +/- 6.260 SE pg/mL 7 day post-TBI). Post-traumatic hypomagnesemia (0.754 +/- 0.015 SE 6 h post-TBI vs. 0.897 +/- 0.021 SE mmol/L control group) and a peak in S100B (95.668 +/- 14.102 SE 6 h post-TBI vs. 30.187 +/- 3.347 SE pg/mL control group) are also present. Conclusion A multi-staged neuropeptide response to TBI is obvious and represents a potential therapeutic strategy for the treatment of intraparenchymal lesions and cerebral edema following TBI.	[Alves, Jose Luis; Mendes, Joao; Pinto, Anabela Mota] Univ Coimbra, Fac Med, Inst Patol Geral, Rua Larga 3, P-3000370 Coimbra, Portugal; [Alves, Jose Luis; Leitao, Ricardo; Silva, Ana Paula] Univ Coimbra, Fac Med, Coimbra Inst Clin & Biomed Res, Rua Larga 3, P-3000370 Coimbra, Portugal		Alves, JL (corresponding author), Univ Coimbra, Fac Med, Inst Patol Geral, Rua Larga 3, P-3000370 Coimbra, Portugal.; Alves, JL (corresponding author), Univ Coimbra, Fac Med, Coimbra Inst Clin & Biomed Res, Rua Larga 3, P-3000370 Coimbra, Portugal.	jlmonteiroalves@gmail.com	Mota-Pinto, Anabela/M-1523-2013; Silva, Ana Paula/L-4184-2014	Mota-Pinto, Anabela/0000-0002-0820-9568; Silva, Ana Paula/0000-0002-7802-8690; Pereira Mendes, Joao Fernando/0000-0002-4697-0542; Leitao, Ricardo/0000-0003-0355-2591; Alves, Jose Luis/0000-0003-4030-2874			Alves JL, 2019, WORLD NEUROSURG, V130, P115, DOI 10.1016/j.wneu.2019.06.212; Ameliorate JL, 2017, MAGNESIUM RES, V30, P88, DOI 10.1684/mrh.2017.0427; Angelucci F, 2014, CAN J PHYSIOL PHARM, V92, P621, DOI 10.1139/cjpp-2014-0099; Campbell DE, 2006, CLIN VACCINE IMMUNOL, V13, P1197, DOI 10.1128/CVI.00174-06; Chiodera P, 2000, EUR J ENDOCRINOL, V143, P715, DOI 10.1530/eje.0.1430715; CORBALLY N, 1990, BIOCHEM PHARMACOL, V39, P1161, DOI 10.1016/0006-2952(90)90257-L; Corrigan F, 2016, BRIT J PHARMACOL, V173, P703, DOI 10.1111/bph.13155; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Croall Iain, 1800, Top Magn Reson Imaging, V24, P267, DOI 10.1097/RMR.0000000000000063; Decressac M, 2009, NEUROBIOL DIS, V34, P441, DOI 10.1016/j.nbd.2009.02.017; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Djordjevic J, 2016, CURR ALZHEIMER RES, V13, P730, DOI 10.2174/1567205013666160222110320; Dobrachinski F, 2017, J NEUROTRAUM, V34, P1318, DOI 10.1089/neu.2016.4563; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; EDYVANE KA, 1994, J AUTONOM NERV SYST, V48, P241, DOI 10.1016/0165-1838(94)90053-1; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Fatoba O, 2016, J NEUROL NEUROSUR PS, V87, pA97, DOI 10.1136/jnnp-2016-314597.277; Frankel M, 2019, J NEUROTRAUM, V36, P2863, DOI 10.1089/neu.2018.5809; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Geloso MC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00085; Giancarelli A, 2016, J SURG RES, V202, P182, DOI 10.1016/j.jss.2015.12.036; He XY, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01049; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Hoffman JR, 2017, AMINO ACIDS, V49, P871, DOI 10.1007/s00726-017-2383-8; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kaniganti T., 2019, SENSITIVITY OLFACTOR, DOI [10.1101/573170, DOI 10.1101/573170]; Leonard AV, 2014, SPINAL CORD, V52, P17, DOI 10.1038/sc.2013.136; Lim LJH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020254; Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z; Lukacs M, 2017, CURR MED CHEM, V24, P3649, DOI 10.2174/0929867324666170712163437; Lynds R, 2017, J PAIN RES, V10, P349, DOI 10.2147/JPR.S120092; Markaki E, 2012, STEREOT FUNCT NEUROS, V90, P104, DOI 10.1159/000335045; MCINTOSH TK, 1992, J CEREBR BLOOD F MET, V12, P697, DOI 10.1038/jcbfm.1992.95; Minkkinen M, 2019, J NEUROTRAUM, V36, P2904, DOI 10.1089/neu.2018.6351; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Morin LP, 2013, EXP NEUROL, V243, P4, DOI 10.1016/j.expneurol.2012.06.026; Morosawa S, 2017, NEUROPEPTIDES, V62, P27, DOI 10.1016/j.npep.2016.12.010; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Naghibi T, 2017, J CLIN DIAGN RES, V11, pPC6, DOI 10.7860/JCDR/2017/19132.9198; Nelson TS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43493-z; Park MS, 2014, J EXERC REHABIL, V10, P148, DOI 10.12965/jer.140109; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Ramamoorthy P, 2011, J NEUROSCI, V31, P14783, DOI 10.1523/JNEUROSCI.2933-11.2011; Sabban EL, 2018, MIL MED, V183, P408, DOI 10.1093/milmed/usx228; Sabban EL, 2015, J NEUROCHEM, V135, P975, DOI 10.1111/jnc.13347; Sampaolo S, 2017, NEUROPEPTIDES, V65, P45, DOI 10.1016/j.npep.2017.04.008; Shandra O, 2019, J NEUROSCI, V39, P1944, DOI 10.1523/JNEUROSCI.1067-18.2018; Silva AP, 2005, J NEUROCHEM, V93, P163, DOI 10.1111/j.1471-4159.2004.03005.x; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Spencer B, 2016, J BIOL CHEM, V291, P1905, DOI 10.1074/jbc.M115.678185; Stovell MG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00426; Sun ZP, 2018, EPILEPSY BEHAV, V87, P188, DOI 10.1016/j.yebeh.2018.08.002; Suvas S, 2017, J IMMUNOL, V199, P1543, DOI 10.4049/jimmunol.1601751; Szczygielski J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00799; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Turner RJ, 2013, BRAIN SCI, V3, P123, DOI 10.3390/brainsci3010123; UCKERMANN O, 2005, INVEST OPHTH VIS SCI, V46, P2224; Vink R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00304; Vink R, 2010, NEUROTHERAPEUTICS, V7, P1, DOI 10.1016/j.nurt.2009.12.001; Wang WJ, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/7898095; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011; Zhang ZL, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9605265; Zhe Z, 2018, BIOSCIENCE REP, V8, P3	66	2	2	1	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-020-01431-z		AUG 2020	11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	MS6ZJ	WOS:000554425000001	32740742	Green Published			2022-02-06	
J	Arcuri, J; Liu, Y; Lee, RCK; Bhattacharya, SK				Arcuri, Jennifer; Liu, Yuan; Lee, Richard K.; Bhattacharya, Sanjoy K.			Lipid profile dataset of optogenetics induced optic nerve regeneration	DATA IN BRIEF			English	Article; Data Paper						Optic nerve crush; Optogenetics; Lipids; Regeneration		The optic nerve transfers visual information from the retina to the brain through the axons of retinal ganglion cells (RGCs). In adult mammals, optic nerve injuries and pro-gressive degenerative diseases lead to the irreversible loss of RGCs, resulting in vision loss and blindness. Optogenetic models have proved useful in manipulating the growth of RGCs through expression and stimulation of channel-rhodopsins (Chr2) in RGCs using the RGC-specific thy-1 promoter. Using transgenic Chr2 mouse (Thy1-ChR2-EYFP) as a model of regeneration, we profile the lipid changes which occur after traumatic optic nerve crush, light stimulation and forced RGC axonal growth. Thy1-ChR2-EYFP and control (C57BL/6) mice were divided in four groups each - 1) no crush and no stimulation, 2) no crush with stimulation, 3) crush and without stimulation, and 4) crush with stimula-tion. After euthanasia, the optic nerves were collected for lipidomic analysis. The Bligh and Dyer method was used for lipid extraction, followed by mass spectrometry lipid profil-ing with a Q-Exactive Orbitrap Liquid Chromatography-Mass Spectrometer (LC MS-MS). The raw scans were analysed with LipidSearch 4.1.3 and the statistical analysis was con-ducted through Metaboanalyst 4.0. (C) 2020 The Authors. Published by Elsevier Inc.	[Arcuri, Jennifer; Liu, Yuan; Lee, Richard K.; Bhattacharya, Sanjoy K.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Arcuri, Jennifer; Lee, Richard K.; Bhattacharya, Sanjoy K.] Miami Integrat Metabol Res Ctr, Miami, FL 33136 USA; [Arcuri, Jennifer; Bhattacharya, Sanjoy K.] Univ Miami, Mol Cellular Pharmacol Grad Program, Miami, FL 33136 USA		Lee, RCK; Bhattacharya, SK (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.; Lee, RCK; Bhattacharya, SK (corresponding author), Miami Integrat Metabol Res Ctr, Miami, FL 33136 USA.; Bhattacharya, SK (corresponding author), Univ Miami, Mol Cellular Pharmacol Grad Program, Miami, FL 33136 USA.	Rlee@med.miami.edu; SBhattacharya@med.miami.edu			US Department of DefenceUnited States Department of Defense [W81XWH1910845]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01EY027257]; NIH Centre Core GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30EY014801]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Walter G Ross Foundation;  [U2C DK119886]	This work was supported in part by US Department of Defence Grant W81XWH1910845, NIH Grant U01EY027257, NIH Centre Core Grant P30EY014801, an unrestricted grant from Research to Prevent Blindness to the Bascom Palmer Eye Institute. RKL and part of this research is supported by the Walter G Ross Foundation. Metabolomics workbench is an effort of NIH Common Fund's Metabolomics Data Repository and Coordinating Centre supported by U2C DK119886	Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Liu Y, 2020, MOL NEUROBIOL, V57, P698, DOI 10.1007/s12035-019-01735-1; Natasha G, 2013, NEW BIOTECHNOL, V30, P461, DOI 10.1016/j.nbt.2013.04.007	3	2	2	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-3409			DATA BRIEF	Data Brief	AUG	2020	31								106001	10.1016/j.dib.2020.106001			7	Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Science & Technology - Other Topics	NO0ZX	WOS:000569216300024	32685640	Green Published, gold			2022-02-06	
J	Balalla, S; Krageloh, C; Medvedev, O; Siegert, R				Balalla, Shivanthi; Krageloh, Chris; Medvedev, Oleg; Siegert, Richard			Is the Rivermead Post-Concussion Symptoms Questionnaire a Reliable and Valid Measure to Assess Long-Term Symptoms in Traumatic Brain Injury and Orthopedic Injury Patients? A Novel Investigation Using Rasch Analysis	NEUROTRAUMA REPORTS			English	Article						brain injuries; orthopedic injuries; post-concussion syndrome; psychometrics; Rasch analysis	POSTCONCUSSION SYNDROME; CONSTRUCT-VALIDITY; PEOPLE	Persistent post-concussion syndrome (PCS) symptoms are known to last years after traumatic brain injury (TBI), and similar symptoms are increasingly being documented among those who have not experienced a TBI. There remains however, a dearth of empirical evidence on the structural composition of symptoms beyond the post-acute symptom phase after TBI, and little is known about the potential use of PCS symptom scales to measure PCS-like symptoms in non-TBI individuals. Our objective was therefore to examine the psychometric performance and dimensionality of the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) as a measure of long-term PCS symptoms among a TBI and non-TBI sample. A case-control sample of 223 patients with injury, consisting of age- and sex-matched TBI participants (n = 109) and orthopedic participants (n = 114) were recruited from a regional trauma registry in New Zealand (NZ), and assessed at mean 2.5 years post-injury. Results from the Rasch analysis showed that the RPQ achieved fit to the Rasch model, demonstrating very good reliability (Person Separation Index [PSI] = 0.87), thereby indicating that the measure can be used reliably for individual and group assessment of symptoms among both TBI and orthopedic patients. In this study we demonstrated evidence of a unidimensional construct of PCS symptoms in both groups, which helps alleviate previous uncertainty about factor structure, and permits the calculation of a total RPQ score. Conversion of ordinal to interval total scores presented within are recommended for clinicians and researchers, to improve instrument precision, and to facilitate the interpretation of change scores and use of parametric methods in data analysis.	[Balalla, Shivanthi; Krageloh, Chris; Siegert, Richard] Auckland Univ Technol, Dept Psychol & Neurosci, 90 Akoranga Dr, Auckland, New Zealand; [Medvedev, Oleg] Univ Waikato, Sch Psychol, Hamilton, New Zealand		Balalla, S (corresponding author), Auckland Univ Technol, Dept Psychol & Neurosci, 90 Akoranga Dr, Auckland, New Zealand.	sbalalla@aut.ac.nz					ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Andrich D., 2009, RUMM2030; Balalla SK, 2019, ARCH PHYS MED REHAB, V100, P1853, DOI 10.1016/j.apmr.2019.05.029; Barker-Collo S, 2019, BRAIN INJURY, V33, P618, DOI 10.1080/02699052.2019.1570339; Barker-Collo S, 2018, BRAIN INJURY, V32, P453, DOI 10.1080/02699052.2018.1429659; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Bond T.G., 2015, APPL RASCH MODEL FUN, V3rd ed; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2004, STUD NEUROPSYCHOL DE, P323; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Kahan M, 2018, BRAIN IMPAIR, V19, P153, DOI 10.1017/Brimp.2018.7; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Leung YY, 2014, J RHEUMATOL, V41, P159, DOI 10.3899/jrheum.130814; Linacre J, 1994, RASCH MEAS T, V7, P328; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Medvedev ON, 2018, PEERJ, V6, DOI 10.7717/peerj.5676; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Reckase M.D., 1979, J EDUC BEHAV STAT, V4, P207, DOI DOI 10.3102/10769986004003207; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Snell DL, 2020, J NEUROTRAUM, V37, P1566, DOI 10.1089/neu.2019.6729; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Thomas M, 2018, BRAIN IMPAIR, V19, P166, DOI 10.1017/Brimp.2017.26; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339	42	2	2	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	AUG 1	2020	1	1					63	72		10.1089/neur.2020.0017			10	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WU6RU	WOS:000716671300001	34223531	Green Submitted, Green Published, hybrid			2022-02-06	
J	Brand, KP; Finkel, AM				Brand, Kevin P.; Finkel, Adam M.			A Decision-Analytic Approach to Addressing the Evidence About Football and Chronic Traumatic Encephalopathy	SEMINARS IN NEUROLOGY			English	Article						CTE; epidemiology; weight of evidence; uncertainty; risk management	PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; BRAIN; ASSOCIATION; PATHOLOGY; CONSENSUS; DISEASE; BALANCE; QUALITY; PLAYERS	Doubts can be raised about almost any assertion that a particular exposure can lead to an increase in a given adverse health effect. Even some of the most well-accepted causal associations in public health, such as that linking cigarette smoking to increased lung cancer risk, have intriguing research questions remaining to be answered. The inquiry whether an exposure causes a disease is never wholly a yes/no question but ought to follow from an appraisal of the weight of evidence supporting the positive conclusion in light of any coherent theories casting doubt on this evidence and the data supporting these. More importantly, such an appraisal cannot be made sensibly without considering the relative consequences to public health and economic welfare of specific actions based on unwarranted credulity (false positives) versus unwarranted skepticism (false negatives). Here we appraise the weight of evidence for the premise that repeated head impacts (RHIs) in professional football can increase the incidence of chronic traumatic encephalopathy (CTE) and, in turn, cause a variety of cognitive and behavioral symptoms. We first dismiss four logical fallacies that should not affect the appraisal of the weight of evidence. We then examine four alternative hypotheses in which RHI is not associated with CTE or symptoms (or both), and we conclude that the chances are small that the RHI -> CTE -> symptoms link is coincidental or artifactual. In particular, we observe that there are many specific interventions for which, even under a skeptical appraisal of the weight of evidence, the costs of a false positive are smaller than the false negative costs of refusing to intervene.	[Brand, Kevin P.] Univ Ottawa, Telfer Sch Management, Ottawa, ON, Canada; [Finkel, Adam M.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, 1415 Washington Hts,6679 SPH 1, Ann Arbor, MI 48109 USA		Finkel, AM (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, 1415 Washington Hts,6679 SPH 1, Ann Arbor, MI 48109 USA.	adfinkel@umich.edu		Finkel, Adam M./0000-0001-6259-9387			Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Ban VS, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.2.FOCUS15609; BELL DE, 1982, OPER RES, V30, P961, DOI 10.1287/opre.30.5.961; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Binney ZO, 2019, NEUROLOGY, V92, P43, DOI 10.1212/WNL.0000000000006699; Branch J, 2019, NEW YORK TIMES, pSP1; Brenson K, 2018, UNIV CHICAGO LEG FOR, V2017, P33; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Carson A, 2017, J NEUROL NEUROSUR PS, V88, P462, DOI 10.1136/jnnp-2016-315510; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CREECH JL, 1974, J OCCUP ENVIRON MED, V16, P150; Daemmrich A, 2002, SOC HIST MED, V15, P137, DOI 10.1093/shm/15.1.137; DeKay ML, 1996, LAW SOCIAL INQUIRY, V21, P95, DOI 10.1111/j.1747-4469.1996.tb00013.x; DeKay ML, 2002, J RISK RES, V5, P391, DOI DOI 10.1080/13669870210166202; Finkel A, 2018, CHICAGO SUN TIMES; Finkel A M, 2018, ARIZ LAW REV, V60, P78; Finkel AM, 2019, LANCET NEUROL, V18, P521, DOI 10.1016/S1474-4422(19)30159-0; Finkel AM, 2019, HUM ECOL RISK ASSESS, V25, P564, DOI 10.1080/10807039.2018.1456899; Finkel AM, 2014, MICHIGAN J ENV ADM L, V4, P91; Fischhoff B, 2011, RISK VERY SHORT INTR; Gao A. F., 2017, INT J PATHOLOGICAL C, V3, P50, DOI [10.23937/2469-5807/1510050, DOI 10.23937/2469-5807/1510050]; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gordis L., 2013, EPIDEMIOLOGY; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins J P, 2008, WOODHEAD PUBL MATER, pi; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lindley D, 2006, UNDERSTANDING UNCERT; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Murad MH, 2018, BMJ EVID-BASED MED, V23, P60, DOI 10.1136/bmjebm-2017-110853; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Neutra R R, 2018, JURIMETRICS, V58, P36; Nguyen VT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4223; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PAGE T, 1978, ECOL LAW QUART, V7, P207; Pearce N, 2007, OCCUP ENVIRON MED, V64, P562, DOI 10.1136/oem.2006.026690; Peel M, 2013, BMJ-BRIT MED J, V347, pf6426; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; PETERMAN TA, 1985, EPIDEMIOL REV, V7, P1; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Randolph C, 2018, ARCH CLIN NEUROPSYCH, V33, P644, DOI 10.1093/arclin/acy063; Rich DQ, 2017, ENVIRON INT, V100, P62, DOI 10.1016/j.envint.2016.12.019; Robinson LA, 2016, REV ENV ECON POLICY, V10, P308, DOI 10.1093/reep/rew011; Schror Karsten, 2007, Paediatr Drugs, V9, P195, DOI 10.2165/00148581-200709030-00008; SOKOL DK, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6426; Solomon G, 2018, DEV NEUROPSYCHOL, V43, P279, DOI 10.1080/87565641.2018.1447575; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; STOLLEY PD, 1991, AM J EPIDEMIOL, V133, P416, DOI 10.1093/oxfordjournals.aje.a115904; Stolley PD, 1991, AM J EPIDEMIOL, V133, P426; Suskind R, 2007, ONE PERCENT DOCTRINE; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Utecht B, 2016, COUNTING DAYS MY MIN; Vos BC, 2018, CLIN J SPORT MED, V28, P91, DOI 10.1097/JSM.0000000000000432; WAGNER JC, 1991, BRIT J IND MED, V48, P399; Wang LC, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-10; Webner D, 2016, BRAIN INJURY, V30, P1718, DOI 10.1080/02699052.2016.1202451; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Zuckerman SL, 2019, J NEUROSURG, V130, P1634, DOI 10.3171/2018.1.JNS172733	69	2	2	0	5	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	AUG	2020	40	04					450	460		10.1055/s-0039-1688484			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NL6KK	WOS:000567521900012	31311037				2022-02-06	
J	Fanton, M; Alizadeh, HV; Domel, AG; Devlin, M; Kurt, M; Mungal, MG; Camarillo, DB; Hawkes, E				Fanton, Michael; Alizadeh, Hossein Vahid; Domel, August G.; Devlin, Matthew; Kurt, Mehmet; Mungal, M. Godfrey; Camarillo, David B.; Hawkes, Elliot			Variable area, constant force shock absorption motivated by traumatic brain injury prevention	SMART MATERIALS AND STRUCTURES			English	Article						shock absorber; brain injury; 3D printing; energy absorption; smart structure	ABSORBER; IMPACT; FLUID	Compact and efficient energy absorption is desirable for numerous applications including manufacturing, transportation, and protective equipment. An ideal shock absorber is a smart material or structure that can adapt its force-displacement properties to minimize the peak impact force regardless of the impact energy. While traditional shock absorbers can produce precisely-tuned ideal force profiles, they are rigid devices that only compress half of their total length, limiting utility in space-constrained applications. Energy absorbers that are soft and collapsible, such as foams, do not have ideal force profiles and generally have insufficient viscoelasticity to adapt to different impact energies. Here, we present a smart structure concept-variable area shock absorption (VASA)-that leverages a changing contact area in a hydraulically damped collapsible system to passively adapt the force to the minimum necessary to absorb the energy of an impact. Using an analytical fluid dynamics model, we derived the contact area as a function of compression to produce a constant force over the entire stroke of a fixed-orifice damper, and validate this concept experimentally using a preliminary 3D-printed prototype. The VASA prototype follows the constant force profile with aNRMSEbetween 0.02-0.25 at impact speeds between 2.3 and 4.3 m s(-1). This new approach for absorbing energy is compatible with full collapse of the absorber, enabling soft devices for space-constrained applications in future work. Potential applications include helmets that must absorb energy at a near-minimum force level across multiple impact energy levels.	[Fanton, Michael; Mungal, M. Godfrey] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Alizadeh, Hossein Vahid; Domel, August G.; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA USA; [Devlin, Matthew; Hawkes, Elliot] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA; [Kurt, Mehmet] Stevens Inst Technol, Dept Mech Engn, Hoboken, NJ 07030 USA; [Mungal, M. Godfrey] Santa Clara Univ, Dept Mech Engn, Santa Clara, CA 95053 USA; [Kurt, Mehmet] Icahn Sch Med Mt Sinai, Biomed Engn & Imaging Inst, New York, NY 10029 USA		Fanton, M (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	mfanton@stanford.edu	Kurt, Mehmet/AAX-3303-2021	Kurt, Mehmet/0000-0002-5618-0296; fanton, michael/0000-0001-8566-5260	Stanford University Child Health Research Institute; Stanford Bio-X Fellowship Program; Office of Naval Research Young Investigator ProgramOffice of Naval Research [N00014-16-1-2949]; NSF Graduate Research Fellowship ProgramNational Science Foundation (NSF)	This work was supported in part by the Stanford University Child Health Research Institute, in part by the Stanford Bio-X Fellowship Program, in part by the Office of Naval Research Young Investigator Program (N00014-16-1-2949), and in part by the NSF Graduate Research Fellowship Program.	Abderezaei J, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.014058; Alizadeh H V, 2019, ARXIV191007722; Baumeister J, 1997, MATER DESIGN, V18, P217, DOI 10.1016/S0261-3069(97)00050-2; Begley MR, 2014, J APPL MECH-T ASME, V81, DOI 10.1115/1.4024992; Boyle C, 2003, MECH MACH THEORY, V38, P1469, DOI 10.1016/S0094-114X(03)00098-3; Clough EC, 2019, MATTER-US, V1, P1519, DOI 10.1016/j.matt.2019.10.004; Corrales MA, 2020, ANN BIOMED ENG, V48, P121, DOI 10.1007/s10439-019-02359-1; Deshmukh SS, 2007, SMART MATER STRUCT, V16, P106, DOI 10.1088/0964-1726/16/1/013; Dixon J.C., 1999, SHOCK ABSORBER HDB, DOI [10.4271/r-176, DOI 10.4271/R-176]; Fanton M, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4044876; Fanton M, 2019, IEEE T BIO-MED ENG, V66, P988, DOI 10.1109/TBME.2018.2866147; Faraj R, 2019, J FRANKLIN I, V356, P7855, DOI 10.1016/j.jfranklin.2019.04.012; Faraj R, 2019, J SOUND VIB, V449, P427, DOI 10.1016/j.jsv.2019.02.022; Faraj R, 2019, J VIB CONTROL, V25, P711, DOI 10.1177/1077546318795532; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; HUNDAL MS, 1977, J SOUND VIB, V50, P195, DOI 10.1016/0022-460X(77)90354-6; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Jutte CV, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2936928; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kuo C, 2018, BIOMECH MODEL MECHAN, V17, P235, DOI 10.1007/s10237-017-0957-8; Kurt M, 2017, ANN BIOMED ENG, V45, P1148, DOI 10.1007/s10439-016-1732-1; Laksari K, 2020, J NEUROTRAUM, V37, P982, DOI 10.1089/neu.2018.6340; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li M, 2018, J MECH ROBOT, V10, DOI 10.1115/1.4040437; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lindholm US., 1974, J CELL PLAST, V10, P127, DOI DOI 10.1177/0021955X7401000306; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meyer D, 2019, IEEE INT CONF ROBOT, P4837, DOI 10.1109/ICRA.2019.8793498; Milecki A, 2012, MECH SYST SIGNAL PR, V28, P528, DOI 10.1016/j.ymssp.2011.11.008; Moss W C, 2011, LLNLSR471496, DOI 10.2172/1021058; Nenno PT, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/12/125019; Newman J. A., 2002, ACCIDENTAL INJURY BI, P303; Nguyen QH, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/3/035012; NOCSAE, 2013, NAT OP COMM STAND AT; Park K, 2005, 2005011711 SAE, DOI [10.4271/2005-01-1711, DOI 10.4271/2005-01-1711]; Pellman E J, NEUROSURGERY, V53, P796; Petek N. K., 1992, SAE TECHNICAL PAPER, DOI [10.4271/920275, DOI 10.4271/920275]; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Schaedler TA, 2014, ADV ENG MATER, V16, P276, DOI 10.1002/adem.201300206; Sonmez U, 2007, J MECH DESIGN, V129, P831, DOI 10.1115/1.2735337; Spinelli DJ, 2018, MATER DESIGN, V154, P153, DOI 10.1016/j.matdes.2018.04.083; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Taylor D P, 2012, ENERGY MANAGEMENT UT; Vahid Alizadeh H., 2011, 2011 IEEE International Symposium on Robotic and Sensors Environments (ROSE 2011), P125, DOI 10.1109/ROSE.2011.6058541; Versace J., 1971, REV SEVERITY INDEX; Warrick J C, 2001, P 16 AIAA AER DEC SY, DOI [10.2514/6.2001-2047, DOI 10.2514/6.2001-2047]; Withnall, 2017, NFL LINEAR IMPACTOR; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029	52	2	2	2	13	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0964-1726	1361-665X		SMART MATER STRUCT	Smart Mater. Struct.	AUG	2020	29	8							085023	10.1088/1361-665X/ab905f			13	Instruments & Instrumentation; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Instruments & Instrumentation; Materials Science	MO7TH	WOS:000551722800001					2022-02-06	
J	Froutan, R; Eghbali, M; Hoseini, SH; Mazloom, SR; Yekaninejad, MS; Boostani, R				Froutan, Razieh; Eghbali, Mohammad; Hoseini, Seyyed Hamid; Mazloom, Seyed Reza; Yekaninejad, Mir Saeed; Boostani, Reza			The effect of music therapy on physiological parameters of patients with traumatic brain injury: A triple-blind randomized controlled clinical trial	COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE			English	Article						Auditory stimulation; Physiological parameters; Brain injury; Intensive care unit; Traumatic brain injury	AUDITORY-STIMULATION; COMATOSE PATIENTS; RESPONSES; LEVEL	Objective: This study aims to investigate the effect of music therapy integrated with family recollection on physiological parameters of patients with traumatic brain injury who are admitted to Intensive Care Units. Methods: Sixty patients were selected through convenience sampling and were then randomly assigned to the intervention group and control group. In the intervention group and for 6 consecutive days, the patients received a combination of music and auditory stimulation twice a day for 15 minutes. The patients' physiological parameters were measured before the intervention, and then 10 minutes and finally 30 minutes after the intervention. The data were analyzed using multilevel modeling method through MLwiN version 2.27. Results: The results showed that there was no significant difference between the two groups in terms of demographic factors and the duration of coma. However, the results of the two-level multiple linear models which were performed for 6 consecutive days indicated a significant decrease in systolic blood pressure, diastolic blood pressure, respiratory rate and heart rate for the patients in the intervention group as compared to the patients in the control group (P < 0.0001). Nevertheless, no significant difference was observed in temperature and oxygen saturation (P > 0.05). Conclusion: Integration of music therapy with family recollection can moderate physiological parameters. Therefore, it is recommended to use this cost-effective treatment along with the routine treatments, especially for patients with traumatic brain injury.	[Froutan, Razieh; Mazloom, Seyed Reza] Mashhad Univ Med Sci, Sch Nursing & Midwifery, Dept Med Surg Nursing, Mashhad, Razavi Khorasan, Iran; [Froutan, Razieh] Mashhad Univ Med Sci, Nursing & Midwifery Care Res Ctr, Mashhad, Razavi Khorasan, Iran; [Eghbali, Mohammad] Univ Social Welf & Rehabil Sci, Dept Nursing, Tehran, Iran; [Eghbali, Mohammad] Univ Social Welf & Rehabil Sci, Student Res Comm, Tehran, Iran; [Hoseini, Seyyed Hamid] Torbat Heydariyeh Univ Med Sci, Sch Nursing & Midwifery, Torbat Heydariyeh Qarani 1, Torbat Heydariyeh 9516915169, Iran; [Yekaninejad, Mir Saeed] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Boostani, Reza] Mashhad Univ Med Sci, Sch Med, Dept Neurol, Ghaem Hosp, Mashhad, Razavi Khorasan, Iran		Hoseini, SH (corresponding author), Torbat Heydariyeh Univ Med Sci, Sch Nursing & Midwifery, Torbat Heydariyeh Qarani 1, Torbat Heydariyeh 9516915169, Iran.	hamidhoseini47@yahoo.com			Mashhad University of Medical Sciences	We should thank all the patients involved in this study and their families and the respected authorities of Shahid Kamyab Hospital, who efficiently cooperated with the researchers. This study is a part of a Master's Degree Thesis in Nursing sponsored by Mashhad University of Medical Sciences.	Bradt J., 2013, COCHRANE DATABASE SY; Cadigan M E, 2001, Prog Cardiovasc Nurs, V16, P5, DOI 10.1111/j.0889-7204.2001.00797.x; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dijkstra BM, 2010, J CLIN NURS, V19, P1030, DOI 10.1111/j.1365-2702.2009.02968.x; Ebrahimzadeh, 2017, J HOLISTIC NURS MIDW, V27, P95; Eghbali M., 2020, NURS PRACT TODAY, V7, P84; GUM SI, 2013, EVID-BASED COMPL ALT, V2013; Halbert J.D., 2018, MUSIC MED, V10, P180; Han L, 2010, J CLIN NURS, V19, P978, DOI 10.1111/j.1365-2702.2009.02845.x; Hegde S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00034; Henricson M., 2008, TACTILE TOUCH INTENS; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Khojeh A, 2018, J RES MED DENT SCI, V6, P69, DOI 10.5455/jrmds.20186311; Lee OKA, 2005, J CLIN NURS, V14, P609, DOI 10.1111/j.1365-2702.2004.01103.x; Maleki M, 2012, HORIZON MED SCI, V18, P66; Moghaddam F., 2016, EFFECT AUDITORY STIM; Mohamed MA, 2021, J MATERN-FETAL NEO M, V34, P3397, DOI 10.1080/14767058.2019.1685971; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Park S, 2016, INT J NURS PRACT, V22, P391, DOI 10.1111/ijn.12448; Parveen Y, 2015, INDIAN J NEUROTRAUM, V12, P128, DOI 10.1055/s-0035-1569470; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Raglio A, 2015, WORLD J PSYCHIATR, V5, P68, DOI 10.5498/wjp.v5.i1.68; Rahimi F, 2019, ACTA MEDICA MEDITERR, V35, P985, DOI 10.19193/0393-6384_2019_2_150; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Sanchez-Sanchez MM, 2014, ENFERM INTENSIV, V25, P15, DOI 10.1016/j.enfi.2013.09.002; Siponkoski ST, 2020, J NEUROTRAUM, V37, P618, DOI 10.1089/neu.2019.6413; Vik BMD, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00177; YekeFallah L., 2018, NURS CRIT CARE, V13, P18; Yousefi Hojatollah, 2015, Iran J Nurs Midwifery Res, V20, P63; Zolfaghari M.A.K.M., 2014, ADV NURSING MIDWIFER, V24, P1	30	2	2	2	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1744-3881	1873-6947		COMPLEMENT THER CLIN	Complement. Ther. Clin. Pract.	AUG	2020	40								101216	10.1016/j.ctcp.2020.101216			7	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Integrative & Complementary Medicine	NO0RB	WOS:000569193300004	32891292				2022-02-06	
J	Gromisch, ES; Kulas, JF; Altalib, H; Kerns, RD; Mattocks, KM; Brandt, CA; Haskell, S				Gromisch, Elizabeth S.; Kulas, Joseph F.; Altalib, Hamada; Kerns, Robert D.; Mattocks, Kristin M.; Brandt, Cynthia A.; Haskell, Sally			Neuropsychological assessments and psychotherapeutic services in Veterans with multiple sclerosis: Rates of utilization and their associations with socio-demographics and clinical characteristics using Veterans Health Administration-based data	MULTIPLE SCLEROSIS AND RELATED DISORDERS			English	Article						Multiple sclerosis; Neuropsychological assessments; Psychological services; Health services research	QUALITY-OF-LIFE; COGNITIVE IMPAIRMENT; GENDER-DIFFERENCES; PAIN; DISABILITY	Background: As cognitive, emotional, and health-related behavioral issues are prevalent among persons with multiple sclerosis (MS), mental health services are a valuable component of comprehensive care. However, it is unknown how many participate in neuropsychological and psychotherapeutic services, and whether the presence of certain co-occurring conditions increase service use. This study aimed to examine the frequency and associated factors (e.g., age, gender, education, race/ethnicity, and co-occurring conditions) of neuropsychological and psychotherapeutic service utilization in the Veterans Health Administration (VHA) among Veterans with MS. Methods: Data were extracted from VHA Corporate Data Warehouse as part of the Women Veterans Cohort Study (WVCS), a longitudinal project with Veterans who served during the Iraq and Afghanistan conflicts. Participants (n = 1,686) were Veterans from the overall WVCS dataset who had three or more VHA MS-related encounters (inpatient, outpatient, and/or disease modifying therapy) within one calendar year between fiscal years 2010 and 2015. Neuropsychological assessment participation was identified by procedural codes 96118 and 96119, while psychotherapeutic services were defined using 90804, 90806, 90808, 96150, 96151, and 96152. Bivariate analyses were conducted to identify socio-demographics and clinical characteristics that differed between Veterans who did and did not use these services. Service dates were compared to the diagnosis dates of the co-occurring conditions to determine whether the majority of the diagnoses preceded the service (e.g., a recognized problem) or were coded the day of or after the initial appointment (e.g., a suspected problem), which informed what co-occurring conditions and participants were included in the subsequent logistic regressions. Results: Two hundred eighty-one Veterans (16.67%) participated in a neuropsychological assessment. Veterans who had an evaluation had higher rates of several co-occurring conditions (ps <0.01), though no significant relationships emerged with any of the socio-demographic variables and participation. After controlling for age, gender, education, and race/ethnicity, two previously diagnosed co-occurring conditions predicted service utilization: traumatic brain injuries (TBIs; OR: 2.33, 95% CI: 1.60, 3.35) and mood disorders (i.e., depressive and bipolar disorders; OR: 1.71, 95% CI: 1.26, 2.31). Psychotherapeutic service usage was more common, occurring in over 45% (n = 771) of the sample. Service utilization was associated with several co-occurring conditions (ps <0.001), as well as level of education (p =.003). Focusing on participants who were diagnosed the day of or after the initial encounter, five co-occurring conditions were predictors of psychotherapeutic service use: mood disorders (OR: 1.81, 95% CI: 1.34, 2.46), anxiety disorders (OR: 1.38, 95% CI: 1.03, 1.85), sleep disorders (OR: 1.55, 95% CI: 1.19, 2.01), alcohol-related disorders (OR: 3.29, 95% CI: 1.79, 6.21), and cognitive disorders (OR: 3.72, 95% CI: 2.29, 6.16). Conclusions: These findings suggest that these services are being utilized by clinicians and Veterans to address the clinical complexity related to having MS and one or more of these other conditions.	[Gromisch, Elizabeth S.] Trinity Hlth New England, Mandell Ctr Multiple Sclerosis, Mt Sinai Rehabil Hosp, 490 Blue Hills Ave, Hartford, CT 06112 USA; [Gromisch, Elizabeth S.; Kulas, Joseph F.; Altalib, Hamada; Kerns, Robert D.; Brandt, Cynthia A.; Haskell, Sally] VA Connecticut Healthcare Syst, 950 Campbell Ave, West Haven, CT 06516 USA; [Gromisch, Elizabeth S.] Univ Connecticut, Sch Med, 263 Farmington Ave, Farmington, CT 06030 USA; [Gromisch, Elizabeth S.] Quinnipiac Univ, Frank H Netter Sch Med, 370 Bassett Rd, North Haven, CT 06473 USA; [Kulas, Joseph F.; Altalib, Hamada; Kerns, Robert D.; Brandt, Cynthia A.; Haskell, Sally] Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA; [Kerns, Robert D.; Brandt, Cynthia A.; Haskell, Sally] VA Connecticut Healthcare Syst, Pain Res Informat Multimorbid & Educ PRIME Ctr, 950 Campbell Ave, West Haven, CT 06516 USA; [Mattocks, Kristin M.] VA Cent Western Massachusetts Healthcare Syst, 421 North Main St, Leeds, MA 01053 USA; [Mattocks, Kristin M.] Univ Massachusetts, Med Sch, 55 N Lake Ave, Worcester, MA 01655 USA		Gromisch, ES (corresponding author), 490 Blue Hills Ave, Hartford, CT 06112 USA.	elizabeth.gromisch@trinityhealthofne.org			U.S. Department of Veteran Affairs, Office of Research and Development, Health Services Research and DevelopmentUS Department of Veterans Affairs	All of the sources of funding for the work described in this publication are acknowledged below:; U.S. Department of Veteran Affairs, Office of Research and Development, Health Services Research and Development. The sponsor had no role in the design and methodology of this study; collection, management, or analysis of the data; and preparation of this manuscript.	Akbar N, 2011, COGN BEHAV NEUROL, V24, P115, DOI 10.1097/WNN.0b013e31822a20ae; Amato Maria Pia, 2008, Expert Rev Neurother, V8, P1585, DOI 10.1586/14737175.8.10.1585; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; APA Services Inc, 2019, HLTH BEH ASS INT SER; Benedict RHB, 2003, MULT SCLER J, V9, P95, DOI 10.1191/1352458503ms861oa; Benito-Leon J, 2002, EUR J NEUROL, V9, P497, DOI 10.1046/j.1468-1331.2002.00450.x; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Clancy Megan, 2015, Int J MS Care, V17, P261, DOI 10.7224/1537-2073.2014-071; Culpepper WJ, 2019, NEUROLOGY, V92, pE1016, DOI 10.1212/WNL.0000000000007043; DUQUETTE P, 1992, CAN J NEUROL SCI, V19, P466, DOI 10.1017/S0317167100041664; Ehde DM, 2015, DISABIL HEALTH J, V8, P452, DOI 10.1016/j.dhjo.2015.03.001; Foley Frederick W, 2012, Int J MS Care, V14, P58, DOI 10.7224/1537-2073-14.2.58; Foley PL, 2013, PAIN, V154, P632, DOI 10.1016/j.pain.2012.12.002; Gallegos AM, 2015, WOMEN HEALTH ISS, V25, P542, DOI 10.1016/j.whi.2015.04.008; Gromisch Elizabeth S, 2016, Int J MS Care, V18, P291, DOI 10.7224/1537-2073.2016-007; Gromisch ES, 2019, INT J MS CARE, V22, P8; Hadjimichael O, 2007, PAIN, V127, P35, DOI 10.1016/j.pain.2006.07.015; Kalb R, 2018, MULT SCLER J, V24, P1665, DOI 10.1177/1352458518803785; Kalmar JH, 2008, NEUROPSYCHOLOGY, V22, P442, DOI 10.1037/0894-4105.22.4.442; Koo KH, 2015, PSYCHIAT SERV, V66, P507, DOI 10.1176/appi.ps.201300498; Lobentanz IS, 2004, ACTA NEUROL SCAND, V110, P6, DOI 10.1111/j.1600-0404.2004.00257.x; Marrie RA, 2010, NEUROLOGY, V74, P1041, DOI 10.1212/WNL.0b013e3181d6b125; Marrie RA, 2015, MULT SCLER J, V21, P305, DOI 10.1177/1352458514564487; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Minden SL, 2014, NEUROLOGY, V82, P174, DOI 10.1212/WNL.0000000000000013; O'Brien A, 2007, ARCH CLIN NEUROPSYCH, V22, P933, DOI 10.1016/j.acn.2007.07.002; Planche V, 2016, EUR J NEUROL, V23, P282, DOI 10.1111/ene.12715; Rogers JM, 2007, J CLIN NEUROSCI, V14, P919, DOI 10.1016/j.jocn.2007.02.006; Rudick R, 1996, ANN NEUROL, V40, P469, DOI 10.1002/ana.410400321; Sainani KL, 2014, PM&R, V6, P841, DOI 10.1016/j.pmrj.2014.08.941; Strober LB, 2014, MULT SCLER RELAT DIS, V3, P473, DOI 10.1016/j.msard.2014.03.004; Sullivan Amy Burleson, 2012, Int J MS Care, V14, P216, DOI 10.7224/1537-2073-14.4.216; TACHIBANA N, 1994, EUR NEUROL, V34, P320, DOI 10.1159/000117070; The Consortium of the Multiple Sclerosis Centers, 2010, COMPR CAR MULT SCLER; van Kessel K, 2008, PSYCHOSOM MED, V70, P205, DOI 10.1097/PSY.0b013e3181643065; Wallin MT, 2019, NEUROLOGY, V92, pE1029, DOI 10.1212/WNL.0000000000007035	36	2	2	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2211-0348	2211-0356		MULT SCLER RELAT DIS	Mult. Scler. Relat. Disord.	AUG	2020	43								102220	10.1016/j.msard.2020.102220			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MK3FA	WOS:000548668100025	32480347				2022-02-06	
J	Hoffman, MR; Morris, R; Smith, T; Denslow, S; Schurr, M				Hoffman, Melissa R.; Morris, Rachel; Smith, Terrie; Denslow, Sheri; Schurr, Michael			Early Comfort Care Following Operative Intervention for Traumatic Injury	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Scientific Meeting of the Southeastern-Surgical-Congress (SESC)	FEB 08-11, 2020	New Orleans, LA	SE Surg Congr		trauma; palliative care; comfort care; withdrawal of life sustaining treatment; advance directives		Background Several studies have described the population of adult trauma patients who undergo withdrawal of life-sustaining treatments (WLST); however, no study has looked specifically at trauma patients who undergo WLST following surgery. Methods This was a retrospective chart review of all trauma patients who underwent surgery at our trauma center between January 1 and December 31, 2017. Demographics were collected along with injury patterns and advance directives. Charts of all patients who died or who were discharged to hospice were analyzed to determine whether WLST occurred. Statistics included Fisher's exact test and Mann-Whitney U test. Results Three thousand and twenty-five adult trauma patients received care and 1495 (49.4%) had operations. Thirty (2.0%) patients underwent WLST, 15 (50.0%) of whom died in the hospital and 15 (50.0%) of whom were discharged to hospice. Twenty-six (86.7%) patients had a palliative care consult and 12 (40.0%) had prior advance directives. The most common injuries were femur fractures and subdural hematomas. Adjusting for age, white race, and age-adjusted CCI, femur fracture patients had, on average, 8.8 more hours between presentation and surgery (95% CI 2.1-15.4, P = .01) and 39 fewer hours between surgery and WLST (95% CI -107-29, P = .26) than traumatic brain injury patients. Discussion The short time between surgery and WLST in this cohort of patients may demonstrate that surgery was not aligned with patients' goals of care. A patient-centered approach that includes surgeon-driven palliative care discussions may help avoid nonbeneficial surgery in the last few days of life.	[Hoffman, Melissa R.; Smith, Terrie] Mission Hosp, Dept Surg, Asheville, NC 28801 USA; [Morris, Rachel; Schurr, Michael] Mt Area Hlth Educ Ctr, Dept Surg, Asheville, NC USA; [Denslow, Sheri] Univ North Carolina Hlth Sci, Dept Res, MAHEC, Asheville, NC USA		Hoffman, MR (corresponding author), Mission Hosp, Dept Surg, Asheville, NC 28801 USA.	Melissa.Hoffman@hcahealthcare.com					ACS TQIP , 2017, PALL CAR BEST PRACT; American College of Surgeions, 2014, Bull Am Coll Surg, V99, P42; Bonne S, 2013, CLIN GERIATR MED, V29, P137, DOI 10.1016/j.cger.2012.10.008; Burns E, 2018, MMWR-MORBID MORTAL W, V67, P509, DOI 10.15585/mmwr.mm6718a1; CDC, 2018, UND CAUS DEATH 1999; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Cunningham HB, 2019, AM J HOSP PALLIAT ME, V36, P669, DOI 10.1177/1049909118823182; Enumah S, 2018, AM J SURG, V215, P1016, DOI 10.1016/j.amjsurg.2018.02.028; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Jawa RS, 2015, AM J SURG, V210, P814, DOI 10.1016/j.amjsurg.2015.04.007; Leonard JM, 2019, INJURY, V50, P1064, DOI 10.1016/j.injury.2019.01.024; Leopold SS, 2016, CLIN ORTHOP RELAT R, V474, P867, DOI 10.1007/s11999-015-4687-x; Mackenzie E., 2008, TRAUMA, V6th; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Simons AE, 2017, AGE AGEING, V46, P946, DOI 10.1093/ageing/afx027	15	2	2	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	AUG	2020	86	8					933	936		10.1177/0003134820940255			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	QF7GV	WOS:000617061600007	32856933				2022-02-06	
J	Huang, JX; Zhang, HP; Zhang, JN; Yu, HP; Lin, ZZ; Cai, YH				Huang, Jianxing; Zhang, Heping; Zhang, Jinning; Yu, Huiping; Lin, Zhizhong; Cai, Yonghui			Spermidine Exhibits Protective Effects Against Traumatic Brain Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Spermidine; Traumatic head injury; Closed head injury; ODC1	BECLIN 1; AUTOPHAGY; BIOMARKERS; POLYAMINES; RAPAMYCIN	Traumatic brain injury (TBI) causes permanent neurological and cognitive impairments. Effective pharmacological interventions remain elusive. Spermidine is a polyamine compound found in our body that may play a role in brain development and congenital function. In this study, we aimed to investigate the therapeutic potential of spermidine for TBI. We employed experimental closed head injury (CHI) model to evaluate the protective function of spermidine on brain injury. We assessed the neurobehavioral function recovery using Neurologic Severity Score (NSS) and Morris water maze test. At histological level, we evaluated the improvement on brain edema, brain-blood barrier integrity, and cell apoptosis. We also measured inflammatory cytokines and brain injury biomarkers to monitor the treatment outcomes. Last, we correlated the level of spermidine with CHI animal model and TBI patients with different levels of severity. Spermidine administration post-CHI was found effectively to accelerate NSS improvement and shorten latency in maze test. We observed consistent improvements in brain edema, BBB function, and cell death in spermidine-treated group. Inflammatory cytokines and TBI biomarkers, e.g., S100B, MBP and CFAP were reduced significantly in treatment group. Interestingly, inhibiting spermidine synthesis influenced the neurobehavioral recovery in CHI mice. ODC1, a rate-limiting enzyme for spermidine synthesis, was found lower in CHI mice. Serum level of spermidine was significantly lower in TBI patients with severe pathological scores. Spermidine pathway may carry an endogenous role in pathophysiological process of CHI. For the first time, we demonstrated that administrating spermidine may provide a new treatment for TBI.	[Huang, Jianxing; Zhang, Heping; Zhang, Jinning; Yu, Huiping; Lin, Zhizhong; Cai, Yonghui] Fujian Med Univ, Dept Neurosurg, Quanzhou Hosp 1, 248-252 Dong Rd, Quanzhou 362000, Fujian, Peoples R China		Zhang, HP; Zhang, JN (corresponding author), Fujian Med Univ, Dept Neurosurg, Quanzhou Hosp 1, 248-252 Dong Rd, Quanzhou 362000, Fujian, Peoples R China.	zhanghp5353@163.com; zhangjinningnew@126.com					Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Au AK, 2017, NEUROCRIT CARE, V26, P348, DOI 10.1007/s12028-016-0351-x; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Hosseinpour-Moghaddam K., 2018, MOL MECH THERAPEUTIC, V233, P6524, DOI DOI 10.1002/jcp.26583; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kuma A, 2017, AUTOPHAGY, V13, P1619, DOI 10.1080/15548627.2017.1343770; Liu F, 2014, MOL MED REP, V9, P1225, DOI 10.3892/mmr.2014.1967; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788; Minois N, 2014, GERONTOLOGY, V60, P319, DOI 10.1159/000356748; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; Portbury SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183683; Ridler Charlotte, 2017, Nat Rev Endocrinol, V13, P66, DOI 10.1038/nrendo.2016.203; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; SCHENKEL E, 1995, J CHROMATOGR B, V668, P189, DOI 10.1016/0378-4347(95)00094-Y; Sharma S, 2018, NEUROCHEM INT, V116, P104, DOI 10.1016/j.neuint.2018.02.010; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Sun LQ, 2018, BEHAV BRAIN RES, V340, P126, DOI 10.1016/j.bbr.2016.09.020; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Yang Y, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.161; Zhao MF, 2016, MOL MED REP, V13, P13, DOI 10.3892/mmr.2015.4551	28	2	2	1	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	AUG	2020	40	6					927	937		10.1007/s10571-019-00783-4			11	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	MD8EN	WOS:000544201700005	31916070				2022-02-06	
J	Jackson, TC; Janesko-Feldman, K; Gorse, K; Vagni, VA; Jackson, EK; Kochanek, PM				Jackson, Travis C.; Janesko-Feldman, Keri; Gorse, Kiersten; Vagni, Vincent A.; Jackson, Edwin K.; Kochanek, Patrick M.			Identification of Novel Targets of RBM5 in the Healthy and Injured Brain	NEUROSCIENCE			English	Article						RBM5; Rims2; neurotransmitter; brain; RNA-binding protein; RNA splicing	CANDIDATE TUMOR-SUPPRESSOR; GENE-EXPRESSION; CIRCULAR RNAS; UP-REGULATION; RIM PROTEINS; RT-PCR; TRANSCRIPTION; INCREASES; APOPTOSIS; PROFILE	The tumor suppressor RNA-binding motif 5 (RBM5) regulates the expression levels and cassette exon-definition (i.e. splicing) of a select set of mRNAs in a tissue-specific manner. Most RBM5-regulated targets were identified in oncological investigations and frequently involve genes which mediate apoptotic cell death. Little is known about the role of RBM5 in the brain. Also, it is unclear if a brain injury may be required to detect RBM5 mediated effects on pro-apoptotic genes due to their low expression levels in the healthy adult CNS at baseline. Conditional/floxed (brain-specific) gene deleter mice were generated to elucidate CNS-specific RBM5 mRNA targets. Male/female mice were subjected to a severe controlled cortical impact (CCI) traumatic brain injury (TBI) in order to increase the background expression of pro-death mRNAs and facilitate testing of the hypothesis that RBM5 inhibition decreases post-injury upregulation of caspases/FAS in the CNS. As expected, a CCI increased caspases/FAS mRNA in the injured cortex. RBM5 KO did not affect their levels or splicing. Surprisingly, KO increased the mRNA levels of novel targets including casein kinase 2 alpha prime interacting protein (Csnka2ip/CKT2) - a gene not thought to be expressed in the brain, contrary to findings here. Twenty-two unique splicing events were also detected in KOs including increased block-inclusion of cassette exons 20-22 in regulating synaptic membrane exocytosis 2 (Rims2). In conclusion, here we used genome-wide transcriptomic analysis on healthy and injured RBM5 KO mouse brain tissue to elucidate the first known gene targets of this enigmatic RBP in this CNS. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of IBRO. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Jackson, Travis C.; Gorse, Kiersten] Univ S Florida, Morsani Coll Med, USF Hlth Heart Inst, Primary Lab, MDD 0742,560 Channelside Dr, Tampa, FL 33602 USA; [Jackson, Travis C.; Gorse, Kiersten] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, 12901 Bruce B Downs BLDV, Tampa, FL 33612 USA; [Janesko-Feldman, Keri; Vagni, Vincent A.; Kochanek, Patrick M.] UPMC Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res, Rangos Res Ctr, 6th Floor, Pittsburgh, PA 15224 USA; [Jackson, Edwin K.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Bridgeside Point Bldg 1,100 Technol Dr, Pittsburgh, PA 15219 USA		Jackson, TC (corresponding author), Univ S Florida, Morsani Coll Med, USF Hlth Heart Inst, MDD 0742,560 Channelside Dr, Tampa, FL 33602 USA.	tcjackson@usf.edu			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS105721, R01NS087978]; University of South Florida Morsani College of Medicine start-up funds; Ake N. Grenvik Chair in Critical Care Medicine	We are grateful to the University of Pittsburgh Genomics Core and to The Moffitt Cancer Center Genomics Core for assistance in RNA studies. This work was supported by NIH/NINDS grants R01NS105721 to TCJ, and R01NS087978 to PMK and EKJ, by the University of South Florida Morsani College of Medicine start-up funds to TCJ, and by the Ake N. Grenvik Chair in Critical Care Medicine to PMK.	Alkelai A, 2019, PROG NEURO-PSYCHOPH, V94, DOI 10.1016/j.pnpbp.2019.109659; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XY, 2009, NUCLEIC ACIDS RES, V37, P2699, DOI 10.1093/nar/gkp094; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Boda E, 2009, J MOL NEUROSCI, V37, P238, DOI 10.1007/s12031-008-9128-9; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Castello J, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010007; Chelluboina B, 2015, STROKE, V46, P3523, DOI 10.1161/STROKEAHA.115.011031; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; de Castro MAG, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.12; Franz G, 2002, J CEREBR BLOOD F MET, V22, P951, DOI 10.1097/00004647-200208000-00006; Fushimi K, 2008, P NATL ACAD SCI USA, V105, P15708, DOI 10.1073/pnas.0805569105; Holdt LM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01262; Hook G, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00178; Hsu FM, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON KNOWLEDGE ENGINEERING AND APPLICATIONS (ICKEA 2016), P12, DOI 10.1109/ICKEA.2016.7802984; Jackson TC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25371-2; Jackson TC, 2018, EXP NEUROL, V300, P232, DOI 10.1016/j.expneurol.2017.11.013; Jackson TC, 2017, NEUROSCIENCE, V361, P93, DOI 10.1016/j.neuroscience.2017.08.014; Jackson TC, 2015, J CEREBR BLOOD F MET, V35, P655, DOI 10.1038/jcbfm.2014.242; Jamsai D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15874-9; Ji PF, 2019, CELL REP, V26, P3444, DOI 10.1016/j.celrep.2019.02.078; Kaeser PS, 2012, P NATL ACAD SCI USA, V109, P11830, DOI 10.1073/pnas.1209318109; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kang YB, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0403-6; Kim KT, 2013, BIOMED REP, V1, P619, DOI 10.3892/br.2013.101; Kisenge RR, 2003, CANCER SCI, V94, P598, DOI 10.1111/j.1349-7006.2003.tb01489.x; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Lion T, 2001, LEUKEMIA, V15, P1033, DOI 10.1038/sj.leu.2402133; Liu N, 2003, EMBO J, V22, P5313, DOI 10.1093/emboj/cdg510; Lotocki G, 2004, J NEUROSCI, V24, P11010, DOI 10.1523/JNEUROSCI.3823-04.2004; McClard CK, 2018, J NEUROSCI, V38, P1443, DOI 10.1523/JNEUROSCI.1641-17.2017; McGill BE, 2018, J NEUROSCI, V38, P200, DOI 10.1523/JNEUROSCI.0936-17.2017; Medrano JL, 2017, J BIOL CHEM, V292, P20975, DOI 10.1074/jbc.M117.806422; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mourtada-Maarabouni M, 2006, EXP CELL RES, V312, P1745, DOI 10.1016/j.yexcr.2006.02.009; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; O'Bryan MK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003628; Oh JJ, 2006, CANCER RES, V66, P3419, DOI 10.1158/0008-5472.CAN-05-1667; Oh JJ, 2002, CANCER RES, V62, P3207; Oh JJ, 2010, LUNG CANCER, V70, P253, DOI 10.1016/j.lungcan.2010.02.012; Romero JP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2816-x; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI [10.1089/neu.2009-0959, 10.1089/neu.2009.0959]; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang Y, 2003, GENOMICS, V81, P126, DOI 10.1016/S0888-7543(02)00024-1; Weidenhofer J, 2006, MOL CELL NEUROSCI, V31, P243, DOI 10.1016/j.mcn.2005.09.013; Weidenhofer J, 2008, J PSYCHIATR RES, V43, P282, DOI 10.1016/j.jpsychires.2008.04.001; Zhang JL, 2015, INT J BIOCHEM CELL B, V60, P43, DOI 10.1016/j.biocel.2014.12.020	55	2	2	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 1	2020	440						299	315		10.1016/j.neuroscience.2020.04.024			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ6PZ	WOS:000548211200009	32335213	Green Accepted, hybrid			2022-02-06	
J	Jaishankar, R; Fanelli, A; Filippidis, A; Vu, T; Holsapple, J; Heldt, T				Jaishankar, Rohan; Fanelli, Andrea; Filippidis, Aristotelis; Vu, Thai; Holsapple, James; Heldt, Thomas			A Spectral Approach to Model-Based Noninvasive Intracranial Pressure Estimation	IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS			English	Article						Intracranial pressure (ICP); arterial blood pressure (ABP); cerebral blood flow velocity (CBFV); brain injury; model-based signal processing	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; UNITED-STATES; GUIDELINES; MANAGEMENT; DISEASE; UPDATE; SYSTEM; WAVE	Background: Intracranial pressure (ICP) normally ranges from 5 to 15 mmHg. Elevation in ICP is an important clinical indicator of neurological injury, and ICP is therefore monitored routinely in several neurological conditions to guide diagnosis and treatment decisions. Current measurement modalities for ICP monitoring are highly invasive, largely limiting the measurement to critically ill patients. An accurate noninvasive method to estimate ICP would dramatically expand the pool of patients that could benefit from this cranial vital sign. Methods: This article presents a spectral approach to model-based ICP estimation from arterial blood pressure (ABP) and cerebral blood flow velocity (CBFV) measurements. The model captures the relationship between the ABP, CBFV, and ICP wave-forms and utilizes a second-order model of the cerebral vasculature to estimate ICP. Results: The estimation approach was validated on two separate clinical datasets, one recorded from thirteen pediatric patients with a total duration of around seven hours, and the other recorded from five adult patients, one hour and 48 minutes in total duration. The algorithm was shown to have an accuracy (mean error) of 0.4 mmHg and -1.5 mmHg, and a precision (standard deviation of the error) of 5.1 mmHg and 4.3 mmHg, in estimating mean ICP (range of 1.3 mmHg to 24.8 mmHg) on the pediatric and adult data, respectively. These results are comparable to previous results and within the clinically relevant range. Additionally, the accuracy and precision in estimating the pulse pressure of ICP on a beat-by-beat basis were found to be 1.3 mmHg and 2.9 mmHg respectively. Conclusion: These contributions take a step towards realizing the goal of implementing a real-time noninvasive ICP estimation modality in a clinical setting, to enable accurate clinical-decision making while overcoming the drawbacks of the invasive ICP modalities.	[Jaishankar, Rohan; Heldt, Thomas] MIT, Inst Med Engn & Sci, Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Jaishankar, Rohan; Heldt, Thomas] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Fanelli, Andrea] MIT, Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Fanelli, Andrea] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Filippidis, Aristotelis; Vu, Thai; Holsapple, James] Boston Med Ctr, Dept Neurosurg, Boston, MA 02118 USA		Heldt, T (corresponding author), MIT, Inst Med Engn & Sci, Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Heldt, T (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	rohanrj@mit.edu; fanelli@mit.edu; aristotelis.filippidis@bmc.org; thai.vu@bmc.org; holsappj@bu.edu; thomas@mit.edu		/0000-0003-0114-1705; Filippidis, Aristotelis/0000-0002-1568-7613; Fanelli, Andrea/0000-0001-9876-9050	Maxim Integrated Products; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS084264]; Philips Healthcare; Grass Instruments Graduate Fellowship from the Department of Electrical Engineering and Computer Science at MIT	This work was supported in part by Maxim Integrated Products, in part by the National Institute of Neurological Disorders and Stroke Grant R21 NS084264, in part by Philips Healthcare, and in part by a Grass Instruments Graduate Fellowship from the Department of Electrical Engineering and Computer Science at MIT.	ADOLPH RJ, 1967, AM J PHYSIOL, V212, P840, DOI 10.1152/ajplegacy.1967.212.4.840; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; BERING EA, 1955, ARCH NEURO PSYCHIATR, V73, P165, DOI 10.1001/archneurpsyc.1955.02330080043012; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brean A, 2006, J Clin Monit Comput, V20, P411, DOI 10.1007/s10877-006-9047-7; Bruce D., 1980, NEUROBIOL CEREBROSPI, V1, P351; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chacon M, 2010, IEEE ENG MED BIO, P996, DOI 10.1109/IEMBS.2010.5627816; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Eide PK, 2008, J NEUROSURG, V109, P912, DOI 10.3171/JNS/2008/109/11/0912; Fanelli A, 2019, J NEUROSURG-PEDIATR, V24, P509, DOI 10.3171/2019.5.PEDS19178; Fanelli A, 2018, ACTA NEUROCHIR SUPPL, V126, P173, DOI 10.1007/978-3-319-65798-1_36; Faul M, 2010, TRAUMATIC BRAIN INJU; Gooch CL, 2017, ANN NEUROL, V81, P479, DOI 10.1002/ana.24897; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Heldt T., 2019, ANNU REV BIOMED ENG, V21, P1; Holt JP, 1941, AM J PHYSIOL, V134, P0292, DOI 10.1152/ajplegacy.1941.134.2.292; Hu X, 2007, IEEE T BIO-MED ENG, V54, P597, DOI 10.1109/TBME.2006.890130; Hu X, 2006, BIOMED SIGNAL PROCES, V1, P64, DOI 10.1016/j.bspc.2006.05.003; Imaduddin S., IEEE T BIOMED ENG; Kashif F., 2013, U.S. Patent, Patent No. [8 366 627B2, 8366627]; Kashif FM, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P369, DOI 10.1109/CIC.2008.4749055; Kashif FM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003249; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; LANGFITT TW, 1965, NEUROLOGY, V15, P622, DOI 10.1212/WNL.15.7.622; Lescot T, 2011, INTENS CARE MED, V37, P875, DOI 10.1007/s00134-011-2182-8; Moringlane RB, 2017, NEUROSURG REV, V40, P655, DOI 10.1007/s10143-017-0823-2; Noraky J., 2014, THESIS; Noraky J, 2016, ACTA NEUROCHIR SUPPL, V122, P65, DOI 10.1007/978-3-319-22533-3_13; Oppenheim A. V., 1997, SIGNALS SYSTEMS; Park C, 2019, IEEE T NEUR SYS REH, V27, P1931, DOI 10.1109/TNSRE.2019.2932273; Popovic Djordje, 2009, Recent Patents on Biomedical Engineering, V2, P165, DOI 10.2174/1874764710902030165; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Schmidt B, 1999, J CEREBR BLOOD F MET, V19, P990, DOI 10.1097/00004647-199909000-00006; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wang JX, 2019, ANN BIOMED ENG, V47, P714, DOI 10.1007/s10439-018-02191-z; Xu P, 2010, IEEE T INF TECHNOL B, V14, P971, DOI 10.1109/TITB.2009.2027317; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9; Zhang X, 2017, PHYSIOL MEAS, V38, P143, DOI 10.1088/1361-6579/aa7256	42	2	2	0	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2194	2168-2208		IEEE J BIOMED HEALTH	IEEE J. Biomed. Health Inform.	AUG	2020	24	8					2398	2406		10.1109/JBHI.2019.2961403			9	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Mathematical & Computational Biology; Medical Informatics	MW9NS	WOS:000557358500025	31880569	Green Submitted, Bronze			2022-02-06	
J	Levitch, CF; McConathey, E; Aghvinian, M; Himmelstein, M; Lipton, ML; Zimmerman, ME				Levitch, Cara F.; McConathey, Eric; Aghvinian, Maral; Himmelstein, Mark; Lipton, Michael L.; Zimmerman, Molly E.			The Impact of Sleep on the Relationship between Soccer Heading Exposure and Neuropsychological Function in College-Age Soccer Players	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injuries; Sleep; Risk factors; Soccer; Cognition; Repetitive head impacts	TRAUMATIC BRAIN-INJURY; FALSE DISCOVERY RATE; COGNITIVE IMPAIRMENT; QUALITY INDEX; PERFORMANCE; RECOVERY; VALIDATION; DISORDERS; EXTENSION; SYMPTOMS	Objective: Soccer is the most popular sport worldwide and is the only sport where athletes purposely use their head to deflect the ball during play, termed "heading" the ball. These repetitive head impacts (RHI) are associated with worse neuropsychological function; however, factors that can increase risk of injury following exposure to such head impacts have been largely unexamined. The present study provided a novel examination of the modifying role of sleep on the relationship between RHI exposure and neuropsychological function in college-age soccer players. Methods: Fifty varsity and intramural college soccer players completed questionnaires assessing recent and long-term heading exposure, a self-report measure of sleep function, and a battery of neuropsychological tests. Results: A high level of recent heading exposure was significantly associated with poorer processing speed, independent of concussion history. With reduced sleep duration, a high level of recent heading exposure was related to worse sustained attention. However, with greater hours of sleep duration, heading exposure was related to preserved neuropsychological outcome in sustained attention. Conclusions: We replicated our earlier finding of an association between recent head impact exposure and worse processing speed in an independent sample. In addition, we found that sleep may serve as a risk or protective factor for soccer players following extensive exposure to head impacts. Ultimately, this study furthers the understanding of factors impacting neuropsychological function in soccer players and provides empirical support for sleep interventions to help ensure safer soccer play and recovery from injury.	[Levitch, Cara F.; McConathey, Eric; Aghvinian, Maral; Himmelstein, Mark; Zimmerman, Molly E.] Fordham Univ, Dept Psychol, 441 East Fordham Rd,Dealy 226, Bronx, NY 10458 USA; [Lipton, Michael L.] Gruss Magnet Resonance Res Ctr, Bronx, NY USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Lipton, Michael L.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Psychiat & Behav Sci, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA		Levitch, CF (corresponding author), Fordham Univ, Dept Psychol, 441 East Fordham Rd,Dealy 226, Bronx, NY 10458 USA.	clevitch@fordham.edu			Fordham University Graduate School of Arts and Sciences	The authors thank Katherine Farber and Jerome Vessichio for their contributions to data collection and data entry. The authors have no relevant conflicts of interest to report. This work was supported by a grant received from the Fordham University Graduate School of Arts and Sciences.	[Anonymous], 2013, NAT METHODS, V10, P1, DOI 10.1038/nmeth.2329; Archer T, 2016, CLIN TER, V167, pE180, DOI 10.7417/CT.2016.1965; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Brown FC, 2002, BEHAV MED, V28, P33, DOI 10.1080/08964280209596396; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Dalmasso C, 2005, BIOINFORMATICS, V21, P660, DOI 10.1093/bioinformatics/bti063; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; FIFA, 2007, FIFA BIG COUNT 2006 FIFA BIG COUNT 2006; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Lipton ML, 2018, J SCI MED SPORT, V21, P363, DOI 10.1016/j.jsams.2017.08.008; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Luke A, 2011, CLIN J SPORT MED, V21, P307, DOI 10.1097/JSM.0b013e3182218f71; Mah CD, 2011, SLEEP, V34, P943, DOI 10.5665/SLEEP.1132; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McIntyre T, 2015, AM REV CAN STUD, V45, P161, DOI 10.1080/02722011.2015.1034285; Merrick J, 2002, J HOMOSEXUAL, V42, P103, DOI 10.1300/J082v42n03_07; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Nedelec M, 2015, SPORTS MED, V45, P1387, DOI 10.1007/s40279-015-0358-z; Piata Wspolna Grupa Robocza Europejskiego Towarzystwa Kardiologicznego i Innych Towarzystw Naukowych ds, 2012, KARDIOL POL, V70, P1, DOI DOI 10.1227/NEU.0B013E31823021B2; Reitan R, 1985, HALSTEAD REITAN NEUR; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Rutherford A, 2009, J CLIN EXP NEUROPSYC, V31, P664, DOI 10.1080/13803390802484755; Samuels C, 2008, NEUROL CLIN, V26, P169, DOI 10.1016/j.ncl.2007.11.012; Schwartz J, 2015, PHYSIOL BEHAV, V151, P541, DOI 10.1016/j.physbeh.2015.08.035; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Taheri M, 2012, J SPORTS MED, V3, P15, DOI DOI 10.5812/ASJSM.34719; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; WARD MF, 1993, AM J PSYCHIAT, V150, P885; Wickens CD, 2015, HUM FACTORS, V57, P930, DOI 10.1177/0018720815571935; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; 2015, DIABETES CARE S, V30, pE67, DOI DOI 10.1097/HTR.0000000000000119	55	2	2	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2020	26	7					633	644	PII S1355617720000211	10.1017/S1355617720000211			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	MY2TG	WOS:000558272100001	32098640				2022-02-06	
J	Manaseer, TS; Whittaker, JL; Isaac, C; Schneider, K; Roberts, MR; Gross, DP				Manaseer, Thaer S.; Whittaker, Jackie L.; Isaac, Codi; Schneider, Kathryn; Roberts, Mary Roduta; Gross, Douglas P.			THE RELIABILITY OF CLINICAL BALANCE TESTS UNDER SINGLE-TASK AND DUAL-TASK TESTING PARADIGMS IN UNINJURED ACTIVE YOUTH AND YOUNG ADULTS	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Adolescent; gait; psychometrics; reaction time; sport; young adult; movement system	ERROR SCORING SYSTEM; REACTION-TIME; GENERALIZABILITY THEORY; VALIDITY; GAIT; ATTENTION; ASSESSMENTS; PERFORMANCE; CONCUSSION; COGNITION	Background: Previous researchers have suggested that balance control deficits are detected more accurately with dual-task testing than single-task testing. However, it is necessary to examine the clinimetric properties of dual-task testing before employing it in clinical and research settings. Objective: To examine and compare the relative and absolute reliability of the Balance Error Scoring System (BESS), Tandem Gait Test (TGT), and Clinical Reaction Time (CRT) under single and dual-task conditions in uninjured active youth and young adults. Study Design: Single-group, repeated-measures study. Methods: Twenty-three individuals [9 female; median age 17 years] completed three trials of the BESS, TGT, and CRT under single and dual-task testing conditions during testing session one. Two raters assessed participants to assess inter-rater reliability. Either later on the same day or the following day, the protocol was repeated by one rater to assess intra-rater reliability. The average of three trials was used to calculate intra-rater (between-session) and inter-rater (within-session) intraclass correlation coefficient (ICC), standard error of measurement (SEM), minimal detectable change (MDC), and Cohen's Kappa coefficient for tests as appropriate under both conditions. Bland-Altman plots (mean difference and 95% limits of agreement) were used to assess for a systematic error associated with a learning effect. Results: Only one participant attended the second session on the following day, while 22 participants (95%) attended the second session within four hours after testing session one. Under single-task testing, estimated ICCs, SEMs, MDCs, and Kappa coefficients ranged from 0.24 to 0.99, 0.3 to 23, 0.8 to 64, and 0.03 to 0.64, respectively. Under dual-task testing, estimated ICCs, SEMs, MDCs, and Kappa coefficients ranged from 0.70 to 0.99, 0.4 to 17, 1.1 to 47, and 0.39 to 0.83, respectively. A learning effect was identified for all tests under all conditions. Conclusion: The BESS is the only clinical test that demonstrated acceptable reliability for clinical use under single-task testing conditions. The BESS, TGT, and CRT all demonstrated acceptable reliability for clinical use under dual-task testing conditions. A practice session should be used to reduce the possible learning effect seen. Further studies examining sources of the systematic error observed are needed.	[Manaseer, Thaer S.; Whittaker, Jackie L.; Gross, Douglas P.] Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, 2-50 Corbett Hall,8205-114 St, Edmonton, AB T6G 2G4, Canada; [Manaseer, Thaer S.] Hashemite Univ, Fac Phys Educ & Sport Sci, Dept Sport Rehabil, Zarqa, Jordan; [Manaseer, Thaer S.; Whittaker, Jackie L.; Isaac, Codi; Gross, Douglas P.] Univ Alberta, Edmonton Clin, Glen Sather Sports Med Clin, Edmonton, AB, Canada; [Whittaker, Jackie L.] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada; [Whittaker, Jackie L.] Arthrit Res Canada, Richmond, BC, Canada; [Isaac, Codi] Isaac Physiotherapy Clin, Edmonton, AB, Canada; [Schneider, Kathryn] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Schneider, Kathryn] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Schneider, Kathryn] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Schneider, Kathryn] Evidence Sport & Spinal Therapy, Calgary, AB, Canada; [Roberts, Mary Roduta] Univ Alberta, Fac Rehabil Med, Dept Occupat Therapy, Edmonton, AB, Canada		Gross, DP (corresponding author), Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, 2-50 Corbett Hall,8205-114 St, Edmonton, AB T6G 2G4, Canada.	dgross@ualberta.ca	Manaseer, Thaer/AAW-5634-2020	Roduta Roberts, Mary/0000-0003-3906-3466			Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Alsalaheen BA, 2015, PHYSICIAN SPORTSMED, V43, P221, DOI 10.1080/00913847.2015.1040717; ANASTASI A, 1998, PSYCHOL TESTING; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Barber-Westin SD, 1999, AM J SPORT MED, V27, P402, DOI 10.1177/03635465990270040201; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Nguyen CH, 2018, J CLEAN PROD, V202, P413, DOI 10.1016/j.jclepro.2018.08.110; Cushman D, 2018, BRAIN INJURY, V32, P569, DOI 10.1080/02699052.2018.1432891; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eckner JT, 2015, PERCEPT MOTOR SKILL, V120, P841, DOI 10.2466/25.15.PMS.120v19x6; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fraizer EV, 2008, GAIT POSTURE, V27, P271, DOI 10.1016/j.gaitpost.2007.04.002; Hansen C, 2017, CLIN J SPORT MED, V27, P64, DOI 10.1097/JSM.0000000000000293; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Huxham FE, 2001, AUST J PHYSIOTHER, V47, P89, DOI 10.1016/S0004-9514(14)60300-7; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Koyama S, 2018, EUR J PHYSIOTHER, V20, P135, DOI 10.1080/21679169.2017.1414304; Loosveldt G, 2008, INT HDB SURVEY METHO, P201; Manaseer TS, 2020, CLIN J SPORT MED, V30, pS11, DOI 10.1097/JSM.0000000000000537; Margolesky J, 2018, NEUROL SCI, V39, P23, DOI 10.1007/s10072-017-3108-1; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Muro-de-la-Herran A, 2014, SENSORS-BASEL, V14, P3362, DOI 10.3390/s140203362; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; National Research Council & Committee on sports- related concussions in youth, 2014, SPORTS RELATED CONCU; Portney L. G., 2000, FDN CLIN RES APPL PR, V2; Quatman-Yates C, 2014, PHYSICIAN SPORTSMED, V42, P32, DOI 10.3810/psm.2014.09.2073; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; ROEBROECK ME, 1993, PHYS THER, V73, P386, DOI 10.1093/ptj/73.6.386; Ross LM, 2011, J SPORT REHABIL, V20, P296, DOI 10.1123/jsr.20.3.296; Schneiders AG, 2010, J SCI MED SPORT, V13, P382, DOI 10.1016/j.jsams.2010.01.003; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	42	2	2	0	0	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	AUG	2020	15	4					487	500		10.26603/ijspt20200487			14	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PK6ZV	WOS:000602591200001	33354382				2022-02-06	
J	Merritt, VC; Jurick, SM; Crocker, LD; Keller, AV; Hoffman, SN; Jak, AJ				Merritt, Victoria C.; Jurick, Sarah M.; Crocker, Laura D.; Keller, Amber V.; Hoffman, Samantha N.; Jak, Amy J.			Factors Associated With Employment and Work Perception in Combat-Exposed Veterans	REHABILITATION PSYCHOLOGY			English	Article						functional outcomes; military veterans; unemployment; symptom repotting; psychiatric distress	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; PAIN CATASTROPHIZING SCALE; QUALITY-OF-LIFE; SELF-EFFICACY; ILLNESS PERCEPTIONS; IRAQI FREEDOM/OPERATION; DISABILITY COMPENSATION; PSYCHOMETRIC EVALUATION	Purpose/Objective: The purpose of this study was 2-fold: (a) to evaluate whether perception of work ability is associated with employment status in a sample of combat-exposed veterans, and (b) to determine whether the same sets of variables that are associated with employment status are also associated with perception of work ability. Research Method/Design: In this cross-sectional study. veterans (N = 83) underwent a neuropsychological assessment and completed questionnaires assessing demographic characteristics, combat-related experiences, and psychiatric and neurobehavioral/health-related symptoms. Primary outcomes of interest were employment status (unemployed vs. employed) and veterans' perception of whether their ability to work has declined due to an ongoing condition (yes vs. no). Results: A chi-square analysis revealed a significant relationship between perception of work ability and employment status. Additionally, psychiatric and neurobehavioral/health-related symptoms were associated with employment status and perception of work ability, whereas demographic characteristics (i.e., service-connected disability rating) and combat-related experiences (i.e., mTBI history) were only associated with perception of work ability. Objective cognitive functioning was not associated with employment status or perception of work ability. Conclusions/Implications: Although preliminary, results suggest that perception of work ability is an important factor to consider when evaluating employment-related outcomes in veterans. Moreover, results indicate that while there is some overlap among the variables associated with employment status and perception of work ability, additional variables are linked with perception of work ability. Taken together. these findings suggest that perception of one's ability to work and factors that influence it may be particularly important treatment targets in the veteran population.	[Merritt, Victoria C.; Crocker, Laura D.; Keller, Amber V.; Hoffman, Samantha N.] VA San Diego Healthcare Syst VASDHS, Res Serv, San Diego, CA USA; [Jurick, Sarah M.; Jak, Amy J.] VA San Diego Healthcare Syst VASDHS, Psychol Serv, San Diego, CA USA; [Jurick, Sarah M.; Crocker, Laura D.; Jak, Amy J.] VA San Diego Healthcare Syst VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Jak, Amy J.] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA		Jak, AJ (corresponding author), VA San Diego Healthcare Syst VASDHS, 151B,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ajak@ucsd.edu		, Sarah/0000-0002-5573-6459; Keller, Amber/0000-0002-2972-784X; Merritt, Victoria/0000-0001-5683-4168; Hoffman, Samantha/0000-0002-2792-8576	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]; VA Clinical Science Research AMP; Development Service [IK2 CX001952]; VA Rehabilitation Research AMP; Development Service [IK2 RX002459]	This work was supported by grant funding from: Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award [W81XWH-13-2-0095] and Department of Veterans Affairs CENC Award [I01 CX001135]. Additionally, Victoria C. Merritt received salary support during this work from a Career Development Award [IK2 CX001952] from the VA Clinical Science Research & Development Service and Laura D. Crocker received salary support during this work from a Career Development Award [IK2 RX002459] from the VA Rehabilitation Research & Development Service. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy, or decision, unless so designated by other official documentation. The authors report no conflicts of interest.	Amara JH, 2019, J HEAD TRAUMA REHAB, V34, P11, DOI 10.1097/HTR.0000000000000404; Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; Bahraini NH, 2018, J HEAD TRAUMA REHAB, V33, pE7, DOI 10.1097/HTR.0000000000000307; BANDURA A, 1993, EDUC PSYCHOL, V28, P117, DOI 10.1207/s15326985ep2802_3; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Beder J, 2011, SOC WORK HEALTH CARE, V50, P515, DOI 10.1080/00981389.2011.554279; Benach J, 2014, ANNU REV PUBL HEALTH, V35, P229, DOI 10.1146/annurev-publhealth-032013-182500; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carlson KF, 2018, ARCH PHYS MED REHAB, V99, pS4, DOI 10.1016/j.apmr.2017.06.027; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Carter WR, 2018, INT J HUM RESOUR MAN, V29, P2483, DOI 10.1080/09585192.2016.1244096; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS1, DOI 10.1016/j.apmr.2017.04.013; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Drew D, 2001, PSYCHIATR SERV, V52, P1479, DOI 10.1176/appi.ps.52.11.1479; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; Erbes CR, 2011, J REHABIL RES DEV, V48, P1159, DOI 10.1682/JRRD.2010.11.0212; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Geuze E, 2009, DEPRESS ANXIETY, V26, P7, DOI 10.1002/da.20476; Green P, 2004, GREENS MEDICAL SYMPT; Greenberg GA, 2007, MIL MED, V172, P162, DOI 10.7205/MILMED.172.2.162; Hamilton AB, 2015, MED CARE, V53, pS32, DOI 10.1097/MLR.0000000000000297; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hawley C.E., 2016, J APPL REHABIL COUS, V47, P28, DOI [10.1891/0047-2220.47.4.28, DOI 10.1891/0047-2220.47.4.28]; Heaton R., 2000, WISCONSIN CARD SORTI; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Horton JL, 2013, OCCUP ENVIRON MED, V70, P408, DOI 10.1136/oemed-2012-101073; Hoving JL, 2010, INT ARCH OCC ENV HEA, V83, P595, DOI 10.1007/s00420-010-0506-6; Judge TA, 2007, J APPL PSYCHOL, V92, P107, DOI 10.1037/0021-9010.92.1.107; Jurick SM, 2018, BRAIN INJURY, V32, P1256, DOI 10.1080/02699052.2018.1493225; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larson GE, 2014, J REHABIL RES DEV, V51, P415, DOI 10.1682/JRRD.2013.06.0135; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lovvik C, 2014, J OCCUP REHABIL, V24, P160, DOI 10.1007/s10926-013-9439-8; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; McGarity S, 2017, J HEAD TRAUMA REHAB, V32, P34, DOI 10.1097/HTR.0000000000000242; McGonagle AK, 2015, J APPL PSYCHOL, V100, P376, DOI 10.1037/a0037974; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Merritt VC, 2019, J CLIN EXP NEUROPSYC, V41, P665, DOI 10.1080/13803395.2019.1610161; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Mortera MH, 2018, ARCH PHYS MED REHAB, V99, pS50, DOI 10.1016/j.apmr.2016.11.026; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Olsen DC, 2018, BRAIN INJURY, V32, P544, DOI 10.1080/02699052.2018.1431845; ONeil M. E., 2013, COMPLICATIONS OF MIL; Osman A, 2000, J BEHAV MED, V23, P351, DOI 10.1023/A:1005548801037; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P739, DOI 10.1002/da.20574; Pittman JOE, 2012, QUAL LIFE RES, V21, P99, DOI 10.1007/s11136-011-9918-3; Pogoda TK, 2018, ARCH PHYS MED REHAB, V99, pS14, DOI 10.1016/j.apmr.2017.06.029; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Ramchand R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0575-z; Resnick SG, 2008, J REHABIL RES DEV, V45, P427, DOI 10.1682/JRRD.2007.06.0093; Samuelson KW, 2017, J TRAUMA STRESS, V30, P521, DOI 10.1002/jts.22223; Samuelson KW, 2017, PSYCHOL TRAUMA-US, V9, P537, DOI 10.1037/tra0000210; Sayer NA, 2014, SOC ISS POLICY REV, V8, P33, DOI 10.1111/sipr.12001; Sheehan D., 2014, THE MINI INTERNATION; Sherman MD, 2015, PROF PSYCHOL-RES PR, V46, P355, DOI 10.1037/pro0000043; Stajkovic AD, 1998, PSYCHOL BULL, V124, P240, DOI 10.1037/0033-2909.124.2.240; Stern L, 2017, ADV DEV HUM RESOUR, V19, P66, DOI 10.1177/1523422316682928; Strauss E., 2006, A COMPENDIUM OF NEUR; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tanielian T., 2008, INVISIBLE WOUNDS OF; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Management of Concussion-Mild Traumatic Brain Injury Working Group, 2016, VA DOD CLINICAL PRAC; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tombaugh T. N., 1996, TEST OF MEMORY MALIN; Tsai J, 2013, J OCCUP REHABIL, V23, P504, DOI 10.1007/s10926-013-9419-z; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; U.S. Bureau of Labor Statistics, 2020, EMPLOYMENT STATUS OF; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Weathers F. W., 2013, THE PTSD CHECKLIST F; Wechsler D., 2008, WECHSLER ADULT INTEL; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wrocklage KM, 2016, J INT NEUROPSYCH SOC, V22, P399, DOI 10.1017/S1355617716000059	91	2	2	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2020	65	3					279	290		10.1037/rep0000323			12	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	NE9VC	WOS:000562951000009	32297778	Green Accepted, Bronze			2022-02-06	
J	Murugan, M; Ravula, A; Gandhi, A; Vegunta, G; Mukkamalla, S; Mujib, W; Chandra, N				Murugan, Madhuvika; Ravula, Arunreddy; Gandhi, Ajay; Vegunta, Geetasravya; Mukkamalla, Sushni; Mujib, Waleed; Chandra, Namas			Chemokine signaling mediated monocyte infiltration affects anxiety-like behavior following blast injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Blast; Brain injury; Microglia; Monocyte infiltration; Chemokine; CCL2-CCR2 signaling	TRAUMATIC BRAIN-INJURY; INFLAMMATORY RESPONSE; RESIDENT MICROGLIA; OXIDATIVE STRESS; RAT MODEL; MILD; CELLS; ACTIVATION; CCR2; EXPRESSION	The activation of resident microglia and infiltrated monocytes are known potent mediators of chronic neuroinflammation following traumatic brain injury (TBI). In this study, we use a mouse model of blast-induced TBI (bTBI) to investigate whether microglia and monocytes contribute to the neuroinflammatory and behavioral consequences of bTBI. Eight-ten week old mice were subject to moderate TBI (180 kPa) in a shock tube. Using double transgenic CCR2(RFP/+): CX3CR1(GFP/+) mice, we were able to note that in addition to resident Cx3CR1+ microglia, infiltrating CCR2+ monocytes also contributed to the expanding macrophage population that was observed after bTBI. The microglia activation and monocyte infiltration occurred as early as 4 h and lasted up to 30d after blast exposure, suggesting chronic inflammation. The infiltration of monocytes may be partly mediated by chemokine CCL2-CCR2 signaling axis and compromised blood brain barrier permeability. Hence, bTBI-induced infiltration of monocytes and production of IL-1 beta were prevented in mice lacking CCR2 (CCR2 KO). Finally, this study showed that interference of monocyte infiltration using CCR2 KO, ameliorated the chronic effects of bTBI such as anxiety-like behavior and short-term memory decline. Taken together, these data suggest that bTBI leads to activation of both resident microglia and infiltrated monocytes. The infiltration of monocytes was partly mediated by CCL2-CCR2 signaling, which in turn contributes to increased production of IL-1 beta leading to behavioral deficits after bTBI. Furthermore, bTBI induced behavioral outcomes were reduced by targeting CCL2-CCR2 signaling, highlighting the significance of this signaling axis in bTBI pathology.	[Murugan, Madhuvika; Ravula, Arunreddy; Gandhi, Ajay; Vegunta, Geetasravya; Mukkamalla, Sushni; Mujib, Waleed; Chandra, Namas] New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med, 111 Lock St,Room105 CHEN Bldg, Newark, NJ 07102 USA		Chandra, N (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med, 111 Lock St,Room105 CHEN Bldg, Newark, NJ 07102 USA.	namas.chandra@njit.edu	Murugan, Madhuvika/AAZ-8533-2020		New Jersey Commission on Brain Injury Research [CBIR16IRG017, CBIR17PIL020, CBIR20IRG011]; USAMRMCU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-15-1-0303]	This work was supported by New Jersey Commission on Brain Injury Research (CBIR16IRG017, CBIR17PIL020, CBIR20IRG011) and USAMRMC (W81XWH-15-1-0303). Eren Alay and Jose Rodriguez were involved in maintenance and running of the shock tube used for blast injuries. We thank Vijayalakshmi Santhakumar for sharing the electrophysiology equipment and resources.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Aertker BM, 2019, J NEUROSCI RES, V97, P698, DOI 10.1002/jnr.24395; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bollmann L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00363; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Clark AL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00873; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Feng LJ, 2019, GLIA, V67, P1434, DOI 10.1002/glia.23616; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Haage V, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0665-y; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Heindl S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00106; Hoffman JR, 2017, AMINO ACIDS, V49, P871, DOI 10.1007/s00726-017-2383-8; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hua Y, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/928236; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; KURIAKOSE J, 2016, INDIAN BIRDS, V11; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Lee S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0544-4; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; McKim DB, 2018, MOL PSYCHIATR, V23, P1421, DOI 10.1038/mp.2017.64; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; Navone SE, 2018, OSTEOARTHR CARTILAGE, V26, P978, DOI 10.1016/j.joca.2018.04.013; Nelson N. W., 2015, BRAIN NEUROTRAUMA MO; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nissen JC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030561; Norman GJ, 2010, MOL PSYCHIATR, V15, P404, DOI 10.1038/mp.2009.91; O'Neil ME, 2017, J CLIN EXP NEUROPSYC, V39, P449, DOI 10.1080/13803395.2016.1232699; Peng JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12029; Perez-Garcia G, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0357-17.2018; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ransohoff RM, 2007, NAT NEUROSCI, V10, P1507, DOI 10.1038/nn1207-1507; Rao KVR, 2018, J NEUROTRAUM, V35, P2077, DOI 10.1089/neu.2017.5358; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Russell AL, 2018, ENDOCRINOLOGY, V159, P2363, DOI 10.1210/en.2018-00203; Saederup N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176931; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Salim S, 2011, BRAIN RES, V1404, P63, DOI 10.1016/j.brainres.2011.06.024; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Severini C, 2014, J ALZHEIMERS DIS, V38, P281, DOI 10.3233/JAD-131070; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Tian DS, 2017, J NEUROSCI, V37, P7878, DOI 10.1523/JNEUROSCI.0315-17.2017; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wang HL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06588; William R.S.R., 1982, INDOCYANINE GREEN IC; Yang L, 2016, BRAIN BEHAV IMMUN, V56, P352, DOI 10.1016/j.bbi.2016.03.001; Younger D, 2019, MOL NEUROBIOL, V56, P5202, DOI 10.1007/s12035-018-1428-7; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007; Zhang JH, 2018, EXP THER MED, V16, P93, DOI 10.3892/etm.2018.6146	69	2	2	5	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	AUG	2020	88						340	352		10.1016/j.bbi.2020.03.029			13	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	MU5JL	WOS:000555709500047	32240765				2022-02-06	
J	Piantella, S; McDonald, SJ; Maruff, P; Wright, BJ				Piantella, Stefan; McDonald, Stuart J.; Maruff, Paul; Wright, Bradley J.			Assessing the Long-Term Impact of Concussion upon Cognition: A 5-Year Prospective Investigation	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Decision making; Attention; Memory; Jockeys; Longitudinal	TRAUMATIC BRAIN-INJURY; TEST-RETEST; BASE-LINE; HEAD-INJURY; MILD; IMPAIRMENT; ATTENTION; HISTORY; SYMPTOMS; DEFICITS	Objective: Jockeys have high rates of concussion, with 5% of jockeys receiving at least one concussion annually. The impact of acute concussion upon cognition is well understood, but less is known about the long-term effects of concussion upon cognition. Our aim was to assess the impact of concussion upon jockeys who had provided pre-concussion assessments of cognition using a prospective design. Method: In this study, over a 5-year period, we assessed the cognitive performance of jockeys with >= 1 medically diagnosed concussion (MDC; n = 17, months since concussion, M = 29.18), against those who had not been concussed (NC; n = 41). Jockeys who had not been concussed in the preceding 6 months completed four computer-based cognitive assessments from the CogSport battery. Results: Unlike the majority of the small existing literature, there was no difference (p >= .05) between theMDC and NC groups after controlling for age and baseline performance. Additionally, we used a measure of reliable change to assess for clinically meaningful decrements from baseline in each test and composite score 5 years later. None of the jockeys in the MDC group recorded significant decrements on any CogSport measure from baseline (z > -1.65). Conclusions: The findings suggest that the presence of concussion does not result in persistent decrements in cognitive performance and that when findings are considered collectively, assessing factors beyond medically diagnosed concussion (e.g., chronic stress, undiagnosed concussion) may improve the interpretation of our current findings.	[Piantella, Stefan; Wright, Bradley J.] La Trobe Univ, Dept Psychol & Counselling, Melbourne, Vic, Australia; [McDonald, Stuart J.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Maruff, Paul] Univ Melbourne, Florey Inst, Parkville, Vic, Australia		Wright, BJ (corresponding author), La Trobe Univ, Sch Psychol & Publ Hlth, Bundoora, Vic 3086, Australia.	b.wright@latrobe.edu.au	Maruff, Paul/AAD-2454-2021	Maruff, Paul/0000-0002-6947-9537; McDonald, Stuart/0000-0001-5190-3179; Wright, Bradley/0000-0002-6428-9128			Alsalaheen B, 2017, SPORTS HEALTH, V9, P324, DOI 10.1177/1941738117713974; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2004, BRIT J SPORT MED, V38, P273, DOI 10.1136/bjsm.2003.000293; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; DeCarli C, 2003, LANCET NEUROL, V2, P15, DOI 10.1016/S1474-4422(03)00262-X; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Hinton-Bayre AD, 2012, CLIN J SPORT MED, V22, P105, DOI 10.1097/JSM.0b013e318248a526; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kuhnell R, 2020, STRESS, V23, P136, DOI 10.1080/10253890.2019.1651285; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Landolt K, 2017, PSYCHONEUROENDOCRINO, V84, P151, DOI 10.1016/j.psyneuen.2017.07.238; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Maerlender AC, 2016, J CLIN EXP NEUROPSYC, V38, P869, DOI 10.1080/13803395.2016.1168781; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Maruff P, 2005, J SLEEP RES, V14, P21, DOI 10.1111/j.1365-2869.2004.00438.x; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; O'Jile JR, 2006, ARCH CLIN NEUROPSYCH, V21, P293, DOI 10.1016/j.acn.2006.03.003; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Piland SG, 2003, J ATHL TRAINING, V38, P104; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Sicard V, 2019, CLIN J SPORT MED, V29, P62, DOI 10.1097/JSM.0000000000000492; Sicard V, 2018, INT J PSYCHOPHYSIOL, V132, P3, DOI 10.1016/j.ijpsycho.2018.03.011; Solbakk AK, 2005, J CLIN EXP NEUROPSYC, V27, P205, DOI 10.1080/13803390490515739; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Tampubolon G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144907; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044	55	2	2	1	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2020	35	5					482	490		10.1093/arclin/acaa012			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NY8KY	WOS:000576633100003	32161939	Bronze			2022-02-06	
J	Stein, TD; Crary, JF				Stein, Thor D.; Crary, John F.			Chronic Traumatic Encephalopathy and Neuropathological Comorbidities	SEMINARS IN NEUROLOGY			English	Article						chronic traumatic encephalopathy; traumatic brain injury; neurodegenerative disease; Alzheimer's disease; comorbidity	CEREBRAL AMYLOID ANGIOPATHY; AMYOTROPHIC-LATERAL-SCLEROSIS; BRAIN-BARRIER DYSFUNCTION; AGE-RELATED TAUOPATHY; BODY-MASS INDEX; ALZHEIMERS-DISEASE; HEAD-INJURY; NEUROFIBRILLARY TANGLES; CEREBROVASCULAR-DISEASE; ARGYROPHILIC GRAINS	With age, the presence of multiple neuropathologies in a single individual becomes increasingly common. Given that traumatic brain injury and the repetitive head impacts (RHIs) that occur in contact sports have been associated with the development of many neurodegenerative diseases, including chronic traumatic encephalopathy (CTE), Alzheimer's disease, Lewy body disease, and amyotrophic lateral sclerosis, it is becoming critical to understand the relationship and interactions between these pathologies. In fact, comorbid pathology is common in CTE and likely influenced by both age and the severity and type of exposure to RHI as well as underlying genetic predisposition. Here, we review the major comorbid pathologies seen with CTE and in former contact sports athletes and discuss what is known about the associations between RHI, age, and the development of neuropathologies. In addition, we examine the distinction between CTE and age-related pathology including primary age-related tauopathy and age-related tau astrogliopathy.	[Stein, Thor D.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Stein, Thor D.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Stein, Thor D.] VA Boston Healthcare Syst, Dept Res, Boston, MA USA; [Stein, Thor D.] VA Boston Healthcare Syst, Dept Pathol & Lab Med, Boston, MA USA; [Stein, Thor D.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Crary, John F.] Icahn Sch Med Mt Sinai, Nash Family Dept Neurosci, Ronald M Loeb Ctr Alzheimers Dis, Dept Pathol,Neuropathol Brain Bank, New York, NY 10029 USA; [Crary, John F.] Icahn Sch Med Mt Sinai, Nash Family Dept Neurosci, Ronald M Loeb Ctr Alzheimers Dis, Res Core, New York, NY 10029 USA		Stein, TD (corresponding author), 150 S Huntington Ave, Boston, MA 02130 USA.	tdstein@bu.edu		Stein, Thor/0000-0001-6954-4477	R56AG057768 [National Institute of Aging] Funding Source: Medline; R01NS095252 [National Institute of Aging] Funding Source: Medline; R01AG057768 [National Institute of Aging] Funding Source: Medline; R01AG062348 [National Institute of Aging] Funding Source: Medline; I01-CX001038 [Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award] Funding Source: Medline; CSRD VA [I01 CX001038] Funding Source: Medline; U01NS086659 [National Institute of Neurological Disorders and Stroke] Funding Source: Medline; RF1AG060961 [National Institute of Aging] Funding Source: Medline; W81XWH-14-1-0399 [Department of Defense] Funding Source: Medline; R01AG054008 [National Institute of Aging] Funding Source: Medline; RF1AG054156 [National Institute of Aging] Funding Source: Medline; P30AG13846 [National Institute of Aging Boston University AD Center] Funding Source: Medline; supplement 0572063345-5 [National Institute of Aging Boston University AD Center] Funding Source: Medline; BX002466 [Veterans Affairs Biorepository] Funding Source: Medline; NIRG-15-363188 [Alzheimer&apos;s Association] Funding Source: Medline		Abner EL, 2017, ANN NEUROL, V81, P549, DOI 10.1002/ana.24903; Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; Alosco ML, 2017, J ALZHEIMERS DIS, V57, P953, DOI 10.3233/JAD-161205; Armstrong RA, 2017, NEUROPATH APPL NEURO, V43, P154, DOI 10.1111/nan.12323; Arvanitakis Z, 2016, LANCET NEUROL, V15, P934, DOI 10.1016/S1474-4422(16)30029-1; Attems J, 2005, ACTA NEUROPATHOL, V110, P222, DOI 10.1007/s00401-005-1064-y; Attems J, 2011, NEUROPATH APPL NEURO, V37, P75, DOI 10.1111/j.1365-2990.2010.01137.x; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Baskota SU, 2019, LAB INVEST, V99, P1068, DOI 10.1038/s41374-018-0166-9; Bell WR, 2019, ALZHEIMERS DEMENT, V15, P8, DOI 10.1016/j.jalz.2018.07.215; Besser LM, 2019, J NEUROPATH EXP NEUR, V78, P219, DOI 10.1093/jnen/nly132; Besser LM, 2017, NEUROLOGY, V89, P1707, DOI 10.1212/WNL.0000000000004521; Bigio EH, 2010, ACTA NEUROPATHOL, V120, P43, DOI 10.1007/s00401-010-0681-2; BOURAS C, 1993, NEUROSCI LETT, V153, P131, DOI 10.1016/0304-3940(93)90305-5; Boyle PA, 2018, ANN NEUROL, V83, P74, DOI 10.1002/ana.25123; BRAAK H, 1987, NEUROSCI LETT, V76, P124, DOI 10.1016/0304-3940(87)90204-7; Braak H, 2013, J ALZHEIMERS DIS, V33, pS155, DOI 10.3233/JAD-2012-129029; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Brady CB, 2013, AMYOTROPH LAT SCL FR, V14, P591, DOI 10.3109/21678421.2013.822516; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; BUEE L, 1994, ACTA NEUROPATHOL, V87, P469; Cerami C, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0369-8; Charidimou A, 2017, NEUROLOGY, V89, P2128, DOI 10.1212/WNL.0000000000004665; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Cragg JJ, 2017, EPIDEMIOLOGY, V28, pE15, DOI 10.1097/EDE.0000000000000589; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Deramecourt V, 2012, NEUROLOGY, V78, P1043, DOI 10.1212/WNL.0b013e31824e8e7f; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Farell M, 2019, CLIN NEUROPATHOL, V38, P51, DOI 10.5414/NP301130; FEANY MB, 1995, AM J PATHOL, V146, P1388; Forrest SL, 2019, J NEUROPATH EXP NEUR, V78, P398, DOI 10.1093/jnen/nlz017; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Golbe LI, 1996, NEUROLOGY, V47, P148, DOI 10.1212/WNL.47.1.148; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gomez-Tortosa E, 2019, NEUROBIOL AGING, V76, DOI 10.1016/j.neurobiolaging.2018.11.010; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Hsu ET, 2018, ACTA NEUROPATHOL, V136, P955, DOI 10.1007/s00401-018-1902-3; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; ITOH Y, 1993, J NEUROL SCI, V116, P135, DOI 10.1016/0022-510X(93)90317-R; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Janocko NJ, 2012, ACTA NEUROPATHOL, V124, P681, DOI 10.1007/s00401-012-1044-y; Jefferson-George KS, 2017, ALZHEIMERS DEMENT, V13, P1048, DOI 10.1016/j.jalz.2017.01.028; Josephs KA, 2008, NEUROBIOL AGING, V29, P566, DOI 10.1016/j.neurobiolaging.2006.10.032; Kalaria RN, 1999, ALZ DIS ASSOC DIS, V13, pS115, DOI 10.1097/00002093-199912003-00017; Keable A, 2016, BBA-MOL BASIS DIS, V1862, P1037, DOI 10.1016/j.bbadis.2015.08.024; Keage HAD, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-3; Keene CD, 2018, ACTA NEUROPATHOL, V135, P303, DOI 10.1007/s00401-017-1801-z; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Kovacs GG, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0552-y; Kovacs GG, 2017, J NEUROPATH EXP NEUR, V76, P270, DOI 10.1093/jnen/nlx007; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Lauer A, 2016, NEUROLOGY, V87, P1488; Leclercq PD, 2005, J NEUROL NEUROSUR PS, V76, P229, DOI 10.1136/jnnp.2003.025528; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lin A, 2018, HAND CLINIC, V158, P309, DOI 10.1016/B978-0-444-63954-7.00029-X; Ling H, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-24; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMillan CT, 2018, ANN CLIN TRANSL NEUR, V5, P927, DOI 10.1002/acn3.581; Mesulam M, 2008, ANN NEUROL, V63, P709, DOI 10.1002/ana.21388; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Morgello S, 2018, J NEUROVIROL, V24, P629, DOI 10.1007/s13365-018-0663-z; Munoz David G, 2007, Am J Alzheimers Dis Other Demen, V22, P294, DOI 10.1177/1533317507302320; Nelson AR, 2016, BBA-MOL BASIS DIS, V1862, P887, DOI 10.1016/j.bbadis.2015.12.016; Nemani SK, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0643-9; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pfeifer LA, 2002, NEUROLOGY, V58, P1629, DOI 10.1212/WNL.58.11.1629; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plassman Brenda L, 2015, Handb Clin Neurol, V128, P711, DOI 10.1016/B978-0-444-63521-1.00044-3; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Robinson JL, 2018, ACTA NEUROPATHOL, V136, P377, DOI 10.1007/s00401-018-1872-5; Robinson JL, 2018, BRAIN, V141, P2181, DOI 10.1093/brain/awy146; Rodriguez Roberta Diehl, 2015, Dement. neuropsychol., V9, P2, DOI 10.1590/S1980-57642015DN91000002; Santa-Maria I, 2012, ACTA NEUROPATHOL, V124, P693, DOI 10.1007/s00401-012-1017-1; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Spillantini MG, 1997, P NATL ACAD SCI USA, V94, P4113, DOI 10.1073/pnas.94.8.4113; Standring OJ, 2019, ACTA NEUROPATHOL, V138, P401, DOI 10.1007/s00401-019-02031-x; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Sugarman MA, 2019, ALZHEIMERS DEMENT, V15, P686, DOI 10.1016/j.jalz.2018.12.015; Takao M, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0368-6; Tarazi A, 2018, J NEUROTRAUM, V35, P1003, DOI 10.1089/neu.2017.5290; Tian J, 2004, NEUROPATH APPL NEURO, V30, P46, DOI 10.1046/j.0305-1846.2003.00510.x; Tian J, 2003, NEUROSCI LETT, V352, P137, DOI 10.1016/j.neulet.2003.08.048; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; Tucker AM, 2009, JAMA-J AM MED ASSOC, V301, P2111, DOI 10.1001/jama.2009.716; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; Walt GS, 2018, J NEUROPATH EXP NEUR, V77, P1091, DOI 10.1093/jnen/nly092; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Weisskopf MG, 2015, EPIDEMIOLOGY, V26, P831, DOI 10.1097/EDE.0000000000000376; YAMADA T, 1992, NEUROSCI LETT, V135, P99, DOI 10.1016/0304-3940(92)90145-W; Zetterberg H, 2018, HAND CLINIC, V158, P323, DOI 10.1016/B978-0-444-63954-7.00030-6	122	2	2	3	4	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	AUG	2020	40	04					384	393		10.1055/s-0040-1713628			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NL6KK	WOS:000567521900006	32629520				2022-02-06	
J	Summaka, M; Zein, H; Elias, E; Naim, I; Fares, Y; Nasser, Z				Summaka, Marwa; Zein, Hiba; Elias, Elias; Naim, Ibrahim; Fares, Youssef; Nasser, Zeina			Prediction of quality of life by Helsinki computed tomography scoring system in patients with traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; Helsinki CT score; project for the epidemiological analysis of critical care patients; Lebanon	1ST YEAR; DEPRESSION; MODERATE; OUTCOMES; MILD; COMMUNITY; DISORDER	Purpose The aim of this study is to assess the association between the Computed Tomography (CT) findings on admission, according to the Helsinki computed tomography CT score, and patient's Quality of Life (QoL) following traumatic brain injury (TBI) in Lebanon. Methods A retrospective study was performed on 49 males suffering from war induced TBI. Participants were stratified into two groups based on the date of injury. Helsinki CT score was calculated for CT scans of participants. Outcomes were assessed using QoL scales including the Project for the Epidemiological Analysis of Critical Care Patients scale (PAEEC). Results Correlation analysis showed that QoL, up to 4 years post-TBI, was significantly associated with Helsinki CT classification. Group 1 of subjects living with TBI for 1-2 years revealed a correlation coefficient r = 0.536,p-value = 0.027, whereas, group 2 including subjects who are injured since 3-4 years, had a correlation coefficient r = 0.565,p-value = 0.001. Conclusion The present study showed that patients with traumatic brain injury experienced significant quality of life deterioration up to 4 years post-TBI. Our findings propose the important role of Helsinki score in predicting the quality of life among patients with TBI.	[Summaka, Marwa; Zein, Hiba; Naim, Ibrahim; Fares, Youssef; Nasser, Zeina] Lebanese Univ, Neurosci Res Ctr, Fac Med Sci, Hadath, Lebanon; [Elias, Elias] Swedish Neurosci Inst, Dept Complex & Minimally Invas Spine Surg, Seattle, WA USA		Nasser, Z (corresponding author), Lebanese Univ, Neurosci Res Ctr, Fac Med Sci, Hadath, Lebanon.	znasser6@gmail.com					Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Prieto-Palomino MA, 2016, BRAIN INJURY, V30, P441, DOI 10.3109/02699052.2016.1141434; Arias-Verdu MD, 2015, QUALITY LIFE 4 YEARS; Azouvi P, 2016, BRAIN INJURY, V30, P1665, DOI 10.1080/02699052.2016.1201593; Balsera EC, 2010, CRIT CARE, V14, DOI [10.1186/cc8668, DOI 10.1186/CC8668]; Boycott N, 2013, J HEAD TRAUMA REHAB, V28, P106, DOI 10.1097/HTR.0b013e31823fe07e; Chabok SY, 2012, NEUROPSYCHOLOGIA, V50, P1444, DOI 10.1016/j.neuropsychologia.2012.02.029; Chiang CC, 2016, QUAL LIFE RES, V25, P2009, DOI 10.1007/s11136-015-1215-0; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; Ding J, 2012, BRAIN INJURY, V26, P1211, DOI 10.3109/02699052.2012.667591; El-Menyar A, 2017, WORLD NEUROSURG, V107, P6, DOI [10.1016/J.WNEU.2017.07.070, 10.1016/j.wneu.2017.07.070]; Eshel Inbal, 2019, Phys Med Rehabil Clin N Am, V30, P189, DOI 10.1016/j.pmr.2018.08.005; Fernandez RR, 1996, INTENS CARE MED, V22, P1034, DOI 10.1007/s001340050209; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Formisano R, 2017, NEUROL SCI, V38, P279, DOI 10.1007/s10072-016-2755-y; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; Haller CS, 2017, BRAIN INJURY, V31, P1903, DOI 10.1080/02699052.2017.1346295; Khan F, 2016, J REHABIL MED, V48, P442, DOI 10.2340/16501977-2084; Lewis FD, 2017, NEUROREHABILITATION, V40, P401, DOI 10.3233/NRE-161427; Mata GV, 1996, J TRAUMA, V41, P326, DOI 10.1097/00005373-199608000-00022; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Pervez M, 2018, NEUROIMAG CLIN N AM, V28, P1, DOI 10.1016/j.nic.2017.09.010; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sabbah Ibtissam, 2003, Health Qual Life Outcomes, V1, P30, DOI 10.1186/1477-7525-1-30; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Stenberg M, 2017, BRAIN INJURY, V31, P351, DOI 10.1080/02699052.2016.1261303; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Takada K, 2016, BRAIN INJURY, V30, P1590, DOI 10.1080/02699052.2016.1199901; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Tsyben A, 2018, ACTA NEUROCHIR, V160, P107, DOI 10.1007/s00701-017-3334-6; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; Yao S, 2017, WORLD NEUROSURG, V101, P528, DOI 10.1016/j.wneu.2017.02.072	36	2	2	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 28	2020	34	9					1229	1236		10.1080/02699052.2020.1799435		AUG 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ND6FI	WOS:000555157200001	32730092				2022-02-06	
J	Suresh, MR; Valdez-Delgado, KK; VanFosson, CA; Trevino, JD; Mann-Salinas, EA; Shackelford, SA; Staudt, AM				Suresh, Mithun R.; Valdez-Delgado, Krystal K.; VanFosson, Christopher A.; Trevino, Jennifer D.; Mann-Salinas, Elizabeth A.; Shackelford, Stacy A.; Staudt, Amanda M.			Anatomic injury patterns in combat casualties treated by forward surgical teams	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Role 2; forward surgical care; military health system; injury pattern; Abbreviated Injury Scale		BACKGROUND Role 2 forward surgical teams provide damage-control resuscitation and surgery for life- and limb-threatening injuries. These teams have limited resources and personnel, so understanding the anatomic injury patterns seen by these teams is vital for providing adequate training and preparation prior to deployment. The objective of this study was to describe the spectrum of injuries treated at Role 2 facilities in Afghanistan. METHODS Using Department of Defense Trauma Registry data, a retrospective, secondary data analysis was conducted. Eligible patients were all battle or non-battle-injured casualties treated by Role 2 forward surgical teams in Afghanistan from October 2005 to June 2018. Abbreviated Injury Scale (AIS) 2005 codes were used to classify each injury and Injury Severity Score (ISS) was calculated for each patient. Patients with multiple trauma were defined as patients with an AIS severity code >2 in at least two ISS body regions. RESULTS The data set included 10,383 eligible patients with 45,225 diagnosis entries (range, 1-27 diagnoses per patient). The largest number of injuries occurred in the lower extremity/pelvis/buttocks (23.9%). Most injuries were categorized as minor (39.4%) or moderate (38.8%) in AIS severity, while the largest number of injuries categorized as severe or worse occurred in the head (13.5%). Among head injuries, 1,872 injuries were associated with a cerebral concussion or diffuse axonal injury, including 50.6% of those injuries being associated with a loss of consciousness. There were 1,224 patients with multiple trauma, and the majority had an injury to the extremities/pelvic girdle (58.2%). Additionally, 3.7% of all eligible patients and 10.5% of all patients with multiple trauma did not survive to Role 2 discharge. CONCLUSION The injury patterns seen in recent conflicts and demonstrated by this study may assist military medical leaders and planners to optimize forward surgical care in future environments, on a larger scale, and utilizing less resources.	[Suresh, Mithun R.; Valdez-Delgado, Krystal K.; VanFosson, Christopher A.; Trevino, Jennifer D.; Staudt, Amanda M.] US Army, Inst Surg Res, San Antonio, TX USA; [Mann-Salinas, Elizabeth A.; Shackelford, Stacy A.] Joint Trauma Syst, San Antonio, TX USA		Staudt, AM (corresponding author), US Army, Inst Surg Res, Geneva Fdn Epidemiologist Trauma Outcomes & Syst, 3698 Chambers Pass JBSA, Ft Sam Houston, TX 78234 USA.	Amanda.m.staudt2.ctr@mail.mil		VanFosson, Christopher/0000-0003-1640-3018	Defense Medical Research and Development Program [W81XWH-15-2-0085]	This work was supported by the Assistant Secretary of Defense for Health Affairs through the Defense Medical Research and Development Program under award W81XWH-15-2-0085. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	[Anonymous], 2012, 4 02 JP, P338; [Anonymous], 2013, ABBREVIATED INJURY S; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balzano FL, 2018, TRANSL ANDROL UROL, V7, P646, DOI 10.21037/tau.2018.04.05; Belmont PJ, 2013, J ORTHOP TRAUMA, V27, pE107, DOI 10.1097/BOT.0b013e3182703188; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Cannon JW, 2016, J AM COLL SURGEONS, V223, P652, DOI 10.1016/j.jamcollsurg.2016.07.009; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Cubano MA., 2013, EMERGENCY WAR SURG, V4th ed.; Davis MR, 2019, J TRAUMA ACUTE CARE, V87, pS1, DOI 10.1097/TA.0000000000002349; De Jong Marla J, 2008, J Trauma Nurs, V15, P174, DOI 10.1097/01.JTN.0000343322.70334.12; Fleming Mark, 2012, J Surg Orthop Adv, V21, P32; Gerhardt RT, 2009, ANN EMERG MED, V53, P169, DOI 10.1016/j.annemergmed.2008.04.013; Hedman TL, 2008, J TRAUMA, V64, pS169, DOI 10.1097/TA.0b013e318160ba0c; Ivey KM, 2012, J TRAUMA ACUTE CARE, V73, pS514, DOI TA.0b013e3182754654; Kauvar DS, 2006, J SURG RES, V132, P195, DOI 10.1016/j.jss.2006.02.043; Kotwal RS, 2018, J TRAUMA ACUTE CARE, V85, P603, DOI 10.1097/TA.0000000000001997; Kotwal RS, 2018, MIL MED, V183, P134, DOI 10.1093/milmed/usx211; Lawnick MM, 2013, J TRAUMA ACUTE CARE, V75, P573, DOI 10.1097/TA.0b013e3182a53bc6; Le TD, 2016, J TRAUMA ACUTE CARE, V81, P114, DOI 10.1097/TA.0000000000001032; Mann-Salinas EA, 2016, J TRAUMA ACUTE CARE, V81, pS121, DOI 10.1097/TA.0000000000001092; Martin MJ, 2019, J TRAUMA ACUTE CARE, V87, pS14, DOI 10.1097/TA.0000000000002200; Mazzoli RA, 2014, J TRAUMA ACUTE CARE, V77, pS156, DOI 10.1097/TA.0000000000000391; Nessen SC, 2009, J TRAUMA, V66, pS37, DOI 10.1097/TA.0b013e31819ce302; Oh John S, 2015, J Trauma Acute Care Surg, V79, pS193, DOI 10.1097/TA.0000000000000735; Owens BD, 2007, J ORTHOP TRAUMA, V21, P254, DOI 10.1097/BOT.0b013e31802f78fb; Possley DR, 2012, SPINE J, V12, P843, DOI 10.1016/j.spinee.2011.10.007; Ramasamy A, 2009, J R Army Med Corps, V155, P265; Ramasamy A, 2009, J R Army Med Corps, V155, P258; Staudt A, 2018, J TRAUMA ACUTE CARE, V85, pS140, DOI 10.1097/TA.0000000000001843; Staudt AM, 2018, CRIT CARE NURSE, V38, pE7, DOI 10.4037/ccn2018532; Thorson CM, 2012, J TRAUMA ACUTE CARE, V73, pS483, DOI 10.1097/TA.0b013e31827546fb	32	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2020	89	2S		2			S231	S236		10.1097/TA.0000000000002720			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	QB5BE	WOS:000614154300034	32282757				2022-02-06	
J	Wettervik, TS; Howells, T; Enblad, P; Lewen, A				Svedung Wettervik, Teodor; Howells, Timothy; Enblad, Per; Lewen, Anders			Intracranial pressure variability: relation to clinical outcome, intracranial pressure-volume index, cerebrovascular reactivity and blood pressure variability	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Traumatic brain injury; Intracranial pressure variability; Neurointensive care; Clinical outcome	TRAUMATIC BRAIN-INJURY; WAVE-FORM; GUIDELINES; MANAGEMENT	It was recently found in traumatic brain injury (TBI) that ICP variability (ICPV) predicted favorable outcome. We hypothesized that ICPV may depend on intracranial compliance, unstable blood pressure and cerebral vasomotion. In this study, we aimed to further investigate the explanatory variables for ICPV and its relation to outcome. Data from 362 TBI patients were retrospectively analyzed day 2 to 5 post-injury. ICPV was evaluated in three ways. First, variability in the sub-minute time interval (similar to B waves) was calculated as the amplitude of the ICP slow waves using a bandpass filter, limiting the analysis to oscillations of 55 to 15 s (ICP AMP 55-15). The second and third ICPV measures were calculated as the deviation from the mean ICP averaged over 30 min (ICPV-30m) and 4 h (ICPV-4h), respectively. All ICPV measures were associated with a reduced intracranial pressure/volume state (high ICP and RAP) and high blood pressure variability in multiple linear regression analyses. Higher ICPV was associated with better pressure reactivity in the univariate, but not the multiple analyses. All ICPV measures were associated with favorable outcome in univariate analysis, but only ICP AMP 55-15 and ICPV-30m did so in the multiple logistic regression analysis. Higher ICPV can be explained by a reduced intracranial compliance and variations in cerebral blood volume due to the vessel response to unstable blood pressure. As ICP AMP 55-15 and ICPV-30m independently predicted favorable outcome, it may represent general cerebral vessel activity, associated with better cerebral blood flow regulation and less secondary insults.	[Svedung Wettervik, Teodor; Howells, Timothy; Enblad, Per; Lewen, Anders] Uppsala Univ, Dept Neurosci, Sect Neurosurg, S-75185 Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, S-75185 Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se; timothy.howells@regionuppsala.se; per.enblad@neuro.uu.se; anders.lewen@neuro.uu.se	Wettervik, Teodor Mikael Svedung/S-5356-2017		Uppsala University	Open access funding provided by Uppsala University. We express our gratitude to Uppsala Clinical Research Center for statistical advice.	Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Calviello L, 2018, NEUROCRIT CARE, V28, P212, DOI 10.1007/s12028-017-0475-7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Fischerstrom A, 2014, ACTA NEUROCHIR, V156, P177, DOI 10.1007/s00701-013-1932-5; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Howells T, 2012, INTENS CARE MED, V38, P1061, DOI 10.1007/s00134-012-2571-7; Kirkness CJ, 2008, ACTA NEUROCHIR SUPPL, V102, P105, DOI 10.1007/978-3-211-85578-2_21; Lang EW, 1999, NEUROL RES, V21, P665, DOI 10.1080/01616412.1999.11740995; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rosner M., 1986, INTRACRANIAL PRESSUR, P137, DOI [10.1007/978-3-642-70971-5_25, DOI 10.1007/978-3-642-70971-5_25]; Spiegelberg A, 2016, INTERDISCIP NEUROSUR, V6, P13, DOI 10.1016/j.inat.2016.03.004; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wettervik TS, 2019, J NEUROTRAUM, V36, P1818, DOI 10.1089/neu.2018.6157; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	23	2	2	2	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	AUG	2020	34	4					733	741		10.1007/s10877-019-00387-9			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	ML7AX	WOS:000549615200015	31538266	Green Published, hybrid			2022-02-06	
J	Vova, JA; Davidson, LT				Vova, Joshua A.; Davidson, Loren T.			Nerve and Tendon Transfers After Spinal Cord Injuries in the Pediatric Population Clinical Decision Making and Rehabilitation Strategies to Optimize Function	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Pediatric; Spinal cord injury; Rehabilitation; Nerve transfer; Tendon transfer; Tetraplegia	ACUTE FLACCID MYELITIS; TRAUMATIC BRAIN-INJURY; UPPER-LIMB; SURGICAL RECONSTRUCTION; CERVICAL-SPINE; TETRAPLEGIA; EXTREMITY; SURGERY; RESTORATION; MANAGEMENT	With improvements in medical care, pediatric patients with spinal cord injuries with tetraplegia are living into adulthood. The goal of rehabilitation following loss of upper extremity function caused by tetraplegia is to maximize function and independence. Physiatrists must be aware of appropriate timing of referral for upper extremity surgery because it can have significant ramifications on the outcome. This article discusses the 2 most commonly used surgical strategies to restore upper extremity function: upper extremity tendon transfer and nerve grafting/transfer. Patient selection, physical examination, electrodiagnostic evaluation, and optimization of postoperative rehabilitation are important.	[Vova, Joshua A.] Childrens Healthcare Atlanta, Dept Phys Med & Rehabil, 1001 Johnson Ferry Rd Northeast, Atlanta, GA 30342 USA; [Davidson, Loren T.] Univ Calif Davis Hlth Syst, Dept Phys Med & Rehabil, 4860 Y St,Suite 3850, Sacramento, CA 95817 USA; [Davidson, Loren T.] Shriners Hosp Children, Sacramento, CA USA		Vova, JA (corresponding author), Childrens Healthcare Atlanta, Dept Phys Med & Rehabil, 1001 Johnson Ferry Rd Northeast, Atlanta, GA 30342 USA.	Joshua.vova@choa.org					Andersen EW, 2017, EUR J NEUROL, V24, P1077, DOI 10.1111/ene.13345; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Bain JR, 2012, PLAST RECONSTR SURG, V130, p559E, DOI 10.1097/PRS.0b013e318262f26b; Bednar MS, 2018, J AM ACAD ORTHOP SUR, V26, pE333, DOI 10.5435/JAAOS-D-15-00465; Bersch I, 2016, ARCH PHYS MED REHAB, V97, pS154, DOI 10.1016/j.apmr.2016.01.035; Bertelli JA, 2017, J NEUROSURG-SPINE, V26, P55, DOI 10.3171/2016.5.SPINE151544; Bertelli JA, 2015, J NEUROSURG, V122, P121, DOI 10.3171/2014.8.JNS14277; Bertelli JA, 2013, J HAND SURG-AM, V38A, P1366, DOI 10.1016/j.jhsa.2013.03.056; Brown Justin M, 2011, Surg Neurol Int, V2, P121, DOI 10.4103/2152-7806.84392; Cain SA, 2015, J BRACHIAL PLEX PERI, V10, pE34, DOI 10.1055/s-0035-1558427; Carr JH, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/515938; Coupaud S, 2008, Technol Health Care, V16, P415; DeVivo MJ, 2018, SPINAL CORD, V56, P666, DOI 10.1038/s41393-018-0067-1; DeVivo MJ, 2004, J SPINAL CORD MED, V27, pS4, DOI 10.1080/10790268.2004.11753778; Fox IK, 2018, TOP SPINAL CORD INJ, V24, P275, DOI 10.1310/sci2403-275; Fox IK, 2018, PM&R, V10, P1173, DOI 10.1016/j.pmrj.2018.03.013; Fox IK, 2016, HAND CLIN, V32, P227, DOI 10.1016/j.hcl.2015.12.013; Fox IK, 2015, PLAST RECONSTR SURG, V136, P780, DOI 10.1097/PRS.0000000000001641; Friden J, 2015, J HAND SURG-AM, V40, P2489, DOI 10.1016/j.jhsa.2015.06.003; Frontera JE, 2017, PHYS MED REH CLIN N, V28, P821, DOI 10.1016/j.pmr.2017.06.013; FU SY, 1995, J NEUROSCI, V15, P3886; Gosk J, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-116; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Hahn J, 2016, ARCH PHYS MED REHAB, V97, pS160, DOI 10.1016/j.apmr.2016.01.038; Hill EJR, 2019, PLAST RECONSTR SURG, V143, p184E, DOI 10.1097/PRS.0000000000005173; Hornyak JE, 2015, PEDIATRIC REHABILITATION: PRINCIPLES AND PRACTICE, FIFTH EDITION, P412; Khalifeh JM, 2019, J NEUROSURG-SPINE, V31, P641, DOI 10.3171/2019.4.SPINE19399; Khalifeh JM, 2019, J NEUROSURG-SPINE, V31, P629, DOI 10.3171/2019.4.SPINE19173; Kozin SH, 2008, HAND CLIN, V24, P203, DOI 10.1016/j.hcl.2008.02.004; LAMB DW, 1983, J BONE JOINT SURG BR, V65, P291, DOI 10.1302/0301-620X.65B3.6841399; Larson EL, 2019, J NEUROSURG-PEDIATR, V24, P209, DOI 10.3171/2019.3.PEDS18550; Lustrin ES, 2003, RADIOGRAPHICS, V23, P539, DOI 10.1148/rg.233025121; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; Mackinnon SE, 2012, J NEUROSURG, V117, P176, DOI 10.3171/2012.3.JNS12328; Madaan P, 2019, PEDIATR NEUROL, V93, P68, DOI 10.1016/j.pediatrneurol.2018.12.018; Mandeville RM, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.5.FOCUS17245; Martin JA, 2017, NEUROLOGY, V89, P129, DOI 10.1212/WNL.0000000000004081; McDonald CM, 2015, PEDIATRIC REHABILITATION: PRINCIPLES AND PRACTICE, FIFTH EDITION, P113; Messacar K, 2016, ANN NEUROL, V80, P326, DOI 10.1002/ana.24730; MOBERG E, 1975, J BONE JOINT SURG AM, VA 57, P196, DOI 10.2106/00004623-197557020-00012; MOBERG E, 1989, J HAND SURG-AM, V14A, P1064, DOI 10.1016/S0363-5023(89)80064-4; Mulcahey MJ, 2011, ARCH PHYS MED REHAB, V92, P1264, DOI 10.1016/j.apmr.2011.03.003; Nath RK, 2019, AM J CASE REP, V20, P668, DOI 10.12659/AJCR.915235; Peckham P H, 1976, Paraplegia, V14, P115; Peljovich A, 2011, REHABILITATION HAND, DOI DOI 10.1016/J.OPTMAT.2011.11.002; Pillen S, 2011, NEUROL RES, V33, P1016, DOI 10.1179/1743132811Y.0000000010; Pino PA, 2019, ANN NEUROL, V86, P607, DOI 10.1002/ana.25558; Punj V, 2016, ARCH PHYS MED REHAB, V97, pS81, DOI 10.1016/j.apmr.2015.11.022; RAMACHANDRAN VS, 1993, P NATL ACAD SCI USA, V90, P10413, DOI 10.1073/pnas.90.22.10413; Saltzman EB, 2018, PEDIATR NEUROL, V88, P25, DOI 10.1016/j.pediatrneurol.2018.07.018; Savic G, 2017, SPINAL CORD, V55, P651, DOI 10.1038/sc.2017.23; Senjaya F, 2013, WORLD NEUROSURG, V80, pE319, DOI 10.1016/j.wneu.2012.10.001; Sharma B, 2014, J REHABIL MED, V46, P370, DOI 10.2340/16501977-1261; Titolo P, 2019, EUR J ORTHOP SURG TR, V29, P521, DOI 10.1007/s00590-018-2352-2; Tung TH, 2010, J HAND SURG-AM, V35A, P332, DOI 10.1016/j.jhsa.2009.12.002; Van Haren K, 2015, JAMA-J AM MED ASSOC, V314, P2663, DOI 10.1001/jama.2015.17275; van Zyl N, 2019, LANCET, V394, P565, DOI 10.1016/S0140-6736(19)31143-2; Vogel Lawrence C, 2012, Handb Clin Neurol, V109, P131, DOI 10.1016/B978-0-444-52137-8.00008-5; Wang WJ, 2019, PLAST RECONSTR SURG, V143, P771, DOI 10.1097/PRS.0000000000005338; Waters PM, 1998, J BONE JOINT SURG AM, V80A, P668, DOI 10.2106/00004623-199805000-00007; Waters RL, 1996, ARCH PHYS MED REHAB, V77, P86, DOI 10.1016/S0003-9993(96)90227-0; Wills BPD, 2006, J AM ACAD ORTHOP SUR, V14, P233, DOI 10.5435/00124635-200604000-00005; Zancolli E, 1978, STRUCTURAL DYNAMIC B, P229	64	2	2	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	AUG	2020	31	3					455	+		10.1016/j.pmr.2020.04.006			17	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	MH7XZ	WOS:000546938300012	32624105				2022-02-06	
J	Wang, RR; He, M; Ou, XF; Xie, XQ; Kang, Y				Wang, Ruoran; He, Min; Ou, Xiaofeng; Xie, Xiaoqi; Kang, Yan			CRP Albumin ratio is positively associated with poor outcome in patients with traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Traumatic brain injury; CRP-Albumin ratio; Prognosis; Survival	C-REACTIVE PROTEIN; PROTEIN/ALBUMIN RATIO; PROGNOSTIC SCORE; PREDICTIVE-VALUE; INFLAMMATION; SURVIVAL	Objectives: The C-reactive protein/albumin ratio (CAR), a novel inflammation-based index, has been proved useful in predicting outcome of various diseases. We designed this study to explore the prognostic value of CAR in patients with traumatic brain injury (TBI). Patients and methods: We retrospectively included 151 patients diagnosed with TBI and collected related clinical and laboratory data. Univariate and multivariate logistic regression were conducted to find independent risk factors of mortality. Then, we incorporated CAR into prognostic model and drew receiver operating characteristic (ROC) curve of models. Finally, we compared the predictive value of different models by evaluating the area under the receiver operating characteristic curves (AUC). Results: In this study, a total of 54 patients had poor survival outcome with mortality rate of 35.8 %. Results of multivariate analysis showed that GCS score in admission (OR 0.700, 95 %Cl 0.570-0.860, p=0.001), acute kidney injury (AKI) (OR 3.952, 95Cl 1.631-9.577, p=0.002) and CAR (OR 1.202, 95Cl 1.039-1.390, p=0.013) were independently associated with in-hospital mortality. The AUC value of predictive model composed of the above three factors was higher than GCS or CAR alone. Conclusion: CAR is an independent risk factor of mortality in patients with TBI. Incorporating CAR into predictive model could increase the value in predicting outcome of TBI patients.	[Wang, Ruoran; He, Min; Ou, Xiaofeng; Xie, Xiaoqi; Kang, Yan] Sichuan Univ, West China Hosp, Dept Intens Care Unit, 37,Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China		Kang, Y (corresponding author), Sichuan Univ, West China Hosp, Dept Intens Care Unit, 37,Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China.	kangyan@scu.edu.cn					Ahmed M, 2015, BRIT J NEUROSURG, V29, P544, DOI 10.3109/02688697.2015.1016892; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Baltazar GA, 2015, AM SURGEON, V81, pE61; Belavic M, 2015, INJURY, V46, pS31, DOI 10.1016/j.injury.2015.10.057; Bernstein JE, 2018, CUREUS, V10, DOI 10.7759/cureus.3529; Cao LJ, 2011, CHINESE J PHYSIOL, V54, P435, DOI [10.4077/CJP.2011.BAA058, 10.4077/CJP.2011.AMM058]; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093167; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Du Clos TW, 2004, IMMUNOL RES, V30, P261, DOI 10.1385/IR:30:3:261; Esper Dema Halasa, 2005, Nutr Clin Pract, V20, P369, DOI 10.1177/0115426505020004369; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feng MJ, 2018, CLIN CHIM ACTA, V480, P84, DOI 10.1016/j.cca.2018.01.044; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Fountas KN, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.2.FOCUS08311; Gibson DJ, 2018, J CLIN GASTROENTEROL, V52, pE48, DOI 10.1097/MCG.0000000000000884; Guo SJ, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3119-6; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Hui L, 2014, EXP THER MED, V7, P1683, DOI 10.3892/etm.2014.1666; Idicula TT, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-18; Jacome T, 2018, NEUROCRIT CARE, V28, P110, DOI 10.1007/s12028-017-0410-y; Jeon YT, 2012, J NEUROSURG ANESTH, V24, P317, DOI 10.1097/ANA.0b013e31826047a2; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; Kaplan M, 2017, HEPATOB PANCREAT DIS, V16, P424, DOI 10.1016/S1499-3872(17)60007-9; Karabag Y, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12928; Kinoshita A, 2015, ANN SURG ONCOL, V22, P803, DOI 10.1245/s10434-014-4048-0; Kocaturk M, 2019, NEUROL NEUROCHIR POL, V53, P205, DOI 10.5603/PJNNS.a2019.0020; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Lopponen P, 2014, J NEUROSURG, V121, P1374, DOI 10.3171/2014.7.JNS132678; Luo HC, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017806; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Montalcini T, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0660-4; MORTENSEN RF, 1976, J IMMUNOL, V117, P774; Mortensen RF, 2001, IMMUNOL RES, V24, P163, DOI 10.1385/IR:24:2:163; Ni XF, 2018, ASIA-PAC J CLIN ONCO, V14, P402, DOI 10.1111/ajco.13055; Ranzani OT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059321; Rencuzogullari I, 2019, REV PORT CARDIOL, V38, P269, DOI 10.1016/j.repc.2018.08.008; Skrifvars MB, 2019, ACTA ANAESTH SCAND, V63, P200, DOI 10.1111/aas.13244; Sproston NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00754; VanGilder RL, 2014, J CLIN NEUROSCI, V21, P547, DOI 10.1016/j.jocn.2013.06.015; Wu MW, 2016, TUMOR BIOL, V37, P12525, DOI 10.1007/s13277-016-5122-y; Zhang DD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01186; Zhang Y, 2016, J CANCER, V7, P1406, DOI 10.7150/jca.15401; Zhou T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10481	47	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2020	195								106051	10.1016/j.clineuro.2020.106051			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PI8VI	WOS:000601361200003	32650209				2022-02-06	
J	Xu, DX; Du, WT; Li, X; Wu, ZX; Yu, GF				Xu, De-Xiao; Du, Wu-Tao; Li, Xiang; Wu, Zhi-Xiang; Yu, Guo-Feng			D-dimer/fibrinogen ratio for the prediction of progressive hemorrhagic injury after traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; D-dimer/fibrinogen ratio; Progressive hemorrhagic injury	D-DIMER; RISK-FACTORS; HEAD TRAUMA; COAGULOPATHY	Background: Progressive hemorrhagic injury (PHI) greatly affects prognosis of traumatic brain injury (TBI). D-dimer/fibrinogen ratio (D/F ratio) may be a potential predictor for venous thromboembolism. This study sought to describe and evaluate any relationship between D/F ratio and PHI after TBI. Methods: This retrospective study included a cohort of 192 TBI patients. Plasma D-dimer and fibrinogen were measured, and subsequently D/F ratio was calculated. Multivariate logistic regression analysis was applied to identify predictors of PHI. Receiver operating characteristic (ROC) curve was conFig.d to analyze predictive capability for PHI. Results: A total of 43 patients (22.4%) experienced PHI. Both Glasgow coma scale (GCS) score (odds ratio [OR], 0.565; 95% CI, 0.464-0.689) and D/F ratio (OR, 4.026; 95% CI, 2.219-7.305) were the two independent predictor for PHI. Area under ROC curve (AUC) of D/F ratio was similar to that of GCS score (AUC, 0.816; 95% CI, 0.754-0.868 vs. AUC, 0.834; 95% CI, 0.773-0.883; P = 0.699). Moreover, D/F ratio significantly improved AUC of GCS score to 0.928 (95% CI, 0.881-0.960; P < 0.001). Conclusions: D/F ratio was strongly predictive of PHI in the studied cohort and, thereby should be considered in the clinical management of TBI patients.	[Xu, De-Xiao; Du, Wu-Tao; Wu, Zhi-Xiang] Peoples Hosp Quzhou, Dept Emergency Med, 2 Zhongloudi Rd, Kecheng Dist 324000, Quzhou, Peoples R China; [Li, Xiang; Yu, Guo-Feng] Peoples Hosp Quzhou, Dept Neurosurg, 2 Zhongloudi Rd, Kecheng Dist 324000, Quzhou, Peoples R China		Yu, GF (corresponding author), Peoples Hosp Quzhou, Dept Neurosurg, 2 Zhongloudi Rd, Kecheng Dist 324000, Quzhou, Peoples R China.	quzhouguofengyu@163.com					Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Barber M, 2004, STROKE, V35, P1421, DOI 10.1161/01.STR.0000126890.63512.41; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Delgado P, 2006, NEUROLOGY, V67, P94, DOI 10.1212/01.wnl.0000223349.97278.e0; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Hajsadeghi S, 2012, CARDIOVASC J AFR, V23, P446, DOI 10.5830/CVJA-2012-041; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Juvela S, 2006, STROKE, V37, P1451, DOI 10.1161/01.STR.0000221710.55467.33; Kara H, 2014, ACTA CLIN BELG, V69, P240, DOI 10.1179/2295333714Y.0000000029; Kuo JR, 2007, EUR J NEUROL, V14, P1073, DOI 10.1111/j.1468-1331.2007.01908.x; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; Liu J, 2016, CHIN J TRAUMATOL, V19, P172, DOI 10.1016/j.cjtee.2016.01.011; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Tong WS, 2012, BRAIN INJURY, V26, P1136, DOI 10.3109/02699052.2012.666437; Wan XY, 2017, ACTA NEUROCHIR, V159, P227, DOI 10.1007/s00701-016-3043-6; Wuillemin WA, 2005, J THROMB HAEMOST, V3, P385, DOI 10.1111/j.1538-7836.2004.01121.x; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Zhang DF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/261825; Zhang J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011774	26	2	2	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	AUG	2020	507						143	148		10.1016/j.cca.2020.04.022			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	LU2XE	WOS:000537623700020	32333859				2022-02-06	
J	Davila, G; Moyano, MP; Edelkraut, L; Moreno-Campos, L; Berthier, ML; Torres-Prioris, MJ; Lopez-Barroso, D				Davila, Guadalupe; Pilar Moyano, Maria; Edelkraut, Lisa; Moreno-Campos, Lorena; Berthier, Marcelo L.; Jose Torres-Prioris, Maria; Lopez-Barroso, Diana			Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy	FRONTIERS IN PHARMACOLOGY			English	Article						language; childhood aphasia; anomia; traumatic brain injury; donepezil; pharmacological treatment; intensive naming therapy	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; REDUCED EVOKED RELEASE; TEST NORMATIVE DATA; BRAIN-INJURY; DOWN-SYNDROME; OPEN-LABEL; ADJUNCTIVE DONEPEZIL; NEURAL PLASTICITY; DRUG-THERAPY; TOKEN TEST	At present, language therapy is the only available treatment for childhood aphasia (CA). Studying new interventions to augment and hasten the benefits provided by language therapy in children is strongly needed. CA frequently emerges as a consequence of traumatic brain injury and, as in the case of adults, it may be associated with dysfunctional activity of neurotransmitter systems. The use of cognitive-enhancing drugs, alone or combined with aphasia therapy, promotes improvement of language deficits in aphasic adults. In this study we report the case of a 9-year-old right-handed girl, subject P, who had chronic anomic aphasia associated with traumatic lesions in the left temporal-parietal cortex. We performed a single-subject, open-label study encompassing administration of the cholinergic agent donepezil (DP) alone during 12 weeks, followed by a combination of DP and intensive naming therapy (INT) for 2 weeks and thereafter by a continued treatment of DP alone during 12 weeks, a 4-week washout period, and another 2 weeks of INT. Four comprehensive language and neuropsychological evaluations were performed at different timepoints along the study, and multiple naming evaluations were performed after each INT in order to assess performance in treated and untreated words. Structural magnetic resonance imaging (MRI) was performed at baseline. MRI revealed two focal lesions in the left hemisphere, one large involving the posterior inferior and middle temporal gyri and another comprising the angular gyrus. Overall, baseline evaluation disclosed marked impairment in naming with mild-to-moderate compromise of spontaneous speech, repetition, and auditory comprehension. Executive and attention functions were also affected, but memory, visuoconstructive, and visuoperceptive functions were preserved. Treatment with DP alone significantly improved spontaneous speech, auditory comprehension, repetition, and picture naming, in addition to processing speed, selective, and sustained attention. Combined DP-INT further improved naming. After washout of both interventions, most of these beneficial changes remained. Importantly, DP produced no side effects and subject P attained the necessary level of language competence to return to regular schooling. In conclusion, the use of DP alone and in combination with INT improved language function and related cognitive posttraumatic deficits in a child with acquired aphasia. Further studies in larger samples are warranted.	[Davila, Guadalupe; Pilar Moyano, Maria; Edelkraut, Lisa; Moreno-Campos, Lorena; Berthier, Marcelo L.; Jose Torres-Prioris, Maria; Lopez-Barroso, Diana] Univ Malaga, Ctr Invest Medicosanitarias, Cognit Neurol & Aphasia Unit, Malaga, Spain; [Davila, Guadalupe; Edelkraut, Lisa; Berthier, Marcelo L.; Jose Torres-Prioris, Maria; Lopez-Barroso, Diana] Inst Invest Biomed Malaga IBIMA, Malaga, Spain; [Davila, Guadalupe; Edelkraut, Lisa; Jose Torres-Prioris, Maria; Lopez-Barroso, Diana] Univ Malaga, Fac Psychol & Speech Therapy, Dept Psychobiol & Methodol Behav Sci, Malaga, Spain; [Davila, Guadalupe; Edelkraut, Lisa; Berthier, Marcelo L.; Jose Torres-Prioris, Maria; Lopez-Barroso, Diana] Univ Malaga, Fac Psychol & Speech Therapy, Language Neurosci Res Lab, Malaga, Spain		Davila, G (corresponding author), Univ Malaga, Ctr Invest Medicosanitarias, Cognit Neurol & Aphasia Unit, Malaga, Spain.; Davila, G (corresponding author), Inst Invest Biomed Malaga IBIMA, Malaga, Spain.; Davila, G (corresponding author), Univ Malaga, Fac Psychol & Speech Therapy, Dept Psychobiol & Methodol Behav Sci, Malaga, Spain.; Davila, G (corresponding author), Univ Malaga, Fac Psychol & Speech Therapy, Language Neurosci Res Lab, Malaga, Spain.	mgdavila@uma.es	Lopez-Barroso, Diana/AAH-6830-2019; Davila, Guadalupe/D-3050-2011; Torres-Prioris, Maria Jose/AAA-1944-2020	Lopez-Barroso, Diana/0000-0002-8938-1959; Davila, Guadalupe/0000-0002-3297-4243; Torres-Prioris, Maria Jose/0000-0003-3795-8151	I Plan for Research and Transfer of the University of Malaga [107/2018]; European Social FundEuropean Social Fund (ESF) [E-29-201-0705972]; Spanish Ministry of Education, Culture, and Sport under the FPU program [FPU17/04136]; University of Malaga; I+D+i Project, Andalucia; European Union Funds (FEDER)European Commission [UMA18-FEDERJA-221]; Ministerio de Economia, Industria y Competitividad, Instituto de Salud Carlos III, Madrid, Spain [PI16/01514]	MM has been funded by I Plan for Research and Transfer of the University of Malaga (Introduction to Research Scholarship for Undergraduate and Master's Students, 107/2018). LM-C has been supported by funds from the European Social Fund (E-29-201-0705972). LE has been funded by a PhD scholarship from the Spanish Ministry of Education, Culture, and Sport under the FPU program (FPU17/04136). MT-P has been funded by a postdoctoral fellowship from the University of Malaga. DL-B has been supported by a I+D+i Project, Andalucia and European Union Funds (FEDER) (UMA18-FEDERJA-221). The work was supported in part by the Ministerio de Economia, Industria y Competitividad, Instituto de Salud Carlos III, Madrid, Spain under Grant: PI16/01514.	AMADUCCI L, 1981, NEUROLOGY, V31, P799, DOI 10.1212/WNL.31.7.799; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Aram D. M., 1998, ACQUIRED APHASIA, P451; ARAM DM, 1985, J CLIN EXP NEUROPSYC, V7, P55, DOI 10.1080/01688638508401242; Arango-Lasprilla JC, 2017, NEUROREHABILITATION, V41, P593, DOI 10.3233/NRE-172241; Ardila A, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/565871; Asaridou SS, 2020, CORTEX, V127, P290, DOI 10.1016/j.cortex.2020.02.006; Avila L, 2010, J CHILD NEUROL, V25, P829, DOI 10.1177/0883073809350724; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Banaschewski T, 2004, EUR CHILD ADOLES PSY, V13, P102, DOI 10.1007/s00787-004-1010-x; Beitchman JH, 2001, J AM ACAD CHILD PSY, V40, P75, DOI 10.1097/00004583-200101000-00019; Benton A., 1994, CONTRIBUTIONS NEUROP; Berthier ML, 2006, NEUROLOGY, V67, P1687, DOI 10.1212/01.wnl.0000242626.69666.e2; Berthier M. L., 1999, TRANSCORTICAL APHASI; Berthier ML, 2021, APHASIOLOGY, V35, P824, DOI 10.1080/02687038.2020.1769987; Berthier ML, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00304; Berthier ML, 2014, APHASIOLOGY, V28, P188, DOI 10.1080/02687038.2013.861057; Berthier ML, 2011, NEUROPSYCHOL REV, V21, P302, DOI 10.1007/s11065-011-9177-7; Berthier ML, 2011, NAT REV NEUROL, V7, P86, DOI 10.1038/nrneurol.2010.201; Berthier ML, 2009, ANN NEUROL, V65, P577, DOI 10.1002/ana.21597; Berthier ML, 2003, NEUROLOGY, V60, P1218, DOI 10.1212/01.WNL.0000055871.82308.41; Best W, 2013, CORTEX, V49, P2345, DOI 10.1016/j.cortex.2013.01.005; Biederman J, 2000, EUR CHILD ADOLES PSY, V9, P51; Birba A, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00178; Birkenkamp R., 1998, D2 TEST ATTENTION; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bowen JM, 2005, PREV SCH FAIL, V49, P34, DOI 10.3200/PSFL.49.4.34-41; Brauer J, 2011, CEREB CORTEX, V21, P459, DOI 10.1093/cercor/bhq108; Breitenstein C, 2017, LANCET, V389, P1528, DOI 10.1016/S0140-6736(17)30067-3; Brickenkamp R, 2002, D2 TEST DE ATENCION; Brownlie EB, 2016, J ABNORM CHILD PSYCH, V44, P1061, DOI 10.1007/s10802-015-0097-5; Buckley AW, 2011, J CHILD ADOL PSYCHOP, V21, P353, DOI 10.1089/cap.2010.0121; Castellino SM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju186; Castellino SM, 2012, PEDIATR BLOOD CANCER, V59, P540, DOI 10.1002/pbc.24078; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cervetto S, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01194; Chapman SS, 2005, BEHAV INTERVENT, V20, P37, DOI 10.1002/bin.168; Cherney LR, 2010, J NEUROL NEUROSUR PS, V81, P1014, DOI 10.1136/jnnp.2009.184036; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; COLTHEART M., 1992, PALPA PSYCHOLINGUIST, V2; Conde-Guzon PA, 2009, REV NEUROLOGIA, V48, P32, DOI 10.33588/rn.4801.2008164; Crawford JR, 2010, COGN NEUROPSYCHOL, V27, P245, DOI 10.1080/02643294.2010.513967; Cubo E, 2008, CLIN THER, V30, P182, DOI 10.1016/j.clinthera.2008.01.010; de la Tremblaye PB, 2019, NEUROPHARMACOLOGY, V145, P13, DOI 10.1016/j.neuropharm.2018.02.032; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; Doyle Robert L, 2006, J Atten Disord, V9, P543, DOI 10.1177/1087054705284091; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Dunn L.M., 2006, PPVT 3 PEABODY TEST; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Forkel SJ, 2020, NEUROLOGY, V94, pE594, DOI 10.1212/WNL.0000000000008746; Foulon C, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy004; Francois C, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0447-18.2019; Francois C, 2016, CORTEX, V77, P95, DOI 10.1016/j.cortex.2016.01.010; Fridriksson J, 2005, APHASIOLOGY, V19, P99, DOI 10.1080/02687030444000660; Fridriksson J, 2018, JAMA NEUROL, V75, P1470, DOI 10.1001/jamaneurol.2018.2287; GARDNER RA, 1981, J CLIN CHILD PSYCHOL, V10, P131, DOI 10.1080/15374418109533032; Gielow MR, 2017, CELL REP, V18, P1817, DOI 10.1016/j.celrep.2017.01.060; Gleichgerrcht E, 2016, RESTOR NEUROL NEUROS, V34, P19, DOI 10.3233/RNN-150511; Heredia CG, 2009, APHASIOLOGY, V23, P192, DOI 10.1080/02687030801942999; HALPERIN JM, 1989, J CLIN EXP NEUROPSYC, V11, P518, DOI 10.1080/01688638908400910; Handen BL, 2011, J CHILD ADOL PSYCHOP, V21, P43, DOI 10.1089/cap.2010.0024; Hardan AY, 2002, J CHILD ADOL PSYCHOP, V12, P237, DOI 10.1089/104454602760386923; Hazell P, 2007, J PAEDIATR CHILD H, V43, P19, DOI 10.1111/j.1440-1754.2007.00995.x; Heller JH, 2004, AM J MED GENET A, V130A, P325, DOI 10.1002/ajmg.a.30184; Herbet G, 2019, COGN NEUROPSYCHOL, V36, P140, DOI 10.1080/02643294.2018.1477749; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hutsler JJ, 1996, CEREB CORTEX, V6, P260, DOI 10.1093/cercor/6.2.260; Ivanova MV, 2016, CORTEX, V85, P165, DOI 10.1016/j.cortex.2016.04.019; Moreno-Martinez FJ, 2015, NEUROCASE, V21, P773, DOI 10.1080/13554794.2015.1006644; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Johnson CJ, 2010, AM J SPEECH-LANG PAT, V19, P51, DOI 10.1044/1058-0360(2009/08-0083); Kaplan E, 1983, BOSTON NAMING TEST; Kertesz A., 2007, WAB R W APHASIA BATT; Kertesz A., 1982, W APHASIA BATTERY; Kishnani PS, 2010, AM J MED GENET A, V152A, P3028, DOI 10.1002/ajmg.a.33730; Kishnani PS, 2004, ARCH NEUROL-CHICAGO, V61, P605, DOI 10.1001/archneur.61.4.605-b; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kurland J, 2010, APHASIOLOGY, V24, P737, DOI 10.1080/02687030903524711; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Laine M., 2006, BRAIN DAMAGE BEHAV C; Lassaletta A, 2015, CHILD NERV SYST, V31, P1877, DOI 10.1007/s00381-015-2829-9; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Lopez-Barroso D, 2020, NEUROIMAGE, V213, DOI 10.1016/j.neuroimage.2020.116722; Lopez-Barroso D, 2013, P NATL ACAD SCI USA, V110, P13168, DOI 10.1073/pnas.1301696110; Lopez-Barroso D, 2011, CEREB CORTEX, V21, P2742, DOI 10.1093/cercor/bhr064; Markello RD, 2018, NEUROIMAGE, V173, P287, DOI 10.1016/j.neuroimage.2018.02.042; Martin N, 2004, BRAIN LANG, V89, P464, DOI 10.1016/j.bandl.2003.12.004; McKinnon ET, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32457-4; Mena-Segovia J, 2017, NEURON, V94, P7, DOI 10.1016/j.neuron.2017.02.027; Mesulam MM, 2004, PROG BRAIN RES, V145, P67, DOI 10.1016/S0079-6123(03)45004-8; Narbona J, 2012, REV NEUROLOGIA, V54, pS127; Noonan KA, 2013, J COGNITIVE NEUROSCI, V25, P1824, DOI 10.1162/jocn_a_00442; Northam GB, 2018, ANN NEUROL, V83, P664, DOI 10.1002/ana.25218; Nugiel T, 2016, COGN AFFECT BEHAV NE, V16, P1003, DOI 10.3758/s13415-016-0448-x; Olabarrieta-Landa L, 2017, NEUROREHABILITATION, V41, P649, DOI 10.3233/NRE-172244; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Pityaratstian Nuttorn, 2005, J Med Assoc Thai, V88 Suppl 4, pS357; Popper CW, 2000, CHILD ADOL PSYCH CL, V9, P605; Portellano J, 2009, MANUAL ENFEN EVALUAC; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Pulvermuller F, 2008, APHASIOLOGY, V22, P563, DOI 10.1080/02687030701612213; Rauschecker AM, 2009, NEUROPSYCHOLOGIA, V47, P180, DOI 10.1016/j.neuropsychologia.2008.08.011; Rey GJ, 1999, ARCH CLIN NEUROPSYCH, V14, P593, DOI 10.1016/S0887-6177(99)00008-6; Reynolds CR, 1996, ARCH CLIN NEUROPSYCH, V11, P29, DOI 10.1016/0887-6177(95)00027-5; Ripolles P, 2017, J NEUROSCI, V37, P11101, DOI 10.1523/JNEUROSCI.1720-17.2017; Rivera D, 2017, NEUROREHABILITATION, V41, P605, DOI 10.3233/NRE-172246; Rojkova K, 2016, BRAIN STRUCT FUNCT, V221, P1751, DOI 10.1007/s00429-015-1001-3; Rokem A, 2010, CURR BIOL, V20, P1723, DOI 10.1016/j.cub.2010.08.027; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; ROTHENBERGER A, 1986, FORTSCHR NEUROL PSYC, V54, P92, DOI 10.1055/s-2007-1001855; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; Sahu JK, 2013, J CHILD NEUROL, V28, P570, DOI 10.1177/0883073812449381; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Sedo M., 2004, INT NEUROPSYCHOLOGIC, V13, P6; Sedo M.A., 2007, FDT TEST 5 DIGITOS; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Sierpowska J, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101704; Simic G, 1999, NEUROSCIENCE, V89, P73, DOI 10.1016/S0306-4522(98)00304-2; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Spencer T, 2002, J Atten Disord, V6 Suppl 1, pS109; Spiridigliozzi GA, 2007, AM J MED GENET A, V143A, P1408, DOI 10.1002/ajmg.a.31790; Srivastava Rohit Kant, 2011, Case Rep Psychiatry, V2011, P563204, DOI 10.1155/2011/563204; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suarez-Gonzalez A, 2015, NEUROCASE, V21, P309, DOI 10.1080/13554794.2014.892624; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Tamasaki A, 2016, BRAIN DEV-JPN, V38, P113, DOI 10.1016/j.braindev.2015.06.006; Tavano A, 2009, BRAIN INJURY, V23, P167, DOI 10.1080/02699050802657012; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thiebaut de Schotten M, 2014, CEREB CORTEX, V24, P989, DOI 10.1093/cercor/bhs383; Thomas-Stonell N, 1994, J HEAD TRAUMA REHAB, V9, P25, DOI DOI 10.1097/00001199-199412000-00005; Thornton SL, 2016, J PEDIATR-US, V172, P147, DOI 10.1016/j.jpeds.2016.01.056; Torres-Prioris MJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67551-z; Turkstra LS, 2015, DEV MED CHILD NEUROL, V57, P217, DOI 10.1111/dmcn.12600; Valle F., 1995, EPLA EVALUACION PROC EPLA EVALUACION PROC; Van Hout A, 1997, Semin Pediatr Neurol, V4, P102; Van Hout A., 2003, HDB NEUROPSYCHOLOGY, P631; VANHOUT A, 1985, DEV MED CHILD NEUROL, V27, P231; Vik Anne, 2006, Tidsskr Nor Laegeforen, V126, P2940; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wechsler D., 2014, WECHSLER INTELLIGENC, V5th; Whiting E, 2007, J INT NEUROPSYCH SOC, V13, P972, DOI 10.1017/S1355617707071317; Wilens TE, 2000, J CHILD ADOL PSYCHOP, V10, P217, DOI 10.1089/10445460050167322; Wiseman-Hakes C, 1998, J HEAD TRAUMA REHAB, V13, P23, DOI 10.1097/00001199-199812000-00005; WOODS BT, 1978, ANN NEUROL, V3, P273, DOI 10.1002/ana.410030315; Yeatman JD, 2013, CORTEX, V49, P301, DOI 10.1016/j.cortex.2011.08.006; Zhang XY, 2018, CNS NEUROL DISORD-DR, V17, P509, DOI 10.2174/1871527317666180706143051	160	2	2	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	JUL 31	2020	11								1144	10.3389/fphar.2020.01144			19	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pharmacology & Pharmacy	ND5RA	WOS:000561955800001	32848757	Green Published, gold			2022-02-06	
J	Kochavi, E; Gruntman, S; Ben-Dor, G; Sherf, I; Meirovich, E; Amir, B; Shushan, G; Sadot, OM				Kochavi, E.; Gruntman, S.; Ben-Dor, G.; Sherf, I.; Meirovich, E.; Amir, B.; Shushan, G.; Sadot, O. M.			Design and Construction of an In-Laboratory Novel Blast Wave Simulator	EXPERIMENTAL MECHANICS			English	Article						Shock Wave; Blast Wave; Blast Simulator; LS-Dyna; Traumatic Brain Injury (TBI); Helmet	MODELS; TBI	Background In spite of the worldwide recognition of the importance of testing blast effects on dummy humans, there is a lack of blast simulators that are capable of generating realistic blast conditions in the laboratory. Objective The objective of the present study was to design, construct and test a blast tube that is able to accurately reproduce loading histories of actual explosions in the laboratory. Methods The design combines some advantages of existing blast-wave generating facilities. Using numerical simulations, a 5-m long blast tube was designed. The blast tube is large enough to enclose dummies including torso and head, wearing vests and/or helmets. Results The system generated blast waves equivalent to those of a spherical explosion of about 3.5 kg TNT with an over pressure of 0.64 bar and a positive phase of 4 ms. The repeatability of the experiments was very good. The blast tube's open end is square of 1.57 m x 1.57 m and although designed for experiments on human dummies, it could be used for testing even full-scale structural components. High quality high-speed photography was demonstrated through the designed windows. Our preliminary study on the effect of a helmet on a dummy's head revealed that the tested helmet amplified by a factor of 2 and more the peak pressure in the back side of the head. Conclusions The newly designed blast tube is capable of simulating close range blast waves, manifested with short positive durations. Experiments with and without helmets revealed the importance of blast testing for improving helmet design.	[Kochavi, E.; Gruntman, S.; Ben-Dor, G.; Sherf, I.; Meirovich, E.; Amir, B.; Sadot, O. M.] Ben Gurion Univ Negev, Dept Mech Engn, Fac Engn Sci, Beer Sheva, Israel; [Ben-Dor, G.; Sadot, O. M.] Ben Gurion Univ Negev, Pearlstone Ctr Aeronaut Engn Studies, Beer Sheva, Israel; [Shushan, G.] Israel Def Forces, Ground Forces Technol Unit, Tel Aviv, Israel		Sadot, OM (corresponding author), Ben Gurion Univ Negev, Dept Mech Engn, Fac Engn Sci, Beer Sheva, Israel.	sorens@bgu.ac.il	Kochavi, Eytan/D-4147-2016	Kochavi, Eytan/0000-0002-2939-1661	Israeli Ministry of Defense [511-4440910173]	This study was partly funded by the Israeli Ministry of Defense under Grant No. 511-4440910173.	Alay E, 2018, SHOCK WAVES, V28, P51, DOI 10.1007/s00193-017-0762-4; Bessette GC, 2016, TR1631 US ARM CORPS; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; FILLER WS, 1960, PHYS FLUIDS, V3, P444, DOI 10.1063/1.1706057; Filler WS, 1960, 6844 NAVORD US NAV O; Ganel R, 2016, ANAL FINITE ELEMENT; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hyde DW, 1988, APPL US ARMY CORPS E; Ismail A, 2017, THESIS; Ismail A, 2020, INT J PROT STRUCT, V11, P135, DOI 10.1177/2041419619858098; Jacques E, 2013, CAN J CIVIL ENG, V40, P427, DOI 10.1139/L2012-014; Kleinschmit NN, 2011, THESIS; Li Y, 2018, CONSTR BUILD MATER, V189, P420, DOI 10.1016/j.conbuildmat.2018.09.005; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Roberts JC, 2012, J BIOMECH, V45, P2899, DOI 10.1016/j.jbiomech.2012.07.027; Stewart JB, 2017, ARLTR7953; Stewart JB, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4914898; Sundaramurthy A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00253; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	21	2	2	3	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4851	1741-2765		EXP MECH	Exp. Mech.	OCT	2020	60	8					1149	1159		10.1007/s11340-020-00650-0		JUL 2020	11	Materials Science, Multidisciplinary; Mechanics; Materials Science, Characterization & Testing	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Mechanics	NS0RO	WOS:000554315700001					2022-02-06	
J	Koh, BI; Lee, HJ; Kwak, PA; Yang, MJ; Kim, JH; Kim, HS; Koh, GY; Kim, I				Koh, Bong Ihn; Lee, Hyuek Jong; Kwak, Pil Ae; Yang, Myung Jin; Kim, Ju-Hee; Kim, Hyung-Seok; Koh, Gou Young; Kim, Injune			VEGFR2 signaling drives meningeal vascular regeneration upon head injury	NATURE COMMUNICATIONS			English	Article							ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; ANGIOGENESIS; MACROPHAGES; NEUROGENESIS; MECHANISMS; VESSELS; MODELS; SYSTEM; FLUID	Upon severe head injury (HI), blood vessels of the meninges and brain parenchyma are inevitably damaged. While limited vascular regeneration of the injured brain has been studied extensively, our understanding of meningeal vascular regeneration following head injury is quite limited. Here, we identify key pathways governing meningeal vascular regeneration following HI. Rapid and complete vascular regeneration in the meninges is predominantly driven by VEGFR2 signaling. Substantial increase of VEGFR2 is observed in both human patients and mouse models of HI, and endothelial cell-specific deletion of Vegfr2 in the latter inhibits meningeal vascular regeneration. We further identify the facilitating, stabilizing and arresting roles of Tie2, PDGFR beta and Dll4 signaling, respectively, in meningeal vascular regeneration. Prolonged inhibition of this angiogenic process following HI compromises immunological and stromal integrity of the injured meninges. These findings establish a molecular framework for meningeal vascular regeneration after HI, and may guide development of wound healing therapeutics. Severe head injury results in critical damage of blood vessels of the meninges and brain parenchyma. Here, the authors describe key pathways governing meningeal vascular regeneration following head injury, characterizing the differential roles of VEGFR2, Tie2, Dll4 and PDGFR beta signaling.	[Koh, Bong Ihn; Koh, Gou Young; Kim, Injune] Korea Adv Inst Sci & Technol KAIST, KI Biocentury, Daejeon 34141, South Korea; [Lee, Hyuek Jong; Kwak, Pil Ae; Yang, Myung Jin; Koh, Gou Young] Inst Basic Sci IBS, Ctr Vasc Res, Daejeon 34141, South Korea; [Yang, Myung Jin; Kim, Ju-Hee; Koh, Gou Young; Kim, Injune] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea; [Kim, Hyung-Seok] Chonnam Natl Univ, Med Sch, Dept Forens Med, Gwangju 61463, South Korea		Koh, GY; Kim, I (corresponding author), Korea Adv Inst Sci & Technol KAIST, KI Biocentury, Daejeon 34141, South Korea.; Koh, GY (corresponding author), Inst Basic Sci IBS, Ctr Vasc Res, Daejeon 34141, South Korea.; Koh, GY; Kim, I (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea.	gykoh@kaist.ac.kr; injunek@kaist.ac.kr	Lee, Hyuek Jong/AAP-9190-2021		National Research Foundation of Korea - Ministry of Science and ICT, Republic of Korea [NRF-2018R1A2A1A05022672]; Institute for Basic Science - Ministry of Science and ICT, Republic of Korea [IBS-R025-D1-2015]; Korea Brain Research Institute - Ministry of Science and ICT, Republic of Korea [19-BR-03-04]	We thank Yoshiaki Kubota (Keio University) for VE-cadherin-Cre-ERT2 mice, Hoon-Ki Sung (University of Toronto) for VEGF-A+/LacZ mice, Masanori Hirashima (Kobe University) for VEGFR2fl/fl mice, Hellmut Augustine (Heidelberg University) for Tie2<SUP>fl/fl,</SUP> David Shima (University College London) for Dll<SUP>4fl/fl</SUP> and Ralf Adams (Max-Planck Institute, Muenster) for PDGFRss-Cre-ERT2 mice. This study was supported by grants from the National Research Foundation of Korea (NRF-2018R1A2A1A05022672, I.K.), Institute for Basic Science (IBS-R025-D1-2015, G.Y.K.), and Korea Brain Research Institute (19-BR-03-04, H.S.K.), all funded by the Ministry of Science and ICT, Republic of Korea.	Ahn JH, 2019, NATURE, V572, P62, DOI 10.1038/s41586-019-1419-5; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Chakarov S., 2019, SCIENCE, V15, P363; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Choi D, 2017, J CLIN INVEST, V127, P1225, DOI 10.1172/JCI87442; Corliss BA, 2016, MICROCIRCULATION, V23, P95, DOI 10.1111/micc.12259; Decimo I, 2012, AM J STEM CELLS, V1, P92; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI 10.1038/s41590-018-0272-2; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Geiseler SJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051362; Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Labat-gest V, 2013, JOVE-J VIS EXP, DOI 10.3791/50370; LI M, 2016, NAT COMMUN, V0144, P00007, DOI DOI 10.1016/J.CLINEURO.2016.02.032; LI M, 2016, BIOMED OPT EXPRESS, V0144, P00007, DOI DOI 10.1016/J.CLINEURO.2016.02.032; LI M, 2016, SCI TRANSL MED, V0144, P00007, DOI DOI 10.1016/J.CLINEURO.2016.02.032; Li M, 2016, CLIN NEUROL NEUROSUR, V144, P7, DOI 10.1016/j.clineuro.2016.02.032; Lim, 2014, BIO PROTOC, V4, P1064, DOI DOI 10.21769/BIOPROTOC.1064; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lu KT, 2011, J NEUROTRAUM, V28, P441, DOI 10.1089/neu.2010.1473; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Mastorakos P, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav0492; Mecheri B, 2018, ACTA HISTOCHEM, V120, P846, DOI 10.1016/j.acthis.2018.09.009; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Okabe K, 2014, CELL, V159, P584, DOI 10.1016/j.cell.2014.09.025; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rua R, 2018, TRENDS MOL MED, V24, P542, DOI 10.1016/j.molmed.2018.04.003; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Saharinen P, 2017, NAT REV DRUG DISCOV, V16, P635, DOI 10.1038/nrd.2016.278; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Savant S, 2015, CELL REP, V12, P1761, DOI 10.1016/j.celrep.2015.08.024; Schain AJ, 2018, ANN NEUROL, V83, P508, DOI 10.1002/ana.25169; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; Weller RO, 2018, ACTA NEUROPATHOL, V135, P363, DOI 10.1007/s00401-018-1809-z; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Zhang Y., 2014, VASCULAR MECH CNS TR, P141	54	2	2	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JUL 31	2020	11	1							3866	10.1038/s41467-020-17545-2			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3GC	WOS:000560401200002	32737287	Green Published, gold			2022-02-06	
J	Donmez-Demir, B; Erdener, SE; Karatas, H; Kaya, Z; Ulusoy, I; Dalkara, T				Donmez-Demir, Buket; Erdener, Sefik Evren; Karatas, Hulya; Kaya, Zeynep; Ulusoy, Ilkay; Dalkara, Turgay			KCl-induced cortical spreading depression waves more heterogeneously propagate than optogenetically-induced waves in lissencephalic brain: an analysis with optical flow tools	SCIENTIFIC REPORTS			English	Article							SPATIOTEMPORAL DYNAMICS; DEPOLARIZATION; CORTEX	Although cortical spreading depolarizations (CSD) were originally assumed to be homogeneously and concentrically propagating waves, evidence obtained first in gyrencephalic brains and later in lissencephalic brains suggested a rather non-uniform propagation, shaped heterogeneously by factors like cortical region differences, vascular anatomy, wave recurrences and refractory periods. Understanding this heterogeneity is important to better evaluate the experimental models on the mechanistics of CSD and to make appropriate clinical estimations on neurological disorders like migraine, stroke, and traumatic brain injury. This study demonstrates the application of optical flow analysis tools for systematic and objective evaluation of spatiotemporal CSD propagation patterns in anesthetized mice and compares the propagation profile in different CSD induction models. Our findings confirm the asymmetric angular CSD propagation in lissencephalic brains and suggest a strong dependency on induction-method, such that continuous potassium chloride application leads to significantly higher angular propagation variability compared to optogenetically-induced CSDs.	[Donmez-Demir, Buket; Erdener, Sefik Evren; Karatas, Hulya; Kaya, Zeynep; Dalkara, Turgay] Hacettepe Univ, Inst Neurol Sci & Psychiat, Ankara, Turkey; [Ulusoy, Ilkay] Middle East Tech Univ, Fac Engn, Dept Elect Elect Engn, Ankara, Turkey		Erdener, SE; Dalkara, T (corresponding author), Hacettepe Univ, Inst Neurol Sci & Psychiat, Ankara, Turkey.	evrenerdener@hacettepe.edu.tr; tdalkara@hacettepe.edu.tr	Karatas, Hulya/J-1459-2013; , ilkay/AAZ-9415-2020; Kaya, Zeynep/AAJ-9593-2021	Karatas, Hulya/0000-0003-4838-6320; Kaya, Zeynep/0000-0003-4764-8624; DONMEZ-DEMIR, BUKET/0000-0002-2101-8061; Dalkara, Turgay/0000-0003-3943-7819	Turkish Academy of SciencesTurkish Academy of Sciences; Science Academy of Turkey	This study was supported by Turkish Academy of Sciences (T.D.) and the Science Academy of Turkey (S.E.E.). We would like to thank Mesut Frat for his excellent technical assistance.	Afrashteh N, 2017, NEUROIMAGE, V153, P58, DOI 10.1016/j.neuroimage.2017.03.034; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Ayata C, 2013, CEPHALALGIA, V33, P604, DOI 10.1177/0333102412470216; Bellot-Saez A, 2017, NEUROSCI BIOBEHAV R, V77, P87, DOI 10.1016/j.neubiorev.2017.03.002; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Bouley J, 2019, J NEUROTRAUM, V36, P1008, DOI 10.1089/neu.2018.5844; Chen SB, 2006, NEUROSCI LETT, V396, P132, DOI 10.1016/j.neulet.2005.11.025; Chung DY, 2019, CEREB CORTEX, V29, P1150, DOI 10.1093/cercor/bhy021; Dhakal KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111488; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Eiselt M, 2004, BRAIN RES, V1028, P83, DOI 10.1016/j.brainres.2004.09.002; Haleh S, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.1.010503; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Kaufmann D, 2017, J CEREBR BLOOD F MET, V37, P1748, DOI 10.1177/0271678X16659496; Kroos JM, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00006; Kumagai T, 2011, J CEREBR BLOOD F MET, V31, P580, DOI 10.1038/jcbfm.2010.128; Li BQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086729; Li Bing, 2015, [Quantitative Biology, 定量生物学], V3, P145; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; MARTINSF.H, 1966, J NEUROPHYSIOL, V29, P715, DOI 10.1152/jn.1966.29.4.715; Milakara D, 2017, NEUROIMAGE-CLIN, V16, P524, DOI 10.1016/j.nicl.2017.09.005; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Plumier JCL, 1997, J CEREBR BLOOD F MET, V17, P781; Santos E, 2014, NEUROIMAGE, V99, P244, DOI 10.1016/j.neuroimage.2014.05.021; Stujenske JM, 2015, CELL REP, V12, P525, DOI 10.1016/j.celrep.2015.06.036; Takizawa T, 2020, J CEREBR BLOOD F MET, V40, P1117, DOI 10.1177/0271678X19859381; Tang YT, 2014, J NEUROPHYSIOL, V112, P2572, DOI 10.1152/jn.00205.2014; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932	31	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 30	2020	10	1							12793	10.1038/s41598-020-69669-6			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA4OJ	WOS:000559797100011	32732932	Green Published, gold			2022-02-06	
J	Baseotto, MC; Morris, PG; Gillespie, DC; Trevethan, CT				Baseotto, Monica C.; Morris, Paul G.; Gillespie, David C.; Trevethan, Ceri T.			Post-traumatic growth and value-directed living after acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Post-traumatic growth; Value-directed living; Acquired brain injury; Valued living; Brain injury rehabilitation	HOSPITAL ANXIETY; SCALE; DEPRESSION; LIFE; RELIABILITY; RESILIENCE; INSTRUMENT; VALIDITY; TRAUMA; SAMPLE	Traumatic events can be associated with positive change, termed "post-traumatic growth." Existing resesarch suggests some overlap between post-traumatic growth and value-directed living. This study sought to explore the relationship between post-traumatic growth and value-directed living after acquired brain injury. Self-report questionnaires including the Posttraumatic Growth Inventory, Valued Living Questionnaire, Engaged Living Scale, Valuing Questionnaire, Hospital Anxiety and Depression Scale, World Health Organization Well-Being Index, Brief Resilience Scale, Trauma Screening Questionnaire and Glasgow Outcome Scale were posted to 317 individuals who had experienced a head injury, stroke or subarachnoid haemorrhage in the previous 3-13 years, with a hospital admission of minimum 7 days. Questionnaires were completed by 81 participants. Post-traumatic growth was significantly positively associated with two measures of value-directed living (VLQ,r = .269; VQ,r = .215). Higher levels of value-directed living were significantly associated with increased positive outcomes (wellbeing) and reduced negative outcomes (distress, post-traumatic stress symptoms). There was no significant association between post-traumatic growth and any of these outcomes. The association between post-traumatic growth and value-directed living indicates possible common underlying processes. Value-directed living appears to be a more useful concept, as it was associated with clinically relevant outcomes. It is recommended that value-directed living interventions are considered in brain injury rehabilitation.	[Baseotto, Monica C.] NHS Borders, Melrose, Scotland; [Morris, Paul G.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Gillespie, David C.] NHS Lothian, Edinburgh, Midlothian, Scotland; [Trevethan, Ceri T.] NHS Grampian, Aberdeen, Scotland		Baseotto, MC (corresponding author), NHS Borders, Melrose, Scotland.	monica.baseotto@borders.scot.nhs.uk		Morris, Paul/0000-0001-8467-1669	NHS Education for Scotland	This research was conducted in part fulfilment of the degree of Doctorate in Clinical Psychology at the University of Edinburgh, funded by NHS Education for Scotland. Clinical supervision was provided by the Department of Neuropsychology, NHS Grampian.	Amat S., 2014, ASIAN SOCIAL SCI, V10, P240, DOI [10.5539/ass.v10n18p240, DOI 10.5539/ASS.V10N18P240]; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158; Cohen J., 1988, STAT POWER ANAL BEHA; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cotter D., 2011, THESIS; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Creswell JD, 2005, PSYCHOL SCI, V16, P846, DOI 10.1111/j.1467-9280.2005.01624.x; Donahue JJ, 2017, J CONTEXT BEHAV SCI, V6, P13, DOI 10.1016/j.jcbs.2017.01.003; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Field A, 2013, DISCOVERING STAT USI; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; Gould KR, 2015, BRAIN INJURY, V29, P283, DOI 10.3109/02699052.2014.974671; Grace JJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01162; Graff HJ, 2018, DISABIL REHABIL, V40, P926, DOI 10.1080/09638288.2017.1280542; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; JENNETT B, 1975, LANCET, V1, P480; Jones JM, 2011, PSYCHOL HEALTH, V26, P353, DOI 10.1080/08870440903440699; Joseph S, 2006, J LOSS TRAUMA, V11, P85, DOI 10.1080/15325020500358241; Karagiorgou O, 2018, DISABIL REHABIL, V40, P655, DOI 10.1080/09638288.2016.1274337; Kelly G, 2018, DISABIL REHABIL, V40, P2916, DOI 10.1080/09638288.2017.1363300; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Ownsworth T, 2011, BRAIN IMPAIR, V12, P79; Paez-Blarrina M, 2008, BEHAV RES THER, V46, P84, DOI 10.1016/j.brat.2007.10.008; Pais C, 2019, NEUROPSYCHOL REHABIL, V29, P625, DOI 10.1080/09602011.2017.1313745; Pais-Hrit C, 2020, NEUROPSYCHOL REHABIL, V30, P1205, DOI 10.1080/09602011.2019.1569536; Powell T, 2012, DISABIL REHABIL, V34, P1461, DOI 10.3109/09638288.2011.644384; Serowik KL, 2018, J PSYCHOPATHOL BEHAV, V40, P615, DOI 10.1007/s10862-018-9679-1; Silva J, 2011, BRAIN IMPAIR, V12, P93, DOI 10.1375/brim.12.2.93; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Smith W, 2013, CLASSICS OF INTERNATIONAL RELATIONS: ESSAYS IN CRITICISM AND APPRECIATION, P167; Smout M, 2014, J CONTEXTUAL BEHAV S, V3, P164, DOI 10.1016/j.jcbs.2014.06.001; Snaith RP, 1994, HADS HOSP ANXIETY DE; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; Trompetter HR, 2013, PSYCHOL ASSESSMENT, V25, P1235, DOI 10.1037/a0033813; VanBuskirk K, 2012, COGNITIVE THER RES, V36, P796, DOI 10.1007/s10608-011-9405-8; Weathers FW, 1991, PTSD CHECKLIST CIVIL; Westphal M, 2007, APPL PSYCHOL-INT REV, V56, P417, DOI 10.1111/j.1464-0597.2007.00298.x; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wilson KG, 2010, PSYCHOL REC, V60, P249, DOI 10.1007/BF03395706; World Health Organization, 1998, WHO 5 WELLB IND; Worthington A., 2008, PSYCHOL APPROACHES R; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	51	2	2	2	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2022	32	1					84	103		10.1080/09602011.2020.1798254		JUL 2020	20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	XW1CD	WOS:000552530500001	32715913	Green Submitted			2022-02-06	
J	Brett, BL; Bobholz, SA; Espana, LY; Huber, DL; Mayer, AR; Harezlak, J; Broglio, SP; McAllister, TW; McCrea, MA; Meier, TB; DiFiori, JP; Saykin, AJ; Wu, YC; Nencka, AS; Giza, CC; Goldman, J; Mihalik, JP; Brooks, A; Duma, SM; Rowson, S				Brett, Benjamin L.; Bobholz, Samuel A.; Espana, Lezlie Y.; Huber, Daniel L.; Mayer, Andrew R.; Harezlak, Jaroslaw; Broglio, Steven P.; McAllister, Thomas W.; McCrea, Michael A.; Meier, Timothy B.; DiFiori, John P.; Saykin, Andrew J.; Wu, Yu-Chien; Nencka, Andrew S.; Giza, Christopher C.; Goldman, Joshua; Mihalik, Jason P.; Brooks, Alison; Duma, Stefan M.; Rowson, Steven		CARE Consortium Investigators	Cumulative Effects of Prior Concussion and Primary Sport Participation on Brain Morphometry in Collegiate Athletes: A Study From the NCAA-DoD CARE Consortium	FRONTIERS IN NEUROLOGY			English	Article						concussion and sports; traumatic brain injury; CARE consortium; brain morphometry; contact sport exposure; grey matter (GM)	LIFE COGNITIVE IMPAIRMENT; SMALLER THALAMIC VOLUMES; REPETITIVE HEAD IMPACTS; HIGH-SCHOOL; RECURRENT CONCUSSION; CORTICAL THICKNESS; SENSATION SEEKING; FOOTBALL PLAYERS; 1ST EXPOSURE; BASE-LINE	Prior studies have reported long-term differences in brain structure (brain morphometry) as being associated with cumulative concussion and contact sport participation. There is emerging evidence to suggest that similar effects of prior concussion and contact sport participation on brain morphometry may be present in younger cohorts of active athletes. We investigated the relationship between prior concussion and primary sport participation with subcortical and cortical structures in active collegiate contact sport and non-contact sport athletes. Contact sport athletes (CS;N= 190) and matched non-contact sport athletes (NCS;N= 95) completed baseline clinical testing and participated in up to four serial neuroimaging sessions across a 6-months period. Subcortical and cortical structural metrics were derived using FreeSurfer. Linear mixed-effects (LME) models examined the effects of years of primary sport participation and prior concussion (0, 1+) on brain structure and baseline clinical variables. Athletes with prior concussion across both groups reported significantly more baseline concussion and psychological symptoms (allps < 0.05). The relationship between years of primary sport participation and thalamic volume differed between CS and NCS (p= 0.015), driven by a significant inverse association between primary years of participation and thalamic volume in CS (p= 0.007). Additional analyses limited to CS alone showed that the relationship between years of primary sport participation and dorsal striatal volume was moderated by concussion history (p= 0.042). Finally, CS with prior concussion had larger hippocampal volumes than CS without prior concussion (p= 0.015). Years of contact sport exposure and prior concussion(s) are associated with differences in subcortical volumes in young-adult, active collegiate athletes, consistent with prior literature in retired, primarily symptomatic contact sport athletes. Longitudinal follow-up studies in these athletes are needed to determine clinical significance of current findings.	[Brett, Benjamin L.; Bobholz, Samuel A.; Espana, Lezlie Y.; Huber, Daniel L.; McCrea, Michael A.; Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Mayer, Andrew R.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Harezlak, Jaroslaw] Indiana Univ, Dept Epidemiol & Biostat, Bloomington, IN USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Bloomington, IN USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [DiFiori, John P.] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA; [Saykin, Andrew J.; Wu, Yu-Chien] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Nencka, Andrew S.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Giza, Christopher C.; Goldman, Joshua] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Mihalik, Jason P.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Brooks, Alison] Univ Wisconsin, Madison, WI 53706 USA; [Duma, Stefan M.; Rowson, Steven] Virginia Tech, Blacksburg, VA USA		Meier, TB (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.; Meier, TB (corresponding author), Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA.; Meier, TB (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	tmeiere@mcw.edu	Bobholz, Sam/ABF-1109-2021; Rowson, Steven/B-1270-2012; Harezlak, Jaroslaw/P-8557-2014	Rowson, Steven/0000-0002-3227-0596; Harezlak, Jaroslaw/0000-0002-3070-7686	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS102225, L30 NS113158, R21 NS099789] Funding Source: Medline		Adler CM, 2018, CLIN J SPORT MED, V28, P100, DOI 10.1097/JSM.0000000000000391; Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Bernal-Rusiel JL, 2013, NEUROIMAGE, V81, P358, DOI 10.1016/j.neuroimage.2013.05.049; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bigler ED, 2018, INT J PSYCHOPHYSIOL, V132, P99, DOI 10.1016/j.ijpsycho.2018.07.474; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Buckley PS, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117703944; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Diehm R, 2004, PERS INDIV DIFFER, V36, P663, DOI 10.1016/S0191-8869(03)00124-7; Espana LY, 2017, J NEUROTRAUM, V34, P3143, DOI 10.1089/neu.2017.5002; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hamer M, 2019, NEUROLOGY, V92, pE594, DOI 10.1212/WNL.0000000000006879; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; Lepage C, 2019, BRAIN IMAGING BEHAV, V13, P725, DOI 10.1007/s11682-018-9895-z; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meier TB, 2016, J NEUROTRAUM, V33, P1349, DOI 10.1089/neu.2015.4118; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Misquitta K, 2018, NEUROIMAGE-CLIN, V19, P551, DOI 10.1016/j.nicl.2018.05.014; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; POTGIETER J, 1990, PERCEPT MOTOR SKILL, V71, P1203, DOI 10.2466/PMS.71.7.1203-1206; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Ritchie SJ, 2017, BRAIN STRUCT FUNCT, V222, P3477, DOI 10.1007/s00429-017-1414-2; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Shore J, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-0233-8; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Terry DP, 2018, BRAIN IMAGING BEHAV, V12, P631, DOI 10.1007/s11682-017-9719-6; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12; Wojtowicz M, 2018, NEUROIMAGE-CLIN, V18, P377, DOI 10.1016/j.nicl.2018.01.005; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zivadinov R, 2018, J HEAD TRAUMA REHAB, V33, pE24, DOI 10.1097/HTR.0000000000000422	55	2	2	5	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 28	2020	11								673	10.3389/fneur.2020.00673			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NC4QB	WOS:000561196500001	32849177	Green Published, gold			2022-02-06	
J	Gillie, BL; Fazio-Sumrok, V; Eagle, SR; Kegel, N; Trbovich, AM; Collins, MW; Kontos, AP				Gillie, Brandon L.; Fazio-Sumrok, Vanessa; Eagle, Shawn R.; Kegel, Nathan; Trbovich, Alicia M.; Collins, Michael W.; Kontos, Anthony P.			Clinical predictors of post-injury anxiety in adolescent patients following concussion	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article; Early Access						Adolescents; anxiety; concussion; mild traumatic brain injury; panic disorder	SPORT-RELATED CONCUSSION; RISK-FACTORS; CHILDREN; DISORDERS; RELIABILITY; SENSITIVITY; STATEMENT; RECOVERY; OUTCOMES; SCREEN	The purpose of the current study was to examine predictors (e.g., pre-injury anxiety and sub-types, concussion symptom severity, neurocognitive performance, and vestibular/ocular-motor impairment) of post-injury anxiety scores following concussion among youth aged 10-18 years. This observational cohort study enrolled patients (n = 129) within 30 days of a diagnosed concussion. Patients completed Screening for Child Anxiety Related Disorders-Child Reports (SCARED-C), Generalized Anxiety Disorder-7 (GAD-7), Post-concussion Symptom Scale, neurocognitive testing, and Vestibular-Ocular Motor Screening. Logistic regression analyses were conducted to evaluate the role of risk factors and clinical outcomes as predictors of mild (GAD-7 > 5) and moderate levels (GAD-7 > 10) of post-injury anxiety. Twenty-two percent (n = 28) of patients reported clinical levels of pre-injury anxiety, and 13% (n = 17) reported clinical levels of post-injury anxiety. The logistic regression model predicting mild or greater anxiety was significant (R-2= 31.7%;p < 0.001) and supported pre-injury panic symptoms (OR = 1.38) and total symptom severity (OR = 1.04) as the most robust predictors. The logistic regression model predicting clinical anxiety was significant (R-2= 47.2%;p < 0.001) and supported non-SRC injury type (OR = 9.48), vestibular dysfunction (OR = 1.74) and pre-injury panic symptoms (OR = 1.57) as the most robust predictors. Results suggest that clinicians should employ measures of pre-injury and post-injury emotional functioning when evaluating and treating concussion among adolescents. Moreover, these results highlight the importance of assessing different types of pre-injury and post-injury anxiety in the context of concussion management.	[Gillie, Brandon L.; Fazio-Sumrok, Vanessa; Eagle, Shawn R.; Kegel, Nathan; Trbovich, Alicia M.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3850 S Water St, Pittsburgh, PA 15203 USA		Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3850 S Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu	Eagle, Shawn/ABG-1388-2020	Eagle, Shawn/0000-0001-6767-1042			Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Balaban CD, 2001, J ANXIETY DISORD, V15, P53, DOI 10.1016/S0887-6185(00)00042-6; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Birmaher B, 1999, J AM ACAD CHILD PSY, V38, P1230, DOI 10.1097/00004583-199910000-00011; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Craske MG, 2005, ANNU REV CLIN PSYCHO, V1, P197, DOI 10.1146/annurev.clinpsy.1.102803.143857; Datta S, 2019, NEUROLOGY, V93, pS32, DOI 10.1212/01.wnl.0000581148.80387.31; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Furman JM, 2006, J VESTIBUL RES-EQUIL, V16, P209; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Guerriero RM, 2018, J CHILD NEUROL, V33, P168, DOI 10.1177/0883073817749655; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kleffelgaard I, 2017, BRAIN INJURY, V31, P1436, DOI 10.1080/02699052.2017.1377348; Kontos A. P., 2016, MENTAL HLTH IMPLICAT; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Lovell MR, 2006, J ATHL TRAINING, V41, P137; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Rieger B, 2019, J INT NEUROPSYCH SOC, V25, P777, DOI 10.1017/S1355617719000468; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stephenson-Brown K, 2019, ARCH CLIN NEUROPSYCH, V34, P755, DOI 10.1093/arclin/acz026.25; Tarkenton T, 2017, ARCH CLIN NEUROPSYCH, V32, P729, DOI 10.1093/arclin/acx076.156; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba	32	2	3	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child												10.1080/21622965.2020.1799790		JUL 2020	7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	MR2KG	WOS:000553417900001	32723100				2022-02-06	
J	Brickell, TA; French, LM; Lippa, SM; Wright, MM; Lange, RT				Brickell, Tracey A.; French, Louis M.; Lippa, Sara M.; Wright, Megan M.; Lange, Rael T.			Caring for a service member or Veteran following traumatic brain injury influences caregiver mental health	MILITARY PSYCHOLOGY			English	Article						Caregiver; service Member Veteran; military; traumatic Brain Injury; post-Traumatic Stress	CENTERED PREVENTIVE INTERVENTION; SOCIAL SUPPORT; FAMILIES; TBI; APPRAISAL; PROGRAM; BURDEN; RISK	This study examined factors related to poor mental health in caregivers assisting service members and Veterans (SMV) following traumatic brain injury (TBI). Participants were 201 military caregivers (96.0% female; Age: M = 39.2 years, SD = 10.2) of SMVs following a mild, moderate, severe, or penetrating TBI. The SF-36v2 Health Survey, Caregiver Appraisal Scale, Mayo-Portland Adaptability Inventory-4, and Caregiver Questionnaire were completed. Caregivers were divided into two mental health groups: Poor Mental Health (n = 108) and Good Mental Health (n = 93). Factors related to poor caregiver mental health were worse general health and stress appraisal, less personal time, unmet needs, and greater financial and employment strain. Factors also related to poor caregiver mental health included assisting a SMV who had sustained a mild TBI, did not have significant hospital care, had post-traumatic stress disorder, depression, and/or anxiety, was experiencing greater functional disability, and was experiencing physical expressions of irritability, anger, and aggression (all p's<.05; d =.29 to d =.64; OR = 1.911 to OR = 4.984). For many military caregivers, poor mental health may be related to the SMVs ongoing comorbid mental health symptoms and less so neurological impairment related to the brain injury. TBI treatment programs require a holistic approach that addresses the behavioral health concerns of both SMVs and their caregivers.	[Brickell, Tracey A.; French, Louis M.; Lippa, Sara M.; Wright, Megan M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 51,Room 1502B,4954 N Palmer Rd, Bethesda, MD 20889 USA; [Brickell, Tracey A.; French, Louis M.; Lippa, Sara M.; Wright, Megan M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Fac Med, Vancouver, BC, Canada		Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 51,Room 1502B,4954 N Palmer Rd, Bethesda, MD 20889 USA.	tbrickell@dvbic.org		french, louis/0000-0002-9451-0604	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This work was supported by the Defense and Veterans Brain Injury Center [NA].	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; Beardslee W, 2011, PREV SCI, V12, P339, DOI 10.1007/s11121-011-0234-5; Brickell TA, 2019, REHABIL PSYCHOL, V64, P72, DOI 10.1037/rep0000249; Brickell TA, 2018, BRAIN INJURY, V32, P1541, DOI 10.1080/02699052.2018.1503328; Brickell TA, 2018, J HEAD TRAUMA REHAB, V33, P133, DOI 10.1097/HTR.0000000000000384; Defense and Veterans Brain Injury Center D., 2018, DOD NUMB TRAUM BRAIN; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; French L. M., 2012, NEUROPSYCHOLOGICAL A, P127; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Griffin J.M., 2014, MILITARY DEPLOYMENT, P259, DOI [10.1007/978-1-4614-8712-8_14, DOI 10.1007/978-1-4614-8712-8_14]; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Iverson G. L., 2016, BRAIN INJURY MED PRI, P470; Iverson G. L., 2016, MILD TRAUMATIC BRAIN; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Lange R. T., J TRAUMATIC STRESS; Lange R. T., 2019, NEUROPSYCHOLOGICAL R; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Lester P, 2016, J AM ACAD CHILD PSY, V55, P14, DOI 10.1016/j.jaac.2015.10.009; Lester P, 2012, AM J PUBLIC HEALTH, V102, pS48, DOI 10.2105/AJPH.2010.300088; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Maruish M.E., 2017, ASSESSMENT HLTH STAT; Monk JK, 2017, J MARITAL FAM THER, V43, P448, DOI 10.1111/jmft.12230; Moriarty H, 2018, J FAM NURS, V24, P184, DOI 10.1177/1074840718773470; Ramchand R., 2014, HIDDEN HEROES AM MIL; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Saltzman WR, 2016, FAM PROCESS, V55, P633, DOI 10.1111/famp.12238; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Stevens LF, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/185941; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Tanielian T, 2013, MILITARY CAREGIVERS; Turner-Bowker, 2007, USERS MANUAL SF 36V2; US Department of Defense, 2019, CONFL CAS; Van Houtven CH., 2016, SHORT TERM IMPACTS V; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	43	2	2	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.	JUL 3	2020	32	4					341	351		10.1080/08995605.2020.1754149		JUL 2020	11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	NG8ZW	WOS:000556767700001					2022-02-06	
J	Tu, YK; Hsueh, YH				Tu, Yuan-Kun; Hsueh, Yu-Huan			Extracellular vesicles isolated from human olfactory ensheathing cells enhance the viability of neural progenitor cells	NEUROLOGICAL RESEARCH			English	Article						Extracellular vesicle; exosome; olfactory ensheathing cell; neural progenitor cell; proliferation; cytotoxicity; neurogenesis	SPINAL-CORD-INJURY; AXONAL REGENERATION; FUNCTIONAL RECOVERY; IN-VITRO; TRANSPLANTATION; EXPRESSION; PROMOTE; REMYELINATION; ANGIOGENESIS; APOPTOSIS	Objective Acquired neurological diseases such as severe traumatic brain or spinal cord injury (SCI) cause irreversible disability. Olfactory ensheathing cell (OEC) transplantation has been trialed as a promising SCI treatment. Extracellular vesicles (EVs), which regulate cell-cell interactions, have recently garnered extensive research interests and emerged as a non-cell-based therapy in neurological disorders, including in SCI animal models. However, there have been no reports of human OEC-EVs and their beneficial effects on neuron regeneration. Here, we investigated the effects of EVs isolated from human OEC on the viability of neuronal cells. Methods EVs were isolated from primary human OECs (hOECs) by serial ultracentrifugation. The hOEC-EVs were characterized by transmission electron microscopy, western blotting, and nanoparticle tracking analyses. We conducted CCK8 and lactate dehydrogenase assays to assess the cell proliferation and cytotoxicity of neural progenitor cells (NPCs) exposed to hOEC-EVs.Tert-butyl hydroperoxide (t-BHP) was utilized to mimic oxidative stress-induced cytotoxicity in NPCs. Results The modal diameter of hOEC-derived EVs was 113.2 nm. Expressions of EV markers such as CD9, CD63, and CD81 were detected by western blotting. hOEC-derived EVs enhanced the proliferation of NPCs and ameliorated cell cytotoxicity mediated by t-BHP. Discussion Our findings reveal a role for hOEC-derived EVs in NPC proliferation and oxidative stress-induced neuronal toxicity model. These results may be useful for developing non-cell therapy OEC-EV-based treatment in acquired nervous system disease.	[Tu, Yuan-Kun; Hsueh, Yu-Huan] I Shou Univ, E Da Hosp, Dept Orthoped Surg, Kaohsiung 824, Taiwan		Tu, YK (corresponding author), I Shou Univ, E Da Hosp, Dept Orthoped Surg, Kaohsiung 824, Taiwan.	ed100130@edah.org.tw					Abbaszadeh HA, 2018, ANAT CELL BIOL, V51, P180, DOI 10.5115/acb.2018.51.3.180; Akiyama Y, 2004, NEURON GLIA BIOL, V1, P47, DOI 10.1017/s1740925x04000079; Lopez-Verrilli MA, 2013, GLIA, V61, P1795, DOI 10.1002/glia.22558; Assinck P, 2017, NAT NEUROSCI, V20, P637, DOI 10.1038/nn.4541; Barber P C, 1982, Bibl Anat, P12; Bavisotto CC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020434; Bunggulawa EJ, 2018, J NANOBIOTECHNOL, V16, DOI 10.1186/s12951-018-0403-9; Chehrehasa F, 2010, MOL CELL NEUROSCI, V45, P277, DOI 10.1016/j.mcn.2010.07.002; Chuah MI, 2011, EXP NEUROL, V229, P46, DOI 10.1016/j.expneurol.2010.08.012; Chung RS, 2004, CELL MOL LIFE SCI, V61, P1238, DOI 10.1007/s00018-004-4026-y; D'Aiuto L, 2014, ORGANOGENESIS, V10, P365, DOI 10.1080/15476278.2015.1011921; Deng JH, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/5653787; DEVON R, 1992, BRAIN RES, V589, P175; DOUCETTE JR, 1984, ANAT REC, V210, P385, DOI 10.1002/ar.1092100214; Drommelschmidt K, 2017, BRAIN BEHAV IMMUN, V60, P220, DOI 10.1016/j.bbi.2016.11.011; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Franceschini IA, 1996, DEV BIOL, V173, P327, DOI 10.1006/dbio.1996.0027; Franklin RJM, 1996, GLIA, V17, P217, DOI 10.1002/(SICI)1098-1136(199607)17:3<217::AID-GLIA4>3.0.CO;2-Y; Fruhbeis C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00182; Guerout N, 2010, GLIA, V58, P1570, DOI 10.1002/glia.21030; Guo SC, 2017, THERANOSTICS, V7, P81, DOI 10.7150/thno.16803; Hagen EM, 2015, WORLD J ORTHOP, V6, P17, DOI 10.5312/wjo.v6.i1.17; Hashemi M, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2275; HASHIMOTO T, 1991, EUR J PHARMACOL, V203, P25, DOI 10.1016/0014-2999(91)90786-P; Hassannejad Z, 2018, IRAN J BASIC MED SCI, V21, P546, DOI 10.22038/IJBMS.2018.24239.6052; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Higginson JR, 2011, EXP NEUROL, V229, P2, DOI 10.1016/j.expneurol.2010.08.020; Hu GW, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt546; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Kato T, 2000, GLIA, V30, P209, DOI 10.1002/(SICI)1098-1136(200005)30:3<209::AID-GLIA1>3.0.CO;2-8; Kumagai G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007706; Lee SS, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0401-z; Lipson AC, 2003, EXP NEUROL, V180, P167, DOI 10.1016/S0014-4886(02)00058-4; Liu W, 2019, J NEUROTRAUM, V36, P469, DOI 10.1089/neu.2018.5835; Lu P, 2019, STEM CELL REP, V13, P105, DOI 10.1016/j.stemcr.2019.05.011; Ma YZ, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0418-3; Marcal H, 2008, J CHEM TECHNOL BIOT, V83, P473, DOI 10.1002/jctb.1900; Murphy DE, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0223-5; Nagoshi N, 2018, STEM CELL TRANSL MED, V7, P806, DOI 10.1002/sctm.17-0269; Nash HH, 2002, J NEUROSCI, V22, P7111; Nazareth L, 2015, J COMP NEUROL, V523, P479, DOI 10.1002/cne.23694; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Pei XX, 2019, EXP CELL RES, V382, DOI 10.1016/j.yexcr.2019.06.019; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Qi X, 2016, INT J BIOL SCI, V12, P836, DOI 10.7150/ijbs.14809; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; Ratajczak MZ, 2014, POL ARCH MED WEWN, V124, P417, DOI 10.20452/pamw.2355; Reza-Zaldivar EE, 2019, NEURAL REGEN RES, V14, P1626, DOI 10.4103/1673-5374.255978; Rong YL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1571-8; Samanta S, 2018, ACTA PHARMACOL SIN, V39, P501, DOI 10.1038/aps.2017.162; Sezer N, 2015, WORLD J ORTHOP, V6, P24, DOI 10.5312/wjo.v6.i1.24; Shabbir A, 2015, STEM CELLS DEV, V24, P1635, DOI 10.1089/scd.2014.0316; Sharma P, 2019, P NATL ACAD SCI USA, V116, P16086, DOI 10.1073/pnas.1902513116; Tao SC, 2017, THERANOSTICS, V7, P733, DOI 10.7150/thno.17450; Tao SC, 2017, THERANOSTICS, V7, P180, DOI 10.7150/thno.17133; Tennent R, 1996, DEV BRAIN RES, V95, P135, DOI 10.1016/0165-3806(96)00091-0; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Wewetzer K, 2001, NEUROSCI LETT, V306, P165, DOI 10.1016/S0304-3940(01)01891-2; Woodhall E, 2001, MOL BRAIN RES, V88, P203, DOI 10.1016/S0169-328X(01)00044-4; Xia B, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00548; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5; Yokota K, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-018-0422-3; Yuan XC, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00319; Zhang W, 2019, EXP EYE RES, V189, DOI 10.1016/j.exer.2019.107813	64	2	3	1	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	NOV 1	2020	42	11					959	967		10.1080/01616412.2020.1794371		JUL 2020	9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OP1ZK	WOS:000551318200001	32700620				2022-02-06	
J	Miki, K; Nonaka, M; Kobayashi, H; Horio, Y; Abe, H; Morishita, T; Iwaasa, M; Inoue, T				Miki, Koichi; Nonaka, Masani; Kobayashi, Hiromasa; Horio, Yoshinobu; Abe, Hiroshi; Morishita, Takashi; Iwaasa, Mitsutoshi; Inoue, Tooru			Optimal surgical indications of endoscopic surgery for traumatic acute subdural hematoma in elderly patients based on a single-institution experience	NEUROSURGICAL REVIEW			English	Article						Acute subdural hematoma; Traumatic brain injury; Endoscopic surgery; Elderly patient	CRANIOTOMY; HEMORRHAGE; EVACUATION; CRANIECTOMY; MORTALITY; RISK	Recently, treatment of acute subdural hematoma (ASDH) by minimally invasive surgery with endoscopy has been successfully demonstrated. However, few case series are available on this procedure for ASDH, and the surgical indication has not been established. We retrospectively analyzed the data of patients (n = 26) aged 65 years or older who underwent endoscopic surgery (ES) for ASDH at our institution between January 2011 and March 2019. We then evaluated the surgical outcomes and procedure-related complications in patients who underwent ES. The mean hematoma reduction rate was over 90%. Percentage of favorable outcomes at discharge was 69.2% in ES-treated patients. The presence of a skull fracture, subarachnoid hemorrhage, midline shift/subdural hematoma thickness ratio > 1.0, and early surgery were associated with postoperative IPHs in patients who underwent ES or conventional surgery for ASDH. The present study revealed that ES for elderly patients with ASDH is likely to be an efficient and safe procedure when patients are selected appropriately. However, ES is not recommended in patients with significant IPHs on initial CT scan. Additionally, ES should be carefully considered in cases with the factors, where IPHs may progress following surgery.	[Miki, Koichi; Nonaka, Masani; Kobayashi, Hiromasa; Horio, Yoshinobu; Abe, Hiroshi; Morishita, Takashi; Inoue, Tooru] Fukuoka Univ, Dept Neurosurg, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan; [Iwaasa, Mitsutoshi] Fukuoka Univ, Fukuoka Univ Hosp & Sch Med, Fac Med, Dept Emergency & Crit Care, Fukuoka, Japan		Nonaka, M (corresponding author), Fukuoka Univ, Dept Neurosurg, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	mmnona@hotmail.com	Horio, Yoshinobu/AAY-2941-2021	Horio, Yoshinobu/0000-0002-7891-1344	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; St. Luke Life Science Institute; Nakatomi Foundation; Takeda Science FoundationTakeda Science Foundation (TSF); Uehara Memorial FoundationUehara Memorial Foundation; Central Research Institute of Fukuoka University; Clinical Research Promotion Foundation Japan; Japan Agency for Medical Research and DevelopmentJapan Agency for Medical Research and Development (AMED)	Dr. T. Morishita received grant support from the Japan Society for the Promotion of Science, St. Luke Life Science Institute, Nakatomi Foundation, Takeda Science Foundation, Uehara Memorial Foundation, and Central Research Institute of Fukuoka University. He also received honoraria from Boston Scientific and Medtronic as a consultant within the past 12 months. Dr. T. Inoue received grant support from the Clinical Research Promotion Foundation Japan and Japan Agency for Medical Research and Development.	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Baucher G, 2019, WORLD NEUROSURG, V126, pE944, DOI 10.1016/j.wneu.2019.02.194; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; Cabinet Office Japan, 2019, CAB OFF JAP ANN REP; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Codd PJ, 2013, J CLIN NEUROSCI, V20, P1751, DOI 10.1016/j.jocn.2013.02.019; Faried A, 2019, CHIN J TRAUMATOL, V22, P286, DOI 10.1016/j.cjtee.2019.05.006; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; HIRSH LF, 1979, NEUROSURGERY, V5, P653, DOI 10.1227/00006123-197912000-00001; Ichimura S, 2019, J CLIN NEUROSCI, V61, P311, DOI 10.1016/j.jocn.2018.11.043; KARAKHAN VB, 1994, ACT NEUR S, V61, P84; Kawasaki T, 2018, ACTA NEUROCHIR, V160, P241, DOI 10.1007/s00701-017-3399-2; M W, 1960, LANCET, V1, P1365; Miki Koichi, 2016, No Shinkei Geka, V44, P455, DOI 10.11477/mf.1436203310; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; Phan K, 2017, WORLD NEUROSURG, V101, P677, DOI 10.1016/j.wneu.2017.03.024; SHENKIN HA, 1982, J NEUROSURG, V57, P254, DOI 10.3171/jns.1982.57.2.0254; Shibahashi K, 2020, J NEUROSURG, V133, P504, DOI 10.3171/2019.4.JNS182660; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sucu HK, 2005, STROKE, V36, P998, DOI 10.1161/01.STR.0000162714.46038.0f; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; Ueba T, 2015, J NEUROL SURG PART A, V76, P63, DOI 10.1055/s-0033-1358606; van Gent JAN, 2020, ACTA NEUROCHIR, V162, P329, DOI 10.1007/s00701-019-04111-z; Yokosuka K, 2015, J NEUROSURG, V123, P1065, DOI 10.3171/2014.10.JNS14915	27	2	2	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	JUN	2021	44	3					1635	1643		10.1007/s10143-020-01351-x		JUL 2020	9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SC5SA	WOS:000551406700001	32700161				2022-02-06	
J	Quilico, EL; Harvey, WJ; Caron, JG; Bloom, GA				Quilico, Enrico L.; Harvey, William J.; Caron, Jeffrey G.; Bloom, Gordon A.			Interpretative Phenomenological Analysis of Community Exercise Experiences after Severe Traumatic Brain Injury	QUALITATIVE RESEARCH IN SPORT EXERCISE AND HEALTH			English	Article						Traumatic brain injury; community-based exercise; interpretative phenomenological analysis; participation; social reintegration	PHYSICAL-ACTIVITY EXPERIENCES; HEALTH; IMPACT; SPORT; PARTICIPATION; INDIVIDUALS; NARRATIVES; PROGRAM; GROWTH; ADULTS	Traumatic brain injury (TBI) is a major public health concern due to its growing incidence and resulting long-term or lifelong impairments. Exercise is a non-stigmatising approach proposed to alleviate the physical, cognitive, social, and emotional consequences after TBI. We used Interpretative Phenomenological Analysis (IPA) to explore the exercise experiences of seven individuals living with a severe TBI, 5-31 years after rehabilitation. We engaged in semi-structured interviews with the participants and we used IPA to explore their post-TBI exercise experiences outside of the clinical setting. Based on our analysis, we found three themes encompassed how TBI-related impairments affected the participants' abilities, self-perceptions, and perspectives on life. The participants also identified optimal environments for exercise participation, as well as perceived physical, social, and psychological effects of exercise. Future recommendations include developing community-based exercise programmes to assist with social reintegration and exploring the full range of benefits obtainable from exercise after a TBI.	[Quilico, Enrico L.] Univ Toronto, Rehabil Sci Inst, Toronto, ON M5G 1V7, Canada; [Harvey, William J.; Bloom, Gordon A.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Harvey, William J.] Douglas Mental Hlth Univ Inst, Clin Res Div, Montreal, PQ, Canada; [Caron, Jeffrey G.] Univ Montreal, Sch Kinesiol & Phys Act Sci, Montreal, PQ, Canada		Quilico, EL (corresponding author), Univ Toronto, Rehabil Sci Inst, Toronto, ON M5G 1V7, Canada.	enrico.quilico@mail.utoronto.ca		Caron, Jeff/0000-0002-4972-2704; Quilico, Enrico/0000-0002-1958-0303			Allan V, 2018, PSYCHOL SPORT EXERC, V37, P170, DOI 10.1016/j.psychsport.2017.10.004; Analytis P, 2018, BRAIN INJURY, V32, P209, DOI 10.1080/02699052.2017.1395479; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Burke SM, 2010, QUAL RES SPORT EXERC, V2, P1, DOI 10.1080/19398440903510137; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Day MC, 2016, PSYCHOL SPORT EXERC, V22, P131, DOI 10.1016/j.psychsport.2015.07.004; Day MC, 2013, DISABIL REHABIL, V35, P2064, DOI 10.3109/09638288.2013.805822; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Driver S, 2018, J HEAD TRAUMA REHAB, V33, pE49, DOI 10.1097/HTR.0000000000000372; Driver S, 2012, BRAIN INJURY, V26, P1482, DOI 10.3109/02699052.2012.694568; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; Fogelman D, 2012, PM&R, V4, P908, DOI 10.1016/j.pmrj.2012.09.028; Frank, 1995, WOUNDED STORYTELLER; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hammersley M., 2007, ETHNOGRAPHY PRINCIPL; Hassett L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub3; Hassett LM, 2011, BRAIN INJURY, V25, P698, DOI 10.3109/02699052.2011.579934; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Howes H, 2005, BRAIN INJURY, V19, P135, DOI 10.1080/02699050410001720077; Jaarsma EA, 2019, ADAPT PHYS ACT Q, V36, P185, DOI 10.1123/apaq.2018-0020; Joseph S, 2012, WHAT DOESNT KILL US; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Peacock S, 2018, PSYCHOL SPORT EXERC, V35, P151, DOI 10.1016/j.psychsport.2017.12.003; Pollard C, 2007, BRIT J HEALTH PSYCH, V12, P347, DOI 10.1348/135910707X197046; Public Health Agency of Canada National Population Health Study of Neurological Conditions (Canada)., 2014, MAPP CONN UND NEUR C; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Rimmer JH, 2012, PM&R, V4, P857, DOI 10.1016/j.pmrj.2012.08.008; Self M, 2013, ADAPT PHYS ACT Q, V30, P20, DOI 10.1123/apaq.30.1.20; Silver J.M., 2018, TXB TRAUMATIC BRAIN; Smith B, 2009, PSYCHOL SPORT EXERC, V10, P279, DOI 10.1016/j.psychsport.2008.07.012; Smith B, 2018, INT REV SPORT EXER P, V11, P101, DOI [10.1080/1750984X.2017.1317357, 10.1080/1750984x.2017.1317357, 10.1109/ACSD.2018.000-4]; Smith B, 2021, DISABIL REHABIL, V43, P3427, DOI 10.1080/09638288.2019.1679896; Smith B, 2013, HEALTH PSYCHOL, V32, P110, DOI 10.1037/a0029187; Smith J.A., 2009, INTERPRETATIVE PHENO; Smith J. A., 2016, ROUTLEDGE HDB QUALIT, P241; Smith L, 2016, DIXIE LIMITED: WRITERS ON WILLIAM FAULKNER AND HIS INFLUENCE, P282; Sparkes AC., 2014, QUALITATIVE RES METH; Sparkes AC, 2011, SPORT EDUC SOC, V16, P357, DOI 10.1080/13573322.2011.565967; Syed UE, 2021, DISABIL REHABIL-ASSI, V16, P332, DOI 10.1080/17483107.2019.1679266; Tawse H, 2012, QUAL RES SPORT EXERC, V4, P206, DOI 10.1080/2159676X.2012.685104; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Vanderbeken I, 2017, NEUROREHABILITATION, V40, P33, DOI 10.3233/NRE-161388; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302	56	2	2	3	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2159-676X	2159-6778		QUAL RES SPORT EXERC	Qual. Res. Sport Exerc. Health	SEP 3	2021	13	5					800	815		10.1080/2159676X.2020.1778064		JUL 2020	16	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	US3HB	WOS:000555053100001					2022-02-06	
J	Soltani, F; Salari, A; Javaherforooshzadeh, F; Nassajjian, N; Kalantari, F				Soltani, Farhad; Salari, Amir; Javaherforooshzadeh, Fatemeh; Nassajjian, Nozar; Kalantari, Farahmand			The effect of melatonin on reduction in the need for sedative agents and duration of mechanical ventilation in traumatic intracranial hemorrhage patients: a randomized controlled trial	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Melatonin; Midazolam; Fentanyl; Morphine sulfate; Sedation; Intensive care unit; Critically ill	INTRACEREBRAL HEMORRHAGE; CIRCADIAN-RHYTHM; BRAIN-INJURY; ANTIOXIDANT; STROKE; DELIRIUM	Purpose This study aimed to determine the effect of exogenous melatonin on the number of sedative drugs and the duration of mechanical ventilation in traumatic intracranial hemorrhage patients in ICU. Methods This double-blind randomized clinical trial study was conducted in the ICU wards of Golestan Hospital, Ahvaz, Iran, from September 2017 to March 2018. In this study, 52 patients with intracerebral hemorrhage were selected by convenient sampling (26 patients in each group) and were randomly assigned to two groups of melatonin and control. Sedation and pain management package was applied to both groups. Outcomes: Amount of the sedative and opioid drug; mechanical ventilation time; ICU staying time; Glasgow Coma Score; hemodynamic parameters. Results There was no significant difference between them in terms of demographic characteristics. Cumulative doses of morphine and mechanical ventilation time were significant in two groups. (P < 0.05) The mean length of ICU staying was not significant. Glasgow Coma Score on the 6th day was significant in two groups (P < 0.05). Diastolic blood pressure was significant between groups (P < 0.001). Conclusion This study presented that morphine consumption and mechanical ventilation time were significantly lower in the melatonin group than in the control. Also, rise in GCS in the melatonin group was faster in the melatonin group than in the control. The use of melatonin can be recommended for patients with ICH in the ICU for better outcomes.	[Soltani, Farhad; Salari, Amir; Javaherforooshzadeh, Fatemeh; Nassajjian, Nozar; Kalantari, Farahmand] Ahvaz Jundishapur Univ Med Sci, Ahvaz Anesthesiol & Pain Res Ctr, Dept Anesthesia, Ahvaz, Iran		Javaherforooshzadeh, F (corresponding author), Ahvaz Jundishapur Univ Med Sci, Ahvaz Anesthesiol & Pain Res Ctr, Dept Anesthesia, Ahvaz, Iran.	f_javaherforoosh@yahoo.com			Ahvaz Jundishapur University of Medical Sciences [PAIN-9611 IR.AJUMS.REC.1396.949]	Financial support for this study was provided by Ahvaz Jundishapur University of Medical Sciences (Grant No: PAIN-9611 IR.AJUMS.REC.1396.949).	Andrabi SS, 2015, ADV PHARM SCI, V2015, P11; Baid H, 2016, CRIT CARE NURS CLIN, V28, P451, DOI 10.1016/j.cnc.2016.07.005; Barlow KM, 2019, J NEUROTRAUM, V36, P523, DOI 10.1089/neu.2018.5752; de Jonghe A, 2010, INT J GERIATR PSYCH, V25, P1201, DOI 10.1002/gps.2454; Dessap AM, 2015, CHEST, V148, P1231, DOI 10.1378/chest.15-0525; Dianatkhah M, 2017, J RES PHARM PRACT, V6, P173, DOI 10.4103/jrpp.JRPP_17_49; Dianatkhah Mehrnoush, 2015, J Tehran Heart Cent, V10, P122; Frisk U, 2004, CLIN SCI, V107, P47, DOI 10.1042/CS20030374; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Guo ZN, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01146; HALVANI A, 2012, EUR RESPIR J S56, V40, pP3477; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hochart A, 2017, EMC NEUROLOGIA, V17, P1; Hsiung NH, 2016, J PAIN RES, V9, P661, DOI 10.2147/JPR.S91036; Ismail SA, 2009, ANESTH ANALG, V108, P1146, DOI 10.1213/ane.0b013e3181907ebe; Jarman AM, 2013, ANAESTH INTENS CARE, V41, P311, DOI 10.1177/0310057X1304100306; Javaherforooshzadeh F, 2018, ANESTH PAIN MED, V8; Javaherforooshzadeh F, 2018, ANESTH PAIN MED, V8; Lekic T, 2010, J NEUROTRAUM, V27, P627, DOI 10.1089/neu.2009.1163; Li SL, 2019, INT J CLIN EXP PATHO, V12, P909; Maitra Souvik, 2013, Saudi J Anaesth, V7, P315, DOI 10.4103/1658-354X.115316; Mistraletti G, 2015, MINERVA ANESTESIOL, V81, P1298; Mistraletti G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040759; Osier N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051539; Qu J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2592935; RIKER RR, 2005, PHARMACOTHERAPY S 2, V25, pS, DOI DOI 10.1592/PHCO.2005.25.5_PART_2.8S; Rojas H, 2008, ANTIOXIDANT EFFECTS, P19; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Silva Y, 2005, STROKE, V36, P86, DOI 10.1161/01.STR.0000149615.51204.0b; Tordjman S, 2017, CURR NEUROPHARMACOL, V15, P434, DOI 10.2174/1570159X14666161228122115; Tsze DS, 2018, ANN EMERG MED, V71, P691, DOI 10.1016/j.annemergmed.2017.09.009; Ward D, 2016, CRIT CARE NURS CLIN, V28, P499, DOI 10.1016/j.cnc.2016.07.008; Watson N, 2016, CELL TRANSPLANT, V25, P883, DOI 10.3727/096368915X689749	33	2	2	1	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-020-01449-3		JUL 2020	7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	MO2MA	WOS:000551365600001	32699918	Green Published, Bronze			2022-02-06	
J	Henry, RJ; Meadows, VE; Stoica, BA; Faden, AI; Loane, DJ				Henry, Rebecca J.; Meadows, Victoria E.; Stoica, Bogdan A.; Faden, Alan I.; Loane, David J.			Longitudinal Assessment of Sensorimotor Function after Controlled Cortical Impact in Mice: Comparison of Beamwalk, Rotarod, and Automated Gait Analysis Tests	JOURNAL OF NEUROTRAUMA			English	Article						beamwalk; CatWalk; gait; neurobehavioral tests; rotarod; sensorimotor; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SPINAL-CORD; MOTOR; NEUROINFLAMMATION; NEURODEGENERATION; IMPAIRMENT; BALANCE; WALKING	Traumatic brain injury (TBI) patients are reported to experience long-term sensorimotor dysfunction, with gait deficits evident up to 2 years after the initial brain trauma. Experimental TBI including rodent models of penetrating ballistic-like brain injury and severe controlled cortical impact (CCI) can induce impairments in static and dynamic gait parameters. It is reported that the majority of deficits in gait-related parameters occur during the acute phase post-injury, as functional outcomes return toward baseline levels at chronic time points. In the present study, we carried out a longitudinal analysis of static, temporal and dynamic gait patterns following moderate-level CCI in adult male C57Bl/6J mice using the automated gait analysis apparatus, CatWalk. For comparison, we also performed longitudinal assessment of fine-motor coordination and function in CCI mice using more traditional sensorimotor behavioral tasks such as the beamwalk and accelerating rotarod tasks. We determined that longitudinal CatWalk analysis did not detect TBI-induced deficits in static, temporal, or dynamic gait parameters at acute or chronic time points. In contrast, the rotarod and beamwalk tasks showed that CCI mice had significant motor function impairments as demonstrated by deficits in balance and fine-motor coordination through 28 days post-injury. Stereological analysis confirmed that CCI produced a significant lesion in the parietal cortex at 28 days post-injury. Overall, these findings demonstrate that CatWalk analysis of gait parameters is not useful for assessment of long-term sensorimotor dysfunction after CCI, and that more traditional neurobehavioral tests should be used to quantify acute and chronic deficits in sensorimotor function.	[Henry, Rebecca J.; Meadows, Victoria E.; Stoica, Bogdan A.; Faden, Alan I.; Loane, David J.] Univ Maryland, Sch Med, Dept Anesthesiol, 655 West Baltimore St BRB,Room 6-013, Baltimore, MD 21201 USA; [Henry, Rebecca J.; Meadows, Victoria E.; Stoica, Bogdan A.; Faden, Alan I.; Loane, David J.] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA; [Loane, David J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland		Henry, RJ (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, 655 West Baltimore St BRB,Room 6-013, Baltimore, MD 21201 USA.	rhenry@som.umaryland.edu	Loane, David/ABD-5177-2021	Loane, David/0000-0003-0393-3503; Henry, Rebecca/0000-0001-8548-1170	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS082308, R01NS037313, R01NS110756]; United States Veterans Affairs [1I01 RX001993]; Science Foundation IrelandScience Foundation IrelandEuropean Commission [17/FRL/4860]	This work was supported by National Institutes of Health grants R01NS082308 (D.J.L), R01NS037313 (A.I.F), and R01NS110756 (D.J.L./A.I.F/B.A.S), a United States Veterans Affairs grant 1I01 RX001993 (B.A.S), and Science Foundation Ireland grant 17/FRL/4860 (D.J.L).	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Cheng HR, 1997, EXP NEUROL, V148, P544, DOI 10.1006/exnr.1997.6708; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Henry RJ, 2019, NEUROTHERAPEUTICS, V16, P216, DOI 10.1007/s13311-018-0665-9; Johnk K, 1999, RESTOR NEUROL NEUROS, V14, P143; Kiehn O, 2010, BIOCHEM BIOPH RES CO, V396, P11, DOI 10.1016/j.bbrc.2010.02.107; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Morton SM, 2007, CEREBELLUM, V6, P79, DOI 10.1080/14734220601187741; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Neckel ND, 2020, J NEUROTRAUM, V37, P517, DOI 10.1089/neu.2018.5959; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; Sackheim AM, 2017, J SURG RES, V213, P100, DOI 10.1016/j.jss.2017.02.016; Schmahmann JD, 2009, NEUROSCIENCE, V162, P852, DOI 10.1016/j.neuroscience.2009.06.023; Schoch B, 2006, NEUROIMAGE, V30, P36, DOI 10.1016/j.neuroimage.2005.09.018; Schonfeld LM, 2017, J NEUROTRAUM, V34, P505, DOI 10.1089/neu.2016.4440; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Simone L, 2015, EUR J NEUROSCI, V42, P2882, DOI 10.1111/ejn.13040; Stoodley CJ, 2016, NEUROIMAGE-CLIN, V12, P765, DOI 10.1016/j.nicl.2016.10.013; Timmann D, 2008, CEREBELLUM, V7, P602, DOI 10.1007/s12311-008-0066-4; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	36	2	2	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2020	37	24					2709	2717		10.1089/neu.2020.7139		JUL 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PF0CR	WOS:000556431700001	32484024	Green Published			2022-02-06	
J	Phyland, RK; McKay, A; Olver, J; Walterfang, M; Hopwood, M; Hicks, AJ; Mortimer, D; Ponsford, JL				Phyland, Ruby K.; McKay, Adam; Olver, John; Walterfang, Mark; Hopwood, Malcolm; Hicks, Amelia J.; Mortimer, Duncan; Ponsford, Jennie L.			Use of olanzapine to treat agitation in traumatic brain injury: study protocol for a randomised controlled trial	TRIALS			English	Article						Traumatic brain injury; Agitation; Post-traumatic amnesia; Pharmacological intervention; Olanzapine; Antipsychotic; Randomised controlled trial	FUNCTIONAL INDEPENDENCE MEASURE; CLOSED-HEAD-INJURY; OF-THE-LITERATURE; INTRAMUSCULAR OLANZAPINE; POSTTRAUMATIC AMNESIA; HALOPERIDOL; REHABILITATION; RECOVERY; BEHAVIOR; OUTCOMES	BackgroundAgitation is common in the early stages of recovery from traumatic brain injury (TBI), when patients are in post-traumatic amnesia (PTA). Agitation is associated with risk of harm to patients and caregivers. Recent guidelines recommend that agitation during PTA is managed using environmental modifications. Agitation is also frequently treated pharmacologically, with the use of atypical antipsychotics such as olanzapine among the most common. This is despite a lack of well-designed studies to support the use of antipsychotics within this context. This study will be a double-blind, placebo-controlled randomised controlled trial. We will examine the efficacy, safety, cost-effectiveness and outcomes associated with the use of olanzapine for reducing agitation in patients in PTA following TBI over and above recommended environmental management.MethodsFifty-eight TBI rehabilitation inpatients who are in PTA and are agitated will receive olanzapine or placebo for the duration of PTA. All participants will additionally receive optimal environmental management for agitation. Measures of agitation, PTA and health will be undertaken at baseline. Treatment administration will begin at a dose of 5mg daily and may be escalated to a maximum dose of 20mg per day. Throughout the treatment period, agitation and PTA will be measured daily, and adverse events monitored weekly. Efficacy will be assessed by treatment group comparison of average Agitated Behaviour Scale scores during PTA. Participants will cease treatment upon emergence from PTA. Agitation levels will continue to be monitored for a further 2 weeks, post-treatment measures of health will be undertaken and cognitive and functional status will be assessed. Level of agitation and functional health will be assessed at hospital discharge. At 3 months post-discharge, functional outcomes and health service utilisation will be measured.DiscussionThis trial will provide crucial evidence to inform the management of agitation in patients in PTA following TBI. It will provide guidance as to whether olanzapine reduces agitation over and above recommended environmental management or conversely whether it increases or prolongs agitation and PTA, increases length of inpatient hospitalisation and impacts longer term cognitive and functional outcomes. It will also speak to the safety and cost-effectiveness of olanzapine use in this population.Trial registrationANZCTR ACTRN12619000284167. Registered on 25 February 2019	[Phyland, Ruby K.; McKay, Adam; Hicks, Amelia J.; Ponsford, Jennie L.] Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia; [Phyland, Ruby K.; McKay, Adam; Hicks, Amelia J.; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, 18 Innovat Walk,Clayton Campus,Wellington Rd, Clayton, Vic 3800, Australia; [Phyland, Ruby K.; McKay, Adam; Hicks, Amelia J.; Ponsford, Jennie L.] Monash Univ, Turner Inst Brain & Mental Hlth, Level 5,18 Innovat Walk,Clayton Campus, Clayton, Vic 3800, Australia; [McKay, Adam] Epworth HealthCare, Dept Psychol, 29 Erin St, Richmond, Vic 3121, Australia; [Olver, John] Epworth HealthCare, Rehabil Med, 89 Bridge Rd, Richmond, Vic 3121, Australia; [Walterfang, Mark; Hopwood, Malcolm] Univ Melbourne, Royal Melbourne Hosp, Dept Psychiat, Level 1 North Block,Grattan St, Parkville, Vic 3052, Australia; [Walterfang, Mark] Royal Melbourne Hosp, 300 Grattan St, Parkville, Vic 3050, Australia; [Walterfang, Mark] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, 30 Royal Parade, Parkville, Vic 3052, Australia; [Hopwood, Malcolm] Univ Melbourne, Professorial Psychiat Unit, Albert Rd Clin, 31 Albert Rd, Melbourne, Vic 3004, Australia; [Mortimer, Duncan] Monash Univ, Monash Business Sch, Ctr Hlth Econ, Bldg H,Level 5,Caulfield Campus, Clayton, Vic 3145, Australia		Phyland, RK (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.; Phyland, RK (corresponding author), Monash Univ, Sch Psychol Sci, 18 Innovat Walk,Clayton Campus,Wellington Rd, Clayton, Vic 3800, Australia.; Phyland, RK (corresponding author), Monash Univ, Turner Inst Brain & Mental Hlth, Level 5,18 Innovat Walk,Clayton Campus, Clayton, Vic 3800, Australia.	ruby.phyland@monash.edu		Olver, John/0000-0001-7069-1191; Phyland, Ruby/0000-0001-5465-3451; Mortimer, Duncan Stuart/0000-0002-7211-6454	Epworth Health Care, Monash University; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1174473]; Monash UniversityMonash University	Monash University is the study sponsor (email:simon.barrett@monash.edu).This project is funded by grants from Epworth Health Care, Monash University and National Health and Medical Research Council investigator grant number APP1174473. An on-site compounding pharmacy (Slade Pharmacy) has been contracted to undertake olanzapine and placebo encapsulation, preparation of group assignment, randomisation and dispensing of treatment to the ward. Melbourne Pathology is contracted to carry out blood sample collection and analysis. These sources of support are not timelimited.	Ahmed S, 2000, BRAIN INJURY, V14, P765; Anderson R.L., 2016, J INTENSIVE CRIT CAR, V2, P1, DOI DOI 10.21767/2471-8505.100023; [Anonymous], 2016, MAN RES IT THEIR ASS; Australian Register of Therapeutic Goods [Internet]. [Canberra (AU)]: Therapeutic goods administration, 2019, AUSTR PROD INF ZYPR; BOGNER J, 1995, NEUROREHABILITATION, V5, P293, DOI 10.3233/NRE-1995-5403; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Bogner J, 2015, ARCH PHYS MED REHAB, V96, pS274, DOI 10.1016/j.apmr.2015.04.020; Breier A, 2002, ARCH GEN PSYCHIAT, V59, P441, DOI 10.1001/archpsyc.59.5.441; Brown H, 2014, APPL MIXED MODELS ME, P3; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Centorrino F, 2007, HUM PSYCHOPHARM CLIN, V22, P455, DOI 10.1002/hup.870; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DeBoussard CN, 2017, CLIN REHABIL, V31, P555, DOI 10.1177/0269215516652184; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Flanagan SR, 2009, PM&R, V1, P76, DOI 10.1016/j.pmrj.2008.10.013; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Francisco GE, 2007, BRAIN INJURY, V21, P1007, DOI 10.1080/02699050701559558; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P917, DOI 10.1016/S0003-9993(97)90050-2; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; Glick HA, 2014, EC EVALUATION CLIN T, V2; Goldstein LB, 2002, NEUROREHAB NEURAL RE, V16, P321, DOI 10.1177/154596830201600402; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Harmsen M, 2004, BRAIN INJURY, V18, P787, DOI 10.1080/02699050410001671757; Helps Y, 2008, 45 AUSTR I HLTH WELF; Hicks AJ, 2018, J NEUROTRAUM, V35, P2755, DOI 10.1089/neu.2018.5738; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Jaywant A, 2018, NEUROPSYCHOL REHABIL, V28, P1055, DOI 10.1080/09602011.2016.1240699; Kalra ID, 2017, J HEAD TRAUMA REHAB, V32, pE61, DOI 10.1097/HTR.0000000000000359; Katagiri H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-20; Kishi T, 2015, J PSYCHIATR RES, V68, P198, DOI 10.1016/j.jpsychires.2015.07.005; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kooda K, 2015, CRIT CARE MED S1, V43, P289, DOI DOI 10.1097/01.CCM.0000474980.38145.7B; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Levy M, 2005, NEUROREHABILITATION, V20, P279; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Luaute J, 2016, ANN PHYS REHABIL MED, V59, P58, DOI 10.1016/j.rehab.2015.11.001; Mackinnon A, 2010, J INTERN MED, V268, P586, DOI 10.1111/j.1365-2796.2010.02274.x; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec JF, 2018, ARCH PHYS MED REHAB, V99, P603, DOI 10.1016/j.apmr.2017.06.038; McKenzie DP, 2015, J PSYCHOSOM RES, V79, P566, DOI 10.1016/j.jpsychores.2015.08.003; MCNENY R, 1995, NEUROREHABILITATION, V5, P211, DOI 10.3233/NRE-1995-5304; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Noe E, 2007, BEHAV NEUROL, V18, P7, DOI 10.1155/2007/529076; Norman R, 2014, MED DECIS MAKING, V34, P773, DOI 10.1177/0272989X13503499; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Rosenberger WF, 2015, RANDOMIZATION CLIN T, V2, P254; Schmidt M., 1996, REY AUDITORY VERBAL; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Silver JM., 2004, NEUROPSYCHIATRY TRAU, P313; SIMPSON GM, 1970, ACTA PSYCHIAT SCAND, P11; Smith, 1973, SYMBOL DIGIT MODALIT; STORCH EA, 2018, NEUROPSYCHOL REHABIL, P1, DOI DOI 10.1080/09602011.2018; Sullivan TR, 2018, STAT METHODS MED RES, V27, P2610, DOI 10.1177/0962280216683570; Teare MD, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-264; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 2009, USERS MANUAL SF 12V2; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; 2010, J PHARMACOL PHARMACO, V1, P42	79	2	2	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JUL 20	2020	21	1							662	10.1186/s13063-020-04553-2			15	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	MR3HM	WOS:000553481200002	32690072	Green Published, gold			2022-02-06	
J	Segovia-Oropeza, M; Santiago-Castaneda, C; Orozco-Suarez, SA; Concha, L; Rocha, L				Segovia-Oropeza, Marysol; Santiago-Castaneda, Cindy; Orozco-Suarez, Sandra Adela; Concha, Luis; Rocha, Luisa			Sodium Cromoglycate Decreases Sensorimotor Impairment and Hippocampal Alterations Induced by Severe Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						hippocampus; hyperexcitability; neuroprotection; sodium cromoglycate; traumatic brain injury	FLUID PERCUSSION INJURY; DISODIUM-CROMOGLYCATE; DENTATE GYRUS; HISTAMINE-RELEASE; NEURONAL INJURY; MAST-CELLS; HYPEREXCITABILITY; MODEL; CA1; CONSEQUENCES	Severe traumatic brain injury (TBI) results in significant functional disturbances in the hippocampus. Studies support that sodium cromoglycate (CG) induces neuroprotective effects. This study focused on investigating the effects of post-TBI subchronic administration of CG on hippocampal hyperexcitability and damage as well as on sensorimotor impairment in rats. In contrast to the control group (Sham+SS group), animals undergoing severe TBI (TBI+SS group) showed sensorimotor dysfunction over the experimental post-TBI period (day 2, 55%,p < 0.001; day 23, 39.5%,p < 0.001; day 30, 38.6%,p < 0.01). On day 30 post-TBI, TBI+SS group showed neuronal hyperexcitability (63.3%,p < 0.01). The hippocampus ipsilateral to the injury showed volume reduction (14.4%, p < 0.001) with a volume of damage of 0.15 +/- 0.09 mm(3). These changes were associated with neuronal loss in the dentate gyrus (ipsilateral, 33%,p < 0.05); hilus (ipsilateral, 77%,p < 0.001; contralateral, 51%,p < 0.001); Cornu Ammonis (CA)1 (ipsilateral, 40%,p < 0.01), and CA3 (ipsilateral, 52%,p < 0.001; contralateral, 34%,p < 0.01). Animals receiving subchronic treatment with CG (50 mg/kg, s.c. daily for 10 days) after TBI (TBI+CG group) displayed a sensorimotor dysfunction less evident than that of the TBI+SS group (p < 0.001). Their hippocampal excitability was similar to that of the Sham+SS group (p = 0.21). The TBI+CG group presented hippocampal volume reduction (12.7%,p = 0.94) and damage (0.10 +/- 0.03 mm(3),p > 0.99) similar to the TBI+SS group. However, their hippocampal neuronal preservation was similar to that of the Sham+SS group. These results indicate that CG represents an appropriate and novel pharmacological strategy to reduce the long-term sensorimotor impairment and hippocampal damage and hyperexcitability that result as consequences of severe TBI.	[Segovia-Oropeza, Marysol; Santiago-Castaneda, Cindy; Rocha, Luisa] Ctr Res & Adv Studies, Dept Pharmacobiol, Mexico City, DF, Mexico; [Orozco-Suarez, Sandra Adela] Natl Med Ctr, Unit Med Res Neurol Dis, Mexico City, DF, Mexico; [Concha, Luis] Univ Nacl Autonoma Mexico, Inst Neurobiol, Campus Juriquilla, Queretaro, Mexico		Rocha, L (corresponding author), Ctr Res & Adv Studies, Dept Pharmacobiol, Mexico City, DF, Mexico.; Concha, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Campus Juriquilla, Queretaro, Mexico.	lconcha@unam.mx; lrocha@cinvestav.mx	Concha, Luis/M-5720-2019		National Council for Sciences and Technology of Mexico (CONACYT) [458195]	This study was supported by the National Council for Sciences and Technology of Mexico (CONACYT Scholarship number 458195).	Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; ASHTON MJ, 1973, TOXICOL APPL PHARM, V26, P319, DOI 10.1016/0041-008X(73)90268-8; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Becker A, 1997, PHYSIOL BEHAV, V62, P1265, DOI 10.1016/S0031-9384(97)00303-X; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Cox J S, 1970, Adv Drug Res, V5, P115; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Ellegood J, 2010, NEUROIMAGE, V53, P1023, DOI 10.1016/j.neuroimage.2010.03.038; Esposito P, 2001, BRAIN RES, V888, P117, DOI 10.1016/S0006-8993(00)03026-2; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Valle-Dorado MG, 2018, EPILEPSY BEHAV, V87, P200, DOI 10.1016/j.yebeh.2018.06.021; Valle-Dorado MG, 2015, NEUROPHARMACOLOGY, V92, P49, DOI 10.1016/j.neuropharm.2014.12.032; Gulyaeva NV, 2019, NEUROCHEM RES, V44, P1306, DOI 10.1007/s11064-018-2662-0; Hayashi T, 2008, AM J PHYSIOL-REG I, V295, pR123, DOI 10.1152/ajpregu.00527.2007; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HOWELL JBL, 1967, LANCET, V2, P539; Huttunen JK, 2018, J NEUROTRAUM, V35, P2708, DOI 10.1089/neu.2017.5308; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Jin YX, 2007, DEV NEUROSCI-BASEL, V29, P373, DOI 10.1159/000105478; Jin YX, 2009, STROKE, V40, P3107, DOI 10.1161/STROKEAHA.109.549691; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; KUSNER EJ, 1973, J PHARMACOL EXP THER, V184, P41; da Silva EZM, 2014, J HISTOCHEM CYTOCHEM, V62, P698, DOI 10.1369/0022155414545334; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; MOSS GF, 1970, TOXICOL APPL PHARM, V17, P699, DOI 10.1016/0041-008X(70)90044-X; Nava F, 1999, EUR J PHARMACOL, V367, P351, DOI 10.1016/S0014-2999(98)00986-8; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Ozga JE, 2018, BEHAV PHARMACOL, V29, P617, DOI 10.1097/FBP.0000000000000430; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pitkanen A., 2012, JASPERS BASIC MECH E, P331; Purves D., 2004, NEUROSCIENCE, V3rd; Racine R., 1997, J NEUROL SCI, V4, P273; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Roe SY, 1997, J NEUROTRAUM, V14, P399, DOI 10.1089/neu.1997.14.399; SAKATA T, 1988, BRAIN RES, V441, P403, DOI 10.1016/0006-8993(88)91423-0; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Sleem, 2016, REACT OXYG SPECIES, V1, P228, DOI 10.20455/ros.2016.833; SLOVITER RS, 1994, ANN NEUROL, V35, P640, DOI 10.1002/ana.410350604; Smith D., 1989, J PHARM PHARMACOL, V32, P823; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Strbian D, 2007, CIRCULATION, V116, P411, DOI 10.1161/CIRCULATIONAHA.106.655423; Strbian D, 2006, J CEREBR BLOOD F MET, V26, P605, DOI 10.1038/sj.jcbfm.9600228; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vuokila N, 2020, NEUROSCIENCE, V433, P21, DOI 10.1016/j.neuroscience.2020.02.045; Wagstyl K, 2018, NEUROMETHODS, V136, P35, DOI 10.1007/978-1-4939-7647-8_3; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wenzel HJ, 2000, HIPPOCAMPUS, V10, P244, DOI 10.1002/1098-1063(2000)10:3<244::AID-HIPO5>3.0.CO;2-7; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yasmin A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00863; Yushkevich PA, 2019, NEUROINFORMATICS, V17, P83, DOI 10.1007/s12021-018-9385-x	75	2	2	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2020	37	23					2595	2603		10.1089/neu.2019.6975		JUL 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PC0XQ	WOS:000556431600001	32484040				2022-02-06	
J	Zhao, T; Wang, ZF; Zhu, TM; Xie, R; Zhu, JH				Zhao, Tong; Wang, Zhifu; Zhu, Tongming; Xie, Rong; Zhu, Jianhong			Downregulation of Thbs4 caused by neurogenic niche changes promotes neuronal regeneration after traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Traumatic brain injury; neurogenic niche; Thrombospondin 4 (Thbs4); SDF-1; neuronal regeneration	NEURAL STEM-CELLS; CIS P-TAU; HEMATOPOIETIC STEM; SCAR FORMATION; GLIAL SCAR; ASTROCYTES; MIGRATION; CXCL12	Objective Following brain injury, the neurogenic niche provides a permissive cue for iatrogenesis rather than neurogenesis; reactive astrocytes play essential roles in orchestrating this process, markedly forming a glial scar around the area of damaged brain tissue. The objective of this study was to alter the neurogenic niche at the injured cortex and study its impact on neurogenesis. Methods We constructed a stromal cell-derived factor 1 (SDF-1) gradient matrix to attract reactive astrocytes to the glial scar core. Results SDF-1 reacted with the astrocytes in the injured site. By changing the neurogenic niche of the injured part of the brain after traumatic brain injury (TBI), SDF-1 downregulated thrombospondin 4 (Thbs4) promoting neuronal cell regeneration and playing a beneficial role in nerve function recovery after brain injury. Discussion The matrix we created in this study could attract and interact with reactive glial cells and, thus, we called it a glial pump. Using the glial pump, we identified a new mechanism of brain injury repair and neuronal regeneration after TBI, which relied on Thbs4 downregulation after the altered neurogenic niche promoted neuronal regeneration and functional recovery.	[Zhao, Tong; Wang, Zhifu; Zhu, Tongming; Xie, Rong; Zhu, Jianhong] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China; [Zhao, Tong; Wang, Zhifu; Zhu, Tongming; Xie, Rong; Zhu, Jianhong] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Inst Brain Sci, Shanghai, Peoples R China; [Zhao, Tong; Wang, Zhifu; Zhu, Tongming; Xie, Rong; Zhu, Jianhong] Fudan Univ, Shanghai Med Coll, Collaborat Innovat Ctr Brain Sci, Shanghai, Peoples R China		Xie, R; Zhu, JH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China.; Zhu, JH (corresponding author), Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Inst Brain Sci, Shanghai, Peoples R China.; Zhu, JH (corresponding author), Fudan Univ, Shanghai Med Coll, Collaborat Innovat Ctr Brain Sci, Shanghai, Peoples R China.	rongxie@fudan.edu.cn; jzhu@fudan.edu.cn			National Nature Science FoundationNational Natural Science Foundation of China (NSFC) [81601069, 31771491]; Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2018YFA0107900, 81471242]	This work was supported by the National Nature Science Foundation [81601069,31771491]; Ministry of Science [2018YFA0107900]; and Technology of China [81471242].	Adamiak M, 2015, ONCOTARGET, V6, P18819, DOI 10.18632/oncotarget.4710; Adelita T, 2017, STEM CELL RES, V22, P61, DOI 10.1016/j.scr.2017.05.013; Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Ataka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081744; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Cheng JP, 2018, ACTA NEUROPATHOL, V136, P507, DOI 10.1007/s00401-018-1893-0; Escot S, 2013, CIRC RES, V113, P505, DOI 10.1161/CIRCRESAHA.113.301333; Farrell Deacon, 2018, Curr Anesthesiol Rep, V8, P279, DOI 10.1007/s40140-018-0286-1; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Haarbauer-Krupa J, 2018, JAMA PEDIATR, V172, P1078, DOI 10.1001/jamapediatrics.2018.2740; Haeger A, 2015, TRENDS CELL BIOL, V25, P556, DOI 10.1016/j.tcb.2015.06.003; Hara M, 2017, NAT MED, V23, P818, DOI 10.1038/nm.4354; Kim BH, 2015, NANO LETT, V15, P969, DOI 10.1021/nl503779e; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Liao RJ, 2019, STEM CELL REP, V12, P532, DOI 10.1016/j.stemcr.2019.01.004; Ma FK, 2018, ACTA BIOMATER, V69, P146, DOI 10.1016/j.actbio.2018.01.001; Mendt M, 2015, CYTOKINE, V76, P214, DOI 10.1016/j.cyto.2015.05.004; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Pearson CS, 2018, ELIFE, V7, DOI 10.7554/eLife.37139; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Shutter LA, 2016, NEW ENGL J MED, V375, P1183, DOI 10.1056/NEJMe1609722; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; STORNETTA RL, 1988, SCIENCE, V242, P1444, DOI 10.1126/science.3201232; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Youn SW, 2011, BLOOD, V117, P4376, DOI 10.1182/blood-2010-07-295964; Zhou Y, 2018, CHIN J NAT MEDICINES, V16, P801, DOI 10.1016/S1875-5364(18)30122-5	31	2	2	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	AUG 2	2020	42	8			SI		703	711		10.1080/01616412.2020.1795590		JUL 2020	9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU3KK	WOS:000550092600001	32684116				2022-02-06	
J	Latifi, R; Azevedo, V; Boci, A; Parsikia, A; Latifi, F; Merrell, RC				Latifi, Rifat; Azevedo, Vanda; Boci, Arian; Parsikia, Afshin; Latifi, Fortesa; Merrell, Ronald C.			Telemedicine Consultation as an Indicator of Local Telemedicine Champions' Contributions, Health Care System Needs or Both: Tales from Two Continents	TELEMEDICINE AND E-HEALTH			English	Article						telemedicine; e-Health; Cabo Verde; Albania; access-to-care; health care needs; telemedicine champion	TELERADIOLOGY; VERDE	Background:Telemedicine systems increase access to care, particularly in remote and developing countries. Nationwide telemedicine programs in Cabo Verde and Albania have been built by the International Virtual e-Hospital Foundation (IVeH) and based on the effective Initiate-Build-Operate-Transfer (IBOT) strategy. The aim of this study was to compare the clinical results between the two programs and examine the relationship between the clinical teleconsultations as an indicator of health care system needs and the contribution of local telemedicine champions. Methods:Data were prospectively collected between 2014 and 2018 from Albania and Cabo Verde. Telemedicine champions were defined as programs, physicians, or hospitals who have contributed at least 100 telemedicine consultations during the study periods. Chi-squared test was utilized to analyze the data. Results:There were 2,442 teleconsultations in Cabo Verde and 2,724 teleconsultations in Albania during the study periods. Using the 100-consultation benchmark as the indicator of telemedicine champion, we identified radiology (n = 1,061), neurotrauma (n = 742), and general neurology or stroke (n = 489) as champion clinical disciplines in Albania. With the same method of 100 consultations, we identified eight champion clinical disciplines in Cabo Verde, including neurology (n = 720), cardiology (n = 313), orthopedics (n = 190), surgery (143), endocrinology (141), otolaryngology (n = 139), urology (n = 139), and dermatology (126). The patient transfer/nontransfer ratio was 0.5 in Cabo Verde and 0.3 in Albania (p < 0.001). Three hospitals in Albania and eight community hospitals/health care centers in Cabo Verde requested the majority of teleconsultations. Two main hospitals in Cabo Verde and Albania responded to the consultations. Conclusion:The successful implementation of a telemedicine program depends on many factors. However, physician champions, who eventually create clinical discipline champions, and represent the hospital champions, are the backbone of the sustainability and progress of any telemedicine program. The number of consultations reflects the lack of local specialty expertise to provide health care service and thus can be used for future planning and investment.	[Latifi, Rifat] New York Med Coll, Westchester Med Ctr, Dept Surg, Sch Med, 100 Woods Rd, Valhalla, NY 10595 USA; [Latifi, Rifat; Parsikia, Afshin; Latifi, Fortesa; Merrell, Ronald C.] Int Virtual E Hosp Fdn, Anchorage, AK USA; [Azevedo, Vanda] Natl Telemed Serv & Prevent & Control Cerebro Car, Praia, Cape Verde; [Boci, Arian] Integrated Telemed & E Hlth Program Albania, Tirana, Albania; [Merrell, Ronald C.] Virginia Commonwealth Univ, Dept Surg, Richmond, VA USA		Latifi, R (corresponding author), New York Med Coll, Westchester Med Ctr, Dept Surg, Sch Med, 100 Woods Rd, Valhalla, NY 10595 USA.	rifat.latifi@wmchealth.org		Latifi, Rifat/0000-0003-1091-3682			Ag Ahmed Mohamed Ali, 2017, Mhealth, V3, P22, DOI 10.21037/mhealth.2017.05.04; Atun R, 2017, LANCET DIABETES ENDO, V5, P622, DOI 10.1016/S2213-8587(17)30181-X; Bashshur RL, 2016, TELEMED E-HEALTH, V22, P868, DOI 10.1089/tmj.2016.0149; Delgado AP, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0180-9; Krupinski E. A., 2014, REP MED IMAGING, V2014, P5, DOI DOI 10.2147/RMI.S48140; Latifi R, 2020, TELEMED E-HEALTH, V26, P164, DOI 10.1089/tmj.2018.0338; Latifi R, 2018, WORLD NEUROSURG, V112, pE747, DOI 10.1016/j.wneu.2018.01.146; Latifi R, 2016, INT J EMERG MED, V9, DOI 10.1186/s12245-016-0124-5; Latifi R, 2015, TELEMED E-HEALTH, V21, P503, DOI 10.1089/tmj.2014.0138; Latifi R, 2014, TELEMED E-HEALTH, V20, P1027, DOI 10.1089/tmj.2014.0026; Latifi Rifat, 2012, Bull Am Coll Surg, V97, P15; Latifi R, 2009, TELEMED J E-HEALTH, V15, P956, DOI 10.1089/tmj.2009.0084; Liu Winnie, 2016, J Diabetes Sci Technol, V10, P1079, DOI 10.1177/1932296816648343; Malasanos T., 2013, Diabetes Spectrum, V26, P226, DOI 10.2337/diaspect.26.4.226; Mohan Viswanathan, 2014, J Diabetes Sci Technol, V8, P256; Olldashi F, 2019, WORLD NEUROSURG, V128, pE340, DOI 10.1016/j.wneu.2019.04.150; Ranschaert ER, 2013, INSIGHTS IMAGING, V4, P93, DOI 10.1007/s13244-012-0210-z; Rehman R, 2015, TENN MED, V1; Skender B, 2017, ALBANIAN J TRAUMA EM, V1, P15; Sorensen JT, 2013, REV ESP CARDIOL, V66, P212, DOI 10.1016/j.rec.2013.01.001; Van der Heijden J, 2015, TELECARDIOLOGY NETHE, DOI [10.13140/RG.2.1.4864.0483, DOI 10.13140/RG.2.1.4864.0483]; Velnar Tomaz, 2019, World J Methodol, V9, P20, DOI 10.5662/wjm.v9.i1.20; Weinberg Jennifer, 2009, Pan Afr Med J, V3, P16; Woldaregay AZ, 2017, JMIR MED INF, V5, P2, DOI 10.2196/medinform.6323; Zulfiqar AA, 2019, ADV PREV MED, V2019, P2102156	25	2	2	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	FEB 1	2021	27	2					200	206		10.1089/tmj.2019.0290		JUL 2020	7	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	QJ2CS	WOS:000556430400001	32706614				2022-02-06	
J	Andelic, N; Roe, C; Brunborg, C; Zeldovich, M; Lovstad, M; Loke, D; Borgen, IM; Voormolen, DC; Howe, EI; Forslund, MV; Dahl, HM; von Steinbuechel, N				Andelic, Nada; Roe, Cecilie; Brunborg, Cathrine; Zeldovich, Marina; Lovstad, Marianne; Loke, Daniel; Borgen, Ida M.; Voormolen, Daphne C.; Howe, Emilie, I; Forslund, Marit, V; Dahl, Hilde M.; von Steinbuechel, Nicole		CTR-TBI Participants Investigators	Frequency of fatigue and its changes in the first 6 months after traumatic brain injury: results from the CENTER-TBI study	JOURNAL OF NEUROLOGY			English	Article						Head injury; Post-traumatic fatigue; Longitudinal studies; Neurological disorders	CONCUSSION SYMPTOMS QUESTIONNAIRE; GENERAL-POPULATION; GENDER-DIFFERENCES; SEVERITY; PREVALENCE; PREDICTORS; RECOVERY; OUTCOMES; SLEEP; MODEL	Background Fatigue is one of the most commonly reported subjective symptoms following traumatic brain injury (TBI). The aims were to assess frequency of fatigue over the first 6 months after TBI, and examine whether fatigue changes could be predicted by demographic characteristics, injury severity and comorbidities. Methods Patients with acute TBI admitted to 65 trauma centers were enrolled in the study Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI). Subjective fatigue was measured by single item on the Rivermead Post-Concussion Symptoms Questionnaire (RPQ), administered at baseline, three and 6 months postinjury. Patients were categorized by clinical care pathway: admitted to an emergency room (ER), a ward (ADM) or an intensive care unit (ICU). Injury severity, preinjury somatic- and psychiatric conditions, depressive and sleep problems were registered at baseline. For prediction of fatigue changes, descriptive statistics and mixed effect logistic regression analysis are reported. Results Fatigue was experienced by 47% of patients at baseline, 48% at 3 months and 46% at 6 months. Patients admitted to ICU had a higher probability of experiencing fatigue than those in ER and ADM strata. Females and individuals with lower age, higher education, more severe intracranial injury, preinjury somatic and psychiatric conditions, sleep disturbance and feeling depressed postinjury had a higher probability of fatigue. Conclusion A high and stable frequency of fatigue was found during the first 6 months after TBI. Specific socio-demographic factors, comorbidities and injury severity characteristics were predictors of fatigue in this study.	[Andelic, Nada; Roe, Cecilie; Borgen, Ida M.; Howe, Emilie, I; Forslund, Marit, V] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Andelic, Nada] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Roe, Cecilie; Howe, Emilie, I; Dahl, Hilde M.] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Brunborg, Cathrine] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Zeldovich, Marina; von Steinbuechel, Nicole] Univ Med Ctr, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Lovstad, Marianne; Loke, Daniel] Sunnaas Rehabil Hosp, Res Dept, Bjornemyr, Norway; [Lovstad, Marianne; Loke, Daniel; Borgen, Ida M.] Univ Oslo, Fac Social Sci, Dept Psychol, Oslo, Norway; [Voormolen, Daphne C.] Univ Med Ctr, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Dahl, Hilde M.] Oslo Univ Hosp, Dept Child Neurol, Oslo, Norway		Andelic, N (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.; Andelic, N (corresponding author), Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway.	nandelic@online.no	Sahuquillo, Juan/B-3577-2008; Ercole, Ari/B-6288-2009; Oresic, Matej/K-7673-2016; Posti, Jussi P./Y-2908-2019; Vande Vyvere, Thijs/AAB-5180-2022; Lagares, Alfonso/B-2969-2011; Volovici, Victor/AAZ-8901-2020; Ledoux, Didier/ABA-8401-2021; Castano-Leon, Ana M/ABF-6322-2020; Raj, Rahul/K-7693-2012; Gomez, Pedro/E-2411-2014	Sahuquillo, Juan/0000-0003-0713-5875; Ercole, Ari/0000-0001-8350-8093; Oresic, Matej/0000-0002-2856-9165; Posti, Jussi P./0000-0002-5925-5193; Vande Vyvere, Thijs/0000-0003-4032-5443; Lagares, Alfonso/0000-0003-3996-0554; Volovici, Victor/0000-0002-5798-5360; Ledoux, Didier/0000-0002-9314-6564; Castano-Leon, Ana M/0000-0002-7918-5049; Sanchez-Porras, Renan/0000-0002-9084-8114; Parizel, Paul M./0000-0002-0221-2854; Bragge, Peter/0000-0003-0745-5131; Van Essen, Thomas/0000-0003-4657-5283; Gratz, Johannes/0000-0001-8717-0544; Rossi, Sandra/0000-0002-9963-8121; Coles, Jonathan/0000-0003-4013-679X; Radoi, Andreea/0000-0002-0677-3544; Newcombe, Virginia/0000-0001-6044-9035; Sakowitz, Oliver/0000-0003-3248-6335; Kondziella, Daniel/0000-0001-5562-9808; Della Corte, Francesco/0000-0003-1736-2318; Stewart, William/0000-0003-2199-2582; Dark, Paul/0000-0003-3309-0164; Raj, Rahul/0000-0003-4243-9591; Gomez, Pedro/0000-0002-4185-5238; Zeiler, Frederick/0000-0003-1737-0510	European Union 7th Framework program (EC grant) [247 602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 247 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA).	Aaronson L S, 1999, Image J Nurs Sch, V31, P45; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barker-Collo S, 2018, BRAIN INJURY, V32, P453, DOI 10.1080/02699052.2018.1429659; Beaulieu-Bonneau S, 2017, NEUROPSYCHOL REHABIL, V27, P983, DOI 10.1080/09602011.2016.1162176; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Clark AL, 2018, J HEAD TRAUMA REHAB, V33, P382, DOI 10.1097/HTR.0000000000000377; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Crichton A, 2018, J HEAD TRAUMA REHAB, V33, P200, DOI 10.1097/HTR.0000000000000330; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Esbjornsson E, 2013, J REHABIL MED; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Juengst SB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01210; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Lerdal A, 2005, SCAND J PUBLIC HEALT, V33, P123, DOI 10.1080/14034940410028406; Lerdal A, 2011, DISABIL REHABIL, V33, P334, DOI 10.3109/09638288.2010.490867; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mayhew D, 2019, ANAESTHESIA, V74, P373, DOI 10.1111/anae.14569; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Royston P, 2004, STAT J, P227; Schiehser DM, 2017, NEUROPSYCHOL REHABIL, V27, P1031, DOI 10.1080/09602011.2016.1215999; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; TEASDALE G, 1974, LANCET, V2, P81; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Whitehead L, 2009, J PAIN SYMPTOM MANAG, V37, P107, DOI 10.1016/j.jpainsymman.2007.08.019; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	41	2	2	2	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	JAN	2021	268	1					61	73		10.1007/s00415-020-10022-2		JUL 2020	13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PU0KM	WOS:000549344200002	32676767	hybrid, Green Published, Green Accepted			2022-02-06	
J	Ramanathan-Elion, DM; Baydoun, HA; Johnstone, B				Ramanathan-Elion, Deepa M.; Baydoun, Hind A.; Johnstone, Brick			Psychological predictors of functional outcomes in service members with traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; functional outcome; posttraumatic stress disorder; psychological functioning; military	POSTTRAUMATIC-STRESS-DISORDER; COMPENSATION-SEEKING; COMBAT VETERANS; RISK-FACTORS; POSTCONCUSSIVE SYMPTOMS; DISABILITY COMPENSATION; DEPRESSIVE SYMPTOMS; CHRONIC PAIN; MILD; MILITARY	Primary Objective Research is increasingly demonstrating the significant impact that non-medical factors can have on outcomes of service members (SMs) with mild traumatic brain injury (mTBI). Thus, the current study examined which demographic, TBI-related factors, and psychological variables are most predictive of functional outcomes. Research Design Retrospective database analysis from medical chart review. Methods and Procedures One hundred forty-one patients who received rehabilitation services at an outpatient TBI military treatment facility between 2013 and 2018. Data collected included demographic variables, time since injury, neuropsychological measures, psychological diagnoses, Personality Assessment Inventory (PAI) scores, and Walter Reed Functional Impairment Scale (FIS). Hierarchical linear regression models were used to predict functional outcomes (measured by FIS total, work, social functioning scales). Main Outcomes and Results Results indicated that comorbid PTSD diagnosis and PAI Negative Impression Management (NIM) score were predictive of total functional, work, and social outcomes, over and above demographic and TBI-related factors. Conclusions Current findings confirmed the importance of evaluating and treating psychological factors, as well as exploring one's responding style (NIM), when managing chronic mTBI in SMs. Given ongoing findings of psychological underpinnings to mTBI outcome, there is further need to focus on early interventions to optimize psychological and functional outcomes for SMs.	[Ramanathan-Elion, Deepa M.] Ft Belvoir Intrepid Spirit Ctr, Dept Behav Hlth, Ft Belvoir, VA USA; [Baydoun, Hind A.] Ft Belvoir Community Hosp, Dept Res Programs, Ft Belvoir, VA USA; [Johnstone, Brick] Ft Belvoir Intrepid Spirit Ctr, Def & Vet Brain Injury Ctr, Ft Belvoir, VA USA; [Johnstone, Brick] Shepherd Ctr, Virginia Crawford Res Inst, Atlanta, GA USA		Ramanathan-Elion, DM (corresponding author), Ft Belvoir Community Hosp, Intrepid Spirit Ctr, Ft Belvoir, VA 22060 USA.	deepa.r.elion.civ@mail.mil		Ramanathan-Elion, Deepa/0000-0001-7723-7346	DHA Contracting Office (CO-NCR) [HT0014-19-C-0004, HT0014]	The views expressed in this manuscript are those of the authors and do not necessarily represent the official policy or position of the Defense Health Agency, Department of Defense, or any other US government agency. This work was prepared under Contract HT0014-19-C-0004 with DHA Contracting Office (CO-NCR) HT0014 and, therefore, is defined as US Government work under Title 17 U.S.C. 101. Per Title 17 U.S.C. 105, copyright protection is not available for any work of the US Government. For more information, please contactdha.DVBICinfo@mail.mil.UNCLASSIFIED	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Aron A, 2000, J PERS SOC PSYCHOL, V78, P273, DOI 10.1037/0022-3514.78.2.273; Ashman TA, 2006, MT SINAI J MED, V73, P999; Belanger HG, 2015, MIL MED, V180, P192, DOI 10.7205/MILMED-D-14-00388; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blais MA, 2010, CLIN APPL PERSONALIT; Bolier L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-119; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Calhoun PS, 2000, J PERS ASSESS, V75, P338, DOI 10.1207/S15327752JPA7502_11; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Centers for Disease Control and Prevention, 2019, TBI GET THE FACTS; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Cook PA, 2018, J NEUROTRAUM, V35, P991, DOI 10.1089/neu.2017.5141; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denning J., 2012, M AM AC CLIN NEUR SE; DeViva JC, 2003, J TRAUMA STRESS, V16, P503, DOI 10.1023/A:1025766713188; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Fredrickson BL, 2000, MOTIV EMOTION, V24, P237, DOI 10.1023/A:1010796329158; Frueh BC, 2003, PSYCHIATR SERV, V54, P84, DOI 10.1176/appi.ps.54.1.84; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gold PB, 1999, J NERV MENT DIS, V187, P680, DOI 10.1097/00005053-199911000-00005; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-1; Hayes D. K., 2015, OTOLARYNGOLOGY HEAD, P87; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; HERMAN JL, 1992, J TRAUMA STRESS, V5, P377, DOI 10.1002/jts.2490050305; Herrell RK, 2014, PSYCHOL SERV, V11, P254, DOI 10.1037/a0037347; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; HYER L, 1987, J CLIN PSYCHOL, V43, P79, DOI 10.1002/1097-4679(198701)43:1<79::AID-JCLP2270430110>3.0.CO;2-P; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Johnstone B, ARCH CLIN NEUROPSYCH; Johnstone B, 2006, NEUROREHABILITATION, V21, P335; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Marchione M., 2012, ALMOST HALF NEW VETS; Matthews LR, 2005, INT J PSYCHOL, V40, P339, DOI 10.1080/00207590444000320; Matthews MD, 2008, MIL PSYCHOL, V20, P289, DOI 10.1080/08995600802345246; McNally RJ, 2013, J ANXIETY DISORD, V27, P520, DOI 10.1016/j.janxdis.2013.07.002; Merritt VC, 2019, J CLIN EXP NEUROPSYC, V41, P665, DOI 10.1080/13803395.2019.1610161; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morey, 1991, PERSONALITY ASSESSME; Morey L.C., 2007, PERSONALITY ASSESSME; Mozley SL, 2005, J PSYCHOPATHOL BEHAV, V27, P179, DOI 10.1007/s10862-005-0634-6; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Resnick PJ, 1997, CLIN ASSESSMENT MALI, P130; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Scott KL, 2016, CLIN NEUROPSYCHOL, V30, P66, DOI 10.1080/13854046.2015.1127427; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tsanadis J, 2007, J INT NEUROPSYCH SOC, V13, P196; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Wechsler D., 2008, WECHSLER ADULT INTEL; Zatzick DF, 2008, ARCH PEDIAT ADOL MED, V162, P642, DOI 10.1001/archpedi.162.7.642	82	2	2	2	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 28	2020	34	9					1183	1192		10.1080/02699052.2020.1793387		JUL 2020	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ND6FI	WOS:000550121300001	32683899				2022-02-06	
J	Readhead, B; Haure-Mirande, JV; Mastroeni, D; Audrain, M; Fanutza, T; Kim, SH; Blitzer, RD; Gandy, S; Dudley, JT; Ehrlich, ME				Readhead, Ben; Haure-Mirande, Jean-Vianney; Mastroeni, Diego; Audrain, Mickael; Fanutza, Tomas; Kim, Soong H.; Blitzer, Robert D.; Gandy, Sam; Dudley, Joel T.; Ehrlich, Michelle E.			miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease	ACTA NEUROPATHOLOGICA			English	Article							TUMOR-SUPPRESSOR BTG3; GENE SET ENRICHMENT; ALKALINE-PHOSPHATASE; MEMORY DEFICITS; SYNAPSE LOSS; MIR-155; MOUSE; MICROGLIA; SENESCENCE; MICRORNAS	MicroRNAs are recognized as important regulators of many facets of physiological brain function while also being implicated in the pathogenesis of several neurological disorders. Dysregulation ofmiR155is widely reported across a variety of neurodegenerative conditions, including Alzheimer's disease (AD), Parkinson's disease, amyotrophic lateral sclerosis, and traumatic brain injury. In previous work, we observed that experimentally validatedmiR155gene targets were consistently enriched among genes identified as differentially expressed across multiple brain tissue and disease contexts. In particular, we found that human herpesvirus-6A (HHV-6A) suppressedmiR155, recapitulating reports ofmiR155inhibition by HHV-6A in infected T-cells, thyrocytes, and natural killer cells. In earlier studies, we also reported the effects of constitutive deletion ofmiR155on accelerating the accumulation of A beta deposits in 4-month-oldAPP/PSEN1mice. Herein, we complete the cumulative characterization of transcriptomic, electrophysiological, neuropathological, and learning behavior profiles from 4-, 8- and 10-month-old WT andAPP/PSEN1mice in the absence or presence ofmiR155. We also integrated human post-mortem brain RNA-sequences from four independent AD consortium studies, together comprising 928 samples collected from six brain regions. We report that gene expression perturbations associated withmiR155deletion in mouse cortex are in aggregate observed to be concordant with AD-associated changes across these independent human late-onset AD (LOAD) data sets, supporting the relevance of our findings to human disease. LOAD has recently been formulated as the clinicopathological manifestation of a multiplex of genetic underpinnings and pathophysiological mechanisms. Our accumulated data are consistent with such a formulation, indicating thatmiR155may be uniquely positioned at the intersection of at least four components of this LOAD "multiplex": (1) innate immune response pathways; (2) viral response gene networks; (3) synaptic pathology; and (4) proamyloidogenic pathways involving the amyloid beta peptide (A beta).	[Readhead, Ben; Mastroeni, Diego] Arizona State Univ, Banner Neurodegenerat Dis Res Ctr, Tempe, AZ 85281 USA; [Readhead, Ben; Dudley, Joel T.; Ehrlich, Michelle E.] Icahn Sch Med Mt Sinai, Icahn Inst Genom Sci & Multiscale Biol, New York, NY 10029 USA; [Haure-Mirande, Jean-Vianney; Audrain, Mickael; Fanutza, Tomas; Kim, Soong H.; Gandy, Sam; Ehrlich, Michelle E.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Blitzer, Robert D.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Blitzer, Robert D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Gandy, Sam] Icahn Sch Med Mt Sinai, Alzheimers Dis Res Ctr, Dept Psychiat, New York, NY 10029 USA; [Ehrlich, Michelle E.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Gandy, Sam] Mt Sinai Ctr Cognit Hlth & NFL Neurol Care, Dept Neurol, New York, NY 10029 USA; [Gandy, Sam] James J Peters VA Med Ctr, 130 West Kingsbridge Rd, New York, NY 10468 USA		Dudley, JT; Ehrlich, ME (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom Sci & Multiscale Biol, New York, NY 10029 USA.; Ehrlich, ME (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.; Ehrlich, ME (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA.	joel.dudley@mssm.edu; michelle.ehrlich@mssm.edu	Haure-Mirande, Jean-Vianney/AAS-9570-2020; Audrain, Mickael/L-9894-2016	Haure-Mirande, Jean-Vianney/0000-0002-5748-9666; Audrain, Mickael/0000-0001-9941-7380	NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, RF1AG57473, U01AG46152, U01AG61356, U01 AG046170, 1R56AG058469, 1R01AG058469, R21AG63968]; Alzheimer's AssociationAlzheimer's Association [AARGD-17-529197]; George B. Link, Jr., Foundation; Scott Moskowitz Foundation for Alzheimer's Research; Jane Martin and Stuart Katz Foundation; Werber Family Foundation; Sara and Gideon Gartner Foundation; Louis B. Mayer Foundation; Lady Va and Sir Deryck Maughan Foundation; Georgianne and Dr. Reza Khatib Foundation; Linda Wachner Foundation; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS080820]; CurePSP Foundation; Mayo Foundation; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U24 NS072026]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinsons Research; Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago; Illinois Department of Public Health (ROSMAP); Translational Genomics Research Institute (genomic);  [P50 AG005138];  [U01AG061835];  [R21AG063068];  [P50 AG016574];  [R01 AG032990];  [U01 AG046139];  [R01 AG018023];  [U01 AG006576];  [U01 AG006786];  [R01 AG025711];  [R01 AG017216];  [R01 AG003949]	S. G. and M. E. E. acknowledge the support of U01 AG046170 from the NIA. B. R., S. G., M. E. E., and J. T. D. acknowledge the support of 1R56AG058469, 1R01AG058469, and R21AG63968 from the NIA, and P50 AG005138 to Mary Sano. B. R. and J. T. D. acknowledge the support of U01AG061835 and R21AG063068 from the NIA. Philanthropic financial support was provided by Katherine Gehl and by the George B. Link, Jr., Foundation. DM acknowledges the support of the Alzheimer's Association (AARGD-17-529197). The computational resources and staff expertise provided by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai also contributed to the performance of this research. The authors also acknowledge Research Computing at Arizona State University for providing computational resources that have contributed to this research. The Scott Moskowitz Foundation for Alzheimer's Research, the Jane Martin and Stuart Katz Foundation, the Werber Family Foundation, the Sara and Gideon Gartner Foundation, the Louis B. Mayer Foundation, the, the Lady Va and Sir Deryck Maughan Foundation, the Georgianne and Dr. Reza Khatib Foundation, and the Linda Wachner Foundation provided additional support. The results published here are in part based on data obtained from the AMP-AD Knowledge Portal (https://adknowledgeportal.synap se.org/). MSBB RNA-sequencing data was generated from postmortem brain tissue collected through the Mount Sinai VA Medical Center Brain Bank and were provided by Dr. Eric Schadt from Mount Sinai School of Medicine. The MAYO TCX RNAseq study data were provided by the following sources: The Mayo Clinic Alzheimers Disease Genetic Studies, led by Dr. Nilufer Ertekin-Taner and Dr. Steven G. Younkin, Mayo Clinic, Jacksonville, FL using samples from the Mayo Clinic Study of Aging, the Mayo Clinic Alzheimer's Disease Research Center, and the Mayo Clinic Brain Bank. Data collection was supported through funding by NIA grants P50 AG016574, R01 AG032990, U01 AG046139, R01 AG018023, U01 AG006576, U01 AG006786, R01 AG025711, R01 AG017216, R01 AG003949, NINDS grant R01 NS080820, CurePSP Foundation, and support from Mayo Foundation. Study data include samples collected through the Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona. The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinsons Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimers Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimers Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinsons Research. The ROS/MAP RNAseq study data were provided by the Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago. Data collection was supported through funding by NIA grants P30AG10161 (ROS), R01AG15819 (ROSMAP; genomics and RNAseq), R01AG17917 (MAP), R01AG30146, R01AG36836 (RNAseq), RF1AG57473 (single nucleus RNAseq), U01AG46152 (ROSMAP AMP-AD, targeted proteomics), U01AG61356 (whole genome sequencing, targeted proteomics, ROSMAP AMP-AD), the Illinois Department of Public Health (ROSMAP), and the Translational Genomics Research Institute (genomic). Additional phenotypic data can be requested at www.radc.	Allen M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.89; Armbrust KR, 2014, J NEUROSCI, V34, P9891, DOI 10.1523/JNEUROSCI.0876-14.2014; Avery AW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21375; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Beckmann ND, 2018, BIORXIV458430; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; Brai E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00447; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Caggiu Elisa, 2018, eNeurologicalSci, V13, P1, DOI 10.1016/j.ensci.2018.09.002; Pena-Philippides JC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0753-x; Caselli E, 2017, VIROL J, V14, DOI 10.1186/s12985-016-0672-6; Chen EY, 2012, BIOINFORMATICS, V28, P105, DOI 10.1093/bioinformatics/btr625; Chen J, 2018, J GENE MED, V20, DOI 10.1002/jgm.3014; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; De Pietri Tonelli Davide, 2014, Methods Mol Biol, V1092, P31, DOI 10.1007/978-1-60327-292-6_3; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Diez-Zaera M, 2011, MOL BIOL CELL, V22, P1014, DOI 10.1091/mbc.E10-09-0740; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Fanutza T, 2015, ELIFE, V4, DOI 10.7554/eLife.09743; Fonta C, 2005, J COMP NEUROL, V486, P179, DOI 10.1002/cne.20524; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Guedes JR, 2014, HUM MOL GENET, V23, P6286, DOI 10.1093/hmg/ddu348; Haure-Mirande JV, 2019, MOL PSYCHIATR, V24, P431, DOI 10.1038/s41380-018-0255-6; Haure-Mirande JV, 2017, ACTA NEUROPATHOL, V134, P769, DOI 10.1007/s00401-017-1737-3; Henry RJ, 2019, NEUROTHERAPEUTICS, V16, P216, DOI 10.1007/s13311-018-0665-9; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kellett KAB, 2011, INT J MOL EPIDEMIOL, V2, P114; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kim SH, 2014, MOL PSYCHIATR, V19, P1235, DOI 10.1038/mp.2014.87; Knight EM, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000237; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lin TY, 2012, ONCOGENE, V31, P3287, DOI 10.1038/onc.2011.491; Lise S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003074; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mishra A, 2015, TWIN RES HUM GENET, V18, P86, DOI 10.1017/thg.2014.79; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Olah J, 2011, J BIOL CHEM, V286, P34088, DOI 10.1074/jbc.M111.243907; Ou YH, 2007, EMBO J, V26, P3968, DOI 10.1038/sj.emboj.7601825; Patrick E, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0191-y; Readhead B, 2018, NEURON, V99, P64, DOI 10.1016/j.neuron.2018.05.023; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rizzo R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02143; Robinson, 2015, F1000 RES, V4, P1521, DOI DOI 10.12688/f1000research.7563.2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Sharma Salil, 2018, J Alzheimers Dis Parkinsonism, V8, DOI 10.4172/2161-0460.1000420; Siegel G, 2011, CURR OPIN GENET DEV, V21, P491, DOI 10.1016/j.gde.2011.04.008; Sierksma A, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0285-1; Sims R, 2020, NAT NEUROSCI, V23, P311, DOI 10.1038/s41593-020-0599-5; Song J, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00061; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sunyer B, 2007, PROTOCOL EXCHANGE, DOI [10.1038/nprot.2007.390., DOI 10.1038/NPROT.2007.390]; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thome AD, 2016, J NEUROSCI, V36, P2383, DOI 10.1523/JNEUROSCI.3900-15.2016; Vardy ERLC, 2012, NEURODEGENER DIS, V9, P31, DOI 10.1159/000329722; Watson L, 2019, NEUROBIOL DIS, V127, P563, DOI 10.1016/j.nbd.2019.04.008; Woodbury ME, 2015, J NEUROSCI, V35, P9764, DOI 10.1523/JNEUROSCI.4790-14.2015; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhao YG, 2009, J VIROL, V83, P489, DOI 10.1128/JVI.01166-08	84	2	2	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	SEP	2020	140	3					295	315		10.1007/s00401-020-02185-z		JUL 2020	21	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	MZ7SX	WOS:000548506700001	32666270	Green Accepted			2022-02-06	
J	Spinola, S; Hoff, RA; Tsai, J				Spinola, Suzanne; Hoff, Rani A.; Tsai, Jack			A psychosocial mediational model of homelessness among US male and female veterans who served in Iraq and Afghanistan	HEALTH & SOCIAL CARE IN THE COMMUNITY			English	Article						adverse childhood event; Afghanistan; gender; homelessness; Iraq; social support; veteran	ADVERSE CHILDHOOD EXPERIENCES; TRAUMATIC BRAIN-INJURY; RISK-FACTORS; SOCIAL SUPPORT; COMBAT VETERANS; MENTAL-HEALTH; WOMEN; RELIABILITY; RESILIENCE; VALIDATION	Few studies have focused on homelessness among Operations Iraqi Freedom, Enduring Freedom and New Dawn (OEF/OIF/OND) veterans, especially female veterans. An explanatory model of homelessness was constructed and tested for each gender. Data collected in the United States from 833 OEF/OIF/OND veterans (41.5% female;M-age = 35.22,SD = 8.86) who completed the baseline assessment of the Survey of the Experiences of Returning Veterans between September 2011 and July 2014 were analysed. Path analysis was used to examine associations between risk factors and any lifetime homelessness, stratified by gender. Adverse childhood events (ACEs) and low social support were significantly associated with lifetime homelessness for both genders. Social support mediated associations between ACEs and homelessness, after controlling for sociodemographic factors. While sociodemographic risk factors are often considered in homeless prevention, these findings highlight the importance of social support among male and female OEF/OIF/OND veterans, underscoring the need to target this life domain in preventing homelessness.	[Spinola, Suzanne] US Dept Vet Affairs, New England Mental Illness Res, Educ & Clin Ctr, West Haven, CT USA; [Spinola, Suzanne; Hoff, Rani A.; Tsai, Jack] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Hoff, Rani A.] US Dept Vet Affairs, Northeast Program Evaluat Ctr, West Haven, CT USA; [Tsai, Jack] US Dept Vet Affairs, Natl Ctr Homelessness Vet, West Haven, CT USA		Tsai, J (corresponding author), VACT, 950 Campbell Ave,151D, West Haven, CT 06516 USA.	Jack.Tsai@uth.tmc.edu	Tsai, Jack/D-3889-2013	Tsai, Jack/0000-0002-0329-648X	U.S. Department of Veterans Affairs Office of Research and Development, Clinical Science Research and Development Grant ZDA1	The Survey of Experiences of Returning Veterans was funded by the U.S. Department of Veterans Affairs Office of Research and Development, Clinical Science Research and Development Grant ZDA1 (PI: Rani Hoff). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Veterans Health Administration (VHA). Neither financial disclosures nor conflicts of interest were reported by the authors of this manuscript.	Bassuk EL, 1997, AM J PUBLIC HEALTH, V87, P241, DOI 10.2105/AJPH.87.2.241; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Bialik K., 2017, CHANGING FACE AM VET; Byrne T, 2013, WOMEN HEALTH, V53, P572, DOI 10.1080/03630242.2013.817504; Donovan S, 2013, AM J PUBLIC HEALTH, V103, pS180, DOI 10.2105/AJPH.2013.301727; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Fargo J, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110112; Felitti VJ, 2009, ACAD PEDIATR, V9, P131, DOI 10.1016/j.acap.2009.03.001; Gamache G, 2003, AM J PUBLIC HEALTH, V93, P1132, DOI 10.2105/AJPH.93.7.1132; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; GRIGSBY C, 1990, J SOC ISSUES, V46, P141, DOI 10.1111/j.1540-4560.1990.tb01803.x; Herman DB, 1997, AM J PUBLIC HEALTH, V87, P249, DOI 10.2105/AJPH.87.2.249; Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4; IBM Corporation, 2015, IBM SPSS STAT SOFTW; Johnstone M, 2016, HOUSING STUD, V31, P410, DOI 10.1080/02673037.2015.1092504; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Laffaye C, 2008, J TRAUMA STRESS, V21, P394, DOI 10.1002/jts.20348; Lucksted A., 2008, PEER HOUSING LOCATIO; Metraux S, 2013, AM J PUBLIC HEALTH, V103, pS255, DOI 10.2105/AJPH.2013.301432; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; O'Connell M. J., 2016, WAR AND FAMILY LIFE, P281; O'Toole TP, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150567; Pietrzak Robert H, 2009, J Spec Oper Med, V9, P74; Racine N, 2018, ARCH WOMEN MENT HLTH, V21, P663, DOI 10.1007/s00737-018-0826-1; ROSENHECK R, 1994, AM J PSYCHIAT, V151, P421; ROSENHECK R, 1991, AM J PUBLIC HEALTH, V81, P643, DOI 10.2105/AJPH.81.5.643; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schwab KA, 2006, NEUROLOGY, V66, pA235; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; SUSSER E, 1993, EPIDEMIOL REV, V15, P546, DOI 10.1093/oxfordjournals.epirev.a036133; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Tsai J., 2012, ADMINISTRATIVE POLIC, V40, P400; Tsai J, 2018, HOMELESSNESS US VETE; Tsai J, 2019, J PUBLIC HEALTH-UK, V41, pE16, DOI 10.1093/pubmed/fdy076; Tsai J, 2017, PSYCHOL SERV, V14, P113, DOI 10.1037/ser0000164; Tsai J, 2016, HEALTH AFFAIR, V35, P966, DOI 10.1377/hlthaff.2015.1555; Tsai J, 2015, EPIDEMIOL REV, V37, P177, DOI 10.1093/epirev/mxu004; Tsai J, 2013, SOC PSYCH PSYCH EPID, V48, P477, DOI 10.1007/s00127-012-0551-4; Tsai J, 2012, PSYCHIAT SERV, V63, P1186, DOI 10.1176/appi.ps.201200100; Tsai J, 2012, PSYCHIATRY, V75, P135, DOI 10.1521/psyc.2012.75.2.135; Tsai J, 2012, PSYCHIAT SERV, V63, P427, DOI 10.1176/appi.ps.201100047; Tsai J, 2011, J HEALTH CARE POOR U, V22, P853, DOI 10.1353/hpu.2011.0081; U.S. Department of Veterans Affairs, 2018, SERV STUD SURV EXP R; U.S. Department of Veterans Affairs Office of Inspector General, 2012, HOM INC RISK FACT BE; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Washington DL, 2010, J HEALTH CARE POOR U, V21, P81, DOI 10.1353/hpu.0.0237; Weathers FW, 1991, PCL C FOR DSM 4; Yano EM, 2006, J GEN INTERN MED, V21, pS93, DOI 10.1111/j.1525-1497.2006.00381.x; Zinzow HM, 2007, TRAUMA VIOLENCE ABUS, V8, P384, DOI 10.1177/1524838007307295	51	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0966-0410	1365-2524		HEALTH SOC CARE COMM	Health Soc. Care Community	MAR	2021	29	2					453	463		10.1111/hsc.13106		JUL 2020	11	Public, Environmental & Occupational Health; Social Work	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Social Work	QU1TK	WOS:000548220400001	32662176				2022-02-06	
J	Holiday, KA; Clark, AL; Merritt, VC; Nakhla, MZ; Sorg, S; Delano-Wood, L; Schiehser, DM				Holiday, Kelsey A.; Clark, Alexandra L.; Merritt, Victoria C.; Nakhla, Marina Z.; Sorg, Scott; Delano-Wood, Lisa; Schiehser, Dawn M.			Response inhibition in Veterans with a history of mild traumatic brain injury: The role of self-reported complaints in objective performance	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; TBI; response inhibition; executive dysfunction; subjective complaints; Go; No-Go	POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSIVE SYMPTOMS; COGNITIVE DEFICITS; OEF/OIF VETERANS; PROCESSING SPEED; HEAD-INJURY; MILITARY; COMBAT; TBI; QUESTIONNAIRE	Introduction Although objective deficits in response inhibition (RI) have been detected in civilians with mild traumatic brain injury (mTBI), it remains unclear whether objective RI is worse in military Veterans with mTBI despite the prevalence of self-reported disinhibition. Assessing RI in Veterans is critical due to their unique characteristics, including combat and blast exposure, in addition to the prevalence of psychiatric comorbidity. Therefore, the aims of this study were to (1) examine RI performance in Veterans with mTBI compared to non-mTBI Veterans and (2) compare RI performance in well-defined subgroups of mTBI Veterans with and without self-reported complaints of disinhibition to non-mTBI Veterans. Method 53 mTBI Veterans and 37 non-mTBI Veterans completed a Go/No-Go RI task and measures of self-reported disinhibition (Frontal Systems Behavior Scale) and psychiatric symptoms. ANCOVAs covarying for mood and demographics compared RI performances of the non-mTBI Veterans to (1) the total sample of mTBI Veterans (n= 53) and to (2) mTBI Veterans with elevated (t-score >= 60; mTBI-SubjDis;n= 23) and low (t-score n= 30) levels of self-reported disinhibition. Results There were no significant differences in RI between the mTBI group as a whole and the non-mTBI Veterans group. However, when Veterans with mTBI were divided into groups by clinically-significant concern about their disinhibition, the mTBI-SubjDis group demonstrated significantly worse RI than the mTBI-NoSubjDis and non-mTBI Veteran groups. No significant differences in RI performance were observed between the mTBI-NoSubjDis and non-mTBI Veteran groups. Conclusions Results indicate that mTBI Veterans with elevated levels of self-reported disinhibition show diminished performance on objective measures of RI, independent of mood. Findings highlight the unique contribution of subjective complaints on executive functioning in mTBI, and they underscore the importance of assessing cognitive complaints in order to identify those most at risk for poor-long term outcomes.	[Holiday, Kelsey A.; Nakhla, Marina Z.] Univ Calif San Diego, San Diego State Univ, San Diego SDSU UCSD Joint Doctoral Program Clin P, San Diego, CA 92103 USA; [Holiday, Kelsey A.; Clark, Alexandra L.; Merritt, Victoria C.; Nakhla, Marina Z.; Sorg, Scott; Delano-Wood, Lisa; Schiehser, Dawn M.] VA San Diego Healthcare Syst VASDHS, Psychol & Res Serv, San Diego, CA USA; [Sorg, Scott; Delano-Wood, Lisa; Schiehser, Dawn M.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Delano-Wood, Lisa; Schiehser, Dawn M.] VA San Diego Healthcare Syst VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA		Schiehser, DM (corresponding author), UC San Diego VA, San Diego, CA 92161 USA.	dschiehser@ucsd.edu			Veterans AffairsUS Department of Veterans Affairs [CDA-2-065-10S, 829-MR -NB-25860]; Department of DefenseUnited States Department of Defense [W81XWH-10-2-0169]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS108573]; Career Development Award from the VA Clinical Science Research & Development Service [IK2 CX001952]; VA Clinical Science R&D Career Development Award [CX001508-02]; University of California, San Diego's Strategic Enhancement of Excellence through Diversity (SEED) Fellowship	This project was funded by Veterans Affairs grants awarded to Drs. Schiehser [CDA-2-065-10S] and Delano-Wood [829-MR -NB-25860]. This work was further supported by grants awarded by the Department of Defense [W81XWH-10-2-0169] to Dr. Delano-Wood and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health [F31NS108573] to Ms. Holiday. Additionally, Dr. Merritt received salary support from a Career Development Award [IK2 CX001952] from the VA Clinical Science Research & Development Service, and Dr. Sorg received salary support from VA Clinical Science R&D Career Development Award [CX001508-02] during the preparation of this manuscript. Additional support was provided to Ms. Nakhla through the University of California, San Diego's Strategic Enhancement of Excellence through Diversity (SEED) Fellowship.	Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Brady KT, 2009, J ADDICT MED, V3, P179, DOI 10.1097/ADM.0b013e3181aa244f; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Carvalho JO, 2013, ASSESSMENT, V20, P632, DOI 10.1177/1073191113492845; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Cohen J., 2013, STAT POWER ANAL BEHA; Cristofori I, 2017, EXECUTIVE FUNCTIONS IN HEALTH AND DISEASE, P421, DOI 10.1016/B978-0-12-803676-1.00018-0; Davenport ND, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00085; Delis D.C., 2000, CALIFORNIA VERBAL LE; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Francis HM, 2017, BRAIN INJURY, V31, P336, DOI 10.1080/02699052.2016.1250954; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Fryer SL, 2007, ALCOHOL CLIN EXP RES, V31, P1415, DOI 10.1111/j.1530-0277.2007.00443.x; Gaines KD, 2016, APPL NEUROPSYCH-ADUL, V23, P115, DOI 10.1080/23279095.2015.1012762; Haber AH, 2006, CLIN NEUROPSYCHOL, V20, P524, DOI 10.1080/13854040590967595; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; IBMCorp, 2017, IBM SPSS STAT MAC VE; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Karr JE, 2019, J CLIN EXP NEUROPSYC, V41, P680, DOI 10.1080/13803395.2019.1611740; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Knutson KM, 2015, J NEUROPSYCH CLIN N, V27, P193, DOI 10.1176/appi.neuropsych.14060126; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mattson EK, 2019, NEUROPSYCHOLOGY, V33, P913, DOI 10.1037/neu0000560; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Mostofsky SH, 2008, J COGNITIVE NEUROSCI, V20, P751, DOI 10.1162/jocn.2008.20500; Mueller JA, 2013, J SPEECH LANG HEAR R, V56, P1051, DOI 10.1044/1092-4388(2012/12-0147); Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Pearce B, 2016, BRAIN INJURY, V30, P1708, DOI 10.1080/02699052.2016.1202450; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Raab GM, 2000, CONTROL CLIN TRIALS, V21, P330, DOI 10.1016/S0197-2456(00)00061-1; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Schneider BA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00474; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Schweinsburg AD, 2004, ANN NY ACAD SCI, V1021, P391, DOI 10.1196/annals.1308.050; Shen IH, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6122; Smith EE, 2020, J CLIN EXP NEUROPSYC, V42, P90, DOI 10.1080/13803395.2019.1676882; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Sorg SF, 2016, J HEAD TRAUMA REHAB, V31, P297, DOI 10.1097/HTR.0000000000000189; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Tarazi A, 2018, J NEUROTRAUM, V35, P1003, DOI 10.1089/neu.2017.5290; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Uzefovsky F, 2016, J AUTISM DEV DISORD, V46, P2774, DOI 10.1007/s10803-016-2788-3; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Weathers F.W., 1993, 9 ANN C ISTSS; Xu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14867-y	69	2	2	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL 2	2020	42	6					556	568		10.1080/13803395.2020.1776847		JUL 2020	13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	MY5JS	WOS:000547684600001	32657255				2022-02-06	
J	Blackwell, LS; Shishido, Y; Howarth, R				Blackwell, Laura S.; Shishido, Yuri; Howarth, Robyn			Cognitive recovery of children and adolescents with moderate to severe TBI during inpatient rehabilitation	DISABILITY AND REHABILITATION			English	Article; Early Access						Adolescent; child; cognition; recovery of function; rehabilitation; traumatic brain injury (TBI)	TRAUMATIC BRAIN-INJURY; LINGUISTIC SCALE; PREDICTORS; OUTCOMES; UTILITY; ASSESSMENTS; AGE	Objective Traumatic brain injury (TBI) is the leading cause of morbidity and mortality in children and adolescents. This study examines the early cognitive-linguistic recovery of pediatric patients who sustained TBI and required inpatient rehabilitation and investigates the contribution of various demographic, clinical, and preinjury factors to recovery. Methods A retrospective chart review of children and adolescents, ages 3-20 years, admitted to an inpatient rehabilitation unit. Acute outcomes were assessed at admission and discharge using the WeeFIM and CALS. Premorbid measures of behavioral and emotional functioning were also collected. Results One hundred and one children and adolescents (mean age = 12.31, SD = 4.46) diagnosed with TBI requiring inpatient rehabilitation were included. Patients displayed significant improvements on cognitive-linguistic skills and functional independence between admission and discharge, with medium to large effect sizes. Premorbid behavioral-emotional functioning was not found to be associated with early cognitive recovery. Conclusion Results suggest that significant functional improvements can be expected for pediatric patients with TBI during inpatient rehabilitation. Consistent with previous literature, injury severity was significantly related to acute outcomes. In conjunction with the WeeFIM, the CALS appears to be a meaningful complement for assessing and monitoring cognitive-linguistic skills during inpatient rehabilitation.Implications for Rehabiliation Our study provides support for the utility of the CALS to assess cognitive recovery during inpatient rehabilitation following moderate to severe TBI. Injury severity and not pre-injury functioning or demographic variables was related to worse scores on the CALS at discharge. Using a measure sensitive to change over admission, such as the CALS, can inform treatment planning.	[Blackwell, Laura S.; Howarth, Robyn] Childrens Healthcare Atlanta, Dept Neuropsychol, 5455 Meridian Mark Rd,Suite 180, Atlanta, GA 30342 USA; [Shishido, Yuri] Kennedy Krieger Inst, Dept Neuropsychol, Baltimore, MD USA; [Shishido, Yuri] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA		Blackwell, LS (corresponding author), Childrens Healthcare Atlanta, Dept Neuropsychol, 5455 Meridian Mark Rd,Suite 180, Atlanta, GA 30342 USA.	laura.blackwell@choa.org					Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P266, DOI 10.1136/adc.2008.147926; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; HALEY SM, 1992, PEDIAT PHYS THERAPY, V4, P24; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Maas A, 2005, HDB CLIN NEUROL, V128, P455; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; Ottenbacher KJ, 2000, ARCH PHYS MED REHAB, V81, P1317, DOI 10.1053/apmr.2000.9387; Peterson RL, 2015, J NEUROPSYCH CLIN N, V27, P280, DOI 10.1176/appi.neuropsych.14120373; Pham K, 2014, J HEAD TRAUMA REHAB, V29, pE44, DOI 10.1097/HTR.0000000000000022; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Risen SR, 2014, J PEDIATR-US, V164, P613, DOI 10.1016/j.jpeds.2013.10.075; Schuchat A, 2018, REPORT C MANAGEMENT; Slomine B, 2008, J HEAD TRAUMA REHAB, V23, P286, DOI 10.1097/01.HTR.0000336841.53338.2f; Slomine BS, 2016, REHABIL PSYCHOL, V61, P328, DOI 10.1037/rep0000096; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Tailor YI, 2013, J PEDIATR REHAB MED, V6, P163, DOI 10.3233/PRM-130248; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008	28	2	2	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2020.1788176		JUL 2020	7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	MI9RW	WOS:000547736300001	32649219				2022-02-06	
J	Suarez-Arrones, L; De Alba, B; Roll, M; Torreno, I; Strutt, S; Freyler, K; Ritzmann, R				Suarez-Arrones, Luis; De Alba, Borja; Roell, Mareike; Torreno, Ignacio; Strutt, Sarah; Freyler, Kathrin; Ritzmann, Ramona			Player Monitoring in Professional Soccer: Spikes in Acute:Chronic Workload Are Dissociated From Injury Occurrence	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						elite sport; distance; running; training; competition; match; contact injuries; non-contact injuries	HEART-RATE; RUNNING PERFORMANCE; OFFICIAL GAMES; TRAINING LOAD; MATCH-PLAY; FOOTBALL; RISK; RATIO; GPS; PREVENTION	This study aimed to determine whether spikes in acute:chronic workload ratio (ACWR) are associated with injury incidence, and to examine the differences in external load due to greater or lesser exposure to matches and the long-term effects of the load during a chronic seasonal period. Fifteen professional soccer players belonging to the squad of a European Champions League club were enrolled in this study. External training and match load were assessed from all athletes using a global positioning system (GPS). We calculated the uncoupled ACWR for 10 consecutive competitive microcycles. Injuries were identified and determined by the days of absence. The differences in external load were determined using a linear mixed-model approach. In addition to the null hypothesis testing, the effect size was calculated. Thirteen athletes who did not suffer an injury exceeded several times the critical threshold of an ACWR > 1.5. This is equivalent to 1 player exceeding the critical threshold for ACWR in total distance (TD), 2 players for ACWR at distance covered above moderate speed (MSD), 2 players for ACWR at distance covered above high speed (HSD), 2 players for ACWR at distance covered above very high speed (VHSD), and 2 players for ACWR in DC at sprint per week. One athlete experienced a non-contact muscle strain injury and another a contact -injury manifested as a concussion; both athletes document an ACWR < 1.5 within the 4 weeks prior to the injury event. Players with lesser participation in official games covered lower TD (-19.6%, very-large ES), MSD (-24.8%, very-large ES), HSD (-25.1%, moderate ES), VHSD (-25.5%, moderate ES), and DC at sprint (-30.6%, moderate ES) over the course of the 10-weeks period in comparison with the players with greater participation in official games. The present study demonstrated that spikes in the ACWR were not related to a subsequent injury occurrence in professional soccer players. Differences in participation in official games caused significant imbalances in the chronic external loads between players in a squad, which should be minimized in training sessions in order to prevent substantial changes in workload for those who usually do not play.	[Suarez-Arrones, Luis] Univ Pablo de Olavide, Sect Phys Educ & Sports, Dept Sports & Comp Sci, Seville, Spain; [Suarez-Arrones, Luis; Torreno, Ignacio] FC Basel 1893, Basel, Switzerland; [De Alba, Borja] FC Sevilla Performance Dept, Seville, Spain; [Roell, Mareike; Freyler, Kathrin] Univ Freiburg, Dept Sport & Sport Sci, Freiburg, Germany; [Ritzmann, Ramona] Praxisklin Rennbahn AG, Muttenz, Switzerland		Freyler, K (corresponding author), Univ Freiburg, Dept Sport & Sport Sci, Freiburg, Germany.	kathrin.freyler@sport.uni-freiburg.de		Suarez Moreno-Arrones, Luis Jesus/0000-0002-5432-4786			Al Haddad H, 2018, J SPORT MED PHYS FIT, V58, P1439, DOI 10.23736/S0022-4707.17.07500-4; Al Haddad H, 2015, INT J SPORT PHYSIOL, V10, P888, DOI 10.1123/ijspp.2014-0539; Andrzejewski M, 2016, INT J PERF ANAL SPOR, V16, P817, DOI 10.1080/24748668.2016.11868930; Campos-Vazquez MA, 2015, INT J SPORT PHYSIOL, V10, P587, DOI 10.1123/ijspp.2014-0294; Bahr R, 2016, BRIT J SPORT MED, V50, P776, DOI 10.1136/bjsports-2016-096256; Bowen L, 2020, BRIT J SPORT MED, V54, P731, DOI 10.1136/bjsports-2018-099422; Bowen L, 2017, BRIT J SPORT MED, V51, P452, DOI 10.1136/bjsports-2015-095820; Buchheit M, 2017, BRIT J SPORT MED, V51, P1325, DOI 10.1136/bjsports-2016-097017; Buchheit M, 2008, J STRENGTH COND RES, V22, P365, DOI 10.1519/JSC.0b013e3181635b2e; Coppalle S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00409; Coutts AJ, 2010, J SCI MED SPORT, V13, P133, DOI 10.1016/j.jsams.2008.09.015; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Engebretsen AH, 2008, AM J SPORT MED, V36, P1052, DOI 10.1177/0363546508314432; Eniseler N, 2005, J STRENGTH COND RES, V19, P799; Fanchini M, 2018, SCI MED FOOTBALL, V2, P108, DOI 10.1080/24733938.2018.1429014; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Hagglund M, 2013, BRIT J SPORT MED, V47, P738, DOI 10.1136/bjsports-2013-092215; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hulin BT, 2016, BRIT J SPORT MED, V50, P231, DOI 10.1136/bjsports-2015-094817; Hulin BT, 2014, BRIT J SPORT MED, V48, P708, DOI 10.1136/bjsports-2013-092524; Impellizzeri F., 2020, SPORTRXIV, DOI [10.31236/osf.io/e8kt4, DOI 10.31236/OSF.IO/E8KT4]; Impellizzeri FM, 2019, INT J SPORT PHYSIOL, V14, P270, DOI 10.1123/ijspp.2018-0935; Jaspers A, 2018, J SCI MED SPORT, V21, P579, DOI 10.1016/j.jsams.2017.10.005; Lolli L, 2020, SCAND J MED SCI SPOR, V30, P523, DOI 10.1111/sms.13591; Malone S, 2019, J SCI MED SPORT, V22, P29, DOI 10.1016/j.jsams.2018.01.010; Malone S, 2018, J SCI MED SPORT, V21, P257, DOI 10.1016/j.jsams.2017.05.016; Malone S, 2017, J SCI MED SPORT, V20, P250, DOI 10.1016/j.jsams.2016.08.005; Martin-Garcia A, 2018, J STRENGTH COND RES, V32, P3511, DOI 10.1519/JSC.0000000000002816; Mendez-Villanueva A, 2011, EUR J APPL PHYSIOL, V111, P2387, DOI 10.1007/s00421-011-1868-5; Paul DJ, 2015, INT J SPORT PHYSIOL, V10, P516, DOI 10.1123/IJSPP.2015-0029; Paulauskas H, 2019, INT J SPORT PHYSIOL, V14, P941, DOI 10.1123/ijspp.2018-0741; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Rampinini E, 2015, INT J SPORTS MED, V36, P49, DOI 10.1055/s-0034-1385866; Schache AG, 2009, GAIT POSTURE, V29, P332, DOI 10.1016/j.gaitpost.2008.10.054; Stevens TGA, 2017, SCI MED FOOTBALL, V1, P117, DOI 10.1080/24733938.2017.1282163; Suarez-Arrones L, 2015, J SPORT MED PHYS FIT, V55, P1417; Suarez-Arrones L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213375; Torreno N, 2016, INT J SPORT PHYSIOL, V11, P940, DOI 10.1123/ijspp.2015-0252; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Wang CC, 2020, SPORTS MED, V50, P1243, DOI 10.1007/s40279-020-01280-1; Winter EM, 2009, J SPORT SCI, V27, P985, DOI 10.1080/02640410903178344	42	2	2	3	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	JUL 8	2020	2								75	10.3389/fspor.2020.00075			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	WF0DU	WOS:000705987100001	33345066	Green Published, gold			2022-02-06	
J	Fischer, JB; Ghouse, A; Tagliabue, S; Maruccia, F; Rey-Perez, A; Baguena, M; Cano, P; Zucca, R; Weigel, UM; Sahuquillo, J; Poca, MA; Durduran, T				Fischer, Jonas B.; Ghouse, Ameer; Tagliabue, Susanna; Maruccia, Federica; Rey-Perez, Anna; Baguena, Marcelino; Cano, Paola; Zucca, Riccardo; Weigel, Udo M.; Sahuquillo, Juan; Poca, Maria A.; Durduran, Turgut			Non-Invasive Estimation of Intracranial Pressure by Diffuse Optics: A Proof-of-Concept Study	JOURNAL OF NEUROTRAUMA			English	Article						diffuse optics; intracranial pressure; near-infrared spectroscopy; neural networks; non-invasive	BLOOD-FLOW; TRANSCRANIAL DOPPLER; CORRELATION SPECTROSCOPY; EPIDURAL SPACE; BRAIN	Intracranial pressure (ICP) is an important parameter to monitor in several neuropathologies. However, because current clinically accepted methods are invasive, its monitoring is limited to patients in critical conditions. On the other hand, there are other less critical conditions for which ICP monitoring could still be useful; therefore, there is a need to develop non-invasive methods. We propose a new method to estimate ICP based on the analysis of the non-invasive measurement of pulsatile, microvascular cerebral blood flow with diffuse correlation spectroscopy. This is achieved by training a recurrent neural network using only the cerebral blood flow as the input. The method is validated using a 50% split sample method using the data from a proof-of-concept study. The study involved a population of infants (n = 6) with external hydrocephalus (initially diagnosed as benign enlargement of subarachnoid spaces) as well as a population of adults (n = 6) with traumatic brain injury. The algorithm was applied to each cohort individually to obtain a model and an ICP estimate. In both diverse cohorts, the non-invasive estimation of ICP was achieved with an accuracy of <4 mm Hg and a negligible small bias. Further, we have achieved a good correlation (Pearson's correlation coefficient >0.9) and good concordance (Lin's concordance correlation coefficient >0.9) in comparison with standard clinical, invasive ICP monitoring. This preliminary work paves the way for further investigations of this tool for the non-invasive, bedside assessment of ICP.	[Fischer, Jonas B.; Ghouse, Ameer; Tagliabue, Susanna; Maruccia, Federica; Durduran, Turgut] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Barcelona, Spain; [Fischer, Jonas B.; Weigel, Udo M.] HemoPhoton SL, Barcelona, Spain; [Maruccia, Federica; Sahuquillo, Juan; Poca, Maria A.] Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain; [Rey-Perez, Anna; Baguena, Marcelino] Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Neurotrauma Intens Care Unit, Barcelona, Spain; [Cano, Paola; Sahuquillo, Juan; Poca, Maria A.] Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Dept Neurosurg, Barcelona, Spain; [Zucca, Riccardo] Barcelona Inst Sci & Technol, Inst Bioengn Catalonia IBEC, Synthet Percept Emot & Cognit Syst SPECS, Barcelona, Spain; [Durduran, Turgut] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain		Durduran, T (corresponding author), ICFO Inst Photon Sci, Mediterranean Technol Pk, Barcelona 08860, Spain.	turgut.durduran@icfo.eu	Zucca, Riccardo/AAA-7570-2020; Sahuquillo, Juan/B-3577-2008; Poca, Maria A./B-8475-2008	Zucca, Riccardo/0000-0003-4808-6010; Sahuquillo, Juan/0000-0003-0713-5875; Poca, Maria A./0000-0002-3831-0536; Maruccia, Federica/0000-0002-3774-7875	European Union's Horizon 2020 project "BitMap: Brain Injury and Trauma Monitoring Using Advanced Photonics'' [675332]; Fundacio CELLEX BarcelonaFoundation CELLEXEuropean Commission; Ministerio de Economia y Competitividad/FEDER (PHOTODEMENTIA) [DPI2015-64358-C2-1-R]; Instituto de Salud Carlos III/FEDER (MEDPHOTAGE) [DTS16/00087, PI18/00468]; "Severo Ochoa'' Programme for Centers of Excellence in RD [SEV-2015-0522]; Obra social "laCaixa'' Foundation (LlumMedBcn); Institucio CERCA, AGAURGeneralitat [2017 SGR 1380]; LASERLAB-EUROPE IV; KidsBrainIT (ERA-NET NEURON); la Fundacio La Marato de TV3 [201709.31, 201724.31]	This work was funded by the European Union's Horizon 2020 project "BitMap: Brain Injury and Trauma Monitoring Using Advanced Photonics'' (No. 675332); Fundacio CELLEX Barcelona; Ministerio de Economia y Competitividad/FEDER (PHOTODEMENTIA, DPI2015-64358-C2-1-R); Instituto de Salud Carlos III/FEDER (MEDPHOTAGE, DTS16/00087 and PI18/00468); the "Severo Ochoa'' Programme for Centers of Excellence in R&D (SEV-2015-0522); the Obra social "laCaixa'' Foundation (LlumMedBcn); Institucio CERCA, AGAURGeneralitat (2017 SGR 1380); LASERLAB-EUROPE IV; KidsBrainIT (ERA-NET NEURON); and la Fundacio La Marato de TV3 (201709.31 and 201724.31).	Poca MA, 2007, J NEUROSURG, V106, P548, DOI 10.3171/jns.2007.106.4.548; Ba J., 2015, ICLR; Baker WB, 2017, J CEREBR BLOOD F MET, V37, P2691, DOI 10.1177/0271678X17709166; Baker WB, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.035004; Baker WB, 2014, BIOMED OPT EXPRESS, V5, P4053, DOI 10.1364/BOE.5.004053; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Bengio Y., 1995, CONVOLUTIONAL NETWOR; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cho K., 2014, P 2014 C EMP METH NA, P1724; Chung J., 2014, NIPS 2014 WORKSH DEE; Dietsche G, 2007, APPL OPTICS, V46, P8506, DOI 10.1364/AO.46.008506; Durduran T, 2004, OPT LETT, V29, P1766, DOI 10.1364/OL.29.001766; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Eide PK, 2010, J NEUROSURG, V113, P1317, DOI 10.3171/2010.7.JNS10483; Farzam P., 2017, SPIE P, V10050, p100500U; Ganslandt O, 2018, J NEUROSURG, V128, P1653, DOI 10.3171/2016.11.JNS152268; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI 10.1162/neco.1997.9.8.1735; Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607; Juul N., 2001, NEUROSURG FOCUS, V11, P1; Kampfl A, 1997, ACT NEUR S, V70, P112; Kashif FM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003249; Khan Marium Naveed, 2017, Surg Neurol Int, V8, P51, DOI 10.4103/sni.sni_403_16; Kim S, 2013, IEEE T BIO-MED ENG, V60, P1126, DOI 10.1109/TBME.2012.2227477; KIRKPATRICK PJ, 1995, J NEUROSURG, V83, P963, DOI 10.3171/jns.1995.83.6.0963; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Mesquita RC, 2013, BIOMED OPT EXPRESS, V4, P978, DOI 10.1364/BOE.4.000978; Mikkelsen R, 2017, CHILD NERV SYST, V33, P91, DOI 10.1007/s00381-016-3267-z; Milroy DJ, 2019, PROCEEDINGS OF 2019 IEEE/ACM 3RD INTERNATIONAL WORKSHOP ON SOFTWARE CORRECTNESS FOR HPC APPLICATIONS (CORRECTNESS 2019), P44, DOI 10.1109/Correctness49594.2019.00011; Miner, 2017, HDB STAT ANAL DATA M; Narayan V, 2018, WORLD NEUROSURG, V114, P293, DOI 10.1016/j.wneu.2018.02.159; Piper I, 2003, ACTA NEUROCHIR, V145, P615, DOI 10.1007/s00701-003-0066-6; Quachtran B, 2016, INT C PATT RECOG, P2491, DOI 10.1109/ICPR.2016.7900010; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Rajajee V, 2018, NEUROCRIT CARE, V29, P280, DOI 10.1007/s12028-018-0540-x; Robba C, 2016, ACTA NEUROL SCAND, V134, P4, DOI 10.1111/ane.12527; Robba C, 2018, INTENS CARE MED, V44, P1284, DOI 10.1007/s00134-018-5305-7; Ruesch A, 2020, BIOMED OPT EXPRESS, V11, P1462, DOI 10.1364/BOE.386612; Ruesch A, 2020, J CEREBR BLOOD F MET, V40, P2304, DOI 10.1177/0271678X19891359; Selb J, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.015005; Spiegelberg A, 2016, INTERDISCIP NEUROSUR, V6, P13, DOI 10.1016/j.inat.2016.03.004; Varsos GV, 2015, J NEUROSURG, V123, P638, DOI 10.3171/2014.10.JNS14613; Wang DT, 2019, NEUROPHOTONICS, V6, DOI 10.1117/1.NPh.6.3.035013; Wang DT, 2016, BIOMED OPT EXPRESS, V7, P776, DOI 10.1364/BOE.7.000776; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9	48	2	2	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2020	37	23					2569	2579		10.1089/neu.2019.6965		JUL 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PC0XQ	WOS:000547981000001	32460617	Green Submitted, Green Published			2022-02-06	
J	Frazier, HN; Ghoweri, AO; Anderson, KL; Lin, RL; Popa, GJ; Mendenhall, MD; Reagan, LP; Craven, RJ; Thibault, O				Frazier, Hilaree N.; Ghoweri, Adam O.; Anderson, Katie L.; Lin, Ruei-Lung; Popa, Gabriel J.; Mendenhall, Michael D.; Reagan, Lawrence P.; Craven, Rolf J.; Thibault, Olivier			Elevating Insulin Signaling Using a Constitutively Active Insulin Receptor Increases Glucose Metabolism and Expression of GLUT3 in Hippocampal Neurons	FRONTIERS IN NEUROSCIENCE			English	Article						hippocampus; neuron; astrocyte; glucose metabolism; GLUT3; signaling	CENTRAL-NERVOUS-SYSTEM; INTRANASALLY ADMINISTERED INSULIN; PRIMARY CULTURED NEURONS; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; GROWTH-FACTOR-I; TRANSPORTER EXPRESSION; GENE-EXPRESSION; IMMUNOHISTOCHEMICAL LOCALIZATION; TYROSINE PHOSPHORYLATION	Insulin signaling is an integral component of healthy brain function, with evidence of positive insulin-mediated alterations in synaptic integrity, cerebral blood flow, inflammation, and memory. However, the specific pathways targeted by this peptide remain unclear. Previously, our lab used a molecular approach to characterize the impact of insulin signaling on voltage-gated calcium channels and has also shown that acute insulin administration reduces calcium-induced calcium release in hippocampal neurons. Here, we explore the relationship between insulin receptor signaling and glucose metabolism using similar methods. Mixed, primary hippocampal cultures were infected with either a control lentivirus or one containing a constitutively active human insulin receptor (IR beta). 2-NBDG imaging was used to obtain indirect measures of glucose uptake and utilization. Other outcome measures include Western immunoblots of GLUT3 and GLUT4 on total membrane and cytosolic subcellular fractions. Glucose imaging data indicate that neurons expressing IR beta show significant elevations in uptake and rates of utilization compared to controls. As expected, astrocytes did not respond to the IR beta treatment. Quantification of Western immunoblots show that IR beta is associated with significant elevations in GLUT3 expression, particularly in the total membrane subcellular fraction, but did not alter GLUT4 expression in either fraction. Our work suggests that insulin plays a significant role in mediating neuronal glucose metabolism, potentially through an upregulation in the expression of GLUT3. This provides further evidence for a potential therapeutic mechanism underlying the beneficial impact of intranasal insulin in the clinic.	[Frazier, Hilaree N.; Ghoweri, Adam O.; Anderson, Katie L.; Lin, Ruei-Lung; Craven, Rolf J.; Thibault, Olivier] Univ Kentucky, Coll Med, Dept Pharmacol & Nutr Sci, Lexington, KY 40506 USA; [Popa, Gabriel J.; Mendenhall, Michael D.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA; [Reagan, Lawrence P.] Univ South Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, Columbia, SC 29208 USA		Thibault, O (corresponding author), Univ Kentucky, Coll Med, Dept Pharmacol & Nutr Sci, Lexington, KY 40506 USA.	othilbau@uky.edu	Thibault, Olivier/AAY-7614-2020	Thibault, Olivier/0000-0002-3548-3466; Frazier, Hilaree/0000-0003-2309-2596	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG033649, T32DK007778, T32AG057461, P30GM110787]; University of Kentucky College of Medicine; University of Kentucky Department of Pharmacology and Nutritional Sciences (Reinvestment Fund Award)	This research was supported by the National Institutes of Health (R01AG033649 to OT, T32DK007778 to HF, and T32AG057461 to AG), the University of Kentucky College of Medicine (fellowship to HF), and the University of Kentucky Department of Pharmacology and Nutritional Sciences (Reinvestment Fund Award). The Molecular Medicine Genetic Technology Core at the University of Kentucky is supported in part by the National Institutes of Health (P30GM110787).	Abe T, 2006, J CEREBR BLOOD F MET, V26, P153, DOI 10.1038/sj.jcbfm.9600175; Adzovic L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0282-z; Akintola AA, 2017, AGING-US, V9, P790, DOI 10.18632/aging.101192; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Baura GD, 1996, DIABETES, V45, P86, DOI 10.2337/diabetes.45.1.86; Beirami E, 2017, NEUROSCI LETT, V660, P122, DOI 10.1016/j.neulet.2017.09.026; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Benomar Y, 2006, ENDOCRINOLOGY, V147, P2550, DOI 10.1210/en.2005-1464; Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; BILAN PJ, 1992, BIOCHEM BIOPH RES CO, V186, P1129, DOI 10.1016/0006-291X(92)90864-H; BOYD FT, 1983, AM J PHYSIOL, V245, pC283, DOI 10.1152/ajpcell.1983.245.3.C283; Brabazon F, 2017, J CEREBR BLOOD F MET, V37, P3203, DOI 10.1177/0271678X16685106; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Bruckner BA, 1999, METABOLISM, V48, P422, DOI 10.1016/S0026-0495(99)90098-7; Chapman CD, 2018, NEUROPHARMACOLOGY, V136, P196, DOI 10.1016/j.neuropharm.2017.11.037; Chen YX, 2018, NEUROTOX RES, V33, P716, DOI 10.1007/s12640-017-9809-7; Chik CL, 1997, ENDOCRINOLOGY, V138, P2033, DOI 10.1210/en.138.5.2033; Choeiri C, 2002, NEUROSCIENCE, V111, P19, DOI 10.1016/S0306-4522(01)00619-4; Cholerton B, 2011, DIABETIC MED, V28, P1463, DOI 10.1111/j.1464-5491.2011.03464.x; CIARALDI T, 1985, ENDOCRINOLOGY, V116, P2179, DOI 10.1210/endo-116-6-2179; Cidad P, 2004, BIOCHEM J, V384, P629, DOI 10.1042/BJ20040886; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; Craft S, 1996, NEUROBIOL AGING, V17, P123, DOI 10.1016/0197-4580(95)02002-0; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; da Silva AX, 2002, J NEUROCHEM, V81, P1328; de la Monte SM, 2013, EXPERT OPIN DRUG DEL, V10, P1699, DOI 10.1517/17425247.2013.856877; Diaz-Garcia CM, 2017, CELL METAB, V26, P361, DOI 10.1016/j.cmet.2017.06.021; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; Dimitriadis G, 2005, CYTOM PART A, V64A, P27, DOI 10.1002/cyto.a.20108; DiNuzzo M, 2010, J CEREBR BLOOD F MET, V30, P1895, DOI 10.1038/jcbfm.2010.151; Dore S, 1997, NEUROSCIENCE, V80, P1033, DOI 10.1016/S0306-4522(97)00154-1; Fattoretti P, 2001, J HISTOCHEM CYTOCHEM, V49, P671, DOI 10.1177/002215540104900518; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; Fladeby C, 2003, BBA-MOL CELL RES, V1593, P201, DOI 10.1016/S0167-4889(02)00390-7; Frazier HN, 2019, NEUROCHEM RES, V44, P269, DOI 10.1007/s11064-018-2510-2; Frazier HN, 2020, J GERONTOL A-BIOL, V75, P1021, DOI 10.1093/gerona/glz105; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Garcia-Casares N, 2014, J ALZHEIMERS DIS, V40, P375, DOI 10.3233/JAD-131736; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013; Goebel SM, 2005, MOL BRAIN RES, V142, P65, DOI 10.1016/j.molbrainres.2005.09.012; Gomez O, 2010, J ANAT, V217, P616, DOI 10.1111/j.1469-7580.2010.01291.x; Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Gupta A, 2012, MOL BIOL CELL, V23, P3882, DOI 10.1091/mbc.E12-05-0337; Heni M, 2014, ACTA DIABETOL, V51, P679, DOI 10.1007/s00592-013-0546-y; Holscher C, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00088; Hoyer S, 1998, J NEURAL TRANSM, V105, P415, DOI 10.1007/s007020050067; Huang TJ, 2005, MOL CELL NEUROSCI, V28, P42, DOI 10.1016/j.mcn.2004.08.009; ISRAEL PA, 1993, BRAIN RES BULL, V30, P571, DOI 10.1016/0361-9230(93)90084-O; Itakura M, 2013, NEUROSCI LETT, V550, P173, DOI 10.1016/j.neulet.2013.06.064; Itoh Y, 2004, J CEREBR BLOOD F MET, V24, P993, DOI 10.1097/01.WCB.0000127661.07591.DE; JOOST HG, 1995, CELL SIGNAL, V7, P85, DOI 10.1016/0898-6568(94)00071-I; KAR S, 1993, J COMP NEUROL, V333, P375, DOI 10.1002/cne.903330306; Kern W, 1999, DIABETES, V48, P557, DOI 10.2337/diabetes.48.3.557; Klip A, 2019, J BIOL CHEM, V294, P11369, DOI 10.1074/jbc.REV119.008351; Kobayashi M, 1996, NEUROSCI LETT, V213, P103, DOI 10.1016/0304-3940(96)12845-7; Kullmann S, 2017, PHYSIOL BEHAV, V176, P134, DOI 10.1016/j.physbeh.2017.03.036; LEBWOHL DE, 1991, J BIOL CHEM, V266, P386; Lee S, 2017, J ENDOCRINOL, V233, pR67, DOI 10.1530/JOE-17-0002; Liu CC, 2015, J NEUROSCI, V35, P5851, DOI 10.1523/JNEUROSCI.5180-14.2015; Lundgaard I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7807; Magistretti PJ, 2009, AM J CLIN NUTR, V90, p875S, DOI 10.3945/ajcn.2009.27462CC; MAHER F, 1991, Molecular and Cellular Neuroscience, V2, P351, DOI 10.1016/1044-7431(91)90066-W; MAHER F, 1994, BIOCHEM J, V301, P379, DOI 10.1042/bj3010379; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; MAHER F, 1995, J NEUROSCI RES, V42, P459, DOI 10.1002/jnr.490420404; Maimaiti S, 2017, NEUROSCIENCE, V364, P130, DOI 10.1016/j.neuroscience.2017.09.019; Maimaiti S, 2016, J GERONTOL A-BIOL, V71, P30, DOI 10.1093/gerona/glu314; Mamik MK, 2016, J NEUROSCI, V36, P10683, DOI 10.1523/JNEUROSCI.1287-16.2016; MANTYCH GJ, 1992, ENDOCRINOLOGY, V131, P1270, DOI 10.1210/en.131.3.1270; Matioli Maria Niures P.S., 2015, Dement. neuropsychol., V9, P96, DOI 10.1590/1980-57642015DN92000003; MCCALL AL, 1994, BRAIN RES, V659, P292, DOI 10.1016/0006-8993(94)90896-6; McEwen BS, 2004, EUR J PHARMACOL, V490, P13, DOI 10.1016/j.ejphar.2004.02.041; McNay EC, 2010, NEUROBIOL LEARN MEM, V93, P546, DOI 10.1016/j.nlm.2010.02.002; Messier Claude, 2005, Neural Plasticity, V12, P311, DOI 10.1155/NP.2005.311; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; NAGAMATSU S, 1993, FEBS LETT, V334, P289, DOI 10.1016/0014-5793(93)80697-S; Natarajan A, 1999, METAB ENG, V1, P320, DOI 10.1006/mben.1999.0125; Pancani T, 2013, NEUROBIOL AGING, V34, P1977, DOI 10.1016/j.neurobiolaging.2013.02.019; Pancani T, 2011, CELL CALCIUM, V50, P548, DOI 10.1016/j.ceca.2011.09.002; Pancani T, 2009, J NEUROCHEM, V109, P1800, DOI 10.1111/j.1471-4159.2009.06107.x; Pearson-Leary J, 2018, BEHAV BRAIN RES, V338, P32, DOI 10.1016/j.bbr.2017.09.033; Pearson-Leary J, 2016, J NEUROSCI, V36, P11851, DOI 10.1523/JNEUROSCI.1700-16.2016; Piroli GG, 2007, NEUROENDOCRINOLOGY, V85, P71, DOI 10.1159/000101694; Piroli GG, 2002, J COMP NEUROL, V452, P103, DOI 10.1002/cne.10368; Porter NM, 1997, J NEUROSCI, V17, P5629; Rajakumar A, 2004, J BIOL CHEM, V279, P26768, DOI 10.1074/jbc.M402735200; Rajasekar N, 2017, MOL NEUROBIOL, V54, P6507, DOI 10.1007/s12035-016-0169-8; RAYNER DV, 1994, CAN J PHYSIOL PHARM, V72, P476, DOI 10.1139/y94-069; Reagan LP, 2000, BRAIN RES, V862, P292, DOI 10.1016/S0006-8993(00)02212-5; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Reno CM, 2017, DIABETES, V66, P587, DOI 10.2337/db16-0917; Salih DAM, 2012, GENE DEV, V26, P2780, DOI 10.1101/gad.208926.112; Schechter R, 1998, BRAIN RES, V808, P270, DOI 10.1016/S0006-8993(98)00842-7; Schulingkamp RJ, 2000, NEUROSCI BIOBEHAV R, V24, P855, DOI 10.1016/S0149-7634(00)00040-3; SCHWARTZ MW, 1990, PEPTIDES, V11, P467, DOI 10.1016/0196-9781(90)90044-6; SENA A, 1995, TRENDS NEUROSCI, V18, P485, DOI 10.1016/0166-2236(95)92770-Q; SHANKER G, 1988, NEUROCHEM RES, V13, P429, DOI 10.1007/BF01268877; Shin BC, 2018, J NEUROSCI, V38, P9579, DOI 10.1523/JNEUROSCI.0503-18.2018; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P47, DOI 10.1016/j.physbeh.2004.07.022; TCHILIAN EZ, 1990, NEUROPEPTIDES, V17, P193, DOI 10.1016/0143-4179(90)90035-W; Thibault O, 2013, EUR J PHARMACOL, V719, P34, DOI 10.1016/j.ejphar.2013.07.024; Uemura E, 2006, EXP NEUROL, V198, P48, DOI 10.1016/j.expneurol.2005.10.035; UNGER J, 1989, NEUROSCIENCE, V31, P143, DOI 10.1016/0306-4522(89)90036-5; UNGER JW, 1991, PROG NEUROBIOL, V36, P343, DOI 10.1016/0301-0082(91)90015-S; Vannucci SJ, 1998, BRAIN RES, V797, P1, DOI 10.1016/S0006-8993(98)00103-6; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Varshney P, 2016, MOL CELL ENDOCRINOL, V429, P50, DOI 10.1016/j.mce.2016.03.035; Winocur G, 2005, BEHAV NEUROSCI, V119, P1389, DOI 10.1037/0735-7044.119.5.1389; Yu S, 2008, BRAIN RES, V1211, P22, DOI 10.1016/j.brainres.2005.04.029; Zaia A, 1996, ARCH GERONTOL GERIAT, V23, P27, DOI 10.1016/0167-4943(96)00705-4; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	121	2	2	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JUL 7	2020	14								668	10.3389/fnins.2020.00668			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP8ZJ	WOS:000552487100001	32733189	Green Published, gold			2022-02-06	
J	Mollahosseini, M; Ahmadirad, H; Goujani, R; Khorramdelazad, H				Mollahosseini, Majid; Ahmadirad, Hadis; Goujani, Reza; Khorramdelazad, Hossein			The Association Between Traumatic Brain Injury and Accelerated Fracture Healing: A Study on the Effects of Growth Factors and Cytokines	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Fracture healing; Cytokine; Growth factor; Traumatic brain injury; Femoral fracture	CALLUS FORMATION; HEAD-INJURY; IN-VIVO; BONE	Evidence suggests that some systemic and local factors, including cytokines and growth factors in patients with traumatic brain injury (TBI), can play an essential role in accelerating fracture healing. The purpose of this study was to evaluate serum levels of some inflammatory cytokines and growth factors in patients with fracture and TBI as well as healthy subjects. In this study, a total number of 30 patients with a femoral fracture, 30 cases with TBI, 30 patients with TBI and a femoral fracture (fracture + TBI group), and 30 healthy subjects were recruited. The Glasgow Coma Scale (GCS) scores were also determined upon their admission. Then, the serum levels of fibroblast growth factor 2 (FGF-2), transforming growth factor-beta (TGF-beta), platelet-derived growth factor (PDGF), bone morphogenetic protein 2 (BMP-2), insulin-like growth factor 1 (IGF-1), interleukin-1 beta (IL-1 beta), and interleukin-6 (IL-6) were measured via enzyme-linked immunosorbent assay (ELISA) technique, 12 h and 4 weeks after injury and hospital admission. The study results demonstrated that the serum levels of BMP-2, FGF-2, IL-1 beta, and PDGF in the femoral fracture + TBI group increased significantly over 12 h and after 4 weeks compared with other groups, but the serum levels of IGF-I, IL-6, and TGF-beta in this group increased in a significant manner at 12 h compared with other studied groups. The findings also showed that the time to union of a femoral fracture was shorter in the fracture + TBI group than in cases with a femoral fracture alone (p = 0.03). Accordingly, it seems that elevated serum levels of BMP-2, PDGF, FGF-2, and IL-1 beta may be associated with healing acceleration in fracture + TBI patients. However, further studies are needed to confirm this claim.	[Mollahosseini, Majid] Rafsanjan Univ Med Sci, Fac Med, Dept Orthoped, Rafsanjan, Iran; [Ahmadirad, Hadis; Khorramdelazad, Hossein] Rafsanjan Univ Med Sci, Res Inst Basic Med Sci, Mol Med Res Ctr, Rafsanjan, Iran; [Goujani, Reza] Rafsanjan Univ Med Sci, Sch Med, Dept Epidemiol, Rafsanjan, Iran; [Khorramdelazad, Hossein] Rafsanjan Univ Med Sci, Sch Med, Dept Immunol, Rafsanjan, Iran		Khorramdelazad, H (corresponding author), Rafsanjan Univ Med Sci, Res Inst Basic Med Sci, Mol Med Res Ctr, Rafsanjan, Iran.; Khorramdelazad, H (corresponding author), Rafsanjan Univ Med Sci, Sch Med, Dept Immunol, Rafsanjan, Iran.	khorramdelazad@gmail.com	Khorramdelazad, Hossein/H-5338-2017	Khorramdelazad, Hossein/0000-0002-0653-2724	Rafsanjan University of Medical Sciences	This project was supported by Rafsanjan University of Medical Sciences.	Bhandari M, 2002, J ORTHOP TRAUMA, V16, P562, DOI 10.1097/00005131-200209000-00004; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Brinker MR, 2000, REV ORTHOPAEDICS, P19; COLLICOTT PE, 1980, JAMA-J AM MED ASSOC, V243, P1156; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Friedenstein A., 1968, Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation, V1, P6; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Gibon E, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0300-9; Hankenson KD, 2015, ADV DRUG DELIVER REV, V94, P3, DOI 10.1016/j.addr.2015.09.008; Hoff P, 2016, IMMUNOL RES, V64, P1195, DOI 10.1007/s12026-016-8868-9; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Hu K, 2016, BONE, V91, P30, DOI 10.1016/j.bone.2016.06.013; Hurley MM, 2016, J CELL BIOCHEM, V117, P599, DOI 10.1002/jcb.25308; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI [10.1089/ten.teb.2009.0687, 10.1089/ten.TEB.2009.0687]; Lee SK, 2006, CURR OPIN RHEUMATOL, V18, P411, DOI 10.1097/01.bor.0000231911.42666.78; Loi F, 2016, BONE, V86, P119, DOI 10.1016/j.bone.2016.02.020; Luvizuto ER, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0210-3; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martino MM, 2015, ADV DRUG DELIVER REV, V94, P41, DOI 10.1016/j.addr.2015.04.007; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Mussano F, 2016, PLATELETS, V27, P467, DOI 10.3109/09537104.2016.1143922; Neugebauer E, 2000, UNFALLCHIRURG, V103, P122, DOI 10.1007/s001130050023; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; Oryan A, 2015, BIOMED ENVIRON SCI, V28, P57, DOI 10.3967/bes2015.006; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; TEASDALE G, 1974, LANCET, V2, P81; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Wallner C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118823; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; Zellin G, 1998, BONE, V22, P613, DOI 10.1016/S8756-3282(98)00059-3; Zhang HL, 2017, STEM CELL TRANSL MED, V6, P1880, DOI 10.1002/sctm.17-0039; Zhang R, 2018, W CHINA PLOS ONE, V13, P1, DOI DOI 10.1371/J0URNAL.P0NE.0190362	33	2	2	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	JAN	2021	71	1					162	168		10.1007/s12031-020-01640-6		JUL 2020	7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	PI6HN	WOS:000545921500001	32632556				2022-02-06	
J	Mondello, S; Guedes, VA; Lai, C; Jeromin, A; Bazarian, JJ; Gill, JM				Mondello, Stefania; Guedes, Vivian A.; Lai, Chen; Jeromin, Andreas; Bazarian, Jeffrey J.; Gill, Jessica M.			Sex Differences in Circulating T-Tau Trajectories After Sports-Concussion and Correlation With Outcome	FRONTIERS IN NEUROLOGY			English	Article						sports-related concussion (SRC); t-tau; sex differences; biomarker; brain injury; traumatic; outcome; return to play	TRAUMATIC BRAIN-INJURY; BASE-LINE; BIOMARKERS; NEUROPATHOLOGY; PERFORMANCE; SYMPTOMS; HISTORY; RETURN	Sex differences in molecular biomarkers after sports-related concussion (SRC) could steadily advance our understanding of injury heterogeneity and complexity, and help capture phenotypic characteristics, by unveiling sex-dependent pathobiological processes and disease mechanisms. Such knowledge will help improve diagnosis, clinical management, and prognosis. Total-tau (t-tau) has recently emerged as a promising blood marker showing sex-associated differences in neurodegenerative diseases. Nonetheless, to date, little is known about the potential influence of sex on its injury-related concentration and dynamics after SRC. We hypothesized that measurements of circulating levels of t-tau over time would reflect a differential vulnerability signature, providing insights into the sex-related phenotypes and their relationship with clinical outcomes. To test this hypothesis, plasma levels of t-tau were measured using an ultrasensitive immunoassay up to 7 days after injury, in 46 concussed athletes (20 males, 26 females). We used trajectory analysis to generate two distinct temporal profiles of t-tau, which were then compared with gender and return to play (RTP). The majority of subjects (similar to 63%) started with low t-tau concentrations that further declined within the first 48 h; while the remaining ("maximal decliners") started with concentrations comparable to the baseline levels that also fell over time, but persisting markedly higher compared with the first profile. The maximal decliner group was primarily composed of female subjects (p=0.007) and was significantly associated with poor outcome (RTP >= 10 days after concussion) (p=0.011). Taken together, our data provide evidence for the existence of sex-related biosignatures following sports-related concussions, possibly indicating a differential effect as a result of distinct brain vulnerability and inherent injury response. Future studies will be required to further elucidate underlying sex-based biological and pathophysiological mechanisms, and determine the value of t-tau signatures for management and therapeutic decision-making in sports-related concussions.	[Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Guedes, Vivian A.; Lai, Chen] NINR, NIH, Bethesda, MD 20892 USA; [Jeromin, Andreas; Gill, Jessica M.] Cohen Vet Biosci, Cambridge, MA USA; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Rochester, NY USA		Mondello, S (corresponding author), Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy.	stm_mondello@hotmail.com	Mondello, Stefania/A-1813-2012	Mondello, Stefania/0000-0002-8587-3614; de Alvarenga Guedes, Vivian/0000-0001-8478-2465	National Institutes of Health, National Institutes of Nursing Research, Intramural Research Program - NIH/NICHD [K24HD064754]	This work was supported by funds from the National Institutes of Health, National Institutes of Nursing Research, Intramural Research Program - NIH/NICHD (award no. K24HD064754). The funders had no role in the study design, collection, analysis, and interpretation of data, nor in the writing of the report or in publication decisions.	Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Alvarez-De-La-Rosa M, 2005, ANN NY ACAD SCI, V1052, P210, DOI 10.1196/annals.1347.016; Arambula SE, 2019, EXP NEUROL, V317, P168, DOI 10.1016/j.expneurol.2019.02.016; Asken BM, 2018, NEUROLOGY, V91, pE2109, DOI 10.1212/WNL.0000000000006613; Asken BM, 2018, NEUROLOGY, V91, pE2133, DOI 10.1212/WNL.0000000000006617; Azar S, 2017, METHODS MOL BIOL, V1598, P45, DOI 10.1007/978-1-4939-6952-4_3; Bazarian JJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19799; Brooks CE, 2017, J NEUROSCI RES, V95, P14, DOI 10.1002/jnr.23902; Clayton JA, 2016, DIALOGUES CLIN NEURO, V18, P357; Clayton JA, 2016, FASEB J, V30, P519, DOI 10.1096/fj.15-279554; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Esopenko Carrie, 2018, Concussion, V3, pCNC55, DOI 10.2217/cnc-2018-0004; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Hamer J, 2020, J NEUROTRAUM, V37, P1197, DOI 10.1089/neu.2019.6800; Hohman TJ, 2018, JAMA NEUROL, V75, P989, DOI 10.1001/jamaneurol.2018.0821; Hunter LE, 2020, JAMA NEUROL, V77, P419, DOI 10.1001/jamaneurol.2019.4828; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mondello S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040977; Mondello S, 2018, EXPERT REV PROTEOMIC, V15, P451, DOI 10.1080/14789450.2018.1464914; Mondello Stefania, 2015, Handb Clin Neurol, V127, P245, DOI 10.1016/B978-0-444-52892-6.00016-7; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nichols E, 2019, LANCET NEUROL, V18, P88, DOI 10.1016/S1474-4422(18)30403-4; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Rahimian R, 2019, NEUROSCIENCE, V405, P14, DOI 10.1016/j.neuroscience.2018.02.048; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Rosen A, 2019, DIVING HYPERB MED, V49, P88, DOI 10.28920/dhm49.2.88-95; Rubin TG, 2018, RADIOLOGY, V289, P478, DOI 10.1148/radiol.2018180217; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Schmithorst VJ, 2008, HUM BRAIN MAPP, V29, P696, DOI 10.1002/hbm.20431; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Theadom A, 2020, NEUROEPIDEMIOLOGY, V54, P192, DOI 10.1159/000505424; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Zetterberg H, 2018, NEURON, V97, P1202, DOI 10.1016/j.neuron.2018.02.030; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	49	2	2	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 7	2020	11								651	10.3389/fneur.2020.00651			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP7GU	WOS:000552370700001	32733367	gold, Green Published			2022-02-06	
J	Hecht, JP; LaDuke, ZJ; Cain-Nielsen, AH; Hemmila, MR; Wahl, WL				Hecht, Jason P.; LaDuke, Zachary J.; Cain-Nielsen, Anne H.; Hemmila, Mark R.; Wahl, Wendy L.			Effect of Preinjury Oral Anticoagulants on Outcomes Following Traumatic Brain Injury from Falls in Older Adults	PHARMACOTHERAPY			English	Article						traumatic brain injury; anticoagulants; antiplatelet agents; factor Xa inhibitors; warfarin	UNITED-STATES; WARFARIN; MORTALITY; ANTIPLATELET; EPIDEMIOLOGY; ASSOCIATION; RIVAROXABAN; MANAGEMENT; APIXABAN; IMPACT	Background Warfarin has been the oral anticoagulant of choice for the treatment of thromboembolic disease. However, upward of 50% of all new anticoagulant prescriptions are now for direct oral anticoagulants (DOAC). Despite this, outcome data evaluating preinjury anticoagulants remain scarce following traumatic brain injury (TBI). Our study objective is to determine the effects of preinjury anticoagulation on outcomes in older adults with TBI. Methods Patient data were obtained from 29 level 1 and 2 trauma centers from 2012 to June 30, 2018. Overall, 8312 patients who were aged 65 years or older, suffering a ground level fall, and with an Abbreviated Injury Scale (AIS) head score of >= 3 were identified. Patients were excluded if they presented with no signs of life or a traumatic mechanism besides ground level fall. Statistical comparisons were made using multivariable analyses with anticoagulant/antiplatelet use as the independent variable. Results Of the total patients with TBI, 3293 were on antiplatelet agents (AP), 669 on warfarin, 414 on warfarin + AP, 188 on DOACs, 116 on DOAC + AP, and 3632 on no anticoagulant. There were 185 (27.7%) patients on warfarin and 43 (22.9%) on a DOAC with a combined outcome of mortality or hospice as compared to 575 (15.8%) in the no anticoagulant group (p<0.001). After adjusting for patient factors, there was an increased risk of mortality or hospice in the warfarin (OR 1.60; 95% CI 1.27-2.01) and DOAC group (OR 1.67; 95% CI 1.07-2.59) as compared to no anticoagulant. Warfarin + AP was associated with an increased risk of mortality or hospice (OR 1.61; 95% CI 1.18-2.21) that was not seen with DOAC + AP (OR 0.93; 95% CI 0.46-1.87) as compared to no anticoagulant. Conclusions In older adults with TBI, preinjury treatment with warfarin or DOACs resulted in an increased risk of mortality or hospice whereas preinjury AP therapy did not increase risk. Future studies are needed with larger sample sizes to directly compare TBI outcomes associated with preinjury warfarin versus DOAC use.	[Hecht, Jason P.; LaDuke, Zachary J.] St Joseph Mercy, Inpatient Pharm, Ann Arbor, MI USA; [Cain-Nielsen, Anne H.; Hemmila, Mark R.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Wahl, Wendy L.] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA		Hecht, JP (corresponding author), St Joseph Mercy Ann Arbor, Inpatient Pharm, 5301 Mcauley Dr, Ypsilanti, MI 48197 USA.	jason.hecht@stjoeshealth.org					Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; [Anonymous], 2016, NTDB ANN PED REP; Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Batey M, 2018, SURGERY, V164, P814, DOI 10.1016/j.surg.2018.05.060; Benzimra M, 2018, PATIENT PREFER ADHER, V12, P79, DOI 10.2147/PPA.S131158; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, P1086, DOI 10.1097/TA.0b013e31826fc7a0; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; DiMaggio C, 2016, INJURY, V47, P1393, DOI 10.1016/j.injury.2016.04.002; Falzon CM, 2013, EMERG MED J, V30, P809, DOI 10.1136/emermed-2012-201687; Feeney JM, 2017, INJURY, V48, P47, DOI 10.1016/j.injury.2016.08.016; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Grandhi R, 2015, WORLD NEUROSURG, V84, P1956, DOI 10.1016/j.wneu.2015.08.042; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Heit JA, 2016, J THROMB THROMBOLYS, V41, P3, DOI 10.1007/s11239-015-1311-6; Hemmila MR, 2017, CRIT CARE CLIN, V33, P193, DOI 10.1016/j.ccc.2016.08.010; Hemmila MR, 2017, J TRAUMA ACUTE CARE, V82, P867, DOI 10.1097/TA.0000000000001401; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Huang M, 2009, SURG NEUROL, V72, P481, DOI 10.1016/j.surneu.2008.12.016; Inohara T, 2018, JAMA-J AM MED ASSOC, V319, P463, DOI 10.1001/jama.2017.21917; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; LaDuke ZJ, 2019, SURGERY, V166, P564, DOI 10.1016/j.surg.2019.04.039; Lakkireddy DR, 2018, HEART RHYTHM; Lane DA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005155; Majeed A, 2017, BLOOD, V130, P1706, DOI 10.1182/blood-2017-05-782060; Maung AA, 2016, J TRAUMA ACUTE CARE, V81, P652, DOI 10.1097/TA.0000000000001189; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Ostenberg I, 2010, HISTORIA-Z ALTE GES, V59, P303; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Prexl O, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0487-0; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; Sumiyoshi K, 2017, BRAIN INJURY, V31, P1445, DOI 10.1080/02699052.2017.1377349; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tollefsen MH, 2018, WORLD NEUROSURG, V114, pE209, DOI 10.1016/j.wneu.2018.02.167; Tomaselli GF, 2017, J AM COLL CARDIOL, V70, P1; Wood B, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0420-y; Zeeshan M, 2018, J TRAUMA ACUTE CARE, V85, P915, DOI 10.1097/TA.0000000000001995; Zheng Y, BLOOD S1, V130, P4912	41	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-0008	1875-9114		PHARMACOTHERAPY	Pharmacotherapy	JUL	2020	40	7					604	613		10.1002/phar.2435		JUL 2020	10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	NE8NA	WOS:000545736100001	32515829	Green Published			2022-02-06	
J	Rimaitis, M; Bilskiene, D; Tamosuitis, T; Vilcinis, R; Rimaitis, K; Macas, A				Rimaitis, Marius; Bilskiene, Diana; Tamosuitis, Tomas; Vilcinis, Rimantas; Rimaitis, Kestutis; Macas, Andrius			Implementation of Thromboelastometry for Coagulation Management in Isolated Traumatic Brain Injury Patients Undergoing Craniotomy	MEDICAL SCIENCE MONITOR			English	Article						Blood Coagulation; Brain Injuries; Intracranial Hemorrhage, Traumatic; Thrombelastography	COAGULOPATHY	Background: Coagulopathy (CP) is a modifiable factor linked with secondary brain damage and poor outcome of traumatic brain injury (TBI). A shift towards goal-directed coagulation management has been observed recently. We investigated whether rotational thromboelastometry (ROTEM) based management could be successfully implemented in TBI patients and improve outcomes. Material/Methods: A prospective, case-control study was performed. Adult patients with isolated TBI requiring craniotomy were included in this study. All patients underwent standard coagulation tests (SCT). Patients were identified as either in control group or in case group. Patients in the case group were additionally tested with ROTEM to specify their coagulation status. Management of the patients in the control group was based on SCT, whereas management of patients in the case group was guided by ROTEM. Outcome measures were as follows: CP rate, protocol adhesion, blood loss, transfusions, progressive hemorrhagic injury (PHI), re-intervention, Glasgow coma score (GCS) and Glasgow outcome score (GOS) at discharge, and in-hospital mortality. Results: There were 134 patients enrolled (65 patients in the control group and 69 patients in the case group). Twenty-six patients in the control group (40%) were found to be coagulopathic (control-CP subgroup) and 34 patients in the case group (49.3%) were found to be coagulopathic (case-CP subgroup). Twenty-five case-CP patients had ROTEM abnormalities triggering protocolized intervention, and 24 of them were treated. Overall ROTEM-based protocol adhesion rate was 85.3%. Postoperative ROTEM parameters of case-CP patients significantly improved, and the number of coagulopathic patients decreased. The incidence of PHI (control versus case group) and neurosurgical re-intervention (control-CP versus case-CP subgroup) was in favor of ROTEM guidance (P<0.05). Mortality and GCS and GOS at discharge did not differ significantly between groups. Conclusions: ROTEM led to consistent coagulation management, improved clot quality, and decreased incidence of PHI and neurosurgical re-intervention. Further studies are needed to confirm benefits of ROTEM in cases of TBI.	[Rimaitis, Marius; Bilskiene, Diana; Rimaitis, Kestutis; Macas, Andrius] Lithuania Univ Hlth Sci, Dept Anesthesiol, Kaunas, Lithuania; [Tamosuitis, Tomas; Vilcinis, Rimantas] Lithuania Univ Hlth Sci, Dept Neurosurg, Kaunas, Lithuania		Rimaitis, M (corresponding author), Lithuania Univ Hlth Sci, Dept Anesthesiol, Kaunas, Lithuania.	marius.rimaitis@lsmuni.lt	Rimaitis, Kestutis/AAM-3276-2021	Rimaitis, Kestutis/0000-0002-2678-0565			Beynon C, 2015, J CLIN NEUROSCI, V22, P252, DOI 10.1016/j.jocn.2014.07.029; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Ellenberger C, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0440-1; Fahrendorff M, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0378-9; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gonzalez E, 2017, CRIT CARE CLIN, V33, P119, DOI 10.1016/j.ccc.2016.09.002; Gratz J, 2019, ANAESTHESIA, V74, P883, DOI 10.1111/anae.14670; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Inaba K, 2015, J TRAUMA ACUTE CARE, V78, P1220, DOI 10.1097/TA.0000000000000536; JENNETT B, 1975, LANCET, V1, P480; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Lier H, 2013, HAMOSTASEOLOGIE, V33, P51, DOI 10.5482/HAMO-12-05-0011; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Schochl H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-15; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Schwarze J, 1993, GRUNDLAGEN STAT, V2; TEASDALE G, 1974, LANCET, V2, P81; Wikkelso A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007871.pub3; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0	26	2	2	0	0	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	JUL 4	2020	26								e922879	10.12659/MSM.922879			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	MF3XM	WOS:000545279500001	32620738	Green Published			2022-02-06	
J	Adams, MS; Niechwiej-Szwedo, E; McIlroy, WE; Staines, WR				Adams, Meaghan S.; Niechwiej-Szwedo, Ewa; McIlroy, William E.; Staines, William R.			A History of Concussion Affects Relevancy-Based Modulation of Cortical Responses to Tactile Stimuli	FRONTIERS IN INTEGRATIVE NEUROSCIENCE			English	Article						task-relevance; electroencephalography; somatosensory ERP; somatosensory processing; sensory gating; concussion	DORSOLATERAL PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; ELECTROPHYSIOLOGICAL ABNORMALITIES; ATTENTION; INHIBITION; RECOVERY; DEFICITS	Modulating cortical excitability based on a stimulus' relevance to the task at hand is a component of sensory gating, and serves to protect higher cortical centers from being overwhelmed with irrelevant information (McIlroy et al.,2003; Kumar et al.,2005; Wasaka et al., 2005). This study examined relevancy-based modulation of cortical excitability, and corresponding behavioral responses, in the face of distracting stimuli in participants with and without a history of concussion (mean age 22 +/- 3 SD years; most recent concussion 39.1 +/- 30 SD months). Participants were required to make a scaled motor response to the amplitudes of visual and tactile stimuli presented individually or concurrently. Task relevance was manipulated, and stimuli were occasionally presented with irrelevant distractors. Electroencephalography (EEG) and task accuracy data were collected from participants with and without a history of concussion. The somatosensory-evoked N70 event-related potential (ERP) was significantly modulated by task relevance in the control group but not in those with a history of concussion, and there was a significantly greater cost to task accuracy in the concussion history group when relevant stimuli were presented with an irrelevant distractor. This study demonstrated that relevancy-based modulation of electrophysiological responses and behavioral correlates of sensory gating differ in people with and without a history of concussion, even after patients were symptom-free and considered recovered from their injuries.	[Adams, Meaghan S.; Niechwiej-Szwedo, Ewa; McIlroy, William E.; Staines, William R.] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada		Adams, MS (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada.	msadamse@yorku.ca			National Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2019-04414]	This work was supported by a research grant (RGPIN-2019-04414) to WS from the National Sciences and Engineering Research Council of Canada (NSERC).	Adams MS, 2019, EXP BRAIN RES, V237, P2747, DOI 10.1007/s00221-019-05633-9; Adams MS, 2017, BEHAV BRAIN RES, V317, P179, DOI 10.1016/j.bbr.2016.09.037; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Bolton DAE, 2011, NEUROPSYCHOLOGIA, V49, P1928, DOI 10.1016/j.neuropsychologia.2011.03.020; Brown KE, 2015, EXP BRAIN RES, V233, P927, DOI 10.1007/s00221-014-4168-6; Dalecki Marc, 2016, Concussion, V1, pCNC14, DOI 10.2217/cnc-2016-0001; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; Fogelson N, 2009, BRAIN, V132, P3002, DOI 10.1093/brain/awp230; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Hurtubise Johanna, 2016, Concussion, V1, pCNC17, DOI 10.2217/cnc-2016-0006; KNIGHT RT, 1989, BRAIN RES, V504, P338, DOI 10.1016/0006-8993(89)91381-4; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McIlroy WE, 2003, BRAIN RES, V961, P73, DOI 10.1016/S0006-8993(02)03845-3; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Tapper A, 2017, J SPORT SCI, V35, P231, DOI 10.1080/02640414.2016.1161214; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Wasaka T, 2005, COGNITIVE BRAIN RES, V23, P354, DOI 10.1016/j.cogbrainres.2004.11.002; YAMAGUCHI S, 1990, BRAIN RES, V521, P281, DOI 10.1016/0006-8993(90)91553-S	28	2	2	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5145			FRONT INTEGR NEUROSC	Front. Integr. Neurosci.	JUL 3	2020	14								33	10.3389/fnint.2020.00033			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	MP7IY	WOS:000552376300001	32719591	Green Published, gold			2022-02-06	
J	Rahimi, S; Ferdowsi, A; Siahposht-Khachaki, A				Rahimi, Siavash; Ferdowsi, Ahmadreza; Siahposht-Khachaki, Ali			Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway	METABOLIC BRAIN DISEASE			English	Article						Metformin; TBI; Neuroprotective; AMPK; BBB disruption; Compound C	PATHOPHYSIOLOGY; MICRODIALYSIS; GLYCOLYSIS; ESTROGEN; EDEMA; MODEL	Metformin is an activator of AMP-activated protein kinase (AMPK). Thus, it has the potential to restore energy in damaged neurons and attenuate secondary brain damage due to traumatic brain injury (TBI). This study aims to investigate the potential neuroprotective effects of metformin through the energy balance reestablishment in acute severe brain injury after TBI and explore the underlying mechanisms.Male Wistar rats were divided into eight groups. The veterinary coma scale (VCS) was used to assess short-term neurological deficits. Blood-Brain barrier (BBB) disruption was evaluated by Evans Blue method 6 h post-injury. Vestibulomotor function was evaluated by beam-walk and beam-balance methods. Brain water content and brain tissue phosphorylated and total AMPK were assessed by the wet/dry method and enzyme-linked immunosorbent assay (ELISA), respectively. In order to eliminate the effect of AMPK, compound C was used as an AMPK inhibitor. The presented study showed that TBI has led to significant brain edema, BBB disruption, neurological deficit, vestibulomotor dysfunction and decrease AMPK phosphorylation in the rat brain. Metformin (100 and 200 mg/kg doses) attenuated brain edema, improved BBB and vestibulomotor dysfunction compared to TBI or Vehicle groups (P < 0.001). Furthermore, the p-AMPK/AMPK ratio was increased by metformin administration compare to TBI or Vehicle groups (p < 0.0001). Inhibition of AMPK by compound C abolished Metformin neuroprotective effects (P < 0.05 compared to Met 200 group). This study suggests that metformin inhibits TBI-mediated secondary injury via phosphorylation of AMPK and improves neurobehavioral function following TBI, which provides a potential therapeutic opportunity in the treatment of TBI.	[Rahimi, Siavash; Ferdowsi, Ahmadreza] Mazandaran Univ Med Sci, Dept Physiol & Pharmacol, Ramsar Campus, Sari, Iran; [Siahposht-Khachaki, Ali] Mazandaran Univ Med Sci, Fac Med, Dept Physiol, POB 48471-91971, Sari, Iran		Siahposht-Khachaki, A (corresponding author), Mazandaran Univ Med Sci, Fac Med, Dept Physiol, POB 48471-91971, Sari, Iran.	a.siahposht@mazums.ac.ir	Rahimi, Siavash/AAF-2528-2021	Rahimi, Siavash/0000-0001-7631-8005; siahposht-khachaki, ali/0000-0001-7505-3148	Mazandaran University of Medical Sciences, Ramsar Campus	This study was funded by Mazandaran University of Medical Sciences, Ramsar Campus, vice-chancellor of research.	Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Aoyama N, 2008, BRAIN RES, V1230, P310, DOI 10.1016/j.brainres.2008.07.006; Arbelaez-Quintero I, 2017, STROKE RES TREAT, V2017, DOI 10.1155/2017/9756429; Ashabi G, 2015, METAB BRAIN DIS, V30, P747, DOI 10.1007/s11011-014-9632-2; Asl SZ, 2013, J NEUROSURG, V119, P353, DOI 10.3171/2013.4.JNS121636; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Carre E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00146; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Farbood Y, 2015, MICROCIRCULATION, V22, P534, DOI 10.1111/micc.12224; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fontaine E, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00753; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Jonker JW, 2004, J PHARMACOL EXP THER, V308, P2, DOI 10.1124/jpet.103.053298; Kotake Y, 2003, CURR MED CHEM, V10, P2507, DOI 10.2174/0929867033456558; Kurtz P, 2013, NEUROCRIT CARE, V19, P311, DOI 10.1007/s12028-013-9919-x; Lannuzel A, 2003, NEUROSCIENCE, V121, P287, DOI 10.1016/S0306-4522(03)00441-X; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Liu YQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0177-4; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mazzeo AT, 2006, J NEUROSURG ANESTH, V18, P170, DOI 10.1097/01.ana.0000210999.18033.f6; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Shahrokhi N, 2018, IRAN J BASIC MED SCI, V21, P301, DOI 10.22038/ijbms.2018.25928.6377; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Taheri A, 2019, J NEUROL, V266, P1988, DOI 10.1007/s00415-019-09366-1; Takata F, 2013, BIOCHEM BIOPH RES CO, V433, P586, DOI 10.1016/j.bbrc.2013.03.036; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vial G, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00294; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	39	2	2	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	OCT	2020	35	7					1135	1144		10.1007/s11011-020-00594-3		JUL 2020	10	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	NJ5WB	WOS:000545201500001	32621159				2022-02-06	
J	Grayson, L; Brady, MC; Togher, L; Ali, M				Grayson, Lynn; Brady, Marian C.; Togher, Leanne; Ali, Myzoon			A survey of cognitive-communication difficulties following TBI: are families receiving the training and support they need?	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						traumatic brain injury; cognitive-communication difficulties; family needs	TRAUMATIC BRAIN-INJURY; SPEECH-LANGUAGE PATHOLOGISTS; INDIVIDUALS; PEOPLE; CONVERSATIONS; PARTNERS; ADULTS; INFORMATION; EXPERIENCES; CAREGIVERS	Background Whilst research into the wide-ranging needs of family members following traumatic brain injury (TBI) is well established, investigation into the specific needs of families in relation to supporting cognitive-communication difficulties, relationships and social participation is limited. Aims To identify the family needs for cognitive-communication difficulties following TBI and to explore whether current services are meeting these needs. Methods & Procedures Following a successful pilot, family members from the UK and Australia were invited via posters, social media and e-mail to take part in an anonymous, communication needs survey. Data arising from the thirty two closed questions (six eligibility, nine demographic and seventeen needs questions) were analysed using SPSS descriptive statistics. Data arising from one open question were analysed using qualitative content analysis. Outcomes & Results A total of 102 family members from the UK (n= 89, 87%) and Australia (n= 13, 13%) completed the survey. The majority of respondents were female (n= 76; 75%), between the ages of 30 and 69 (n= 88; 87%), and either a parent or a partner of the person following TBI (n= 78;76%). Respondents rated information about expected recovery from cognitive-communication difficulties and training in helpful strategies as their most important needs. The majority of respondents (more than 60%) were not satisfied that any of their cognitive-communication needs had been fully met and high levels of unmet need remained evident at three years or more post-injury. Written information, communication partner training and counselling were identified as key supports. Conclusions & Implications Families report high levels of unmet need for managing cognitive-communication difficulties following TBI. Access to written information and communication partner training should be available to families at various time points following TBI and not just in the early stages. What this paper addsWhat this paper adds to existing knowledgeWhat is already known on this subjectWhat are the potential or actual clinical implications of this work? Attempting to support a person who has cognitive-communication difficulties following TBI has been found to be highly burdensome for family members. However, few studies have asked how families perceive their needs in relation to cognitive-communication difficulties or measured how well current services are meeting their needs. This study demonstrates that current speech and language therapy services are not yet meeting the needs of the relatives of individuals with cognitive-communication difficulties following TBI. Important insights into the information, training and support families' rate as important are identified in addition to how these needs develop over time. Speech and language therapy service design requires to reflect the ongoing nature of familial needs for cognitive-communication difficulties following TBI. Families require access to appropriate literature, speech and language therapy support, and communication partner training in the longer term, not just in the acute phase.	[Grayson, Lynn; Brady, Marian C.; Ali, Myzoon] Glasgow Caledonian Univ, NMAHP Res Unit, Glasgow, Lanark, Scotland; [Grayson, Lynn] NHS Lanarkshire, Community Brain Injury Team, Carluke, Scotland; [Togher, Leanne] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia		Grayson, L (corresponding author), Glasgow Caledonian Univ, NMAHP Res Unit, Glasgow, Lanark, Scotland.	lynn.grayson@gcu.ac.uk	Brady, Marian C/ABA-4241-2021; Togher, Leanne/AAC-7083-2019	Brady, Marian C/0000-0002-4589-7021; Ali, Myzoon/0000-0001-5899-2485; Grayson, Lynn/0000-0002-5677-5732	NHS Lanarkshire	The authors acknowledge and thank the respondents to the online and paper surveys which informed this research. Ethical approval was sought from and granted by Glasgow Caledonian University for this study. This work was part of an MPhil, undertaken by the first author, which was funded by NHS Lanarkshire. The data that support the findings of this study are available from the corresponding author, upon reasonable request.	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Blake ML, 2013, AM J SPEECH-LANG PAT, V22, P146, DOI 10.1044/1058-0360(2012/12-0021); Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Creswell J. W., 2018, RES DESIGN QUALITATI; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Hilton R, 2014, APHASIOLOGY, V28, P797, DOI 10.1080/02687038.2014.906562; Isaki E, 2000, BRAIN INJURY, V14, P441; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Kreutzer JS, 1989, FAMILY NEEDS QUESTIO; Kulnik S. T., 2019, DESIGN HLTH     0416, P1; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Man DWK, 2002, BRAIN INJURY, V16, P1025, DOI 10.1080/0269905021000010087; Mann K, 2015, APHASIOLOGY, V29, P1082, DOI 10.1080/02687038.2015.1035226; Matheson, 2020, ARCH REHABILITATION, V2; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; O'Rourke A, 2018, INT J LANG COMM DIS, V53, P1150, DOI 10.1111/1460-6984.12428; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Riedeman S, 2018, AM J SPEECH-LANG PAT, V27, P181, DOI 10.1044/2017_AJSLP-17-0011; Rietdijk R, 2020, J SPEECH LANG HEAR R, V63, P615, DOI 10.1044/2019_JSLHR-19-00076; Rose TA, 2019, INT J SPEECH-LANG PA, V21, P470, DOI 10.1080/17549507.2019.1651396; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Short J, 2014, INT J SPEECH-LANG PA, V16, P219, DOI 10.3109/17549507.2014.882413; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Townshend J, 2018, FAM J, V26, P77, DOI 10.1177/1066480717752905; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303	40	2	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	SEP	2020	55	5					712	723		10.1111/1460-6984.12555		JUL 2020	12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	NM2LS	WOS:000545482300001	32618085	Green Published, hybrid			2022-02-06	
J	Aleem, M; Goswami, N; Kumar, M; Manda, K				Aleem, Mohd; Goswami, Nidhi; Kumar, Mayank; Manda, Kailash			Low-pressure fluid percussion minimally adds to the sham craniectomy-induced neurobehavioral changes: Implication for experimental traumatic brain injury model	EXPERIMENTAL NEUROLOGY			English	Article						Craniectomy; Fluid percussion injury; Neurogenesis; Neuroinflammation; Behavior		Modeling experimental traumatic brain injury (TBI) in rodents is necessarily required to understand the pathophysiological and neurobehavioral consequences of neurotrauma. Numerous models have been developed to study experimental TBI. Fluid percussion injury (FPI) is the most extensively used model to represent clinical phenotypes. Nevertheless, the surgical 'sham' procedure (craniectomy), a prerequisite of FPI, is the impeding factor in experimental TBI. We hypothesized that if craniectomy causes substantial structural and functional changes in the brain, it might mimic the mild FPI-induced neurobehavioral dysfunctions. To understand the hypothesis, C57BL/6 mice were exposed to lateral FPI at 1.2 atm pressure and changes in the neuronal architecture, hippocampal neurogenesis, neuroinflammation, and behavioral functions were compared to the sham (craniectomy) and control mice at day 7 post-FPI. We observed that both the craniectomy and FPI significantly augmented the ipsilateral hippocampal neurogenesis as evaluated by DCX and Beta-III tubulin immunoreactivity. Similarly, a significant increase in GFAP and TMEM immunoreactivity in CA1 and CA3 regions showed that craniectomy mimics FPI-induced neuroinflammation. The additive damaging effect of craniectomy with FPI was also reported in the term of axonal and dendritic fragmentation, swelling and neuronal death using silver staining, Fluoro-jade, and MAP-2 immunoreactivity. Sham-exposed mice showed a significant functional decrease in grip strength. Our results indicate that sham craniectomy itself is enough to cause TBI like characteristics, and thus fluid percussion at mild pressure is minimally additive with craniectomy. Considering the method as a mixed (focal & diffused) injury model, the 'net neurotrauma severity' should be compared with naive control instead of the sham as it is an outcome of cumulative damage due to fluid pressure and craniectomy. Nevertheless, to understand the long term consequences of neurotrauma, the extent of recovery in surgical sham may separately be quantified.	[Aleem, Mohd; Goswami, Nidhi; Kumar, Mayank; Manda, Kailash] Inst Nucl Med & Allied Sci, Div Behav Neurosci, Delhi 110054, India		Manda, K (corresponding author), Inst Nucl Med & Allied Sci, Div Behav Neurosci, Delhi 110054, India.	kailashmanda@gmail.com	Manda, Kailash/K-4119-2014; Aleem, Mohd/ABE-6569-2021; Manda, Kailash/AAY-1523-2021; Kumar, Mayank/AAG-6370-2021	Manda, Kailash/0000-0002-0188-6697; Aleem, Mohd/0000-0003-1457-0090; Manda, Kailash/0000-0002-0188-6697; 	DRDO & CSIR, Government of India	The authors thankfully acknowledge the financial support granted by the DRDO & CSIR, Government of India.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bhowmick S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010011; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Fiorin FD, 2018, J NEUROSCI METH, V307, P23, DOI 10.1016/j.jneumeth.2018.06.004; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Folweiler KA, 2018, J NEUROTRAUM, V35, P1304, DOI 10.1089/neu.2017.5350; Forcelli PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081401; Galgano M., 2015, J NEUROL NEUROBIOL, V2; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Katariwala NM, 2001, NEUROLOGY, V57, P1505, DOI 10.1212/WNL.57.8.1505; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kumar M, 2013, EXP NEUROL, V248, P360, DOI 10.1016/j.expneurol.2013.06.005; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Ling G.S., 2004, CURR PROTOC NEUROSCI, V28, P2; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Metz Gerlinde A, 2009, J Vis Exp, DOI 10.3791/1204; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Shapiro LA, 2017, CELL TRANSPLANT, V26, P1314, DOI 10.1177/0963689717714099; Singh K, 2016, NMR BIOMED, V29, P1748, DOI 10.1002/nbm.3627; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	36	2	2	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2020	329								113290	10.1016/j.expneurol.2020.113290			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LT0MX	WOS:000536772200013	32240659				2022-02-06	
J	Cancelliere, C; Boyle, E; Cote, P; Holm, LW; Salmi, LR; Cassidy, JD				Cancelliere, Carol; Boyle, Eleanor; Cote, Pierre; Holm, Lena W.; Salmi, Louis Rachid; Cassidy, J. David			Development and validation of a model predicting post-traumatic headache six months after a motor vehicle collision in adults	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Post-traumatic headache; Prognosis; Craniocerebral trauma; Neck injuries	WHIPLASH-ASSOCIATED DISORDERS; CLINICAL-PRACTICE GUIDELINES; TRAUMATIC BRAIN-INJURY; LOW-BACK-PAIN; NECK PAIN; ONTARIO PROTOCOL; PSYCHOLOGICAL-FACTORS; PROGNOSTIC-FACTORS; FEAR-AVOIDANCE; CUT-POINTS	Importance: The prognosis of post-traumatic headache is poorly understood. Objective: To develop and validate a prognostic model to predict the presence of post-traumatic headache six months after a traffic collision in adults with incident post-traumatic headache. Design: Secondary analyses of adults with incident post-traumatic headache injured in traffic collisions between November 1997 and December 1999 in Saskatchewan, Canada (development cohort); and between January 2004 and January 2005 in Sweden (validation cohort). Setting: The Saskatchewan cohort (development) was population-based (N = 4162). The Swedish cohort (validation) (N = 379) were claimants from two insurance companies covering 20 % of cars driven in Sweden in 2004. Participants: All adults injured in traffic collisions who completed a baseline questionnaire within 30 days of collision. Excluded were those hospitalized > 2 days, lost consciousness > 30 min, or reported headache < 3/10 on the numerical rating scale. Follow-up rates for both cohorts were approximately 80 %. Predictors: Baseline sociodemographic, pre-injury, and injury factors. Outcome: Self-reported headache pain intensity >= 3 (numerical rating scale) six months after injury. Results: Both cohorts were predominantly female (69.7 % in Saskatchewan, 65.2 % in Sweden), with median ages 35.9 years (Saskatchewan), and 38.0 years (Sweden). Predictors were age, work status, headache pain intensity, symptoms in arms or hands, dizziness or unsteadiness, stiffness in neck, pre-existing headache, and lower recovery expectations. With a positive score (i.e., >= 0.75 probability), the model can rule in the presence of post-traumatic headache at six months (development: specificity = 99.8 %, 95 % CI 99.5 %-99.9 %; sensitivity = 1.6 %, 95 % CI 1.0 %-2.6 %; positive likelihood ratio (LR +) = 8.0, 95 % CI 2.7-24.1; negative likelihood ratio (LR-) = 1.0, 95 % CI 1.0 -1.0; validation: specificity = 95.5 %, 95 % CI 91.1 %-97.8 %; sensitivity = 27.2 %, 95 % CI 20.4 %-35.2 %); LR+ = 6.0, 95 % CI 2.8 -13.2; LR- = 0.8, 95 % CI 0.7 - 0.8). Conclusions and relevance: Clinicians can collect patient information on the eight predictors of our model to identify patients that will report ongoing post-traumatic headache six months after a traffic collision. Future research should focus on selecting patients at high risk of poor outcomes (using our model) for inclusion in intervention studies, and determining effective interventions for these patients.	[Cancelliere, Carol; Cote, Pierre] Ontario Tech Univ, Fac Hlth Sci, 2000 Simcoe St North,Sci Bldg,Room 3000, Oshawa, ON L1H 7K4, Canada; [Cancelliere, Carol; Cote, Pierre] Ontario Tech Univ, Ctr Disabil Prevent & Rehabil, Oshawa, ON, Canada; [Cancelliere, Carol; Cote, Pierre] Canadian Mem Chiropract Coll, Oshawa, ON, Canada; [Boyle, Eleanor] Univ Southern Denmark, Fac Hlth Sci, Dept Sport Sci & Clin Biomech, Odense, Denmark; [Cote, Pierre; Cassidy, J. David] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Cote, Pierre; Cassidy, J. David] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Cote, Pierre] Ontario Tech Univ, Fac Hlth Sci, Canada Res Chair Disabil Prevent & Rehabil, Oshawa, ON, Canada; [Cote, Pierre] Canadian Mem Chiropract Coll, Toronto, ON, Canada; [Holm, Lena W.] Karolinska Inst, Inst Environm Med, Musculoskeletal & Sports Injury Epidemiol Ctr, Stockholm, Sweden; [Salmi, Louis Rachid] Univ Bordeaux, ISPED Bordeaux Sch Publ Hlth, F-33000 Bordeaux, France; [Salmi, Louis Rachid] Ctr INSERM U1219 Bordeaux Populat Hlth, F-33000 Bordeaux, France; [Salmi, Louis Rachid] CHU Bordeaux, Pole Sante Publ, Serv Informat Med, F-33000 Bordeaux, France		Cancelliere, C (corresponding author), Ontario Tech Univ, Fac Hlth Sci, 2000 Simcoe St North,Sci Bldg,Room 3000, Oshawa, ON L1H 7K4, Canada.	carolina.cancelliere@uoit.ca	Cote, Pierre/AAG-5358-2021; Boyle, Eleanor/G-4567-2016	Cote, Pierre/0000-0002-6986-6676; Boyle, Eleanor/0000-0002-9012-9128	Canadian Institutes of Health Research Doctoral AwardCanadian Institutes of Health Research (CIHR)	CC was funded by a Canadian Institutes of Health Research Doctoral Award (2013-2015). CC completed the first draft, all analyses, results and interpretation. EB, PC, LWH, LRS, and JDC contributed to all analyses, results and interpretation. JDC conceived of the study. All authors approved the final manuscript.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersen TE, 2016, EUR J PAIN, V20, P1241, DOI 10.1002/ejp.848; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bohman T, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-264; Bolton JE, 1999, PAIN, V83, P533, DOI 10.1016/S0304-3959(99)00161-X; Buse DC, 2013, HEADACHE, V53, P1278, DOI 10.1111/head.12150; Carroll LJ, 2009, J MANIP PHYSIOL THER, V32, pS97, DOI 10.1016/j.jmpt.2008.11.014; Carroll LJ, 2009, J RHEUMATOL, V36, P1063, DOI 10.3899/jrheum.080680; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2007, SPINE, V32, P126, DOI 10.1097/01.brs.0000249526.76788.e8; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Cote P, 2020, ENABLING RECOVERY CO; Cote P, 2007, ARTHRIT RHEUM-ARTHR, V57, P861, DOI 10.1002/art.22775; Cote P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2017-021283; Cote P, 2016, EUR SPINE J, V25, P2000, DOI 10.1007/s00586-016-4467-7; Crutebo S, 2010, J RHEUMATOL, V37, P1527, DOI 10.3899/jrheum.091321; Devins G., 1988, PSYCHOL HEALTH, V2, P139, DOI DOI 10.1080/08870448808400349; Fejer R, 2005, PAIN, V119, P176, DOI 10.1016/j.pain.2005.09.033; Ferrari R, 2005, ANN RHEUM DIS, V64, P1337, DOI 10.1136/ard.2004.034447; GREMBOWSKI D, 1993, J HEALTH SOC BEHAV, V34, P89, DOI 10.2307/2137237; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hartling L, 2002, ACCIDENT ANAL PREV, V34, P531, DOI 10.1016/S0001-4575(01)00051-3; Hassani-Mahmooei B, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1386-6; Hincapie CA, 2010, J OCCUP ENVIRON MED, V52, P434, DOI 10.1097/JOM.0b013e3181bb806d; Holm LW, 2008, PLOS MED, V5, P760, DOI 10.1371/journal.pmed.0050105; Holm LW, 2008, SPINE, V33, pS52, DOI 10.1097/BRS.0b013e3181643ece; Hosmer D. W., 2004, APPL LOGISTIC REGRES; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Jensen MP, 2001, PAIN, V91, P317, DOI 10.1016/S0304-3959(00)00459-0; Johansson MS, 2015, EUR J PAIN, V19, P1486, DOI 10.1002/ejp.681; KEEFE FJ, 1992, PAIN, V51, P131, DOI 10.1016/0304-3959(92)90253-8; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kraft P, 2009, NAT REV GENET, V10, P264, DOI 10.1038/nrg2516; Krebs EE, 2007, J GEN INTERN MED, V22, P1453, DOI 10.1007/s11606-007-0321-2; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Lantz PM, 2001, SOC SCI MED, V53, P29, DOI 10.1016/S0277-9536(00)00319-1; Leonardi Matilde, 2005, J Headache Pain, V6, P429, DOI 10.1007/s10194-005-0252-4; Leung L, 2012, INDIAN J PSYCHOL MED, V34, P204, DOI 10.4103/0253-7176.106012; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Mann M, 2004, HEALTH EDUC RES, V19, P357, DOI 10.1093/her/cyg041; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McLean SA, 2014, PAIN, V155, P309, DOI 10.1016/j.pain.2013.10.016; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Nash JM, 2006, HEADACHE, V46, P1377, DOI 10.1111/j.1526-4610.2006.00580.x; Nederhand MJ, 2004, ARCH PHYS MED REHAB, V85, P496, DOI 10.1016/j.apmr.2003.06.019; Partheni M, 2000, CLIN EXP RHEUMATOL, V18, P67; Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589; Ritchie C, 2013, PAIN, V154, P2198, DOI 10.1016/j.pain.2013.07.001; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Russo A, 2014, NEUROL SCI, V35, pS153, DOI 10.1007/s10072-014-1758-9; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; SCHELP L, 1990, PUBLIC HEALTH, V104, P55, DOI 10.1016/S0033-3506(05)80346-4; Scholten-Peeters GGM, 2003, PAIN, V104, P303, DOI 10.1016/S0304-3959(03)00050-2; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Seeman TE, 2001, ANN NY ACAD SCI, V954, P88; Sterling M, 2005, PAIN, V114, P141, DOI 10.1016/j.pain.2004.12.005; Steyerberg, 2019, CLIN PREDICTION MODE; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sullivan MJL, 2011, SPINE, V36, pS244, DOI 10.1097/BRS.0b013e3182387fed; Varatharajan S, 2016, EUR SPINE J, V25, P1971, DOI 10.1007/s00586-016-4376-9; Walton DM, 2013, J ORTHOP SPORT PHYS, V43, P31, DOI 10.2519/jospt.2013.4507; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Watson M, 2005, EUR J CANCER, V41, P1710, DOI 10.1016/j.ejca.2005.01.012; Williams M, 2007, SPINE, V32, pE764, DOI 10.1097/BRS.0b013e31815b6565; Williamson E, 2008, PAIN, V135, P20, DOI 10.1016/j.pain.2007.04.035; Wong JJ, 2017, EUR J PAIN, V21, P201, DOI 10.1002/ejp.931; World Health Organization, 2004, ICD 10 INT STAT CLAS; Zajacova A, 2011, AM J EPIDEMIOL, V174, P977, DOI 10.1093/aje/kwr204; Zelman DC, 2003, PAIN, V106, P35, DOI 10.1016/S0304-3959(03)00274-4	78	2	2	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUL	2020	142								105580	10.1016/j.aap.2020.105580			10	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	LY6QF	WOS:000540652500010	32445970				2022-02-06	
J	Chen, X; Chai, Y; Wang, SB; Wang, JC; Yue, SY; Jiang, RC; Zhang, JN				Chen, Xin; Chai, Yan; Wang, Shao-Bo; Wang, Jia-Chong; Yue, Shu-Yuan; Jiang, Rong-Cai; Zhang, Jian-Ning			Risk factors for corticosteroid insufficiency during the sub-acute phase of acute traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article							CARE MEDICINE SCCM; CRITICAL-ILLNESS; EUROPEAN-SOCIETY; MANAGEMENT; DIAGNOSIS; GUIDELINES; MECHANISM; CIRRHOSIS; CIRCI	Hypothalamic-pituitary-adrenal axis dysfunction may lead to the occurrence of critical illness-related corticosteroid insufficiency. Critical illness-related corticosteroid insufficiency can easily occur after traumatic brain injury, but few studies have examined this occurrence. A multicenter, prospective, cohort study was performed to evaluate the function of the hypothalamic-pituitary-adrenal axis and the incidence of critical illness-related corticosteroid insufficiency during the sub-acute phase of traumatic brain injury. One hundred and forty patients with acute traumatic brain injury were enrolled from the neurosurgical departments of three tertiary-level hospitals in China, and the critical illness-related corticosteroid insufficiency incidence, critical-illness-related corticosteroid insufficiency-related risk factors, complications, and 28-day mortality among these patients was recorded. Critical illness-related corticosteroid insufficiency was diagnosed in patients with plasma total cortisol levels less than 10 mu g/dL (275.9 nM) on post-injury day 4 or when serum cortisol was insufficiently suppressed (less than 50%) during a dexamethasone suppression test on post-injury day 5. The results demonstrated that critical illness-related corticosteroid insufficiency occurred during the sub-acute phase of traumatic brain injury in 5.6% of patients with mild injury, 22.5% of patients with moderate injury, and 52.2% of patients with severe injury. Traumatic brain injury-induced critical illness-related corticosteroid insufficiency was strongly correlated to injury severity during the sub-acute stage of traumatic brain injury. Traumatic brain injury patients with critical illness-related corticosteroid insufficiency frequently presented with hemorrhagic cerebral contusions, diffuse axonal injury, brain herniation, and hypotension. Differences in the incidence of hospital-acquired pneumonia, gastrointestinal bleeding, and 28-day mortality were observed between patients with and without critical illness-related corticosteroid insufficiency during the sub-acute phase of traumatic brain injury. Hypotension, brain-injury severity, and the types of traumatic brain injury were independent risk factors for traumatic brain injury-induced critical illness-related corticosteroid insufficiency. These findings indicate that critical illness-related corticosteroid insufficiency is common during the sub-acute phase of traumatic brain injury and is strongly associated with poor prognosis. The dexamethasone suppression test is a practical assay for the evaluation of hypothalamic-pituitary-adrenal axis function and for the diagnosis of critical illness-related corticosteroid insufficiency in patients with traumatic brain injury, especially those with hypotension, hemorrhagic cerebral contusions, diffuse axonal injury, and brain herniation. Sub-acute infection of acute traumatic brain injury may be an important factor associated with the occurrence and development of critical illness-related corticosteroid insufficiency. This study protocol was approved by the Ethics Committee of General Hospital of Tianjin Medical University, China in December 2011 (approval No. 201189).	[Chen, Xin; Yue, Shu-Yuan; Jiang, Rong-Cai] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China; [Chai, Yan; Zhang, Jian-Ning] Tianjin Neurol Inst, Tianjin, Peoples R China; [Chai, Yan; Zhang, Jian-Ning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Chai, Yan; Zhang, Jian-Ning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China; [Wang, Shao-Bo] Ordos Cent Hosp, Dept Neurosurg, Ordos, Inner Mongolia, Peoples R China; [Wang, Jia-Chong] Cent S Univ, Xiangya Med Coll, Affiliated Haikou Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China		Chen, X (corresponding author), Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China.; Zhang, JN (corresponding author), Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China.; Zhang, JN (corresponding author), Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China.	xinchentianjin@me.com; jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671902, 81501704]; Project of Tianjin Applied Basic and Cutting-edge Technological Research of China [17JCYBJC25200, 15JCQNJC44900]; Tianjin Health Care Elite Prominent Young Doctor Development Program; Young and Middle-aged Backbone Innovative Talent Program	This work was supported by the National Natural Science Foundation of China, No. 81671902 (to XC); 81501704 (to YC); the Project of Tianjin Applied Basic and Cutting-edge Technological Research of China, No. 17JCYBJC25200 (to XC); 15JCQNJC44900 (to YC); the Tianjin Health Care Elite Prominent Young Doctor Development Program (to XC); the Young and Middle-aged Backbone Innovative Talent Program (to XC). The funding bodies played no role in the study design, in the collection, analysis and interpretation of data, in the writing of the paper, and in the decision to submit the paper for publication.	Annane D, 2018, INTENS CARE MED, V44, P401, DOI 10.1007/s00134-018-5071-6; Annane D, 2017, INTENS CARE MED, V43, P1751, DOI 10.1007/s00134-017-4919-5; Annane D, 2010, CRIT CARE MED, V38, P721, DOI 10.1097/CCM.0b013e3181c54620; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Burry L, 2013, SHOCK, V39, P144, DOI 10.1097/SHK.0b013e31827daf0b; Caplan HW, 2019, CURR SURG REP, V7, DOI 10.1007/s40137-019-0237-x; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen X, 2014, J NEUROL SCI, V342, P93, DOI 10.1016/j.jns.2014.04.032; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Clervius H, 2019, NEURAL REGEN RES, V14, P1699, DOI 10.4103/1673-5374.255620; Cuesta JM, 2012, CRIT CARE MED, V40, P3283, DOI 10.1097/CCM.0b013e31826567eb; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Direk N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164348; Ducrocq N, 2018, SHOCK, V50, P408, DOI 10.1097/SHK.0000000000001090; EDWARDS OM, 1986, MEDICINE, V65, P281; Figaji A, 2019, NEUROSURGERY, V85, pE386, DOI 10.1093/neuros/nyz208; Findling JW, 2017, EUR J ENDOCRINOL, V176, pR205, DOI 10.1530/EJE-16-0946; Fleseriu M, 2009, ENDOCR PRACT, V15, P632, DOI 10.4158/EP09180.RA; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Jang SH, 2019, NEURAL REGEN RES, V14, P1556, DOI 10.4103/1673-5374.255977; Jung B, 2012, CRIT CARE, V16, DOI 10.1186/cc11871; King Daniel, 2019, AANA J, V87, P97; Koch A, 2014, CRIT CARE MED, V42, P2639, DOI 10.1097/CCM.0000000000000598; Lanks CW, 2019, MED CLIN N AM, V103, P487, DOI 10.1016/j.mcna.2018.12.008; Lu GY, 2020, WORLD NEUROSURG, V133, pE135, DOI 10.1016/j.wneu.2019.08.184; Lu SJ, 2016, J PSYCHIATR RES, V78, P24, DOI 10.1016/j.jpsychires.2016.03.009; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Marik PE, 2009, CHEST, V135, P181, DOI 10.1378/chest.08-1149; Marincowitz C, 2020, J NEUROTRAUM, V37, P324, DOI 10.1089/neu.2019.6652; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Ok You Jung, 2018, Korean J Thorac Cardiovasc Surg, V51, P109, DOI 10.5090/kjtcs.2018.51.2.109; Pai AK, 2017, PEDIATR CLIN N AM, V64, P543, DOI 10.1016/j.pcl.2017.01.014; Pastores SM, 2018, CRIT CARE MED, V46, P146, DOI 10.1097/CCM.0000000000002840; Peng YS, 2009, CRIT CARE, V13, DOI 10.1186/cc7978; Polito A, 2011, CRIT CARE MED, V39, P597, DOI 10.1097/CCM.0b013e31820b7426; Roquilly A, 2013, CRIT CARE, V17, DOI 10.1186/cc13138; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Rouanet C, 2017, ARQ NEURO-PSIQUIAT, V75, P387, DOI [10.1590/0004-282X20170048, 10.1590/0004-282x20170048]; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Seki K, 2018, NEURAL REGEN RES, V13, P1159, DOI 10.4103/1673-5374.235019; Seravalli L, 2009, NEW ENGL J MED, V361, P824; Teblick A, 2019, NAT REV ENDOCRINOL, V15, P417, DOI 10.1038/s41574-019-0185-7; Triantos CK, 2011, CLIN GASTROENTEROL H, V9, P595, DOI 10.1016/j.cgh.2011.03.033; Tsai MH, 2014, CRIT CARE MED, V42, P2546, DOI 10.1097/CCM.0000000000000544; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Volovici V, 2019, J NEUROTRAUM, V36, P3183, DOI 10.1089/neu.2019.6474; Walker ML, 2011, AM SURGEON, V77, P579; Wang ZY, 2020, J NEUROTRAUM, V37, P1221, DOI 10.1089/neu.2019.6742; Wongsurakiat P, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0944-1; Yang Y, 2014, J TRAUMA ACUTE CARE, V76, P1390, DOI 10.1097/TA.0000000000000221	52	2	2	1	22	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUL	2020	15	7					1259	1265		10.4103/1673-5374.272611			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	KC8CS	WOS:000507400100016	31960811	gold, Green Published			2022-02-06	
J	Yong, JPCP; Lee, JH; Howell, DR; Meehan, WP; Iverson, GL; Gardner, AJ				Chung Pin Yong, Jean-Paul; Lee, Jin H.; Howell, David R.; Meehan, William P., III; Iverson, Grant L.; Gardner, Andrew J.			Effects of Exercise on Sport Concussion Assessment Tool-Third Edition Performance in Women	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						SCAT3; sideline screening; athletes; concussion management	SEX-DIFFERENCES; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; POSTURAL STABILITY; HIGH-SCHOOL; BASE-LINE; SYMPTOMS; RECOVERY; OUTCOMES; FEMALE	Objective: The purpose of this study was to examine the influence of a brief exercise protocol on Sport Concussion Assessment Tool-Third Edition (SCAT3) performance in amateur women athletes. Design: Cross-over repeated-measures design. Setting: Off-season, uninjured community amateur athletes. Participants: We examined 87 amateur women athlete volunteers (age = 29.9, SD = 6.9 years). Independent Variables: Participants were assessed using the SCAT3 under 2 conditions: at rest and after a 5-minute physical exertion protocol, completed in a counterbalanced order. Main Outcome Measures: Participants' performance on the various components of the SCAT3 under the 2 conditions: at rest and after a 5-minute physical exertion protocol. Results: No significant differences were detected between at-rest and postexercise conditions for the balance, orientation, or cognitive components of the SCAT3. There were no significant differences in the proportion of participants who endorsed specific symptoms at rest compared with the postexercise condition (P> 0.05). However, women athletes who rated their exertion after exercise as "hard" or greater (Borg scale rating 13-20) reported significantly greater blurred vision (M = 0.25, SD = 0.62 vs M = 0.00, SD = 0.00;P= 0.006) and fatigue/low energy (M = 1.38, SD = 1.17 vs M = 0.66, SD = 0.91;P= 0.002) symptoms after exercise than those who rated their exertion as "light" or lower (Borg scale rating 6-12). Conclusions: In this study of women athletes, a brief bout of exercise did not seem to adversely affect SCAT3 performance and had only small effects on self-reported symptoms. There were differences in symptom reporting, however, in the subgroup of women who rated their exertion levels as "hard" or greater; they reported more blurred vision and fatigue/low energy.	[Chung Pin Yong, Jean-Paul] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Lee, Jin H.] Univ Queensland, Sch Human Movement & Nutr Sci, St Lucia, Qld, Australia; [Howell, David R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.] Boston Childrens Hosp, Div Sports Med, Dept Orthopaed, Boston, MA USA; [Howell, David R.] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Boston, MA 02115 USA; [Meehan, William P., III] Sports Concuss Clin, Div Sports Med, Boston, MA USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] MassGen Hosp Children Sport Concuss Program, Boston, MA USA; [Iverson, Grant L.] A Red Sox Fdn, Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Gardner, Andrew J.] Univ Newcastle, Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Gardner, Andrew J.] John Hunter Hosp, Hunter New England Local Hlth Dist Sports Concuss, Newcastle, NSW, Australia		Gardner, AJ (corresponding author), Calvary Mater Hosp, Prior Res Ctr Stroke & Brain Injury, Level 5,McAuley Bldg, Waratah, NSW 2298, Australia.	Andrew.Gardner@neurogard.com.au		Gardner, Andrew/0000-0001-5031-5586	National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; Harvard University - NFL Players Association; ImPACT Applications, Inc; CNS Vital Signs; Psychological Assessment Resources (PAR, Inc); MooneyReed Charitable Foundation; Australian Football League (AFL); NSW Sporting Injuries Committee; Brain Foundation (Australia); Hunter Medical Research Institute (HMRI); ImPACT Applications, Inc.	W.P.M. receives royalties from (1) ABC-Clio publishing for the sale of his books Kids, Sports, and Concussion: A guide for coaches and parents, and Concussions; (2) Springer International for the book Head and Neck Injuries in Young Athlete; and (3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and by a grant from the Football Players Health Study at Harvard University, which is funded by the NFL Players Association. Grant Iverson has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild TBI and sport-related concussion at meetings, scientific conferences, and symposiums. He has a clinical and consulting practice in forensic neuropsychology involving individuals who have sustained mild TBIs (including athletes). He has received research funding from several test publishing companies, including ImPACT Applications, Inc, CNS Vital Signs, and Psychological Assessment Resources (PAR, Inc). He acknowledges unrestricted philanthropic support from the MooneyReed Charitable Foundation and ImPACT Applications, Inc. Andrew Gardner has a clinical practice in neuropsychology involving individuals who have sustained sport-related concussion (including current and former athletes). He has operated as a contracted concussion consultant to the Australian Rugby Union (ARU) from July 2016. He has received travel funding from the Australian Football League (AFL) to present at the Concussion in Football Conference in 2013 and 2017. Previous grant funding includes the NSW Sporting Injuries Committee, the Brain Foundation (Australia), and the Hunter Medical Research Institute (HMRI), supported by Jennie Thomas.	Alexandre D, 2012, J STRENGTH COND RES, V26, P2890, DOI 10.1519/JSC.0b013e3182429ac7; [Anonymous], 2013, Br J Sports Med, V47, P259; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Borg G., 1998, BORGS PERCEIVED EXER; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lin JH, 2017, ORTHOP J SPORTS MED, V5; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Mayers LB, 2013, J NEUROPSYCH CLIN N, V25, P115, DOI 10.1176/appi.neuropsych.11120374; McClaran SR, 1998, J APPL PHYSIOL, V84, P1872, DOI 10.1152/jappl.1998.84.6.1872; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; MEAD J, 1980, AM REV RESPIR DIS, V121, P339; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Morissette MP, 2014, CURR RES CONCUSSION, V1, P19; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Sheel AW, 2004, SPORTS MED, V34, P567, DOI 10.2165/00007256-200434090-00002; Susco TM, 2004, J ATHL TRAINING, V39, P241; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wheatley CM, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-445; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	46	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2020	30	4					353	359		10.1097/JSM.0000000000000605			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NA4GG	WOS:000559774000013	30015637				2022-02-06	
J	Clausen, NG; Antonsen, S; Spielmann, N; Hansen, TG; Weiss, M; Ringer, SK				Clausen, Nicola G.; Antonsen, Steen; Spielmann, Nelly; Hansen, Tom G.; Weiss, Markus; Ringer, Simone K.			Hypotension and Hypocapnia During General Anesthesia in Piglets: Study of S100b as an Acute Biomarker for Cerebral Tissue Injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						anesthesia; general; cerebral circulation; vascular hypotension; domestic pig; biologic marker; S100 calcium binding protein beta subunit	POSSIBLE MARKER; SERUM S-100B; BRAIN-DAMAGE; PROTEIN; BLOOD; PRESSURE; SURGERY; OXYGENATION; S-100-BETA; PERFUSION	Background: Hypotension and/or hypocapnia might increase general anesthesia (GA)-related neuromorbidity in infants, but safe levels of perioperative blood pressure are poorly defined. Serum protein S100b has been used as screening, monitoring, and prediction tool in the management of patients with traumatic brain injury. Using an animal model, we investigated serum S100b as an acute biomarker of cerebral hypoperfusion and cerebral cell dysfunction during hypotension, hypocapnia, or combined hypotension/hypocapnia during GA. Methods: Fifty-seven sevoflurane-midazolam anesthetized piglets aged 4 to 6 weeks were randomly allocated to control (n=9), hypotension (n=18), hypocapnia (n=20), or combined hypotension and hypocapnia (n=10). Hypotension (target mean arterial blood pressure: 35 to 38 or 27 to 30 mm Hg) was induced by blood withdrawal and nitroprusside infusion, and hypocapnia by hyperventilation (target PaCO2: 28 to 30 and 23 to 25 mm Hg). Serum S100b and albumin were measured at baseline, before and 60 minutes after the interventions, and following 60-minute recovery. Results: Serum S100b concentrations decreased over time (P=0.001), but there was no difference in S100b between control piglets and those exposed to hypotension, hypocapnea, or a combination of the both (P=0.105). Albumin decreased in all 4 groups (P=0.001). Conclusion: S100b did not increase following 60 minutes of systemic hypotension and/or hypocapnia during GA in piglets. In this setting, the use of S100b as a biomarker of cerebral cell tissue dysfunction cannot be supported.	[Clausen, Nicola G.; Hansen, Tom G.] Odense Univ Hosp, Dept Anesthesiol & Intens Care, Odense, Denmark; [Antonsen, Steen] Odense Univ Hosp, Dept Clin Biochem, Svendborg, Denmark; [Clausen, Nicola G.; Spielmann, Nelly; Weiss, Markus] Univ Childrens Hosp, Childrens Res Ctr, Zurich, Switzerland; [Clausen, Nicola G.; Spielmann, Nelly; Weiss, Markus] Univ Childrens Hosp, Dept Anesthesiol, Zurich, Switzerland; [Ringer, Simone K.] Univ Zurich, Vetsuisse Fac, Sect Anesthesiol, Zurich, Switzerland		Clausen, NG (corresponding author), Odense Univ Hosp, Dept Anesthesiol & Intens Care, Odense, Denmark.; Clausen, NG (corresponding author), Univ Childrens Hosp, Childrens Res Ctr, Zurich, Switzerland.; Clausen, NG (corresponding author), Univ Childrens Hosp, Dept Anesthesiol, Zurich, Switzerland.	nicola@nicola.dk		clausen, nicola groes/0000-0002-3590-5171; Hansen, Tom/0000-0002-5896-9768	Department of Anesthesiology and Intensive Care Medicine, University Hospital Odense; European Society of Anesthesia	The study is part of Mrs. Clausen's PhD project, which was awarded the ESA MAQUET GRANT at the annual meeting of the European Society of Anesthesia 2015. Mrs Clausen's project is further supported by funds provided by the Department of Anesthesiology and Intensive Care Medicine, University Hospital Odense.	Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; Clausen T, 2004, BRAIN RES, V1019, P113, DOI 10.1016/j.brainres.2004.05.099; Gazzolo D, 2003, ARCH PEDIAT ADOL MED, V157, P1163, DOI 10.1001/archpedi.157.12.1163; Gazzolo D, 2002, CRIT CARE MED, V30, P1356, DOI 10.1097/00003246-200206000-00037; Gunn JK, 2016, ARCH DIS CHILD, V101, P1010, DOI 10.1136/archdischild-2015-309449; Hansen TG, 2017, EUR J ANAESTH, V34, P327, DOI 10.1097/EJA.0000000000000629; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jiang M, 2017, MED GAS RES, V7, P48, DOI 10.4103/2045-9912.202910; Johnsson P, 2000, SCAND CARDIOVASC J, V34, P548, DOI 10.1080/140174300750064459; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Jonsson H, 1999, ANN THORAC SURG, V68, P2202, DOI 10.1016/S0003-4975(99)00851-6; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Larsson A, 2005, ANESTH ANALG, V101, P1465, DOI 10.1213/01.ANE.0000180193.29655.6A; Michelet D, 2015, PEDIATR ANESTH, V25, P681, DOI 10.1111/pan.12671; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Raabe A, 2003, CLIN CHEM LAB MED, V41, P700, DOI 10.1515/CCLM.2003.106; Ringer SK, 2018, BRIT J ANAESTH, V121, P1308, DOI 10.1016/j.bja.2018.07.041; Ringer SK, 2016, PEDIATR ANESTH, V26, P909, DOI 10.1111/pan.12956; Semenas E, 2010, ACTA ANAESTH SCAND, V54, P343, DOI 10.1111/j.1399-6576.2009.02125.x; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Trakas E, 2017, PEDIATR NEUROL, V72, P56, DOI 10.1016/j.pediatrneurol.2017.04.011; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Wei HF, 2007, NEUROSCI LETT, V425, P59, DOI 10.1016/j.neulet.2007.08.011; Whitaker EE, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-015-0079-9; Ytrebo LM, 2000, SCAND J GASTROENTERO, V35, P546; Zaigham M, 2017, EARLY HUM DEV, V112, P48, DOI 10.1016/j.earlhumdev.2017.07.015; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	30	2	2	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2020	32	3					273	278		10.1097/ANA.0000000000000601			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	MC3TE	WOS:000543212900014	31022077	Green Accepted			2022-02-06	
J	Dal Pozzo, V; Crowell, B; Briski, N; Crockett, DP; D'Arcangelo, G				Dal Pozzo, Valentina; Crowell, Beth; Briski, Nicholas; Crockett, David P.; D'Arcangelo, Gabriella			Reduced Reelin Expression in the Hippocampus after Traumatic Brain Injury	BIOMOLECULES			English	Article						hippocampus; cerebral cortex; cell death; trauma	CONTROLLED CORTICAL IMPACT; NEURONS; NEURODEGENERATION; DEFICIENCY; RECEPTOR; MODEL	Traumatic brain injury (TBI) is a relatively common occurrence following accidents or violence, and often results in long-term cognitive or motor disability. Despite the high health cost associated with this type of injury, presently there are no effective treatments for many neurological symptoms resulting from TBI. This is due in part to our limited understanding of the mechanisms underlying brain dysfunction after injury. In this study, we used the mouse controlled cortical impact (CCI) model to investigate the effects of TBI, and focused on Reelin, an extracellular protein that critically regulates brain development and modulates synaptic activity in the adult brain. We found that Reelin expression decreases in forebrain regions after TBI, and that the number of Reelin-expressing cells decrease specifically in the hippocampus, an area of the brain that plays an important role in learning and memory. We also conducted in vitro experiments using mouse neuronal cultures and discovered that Reelin protects hippocampal neuronal cells from glutamate-induced neurotoxicity, a well-known secondary effect of TBI. Together our findings suggest that the loss of Reelin expression may contribute to neuronal death in the hippocampus after TBI, and raise the possibility that increasing Reelin levels or signaling activity may promote functional recovery.	[Dal Pozzo, Valentina] Rutgers Robert Wood Johnson Med Sch, Grad Program Neurosci, Piscataway, NJ 08854 USA; [Dal Pozzo, Valentina; Crowell, Beth; Briski, Nicholas; D'Arcangelo, Gabriella] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Crockett, David P.] Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA		D'Arcangelo, G (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.	valentinadalpozzo@gmail.com; bcrowell@dls.rutgers.edu; ndb55@scarletmail.rutgers.edu; crockett@rwjms.rutgers.edu; darcangelo@dls.rutgers.edu		Crockett, David Paul/0000-0002-8137-755X; Briski, Nicholas/0000-0003-0778-9019	New Jersey Commission on Brain Injury Research [CBR15FEL012]; National Science FoundationNational Science Foundation (NSF) [IOS-1755184]	This work was supported by predoctoral fellowship CBR15FEL012 from the New Jersey Commission on Brain Injury Research (V.D.P.) and research grant IOS-1755184 from the National Science Foundation (G.D.).	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Alcantara S, 1998, J NEUROSCI, V18, P7779; Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Brizuela M, 2017, J NEUROTRAUM, V34, P2504, DOI 10.1089/neu.2017.4977; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Cordoba-Chacon J, 2011, AM J PHYSIOL-ENDOC M, V300, pE46, DOI 10.1152/ajpendo.00514.2010; Courtes S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020430; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Filice F, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0192-8; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jones KJ, 2018, P NATL ACAD SCI USA, V115, pE5805, DOI 10.1073/pnas.1716750115; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Lambert de Rouvroit C, 1998, Adv Anat Embryol Cell Biol, V150, P1; Lane-Donovan C, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa6674; Lee GH, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00122; Lee GH, 2014, J BIOL CHEM, V289, P20307, DOI 10.1074/jbc.M114.576249; Lu LH, 2019, J NEUROTRAUM, V36, P1828, DOI 10.1089/neu.2018.5929; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Nichols J, 2018, J PHYSIOL-LONDON, V596, P1277, DOI 10.1113/JP275393; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Pesold C, 1999, P NATL ACAD SCI USA, V96, P3217, DOI 10.1073/pnas.96.6.3217; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Pulido JS, 2007, GRAEF ARCH CLIN EXP, V245, P889, DOI 10.1007/s00417-006-0458-4; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Sinagra M, 2005, J NEUROSCI, V25, P6127, DOI 10.1523/JNEUROSCI.1757-05.2005; Stary CM, 2015, STROKE, V46, P551, DOI 10.1161/STROKEAHA.114.007041; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Ventruti A, 2011, NEUROSCIENCE, V189, P32, DOI 10.1016/j.neuroscience.2011.05.050; Wasser CR, 2017, J BIOL CHEM, V292, P1330, DOI 10.1074/jbc.R116.766782; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Yamakage Y, 2019, MOL CELL NEUROSCI, V100, DOI 10.1016/j.mcn.2019.103401; Yasui N, 2011, J BIOL CHEM, V286, P35247, DOI 10.1074/jbc.M111.242719	47	2	2	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2218-273X		BIOMOLECULES	Biomolecules	JUL	2020	10	7							975	10.3390/biom10070975			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MX2IO	WOS:000557549900001	32610618	Green Published			2022-02-06	
J	Dalena, MM; Liu, FC; Halsey, JN; Lee, ES; Granick, MS				Dalena, Margaret M.; Liu, Farrah C.; Halsey, Jordan N.; Lee, Edward S.; Granick, Mark S.			Assessment of Panfacial Fractures in the Pediatric Population	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							MANAGEMENT; INJURIES	Purpose: Management of panfacial fractures is critical and often difficult in adults; however, there is little to no literature regarding these fractures in the pediatric population. In this study, we present our experience to provide insight and further investigation regarding prevention and management strategies within the pediatric population. Patients and Methods: We performed a retrospective chart review of all panfacial fractures in the pediatric population between 2002 and 2014 treated at an urban, level 1 trauma center (University Hospital, Newark, NJ). Data including patient demographic characteristics, mechanisms of injury, locations of fractures, concomitant injuries, and surgical management strategies were collected. Results: We identified 82 patients aged 18 years or younger who had sustained a panfacial fracture. The mean age at the time of injury was 12.9 years, with a male predominance of 64.9%. A total of 335 fractures were identified on radiologic imaging. The most common etiologies were motor vehicle accidents and pedestrians being struck. Orbital, frontal sinus, nasal, and zygoma fractures were the most common fractures. The mean score on the Glasgow Coma Scale on arrival was 12.0. A total of 29 patients were intubated on arrival-or before arrival-at the trauma bay. A surgical airway was required in 9 patients. The most common concomitant injuries were traumatic brain injury, intracranial hemorrhage, and skull fracture. Surgical repair was required in 38 patients. The cephalic-to-caudal approach was used most, followed by caudal to cephalic, medial to lateral, and lateral to medial. Within a year of the initial surgical procedure, 4 patients underwent reoperations for complications. Four patients died. Conclusions: Pediatric panfacial fractures are rare occurrences; however, the impact of these injuries can be devastating, with concomitant life-threatening injuries and complications. Given the lack of literature, as well as the preventable nature of these injuries, we hope this study can address primary prevention strategies and provide insight toward the management and characteristics of these fractures. (C) 2020 American Association of Oral and Maxillofacial Surgeons	[Dalena, Margaret M.; Halsey, Jordan N.; Granick, Mark S.] Rutgers New Jersey Med Sch, Dept Surg, Div Plast & Reconstruct Surg, 185 S Orange Ave, Newark, NJ 07103 USA; [Liu, Farrah C.] Stanford Univ, Sch Med, Div Plast & Reconstruct Surg, Palo Alto, CA 94304 USA; [Lee, Edward S.] Rutgers New Jersey Med Sch, Dept Surg, Div Plast & Reconstruct Surg, Plast Surg, Newark, NJ USA		Halsey, JN (corresponding author), Rutgers New Jersey Med Sch, Dept Surg, Div Plast & Reconstruct Surg, 185 S Orange Ave, Newark, NJ 07103 USA.	jh1145@njms.rutgers.edu					Ali K, 2017, SEMIN PLAST SURG, V31, P108, DOI 10.1055/s-0037-1601579; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Boyette JR, 2014, OTOLARYNG CLIN N AM, V47, P747, DOI 10.1016/j.otc.2014.06.008; Braun TL, 2017, SEMIN PLAST SURG, V31, P118, DOI 10.1055/s-0037-1601380; Choi JW, 2019, J CRANIOFAC SURG, V30, P1255, DOI 10.1097/SCS.0000000000005528; Curtis W, 2013, ORAL MAXIL SURG CLIN, V25, P649, DOI 10.1016/j.coms.2013.07.010; Degala S, 2015, J MAXILLOFAC ORAL SU, V14, P986, DOI 10.1007/s12663-015-0769-2; Filinte GT, 2015, ULUS TRAVMA ACIL CER, V21, P509, DOI 10.5505/tjtes.2015.23922; Follmar KE, 2007, J TRAUMA, V63, P831, DOI 10.1097/TA.0b013e3181492f41; Haug RH, 2000, ORAL SURG ORAL MED O, V90, P126, DOI 10.1067/moe.2000.107974; Khader R, 2014, ORAL MAXILLOFAC SURG, V18, P99, DOI 10.1007/s10006-013-0403-8; Kim Jiye, 2016, Arch Craniofac Surg, V17, P181, DOI 10.7181/acfs.2016.17.4.181; MARKOWITZ BL, 1989, CLIN PLAST SURG, V16, P105; Morales JL, 2010, J CRANIOFAC SURG, V21, P1226, DOI 10.1097/SCS.0b013e3181e41863; Pisano Justin, 2019, Atlas Oral Maxillofac Surg Clin North Am, V27, P83, DOI 10.1016/j.cxom.2019.04.001; Ryan ML, 2011, J CRANIOFAC SURG, V22, P1183, DOI 10.1097/SCS.0b013e31821c0d52; Wang LX, 2019, FACIAL PLAST SURG, V35, P565, DOI 10.1055/s-0039-1700800; Yasonov S A, 2017, Zh Vopr Neirokhir Im N N Burdenko, V81, P48, DOI 10.17116/neiro201781648-55; Yu J, 2011, J CRANIOFAC SURG, V22, P1247, DOI 10.1097/SCS.0b013e31821c6955; Yun Seonsik, 2018, Arch Craniofac Surg, V19, P1, DOI 10.7181/acfs.2018.19.1.1	20	2	2	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	JUL	2020	78	7					1156	1161		10.1016/j.joms.2020.03.001			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	MF4OP	WOS:000545324000025	32247625				2022-02-06	
J	Delaplain, PT; Albertson, S; Grigorian, A; Williams, B; Smith, M; Inaba, K; Lekawa, M; Nahmias, J				Delaplain, Patrick T.; Albertson, Spencer; Grigorian, Areg; Williams, Barbara; Smith, Megan; Inaba, Kenji; Lekawa, Michael; Nahmias, Jeffry			Early cognitive impairment is common after intracranial hemorrhage with mild traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	33rd Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 14-18, 2020	Orlando, FL	Eastern Assoc Surg Trauma		Traumatic brain injury; cognitive impairment; intracranial hemorrhage	GLASGOW COMA SCALE; PREDICTION; OUTCOMES; ADULTS; CLASSIFICATION; MANAGEMENT; VALIDITY; MODERATE; PATIENT	BACKDROP: The incidence of early cognitive impairment (ECI) after traumatic brain injury (TBI) is unknown. We hypothesized ECI is common and can be predicted based on Glasgow Coma Scale (GCS) and Brain Injury Guideline (BIG) category. METHODS: A single-center, retrospective review of adult trauma patients (2014-2016) with intracranial hemorrhage (ICH) and mild TBI (GCS score, 13-15) was performed. The primary outcome was ECI, defined as a Rancho Los Amigos score less than 8. Routine cognitive evaluation is performed on all ICH patients at our institution. Comparisons between ECI and no-ECI groups regarding demographic, cognitive, and clinical outcomes were evaluated using bivariate statistics. The odds of ECI were evaluated using a multivariable logistic regression. RESULTS: There were 465 patients with mild TBI, 70.3% were male, and the average age was 53 +/- 23 years. The most common mechanism of injury was fall (41.1%) followed by motor vehicle collision (15.9%). The incidence of ECI was 51.4% (n = 239). The incidence in patients with a GCS score of 15 was 42.9%, and BIG 1 category was 42.7%. There were no differences in demographics (age, sex, comorbidities), mechanism of injury, or imaging when comparing ECI patients with no-ECI patients. The GCS score was lower in the ECI group (14.4 vs. 14.7, p < 0.001). Patients with ECI were also less likely to be discharged home (58.2% vs. 78.3%, p < 0.001). Lower GCS-verbal, BIG category 3, and presence of pelvic/extremity fractures were strong risk factors for ECI in a logistic regression model adjusted for age, loss of consciousness, anticoagulants, narcotic administration, and Rotterdam score. CONCLUSION: Half of all patients with ICH and mild TBI had ECI. Both lower initial GCS score and BIG category 3 were associated with increased likelihood of ECI. Therefore, we recommend all patients with ICH and mild TBI undergo cognitive evaluation. (Copyright (C) 2020 Wolters Kluwer Health, Inc. All rights reserved.)	[Delaplain, Patrick T.; Albertson, Spencer; Grigorian, Areg; Williams, Barbara; Lekawa, Michael; Nahmias, Jeffry] Univ Calif Irvine, Dept Surg, Div Trauma Burns & Surg Crit Care, Irvine, CA 92717 USA; [Smith, Megan] Univ Calif Irvine, Ctr Stat Counseling, Irvine, CA USA; [Inaba, Kenji] Univ Southern Calif, Dept Surg, Los Angeles, CA 90007 USA		Delaplain, PT (corresponding author), Univ Calif, Irvine Med Ctr, Suite 1600,333 City Blvd West, Orange, CA 92868 USA.	pdelapla@hs.uci.edu	Nahmias, Jeffry/ABA-1850-2020	Nahmias, Jeffry/0000-0003-0094-571X	Department of Trauma, Burns and Critical Care at the University of California, Irvine Medical Center	There were no external sources of funding related to this project. It was funded in its entirety by the Department of Trauma, Burns and Critical Care at the University of California, Irvine Medical Center.	Andrew SF, 2017, WORLD NEUROSURG, V97, P156, DOI 10.1016/j.wneu.2016.09.081; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; de Guise E, 2005, CAN J NEUROL SCI, V32, P186, DOI 10.1017/S0317167100003954; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hagen C, 1979, REHABILITATION HEAD, P87; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kupas DF, 2016, ANN EMERG MED, V68, P744, DOI 10.1016/j.annemergmed.2016.06.017; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Nahmias J, 2018, AM SURGEON, V84, P652; National Center for Injury Prevention & Control, 2003, REP C MILD TRAUM BRA; Raymond J, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6603a1; Suto Y, 2018, J TRAUMA ACUTE CARE, V85, P275, DOI 10.1097/TA.0000000000001957; Taylor CA, 2013, TRAUMATIC BRAIN INJU; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Wong GKC, 2013, BRAIN INJURY, V27, P394, DOI 10.3109/02699052.2012.750746	30	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2020	89	1					215	221		10.1097/TA.0000000000002641			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	MJ2BL	WOS:000547897300034	32102043				2022-02-06	
J	Diaz, MF; Horton, PD; Kumar, A; Livingston, M; Mohammadalipour, A; Xue, H; Skibber, MA; Ewere, A; Furman, NET; Aroom, KR; Zhang, SL; Gill, BS; Cox, CS; Wenzel, PL				Diaz, Miguel F.; Horton, Paulina D.; Kumar, Akshita; Livingston, Megan; Mohammadalipour, Amina; Xue, Hasen; Skibber, Max A.; Ewere, Adesuwa; Furman, Naama E. Toledano; Aroom, Kevin R.; Zhang, Songlin; Gill, Brijesh S.; Cox, Charles S., Jr.; Wenzel, Pamela L.			Injury intensifies T cell mediated graft-versus-host disease in a humanized model of traumatic brain injury	SCIENTIFIC REPORTS			English	Article							MESENCHYMAL STROMAL CELLS; BONE-MARROW; STEM-CELLS; PROSTAGLANDIN E-2; B-CELLS; INFLAMMATION; PHENOTYPE; RESPONSES; NEURONS; CD4(+)	The immune system plays critical roles in promoting tissue repair during recovery from neurotrauma but is also responsible for unchecked inflammation that causes neuronal cell death, systemic stress, and lethal immunodepression. Understanding the immune response to neurotrauma is an urgent priority, yet current models of traumatic brain injury (TBI) inadequately recapitulate the human immune response. Here, we report the first description of a humanized model of TBI and show that TBI places significant stress on the bone marrow. Hematopoietic cells of the marrow are regionally decimated, with evidence pointing to exacerbation of underlying graft-versus-host disease (GVHD) linked to presence of human T cells in the marrow. Despite complexities of the humanized mouse, marrow aplasia caused by TBI could be alleviated by cell therapy with human bone marrow mesenchymal stromal cells (MSCs). We conclude that MSCs could be used to ameliorate syndromes triggered by hypercytokinemia in settings of secondary inflammatory stimulus that upset marrow homeostasis such as TBI. More broadly, this study highlights the importance of understanding how underlying immune disorders including immunodepression, autoimmunity, and GVHD might be intensified by injury.	[Diaz, Miguel F.; Horton, Paulina D.; Kumar, Akshita; Livingston, Megan; Xue, Hasen; Skibber, Max A.; Ewere, Adesuwa; Furman, Naama E. Toledano; Aroom, Kevin R.; Cox, Charles S., Jr.; Wenzel, Pamela L.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, Childrens Regenerat Med Program, Houston, TX 77030 USA; [Diaz, Miguel F.; Horton, Paulina D.; Livingston, Megan; Ewere, Adesuwa; Cox, Charles S., Jr.; Wenzel, Pamela L.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, Ctr Stem Cell & Regenerat Med, Houston, TX 77030 USA; [Diaz, Miguel F.; Horton, Paulina D.; Livingston, Megan; Mohammadalipour, Amina; Wenzel, Pamela L.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Skibber, Max A.; Gill, Brijesh S.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Surg, Houston, TX 77030 USA; [Zhang, Songlin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Ewere, Adesuwa] Univ Texas Med Branch, Sch Med, Galveston, TX 77555 USA		Wenzel, PL (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, Childrens Regenerat Med Program, Houston, TX 77030 USA.; Wenzel, PL (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, Ctr Stem Cell & Regenerat Med, Houston, TX 77030 USA.; Wenzel, PL (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	Pamela.L.Wenzel@uth.tmc.edu	Wenzel, Pamela/AAJ-1944-2021	Wenzel, Pamela/0000-0002-4530-015X; Ewere, Adesuwa/0000-0002-4530-5890; Kumar, Akshita/0000-0002-4021-4092	State of Texas Emerging Technology Fund; American Society of Hematology Scholar Award; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01DK092365, R01DK111599]; Mission Connect: a Program of the TIRR Foundation [014-121, 016-118]; Cancer Prevention and Research Institute of Texas [RP110776]	This work was supported by grants from the State of Texas Emerging Technology Fund, American Society of Hematology Scholar Award, National Institutes of Health (K01DK092365, R01DK111599), and Mission Connect: a Program of the TIRR Foundation (014-121, 016-118) to P.L.W. Flow cytometry instrumentation was supported in part through the Cancer Prevention and Research Institute of Texas (RP110776).	Absinta M, 2017, ELIFE, V6, DOI 10.7554/eLife.29738; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aversa F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02769; Awaya N, 2002, EXP HEMATOL, V30, P937, DOI 10.1016/S0301-472X(02)00821-4; Bagnara D, 2011, BLOOD, V117, P5463, DOI 10.1182/blood-2010-12-324210; Baruch K, 2016, NAT MED, V22, P135, DOI 10.1038/nm.4022; Baruch K, 2013, BRAIN BEHAV IMMUN, V34, P11, DOI 10.1016/j.bbi.2013.04.002; Bassi EJ, 2012, STEM CELL REV REP, V8, P329, DOI 10.1007/s12015-011-9311-1; Bedi SS, 2013, J NEUROSCI METH, V219, P176, DOI 10.1016/j.jneumeth.2013.07.017; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Cao CH, 2009, NEUROBIOL DIS, V34, P63, DOI 10.1016/j.nbd.2008.12.015; Carpenter RS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55729-z; Chenouard A, 2015, MOL IMMUNOL, V68, P350, DOI 10.1016/j.molimm.2015.09.001; Cherry JD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0411-8; Choi B, 2011, CLIN IMMUNOL, V139, P321, DOI 10.1016/j.clim.2011.02.019; Cowen Edward West, 2016, JAMA Dermatol, V152, P356, DOI 10.1001/jamadermatol.2015.5659; Cox AL, 2006, J NEUROIMMUNOL, V174, P180, DOI 10.1016/j.jneuroim.2006.01.007; Daglas M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00981; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011; Diaz MF, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2513; Diaz MF, 2017, STEM CELLS, V35, P1259, DOI 10.1002/stem.2587; Diaz MF, 2015, J EXP MED, V212, P665, DOI 10.1084/jem.20142235; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Duran-Struuck R, 2009, J AM ASSOC LAB ANIM, V48, P11; Ehx G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01943; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Fisher Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010830; Fuchs A, 2019, J IMMUNOL, V202, P3020, DOI 10.4049/jimmunol.1801456; Garg SK, 2009, J NEUROCHEM, V108, P1155, DOI 10.1111/j.1471-4159.2009.05872.x; Gentile LF, 2014, CRIT CARE MED, V42, P1406, DOI 10.1097/CCM.0000000000000222; Geraghty NJ, 2019, TRANSPL IMMUNOL, V54, P38, DOI 10.1016/j.trim.2019.02.003; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; HARLINGBERG C, 1989, J NEUROIMMUNOL, V25, P185, DOI 10.1016/0165-5728(89)90136-7; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; Hauben E, 2000, LANCET, V355, P286, DOI 10.1016/S0140-6736(99)05140-5; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jordan MB, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27929; Kawahara K, 2012, NEUROSCIENCE, V207, P243, DOI 10.1016/j.neuroscience.2012.01.049; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Krenger W, 1996, IMMUNOL RES, V15, P50, DOI 10.1007/BF02918284; Kumar Manoj, 2016, J Clin Orthop Trauma, V7, P282; Lee HJ, 2017, CELL SIGNAL, V38, P1, DOI 10.1016/j.cellsig.2017.06.012; Lepelletier D, 2010, J NEUROSURG ANESTHES, V22; Li L, 2020, AGING-US, V12, P7397, DOI 10.18632/aging.103086; Li M, 2011, ADVANCES IN HETEROGENEOUS MATERIAL MECHANICS 2011, P71; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Li Nan, 2015, Methods Mol Biol, V1212, P183, DOI 10.1007/7651_2014_95; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Livingston DH, 2003, ANN SURG, V238, P748, DOI 10.1097/01.sla.0000094441.38807.09; Lu H, 2004, ANAL CHEM, V76, P5257, DOI 10.1021/ac049837t; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Matsuoka K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005265; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Mohty M, 2005, BLOOD, V106, P4407, DOI 10.1182/blood-2005-07-2919; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Nikolic WV, 2007, P NATL ACAD SCI USA, V104, P2507, DOI 10.1073/pnas.0609377104; Nishi Y, 2019, TRANSPL IMMUNOL, V55, DOI 10.1016/j.trim.2019.03.004; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Piper C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00163; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Prajeeth CK, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0978-3; Prevosto C, 2007, HAEMATOLOGICA, V92, P881, DOI 10.3324/haematol.11240; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Savitz SI, 2016, STEM CELLS, V34, P537, DOI 10.1002/stem.2253; Seifert HA, 2012, J NEUROIMMUNE PHARM, V7, P1017, DOI 10.1007/s11481-012-9406-8; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Shi M, 2011, CLIN EXP IMMUNOL, V164, P1, DOI 10.1111/j.1365-2249.2011.04327.x; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Sondergaard H, 2013, CLIN EXP IMMUNOL, V172, P300, DOI 10.1111/cei.12051; Szyska M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00118; TAGA K, 1993, BLOOD, V81, P2964; Thelin EP, 2018, J NEUROTRAUM, V35, P341, DOI 10.1089/neu.2017.5155; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Walsh JT, 2015, J CLIN INVEST, V125, P699, DOI [10.1172/JCI176210, 10.1172/JCI76210]; Watanabe M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38387; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang YX, 2019, NEUROIMMUNOMODULAT, V26, P43, DOI 10.1159/000495465; Ye JY, 2010, HAEMATOL-HEMATOL J, V95, P1745, DOI 10.3324/haematol.2009.020958; Yoshihara S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00186; Zhao XR, 2015, J NEUROSCI, V35, P11281, DOI 10.1523/JNEUROSCI.1685-15.2015; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310	99	2	2	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUL 1	2020	10	1							10729	10.1038/s41598-020-67723-x			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MH2GR	WOS:000546550700043	32612177	gold, Green Published			2022-02-06	
J	Eldes, T; Celiker, FB; Bilir, O; Ersunan, G; Yavasi, O; Turan, A; Toprak, U				Eldes, Tugba; Celiker, Fatma Beyazal; Bilir, Ozlem; Ersunan, Gokhan; Yavasi, Ozcan; Turan, Arzu; Toprak, Ugur			How important is susceptibility-weighted imaging in mild traumatic brain injury?	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Axonal injury; microhemorrhage; mild traumatic brain injury; susceptibility-weighted	WHITE-MATTER INJURY; CEREBRAL MICROBLEEDS; HEAD-INJURY; 3T; RELIABILITY	BACKGROUND: Mild traumatic brain injury (mTBI) is a public health problem that is recognized as a "silent epidemic" in its late stages due to undiagnosed axonal damage rated 13 and above on the Glasgow Coma Scale (GCS). Injury-related microhemorrhages often cannot be detected on computed tomography (CT) scans and conventional magnetic resonance imaging (MRI). This study aims to investigate whether susceptibility-weighted imaging is feasible in mTBI patients. METHODS: Fifty-eight patients with GCS scores of 14 and 15 and with symptoms of brief mental fogs, impairment of concentration, memory loss, headache, dizziness, or imbalance after brain injury were examined at the emergency service. A brain CT scan and MRI containing diffusion-weighted and susceptibility-weighted imaging (SWI) sequences were performed on the patients whose symptoms did not seem to alleviate after the sixth hour. Thirteen patients were excluded from this study because of advanced age, diabetes, a history of hypertension or its chronic sequelae, or acute cerebrovascular disease; 45 patients were included in this study. RESULTS: The patients' CT results were normal, and no diffusion restrictions were observed. The SWI revealed microhemorrhages in seven patients (15.6%). Five of these patients had hyperintense areas in conventional sequences corresponding to the hemorrhages spotted in the SWI. In three of the five patients, these pockets of hemorrhages were higher in number and size in comparison with conventional in the SWI sequence. CONCLUSION: Susceptibility-weighted imaging, which can be used to assess the presence and severity of microhemorrhages due to diffuse axonal injury, is recommended for determining the cause of symptoms in patients with mTBI, to continue targeted treatment and prevent complications that may develop.	[Eldes, Tugba; Celiker, Fatma Beyazal; Turan, Arzu] Recep Tayyip Erdogan Univ, Dept Radiol, Fac Med, Rize, Turkey; [Bilir, Ozlem; Ersunan, Gokhan; Yavasi, Ozcan] Recep Tayyip Erdogan Univ, Dept Emergency Med, Fac Med, Rize, Turkey; [Toprak, Ugur] Eskisehir Osmangazi Univ, Dept Radiol, Fac Med, Eskisehir, Turkey		Eldes, T (corresponding author), Recep Tayyip Erdogan Univ, Dept Radiol, Fac Med, Rize, Turkey.	eldestugba@gmail.com		toprak, ugur/0000-0002-1244-2485			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American College of Radiology ACR Appropriateness Criteria, CLIN COND HEAD TRAUM; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bian W, 2014, NEURORADIOLOGY, V56, P91, DOI 10.1007/s00234-013-1297-8; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Casson Ira R, 2006, Neurosurgery, V58, pE1003, DOI 10.1227/01.NEY.0000217313.15590.C5; Choi P, 2012, STROKE, V43, P1505, DOI 10.1161/STROKEAHA.111.647271; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Haacke EM, 2007, AM J NEURORADIOL, V28, P316; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hanyu H, 2003, NEUROSCI LETT, V340, P213, DOI 10.1016/S0304-3940(03)00121-6; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Wycliffe ND, 2004, J MAGN RESON IMAGING, V20, P372, DOI 10.1002/jmri.20130	26	2	2	2	4	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	JUL	2020	26	4					574	579		10.14744/tjtes.2019.35485			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	OE5TQ	WOS:000580593100012	32589248				2022-02-06	
J	Guo, JH; Yang, JZ; Yi, HG; Singichetti, B; Stavrinos, D; Peek-Asa, C				Guo, Jinhong; Yang, Jingzhen; Yi, Honggang; Singichetti, Bhavna; Stavrinos, Despina; Peek-Asa, Corinne			Differences in Postinjury Psychological Symptoms Between Collegiate Athletes With Concussions and Orthopedic Injuries	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; orthopedic injury; collegiate athletes; psychological symptoms	BRAIN-INJURY; SPORTS; DEPRESSION; RESPONSES; OUTCOMES; STATES; RETURN; RISK; PLAY; FEAR	Objective: To describe the differences in postinjury psychological symptoms among Division I collegiate student athletes who sustained concussions versus orthopedic injures and to examine the effects of injury type on postinjury psychological symptoms during the course of recovery. Design: A prospective cohort study with repeated measures. Setting: Two Big 10 Conference universities. Participants: Student athletes who were at least 18 years old and participated in one of 9 National Collegiate Athletic Association (NCAA) Division I-sponsored sports during the 2007 to 2011 seasons. Main Outcome Measures: Baseline depressive symptoms and anxiety were measured at enrollment. On identification of an eligible injury, follow-up surveys were conducted among injured athletes at multiple intervals until the injured athlete returned to play. Depressive symptoms, anxiety, fear of return-to-play, and fear of reinjury were measured at the postinjury follow-ups. Results: The concussion group had significantly lower scores of fear of return-to-play (B= -0.94,P= 0.0278) and fear of reinjury (B= -1.11,P= 0.0152) compared with the orthopedic injury group. The concussion group scored higher on depressive symptoms than the orthopedic injury group at 1 month after injury (P= 0.0264), although both groups scored similarly at baseline (P= 0.9729) and at 1 week after injury (P= 0.1475). Conclusions: Patterns of psychological disturbance differ after concussions and orthopedic injures. Further research is warranted to identify the factors contributing to these differences and to develop effective intervention programs to prevent these symptoms.	[Guo, Jinhong; Yang, Jingzhen; Yi, Honggang; Singichetti, Bhavna] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH USA; [Yang, Jingzhen; Yi, Honggang] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA; [Yi, Honggang] Nanjing Med Univ, Dept Biostat, Sch Publ Hlth, Nanjing, Peoples R China; [Stavrinos, Despina] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Peek-Asa, Corinne] Univ Iowa, Dept Occupat & Environm Hlth, Iowa City, IA USA		Yang, JZ (corresponding author), Ohio State Univ, Dept Pediat, Ctr Injury Res & Prevent, Res Inst,Nationwide Childrens Hosp, 700 Childrens Dr,WB5403, Columbus, OH 43205 USA.	Ginger.Yang@NationwideChildrens.Org		Singichetti, Bhavna/0000-0002-2188-3979	University of Iowa Injury Prevention Research Center; Centers for Disease Control and Prevention (CDC)/National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CD001167-01]	Supported by the University of Iowa Injury Prevention Research Center, and funded by grant #R49 CD001167-01of the Centers for Disease Control and Prevention (CDC)/National Center for Injury Prevention and Control.	Albright JP, 2004, AM J SPORT MED, V32, P1394, DOI 10.1177/0363546504264159; Ardern CL, 2016, OPER TECHN SPORT MED, V24, P77, DOI 10.1053/j.otsm.2015.09.006; Ardern CL, 2012, J SCI MED SPORT, V15, P488, DOI 10.1016/j.jsams.2012.03.015; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brown GT, 2014, MIND BOD SPORT UND S; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Junge A, 2000, AM J SPORT MED, V28, pS10; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kisch J, 2005, SUICIDE LIFE-THREAT, V35, P3, DOI 10.1521/suli.35.1.3.59263; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; Mormile MEE, 2018, J SPORT REHABIL, V27, P16, DOI 10.1123/jsr.2016-0140; Morrey MA, 1999, CLIN J SPORT MED, V9, P63, DOI 10.1097/00042752-199904000-00004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; Ross CA, 2017, PHYSIOTHER THEOR PR, V33, P103, DOI 10.1080/09593985.2016.1271847; Spielberger C.D., 1968, STATE TRAIT ANXIETY; te Wierike SCM, 2013, SCAND J MED SCI SPOR, V23, P527, DOI 10.1111/sms.12010; Thatcher J, 2007, J SPORT REHABIL, V16, P343, DOI 10.1123/jsr.16.4.343; van Wilgen CP, 2010, DISABIL REHABIL, V32, P1576, DOI 10.3109/09638281003596857; Weiss MR, 2003, J ATHL TRAINING, V38, P172; Wiese-Bjornstal DM, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2010.01195.x; Wolanin A, 2015, CURR SPORT MED REP, V14, P56, DOI 10.1249/JSR.0000000000000123	33	2	2	4	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2020	30	4					360	365		10.1097/JSM.0000000000000621			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	NA4GG	WOS:000559774000014	29933281				2022-02-06	
J	Huo, JY; Qi, ZX; Chen, S; Wang, Q; Wu, XH; Zang, D; Hiromi, T; Tan, JX; Zhang, LC; Tang, WJ; Shen, DG				Huo, Jiayu; Qi, Zengxin; Chen, Sen; Wang, Qian; Wu, Xuehai; Zang, Di; Hiromi, Tanikawa; Tan, Jiaxing; Zhang, Lichi; Tang, Weijun; Shen, Dinggang			Neuroimage-Based Consciousness Evaluation of Patients with Secondary Doubtful Hydrocephalus Before and After Lumbar Drainage	NEUROSCIENCE BULLETIN			English	Article						Hydrocephalus; Disorder of consciousness; Structural imaging; Feature selection; Regression	TRAUMATIC BRAIN-INJURY; NORMAL-PRESSURE HYDROCEPHALUS; VEGETATIVE STATE; COMA; MODELS; LEVEL; DTI	Hydrocephalus is often treated with a cerebrospinal fluid shunt (CFS) for excessive amounts of cerebrospinal fluid in the brain. However, it is very difficult to distinguish whether the ventricular enlargement is due to hydrocephalus or other causes, such as brain atrophy after brain damage and surgery. The non-trivial evaluation of the consciousness level, along with a continuous drainage test of the lumbar cistern is thus clinically important before the decision for CFS is made. We studied 32 secondary mild hydrocephalus patients with different consciousness levels, who received T1 and diffusion tensor imaging magnetic resonance scans before and after lumbar cerebrospinal fluid drainage. We applied a novel machine-learning method to find the most discriminative features from the multi-modal neuroimages. Then, we built a regression model to regress the JFK Coma Recovery Scale-Revised (CRS-R) scores to quantify the level of consciousness. The experimental results showed that our method not only approximated the CRS-R scores but also tracked the temporal changes in individual patients. The regression model has high potential for the evaluation of consciousness in clinical practice.	[Huo, Jiayu; Chen, Sen; Wang, Qian; Zhang, Lichi] Shanghai Jiao Tong Univ, Inst Med Imaging Technol, Shanghai 200030, Peoples R China; [Qi, Zengxin; Wu, Xuehai; Zang, Di; Hiromi, Tanikawa; Tan, Jiaxing] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurosurg, Shanghai 200030, Peoples R China; [Qi, Zengxin; Wu, Xuehai; Zang, Di; Hiromi, Tanikawa; Tan, Jiaxing] Fudan Univ, Shanghai Clin Med Ctr Neurosurg, Shanghai Key Lab Brain Funct Restorat & Neutral R, Neurosurg Inst, Shanghai 200030, Peoples R China; [Qi, Zengxin; Wu, Xuehai; Zang, Di; Hiromi, Tanikawa; Tan, Jiaxing] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200030, Peoples R China; [Qi, Zengxin; Wu, Xuehai; Zang, Di; Hiromi, Tanikawa; Tan, Jiaxing] Fudan Univ, Minist Educ, Frontiers Ctr Brain Sci, Sch Basic Med Sci, Shanghai 200030, Peoples R China; [Qi, Zengxin; Wu, Xuehai; Zang, Di; Hiromi, Tanikawa; Tan, Jiaxing] Fudan Univ, Inst Brain Sci, Shanghai 200030, Peoples R China; [Tang, Weijun] Fudan Univ, Dept Radiol, Huashan Hosp, Shanghai 200030, Peoples R China; [Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA; [Shen, Dinggang] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC 27599 USA; [Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul 02841, South Korea		Zhang, LC (corresponding author), Shanghai Jiao Tong Univ, Inst Med Imaging Technol, Shanghai 200030, Peoples R China.; Tang, WJ (corresponding author), Fudan Univ, Dept Radiol, Huashan Hosp, Shanghai 200030, Peoples R China.	lichizhang@sjtu.edu.cn; tangwj83@gmail.com	Shen, Dinggang/ABF-6812-2020	Shen, Dinggang/0000-0002-7934-5698; Huo, Jiayu/0000-0002-9811-0368	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571025, 81702461]; National Key Research and Development Program of China [2018YFC0116400]; Shanghai Science Foundation [18410711300]; Shanghai Science and Technology Development Funds [16JC1420100]; Shanghai Sailing Program [17YF1426600]; STCSMScience & Technology Commission of Shanghai Municipality (STCSM) [19QC1400600, 17411953300]; Shanghai Pujiang ProgramShanghai Pujiang Program [19PJ1406800]; Shanghai Municipal Science and Technology Major Project [2018SHZDZX01]; ZJlab of Shanghai Jiao Tong University; Interdisciplinary Program of Shanghai Jiao Tong University	This work was supported by the National Natural Science Foundation of China (81571025 and 81702461), the National Key Research and Development Program of China (2018YFC0116400), the International Cooperation Project from Shanghai Science Foundation (18410711300), Shanghai Science and Technology Development Funds (16JC1420100), the Shanghai Sailing Program (17YF1426600), STCSM (19QC1400600, 17411953300), the Shanghai Pujiang Program (19PJ1406800), the Shanghai Municipal Science and Technology Major Project (No.2018SHZDZX01) and ZJlab, and the Interdisciplinary Program of Shanghai Jiao Tong University.	Assaf Y, 2006, AM J NEURORADIOL, V27, P1717; Bai L, 2019, IEEE T CYBERN; Bai L, 2016, PATTERN RECOGN, V50, P233, DOI 10.1016/j.patcog.2015.08.006; Cavaliere C, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01028; Chari A, 2014, J NEUROSURG, V120, P697, DOI 10.3171/2013.11.JNS121895; Daou B, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.6.FOCUS16189; Del Bigio MR, 2010, DEV DISABIL RES REV, V16, P16, DOI 10.1002/ddrr.94; Di Perri C, 2014, WORLD J RADIOL, V6, P589, DOI 10.4329/wjr.v6.i8.589; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Governale LS, 2008, NEUROSURGERY, V63, P379, DOI 10.1227/01.NEU.0000327023.18220.88; Greitz D, 2004, NEUROSURG REV, V27, P145, DOI 10.1007/s10143-004-0326-9; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Hoza D, 2015, NEUROSURG REV, V38, P239, DOI 10.1007/s10143-014-0584-0; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Khoo HM, 2016, J NEUROSURG, V124, P350, DOI 10.3171/2015.1.JNS141633; Kia SM, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00619; Kim MJ, 2011, AM J NEURORADIOL, V32, P1496, DOI 10.3174/ajnr.A2531; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Marmarou A, 2005, J NEUROSURG, V102, P987, DOI 10.3171/jns.2005.102.6.0987; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Noirhomme Q, 2017, NEUROIMAGE, V145, P288, DOI 10.1016/j.neuroimage.2015.12.006; Osuka S, 2010, J NEUROSURG, V112, P832, DOI 10.3171/2009.7.JNS09550; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Qin PM, 2015, ANN NEUROL, V78, P594, DOI 10.1002/ana.24479; Tolosi L, 2011, BIOINFORMATICS, V27, P1986, DOI 10.1093/bioinformatics/btr300; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Weichwald S, 2015, NEUROIMAGE, V110, P48, DOI 10.1016/j.neuroimage.2015.01.036; Wu XH, 2018, NEUROSCI BULL, V34, P668, DOI 10.1007/s12264-018-0253-3; Wu XH, 2015, J NEUROSCI, V35, P12932, DOI 10.1523/JNEUROSCI.0415-15.2015; Yeh Fang-Cheng, 2013, PLOS ONE, V8; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263; Zhang LC, 2017, NEUROCOMPUTING, V229, P3, DOI 10.1016/j.neucom.2016.05.082; Zhang LC, 2016, MED PHYS, V43, P1175, DOI 10.1118/1.4941011; Zhao CL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005063	39	2	3	4	10	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1673-7067	1995-8218		NEUROSCI BULL	Neurosci. Bull.	SEP	2020	36	9					985	996		10.1007/s12264-020-00542-2		JUL 2020	12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NJ9UB	WOS:000544547900001	32607740	Green Published			2022-02-06	
J	Meier, TB; Nitta, ME; Teague, TK; Nelson, LD; McCrea, MA; Savitz, J				Meier, Timothy B.; Nitta, Morgan E.; Teague, T. Kent; Nelson, Lindsay D.; McCrea, Michael A.; Savitz, Jonathan			Prospective study of the effects of sport-related concussion on serum kynurenine pathway metabolites	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Concussion; Mild traumatic brain injury; Kynurenine; Mood symptoms	TRAUMATIC BRAIN-INJURY; MAJOR DEPRESSIVE DISORDER; QUINOLINIC ACID; INDOLEAMINE 2,3-DIOXYGENASE; FUNCTIONAL CONNECTIVITY; RECURRENT CONCUSSION; CEREBROSPINAL-FLUID; HUMAN MICROGLIA; HIPPOCAMPAL; SYMPTOMS	Reports of neurodegenerative and psychiatric disease in former athletes have increased public concern about the acute and chronic effects of sport-related concussions (SRC). The biological factors underlying individual differences in the psychiatric sequalae of SRC and their role in potential long-term negative outcomes have not been determined. One understudied biological consequence of the known inflammatory response to concussion is the activation of a key immunoregulatory pathway, the kynurenine pathway (KP). Activation of the KP produces several neuroactive metabolites that have been associated with psychiatric and neurodegenerative diseases. We tested the hypothesis that SRC results in an elevation of serum KP metabolites with neurotoxic properties (quinolinic acid [QuinA], 3-hydroxykynurenine [3HK]) together with a reduction in the neuroprotective metabolite kynurenic acid (KynA), and that these metabolites would predict post-concussion psychological symptoms. Additionally, because brain injury is thought to prime the immune system, a secondary goal was to test the hypothesis that athletes with acute SRC and a history of prior SRC would have elevated neurotoxic relative to neuroprotective KP metabolites compared to athletes that were concussed for the first time. High school and collegiate football players (N =1136) were enrolled at a preseason baseline visit that included clinical testing and blood specimen collection. Athletes that suffered a SRC (N =59) completed follow-up visits within 6-hours (early-acute), at 24-48 h (late-acute) and at 8, 15, and 45 days post-injury. Uninjured contact sport (CC; N=54) and non-contact sport athletes completed similar visits and served as controls (NCC; N =30). SRC athletes had significantly elevated psychological symptoms, assessed using the Brief Symptom Inventory-18 (BSI), acutely following injury relative to both control groups. There was a group-by-visit interaction on the ratio of KynA to 3HK in serum, a neuroprotective index, with elevated KynA/3HK in athletes with SRC at the early-acute visit relative to later visits. Importantly, athletes with greater elevation in this neuroprotective index at the earlyacute visit reported fewer depressive symptoms at the late-acute visit. Finally, SRC athletes with prior concussion had significantly lower serum KynA/QuinA at all visits compared to SRC athletes with no prior concussion, an effect driven by elevated QuinA in SRC athletes with prior concussion. These results suggest that early-acute activation of the KynA branch of the KP may protect against the development of depressive symptoms following concussion. Furthermore, they highlight the potential of serum QuinA as a biomarker for repetitive head injury and provide insight into possible mechanisms linking prior concussion with subsequent injury.	[Meier, Timothy B.; Nitta, Morgan E.; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Nitta, Morgan E.] Marquette Univ, Dept Psychol, Milwaukee, WI 53233 USA; [Teague, T. Kent] Univ Oklahoma, Sch Community Med, Dept Surg, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Sch Community Med, Dept Psychiat, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Pharm, Dept Pharmaceut Sci, Tulsa, OK USA; [Teague, T. Kent] Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK USA; [Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Savitz, Jonathan] Laureate Inst Brain Res, Tulsa, OK USA; [Savitz, Jonathan] Univ Tulsa, Oxley Coll Hlth Sci, Tulsa, OK 74104 USA		Meier, TB (corresponding author), Med Coll Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu	Teague, T. Kent/A-2527-2008; Savitz, Jonathan/C-3088-2009	Teague, T. Kent/0000-0002-4680-5440; Savitz, Jonathan/0000-0001-8143-182X	Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research [W81XWH-14-1-0561]; National Institute of Neurological Disorders And Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS099789]; National Institute of Neurological Disorders And StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102225]; Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM121312]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH113871]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436]	This work was supported by the Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research through Award No. W81XWH-14-1-0561. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. Support for this work was also provided by the National Institute of Neurological Disorders And Stroke of the National Institutes of Health under Award Number R21NS099789. TM acknowledges additional support from the National Institute of Neurological Disorders And Stroke (R01NS102225) and through a project funded through the Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin. JS acknowledges support from the National Institute of General Medical Sciences (P20GM121312) and the National Institute of Mental Health (R21MH113871). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The REDCap electronic database and the Adult Translational Research Unit used for this project were supported by the National Center for Advancing Translational Sciences, National Institutes of Health, Award Number UL1TR001436.	Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Amaral M, 2013, J MOL MED, V91, P705, DOI 10.1007/s00109-013-1046-9; Bay-Richter C, 2015, BRAIN BEHAV IMMUN, V43, P110, DOI 10.1016/j.bbi.2014.07.012; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Carpenedo R, 2001, EUR J NEUROSCI, V13, P2141, DOI 10.1046/j.0953-816x.2001.01592.x; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Cho HJ, 2017, J PSYCHOSOM RES, V99, P1, DOI 10.1016/j.jpsychores.2017.05.016; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; Derogatis LR., 2004, SCL 90 R BRIEF SYMPT; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Doolin K, 2018, PSYCHONEUROENDOCRINO, V95, P8, DOI 10.1016/j.psyneuen.2018.05.019; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Espey MG, 1997, NEUROREPORT, V8, P431, DOI 10.1097/00001756-199701200-00011; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; FOSTER AC, 1984, EXP NEUROL, V84, P428, DOI 10.1016/0014-4886(84)90239-5; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Gill J, 2016, J HEAD TRAUMA REHAB, V31, P269, DOI 10.1097/HTR.0000000000000191; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HEYES MP, 1992, J NEUROIMMUNOL, V40, P71, DOI 10.1016/0165-5728(92)90214-6; Heyes MP, 1997, J NEUROCHEM, V68, P280; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KESSLER M, 1989, J NEUROCHEM, V52, P1319, DOI 10.1111/j.1471-4159.1989.tb01881.x; Klein AP, 2019, J NEUROTRAUM, V36, P1776, DOI 10.1089/neu.2018.6055; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Colin-Gonzalez AL, 2013, NEUROTOXICOLOGY, V34, P189, DOI 10.1016/j.neuro.2012.11.007; Mackay GM, 2006, EUR J NEUROL, V13, P30, DOI 10.1111/j.1468-1331.2006.01220.x; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; McCuddy WT, 2018, NEUROIMAGE-CLIN, V19, P434, DOI 10.1016/j.nicl.2018.05.011; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Meier TB, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6471; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Meier TB, 2017, J NEUROTRAUM, V34, P824, DOI 10.1089/neu.2016.4599; Meier TB, 2016, J NEUROTRAUM, V33, P1349, DOI 10.1089/neu.2015.4118; Meier TB, 2016, BRAIN BEHAV IMMUN, V53, P39, DOI 10.1016/j.bbi.2015.11.003; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Myint AM, 2007, J AFFECT DISORDERS, V98, P143, DOI 10.1016/j.jad.2006.07.013; Nitta ME, 2019, NEUROLOGY, V93, pE497, DOI 10.1212/WNL.0000000000007864; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Parrott JM, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.200; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Rahman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006344; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Ritchie EV, 2018, BRAIN INJURY, V32, P523, DOI 10.1080/02699052.2018.1429662; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Savitz J, 2020, MOL PSYCHIATR, V25, P131, DOI 10.1038/s41380-019-0414-4; Savitz J, 2015, BRAIN BEHAV IMMUN, V46, P55, DOI 10.1016/j.bbi.2015.02.007; Savitz J, 2015, NEUROPSYCHOPHARMACOL, V40, P463, DOI 10.1038/npp.2014.194; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Singh R, 2016, J NEUROL NEUROSUR PS, V87, P670, DOI 10.1136/jnnp-2015-311369; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94; Tasci A, 2003, NEUROL RES, V25, P871, DOI 10.1179/016164103771953998; Van Pelt KL, 2019, INJURY EPIDEMIOL, V6, DOI 10.1186/s40621-018-0178-3; WechslerD, 2001, WECHSLER TEST ADULT; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Yan EB, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0328-2; Yang WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32987; Young KD, 2016, BRAIN BEHAV IMMUN, V56, P335, DOI 10.1016/j.bbi.2016.04.007; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zetterberg Henrik, 2016, Concussion, V1, pCNC12, DOI 10.2217/cnc-2015-0002; Zunszain PA, 2012, NEUROPSYCHOPHARMACOL, V37, P939, DOI 10.1038/npp.2011.277	82	2	2	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JUL	2020	87						715	724		10.1016/j.bbi.2020.03.002			10	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology; Neurosciences & Neurology; Psychiatry	MC0CQ	WOS:000542965400119	32147388	Green Accepted			2022-02-06	
J	Morissette, MP; Prior, HJ; Tate, RB; Wade, J; Leiter, JRS				Morissette, Marc P.; Prior, Heather J.; Tate, Robert B.; Wade, John; Leiter, Jeff R. S.			Associations between concussion and risk of diagnosis of psychological and neurological disorders: a retrospective population-based cohort study	FAMILY MEDICINE AND COMMUNITY HEALTH			English	Article						epidemiology; public health	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; ALZHEIMERS-DISEASE; DEPRESSION; DEMENTIA; PREVALENCE; ANXIETY	Objective To investigate associations between concussion and the risk of follow-up diagnoses of attention-deficit hyperactivity disorder (ADHD), mood and anxiety disorders (MADs), dementia and Parkinson's disease. Design A retrospective population-based cohort study. Setting Administrative health data for the Province of Manitoba between 1990-1991 and 2014-2015. Participants A total of 47 483 individuals were diagnosed with a concussion using International Classification of Diseases (ICD) codes (ICD-9-CM: 850; ICD-10-CA: S06.0). All concussed subjects were matched with healthy controls at a 3:1 ratio based on age, sex and geographical location. Associations between concussion and conditions of interest diagnosed later in life were assessed using a stratified Cox proportional hazards regression model, with adjustments for socioeconomic status and pre-existing medical conditions. Results 28 021 men (mean age +/- SD, 25 +/- 18 years) and 19 462 women (30 +/- 21 years) were included in the concussion group, while 81 871 men (25 +/- 18 years) and 57 159 women (30 +/- 21 years) were included in the matched control group. Concussion was associated with adjusted hazard ratios of 1.39 (95% CI 1.32 to 1.46, p<0.001) for ADHD, 1.72 (95% CI 1.69 to 1.76; p<0.001) for MADs, 1.72 (95% CI 1.61 to 1.84; p<0.001) for dementia and 1.57 (95% CI 1.41 to 1.75; p<0.001) for Parkinson's disease. Conclusion Concussion was associated with an increased risk of diagnosis for all four conditions of interest later in life.	[Morissette, Marc P.] Pan Am Clin Fdn, Winnipeg, MB, Canada; [Morissette, Marc P.] Univ Manitoba, Fac Grad Studies, Appl Hlth Sci, Winnipeg, MB, Canada; [Prior, Heather J.] Univ Manitoba, Rady Fac Hlth Sci, Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada; [Tate, Robert B.] Univ Manitoba, Rady Fac Hlth Sci, Community Hlth Sci, Winnipeg, MB, Canada; [Wade, John] Univ Manitoba, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Leiter, Jeff R. S.] Univ Manitoba, Fac Kinesiol & Recreat Management, Winnipeg, MB, Canada		Morissette, MP (corresponding author), Pan Am Clin Fdn, Winnipeg, MB, Canada.; Morissette, MP (corresponding author), Univ Manitoba, Fac Grad Studies, Appl Hlth Sci, Winnipeg, MB, Canada.	mmorissette2@panamclinic.com		Morissette, Marc/0000-0002-5342-8938	Pan Am Clinic Foundation; Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate ScholarshipCanadian Institutes of Health Research (CIHR)	This study was funded by the Pan Am Clinic Foundation. MPM was supported by a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Barca ML, 2019, INT PSYCHOGERIATR, V31, P597, DOI 10.1017/S1041610218001199; Bennett S, 2014, MATURITAS, V79, P184, DOI 10.1016/j.maturitas.2014.05.009; Bergem ALM, 1997, ARCH GEN PSYCHIAT, V54, P264; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P733, DOI 10.1111/cpf.12487; Canadian Institute for Health Information, 2012, INT STAT CLASS DIS R; Centers for Disease Control and Prevention and others, 2013, INT CLASS DIS 9 REV; Chartier M.B.M., 2016, MENTAL HLTH MANITOBA; Chen Q, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204516; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Daugherty J, 2019, HEALTH EDUC J, V78, P784, DOI 10.1177/0017896919846185; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faraone SV, 2019, MOL PSYCHIATR, V24, P562, DOI 10.1038/s41380-018-0070-0; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gatz M, 1997, J GERONTOL A-BIOL, V52, pM117, DOI 10.1093/gerona/52A.2.M117; Giza C, 2018, HAND CLINIC, V158, P51, DOI 10.1016/B978-0-444-63954-7.00006-9; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guttman M, 2003, MOVEMENT DISORD, V18, P313, DOI 10.1002/mds.10333; Hane FT, 2017, J ALZHEIMERS DIS, V57, P645, DOI 10.3233/JAD-160907; Kelly JP, 1997, NEUROLOGY, V48, P581; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Linden A, 2013, J EVAL CLIN PRACT, V19, P968, DOI 10.1111/jep.12072; Lix, 2016, CANC DATA LINKAGE MA; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Manitoba Centre for Health Policy, 2013, CONC MOOD ANX DIS ME; Manitoba Centre for Health Policy, 2016, CONC ATT DEF HYP DIS; Manitoba Centre for Health Policy, CONC SOC FACT IND SE; Manitoba Centre for Health Policy, 2013, CONC DEM; Manitoba Centre for Health Policy, CONC CHARLS COM IND; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McAllister TW, 2018, HAND CLINIC, V158, P153, DOI 10.1016/B978-0-444-63954-7.00016-1; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDevitt J, 2017, CONCUSSION, V2, pCNC26, DOI 10.2217/cnc-2016-0020; Riedel O, 2010, J NEUROL, V257, P1073, DOI 10.1007/s00415-010-5465-z; Ritchie EV, 2018, BRAIN INJURY, V32, P523, DOI 10.1080/02699052.2018.1429662; Rugbjerg K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2494; Schrag A, 2017, INT REV NEUROBIOL, V133, P623, DOI [10.1016/bs.im.2017.05.024, 10.1016/bs.irn.2017.05.024]; Slade T, 2006, PSYCHOL MED, V36, P1593, DOI 10.1017/S0033291706008452; Smith M, 2018, J AM MED INFORM ASSN, V25, P224, DOI 10.1093/jamia/ocx078; Soares NM, 2019, J NEURAL TRANSM, V126, P219, DOI 10.1007/s00702-018-1947-4; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Yang LY, 2016, PEDIATR RES, V80, P356, DOI 10.1038/pr.2016.85; Zbozinek TD, 2012, DEPRESS ANXIETY, V29, P1065, DOI 10.1002/da.22026; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	50	2	2	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2305-6983	2009-8774		FAM MED COMMUNITY HE	Fam. Med. Community Health	JUL	2020	8	3							e000390	10.1136/fmch-2020-000390			9	Primary Health Care	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NC3KT	WOS:000561114500001	32719017	gold, Green Published			2022-02-06	
J	Santing, JAL; van den Brand, CL; Jellema, K				Santing, Juliette A. L.; van den Brand, Crispijn L.; Jellema, Korne			Traumatic Brain Injury during the SARS-CoV-2 Pandemic	NEUROTRAUMA REPORTS			English	Article						coronavirus; COVID-19; head trauma; SARS-CoV-2; traumatic brain injury		Emergency departments (EDs) are eerily quiet for illnesses apart from COVID-19. In this short communication, we assessed the effect of COVID-19 on ED attendance rates for traumatic brain injury (TBI). Data were collected from all consecutive patients with TBI attending our hospital (Haaglanden Medical Center, The Hague, The Netherlands) during the first 3 weeks of the Dutch lockdown (from March 18 to April 6) and for the same period last year. We observed a 36% decrease in ED attendance for TBI since the beginning of the SARS-CoV-2 pandemic (91 vs. 143). Patients who presented during the lockdown were significantly older compared with the patients who visited the ED in the previous year (72 vs. 57, p = 0.01). No other significant differences were found.	[Santing, Juliette A. L.; Jellema, Korne] Haaglanden Med Ctr, Dept Neurol, Lijnbaan 32, NL-2512 VA The Hague, Netherlands; [van den Brand, Crispijn L.] Haaglanden Med Ctr, Dept Emergency Med, The Hague, Netherlands; [van den Brand, Crispijn L.] Dutch Inst Clin Auditing, Leiden, Netherlands		Santing, JAL (corresponding author), Haaglanden Med Ctr, Dept Neurol, Lijnbaan 32, NL-2512 VA The Hague, Netherlands.	j.santing@haaglandenmc.nl					Hodgkinson S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g104; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; National Health Service (NHS) England, 2020, A E ATT EM ADM ADM 2; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967	5	2	2	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	JUL 1	2020	1	1					5	7		10.1089/neur.2020.0001			3	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WV1MY	WOS:000717002800003	34223525	hybrid, Green Published			2022-02-06	
J	Schiffman, HJ; Olufs, ZPG; Lasarev, MR; Wassarman, DA; Perouansky, M				Schiffman, Hannah J.; Olufs, Zachariah P. G.; Lasarev, Michael R.; Wassarman, David A.; Perouansky, Misha			Ageing and genetic background influence anaesthetic effects in a D. melanogaster model of blunt trauma with brain injury	BRITISH JOURNAL OF ANAESTHESIA			English	Article						aquaporin; Drosophila; genetics; GWAS; hyperoxia; isoflurane; mortality; sevoflurane; toxicity	ENDOPLASMIC-RETICULUM STRESS; AQUAPORIN-4; EDEMA; ISOFLURANE; CHANNEL; POLYMORPHISMS; MORTALITY; HYPEROXIA; AGENTS	Background: General anaesthetics interact with the pathophysiological mechanisms of traumatic brain injury (TBI). We used a Drosophila melanogaster (fruit fly) model to test the hypothesis that ageing and genetic background modulate the effect of anaesthetics and hyperoxia on TBI-induced mortality in the context of blunt trauma. Methods: We exposed flies to isoflurane or sevoflurane under normoxic or hyperoxic conditions and TBI, and subsequently quantified the effect on mortality 24 h after injury. To determine the effect of age on anaesthetic-induced mortality, we analysed flies at 1-8 and 43-50 days old. To determine the effect of genetic background, we performed a genome-wide association study (GWAS) analysis on a collection of young inbred, fully sequenced lines. Results: Exposure to anaesthetics and hyperoxia differentially affected mortality in young and old flies. Pre-exposure of young but not old flies to anaesthetics reduced mortality. Post-exposure selectively increased mortality. For old but not young flies, hyperoxia enhanced the effect on mortality of post-exposure to isoflurane but not to sevoflurane. Post-exposure to isoflurane in hyperoxia increased the mortality of young fly lines in the Drosophila Genetic Reference Panel collection to different extents. GWAS analysis of these data identified single nucleotide polymorphisms in genes involved in cell water regulation and oxygen sensing as being associated with the post-exposure effect on mortality. Conclusions: Ageing and genetic background influence the effects of volatile general anaesthetics and hyperoxia on mortality in the context of traumatic brain injury. Polymorphisms in specific genes are identified as potential causes of ageing and genetic effects.	[Schiffman, Hannah J.; Olufs, Zachariah P. G.; Perouansky, Misha] Univ Wisconsin, Sch Med & Publ Hlth, Dept Anesthesiol, Madison, WI 53792 USA; [Lasarev, Michael R.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI USA; [Wassarman, David A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Genet, Madison, WI USA		Perouansky, M (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Anesthesiol, Madison, WI 53792 USA.	mperouansky@wisc.edu			University of Wisconsin Institute for Clinical and Translational Research (ICTR) via the Clinical and Translational Science Award (CTSA) program through the National Center for Advancing Translational Sciences (NCATS) [1UL1TR002373]; Department of Anesthesiology, University of Wisconsin-Madison, WI, USA	University of Wisconsin Institute for Clinical and Translational Research (ICTR) via the Clinical and Translational Science Award (CTSA) program through the National Center for Advancing Translational Sciences (NCATS) (grant number 1UL1TR002373) and Department of Anesthesiology, University of Wisconsin-Madison, WI, USA (seed grant) to MP.	Akdemir G, 2014, NEUROSCI LETT, V574, P70, DOI 10.1016/j.neulet.2014.03.073; Alsulaim HA, 2017, AM J SURG, V214, P207, DOI 10.1016/j.amjsurg.2016.07.012; Appelboom G, 2015, NEUROL RES, V37, P657, DOI 10.1179/1743132815Y.0000000047; Berger M, 2018, ANESTH ANALG, V127, P1406, DOI 10.1213/ANE.0000000000003841; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; Evered L, 2018, ANESTHESIOLOGY, V129, P872, DOI 10.1097/ALN.0000000000002334; Fischer JA, 2018, ANESTH ANALG, V126, P1979, DOI 10.1213/ANE.0000000000002906; Gruenewald C, 2009, FREE RADICAL BIO MED, V46, P1668, DOI 10.1016/j.freeradbiomed.2009.03.025; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Jevtovic-Todorovic V, 2013, BRIT J ANAESTH, V111, P143, DOI 10.1093/bja/aet177; Katada R, 2014, FASEB J, V28, P705, DOI 10.1096/fj.13-231274; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kilgannon JH, 2011, CIRCULATION, V123, P2717, DOI 10.1161/CIRCULATIONAHA.110.001016; Kitano H, 2007, J CEREBR BLOOD F MET, V27, P1108, DOI 10.1038/sj.jcbfm.9600410; Kleffner I, 2008, STROKE, V39, P1333, DOI 10.1161/STROKEAHA.107.500785; Komita M, 2013, ANESTH ANALG, V117, P1197, DOI 10.1213/ANE.0b013e3182a74773; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Matta JA, 2008, P NATL ACAD SCI USA, V105, P8784, DOI 10.1073/pnas.0711038105; Mio Y, 2008, ANESTHESIOLOGY, V108, P612, DOI 10.1097/ALN.0b013e318167af2d; Naidoo N, 2009, REV NEUROSCIENCE, V20, P23; Olufs ZPG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20720-7; RAMPIL IJ, 1991, ANESTHESIOLOGY, V74, P429, DOI 10.1097/00000542-199103000-00007; Ren GY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11607-0; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Sniecinski R, 2004, ANESTHESIOLOGY, V100, P589, DOI 10.1097/00000542-200403000-00019; Sorani MD, 2008, HUM MOL GENET, V17, P2379, DOI 10.1093/hmg/ddn138; STEVENS WC, 1975, ANESTHESIOLOGY, V42, P197, DOI 10.1097/00000542-197502000-00014; Stollings LM, 2016, ANESTHESIOLOGY, V125, P399, DOI 10.1097/ALN.0000000000001195; Tavare AN, 2012, INT J CANCER, V130, P1237, DOI 10.1002/ijc.26448; Turnheim M, 2004, EXP GERONTOL, V39, P1731, DOI 10.1016/j.exger.2004.05.011; Wanner SP, 2012, CELL CYCLE, V11, P343, DOI 10.4161/cc.11.2.18772; Yuki K, 2008, FASEB J, V22, P4109, DOI 10.1096/fj.08-113324; Zeileis A, 2006, J STAT SOFTW, V16	38	2	2	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	JUL	2020	125	1					77	86		10.1016/j.bja.2020.03.029			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	MD9XJ	WOS:000544318800085	32466842	Green Published, Bronze			2022-02-06	
J	Sharma, J; Defoe, D; Gillen, J; Kuo, YH; Perez, J; Dalal, S; Dayal, S; Kiselak, E; Rippey, K; Kaul, S; Cohn, S				Sharma, Jyoti; Defoe, Danielle; Gillen, Jenna; Kuo, Yen-Hong; Perez, Javier; Dalal, Setu; Dayal, Saraswati; Kiselak, Elizabeth; Rippey, Kelly; Kaul, Sanjeev; Cohn, Stephen			Putting a halt to unnecessary transfers: Do patients with isolated subarachnoid hemorrhage and Glasgow Coma Scale of 13 to 15 need a trauma center?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	33rd Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 14-18, 2020	Orlando, FL	Eastern Assoc Surg Trauma		Blunt trauma; transfers; traumatic subarachnoid hemorrhage	BRAIN-INJURY; OUTCOMES	OBJECTIVES: Trauma patients with isolated subarachnoid hemorrhage (iSAH) presenting to nontrauma centers are typically transferred to an institution with neurosurgical availability. However, recent studies suggest that iSAH is a benign clinical entity with an excellent prognosis. This investigation aims to evaluate the neurosurgical outcomes of traumatic iSAH with Glasgow Coma Scale (GCS) of 13 to 15 who were transferred to a higher level of care. METHODS: The American College of Surgeon Trauma Quality Improvement Program was retrospectively analyzed from 2010 to 2015 for transferred patients 16 years and older with blunt trauma, iSAH, and GCS of 13 or greater. Those with any other body region Abbreviated Injury Scale of 3 or greater, positive or unknown alcohol/drug status, and requiring mechanical ventilation were excluded. The primary outcome was need for neurosurgical intervention (i.e., intracranial monitor or craniotomy/craniectomy). RESULTS: A total of 11,380 patients with blunt trauma, iSAH, and GCS of 13 to 15 were transferred to an American College of Surgeon level I/II from 2010 to 2015. These patients were 65 years and older (median, 72 [interquartile range (IQR), 59-81]) and white (83%) and had one or more comorbidities (72%). Eighteen percent reported a bleeding diathesis/chronic anticoagulation on admission. Most patients had fallen (80%), had a GCS of 15 (84%), and were mildly injured (median Injury Severity Score, 9 [IQR, 5-14]). Only 1.7% required neurosurgical intervention with 55% of patients being admitted to the intensive care unit for a median of 2 days (IQR, 1-3 days). Furthermore, 2.2% of the patients died. The median hospital length of stay was only 3 days (IQR, 2-5 days), and the most common discharge location was home with self-care (62%). Patient factors favoring neurosurgical intervention included high Injury Severity Score, low GCS, and chronic anticoagulation. CONCLUSION: Trauma patients transferred for iSAH with GCS of 13 to 15 are at very low risk for requiring neurosurgical intervention. (Copyright (C) 2020 Wolters Kluwer Health, Inc. All rights reserved.)	[Sharma, Jyoti; Perez, Javier; Dalal, Setu; Kiselak, Elizabeth; Kaul, Sanjeev; Cohn, Stephen] Hackensack Univ, Med Ctr, Dept Trauma Surg Crit Care & Injury Prevent, 30 Prospect Ave,G834, Hackensack, NJ 07601 USA; [Defoe, Danielle; Gillen, Jenna] Hackensack Univ, Med Ctr, Palisades Med Ctr, Dept Surg, Hackensack, NJ USA; [Kuo, Yen-Hong] Hackensack Univ, Med Ctr, Off Res Adm, Hackensack, NJ USA		Sharma, J (corresponding author), Hackensack Univ, Med Ctr, Dept Trauma Surg Crit Care & Injury Prevent, 30 Prospect Ave,G834, Hackensack, NJ 07601 USA.	jyoti.sharma@hackensackmeridian.org					Ashkenazi I, 2007, EMERG MED J, V24, P550, DOI 10.1136/emj.2006.044461; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Gates M, 2017, WORLD NEUROSURG, V100, P417, DOI 10.1016/j.wneu.2017.01.046; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Newgard CD, 2013, J AM COLL SURGEONS, V216, P147, DOI 10.1016/j.jamcollsurg.2012.08.017; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Witiw CD, 2018, CRIT CARE MED, V46, P430, DOI 10.1097/CCM.0000000000002931; Yun BJ, 2017, AM J EMERG MED, V35, P1281, DOI 10.1016/j.ajem.2017.03.071	9	2	2	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2020	89	1					222	225		10.1097/TA.0000000000002645			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	MJ2BL	WOS:000547897300035	32118824				2022-02-06	
J	Wasserman, EB; Coberley, M; Anderson, S; Grant, M; Hardin, JA				Wasserman, Erin B.; Coberley, Mark; Anderson, Scott; Grant, Murphy; Hardin, James Allen			Concussion Rates Differ by Practice Type and Equipment Worn in an Autonomy Five Collegiate Football Conference	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; injury prevention; football; epidemiology	HEAD-IMPACT EXPOSURE; HIGH-SCHOOL; AMERICAN FOOTBALL; EPIDEMIOLOGY; ASSOCIATION; INJURIES; PLAYERS; RISK	Objective: Evaluate the rate of concussions across Big 12 Conference football programs based on (1) equipment worn, (2) contact level, (3) preseason practice versus in-season practice versus games, and (4) mechanism of injury for concussion. Design: Descriptive epidemiology study. Setting: Big 12 Conference football practices and competitions. Patients (or Participants): Big 12 Conference football teams. Assessment of Risk Factors: All Big 12 Conference institutions collected data on practice types, equipment worn, practice and game participation, and concussions during the fall, preseasons and regular seasons, from 2013 to 2016. Main Outcome Measures: Injury rates and injury rate ratios were reported with 95% confidence intervals (CIs). Results: From 2013 to 2016, there were 375 concussions reported [0.98/1000 athlete exposures (AEs) (95% CI, 0.88-1.08)], an average of approximately 9 concussions per team per year. Concussion rates were highest in games (5.73/1000 AE), but among practices, concussion rates were highest in full-pad (1.18/1000 AEs) and live-contact (1.28/1000 AEs) practices. Concussion rates increased with increasing contact and equipment worn. Concussion rates were higher in the preseason than in the regular season, even when stratifying by contact level and equipment worn. Conclusions: Practice concussion rates are highest during fully padded and live-contact practices, supporting limitations on practice contact and equipment worn to reduce the risk associated with head-impact exposure. Higher concussion rates in the preseason and during games indicate an effect of play intensity on concussion risk, and further research is needed to evaluate the direct effect of practice contact level and equipment guidelines and restrictions on concussion incidence.	[Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Coberley, Mark] Iowa State Univ, Dept Athlet, Ames, IA USA; [Anderson, Scott] Univ Oklahoma, Dept Athlet, Norman, OK 73019 USA; [Grant, Murphy] Univ Kansas, Dept Athlet, Lawrence, KS 66045 USA; [Hardin, James Allen] Univ Texas Austin, Dept Intercollegiate Athlet, Austin, TX 78712 USA		Wasserman, EB (corresponding author), Datalys Ctr Sports Injury Res & Prevent Inc, 401 W Michigan St,Suite 500, Indianapolis, IN 46208 USA.	ewasserman@datalyscenter.org		Wasserman, Erin/0000-0001-5957-5878			Belson K, 2016, NY TIMES; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Big 12 Conference, 2016, 2016 17 C HDB; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Cantu RC, 2003, NEUROSURGERY, V53, P358, DOI 10.1227/01.NEU.0000073422.01886.88; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Dick R, 2007, J ATHL TRAINING, V42, P221; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, AM J SPORT MED, V43, P1134, DOI 10.1177/0363546515570622; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; NCAA, 2016, 2016 2017 NCAA FOOTB; NCAA Sport Science Institute, 2017, INT CONS YEAR ROUND; NCAA Sport Science Institute, 2017, CONC SAF PROT MAN; NCAA Sport Science Institute, 2017, CONC SAF PROT CHECKL; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	25	2	2	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2020	30	4					366	371		10.1097/JSM.0000000000000615			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	NA4GG	WOS:000559774000015	29952843				2022-02-06	
J	Ved, R; Fraser, R; Hamadneh, S; Zaben, M; Leach, P				Ved, Ronak; Fraser, Rebecca; Hamadneh, Sarah; Zaben, Malik; Leach, Paul			Clinical features associated with the development of hydrocephalus following TBI in the paediatric age group	CHILDS NERVOUS SYSTEM			English	Article						Hydrocephalus; Paediatric; Trauma; Injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HYDROCEPHALUS; RISK-FACTORS	Introduction Predictive factors for post-traumatic hydrocephalus (PTH) in adults have been elucidated but remain uncertain for children. We aimed to identify the prevalence of PTH in paediatric patients and identify clinical/radiological factors which may increase the probability of children developing PTH. Methods This was a retrospective study of all patients < 16 years old admitted to our unit with traumatic brain injury (TBI) between March 2013 and June 2018, 108 patients in total. Patients were classified as mild (13-15), moderate (9-12) or severe (3-8) TBI based on admission GCS. Three independent reviewers collected data from case notes. CT scans were reviewed for hydrocephalus using Evan's index. Two-tailed Fisher's exact tests with apvalue < 0.05 were considered statistically significant. Results Median patient age was 7 years, and 65% were males (n = 70). PTH wasn't identified in any patients with mild/moderate TBI (n = 79). In cases of severe TBI (n = 29), three patients developed PTH requiring ventriculoperitoneal shunting (10%;p = 0.02). Radiological features which were significantly more common in the PTH group were intraventricular haemorrhage (p = 0.05) and subarachnoid haemorrhage (p = 0.03). There was also a trend towards a statistically significant association with subdural haematoma (p = 0.07). The need for other neurosurgical procedures, such as fracture elevation and craniotomy, did not increase the probability of developing with PTH (p = 0.08). Discussion The prevalence of PTH in our study is 2.7%. Factors which may be associated with a higher probability of developing PTH may include IVH, SAH, severity of TBI, and subdural haematoma. We propose a national prospective multicentre database of paediatric PTH. The data collected on prevalence, presentation, risk factors, and management could guide contemporary management and improve the outcomes of children with PTH.	[Ved, Ronak; Fraser, Rebecca; Hamadneh, Sarah; Zaben, Malik; Leach, Paul] Univ Hosp Wales, Dept Neurosurg, 4th Floor,Heath Pk Way, Cardiff CF14 4XW, Wales		Ved, R (corresponding author), Univ Hosp Wales, Dept Neurosurg, 4th Floor,Heath Pk Way, Cardiff CF14 4XW, Wales.	vedr@cardiff.ac.uk		Zaben, Malik/0000-0002-7446-4532			BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; Bonow RH, 2018, NEUROSURGERY, V83, P732, DOI 10.1093/neuros/nyx470; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Dewan MC, J NEUROSURG, V1, P1; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Licata C, 2001, J Neurosurg Sci, V45, P141; Low CYD, 2013, J CLIN NEUROSCI, V20, P867, DOI 10.1016/j.jocn.2012.06.007; Matsumoto S, 1990, ANN REV HYDROCEPHALU, V6, P147; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Rumalla K, 2018, PEDIATR NEUROL, V80, P70, DOI 10.1016/j.pediatrneurol.2017.11.015; Silver B V, 1997, Pediatr Rehabil, V1, P123; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721	16	2	2	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2021	37	2					511	517		10.1007/s00381-020-04764-7		JUN 2020	7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	PX7WG	WOS:000544152000001	32601900	hybrid, Green Accepted, Green Published			2022-02-06	
J	DeCicco, JP; Roby, PR; DeLellis, SM; Healy, ML; Kane, SF; Lynch, JH; Means, GE; Mihalik, JP				DeCicco, Jamie P.; Roby, Patricia R.; DeLellis, Stephen M.; Healy, Marshall L.; Kane, Shawn F.; Lynch, James H.; Means, Gary E.; Mihalik, Jason P.			The relationship between neurovascular coupling, vision and sensory performance, and concussion history in Special Operations Forces combat soldiers	CLINICAL NEUROPSYCHOLOGIST			English	Article						Blast injury; cerebrovascular reactivity; mild traumatic brain injury; military; neuroimaging	RECURRENT CONCUSSION; CONTRAST SENSITIVITY; INJURY	Objective:To determine the relationship between neurovascular coupling (NVC), vision and sensory performance in Special Operations Forces (SOF) combat soldiers with and without concussion history. Methods:We studied 61 SOF combat soldiers (male, age = 33.8 +/- 3.7 years,n = 40 with concussion history [Median = 3; range = 1-10+]). We instrumented our participants with transcranial Doppler to quantify NVC response during reading and visual search tasks. All participants completed vision and sensory performance testing (Senaptec Sensory Station). We performed separate multiple regressions to determine if relationships between NVC and vision and sensory performance testing existed while controlling for concussion history, and to investigate the interaction between NVC and concussion history. Results:Those with higher visual search NVC response magnitudes demonstrated significantly worse contrast sensitivity when controlling for concussion history (F-1,F-60=4.57,ss = 0.03,p = .04,R-2= 12.6%). We did not observe any other significant relationships between NVC and visual and sensory performance tests nor did we observe any significant interactions between NVC and concussion history (p > .05). Conclusions:Heightened NVC response magnitudes are related to reduced contrast sensitivity in SOF combat soldiers. Because concussion history does not impact the relationships between outcomes, these measures may be utilized for performance evaluation at any point in a soldier's career. The lack of relationships between NVC response magnitude and some of the other vision and sensory performance outcomes suggests that implementing NVC assessment may add unique information and enable clinicians to detect physiological deficits that may otherwise go undetected.	[DeCicco, Jamie P.; Roby, Patricia R.; Kane, Shawn F.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27599 USA; [Roby, Patricia R.; Mihalik, Jason P.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC 27599 USA; [DeLellis, Stephen M.] Def Med Strategies LLC, Fayetteville, NC USA; [Healy, Marshall L.; Lynch, James H.; Means, Gary E.] US Army Special Operat Command, Ft Bragg, NC USA; [Kane, Shawn F.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27599 USA		Mihalik, JP (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 2201 Stallings Evans Sports Med Ctr, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu		kane, Shawn/0000-0002-9110-5224; Roby, Patricia/0000-0003-0166-4274	United States Army Special Operations Command; Preservation of the Force and Family Program at US Special Operations Command; Henry M Jackson Foundation; Uniformed Services University	These data were collected as part of a program funded by the United States Army Special Operations Command. Additionally, this work was supported by funding secured by the Preservation of the Force and Family Program at US Special Operations Command and executed as a subaward issued to the University of North Carolina at Chapel Hill by the Henry M Jackson Foundation under a cooperative agreement with the Uniformed Services University. Dr. Mihalik is Chief Science Office and has an equity interest in Senaptec Inc. The authors have no other conflicts of interest to report.	[Anonymous], DOD WORLDW NUMB TBI; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Carrasco M, 2006, PROG BRAIN RES, V154, P33; DeLellis Stephen M, 2009, J Spec Oper Med, V9, P36; Forsten R. D., 2008, J SPECIAL OPERATIONS, V8, P74; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; KELLY DH, 1977, OPT ACTA, V24, P107, DOI 10.1080/713819495; Kramer M. R., 2020, ATHLETIC TRAINING SP, DOI [10.3928/19425864-20200206-01, DOI 10.3928/19425864-20200206-01]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lennie P., 2002, VISUAL IMPAIRMENTS D, DOI [https://doi.org/10.17226/10320, 10.17226/10320, DOI 10.17226/10320]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; O'Carroll DC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0043; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Richman E. A., 2020, TRAUMATIC BRAIN INJU; Riva CE, 2005, PROG RETIN EYE RES, V24, P183, DOI 10.1016/j.preteyeres.2004.07.002; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Smirl JD, 2016, J NEUROSCI METH, V270, P92, DOI 10.1016/j.jneumeth.2016.06.007; Triantaphillidou S, 2019, SIGNAL PROCESS-IMAGE, V75, P64, DOI 10.1016/j.image.2019.03.002; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Wright AD, 2017, J NEUROTRAUM, V34, P3097, DOI 10.1089/neu.2017.5020	27	2	2	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 22	2020	34	6			SI		1215	1225		10.1080/13854046.2020.1783367		JUN 2020	11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	MV0HS	WOS:000549608600001	32603258				2022-02-06	
J	Stephenson, DD; Meier, TB; Reddy, SP; Robertson-Benta, CR; Hergert, DC; Dodd, AB; Shaff, NA; Ling, JM; Oglesbee, SJ; Campbell, RA; Phillips, JP; Sapien, RE; Mayer, AR				Stephenson, David D.; Meier, Timothy B.; Reddy, Sharvani Pabbathi; Robertson-Benta, Cidney R.; Hergert, Danielle C.; Dodd, Andrew B.; Shaff, Nicholas A.; Ling, Josef M.; Oglesbee, Scott J.; Campbell, Richard A.; Phillips, John P.; Sapien, Robert E.; Mayer, Andrew R.			Resting-State Power and Regional Connectivity After Pediatric Mild Traumatic Brain Injury	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						pediatric; mild traumatic brain injury; low-frequency amplitude; regional connectivity; persistent postconcussive symptoms	DEFAULT MODE NETWORK; ACUTE CONCUSSION; FMRI DATA; CHILDREN; SYMPTOMS; HOMOGENEITY; PLASTICITY; AMPLITUDE; FOOTBALL; RECOVERY	Background Physiological recovery from pediatric mild traumatic brain injury (pmTBI) as a function of age remains actively debated, with the majority of studies relying on subjective symptom report rather than objective markers of brain physiology. Purpose To examine potential abnormalities in fractional amplitude of low-frequency fluctuations (fALFF) or regional homogeniety (ReHo) during resting-state fMRI following pmTBI. Study Type Prospective cohort. Population Consecutively recruited pmTBI (N =105; 8-18 years old) and age- and sex-matched healthy controls (HC;N =113). Field Strength/Sequence 3T multiecho gradient T-1-weighted and single-shot gradient-echo echo-planar imaging. Assessment All pmTBI participants were assessed 1 week and 4 months postinjury (HC assessed at equivalent timepoints after the first visit). Comprehensive demographic, clinical, and cognitive batteries were performed in addition to primary investigation of fALFF and ReHo. All pmTBI were classified as "persistent" or "recovered" based on both assessment periods. Statistical Tests Chi-square, nonparametric, and generalized linear models for demographic data. Generalized estimating equations for clinical and cognitive data. Voxelwise general linear models (AFNI's 3dMVM) for fALFF and ReHo assessment. Results Evidence of recovery was observed for some, but not all, clinical and cognitive measures at 4 months postinjury. fALFF was increased in the left striatum for pmTBI relative to HC both at 1 week and 4 months postinjury; whereas no significant group differences (P > 0.001) were observed for ReHo. Age-at-injury did not moderate either resting-state metric across groups. In contrast to analyses of pmTBI as a whole, there were no significant (P > 0.001) differences in either fALFF or ReHo in patients with persistent postconcussive symptoms compared to recovered patients and controls at 4 months postinjury. Data Conclusions Our findings suggest prolonged clinical recovery and alterations in the relative amplitude of resting-state fluctuations up to 4 months postinjury, but no clear relationship with age-at-injury or subjective symptom report. Level of Evidence 1 Technical Efficacy 2	[Stephenson, David D.; Reddy, Sharvani Pabbathi; Robertson-Benta, Cidney R.; Hergert, Danielle C.; Dodd, Andrew B.; Shaff, Nicholas A.; Ling, Josef M.; Phillips, John P.; Mayer, Andrew R.] Mind Res Network LBERI, Albuquerque, NM USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Oglesbee, Scott J.; Sapien, Robert E.] Univ New Mexico, Emergency Med, Albuquerque, NM 87131 USA; [Campbell, Richard A.; Mayer, Andrew R.] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA; [Campbell, Richard A.; Mayer, Andrew R.] Univ New Mexico, Dept Behav Sci, Albuquerque, NM 87131 USA; [Phillips, John P.; Mayer, Andrew R.] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA		Mayer, AR (corresponding author), Mind Res Network, Pete & Nancy Domen Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	amayer@mrn.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH 01 R01 NS098494-01A1]	This research was supported by grants from the National Institutes of Health (https://www.nih.gov; grant numbers NIH 01 R01 NS098494-01A1 and -03S1A1) to Andrew R. Mayer. The NIH had no role in study review, data collection and analysis, decision to publish, or preparation of the article.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Bray S, 2017, HUM BRAIN MAPP, V38, P2398, DOI 10.1002/hbm.23526; Buysse DJ, 2010, SLEEP, V33, P781, DOI 10.1093/sleep/33.6.781; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Delis DC., 2001, DELIS KAPLAN EXECUTI; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Derogatis LR., 2004, USE PSYCHOL TESTING, P1; Dodd AB, 2020, J CEREBR BLOOD F MET, V40, P2491, DOI 10.1177/0271678X19896883; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iyer KK, 2019, ANN CLIN TRANSL NEUR, V6, P954, DOI 10.1002/acn3.764; Kolb B, 2007, DEV PSYCHOBIOL, V49, P107, DOI 10.1002/dev.20199; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kriz PK, 2016, J PEDIATR-US, V171, P234, DOI 10.1016/j.jpeds.2015.12.006; Lambregts SAM, 2018, BRAIN INJURY, V32, P230, DOI 10.1080/02699052.2017.1406990; Lopez-Larson MP, 2011, DEV COGN NEUROS-NETH, V1, P187, DOI 10.1016/j.dcn.2010.10.001; Madhavan R, 2019, J NEUROTRAUM, V36, P650, DOI 10.1089/neu.2018.5739; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayer AR, 2020, J NEUROTRAUM, V37, P1504, DOI 10.1089/neu.2019.6805; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; Meier TB, 2019, J NEUROTRAUM, V37, P152; Meier TB, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6471; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Power JD, 2018, P NATL ACAD SCI USA, V115, pE2105, DOI 10.1073/pnas.1720985115; PRINZ RJ, 1979, J APPL BEHAV ANAL, V12, P691, DOI 10.1901/jaba.1979.12-691; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Rausa VC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0881-z; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Taylor PA, 2013, BRAIN CONNECT, V3, P523, DOI 10.1089/brain.2013.0154; van der Horn HJ, 2017, J NEUROTRAUM, V34, P3262, DOI 10.1089/neu.2017.5185; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wechsler D., 2014, WECHSLER INTELLIGENC, V5th; Wechsler D., 2008, WECHSLER ADULT INTEL; White T, 2014, BRAIN CONNECT, V4, P417, DOI 10.1089/brain.2013.0195; Wilkinson G.S., 2006, WRAT 4 WIDE RANGE AC; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhan J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00027; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	57	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	DEC	2020	52	6					1701	1713		10.1002/jmri.27249		JUN 2020	13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Radiology, Nuclear Medicine & Medical Imaging	OS1QN	WOS:000543444200001	32592270				2022-02-06	
J	Asfaw, MA; Zerdo, Z; Churko, C; Seife, F; Yihune, M; Chisha, Y; Teshome, A; Getachew, B; Negussu, N				Asfaw, Mekuria Asnakew; Zerdo, Zerihun; Churko, Chuchu; Seife, Fikre; Yihune, Manaye; Chisha, Yilma; Teshome, Abinet; Getachew, Birhanu; Negussu, Nebiyu			Preventive chemotherapy coverage against soil-transmitted helminth infection among school age children: Implications from coverage validation survey in Ethiopia, 2019	PLOS ONE			English	Article								Background Soil-transmitted helminth (STH) infections remain the most common neglected tropical diseases among children living mainly in low-resource settings. Preventive chemotherapy (PC) has been implemented as one of the main public health interventions to control and eliminate STH infections. Although data on routine coverage of PC against STH are available at different level of the health system; these data are unreliable as they are subject to errors and manipulation and evidence is lacking on validated treatment coverage. Thus, this study aimed to determine anthelminthic coverage among school age children (SAC) to inform decision made in PC program implementation. Methods We conducted a community-based cross-sectional coverage survey in ten districts of Ethiopia; in April 2019. Sample size was computed automatically using Coverage Survey Builder (CSB) tool in Microsoft excel. Thirty segments were randomly selected per each selected districts. Collected data were cleaned and analysed using SPSS software (IBM, version 25). Principal findings In all, 8154 SAC participated in the study. The overall anthelminthic coverage was found to be 71% (95%confidence interval (CI) = 70-71.9%). The reported coverage was lower than the surveyed coverage only in Guagusa district. The PC coverage among males (71.9%) was slightly higher than females' coverage (70%); and the coverage in the age group between10 and 14 years (77%) was higher compared with the age group between 5 and 9 years (64.3%). In addition, the PC coverage in school attending children (81.1%) was much higher than coverage in non-enrolled children (28.3%). Moreover, the most frequently mentioned reasons for not swallowing drugs were drug not given (24.75%) and not attending school (19.75%). Concussion This study showed that only five out of ten districts met the target threshold (minimum 75%) for effective coverage. Hence, implementations of preventive chemotherapy should be improved in those districts with low coverage data.	[Asfaw, Mekuria Asnakew; Zerdo, Zerihun; Churko, Chuchu] Arba Minch Univ, Collaborat Res & Training Ctr NTDs, Arba Minch, Ethiopia; [Seife, Fikre; Negussu, Nebiyu] Fed Minist Hlth, Neglected Trop Dis, Addis Ababa, Ethiopia; [Yihune, Manaye; Chisha, Yilma; Teshome, Abinet] Arba Minch Univ, Coll Med & Hlth Sci, Arba Minch, Ethiopia; [Getachew, Birhanu] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia		Asfaw, MA (corresponding author), Arba Minch Univ, Collaborat Res & Training Ctr NTDs, Arba Minch, Ethiopia.	maksambaramr23@gmail.com	Asfaw, Mekuria Asnakew/ABA-6150-2020; Churko, Chuchu/AAM-9809-2021	asfaw, mekuria/0000-0002-5718-0001	Federal Ministry of Health	This study is made possible by the generous support of Federal Ministry of Health.	[Anonymous], 2015, TRANSPLANTATION DIRE, V1, pe2, DOI 10.1097/TXD.0000000000000509; [Anonymous], 2017, LANCET GLOB HEALTH, V5, pe428; Cohn DA, 2019, INT HEALTH, V11, P370, DOI 10.1093/inthealth/ihz012; Dembele M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001574; Federal Democratic Republic of Ethiopia Ministry of Health, 2016, 2 ED ETH NAT MAST PL; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Kabatereine NB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000755; Owada K, 2017, ADV PARASIT, V98, P1, DOI 10.1016/bs.apar.2017.05.002; Pabalan N, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0005523; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Pullan RL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-81; S BE, 2018, J CROHNS COLITIS, V12, pS049; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; WHO, 2017, CROSS BILL PREV CHEM; WHO, 2018, WKLY EPIDEMIOL REC, V93, P681; World Health Organization, 2006, PREV CHEM HUM HELM C; World Health Organization, 2020, END NEGL ATT SUST DE; World Health Organization, SOIL TRANSM HELM EL; World Health Organization, 2019, UN HLTH COV WHO KEY; World Health Organization, UN COMB NTDS; Worrell C, 2012, AM J TROP MED HYG, V87, P216, DOI 10.4269/ajtmh.2012.12-0167; 2019, J CROHNS COLITIS S1, V13	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2020	15	6							e0235281	10.1371/journal.pone.0235281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0YE	WOS:000545759800002	32589660	Green Published, gold			2022-02-06	
J	Siebold, L; Krueger, AC; Abdala, JA; Figueroa, JD; Bartnik-Olson, B; Holshouser, B; Wilson, CG; Ashwal, S				Siebold, Lorraine; Krueger, Amy C.; Abdala, Jonathan A.; Figueroa, Johnny D.; Bartnik-Olson, Brenda; Holshouser, Barbara; Wilson, Christopher G.; Ashwal, Stephen			Cosyntropin Attenuates Neuroinflammation in a Mouse Model of Traumatic Brain Injury	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						traumatic brain injury; ACTH; microglia; behavior; neuroinflammation; neutrophils; cosyntropin	MELANOCYTE-STIMULATING HORMONE; ADRENOCORTICOTROPIC HORMONE; CEREBRAL-ISCHEMIA; MESSENGER-RNA; GLUCOCORTICOIDS MODULATE; MELANOCORTIN RECEPTORS; SYNAPTIC PLASTICITY; RAT HIPPOCAMPUS; HEAD-INJURY; ACTHAR GEL	Aim: Traumatic brain injury (TBI) is a leading cause of mortality/morbidity and is associated with chronic neuroinflammation. Melanocortin receptor agonists including adrenocorticotropic hormone (ACTH) ameliorate inflammation and provide a novel therapeutic approach. We examined the effect of long-acting cosyntropin (CoSyn), a synthetic ACTH analog, on the early inflammatory response and functional outcome following experimental TBI. Methods: The controlled cortical impact model was used to induce TBI in mice. Mice were assigned to injury and treatment protocols resulting in four experimental groups including sham + saline, sham + CoSyn, TBI + saline, and TBI + CoSyn. Treatment was administered subcutaneously 3 h post-injury and daily injections were given for up to 7 days post-injury. The early inflammatory response was evaluated at 3 days post-injury through the evaluation of cytokine expression (IL1 beta and TNF alpha) and immune cell response. Quantification of immune cell response included cell counts of microglia/macrophages (Iba1+ cells) and neutrophils (MPO+ cells) in the cortex and hippocampus. Behavioral testing (n= 10-14 animals/group) included open field (OF) and novel object recognition (NOR) during the first week following injury and Morris water maze (MWM) at 10-15 days post-injury. Results: Immune cell quantification showed decreased accumulation of Iba1+ cells in the perilesional cortex and CA1 region of the hippocampus for CoSyn-treated TBI animals compared to saline-treated. Reduced numbers of MPO+ cells were also found in the perilesional cortex and hippocampus in CoSyn treated TBI mice compared to their saline-treated counterparts. Furthermore, CoSyn treatment reduced IL1 beta expression in the cortex of TBI mice. Behavioral testing showed a treatment effect of CoSyn for NOR with CoSyn increasing the discrimination ratio in both TBI and Sham groups, indicating increased memory performance. CoSyn also decreased latency to find platform during the early training period of the MWM when comparing CoSyn to saline-treated TBI mice suggesting moderate improvements in spatial memory following CoSyn treatment. Conclusion: Reduced microglia/macrophage accumulation and neutrophil infiltration in conjunction with moderate improvements in spatial learning in our CoSyn treated TBI mice suggests a beneficial anti-inflammatory effect of CoSyn following TBI.	[Siebold, Lorraine; Krueger, Amy C.; Figueroa, Johnny D.; Wilson, Christopher G.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA; [Siebold, Lorraine; Abdala, Jonathan A.; Wilson, Christopher G.] Loma Linda Univ, Lawrence D Longo MD Ctr Perinatal Biol, Loma Linda, CA 92350 USA; [Figueroa, Johnny D.] Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA USA; [Bartnik-Olson, Brenda; Holshouser, Barbara] Loma Linda Univ, Med Ctr, Dept Radiol, Loma Linda, CA USA; [Wilson, Christopher G.; Ashwal, Stephen] Loma Linda Univ, Med Ctr, Dept Pediat, Loma Linda, CA USA		Siebold, L (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA.; Siebold, L (corresponding author), Loma Linda Univ, Lawrence D Longo MD Ctr Perinatal Biol, Loma Linda, CA 92350 USA.	lsiebold@llu.edu	Figueroa, Johnny/AAL-7791-2020	Figueroa, Johnny/0000-0003-4769-8736; Bartnik-Olson, Brenda/0000-0002-1137-9437	Foundation for the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH NICHD HD092941-01]; Pediatric Epilepsy Research Foundation (PERF); Loma Linda University Pediatric Education and Research Training (PERT) grant	This research was supported by (Foundation for the National Institutes of Health) NIH NICHD HD092941-01, Pediatric Epilepsy Research Foundation (PERF) and Loma Linda University Pediatric Education and Research Training (PERT) grant.	Aharon MA, 2017, J VET EMERG CRIT CAR, V27, P267, DOI 10.1111/vec.12603; Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Al-Barazanji KA, 2001, HORM METAB RES, V33, P480, DOI 10.1055/s-2001-16941; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Arrat H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125638; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Basu A, 2002, J NEUROSCI, V22, P6071; Berkovich R, 2013, NEUROTHERAPEUTICS, V10, P97, DOI 10.1007/s13311-012-0160-7; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bertolini A, 2009, PHARMACOL RES, V59, P13, DOI 10.1016/j.phrs.2008.10.005; Bitto A, 2012, CRIT CARE MED, V40, P945, DOI 10.1097/CCM.0b013e318236efde; Blank T, 2013, GLIA, V61, P62, DOI 10.1002/glia.22372; Brown DL, 2017, J TOXICOL PATHOL, V30, P183, DOI 10.1293/tox.2017-0013; Brunson KL, 2001, ANN NEUROL, V49, P304, DOI 10.1002/ana.66; Burkholder Tanya, 2012, Curr Protoc Mouse Biol, V2, P145; Campolo M, 2013, J ENDOCRINOL, V217, P291, DOI 10.1530/JOE-13-0022; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Carniglia L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158564; Catania A, 2004, PHARMACOL REV, V56, P1, DOI 10.1124/pr.56.1.1; Catania A, 2008, TRENDS NEUROSCI, V31, P353, DOI 10.1016/j.tins.2008.04.002; Chen M, 2007, BIOCHEMISTRY-US, V46, P11389, DOI 10.1021/bi700125e; Chen SP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1140-6; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cusick MF, 2015, AUTOIMMUNITY, V48, P222, DOI 10.3109/08916934.2014.984836; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; DAVAL JL, 1985, J CELL PHYSIOL, V124, P75, DOI 10.1002/jcp.1041240113; Decker DA, 2014, LUPUS, V23, P802, DOI 10.1177/0961203314531840; Dinkel K, 2003, J NEUROCHEM, V84, P705, DOI 10.1046/j.1471-4159.2003.01604.x; Dong TT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0663-y; Edwards P, 2005, LANCET, V365, P1957; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Feng GL, 2018, BRAIN RES, V1696, P22, DOI 10.1016/j.brainres.2018.05.044; Flanagan SR, 2015, ARCH PHYS MED REHAB, V96, P1753, DOI 10.1016/j.apmr.2015.07.001; Flygt J, 2018, J NEUROTRAUM, V35, P2837, DOI 10.1089/neu.2018.5660; Food and Drug Administration, 2010, HP ACTH GEL REP CORT; Fox C, 2005, J CEREBR BLOOD F MET, V25, P1138, DOI 10.1038/sj.jcbfm.9600121; Gallo-Payet N, 2016, J MOL ENDOCRINOL, V56, pT135, DOI 10.1530/JME-15-0257; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gettig J., 2009, HP ACTHAR GEL COSY 8, V8, P250; Getting SJ, 2002, ARTHRITIS RHEUM, V46, P2765, DOI 10.1002/art.10526; Giuliani D, 2011, ACTA NEUROPATHOL, V122, P443, DOI 10.1007/s00401-011-0873-4; Golde S, 2003, EUR J NEUROSCI, V18, P2527, DOI 10.1046/j.1460-9568.2003.02917.x; Golub VM, 2015, FRONT AGING NEUROSCI, V7, DOI [10.5589/fnagi.2015.00196, 10.3389/fnagi.2015.00196]; GOVERDE HJM, 1984, FEBS LETT, V173, P23, DOI 10.1016/0014-5793(84)81009-1; Grundy PL, 2000, NEUROREPORT, V11, P3381, DOI 10.1097/00001756-200010200-00023; Grundy PL, 2001, BRAIN RES, V892, P386, DOI 10.1016/S0006-8993(00)03258-3; Habbas S, 2015, CELL, V163, P1730, DOI 10.1016/j.cell.2015.11.023; Harazin A, 2018, PEERJ, V6, DOI 10.7717/peerj.4774; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Holloway PM, 2015, ARTERIOSCL THROM VAS, V35, P1936, DOI 10.1161/ATVBAHA.115.305348; Huang QH, 2002, NEUROSCI LETT, V334, P186, DOI 10.1016/S0304-3940(02)01088-1; Ichiyama T, 1999, BRAIN RES, V836, P31, DOI 10.1016/S0006-8993(99)01584-X; Jin WN, 2017, J CEREBR BLOOD F MET, V37, P2224, DOI 10.1177/0271678X17694185; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Joksimovic J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00172; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Krashes MJ, 2016, NAT NEUROSCI, V19, P206, DOI 10.1038/nn.4202; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lisak RP, 2015, EXP NEUROL, V273, P161, DOI 10.1016/j.expneurol.2015.08.012; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; Ma YY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0504-z; Machado I, 2018, NEUROPHARMACOLOGY, V128, P314, DOI 10.1016/j.neuropharm.2017.09.041; Marcos R, 2012, J ANAT, V220, P303, DOI 10.1111/j.1469-7580.2012.01475.x; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Montero-Melendez T, 2015, SEMIN IMMUNOL, V27, P216, DOI 10.1016/j.smim.2015.02.003; Montero-Melendez T, 2015, J IMMUNOL, V194, P3381, DOI 10.4049/jimmunol.1402645; Montero-Melendez T, 2011, AM J PATHOL, V179, P259, DOI 10.1016/j.ajpath.2011.03.042; Mouton P. R., 2002, PRINCIPLES PRACTICES; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nadeau S, 2002, J IMMUNOL, V169, P3370, DOI 10.4049/jimmunol.169.6.3370; Nasiri J, 2017, IRAN J CHILD NEUROL, V11, P19; Ozen I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020387; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Paragliola RM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102201; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Ross AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00021; Saba J, 2019, MOL CELL NEUROSCI, V94, P41, DOI 10.1016/j.mcn.2018.12.002; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Scantlebury MH, 2017, NEUROSCI LETT, V645, P14, DOI 10.1016/j.neulet.2017.02.069; Scerif M, 2013, J ENDOCRINOL, V219, P79, DOI 10.1530/JOE-13-0192; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Scholzen TE, 2003, ENDOCRINOLOGY, V144, P360, DOI 10.1210/en.2002-220651; Schulz C, 2010, AM J PHYSIOL-ENDOC M, V298, pE237, DOI 10.1152/ajpendo.00408.2009; Shen Y, 2016, CELL REP, V17, P1819, DOI 10.1016/j.celrep.2016.10.043; Shen Y, 2013, J NEUROSCI, V33, P464, DOI 10.1523/JNEUROSCI.3282-12.2013; Shipp SL, 2015, NEUROPEPTIDES, V53, P29, DOI 10.1016/j.npep.2015.07.005; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Spaccapelo L, 2011, EUR J PHARMACOL, V670, P479, DOI 10.1016/j.ejphar.2011.09.015; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Tapp ZM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00345; Do TTH, 2019, J STEROID BIOCHEM, V185, P150, DOI 10.1016/j.jsbmb.2018.08.010; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Veldhuis JD, 2001, J CLIN ENDOCR METAB, V86, P5554, DOI 10.1210/jc.86.11.5554; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; Yang JH, 2016, BRAIN RES BULL, V120, P25, DOI 10.1016/j.brainresbull.2015.10.012; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Younger D, 2019, MOL NEUROBIOL, V56, P5202, DOI 10.1007/s12035-018-1428-7; Zhang ZY, 2007, ACTA NEUROPATHOL, V113, P675, DOI 10.1007/s00401-007-0195-8	113	2	2	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	JUN 26	2020	13								109	10.3389/fnmol.2020.00109			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MO8YW	WOS:000551804900001	32670020	gold, Green Published			2022-02-06	
J	Holmstrom, U; Tsitsopoulos, PP; Holtz, A; Saki, K; Shaw, G; Mondello, S; Marklund, N				Holmstrom, Ulrika; Tsitsopoulos, Parmenion P.; Holtz, Anders; Saki, Konstantin; Shaw, Gerry; Mondello, Stefania; Marklund, Niklas			Cerebrospinal fluid levels of GFAP and pNF-H are elevated in patients with chronic spinal cord injury and neurological deterioration	ACTA NEUROCHIRURGICA			English	Article						Spinal cord injury; Biomarkers; Syringomyelia; Cerebrospinal fluid; Tethering of the spinal cord (TSC); Glial fibrillary acidic protein (GFAP); Ubiquitin C-terminal hydrolase L1 (UCH-L1); Neurofilament; Post-traumatic myelopathy	POSTTRAUMATIC SYRINGOMYELIA; SURGICAL-TREATMENT; BIOMARKERS; MANAGEMENT; SEVERITY; MYELOPATHY; BLOOD; MODEL; NEUROTRAUMA; MARKERS	Background Years after a traumatic spinal cord injury (SCI), a subset of patients may develop progressive clinical deterioration due to intradural scar formation and spinal cord tethering, with or without an associated syringomyelia. Meningitis, intradural hemorrhages, or intradural tumor surgery may also trigger glial scar formation and spinal cord tethering, leading to neurological worsening. Surgery is the treatment of choice in these chronic SCI patients. Objective We hypothesized that cerebrospinal fluid (CSF) and plasma biomarkers could track ongoing neuronal loss and scar formation in patients with spinal cord tethering and are associated with clinical symptoms. Methods We prospectively enrolled 12 patients with spinal cord tethering and measured glial fibrillary acidic protein (GFAP), ubiquitin C-terminal hydrolase L1 (UCH-L1), and phosphorylated Neurofilament-heavy (pNF-H) in CSF and blood. Seven patients with benign lumbar intradural tumors and 7 patients with cervical radiculopathy without spinal cord involvement served as controls. Results All evaluated biomarker levels were markedly higher in CSF than in plasma, without any correlation between the two compartments. When compared with radiculopathy controls, CSF GFAP and pNF-H levels were higher in patients with spinal cord tethering (p <= 0.05). In contrast, CSF UCH-L1 levels were not altered in chronic SCI patients when compared with either control groups. Conclusions The present findings suggest that in patients with spinal cord tethering, CSF GFAP and pNF-H levels might reflect ongoing scar formation and neuronal injury potentially responsible for progressive neurological deterioration.	[Holmstrom, Ulrika; Tsitsopoulos, Parmenion P.; Holtz, Anders; Saki, Konstantin; Marklund, Niklas] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden; [Tsitsopoulos, Parmenion P.] Aristotle Univ Thessaloniki, Hippokratio Gen Hosp, Dept Neurosurg, Fac Med, Thessaloniki, Greece; [Shaw, Gerry] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Marklund, Niklas] Neurosurg Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Lund, Sweden		Tsitsopoulos, PP (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden.; Tsitsopoulos, PP (corresponding author), Aristotle Univ Thessaloniki, Hippokratio Gen Hosp, Dept Neurosurg, Fac Med, Thessaloniki, Greece.	ptsitsopoulos@auth.gr	Mondello, Stefania/A-1813-2012	Mondello, Stefania/0000-0002-8587-3614	Uppsala University; Uppsala University Hospital funds (ALF funds); RTF Foundation; Swedish Research CouncilSwedish Research CouncilEuropean Commission	Open Access funding provided by Uppsala University. This study was supported by funds from Uppsala University Hospital funds (ALF funds; to NM and UH), from RTF Foundation (to NM), and from the Swedish Research Council (to NM).	Ahadi R, 2015, SPINE, V40, pE823, DOI 10.1097/BRS.0000000000000654; Albayar AA, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00027; Anderson RE, 2003, J CARDIOTHOR VASC AN, V17, P598, DOI 10.1016/S1053-0770(03)00203-9; BIYANI A, 1994, PARAPLEGIA, V32, P723, DOI 10.1038/sc.1994.117; Blennow K, 2018, J ALZHEIMERS DIS, V62, P1125, DOI 10.3233/JAD-170773; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Boylan K, 2009, J NEUROCHEM, V111, P1182, DOI 10.1111/j.1471-4159.2009.06386.x; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; CHO KH, 1994, J NEUROSURG, V80, P133, DOI 10.3171/jns.1994.80.1.0133; Dalkilic T, 2018, J NEUROTRAUM, V35, P435, DOI 10.1089/neu.2017.5357; EDGAR R, 1994, BRIT J NEUROSURG, V8, P7, DOI 10.3109/02688699409002388; ElMasry WS, 1996, J NEUROL NEUROSUR PS, V60, P141, DOI 10.1136/jnnp.60.2.141; Falci SP, 2009, J NEUROSURG-SPINE, V11, P445, DOI 10.3171/2009.4.SPINE09333; Fukui M, 2009, J ORTHOP SCI, V14, P348, DOI 10.1007/s00776-009-1337-8; Garces-Ambrossi GL, 2009, J NEUROSURG-SPINE, V11, P304, DOI 10.3171/2009.4.SPINE08265; Gong B, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00004; Greitz D, 2006, NEUROSURG REV, V29, P251, DOI 10.1007/s10143-006-0029-5; Guez M, 2003, J NEUROTRAUM, V20, P853, DOI 10.1089/089771503322385782; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; HARRIS J, 1991, J NEUROSCI RES, V30, P47, DOI 10.1002/jnr.490300107; Hayashi T, 2013, J NEUROSURG-PEDIATR, V11, P133, DOI 10.3171/2012.10.PEDS12220; Hellewell SC, 2018, CRIT CARE MED, V46, P554, DOI 10.1097/CCM.0000000000002938; Holmstrom U, 2018, SPINAL CORD, V56, P873, DOI 10.1038/s41393-018-0094-y; Jones A, 2017, CLIN EXP EMERG MED, V4, P121, DOI 10.15441/ceem.17.226; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Klekamp J, 2001, NEUROSURGERY, V48, P174, DOI 10.1097/00006123-200101000-00031; Klekamp J, 2012, J NEUROSURG-SPINE, V17, P199, DOI 10.3171/2012.5.SPINE11904; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Kwon BK, 2019, SPINAL CORD, V57, P819, DOI 10.1038/s41393-019-0319-8; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Lee GYF, 2006, J NEUROSURG-SPINE, V4, P123, DOI 10.3171/spi.2006.4.2.123; Lee TT, 2001, SPINE, V26, pS119, DOI 10.1097/00007632-200112151-00020; Lee TT, 2000, J NEUROSURG, V92, P149, DOI 10.3171/spi.2000.92.2.0149; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Nayak NR, 2019, GLOB SPINE J, V9, P67, DOI 10.1177/2192568217701104; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Schurch B, 1996, J NEUROL NEUROSUR PS, V60, P61, DOI 10.1136/jnnp.60.1.61; Sgouros S, 1996, J NEUROSURG, V85, P197, DOI 10.3171/jns.1996.85.2.0197; SGOUROS S, 1995, J NEUROSURG, V82, P1, DOI 10.3171/jns.1995.82.1.0001; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Singh Ajai, 2017, Int J Crit Illn Inj Sci, V7, P212, DOI 10.4103/IJCIIS.IJCIIS_73_16; Takahashi H, 2018, EUR SPINE J, V27, P1824, DOI 10.1007/s00586-018-5549-5; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Wang KK, 2017, EXPERT OPIN THER TAR, V21, P627, DOI 10.1080/14728222.2017.1321635; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WILLIAMS B, 1992, BRIT J NEUROSURG, V6, P517, DOI 10.3109/02688699209002367; Wyndaele JJ, 2011, SPINAL CORD, V49, P857, DOI 10.1038/sc.2011.85; Yang ZH, 2019, J NEUROTRAUM, V36, P348, DOI 10.1089/neu.2017.5586; Yang ZH, 2018, MOL NEUROBIOL, V55, P2174, DOI 10.1007/s12035-017-0424-7; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	57	2	2	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2020	162	9					2075	2086		10.1007/s00701-020-04422-6		JUN 2020	12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MX4EV	WOS:000543334700001	32588294	Green Published, hybrid			2022-02-06	
J	Schellenberg, M; Benjamin, E; Owattanapanich, N; Inaba, K; Demetriades, D				Schellenberg, Morgan; Benjamin, Elizabeth; Owattanapanich, Natthida; Inaba, Kenji; Demetriades, Demetrios			The impact of delayed time to first CT head in traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Computed tomography of the head; Undertriage; Time to intervention; Trauma	MORTALITY; WOUNDS	Purpose Trauma team activation (TTA) criteria trigger early mobilization of resources for the sickest trauma patients. Patients with moderately depressed GCS who do not trigger the highest level activation are at risk for adverse outcomes, potentially from delayed time to intervention. The study objective was to define the impact of time to first CT Head (CTH) on outcomes among blunt trauma patients with moderately depressed GCS. Methods Patients from the Trauma Quality Improvement Program (TQIP) databank (2013-2016) with first ED GCS 9-12 were included. Transfers, penetrating mechanisms, death < 24 h, AIS = 6 in any body region, and patients with severe associated injuries were excluded. Study groups were defined by time to first CTH after ED arrival: immediate (<= 1 h) vs. delayed (1-6 h). Primary outcomes were time to neurosurgical intervention and time to ED discharge. Results After exclusions, 4997 patients were identified. Of these, 79% (n = 3,954) underwent immediate CTH and 21% (n = 1,043) had delayed CTH. Median GCS was 11 [10-12] in both groups and there was no difference in median Head AIS (4 [3-4] vs. 4 [3-4],p = 0.586). Time to craniotomy and ICP monitor insertion were longer in the delayed group (4.2 h [3.0-7.6] vs. 3.1 h [2.1-8.7],p = 0.001; and 5.7 h [3.8-13.0] vs. 4.4 h [2.6-12.0],p = 0.008), as was time in the ED (4.3 h [2.7-6.5] vs. 2.1 h [1.2-3.7],p < 0.001). There was no difference in need for craniotomy (11% vs. 10%,p = 0.287), need for ICP monitor (12% vs. 12%,p = 0.899), or mortality (11% vs. 9%,p = 0.160). On multivariate analysis, age > 65 (OR 2.813,p < 0.001), SBP < 90 mmHg (OR 2.934,p < 0.001), ED intubation (OR 1.486,p = 0.001), and Head AIS scores of 4 (OR 1.884,p < 0.001) and 5 (OR 6.729,p < 0.001) were independently associated with death. Conclusions Immediate CTH for blunt trauma patients with moderately depressed GCS decreases time to intervention and reduces ED time. A protocol to shorten time to CTH may be beneficial for both patients and hospitals.	[Schellenberg, Morgan; Benjamin, Elizabeth; Owattanapanich, Natthida; Inaba, Kenji; Demetriades, Demetrios] Univ Southern Calif, LAC USC Med Ctr, Div Trauma & Surg Crit Care, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA		Schellenberg, M (corresponding author), Univ Southern Calif, LAC USC Med Ctr, Div Trauma & Surg Crit Care, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA.	morgan.schellenberg@med.usc.edu					American College of Surgeons Committee on Trauma (ACS COT), 2014, RESOURCES OPTIMAL CA; Bardes JM, 2019, J EMERG MED, V57, P151, DOI 10.1016/j.jemermed.2019.04.003; Beck Michael J, 2016, Hosp Pract (1995), V44, P252; Benjamin ER, 2018, J EMERG MED, V55, P278, DOI 10.1016/j.jemermed.2018.02.001; Cull J, 2019, AM SURGEON, V85, P524; Davis JW, 2017, J TRAUMA ACUTE CARE, V83, P1173, DOI 10.1097/TA.0000000000001623; Garrett JS, 2018, AM J EMERG MED, V36, P1581, DOI 10.1016/j.ajem.2018.01.035; Haq N, 2018, INTERN EMERG MED, V13, P923, DOI 10.1007/s11739-018-1786-1; Kotwal RS, 2016, JAMA SURG, V151, P15, DOI 10.1001/jamasurg.2015.3104; Matsushima K, 2018, J TRAUMA ACUTE CARE, V84, P685, DOI 10.1097/TA.0000000000001803; Meizoso JP, 2016, J TRAUMA ACUTE CARE, V81, P685, DOI 10.1097/TA.0000000000001198; Polites SF, 2018, AM J SURG, V216, P813, DOI 10.1016/j.amjsurg.2018.07.061; Schellenberg M, 2019, J TRAUMA ACUTE CARE, V87, P865, DOI 10.1097/TA.0000000000002393; Tignanelli CJ, 2018, J TRAUMA ACUTE CARE, V84, P287, DOI 10.1097/TA.0000000000001745	14	2	2	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2021	47	5			SI		1511	1516		10.1007/s00068-020-01421-1		JUN 2020	6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UW8UR	WOS:000543297800001	32588082	Bronze, Green Published			2022-02-06	
J	Tate, RL; Lane-Brown, AT; Myles, BM; Cameron, ID				Tate, Robyn L.; Lane-Brown, Amanda T.; Myles, Bridget M.; Cameron, Ian D.			A longitudinal study of support needs after severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; care needs; support needs; disability; outcome	SERVICE NEEDS; RATING-SCALE; HEALTH-CARE; HEAD-INJURY; FOLLOW-UP; PEOPLE; DISABILITY; TBI; ADULTS; COMA	Objectives The need for support following traumatic brain injury (TBI) is well documented. Yet the evidence is limited about the types of support required, how support needs change over time, and the effect of level of disability. This study addresses this limitation in the evidence. Method Longitudinal design with a state-wide inception cohort of 131 people with severe TBI. Support needs were assessed using the Care and Needs Scale at 3- and 5-years post-trauma. Results By 3 years post-trauma, the level of disability on the Disability Rating Scale stabilized (49.6% low disability, 39.7% moderate disability, 10.7% severe disability). By contrast, support needs were high at 3 years (95%) and 5 years (94%). The most common type of support need was psychosocial (95%), then instrumental activities of daily living (IADL; 63%). The most frequently occurring intensity level of support need was every few days (24%). A significant increase in the total number of support needs occurred between 3 and 5 years, particularly for IADL supports. At the individual participant level, intensity of support changed for 53% (increase in 35% and decrease in 18%). Disability subgroups showed different patterns of support needs. Conclusions Support needs after severe TBI are prevalent, varied, and change over time, which have implications for care-giving and service delivery.	[Tate, Robyn L.; Myles, Bridget M.; Cameron, Ian D.] Univ Sydney, Fac Med & Hlth, John Walsh Ctr Rehabil Res, Kolling Inst Med Res, Sydney, NSW, Australia; [Lane-Brown, Amanda T.] Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia		Tate, RL (corresponding author), Univ Sydney, Fac Med & Hlth, John Walsh Ctr Rehabil Res, Kolling Inst Med Res, Sydney, NSW, Australia.	robyn.tate@sydney.edu.au			Lifetime Care and Support Authority of New South Wales	This work was supported by the Lifetime Care and Support Authority of New South Wales [N/A].	Bailey EK, 2017, J HEAD TRAUMA REHAB, V32, P245, DOI 10.1097/HTR.0000000000000317; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bode RK, 2002, ARCH PHYS MED REHAB, V83, P100, DOI 10.1053/apmr.2002.26073; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V19;303; Brickell TA, 2019, REHABIL PSYCHOL, V64, P72, DOI 10.1037/rep0000249; Clark-Wilson J, 2016, BRAIN INJURY, V30, P872, DOI 10.3109/02699052.2016.1146799; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Drag L, 2013, J HEAD TRAUMA REHAB, V28, P39, DOI 10.1097/HTR.0b013e318263bb61; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Hoofien D., 2001, 189209 BRAIN INJ, V15, P10; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford J, 2013, TRAUMATIC BRAIN INJU, P1; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Sample PL, 2005, J HEAD TRAUMA REHAB, V20, P270, DOI 10.1097/00001199-200505000-00009; Sloan S., 2007, BRAIN IMPAIR, V8, P251, DOI [10.1375/brim.8.3.251, DOI 10.1375/BRIM.8.3.251]; Soo C, 2007, J HEAD TRAUMA REHAB, V22, P288, DOI 10.1097/01.HTR.0000290973.01872.4c; Soo C, 2010, ARCH PHYS MED REHAB, V91, P905, DOI 10.1016/j.apmr.2009.11.033; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Tate RL, 2010, COMPENDIUM TESTS SCA; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Toor GK, 2016, ARCH PHYS MED REHAB, V97, pS54, DOI 10.1016/j.apmr.2015.02.010; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; Wright J., 2000, CTR OUTCOME MEASUREM	43	2	2	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 2	2020	34	8					991	1000		10.1080/02699052.2020.1764101		JUN 2020	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MK8SK	WOS:000547339600001	32579407				2022-02-06	
J	Moore, AL; Carpenter, DM; James, RL; Miller, TM; Moore, JJ; Disbrow, EA; Ledbetter, CR				Moore, Amy Lawson; Carpenter, Dick M., II; James, Randolph L.; Miller, Terissa Michele; Moore, Jeffrey J.; Disbrow, Elizabeth A.; Ledbetter, Christina R.			Neuroimaging and Neuropsychological Outcomes Following Clinician-Delivered Cognitive Training for Six Patients With Mild Brain Injury: A Multiple Case Study	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						cognitive training; cognitive rehabilitation; MRI; LearningRx; brain training; mild TBI; concussion; brain injury	CONTROL NETWORKS; CHILDREN; CONNECTIVITY; PLASTICITY; REHABILITATION; METAANALYSIS; DYSFUNCTION; CEREBELLUM; DISORDERS; ATTENTION	Nearly half of all mild brain injury sufferers experience long-term cognitive impairment, so an important goal in rehabilitation is to address their multiple cognitive deficits to help them return to prior levels of functioning. Cognitive training, or the use of repeated mental exercises to enhance cognition, is one remediation method for brain injury. The primary purpose of this hypothesis-generating pilot study was to explore the statistical and clinical significance of cognitive changes and transfer of training to real-life functioning following 60 h of Brain Booster, a clinician-delivered cognitive training program, for six patients with mild traumatic brain injury (TBI) or non-traumatic acquired brain injury (ABI). The secondary purpose was to explore changes in functional connectivity and neural correlates of cognitive test gains following the training. We used a multiple case study design to document significant changes in cognitive test scores, overall IQ score, and symptom ratings; and we used magnetic resonance imaging (MRI) to explore trends in functional network connectivity and neural correlates of cognitive change. All cognitive test scores showed improvement with statistically significant changes on five of the seven measures (long-term memory, processing speed, reasoning, auditory processing, and overall IQ score). The mean change in IQ score was 20 points, from a mean of 108 to a mean of 128. Five themes emerged from the qualitative data analysis including improvements in cognition, mood, social identity, performance, and Instrumental Activities of Daily Living (IADLs). With MRI, we documented significant region-to-region changes in connectivity following cognitive training including those involving the cerebellum and cerebellar networks. We also found significant correlations between changes in IQ score and change in white matter integrity of bilateral corticospinal tracts (CST) and the left uncinate fasciculus. This study adds to the growing body of literature examining the effects of cognitive training for mild TBI and ABI, and to the collection of research on the benefits of cognitive training in general.	[Moore, Amy Lawson; Miller, Terissa Michele] Gibson Inst Cognit Res, Dept Psychol, Colorado Springs, CO 80919 USA; [Carpenter, Dick M., II] Univ Colorado, Coll Educ, Colorado Springs, CO 80907 USA; [James, Randolph L.] True Life Med, Woodland Pk, CO USA; [Moore, Jeffrey J.] Colorado State Univ Pueblo, Sch Nursing, Pueblo, CO USA; [Disbrow, Elizabeth A.] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71105 USA; [Disbrow, Elizabeth A.; Ledbetter, Christina R.] Louisiana State Univ, Ctr Brain Hlth, Dept Neurol, Shreveport, LA 71105 USA; [Ledbetter, Christina R.] Louisiana State Univ, Hlth Sci Ctr, Dept Neurosurg, Shreveport, LA 71105 USA		Moore, AL (corresponding author), Gibson Inst Cognit Res, Dept Psychol, Colorado Springs, CO 80919 USA.	amoore@gibsonresearch.org			LearningRx	Funding for the study was provided by a research grant to Gibson Institute of Cognitive Research from LearningRx.	[Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; [Anonymous], 2015, C TRAUM BRAIN INJ US; Bandura A., 1994, SELF EFFICACY, P71; Barquero LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083668; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BEZZOLA L, 2012, FRONT HUM NEUROSCI, V6, DOI DOI 10.3389/fnhum.2013.00779; Braeckman K, 2019, JOVE-J VIS EXP, DOI 10.3791/60012; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Carpenter DM, 2016, APPL COGNITIVE PSYCH, V30, P815, DOI 10.1002/acp.3257; Catharine V, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101827; Chattopadhyay S, 2017, EBIOMEDICINE, V17, P216, DOI 10.1016/j.ebiom.2017.02.010; Chepenik LG, 2007, EMOTION, V7, P802, DOI 10.1037/1528-3542.7.4.802; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Deng LF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45463-x; Ernst A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002045; Finc K., 2019, BIORXIV, DOI [10.1101/685487, DOI 10.1101/685487]; Floyer-Lea A, 2005, J NEUROPHYSIOL, V94, P512, DOI 10.1152/jn.00717.2004; Gibson K., 2013, BRAIN BOOSTER WORKBO; Hallock H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00537; Han K, 2020, NEUROREHAB NEURAL RE, V34, P26, DOI 10.1177/1545968319868710; Han K, 2018, NEUROIMAGE-CLIN, V18, P262, DOI 10.1016/j.nicl.2018.01.030; Han KW, 2018, HUM BRAIN MAPP, V39, P2955, DOI 10.1002/hbm.24052; Han K, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.687; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Holleran L, 2020, AM J PSYCHIAT, V177, P537, DOI 10.1176/appi.ajp.2019.19030225; Houghton Catherine, 2013, Nurse Res, V20, P12; Huang J. C., 2009, J BEHAV OPTOM, V20, P95; Hurtubise JM, 2020, J NEUROTRAUM, V37, P1528, DOI 10.1089/neu.2019.6765; Iaccarino Mary Alexis, 2015, Handb Clin Neurol, V127, P411, DOI 10.1016/B978-0-444-52892-6.00026-X; Imfeld A, 2009, NEUROIMAGE, V46, P600, DOI 10.1016/j.neuroimage.2009.02.025; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; James R, 2019, OBM INTEGRAT COMPLEM, V4, P3054, DOI [10.21926/obm.icm.1903054, DOI 10.21926/OBM.ICM.1903054]; Jolles DD, 2013, HUM BRAIN MAPP, V34, P396, DOI 10.1002/hbm.21444; Kim E, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091318; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kolakowsky-Hayner S., 2010, CTR OUTCOME MEAS BRA; Kuiper JS, 2016, INT J EPIDEMIOL, V45, P1169, DOI 10.1093/ije/dyw089; Leaver AM, 2016, CEREB CORTEX, V26, P4337, DOI 10.1093/cercor/bhv207; Ledbetter C., 2016, SOC NEUR SAN DIEGO C; Ledbetter C, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00825; Liu L., 2016, J ED LEARNING, V5, P129, DOI [DOI 10.5539/jel.v5n2p129, DOI 10.5539/JEL.V5N2P129]; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Moore A.L., 2019, PSYCHOL NEUROSCI, V12, P291, DOI [10.1037/pne0000162, DOI 10.1037/PNE0000162]; Moore AL, 2018, NEUROPSYCH DIS TREAT, V14, P1671, DOI 10.2147/NDT.S165418; Morikawa M, 2010, PSYCHOGERIATRICS, V10, P15, DOI 10.1111/j.1479-8301.2010.00312.x; Nieto-Castanon A., 2020, HDB FMRI METHODS CON; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Pardini M, 2012, J AUTISM DEV DISORD, V42, P585, DOI 10.1007/s10803-011-1281-2; Phillips NL, 2016, J NEUROTRAUM, V33, P2097, DOI 10.1089/neu.2015.4358; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schrank F. A., 2014, WOODCOCK JOHNSON IV; Schwartz J. M., 2003, MIND BRAIN NEUROPLAS; Seguin M, 2018, ANN PHYS REHABIL MED, V61, P189, DOI 10.1016/j.rehab.2017.05.001; Sharma B, 2017, DISABIL REHABIL, V39, P1380, DOI 10.1080/09638288.2016.1195453; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Takeuchi H, 2014, HUM BRAIN MAPP, V35, P3646, DOI 10.1002/hbm.22427; Tetnowski J., 2015, PERSPECTIVES FLUENCY, V25, P39, DOI [10.1044/ffd25.1.39, DOI 10.1044/FFD25.1.39]; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Watson CG, 2018, J PEDIATR-US, V200, P140, DOI 10.1016/j.jpeds.2018.04.022; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Yendiki A, 2016, NEUROIMAGE, V127, P277, DOI 10.1016/j.neuroimage.2015.12.003; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Yin R., 2010, ENCY CASE STUDY RES, P21, DOI [10.4135/9781412957397, DOI 10.4135/9781412957397]; Yin R. K., 2014, CASE STUDY RES APPL	71	2	2	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JUN 24	2020	14								229	10.3389/fnhum.2020.00229			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	ML4GT	WOS:000549427200001	32670040	Green Published, gold			2022-02-06	
J	Raja, A; Trivedi, PD; Dhamoon, MS				Raja, Aishwarya; Trivedi, Parth D.; Dhamoon, Mandip S.			Discharge against medical advice among neurological patients: Characteristics and outcomes	HEALTH SERVICES RESEARCH			English	Article						discharge disposition; neurological condition; outcomes	RISK; ICD-9-CM; CODES; TRANSCATHETER; READMISSION; VALIDATION; ACCURACY; STROKE; LEAVE	Objective To study characteristics and outcomes of patients with stroke, traumatic brain injury (TBI), and epilepsy with discharge against medical advice (DAMA). Data Sources/Study Setting Retrospective analysis of the 2013 Nationwide Readmissions Database, a nationally representative inpatient administrative dataset. Study Design Associations between predictors and DAMA at index admission were analyzed using adjusted logistic models. We examined 30-day all-cause readmissions. Data Collection Methods Patients aged >= 18 years at index admission for International Classification of Diseases-9 diagnosis code of epilepsy, TBI, or stroke were included. Principal Findings Discharge against medical advice occurred in 1998/58278 patients (3.43 percent) in the epilepsy group, 1762/211 213 (0.83 percent) in the stroke group, and 1289/74 652 (1.73 percent) in the TBI group. Factors consistently associated with increased likelihood of DAMA included lower age, male sex, non-Medicare and nonprivate insurance, lower socioeconomic status, and behavioral risk factors (smoking history, alcohol history, and drug use). The crude 30-day all-cause readmission rate for those with DAMA from their index admission was 16.4 percent for the stroke cohort, 13.9 percent for epilepsy, and 13.4 percent for TBI. DAMA at index admission was significantly associated with increased risk of 30-day all-cause readmission among all groups (adjusted odds ratio 1.79, 95% CI: 1.65-1.94,P < .0001). Conclusions Age, sex, insurance status, socioeconomic status, and behavioral factors were associated with DAMA in neurological patients. Further research is needed to develop interventions to reduce DAMA in high-risk groups.	[Raja, Aishwarya; Trivedi, Parth D.; Dhamoon, Mandip S.] Icahn Sch Med Mt Sinai, Dept Neurol, 1468 Madison Ave,Annenberg 301B, New York, NY 10029 USA		Dhamoon, MS (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, 1468 Madison Ave,Annenberg 301B, New York, NY 10029 USA.	mandip.dhamoon@mssm.edu					Alfandre DJ, 2009, MAYO CLIN PROC, V84, P255, DOI 10.1016/S0025-6196(11)61143-9; Aliyu Z, 2002, INT J CLIN PRACT, V56, P325; Benesch C, 1997, NEUROLOGY, V49, P660, DOI 10.1212/WNL.49.3.660; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Garland A, 2013, CAN MED ASSOC J, V185, P1207, DOI 10.1503/cmaj.130029; Glasgow JM, 2010, J GEN INTERN MED, V25, P926, DOI 10.1007/s11606-010-1371-4; Gleason TG, 2016, J THORAC CARDIOV SUR, V152, P85, DOI 10.1016/j.jtcvs.2016.02.073; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Hesdorffer DC, 2016, CNS SPECTRUMS, V21, P230, DOI 10.1017/S1092852915000929; Hwang SW, 2003, CAN MED ASSOC J, V168, P417; Jefferies K, 2007, J NEUROL NEUROSUR PS, V78, P414, DOI 10.1136/jnnp.2006.103044; Jette N, 2010, EPILEPSIA, V51, P62, DOI 10.1111/j.1528-1167.2009.02201.x; Lee CA, 2016, CLIN EXP EMERG MED, V3, P88, DOI 10.15441/ceem.15.015; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Magauran BG, 2009, EMERG MED CLIN N AM, V27, P605, DOI 10.1016/j.emc.2009.08.001; Marcoux J, 2017, CAN J NEUROL SCI, V44, P311, DOI 10.1017/cjn.2016.241; Onukwugha E, 2009, NEUROREHABILITATION, V24, P67, DOI 10.3233/NRE-2009-0455; Reid AY, 2012, EPILEPSY RES, V102, P173, DOI 10.1016/j.eplepsyres.2012.05.009; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; Spooner KK, 2017, MAYO CLIN PROC, V92, P525, DOI 10.1016/j.mayocp.2016.12.022; Wiley LK, 2013, J AM MED INFORM ASSN, V20, P652, DOI 10.1136/amiajnl-2012-001557; Yong TY, 2013, INTERN MED J, V43, P798, DOI 10.1111/imj.12109; Yuan Sharleen, 2018, S D Med, V71, P214	25	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-9124	1475-6773		HEALTH SERV RES	Health Serv. Res.	OCT	2020	55	5					681	689		10.1111/1475-6773.13306		JUN 2020	9	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	NS9DA	WOS:000542348500001	32578887	Green Published			2022-02-06	
J	St Hilaire, C; Johnson, A; Loseth, C; Alipour, H; Faunce, N; Kaminski, S; Sharma, R				St Hilaire, Cameron; Johnson, Arianne; Loseth, Caitlin; Alipour, Hamid; Faunce, Nick; Kaminski, Stephen; Sharma, Rohit			Facial fractures and associated injuries in high- versus low-energy trauma: all are not created equal	MAXILLOFACIAL PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article						Facial fractures; High-energy mechanisms; Low-energy mechanisms; Outcomes		Introduction Facial fractures (FFs) occur after high- and low-energy trauma; differences in associated injuries and outcomes have not been well articulated. Objective To compare the epidemiology, management, and outcomes of patients suffering FFs from high-energy and low-energy mechanisms. Methods We conducted a 6-year retrospective local trauma registry analysis of adults aged 18-55 years old that suffered a FF treated at the Santa Barbara Cottage Hospital. Fracture patterns, concomitant injuries, procedures, and outcomes were compared between patients that suffered a high-energy mechanism (HEM: motor vehicle crash, bicycle crash, auto versus pedestrian, falls from height > 20 feet) and those that suffered a low-energy mechanism (LEM: assault, ground-level falls) of injury. Results FFs occurred in 123 patients, 25 from an HEM and 98 from an LEM. Rates of Le Fort (HEM 12% vs. LEM 3%,P= 0.10), mandible (HEM 20% vs. LEM 38%,P= 0.11), midface (HEM 84% vs. LEM 67%,P= 0.14), and upper face (HEM 24% vs. LEM 13%,P= 0.217) fractures did not significantly differ between the HEM and LEM groups, nor did facial operative rates (HEM 28% vs. LEM 40%,P= 0.36). FFs after an HEM event were associated with increased Injury Severity Scores (HEM 16.8 vs. LEM 7.5,P<0.001), ICU admittance (HEM 60% vs. LEM 13.3%,P<0.001), intracranial hemorrhage (ICH) (HEM 52% vs. LEM 15%,P<0.001), cervical spine fractures (HEM 12% vs. LEM 0%,P= 0.008), truncal/lower extremity injuries (HEM 60% vs. LEM 6%,P<0.001), neurosurgical procedures for the management of ICH (HEM 54% vs. LEM 36%,P= 0.003), and decreased Glasgow Coma Score on arrival (HEM 11.7 vs. LEM 14.2,P<0.001). Conclusion FFs after HEM events were associated with severe and multifocal injuries. FFs after LEM events were associated with ICH, concussions, and cervical spine fractures. Mechanism-based screening strategies will allow for the appropriate detection and management of injuries that occur concomitant to FFs. Type of study Retrospective cohort study.	[St Hilaire, Cameron; Johnson, Arianne; Loseth, Caitlin; Alipour, Hamid; Faunce, Nick; Kaminski, Stephen; Sharma, Rohit] Santa Barbara Cottage Hosp, Santa Barbara, CA 93105 USA		Sharma, R (corresponding author), Santa Barbara Cottage Hosp, Santa Barbara, CA 93105 USA.	rsharma@sbch.org		Sharma, Rohit/0000-0002-5902-458X; St. Hilaire, Cameron/0000-0002-6190-2804			Abosadegh MM, 2017, DENT TRAUMATOL, V33, P369, DOI 10.1111/edt.12349; Beogo R, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.119.3379; Gartshore L, 2010, BRIT J ORAL MAX SURG, V48, P173, DOI 10.1016/j.bjoms.2009.09.003; Haider AH, 2009, J SURG RES, V153, P138, DOI 10.1016/j.jss.2008.04.011; Hohlrieder M, 2003, INTENS CARE MED, V29, P1095, DOI 10.1007/s00134-003-1804-1; Joshi UM, 2018, J MAXILLOFAC ORAL SU, V17, P531, DOI 10.1007/s12663-017-1078-8; Le TMT, 2019, ANN PLAS SURG, V82, pS179, DOI 10.1097/SAP.0000000000001883; Pappachan B, 2012, J MAXILLOFAC ORAL SU, V11, P224, DOI 10.1007/s12663-011-0289-7; Pham TT, 2019, CRANIOMAX TRAUM REC, V12, P221, DOI 10.1055/s-0039-1677724; R Core Team, 2018, STATS PACK LANG ENV; Rao S Girish, 2019, Eur J Trauma Emerg Surg, DOI 10.1007/s00068-019-01099-0; United States Congress, 2010, IN RED UNN RAD EXP M	12	2	2	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2288-8101	2288-8586		MAX PLAST RECONSTR S	Maxillofac. Plast. Reconstr. Sur.	JUN 24	2020	42	1							22	10.1186/s40902-020-00264-5			6	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	ME8SV	WOS:000544924500001	32601595	Green Published, gold			2022-02-06	
J	Chou, DW; Kshirsagar, R; Liang, J				Chou, David W.; Kshirsagar, Rijul; Liang, Jonathan			Head and Neck Injuries from Rock Climbing: A Query of the National Electronic Injury Surveillance System	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article						trauma; facial trauma; facial fracture; concussion; rock climbing; laceration; head and neck injury; skull fracture; NEISS	SEX-DIFFERENCES; RISK-FACTORS; EPIDEMIOLOGY; SPORT; CLIMBERS; TRENDS	Objective: We describe the incidence and characteristics of patients with head and neck injuries from rock climbing who present to United States emergency departments and evaluate predictors of hospitalization. Methods: The National Electronic Injury Surveillance System (NEISS) database was queried for rock climbing injuries to the head, face, mouth, neck, and ear under product code "mountain climbing" from the years 2009 to 2018. Demographics, injury characteristics, and disposition data were reviewed. Data were evaluated using chi-square analysis with Cochran-Mantel-Haenszal odds ratios (ORs). Results: An estimated 5067 patients (from 129 raw NEISS case numbers) suffered head and neck injuries from rock climbing nationally from 2009 to 2018. Concussion/closed head injury was the most common injury (44%), followed by laceration (23%), soft tissue injury (15%), neck strain/sprain (6%), skull fracture (3%), facial fracture (3%), intracranial hemorrhage (3%), cervical spine fracture (2%), unspecified facial trauma (1%), and dental trauma (0.3%). Males more frequently suffered lacerations (OR 1.6), soft tissue injuries (OR 23.3), cervical spine fractures (OR 336.7), intracranial hemorrhage (OR 582.0), and skull fractures (OR 6.2) than females. Compared to shorter falls, falls over 20 ft were more commonly associated with laceration (OR 2.0), soft tissue injury (OR 3.5), facial fracture (OR 7.5), dental trauma (OR 6.6), intracranial hemorrhage (OR 951.8), skull fracture (OR 81.2), and hospitalization (OR 3.8). Injuries associated with hospitalization included facial fracture (OR 23.7), cervical spine fracture (OR 24.6), intracranial hemorrhage (OR 2210.2), and skull fracture (OR 9.8). Conclusions: Concussions and facial lacerations are the most common head and neck injuries from rock climbing. Males more commonly suffer severe injuries. Falls over 20 ft are associated with more severe injuries and an increased likelihood of hospitalization.	[Chou, David W.; Kshirsagar, Rijul; Liang, Jonathan] Kaiser Permanente Oakland Med Ctr, Dept Head & Neck Surg, 3600 Broadway, Oakland, CA 94611 USA		Chou, DW (corresponding author), Kaiser Permanente Oakland Med Ctr, Dept Head & Neck Surg, 3600 Broadway, Oakland, CA 94611 USA.	david.x.chou@kp.org		Chou, David/0000-0003-4050-8178; Kshirsagar, Rijul/0000-0002-3113-2685			American Alpine Club, 2019, AM ALP CLUB WEBS; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Backe S, 2009, SCAND J MED SCI SPOR, V19, P850, DOI 10.1111/j.1600-0838.2008.00851.x; Bernard M, 2019, J SURG RES, V234, P149, DOI 10.1016/j.jss.2018.09.004; Bobian MR, 2016, ANN OTO RHINOL LARYN, V125, P992, DOI 10.1177/0003489416668195; Buzzacott P, 2019, WILD ENVIRON MED, V30, P121, DOI 10.1016/j.wem.2018.11.009; Carniol ET, 2015, OTOLARYNG HEAD NECK, V153, P957, DOI 10.1177/0194599815602668; Center for Disease Control and Prevention, DEF WISQARS NONF; Chang CY, 2016, CURR PROBL DIAGN RAD, V45, P205, DOI 10.1067/j.cpradiol.2015.07.003; Climbing Wall Association, 2018, IND CLIMB IND REP; Deeks J., STAT ALGORITHMS REV; DEHAVEN KE, 1986, AM J SPORT MED, V14, P218, DOI 10.1177/036354658601400307; Gerdes EM, 2006, J TRAUMA, V61, P1517, DOI 10.1097/01.ta.0000209402.40864.b2; Giesbrecht N, 2003, DRINKING CASUALTIES; GINSBURG HJ, 1982, CHILD DEV, V53, P426, DOI 10.1111/j.1467-8624.1982.tb01332.x; Guys NP, 2018, INT J PEDIATR OTORHI, V111, P153, DOI 10.1016/j.ijporl.2018.06.009; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Hojjat H, 2016, ANN OTO RHINOL LARYN, V125, P652, DOI 10.1177/0003489416644617; IBIS World, 2018, IND CLIMB WALLS IND; International Federation of Sport Climbing, 2019, INT FED SPORT CLIMB; Jones G, 2016, CURR SPORT MED REP, V15, P400, DOI 10.1249/JSR.0000000000000304; Knoblach RA, 2019, ENCY EVOLUTIONARY PS; Lack DA, 2012, WILD ENVIRON MED, V23, P223, DOI 10.1016/j.wem.2012.04.002; Lawrence LA, 2015, LARYNGOSCOPE, V125, P589, DOI 10.1002/lary.24893; Lendrem BD, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7094; McDonald JW, 2017, WILD ENVIRON MED, V28, P185, DOI 10.1016/j.wem.2017.05.001; Nelson NG, 2009, AM J PREV MED, V37, P195, DOI 10.1016/j.amepre.2009.04.025; Olympic Games, SPORT CLIMB; Othman S, 2019, CRANIOMAX TRAUM REC, V12, P266, DOI 10.1055/s-0039-1679930; Outdoor Industry Association, 2018, OUTD PART REP; Pagano M, 2000, PRINCIPLES BIOSTATIS, V2nd; Richardson GD, 2018, WILD ENVIRON MED, V29, P338, DOI 10.1016/j.wem.2018.04.001; RIVARA FP, 1982, AM J DIS CHILD, V136, P502, DOI 10.1001/archpedi.1982.03970420026004; Schoffl V, 2017, WILD ENVIRON MED, V28, P377, DOI 10.1016/j.wem.2017.07.008; Schoffl V, 2015, WILD ENVIRON MED, V26, P62, DOI 10.1016/j.wem.2014.08.013; Schoffl V, 2012, MED SPORT SCI, V58, P17, DOI 10.1159/000338575; Schoffl V, 2010, SPORTS MED, V40, P657, DOI 10.2165/11533690-000000000-00000; Woollings KY, 2015, BRIT J SPORT MED, V49, P1094, DOI 10.1136/bjsports-2014-094372	38	2	2	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.	JAN	2021	130	1					18	23	0003489420936710	10.1177/0003489420936710		JUN 2020	6	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	PG7KF	WOS:000542300500001	32567394				2022-02-06	
J	Satiennam, T; Kumphong, J; Satiennam, W; Klungboonkrong, P; Jaensirisak, S; Ratanavaraha, V				Satiennam, Thaned; Kumphong, Jetsada; Satiennam, Wichuda; Klungboonkrong, Pongrid; Jaensirisak, Sittha; Ratanavaraha, Vatanavongs			Change in helmet use behavior enforced by CCTV cameras with automatic helmet use detection system on an urban arterial road	TRAFFIC INJURY PREVENTION			English	Article						Helmet use; motorcyclist; CCTV camera enforcement; logistic regression; urban arterial road	MOTORCYCLISTS; HEAD; INJURY; RISK; NECK	Objective:Many developing countries experience a high death toll among motorcycle users (both drivers and passengers), primarily due to a relatively low rate of helmet use resulting from ineffective helmet law enforcement. The objectives of this study are to explore the change in helmet use behavior due to helmet use enforcement by closed-circuit television (CCTV) camera technology with an automatic helmet use detection system and to identify the factors associated with helmet use along an urban arterial road in the city of Khon Kaen, Thailand. Methods:Data collection was carried out on 49,128 samples by video cameras installed at 5 signalized intersections during 2 periods, namely, before and during the CCTV camera enforcement. The study applied logistic regression analysis to determine factors associated with helmet use and to compare the ratio of helmet use for each variable according to the odds ratio. Results:The study found that CCTV camera enforcement could increase helmet usage at all study intersections by 5.3%. The results imply that 4 factors, including riding status, number of passengers, day of week, and traffic conditions, significantly affected helmet use both before and during the CCTV camera enforcement. Remarkably, 2 more variables, age and police inspection, significantly affected helmet use during the CCTV camera enforcement period. Conclusions:This study confirms that CCTV camera enforcement can be an important driving force for changing helmet use behavior, particularly for child passengers. Moreover, CCTV camera enforcement can support enforcement by extending coverage to a 24-h period and to intersections without police inspection.	[Satiennam, Thaned; Kumphong, Jetsada; Satiennam, Wichuda; Klungboonkrong, Pongrid] Khon Kaen Univ, Fac Engn, 123 Mitrapap Rd, Khon Kaen 40002, Thailand; [Jaensirisak, Sittha] Ubon Ratchathani Univ, Fac Engn, Ubon Ratchathani, Thailand; [Ratanavaraha, Vatanavongs] Suranaree Univ Technol, Inst Engn, Sch Transportat Engn, Nakhon Ratchasima, Thailand		Satiennam, T (corresponding author), Khon Kaen Univ, Fac Engn, 123 Mitrapap Rd, Khon Kaen 40002, Thailand.	sthaned@kku.ac.th		Klungboonkrong, Pongrid/0000-0002-6721-9272	Graduate School, Khon Kaen University, Thailand	This research received a Research Fund for Supporting Lecturer to Admit High Potential Student to Study and Research on His Expert Program Year 2016 at the Graduate School, Khon Kaen University, Thailand.	Adnan M, 2019, IATSS RES, V43, P195, DOI 10.1016/j.iatssr.2019.02.001; Akaateba MA, 2014, ACCIDENT ANAL PREV, V64, P18, DOI 10.1016/j.aap.2013.11.008; DeMarco AL, 2010, ACCIDENT ANAL PREV, V42, P1778, DOI 10.1016/j.aap.2010.04.019; Eby DW, 2011, HANDBOOK OF TRAFFIC PSYCHOLOGY, P61, DOI 10.1016/B978-0-12-381984-0.10005-0; Erhardt T, 2016, ACCIDENT ANAL PREV, V86, P23, DOI 10.1016/j.aap.2015.10.004; Fuentes C, 2010, TRANSPORT RES F-TRAF, V13, P289, DOI 10.1016/j.trf.2010.06.007; Hair JF., 2014, MULTIVARIATE DATA AN, V7; Hijar M, 2011, HANDBOOK OF TRAFFIC PSYCHOLOGY, P27, DOI 10.1016/B978-0-12-381984-0.10003-7; Hung DV, 2008, ACCIDENT ANAL PREV, V40, P1627, DOI 10.1016/j.aap.2008.05.002; Jiwattanakulpaisarn P, 2013, GLOB HEALTH PROMOT, V20, P14, DOI 10.1177/1757975913499030; Kanitpong K, 2008, TRANSP RES RECORD, P66, DOI 10.3141/2048-09; Kumphong J, 2018, J SAFETY RES, V67, P93, DOI 10.1016/j.jsr.2018.09.011; La Torre F, 2019, J SAFETY RES, V69, P115, DOI 10.1016/j.jsr.2019.03.006; Li LP, 2008, ACCIDENT ANAL PREV, V40, P1937, DOI 10.1016/j.aap.2008.06.019; Ratanavaraha V, 2013, TRANSPORT POLICY, V25, P111, DOI 10.1016/j.tranpol.2012.11.002; Rice TM, 2016, ACCIDENT ANAL PREV, V91, P200, DOI 10.1016/j.aap.2016.03.002; Tankasem P, 2019, TRANSP RES INTERDISC, V1, P100032, DOI 10.1016/j.trip.2019.100032; WHO. World Health Organization, 2018, GLOBAL STATUS REPORT; Wonghabut P, 2018, IOP C SER EARTH ENV, V143, DOI 10.1088/1755-1315/143/1/012063; Xuequn Y, 2011, ACCIDENT ANAL PREV, V43, P214, DOI 10.1016/j.aap.2010.08.012	20	2	2	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	OCT 2	2020	21	7					494	499		10.1080/15389588.2020.1778170		JUN 2020	6	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	NJ1HC	WOS:000545858100001	32559159				2022-02-06	
J	Koller, M; Rafter, D; Shok, G; Murphy, S; Kiaei, S; Samadani, U				Koller, Michael; Rafter, Daniel; Shok, Gillian; Murphy, Sean; Kiaei, Sheena; Samadani, Uzma			A retrospective descriptive study of cranioplasty failure rates and contributing factors in novel 3D printed calcium phosphate implants compared to traditional materials	3D PRINTING IN MEDICINE			English	Article						3D-printed; Cranioplasty; Cranial implant; Craniectomy; Traumatic brain injury	BONE-GRAFT INFECTION; DECOMPRESSIVE CRANIECTOMY; AUTOLOGOUS CRANIOPLASTY; TITANIUM; EXPERIENCE; CHILDREN; DESIGN; POLYETHERETHERKETONE; OUTCOMES	BackgroundFailure rates with cranioplasty procedures have driven efforts to improve graft material and reduce reoperation. One promising allograft source is a 3D-printed titanium mesh with calcium phosphate filler. This study evaluated failure rates and pertinent characteristics of these novel 3D-grafts compared to traditional materials.MethodsSixty patients were retrospectively identified who underwent a cranioplasty between January 2015-December 2017. Specific data points related to graft failure were collected for all surgical admissions, from the primary injury to their most recent. These included, but were not limited to, initial physical exam findings, vitals, comorbid conditions, surgery length, estimated blood loss, incision type, and need for revision. Failure rates of 3D-printed allografts were compared to traditional grafts.ResultsA total of 60 subjects were identified who underwent 71 unique cranioplasty procedures (3D=13, Synthetic=12, Autologous=46). There were 14 total failures, demonstrating a 19.7% overall failure rate. Specifically, 15.4% (n=2) of 3D, 19.6% (n=9) of autologous, and 25.0% (n=3) of synthetic grafts required revision. Patients receiving 3D-grafts had the shortest overall mean surgery times (200.854.3min) and lowest infection rates (7.7%) compared to autologous (210.5 +/- 47.9min | 25.0%) and synthetic models (217.6 +/- 77.3min | 8.7%), though significance was unable to be determined. Tobacco use and trap-door incisions were associated with increased failure rates relative to straight or curved incisions in autologous grafts. Cranioplasties performed less than 3 months after craniectomy appeared to fail more often than those performed at least three months after craniectomy, for the synthetic group.Conclusion We concluded that 3D-printed cranioplasty grafts may lead to lower failure rates and shorter surgery times compared to traditional cranioplasty materials in our limited population. 3D-implants hold promise for cranial reconstruction after TBI.	[Koller, Michael; Rafter, Daniel; Shok, Gillian; Murphy, Sean; Kiaei, Sheena; Samadani, Uzma] Univ Minnesota, Dept Bioinformat & Computat Biol, 101 Pleasant St Southeast, Minneapolis, MN 55455 USA; [Rafter, Daniel; Samadani, Uzma] Minneapolis VA Med Ctr, Dept Neurosurg, 1 Vet Dr, Minneapolis, MN 55417 USA		Koller, M (corresponding author), Univ Minnesota, Dept Bioinformat & Computat Biol, 101 Pleasant St Southeast, Minneapolis, MN 55455 USA.	kolle153@umn.edu					Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Blum KS, 1997, PEDIATR NEUROSURG, V26, P33, DOI 10.1159/000121158; Bobinski L, 2013, CLIN NEUROL NEUROSUR, V115, P1788, DOI 10.1016/j.clineuro.2013.04.013; Bonda DJ, 2015, NEUROSURGERY, V77, P814, DOI 10.1227/NEU.0000000000000899; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Cheah PP, 2017, MALAYS J MED SCI, V24, P68, DOI 10.21315/mjms2017.24.6.8; Coulter IC, 2014, ACTA NEUROCHIR, V156, P1361, DOI 10.1007/s00701-014-2081-1; de Monaco BA, 2013, NEUROPSYCH DIS TREAT, V9, P1801, DOI 10.2147/NDT.S43806; Evins AI, 2018, OPER NEUROSURG, V15, P341, DOI 10.1093/ons/opx280; Gilardino MS, 2009, PLAST RECONSTR SURG, V123, P983, DOI 10.1097/PRS.0b013e318199f6ad; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Hay JA, 2017, WORLD NEUROSURG, V105, P971, DOI 10.1016/j.wneu.2017.05.007; Honeybul S, 2017, J NEUROSURG, V126, P81, DOI 10.3171/2015.12.JNS152004; Honeybul S, 2016, BRIT J NEUROSURG, V30, P523, DOI 10.1080/02688697.2016.1187259; Kim BJ, 2012, J KOREAN NEUROSURG S, V52, P541, DOI 10.3340/jkns.2012.52.6.541; Kim H, 2013, ACTA NEUROCHIR, V155, P2171, DOI 10.1007/s00701-013-1877-8; Kim Sung Hoon, 2017, Korean J Neurotrauma, V13, P15, DOI 10.13004/kjnt.2017.13.1.15; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kumar NG, 2015, J MAXILLOFAC ORAL SU, V14, P920, DOI 10.1007/s12663-015-0776-3; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lee CH, 2012, J TRAUMA ACUTE CARE, V73, P255, DOI 10.1097/TA.0b013e318256a150; Lethaus B, 2014, J CRANIOFAC SURG, V25, P206, DOI 10.1097/SCS.0000000000000396; Lethaus B, 2012, J NEUROTRAUM, V29, P1077, DOI 10.1089/neu.2011.1794; Lim JY, 2017, CHILD NERV SYST, V33, P1553, DOI 10.1007/s00381-017-3486-y; Linder LKB, 2019, WORLD NEUROSURG, V122, pE399, DOI 10.1016/j.wneu.2018.10.061; Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Mobbs RJ, 2017, J NEUROSURG-SPINE, V26, P513, DOI 10.3171/2016.9.SPINE16371; Msallem B, 2017, PRS-GLOB OPEN, V5, DOI 10.1097/GOX.0000000000001582; Oh JH, 2018, MAX PLAST RECONSTR S, V40, DOI 10.1186/s40902-018-0141-9; Parthasarathy Jayanthi, 2014, Ann Maxillofac Surg, V4, P9, DOI 10.4103/2231-0746.133065; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; Punchak M, 2017, J CLIN NEUROSCI, V41, P30, DOI 10.1016/j.jocn.2017.03.028; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Shah AM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13561; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Sun YR, 2019, J NEUROSURG, V131, P40, DOI 10.3171/2018.1.JNS171804; Tan ETW, 2016, J NEUROSURG, V124, P1531, DOI 10.3171/2015.5.JNS15119; Thien A, 2015, WORLD NEUROSURG, V83, P176, DOI 10.1016/j.wneu.2014.06.003; van de Vijfeijken SECM, 2019, J CRANIO MAXILL SURG, V47, P1420, DOI 10.1016/j.jcms.2019.02.007; van de Vijfeijken SECM, 2018, WORLD NEUROSURG, V117, P443, DOI 10.1016/j.wneu.2018.05.193; Zanaty M, 2015, J NEUROSURG, V123, P182, DOI 10.3171/2014.9.JNS14405	45	2	2	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2365-6271		3D PRINT MED	3D Print. Med.	JUN 17	2020	6	1							14	10.1186/s41205-020-00066-5			10	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	UW1EI	WOS:000699907900001	32556704	Green Published, gold			2022-02-06	
J	Lorente, L; Martin, MM; Ruiz, C; Abreu-Gonzalez, P; Perez-Cejas, A; Gonzalez-Rivero, AF; Ramos-Gomez, L; Argueso, M; Sole-Violan, J; Caceres, JJ; Jimenez, A; Garcia-Marin, V				Lorente, Leonardo; Martin, Maria M.; Ruiz, Candelaria; Abreu-Gonzalez, Pedro; Perez-Cejas, Antonia; Gonzalez-Rivero, Agustin F.; Ramos-Gomez, Luis; Argueso, Monica; Sole-Violan, Jordi; Caceres, Juan J.; Jimenez, Alejandro; Garcia-Marin, Victor			Red blood cell distribution width as mortality biomarker in patients with traumatic brain injury	ACTA NEUROLOGICA BELGICA			English	Article						Red blood cell distribution width; Traumatic brain injury; Patients; Mortality; Prognosis	DIAGNOSIS; SEVERITY	One study found higher red blood cell distribution width (RDW) on the admission of traumatic brain injury (TBI) in non-surviving patients; however, a regression analysis was not carried out to establish an association between RDW and TBI mortality. Thus, the objectives of this study were to determine whether there is an association between RDW and TBI mortality, and to describe the temporal profile of RDW during the first week. Isolated (< 10 points in non-cranial aspects of Injury Severity Score) and severe (< 9 points in Glasgow Coma Scale) TBI patients were included. RDW at days 1, 4, and 8 of TBI were determined. The end-point study was 30-day mortality. Ninety-seven surviving patients compared to the 38 non-surviving patients had higher RDW at days 1 (p < 0.001), 4 (p < 0.001), and 8 (p < 0.001). The area under the curve (95% CI) for prediction of mortality by RDW at days 1, 4, and 8 was 0.81 (0.73-0.87;p < 0.001), 0.92 (0.85-0.96;p < 0.001) and 0.94 (0.88-0.98;p < 0.001). Regression analysis showed an association between RDW and mortality (odds ratio = 1.778; 95% CI 1.312-2.409;p < 0.001). The association found between RDW on admission and mortality is the main new finding of our study. Regarding the temporal profile of RDW, the fact that RDW during the first week of TBI may help in estimating prognosis is another interesting finding of our study.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Martin, Maria M.; Ruiz, Candelaria] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Crta Rosario S-N, Santa Cruz De Tenerife 38010, Spain; [Abreu-Gonzalez, Pedro] Univ La Laguna, Fac Med, Dept Physiol, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Perez-Cejas, Antonia; Gonzalez-Rivero, Agustin F.] Hosp Univ Canarias, Lab Dept, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Ramos-Gomez, Luis] Hosp Gen La Palma, Intens Care Unit, Buenavista Rriba S-N, Brena Alta 38713, La Palma, Spain; [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Avda Blasco Ibanez 17-19, Valencia 46004, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, CIBERES, Intens Care Unit, Barranco La Ballena S-N, Las Palmas Gran Canaria 35010, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Plaza Dr Pasteur S-N, Las Palmas Gran Canaria 35016, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Garcia-Marin, Victor] Hosp Univ Canarias, Dept Neurosurg, San Cristobal la Laguna 38320, Santa Cruz De T, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain.	lorentemartin@msn.com; mar.martinvelasco@gmail.com; laje@telefonica.net; pabreu@ull.es; aperezcejas@gmail.com; agonriv@hotmail.com; lramosgomez@gmail.com; moni_begasa@hotmail.com; jsolvio@gobiernodecanarias.org; juanjose.caceresagra@gobiernodecanarias.org; ajimenersosa@gmail.com; vicgarmar666@gmail.com		Jimenez-Sosa, Alejandro/0000-0001-8732-2616	Fundacion DISA a la Investigacion Medica 2017 (Santa Cruz de Tenerife. Spain) [OA18/011]; Instituto de Salud Carlos III (Madrid, Spain)Instituto de Salud Carlos III [PI-18-00500]; Fondo Europeo de Desarrollo Regional (FEDER)European Commission	This study was supported by a Grant (OA18/011) from Fundacion DISA a la Investigacion Medica 2017 (Santa Cruz de Tenerife. Spain) and a Grant from Instituto de Salud Carlos III (PI-18-00500) (Madrid, Spain) and co-financed with Fondo Europeo de Desarrollo Regional (FEDER). Funding did not influence the study design, the collection, analysis and interpretation of data, the manuscript writing, and the decision to submit it for publication.	Abrahan LL, 2018, CARDIOL RES, V9, P144, DOI 10.14740/cr732w; Aslan D, 2002, AM J HEMATOL, V69, P31, DOI 10.1002/ajh.10011; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Fontana V, 2018, MINERVA ANESTESIOL, V84, P693, DOI 10.23736/S0375-9393.17.12102-4; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Goyal H, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.61; Hu ZD, 2020, CLIN BIOCHEM, V77, P1, DOI 10.1016/j.clinbiochem.2020.01.001; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105436; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Milas GP, 2019, EXPERT REV GASTROENT, V13, P877, DOI 10.1080/17474124.2019.1653757; Pierce CN, 2005, PERFUSION-UK, V20, P83, DOI 10.1191/0267659105pf793oa; Sadaka Farid, 2018, J Clin Med Res, V10, P9, DOI 10.14740/jocmr3173w; Salvatori M, 2019, KARDIOL POL, V77, P632, DOI 10.33963/KP.14818; Scharte M, 2003, CRIT CARE MED, V31, pS651, DOI 10.1097/01.CCM.0000098036.90796.ED; Song SY, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01237; TEASDALE G, 1974, LANCET, V2, P81; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Zhang B, 2015, INT J CLIN EXP MED, V8, P19172	20	2	2	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	JUN	2021	121	3					715	720		10.1007/s13760-020-01409-z		JUN 2020	6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SJ9WG	WOS:000542071800001	32572840				2022-02-06	
J	Mannix, R; Morriss, NJ; Conley, GM; Meehan, WP; Nedder, A; Qiu, JH; Float, J; DiCesare, CA; Myer, GD				Mannix, Rebekah; Morriss, Nicholas J.; Conley, Grace M.; Meehan, William P., III; Nedder, Arthur; Qiu, Jianhua; Float, Jamison; DiCesare, Christopher A.; Myer, Gregory D.			Internal Jugular Vein Compression Collar Mitigates Histopathological Alterations after Closed Head Rotational Head Impact in Swine: A Pilot Study	NEUROSCIENCE			English	Article						mild traumatic brain injury; immunohistochemistry; phosphorylated tau	CHRONIC TRAUMATIC ENCEPHALOPATHY; BRAIN-INJURY; WORKING-MEMORY; AXONAL INJURY; SEASON; CONCUSSION; ACTIVATION; DISEASE; MODEL; TAU	Recently, there has been increased concern about microstructural brain changes after head trauma. Clinical studies have investigated a neck collar that applies gentle bilateral jugular vein compression, designed to increase intracranial blood volume and brain stiffness during head trauma, which neuroimaging has shown to result in a reduction in brain microstructural alterations after a season of American football and soccer. Here, we utilized a swine model of mild traumatic brain injury to investigate the effects of internal jugular vein (IJV) compression on histopathological outcomes after injury. Animals were randomized to collar treatment (n=8) or noncollar treatment (n=6), anesthetized and suspended such that the head was supported by breakable tape. A custom-built device was used to impact the head, thus allowing the head to break the tape and rotate along the sagittal plane. Accelerometer data were collected for each group. Sham injured animals (n=2) were exposed to anesthesia only. Following single head trauma, animals were euthanized and brains collected for histology. Whole slide immunohistochemistry was analyzed using Qupath software. There was no difference in linear or rotational acceleration between injured collar and non-collar animals (p>0.05). Injured animals demonstrated higher levels of the phosphorylated tau epitope AT8 (p<0.05) and the inflammatory microglial marker IBA1 (p<0.05) across the entire brain, but the effect of injury was markedly reduced by collar treatment (p<0.05) The current results indicate that internal jugular venous compression protects against histopathological alterations related to closed head trauma exposure. (C) 2020 IBRO. Published by Elsevier Ltd. All rights reserved.	[Mannix, Rebekah; Morriss, Nicholas J.; Conley, Grace M.; Qiu, Jianhua] Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA; [Mannix, Rebekah; Meehan, William P., III] Harvard Med Sch, Boston, MA 02115 USA; [Meehan, William P., III] Boston Childrens Hosp, Dept Orthoped, Boston, MA 02115 USA; [Meehan, William P., III; Qiu, Jianhua] Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P., III; Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Float, Jamison; DiCesare, Christopher A.; Myer, Gregory D.] Prior Designs, Columbus, OH USA; [Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, SPORT Ctr, Cincinnati, OH 45229 USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Orthopaed Surg, Cincinnati, OH USA; [Nedder, Arthur] Boston Childrens Hosp, DVM Anim Resources Childrens Hosp, Boston, MA 02115 USA		Mannix, R (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	Rebekah.Mannix@childrens.harvard.edu	DiCesare, Christopher/AAA-3327-2021; DiCesare, Christopher/ABH-9573-2020; Myer, Gregory/H-6572-2016	DiCesare, Christopher/0000-0002-6576-4904; Myer, Gregory/0000-0002-9983-8422; Conley, Grace/0000-0002-2920-9735; Mannix, Rebekah/0000-0003-3608-2792	CHB IDDRC; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; National Football League; Q30 Sports Innovations, LLC	This work was supported in part by funding from the CHB IDDRC and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and the National Football League. Q30 Sports Innovations, LLC funded the development of the swine jugular compression collar to Priority Designs and provided funding for portions of this project.	Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bonnette S, 2018, EXP BRAIN RES, V236, P2691, DOI 10.1007/s00221-018-5328-x; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; GILLAND O, 1969, AMER J ROENTGENOL RA, V106, P369, DOI 10.2214/ajr.106.2.369; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Laurent C, 2018, BIOMED J, V41, P21, DOI 10.1016/j.bj.2018.01.003; Margulies SS, 2013, PEDIAT INJURY BIOMEC, P157; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Myer GD, 2018, BR J SPORTS MED; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Noy S, 2016, J NEUROPATHOL EXP NE; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Schneider DK, 2019, J NEUROTRAUMA; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Yuan W, 2018, J NEUROTRAUMA; Yuan WH, 2018, J NEUROTRAUM, V35, P1248, DOI 10.1089/neu.2017.5262; Yuan WH, 2017, J NEUROTRAUM, V34, P2432, DOI 10.1089/neu.2016.4834; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	28	2	2	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUN 15	2020	437						132	144		10.1016/j.neuroscience.2020.04.009			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW7AH	WOS:000539294900014	32283181				2022-02-06	
J	Shadnoush, M; Zahedi, H; Norouzy, A; Sahebkar, A; Sadeghi, O; Najafi, A; Hosseini, S; Qorbani, M; Ahmadi, A; Ardehali, SH; Hosseinzadeh-Attar, MJ				Shadnoush, Mahdi; Zahedi, Hoda; Norouzy, Abdolreza; Sahebkar, Amirhossein; Sadeghi, Omid; Najafi, Atabak; Hosseini, Saeed; Qorbani, Mostafa; Ahmadi, Arezoo; Ardehali, Seyed Hossein; Hosseinzadeh-Attar, Mohammad Javad			Effects of supplementation with curcuminoids on serum adipokines in critically ill patients: a randomized double-blind placebo-controlled trial	PHYTOTHERAPY RESEARCH			English	Article						adiponectin; curcumin; enteral nutrition; intensive care unit; leptin	MAJOR DEPRESSION; GENE-EXPRESSION; ADIPONECTIN; LEPTIN; INFLAMMATION; EXTRACT; OBESITY; ROLES; IL-6	Previous studies have shown a beneficial effect of curcuminoids supplementation on serum concentrations of adipokines; however, there are no published studies that have examined this effect among critically ill patients. We aimed to assess the effects of supplementation with curcuminoids on serum concentrations of leptin and adiponectin in critically ill patients with traumatic brain injury (TBI). In this trial, 62 critically ill patients with TBI, aged 18-65 years, were randomly allocated to receive either 500 mg/day curcuminoids (co-administered with 5 mg/day piperine) or matched placebo for 7 days. Patients in both intervention groups received routine treatments for TBI as well as enteral nutrition. Serum concentrations of leptin and adiponectin were measured at baseline and at the end of trial. We found a significant reduction in serum levels of leptin in both curcuminoids (47.1%) and placebo (22.8%) groups; though the magnitude of reduction was greater in the former (p < .05). Supplementation with curcumioinds was not found to alter serum concentrations of adiponectin (p > .05). Supplementation with curcumioinds significantly reduced serum levels of leptin but had no significant effect on adiponectin levels in critically ill patients with TBI. Further clinical trials, particularly those with a long-term period, are needed to confirm our findings.	[Shadnoush, Mahdi] Semnan Univ Med Sci, Fac Med, Semnan, Iran; [Shadnoush, Mahdi] Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Dept Clin Nutr, Tehran, Iran; [Zahedi, Hoda; Hosseini, Saeed; Hosseinzadeh-Attar, Mohammad Javad] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Clin Nutr, Tehran, Iran; [Norouzy, Abdolreza] Mashhad Univ Med Sci, Fac Med, Dept Nutr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran; [Sadeghi, Omid] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran; [Najafi, Atabak; Ahmadi, Arezoo] Univ Tehran Med Sci, Sina Hosp, Fac Med, Dept Anesthesiol & Crit Care Med, Tehran, Iran; [Qorbani, Mostafa] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran; [Ardehali, Seyed Hossein] Shahid Beheshti Univ Med Sci, Shohadaye Tajrish Hosp, Dept Anesthesiol & Crit Care, Tehran, Iran		Hosseinzadeh-Attar, MJ (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, 44,Hojjat Dost Alley,Naderi St,Keshavarz Blvd, Tehran, Iran.	hosseinzadeh.md.phd@gmail.com	Zahedi, Hoda/AAO-9339-2021; Norouzy, Abdolreza/AAX-1160-2020; Sahebkar, Amirhossein/B-5124-2018; Shadnoush/U-5147-2017; Hosseinzadeh-Attar, Mohammad Javad/E-9358-2018	Zahedi, Hoda/0000-0003-4431-7459; Shadnoush/0000-0002-3716-0994; Hosseinzadeh-Attar, Mohammad Javad/0000-0002-5787-4089; Najafi, Atabak/0000-0002-1663-9533	Tehran University of Medical Sciences and Health ServicesTehran University of Medical Sciences [9604-161-37823]	Tehran University of Medical Sciences and Health Services, Grant/Award Number: 9604-161-37823	Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004; Atkin SL, 2017, PHYTOTHER RES, V31, P1836, DOI 10.1002/ptr.5905; Basnet P, 2011, MOLECULES, V16, P4567, DOI 10.3390/molecules16064567; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Chuengsamarn S, 2014, J NUTR BIOCHEM, V25, P144, DOI 10.1016/j.jnutbio.2013.09.013; Chuengsamarn S, 2012, DIABETES CARE, V35, P2121, DOI 10.2337/dc12-0116; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Esfahani M, 2015, IRAN J BASIC MED SCI, V18, P430; Ghadge AA, 2018, CYTOKINE GROWTH F R, V39, P151, DOI 10.1016/j.cytogfr.2018.01.004; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Gubari MIM, 2019, ARCH ACAD EMERG MED, V7; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hajavi J, 2017, J CELL BIOCHEM, V118, P4170, DOI 10.1002/jcb.26121; Hasani-Ranjbar S, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-28; Hewlings SJ, 2017, FOODS, V6, DOI 10.3390/foods6100092; Heyland DK, 2011, CRIT CARE, V15, DOI 10.1186/cc10546; Ismail NA, 2016, RES J PHARM BIOL CHE, V7, P1891; Jain SK, 2009, ANTIOXID REDOX SIGN, V11, P241, DOI 10.1089/ars.2008.2140; Jernas M, 2009, METABOLISM, V58, P102, DOI 10.1016/j.metabol.2008.08.012; Karimian MS, 2017, CYTOKINE GROWTH F R, V33, P55, DOI 10.1016/j.cytogfr.2016.10.001; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koch A, 2011, J CRIT CARE, V26, P166, DOI 10.1016/j.jcrc.2010.07.015; Koch A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/473540; Kubota M, 2012, NUTR CANCER, V64, P72, DOI 10.1080/01635581.2012.630554; Kuchnia AJ, 2018, NUTR CLIN PRACT, V33, P107, DOI 10.1177/0884533617722164; La Cava A, 2004, J MOL MED, V82, P4, DOI 10.1007/s00109-003-0492-1; La Cava A, 2017, CYTOKINE, V98, P51, DOI 10.1016/j.cyto.2016.10.011; La Cava Antonio, 2012, Inflammation & Allergy Drug Targets, V11, P298; Langouche L, 2009, CRIT CARE, V13, DOI 10.1186/cc7956; Loggers SAI, 2017, EUR J TRAUMA EMERG S, V43, P823, DOI 10.1007/s00068-016-0744-8; Lopresti AL, 2017, J AFFECT DISORDERS, V207, P188, DOI 10.1016/j.jad.2016.09.047; Lopresti AL, 2015, EUR NEUROPSYCHOPHARM, V25, P38, DOI 10.1016/j.euroneuro.2014.11.015; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Mohammadi A, 2019, J NUTR BIOCHEM, V66, P1, DOI 10.1016/j.jnutbio.2018.12.005; Naksuriya O, 2014, BIOMATERIALS, V35, P3365, DOI 10.1016/j.biomaterials.2013.12.090; Nejati-Koshki K, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-66; Nejati-Koshki K, 2013, ASIAN PAC J CANCER P, V14, P6595, DOI 10.7314/APJCP.2013.14.11.6595; Nuttall FQ, 2015, NUTR TODAY, V50, P117, DOI [DOI 10.1097/NT.0000000000000092, 10.1097/NT.0000000000000092]; Ohara K, 2009, PHYTOMEDICINE, V16, P130, DOI 10.1016/j.phymed.2008.09.012; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Panahi Y, 2017, INFLAMMOPHARMACOLOGY, V25, P25, DOI 10.1007/s10787-016-0301-4; Panahi Y, 2016, NUTRITION, V32, P1116, DOI 10.1016/j.nut.2016.03.018; Panahi Y, 2016, BIOMED PHARMACOTHER, V82, P578, DOI 10.1016/j.biopha.2016.05.037; Panahi Yunes, 2016, Journal of Dietary Supplements, V13, P209, DOI 10.3109/19390211.2015.1008611; Salahshooh M. M., 2017, Comparative Clinical Pathology, V26, P17, DOI 10.1007/s00580-016-2339-5; Shehzad A, 2011, EUR J NUTR, V50, P151, DOI 10.1007/s00394-011-0188-1; Simental-Mendia LE, 2019, OBES RES CLIN PRACT, V13, P340, DOI 10.1016/j.orcp.2019.04.003; Tarnowski MS, 2018, NUTR CLIN PRACT, V33, P887, DOI 10.1177/0884533617716432; Taylor BE, 2016, CRIT CARE MED, V44, P390, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; Uji Y, 2009, SURGERY, V145, P550, DOI 10.1016/j.surg.2009.01.010; Venkatesh B, 2009, CRIT CARE, V13, DOI 10.1186/cc7941; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	54	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	DEC	2020	34	12					3180	3188		10.1002/ptr.6749		JUN 2020	9	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	PC4GH	WOS:000540235600001	32542818				2022-02-06	
J	Wolf, MS; Rakkar, J; Horvat, CM; Simon, DW; Kochanek, PM; Clermont, G; Clark, RSB				Wolf, Michael S.; Rakkar, Jaskaran; Horvat, Christopher M.; Simon, Dennis W.; Kochanek, Patrick M.; Clermont, Gilles; Clark, Robert S. B.			Assessment of Dynamic Intracranial Compliance in Children with Severe Traumatic Brain Injury: Proof-of-Concept	NEUROCRITICAL CARE			English	Article						Cerebral blood volume; CO(2)reactivity; Head injury; Intracranial pressure; Pressure-volume index	CEREBRAL BLOOD-VOLUME; TIDAL CARBON-DIOXIDE; SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; PERFUSION-PRESSURE; ARTERIAL FRACTION; FLOW; HYPOCAPNIA; RESPONSES; INDEX	Background and Aims Intracranial compliance refers to the relationship between a change in intracranial volume and the resultant change in intracranial pressure (ICP). Measurement of compliance is useful in managing cardiovascular and respiratory failure; however, there are no contemporary means to assess intracranial compliance. Knowledge of intracranial compliance could complement ICP and cerebral perfusion pressure (CPP) monitoring in patients with severe traumatic brain injury (TBI) and may enable a proactive approach to ICP management. In this proof-of-concept study, we aimed to capitalize on the physiologic principles of intracranial compliance and vascular reactivity to CO2, and standard-of-care neurocritical care monitoring, to develop a method to assess dynamic intracranial compliance. Methods Continuous ICP and end-tidal CO2(ETCO2) data from children with severe TBI were collected after obtaining informed consent in this Institutional Review Board-approved study. An intracranial pressure-PCO(2)Compliance Index (PCI) was derived by calculating the moment-to-moment correlation between change in ICP and change in ETCO2. As such, "good" compliance may be reflected by a lack of correlation between time-synched changes in ICP in response to changes in ETCO2, and "poor" compliance may be reflected by a positive correlation between changes in ICP in response to changes in ETCO2. Results A total of 978 h of ICP and ETCO(2)data were collected and analyzed from eight patients with severe TBI. Demographic and clinical characteristics included patient age 7.1 +/- 5.8 years (mean +/- SD); 6/8 male; initial Glasgow Coma Scale score 3 [3-7] (median [IQR]); 6/8 had decompressive surgery; 7.1 +/- 1.4 ICP monitor days; ICU length of stay (LOS) 16.1 +/- 6.8 days; hospital LOS 25.9 +/- 8.4 days; and survival 100%. The mean PCI for all patients throughout the monitoring period was 0.18 +/- 0.04, where mean ICP was 13.7 +/- 2.1 mmHg. In this cohort, PCI was observed to be consistently above 0.18 by 12 h after monitor placement. Percent time spent with PCI thresholds > 0.1, 0.2, and 0.3 were 62% [24], 38% [14], and 23% [15], respectively. The percentage of time spent with an ICP threshold > 20 mmHg was 5.1% [14.6]. Conclusions Indirect assessment of dynamic intracranial compliance in TBI patients using standard-of-care monitoring appears feasible and suggests a prolonged period of derangement out to 5 days post-injury. Further study is ongoing to determine if the PCI-a new physiologic index, complements utility of ICP and/or CPP in guiding management of patients with severe TBI.	[Wolf, Michael S.; Horvat, Christopher M.; Simon, Dennis W.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Wolf, Michael S.] Vanderbilt Univ, Dept Pediat, Sch Med, Div Crit Care Med, Nashville, TN USA; [Rakkar, Jaskaran; Horvat, Christopher M.; Simon, Dennis W.; Kochanek, Patrick M.; Clermont, Gilles; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Horvat, Christopher M.; Simon, Dennis W.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Dept Pediat, Sch Med, Pittsburgh, PA 15260 USA; [Horvat, Christopher M.; Simon, Dennis W.; Kochanek, Patrick M.; Clark, Robert S. B.] UPMC Childrens Hosp Pittsburgh, Brain Care Inst, Fac Pavilion,Suite 2000,4401 Penn Ave, Pittsburgh, PA 15224 USA; [Clermont, Gilles] Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA		Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.; Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.; Clark, RSB (corresponding author), Univ Pittsburgh, Dept Pediat, Sch Med, Pittsburgh, PA 15260 USA.; Clark, RSB (corresponding author), UPMC Childrens Hosp Pittsburgh, Brain Care Inst, Fac Pavilion,Suite 2000,4401 Penn Ave, Pittsburgh, PA 15224 USA.	clarkrs@upmc.edu	Wolf, Michael/V-3351-2018	Wolf, Michael/0000-0002-4342-6517; Rakkar, Jaskaran/0000-0002-4786-1807	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HD40686, R21 NS115174]; Children's Hospital of Pittsburgh Scientific Program	This study was supported by NIH T32 HD40686 (MSW, JR) and R21 NS115174 (CMH, GC, RSBC), and the Children's Hospital of Pittsburgh Scientific Program.	Abdullah J, 2005, ACT NEUR S, V95, P311; Akhondi-Asl A, 2018, CRIT CARE MED, V46, pE1160, DOI 10.1097/CCM.0000000000003434; Battisti-Charbonney A, 2011, J PHYSIOL-LONDON, V589, P3039, DOI 10.1113/jphysiol.2011.206052; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Brugniaux JV, 2007, RESP PHYSIOL NEUROBI, V158, P212, DOI 10.1016/j.resp.2007.04.008; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clermont G, 2004, INTENS CARE MED, V30, P2237, DOI 10.1007/s00134-004-2456-5; Czosnyka M, 2012, NEUROL RES, V34, P17, DOI 10.1179/1743132811Y.0000000040; Davson H, 1966, Sci Basis Med Annu Rev, P238; Donnelly J, 2018, ACTA NEUROCHIR SUPPL, V126, P209, DOI 10.1007/978-3-319-65798-1_43; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Engvall C, 2008, J NEUROSURG ANESTH, V20, P41, DOI 10.1097/ANA.0b013e31815d4c70; GREENBERG JH, 1978, CIRC RES, V43, P324, DOI 10.1161/01.RES.43.2.324; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Ito H, 2005, J CEREBR BLOOD F MET, V25, P852, DOI 10.1038/sj.jcbfm.9600076; Ito H, 2003, J CEREBR BLOOD F MET, V23, P665, DOI 10.1097/01.WCB.0000067721.64998.F5; Ito H, 2001, ANN NUCL MED, V15, P111, DOI 10.1007/BF02988600; Kim Sunghan, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P9; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Kochanek PM, 2019, NEUROSURGERY; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Maa T, 2016, J NEUROSURG-PEDIATR, V18, P73, DOI 10.3171/2016.1.PEDS15564; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murphy S, 2017, J NEUROTRAUM, V34, P2220, DOI 10.1089/neu.2016.4793; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Oehmichen M, 2003, ACTA NEUROPATHOL, V105, P570, DOI 10.1007/s00401-003-0683-4; PHELPS ME, 1973, J APPL PHYSIOL, V35, P274, DOI 10.1152/jappl.1973.35.2.274; Picetti E, 2017, ACTA NEUROCHIR, V159, P615, DOI 10.1007/s00701-017-3118-z; Portella G, 2005, ACTA NEUROCHIR, V147, P707, DOI 10.1007/s00701-005-0537-z; Puppo C, 2019, J CLIN MED COMPUT; Razi E, 2012, ARCH TRAUMA RES, V1, P58, DOI 10.5812/atr.6444; Reinstrup P, 2001, ANESTHESIOLOGY, V95, P1079, DOI 10.1097/00000542-200111000-00009; Rostrup E, 2005, NEUROIMAGE, V24, P1, DOI 10.1016/j.neuroimage.2004.09.043; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; SHAPIRO K, 1980, ANN NEUROL, V7, P508, DOI 10.1002/ana.410070603; SMITH AL, 1971, J APPL PHYSIOL, V31, P701, DOI 10.1152/jappl.1971.31.5.701; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vovk A, 2002, CAN J PHYSIOL PHARM, V80, P819, DOI 10.1139/Y02-105	43	2	2	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2021	34	1					209	217		10.1007/s12028-020-01004-3		JUN 2020	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QT6MJ	WOS:000541020500003	32556856	Bronze, Green Published			2022-02-06	
J	Chen, WS; Post, A; Karton, C; Gilchrist, MD; Robidoux, M; Hoshizaki, TB				Chen, Wesley; Post, Andrew; Karton, Clara; Gilchrist, Michael D.; Robidoux, Michael; Hoshizaki, T. Blaine			A comparison of frequency and magnitude of head impacts between Pee Wee And Bantam youth ice hockey	SPORTS BIOMECHANICS			English	Article; Early Access						Concussion; strain; traumatic brain injury; youth	SERUM NEUROFILAMENT LIGHT; TRAUMATIC BRAIN-INJURY; WHITE-MATTER; INTRACRANIAL-PRESSURE; VIDEO ANALYSIS; BODY CHECKING; SINGLE SEASON; RISK-FACTORS; CONCUSSION; ACCELERATION	The purpose of this research was to compare the frequency and magnitude of head impact events between Pee Wee and Bantam ice hockey players. Videos of Pee Wee and Bantam boys' ice hockey were analysed to determine the frequency and type of head impact events. The head impact events were then reconstructed in the laboratory using physical and finite element models to determine the magnitude of strain in the brain tissues. The results showed that Pee Wee boys experienced more head impacts from elbows and boards, while Bantam players had more head impacts to the glass. Pee Wee and Bantam players experienced similar frequency and magnitudes of very low, low, and medium and above (med+) levels of strain to the brain. This research suggests to ice hockey leagues and coaches that to reduce the incidence of these levels of brain trauma, consideration must be given to either reducing the level of contact along the boards or the removal of body checking. In addition, companies who innovate in ice hockey should develop protective devices and equipment strategies that aim to reduce the risk of head injury from shoulder and glass impacts for Bantam players.	[Chen, Wesley; Post, Andrew; Karton, Clara; Robidoux, Michael; Hoshizaki, T. Blaine] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Post, Andrew; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), Univ Ottawa, Human Kinet, Ottawa, ON, Canada.; Post, A (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.	apost@uottawa.ca		Post, Andrew/0000-0002-5960-5552	Natural Sciences and Engineering Council of Canada Collaborative Research and Development Grant	This research was supported by a Natural Sciences and Engineering Council of Canada Collaborative Research and Development Grant.	Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Eckner JT, 2018, AM J SPORT MED, V46, P2253, DOI 10.1177/0363546518777244; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Fryar Cheryl D, 2012, Vital Health Stat 11, P1; Gennarelli T. A., 2015, P IRCOBI C; Gilchrist, 2016, TRAUM BRAIN INJ CLIN; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki T.B., 2014, J NEUROL NEUROPHYS, V5, P1, DOI 10.4172/2155-9562.1000181; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Karton C., 2018, CAN SOC BIOM HAL CAN; Karton C., 2014, INFLUENCE IMPACT MAS, P23; Karton C, 2018, HAND CLINIC, V158, P39, DOI 10.1016/B978-0-444-63954-7.00005-7; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Lu KP, 2016, JAMA NEUROL, V73, P1356, DOI 10.1001/jamaneurol.2016.2027; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Mennes M, 2014, NEUROIMAGE, V98, P513, DOI 10.1016/j.neuroimage.2014.04.030; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Oeur A., 2018, THESIS; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Post A., 2019, 42 CAN MED BIOL ENG; Post A., 2014, INT RES COUNC BIOM I; Post A., 2016, INT RES COUNC BIOM I; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Potvin BM, 2019, J BIOMECH, V91, P43, DOI 10.1016/j.jbiomech.2019.05.002; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Wattie N, 2007, PEDIATRICS, V120, P142, DOI 10.1542/peds.2006-2672; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06; Yang J., 2011, INVESTIGATION BRAIN; Zanetti K., 2013, INT RES COUNC BIOM I; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	77	2	2	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.												10.1080/14763141.2020.1754450		JUN 2020	24	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	MF3JM	WOS:000545241600001	32538288				2022-02-06	
J	Goyal, K; Tomar, GS; Sengar, K; Singh, GP; Aggarwal, R; Soni, KD; Mathur, P; Kedia, S; Prabhakar, H				Goyal, Keshav; Tomar, Gaurav Singh; Sengar, Kangana; Singh, Gyaninder Pal; Aggarwal, Richa; Soni, Kapil Dev; Mathur, Purva; Kedia, Shweta; Prabhakar, Hemanshu			Prognostic Value of Serially Estimated Serum Procalcitonin Levels in Traumatic Brain Injury Patients With or Without Extra Cranial Injury on Early In-hospital Mortality: A Longitudinal Observational Study	NEUROCRITICAL CARE			English	Article						Procalcitonin; Mortality; Traumatic brain injury; Sepsis	MULTIPLE INJURIES; SEPSIS; SEVERITY; SURGERY; MARKERS	Background Traumatic brain injury (TBI) is associated with majority of trauma deaths, and objective tools are required to understand the severity of injury. The application of a biomarker like procalcitonin (PCT) in TBI may allow for assessment of severity and thus aid in prognostication and correlation with mortality and outcome. Aims The primary objective is to determine the correlation between PCT concentrations with TBI outcomes (mainly in terms of mortality) at intensive care unit (ICU)/hospital discharge. Secondary objectives are to evaluate correlation with associated extra cranial injuries and complications during hospital stay. Methods In total, 186 TBI patients aged > 18 years with minimum survival for at least 12 h admitted to the ICU at the level 1 trauma center were prospectively included in the study and divided into two groups: TBI with and without extra cranial injuries. All admitted patients were treated according to the standard institutional protocol. The PCT levels were obtained on admission, on day 2, and 5. Clinical, laboratory, diagnostic, and therapeutic data were also collected. Primary mortality is defined as death related to central nervous system (CNS) injury, while secondary mortality defined as death related to sepsis or extracranial cause. Results Median PCT levels at admission, day 2, and day 5 in TBI patients with extracranial injuries were 3.0, 0.83, and 0.69 ng/ml. In total, primary mortality was observed in 18 (9.7%) patients, while secondary causes were attributable in 20 (12.3%) patients. Regression analysis for primarily CNS cause of mortality showed PCT cutoff level at admission more than 5.5 ng/ml carried sensitivity and specificity of 75%, but for secondary cause (sepsis) of mortality, PCT cutoff values on day 2 > 1.15 ng/ml were derived significant with sensitivity of 70% and specificity of 66%. No significant association of parameters like length of ICU stay, Glasgow outcome scale (GOS), and primary/secondary mortality with the presence of extracranial injuries in TBI patients as compared with TBI alone was noted. Conclusion This observational study demonstrates the poor correlation between PCT concentrations with outcome at days 1, 2, and 5 post-injury. The predicted relationship between PCT levels and outcome was not confirmed, and that these results do not support the prognostic utility of PCT biomarker in this population for outcome (mortality) assessment in TBI patients with or without extracranial injuries.	[Goyal, Keshav; Tomar, Gaurav Singh; Singh, Gyaninder Pal; Prabhakar, Hemanshu] All India Inst Med Sci, Neurosci Ctr, Dept Neuroanaesthesiol & Crit Care, 7th Floor,710, New Delhi 110029, India; [Sengar, Kangana] All India Inst Med Sci, JPN Apex Trauma Ctr, Dept Lab Med, New Delhi, India; [Aggarwal, Richa; Soni, Kapil Dev] All India Inst Med Sci, JPN Apex Trauma Ctr, Dept Crit Care & Intens Care, New Delhi, India; [Mathur, Purva] All India Inst Med Sci, JPN Apex Trauma Ctr, Dept Microbiol, New Delhi, India; [Kedia, Shweta] All India Inst Med Sci, Neurosci Ctr, Dept Neurosurg, New Delhi, India		Goyal, K (corresponding author), All India Inst Med Sci, Neurosci Ctr, Dept Neuroanaesthesiol & Crit Care, 7th Floor,710, New Delhi 110029, India.	keshavgoyalster@gmail.com	SINGH, GYANINDER/T-7976-2017	SINGH, GYANINDER/0000-0002-6702-6892; Goyal, Keshav/0000-0001-9139-0689			ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balci C, 2003, CRIT CARE, V7, P85, DOI 10.1186/cc1843; Balci C, 2009, J INT MED RES, V37, P1709, DOI 10.1177/147323000903700606; Becker KL, 2010, BRIT J PHARMACOL, V159, P253, DOI 10.1111/j.1476-5381.2009.00433.x; Carlet J, 1999, INFECT DIS CLIN N AM, V13, P483, DOI 10.1016/S0891-5520(05)70087-8; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Deng SX, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-48; Duflo F, 2002, ANESTHESIOLOGY, V96, P74, DOI 10.1097/00000542-200201000-00018; Luyt CE, 2005, AM J RESP CRIT CARE, V171, P48, DOI 10.1164/rccm.200406-746Oc; Maier M, 2009, J TRAUMA, V66, P243, DOI 10.1097/TA.0b013e31817c966f; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Maruna P, 2000, PHYSIOL RES, V49, pS57; Meisner M, 2002, INTENS CARE MED, V28, P1094, DOI 10.1007/s00134-002-1392-5; Meisner M, 1998, INTENS CARE MED, V24, P680, DOI 10.1007/s001340050644; Mokart D, 2005, BRIT J ANAESTH, V94, P767, DOI 10.1093/bja/aei143; Muller B, 2000, CRIT CARE MED, V28, P977, DOI 10.1097/00003246-200004000-00011; Nijsten MWN, 2000, CRIT CARE MED, V28, P458, DOI 10.1097/00003246-200002000-00028; Nobre V, 2008, AM J RESP CRIT CARE, V177, P498, DOI 10.1164/rccm.200708-1238OC; Nylen ES, 1996, AM J MED SCI, V312, P12, DOI 10.1016/S0002-9629(15)41740-9; Oberhoffer M, 1999, J LAB CLIN MED, V134, P49, DOI 10.1016/S0022-2143(99)90053-7; Reith HB, 1998, DIGEST SURG, V15, P260, DOI 10.1159/000018625; Samsudin Intan, 2017, Clin Biochem Rev, V38, P59; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Vijayan AL, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0246-8; Wanner GA, 2000, CRIT CARE MED, V28, P950, DOI 10.1097/00003246-200004000-00007	28	2	2	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2021	34	1					182	192		10.1007/s12028-020-01009-y		JUN 2020	11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QT6MJ	WOS:000551429300001	32533544	Green Published, Bronze			2022-02-06	
J	Treble-Barna, A; Patronick, J; Uchani, S; Marousis, NC; Zigler, CK; Fink, EL; Kochanek, PM; Conley, YP; Yeates, KO				Treble-Barna, Amery; Patronick, Jamie; Uchani, Srivatsan; Marousis, Noelle C.; Zigler, Christina K.; Fink, Ericka L.; Kochanek, Patrick M.; Conley, Yvette P.; Yeates, Keith Owen			Epigenetic Effects on Pediatric Traumatic Brain Injury Recovery (EETR): An Observational, Prospective, Longitudinal Concurrent Cohort Study Protocol	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; precision medicine; childhood adversity; epigenetics; brain-derived neurotrophic factor	NEUROTROPHIC FACTOR BDNF; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ACTIVITY-DEPENDENT SECRETION; DNA METHYLATION; VAL66MET POLYMORPHISM; ACADEMIC-PERFORMANCE; TRAJECTORY ANALYSIS; EXECUTIVE FUNCTION; PSYCHOSOCIAL RISK; FACTOR EXPRESSION	Introduction:Unexplained heterogeneity in outcomes following pediatric traumatic brain injury (TBI) is one of the most critical barriers to the development of effective prognostic tools and therapeutics. The addition of personal biological factors to our prediction models may account for a significant portion of unexplained variance and advance the field toward precision rehabilitation medicine. The overarching goal of the Epigenetic Effects on Pediatric Traumatic Brain Injury Recovery (EETR) study is to investigate an epigenetic biomarker involved in both childhood adversity and postinjury neuroplasticity to better understand heterogeneity in neurobehavioral outcomes following pediatric TBI. Our primary hypothesis is that childhood adversity will be associated with worse neurobehavioral recovery in part through an epigenetically mediated reduction in brain-derived neurotrophic factor (BDNF) expression in response to TBI. Methods and analysis:EETR is an observational, prospective, longitudinal concurrent cohort study of children aged 3-18 years with either TBI (n= 200) or orthopedic injury (n= 100), recruited from the UPMC Children's Hospital of Pittsburgh. Participants complete study visits acutely and at 6 and 12 months postinjury. Blood and saliva biosamples are collected at all time points-and cerebrospinal fluid (CSF) when available acutely-for epigenetic and proteomic analysis ofBDNF. Additional measures assess injury characteristics, pre- and postinjury child neurobehavioral functioning, childhood adversity, and potential covariates/confounders. Recruitment began in July 2017 and will occur for similar to 6 years, with data collection complete by mid-2023. Analyses will characterizeBDNFDNA methylation and protein levels over the recovery period and investigate this novel biomarker as a potential biological mechanism underlying the known association between childhood adversity and worse neurobehavioral outcomes following pediatric TBI. Ethics and dissemination:The study received ethics approval from the University of Pittsburgh Institutional Review Board. Participants and their parents provide informed consent/assent. Research findings will be disseminated via local and international conference presentations and manuscripts submitted to peer-reviewed journals.	[Treble-Barna, Amery; Patronick, Jamie; Uchani, Srivatsan; Marousis, Noelle C.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Zigler, Christina K.] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA; [Fink, Ericka L.; Kochanek, Patrick M.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res,Sch Med, Div Pediat Crit Care Med,Dept Crit Care & Pediat, Pittsburgh, PA USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Dept Hlth Promot & Dev, Pittsburgh, PA 15261 USA; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Dept Psychol, Calgary, AB, Canada		Treble-Barna, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA.	amery.treble-barna@pitt.edu	Fink, Ericka/AAU-9792-2021; Yeates, Keith/AAJ-4223-2020	Conley, Yvette/0000-0002-1784-6067	National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01 HD097030, T32 HD040686]; National Center for Advancing Translational Sciences (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR001856]; Society for Clinical Neuropsychology Early Career Pilot Award; UPMC Children's Hospital of Pittsburgh Scientific Program; University of Pittsburgh/UPMC Rehabilitation Institute Pilot Award	This research was supported in part by grants K01 HD097030 (PI AT-B) and T32 HD040686 (PI PK) from the National Institute of Child Health and Human Development (NICHD) and KL2 TR001856 (PI Rubio) from the National Center for Advancing Translational Sciences (NCATS), the Society for Clinical Neuropsychology Early Career Pilot Award (PI AT-B), the UPMC Children's Hospital of Pittsburgh Scientific Program (PI AT-B), and the University of Pittsburgh/UPMC Rehabilitation Institute Pilot Award (PI AT-B). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Asarnow R, 1995, TRAUMA BRAIN INJ CHI, V67, P653; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bakulski Kelly M, 2016, Curr Behav Neurosci Rep, V3, P264, DOI 10.1007/s40473-016-0083-4; Barker PA, 2009, NAT NEUROSCI, V12, P105, DOI 10.1038/nn0209-105; Berger RP, 2010, DEV NEUROSCI-BASEL, V32, P396, DOI 10.1159/000316803; Blaze J, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00079; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Cattane N, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1383-2; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Chen XP, 2017, NEUROCHEM RES, V42, P1308, DOI 10.1007/s11064-016-2172-x; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Cicchetti D, 2016, DEV PSYCHOPATHOL, V28, P1305, DOI 10.1017/S0954579416000869; Cortes-Mendoza J, 2013, INT J DEV NEUROSCI, V31, P359, DOI 10.1016/j.ijdevneu.2013.04.003; Dadds MR, 2016, EUR CHILD ADOLES PSY, V25, P1081, DOI 10.1007/s00787-016-0828-3; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Durish CL, 2018, J INT NEUROPSYCH SOC, V24, P759, DOI 10.1017/S1355617718000437; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Frankfurt S, 2016, COUNS PSYCHOL, V44, P622, DOI 10.1177/0011000016658097; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Gioia G. A., 2003, BEHAV RATING INVENTO; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Grigorenko EL, 2016, DEV PSYCHOPATHOL, V28, P1285, DOI 10.1017/S0954579416000857; Hannon E, 2015, EPIGENETICS-US, V10, P1024, DOI 10.1080/15592294.2015.1100786; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Heinrich H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03326-3; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hing B, 2018, AM J MED GENET B, V177, P143, DOI 10.1002/ajmg.b.32616; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Iughetti L, 2011, NEUROPEPTIDES, V45, P205, DOI 10.1016/j.npep.2011.02.002; Januar V, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.114; Joehanes R, 2016, CIRC-CARDIOVASC GENE, V9, P436, DOI 10.1161/CIRCGENETICS.116.001506; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones MJ, 2015, AGING CELL, V14, P924, DOI 10.1111/acel.12349; Kang HJ, 2019, INT J GERIATR PSYCH, V34, P1706, DOI 10.1002/gps.5185; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kazak AE, 2015, ACTA ONCOL, V54, P574, DOI 10.3109/0284186X.2014.995774; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Kenworthy, 2015, BEHAV RATING INVENTO; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Koven NS, 2014, NEUROPSYCHOBIOLOGY, V69, P227, DOI 10.1159/000362242; Kuban KCK, 2018, J PEDIATR-US, V201, P40, DOI 10.1016/j.jpeds.2018.05.021; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kurowski B.G., 2015, ARCH PHYS MED REHAB, V96, pe2, DOI DOI 10.1016/j.apmr.2015.08.004; Kurowski BG, 2017, J NEUROTRAUM, V34, P2280, DOI 10.1089/neu.2016.4856; Leckie RL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00985; Lewin GR, 2014, NEUROTROPHIC FACTORS, DOI [10.1007/978-3-642-45106-5, DOI 10.1007/978-3-642-45106-5]; Li HM, 2014, PSYCHIAT RES, V217, P191, DOI 10.1016/j.psychres.2014.03.011; Li M, 2016, BEHAV BRAIN RES, V313, P177, DOI 10.1016/j.bbr.2016.07.025; Lindsey HM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01296; Liu BL, 2010, NEURO-ONCOLOGY, V12, P540, DOI 10.1093/neuonc/nop064; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Madurski C, 2018, CRIT CARE MED, V46, P393, DOI 10.1097/01.ccm.0000528827.52141.9a; Marioni RE, 2018, MOL PSYCHIATR, V23, P2133, DOI 10.1038/s41380-017-0008-y; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Maschietto M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44547; Masliah E, 2013, EPIGENETICS-US, V8, P1030, DOI 10.4161/epi.25865; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Munoz MJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00044; Muthen L.K., 2015, MPLUS USERS GUIDE, V5th; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Nagin DS., 2005, GROUP BASED MODELING, DOI [10.4159/9780674041318, DOI 10.4159/9780674041318]; Newton DF, 2017, PSYCHOPHARMACOLOGY, V234, P647, DOI 10.1007/s00213-016-4500-x; Nikolova YS, 2015, TRENDS COGN SCI, V19, P366, DOI 10.1016/j.tics.2015.05.003; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Perroud N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.140; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Pinelis V G, 2015, Zh Nevrol Psikhiatr Im S S Korsakova, V115, P66, DOI 10.17116/jnevro20151158166-72; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Riley AW, 2004, MED CARE, V42, P221, DOI 10.1097/01.mlr.0000114910.46921.73; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Roberts RM, 2016, DEV NEUROPSYCHOL, V41, P176, DOI 10.1080/87565641.2016.1186167; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sasi M, 2017, PFLUG ARCH EUR J PHY, V469, P593, DOI 10.1007/s00424-017-1964-4; Schuster AA, 2018, J NEUROTRAUM, V35, pA275; Seo MK, 2016, NEUROPHARMACOLOGY, V105, P388, DOI 10.1016/j.neuropharm.2016.02.009; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Smith AK, 2015, AM J MED GENET B, V168, P36, DOI 10.1002/ajmg.b.32278; Sparrow S.S., 2016, VINELAND ADAPTIVE BE, V3rd ed.; STARFIELD B, 1995, MED CARE, V33, P553, DOI 10.1097/00005650-199505000-00008; Stenz L, 2015, NEUROSCI RES, V91, P1, DOI 10.1016/j.neures.2014.10.003; Szyf M, 2013, CHILD DEV, V84, P49, DOI 10.1111/j.1467-8624.2012.01793.x; Taurines R, 2014, J NEURAL TRANSM, V121, P1117, DOI 10.1007/s00702-014-1162-x; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Thaler L, 2014, PROG NEURO-PSYCHOPH, V54, P43, DOI 10.1016/j.pnpbp.2014.04.010; Thompson EE, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0491-2; Tofighi D, 2010, ADV LATENT VARIABLE, P317; Traub F, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2569; Treble-Barna A, 2020, J NEUROTRAUM, V37, P1491, DOI 10.1089/neu.2019.6866; Treble-Barna A, 2019, J NEUROTRAUM, V36, pA58; Treble-Barna A, 2018, J NEUROTRAUM, V35, pA273; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; Treble-Barna A, 2017, J NEUROTRAUM, V34, P1919, DOI 10.1089/neu.2016.4840; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Treble-Barna A, 2016, DEV PSYCHOL, V52, P1777, DOI 10.1037/dev0000208; Tyrka AR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.112; Unternaehrer E, 2015, STRESS, V18, P451, DOI 10.3109/10253890.2015.1038992; Ursini G, 2016, EPIGENETICS-US, V11, P11, DOI 10.1080/15592294.2015.1117736; Vaiserman AM, 2015, DEV DYNAM, V244, P254, DOI 10.1002/dvdy.24211; van der Kolk NM, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.08.023; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Weder N, 2014, J AM ACAD CHILD PSY, V53, P417, DOI 10.1016/j.jaac.2013.12.025; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wilkosc M, 2016, ACTA NEUROBIOL EXP, V76, P43; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zeni CP, 2016, ACTA PSYCHIAT SCAND, V134, P268, DOI 10.1111/acps.12587; Zwipp J, 2014, PROG NEURO-PSYCHOPH, V54, P163, DOI 10.1016/j.pnpbp.2014.05.006	129	2	2	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 12	2020	11								460	10.3389/fneur.2020.00460			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MD3JC	WOS:000543866500001	32595586	Green Published, gold			2022-02-06	
J	Kyyriainen, J; Tapiala, J; Lipponen, A; Ndode-Ekane, XE; Pitkanen, A				Kyyriainen, Jenni; Tapiala, Jesse; Lipponen, Anssi; Ndode-Ekane, Xavier Ekolle; Pitkanen, Asla			Plau/Plaur double-deficiency did not worsen lesion severity or vascular integrity after traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Double knockout; Lateral fluid-percussion injury; Pericyte; Platelet-derived growth factor receptor beta; Unfolded maps	SMOOTH-MUSCLE-CELLS; PLASMINOGEN-ACTIVATOR; UROKINASE; EPILEPTOGENESIS; BARRIER; MODEL	Binding of urokinase-type plasminogen activator receptor (uPAR) to its ligand uPA or to its plasma membrane partner, platelet-derived growth factor receptor beta (PDGFR beta), promotes neuroprotection, cell proliferation, and angiogenesis. Following injury, single deficiency in uPA or uPAR leads in increased tissue loss and compromised vascular remodeling. We hypothesized that double-deficiency of uPAR (Plaur) and uPA (Plau) would result in increased lesion area and poor vascular integrity after traumatic brain injury (TBI). TBI was induced by lateral fluid-percussion injury in Plau/Plaur double-knockout (dKO) and wild-type (Wt) mice. The cortical lesion area was quantified in unfolded cortical maps prepared from thionin-stained sections at 4 d or 30 d post-TBI. The density of PDGFR beta+ pericytes and blood vessels was calculated from immunostained sections. Blood-brain barrier leakage was analyzed using ImageJ (R) from IgG-immunostained sections. Genotype had no effect on the total area of the cortical lesion at 4 d or 30 d post-TBI (p > 0.05) or its progression as the overall lesion area was comparable at 4 d and 30 d post-TBI in both genotypes (p > 0.05). Subfield analysis, however, indicated that damage to the visual cortex at 4 d post-TBI in dKO-TBI mice was 53 % of that in Wt-TBI mice (p < 0.05). Both genotypes had a higher density of PDGFR beta-positive pericytes at 4 d than at 30 d post-TBI (p < 0.05), but no genotype effect was detected between these time-points (p > 0.05). TBI-induced increase in the density of PDGFR beta+ blood vessels at the region adjacent to the lesion core was comparable in both genotypes (p > 0.05). Genotype had no effect on TBI-induced IgG leakage into the perilesional cortical parenchyma (p > 0.05). Contrary to our expectations, Plau/Plaur double-deficiency did not aggravate TBI-related structural outcome.	[Kyyriainen, Jenni; Tapiala, Jesse; Lipponen, Anssi; Ndode-Ekane, Xavier Ekolle; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi		Tapiala, Jesse/0000-0003-3338-7152; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632; Lipponen, Anssi/0000-0002-4403-9084	Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909, 2285733-9]; Instrumentarium Foundation; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science; Epilepsy Foundation	We thank Mr. Jarmo Hartikainen and Mrs. Merja Lukkari for their excellent technical assistance. We also thank the UEF Cell and Tissue Imaging Unit for guidance and equipment service. This study was supported by the Medical Research Council of the Academy of Finland (Grants 272249, 273909, and 2285733-9) (A.P.), Instrumentarium Foundation, Finnish Cultural Foundation and Epilepsy Foundation.	Anwer M, 2019, NEUROSCIENCE, V415, P184, DOI 10.1016/j.neuroscience.2019.07.040; Balsara RD, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-10; Bolkvadze T, 2016, EPILEPSY BEHAV, V60, P187, DOI 10.1016/j.yebeh.2016.04.038; Bolkvadze T, 2015, EPILEPSY BEHAV, V51, P19, DOI 10.1016/j.yebeh.2015.06.037; BUGGE TH, 1995, J BIOL CHEM, V270, P16886, DOI 10.1074/jbc.270.28.16886; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Ciszek R, 2020, NEUROINFORMATICS, V18, P307, DOI 10.1007/s12021-019-09444-9; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Eden G, 2011, CURR PHARM DESIGN, V17, P1874, DOI 10.2174/138161211796718215; Franklin K., 2007, MOUSE BRAIN STEREOTA, VThird; Fuhrman B, 2009, CARDIOVASC RES, V84, P145, DOI 10.1093/cvr/cvp184; Garbelli R, 2015, NEUROSCIENCE, V306, P18, DOI 10.1016/j.neuroscience.2015.07.090; George N, 2018, J NEUROSCI RES, V96, P573, DOI 10.1002/jnr.24151; Gupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017123; Kataoka K, 2000, BRAIN RES, V887, P187, DOI 10.1016/S0006-8993(00)03042-0; Kiyan J, 2005, EMBO J, V24, P1787, DOI 10.1038/sj.emboj.7600669; Kiyan Y, 2012, ARTERIOSCL THROM VAS, V32, P110, DOI 10.1161/ATVBAHA.111.234369; Kyyriainen J, 2019, EPILEPSY RES, V151, P67, DOI 10.1016/j.eplepsyres.2019.02.009; Kyyriainen J, 2017, GLIA, V65, P322, DOI 10.1002/glia.23094; Lahtinen L, 2010, NEUROBIOL DIS, V37, P692, DOI 10.1016/j.nbd.2009.12.008; Malla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013731; Marcos-Contreras OA, 2016, BLOOD, V128, P2423, DOI 10.1182/blood-2016-03-705384; Milesi S, 2014, NEUROBIOL DIS, V71, P151, DOI 10.1016/j.nbd.2014.07.010; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; Nagai N, 2008, NEUROSCI LETT, V432, P46, DOI 10.1016/j.neulet.2007.12.004; Nagai N, 2010, BRAIN RES, V1322, P109, DOI 10.1016/j.brainres.2010.01.077; Ndode-Ekane XE, 2013, MOL NEUROBIOL, V47, P914, DOI 10.1007/s12035-012-8386-2; Niego B, 2014, J CEREBR BLOOD F MET, V34, P1283, DOI 10.1038/jcbfm.2014.99; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Reeves C., 2019, NEUROPATHOL APPL NEU; Sashindranath M., 2012, BRAIN 11, V135; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Tan Q, 2017, J NEUROSURG, V126, P548, DOI 10.3171/2016.1.JNS152287; Wu F, 2014, J NEUROSCI, V34, P14219, DOI 10.1523/JNEUROSCI.5309-13.2014	34	2	2	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 11	2020	729								134935	10.1016/j.neulet.2020.134935			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LR2RT	WOS:000535543600003	32360936				2022-02-06	
J	Walton, SR; Malin, SK; Kranz, S; Broshek, DK; Hertel, J; Resch, JE				Walton, Samuel R.; Malin, Steven K.; Kranz, Sibylle; Broshek, Donna K.; Hertel, Jay; Resch, Jacob E.			Whole-Body Metabolism, Carbohydrate Utilization, and Caloric Energy Balance After Sport Concussion: A Pilot Study	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; pathophysiology; metabolism; energy expenditure; energy balance	BRAIN INJURY; HEAD-INJURY; VALIDITY; LACTATE; RELIABILITY; STATEMENT; INDEXES; GLUCOSE; OXYGEN	Background: Sport concussion (SC) causes an energy crisis in the brain by increasing energy demand, decreasing energy supply, and altering metabolic resources. Whole-body resting metabolic rate (RMR) is elevated after more severe brain injuries, but RMR changes are unknown after SC. The purpose of this study was to longitudinally examine energy-related changes in collegiate athletes after SC. Hypothesis: RMR and energy consumption will increase acutely after SC and will return to control levels with recovery. Study Design: Case-control study. Methods: A total of 20 collegiate athletes with SC (mean age, 19.3 +/- 1.08 years; mean height, 1.77 +/- 0.11 m; mean weight, 79.6 +/- 23.37 kg; 55% female) were compared with 20 matched controls (mean age, 20.8 +/- 2.17 years; mean height, 1.77 +/- 0.10 m; mean weight, 81.9 +/- 23.45 kg; 55% female). RMR, percentage carbohydrate use (%CHO), and energy balance (EBal; ratio between caloric consumption and expenditure) were assessed 3 times: T-1, <= 72 hours after SC; T-2, 7 days after T-1; and T-F, after symptom resolution. A 2 x 2 x 3 (group x sex x time) multivariate analysis of variance assessed RMR, %CHO, and EBal. Changes in RMR, %CHO, and EBal (T(1)to T-F) were correlated with days to symptom-free and days to return to play in the concussed group. Results: Women reported being symptom-free (median, 6 days; range, 3-10 days) sooner than men (median, 11 days; range, 7-16 days). RMR and %CHO did not differ across time between groups or for group x sex interaction. SC participants had higher EBal than controls at T-1(P= 0.016) and T-2(P= 0.010). In men with SC, increasing %CHO over time correlated with days to symptom-free (r= 0.735 andP= 0.038, respectively) and days to return to play (r= 0.829 andP= 0.021, respectively). Conclusion: Participants with SC were in energy surplus acutely after injury. Although women recovered more quickly than men, men had carbohydrate metabolism changes that correlated with recovery time.	[Walton, Samuel R.; Malin, Steven K.; Kranz, Sibylle; Hertel, Jay; Resch, Jacob E.] Univ Virginia, Dept Kinesiol, 210 Emmet St South, Charlottesville, VA 22904 USA; [Walton, Samuel R.] Univ N Carolina, Ctr Study Retired Athletes, Chapel Hill, NC 27515 USA; [Walton, Samuel R.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Broshek, Donna K.] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA		Walton, SR (corresponding author), Univ Virginia, Dept Kinesiol, 210 Emmet St South, Charlottesville, VA 22904 USA.	swaltonatc@gmail.com	Kranz, Sibylle/G-1728-2017; Broshek, Donna/ABA-4208-2021	Kranz, Sibylle/0000-0001-5637-1706; Broshek, Donna/0000-0002-7175-7815; Walton, Samuel/0000-0003-2647-5701			Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Borsheim E, 2003, SPORTS MED, V33, P1037; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Brooks GA., 2005, EXERCISE PHYSL HUMAN, V4th ed; Capling L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121313; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; Cohen J., 2013, STAT POWER ANAL BEHA; Cooper JA, 2009, J AM DIET ASSOC, V109, P128, DOI 10.1016/j.jada.2008.10.004; Cramer H., 1946, MATH METHODS STAT; Fokkema T, 2017, MED SCI SPORT EXER, V49, P793, DOI 10.1249/MSS.0000000000001146; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P19, DOI 10.1007/BF00735865; Heyward VH, 2010, ADV FITNESS ASSESSME, V6th, P231; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kuo CC, 2005, J APPL PHYSIOL, V99, P349, DOI 10.1152/japplphysiol.00997.2004; MAGISTRETTI PJ, 2008, FUNDAMENTAL NEUROSCI, P271; Magkos F, 2003, CURR OPIN CLIN NUTR, V6, P539, DOI 10.1097/00075197-200309000-00007; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471; MOORE R, 1989, J TRAUMA, V29, P1633, DOI 10.1097/00005373-198912000-00007; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; RUDERMAN NB, 1974, BIOCHEM J, V138, P1; Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634; Teixeira V, 2018, NUTR DIET, V75, P219, DOI 10.1111/1747-0080.12401; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	33	2	2	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JUL	2020	12	4					382	389	1941738120923869	10.1177/1941738120923869		JUN 2020	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ME5JO	WOS:000539861100001	32520660	Green Published			2022-02-06	
J	da Silva, NM; Cowie, CJA; Blamire, AM; Forsyth, R; Taylor, PN				Moreira da Silva, Nadia; Cowie, Christopher J. A.; Blamire, Andrew M.; Forsyth, Rob; Taylor, Peter Neal			Investigating Brain Network Changes and Their Association With Cognitive Recovery After Traumatic Brain Injury: A Longitudinal Analysis	FRONTIERS IN NEUROLOGY			English	Article						TBI; longitudinal; graph theoretical analysis; network; structural connectivity	CONNECTIVITY; DYSFUNCTION; TASK	Traumatic brain injury (TBI) can result in acute cognitive deficits and diffuse axonal injury reflected in white matter brain network alterations, which may, or may not, later recover. Our objective is to first characterize the ways in which brain networks change after TBI and, second, investigate if those changes are associated with recovery of cognitive deficits. We aim to make initial progress in discerning the relationships between brain network changes, and their (dys)functional correlates. We analyze longitudinally acquired MRI from 23 TBI patients (two time points: 6 days, 12 months post-injury) and cross-sectional data from 28 controls to construct white matter brain networks. Cognitive assessment was also performed. Graph theory and regression analysis were applied to identify changed brain network metrics after injury that are associated with subsequent improvements in cognitive function. Sixteen brain network metrics were found to be discriminative of different post-injury phases. Eleven of those explain 90% (adjustedR(2)) of the variability observed in cognitive recovery following TBI. Brain network metrics that had a high contribution to the explained variance were found in frontal and temporal cortex, additional to the anterior cingulate cortex. Our preliminary study suggests that network reorganization may be related to recovery of impaired cognitive function in the first year after a TBI.	[Moreira da Silva, Nadia; Taylor, Peter Neal] Newcastle Univ, Sch Comp, Interdisciplinary Complex Syst Grp, CNNP Lab, Newcastle Upon Tyne, Tyne & Wear, England; [Cowie, Christopher J. A.] Newcastle Univ, Inst Neurosci, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Cowie, Christopher J. A.] Newcastle upon Tyne Hosp NHS Fdn Trust, Dept Neurosurg, Newcastle Upon Tyne, Tyne & Wear, England; [Blamire, Andrew M.; Forsyth, Rob] Newcastle Univ, Newcastle MR Ctr, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England		Taylor, PN (corresponding author), Newcastle Univ, Sch Comp, Interdisciplinary Complex Syst Grp, CNNP Lab, Newcastle Upon Tyne, Tyne & Wear, England.	peter.taylor@newcastle.ac.uk	Blamire, Andrew/AAU-6100-2021; Taylor, Peter/E-8927-2011	Taylor, Peter/0000-0003-2144-9838; Blamire, Andrew/0000-0002-8749-1257; Cowie, Christopher/0000-0003-0439-2278	Sir Jules Thorn Biomedical Research Award [SJT/05]; Wellcome TrustWellcome TrustEuropean Commission [105617/Z/14/Z]	Patient recruitment and acquisition of all MRI scan and experimental data were funded by a Sir Jules Thorn Biomedical Research Award (AMB), SJT/05. PT was funded by Wellcome Trust (105617/Z/14/Z).	Aerts H, 2016, BRAIN, V139, P3063, DOI 10.1093/brain/aww194; Aribisala BS, 2014, J COMPUT ASSIST TOMO, V38, P915, DOI 10.1097/RCT.0000000000000143; Bader-El-Den M, 2012, LECT NOTES COMPUT SC, V7664, P506, DOI 10.1007/978-3-642-34481-7_62; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Barik Kasturi, 2019, Brain Inform, V6, P2, DOI 10.1186/s40708-019-0094-5; Bubb EJ, 2018, NEUROSCI BIOBEHAV R, V92, P104, DOI 10.1016/j.neubiorev.2018.05.008; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Coughhlan AK, 2007, BIRT MEMORY INFORM P; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Elderkin-Thompson V, 2009, INT J GERIATR PSYCH, V24, P459, DOI 10.1002/gps.2137; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; Hubert M, 2009, COMPUT STAT DATA AN, V53, P2264, DOI 10.1016/j.csda.2008.05.027; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kim V, 2017, THESIS, P401; Kramer J.H., 2001, DELIS KAPLAN EXECUTI, DOI [10.1037/t15082-000., DOI 10.1037/T15082-000]; Kuceyeski A, 2011, NEUROIMAGE, V58, P109, DOI 10.1016/j.neuroimage.2011.05.087; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Leisman G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00016; Mai J.K., 2011, HUMAN NERVOUS SYSTEM, V3rd; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Messer D, 2016, BRIT J EDUC PSYCHOL, V86, P412, DOI 10.1111/bjep.12115; Nakai Toshiharu, 2005, Magn Reson Med Sci, V4, P75, DOI 10.2463/mrms.4.75; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Peng K, 2018, PROG NEUROBIOL, V161, P1, DOI 10.1016/j.pneurobio.2017.11.004; Rigon J, 2017, RESTOR NEUROL NEUROS, V35, P115, DOI 10.3233/RNN-150538; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shallice T, 2008, CORTEX, V44, P794, DOI 10.1016/j.cortex.2007.04.002; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Solem RC, 2015, AM J ORTHOD DENTOFAC, V148, P205, DOI 10.1016/j.ajodo.2015.05.006; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; Taylor PN, 2020, NEUROLOGY, V94, pE1021, DOI [10.1212/WNL.0000000000009053, 10.1212/WNL.0000000000008902]; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; Thedchanamoorthy G, 2014, PROCEDIA COMPUT SCI, V29, P2449, DOI 10.1016/j.procs.2014.05.229; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xu JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep18883; Yeh FC, 2018, NEUROIMAGE, V178, P57, DOI 10.1016/j.neuroimage.2018.05.027; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	47	2	2	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 9	2020	11								369	10.3389/fneur.2020.00369			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MD3EB	WOS:000543853400001	32581989	Green Published, gold			2022-02-06	
J	Kowalczyk, CL; Eagle, SR; Holland, CL; Collins, MW; Kontos, AP				Kowalczyk, Claire L.; Eagle, Shawn R.; Holland, Cyndi L.; Collins, Michael W.; Kontos, Anthony P.			Average symptom severity and related predictors of prolonged recovery in pediatric patients with concussion	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article; Early Access						Concussion; mild traumatic brain injury; symptom burden; early intervention	SPORT-RELATED CONCUSSION; REST; SOMATIZATION; DURATION; OUTCOMES; CHILDREN	The purpose of this study is to compare the predictive utility of total number of individual symptoms endorsed, total symptom severity, and average symptom severity on prolonged recovery among children/adolescents with a concussion. Patients (n = 115) completed the Post-Concussion Symptom Scale (PCSS) at their initial clinical visit (7.9 +/- 6.6 days) days post-injury. PCSS outcomes were total symptom severity (i.e., total PCSS score), number of symptoms endorsed (i.e., number out of 22-items on the PCSS with a symptom score >0) and average symptom severity (i.e., mean of scores for each of the 22-items on the PCSS, not just endorsed symptoms). Logistic regression was performed with all symptom measures and recovery time >30 days as the binary outcome. Logistic regression indicated that average symptom severity (OR = 1.9; p = 0.01) and later time to first clinical visit (OR = 5.0;p < 0.001) were the only significant predictors of recovery time. Average symptom severity at initial clinic visit and earlier clinical visit may be a better predictor of recovery time than total number of symptoms endorsed or total symptom severity among children and adolescents.	[Kowalczyk, Claire L.; Eagle, Shawn R.; Holland, Cyndi L.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, UPMC Freddie Fu Sports Med Ctr Concuss Program, Pittsburgh, PA USA		Kontos, AP (corresponding author), Univ Pittsburgh, UPMC Freddie Fu Sports Med Ctr Concuss Program, Sch Med, Dept Orthopaed Surg, 3850 S Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu	Eagle, Shawn/ABG-1388-2020	Eagle, Shawn/0000-0001-6767-1042			Bayen E, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00320; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Domschke K, 2010, CLIN PSYCHOL REV, V30, P1, DOI 10.1016/j.cpr.2009.08.008; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Faul M, 2010, TRAUMATIC BRAIN INJU; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; McCrory P., 2017, 5 INT C CONC SPORT B; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	26	2	2	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child												10.1080/21622965.2020.1774376		JUN 2020	5	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	ME2HY	WOS:000544481600001	32515244				2022-02-06	
J	Hoffman, H; Bunch, KM; Protas, M; Chin, LS				Hoffman, Haydn; Bunch, Katherine M.; Protas, Matthew; Chin, Lawrence S.			The Effect of Timing of Intracranial Pressure Monitor Placement in Patients with Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Brain injuries; Traumatic; Intracranial pressure; Neurosurgery	SEVERE HEAD-INJURY; IMPACT	Background/Objective Intracranial pressure (ICP) monitor placement is indicated for patients with severe traumatic brain injury (sTBI) to minimize secondary brain injury. There is little evidence to guide the optimal timing of ICP monitor placement. Methods A retrospective cohort study using the National Trauma Data Bank (NTDB) from 2013 to 2017 was performed. The NTDB was queried to identify patients with sTBI who underwent external ventricular drain or intraparenchymal ICP monitor placement. Propensity score matching was used to create matched pairs of patients who underwent early compared to late ICP monitor placement using 6-h and 12-h cutoffs. The outcomes of interest were in-hospital mortality, non-routine discharge disposition, total length of stay (LOS), intensive care unit (ICU) LOS, and number of days mechanically ventilated. Results A total of 5057 patients with sTBI were included in the study. In-hospital mortality for patients with early compared to late ICP monitor placement was 33.6% and 30.4%, respectively (p = 0.049). The incidence of non-routine disposition was 92.6% in the within 6 h group and 94.4% in the late placement group (p = 0.037). Hospital LOS, ICU LOS, and number of days mechanically ventilated were significantly greater in the late ICP monitoring group. Similar results were seen when using a 12-h cutoff for late ICP monitor placement. In the Cox proportional hazards model, craniotomy (HR 1.097, 95% CI 1.037-1.160) and isolated intracranial injury (HR 1.128, 95% CI 1.055-1.207) were associated with early ICP monitor placement. Hypotension was negatively associated with early ICP monitor placement (HR 0.801, 95% CI 0.725-0.884). Conclusion Despite a statistically marginal association between mortality and early ICP monitor placement, most outcomes were superior when ICP monitors were placed within 6 or 12 h of arrival. This may be due to earlier identification and treatment of intracranial hypertension.	[Hoffman, Haydn; Bunch, Katherine M.; Protas, Matthew; Chin, Lawrence S.] SUNY Upstate Med Univ, Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA		Hoffman, H (corresponding author), SUNY Upstate Med Univ, Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA.	hoffmanh@upstate.edu		Hoffman, Haydn/0000-0002-2967-6528			Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balakrishnan B, 2018, PEDIATR NEUROSURG, V53, P379, DOI 10.1159/000494028; BORN JD, 1984, NEUROCHIRURGIE, V30, P329; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Davidson GH, 2012, J TRAUMA ACUTE CARE, V73, P162, DOI 10.1097/TA.0b013e31825699b4; FALCAO ALE, 1995, ARQ NEURO-PSIQUIAT, V53, P390, DOI 10.1590/S0004-282X1995000300004; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; MacLaughlin BW, 2015, AM J SURG, V210, P1082, DOI 10.1016/j.amjsurg.2015.08.007; Majdan M, 2014, MINERVA ANESTESIOL, V80, P1261; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Zhang K, 2016, BRIT J NEUROSURG, V30, P251, DOI 10.3109/02688697.2016.1139052	20	2	2	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2021	34	1					167	174		10.1007/s12028-020-01002-5		JUN 2020	8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QT6MJ	WOS:000538237100001	32504255				2022-02-06	
J	Kook, JH; Vaughn, KA; DeMaster, DM; Ewing-Cobbs, L; Vannucci, M				Kook, Jeong Hwan; Vaughn, Kelly A.; DeMaster, Dana M.; Ewing-Cobbs, Linda; Vannucci, Marina			BVAR-Connect: A Variational Bayes Approach to Multi-Subject Vector Autoregressive Models for Inference on Brain Connectivity Networks	NEUROINFORMATICS			English	Article						Bayesian hierarchical models; Multi-Modal imaging; Resting-state fMRI; Variable selection; Variational inference; Autoregressive models	VARIABLE-SELECTION; GRANGER CAUSALITY; FMRI; TIME; MRI; MOVEMENT; IMPACT; INJURY	In this paper we propose BVAR-connect, a variational inference approach to a Bayesian multi-subject vector autoregressive (VAR) model for inference on effective brain connectivity based on resting-state functional MRI data. The modeling framework uses a Bayesian variable selection approach that flexibly integrates multi-modal data, in particular structural diffusion tensor imaging (DTI) data, into the prior construction. The variational inference approach we develop allows scalability of the methods and results in the ability to estimate subject- and group-level brain connectivity networks over whole-brain parcellations of the data. We provide a brief description of a user-friendly MATLAB GUI released for public use. We assess performance on simulated data, where we show that the proposed inference method can achieve comparable accuracy to the sampling-based Markov Chain Monte Carlo approach but at a much lower computational cost. We also address the case of subject groups with imbalanced sample sizes. Finally, we illustrate the methods on resting-state functional MRI and structural DTI data on children with a history of traumatic injury.	[Kook, Jeong Hwan; Vannucci, Marina] Rice Univ, Dept Stat, Houston, TX 77005 USA; [Vaughn, Kelly A.; DeMaster, Dana M.; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Dept Pediat, Houston, TX 77030 USA		Kook, JH; Vannucci, M (corresponding author), Rice Univ, Dept Stat, Houston, TX 77005 USA.	eric.jeong.kook@gmail.com; marina@rice.edu			National Science FoundationNational Science Foundation (NSF) [NSF/SES 1659925]; Hamill Innovation Award, Rice University; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS046308]	Funding/support for this research was provided by (1) National Science Foundation NSF/SES 1659925 (MV); (2) Hamill Innovation Award, Rice University (MV and DDM); (3) National Institutes of Health R01 NS046308 (LEC).	Andersson JLR, 2016, NEUROIMAGE, V141, P556, DOI 10.1016/j.neuroimage.2016.06.058; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2015, NEUROIMAGE, V122, P166, DOI 10.1016/j.neuroimage.2015.07.067; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Banerjee S, 2003, MONOGRAPHS STAT APPL; Beal M. J., 2003, THESIS; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bishop C.M., ABS13013838 CORR; Bishop CM., 2006, PATTERN RECOGN; Blei DM, 2017, J AM STAT ASSOC, V112, P859, DOI 10.1080/01621459.2017.1285773; Brown PJ, 1998, J R STAT SOC B, V60, P627, DOI 10.1111/1467-9868.00144; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Chiang S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190220; Chiang S, 2017, HUM BRAIN MAPP, V38, P1311, DOI 10.1002/hbm.23456; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deshpande G, 2009, HUM BRAIN MAPP, V30, P1361, DOI 10.1002/hbm.20606; Ewing-Cobbs L, 2019, J NEUROTRAUM, V36, P1738, DOI 10.1089/neu.2018.6071; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Flandin G, 2007, NEUROIMAGE, V34, P1108, DOI 10.1016/j.neuroimage.2006.10.005; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; George EI, 1997, STAT SINICA, V7, P339; Ghosh S, 2011, ARTIFACT DETECTION T, V7, P11; Goelman G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111554; Gorrostieta C, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00159; Gorrostieta C, 2012, NEUROIMAGE, V59, P3347, DOI 10.1016/j.neuroimage.2011.08.115; Graham MS, 2016, NEUROIMAGE, V125, P1079, DOI 10.1016/j.neuroimage.2015.11.006; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Henson R, 2001, NEUROIMAGE, V13, pS149; Higgins IA, 2018, NEUROIMAGE, V181, P263, DOI 10.1016/j.neuroimage.2018.07.015; Kang H, 2017, BRAIN CONNECT, V7, P219, DOI 10.1089/brain.2016.0447; Kook JH, 2019, STAT BIOSCI, V11, P3, DOI 10.1007/s12561-017-9205-0; Li JN, 2008, NEUROIMAGE, V41, P398, DOI 10.1016/j.neuroimage.2008.01.068; Mcintosh A., 1994, HUM BRAIN MAPP, V2, P2, DOI DOI 10.1002/HBM.460020104; Penny W, 2003, NEUROIMAGE, V19, P727, DOI 10.1016/S1053-8119(03)00071-5; Polson NG, 2013, J AM STAT ASSOC, V108, P1339, DOI 10.1080/01621459.2013.829001; Rajapakse JC, 2007, NEUROIMAGE, V37, P749, DOI 10.1016/j.neuroimage.2007.06.003; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Ryali S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005138; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scott JG, 2010, ANN STAT, V38, P2587, DOI 10.1214/10-AOS792; TEASDALE G, 1974, LANCET, V2, P81; Titsias M.K., 2011, SPIKE SLAB VARIATION, V24; Warnick R, 2018, J AM STAT ASSOC, V113, P134, DOI 10.1080/01621459.2017.1379404; Watson CG, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101673; Wen XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067428; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Woolrich MW, 2004, NEUROIMAGE, V21, P1748, DOI 10.1016/j.neuroimage.2003.12.024; Yu Z, 2016, J AM STAT ASSOC, V111, P549, DOI 10.1080/01621459.2015.1133425; Zhang LL, 2016, ANN APPL STAT, V10, P638, DOI 10.1214/16-AOAS926	54	2	2	3	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1539-2791	1559-0089		NEUROINFORMATICS	Neuroinformatics	JAN	2021	19	1					39	56		10.1007/s12021-020-09472-w		JUN 2020	18	Computer Science, Interdisciplinary Applications; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Neurosciences & Neurology	PO2EA	WOS:000538217700001	32504259	Green Submitted			2022-02-06	
J	Bradley, SE; Haun, JL; Powell-Cope, G; Haire, S; Belanger, HG				Bradley, Sarah E.; Haun, Jolie; Powell-Cope, Gail; Haire, Sharon; Belanger, Heather G.			Qualitative assessment of the use of a smart phone application to manage post-concussion symptoms in Veterans with traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; concussion; mental health; service members; Veterans; mobile health; smartphone apps	MINOR HEAD-INJURY; LIFE SATISFACTION; MILD; CARE; STIGMA	Purpose As part of a larger study to test the efficacy of the Concussion Coach cell phone application for patients with post-concussion symptoms, qualitative data were gathered to assess barriers and facilitators for app use and differences in use of the app among those who declined or improved in symptom severity, or were low-use users. Materials and Methods Using a prospective descriptive study design, 35 semi-structured qualitative interviews were conducted between 2016-2018. Participants had a history of mild traumatic brain injury and were symptomatic. Interview data were analyzed using qualitative content analysis. Results Primary facilitators were the app's ease of use, privacy, availability/portability, and increased self-efficacy of the user. Primary barriers were a lack of sufficient app training, stigma, overly "basic" content, and symptom severity. While there were not prominent differences among user groups, users whose symptom severity improved described using more modules of the app than users who declined. Low-users attributed not using the app to content that was too basic or to their forgetting. Conclusion Interview data suggest that Concussion Coach can benefit Veterans with post-concussive symptoms through increased agency, perceived benefits to emotional well-being, and the availability of non-stigmatized strategies for symptom management.	[Bradley, Sarah E.; Haun, Jolie; Powell-Cope, Gail; Haire, Sharon] James A Haley Vet Hosp, Res Serv, Tampa, FL 33612 USA; [Haun, Jolie] Univ S Florida, Coll Publ Hlth, Tampa, FL 33620 USA; [Belanger, Heather G.] US Special Operat Command, Def & Vet Brain Injury Ctr DVBIC, Tampa, FL USA; [Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Belanger, Heather G.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA		Bradley, SE (corresponding author), James A Haley Vet Hosp & Clin, Res Serv, 8900 Grand Oaks Circle 151R, Tampa, FL 33637 USA.	sarah.bradley5@va.gov		Bradley, Sarah/0000-0003-0233-5851	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs [MDA 905-03-2-0003]; U.S. Department of DefenseUnited States Department of Defense	This work was supported by the Defense and Veterans Brain Injury Center [MDA 905-03-2-0003]; U.S. Department of Defense.	Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; BOHNEN N, 1992, INT J NEUROSCI, V64, P97, DOI 10.3109/00207459209000536; Boulding W, 2011, AM J MANAG CARE, V17, P41; Boulos MNK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-24; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan PW, 2002, CLIN PSYCHOL-SCI PR, V9, P35, DOI 10.1093/clipsy/9.1.35; Darkins A, 2008, TELEMED J E-HEALTH, V14, P1118, DOI 10.1089/tmj.2008.0021; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Giota K. G., 2014, E HLTH TELECOMMUNICA, V03, P19, DOI [10.4236/etsn.2014.33003, DOI 10.4236/ETSN.2014.33003]; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; Kuhn E, 2014, MIL MED, V179, P12, DOI 10.7205/MILMED-D-13-00271; Kwan V, 2019, J HEAD TRAUMA REHAB, V34, pE45, DOI 10.1097/HTR.0000000000000425; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Manary MP, 2013, NEW ENGL J MED, V368, P201, DOI 10.1056/NEJMp1211775; Matthews M, 2008, HDB RES USER INTERFA, P635, DOI DOI 10.4018/978-1-59904-871-0.CH038; Miles M., 2020, QUALITATIVE DATA ANA, V4th ed.; Mittal D, 2013, PSYCHIATR REHABIL J, V36, P86, DOI 10.1037/h0094976; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Peake JM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00743; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Torous J, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.2994; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Yen CF, 2009, DEPRESS ANXIETY, V26, P1033, DOI 10.1002/da.20413	30	2	2	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 2	2020	34	8					1031	1038		10.1080/02699052.2020.1771770		JUN 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MK8SK	WOS:000542788900001	32493066				2022-02-06	
J	Alkhamis, F; Nazish, S				Alkhamis, Fahad; Nazish, Saima			Electroencephalographic Grading of Neuronal Dysfunction in Various Etiologies of Encephalopathy	CLINICAL EEG AND NEUROSCIENCE			English	Article						electroencephalography; encephalopathy; etiology; grading	CARDIAC-ARREST; EEG; PROGNOSIS; PROGNOSTICATION; PREDICTION; INJURY; RISK; COMA	Objective: The objective of this work was to study the electroencephalographic (EEG) grading of neuronal dysfunction in encephalopathy of various etiologies and assess their association with clinical outcomes. Subjects and Methods: This retrospective cross-sectional study was performed between June and November 2018 at the Neurology Department of King Fahd Hospital of University, Kingdom of Saudi Arabia (KSA) and involved a review and analysis of EEG and medical records pertaining to 222 patients in whom encephalopathy was diagnosed. Results: In patients suffering from encephalopathy, advanced age (P = .01), low Glasgow Coma Scale (GCS) scores (P = .00), and certain etiologies, namely hypoxic-ischemic encephalopathy (HIE) (P = .00), septic encephalopathy (P = .01), and other illnesses (P = .00), were significantly associated with unfavorable clinical outcomes, whereas traumatic brain injury (TBI) (P = .01) and GCS >7 (P = .00) were associated with favorable outcomes. Among different etiologies, EEG grade I (P = .02) and grade IV (P = .04) neuronal dysfunction was significantly associated with TBI while grade III (P = .05) and grade V (P = .02) neuronal dysfunction was significantly associated with HIE. Grade I (P = .03) neuronal dysfunction was mostly observed in septic encephalopathy cases, while patients suffering from other illnesses were also found to have grade I (P = .04) and grade IV (P = .05) neuronal dysfunction based on their EEG. Conclusion: EEG is being conducted routinely to determine the course and severity of various forms of encephalopathy. However, the clinical implications of EEG grading for neuronal dysfunction are largely dependent on underlying etiology and other clinical parameters, such as age and GCS score. Further larger prospective cohort studies involving other important prognostic parameters and continuous EEG monitoring are thus needed.	[Alkhamis, Fahad; Nazish, Saima] Imam Abdulrahman Bin Faisal Univ, Dept Neurol, Coll Med, Dammam, Saudi Arabia		Nazish, S (corresponding author), Imam Abdulrahman Bin Faisal Univ, Dept Neurol, King Fahd Hosp Univ, Dammam 31952, Saudi Arabia.	snmohammadali@iau.edu.sa	nazish, saima/E-8004-2017	nazish, saima/0000-0003-4301-8836			Martinez JA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001599; Berkhoff M, 2000, CLIN NEUROPHYSIOL, V111, P297, DOI 10.1016/S1388-2457(99)00246-1; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Cloostermans MC, 2012, CRIT CARE MED, V40, P2867, DOI 10.1097/CCM.0b013e31825b94f0; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; Faigle R, 2013, J CLIN NEUROPHYSIOL, V30, P505, DOI 10.1097/WNP.0b013e3182a73db9; Ganai S, 2007, ARCH SURG-CHICAGO, V142, P1072, DOI 10.1001/archsurg.142.11.1072; Gujjar AR, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.06.009; Harmon LA, 2013, J AM OSTEOPATH ASSOC, V113, P891, DOI 10.7556/jaoa.2013.067; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Iacobone Emanuele, 2009, Crit Care Med, V37, pS331, DOI 10.1097/CCM.0b013e3181b6ed58; Kanich W, 2002, AM J EMERG MED, V20, P613, DOI 10.1053/ajem.2002.35464; Kaplan PW, 2011, J CLIN NEUROPHYSIOL, V28, P233, DOI 10.1097/WNP.0b013e31821c33a0; Kaplan PW, 2000, CLIN NEUROPHYSIOL, V111, P584, DOI 10.1016/S1388-2457(99)00303-X; Kaplan PW, 1999, CLIN NEUROPHYSIOL, V110, P205, DOI 10.1016/S1388-2457(98)00046-7; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Nazish S, 2021, CLIN EEG NEUROSCI, V52, P280, DOI 10.1177/1550059420910559; Oddo M, 2011, CURR OPIN CRIT CARE, V17, P254, DOI 10.1097/MCC.0b013e328344f2ae; RIVIEREZ M, 1991, ACTA NEUROCHIR, V110, P17, DOI 10.1007/BF01402042; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rossetti AO, 2012, NEUROLOGY, V78, P796, DOI 10.1212/WNL.0b013e318249f6bb; Sandroni C, 2015, CURR OPIN CRIT CARE, V21, P209, DOI 10.1097/MCC.0000000000000202; Sivaraju A, 2015, INTENS CARE MED, V41, P1264, DOI 10.1007/s00134-015-3834-x; Thenayan EAL, 2010, J CRIT CARE, V25, P300, DOI 10.1016/j.jcrc.2009.06.049; Watson PL, 2008, CRIT CARE MED, V36, P3171, DOI 10.1097/CCM.0b013e318186b9ce; Westhall E, 2016, NEUROLOGY, V86, P1482, DOI 10.1212/WNL.0000000000002462; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Young GB, 1997, CAN J NEUROL SCI, V24, P320, DOI 10.1017/S0317167100032996; YOUNG GB, 1992, J CLIN NEUROPHYSIOL, V9, P145, DOI 10.1097/00004691-199201000-00016; Ziai WC, 2012, CLIN NEUROPHYSIOL, V123, P910, DOI 10.1016/j.clinph.2011.07.053	32	2	2	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1550-0594	2169-5202		CLIN EEG NEUROSCI	Clin. EEG Neurosci.	NOV	2020	51	6					420	425	1550059420925962	10.1177/1550059420925962		JUN 2020	6	Clinical Neurology; Neurosciences; Neuroimaging; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	NF0WL	WOS:000538495600001	32483980				2022-02-06	
J	Szu, JI; Patel, DD; Chaturvedi, S; Lovelace, JW; Binder, DK				Szu, Jenny I.; Patel, Dillon D.; Chaturvedi, Som; Lovelace, Jonathan W.; Binder, Devin K.			Modulation of posttraumatic epileptogenesis in aquaporin-4 knockout mice	EPILEPSIA			English	Article						aquaporin-4; electrographic seizure duration; electrographic seizure threshold; posttraumatic epilepsy; power spectral density; spontaneous recurring seizures	CONTROLLED CORTICAL IMPACT; SEIZURE SUSCEPTIBILITY; BRAIN-INJURY; HEAD-INJURY; WATER; EPILEPSY; MODEL; HIPPOCAMPUS; PHENOTYPE; SEQUELAE	Objective To determine the role of aquaporin-4 (AQP4) in posttraumatic epileptogenesis using long-term video-electroencephalographic (vEEG) recordings. Here, differences in EEG were analyzed between wild-type (WT) and AQP4 knockout (KO) mice and between mice with and without posttraumatic epilepsy (PTE). Methods WT and AQP4 KO mice were subjected to a single controlled cortical impact traumatic brain injury (TBI) in the frontal cortex, and vEEG was recorded in the ipsilateral hippocampus at 14, 30, 60, and 90 days postinjury (dpi). Intrahippocampal electrical stimulation was also used to assess electrographic seizure threshold and electrographic seizure duration (ESD). Results The mean seizure frequency per day for WT mice was 0.07 +/- 0.07, 0.11 +/- 0.07, 0.26 +/- 0.13, and 0.12 +/- 0.10 at 14, 30, 60, and 90 dpi, respectively. The mean seizure frequency per day for AQP4 KO mice was 0.45 +/- 0.27, 0.29 +/- 0.12, and 0.26 +/- 0.19 at 14, 30, and 60 dpi, respectively. The mean seizure duration was 15 +/- 2 seconds and 24 +/- 3 seconds for WT and AQP4 KO mice, respectively. The percentage of mice that developed PTE were 28% and 37% for WT and AQP4 KO mice, respectively. Power spectral density (PSD) analysis revealed alterations in EEG frequency bands between sham and TBI in both genotypes. Additionally, PSD analysis of spontaneous recurrent seizures revealed alterations in delta power between genotypes. Morlet wavelet analysis detected heterogeneity in EEG seizure subtypes and dynamic EEG power patterns after TBI. Compared with AQP4 KO mice, a significant increase in ESD was observed in WT mice at 14 dpi. Significance Posttraumatic seizures (PTSs) may be modulated by the astrocyte water channel AQP4. Absence of AQP4 increases the number of spontaneous seizures, increases seizure duration, and alters EEG power patterns of PTSs.	[Szu, Jenny I.; Patel, Dillon D.; Chaturvedi, Som; Lovelace, Jonathan W.; Binder, Devin K.] Univ Calif Riverside, Div Biomed Sci, Ctr Glial Neuronal Interact, Sch Med, Riverside, CA 92521 USA		Binder, DK (corresponding author), Univ Calif Riverside, Div Biomed Sci, Sch Med, 1247 Webber Hall, Riverside, CA 92521 USA.	dbinder@ucr.edu					Alvestad S, 2013, EPILEPSY RES, V105, P30, DOI 10.1016/j.eplepsyres.2013.01.006; Ben-Ari Y, 2001, EPILEPSIA, V42, P5, DOI 10.1046/j.1528-1157.2001.042suppl.3005.x; Binder DK, 2012, GLIA, V60, P1203, DOI 10.1002/glia.22317; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; Eid T, 2005, P NATL ACAD SCI USA, V102, P1193, DOI 10.1073/pnas.0409308102; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Kim JE, 2009, NEUROSCIENCE, V163, P781, DOI 10.1016/j.neuroscience.2009.07.028; Kim JE, 2010, J COMP NEUROL, V518, P4612, DOI 10.1002/cne.22482; Lapato AS, 2017, NEUROSCIENCE, V346, P409, DOI 10.1016/j.neuroscience.2017.01.035; Lee DJ, 2012, EXP NEUROL, V235, P246, DOI 10.1016/j.expneurol.2012.02.002; Lee TS, 2004, ACTA NEUROPATHOL, V108, P493, DOI 10.1007/s00401-004-0910-7; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Paxinos G, 2001, MOUSE BRAIN ATLAS ST; Pijet B, 2018, MOL NEUROBIOL, V55, P9294, DOI 10.1007/s12035-018-1061-5; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; PohlmannEden B, 1997, ACTA NEUROL SCAND, V95, P257, DOI 10.1111/j.1600-0404.1997.tb00206.x; Reid IC, 1997, SEIZURE, V6, P351, DOI 10.1016/S1059-1311(97)80034-9; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Skucas VA, 2011, J NEUROSCI, V31, P6392, DOI 10.1523/JNEUROSCI.6249-10.2011; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Szu JI, 2020, NEUROSCIENCE, V428, P140, DOI 10.1016/j.neuroscience.2019.12.006; Szu JI, 2016, FRONT INTEGR NEUROSC, V10, DOI 10.3389/fnint.2016.00008; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Watrous AJ, 2011, J NEUROPHYSIOL, V105, P1747, DOI 10.1152/jn.00921.2010; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675	45	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	JUL	2020	61	7					1503	1514		10.1111/epi.16551		JUN 2020	12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP1BJ	WOS:000536970700001	32484924				2022-02-06	
J	Ahmari, M; Sharafi, A; Mahmoudi, J; Jafari-Anarkoli, I; Gharbavi, M; Hosseini, MJ				Ahmari, Mahroo; Sharafi, Ali; Mahmoudi, Javad; Jafari-Anarkoli, Iraj; Gharbavi, Mahmoud; Hosseini, Mir-Jamal			Selegiline (l-Deprenyl) Mitigated Oxidative Stress, Cognitive Abnormalities, and Histopathological Change in Rats: Alternative Therapy in Transient Global Ischemia	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Behavioral abnormality; Transient global ischemia; Oxidative stress; Selegiline	CEREBRAL-ISCHEMIA; STROKE; SURVIVAL; SYSTEM; SAFETY; POWER	Selegiline (l-deprenyl) is the major drug which is used in the treatment of Parkinson's disease because of its neurotrophic and antiapoptotic properties. Previous studies suggested that low dose of L-methamphetamine (L-METH) caused lower mortality rate in patients with severe traumatic brain injury. As L-methamphetamine is one of the metabolites of selegiline, the present study aims to examine whether l-deprenyl can improve cognitive, biochemical, and histopathological injury in animal model of transient global ischemia. The animals were randomized in ten groups orally gavaged three times a week for 28 days. Then, novel object recognition (NOR) was conducted to assess their behavioral abnormality. After scarification of the rats, their brains were divided into two sections to measure oxidative stress parameters and perform pathological evaluations in rats. Our data revealed the involvement of oxidative stress, behavioral despair, and pathological data in transient global ischemia rats. Significant recovery in cognitive behavior, oxidative stress biomarker, and number of dead cell in histopathological assay was observed in rats treated with 1,2 and 4 mg/kg of selegiline. So, selegiline appears to be useful in alternative therapy of transient global ischemia.	[Ahmari, Mahroo; Sharafi, Ali; Hosseini, Mir-Jamal] Zanjan Univ Med Sci, Zanjan Appl Pharmacol Res Ctr, Zanjan, Iran; [Ahmari, Mahroo; Hosseini, Mir-Jamal] Zanjan Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, POB 45139-56184, Zanjan, Iran; [Sharafi, Ali; Gharbavi, Mahmoud] Zanjan Univ Med Sci, Zanjan Pharmaceut Biotechnol Res Ctr, Zanjan, Iran; [Mahmoudi, Javad] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran; [Jafari-Anarkoli, Iraj] Zanjan Univ Med Sci, Sch Med, Dept Anat Sci, Zanjan, Iran		Hosseini, MJ (corresponding author), Zanjan Univ Med Sci, Zanjan Appl Pharmacol Res Ctr, Zanjan, Iran.; Hosseini, MJ (corresponding author), Zanjan Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, POB 45139-56184, Zanjan, Iran.	jamal_hossini@yahoo.com	Sharafi, Ali/M-5884-2016; Hosseini, Mir-Jamal/M-5912-2016	Sharafi, Ali/0000-0002-6012-1424; Hosseini, Mir-Jamal/0000-0001-6300-7398	Zanjan University of Medical Sciences [A-12-769-24]	This work was supported by the deputy of research of Zanjan University of Medical Sciences (Grant NO: A-12-769-24).	Amiri S, 2017, NEUROSCIENCE, V340, P373, DOI 10.1016/j.neuroscience.2016.11.003; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Arteaga O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142424; Bartolo M, 2015, J NEUROL SCI, V349, P117, DOI 10.1016/j.jns.2014.12.039; Benzie IFF, 1999, J AGR FOOD CHEM, V47, P633, DOI 10.1021/jf9807768; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Chaudhary N, 2011, POSTGRAD MED J, V87, P714, DOI 10.1136/pgmj.2010.105171; Cheng-Ching E, 2012, NEUROLOGY, V79, pS68, DOI 10.1212/WNL.0b013e3182695871; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; de Farias CC, 2014, BRAZ J PHARM SCI, V50, P819, DOI 10.1590/S1984-82502014000400017; Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007; Ebadi M, 2002, J NEUROSCI RES, V67, P285, DOI 10.1002/jnr.10148; Ebadi M, 1998, RECENT ADV NEURODEGE, P256; Engelter ST, 2013, EUR J PHYS REHAB MED, V49, P261; Goverdhan P, 2012, INT J ALZHEIMERS DIS, V2012; Hachinski V, 2002, STROKE, V33, P1; Heikal TM., 2012, INT J PHARM PHARM SC, V4, P603; HEINONEN EH, 1994, CLIN PHARMACOL THER, V56, P742, DOI 10.1038/clpt.1994.204; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Okouchi M, 2009, CURR NEUROVASC RES, V6, P267, DOI 10.2174/156720209789630348; Pourahmad J, 2011, PESTIC BIOCHEM PHYS, V99, P105, DOI 10.1016/j.pestbp.2010.11.006; Puurunen K, 2001, EXP NEUROL, V167, P348, DOI 10.1006/exnr.2000.7563; Rau TF, 2014, EXP NEUROL, V253, P31, DOI 10.1016/j.expneurol.2013.12.001; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Robinson DS, 2008, J AFFECT DISORDERS, V105, P15, DOI 10.1016/j.jad.2007.04.024; Simon L, 2005, LIFE SCI, V78, P225, DOI 10.1016/j.lfs.2005.04.078; Song J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/426069; Takahashi K, 2010, BIOL PHARM BULL, V33, P556, DOI 10.1248/bpb.33.556; Takahata K, 2006, J NEURAL TRANSM, V113, P151, DOI 10.1007/s00702-005-0309-1; Takahata K, 2003, EUR J PHARMACOL, V458, P81, DOI 10.1016/S0014-2999(02)02729-2; Tuhrim S, 2002, MT SINAI J MED, V69, P121; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; Wasan H, 2019, J NEUROL SCI, V405, DOI 10.1016/j.jns.2019.10.713; Yagi K, 1981, J APPL BIOCHEM, V3, P58; Zeng XZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151620	38	2	2	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	OCT	2020	70	10					1639	1648		10.1007/s12031-020-01544-5		JUN 2020	10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	NN9HK	WOS:000537377700001	32488846				2022-02-06	
J	Aquilani, R; Costa, A; Maestri, R; Ramusino, MC; Pierobon, A; Dossena, M; Solerte, SB; Condino, AM; Torlaschi, V; Bini, P; Boselli, M; Ceroni, M; Buonocore, D; Boschi, F; Bruni, M; Verri, M				Aquilani, Roberto; Costa, Alfredo; Maestri, Roberto; Ramusino, Matteo Cotta; Pierobon, Antonia; Dossena, Maurizia; Solerte, Sebastiano Bruno; Condino, Anna Maria; Torlaschi, Valeria; Bini, Paola; Boselli, Mirella; Ceroni, Mauro; Buonocore, Daniela; Boschi, Federica; Bruni, Mariella; Verri, Manuela			Mini Nutritional Assessment May Identify a Dual Pattern of Perturbed Plasma Amino Acids in Patients with Alzheimer's Disease: A Window to Metabolic and Physical Rehabilitation?	NUTRIENTS			English	Article						Alzheimer's disease; plasma amino acids; nutritional state; cognitive tests	BRANCHED-CHAIN AMINOTRANSFERASE; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; SKELETAL-MUSCLE; NEUROINFLAMMATION; PROGRESSION; ASSOCIATION; EXPRESSION; DIAGNOSIS	Conflicting results about alterations of plasma amino acid (AA) levels are reported in subjects with Alzheimer's disease (AD). The current study aimed to provide more homogeneous AA profiles and correlations between AAs and cognitive tests. Venous plasma AAs were measured in 54 fasting patients with AD (37 males, 17 females; 74.63 +/- 8.03 yrs; 3.2 +/- 1.9 yrs from symptom onset). Seventeen matched subjects without neurodegenerative symptoms (NNDS) served as a control group (C-NNDS). Patients were tested for short-term verbal memory and attention capacity and stratified for nutritional state (Mini Nutritional Assessment, MNA). Compared to C-NNDS, patients exhibited lower plasma levels of aspartic acid and taurine (p< 0.0001) and higher 3-methylhistidine (p< 0.0001), which were independent of patients' MNA. In comparison to normonourished AD, the patients at risk of and with malnutrition showed a tendency towards lower ratios of Essential AAs/Total AAs, Branched-chain AAs/Total AAs, and Branched-chain AAs/Essential AAs. Serine and histidine were positively correlated with verbal memory and attention capacity deficits, respectively. Total AAs negatively correlated with attention capacity deficits. Stratifying patients with AD for MNA may identify a dual pattern of altered AAs, one due to AD per se and the other linked to nutritional state. Significant correlations were observed between several AAs and cognitive tests.	[Aquilani, Roberto; Dossena, Maurizia; Buonocore, Daniela; Verri, Manuela] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, I-27100 Pavia, Italy; [Costa, Alfredo; Ramusino, Matteo Cotta; Bini, Paola] IRCCS Mondino Fdn, Ctr Cognit & Behav Disorders, I-27100 Pavia, Italy; [Costa, Alfredo; Ramusino, Matteo Cotta; Bini, Paola; Ceroni, Mauro] Univ Pavia, Dept Brain & Behav, I-27100 Pavia, Italy; [Maestri, Roberto] Ist Clin Sci Maugeri IRCCS, Dept Biomed Engn, Montescano Inst, I-27040 Montescano, PV, Italy; [Pierobon, Antonia; Torlaschi, Valeria] Ist Clin Sci Maugeri IRCCS, Montescano Inst, Psychol Unit, I-27040 Montescano, PV, Italy; [Solerte, Sebastiano Bruno] Univ Pavia, Dept Internal Med, I-27100 Pavia, Italy; [Condino, Anna Maria; Boschi, Federica] Univ Pavia, Dept Drug Sci, I-27100 Pavia, Italy; [Boselli, Mirella] Ist Clin Sci Maugeri IRCCS, Montescano Inst, Neurorehabil Unit, I-27040 Montescano, PV, Italy; [Ceroni, Mauro] IRCCS Mondino Fdn, Gen Neurol Unit, I-27100 Pavia, Italy; [Bruni, Mariella] Ist Clin Sci Maugeri IRCCS, Pavia Inst, Med Lab Serv, I-27100 Pavia, Italy		Verri, M (corresponding author), Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, I-27100 Pavia, Italy.	dottore.aquilani@gmail.com; alfredo.costa@mondino.it; roberto.maestri@icsmaugeri.it; matteo.cottaramusino@mondino.it; antonia.pierobon@icsmaugeri.it; maurizia.dossena@unipv.it; bruno.solerte@unipv.it; annamaria.condino@unipv.it; valeria.torlaschi@icsmaugeri.it; paola.bini@mondino.it; mirella.boselli@icsmaugeri.it; mauro.ceroni@unipv.it; daniela.buonocore@unipv.it; federica.boschi@unipv.it; mariella.bruni@icsmaugeri.it; manuela.verri@unipv.it	Torlaschi, Valeria/E-9095-2019; Pierobon, Antonia/AAA-2859-2021; Maestri, Roberto/J-8168-2016; pinna, gian domenico/ABI-7618-2020; Cotta Ramusino, Matteo/AAC-3849-2022; Costa, Alfredo/J-8366-2016; Maestri, Roberto/AAA-7585-2019	Torlaschi, Valeria/0000-0002-4534-3547; Pierobon, Antonia/0000-0002-4678-781X; Maestri, Roberto/0000-0002-2873-0430; pinna, gian domenico/0000-0001-7667-6662; Costa, Alfredo/0000-0001-7312-8011; Maestri, Roberto/0000-0002-2873-0430	Italian Ministry of Education, University and Research (MIUR), Dipartimenti di Eccellenza Program (2018-2022)-Dept. of Biology and Biotechnology "L. Spallanzani", University of PaviaMinistry of Education, Universities and Research (MIUR)	This research was supported by the Italian Ministry of Education, University and Research (MIUR), Dipartimenti di Eccellenza Program (2018-2022)-Dept. of Biology and Biotechnology "L. Spallanzani", University of Pavia (to R.A., M.D., D.B., M.V.)	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; [Anonymous], 1987, Ital J Neurol Sci, VSuppl 8, P1; Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Aquilani R, 2008, ARCH PHYS MED REHAB, V89, P1642, DOI 10.1016/j.apmr.2008.02.023; Aquilani R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112667; Aquilani R, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111251; Ardura-Fabregat A, 2017, CNS DRUGS, V31, P1057, DOI 10.1007/s40263-017-0483-3; AZUMA J, 1992, JPN CIRC J, V56, P95, DOI 10.1253/jcj.56.95; BARRIO JR, 1982, J MED CHEM, V25, P93, DOI 10.1021/jm00343a020; BASUN H, 1990, J NEURAL TRANSM-PARK, V2, P295, DOI 10.1007/BF02252924; Blomstrand E, 1997, ACTA PHYSIOL SCAND, V159, P41, DOI 10.1046/j.1365-201X.1997.547327000.x; BORNSTEIN RA, 1990, PSYCHIAT RES, V33, P301, DOI 10.1016/0165-1781(90)90046-8; Brito A, 2017, J NUTR, V147, P1839, DOI 10.3945/jn.117.248278; BURNS AH, 1978, AM J PHYSIOL, V235, pE461, DOI 10.1152/ajpendo.1978.235.5.E461; Burns JM, 2010, ARCH NEUROL-CHICAGO, V67, P428, DOI 10.1001/archneurol.2010.38; Calsolaro V, 2016, ALZHEIMERS DEMENT, V12, P719, DOI 10.1016/j.jalz.2016.02.010; Carubelli V, 2015, HEART FAIL REV, V20, P39, DOI 10.1007/s10741-014-9436-9; CERRA FB, 1985, JPEN-PARENTER ENTER, V9, P288, DOI 10.1177/0148607185009003288; CHAPLIN ER, 1976, J NEUROCHEM, V26, P701, DOI 10.1111/j.1471-4159.1976.tb04440.x; Chen ZC, 2013, PROG NEUROBIOL, V108, P21, DOI 10.1016/j.pneurobio.2013.06.004; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; COOPER AJL, 1987, PHYSIOL REV, V67, P440, DOI 10.1152/physrev.1987.67.2.440; Corso G, 2017, DEMENT GER COGN D EX, V7, P143, DOI 10.1159/000466688; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; Drabkova P, 2015, ADV CLIN EXP MED, V24, P447, DOI 10.17219/acem/29223; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; FERNSTROM JD, 1983, PHYSIOL REV, V63, P484, DOI 10.1152/physrev.1983.63.2.484; Ferris SH, 2003, ALZ DIS ASSOC DIS, V17, pS92, DOI 10.1097/00002093-200307003-00006; Fonteh AN, 2007, AMINO ACIDS, V32, P213, DOI 10.1007/s00726-006-0409-8; Garcia-Espinosa MA, 2007, J NEUROCHEM, V100, P1458, DOI 10.1111/j.1471-4159.2006.04332.x; Gijsman HJ, 2002, PSYCHOPHARMACOLOGY, V160, P192, DOI 10.1007/s00213-001-0970-5; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Giulietti A, 2016, CURR NEUROPHARMACOL, V14, P177, DOI 10.2174/1570159X13666150928155321; GRIMBLE RF, 1992, J NUTR, V122, P2066, DOI 10.1093/jn/122.11.2066; HALL TR, 1993, J BIOL CHEM, V268, P3092; HAMMER JA, 1981, BIOCHEM J, V198, P53, DOI 10.1042/bj1980053; HASSMEN P, 1994, NUTRITION, V10, P405; Hudd F, 2019, J ALZHEIMERS DIS, V67, P931, DOI 10.3233/JAD-180879; Hull J, 2015, J ALZHEIMERS DIS, V45, P891, DOI 10.3233/JAD-142970; HUTSON SM, 1992, J BIOL CHEM, V267, P15681; Ibanez C, 2012, ANAL CHEM, V84, P8532, DOI 10.1021/ac301243k; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; Jimenez-Jimenez FJ, 1998, J NEURAL TRANSM, V105, P269, DOI 10.1007/s007020050056; Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007; JORDAN MK, 1985, DEV MED CHILD NEUROL, V27, P33; Kadowaki M, 2003, J NUTR, V133, p2052S, DOI 10.1093/jn/133.6.2052S; Kaiser E, 2010, NEURODEGENER DIS, V7, P251, DOI 10.1159/000287953; Kuo YM, 2000, AM J PATHOL, V156, P797, DOI 10.1016/S0002-9440(10)64947-4; Lieth E, 2001, J NEUROCHEM, V76, P1712, DOI 10.1046/j.1471-4159.2001.00156.x; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Liu P, 2019, BRAIN BEHAV IMMUN, V80, P633, DOI 10.1016/j.bbi.2019.05.008; Liu Ying, 2014, Central Nervous System Agents in Medicinal Chemistry, V14, P113; Lu CD, 2018, AGING-US, V10, P3117, DOI 10.18632/aging.101615; Luo Y, 2014, CANCER RES, V74, P330, DOI 10.1158/0008-5472.CAN-13-1052; Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52; Madras BK, 2005, BIOL PSYCHIAT, V57, P1397, DOI 10.1016/j.biopsych.2004.10.011; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mittleman KD, 1998, MED SCI SPORT EXER, V30, P83, DOI 10.1097/00005768-199801000-00012; Morifuji M, 2010, J AGR FOOD CHEM, V58, P8788, DOI 10.1021/jf101912n; Mukhamedyarov MA, 2011, MUSCLE NERVE, V43, P872, DOI 10.1002/mus.22000; Nilsson LG, 2009, SCAND J PSYCHOL, V50, P660, DOI 10.1111/j.1467-9450.2009.00777.x; Olazaran J, 2015, J ALZHEIMERS DIS, V45, P1157, DOI 10.3233/JAD-142925; OLDENDORF WH, 1971, AM J PHYSIOL, V221, P1629, DOI 10.1152/ajplegacy.1971.221.6.1629; Ousset PJ, 2008, ALZ DIS ASSOC DIS, V22, P66, DOI 10.1097/WAD.0b013e31815a9dbb; Parnetti L, 2012, J ALZHEIMERS DIS, V29, P229, DOI 10.3233/JAD-2011-111349; Perissinotto E, 2002, BRIT J NUTR, V87, P177, DOI 10.1079/BJN2001487; Ravaglia G, 2004, AM J CLIN NUTR, V80, P483, DOI 10.1093/ajcn/80.2.483; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shoemark DK, 2015, J ALZHEIMERS DIS, V43, P725, DOI 10.3233/JAD-141170; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Solerte SB, 2004, AM J CARDIOL, V93, p23A, DOI 10.1016/i.amjcard.2003.11.006; Spencer SJ, 2017, NEUROBIOL AGING, V58, P88, DOI 10.1016/j.neurobiolaging.2017.06.014; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; Toledo JB, 2017, ALZHEIMERS DEMENT, V13, P965, DOI 10.1016/j.jalz.2017.01.020; Tynkkynen J, 2018, ALZHEIMERS DEMENT, V14, P723, DOI 10.1016/j.jalz.2018.01.003; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3; Verri M, 2012, INT J IMMUNOPATH PH, V25, P345, DOI 10.1177/039463201202500204; Verri M, 2018, INT J IMMUNOPATH PH, V32, DOI 10.1177/2058738418817707; Wilens TE, 2008, J CLIN PSYCHOPHARM, V28, pS46, DOI 10.1097/JCP.0b013e318173312f	80	2	2	7	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6643		NUTRIENTS	Nutrients	JUN	2020	12	6							1845	10.3390/nu12061845			18	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nutrition & Dietetics	ML1BZ	WOS:000549211700001	32575805	gold, Green Published			2022-02-06	
J	Burwinkel, JR; Xu, BY; Crukley, J				Burwinkel, Justin R.; Xu, Buye; Crukley, Jeff			Preliminary Examination of the Accuracy of a Fall Detection Device Embedded into Hearing Instruments	JOURNAL OF THE AMERICAN ACADEMY OF AUDIOLOGY			English	Article						accelerometry; accidental falls; activities of daily living; adult; hearing aids and assistive listening devices; motion	OLDER-ADULTS; RISK-FACTORS; PEOPLE; EPIDEMIOLOGY; PATIENT; INJURY; HEAD	Background Accidental falls are a significant health risk to older adults and patients seen in audiology clinics. Personal emergency response systems are effective in preventing long lies (defined as remaining on the floor or ground for greater than one hour after a fall), but some individuals would prefer to wear less-conspicuous devices than a traditional neck-worn pendant. No previous investigation has compared the accuracy of head-worn fall detection devices with those worn on other parts of the body. In this study, we compared the accuracy of one commonly used fall detection pendant with two variants of a new hearing instrument-based fall detection system. Purpose The purpose of the study was to evaluate the accuracy of detecting falls by using inertial sensors embedded in hearing instruments. Research Design A study with repeated measures for one group. Study Sample Ten young adults served as participants. All participants had normal or corrected-to-normal vision during testing. Individuals were excluded if they had self-reported cardiac disorders, recent concussions, or musculoskeletal conditions. Data Collection and Analysis Data were collected from inertial measurement unit (IMU) sensors, embedded into a binaural set of hearing instruments, during laboratory-based simulations of falls, near-falls, and activities of daily living (ADLs). The detection state of a fall detection pendant was simultaneously recorded during performance of each trial and compared with the outputs of offline hearing instrument firmware emulators. Results One hearing instrument-based fall detection system was more accurate than the fall detection pendant. A second hearing instrument-based fall detection system performed similar to the fall detection pendant. Each of the three fall detection systems investigated were robust against false-positive detections during ADLs. Conclusions Preliminary findings demonstrate that hearing instruments embedded with a fall detection device (FDD) may be a suitable alternative to more traditional forms of FDDs (e.g., pendant, wrist-worn device, etc.) for detecting falls and potentially preventing long lies.	[Burwinkel, Justin R.; Xu, Buye; Crukley, Jeff] Starkey Hearing Technol, Eden Prairie, MN 55344 USA		Burwinkel, JR (corresponding author), Starkey Hearing Technol, Eden Prairie, MN 55344 USA.	justin_burwinkel@starkey.com			Starkey Hearing Technologies	This study received financial support from Starkey Hearing Technologies.	Agmon M, 2017, J AM ACAD AUDIOL, V28, P575, DOI 10.3766/jaaa.16044; Aguiar B., 2014, P IEEE INT S MED MEA, DOI [10.1109/MeMeA.2014.6860110, DOI 10.1109/MEMEA.2014.6860110]; [Anonymous], 2018, DESIGNING TECHNOLOGY; [Anonymous], 2018, VERS 9 4; Aziz O, 2014, GAIT POSTURE, V39, P506, DOI 10.1016/j.gaitpost.2013.08.034; Bagala F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037062, 10.1371/journal.pone.0034473]; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Bourke AK, 2010, J BIOMECH, V43, P3051, DOI 10.1016/j.jbiomech.2010.07.005; Chaudhuri S, 2017, J APPL GERONTOL, V36, P915, DOI 10.1177/0733464815591211; Choi WJ, 2017, CLIN BIOMECH, V49, P28, DOI 10.1016/j.clinbiomech.2017.08.007; Choi WJ, 2015, J BIOMECH, V48, P911, DOI 10.1016/j.jbiomech.2015.02.025; Cola G, 2017, WIRELESS MOBILE COMM, V192, P217; Criter RE, 2016, INT J AUDIOL, V55, P564, DOI 10.1080/14992027.2016.1193235; Demiris G, 2008, INT J TECHNOL ASSESS, V24, P120, DOI 10.1017/S0266462307080154; Fleming J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2227; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Igual R, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-66; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Institute of Medicine (US) Division of Health Promotion and Disease Prevention, 1992, FALLS OLDER PERSONS, P263; Kangas M, 2012, GAIT POSTURE, V35, P500, DOI 10.1016/j.gaitpost.2011.11.016; Kim H, 2016, GERIATR GERONTOL INT, V16, P110, DOI 10.1111/ggi.12723; Li Y, 2010, IEEE ENG MED BIO, P2242, DOI 10.1109/IEMBS.2010.5627368; Lin FR, 2012, ARCH INTERN MED, V172, P369, DOI 10.1001/archinternmed.2011.728; Lindemann U, 2005, MED BIOL ENG COMPUT, V43, P548, DOI 10.1007/BF02351026; Lipsitz LA, 2016, J AM GERIATR SOC, V64, P365, DOI 10.1111/jgs.13708; Philips Lifeline, 2013, PHIL LIF AUTOALERT H; R Core Team, 2018, STATS PACK LANG ENV; Rauterkus EP, 2014, J AM ACAD AUDIOL, V25, P893, DOI 10.3766/jaaa.25.9.10; Revelle W.\, 2018, PSYCH PROCEDURES PSY; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Rougier C, 2007, 21ST INTERNATIONAL CONFERENCE ON ADVANCED NETWORKING AND APPLICATIONS WORKSHOPS/SYMPOSIA, VOL 2, PROCEEDINGS, P875, DOI 10.1109/ainaw.2007.181; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Teo DB, 2018, INTERN MED J, V48, P1048, DOI 10.1111/imj.13794; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65	35	2	3	0	1	AMER ACAD AUDIOLOGY	RESTON	11730 PLAZA DR, STE 300, RESTON, VA 20190 USA	1050-0545	2157-3107		J AM ACAD AUDIOL	J. Am. Acad. Audiol.	JUN	2020	31	6					393	403		10.3766/jaaa.19056			11	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Otorhinolaryngology	MV2FQ	WOS:000556178700004	31914373	Bronze			2022-02-06	
J	Christian-Brandt, AS; Santacrose, D				Christian-Brandt, Allison S.; Santacrose, Diana			Adapting PCIT to Address Mental Health Care Disparities Among Underserved Families Impacted by Pediatric Illness: A Case Series of Bedside PCIT	CLINICAL PRACTICE IN PEDIATRIC PSYCHOLOGY			English	Article						care disparities; pediatric health; pediatric illness; parent training; parent-child interaction therapy	CHILD INTERACTION THERAPY; TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; QUALITY-OF-LIFE; CLINICAL-SIGNIFICANCE; PARENTING BEHAVIORS; ETHNIC DISPARITIES; ADHERENCE; YOUTH; STRESS	Objective: Medically ill children are at elevated risk for mental health issues (Black-man, Gurka, Gurka, & Oliver, 2011), which can negatively affect health status (De-More, Adams, Wilson, & Hogan, 2005; Johnston & Martin-Herz, 2010). Given that children from diverse racial/ethnic backgrounds are disproportionately impacted by medical conditions (Mehta, Lee, & Ylitalo, 2013) and experience marked mental health care disparities (Marrast, Himmelstein, & Woolhandler, 2016), innovative interventions are necessary for meeting the needs of underserved families. Methods: The current study presents an adaptation of parent-child interaction therapy (PCIT) for medical settings that seeks to reduce barriers to care among underserved children with medical conditions and their families. We present outcomes from a case series of bedside PCIT among 5 low-socioeconomic status, medically ill children (3-6 years old; 2 Hispanic, 1 Black, 2 non-Hispanic White) exhibiting medical trauma and disruptive behavior. Main adaptations to standard PCIT included flexible setting delivery, psychoeducation on parenting a medically ill child, and modification of time-out based on child capacity. Results: All families completed treatment and demonstrated reliable and clinically meaningful change in child traumatic stress, child disruptive behavior, and parenting stress. Systematic behavioral observations also indicated improved parenting practices. Conclusions: Results suggest that PCIT can be adapted for medical settings and has the potential to address care disparities among diverse, low-socioeconomic status families impacted by pediatric medical illness. Continued research on bedside PCIT will further elucidate the feasibility and effectiveness of this adaptation, as compared with standard PCIT and typical behavioral health supports in medical settings.	[Christian-Brandt, Allison S.] Pacific Univ, Sch Grad Psychol, 190 Southeast 8th Ave,Suite 260, Hillsboro, OR 97123 USA; [Santacrose, Diana] Loyola Marymount Univ, Dept Psychol, Los Angeles, CA 90045 USA		Christian-Brandt, AS (corresponding author), Pacific Univ, Sch Grad Psychol, 190 Southeast 8th Ave,Suite 260, Hillsboro, OR 97123 USA.	ABrandt@pacificu.edu		Santacrose, Diana/0000-0002-1759-0727			Abidin R. R., 2012, PARENTING STRESS IND; Abrahamse M., 2018, HDB PARENT CHILD INT, P269, DOI [10.1007/978-3-319-97698-3_17, DOI 10.1007/978-3-319-97698-3_17]; Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Asarnow JR, 2015, JAMA PEDIATR, V169, P929, DOI 10.1001/jamapediatrics.2015.1141; Bagner DM, 2004, J CLIN PSYCHOL MED S, V11, P1, DOI 10.1023/B:JOCS.0000016264.02407.fd; Berkovits MD, 2010, BEHAV THER, V41, P375, DOI 10.1016/j.beth.2009.11.002; Berry JG, 2010, PEDIATRICS, V126, pS111, DOI 10.1542/peds.2010-1466D; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; BigFoot D. S., 2018, HDB PARENT CHILD INT, P235; Bitsko Rebecca H, 2016, MMWR Morb Mortal Wkly Rep, V65, P221, DOI 10.15585/mmwr.mm6509a1; Blackman JA, 2011, J PAEDIATR CHILD H, V47, P742, DOI 10.1111/j.1440-1754.2011.02044.x; Brabson L.A., 2018, HDB PARENT CHILD INT, P251, DOI [10.1007/978-3-030-03213-5_14, DOI 10.1007/978-3-030-03213-5_14]; Briere J., 2005, TRAUMA SYMPTOM CHECK; Chaffin M, 2004, CHILD YOUTH SERV REV, V26, P1097, DOI 10.1016/j.childyouth.2004.08.008; Christian- Brandt A., 2017, PAR CHILD INT THER I; Christian-Brandt A. S., 2019, BEDSIDE PCIT TREATME; Christian-Brandt A. S., 2018, HDB PARENT CHILD INT, P253, DOI [10.1007/978-3-319-97698-3_16, DOI 10.1007/978-3-319-97698-3_16]; Cohen DM, 2004, J PEDIATR PSYCHOL, V29, P171, DOI 10.1093/jpepsy/jsh019; Cohen ML, 2012, J PEDIATR PSYCHOL, V37, P251, DOI 10.1093/jpepsy/jsr086; Danko CM, 2016, CHILD YOUTH SERV REV, V60, P42, DOI 10.1016/j.childyouth.2015.11.007; DeMaso DR, 2004, AM J CARDIOL, V93, P582, DOI 10.1016/j.amjcard.2003.11.022; DeMore M, 2005, CHILD HEALTH CARE, V34, P245, DOI 10.1207/s15326888chc3404_1; Department of Health and Human Services, 2019, DHHS PUBL; Duke DC, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0532-y; Durkin K., 2019, MENTAL HLTH, V15, P878; Eyberg S. M., 2011, PARENT CHILD INTERAC; Eyberg S. M., 2013, DYADIC PARENT CHILD; Fernandez MA, 2011, CHILD FAM BEHAV THER, V33, P32, DOI 10.1080/07317107.2011.545011; Forgey M, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0340-5; Funderburk B.W., 2003, EARLY EDUC DEV, V14, DOI [10.1207/s15566935eed1401_5, DOI 10.1207/s15566935eed1401_5, DOI 10.1207/S15566935EED1401_5]; Garcia D., 2016, EVIDENCEBASED PRACTI, V1, P40, DOI [10.1080/23794925.2016.1191977, DOI 10.1080/23794925.2016.1191977]; Gerson AC, 2004, PEDIATR TRANSPLANT, V8, P543, DOI 10.1111/j.1399-3046.2004.00215.x; Jacobson NS, 1999, J CONSULT CLIN PSYCH, V67, P300, DOI 10.1037/0022-006X.67.3.300; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Johnston BD, 2010, PEDIATRICS, V125, P483, DOI 10.1542/peds.2009-1594; Kapke TL, 2016, CLIN CHILD FAM PSYCH, V19, P329, DOI 10.1007/s10567-016-0213-2; Kassam-Adams N., 2018, HDB PEDIAT PSYCHOL; Landolt MA, 2009, AUST NZ J PSYCHIAT, V43, P746, DOI 10.1080/00048670903001919; Lescano C. M., 2017, HDB PEDIAT PSYCHOL, P499; Lieneman CC, 2019, PSYCHOL RES BEHAV MA, V12, P543, DOI 10.2147/PRBM.S207370; Lieneman CC, 2017, PSYCHOL RES BEHAV MA, V10, P239, DOI 10.2147/PRBM.S91200; Loder, 2015, DISPARITIES CHILD AD; Marrast L, 2016, INT J HEALTH SERV, V46, P810, DOI 10.1177/0020731416662736; Mehta NK, 2013, SOC SCI MED, V95, P6, DOI 10.1016/j.socscimed.2012.09.011; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Miller LM, 2008, CHILD YOUTH CARE FOR, V37, P153, DOI 10.1007/s10566-008-9058-2; Morawska A, 2015, J CHILD HEALTH CARE, V19, P5, DOI 10.1177/1367493513496664; Newacheck PW, 2002, AMBUL PEDIATR, V2, P247, DOI 10.1367/1539-4409(2002)002<0247:RAEDIA>2.0.CO;2; O'Hara LK, 2013, J PEDIATR PSYCHOL, V38, P675, DOI 10.1093/jpepsy/jst007; Parent-Child Interaction Therapy International, 2019, REC DEV AD PAR CHILD; Pincus, 1999, EYBERG CHILD BEHAV I; Pinquart M, 2018, STRESS HEALTH, V34, P197, DOI 10.1002/smi.2780; Pinquart M, 2013, J PEDIATR PSYCHOL, V38, P708, DOI 10.1093/jpepsy/jst020; Pinquart M, 2011, J PEDIATR PSYCHOL, V36, P1003, DOI 10.1093/jpepsy/jsr042; Price JH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/787616; Radcliff Z, 2018, J PEDIATR PSYCHOL, V43, P185, DOI 10.1093/jpepsy/jsx107; Timmer SG, 2006, CHILD YOUTH SERV REV, V28, P1, DOI 10.1016/j.childyouth.2005.01.006; Tyler E.T., 2017, BEHAV HLTH INTEGRATI; U.S. Department of Health and Human Services, 2016, DHHS PUBL; van Dyck PC, 2004, ARCH PEDIAT ADOL MED, V158, P884, DOI 10.1001/archpedi.158.9.884	60	2	2	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	2169-4826	2169-4834		CLIN PRACT PEDIAT PS	Clin. Pract. Pediatr. Psychol.	JUN	2020	8	2			SI		164	175		10.1037/cpp0000322			12	Psychology, Clinical; Psychology, Developmental	Emerging Sources Citation Index (ESCI)	Psychology	RZ6SF	WOS:000648730700007					2022-02-06	
J	Ciarlone, SL; Statz, JK; Goodrich, JA; Norris, JN; Goforth, CW; Ahlers, ST; Tschiffely, AE				Ciarlone, Stephanie L.; Statz, Jonathan K.; Goodrich, Jessica A.; Norris, Jacob N.; Goforth, Carl W.; Ahlers, Stephen T.; Tschiffely, Anna E.			Neuroendocrine function and associated mental health outcomes following mild traumatic brain injury in OEF-deployed service members	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						concussion; military; neuroendocrine; pituitary; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; ANTERIOR-PITUITARY FUNCTION; LUTEINIZING-HORMONE SECRETION; LONGITUDINAL COURSE; TESTOSTERONE LEVELS; ACUTE-PHASE; SYMPTOMS; DYSFUNCTION; HYPOPITUITARISM; CORTISOL	Mild traumatic brain injury (mTBI) has been linked to mental health disorders (MHDs) and pituitary function alterations. Due to the complex relationship of mTBI, the neuroendocrine system, and MHDs, we propose that neuroendocrine dysfunction (NED) may play a role in negative long-term health outcomes. The goal of this study was to determine if blast-concussed service members (SMs) have a stronger likelihood of developing NED. We hypothesized that NED either pre- or post-injury is associated with poor mental and physical health outcomes. Serum samples from the Armed Forces Health Surveillance Branch were obtained from concussed (n = 59) and non-concussed (n = 72) SMs treated at the Concussion Restoration Care Center (CRCC) in Afghanistan. Serum was collected within 2 years prior to deployment and one or two times within 3 years following their CRCC visit. Samples were analyzed for luteinizing hormone (LH), testosterone, human growth hormone, cortisol, and prolactin to assess post-injury neuroendocrine function. Results indicate that SMs who incurred an mTBI exhibited long-term LH and testosterone deficiencies 3 years following injury compared to controls. Specifically, 47.6% of head-injured SMs displayed hypofunction in at least one of five hormones at 3 years post-injury. Anxiety disorders were the most common MHD observed in concussed SMs with hypopituitarism, while there was also a trend for SMs with chronic pituitary dysfunction to have MHD diagnoses. Findings indicate blast-related mTBI may be associated with long-term health outcomes following a period of incubation. Neuroendocrine screenings may increase treatment opportunities, inform rehabilitation strategies, and improve overall quality of life for patients.	[Ciarlone, Stephanie L.; Statz, Jonathan K.; Goodrich, Jessica A.; Goforth, Carl W.; Ahlers, Stephen T.; Tschiffely, Anna E.] Naval Med Res Ctr, Neurotrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Ciarlone, Stephanie L.; Statz, Jonathan K.; Goodrich, Jessica A.] Henry M Jackson Fdn Inc, Bethesda, MD USA; [Norris, Jacob N.] Space & Naval Warfare Syst Ctr Pacific, Cyber Sci & Technol Dept, San Diego, CA USA; [Goforth, Carl W.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Statz, JK (corresponding author), Naval Med Res Ctr, Neurotrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	jonathan.k.statz.ctr@mail.mil					Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agimi Y, 2019, MIL MED, V184, pE233, DOI 10.1093/milmed/usy313; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Benvenga S, 2019, PITUITARY, V22, P229, DOI 10.1007/s11102-019-00949-9; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Borrow AP, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12403; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Chavez-Castillo M, 2019, ADV PHARMACOL SCI, V2019, DOI 10.1155/2019/7943481; CHEUNG CY, 1983, ENDOCRINOLOGY, V113, P632, DOI 10.1210/endo-113-2-632; Delahanty DL, 2000, BIOL PSYCHIAT, V48, P940, DOI 10.1016/S0006-3223(00)00896-9; Dorn LD, 1997, J CLIN ENDOCR METAB, V82, P912, DOI 10.1210/jc.82.3.912; Grattan DR, 2007, ENDOCRINOLOGY, V148, P4344, DOI 10.1210/en.2007-0403; Greer N, 2016, PREVALENCE EPIDEMIOL; Guerrero AF, 2010, MIL MED, V175, P574, DOI 10.7205/MILMED-D-09-00189; Heinrichs M, 2005, AM J PSYCHIAT, V162, P2276, DOI 10.1176/appi.ajp.162.12.2276; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ioachimescu AG, 2015, PITUITARY, V18, P535, DOI 10.1007/s11102-014-0606-5; Karlovic D, 2012, NEUROPSYCHOBIOLOGY, V65, P90, DOI 10.1159/000329556; Kellner M, 2002, ACTA PSYCHIAT SCAND, V105, P153, DOI 10.1034/j.1600-0447.2002.01012.x; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Lehrner A, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23797; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Li SQ, 2004, AATCC REV, V4, P44; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Lu LH, 2019, NEUROREHABILITATION, V44, P511, DOI 10.3233/NRE-192702; Mac Donald CL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6676; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; MASON JW, 1990, J TRAUMA STRESS, V3, P449; Meewisse ML, 2007, BRIT J PSYCHIAT, V191, P387, DOI 10.1192/bjp.bp.106.024877; Morris MC, 2012, CLIN PSYCHOL REV, V32, P301, DOI 10.1016/j.cpr.2012.02.002; NCIPC, 2003, REP C MILD TRAUM BRA; NOEL GL, 1972, J CLIN ENDOCR METAB, V35, P840, DOI 10.1210/jcem-35-6-840; Pavlov V, 2019, BRAIN INJURY, V33, P1151, DOI 10.1080/02699052.2019.1629022; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Reijnen A, 2015, PSYCHONEUROENDOCRINO, V51, P525, DOI 10.1016/j.psyneuen.2014.07.017; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Simeon D, 2007, PSYCHONEUROENDOCRINO, V32, P1149, DOI 10.1016/j.psyneuen.2007.08.005; Spivak B, 2003, NEUROPSYCHOBIOLOGY, V47, P57, DOI 10.1159/000070009; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Theeler BJ, 2012, CURR TREAT OPTION NE, V14, P36, DOI 10.1007/s11940-011-0157-2; Undurti A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00072; van Aken MO, 2005, J CLIN ENDOCR METAB, V90, P3279, DOI 10.1210/jc.2004-1375; van Zuiden M, 2012, PSYCHONEUROENDOCRINO, V37, P1822, DOI 10.1016/j.psyneuen.2012.03.018; van Zuiden M, 2011, J PSYCHIATR RES, V45, P713, DOI 10.1016/j.jpsychires.2010.11.013; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Walsh K, 2013, PSYCHONEUROENDOCRINO, V38, P2520, DOI 10.1016/j.psyneuen.2013.05.017; West TA, 2014, J FAM PRACTICE, V63, P11; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Yehuda R, 2005, HANDB EXP PHARM, V169, P371; Zaben M, 2013, DISABIL REHABIL, V35, P522, DOI 10.3109/09638288.2012.697252	59	2	2	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2020	98	6					1174	1187		10.1002/jnr.24604			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LG8YQ	WOS:000528379600015	32157738				2022-02-06	
J	Clark, JM; Connor, TA; Post, A; Hoshizaki, TB; Annaidh, AN; Gilchrist, MD				Clark, J. Michio; Connor, Thomas A.; Post, Andrew; Hoshizaki, T. Blaine; Annaidh, Aisling Ni; Gilchrist, Michael D.			Could a Compliant Foam Anvil Characterize the Biofidelic Impact Response of Equestrian Helmets?	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						head injury; equestrian fall accidents; helmet certification	GREAT-BRITAIN; SUBDURAL-HEMATOMA; DYNAMIC-RESPONSE; INJURIES; HEAD; CONCUSSION; ACCELERATION; IRELAND; SPORT; RECONSTRUCTION	The performance of equestrian helmets to protect against brain injuries caused by fall impacts against compliant surfaces such as turf has not been studied widely. We characterize the kinematic response of simulated fall impacts to turf through field tests on horse racetracks and laboratory experiments. The kinematic response characteristics and ground stiffness at different going ratings (GRs) (standard measurement of racetrack condition) were obtained from 1 m and 2 m drop tests of an instrumented hemispherical impactor onto a turf racetrack. The "Hard" rating resulted in higher peak linear accelerations and stiffness, and shorter impact durations than the "Soft" and "Heavy" ratings. Insignificant differences were found among the other GRs, but a strong overall relationship was evident between the "going rating" and the kinematic response. This relationship was used to propose a series of three synthetic foam anvils as turf surrogates in equestrian falls corresponding to ranges of GRs of (i) heavy-soft (H-S), (ii) good-firm (G-F), and (iii) firm-hard (F-H). Laboratory experiments consisted of a helmeted headform being dropped onto natural turf and the turf surrogate anvils using a monorail drop rig. These experiments revealed that the magnitudes and durations of the linear and rotational accelerations for helmeted impacts to turf/turf surrogates were similar to those in concussive sports falls and collisions. Since the compliance of an impacted surface influences the dynamic response of a jockey's head during a fall impact against the ground, it is important that this is considered during both accident reconstructions and helmet certification tests.	[Clark, J. Michio; Connor, Thomas A.; Annaidh, Aisling Ni; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Connor, Thomas A.] Charles Owen & Co Ltd, Royal Works Croesfoel Ind Pk, Wrexham LL14 4BJ, Wales; [Post, Andrew] St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Sch Human Kinet, 200 Lees Ave, Ottawa, ON K1N 6N5, Canada		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.; Gilchrist, MD (corresponding author), Univ Ottawa, Sch Human Kinet, 200 Lees Ave, Ottawa, ON K1N 6N5, Canada.	michael.gilchrist@ucd.ie	Ni Annaidh, Aisling/ABF-8938-2021	Ni Annaidh, Aisling/0000-0002-9929-4541	European Union's Horizon 2020 research and innovation program under the Marie Skiodowska-Curie grant agreement [642662]	This research has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Skiodowska-Curie grant agreement No. 642662. The assistance of Peter Davis of UCD's School of Mechanical and Materials Engineering with equipment design and data collection is gratefully acknowledged.	Abu-Zidan FM, 2003, INJURY, V34, P897, DOI 10.1016/S0020-1383(03)00054-8; ASTM F1163-15, 2015, F116315 ASTM; Balendra G, 2007, BRIT J SPORT MED, V41, P162, DOI 10.1136/bjsm.2006.033894; BIXBYHAMMETT D, 1990, SPORTS MED, V9, P36, DOI 10.2165/00007256-199009010-00004; BOND GR, 1995, PEDIATRICS, V95, P487; Bourdet N., 2015, P IRCOBI C LYON FRAN, P9; Brighton J. L., 2004, Patent, Patent No. [US/2004/0079141A1, 20040079141]; BSI, 2011, HELM EQ US; Clark JM, 2019, SPORT BIOMECH, DOI 10.1080/14763141.2019.1599062; Clark JM, 2020, SPORT BIOMECH, V19, P510, DOI 10.1080/14763141.2018.1510975; Clark JM, 2017, COMPUT METHOD BIOMEC, V20, P1299, DOI 10.1080/10255842.2017.1341977; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Connor TA, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0193-0; Cui L, 2009, MATER DESIGN, V30, P3414, DOI 10.1016/j.matdes.2009.03.044; DABREU F, 1976, LANCET, V1, P1241; De Alvarenga V, 2019, J NEUROTRAUM, V36, pA4, DOI 10.1089/neu.2018.6143; EN, 2016, EN13842016 EN; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Fleming PRI, 2001, CLIN EXP OPHTHALMOL, V29, P208, DOI 10.1046/j.1442-9071.2001.00430.x; Forero Rueda M. A., 2007, P STARSS C LOUGHB UK; Gabbe BJ, 2005, BRIT J SPORT MED, V39, P573, DOI 10.1136/bjsm.2004.015750; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Gimbel GM, 2008, EUR J SPORT SCI, V8, P341, DOI 10.1080/17461390802438763; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hobbs Gregory D., 1994, Journal of Emergency Medicine, V12, P143, DOI 10.1016/0736-4679(94)90690-4; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Holland AJA, 2001, MED J AUSTRALIA, V175, P609, DOI 10.5694/j.1326-5377.2001.tb143746.x; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hubbard R., 1974, 741193 SAE, DOI [10.4271/741193, DOI 10.4271/741193]; Hutchinson TP, 2014, EUR J SPORT SCI, V14, pS377, DOI 10.1080/17461391.2012.705334; INGEMARSON H, 1989, J TRAUMA, V29, P25, DOI 10.1097/00005373-198901000-00005; Lim J, 2003, ANZ J SURG, V73, P567, DOI 10.1046/j.1445-2197.2003.02707.x; LINDSAY KW, 1980, BRIT MED J, V281, P789, DOI 10.1136/bmj.281.6243.789; McCrory P, 2006, BRIT J SPORT MED, V40, P614, DOI 10.1136/bjsm.2006.028449; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; MILLS NJ, 1989, INJURY, V20, P189, DOI 10.1016/0020-1383(89)90108-3; Newman J. A., 2000, P IRCOBI C MONTP FRA; Northey G, 2003, NZ MED J, V116, P1182; Oeur RA, 2019, INT J CRASHWORTHINES, V24, P326, DOI 10.1080/13588265.2018.1441617; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Petridou E, 2004, J TRAUMA, V56, P643, DOI 10.1097/01.TA.0000053470.38129.F4; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2017, J NEUROSURG-PEDIATR, V19, P641, DOI 10.3171/2016.11.PEDS16383; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; PRESS JM, 1995, CLIN J SPORT MED, V5, P236, DOI 10.1097/00042752-199510000-00005; Rousseau P, 2009, AM SOC TEST MATER, V1516, P152, DOI 10.1520/JAI101877; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Rueda MAF, 2009, MATER DESIGN, V30, P3405, DOI 10.1016/j.matdes.2009.03.037; Rueda MAF, 2010, INJURY, V41, P533, DOI 10.1016/j.injury.2009.05.009; Toma M, 2018, BRAIN INJURY, V32, P1576, DOI 10.1080/02699052.2018.1502470; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; van Den Bosch H. L. A., 2006, THESIS; Van Lierde C, 2005, THESIS; Waller AE, 2000, JAMA-J AM MED ASSOC, V283, P1326, DOI 10.1001/jama.283.10.1326; WILLINGER R, 1994, ACCIDENT ANAL PREV, V26, P767, DOI 10.1016/0001-4575(94)90053-1; Willinger R, 2001, INT J CRASHWORTHINES, V6, P281, DOI 10.1533/cras.2001.0178; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z	62	2	2	0	2	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	JUN 1	2020	142	6							061006	10.1115/1.4045403			9	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	LO8GA	WOS:000533863000004	31701123				2022-02-06	
J	Duan, AW; Zhou, MX; Qiu, JL; Feng, CJ; Yin, ZY; Li, K				Duan, Aowen; Zhou, Mingxia; Qiu, Jinlong; Feng, Chengjian; Yin, Zhiyong; Li, Kui			A 6-year survey of road traffic accidents in Southwest China: Emphasis on traumatic brain injury	JOURNAL OF SAFETY RESEARCH			English	Article						Traumatic brain injury; Road traffic accidents; Epidemiological survey; Injury risk	HEAD-INJURIES; PEDESTRIANS; PATTERN	Background: The objective of this study is to provide an up-to-date overview of the patterns of injuries, especially traumatic brain injury (TBI) caused by RTAs and to discuss some of the public health consequences. Methods: A scientific team was established to collect road traffic accidents occurring between 2013 and 2018 in Chongqing, Southwest China. For each accident, the environment-, vehicle-, and person- variables were analyzed and determined. The overall injury distribution and TBI patterns of four types of road users (driver, passenger, motorcyclist and pedestrian) were compared. The environmental and time distribution of accidents with TBI were shown by bar and pie chart. The risks of severe brain injury whether motorcyclist wearing helmets or not were compared and the risk factors of severe TBI in pedestrian were determined by odds ratio analysis. Results: This study enrolled 2131 accidents with 2741 persons of all kind of traffic participants, 1149 of them suffered AIS1+ head injury and 1598(58%) died in 7 days. The most common cause of deaths is due to head injury with 714(85%) and 1266(79%) persons died within 2 hours. Among 423 persons suffered both skull fracture and intracranial injury, 102 (24.1%) have an intracranial injury but no skull fractures, while none of the skull fractures without intracranial injury was found. Besides, motorcyclists without a helmet were at higher risks for all the brain injury categories. The risk of pedestrian suffering severe TBI at an impact speed of more than 70 km/h is 100 times higher than that with an impact speed of less than 40 km/h. Conclusion: It is urgently needed to develop a more reliable brain injury evaluation criterion for better protection of the road users. We believe that strengthening the emergency care to head injury at the scene is the most effective way to reduce traffic fatality. (C) 2020 National Safety Council and Elsevier Ltd. All rights reserved.	[Duan, Aowen; Zhou, Mingxia; Qiu, Jinlong; Yin, Zhiyong; Li, Kui] Army Med Univ, Daping Hosp, Inst Surg Res,Dept 4, Chongqing Key Lab Vehicle Crash Bioimpact & Traff, Chongqing, Peoples R China; [Duan, Aowen] Army Med Univ, Daping Hosp, Dept Med Engn, Chongqing, Peoples R China; [Feng, Chengjian] Peoples Liberat Army 958th Hosp, Dept Med Engn, Chongqing, Peoples R China		Yin, ZY; Li, K (corresponding author), Army Med Univ, Daping Hosp, Inst Surg Res,Dept 4, Chongqing Key Lab Vehicle Crash Bioimpact & Traff, Chongqing, Peoples R China.	yinzhiyong@caeri.com.cn; likui0708@126.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31800788]; National Key Research and Development Program of China [2016YFC0800702-3]	This work is financially supported by the National Nature Science Foundation of China (grant number: 31800788) and the National Key Research and Development Program of China (grant number: 2016YFC0800702-3). It is appreciated that the Institute of Surgery, Army Military University, Chongqing, China supply the data in this study.	Antona-Makoshi J, 2018, ACCIDENT ANAL PREV, V117, P98, DOI 10.1016/j.aap.2018.04.009; Bener Abdulbari, 2009, Int Emerg Nurs, V17, P52, DOI 10.1016/j.ienj.2008.07.007; Fahlstedt M, 2015, J BIOMECH, V48, P1331, DOI 10.1016/j.jbiomech.2015.02.057; Glasz A, 2017, TRANSP RES PROC, V24, P474, DOI 10.1016/j.trpro.2017.05.085; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; Hamdane H, 2016, INT J CRASHWORTHINES, V21, P51, DOI 10.1080/13588265.2015.1113618; Huang J, 2018, ACCIDENT ANAL PREV, V119, P91, DOI 10.1016/j.aap.2018.07.012; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A., 2018, HEAD INJURY RES COMP, P111, DOI [10.1007/9783-319-49792-1_4, DOI 10.1007/9783-319-49792-1_4]; Kong CY, 2010, ACCIDENT ANAL PREV, V42, P987, DOI 10.1016/j.aap.2009.11.006; Kumar A, 2008, INDIAN J NEUROTRAUM, V5, P63, DOI 10.1016/S0973-0508(08)80002-0; Liu B., 2009, COCHRANE DB SYST REV, V4, P1; Majdan M, 2013, EUR J PUBLIC HEALTH, V23, P682, DOI 10.1093/eurpub/cks074; Mangal Govind, 2017, J MED SCI CLIN RES, V05, P21115, DOI [10.18535/jmscr/v5i4.218, DOI 10.18535/JMSCR/V5I4.218]; Martin AJ, 2010, GERONTOLOGY, V56, P266, DOI 10.1159/000258052; Montoya D, 2018, INT J CRASHWORTHINES, V23, P497, DOI 10.1080/13588265.2017.1345602; Noh Y, 2018, TRAFFIC INJ PREV, V19, P874, DOI 10.1080/15389588.2018.1509209; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rochette LM, 2009, J SAFETY RES, V40, P353, DOI 10.1016/j.jsr.2009.08.003; Rosen E, 2011, ACCIDENT ANAL PREV, V43, P25, DOI 10.1016/j.aap.2010.04.003; Rosen E, 2009, ACCIDENT ANAL PREV, V41, P536, DOI 10.1016/j.aap.2009.02.002; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Santamarina-Rubio E, 2007, ACCIDENT ANAL PREV, V39, P1, DOI 10.1016/j.aap.2006.06.019; Shamim M, 2017, INDIAN J SURG, V79, P332, DOI 10.1007/s12262-017-1605-3; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Tantibundit P, 2016, INJURY PREV, V22, pA213, DOI 10.1136/injuryprev-2016-042156.595; Uttley J, 2017, ACCIDENT ANAL PREV, V108, P189, DOI 10.1016/j.aap.2017.09.005; Vargo J, 2015, MMWR-MORBID MORTAL W, V64, P837, DOI 10.15585/mmwr.mm6431a1; Wang F, 2011, J ASIAN NAT PROD RES, V13, P193, DOI 10.1080/10286020.2010.548808; World Health Organization, 2019, GLOB STAT REP ROAD S; Youssef MRL, 2015, J EGYPT PUBLIC HEAL, V90, P139, DOI 10.1097/01.EPX.0000473569.10092.e7; Yu YD, 2017, ECOL INDIC, V75, P27, DOI 10.1016/j.ecolind.2016.12.027; Zhang T, 2010, SAFETY SCI, V48, P640, DOI 10.1016/j.ssci.2010.01.013; Zhao FL, 2015, INT J VEHICLE SAF, V8, P180, DOI DOI 10.1504/IJVS.2015.068692; Zhao H, 2014, J FORENSIC LEG MED, V27, P76, DOI 10.1016/j.jflm.2014.08.003; Zhao H, 2013, TRAFFIC INJ PREV, V14, P712, DOI 10.1080/15389588.2012.752574; Zhao H, 2011, FORENSIC SCI INT, V207, P188, DOI 10.1016/j.forsciint.2010.10.003; Zhao W, 2017, ANN BIOMED ENG, V45, P2437, DOI 10.1007/s10439-017-1888-3	39	2	2	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	JUN	2020	73						161	169		10.1016/j.jsr.2020.02.010			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	MB4ZU	WOS:000542613300017	32563388				2022-02-06	
J	Ebrahimian, A; Tourdeh, M; Paknazar, F; Davari, H				Ebrahimian, Abbasali; Tourdeh, Maedeh; Paknazar, Fatemeh; Davari, Hossein			The Effect of the Open and Closed System Suctions on Pain Severity and Physiological Indicators in Mechanically Ventilated Patients with Traumatic Brain Injury: A Randomised Controlled Trial	TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION			English	Article						Close tracheal suction system; open tracheal suction system; pain; physiological indicators; traumatic brain injury	INTENSIVE-CARE-UNIT; OXYGEN-SATURATION; HEART-RATE; PRESSURE; VALIDATION; ADULT; TUBE	Objective: Tracheal suctioning can cause pain and physiological indicator variations in patients with traumatic brain injury (TBI). The aim of the present study was to compare pain severity and physiological indicator variations during the closed tracheal suction system (CTSS) and open tracheal suction system (OTSS) in patients with TBI. Methods: This study was a clinical trial. Samples included all ventilated patients with TBI. The patients were randomly divided into the OTSS and CTSS groups. In both groups, the Critical Care Pain Observation Tool (CPOT) and physiological indicators were recorded by three nurses prior to suctioning, the end of suctioning and 5 min after suction completion. Data were analysed using the independent t-test and repeated measurement tests. Results: A total of 112 patients participated in the present study. Before the interventions, the mean value of the Glasgow Coma Scale was 6.45 +/- 1.13, blood pressure 128.33 +/- 20.54, saturated oxygen in arterial blood (SpO(2)) 96.74 +/- 2.76, respiratory rate (RR) 15.06 +/- 3.98, end-tidal CO2 (EtCO2) 36.2 +/- 21.98, heart rate 82.18 +/- 42.33 and CPOT-based pain 0.43 +/- 0.94 in the patients. Independent t-test was used to compare CTSS and OTSS, suggesting significant differences with respect to the mean values of SpO(2), RR and EtCO2 immediately after suctioning. This test showed significant differences between the two groups with respect to pain intensity at all three points of measurement. The two groups were also found to be significantly different with respect to RR measured 5 min after suctioning (p<0.05). Conclusion: Compared to OTSS, CTSS can cause higher reductions in pain levels during and after suctioning in patients with head traumas and can also cause higher improvements in physiological indicators, such as RR, O-2 saturation and EtCO2.	[Ebrahimian, Abbasali] Semnan Univ Med Sci, Nursing Care Res Ctr, Semnan, Iran; [Tourdeh, Maedeh] Qom Univ Med Sci, Sch Paramed, Qom, Iran; [Paknazar, Fatemeh] Semnan Univ Med Sci, Social Determinants Hlth Res Ctr, Semnan, Iran; [Davari, Hossein] Semnan Univ Med Sci, Student Res Comm, Semnan, Iran		Davari, H (corresponding author), Semnan Univ Med Sci, Student Res Comm, Semnan, Iran.	hosseindavari30@yahoo.com	Ebrahimian, Abbasali/J-9348-2017; Paknazar, Fatemeh/AAZ-5041-2021	Ebrahimian, Abbasali/0000-0003-2665-0514; Paknazar, Fatemeh/0000-0001-8834-5078			Afshari A, 2014, NURS MIDWIFERY STUD, V3, DOI 10.17795/nmsjournal14097; Ayfer A, 2016, AM SOC PAIN MANAGEME, V15, P11; Chen HJ, 2015, PAIN MANAG NURS, V16, P105, DOI 10.1016/j.pmn.2014.05.012; Dastdadeh R., 2016, ANESTH PAIN MED, V6, DOI [10.5812/aapm.38337, DOI 10.5812/AAPM.38337]; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Gelinas C, 2007, CLIN J PAIN, V23, P497, DOI 10.1097/ajp.0b013e31806a23fb; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Javadi M, 2017, ANN TROP MED PUBLIC, V10, P1312, DOI [10.4103/atmph.atmph_181_17, 10.4103/ATMPH.ATMPH_181_17]; JINHEON JEONG, 2014, Acute and Critical Care, V29, P7, DOI 10.4266/kjccm.2014.29.1.7; John P.A, 2010, NEUROCRITICAL CARE G, P1; Jongerden IP, 2007, CRIT CARE MED, V35, P260, DOI 10.1097/01.CCM.0000251126.45980.E8; Jongerden IP, 2012, J CRIT CARE, V27, P647, DOI 10.1016/j.jcrc.2012.02.016; Juneja D, 2011, INDIAN J CRIT CARE M, V15, P168, DOI 10.4103/0972-5229.84902; Kuriyama A, 2015, INTENS CARE MED, V41, P402, DOI 10.1007/s00134-014-3565-4; Lasocki S, 2006, ANESTHESIOLOGY, V104, P39, DOI 10.1097/00000542-200601000-00008; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mohammadpour Ali, 2015, Iran J Nurs Midwifery Res, V20, P195; Pedersen Carsten M, 2009, Intensive Crit Care Nurs, V25, P21, DOI 10.1016/j.iccn.2008.05.004; Seguin P, 2018, INDIAN J CRIT CARE M, V22, P1, DOI 10.4103/ijccm.IJCCM_350_17; Stamenkovic DM, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00023; Subhash Mengar R., 2018, INT J NURS ED, V10, P109; Ugras GA, 2012, J NEUROSCI NURS, V44, pE1, DOI 10.1097/JNN.0b013e3182682f69	22	2	2	0	9	AVES	SISLI	BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY		2667-6370		TURK J ANAESTHESIOL	Turk. J. Anaesthesiol. Reanim.	JUN	2020	48	3					202	207		10.5152/TJAR.2019.03342			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	LV5MQ	WOS:000538479400005	32551447	Green Published			2022-02-06	
J	Ezer, T; Wright, MS; Fins, JJ				Ezer, Tamar; Wright, Megan S.; Fins, Joseph J.			The Neglect of Persons with Severe Brain Injury in the United States: An International Human Rights Analysis	HEALTH AND HUMAN RIGHTS			English	Article							MINIMALLY CONSCIOUS STATE; DISORDERS	Brain injury contributes more to death and disability globally than any other traumatic incident. While the past decade has seen significant medical advances, laws and policies remain stumbling blocks to treatment and care. The quality of life of persons with severe brain injury often declines with unnecessary institutionalization and inadequate access to rehabilitation and assistive technologies. This raises a host of rights violations that are hidden, given that persons with severe brain injury are generally invisible and marginalized. This article highlights the current neglect and experiences of persons with severe brain injury in the United States, analyzing the rights to life, health, benefit from scientific progress, education, freedom of expression, community, family, and equality.	[Ezer, Tamar] Univ Miami, Sch Law, Human Rights Clin, Law, Miami, FL 33146 USA; [Wright, Megan S.] Penn State Law, Law Med & Sociol, University Pk, PA USA; [Wright, Megan S.] Penn State Coll Med, Dept Humanities, Hershey, PA USA; [Wright, Megan S.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Wright, Megan S.] Weill Cornell Med Coll, Med Eth Med, New York, NY USA; [Fins, Joseph J.] Weill Cornell Med Coll, Med Eth, New York, NY USA; [Fins, Joseph J.] Weill Cornell Med Coll, Med, New York, NY USA; [Fins, Joseph J.] Weill Cornell Med Coll, Med Psychiat, New York, NY USA; [Fins, Joseph J.] Weill Cornell Med Coll, Med Eth Neurol, New York, NY USA; [Fins, Joseph J.] Weill Cornell Med Coll, Med Eth Rehabil Med, New York, NY USA; [Fins, Joseph J.] Weill Cornell Med Coll, Hlth Care Policy & Res, New York, NY USA; [Fins, Joseph J.] Weill Cornell Med Coll, Consortium Adv Study Brain Injury, New York, NY USA; [Fins, Joseph J.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Fins, Joseph J.] Yale Law Sch, Med Bioeth & Law, New Haven, CT USA		Ezer, T (corresponding author), Univ Miami, Sch Law, Human Rights Clin, Law, Miami, FL 33146 USA.			Fins, Joseph/0000-0002-7221-0053			Agaronnik ND, 2019, HEALTH AFFAIR, V38, P545, DOI 10.1377/hlthaff.2018.05060; [Anonymous], 2020, COMMUNICATION   0418; [Anonymous], 2011, WORLD REP DIS; Brainline, WHAT HAPP IMM INJ; Cullen N, 2007, J HEAD TRAUMA REHAB, V22, P214, DOI 10.1097/01.HTR.0000281836.54602.6d; Dewan M., 2018, J NEUROSURG, P2; Fins J. J., 2016, COMMUNICATION   1102; Fins J. J., 2006, PALLIAT SUPPORT CARE, V4, P170; Fins J. J., 2015, RIGHTS COME MIND BRA, P17; Fins J. J., 2016, AEON            0510; Fins JJ, 2015, OXFORD TXB PALLIATIV, P285; Fins JJ, 2019, PLUM POSNERS DIAGNOS, P449; Fins JJ, 2017, NY TIMES; Fins JJ, 2017, AJOB NEUROSCI, V8, P131; Fins JJ, 2007, ARCH NEUROL-CHICAGO, V64, P1400, DOI 10.1001/archneur.64.10.1400; Fins JJ, 2007, AM J BIOETHICS, V7, P51, DOI 10.1080/15265160601064231; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Fins JJ, 2019, HASTINGS CENT REP, V49, P14, DOI 10.1002/hast.1030; Fins JJ, 2018, BRAIN INJURY, V32, P670, DOI 10.1080/02699052.2018.1430377; Fins JJ, 2016, J LAW MED ETHICS, V44, P182, DOI 10.1177/1073110516644209; Fins JJ, 2010, NEUROMODULATION, V13, P153, DOI 10.1111/j.1525-1403.2009.00238.x; Giacino J. T., 2014, NATURE REV NEUROLOGY, P10; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1699, DOI 10.1016/j.apmr.2018.07.001; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Kalmar K., 2007, ARCH PHYS MED REHAB, V85, P454; Leuthardt E. C., 2014, SCIENTIST; Mukherjee P, 2006, NEUROIMAG CLIN N AM, V16, P19, DOI 10.1016/j.nic.2005.11.004; National Association of Real Estate Investment Trusts, 1998, REP C EFF INCR SPEED, P1; Nikase-Richardson R., 2012, J NEUROTRAUM, V59, P62; Nikase-Richardson R., 2012, J NEUROTRAUM, V59, P59; Record KL, 2012, AM J LAW MED, V38, P537, DOI 10.1177/009885881203800211; Ridic Goran, 2012, Mater Sociomed, V24, P112, DOI 10.5455/msm.2012.24.112-120; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Salzman L., 2010, U COLORADO LAW REV, V81, P157; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sizoo EM, 2010, NEURO-ONCOLOGY, V12, P1162, DOI 10.1093/neuonc/nop045; Thengone DJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6113; Thibaut A., 2019, LANCET NEUROLOGY, V18; Ulrich M. R., 2016, LINCOLNS PROMISE C D; Wright M. S., 2020, MARYLAND LAW REV, V79; Wright M.S., 2020, J LAW MED ETHICS; Wright M. S., 2018, STANFORD TECHNOLOGY, V21, P276; Wright M. S., 2016, YALE J HLTH POLICY L, V16, P236; Wright MS, 2017, KENNEDY INST ETHIC J, V27, P43, DOI 10.1353/ken.2017.0003; Wright MS., 2018, AJOB NEUROSCI, V9, P56; Wright MS, 2018, FLORIDA STATE U LAW, V45, P313; Wright MS, 2016, YALE J HLTH POLICY L, V16, P233	50	2	2	0	1	HARVARD UNIV PRESS	CAMBRIDGE	79 GARDEN ST, CAMBRIDGE, MA 02138 USA	1079-0969	2150-4113		HEALTH HUM RIGHTS	Health Hum. Rights	JUN	2020	22	1					265	278					14	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	MC6FC	WOS:000543379300023	32669806				2022-02-06	
J	Fatima, N; Mohamed, ME; De Leon, A; El Beltagi, A; Shuaib, A; Saqqur, M				Fatima, Nida; Mohamed, Mohamed Elsayed; De Leon, Alvino; El Beltagi, Ahmed; Shuaib, Ashfaq; Saqqur, Maher			Comparative Radiographic Factors Predicting Functional Outcome After Decompressive Craniectomy in Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article							SEVERE HEAD-INJURY; BASAL CISTERNS; CLASSIFICATION; MANAGEMENT		[Fatima, Nida] Hamad Gen Hosp, Dept Neurosurg, Doha, Qatar; [Fatima, Nida] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Mohamed, Mohamed Elsayed; El Beltagi, Ahmed] Hamad Gen Hosp, Dept Neuroradiol, Doha, Qatar; [De Leon, Alvino] Hosp Santo Tomas, Dept Neurosurg, Panama City, Panama; [Shuaib, Ashfaq; Saqqur, Maher] Univ Alberta, Dept Neurol, Edmonton, AB, Canada		Fatima, N (corresponding author), Hamad Gen Hosp, Dept Neurosurg, Doha, Qatar.; Fatima, N (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA.	nfatima@mgh.harvard.edu	Fatima, Nida/ABG-9595-2021	EL BELTAGI, AHMED/0000-0003-4135-6188; Fatima, Nida/0000-0002-0976-888X			Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; COLQUHOUN IR, 1989, CLIN RADIOL, V40, P13, DOI 10.1016/S0009-9260(89)80006-6; Cotte J, 2014, NEW ENGL J MED, V371, P971, DOI 10.1056/NEJMc1407775; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fatima N, 2020, WORLD NEUROSURG, V133, pE267, DOI 10.1016/j.wneu.2019.08.223; Fatima Nida, 2019, Asian J Neurosurg, V14, P382, DOI 10.4103/ajns.AJNS_8_19; Finkelstein E., 2006, INCIDENCE EC BURDEN; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Lee Bruce, 2005, NeuroRx, V2, P372; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Moon Ji Won, 2017, Korean J Neurotrauma, V13, P1, DOI 10.13004/kjnt.2017.13.1.1; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	22	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2020	138						E876	E882		10.1016/j.wneu.2020.03.118			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LY7RI	WOS:000540724700023	32251815				2022-02-06	
J	Harris, L; Hateley, S; Tsang, KT; Wilson, M; Seemungal, BM				Harris, Lauren; Hateley, Sofie; Tsang, K. T.; Wilson, M.; Seemungal, B. M.			Impact of anti-epileptic drug choice on discharge in acute traumatic brain injury patients	JOURNAL OF NEUROLOGY			English	Article						All clinical neurology; All epilepsy; seizures; Anti-epileptic drugs; Prognosis	SEIZURE PROPHYLAXIS; PHENYTOIN; LEVETIRACETAM; PREVENTION; METAANALYSIS	Background Anti-epileptic drug (AED) prophylaxis in the first-seven days post-traumatic brain injury (TBI) is known to reduce seizure frequency acutely. AED efficacy is equivalent; therefore, choice of AED may rest with their side-effects. We hypothesise that AEDs that impair balance will prolong recovery, shown by a longer hospital stay. We compared length of hospital stay (and reported dizziness) in TBI patients receiving the commonest AEDs used in our TBI patients, Phenytoin (which may cause imbalance), and Levetiracetam (which does not affect balance). Method A retrospective observational study was performed on TBI patients admitted to a Major Trauma Unit between October 2013 and June 2018. 100 of 278 patients treated with phenytoin or levetiracetam monotherapy for seizure prophylaxis were included. The inclusion criteria of admission Glasgow Coma Score of 14 or more and length of stay less than 3 weeks minimised confounding variables such as non-ambulant patients. Length of hospital stay and incidence of dizziness were assessed. Results The length of hospital stay was longer for patients on Phenytoin versus Levetiracetam, i.e., 10.74 vs. 7.58 days (p = 0.015; unpaired, two-sidedttest). Dizziness reported by patients on phenytoin was 24% and levetiracetam was 8% (p = 0.018; Chi-squared test). Conclusion In this cohort, using Phenytoin for acute TBI, seizure prophylaxis was associated with longer length of stay and more dizziness compared to Levetiracetam. Given their equivalent AED efficacy in acute TBI seizure prophylaxis, our data suggest that Levetiracetam is preferable to Phenytoin for early seizure prophylaxis in TBI. This requires evaluation in larger, prospective studies.	[Harris, Lauren; Tsang, K. T.; Wilson, M.] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Neurolosurg Dept, London, England; [Hateley, Sofie] Imperial Coll Healthcare NHS Trust, Dept Neurol, London, England; [Seemungal, B. M.] Imperial Coll London, Div Brain Sci, Neurootol Unit, London, England		Harris, L (corresponding author), Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Neurolosurg Dept, London, England.; Seemungal, BM (corresponding author), Imperial Coll London, Div Brain Sci, Neurootol Unit, London, England.	Lauren.harris7@nhs.net; sofie.hateley@nhs.net; mark.wilson19@nhs.net; b.seemungal@imperial.ac.uk		Seemungal, Barry/0000-0002-6578-0904; Wilson, Mark/0000-0002-2346-4911	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/P006493/1, MR/T023880/1] Funding Source: UKRI; Department of HealthEuropean Commission [ICA-CDRF-2017-03-070] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/T023880/1, MR/P006493/1] Funding Source: Medline		[Anonymous], 2014, HEAD INJ PRIOR QUAL; [Anonymous], 2007, BRIT NAT FORM LEV PH; Arshad Q, 2017, CLIN NEUROL NEUROSUR, V155, P17, DOI 10.1016/j.clineuro.2017.01.021; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Gabriel WM, 2014, ANN PHARMACOTHER, V48, P1440, DOI 10.1177/1060028014549013; Khan NR, 2016, NEUROSURGERY, V79, P775, DOI 10.1227/NEU.0000000000001445; Khan Shahbaz Ali, 2016, J Ayub Med Coll Abbottabad, V28, P455; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marcus HJ, 2019, J NEUROL, V266, P2430, DOI 10.1007/s00415-019-09403-z; Mee H, 2019, ACTA NEUROCHIR, V161, P457, DOI 10.1007/s00701-018-3683-9; Naidech AM, 2018, CRIT CARE MED, V46, P1480, DOI 10.1097/CCM.0000000000003272; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Wilson CD, 2018, WORLD NEUROSURG, V110, pE901, DOI 10.1016/j.wneu.2017.11.116; Xu JC, 2016, BRAIN INJURY, V30, P1054, DOI 10.3109/02699052.2016.1170882; Yang Y, 2016, CNS DRUGS, V30, P677, DOI 10.1007/s40263-016-0365-0	21	2	2	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	JUN	2020	267	6					1774	1779		10.1007/s00415-020-09769-5			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LX9PO	WOS:000540157500024	32130500	Green Published, hybrid			2022-02-06	
J	Hsu, MH; Kuo, HC; Lin, JJ; Chou, MY; Lin, YJ; Hung, PL				Hsu, Mei-Hsin; Kuo, Hsuan-Chang; Lin, Jainn-Jim; Chou, Ming-Yi; Lin, Ying-Jui; Hung, Pi-Lien			Therapeutic hypothermia for pediatric refractory status epilepticus May Ameliorate post-status epilepticus epilepsy	BIOMEDICAL JOURNAL			English	Article						Therapeutic hypothermia; Pediatric refractory status epilepticus; Pharmacoresistant refractory status epilepticus; Post-status epilepticus epilepsy; Febrile infection-related epilepsy syndrome; Temperature management system	CONVULSIVE STATUS EPILEPTICUS; CARDIAC-ARREST; MILD HYPOTHERMIA; PREDICTORS; NEUROPROTECTION; MANAGEMENT; PROGNOSIS; TIME	Background: To compare the clinical characteristics and outcomes of pediatric patients with refractory status epilepticus (RSE) and super-refractory status epilepticus (SRSE) who received therapeutic hypothermia (TH) plus anticonvulsants or anticonvulsants alone. Methods: Two-medical referral centers, retrospective cohort study. Pediatric Intensive Care Unit (PICU) at Taoyuan Chang Gung Children's hospital and Kaohsiung Chang Gung Memorial Hospital. We reviewed the medical records of 23 patients with RSE/SRSE who were admitted to PICU from January 2014 to December 2017. Of these, 11 patients received TH (TH group) and 12 patients did not (control group). Results: The selective endpoints were RSE/SRSE duration, length of PICU stay, and Glasgow Outcome Scale (GOS) score. We applied TH using the Artic Sun (R) temperature management system (target temperature, 34-35 degrees C; duration, 48-72 h). Of the 11 patients who received TH, 7 had febrile infection-related epilepsy syndrome (FIRSE), one had Dravet syndrome, and three had traumatic brain injury. The TH group had significantly shortern seizure durations than did the control group (hrs; median (IQR) 24(40) vs. 96(90), p < 0.05). Two patients in the TH group died of pulmonary embolism and extreme brain edema. The length of PICU stay was similar between the groups (days; median (IQR) 30(42) v.s 30.5(30.25)). The TH group had significantly better long-term outcomes than did the control group (GOS score, median (IQR) 4(2) v.s 3 (0.75), p = 0.01*). The TH group had a significantly lower incidence of later chronic refractory epilepsy than did the control group (TH v.s nonTH, 5/11 (45%) v.s. 12/12(100%), p < 0.01). Conclusions: TH effectively reduced the seizure burden in patients with RSE/SRSE. Our findings support that for patients with RSE/SRSE, TH shortens the seizure duration, ultimately reducing the occurrence of post-status epilepticus epilepsy and improving patients' long-term survival.	[Chou, Ming-Yi; Hung, Pi-Lien] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Pediat Neurol,Dept Pediat, Kaohsiung, Taiwan; [Hsu, Mei-Hsin; Kuo, Hsuan-Chang; Lin, Ying-Jui] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Pediat Crit Care,Dept Pediat, Kaohsiung, Taiwan; [Lin, Jainn-Jim] Chang Gung Childrens Hosp Linkou, Div Pediat Crit Care & Emergency Med, Taoyuan, Taiwan; [Kuo, Hsuan-Chang] Meiho Univ, Dept Nursing, Neipu, Taiwan; [Lin, Jainn-Jim] Chang Gung Univ, Coll Med, Taoyuan, Taiwan		Lin, YJ; Hung, PL (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat, 123 Ta Pei Rd, Kaohsiung 833, Taiwan.	rayray@cgmh.org.tw; flora1402@cgmh.org.tw	Yue, Yuhang/AAW-9279-2021		Research Support Scheme of Chang Gung Memorial Hospital [CMRPG8G0951]	This study was supported by grants from the Research Support Scheme of Chang Gung Memorial Hospital (CMRPG8G0951). We appreciated the Biostatistics Center, Kaohsiung Chang Gung Memorial Hospital for statistics work.	Aroor Shrikiran, 2017, J Clin Diagn Res, V11, pSD03, DOI 10.7860/JCDR/2017/24989.9742; Atkins DL, 2006, PEDIATRICS, V117, pE989; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bayrlee A, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0589-2; Bennett AE, 2014, CLIN NEUROL NEUROSUR, V126, P103, DOI 10.1016/j.clineuro.2014.08.032; Bisschops LLA, 2010, CRIT CARE MED, V38, P1542, DOI 10.1097/CCM.0b013e3181e2cc1e; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Buttram SDW, 2015, THER HYPOTHERMIA TEM, V5, P198, DOI 10.1089/ther.2015.0016; COOLEY D A, 1957, Nebr State Med J, V42, P77; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Gainza-Lein M, 2018, JAMA NEUROL, V75, P410, DOI 10.1001/jamaneurol.2017.4382; Guidotti I, 2016, DEV MED CHILD NEUROL, V58, P1235, DOI 10.1111/dmcn.13195; Guilliams K, 2013, EPILEPSIA, V54, P1586, DOI 10.1111/epi.12331; Halawa EF, 2015, J CHILD NEUROL, V30, P1736, DOI 10.1177/0883073815579706; Hocker SE, 2013, JAMA NEUROL, V70, P72, DOI 10.1001/jamaneurol.2013.578; Hommady RH, 2017, ANN SAUDI MED, V37, P455, DOI 10.5144/0256-4947.2017.455; Ichinose M, 2014, J NEUROSCI RES, V92, P1270, DOI 10.1002/jnr.23418; JULIAN OC, 1956, ARCH SURG-CHICAGO, V73, P493; Kowski AB, 2012, BRAIN RES, V1446, P119, DOI 10.1016/j.brainres.2012.01.022; Kuroda Y, 2016, J INTENSIVE CARE, V4, DOI [10.1186/s40560-016-0168-x, 10.1186/s40560-016-0141-8]; Legriel S, 2017, J EMERG MED, V53, P140, DOI 10.1016/j.jemermed.2017.03.029; Legriel S, 2016, NEW ENGL J MED, V375, P2457, DOI 10.1056/NEJMoa1608193; Legriel S, 2010, CRIT CARE MED, V38, P2295, DOI 10.1097/CCM.0b013e3181f859a6; LEWIS FJ, 1958, AM J CARDIOL, V2, P287, DOI 10.1016/0002-9149(58)90205-4; Lin JJ, 2020, BIOMED J, V43, P211, DOI 10.1016/j.bj.2019.12.003; Lin JJ, 2018, RESUSCITATION, V133, P180, DOI 10.1016/j.resuscitation.2018.08.019; Lin JJ, 2012, PEDIATR NEUROL, V47, P448, DOI 10.1016/j.pediatrneurol.2012.08.013; Mohammed HS, 2015, GEN PHYSIOL BIOPHYS, V34, P425, DOI 10.4149/gpb_2015022; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; ORLOWSKI JP, 1984, CRIT CARE MED, V12, P367, DOI 10.1097/00003246-198404000-00006; Ostrowsky K, 2010, SEMIN PEDIATR NEUROL, V17, P195, DOI 10.1016/j.spen.2010.06.012; Reig Saenz R, 2005, An Pediatr (Barc), V63, P307; Fernandez IS, 2015, NEUROLOGY, V84, P2304, DOI 10.1212/WNL.0000000000001673; Satas S, 2000, BIOL NEONATE, V77, P50; Shein SL, 2012, THER HYPOTHERMIA TEM, V2, P144, DOI 10.1089/ther.2012.0013; Shorvon S, 2012, BRAIN, V135, P2314, DOI 10.1093/brain/aws091; Shrestha GS, 2015, INDIAN J CRIT CARE M, V19, P283, DOI 10.4103/0972-5229.156484; Soleimanpour H, 2014, J CARDIOVASC THORAC, V6, P1, DOI 10.5681/jcvtr.2014.001; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Tokutomi T, 2007, NEUROSURGERY, V61, P256, DOI [10.1227/01.NEU.00000038737.13185.C4, 10.1227/01.neu.0000279221.38257.1a]; Wilkes R, 2013, CRIT CARE CLIN, V29, P239, DOI 10.1016/j.ccc.2012.11.007; Wira C, 2006, RESUSCITATION, V69, P509, DOI 10.1016/j.resuscitation.2005.10.028	42	2	3	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2319-4170	2320-2890		BIOMED J	Biomed. J.	JUN	2020	43	3					277	284		10.1016/j.bj.2020.04.004			8	Biochemistry & Molecular Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine	NL8JO	WOS:000567655300012	32330677	gold, Green Published			2022-02-06	
J	James, V; Chong, SL; Shetty, SS; Ong, GY				James, Vigil; Chong, Shu-Ling; Shetty, Shanti S.; Ong, Gene Y.			Early coagulopathy in children with isolated blunt head injury is associated with mortality and poor neurological outcomes	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						isolated head injury; pediatric; coagulopathy; neurological outcome; mortality publishing; style; guidelines; trauma	TRAUMATIC BRAIN-INJURY; SCALE; EPIDEMIOLOGY; DISORDERS; PREDICTOR	OBJECTIVE Traumatic brain injury (TBI) is the leading cause of long-term disability and death in children and adolescents globally. Long-term adverse outcomes, including physical, cognitive, and behavioral sequelae, have been reported after TBI in a significant number of pediatric patients. In this study the authors sought to investigate the epidemiology of TBI-associated coagulopathy and its association with mortality and poor neurological outcome in a pediatric population with isolated moderate to severe blunt head injury treated at the authors' institution. METHODS This retrospective study was conducted in the children's emergency department between January 2010 and December 2016. Children < 18 years old who presented with isolated moderate to severe blunt head injury were included in the study. The authors collected data on patient demographics, clinical presentation, and TBI management. Outcomes studied were death and poor neurological outcome defined by a score of < 7 (death, moderate to severe neurological disability) at 6 months postinjury on the pediatric version of the Glasgow Outcome Scale-Extended (GOS-E Peds). RESULTS In 155 pediatric patients who presented with isolated moderate to severe blunt head injury, early coagulopathy was observed in 33 (21.3%) patients during the initial blood investigations done in the emergency department. The mean (SD) age of the study group was 7.03 (5.08) years and the predominant mechanism of injury was fall from height (65.2%). The median Abbreviated Injury Scale of the head (AIS head) score was 4 and the median GCS score was 13 (IQR 12-15). TBI- associated coagulopathy was independently associated with GOS-E Peds score < 7 (p = 0.02, adjusted OR 6.07, 95% CI 1.32-27.83). The overall mortality rate was 5.8%. After adjusting for confounders, only AIS head score and hypotension at triage remained significantly associated with TBI-associated coagulopathy. CONCLUSIONS TBI-associated coagulopathy was independently associated with GOS-E Peds score < 7 at 6 months postinjury. Larger prospective studies are needed to investigate the use of TBI-associated coagulopathy to prognosticate these critical clinical outcomes.	[James, Vigil; Chong, Shu-Ling; Shetty, Shanti S.; Ong, Gene Y.] KK Womens & Childrens Hosp, Childrens Emergency, Singapore, Singapore		Ong, GY (corresponding author), KK Womens & Childrens Hosp, Childrens Emergency, Singapore, Singapore.	geneong@yahoo.com	Ong, Gene/W-3154-2019	Ong, Gene/0000-0002-9879-0594; james, vigil/0000-0002-2494-9726			Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bruins BB, 2012, PEDIATR CRIT CARE ME, V13, P491, DOI 10.1097/PCC.0b013e318238b5f5; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Chen C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061171; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Doshi BS, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.2891.2891; Folkerson LE, 2018, AM J EMERG MED, V36, P38, DOI 10.1016/j.ajem.2017.06.057; Gardner A, 2013, PEDIATR EMERG CARE, V29, P879, DOI 10.1097/PEC.0b013e31829ec0ee; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Johnson MA, 2018, WEST J EMERG MED, V19, P452, DOI 10.5811/westjem.2018.2.36404; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Konigs M, 2016, EUR J NEUROL, V23, P21, DOI 10.1111/ene.12719; Liu J, 2016, CHIN J TRAUMATOL, V19, P172, DOI 10.1016/j.cjtee.2016.01.011; Loftis KL, 2018, TRAFFIC INJ PREV, V19, pS109, DOI 10.1080/15389588.2018.1512747; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; Peiniger S, 2012, PEDIATR CRIT CARE ME, V13, P455, DOI 10.1097/PCC.0b013e31823893c5; Podolsky-Gondim GG, 2018, CHILD NERV SYST, V34, P2455, DOI 10.1007/s00381-018-3989-1; Recla M, 2013, BRAIN INJURY, V27, P862, DOI 10.3109/02699052.2013.775499; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Stolla M, 2019, TRANSFUSION, V59, P1522, DOI 10.1111/trf.15169; Strumwasser A, 2016, J TRAUMA ACUTE CARE, V81, P312, DOI 10.1097/TA.0000000000001060; Suttipongkaset P, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0594; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Verchere J, 2013, LANCET NEUROL, V12, P426, DOI 10.1016/S1474-4422(13)70073-5; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Yates MT, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070659; Zhang DF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/261825; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	33	2	2	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2020	25	6					663	669		10.3171/2019.12.PEDS19531			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	PA5AN	WOS:000595648500006	32114542	Bronze			2022-02-06	
J	Li, XW; He, RZ; Li, Y; Ruan, ZF				Li, X-W; He, R-Z; Li, Y.; Ruan, Z-F			Tizoxanide mitigates inflammatory response in LPS-induced neuroinflammation in microglia via restraining p38/MAPK pathway	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Tizoxanide; Neuroinflammation; Microglia; p38/MAPK pathway; Traumatic brain injury	NITAZOXANIDE; PHARMACOKINETICS; VIRUS	OBJECTIVE: Traumatic brain injury (TBI) induced neuroinflammation is featured as excessive glial inflammatory activation and violent neurologic destruction and dysfunction. Massive microglia activation in situ and disrupt of blood-brain barrier contribute to severely collapsed nervous system. Tizoxanide (TIZ), a synthetic thiazolide derivative agent possessing a broad-spectrum anti-infective effect, currently shows a potential resistance against pathogens like bacteria, virus and parasites, while its underlying role in neuroinflammation is elusive. The study aimed to explore the effect of TIZ on neuroinflammation In vitro microglia. MATERIALS AND METHODS: Primary microglia were accepted to neuroinflammatory activation via lipopolysaccharide (LPS) administration. TIZ was conducted to pretreatment of microglia. Cell viability, inflammatory cytokines, chemotaxis, nitric oxide release, inflammation-related enzymes, and mitogen-activated protein kinase (MAPK) pathway activation in microglia were investigated respectively. RESULTS: We demonstrated that TIZ administration attenuates inflammatory cytokines and chemokines through quantitative real-time polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA) of medium supernatant. In addition, TIZ reduces pro-inflammatory mediators and nitric oxide release in microglia. Furtherly, TIZ inhibits the level of p38/MAPK pathway in LPS stimuli, indicating that TIZ negatively regulates neuroinflammation via inhibiting p38/MAPK pathway. CONCLUSIONS: TIZ is verified to be an anti-inflammation effect on neuroinflammation in microglia via downregulation of p38/MAPK pathway, which restrains inflammation by reduced inflammatory cytokines, chemokines and mediators and decreased nitric oxide release. To summarize, TIZ is considered to be a promising reagent to alleviate neuroinflammation targeting microglia in nervous system injury.	[Li, X-W; Ruan, Z-F] Univ South China, Dept Neurol, Affiliated Hosp 1, Hengyang, Peoples R China; [He, R-Z] Univ South China, Natl & Local Joint Engn Lab High Mol Diag Technol, Translat Med Inst,Peoples Hosp 1, Collaborat Res Ctr Postdoctoral Mobile Stn,Cent S, Chenzhou, Peoples R China; [Li, Y.] Univ South China, Affiliated Nanhua Hosp, Dept Anesthesiol, Hengyang, Peoples R China		Ruan, ZF (corresponding author), Univ South China, Dept Neurol, Affiliated Hosp 1, Hengyang, Peoples R China.	ruanzhongfan@sina.com			Hunan Provincial Commission of Health [20200497]	Hunan Provincial Commission of Health (20200497).	Ai N, 2015, PHARM RES-DORDR, V32, P2798, DOI 10.1007/s11095-015-1665-7; Aneja RK, 2019, J NEUROTRAUM, V36, P360, DOI 10.1089/neu.2018.5664; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Chen SP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1140-6; Dang W, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/aac.00707-18, 10.1128/AAC.00707-18]; FELIG P, 1979, DIABETES, V28, P71, DOI 10.2337/diab.28.1.S71; Greenhalgh AD, 2020, NAT REV NEUROSCI, V21, P139, DOI 10.1038/s41583-020-0263-9; Guo SX, 2020, BIOMED CHROMATOGR, V34, DOI 10.1002/bmc.4716; Gupta A, 2017, MOL PHARMACEUT, V14, P1204, DOI 10.1021/acs.molpharmaceut.6b01089; Harland M, 2020, J NEUROSCI, V40, P1756, DOI 10.1523/JNEUROSCI.2324-19.2020; Ruiz-Olmedo MI, 2017, SAUDI PHARM J, V25, P413, DOI 10.1016/j.jsps.2016.09.005; Jeong YH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20164015; Korba BE, 2008, ANTIMICROB AGENTS CH, V52, P4069, DOI 10.1128/AAC.00078-08; Korba BE, 2008, ANTIVIR RES, V77, P56, DOI 10.1016/j.antiviral.2007.08.005; Lam KKY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002691; Lee S, 2014, NAT CHEM BIOL, V10, P1055, DOI 10.1038/nchembio.1669; Liang HM, 2018, PART FIBRE TOXICOL, V15, DOI 10.1186/s12989-018-0274-0; Lim SW, 2017, NEUROCRIT CARE, V26, P122, DOI 10.1007/s12028-016-0290-6; Madore C, 2020, IMMUNITY, V52, P222, DOI 10.1016/j.immuni.2019.12.003; Palomares-Alonso F, 2007, J ANTIMICROB CHEMOTH, V59, P212, DOI 10.1093/jac/dkl463; Park J, 2018, J CONTROL RELEASE, V284, P152, DOI 10.1016/j.jconrel.2018.06.021; Park J, 2019, J CELL BIOCHEM, V120, P1742, DOI 10.1002/jcb.27464; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014; Shou JQ, 2020, ARCH PHARM RES, V43, P257, DOI 10.1007/s12272-019-01202-4; Shou JQ, 2019, INFLAMMATION, V42, P1336, DOI 10.1007/s10753-019-00994-3; Trabattoni D, 2016, SCI REP-UK, V6, DOI 10.1038/srep27148; Voet S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04376-5; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yang L, 2020, NEUROBIOL DIS, V140, DOI 10.1016/j.nbd.2020.104814; Yu YH, 2017, BIOCHEM BIOPH RES CO, V491, P478, DOI 10.1016/j.bbrc.2017.07.021; Zhang JW, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1688-9	33	2	2	1	2	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	JUN	2020	24	11					6446	6454					9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	MA8VZ	WOS:000542190000067	32572942				2022-02-06	
J	Li, Y; Zhang, W; Meng, QL; Jiang, G; Wu, CW				Li, Yang; Zhang, Wei; Meng, Qing Ling; Jiang, Gang; Wu, Cheng Wei			How woodpecker protects its brain from concussion during pecking compared with chicken and pigeon	AIP ADVANCES			English	Article							IMPACT; TONGUE	Head injury has become a threat to human life in transportation accidents, construction. and sports. However, woodpeckers can avoid injuring their brain during high velocity and frequency pecking. To reveal the underlying secret, the pecking process of woodpeckers is simulated and compared with that of chickens and pigeons to study the stress wave propagation in their head. The pecking data of live chickens and pigeons are simultaneously obtained from the force sensor and the high-speed video system. The morphological information of the three birds' heads is also investigated using Micro Computed Tomography (Micro-CT) scanning. The results show that the woodpecker has the highest skull volume fraction and beak length fraction, which could potentially increase its head structural strength and provide more space to dissipate impact stress. The finite element head models of the woodpecker, chicken, and pigeon are established based on the micro-CT images and performed pecking process simulations. The simulated results suggest that the stress wave propagates through both the upper-beak and lower-beak of the woodpecker to ensure the enough structural strength in order to overcome the fierce impact. On the other hand, the structural strength requirement of the chicken and pigeon is not as high as the woodpecker due to their lower pecking intensity. Setting the stouter lower-beak of the chicken and the pigeon as the primary wave propagation path not only ensures their head safety but also avoids direct impact to their brain. The biomechanical design of the bird's heads, setting a special propagation path for the stress wave, may inspire new approaches to improve and design impact resistance equipment.	[Li, Yang; Zhang, Wei; Meng, Qing Ling; Jiang, Gang; Wu, Cheng Wei] Dalian Univ Technol, Dept Engn Mech, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China; [Meng, Qing Ling] Tianjin Chengjian Univ, Tianjin Key Lab Civil Struct Protect & Reinforcem, Tianjin 300384, Peoples R China		Wu, CW (corresponding author), Dalian Univ Technol, Dept Engn Mech, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China.	cwwu@dlut.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51775541, U1908233, 11772086]; National Key R&D Project of China [2018YFA0704104, 2018YFA0704103]; NSFC of Liaoning Province [2019-KF-02-01]	This work was supported by the National Natural Science Foundation of China (Grant Nos. 51775541, U1908233, and 11772086), National Key R&D Project of China (Grant Nos. 2018YFA0704104 and 2018YFA0704103), and NSFC of Liaoning Province (Grant No. 2019-KF-02-01). The authors declare that they have no conflict of interest.	Bock WJ, 1999, OSTRICH, V70, P23, DOI 10.1080/00306525.1999.9639746; BOCK WJ, 1966, AUK, V83, P10, DOI 10.2307/4082976; Faul M., 2010, BRAIN INJURY, V24, P115, DOI [10.3109/02699051003648227, DOI 10.3109/02699051003648227]; Gibson LJ, 2006, J ZOOL, V270, P462, DOI 10.1111/j.1469-7998.2006.00166.x; Gindl W, 2002, COMPOS PART A-APPL S, V33, P1141, DOI 10.1016/S1359-835X(02)00080-5; Holbourn AHS, 1943, LANCET, V2, P438; Jung JY, 2016, ACTA BIOMATER, V37, P1, DOI 10.1016/j.actbio.2016.03.030; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; Lee N, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/6/066004; Lee N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0274; Liu YZ, 2017, INT J IMPACT ENG, V108, P263, DOI 10.1016/j.ijimpeng.2017.05.016; Liu YZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122677; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; MAY PRA, 1976, LANCET, V1, P454; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; Oda J, 2006, JSME INT J A-SOLID M, V49, P390, DOI 10.1299/jsmea.49.390; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; SPRING LOWELL W., 1965, CONDOR, V67, P457, DOI 10.2307/1365612; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Vincent IFV, 2007, P I MECH ENG C-J MEC, V221, P1141, DOI 10.1243/09544062JMES574; Wang L., 2013, WORLD C MED PHYS BIO; Wang LZ, 2011, SCI CHINA LIFE SCI, V54, P1036, DOI 10.1007/s11427-011-4242-2; Wang LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026490; Wegst UGK, 2004, PHILOS MAG, V84, P2167, DOI 10.1080/14786430410001680935; Wheatley BB, 2016, J MECH BEHAV BIOMED, V53, P445, DOI 10.1016/j.jmbbm.2015.08.041; Wu CW, 2015, J PHYS CONF SER, V628, DOI 10.1088/1742-6596/628/1/012007; Yamamoto T, 2007, ADV SPACE RES, V39, P472, DOI 10.1016/j.asr.2003.04.078; Yoon SH, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/1/016003; Zhou P, 2009, J BIONIC ENG, V6, P214, DOI 10.1016/S1672-6529(08)60126-2; Zhu ZD, 2012, AIP ADV, V2, DOI 10.1063/1.4770305; Zhu ZD, 2014, SCI CHINA TECHNOL SC, V57, P1269, DOI 10.1007/s11431-014-5582-5; Zhu ZD, 2014, J BIONIC ENG, V11, P282, DOI 10.1016/S1672-6529(14)60045-7	33	2	2	6	10	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA		2158-3226		AIP ADV	AIP Adv.	JUN 1	2020	10	6								10.1063/5.0004546			10	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Materials Science; Physics	LW6KR	WOS:000539253600001		gold			2022-02-06	
J	Miller, GF; Kegler, SR; Stone, DM				Miller, Gabrielle F.; Kegler, Scott R.; Stone, Deborah M.			Traumatic Brain Injury-Related Deaths From Firearm Suicide: United States, 2008-2017	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							TRENDS; RATES	Objectives. To document the increasing influence of firearm suicide on the incidence of traumatic brain injury (TBI)-related death in the United States. Methods. We used national vital statistics data from 2008 to 2017 to identify TBI-related deaths, overall and by cause, among US residents. National counts stratified by year, sex, and age group (to facilitate age adjustment) were merged with corresponding population estimates to calculate incidence rates. Results. During the 10-year period beginning in 2008, when it became the leading cause of TBI-related death in the United States, firearm suicide accounted for nearly half (48.3%) of the increase in the absolute incidence of TBI-related death when combining all injury categories showing absolute increases. Rates of TBI-related firearm suicide increased among both males and females. Conclusions. Safe storage of firearms among people at risk and training of health care providers and community members to identify and support people who may be thinking of suicide are part of a comprehensive public health approach to suicide prevention. Public Health Implications. States, communities, and health care systems can save lives by prioritizing comprehensive suicide prevention.	[Miller, Gabrielle F.; Kegler, Scott R.; Stone, Deborah M.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Prevent, Atlanta, GA USA		Miller, GF (corresponding author), CDC, Natl Ctr Injury Prevent & Control, Div Injury Prevent, 4770 Buford Hwy NE,Mailstop S106-10, Atlanta, GA 30341 USA.	ygm3@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Alao T, 2020, STATPEARLS; Centers for Disease Control and Prevention, 2018, WID RANG ONL DAT EP; Centers for Disease Control and Prevention CDC National Center for Injury Prevention and Control Data Statistics Fatal Injury Report, 2018, WEB BAS INJ STAT QUE WEB BAS INJ STAT QUE; Faul M, 2010, TRAUMATIC BRAIN INJU; Hawton K, 2001, BMJ-BRIT MED J, V322, P1203, DOI 10.1136/bmj.322.7296.1203; KREITMAN N, 1984, J EPIDEMIOL COMMUN H, V38, P1, DOI 10.1136/jech.38.1.1; National Centre for Health Statistics, ICD 10 EXT CAUS INJ; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Spicer RS, 2000, AM J PUBLIC HEALTH, V90, P1885, DOI 10.2105/AJPH.90.12.1885; Stone DM, 2018, MMWR-MORBID MORTAL W, V67, P617, DOI 10.15585/mmwr.mm6722a1; Stone DM, 2017, PREVENTING SUICIDE T; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF	12	2	2	0	0	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	JUN	2020	110	6					897	899		10.2105/AJPH.2020.305622			3	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	LK7ZV	WOS:000531081000052	32298184	Green Published			2022-02-06	
J	Milroy, JJ; Wyrick, DL; Rulison, KL; Sanders, L; Mendenhall, B				Milroy, Jeffrey J.; Wyrick, David L.; Rulison, Kelly L.; Sanders, Lindsey; Mendenhall, Brandon			Using the Integrated Behavioral Model to Determine Sport -Related Concussion Reporting Intentions Among Collegiate Athletes	JOURNAL OF ADOLESCENT HEALTH			English	Article							ICE HOCKEY; EDUCATION; PREVENTION; OUTCOMES; NORMS		[Milroy, Jeffrey J.; Wyrick, David L.; Rulison, Kelly L.; Sanders, Lindsey; Mendenhall, Brandon] Univ N Carolina, Dept Publ Hlth Educ, Greensboro, NC 27412 USA; [Milroy, Jeffrey J.; Wyrick, David L.; Sanders, Lindsey] Inst Promote Athlete Hlth & Wellness, Greensboro, NC USA		Milroy, JJ (corresponding author), Univ N Carolina, Dept Publ Hlth Educ, Greensboro, NC 27412 USA.	jjmilroy@uncg.edu			National Collegiate Athletic Association; United States Department of DefenseUnited States Department of Defense	A Mind Matters Challenge Research grant from the National Collegiate Athletic Association and the United States Department of Defense provided funding to collect the data analyzed in this study.	[Anonymous], NCAA DEM SEARCH; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Bolter ND, 2013, SPORT EXERC PERFORM, V2, P32, DOI 10.1037/a0029802; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Fishbein M, 2003, COMMUN THEOR, V13, P164, DOI 10.1111/j.1468-2885.2003.tb00287.x; Foster CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215030; Jessiman-Perreault G., 2016, Advances in Physical Education, V6, P178, DOI 10.4236/ape.2016.63020; Jowett S, 2002, SOLUTIONS SPORT PSYC; Katz J, 2013, VIOLENCE VICTIMS, V28, P1054, DOI 10.1891/0886-6708.VV-D-12-00113; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larimer ME, 2004, PSYCHOL ADDICT BEHAV, V18, P203, DOI 10.1037/0893-164X.18.3.203; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Milroy JJ, 2018, J CLIN SPORT PSYCHOL, V12, P268, DOI 10.1123/jcsp.2017-0029; National Collegiate Athletic Association, 2014, NCAA SPORTS MED HDB; Price MS, 2013, J APPL SPORT PSYCHOL, V25, P265, DOI 10.1080/10413200.2012.725703; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Watts H.A., 2018, COLL STUDENT AFFAIRS, V36, P110, DOI DOI 10.1353/CSJ.2018.0019	30	2	2	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	JUN	2020	66	6					705	712		10.1016/j.jadohealth.2020.01.027			8	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Public, Environmental & Occupational Health; Pediatrics	LY3VZ	WOS:000540458000013	32169526	Green Published			2022-02-06	
J	Nguyen, MQ; King, D; Pearce, AJ				Nguyen, Minh Q.; King, Doug; Pearce, Alan J.			A Reliability and Comparative Analysis of the New Randomized King-Devick Test	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article							VISUAL SCREENING TOOL; FRONTAL EYE FIELD; RUGBY LEAGUE; CONCUSSION; MOVEMENTS; SACCADES; LESIONS	Objective: The King-Devick (K-D) test is a rapid visual screening tool that can assess underlying brain trauma such as concussion via impairments in saccadic rhythm. A new tablet version of the K-D test using randomized numbers is now available, but reliability for this new version and comparison to the traditional K-D test has not yet been reported. Known for learning effects in the test, the aim of this study was to determine test-retest reliability and to compare performance of the new "randomized" version to the "traditional" K-D test version. We hypothesized that the "traditional" K-D test would show a greater rate of improvement with repeat application, compared with the "randomized" K-D test. Methods: Using a cross-sectional, repeated measures design in a healthy university student cohort (n = 96; age 21.6 +/- 2.8 years; 49 women, 47 men), participants were required to complete the K-D test twice with a one-week break between testing sessions. Participants were randomly assigned into a "traditional" group, where they completed a test-retest of the established K-D protocol, using the same numbers; or the "randomized" group, where they completed test-retest protocol using 2 different sets of numbers. Results: Reliability testing showed a strong intraclass correlation coefficient for both the "traditional" test group (control group; 0.95 [CI: 0.91-0.97]) and the "randomized test group" (0.97 [CI: 0.95-0.98]). However, contrary to our hypothesis, no differences were found between "traditional" and "randomized" groups for baseline (control: 42.5 seconds [CI: 40.2-44.9 s] vs randomized: 41.5 [38.7-44.4], P = 0.23) and repeated testing between groups (control: 40.0 seconds [37.9-42.1 s] vs randomized: 39.5 [36.9-42.0], P = 0.55), with both groups showing improved times with repeated testing (control: 2.1 seconds [CI: 1.1-3.2 seconds] and randomized: 1.9 seconds CI: [0.9-2.9 seconds], P < 0.001). Conclusions: The "randomized" version of the K-D test, using different sets of numbers, demonstrates good reliability that is comparable to the traditional K-D testing protocol that uses the same number sets. However, similar to the "traditional" K-D test, learning effects were also observed in the "randomized" test, suggesting that learning effects are not because of content memorization, but rather familiarity of the test. As a result, although either test format is suitable for sideline concussion screening or return to play decisions, comparison of data should be made to the individual's baseline rather than to normative data sets.	[Nguyen, Minh Q.; Pearce, Alan J.] La Trobe Univ, Sch Allied Hlth Human Serv & Sport, Melbourne, Vic 3083, Australia; [King, Doug] Auckland Univ Technol, Fac Hlth & Environm Sci, Sports Performance Res Inst New Zealand SPRINZ, Auckland, New Zealand		Pearce, AJ (corresponding author), La Trobe Univ, Sch Allied Hlth Human Serv & Sport, Melbourne, Vic 3083, Australia.	alan.pearce@latrobe.edu.au			Sport Health Check charity (Australia); Australian Football League (Melbourne, Australia); Samsung Corporation Australia (Sydney, Australia)Samsung; Impact Technologies Inc (Perth, Australia)	A. J. Pearce is supported, in-part, by funding from Sport Health Check charity (Australia), and has previously received in-part funding from the Australian Football League (Melbourne, Australia), Samsung Corporation Australia (Sydney, Australia), and Impact Technologies Inc (Perth, Australia). The remaining authors report no conflicts of interest.	Ayaz H., 2014, J NEUROSCI NEUROENG, V3, P41, DOI [DOI 10.1166/JNSNE.2014.1095, 10.1166/jnsne.2014.1095]; Campbell D.T., 1999, PRIMER REGRESSION AR; D'Amico N, 2017, J ATTHL TRAIN, V52, pS237; Davies EC, 2012, NEUROLOGY, V78, pE103, DOI 10.1212/WNL.0b013e318251833d; Dickson TJ, 2019, J SCI MED SPORT, V22, pS34, DOI 10.1016/j.jsams.2018.08.013; Dumire RD, 2018, GERIATRIC TRAUMA ACU, P55; Eddy R, 2020, CLIN J SPORT MED, V30, P239, DOI 10.1097/JSM.0000000000000586; Elkington L, 2019, CONCUSSION SPORT POS; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Hausknecht JP, 2007, J APPL PSYCHOL, V92, P373, DOI 10.1037/0021-9010.92.2.373; Hecimoyich M, 2018, J SCI MED SPORT, V21, P1004, DOI 10.1016/j.jsams.2018.03.011; Heitger MH, 2002, PROG BRAIN RES, V140, P433; King AT., 1976, PROPOSED KING DEVICK; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; MESSICK S, 1981, PSYCHOL BULL, V89, P191, DOI 10.1037/0033-2909.89.2.191; Moster S, 2014, J NEUROL SCI, V343, P105, DOI 10.1016/j.jns.2014.05.047; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; Ploner CJ, 1999, J NEUROPHYSIOL, V82, P1086; Rist B., 2017, INT J EXERC SCI, V10, P619; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; SACKETT PR, 1989, INT REV IND ORG PSYC, P145; SPARKS DL, 1990, ANNU REV NEUROSCI, V13, P309, DOI 10.1146/annurev.ne.13.030190.001521; Stepanek J, 2014, AVIAT SPACE ENVIR MD, V85, P700, DOI 10.3357/ASEM.3645.2014; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; White OB, 2012, J NEURO-OPHTHALMOL, V32, P266, DOI 10.1097/WNO.0b013e3182688230; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211	38	2	2	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1070-8022	1536-5166		J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	JUN	2020	40	2					207	212		10.1097/WNO.0000000000000829			6	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	LW6HJ	WOS:000539245000016	31453920	Bronze			2022-02-06	
J	O'Neill, KM; Jean, RA; Savetamal, A; Dyke, A; Prunty, R; Stone, A; Castillo, A; Gregg, SC				O'Neill, Kathleen M.; Jean, Raymond A.; Savetamal, Alisa; Dyke, Ann; Prunty, Roseanne; Stone, Andrew; Castillo, Andrea; Gregg, Shea C.			When to Admit to Observation: Predicting Length of Stay for Anticoagulated Elderly Fall Victims	JOURNAL OF SURGICAL RESEARCH			English	Article						Financial toxicity; Head injury; Geriatric; Trauma	DELAYED INTRACRANIAL HEMORRHAGE; TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; DISCHARGE; THERAPY; RISK	Background: Geriatric patients who fall while taking an anticoagulant have a small but significant risk of delayed intracranial hemorrhage requiring observation for 24 h. However, the medical complexity associated with geriatric care may necessitate a longer stay in the hospital. Little is known about the factors associated with a successful observational status stay (<2 d) for this population. Materials and methods: Elderly patients who fell while taking an anticoagulant admitted from 2012 to 2017 at an ACS level II trauma center were included in a retrospective cohort study to determine what factors were associated with a stay consistent with observational status. Inclusion criteria: age > 65 y old, negative initial head CT, and one of the following: INR>3.5 if on warfarin, GCS<14, external signs of trauma, or focal neurological deficits. Results: The cohort included 369 patients. Factors associated with decreased likelihood of successful observational status included the need for services after discharge such as an extended care facility (OR 0.06, 95% CI 0.02-0.19, P < 0.001) or visiting nurse agency services (OR 0.27, 95% CI 0.10-0.75, P < 0.001), a dementia diagnosis (OR 0.17, 95% CI 0.04-0.70, P = 0.014), increasing number of medications (OR 0.91, 95% CI 0.84-0.99, P = 0.031), and the use of coumadin (OR 0.28, 95% CI 0.12-0.70, P = 0.006). Conclusions: For trauma providers, knowing your patient's medication use and particularly type of anticoagulant, comorbidities including dementia, and likely need for services after discharge will help guide the decision to admit the patient for what may be a reasonably lengthy stay versus a brief observation in the hospital for elderly fall victims on anticoagulation. (C) 2020 Elsevier Inc. All rights reserved.	[O'Neill, Kathleen M.; Jean, Raymond A.] Yale Sch Med, Dept Surg, 330 Cedar St,FMB 107, New Haven, CT 06510 USA; [Savetamal, Alisa; Dyke, Ann; Prunty, Roseanne; Stone, Andrew; Castillo, Andrea; Gregg, Shea C.] Yale New Haven Hlth, Bridgeport Hosp, Dept Surg, Bridgeport, CT USA		O'Neill, KM (corresponding author), Yale Sch Med, Dept Surg, 330 Cedar St,FMB 107, New Haven, CT 06510 USA.			Castillo, Andrea/0000-0002-6850-0613; Jean, Raymond/0000-0001-5421-0386	National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1 TR001864]	Dr. O'Neill acknowledges that this publication was made possible by CTSA Grant Number TL1 TR001864 from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.	Bo M, 2016, GERIATR GERONTOL INT, V16, P314, DOI 10.1111/ggi.12471; Challis D, 2014, INT J GERIATR PSYCH, V29, P160, DOI 10.1002/gps.3983; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Chin JJ, 2001, ANN ACAD MED SINGAP, V30, P593; Claudia C, 2011, J TRAUMA, V70, P906, DOI 10.1097/TA.0b013e3182031ab7; Cutshaw CA, 2016, INT J HEALTH SERV, V46, P36, DOI 10.1177/0020731415614249; FALCONE D, 1991, HEALTH SERV RES, V26, P339; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Miller J, 2015, J TRAUMA ACUTE CARE, V79, P310, DOI 10.1097/TA.0000000000000725; Moore G, 2018, GERIATR GERONTOL INT, V18, P530, DOI 10.1111/ggi.13212; Uccella L, 2016, WORLD NEUROSURG, V93, P100, DOI 10.1016/j.wneu.2016.05.061; Victor CR, 2000, HEALTH SOC CARE COMM, V8, P443, DOI 10.1046/j.1365-2524.2000.00270.x; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	14	2	2	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN	2020	250						156	160		10.1016/j.jss.2020.01.006			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	LS7CB	WOS:000536537100002	32065966				2022-02-06	
J	Park, JS; You, Y; Ahn, HJ; Min, JH; Jeong, W; Yoo, I; Cho, Y; Ryu, S; Lee, J; Kim, S; Cho, SU; Oh, SK; Kang, CS; Lee, BK				Park, Jung Soo; You, Yeonho; Ahn, Hong Joon; Min, Jin Hong; Jeong, Wonjoon; Yoo, Insool; Cho, Yongchul; Ryu, Seung; Lee, Jinwoong; Kim, Seungwhan; Cho, Sung Uk; Oh, Se Kwang; Kang, Chang Shin; Lee, Byung Kook			Cerebrospinal fluid lactate dehydrogenase as a potential predictor of neurologic outcomes in cardiac arrest survivors who underwent target temperature management	JOURNAL OF CRITICAL CARE			English	Article						Cardiac arrest; Prognostication; Cerebrospinal fluid; Lactate dehydrogenase	EUROPEAN RESUSCITATION COUNCIL; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; POSTRESUSCITATION CARE; CEREBRAL METABOLISM; MICRODIALYSIS; ASSOCIATION; ENZYMES; SERUM	Purpose: Cerebrospinal fluid (CSF) lactate dehydrogenase (LDH) levels increase in patients with brain injury. We investigated neurologic outcomes associated with CSF LDH levels in out-of-hospital cardiac arrest (OHCA) survivors who underwent target temperature management (TTM). Materials andmethods: Thiswas a prospective single-centre observational study from April 2018 toMay 2019 on a cohort of 41 patients. CSF and serum LDH samples were obtained immediately (LDH0) and at 24 (LDH24), 48 (LDH48), and 72 h (LDH72) after return of spontaneous circulation (ROSC). Neurologic outcomes were assessed at 3 months after ROSC using the Cerebral Performance Category scale. Results: Twenty-one patients had a poor neurologic outcome. CSF LDH levels were significantly higher in the poor neurologic outcome group at each time point. The area under the curve (AUC) of CSF LDH48was 0.941 (95% confidence interval [CI], 0.806-0.992). With a cut off value of 250 U/L, CSF LDH48 had a high sensitivity (94.1%; 95% CI, 71.3-99.9) at 100% specificity. Conclusions: CSF LDH level at 48 h was a highly specific and sensitive marker for 3-month poor neurologic outcome. This may constitute a useful predictive marker for neurologic outcome in OHCA survivors treated with TTM. (c) 2020 Elsevier Inc. All rights reserved.	[Park, Jung Soo; You, Yeonho; Ahn, Hong Joon; Min, Jin Hong; Jeong, Wonjoon; Yoo, Insool; Cho, Yongchul; Ryu, Seung; Lee, Jinwoong; Kim, Seungwhan; Cho, Sung Uk; Oh, Se Kwang; Kang, Chang Shin] Chungnam Natl Univ Hosp, Dept Emergency Med, 282 Munhwa Ro, Daejeon, South Korea; [Park, Jung Soo; Yoo, Insool; Kim, Seungwhan] Chungnam Natl Univ, Dept Emergency Med, Coll Med, Daejeon, South Korea; [Lee, Byung Kook] Chonnam Natl Univ, Sch Med, Dept Emergency Med, Gwangju, South Korea		Ahn, HJ (corresponding author), Chungnam Natl Univ Hosp, Dept Emergency Med, 282 Munhwa Ro, Daejeon, South Korea.	jooniahn@daum.net	Kang, Changshin/AAS-9279-2021; Lee, Byung Kook/M-2236-2018	Lee, Byung Kook/0000-0003-3571-9448; Park, jung soo/0000-0002-4283-5423; Min, Jin Hong/0000-0003-0042-5167	National Research Foundation of Korea (NRF) - Korea government (MSIT) [2019R1F1A1041024]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2019R1F1A1041024).	Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Vazquez JA, 2009, J EMERG MED, V37, P93, DOI 10.1016/j.jemermed.2008.04.032; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bittar PG, 1996, J CEREBR BLOOD F MET, V16, P1079, DOI 10.1097/00004647-199611000-00001; Carpenter KLH, 2014, EUR J PHARM SCI, V57, P87, DOI 10.1016/j.ejps.2013.12.012; Chalkias A, 2012, HEART FAIL REV, V17, P117, DOI 10.1007/s10741-011-9255-1; Cronberg T, 2019, CURR OPIN CRIT CARE, V25, P211, DOI 10.1097/MCC.0000000000000611; Hayman EG, 2018, NEUROCRIT CARE, V28, P276, DOI 10.1007/s12028-017-0474-8; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Huntgeburth M, 2014, NEUROCRIT CARE, V20, P358, DOI 10.1007/s12028-013-9848-8; KARKELA J, 1992, CRIT CARE MED, V20, P378; Khosroshahi N, 2015, IRAN J CHILD NEUROL, V9, P31; Kim JC, 2017, CLIN EXP EMERG MED, V4, P10, DOI 10.15441/ceem.16.149; Lafrenaye AD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020330; Mentzelopoulos SD, 2017, RESUSCITATION, V121, pA12, DOI 10.1016/j.resuscitation.2017.10.013; Muengtaweepongsa Sombat, 2017, World J Methodol, V7, P55, DOI 10.5662/wjm.v7.i2.55; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Pandya Rachna S., 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P81; Parakh N, 2002, NEUROL INDIA, V50, P518; Reis C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010129; Saha A, 2016, ISOR JDMS, V15, P53; Stammet P, 2015, J AM COLL CARDIOL, V65, P2104, DOI 10.1016/j.jacc.2015.03.538; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; TWIJNSTRA A, 1987, J NEUROL NEUROSUR PS, V50, P313, DOI 10.1136/jnnp.50.3.313; UEBA T, 1994, NEUROSURGERY, V34, P221, DOI 10.1227/00006123-199402000-00003; Watts ME, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00216; You Y, 2019, RESUSCITATION, V145, P185, DOI 10.1016/j.resuscitation.2019.09.027; You Y, 2018, RESUSCITATION, V131, P42, DOI 10.1016/j.resuscitation.2018.08.003; Yum SK, 2017, J MATERN-FETAL NEO M, V30, P1177, DOI 10.1080/14767058.2016.1208745	31	2	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	JUN	2020	57						49	54		10.1016/j.jcrc.2020.02.001			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LS6NT	WOS:000536499000009	32062287				2022-02-06	
J	Pinar, C; Trivino-Paredes, J; Perreault, ST; Christie, BR				Pinar, Cristina; Trivino-Paredes, Juan; Perreault, Samantha T.; Christie, Brian R.			Hippocampal cognitive impairment in juvenile rats after repeated mild traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						mTBI; Sex differences; Juvenile; Learning and memory	POST-CONCUSSION SYMPTOMS; SEX-DIFFERENCES; NEUROCOGNITIVE PERFORMANCE; SYNAPTIC PLASTICITY; MOUSE MODEL; HIGH-SCHOOL; HYPERPHOSPHORYLATED TAU; DECISION-MAKING; OBJECT LOCATION; SODIUM SELENATE	There is growing awareness that repeated mild traumatic brain injury (r-mTBI) can cause deficits in learning and memory performance, however there is still a paucity of preclinical data identifying the extent of these deficits. Epidemiological data shows that juveniles are at high risk to sustain r-mTBI, and these injuries may cause significant changes in cognitive abilities, as they occur during a period where the brain is still maturing. This is particularly true for the hippocampus, a brain region important for learning and memory processes. R-mTBI during the juvenile period may disrupt functional capacity of the hippocampus, and thus the normal development of cognitive processes associated with this structure. To examine this issue we used a model of awake closed head injury (ACHI) and administered 8 impacts over a 4 day period to juvenile male and female rats (P25-28). A neurological assessment was preformed after each impact, and anxiety and learning related behaviours were examined 1 and 7 days after the last impact. Our results indicate that r-mTBI was associated with sensorimotor deficits in the acute phase immediately after each procedure. R-mTBI also reduced the capacity for hippocampal-dependent learning for at least 7 days post-injury, but did not result in any long-lasting changes in anxiety-related behaviours.	[Pinar, Cristina; Trivino-Paredes, Juan; Perreault, Samantha T.; Christie, Brian R.] Univ Victoria, Div Med Sci, 3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada; [Christie, Brian R.] Univ British Columbia, Isl Med Program, Victoria, BC V8P 5C2, Canada; [Christie, Brian R.] Univ British Columbia, Dept Cellular & Physiol Sci, Victoria, BC V8P 5C2, Canada		Christie, BR (corresponding author), Univ Victoria, Div Med Sci, 3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada.	brain64@uvic.ca	Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); CIHRCanadian Institutes of Health Research (CIHR); CFICanada Foundation for Innovation; Agusti Pedro i Pons Foundation	This work was supported by funding from NSERC, CIHR and CFI to BRC. CP was supported by Agusti Pedro i Pons Foundation. The authors would like to extend their gratitude to Dan McIlvaney for assistance in developing and printing the helmets described in this report. The authors would also like to thank Chris Secord in the University of Victoria Faculty of Science Machine Shop for their assistance in and designing and developing the impactor tips.	Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Arain M, 2015, ANN CLIN TRANSL NEUR, V2, P289, DOI 10.1002/acn3.163; Assini FL, 2009, BEHAV BRAIN RES, V204, P206, DOI 10.1016/j.bbr.2009.06.005; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Carmody DP, 2004, NEURORADIOLOGY, V46, P781, DOI 10.1007/s00234-004-1241-z; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Cheng WH, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0461-0; Christie Brian R, 2019, Curr Protoc Neurosci, V89, pe80, DOI 10.1002/cpns.80; Cockrell J., 1997, TRAUMATIC BRAIN INJU, V82, P1; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Denninger JK, 2018, JOVE-J VIS EXP, DOI 10.3791/58593; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Echemendia RJ., 2017, BR J SPORTS MED; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Frieden T.R., 2015, CDC NIH REP C, P1, DOI [10.3171/2009.10.JNS091500, DOI 10.3171/2009.10.JNS091500]; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gawel K, 2019, N-S ARCH PHARMACOL, V392, P1, DOI 10.1007/s00210-018-1589-y; Greco T., 2019, MECH UNDERLYING VULN; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Haettig J, 2011, LEARN MEMORY, V18, P71, DOI 10.1101/lm.1986911; Haynes RL, 2005, J COMP NEUROL, V484, P156, DOI 10.1002/cne.20453; Jankowski MM, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00045; Jones N.C., 2008, EXPT TRAUMATIC BRAIN, P1367; Jones N.C., 2007, ELEVATED ANXIETY DEP, DOI [10.1016/j.expneurol.2007.09.026, DOI 10.1016/J.EXPNEUROL.2007.09.026]; Kandiah N, 2014, PARKINSONISM RELAT D, V20, P1203, DOI 10.1016/j.parkreldis.2014.08.024; Kannangara TS, 2011, NEUROBIOL AGING, V32, P2279, DOI 10.1016/j.neurobiolaging.2009.12.025; Koizumi H, 2004, BRAIN DEV-JPN, V26, P434, DOI 10.1016/j.braindev.2003.09.011; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salmond CH, 2005, J NEUROTRAUM, V22, P613, DOI 10.1089/neu.2005.22.613; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Shultz SR, 2020, J NEUROTRAUM, V37, P2381, DOI 10.1089/neu.2018.6149; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Spear LP, 2013, J ADOLESCENT HEALTH, V52, pS7, DOI 10.1016/j.jadohealth.2012.05.006; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Verger K, 2000, BRAIN INJURY, V14, P495; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; White ER, 2017, J NEUROTRAUM, V34, P1111, DOI 10.1089/neu.2016.4638; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Ylvisaker M., 1998, COLLABORATIVE BRAIN, P1; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Zhang BL, 2011, CHINESE MED J-PEKING, V124, P740, DOI 10.3760/cma.j.issn.0366-6999.2011.05.020; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	97	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUN 1	2020	387								112585	10.1016/j.bbr.2020.112585			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	LK7YF	WOS:000531076800001	32184155				2022-02-06	
J	Regenbrecht, F; Glindemann, R; Buttner-Kunerl, J				Regenbrecht, Frank; Glindemann, Ralf; Buttner-Kunerl, Julia			The Necessity for Assessing Rating Procedures in the Treatment Planning Process in Cognitive Communication Disorders	SPRACHE-STIMME-GEHOR			German	Article							TRAUMATIC BRAIN-INJURY; VALIDITY; ABILITY		[Regenbrecht, Frank] Univ Klinikum Leipzig, Tagesklin Kognit Neurol, Leipzig, Germany; [Glindemann, Ralf] LMU Munchen, Entwicklungsgrp Klin Neuropsychol EKN, Munich, Germany; [Buttner-Kunerl, Julia] LMU Munchen, Fak Sprach & Literaturwissensch, Dept Germanist Komparatist Nordist 13, Deutsch Fremdsprache Studiengang Sprachtherapie, Munich, Germany		Regenbrecht, F (corresponding author), Tagesklin Kognit Neurol, Liebigstr 16,Haus 2, D-04103 Leipzig, Germany.	frank.regenbrecht@medizin.uni-leipzig.de					Buttner J., 2019, FORTSCHRITTE NEUROPS, V19; Buttner J, 2016, UNVEROFFENTLICHTES M; Cummings L, 2009, CLINICAL PRAGMATICS, P88; Damico J. S., 1985, COMMUNICATION SKILLS, P165; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Glindemann R, 2009, KOGNITIVNEUROLINGUIS, V21, P59; Grice H P, 1975, SPEECH ACTS SYNTAX S, V3, P41; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; Matthes-von Cramon G, 2000, LEHRBUCH KLIN NEUROP, P392; Meyer K, 2014, THESIS; Regenbrecht F, 2017, KOGNITIVE KOMMUNIKAT, V1, P16; Regenbrecht F, 2017, UNVEROFFENTLICHTES M; Schwarz Mathias Romme, 2013, THESIS; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Thone-Otto A, 2018, PERSONLICHKEITS VERH	16	2	2	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0342-0477	1439-1260		SPRACHE-STIMME-GEHOR	Sprache-Stimme-Gehor	JUN	2020	44	2					78	83		10.1055/a-1043-7259			6	Otorhinolaryngology; Rehabilitation	Emerging Sources Citation Index (ESCI)	Otorhinolaryngology; Rehabilitation	MB9XC	WOS:000542949800013		Bronze			2022-02-06	
J	Rennie, BJ; Goforth, AN				Rennie, Brandon J.; Goforth, Anisa N.			A Qualitative Examination of Social Changes and Challenges in Rural Adolescents With Traumatic Brain Injury	RURAL SPECIAL EDUCATION QUARTERLY			English	Article						rural special education; traumatic brain injury; concussion; social adjustment; interaction	UNITED-STATES; HEALTH-CARE; SHORT-TERM; CHILDREN; OUTCOMES; RECOVERY; IMPACT	This article describes the results of a qualitative investigation of social changes and challenges for rural adolescents who have a traumatic brain injury (TBI). We interviewed adolescents with mild to moderate TBI and their mothers using an iterative approach based in grounded theory. Interviews focused on social adjustment and interaction as well as environmental variables, especially those related to the adolescents' rural status. In-depth interviews produced multifaceted and interrelated social process themes expressed by participants in the study. Four umbrella themes emerged, which were personal change, environmental response, social needs, and facilitators and inhibitors of intentional changes (FIICs). These themes, and their subthemes, capture both assets and needs as they develop over time and provide guidance for both researchers and practitioners working with adolescents who have a TBI.	[Rennie, Brandon J.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Goforth, Anisa N.] Univ Montana, Missoula, MT 59812 USA		Rennie, BJ (corresponding author), Univ New Mexico, Ctr Dev & Disabil, Hlth Sci Ctr, 2300 Menaul Blvd NE, Albuquerque, NM 87107 USA.	brennie@salud.unm.edu		Goforth, Anisa/0000-0003-0745-6206			Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Beebe-Frankenberger M., 2014, BEST PRACTICES SCH P, VVI, P143; Benton A.L., 1976, MULTILINGUAL EXAMINA; Bowen GA, 2009, INT J SOC RES METHOD, V12, P305, DOI 10.1080/13645570802156196; Brenner LA, 2007, J HEAD TRAUMA REHAB, V22, P56, DOI 10.1097/00001199-200701000-00007; Bryman A., 2001, SOCIAL RES METHODS; Crisp R., 1994, J APPL REHABILITATIO, V25, P16; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Faul M, 2010, TRAUMATIC BRAIN INJU; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Goforth A. N., 2016, CONT SCH PSYCHOL, V21, P58, DOI [10.1007/s40688-016-0110-1, DOI 10.1007/S40688-016-0110-1]; Gresham FM., 1990, SOCIAL SKILLS RATING; Guba EG., 1989, 4 GENERATION EVALUAT; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Helflinger C.A., 2014, J RURAL MENT HLTH, V38, P9, DOI DOI 10.1037/RMH0000010; Henwood K, 2003, QUALITATIVE RESEARCH IN PSYCHOLOGY: EXPANDING PERSPECTIVES IN METHODOLOGY AND DESIGN, P131, DOI 10.1037/10595-008; Howell E, 2008, J HEALTH CARE POOR U, V19, P237, DOI 10.1353/hpu.2008.0008; Jones M, 2017, J OCCUP SCI, V24, P88, DOI 10.1080/14427591.2016.1224444; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lennon A, 2014, BRAIN INJURY, V28, P27, DOI 10.3109/02699052.2013.848378; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morse JM, 2002, INT J QUAL METH, V1, P13, DOI DOI 10.1177/160940690200100202; National Institute of Neurological Disorders and Stroke, 2010, US MAN QUAL LIF NEUR; NVivo, 2014, VERS 10; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Robertson B. D., 2010, DISS ABSTR INT A, V71, P354; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Solovieva TI, 2014, J REHABIL, V80, P10; Spearman RC, 2007, BRAIN INJURY, V21, P837, DOI 10.1080/02699050701426857; Stamm BH, 2007, PROF PSYCHOL-RES PR, V38, P298, DOI 10.1037/0735-7028.38.3.298; Strauss A., 2008, BASICS QUALITATIVE R, DOI 10.1080/13504620500081384.; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2008, WECHSLER ADULT INTEL; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Wolfe KR, 2015, J PEDIATR PSYCHOL, V40, P272, DOI 10.1093/jpepsy/jsu060; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; YEATES KO, 1991, MERRILL PALMER QUART, V37, P369	41	2	2	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	8756-8705	2168-8605		RURAL SPEC EDUC Q	Rural Spec. Educ. Q.	JUN	2020	39	2			SI		91	103		10.1177/8756870519892886			13	Education, Special	Emerging Sources Citation Index (ESCI)	Education & Educational Research	LR8ZP	WOS:000535985500005					2022-02-06	
J	Rogers, RC; Hasser, EM; Hermann, GE				Rogers, Richard C.; Hasser, Eileen M.; Hermann, Gerlinda E.			Thrombin action on astrocytes in the hindbrain of the rat disrupts glycemic and respiratory control	AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY			English	Article						hyperglycemia; nucleus of the solitary tract; phrenic nerve activity; respiratory arrest; trauma	NEURONAL-ACTIVITY; SOLITARY TRACT; CATECHOLAMINERGIC NEURONS; CALCIUM OSCILLATIONS; ACTIVATES ASTROCYTES; GLIAL-CELLS; BRAIN; GLUTAMATE; NUCLEUS; MODULATION	Severe trauma can produce a postinjury "metabolic self-destruction" characterized by catabolic metabolism and hyperglycemia. The severity of the hyperglycemia is highly correlated with posttrauma morbidity and mortality. Although no mechanism has been posited to connect severe trauma with a loss of autonomic control over metabolism, traumatic injury causes other failures of autonomic function, notably. gastric stasis and ulceration ("Cushing's ulcer"), which has been connected with the generation of thrombin. Our previous studies established that proteinase-activated receptors (PAR1; "thrombin receptors") located on astrocytes in the autonomically critical nucleus of the solitary tract (NST) can modulate gastric control circuit neurons to cause gastric stasis. Hindbrain astrocytes have also been implicated as important detectors of low glucose or glucose utilization. When activated, these astrocytes communicate with hindbrain catecholamine neurons that, in turn, trigger counter-regulatory responses (CRR). There may be a convergence between the effects of thrombin to derange hindbrain gastrointestinal control and the hindbrain circuitry that initiates CRR to increase glycemia in reaction to critical hypoglycemia. Our results suggest that thrombin acts within the NST to increase glycemia through an astrocyte-dependent mechanism. Blockade of purinergic gliotransmission pathways interrupted the effect of thrombin to increase glycemia. Our studies also revealed that thrombin, acting in the NST, produced a rapid, dramatic, and potentially lethal suppression of respiratory rhythm that was also a function of purinergic gliotransmission. These results suggest that the critical connection between traumatic injury and a general collapse of autonomic regulation involves thrombin action on astrocytes.	[Rogers, Richard C.; Hermann, Gerlinda E.] Pennington Biomed Res Ctr, Auton Neurosci Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Hasser, Eileen M.] Univ Missouri, Dalton Cardiovasc Res Ctr, Biomed Sci, Columbia, MO USA		Hermann, GE (corresponding author), Pennington Biomed Res Ctr, Auton Neurosci Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gerlinda.hermann@pbrc.edu	hermann, gerlinda/N-1967-2017	hermann, gerlinda/0000-0003-0405-2820; Hasser, Eileen/0000-0003-4552-1021	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-60664, NS-096113, DK-108765, HL-132836]	Funding support for this work came from National Institutes of Health Grants NS-60664, NS-096113, DK-108765, and HL-132836 and the John S. McIlhenny Professorship.	Ahn HS, 2000, BIOCHEM PHARMACOL, V60, P1425, DOI 10.1016/S0006-2952(00)00460-3; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Ballian N, 2010, BURNS, V36, P599, DOI 10.1016/j.burns.2009.11.008; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Blessing WW, 1997, LOWER BRAINSTEM BODI, P29; Bosarge Patrick L, 2013, Adv Surg, V47, P287; BUELKESAM J, 1978, LAB ANIM SCI, V28, P157; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Campos CA, 2015, AM J PHYSIOL-REG I, V308, pR1, DOI 10.1152/ajpregu.00388.2014; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Contreras-Ferrat A, 2014, CELL CALCIUM, V56, P390, DOI 10.1016/j.ceca.2014.08.012; Eakins James, 2009, J Diabetes Sci Technol, V3, P1373; Erlichman JS, 2010, RESP PHYSIOL NEUROBI, V173, P305, DOI 10.1016/j.resp.2010.06.009; Erlichman JS, 2010, J APPL PHYSIOL, V108, P1803, DOI 10.1152/japplphysiol.01321.2009; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Funk GD, 2010, J PHYSIOL-LONDON, V588, P4335, DOI 10.1113/jphysiol.2010.200196; Garcia-Caceres C, 2016, CELL, V166, P867, DOI 10.1016/j.cell.2016.07.028; Gourine AV, 2011, EXP PHYSIOL, V96, P411, DOI 10.1113/expphysiol.2010.053165; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hartl WH, 2014, NUTRITION, V30, P261, DOI 10.1016/j.nut.2013.07.019; HASSEL B, 1992, BRAIN RES, V576, P120, DOI 10.1016/0006-8993(92)90616-H; Hermann GE, 2005, J PHYSIOL-LONDON, V562, P553, DOI 10.1113/jphysiol.2004.076919; Hermann GE, 2008, NEUROSCIENTIST, V14, P53, DOI 10.1177/1073858407305725; Hermann GE, 2009, J NEUROSCI, V29, P9292, DOI 10.1523/JNEUROSCI.6063-08.2009; Hermann GE, 2009, BRAIN RES, V1273, P72, DOI 10.1016/j.brainres.2009.03.059; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Huda R, 2018, J PHYSIOL-LONDON, V596, P497, DOI 10.1113/JP275127; Huxtable AG, 2009, J NEUROSCI, V29, P14713, DOI 10.1523/JNEUROSCI.2660-09.2009; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Klip A, 2005, J CLIN INVEST, V115, P3403, DOI 10.1172/JCI27208; Koufakis T, 2019, HIGH ALT MED BIOL, V20, P1, DOI 10.1089/ham.2018.0076; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; LOHSE MJ, 1987, N-S ARCH PHARMACOL, V336, P204, DOI 10.1007/BF00165806; Losser MR, 2010, CRIT CARE, V14, DOI 10.1186/cc9100; Lu WY, 1997, NEUROSURGERY, V41, P416, DOI 10.1097/00006123-199708000-00017; Martin ED, 2007, GLIA, V55, P36, DOI 10.1002/glia.20431; Marty N, 2005, J CLIN INVEST, V115, P3545, DOI 10.1172/JCI26309; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Matott MP, 2017, J PHYSIOL-LONDON, V595, P6045, DOI 10.1113/JP274620; Matott MP, 2016, J NEUROPHYSIOL, V115, P1691, DOI 10.1152/jn.01054.2015; McDougal DH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00249; McDougal DH, 2013, AUTON NEUROSCI-BASIC, V175, P61, DOI 10.1016/j.autneu.2012.12.006; McDougal DH, 2011, J NEUROSCI, V31, P14037, DOI 10.1523/JNEUROSCI.2855-11.2011; Newhouse LP, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13106; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Porter JT, 1996, J NEUROSCI, V16, P5073; Rafacho A, 2013, ACTA PHYSIOL, V209, P77, DOI 10.1111/apha.12118; Rajani V, 2018, J PHYSIOL-LONDON, V596, P3245, DOI 10.1113/JP274727; Ribeiro JA, 2010, J ALZHEIMERS DIS, V20, pS3, DOI 10.3233/JAD-2010-1379; Ritter S, 2011, ENDOCRINOLOGY, V152, P4019, DOI 10.1210/en.2010-1458; ROGERS RC, 1995, AM J PHYSIOL-GASTR L, V268, pG1, DOI 10.1152/ajpgi.1995.268.1.G1; Rogers RC, 2018, AM J PHYSIOL-REG I, V315, pR153, DOI 10.1152/ajpregu.00368.2017; Rogers RC, 2016, AM J PHYSIOL-REG I, V310, pR1102, DOI 10.1152/ajpregu.00493.2015; Rohatgi T, 2004, NEUROSCIENTIST, V10, P501, DOI 10.1177/1073858404269955; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Seabrook GR, 2002, J PHARMACOL EXP THER, V303, P1052, DOI 10.1124/jpet.102.040394; Strohl KP, 1996, SLEEP, V19, pS225, DOI 10.1093/sleep/19.suppl_10.S225; SWANSON RA, 1994, BRAIN RES, V664, P94, DOI 10.1016/0006-8993(94)91958-5; Tanaka K, 2009, ANESTHESIOLOGY, V111, P1044, DOI 10.1097/ALN.0b013e3181bbcb0d; Torrella M, 2015, DIABETES METAB, V41, P312, DOI 10.1016/j.diabet.2015.01.002; Turovsky E, 2016, J NEUROSCI, V36, P10750, DOI 10.1523/JNEUROSCI.1281-16.2016; Vance KM, 2015, J NEUROSCI, V35, P776, DOI 10.1523/JNEUROSCI.3105-14.2015; Vreugdenhil HA, 2004, EUR RESPIR J, V23, P122, DOI 10.1183/09031936.03.00035003; Wood J.D., 2012, PHYSL GASTROINTESTIN, P861, DOI [10.1016/B978-0-12-382026-6.00031-2, DOI 10.1016/B978-0-12-382026-6.00031-2]; YOUNG B, 1992, J NEUROTRAUM, V9, pS375	76	2	2	0	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6119	1522-1490		AM J PHYSIOL-REG I	Am. J. Physiol.-Regul. Integr. Comp. Physiol.	JUN	2020	318	6					R1068	R1077		10.1152/ajpregu.00033.2020			10	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	OG0XE	WOS:000581617400006	32320636	Green Published, hybrid			2022-02-06	
J	Salehi, R; Mofateh, R; Mehravar, M; Negahban, H; Tajali, S; Monjezi, S				Salehi, Reza; Mofateh, Razieh; Mehravar, Mohammad; Negahban, Hossein; Tajali, Shirin; Monjezi, Saeideh			Comparison of the lower limb inter-segmental coordination during walking between healthy controls and people with multiple sclerosis with and without fall history	MULTIPLE SCLEROSIS AND RELATED DISORDERS			English	Article						Multiple sclerosis; Fall; Gait; Inter-segmental coordination; Variability	JOINT COORDINATION; DIVIDED-ATTENTION; TREADMILL WALKING; GAIT VARIABILITY; MOVEMENT; YOUNG; CONCUSSION; DIFFERS; BALANCE; PELVIS	Background: This research aims to compare lower limb inter -segmental coordination, a higher order property of the human movement system, during walking between healthy controls and people with multiple sclerosis (PwMS) with and without fall history. Methods: Fifty PwMS (25 patients with fall history and 25 patients without fall history) and 25 healthy controls participated in the present study. Three-dimensional coordinate data of the lower limbs were collected during treadmill walking at a preferred walking speed. The phasing relationship and its variability between lower limb segments were evaluated using the mean absolute relative phase (MARP) and deviation phase (DP) during the stance and swing phases of gait. Results: Compared to healthy controls, both groups of PwMS demonstrated signi ficantly greater shank -thigh MARP values during the stance phase ( p < 0.001). In addition, MARP values of foot -shank coordination were signi ficantly smaller in both groups of PwMS than the healthy controls during both the stance and swing phases ( p < 0.001). For the DP of shank -thigh coordination, our analysis revealed greater values in both MS fallers and non-fallers compared to healthy controls during the stance ( p < 0.001) and swing phases ( p < 0.001, p = 0.004, respectively). Moreover, MS fallers demonstrated greater DP values than non-fallers in swing phase ( p = 0.02). For the DP of foot -shank coordination, MS fallers showed greater values compared to non-fallers and healthy controls during the stance ( p = 0.009, p = 0.001, respectively) and swing phases ( p = 0.01, p = 0.006, re- spectively). Conclusion: Our results suggest that in addition to traditional gait parameters, examining and also facilitating lower limb inter -segmental coordination should be considered in future studies aimed at improving gait per- formance and reducing risk of falling in PwMS.	[Salehi, Reza] Iran Univ Med Sci, Sch Rehabil Sci, Dept Rehabil Management, Rehabil Res Ctr, Tehran, Iran; [Mofateh, Razieh; Mehravar, Mohammad; Tajali, Shirin; Monjezi, Saeideh] Ahvaz Jundishapur Univ Med Sci, Musculoskeletal Rehabil Res Ctr, Ahvaz, Iran; [Negahban, Hossein] Mashhad Univ Med Sci, Sch Paramed Sci, Dept Phys Therapy, Mashhad, Razavi Khorasan, Iran; [Negahban, Hossein] Mashhad Univ Med Sci, Orthoped Res Ctr, Mashhad, Razavi Khorasan, Iran; [Tajali, Shirin] Univ Toronto, Dept Phys Therapy, Univ Hlth Network UHN, Toronto, ON, Canada; [Monjezi, Saeideh] Ahvaz Jundishapur Univ Med Sci, Student Res Comm, Ahvaz, Iran		Mofateh, R (corresponding author), Ahvaz Jundishapur Univ Med Sci, Musculoskeletal Rehabil Res Ctr, Ahvaz, Iran.	mofatehr@yahoo.com	Monjezi, Saeideh/AAD-7401-2020; Mehravar, Mohamad/L-8621-2017; Mofateh, Razieh/AAY-7108-2020; salehi, reza/Q-5721-2017	Monjezi, Saeideh/0000-0001-9963-8108; Mehravar, Mohamad/0000-0001-8834-6521; Mofateh, Razieh/0000-0003-0902-1900; salehi, reza/0000-0001-6793-7293	Ahvaz Jundishapur University of Medical Sciences	This investigation was supported by the Ahvaz Jundishapur University of Medical Sciences (grant no: pht-9418).	Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; Bernshtein NA, 1967, COORDINATION REGULAT; Byrne JE, 2002, PERCEPT MOTOR SKILL, V94, P265, DOI 10.2466/PMS.94.1.265-280; Cameron MH, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/496325; Carollo JJ, 2018, CLIN BIOMECH, V59, P40, DOI 10.1016/j.clinbiomech.2018.07.015; Chen HL, 2015, J MED BIOL ENG, V35, P28, DOI 10.1007/s40846-015-0002-2; Chiu SL, 2015, GAIT POSTURE, V42, P152, DOI 10.1016/j.gaitpost.2015.05.003; Chiu SL, 2015, GAIT POSTURE, V41, P316, DOI 10.1016/j.gaitpost.2014.09.015; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Chiu SL, 2013, CLIN BIOMECH, V28, P454, DOI 10.1016/j.clinbiomech.2013.03.001; Chiu SL, 2012, J BIOMECH, V45, P275, DOI 10.1016/j.jbiomech.2011.10.028; Comber L, 2017, GAIT POSTURE, V51, P25, DOI 10.1016/j.gaitpost.2016.09.026; CORDO P, 1994, J NEUROPHYSIOL, V71, P1848, DOI 10.1152/jn.1994.71.5.1848; Cordo PJ, 2004, PROG BRAIN RES, V143, P29, DOI 10.1016/S0079-6123(03)43003-3; Ebrahimi S, 2017, HUM MOVEMENT SCI, V52, P55, DOI 10.1016/j.humov.2017.01.004; Ghanavati T, 2014, J BIOMECH, V47, P2300, DOI 10.1016/j.jbiomech.2014.04.038; Gianni C, 2014, CLIN REHABIL, V28, P704, DOI 10.1177/0269215513517575; Gunn H, 2014, ARCH PHYS MED REHAB, V95, P538, DOI 10.1016/j.apmr.2013.08.244; Hafer JF, 2017, GAIT POSTURE, V51, P222, DOI 10.1016/j.gaitpost.2016.11.004; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; Huisinga JM, 2013, ANN BIOMED ENG, V41, P1670, DOI 10.1007/s10439-012-0697-y; Kalron A, 2018, J NEURAL TRANSM, V125, P945, DOI 10.1007/s00702-018-1843-y; Kalron M, 2017, PEDIATR NEUROL, V68, P73, DOI 10.1016/j.pediatrneurol.2016.11.004; Kasser SL, 2011, ARCH PHYS MED REHAB, V92, P1840, DOI 10.1016/j.apmr.2011.06.004; Kirtley C., 2006, CLIN GAIT ANAL THEOR; Lacquaniti F, 1997, ARCH ITAL BIOL, V135, P353; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Lublin FD, 2014, EUR NEUROL, V72, P1, DOI 10.1159/000367614; Mayville JM, 2002, HUM BRAIN MAPP, V17, P214, DOI 10.1002/hbm.10065; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Mofateh R, 2017, MULT SCLER RELAT DIS, V18, P8, DOI 10.1016/j.msard.2017.09.002; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Rafiaei M, 2016, PROSTHET ORTHOT INT, V40, P202, DOI 10.1177/0309364615588346; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; Seay JF, 2011, CLIN BIOMECH, V26, P572, DOI 10.1016/j.clinbiomech.2010.11.012; Shafizadeh M., 2013, CLIN KINESIOL, V67; Siciliano B., 2016, SPRINGER HDB ROBOTIC; Sinkjaer T, 1996, J NEUROL, V243, P566, DOI 10.1007/BF00900943; Socie MJ, 2013, ANN BIOMED ENG, V41, P1740, DOI 10.1007/s10439-012-0685-2; Sosnoff JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028021; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; Tajali S, 2019, CLIN BIOMECH, V67, P197, DOI 10.1016/j.clinbiomech.2019.05.013; Tajali S, 2017, MULT SCLER RELAT DIS, V17, P69, DOI 10.1016/j.msard.2017.06.014; WINTER DA, 1992, PHYS THER, V72, P45, DOI 10.1093/ptj/72.1.45; Woollacott, 2007, MOTOR CONTROL TRANSL; Yamagata M, 2019, J BIOMECH, V82, P204, DOI 10.1016/j.jbiomech.2018.10.032; Zackowski KM, 2002, EXP BRAIN RES, V146, P511, DOI 10.1007/s00221-002-1191-9; ZAJAC FE, 1993, J BIOMECH, V26, P109, DOI 10.1016/0021-9290(93)90083-Q; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	49	2	3	2	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2211-0348	2211-0356		MULT SCLER RELAT DIS	Mult. Scler. Relat. Disord.	JUN	2020	41								102053	10.1016/j.msard.2020.102053			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD6FW	WOS:000544068400009	32203931				2022-02-06	
J	Shald, EA; Reeder, J; Finnick, M; Patel, L; Evans, K; Faber, RK; Gilbert, BW				Shald, Elizabeth A.; Reeder, Jacob; Finnick, Michael; Patel, Lshani; Evans, Kyle; Faber, Rebecca K.; Gilbert, Brian W.			Pharmacological Treatment for Paroxysmal Sympathetic Hyperactivity	CRITICAL CARE NURSE			English	Article							TRAUMATIC BRAIN-INJURY; DYSAUTONOMIA	BACKGROUND Paroxysmal sympathetic hyperactivity, which affects up to 10% of all acquired brain injury survivors, is characterized by elevated heart rate, blood pressure, respiratory rate, and temperature; diaphoresis; and increased posturing. Pharmacological agents that have been studied in the management of this disorder include opiates, g-aminobutyric acid agents, dopaminergic agents, and beta blockers. Although paroxysmal sympathetic hyperactivity is a relatively common complication after acquired brain injury, there is a paucity of recommendations or comparisons of agents for the management of this disorder. OBJECTIVE To evaluate all relevant literature on pharmacological therapies used to manage patients with paroxysmal sympathetic hyperactivity to help elucidate possible best practices. METHODS Of the 27 studies evaluated for inclusion, 10 studies received full review: 4 retrospective cohort studies, 5 single case studies, and 1 case series. RESULTS Monotherapy is usually not effective in the management of paroxysmal sympathetic hyperactivity and multiple agents with different mechanisms of action should be considered. alpha(2)-Agonists such as dexmedetomidine may hold some slight clinical efficacy over agents like propofol, and with respect to oral medications, propranolol might convey some slight advantage compared to others. However, with the limited data available, these results must be interpreted with caution. CONCLUSIONS As the treatment of paroxysmal sympathetic hyperactivity is reactive to symptomatic evolution over time, critical care nurses play a vital role in the monitoring and treatment of these patients. Limited data exist on the management of paroxysmal sympathetic hyperactivity and larger robust data sets are needed to guide decision-making.	[Shald, Elizabeth A.; Finnick, Michael; Patel, Lshani; Evans, Kyle] Univ Florida, Coll Pharm, Jacksonville, FL USA; [Reeder, Jacob; Gilbert, Brian W.] Wesley Med Ctr, 550 N Hillside Ave, Wichita, KS 67214 USA; [Faber, Rebecca K.] Wesley Med Ctr, Nursing, Wichita, KS USA		Gilbert, BW (corresponding author), Wesley Med Ctr, 550 N Hillside Ave, Wichita, KS 67214 USA.	brian.gilbert.pharmd@gmail.com					Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Lemke DM, 2007, CRIT CARE NURSE, V27, P30; Liu Y, 2013, CASE REP MED, V2013, DOI 10.1155/2013/358182; May CC, 2015, PHARMACOTHERAPY, V35, pE27, DOI 10.1002/phar.1568; Penfield W, 1954, EPILEPSY FUNCTIONAL, P412; Peng Y, 2017, ONCOTARGET, V8, P69012, DOI 10.18632/oncotarget.16920; Pozzi M, 2017, J HEAD TRAUMA REHAB, V32, P117, DOI 10.1097/HTR.0000000000000255; Pozzi M, 2015, J HEAD TRAUMA REHAB, V30, P357, DOI 10.1097/HTR.0000000000000084; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Raithel Deborah S, 2015, J Pediatr Pharmacol Ther, V20, P335, DOI 10.5863/1551-6776-20.4.335; Siefferman JW, 2015, CASE REP NEUROL MED, V2015, DOI 10.1155/2015/421563; Tang QL, 2017, PEERJ, V5, DOI 10.7717/peerj.2986	15	2	2	1	1	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	0279-5442	1940-8250		CRIT CARE NURSE	Crit. Care Nurse	JUN	2020	40	3					E9	E16		10.4037/ccn2020348			8	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	NO3FM	WOS:000569370200002	32476028	Bronze			2022-02-06	
J	Straudi, S; Severini, G; Da Roit, M; Pizzongolo, LD; Martinuzzi, C; Basaglia, N				Straudi, Sofia; Severini, Giacomo; Da Roit, Marco; Pizzongolo, Laura Di Marco; Martinuzzi, Carlotta; Basaglia, Nino			The dose of robot-assisted gait therapy may influence functional recovery in a multidisciplinary rehabilitation program: an exploratory retrospective study	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						clinical practice; functional recovery; multidisciplinary rehabilitation; robot-assisted gait training	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; INPATIENT REHABILITATION; NEUROREHABILITATION; INDEPENDENCE; EPIDEMIOLOGY; GUIDELINES; LOKOMAT; PEOPLE; STROKE	Robot-assisted gait training (RAGT) has been introduced in clinical practice to increase training intensity in patients with neurological disorders. In this observational study, we investigated the effect of the number of RAGT sessions on functional recovery in a heterogeneous cohort of patients. We included patients with a diagnosis of gait impairment due to a neurological disease. A set of demographic, clinical, functional and training parameters was collected for each participant. Each patient received RAGT with an exoskeleton (Lokomat; Hocoma, Volketswil, Switzerland) as part of a multidisciplinary rehabilitation program. We stratified the patients as good responders and poor responders and investigated the effect of varying the number of RAGT sessions with a series of logistic regression models. A total of 143 patients were included in this analysis (good responders = 65, poor responders = 78). Good responder patients spent more days in the hospital (P < 0.01) and underwent a higher number of RAGT sessions (P = 0.04) compared to poor responder patients. Logistic regression models estimated that adding six RAGT sessions mildly increased (by approximately 4%) the probability of a patient becoming a good responder. The rehabilitation phase (subacute/chronic) appeared to be the main determinant of the probability of being a good responder, and stroke patients appeared to be more sensitive to changes in the number of RAGT sessions. Our results seem to confirm previous observations that robotic therapy increases the intensity of rehabilitation, possibly leading to a greater functional recovery in subacute patients with greater impairment.	[Straudi, Sofia; Da Roit, Marco; Pizzongolo, Laura Di Marco; Martinuzzi, Carlotta; Basaglia, Nino] Ferrara Univ Hosp, Neurosci & Rehabil Dept, Via Aldo Moro 8, I-44124 Ferrara, Italy; [Severini, Giacomo] Univ Coll Dublin, Sch Elect & Elect Engn, Dublin, Ireland		Straudi, S (corresponding author), Ferrara Univ Hosp, Neurosci & Rehabil Dept, Via Aldo Moro 8, I-44124 Ferrara, Italy.	s.straudi@ospfe.it	Da Roit, Marco/G-4784-2015; Straudi, Sofia/AAI-6971-2021; Da Roit, Marco/N-7330-2019	Da Roit, Marco/0000-0003-3328-7047; Straudi, Sofia/0000-0002-2061-9922; Da Roit, Marco/0000-0003-3328-7047	Emilia-Romagna regionRegione Emilia Romagna [1786/2012]	Marco Da Roit, Laura Di Marco Pizzongolo and Carlotta Martinuzzi were supported by Emilia-Romagna region (grant 1786/2012).	Ashley JG, 2018, BRAIN INJURY, V32, P600, DOI 10.1080/02699052.2018.1432896; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Chiavaroli F, 2016, DISABIL REHABIL, V38, P2038, DOI 10.3109/09638288.2015.1111439; Chisari C, 2015, EUR J PHYS REHAB MED, V51, P59; Conesa L, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-13; Dierick F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178636; Edwards MJ, 2003, DISABIL REHABIL, V25, P405, DOI 10.1080/0963828031000062642; Esquenazi A, 2017, PM&R, V9, P839, DOI 10.1016/j.pmrj.2016.12.010; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Lexell J, 2015, NEUROREHABILITATION, V36, P5, DOI 10.3233/NRE-141184; McLafferty FS, 2016, NEUROREHABILITATION, V39, P423, DOI 10.3233/NRE-161373; Mehrholz J, 2017, STROKE, V48, pE188, DOI 10.1161/STROKEAHA.117.018018; Morone G, 2018, RESTOR NEUROL NEUROS, V36, P293, DOI 10.3233/RNN-170799; Morone G, 2011, NEUROREHAB NEURAL RE, V25, P636, DOI 10.1177/1545968311401034; Nam KY, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0232-3; Schwartz I, 2015, ANN BIOMED ENG, V43, P1260, DOI 10.1007/s10439-015-1283-x; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Stabel HH, 2017, ARCH PHYS MED REHAB, V98, P759, DOI 10.1016/j.apmr.2016.11.010; Straudi S, 2016, MULT SCLER J, V22, P373, DOI 10.1177/1352458515620933; van der Putten JJMF, 1999, J NEUROL NEUROSUR PS, V66, P480, DOI 10.1136/jnnp.66.4.480; Veerbeek JM, 2011, STROKE, V42, P3311, DOI 10.1161/STROKEAHA.111.623819; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Whiteneck G, 2011, J SPINAL CORD MED, V34, P133, DOI 10.1179/107902611X12971826988011; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098	26	2	2	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	JUN	2020	43	2					175	182		10.1097/MRR.0000000000000407			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	LO8LB	WOS:000533876100012	32221149				2022-02-06	
J	Sun, YY; Zhu, L; Sun, ZL; Feng, DF				Sun, Yi-Yu; Zhu, Liang; Sun, Zhao-Liang; Feng, Dong-Fu			CRMP2 improves memory deficits by enhancing the maturation of neuronal dendritic spines after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						CRMP2; Traumatic brain injury; Dendritic spine; Learn and memory function	RESPONSE MEDIATOR PROTEIN-2; ACTIN CYTOSKELETON; PLASTICITY; DYNAMICS; RECEPTOR; PHOSPHORYLATION; TRANSPORT; MODEL	Our recent study investigated the role of collapsin response mediator protein-2 (CRMP2) on dendritic spine morphology and memory function after traumatic brain injury (TBI). First, we examined the density and morphology of dendritic spines in Thy1-GFP mice on the 1 st day (P1D) and 7th day (P7D) after controlled cortical impact injury (CCI). The dendritic spine density in the hippocampus was decreased on P1D, in which mainly mushroom-type and thin-type spines were lost. The density of dendritic spines was increased on P7D, most of which were of the thin type. Next, we explored the expression of CRMP2 on P1D and P7D. CRMP2 expression was decreased on P1D, but the levels of the CRMP2 breakdown product were increased. On P7D, the expression pattern was the opposite. Then, we constructed CRMP2 overexpression and knockdown plasmids and transfected them into cultured neurons in vitro. CRMP2 increased the dendritic spine density of cultured neurons and the proportion of mushroom-type spines, while CRMP2-shRNA reduced the dendritic spine density and the proportion of mushroom-type spines. To determine the role of CRMP2 in dendritic spines after TBI, we stereotactically injected the CRMP2 overexpression and knockdown viruses into the hippocampus and found that CRMP2 increased the dendritic spine density and the proportion of mushroom-type spines after TBI. Meanwhile, as suggested by the morphological changes, fear conditioning behavioral experiments confirmed that CRMP2 improved memory deficits after TBI.	[Sun, Yi-Yu; Zhu, Liang; Sun, Zhao-Liang; Feng, Dong-Fu] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Neurosurg, Shanghai 201999, Peoples R China; [Feng, Dong-Fu] Shanghai Jiao Tong Univ, Sch Med, Inst Traumat Med, Shanghai 201999, Peoples R China		Feng, DF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Neurosurg, Shanghai 201999, Peoples R China.	drneuro@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372047, 81772059]	This work was supported by National Natural Science Foundation of China (81372047, 81772059).	Abe H, 2018, SCIENCE, V360, P50, DOI 10.1126/science.aao2300; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Bellot A, 2014, BRAIN RES, V1573, P1, DOI 10.1016/j.brainres.2014.05.024; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Chi XX, 2009, J CELL SCI, V122, P4351, DOI 10.1242/jcs.053280; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Frotscher M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00094; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gibbs KL, 2015, TRENDS BIOCHEM SCI, V40, P597, DOI 10.1016/j.tibs.2015.08.003; Gipson CD, 2017, GENES BRAIN BEHAV, V16, P101, DOI 10.1111/gbb.12324; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Hart Tessa, 2017, Arch Phys Med Rehabil, V98, P407, DOI 10.1016/j.apmr.2016.09.112; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Hensley K, 2010, J NEUROSCI, V30, P2979, DOI 10.1523/JNEUROSCI.5247-09.2010; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hou ST, 2009, J NEUROCHEM, V111, P870, DOI 10.1111/j.1471-4159.2009.06375.x; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Ip JPK, 2014, NEUROSCIENTIST, V20, P589, DOI 10.1177/1073858413514278; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Lei WL, 2016, CURR OPIN NEUROBIOL, V39, P86, DOI 10.1016/j.conb.2016.04.010; Makihara H, 2016, GENES CELLS, V21, P994, DOI 10.1111/gtc.12399; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Nagai J, 2016, EXP NEUROL, V277, P283, DOI 10.1016/j.expneurol.2016.01.015; Nakamura H, 2016, GENES CELLS, V21, P1059, DOI 10.1111/gtc.12403; Paulin JJW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6170509; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Ratliff WA, 2019, EXP NEUROL, V315, P9, DOI 10.1016/j.expneurol.2019.01.020; Segal M, 2017, NEUROBIOL LEARN MEM, V138, P3, DOI 10.1016/j.nlm.2016.06.007; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wilson SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00135; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu NJ, 2011, NAT NEUROSCI, V14, P1421, DOI 10.1038/nn.2931; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang Hongsheng, 2016, NAT COMMUN, V7; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z	53	2	2	4	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2020	328								113253	10.1016/j.expneurol.2020.113253			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LG1SA	WOS:000527888300005	32084454				2022-02-06	
J	Sunderaraman, P; Ho, S; Chapman, S; Joyce, JL; Colvin, L; Omollo, S; Pleshkevich, M; Cosentino, S				Sunderaraman, Preeti; Ho, Sarah; Chapman, Silvia; Joyce, Jillian L.; Colvin, Leigh; Omollo, Shalom; Pleshkevich, Maria; Cosentino, Stephanie			Technology Use in Everyday Financial Activities: Evidence from Online and Offline Survey Data	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Financial capacity; Financial decision-making; Online banking; Mobile banking; Information technology; Assessment	TRAUMATIC BRAIN-INJURY; INTERNET BANKING ADOPTION; OLDER-ADULTS; INFORMATION; GUIDELINES; ABILITIES; CAPACITY; AGE	Objective: Internet use and mobile devices permeate every aspect of our lives and are changing our financial habits. Assessment of financial decision-making (FDM) has not yet caught up to apparent changes in financial behavior. To modernize assessment methods and create current and comprehensive FDM frameworks, we first need to establish the most commonly used and most preferred methods of performing specific financial activities. Method: Cross-sectional survey data were collected using an online platform and offline approaches (in person and by mail) (N = 234). The frequency of using technological (e.g., laptop) and non-technological (e.g., in-person banking) means of completing seven financial activities was assessed first, including Depositing checks, Reviewing bank statements, Keeping track of money spent, Transferring funds, Withdrawing cash, Paying bills, and Purchasing products online. Second, preference for technological versus non-technological methods was assessed. Finally, linear regression models examined associations between demographics and preference for technological methods for each financial activity. Results: The majority of respondents (77% online, 74% offline) used technology to perform various financial activities and preferred technological to non-technological methods for completing five out of the six financial activities. Increased preference for technological methods was associated with younger age for all the financial activities, and higher education was associated with reviewing bank statement and transferring funds. Conclusions: Our survey findings provide empirical evidence for the changing nature of our financial habits. We discuss the implications of this change for researchers, clinicians, and the individuals themselves and emphasize the importance of modernizing FDM tools.	[Sunderaraman, Preeti; Ho, Sarah; Chapman, Silvia; Joyce, Jillian L.; Colvin, Leigh; Omollo, Shalom; Pleshkevich, Maria; Cosentino, Stephanie] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, Cognit Neurosci Div, New York, NY 10032 USA; [Sunderaraman, Preeti; Chapman, Silvia; Joyce, Jillian L.; Pleshkevich, Maria; Cosentino, Stephanie] Columbia Univ, GH Sergievsky Ctr, Med Ctr, New York, NY 10032 USA; [Sunderaraman, Preeti; Cosentino, Stephanie] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA		Sunderaraman, P (corresponding author), Columbia Univ, Med Ctr, Taub Inst, Cognit Neurosci Div, 630 West 168th St,P&S Box 16, New York, NY 10032 USA.; Sunderaraman, P (corresponding author), Columbia Univ, Med Ctr, Gertrude H Sergievsky Ctr, 630 West 168th St,P&S Box 16, New York, NY 10032 USA.	ps2548@cumc.columbia.edu	CHAPMAN, SILVIA/AAU-4316-2020	CHAPMAN, SILVIA/0000-0002-4508-4557; Ho, Sarah/0000-0002-6249-0450	National Institutes of Health's Ruth L. Kirschstein Predoctoral Individual National Research Service AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5F32AG053035-02]; National Academy of Neuropsychology Clinical Research Grant	This work was supported by the National Institutes of Health's Ruth L. Kirschstein Predoctoral Individual National Research Service Award (5F32AG053035-02) and by the National Academy of Neuropsychology Clinical Research Grant.	[Anonymous], 2015, US NEWS WORLD REPORT; [Anonymous], 2017, INT BROADB FACT SHEE; Appelbaum P, 2016, INFORM SOCIAL SECURI, DOI 10.21922; Bank of America, 2017, TRENDS CONS MOB REP; Bimber B, 2000, SOC SCI QUART, V81, P868; Chang H.-C., 2006, J AM ACAD BUSINESS, V9, P210; Chiou JS, 2012, BEHAV INFORM TECHNOL, V31, P859, DOI 10.1080/0144929X.2010.549509; Choudrie J, 2018, J BUS RES, V88, P449, DOI 10.1016/j.jbusres.2017.11.029; Choudrie J, 2014, TECHNOL FORECAST SOC, V89, P293, DOI 10.1016/j.techfore.2014.08.007; Consumer Financial Protection Bureau, 2016, REP REC FIGHT ELD FI, P3; Czaja SJ, 2017, J ALZHEIMERS DIS, V57, P1229, DOI 10.3233/JAD-161183; Engel L, 2016, J CLIN EXP NEUROPSYC, V38, P76, DOI 10.1080/13803395.2015.1087468; Finucane ML, 2005, PSYCHOL AGING, V20, P71, DOI 10.1037/0882-7974.20.1.71; Flavian C, 2006, INT J BANK MARK, V24, P406, DOI 10.1108/02652320610701735; Fox S, 2013, 51 US ADULTS BANK ON; Gamble K. J., 2015, DOES AGING AFFECT FI; Germine L., 2018, CLIN NEUROPSYCHOL, V33, P1; Giordani G, 2014, J ECON STUD, V41, P586, DOI 10.1108/JES-04-2011-0042; Griffith HR, 2003, NEUROLOGY, V60, P449, DOI 10.1212/WNL.60.3.449; Hoofien D, 2001, BRAIN INJURY, V15, P189; Joshi VK, 2016, 2016 INTERNATIONAL CONFERENCE ON ADVANCES IN ELECTRICAL, ELECTRONIC AND SYSTEMS ENGINEERING (ICAEES), P58, DOI 10.1109/ICAEES.2016.7888009; Ke Chen, 2011, Gerontechnology, V10, P1, DOI 10.4017/gt.2011.10.01.006.00; Kleijnen M, 2009, J ECON PSYCHOL, V30, P344, DOI 10.1016/j.joep.2009.02.004; Korniotis GM, 2011, REV ECON STAT, V93, P244, DOI 10.1162/REST_a_00053; Kwon WS, 2010, J FASH MARK MANAG, V14, P335, DOI 10.1108/13612021011061825; Laukkanen T, 2007, J CONSUM MARK, V24, P419, DOI 10.1108/07363760710834834; Lera-Lopez F, 2011, ECON INNOV NEW TECH, V20, P127, DOI 10.1080/10438590903378017; Lian JW, 2014, COMPUT HUM BEHAV, V37, P133, DOI 10.1016/j.chb.2014.04.028; Lichtenberg PA, 2015, CLIN GERONTOLOGIST, V38, P49, DOI 10.1080/07317115.2014.970318; Lusardi A., 2017, BUS ECON, V42, P35, DOI [DOI 10.2145/20070104, 10.2145/20070104]; Mansumitrchai S., 2012, INT J MANAGEMENT MAR, V5, P103; Marson D, 2016, ARCH CLIN NEUROPSYCH, V31, P541, DOI 10.1093/arclin/acw052; Martin RC, 2012, J HEAD TRAUMA REHAB, V27, pE81, DOI 10.1097/HTR.0b013e318273de49; Menard S.W., 1995, APPL LOGISTIC REGRES; Miller JB, 2017, ARCH CLIN NEUROPSYCH, V32, P541, DOI 10.1093/arclin/acx050; Molesworth M., 2002, J CONSUMER BEHAV INT, V2, P155, DOI [DOI 10.1002/CB.97, 10.1002/cb.97]; Mottola GR., 2013, NUMERACY, V6, P4, DOI [10.5038/1936-4660.6.2.4, DOI 10.5038/1936-4660.6.2.4]; Myers R. H., 1990, CLASSICAL MODERN REG, V2; National Academies of Sciences Engineering & Medicine, 2016, INF SOC SEC PROC FIN; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Polasik M, 2009, INT J BANK MARK, V27, P32, DOI 10.1108/02652320910928227; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; RAM S, 1987, ADV CONSUM RES, V14, P208; Selwyn N, 2004, J AGING STUD, V18, P369, DOI 10.1016/j.jaging.2004.06.008; Settle, 2011, J BUSINESS EC RES, V9, P99, DOI [10.19030/jber.v9i1.946, DOI 10.19030/JBER.V9I1.946]; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Spreng RN, 2017, J GERONTOL A-BIOL, V72, P1365, DOI 10.1093/gerona/glx051; Sunderaraman P, 2019, BRAIN INJURY, V33, P991, DOI 10.1080/02699052.2019.1570340; Sunderaraman P, 2018, J HEAD TRAUMA REHAB, V33, pE85, DOI 10.1097/HTR.0000000000000382; Taha J, 2009, GERONTOLOGIST, V49, P663, DOI 10.1093/geront/gnp058; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Wagner N, 2010, COMPUT HUM BEHAV, V26, P870, DOI 10.1016/j.chb.2010.03.029; WHITE H, 2004, J FINANCIAL SERVICES, V0009, P00049; Yiu CS, 2007, INT J INFORM MANAGE, V27, P336, DOI 10.1016/j.ijinfomgt.2007.03.002; Jimenez JRZ, 2019, J BEHAV EXP FINANC, V22, P31, DOI 10.1016/j.jbef.2019.01.004	55	2	2	1	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2020	35	4					385	400		10.1093/arclin/acz042			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN7WD	WOS:000568996800005	31696205	Bronze, Green Published			2022-02-06	
J	Vehvilainen, J; Brinck, T; Lindfors, M; Numminen, J; Siironen, J; Raj, R				Vehvilainen, Juho; Brinck, Tuomas; Lindfors, Matias; Numminen, Jussi; Siironen, Jari; Raj, Rahul			Occurrence and prognostic effect of cervical spine injuries and cervical artery injuries with concomitant severe head injury	ACTA NEUROCHIRURGICA			English	Article						Head injury; Traumatic brain injury; Blunt cerebrovascular injury; Cervical spine injury; Cervical trauma	BLUNT CEREBROVASCULAR INJURY; TRAUMATIC BRAIN-INJURY; ANTIPLATELET TREATMENT; SCREENING CRITERIA; ANTICOAGULATION; RADIOGRAPHY; ANGIOGRAPHY; DISSECTION; MANAGEMENT; STROKE	Background Blunt cerebrovascular injuries (BCVIs) and cervical spinal injuries (CSIs) are not uncommon injuries in patients with severe head injury and may affect patient recovery. We aimed to assess the independent relationship between BCVI, CSI, and outcome in patients with severe head injury. Methods We identified patients with severe head injury from the Helsinki Trauma Registry treated during 2015-2017 in a large level 1 trauma hospital. We assessed the association between BCVI and SCI using multivariable logistic regression, adjusting for injury severity. Our primary outcome was functional outcome at 6 months, and our secondary outcome was 6-month mortality. Results Of 255 patients with a cervical spine CT, 26 patients (10%) had a CSI, and of 194 patients with cervical CT angiography, 16 patients (8%) had a BCVI. Four of the 16 BCVI patients had a BCVI-related brain infarction, and four of the CSI patients had some form of spinal cord injury. After adjusting for injury severity in multivariable logistic regression analysis, BCVI associated with poor functional outcome (odds ratio [OR] = 6.0, 95% CI [confidence intervals] = 1.4-26.5) and mortality (OR = 7.9, 95% CI 2.0-31.4). We did not find any association between CSI and outcome. Conclusions We found that BCVI with concomitant head injury was an independent predictor of poor outcome in patients with severe head injury, but we found no association between CSI and outcome after severe head injury. Whether the association between BCVI and poor outcome is an indirect marker of a more severe injury or a result of treatment needs further investigations.	[Vehvilainen, Juho; Lindfors, Matias; Siironen, Jari; Raj, Rahul] Univ Helsinki, Dept Neurosurg, Topeliuksenkatu 5,POB 266, Helsinki 00029, Finland; [Vehvilainen, Juho; Brinck, Tuomas; Lindfors, Matias; Numminen, Jussi; Siironen, Jari; Raj, Rahul] Helsinki Univ Hosp, Topeliuksenkatu 5,POB 266, Helsinki 00029, Finland; [Brinck, Tuomas] Univ Helsinki, Dept Orthopaed & Traumatol, Helsinki, Finland; [Numminen, Jussi] Univ Helsinki, Dept Radiol, Helsinki, Finland		Raj, R (corresponding author), Univ Helsinki, Dept Neurosurg, Topeliuksenkatu 5,POB 266, Helsinki 00029, Finland.; Raj, R (corresponding author), Helsinki Univ Hosp, Topeliuksenkatu 5,POB 266, Helsinki 00029, Finland.	Rahul.raj@hus.fi	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591			Berne JD, 2001, J AM COLL SURGEONS, V192, P314, DOI 10.1016/S1072-7515(01)00772-4; Biffl WL, 2006, J TRAUMA, V60, P745, DOI 10.1097/01.ta.0000204034.94034.c4; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Borisch I, 2007, ACTA RADIOL, V48, P798, DOI 10.1080/02841850701422104; Brommeland T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0559-1; Brott TG, 2011, CIRCULATION, V124, pE54, DOI [10.1161/CIR.0b013e31820d8c98, 10.1161/CIR.0b0113e31820d8c98]; Ciapetti M, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-61; Cothren CC, 2009, ARCH SURG-CHICAGO, V144, P685, DOI 10.1001/archsurg.2009.111; Cothren CC, 2003, J TRAUMA, V55, P811, DOI 10.1097/01.TA.0000092700.92587.32; Daou B, 2017, NEUROSURGERY, V80, P368, DOI 10.1093/neuros/nyw086; Drainer EK, 2003, INJURY, V34, P330, DOI 10.1016/S0020-1383(02)00260-7; Esnault P, 2017, J NEUROSURG, V127, P16, DOI 10.3171/2016.4.JNS152600; Franz RW, 2012, J AM COLL SURGEONS, V214, P313, DOI 10.1016/j.jamcollsurg.2011.11.012; Geddes AE, 2016, AM J SURG, V212, P1167, DOI 10.1016/j.amjsurg.2016.09.016; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Ghobrial GM, 2014, CLIN NEUROL NEUROSUR, V123, P174, DOI 10.1016/j.clineuro.2014.05.013; Griessenauer CJ, 2013, J NEUROSURG, V118, P397, DOI 10.3171/2012.11.JNS121038; Grigorian A, 2018, SURGERY, V164, P494, DOI 10.1016/j.surg.2018.04.032; Grossman MD, 1999, J TRAUMA, V47, P684, DOI 10.1097/00005373-199910000-00012; Harrop JS, 2001, SPINE, V26, P340, DOI 10.1097/00007632-200102150-00008; Heinanen M, 2017, SCAND J SURG, V106, P269, DOI 10.1177/1457496916685236; Hoffman JR, 1998, ANN EMERG MED, V32, P461, DOI 10.1016/S0196-0644(98)70176-3; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; JENNETT B, 1975, LANCET, V1, P480; Lauerman MH, 2015, J TRAUMA ACUTE CARE, V78, P1071, DOI 10.1097/TA.0000000000000654; Lindfors M, 2018, ACTA NEUROCHIR, V160, P2107, DOI 10.1007/s00701-018-3670-1; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Markus HS, 2015, LANCET NEUROL, V14, P361, DOI 10.1016/S1474-4422(15)70018-9; Mayberry JC, 2004, ARCH SURG-CHICAGO, V139, P609, DOI 10.1001/archsurg.139.6.609; McNutt MK, 2018, INJURY, V49, P67, DOI 10.1016/j.injury.2017.07.036; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Shafafy Roozbeh, 2017, J Spine Surg, V3, P217, DOI 10.21037/jss.2017.05.10; Shahan CP, 2016, J TRAUMA ACUTE CARE, V80, P915, DOI 10.1097/TA.0000000000001041; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Thesleff T, 2017, ACTA NEUROCHIR, V159, P907, DOI 10.1007/s00701-017-3133-0; Tobert DG, 2018, J BONE JOINT SURG AM, V100, P1490, DOI 10.2106/JBJS.18.00107; Weber CD, 2018, WORLD J SURG, V42, P2043, DOI 10.1007/s00268-017-4408-6; WILLIAMS J, 1992, ANN EMERG MED, V21, P719, DOI 10.1016/S0196-0644(05)82786-6; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	42	2	2	2	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUN	2020	162	6					1445	1453		10.1007/s00701-020-04279-9			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LR0JQ	WOS:000535383400035	32157398	hybrid, Green Published			2022-02-06	
J	Vitturi, BK; Sanvito, WL				Vitturi, Bruno Kusznir; Sanvito, Wilson Luiz			The neurology behind three wounded French artists during the great world war	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						art; history of neurology; traumatic brain injury; World War I; peripheral neuropathy		A unique association joins Guillaume Apollinaire, Blaise Cendrars and Louis Ferdinand Celine. Besides being great exponents of French literature, they were all neurologically wounded during the First World War. Apollinaire had a traumatic brain injury, Cendrars developed phantom limb neuropathic pain and Celine presented radial nerve paralysis. There is quite an evidence that supports that their artistic output was also influenced by acquired neurological conditions during the war. The examples of these three French authors reveal the surprising intimacy Neurology can share with art and history.	[Vitturi, Bruno Kusznir; Sanvito, Wilson Luiz] Fac Ciencias Med Santa Casa Sao Paulo, Dept Neurol, Sao Paulo, SP, Brazil		Vitturi, BK (corresponding author), Santa Casa Sao Paulo Sch Med Sci, Rua Dr Cesario Motta Jr 112, BR-01221020 Sao Paulo, SP, Brazil.	z_azu@hotmail.com	Vitturi, Bruno Kusznir/Y-1238-2018	Vitturi, Bruno Kusznir/0000-0002-2821-9042			Bogousslavsky J, 2003, REV NEUROL-FRANCE, V159, P171; Bogousslavsky J, 2016, FRONT NEUROL NEUROSC, V38, P155, DOI 10.1159/000442654; Maingon Claire, 2018, Front Neurol Neurosci, V43, P37, DOI 10.1159/000490403; Tatu L, 2017, REV NEUROL-FRANCE, V173, P125, DOI 10.1016/j.neurol.2017.02.010; Tatu Laurent, 2018, Front Neurol Neurosci, V43, P47, DOI 10.1159/000490404; Tatu Laurent, 2018, Front Neurol Neurosci, V43, P23, DOI 10.1159/000490401; Taut L, 2010, FRONT NEUROL NEUROSC, V27, P143, DOI 10.1159/000311198; Vitturi BK, 2019, ARQ NEURO-PSIQUIAT, V77, P136, DOI [10.1590/0004-282x20180134, 10.1590/0004-282X20180134]; Vitturi BK, 2017, ARQ NEURO-PSIQUIAT, V75, P892, DOI [10.1590/0004-282X20170145, 10.1590/0004-282x20170145]	9	2	2	0	0	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	JUN	2020	78	6					380	382		10.1590/0004-282X20190157			3	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	MD8WX	WOS:000544249700010	31967214	Green Published, gold			2022-02-06	
J	Zhang, B; Joseph, B; Saatman, KE; Chen, L				Zhang, Bei; Joseph, Binoy; Saatman, Kathryn E.; Chen, Lei			Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article							STROKE; THERAPIES	Neural stem cell (NSC) therapy is an emerging innovative treatment for stroke, traumatic brain injury and neurodegenerative disorders. As compared to intracranial delivery, intra-arterial administration of NSCs is less invasive and produces a more diffuse distribution of NSCs within the brain parenchyma. Further, intra-arterial delivery allows the first-pass effect in the brain circulation, lessening the potential for trapping of cells in peripheral organs, such as liver and spleen, a complication associated with peripheral injections. Here, we detail the methodology, in both mice and rats, for delivery of NSCs through the common carotid artery (mouse) or external carotid artery (rat) to the ipsilateral hemisphere after an ischemic stroke. Using GFP-labeled NSCs, we illustrate the widespread distribution achieved throughout the rodent ipsilateral hemisphere at 1 d, 1 week and 4 weeks after postischemic delivery, with a higher density in or near the ischemic injury site. In addition to long-term survival, we show evidence of differentiation of GFP-labeled cells at 4 weeks. The intra-arterial delivery approach described here for NSCs can also be used for administration of therapeutic compounds, and thus has broad applicability to varied CNS injury and disease models across multiple species.	[Zhang, Bei] Shaanxi Univ Chinese Med, Coll Publ Hlth, Xianyang, Shaanxi, Peoples R China; [Joseph, Binoy; Saatman, Kathryn E.; Chen, Lei] Univ Kentucky, Dept Physiol, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA		Chen, L (corresponding author), Univ Kentucky, Dept Physiol, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA.	lei.chen@uky.edu			AHAAmerican Heart Association [14SDG20480186]; Subject innovation team of Shanxi University of Chinese Medicine [2019-QN07]; Kentucky Spinal Cord and Head Injury Research Trust [14-12A]	This research was supported by the following: AHA Award 14SDG20480186 for LC, Subject innovation team of Shanxi University of Chinese Medicine 2019-QN07 for BZ, and Kentucky Spinal Cord and Head Injury Research Trust grant 14-12A for KES and LC.	Argibay B, 2017, SCI REP-UK, V7, DOI 10.1038/srep40758; Bertrand L., 2017, J VISUALIZED EXPT; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Boese AC, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0913-2; Boltze J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00155; Chen L, 2009, J NEUROSCI RES, V87, P1718, DOI 10.1002/jnr.21973; Chua JY, 2011, J CEREBR BLOOD F MET, V31, P1263, DOI 10.1038/jcbfm.2010.213; Duma C, 2019, MOL BIOL REP, V46, P5257, DOI 10.1007/s11033-019-04983-5; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Guzman R, 2018, STROKE, V49, P1075, DOI 10.1161/STROKEAHA.117.018288; Huang C, 2019, NEUROIMAGE, V198, P160, DOI 10.1016/j.neuroimage.2019.05.047; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kokaia Z, 2018, STROKE, V49, P1091, DOI 10.1161/STROKEAHA.117.018291; Leda AR, 2017, JOVE-J VIS EXP, DOI 10.3791/54804; Misra V, 2012, NEUROLOGY, V79, pS207, DOI 10.1212/WNL.0b013e31826959d2; Misra V, 2012, STEM CELLS DEV, V21, P1007, DOI 10.1089/scd.2011.0612; Muir KW, 2017, NEUROCHEM INT, V106, P108, DOI 10.1016/j.neuint.2016.09.011; Muir KW, 2011, TRANSL STROKE RES, V2, P266, DOI 10.1007/s12975-011-0095-z; Potts Matthew B, 2013, Surg Neurol Int, V4, pS22, DOI 10.4103/2152-7806.109190; Progatzky F, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0001; Savitz SI, 2018, STROKE, V49, P1056, DOI 10.1161/STROKEAHA.118.019561; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Wang YL, 2018, LANCET NEUROL, V17, P2, DOI 10.1016/S1474-4422(17)30421-0; Wechsler LR, 2018, STROKE, V49, P1066, DOI 10.1161/STROKEAHA.117.018290; Wong JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136967; Zhang B, 2010, J NEUROSCI RES, V88, P2859, DOI 10.1002/jnr.22450	26	2	2	0	1	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUN	2020		160							e61119	10.3791/61119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MH1NJ	WOS:000546499200138	32658201				2022-02-06	
J	Zhang, GH; Murthy, KD; Pare, RB; Qian, YH				Zhang, Gui-hong; Murthy, Krishna Dilip; Binti Pare, Rahmawati; Qian, Yi-hua			Protective effect of T beta 4 on central nervous system tissues and its developmental prospects	EUROPEAN JOURNAL OF INFLAMMATION			English	Article						Alzheimer's disease; astrocyte; central nervous system; inflammation; microglia; neurons; oligodendrocyte; thymosin beta4	ENDOTHELIAL PROGENITOR CELLS; BETA(4) MESSENGER-RNA; THYMOSIN BETA-4; RAT-BRAIN; OLIGODENDROCYTE DIFFERENTIATION; EXPERIMENTAL-MODELS; EXPRESSION; MICROGLIA; PEPTIDES; CHICK	Tissue repair and regeneration in the central nervous system (CNS) remains a serious medical problem. CNS diseases such as traumatic and neurological brain injuries have a high mortality and disability rate, thereby bringing a considerable amount of economic burden to society and families. How to treat traumatic and neurological brain injuries has always been a serious issue faced by neurosurgeons. The global incidence of traumatic and neurological brain injuries has gradually increased and become a global challenge. Thymosin beta 4 (T beta 4) is the main G-actin variant molecule in eukaryotic cells. During the development of the CNS, T beta 4 regulates neurogenesis, tangential expansion, tissue growth, and cerebral hemisphere folding. In addition, T beta 4 has anti-apoptotic and anti-inflammatory properties. It promotes angiogenesis, wound healing, stem/progenitor cell differentiation, and other characteristics of cell migration and survival, providing a scientific basis for the repair and regeneration of injured nerve tissue. This review provides evidence to support the role of T beta 4 in the protection and repair of nervous tissue in CNS diseases, especially with the potential to control brain inflammatory processes, and thus open up new therapeutic applications for a series of neurodegenerative diseases.	[Zhang, Gui-hong] Xian Int Univ, Sch Med, Xian, Peoples R China; [Zhang, Gui-hong; Murthy, Krishna Dilip; Binti Pare, Rahmawati] UMS, Fac Med & Hlth Sci FPSK, Dept Biomed Sci & Therapeut, Kota Kinabalu, Sabah, Malaysia; [Qian, Yi-hua] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Human Anat Histol & Embryol, Hlth Sci Ctr, 76 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China		Qian, YH (corresponding author), Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Human Anat Histol & Embryol, Hlth Sci Ctr, 76 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.	qianyh38@mail.xjtu.edu.cn			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571251, 81071035, 81500928]; Key Project-Basic Research Plan of Natural Science in Shaanxi Province of China [2019JZ-21]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Natural Science Foundation of China (Nos 81571251, 81071035, and 81500928), Key Project-Basic Research Plan of Natural Science in Shaanxi Province of China (2019JZ-21).	a ?B, 2015, INTERACTION THYMUS T, V1, P18; Adalatkhah H, 2015, DRUG DES DEV THER, V9, P4219, DOI 10.2147/DDDT.S80713; Anadon R, 2001, BRAIN RES, V894, P255, DOI 10.1016/S0006-8993(01)02024-8; Badamchian M, 2003, INT IMMUNOPHARMACOL, V3, P1225, DOI 10.1016/S1567-5769(03)00024-9; Blumenthal I, 2004, EUR J PEDIATR, V163, P435, DOI 10.1007/s00431-004-1477-y; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Carpintero P, 1999, NEUROSCIENCE, V90, P1433, DOI 10.1016/S0306-4522(98)00494-1; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; Cheng P, 2014, NEUROPHARMACOLOGY, V85, P408, DOI 10.1016/j.neuropharm.2014.06.004; Choe J, 2005, BIOCHEM BIOPH RES CO, V331, P43, DOI 10.1016/j.bbrc.2005.03.130; Choi SY, 2007, BIOCHEM BIOPH RES CO, V362, P587, DOI 10.1016/j.bbrc.2007.08.031; Chopp M, 2015, EXPERT OPIN EMERG DR, V20, P523, DOI 10.1517/14728214.2015.1061993; Chopp M, 2015, EXPERT OPIN BIOL TH, V15, pS9, DOI 10.1517/14712598.2015.1005596; Cierniewski CS, 2012, ANN NY ACAD SCI, V1269, P44, DOI 10.1111/j.1749-6632.2012.06685.x; CONDON MR, 1992, J MOL NEUROSCI, V3, P165, DOI 10.1007/BF02919408; Conte E, 2015, EXPERT OPIN BIOL TH, V15, pS211, DOI 10.1517/14712598.2015.1026804; Crockford D, 2007, ANN NY ACAD SCI, V1112, P385, DOI 10.1196/annals.1415.051; Dong JH, 2005, NEUROREPORT, V16, P1629, DOI 10.1097/01.wnr.0000183326.21241.48; Farkas E, 2005, NEUROSCI LETT, V387, P168, DOI 10.1016/j.neulet.2005.06.036; Garaci E, 2015, EXPERT OPIN BIOL TH, V15, pS1, DOI 10.1517/14712598.2015.1044893; Girardi M, 2003, IMMUNOLOGY, V109, P1, DOI 10.1046/j.1365-2567.2003.01616.x; Gold Michael, 2013, J Clin Aesthet Dermatol, V6, P32; GOLDSTEI.AL, 1966, P NATL ACAD SCI USA, V56, P1010, DOI 10.1073/pnas.56.3.1010; Goldstein AL, 2012, EXPERT OPIN BIOL TH, V12, P37, DOI 10.1517/14712598.2012.634793; Gomez-Marquez Jaime, 2002, Cerebellum, V1, P95; Grant D S, 1999, Angiogenesis, V3, P125, DOI 10.1023/A:1009041911493; Hinkel R, 2015, J MOL CELL CARDIOL, V87, P113, DOI 10.1016/j.yjmcc.2015.07.004; Hinkel R, 2010, ANN NY ACAD SCI, V1194, P105, DOI 10.1111/j.1749-6632.2010.05489.x; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Huff T, 2004, J CELL SCI, V117, P5333, DOI 10.1242/jcs.01404; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Jo JO, 2010, BBA-MOL CELL RES, V1803, P1244, DOI 10.1016/j.bbamcr.2010.07.005; Kim DH, 2015, NEUROSCIENCE, V310, P51, DOI 10.1016/j.neuroscience.2015.09.017; Kim Y, 2006, BRAIN RES, V1085, P177, DOI 10.1016/j.brainres.2006.01.065; Koutrafouri V, 2001, BBA-GEN SUBJECTS, V1568, P60, DOI 10.1016/S0304-4165(01)00200-8; Koutrafouri V, 2003, PEPTIDES, V24, P107, DOI 10.1016/S0196-9781(02)00282-6; Kuzan A, 2016, ADV CLIN EXP MED, V25, P1331, DOI 10.17219/acem/32026; Lachowicz JI, 2019, COORDIN CHEM REV, V396, P117, DOI 10.1016/j.ccr.2019.06.008; Lee SI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146708; Lee SH, 2001, ONCOGENE, V20, P6700, DOI 10.1038/sj.onc.1204683; Lever M, 2017, HISTOCHEM CELL BIOL, V147, P555, DOI 10.1007/s00418-016-1529-1; Li J, 2013, MOL MED REP, V7, P598, DOI 10.3892/mmr.2012.1180; Liman TG, 2012, CEREBROVASC DIS, V33, P492, DOI 10.1159/000337155; Liu DS, 2014, ZHONGGUO ZUZHI GONGC, V18, P6573; Lunin SM, 2010, EXPERT OPIN THER TAR, V14, P775, DOI 10.1517/14728222.2010.499127; Marks ED, 2016, VITAM HORM, V102, P227, DOI 10.1016/bs.vh.2016.04.010; Morris DC, 2010, NEUROSCIENCE, V169, P674, DOI 10.1016/j.neuroscience.2010.05.017; Morris DC, 2010, ANN NY ACAD SCI, V1194, P112, DOI 10.1111/j.1749-6632.2010.05469.x; Pardon MC, 2018, EXPERT OPIN BIOL TH, V18, P165, DOI 10.1080/14712598.2018.1486817; Paulussen M, 2012, BRAIN STRUCT FUNCT, V217, P81, DOI 10.1007/s00429-011-0330-0; Philp D, 2004, MECH AGEING DEV, V125, P113, DOI 10.1016/j.mad.2003.11.005; Pipes GT, 2016, VITAM HORM, V102, P209, DOI 10.1016/bs.vh.2016.04.004; Popoli P, 2007, ANN NY ACAD SCI, V1112, P219, DOI 10.1196/annals.1415.033; Qiu P, 2007, J CELL PHYSIOL, V212, P165, DOI 10.1002/jcp.21012; Qiu P, 2011, FASEB J, V25, P1815, DOI 10.1096/fj.10-167940; Renault L, 2016, VITAM HORM, V102, P25, DOI 10.1016/bs.vh.2016.04.006; Rensink AAM, 2004, NEUROPATH APPL NEURO, V30, P279, DOI 10.1111/j.1365-2990.2004.00536.x; Samara P, 2016, VITAM HORM, V102, P179, DOI 10.1016/bs.vh.2016.04.008; Santra M, 2016, J NEUROCHEM, V136, P118, DOI 10.1111/jnc.13394; Santra M, 2014, J BIOL CHEM, V289, P19508, DOI 10.1074/jbc.M113.529966; Santra M, 2012, GLIA, V60, P1826, DOI 10.1002/glia.22400; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Severa M, 2019, MULT SCLER RELAT DIS, V27, P52, DOI 10.1016/j.msard.2018.09.035; Shomali N, 2020, J CELL PHYSIOL, V235, P3270, DOI 10.1002/jcp.29293; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Sosne G, 2007, EXP EYE RES, V84, P663, DOI 10.1016/j.exer.2006.12.004; Sosne G, 2015, INVEST OPHTH VIS SCI, V56, P5110, DOI 10.1167/iovs.15-16890; Sosne G, 2010, FASEB J, V24, P2144, DOI 10.1096/fj.09-142307; Sosne G, 2010, ANN NY ACAD SCI, V1194, P190, DOI 10.1111/j.1749-6632.2010.05472.x; Sun W, 2007, ANN NY ACAD SCI, V1112, P210, DOI 10.1196/annals.1415.013; Takata K, 2007, FEBS LETT, V581, P475, DOI 10.1016/j.febslet.2007.01.009; Tapp H, 2009, BIOTECH HISTOCHEM, V84, P287, DOI 10.3109/10520290903116884; Vartiainen N, 1996, NEUROREPORT, V7, P1613, DOI 10.1097/00001756-199607080-00017; Vasilopoulou E, 2015, EXPERT OPIN BIOL TH, V15, pS187, DOI 10.1517/14712598.2015.1009891; Vicente E, 2009, BRAIN RES, V1251, P204, DOI 10.1016/j.brainres.2008.11.032; Wang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159665; Wang L, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/173656; Wirsching HG, 2014, BRAIN, V137, P433, DOI 10.1093/brain/awt333; Wirsching HG, 2012, J COMP NEUROL, V520, P1650, DOI 10.1002/cne.23004; Wuchert F, 2009, J NEUROIMMUNOL, V206, P44, DOI 10.1016/j.jneuroim.2008.10.010; Xiong Y, 2012, ANN NY ACAD SCI, V1270, P51, DOI 10.1111/j.1749-6632.2012.06683.x; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Xiong Y, 2010, DISCOV MED, V10, P434; YAMAMOTO M, 1994, DEV BRAIN RES, V79, P177, DOI 10.1016/0165-3806(94)90122-8; Yang H, 2008, NEUROCHEM RES, V33, P2269, DOI 10.1007/s11064-008-9712-y; Yang H, 2010, CELL MOL NEUROBIOL, V30, P149, DOI 10.1007/s10571-009-9439-6; Young JD, 1999, NAT MED, V5, P1424; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zhang J, 2009, NEUROSCIENCE, V164, P1887, DOI 10.1016/j.neuroscience.2009.09.054; Zhang JF, 2016, CELL PHYSIOL BIOCHEM, V38, P2230, DOI 10.1159/000445578; Zhang J, 2016, NEUROBIOL DIS, V88, P85, DOI 10.1016/j.nbd.2016.01.010; Zhang Y., 2017, INT J CRASHWORTHINES, V3, P1, DOI DOI 10.1109/TGRS.2015.2479299; Zhao YB, 2011, J CELL PHYSIOL, V226, P2798, DOI 10.1002/jcp.22624; Zhou T, 2015, NEUROREPORT, V26, P1032, DOI 10.1097/WNR.0000000000000463; Zhou X, 2011, DERMATOL SURG, V37, P962, DOI 10.1111/j.1524-4725.2011.02001.x	95	2	2	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1721-727X	2058-7392		EUR J INFLAMM	Eur. J. Inflamm.	JUN	2020	18								2058739220934559	10.1177/2058739220934559			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MF9HN	WOS:000545648800001		gold			2022-02-06	
J	Altayar, AS; Abouelela, AZ; Abdelshafey, EE; Mohammed, KSS; Hassan, AA; Khattab, MA; Alhabashy, W; Gomaa, W; Mohammed, AF; Umerani, MS				Altayar, Ashraf S.; Abouelela, Amr Z.; Abdelshafey, Eslam E.; Mohammed, Khaled S. S.; Hassan, Ahmed A.; Khattab, Mohammed A.; Alhabashy, Walid; Gomaa, Wael; Mohammed, Amr F.; Umerani, Muhammad S.			Optic nerve sheath diameter by ultrasound is a good screening tool for high intracranial pressure in traumatic brain injury	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Intracranial pressure; Ocular ultrasonography; Optic nerve sheath diameter; Traumatic brain injury	ULTRASONOGRAPHY; MANAGEMENT	Objectives This study aimed to determine the role of ONSD measurement by US for diagnosis of high ICP in TBI patients. Methods ONSD measurement by US was performed in adult TBI patients within 1 h of planned CT brain, while CT signs of high ICP were determined. Invasive ICP measurement was performed simultaneously in patients who had intraventricular device in situ. High ICP was determined as ICP > 22 mmHg. Results A total of 48 patients were enrolled. Twenty-eight patients had positive CT criteria for high ICP, while 20 patients were negative. The mean value of ONSD was 0.63 +/- 0.06 cm in positive group compared with 0.55 +/- 0.07 cm in negative one with significant difference (p < 0.001). A total of 22 patients had intraventricular device. Thirteen patients had high ICP, while 9 patients had normal ICP. The mean value of ONSD was 0.66 +/- 0.05 cm in high ICP group compared with 0.58 +/- 0.08 cm in normal one with significant difference (p = 0.004). ONSD with cut-off value > 0.61 cm predicted high ICP with sensitivity of 84.62% and specificity of 66.67% with significant AUC of 0.85 (p = 0.006). Conclusion ONSD measurement by ultrasound is a good screening tool for high ICP in traumatic brain injury patients.	[Altayar, Ashraf S.; Abdelshafey, Eslam E.] Secur Forces Hosp, Dammam, Saudi Arabia; [Abouelela, Amr Z.; Abdelshafey, Eslam E.; Hassan, Ahmed A.] Univ Alexandria, Fac Med, Alexandria, Egypt; [Abouelela, Amr Z.; Mohammed, Khaled S. S.; Gomaa, Wael; Umerani, Muhammad S.] King Fahd Mil Med Complex, Dhahran, Saudi Arabia; [Khattab, Mohammed A.] Royal Preston Hosp, Preston, Lancs, England; [Alhabashy, Walid] Beaumont Univ Hosp, Beaumont, Ireland; [Mohammed, Amr F.] Galway Univ Hosp, Galway, Ireland		Abdelshafey, EE (corresponding author), Secur Forces Hosp, Dammam, Saudi Arabia.; Abdelshafey, EE (corresponding author), Univ Alexandria, Fac Med, Alexandria, Egypt.	eslam.abdelshafey@alexmed.edu.eg	Umerani, Muhammad Sohail/Y-9707-2019	Umerani, Muhammad Sohail/0000-0001-7598-6650; Aly, Walid/0000-0003-3967-7265			Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen LM, 2019, BRIT J OPHTHALMOL, V103, P437, DOI 10.1136/bjophthalmol-2018-312934; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Golshani K, 2015, EMERGENCY, V3, P54; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Joseph B, 2015, ANN SURG, V262, P440, DOI 10.1097/SLA.0000000000001418; Kim SE, 2019, ACTA RADIOL, V60, P221, DOI 10.1177/0284185118776501; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Robba C, 2018, INTENS CARE MED, V44, P1284, DOI 10.1007/s00134-018-5305-7; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Wang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130660	13	2	3	0	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	FEB	2021	190	1					387	393		10.1007/s11845-020-02242-2		MAY 2020	7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QA4RL	WOS:000536426100001	32474811				2022-02-06	
J	Zhao, JJ; Guo, XY; Wang, B; Yang, ZB; Huang, TQ; Guo, D; Zhang, M; Song, JN				Zhao, Junjie; Guo, Xiaoye; Wang, Bo; Yang, Zhongbo; Huang, Tingqin; Guo, Dan; Zhang, Ming; Song, Jinning			MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats	NEUROCHEMICAL RESEARCH			English	Article						MCC950; NLRP3; Inflammasome; Diffuse axonal injury	TRAUMATIC BRAIN-INJURY; MICROGLIA/MACROPHAGE POLARIZATION; WHITE-MATTER; CELL-DEATH; ACTIVATION	Increasing evidence has revealed that neuroinflammation plays a pivotal role in axonal injures. Nucleotide oligomerization domain (NOD)-like receptor protein (NLRP3) inflammasome is reported to be widely involved with the pathology of central nervous system disorders. But the role of NLRP3 in diffuse axonal injury (DAI) are rarely reported. The purpose of this study was to investigate the expression of NLRP3 after diffuse axonal injury and the role of NLRP3 in axonal injures. The lateral head rotation device was used to establish DAI model of rats. Immunohistochemical staining for beta-amyloid precursor protein and Bielschowsky silver staining were used to assess axonal injures and axonal loss. Terminal Deoxynucleotidyl Transferase-Mediated Digoxigenin-dUTP-Biotin Nick-End Labelling Assay was used to detect cell apoptosis. Brain water content was used to assess cerebral edema and the modified Neurologic Severity Score was used to assess the neurological deficits. Components of NLRP3 inflammasome, such as NLRP3, apoptosis-associated speck-like (ASC) adapter protein and caspase-1, and pro-inflammatory cytokines, for example IL-18 and IL-1 beta, were over-expressed in early stages of DAI. MCC950, a selective small-molecule inhibitor of NLRP3 inflammasome, inhibited the over-expression of NLRP3 inflammasome and pro-inflammatory cytokines after DAI. MCC950 alleviated axonal injures and cell apoptosis. MCC950 also decreased brain water content and alleviated neurologic deficits 1 day and 3 days after DAI but not 7 days after DAI. These results suggest that MCC950 treatment in the early stages of DAI has a time limiting effect in preventing from axonal injuries and neurological deficits, and that NLRP3 inflammasome plays an important role in axonal injures and may be a potential candidate for axonal injures following DAI.	[Zhao, Junjie; Guo, Xiaoye; Wang, Bo; Yang, Zhongbo; Song, Jinning] Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Yanta Rd 277, Xian 710061, Shaanxi, Peoples R China; [Huang, Tingqin; Zhang, Ming] Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 2, Xian 710004, Shaanxi, Peoples R China; [Guo, Dan] Xian Med Univ, Dept Sci & Technol, Xian 710021, Shaanxi, Peoples R China		Song, JN (corresponding author), Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Yanta Rd 277, Xian 710061, Shaanxi, Peoples R China.	jinningsong@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471179]	We gratefully acknowledge the National Natural Science Foundation of China (No. 81471179) in funding this research. We also acknowledge Translational Medicine of the First Affiliated Hospital of Xi'an Jiaotong University for support of laboratory instruments.	Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Chen JL, 2010, J CEREBR BLOOD F MET, V30, P102, DOI 10.1038/jcbfm.2009.187; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; Dempsey C, 2017, BRAIN BEHAV IMMUN, V61, P306, DOI 10.1016/j.bbi.2016.12.014; Fann DYW, 2018, MOL NEUROBIOL, V55, P1082, DOI 10.1007/s12035-017-0394-9; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; He XF, 2020, J CEREBR BLOOD F MET, V40, P1048, DOI 10.1177/0271678X19856226; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Huang TQ, 2018, NEUROREPORT, V29, P661, DOI [10.1097/WNR.0000000000001015, 10.1097/wnr.0000000000001015]; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Li Y, 2013, BRAIN RES, V1495, P95, DOI 10.1016/j.brainres.2012.12.005; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Luo YJ, 2019, BRAIN RES BULL, V146, P320, DOI 10.1016/j.brainresbull.2019.01.027; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Man SM, 2016, NAT REV IMMUNOL, V16, P7, DOI 10.1038/nri.2015.7; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Rudolfson N, 2019, J NEUROSURG, V130, P1149, DOI 10.3171/2017.12.JNS17281; Sarkar S, 2017, NPJ PARKINSON DIS, V3, DOI 10.1038/s41531-017-0032-2; Vanaja SK, 2015, TRENDS CELL BIOL, V25, P308, DOI 10.1016/j.tcb.2014.12.009; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang S, 2019, INT IMMUNOPHARMACOL, V67, P458, DOI 10.1016/j.intimp.2018.12.019; Xiong T, 2018, J NEUROPATH EXP NEUR, V77, P383, DOI 10.1093/jnen/nly015; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Zhao JJ, 2019, NEUROSCI LETT, V708, DOI 10.1016/j.neulet.2019.134335; Zhao YL, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/1570917; Zhao YL, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4706915; Zhou KR, 2018, STROKE, V49, P175, DOI 10.1161/STROKEAHA.117.018593; Zhou KR, 2017, EXP NEUROL, V295, P116, DOI 10.1016/j.expneurol.2017.06.003	33	2	2	5	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	SEP	2020	45	9					2020	2031		10.1007/s11064-020-03063-6		MAY 2020	12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	MZ6TF	WOS:000536447300001	32474832				2022-02-06	
J	Ju, FX; Hou, RX; Xiong, J; Shi, HF; Chen, YX; Wang, JF				Ju, Fa-xin; Hou, Rui-xing; Xiong, Jin; Shi, Hong-fei; Chen, Yi-xin; Wang, Jun-fei			Outcomes of Femoral Neck Fractures Treated with Cannulated Internal Fixation in Elderly Patients: A Long-Term Follow-Up Study	ORTHOPAEDIC SURGERY			English	Article						Femoral neck fracture; Garden fracture type; Harris hip score; Internal fixation; Pauwels angle	HARRIS HIP SCORE; AVASCULAR NECROSIS; ARTHROPLASTY; REPLACEMENT; MANAGEMENT; SYSTEM; COSTS; HEAD	Objectives To evaluate the long-term efficacy of cannulated internal fixation in patients who sustain femoral neck fracture (FNF) and risk factors influencing the outcomes. Methods This retrospective study analyzed data from 73 elderly patients aged >= 60 years old, hospitalized for FNF and treated with cannulated internal fixation between August 2008 and July 2016. The inclusion criteria were: (i) patients aged >= 60 years; (ii) patients with recent femoral neck fracture, with times of injury ranging from 12-72 h; and (iii) patients who underwent Garden II-IV closed reduction and internal fixation. Patients were classified based on the Garden fracture type and Pauwels angle. Clinical data and radiographs before and after the surgery were collected. Subsequently, surgery was performed with the patient in supine position, under general or lumbar epidural anesthesia. Closed reduction was performed until satisfactory fracture reduction quality was achieved. The weight of all included patients were <75 kg, and thus, minimal internal fixation was performed. The ischemic necrosis of the femoral head was diagnosed by considering the symptoms, signs, and radiological findings. Harris hip scores were used to evaluate postoperative recovery of hip function. Furthermore, relationships between Garden fracture type and necrosis rate of the femoral head, Pauwels angle and necrosis rate of the femoral head, Garden fracture type and Harris hip score, and age and Harris hip score were analyzed. Results The mean duration of surgery was 1 +/- 0.17 h and blood loss for all the patients was approximately 15 mL. The included patients were followed up for 13-128 months, with an average follow-up of 61 months. Among the included 73 patients, 65 (89.0%) exhibited satisfactory union, seven (9.6%) had femoral head necrosis, and one (1.4%) had nonunion. For seven patients with femoral head necrosis, there were two, two, and three patients classified as Garden IV, Garden III, and Garden II, respectively, and two and five patients classified as Pauwels II and Pauwels III, respectively. Among the seven cases, four underwent hip replacement. Garden fracture type was not significantly associated with femoral head necrosis (chi(2) = 0.44, P > 0.05) or Harris score (chi(2) = 1.43, P > 0.05). Patients with Pauwels I (0%) and II (4.3%) fractures exhibited a significantly lower necrosis rate than those with Pauwels III fractures (41.7%) (P < 0.05). Conclusions Cannulated internal fixation was more suitable for older Chinese patients with Pauwels I/II fractures than those with Pauwels III fractures.	[Ju, Fa-xin; Hou, Rui-xing] Soochow Univ, Ruihua Affiliated Hosp, Suzhou, Peoples R China; [Ju, Fa-xin] Baoying Cty Peoples Hosp Jiangsu Prov, Orthoped Dept, Yangzhou, Jiangsu, Peoples R China; [Xiong, Jin; Shi, Hong-fei; Chen, Yi-xin; Wang, Jun-fei] Nanjing Univ, Med Sch, Affiliated Hosp Nanjing, Nanjing, Peoples R China		Wang, JF (corresponding author), Nanjing Univ, Affiliated Hosp, Dept Orthoped, Nanjing Drum Tower Hosp,Med Sch, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	1648764977@qq.com; huarui1000@163.com; wangjf1923@163.com			Category B Funding Program of Jiangsu Province "Summit of the Six Top Talents" [2015-WSW-066]; Young Medical Talent Program in Jiangsu Province [NRC2016801]	This work was supported by Category B Funding Program of Jiangsu Province "Summit of the Six Top Talents"(Program No. 2015-WSW-066) and Young Medical Talent Program in Jiangsu Province (Program No. NRC2016801).	Ayeni OR, 2011, J BONE JOINT SURG AM, V93A, P893, DOI 10.2106/JBJS.J.00792; Bachiller FGC, 2002, CLIN ORTHOP RELAT R, P87; Banaszkiewicz P.A., 2014, CLASSIC PAPERS ORTHO, V1st ed., P13; BARNES R, 1976, J BONE JOINT SURG BR, V58, P2, DOI 10.1302/0301-620X.58B1.1270491; Bhandari M, 2005, J BONE JOINT SURG AM, V87A, P2122, DOI 10.2106/JBJS.E.00535; Catto M, 1965, J Bone Joint Surg Br, V47, P749; COOPER C, 1993, AM J EPIDEMIOL, V137, P1001, DOI 10.1093/oxfordjournals.aje.a116756; DARCY J, 1976, J BONE JOINT SURG BR, V58, P279, DOI 10.1302/0301-620X.58B3.182698; Faje A, 2012, CURR OSTEOPOROS REP, V10, P208, DOI 10.1007/s11914-012-0106-3; Johansson T, 2006, INT ORTHOP, V30, P1, DOI 10.1007/s00264-005-0037-z; Kannan A, 2012, INT ORTHOP, V36, P1, DOI 10.1007/s00264-011-1354-z; Kim H, 2017, OSTEOPOROSIS INT, V28, P2137, DOI 10.1007/s00198-017-4015-2; Liang CW, 2015, INT J CLIN EXP MED, V8, P6784; Liu YJ, 2012, ORTHOPEDICS, V35, pE137, DOI 10.3928/01477447-20120123-09; Lu-Yao GL, 2005, J BONE JOINT SURG AM, V3, P29; Nikolopoulos KE, 2003, INJURY, V34, P525, DOI 10.1016/S0020-1383(02)00367-4; Pawar AY, 2015, ASIAN SPINE J, V9, P966, DOI 10.4184/asj.2015.9.6.966; Rogmark C, 2016, BONE JOINT J, V98B, P291, DOI 10.1302/0301-620X.98B3.36515; Schep NWL, 2004, INJURY, V35, P1003, DOI 10.1016/j.injury.2003.07.001; Soderman P, 2001, CLIN ORTHOP RELAT R, P189; Wang T, 2014, ORTHOPEDICS, V37, pE1117, DOI 10.3928/01477447-20141124-60; Xiao YP, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0827-9; Zhang Li-Zhi, 2018, Zhongguo Gu Shang, V31, P103, DOI 10.3969/j.issn.1003-0034.2018.02.002; Zielinski SM, 2014, OSTEOPOROSIS INT, V25, P875, DOI 10.1007/s00198-013-2487-2	24	2	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-7853	1757-7861		ORTHOP SURG	Orthop. Surg.	JUN	2020	12	3					809	818		10.1111/os.12683		MAY 2020	10	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	MA1LI	WOS:000535711000001	32462816	gold, Green Published			2022-02-06	
J	Salman, M; Kaushik, P; Tabassum, H; Parvez, S				Salman, Mohd; Kaushik, Pooja; Tabassum, Heena; Parvez, Suhel			Melatonin Provides Neuroprotection Following Traumatic Brain Injury-Promoted Mitochondrial Perturbation in Wistar Rat	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Melatonin; Drp1; Mitochondria dysfunction; Neuroprotection; Repair	INDUCED OXIDATIVE STRESS; CELL-DEATH; FISSION; APOPTOSIS; DYNAMICS; MDIVI-1; MODEL; DRP1; HIPPOCAMPUS; DYSFUNCTION	Excessive mitochondrial fission has been implicated in the etiology of neuronal cell death in traumatic brain injury (TBI). In the present study, we examined the efficacy of melatonin (Mel) as a neuroprotective agent against TBI-induced oxidative damage and mitochondrial dysfunction. We assessed the impact of Mel post-treatment (10 mg/kg b.wt.,i.p.) at different time intervals in TBI-subjected Wistar rats. We found that the Mel treatment significantly attenuated brain edema, oxidative damage, mitochondrial fission, and promoted mitochondrial fusion. Additionally, Mel-treated rats showed restoration of mitochondrial membrane potential and oxidative phosphorylation with a concomitant reduction in cytochrome-c release. Further, Mel treatment significantly inhibited the translocation of Bax and Drp1 proteins to mitochondria in TBI-subjected rats. The restorative role of Mel treatment in TBI rats was supported by the mitochondrial ultra-structural analysis, which showed activation of mitochondrial fusion mechanism. Mel enhanced mitochondrial biogenesis by upregulation of PGC-1 alpha protein. Our results demonstrated the remedial role of Mel in ameliorating mitochondrial dysfunctions that are modulated in TBI-subjected rats and provided support for mitochondrial-mediated neuroprotection as a putative therapeutic agent in the brain trauma.	[Salman, Mohd; Kaushik, Pooja; Parvez, Suhel] Jamia Hamdard, Dept Med Elementol & Toxicol, Sch Chem & Life Sci, New Delhi 110062, India; [Tabassum, Heena] Govt India, Div Basic Med Sci, Indian Council Med Res, Minist Hlth & Family Welf, POB 4911, New Delhi 110029, India		Parvez, S (corresponding author), Jamia Hamdard, Dept Med Elementol & Toxicol, Sch Chem & Life Sci, New Delhi 110062, India.	sparvez@jamiahamdard.ac.in	Salman, Mohd/AAN-8924-2021	Salman, Mohd/0000-0002-7330-8108	ICMRIndian Council of Medical Research (ICMR) [3/1/2/4/Trauma/2009-NCD-1]; University Grant CommissionUniversity Grants Commission, India [25-1/2014-15(BSR)/7-91/2017/(BSR)]; Department of Science and Technology, Government of IndiaDepartment of Science & Technology (India) [SR/CSI/PDF-76/2012]; Science and Engineering Research Board, New Delhi, Government of India [2016/001070/HS]; Ministry of Science & Technology, Government of India under DST-FIST program [SR/FST/LS-I/2017/05(C), SR/PURSE Phase2/39 (C)]; Ministry of Science & Technology, Government of India under DST-PURSE program [SR/FST/LS-I/2017/05(C), SR/PURSE Phase2/39 (C)]	Mohd Salman is a recipient of the Senior Research Fellowship from ICMR [F.No.3/1/2/4/Trauma/2009-NCD-1], and Pooja Kaushik is a recipient of the Senior Research Fellowship from University Grant Commission [F.No.-25-1/2014-15(BSR)/7-91/2017/(BSR)]. Dr. Heena Tabassum is grateful to the Department of Science and Technology, Government of India, for financial grant (DST Cognitive Science Initiative Program, sanction no. SR/CSI/PDF-76/2012). The Grant no.[2016/001070/HS)], received as Extramural Research Grant from the Science and Engineering Research Board, New Delhi, Government of India, to Prof. Suhel Parvez is also thankfully acknowledged. The Grant no.[SR/FST/LS-I/2017/05(C)] and [SR/PURSE Phase2/39 (C)] received from the Ministry of Science & Technology, Government of India, to Jamia Hamdard under DST-FIST and DST-PURSE programs are also thankfully acknowledged. The authors would like to thank Dr. Pradeep K. Rai, BD-JH FACS Academy, BD Biosciences, India for his help in flow cytometry analysis.	Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Andrabi SS, 2017, DIS MODEL MECH, V10, P787, DOI 10.1242/dmm.025692; Areti A, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12393; Ashafaq M, 2017, MOL NEUROBIOL, V54, P5941, DOI 10.1007/s12035-016-0096-8; Ates O, 2006, INT J DEV NEUROSCI, V24, P357, DOI 10.1016/j.ijdevneu.2006.08.003; Bordt EA, 2017, DEV CELL, V40, P583, DOI 10.1016/j.devcel.2017.02.020; Chaudhary S, 2012, NEUROSCIENCE, V225, P258, DOI 10.1016/j.neuroscience.2012.08.060; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen H, 2016, CLIN EXP PHARMACOL P, V43, P1107, DOI 10.1111/1440-1681.12650; Chen JY, 2014, J PINEAL RES, V56, P12, DOI 10.1111/jpi.12086; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cid-Castro C, 2018, CELL MOL NEUROBIOL, V38, P995, DOI 10.1007/s10571-018-0584-7; Cui Hai-Feng, 2012, J Anal Methods Chem, V2012, P793468, DOI 10.1155/2012/793468; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Ding MG, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12491; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dobrachinski F, 2017, J NEUROTRAUM, V34, P1318, DOI 10.1089/neu.2016.4563; Dongare S, 2016, MOL VIS, V22, P599; Ehsaei M, 2015, ACTA NEUROL BELG, V115, P69, DOI 10.1007/s13760-014-0300-4; Feng Y, 2017, CELL MOL NEUROBIOL, V37, P155, DOI 10.1007/s10571-016-0356-1; Filippi BM, 2017, CELL REP, V18, P2301, DOI 10.1016/j.celrep.2017.02.035; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Flippo KH, 2017, J CELL SCI, V130, P671, DOI 10.1242/jcs.171017; Furio AM, 2007, J PINEAL RES, V43, P404, DOI 10.1111/j.1600-079X.2007.00491.x; Hroudova J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/175062; Hung CHL, 2018, REDOX BIOL, V14, P7, DOI 10.1016/j.redox.2017.08.010; Ismailoglu O, 2012, TURK NEUROSURG, V22, P740, DOI 10.5137/1019-5149.JTN.6197-12.1; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kim DI, 2016, BBA-MOL CELL RES, V1863, P2820, DOI 10.1016/j.bbamcr.2016.09.003; Li HN, 2017, NEUROCHEM RES, V42, P1096, DOI 10.1007/s11064-016-2143-2; Li Y, 2015, NEUROSCIENCE, V311, P67, DOI 10.1016/j.neuroscience.2015.10.020; Meyer JN, 2017, TOXICOLOGY, V391, P42, DOI 10.1016/j.tox.2017.07.019; Min JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05555; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Peng KG, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6705621; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Rasheed MZ, 2018, J ENVIRON PATHOL TOX, V37, P139, DOI 10.1615/JEnvironPatholToxicolOncol.2018025666; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Sheridan C, 2010, MITOCHONDRION, V10, P640, DOI 10.1016/j.mito.2010.08.005; Tabassum H, 2017, NEUROCHEM INT, V104, P11, DOI 10.1016/j.neuint.2016.12.010; Wang JW, 2014, J SURG RES, V186, P328, DOI 10.1016/j.jss.2013.08.027; Waseem M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180953; Waseem M, 2016, MITOCHONDRION, V30, P168, DOI 10.1016/j.mito.2016.08.001; Watts LT, 2016, NEURAL REGEN RES, V11, P1403, DOI 10.4103/1673-5374.191205; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Webster KA, 2012, FUTUR CARDIOL, V8, P863, DOI [10.2217/fca.12.58, 10.2217/FCA.12.58]; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Weil R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01243; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Xi Y, 2018, BBA-MOL BASIS DIS, V1864, P2859, DOI 10.1016/j.bbadis.2018.05.018; Xie LL, 2018, CANCER SCI, V109, P3686, DOI 10.1111/cas.13830; Yuruker V, 2015, METAB BRAIN DIS, V30, P223, DOI 10.1007/s11011-014-9623-3; Zhao LT, 2015, BIOCHEM BIOPH RES CO, V461, P537, DOI 10.1016/j.bbrc.2015.04.066	58	2	2	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAY	2021	41	4					765	781		10.1007/s10571-020-00884-5		MAY 2020	17	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	RD3PJ	WOS:000559587600002	32468441				2022-02-06	
J	Abujaber, A; Fadlalla, A; Gammoh, D; Abdelrahman, H; Mollazehi, M; El-Menyar, A				Abujaber, Ahmad; Fadlalla, Adam; Gammoh, Diala; Abdelrahman, Husham; Mollazehi, Monira; El-Menyar, Ayman			Prediction of in-hospital mortality in patients with post traumatic brain injury using National Trauma Registry and Machine Learning Approach	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Prediction models; Traumatic brain injury; Machine learning approach	EXTERNAL VALIDATION; OUTCOME PREDICTION; PROGNOSTIC MODELS; CLASSIFICATION; ADMISSIONS; TRISS; CRASH; SCALE; COMA	Background The use of machine learning techniques to predict diseases outcomes has grown significantly in the last decade. Several studies prove that the machine learning predictive techniques outperform the classical multivariate techniques. We aimed to build a machine learning predictive model to predict the in-hospital mortality for patients who sustained Traumatic Brain Injury (TBI). Methods Adult patients with TBI who were hospitalized in the level 1 trauma center in the period from January 2014 to February 2019 were included in this study. Patients' demographics, injury characteristics and CT findings were used as predictors. The predictive performance of Artificial Neural Networks (ANN) and Support Vector Machines (SVM) was evaluated in terms of accuracy, Area Under the Curve (AUC), sensitivity, precision, Negative Predictive Value (NPV), specificity and F-score. Results A total of 1620 eligible patients were included in the study (1417 survival and 203 non-survivals). Both models achieved accuracy over 91% and AUC over 93%. SVM achieved the optimal performance with accuracy 95.6% and AUC 96%. Conclusions for prediction of mortality in patients with TBI, SVM outperformed the well-known classical models that utilized the conventional multivariate analytical techniques.	[Abujaber, Ahmad] Hamad Med Corp, Nursing, Doha, Qatar; [Fadlalla, Adam] Qatar Univ, Coll Business & Econ, Management Informat Syst, Doha, Qatar; [Gammoh, Diala] Univ Cent Florida, Ind Engn, Orlando, FL 32816 USA; [Abdelrahman, Husham; Mollazehi, Monira] Hamad Med Corp, Dept Surg, Trauma Surg, Doha, Qatar; [El-Menyar, Ayman] Hamad Med Corp, Dept Surg, Clin Res, Trauma Surg, Doha, Qatar; [El-Menyar, Ayman] Hamad Gen Hosp, Dept Clin Med, Weill Cornell Med Coll, Doha, Qatar		El-Menyar, A (corresponding author), Hamad Med Corp, Dept Surg, Clin Res, Trauma Surg, Doha, Qatar.; El-Menyar, A (corresponding author), Hamad Gen Hosp, Dept Clin Med, Weill Cornell Med Coll, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X	Qatar National Library	We would like to thank the national trauma registry team at HMC and the faculty of business and economics at Qatar University. The publication of this article was funded by the Qatar National Library.	Aljerian N, 2018, ANN SAUDI MED, V38, P488, DOI 10.5144/0256-4947.2018.488; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Anselmi L, 2017, BMJ QUAL SAF, V26, P613, DOI 10.1136/bmjqs-2016-005680; Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Boutin A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014472; Bratton S, 2007, J NEUROTRAUM, V24, P7; Carter EL, 2016, BRIT J NEUROSURG, V30, P227, DOI 10.3109/02688697.2016.1139048; Chen CJ, 2013, AM J CRIT CARE, V22, P506, DOI 10.4037/ajcc2013950; Cui SZ, 2018, COMPUT METH PROG BIO, V166, P123, DOI 10.1016/j.cmpb.2018.10.012; Dag A, 2017, DECIS SUPPORT SYST, V94, P42, DOI 10.1016/j.dss.2016.10.005; Das A, 2003, LANCET, V362, P1261, DOI 10.1016/S0140-6736(03)14568-0; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Domingues CD, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0171-8; East JM, 2018, CURR OPIN ANESTHESIO, V31, P219, DOI 10.1097/ACO.0000000000000566; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Garcia-Laencina PJ, 2015, COMPUT BIOL MED, V59, P125, DOI 10.1016/j.compbiomed.2015.02.006; Hale AT, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS17773; Han J, 2012, MOR KAUF D, P1; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Han L, 2018, BMJ QUAL SAF, V27, P445, DOI 10.1136/bmjqs-2017-006784; Inoue A, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2276-6; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maeda Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221791; Mohseni Shahin, 2012, J Emerg Trauma Shock, V5, P11, DOI 10.4103/0974-2700.93102; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Rached MAKB, 2019, INJURY, V50, P65, DOI 10.1016/j.injury.2018.08.022; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Ramesh VG, 2008, J CLIN NEUROSCI, V15, P1110, DOI 10.1016/j.jocn.2007.08.033; Rau Cheng-Shyuan, 2018, PLoS One, V13, pe0207192, DOI 10.1371/journal.pone.0207192; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Schumacher P, 2010, J EDUC BUS, V85, P258, DOI 10.1080/08832320903449477; Senders JT, 2018, WORLD NEUROSURG, V109, P476, DOI 10.1016/j.wneu.2017.09.149; TEASDALE G, 1974, LANCET, V2, P81; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Walker AS, 2017, LANCET, V390, P62, DOI [10.1016/S0140-6736(17)30782-1, 10.1016/s0140-6736(17)30782-1]; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032; Zolbanin HM, 2015, DECIS SUPPORT SYST, V74, P150, DOI 10.1016/j.dss.2015.04.003	45	2	2	2	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAY 27	2020	28	1							44	10.1186/s13049-020-00738-5			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LV4CI	WOS:000538385000001	32460867	gold, Green Published			2022-02-06	
J	Lempke, LB; Rawlins, MLW; Anderson, MN; Miller, LS; Lynall, RC; Schmidt, JD				Lempke, Landon B.; Rawlins, Michelle L. Weber; Anderson, Melissa N.; Miller, L. Stephen; Lynall, Robert C.; Schmidt, Julianne D.			The Influence of Socioeconomic Status and Academic Standing on Concussion-Reporting Intentions and Behaviors in Collegiate Athletes	HEALTH PROMOTION PRACTICE			English	Article						brain concussion; communication; injury prevention; self-disclosure; concussion nondisclosure	SPORT-RELATED CONCUSSION; FOOTBALL PLAYERS; EDUCATION; KNOWLEDGE; CARE; HERITABILITY; SYMPTOMS; SEX	Concussion education have served as a keystone for improving concussion reporting. Numerous factors affecting concussion reporting have been explored; however, the role of socioeconomic status (SES) in reporting has not been established. We examined the influence of SES and academic achievement (high-school grade point average [HS-GPA] and American College Testing [ACT] composite scores) on athletes' concussion-reporting intentions and behaviors. A cross-sectional study was employed among 191 athletes (94 female; age 19.3 +/- 1.2 years). Athletes reported SES metrics (parental education and occupation, household income, HS-GPA, and ACT composite score) prior to their athletic season and completed a survey assessing symptom- and concussion-reporting intentions. Symptom- and concussion-reporting behaviors were assessed among athletes who experienced a concussion within the past year. SES was determined using the Hollingshead Four-Factor Index grouping athletes into SES strata. Athletes were grouped into low/high categories for academic achievement and household income variables. The 191 athletes were included for symptom- and concussion-reporting intentions analyses, while 46 and 41 were included for symptom- and concussion-reporting behavior, respectively. Nonparametric statistics with false discovery rate adjusted p values were employed. We found symptom- and concussion-reporting intentions, and symptom- and concussion-reporting behaviors were not significantly different based on SES strata (all p values >=.64), household income (all p values >=.64), HS-GPA (all p values >=.24), or ACT scores (all p values >=.25). Overall, SES and academic achievement may not play a role in understanding concussion reporting among middle- to high-SES collegiate athletes. Implementing policies targeting certain SES and academic levels might be an ineffective health care strategy for increasing reporting.	[Lempke, Landon B.; Rawlins, Michelle L. Weber; Anderson, Melissa N.; Miller, L. Stephen; Lynall, Robert C.; Schmidt, Julianne D.] Univ Georgia, Athens, GA 30602 USA; [Rawlins, Michelle L. Weber] AT Still Univ, Mesa, AZ USA		Lempke, LB (corresponding author), Univ Georgia, UGA Concuss Res Lab, Dept Kinesiol, Ramsey Student Ctr, 330 River Rd, Athens, GA 30606 USA.	lblempke@uga.edu	Lempke, Landon/C-4800-2018; Lynall, Robert/M-2888-2014	Lempke, Landon/0000-0003-0007-1362; Lynall, Robert/0000-0002-0785-6640	Grand Alliance Concussion Assessment, Research and Education Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; U.S. Army Medical Research Acquisition Activity, Fort Detrick, MD, USA; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; NCAA; DoD Mind Matters Challenge: Changing Attitudes about Concussions in Young and Emerging Adults; DoD as part of the Concussion Assessment, Research and Education (CARE) Consortium	This study was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research and Education Consortium, funded by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, USA, is the awarding and administering acquisition office. All other authors declare no potential conflicts of interest. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the DOD(Defense Health Program funds). This study was also conducted with support from the NCAA and DoD Mind Matters Challenge: Changing Attitudes about Concussions in Young and Emerging Adults. Dr. Schmidt has received research grant funding from the NCAA and DoD as part of the Concussion Assessment, Research and Education (CARE) Consortium, and separately for her work on the awarded Mind Matters Challenge grant (both associated with this manuscript). Address correspondence to Landon B. Lempke, UGA Concussion Research Laboratory, Department of Kinesiology, University of Georgia, Ramsey Student Center, 330 River Road, Athens, GA 30606, USA; e-mail: lblempke@uga.edu.	Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Becker G, 2003, AM J PUBLIC HEALTH, V93, P742, DOI 10.2105/AJPH.93.5.742; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Carroll-Alfano M, 2017, J ATHL TRAINING, V52, P689, DOI 10.4085/1062-6050-52.3.08; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Cirino PT, 2002, ASSESSMENT, V9, P145, DOI 10.1177/10791102009002005; Delaney JS, 2018, CLIN J SPORT MED, V28, P1, DOI 10.1097/JSM.0000000000000495; Druckman J. N., 2018, The Sport Journal, V21, punpaginated; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Hemingway H, 1997, AM J PUBLIC HEALTH, V87, P1484, DOI 10.2105/AJPH.87.9.1484; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Reisner A, 2017, J PEDIATR-US, V184, P26, DOI 10.1016/j.jpeds.2017.01.045; Richardson A, 2012, J HEALTH CARE POOR U, V23, P1477, DOI 10.1353/hpu.2012.0181; Sallis JF, 2015, HLTH BEHAV THEORY RE, V5, P43; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; The National Collegiate Athletic Association, 2016, MIND MATT CHALL; Trinidad KJ, 2013, CLIN J SPORT MED, V23, P462, DOI 10.1097/JSM.0b013e318295e425; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; Tuvblad C, 2006, J CHILD PSYCHOL PSYC, V47, P734, DOI 10.1111/j.1469-7610.2005.01552.x; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; WHITE KR, 1982, PSYCHOL BULL, V91, P461, DOI 10.1037/0033-2909.91.3.461; Zuckerman SL, 2017, J NEUROSURG-PEDIATR, V19, P652, DOI 10.3171/2017.1.PEDS16611; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	40	2	2	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1524-8399	1552-6372		HEALTH PROMOT PRACT	Health Promot. Pract.	SEP	2021	22	5					649	658	1524839920920289	10.1177/1524839920920289		MAY 2020	10	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	TZ6RQ	WOS:000535031000001	32443945	Bronze			2022-02-06	
J	Barnes, S; Beeke, S; Bloch, S				Barnes, Scott; Beeke, Suzanne; Bloch, Steven			How is right hemisphere communication disorder disabling? Evidence from response mobilizing actions in conversation	DISABILITY AND REHABILITATION			English	Article						Communication disabilities; neurogenic communication disorders; speech pathology; Social participation; cerebrovascular stroke	TRAUMATIC BRAIN-INJURY; FUNCTIONAL OUTCOMES; STROKE; DISABILITY; PEOPLE; REHABILITATION; PARTICIPATION; DYSARTHRIA; ABILITIES; LANGUAGE	Aim: Assessment and intervention strategies for communication disorders caused by right hemisphere stroke are at an early stage of development. There is also little evidence on how right hemisphere communication disorder is disabling for everyday life. This study explores how a woman with conversational problems following right hemisphere stroke participated in everyday conversation with family members. Method: One hour of triadic conversation was recorded and analyzed using the descriptive qualitative methodology of conversation analysis. It focused on attempts by the woman with right hemisphere stroke to direct conversation with "response mobilizing" communicative acts, i.e., communicative acts that set out clear expectations about who should speak, and how they should respond. Results: Seventy-eight communicative acts produced by the woman with right hemisphere communication disorder were divided into five groupings based on how her conversation partners addressed them. Around half of her response mobilizing communicative acts received unsupportive responses from her conversation partners, including minimal acknowledgements, explicit rejections, and ignoring responses. Conclusion: The findings of this study provide novel insight into the ways that right hemisphere communication disorder affects routine communication, and the nature of the disability it causes. This information will support the future development of evidence-based speech pathology assessment and intervention for right hemisphere stroke.	[Barnes, Scott] Macquarie Univ, Dept Linguist, Sydney, NSW, Australia; [Beeke, Suzanne; Bloch, Steven] UCL, Dept Language & Cognit, London, England		Barnes, S (corresponding author), Macquarie Univ, Dept Linguist, N Ryde, NSW 2109, Australia.	scott.barnes@mq.edu.au		Bloch, Steven/0000-0002-5355-8134; Barnes, Scott/0000-0001-5299-0550	Macquarie University Research Development Grant [5201700298]	This research was funded by a Macquarie University Research Development Grant [5201700298].	Antaki C, 2017, SOCIOL HEALTH ILL, V39, P581, DOI 10.1111/1467-9566.12500; Baker C, 2018, DISABIL REHABIL, V40, P1870, DOI 10.1080/09638288.2017.1315181; Barnes S, 2020, CLIN LINGUIST PHONET, V34, P910, DOI 10.1080/02699206.2019.1700309; Barnes S, 2019, J NEUROLINGUIST, V52, DOI 10.1016/j.jneuroling.2019.100850; Barnes S, 2019, CLIN LINGUIST PHONET, V33, P219, DOI 10.1080/02699206.2018.1498541; Barnes S, 2010, CLIN LINGUIST PHONET, V24, P55, DOI 10.3109/02699200903349734; Baron C, 1999, TOP STROKE REHABIL, V5, P55; Beeke Suzanne, 2007, Seminars in Speech and Language, V28, P136, DOI 10.1055/s-2007-970571; Blake ML, 2013, AM J SPEECH-LANG PAT, V22, P146, DOI 10.1044/1058-0360(2012/12-0021); Bloch S, 2009, INT J LANG COMM DIS, V44, P769, DOI 10.1080/13682820802546969; Bloch S, 2008, CLIN LINGUIST PHONET, V22, P974, DOI 10.1080/02699200802394831; Blythe J, GETTING OTHERS DO TH, P1; Blythe J, 2018, RES LANG SOC INTERAC, V51, P145, DOI 10.1080/08351813.2018.1449441; Bolden GB, 2012, LANG SOC, V41, P97, DOI 10.1017/S0047404511000923; Brady M, 2006, J NEUROLINGUIST, V19, P291, DOI 10.1016/j.jneuroling.2005.12.001; Buntinx WHE, 2010, J POLICY PRACT INTEL, V7, P283, DOI 10.1111/j.1741-1130.2010.00278.x; Chantraine Y, 1998, J NEUROLINGUIST, V11, P21, DOI 10.1016/S0911-6044(98)00003-7; Douglas JM, 2017, BRAIN IMPAIR, V18, P321, DOI 10.1017/BrImp.2017.20; Enfield NJ, 2017, DISTRIBUTED AGENCY, P1; Englert C, 2010, J PRAGMATICS, V42, P2666, DOI 10.1016/j.pragma.2010.04.005; Ferre P, 2012, FOLIA PHONIATR LOGO, V64, P199, DOI 10.1159/000340017; Finch E, 2016, BRAIN INJURY, V30, P883, DOI 10.3109/02699052.2016.1146959; Gardner R, 2001, LISTENERS TALK RESPO; Hartley SD, 2002, SOC SCI MED, V54, P1543, DOI 10.1016/S0277-9536(01)00136-8; Heinemann T, 2010, J PRAGMATICS, V42, P2703, DOI 10.1016/j.pragma.2010.04.007; Hepburn Alexa, 2017, TRANSCRIBING SOCIAL; Heritage J, 2012, RES LANG SOC INTERAC, V45, P30, DOI 10.1080/08351813.2012.646685; Hewetson R, 2018, APHASIOLOGY, V32, P164, DOI 10.1080/02687038.2017.1315045; Hewetson R, 2017, TOP STROKE REHABIL, V24, P330, DOI 10.1080/10749357.2017.1289622; Hilari K, 2015, FOLIA PHONIATR LOGO, V67, P114, DOI 10.1159/000440997; Humphreys GW, 2012, BCOS BRAIN BEHAV ANA; Joanette Y, 2015, MONTREAL PROTOCOL EV; Kennedy MRT, 2000, AM J SPEECH-LANG PAT, V9, P72, DOI 10.1044/1058-0360.0901.72; Laakso M, 1999, APHASIOLOGY, V13, P345, DOI 10.1080/026870399402136; Le Dorze G, 2010, DISABIL REHABIL, V32, P1073, DOI 10.3109/09638280903374121; Lehman Blake M, 2018, RIGHT HEMISPHERE DIS; Lock S, 2001, SUPPORTING PARTNERS; Mackenzie C, 2008, EVID BASED COMMUN AS, V2, P235, DOI DOI 10.1080/17489530802615336; MACKENZIE C, 2001, ADV SPEECH LANGUAGE, V3, P81, DOI DOI 10.3109/14417040109003716; McKeon A, 2018, DISABIL REHABIL, V40, P974, DOI 10.1080/09638288.2017.1280545; Odell KH, 2005, APHASIOLOGY, V19, P807, DOI 10.1080/02687030500239226; Rossano F, 2010, J PRAGMATICS, V42, P2756, DOI 10.1016/j.pragma.2010.04.010; Schegloff EA, 2007, SEQUENCE ORGANIZATION IN INTERACTION: A PRIMER IN CONVERSATION ANALYSIS I, P1, DOI 10.2277/ 0521532795; Schegloff EA, 2006, ROOTS HUMAN SOCIALIT, P70, DOI DOI 10.4324/9781003135517-4; Sherratt S, 2012, J NEUROLINGUIST, V25, P213, DOI 10.1016/j.jneuroling.2012.01.001; Sidnell J., 2013, HDB CONVERSATION ANA; Simmons-Mackie N, 2016, ARCH PHYS MED REHAB, V97, P2202, DOI 10.1016/j.apmr.2016.03.023; Stein MS, 2016, DISABIL REHABIL, V38, P315, DOI 10.3109/09638288.2015.1037865; Stivers T, 2006, LANG SOC, V35, P367, DOI 10.1017/S0047404506060179; Stivers T, 2010, J PRAGMATICS, V42, P2772, DOI 10.1016/j.pragma.2010.04.011; Stivers T, 2010, RES LANG SOC INTERAC, V43, P3, DOI 10.1080/08351810903471258; Stivers T, 2009, P NATL ACAD SCI USA, V106, P10587, DOI 10.1073/pnas.0903616106; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Waring HZ, 2012, DISCOURSE STUD, V14, P477, DOI 10.1177/1461445611433787	54	2	2	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JAN 16	2022	44	2					261	274		10.1080/09638288.2020.1766123		MAY 2020	14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	YO7HM	WOS:000538900500001	32449410	Green Submitted			2022-02-06	
J	Kapur, N				Kapur, Narinder			Paradoxes in rehabilitation	DISABILITY AND REHABILITATION			English	Article						Ultrabilitation; Paradoxes; Rehabilitation; Illusions; Post-traumatic Growth; Exceptional Recovery; Positive Neuropsychology	MIRROR VISUAL FEEDBACK; TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC GROWTH INVENTORY; RUBBER-HAND ILLUSION; PHANTOM LIMB PAIN; LATE RECOVERY; HEAD-INJURY; POSITIVE PSYCHOLOGY; STROKE SURVIVORS; THERAPY	Paradoxical enhancement and paradoxical recovery of function after brain injury harmonize well with the concept of "ultrabilitation" and its focus on novel forms of flourishing in rehabilitation settings. I consider three sets of paradoxes which may impact on brain injury rehabilitation. Firstly, I consider post-traumatic growth after brain injury and its key determinants. Secondly, I review the role of illusions in rehabilitation and the paradox that some clinical conditions may be improved by invoking perceptual distortions. Thirdly, I consider paradoxical recovery profiles after brain injury, since knowledge of such paradoxical profiles may help inform attempts at rehabilitation of some patients. Finally, I consider how some of these paradoxes relate to components of ultrabilitation, and in addition to the nascent field of positive neuropsychology and the concept of resilience after brain injury.	[Kapur, Narinder] UCL, Res Dept Clin Psychol, 1-19 Torrington Pl, London WC1E 7HJ, England; [Kapur, Narinder] Imperial Coll Healthcare NHS Trust, London, England; [Kapur, Narinder] Elysium Neurol Serv, Daventry, England		Kapur, N (corresponding author), UCL, Res Dept Clin Psychol, 1-19 Torrington Pl, London WC1E 7HJ, England.	n.kapur@ucl.ac.uk					Akhtar M., 2017, WHAT IS POSTTRAUMATI; Arya KN, 2019, NEUROPSYCHOL REHABIL, V29, P1193, DOI 10.1080/09602011.2017.1377087; Arya KN, 2015, J STROKE CEREBROVASC, V24, P1738, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.026; Baricich A, 2017, FUNCT NEUROL, V32, P131; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Bolognini N, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00212; Buetow SA, 2017, DISABIL REHABIL, P1; Champod AS, 2018, NEUROPSYCHOL REHABIL, V28, P491, DOI 10.1080/09602011.2016.1182032; CHANDRASEKHAR S, 1984, SCIENCE, V226, P497, DOI 10.1126/science.226.4674.497; Christ O, 2014, NEUROSCI BIOBEHAV R, V44, P33, DOI 10.1016/j.neubiorev.2014.02.013; Clark ME, 2012, JAMA-J AM MED ASSOC, V308, P1983, DOI 10.1001/2012.jama.10596; Colmenero LH, 2018, PROSTHET ORTHOT INT, V42, P288, DOI 10.1177/0309364617740230; Coulombe S, 2016, J ENVIRON PSYCHOL, V46, P42, DOI 10.1016/j.jenvp.2016.03.002; Coyne JC, 2010, ANN BEHAV MED, V39, P35, DOI 10.1007/s12160-010-9157-9; Cullen B, 2018, NEUROPSYCHOL REHABIL, V28, P17, DOI 10.1080/09602011.2015.1131722; Donders J, 2018, ARCH CLIN NEUROPSYCH; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Fellinghauer B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-655; Gangstad B, 2009, REHABIL PSYCHOL, V54, P69, DOI 10.1037/a0014639; Gillen G, 2005, AM J OCCUP THER, V59, P346, DOI 10.5014/ajot.59.3.346; Grace JJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01162; Greene J, 2016, POSITIVE NEUROSCIENC; Haidt J., 2006, HAPPINESS HYPOTHESIS; Hallam W, 2014, BRIT J HEALTH PSYCH, V19, P619, DOI 10.1111/bjhp.12064; Hanks RA, 2016, REHABIL PSYCHOL, V61, P269, DOI 10.1037/rep0000069; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hulbert JC, 2018, J EXP PSYCHOL GEN, V147, P1931, DOI 10.1037/xge0000461; Jenkinson PM, 2013, NEUROPSYCHOLOGIA, V51, P1453, DOI 10.1016/j.neuropsychologia.2013.03.029; Jha A, 2011, ENERGY TECHNOLOGY 2011: CARBON DIOXIDE AND OTHER GREENHOUSE GAS REDUCTION METALLURGY AND WASTE HEAT RECOVERY, P183; Kapur, 2011, PARADOXICAL BRAIN, P177, DOI [DOI 10.1017/CBO9780511978098.011, 10.1017/CBO9780511978098.011]; Kapur N., 1997, INJURED BRAINS MEDIC; Kapur N, 2011, PARADOXICAL BRAIN, P418; Kapur N, 2013, NEUROSCIENTIST, V19, P354, DOI 10.1177/1073858412470976; Kapur Narinder, 2011, PARADOXICAL BRAIN, P1, DOI [10.1017/CBO9780511978098, DOI 10.1017/CBO9780511978098]; Karagiorgou O, 2018, DISABIL REHABIL, V40, P655, DOI 10.1080/09638288.2016.1274337; Karagiorgou O, 2016, J LOSS TRAUMA, V21, P589, DOI 10.1080/15325024.2016.1161427; Kelly G, 2018, DISABIL REHABIL, V40, P2916, DOI 10.1080/09638288.2017.1363300; Kitadono K, 2007, NEUROCASE, V13, P260, DOI 10.1080/13554790701625815; Kuenemund A, 2016, J HEALTH PSYCHOL, V21, P679, DOI 10.1177/1359105314535457; Kushner DS, 2015, AM J PHYS MED REHAB, V94, P154, DOI 10.1097/PHM.0000000000000189; Lenggenhager B, 2013, NEUROREHAB NEURAL RE, V27, P704, DOI 10.1177/1545968313491009; Leung YW, 2010, J HEALTH PSYCHOL, V15, P1049, DOI 10.1177/1359105309360577; Lewkowicz D, 2011, PARADOXICAL BRAIN, P110; Linley P.A, 2008, TRAUMA RECOVERY GROW; Liu Cathy, 2014, Ann Intern Med, V160, P286; Loui P, 2011, J COGNITIVE NEUROSCI, V23, P1015, DOI 10.1162/jocn.2010.21500; Manly T, 2011, PARADOXICAL BRAIN, P74; Marwitz JH, 2018, ARCH PHYS MED REHAB, V99, P264, DOI 10.1016/j.apmr.2017.06.013; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; Mauss IB, 2011, EMOTION, V11, P807, DOI 10.1037/a0022010; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Moore B, 2017, POSTTRAUMATIC GROWTH; Mottron L, 2013, NEUROSCI BIOBEHAV R, V37, P209, DOI 10.1016/j.neubiorev.2012.11.016; Moudrous W, 2017, ACTA NEUROL BELG, V117, P733, DOI 10.1007/s13760-016-0712-4; Nalder E, 2019, DISABIL REHABIL, V41, P2708, DOI 10.1080/09638288.2018.1474495; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Ortiz-Catalan M, 2016, LANCET, V388, P2885, DOI 10.1016/S0140-6736(16)31598-7; Osborn C, 2000, MY HEAD DOCTORS OWN; Pandian JD, 2014, NEUROLOGY, V83, P1012, DOI 10.1212/WNL.0000000000000773; Peng ZY, 2018, J NEUROSCI NURS, V50, P252, DOI 10.1097/JNN.0000000000000371; Peterson C, 2008, J TRAUMA STRESS, V21, P214, DOI 10.1002/jts.20332; Potts MA, 2012, PM&R, V4, P530, DOI 10.1016/j.pmrj.2012.01.015; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Rabinowitz AR, 2018, APPL NEUROPSYCH-ADUL, V25, P295, DOI 10.1080/23279095.2018.1458514; Ramachandran VS, 2009, NEUROCASE, V15, P357, DOI 10.1080/13554790903081767; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; Ramadugu S, 2017, INDIAN J PSYCHIAT, V59, P457, DOI 10.4103/psychiatry.IndianJPsychiatry_259_16; Randolph JJ, 2018, APPL NEUROPSYCH-ADUL, V25, P287, DOI 10.1080/23279095.2018.1457465; REILLY PL, 1975, LANCET, V2, P375; Reinersmann A, 2013, PAIN, V154, P1519, DOI 10.1016/j.pain.2013.03.039; Rendon JU, 2016, NEW SCI POSTTRAUMATI; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; Rothgangel A, 2018, CLIN REHABIL, V32, P1591, DOI 10.1177/0269215518785948; Sacks O., 1985, MAN WHO MISTOOK HIS; Sacks O., 1995, ANTHR MARS; Schmalzl L, 2013, CLIN J PAIN, V29, pE10, DOI 10.1097/AJP.0b013e3182850573; Schutz L, 2010, HEAD INJURY RECOVERY; Schutz LE, 2007, J HEAD TRAUMA REHAB, V22, P48, DOI 10.1097/00001199-200701000-00006; Schwartzbaum J, 2011, PARADOXICAL BRAIN, P261; Seeley WW, 2008, BRAIN, V131, P39, DOI 10.1093/brain/awm270; Seery MD, 2013, PSYCHOL SCI, V24, P1181, DOI 10.1177/0956797612469210; Sekely A, 2018, DISABIL REHABIL, P1; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; Stewart TL, 2013, AGING MENT HEALTH, V17, P375, DOI 10.1080/13607863.2012.743963; Sumitani M, 2008, RHEUMATOLOGY, V47, P1038, DOI 10.1093/rheumatology/ken170; Tabares-Seisdedos R, 2013, J COMORB, V3, P13; Taku K, 2008, J TRAUMA STRESS, V21, P158, DOI 10.1002/jts.20305; Tedeschi R.G., 2018, POSTTRAUMATIC GROWTH; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Thomas D, 2010, BMJ-BRIT MED J, V341, P398; Thomas D, 2009, INT J THER REHABIL, V16, P497, DOI 10.12968/ijtr.2009.16.9.43768; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; Vural SP, 2016, ARCH PHYS MED REHAB, V97, P575, DOI 10.1016/j.apmr.2015.12.008; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Warlow Charles, 2013, Pract Neurol, V13, P260, DOI 10.1136/practneurol-2013-000627; Wilczek F, 2005, P NATL ACAD SCI USA, V102, P8403, DOI 10.1073/pnas.0501642102; Wilson BA, 2016, SURVIVING BRAIN INJU; Wilson BA, 2013, BRAIN INJURY, V27, P944, DOI 10.3109/02699052.2013.775495; Wood AM, 2010, CLIN PSYCHOL REV, V30, P819, DOI 10.1016/j.cpr.2010.06.003; Yang Y, 2018, NEUROSCIENCE, V390, P318, DOI 10.1016/j.neuroscience.2018.06.044; Yelden K, 2018, DISABIL REHABIL, V40, P2433, DOI 10.1080/09638288.2017.1339209; Yerdelen D, 2015, NEUROSCIENCES, V20, P164, DOI 10.17712/nsj.2015.2.20140588; Zimmerman S., 2011, PARADOXICAL BRAIN, P130	106	2	2	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAY 21	2020	42	11					1495	1502		10.1080/09638288.2019.1572795			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	LV8OX	WOS:000538699400003	30741029				2022-02-06	
J	Liu, YL; Nacewicz, BM; Zhao, GY; Adluru, N; Kirk, GR; Ferrazzano, PA; Styner, MA; Alexander, AL				Liu, Yilin; Nacewicz, Brendon M.; Zhao, Gengyan; Adluru, Nagesh; Kirk, Gregory R.; Ferrazzano, Peter A.; Styner, Martin A.; Alexander, Andrew L.			A 3D Fully Convolutional Neural Network With Top-Down Attention-Guided Refinement for Accurate and Robust Automatic Segmentation of Amygdala and Its Subnuclei	FRONTIERS IN NEUROSCIENCE			English	Article						deep learning; fully convolutional neural network; amygdala; structural MRI; segmentation; harmonization; generalization	ATLAS SELECTION; BRAIN IMAGES; FEAR; HIPPOCAMPAL; IMPAIRMENT	Recent advances in deep learning have improved the segmentation accuracy of subcortical brain structures, which would be useful in neuroimaging studies of many neurological disorders. However, most existing deep learning based approaches in neuroimaging do not investigate the specific difficulties that exist in segmenting extremely small but important brain regions such as the subnuclei of the amygdala. To tackle this challenging task, we developed a dual-branch dilated residual 3D fully convolutional network with parallel convolutions to extract more global context and alleviate the class imbalance issue by maintaining a small receptive field that is just the size of the regions of interest (ROIs). We also conduct multi-scale feature fusion in both parallel and series to compensate the potential information loss during convolutions, which has been shown to be important for small objects. The serial feature fusion enabled by residual connections is further enhanced by a proposed top-down attention-guided refinement unit, where the high-resolution low-level spatial details are selectively integrated to complement the high-level but coarse semantic information, enriching the final feature representations. As a result, the segmentations resulting from our method are more accurate both volumetrically and morphologically, compared with other deep learning based approaches. To the best of our knowledge, this work is the first deep learning-based approach that targets the subregions of the amygdala. We also demonstrated the feasibility of using a cycle-consistent generative adversarial network (CycleGAN) to harmonize multi-site MRI data, and show that our method generalizes well to challenging traumatic brain injury (TBI) datasets collected from multiple centers. This appears to be a promising strategy for image segmentation for multiple site studies and increased morphological variability from significant brain pathology.	[Liu, Yilin; Adluru, Nagesh; Kirk, Gregory R.; Ferrazzano, Peter A.; Alexander, Andrew L.] Univ Wisconsin, Waisman Brain Imaging Lab, Madison, WI 53715 USA; [Nacewicz, Brendon M.; Alexander, Andrew L.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Zhao, Gengyan; Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA; [Ferrazzano, Peter A.] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Styner, Martin A.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA; [Styner, Martin A.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA		Alexander, AL (corresponding author), Univ Wisconsin, Waisman Brain Imaging Lab, Madison, WI 53715 USA.; Alexander, AL (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA.; Alexander, AL (corresponding author), Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA.	alalexander2@wisc.edu	Styner, Martin/AAS-9949-2020; Alexander, Andrew/ABA-2806-2020	Styner, Martin/0000-0002-8747-5118; 	NARSAD: Brain and Behavior grantNARSAD [24103]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS R01 NS092870]; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P50 MH100031]; Waisman Center U54 IDDRC from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54 HD090256]; Center for Predictive and Computational Phenotyping (CPCP) [U54-AI117924-03]; Alzheimer's Disease Connectome Project (ADCP) [UF1-AG051216-01A1, R56-AG052698-01]; BRAIN Initiative [R01-EB022883-01]	This work was supported by NARSAD: Brain and Behavior grant 24103 (to BN) and National Institutes of Health grant funding NINDS R01 NS092870, NIMH P50 MH100031 and the Waisman Center U54 IDDRC from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54 HD090256). NA was also supported in part by the BRAIN Initiative R01-EB022883-01, the Center for Predictive and Computational Phenotyping (CPCP) U54-AI117924-03, the Alzheimer's Disease Connectome Project (ADCP) UF1-AG051216-01A1 and R56-AG052698-01.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; AMARAL D G, 1992, P1; [Anonymous], 2016, MULTISCALE CONTEXT A; Babalola KO, 2009, NEUROIMAGE, V47, P1435, DOI 10.1016/j.neuroimage.2009.05.029; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Chen Y, 2017, 2017 4TH INTERNATIONAL CONFERENCE ON INFORMATION SCIENCE AND CONTROL ENGINEERING (ICISCE), P1467, DOI 10.1109/ICISCE.2017.306; Cho K., 2014, ARXIV14090473; Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49; Ciresan D.C., 2011, 22 INT JOINT C ART I; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dalmis MU, 2017, MED PHYS, V44, P533, DOI 10.1002/mp.12079; de Brebisson Alexandre, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P20, DOI 10.1109/CVPRW.2015.7301312; Galleguillos C, 2010, COMPUT VIS IMAGE UND, V114, P712, DOI 10.1016/j.cviu.2010.02.004; Geremia E, 2011, NEUROIMAGE, V57, P378, DOI 10.1016/j.neuroimage.2011.03.080; Ghafoorian M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05300-5; Gibson E, 2018, LECT NOTES COMPUT SC, V11073, P506, DOI 10.1007/978-3-030-00937-3_58; Gibson E, 2018, COMPUT METH PROG BIO, V158, P113, DOI 10.1016/j.cmpb.2018.01.025; Glorot X., 2011, P 14 INT C ARTIFICIA, DOI DOI 10.1.1.208.6449; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672; Hanson JL, 2015, BIOL PSYCHIAT, V77, P314, DOI 10.1016/j.biopsych.2014.04.020; Hanson JL, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00166; Hariharan Bharath, 2015, PROC CVPR IEEE, DOI DOI 10.1109/CVPR.2015.7298642; Hrybouski S, 2016, NEUROIMAGE, V133, P98, DOI 10.1016/j.neuroimage.2016.02.056; Hu J, 2018, PROC CVPR IEEE, P7132, DOI [10.1109/CVPR.2018.00745, 10.1109/TPAMI.2019.2913372]; Hu PY, 2017, PROC CVPR IEEE, P1522, DOI 10.1109/CVPR.2017.166; Ioffe S., 2015, ARXIV 1502 03167, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Isola P, 2017, PROC CVPR IEEE, P5967, DOI 10.1109/CVPR.2017.632; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson J, 2016, LECT NOTES COMPUT SC, V9906, P694, DOI 10.1007/978-3-319-46475-6_43; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Karani N, 2018, LECT NOTES COMPUT SC, V11070, P476, DOI 10.1007/978-3-030-00928-1_54; Knight DC, 2005, NEUROIMAGE, V26, P1193, DOI 10.1016/j.neuroimage.2005.03.020; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kushibar K, 2018, MED IMAGE ANAL, V48, P177, DOI 10.1016/j.media.2018.06.006; Kwapis JL, 2017, NEUROPSYCHOPHARMACOL, V42, P1284, DOI 10.1038/npp.2016.274; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Li WQ, 2017, LECT NOTES COMPUT SC, V10265, P348, DOI 10.1007/978-3-319-59050-9_28; Lin TY, 2017, PROC CVPR IEEE, P936, DOI 10.1109/CVPR.2017.106; Liu Y., 2018, P ANN M INT SOC MAGN; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Mai J.K., 2015, ATLAS HUMAN BRAIN, V4th; Maltbie E, 2012, NEUROIMAGE, V59, P1315, DOI 10.1016/j.neuroimage.2011.08.025; Milletari F, 2016, INT CONF 3D VISION, P565, DOI 10.1109/3DV.2016.79; Moeskops P, 2016, IEEE T MED IMAGING, V35, P1252, DOI 10.1109/TMI.2016.2548501; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; Nacewicz BM, 2012, NEUROIMAGE, V59, P2548, DOI 10.1016/j.neuroimage.2011.08.090; Negahdar M, 2018, PROC SPIE, V10575, DOI 10.1117/12.2293723; Noh H, 2015, IEEE I CONF COMP VIS, P1520, DOI 10.1109/ICCV.2015.178; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Roy AG, 2018, LECT NOTES COMPUT SC, V11070, P421, DOI 10.1007/978-3-030-00928-1_48; Saygin ZM, 2017, NEUROIMAGE, V155, P370, DOI 10.1016/j.neuroimage.2017.04.046; Schoemaker D, 2016, NEUROIMAGE, V129, P1, DOI 10.1016/j.neuroimage.2016.01.038; Shenton ME, 2002, PSYCHIAT RES-NEUROIM, V115, P15, DOI 10.1016/S0925-4927(02)00025-2; Shrivastava A., 2016, ARXIV PREPRINT ARXIV; Simonyan K., 2014, ARXIV, DOI DOI 10.1109/CVPR.2015.7298594; Tang XY, 2015, HUM BRAIN MAPP, V36, P2093, DOI 10.1002/hbm.22758; Tyszka JM, 2016, HUM BRAIN MAPP, V37, P3979, DOI 10.1002/hbm.23289; Wang JH, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00007; Yoon S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157856; Zhang ZL, 2018, LECT NOTES COMPUT SC, V11214, P273, DOI 10.1007/978-3-030-01249-6_17; Zhao GY, 2018, NEUROIMAGE, V175, P32, DOI 10.1016/j.neuroimage.2018.03.065; Zhu JY, 2017, IEEE I CONF COMP VIS, P2242, DOI 10.1109/ICCV.2017.244	69	2	2	4	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAY 21	2020	14								260	10.3389/fnins.2020.00260			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW8QX	WOS:000539409600001	32508558	Green Published, gold			2022-02-06	
J	Sungura, RE; Spitsbergen, JM; Mpolya, EA; Sauli, E; Vianney, JM				Sungura, Richard Erasto; Spitsbergen, John Martin; Mpolya, Emmanuel Abraham; Sauli, Elingarami; Vianney, John-Mary			The neuroimaging magnitude of pediatric brain atrophy in northern Tanzania	PAN AFRICAN MEDICAL JOURNAL			English	Article						Brain atrophy; brain volume; evans index; neuroimaging	DAVIDOFF-MASSON-SYNDROME; TRAUMATIC BRAIN; CEREBRAL HEMIATROPHY; MATTER; INJURY; TOMOGRAPHY; ENCEPHALOPATHY; COMPLICATIONS; INFLAMMATION; PREVALENCE	Introduction: the loss of parenchymal brain volume per normative age comparison is a distinctive feature of brain atrophy. While the condition is the most prevalent to elderly, it has also been observed in pediatric ages. Various causes such as trauma, infection, and malnutrition have been reported to trigger the loss of brain tissues volume. Despite this literature based knowledge of risk factors, the magnitude of brain atrophy in pediatric age group is scantly addressed in most developing countries including Tanzania. The current study aims to understand the magnitude of brain atrophy in children residing in Northern Zone, Tanzania. Methods: a cross-sectional hospital survey was performed in which 455 children who were presented with various brain pathologies from the year 2013 to 2019 and whose brains examined by Computerized tomography (CT)-Scanners were recruited in the study. The brain statuses were examined using three linear radiological methods including the measure of sul cal-width, Evans index, and lateral ventricular body width. Results: results showed a significant number of atrophied brains among children in Northern Tanzania and that the condition was observed to have a 1:1 male to female ratio. The prevalence of pediatric brain atrophy was found to be 16.04%. Conclusion: the cortical subtype of brain atrophy presented as the most prevalent type of brain volume loss. The findings of this study suggest existence of considerable trends of brain atrophy in children which need special attention and mitigation plans.	[Sungura, Richard Erasto; Mpolya, Emmanuel Abraham; Sauli, Elingarami; Vianney, John-Mary] Nelson Mandela African Inst Sci & Technol, Sch Life Sci & Bioengn, Dept Hlth & Biomed Sci, Arusha, Tanzania; [Spitsbergen, John Martin] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA		Sungura, RE (corresponding author), Nelson Mandela African Inst Sci & Technol, Sch Life Sci & Bioengn, Dept Hlth & Biomed Sci, Arusha, Tanzania.						AKINYINKA OO, 1995, ANN TROP PAEDIATR, V15, P329, DOI 10.1080/02724936.1995.11747793; Appelman APA, 2009, CEREBROVASC DIS, V28, P227, DOI 10.1159/000226774; Aravalli RN, 2007, J NEUROIMMUNE PHARM, V2, P297, DOI 10.1007/s11481-007-9071-5; Atalar MH, 2007, PEDIATR INT, V49, P70, DOI 10.1111/j.1442-200X.2007.02299.x; Birge SJ, 2003, CLIN GERIATR MED, V19, P617, DOI 10.1016/S0749-0690(02)00143-X; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burd I, 2012, AM J REPROD IMMUNOL, V67, P287, DOI 10.1111/j.1600-0897.2012.01110.x; Capizzano AA, 2004, J NEUROL NEUROSUR PS, V75, P822, DOI 10.1136/jnnp.2003.019273; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Chiriboga CA, 2005, J PEDIATR-US, V146, P402, DOI 10.1016/j.jpeds.2004.10.021; Coppen EM, 2018, PARKINSONISM RELAT D, V46, P56, DOI 10.1016/j.parkreldis.2017.11.001; de van der Schueren MAE, 2016, J AM GERIATR SOC, V64, P2457, DOI 10.1111/jgs.14385; Deoni SCL, 2011, J NEUROSCI, V31, P784, DOI 10.1523/JNEUROSCI.2106-10.2011; Duning T, 2005, NEUROLOGY, V64, P548, DOI 10.1212/01.WNL.0000150542.16969.CC; Espeland MA, 2013, DIABETES CARE, V36, P90, DOI 10.2337/dc12-0555; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Garcia-Valdecasas-Campelo E, 2007, ALCOHOL ALCOHOLISM, V42, P533, DOI 10.1093/alcalc/agm065; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; GELMAN BB, 1992, ANN NEUROL, V32, P31, DOI 10.1002/ana.410320107; Ghosh A, 2009, BRAIN INJURY, V23, P228, DOI 10.1080/02699050802672789; HATAZAWA J, 1982, J AM GERIATR SOC, V30, P235, DOI 10.1111/j.1532-5415.1982.tb07092.x; Hayakawa K, 2002, EUR RADIOL, V12, P2542, DOI 10.1007/s00330-002-1329-y; Jerneren F, 2015, AM J CLIN NUTR, V102, P215, DOI 10.3945/ajcn.114.103283; Jouvent E, 2007, STROKE, V38, P1786, DOI 10.1161/STROKEAHA.106.478263; Kabat J, 2012, POL J RADIOL, V77, P35, DOI 10.12659/PJR.882968; Kenney D, 2013, NEUROLOGY, V80, P1540; Kitagaki H, 1998, AM J NEURORADIOL, V19, P1277; Kochunov P, 2005, HUM BRAIN MAPP, V26, P210, DOI 10.1002/hbm.20198; Kulak W, 2003, BRAIN DEV-JPN, V25, P499, DOI 10.1016/S0387-7604(03)00040-8; Kumar A., 2018, EVALUATION, V4; Lukas C, 2010, J NEUROL NEUROSUR PS, V81, P1351, DOI 10.1136/jnnp.2009.199968; McMillen R., 2011, BR J HEALTHCARE ASSI, V5, P117; Muola D., 2017, PREVALENCE PATTERN W; Obajimi M O, 2004, West Afr J Med, V23, P167; Peper JS, 2009, PSYCHONEUROENDOCRINO, V34, P332, DOI 10.1016/j.psyneuen.2008.09.012; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Shrestha RK, 2015, JSSN, V18, P26; Silvennoinen HM, 2007, AM J NEURORADIOL, V28, P1299, DOI 10.3174/ajnr.A0574; Siren AL, 2006, BRAIN, V129, P480, DOI 10.1093/brain/awh703; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sohrabji F, 2015, FRONT NEUROENDOCRIN, V36, P1, DOI 10.1016/j.yfrne.2014.05.003; Soussain C, 2009, LANCET, V374, P1639, DOI 10.1016/S0140-6736(09)61299-X; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Thakkar PA, 2016, J PEDIATR NEUROSCI, V11, P252, DOI 10.4103/1817-1745.193365; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Ygberg S, 2012, ACTA PAEDIATR, V101, P120, DOI 10.1111/j.1651-2227.2011.02494.x; Zahr NM, 2011, NAT REV NEUROL, V7, P284, DOI 10.1038/nrneurol.2011.42; ZENEROLI ML, 1987, J HEPATOL, V4, P283, DOI 10.1016/S0168-8278(87)80536-6; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687, DOI 10.1148/130.3.687; Zivadinov R, 2005, J NEUROIMAGING, V15, P27, DOI 10.1177/1051228404271010	52	2	2	0	0	AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET	KAMPALA	PO BOX 12874, KAMPALA, 00000, UGANDA	1937-8688			PAN AFR MED J	Pan Afr. Med. J.	MAY 21	2020	36								25	10.11604/pamj.2020.36.25.22515			11	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	MH1XN	WOS:000546526700001	32774602	gold, Green Published			2022-02-06	
J	Su, YX; Jin, C; Duan, XK; Wang, J; Li, K				Su, Yuxi; Jin, Chen; Duan, Xiaokun; Wang, Jing; Li, Kuang			Treatment of displaced radial neck fractures under ultrasonographic guidance in children	INTERNATIONAL ORTHOPAEDICS			English	Article						Close reduction; Kirschner wires; Radial neck fracture; Ultrasound	PERCUTANEOUS REDUCTION; ULTRASOUND; DIAGNOSIS; MANAGEMENT; FIXATION; HEAD	Purpose This study aimed to evaluate the feasibility of reduction under ultrasonographic (US) guidance with Kirschner wires (K-wires) and fixation with elastic stable intramedullary nails (ESINs) in the treatment of radial neck fractures (RNFs). Methods This retrospective study included 50 children treated for Judet types III and IV RNFs at our hospital from September 2015 to November 2018. Patients were divided into two groups: group A (without US) and group B (with US). Group A patients were treated using the Metaizeau technique; one K-wire was used for reduction under the guidance of X-ray fluoroscopy. Group B patients were treated using the same technique, but under the guidance of US. Post-operative radiographs, elbow function, and complications were analyzed. Results All patients were followed up over a period of 12 months. Five patients in group A had posterior interosseous nerve (PIN) injury, whereas no patient in group B had PIN injury (p = 0.016). The use of US guidance resulted in lower radiation exposure and shorter operation time. According to the Mayo Elbow Performance Index, there was no significant difference between the two groups (p = 0.814), including post-operative complications (radial head necrosis, fracture displacement, or stiffness). Conclusion US guidance during surgery is feasible to treat Judet type III and IV RNFs. US guidance can significantly reduce X-ray radiation exposure and the risk of PIN injury.	[Su, Yuxi] Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Chongqing Key Lab Pediat, Minist Educ,Dept Orthopaed 2,Key Lab Child Dev &, Chongqing, Peoples R China; [Su, Yuxi] Chongqing Med Univ, Childrens Hosp, China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China; [Jin, Chen; Li, Kuang] Shandong First Med Univ Shandong, Affiliated Hosp 2, Pediat Surg, Changcheng Rd 619, Tai An, Shandong, Peoples R China; [Duan, Xiaokun] Shandong Wendeng Osteopath Hosp, Pediat Orthoped, Weihai, Shandong, Peoples R China; [Wang, Jing] Shandong First Med Univ Shandong, Affiliated Hosp 2, Ultrasound Dept, Tai An, Shandong, Peoples R China		Li, K (corresponding author), Shandong First Med Univ Shandong, Affiliated Hosp 2, Pediat Surg, Changcheng Rd 619, Tai An, Shandong, Peoples R China.	suyuxi@hospital.cqmu.edu.cn; 472185596@qq.com; 272945568@qq.com; lesbianing@163.com; hflikung@126.com					Ali AAW, 2016, PEDIATR EMERG CARE, V32, P192, DOI 10.1097/PEC.0000000000000732; Bellavia MA, 2017, MUSCLE NERVE, V56, pE18, DOI 10.1002/mus.25636; BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; Cevik N, 2018, ACTA ORTHOP TRAUMATO, V52, P428, DOI 10.1016/j.aott.2018.07.007; Cha SM, 2012, INT ORTHOP, V36, P803, DOI 10.1007/s00264-011-1387-3; Choi WS, 2017, J ORTHOP TRAUMA, V31, pE150, DOI 10.1097/BOT.0000000000000790; Connolly B, 2006, PEDIATR RADIOL, V36, P163, DOI 10.1007/s00247-006-0192-4; Cossio A, 2014, INJURY, V45, pS80, DOI 10.1016/j.injury.2014.10.028; Du XP, 2019, J INT MED RES, V47, P5497, DOI 10.1177/0300060519825990; Kaiser M, 2016, ACTA ORTHOP, V87, P529, DOI 10.1080/17453674.2016.1203700; Kozaci N, 2017, INJURY, V48, P542, DOI 10.1016/j.injury.2016.12.018; Lee JE, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1891-8; Li XT, 2019, ORTHOP TRAUMATOL-SUR, V105, P557, DOI 10.1016/j.otsr.2019.02.005; Malahias MA, 2018, ARCH BONE JT SURG-AB, V6, P539; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; Nicholson LT, 2019, J AM ACAD ORTHOP SUR, V27, pE876, DOI 10.5435/JAAOS-D-18-00204; Qiao F, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2947-8; Rowlands R, 2017, J EMERG MED, V52, P208, DOI 10.1016/j.jemermed.2016.10.013; S R Karthick, 2020, J Clin Orthop Trauma, V11, P324, DOI 10.1016/j.jcot.2019.04.013; Soldado F, 2015, ARCH BONE JT SURG-AB, V3, P169; Song KS, 2015, J PEDIATR ORTHOPED, V35, pE26, DOI 10.1097/BPO.0000000000000305; Su YX, 2021, J INVEST SURG, V34, P479, DOI 10.1080/08941939.2019.1649766; Tokarski J, 2018, J PEDIATR-US, V198, P214, DOI 10.1016/j.jpeds.2018.02.072; Wellsh BM, 2016, AM J EMERG MED, V34, P40, DOI 10.1016/j.ajem.2015.09.013	24	2	3	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	NOV	2020	44	11					2337	2342		10.1007/s00264-020-04630-w		MAY 2020	6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	OE5KS	WOS:000534570900001	32430548				2022-02-06	
J	Koenig, S; Wu, ZY; Gao, Y; Li, XB				Koenig, Scott; Wu, Ziyan; Gao, Yu; Li, Xiaobo			Abnormal Cortical Activation in Visual Attention Processing in Sub-Clinical Psychopathic Traits and Traumatic Brain Injury: Evidence from an fNIRS Study	JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT			English	Article						Psychopathy; Psychopathic traits; Attention; Traumatic brain injury (TBI); Functional near-infrared spectroscopy (fNIRS)	CONTINUOUS PERFORMANCE TASK; PERSONALITY-INVENTORY; FUNCTIONAL CONNECTIVITY; CRIMINAL PSYCHOPATHS; CONDUCT PROBLEMS; DECISION-MAKING; VALIDITY; CHILDREN; P3; HETEROGENEITY	Psychopathy is characterized by impulsivity, antisocial behavior, and deficient affect, and it has also been associated with attention deficits. However, studies of the relationship between psychopathy and the underlying neurophysiology of attention have yielded mixed results, which may be due to the heterogeneous nature of psychopathy as well as the failure to account for the influence of a history of traumatic brain injury (TBI). This study investigated whether the neurophysiology of attention is differentially associated with individual psychopathic traits, and whether a history of TBI may change these associations. Psychopathic traits were assessed among college students (age = 18-26 years; 63% male) with (n = 20) and without (n = 23) a history of mild TBI. Brain activation in bilateral middle frontal gyri (MFG) was measured with functional near-infrared spectroscopy (fNIRS) during a block-designed (rest and task blocks) visual sustained attention task. Relative to non-TBI controls, participants with a history of TBI showed significantly more activation in the right MFG in response to the task. In participants without a history of TBI, self-centered impulsivity was positively associated with activation in the right MFG during the rest blocks, while coldheartedness was negatively associated with activation in the left MFG during the task. No relationships between psychopathic traits and MFG activation were found in those with a history of TBI. These findings indicate that MFG hypoactivation and hyperactivation may contribute to the affective coldness and impulsivity of psychopathy, respectively, and highlight the importance of assessing TBI in psychopathy research.	[Koenig, Scott; Gao, Yu] CUNY, Grad Ctr, New York, NY USA; [Koenig, Scott; Gao, Yu] CUNY Brooklyn Coll, Dept Psychol, Brooklyn, NY 11210 USA; [Wu, Ziyan; Li, Xiaobo] New Jersey Inst Technol, Dept Elect & Comp Engn, Newark, NJ 07102 USA; [Li, Xiaobo] New Jersey Inst Technol, Dept Biomed Engn, 323 Martin Luther King Blvd,Fenster 613, Newark, NJ 07102 USA		Wu, ZY; Li, XB (corresponding author), New Jersey Inst Technol, Dept Elect & Comp Engn, Newark, NJ 07102 USA.; Li, XB (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, 323 Martin Luther King Blvd,Fenster 613, Newark, NJ 07102 USA.	xli.aecom@gmail.com			New Jersey Commission on Brain Injury Research [CBIR17PIL012]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03MH109791]; New Jersey Institute of Technology Start-up Award	This work was partially supported by research grants from the New Jersey Commission on Brain Injury Research (CBIR17PIL012), the National Institutes of Health (R03MH109791) and New Jersey Institute of Technology Start-up Award to Dr. Xiaobo Li.	Andersson M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-41; Bach-y-Rita P, 2003, BRAIN INJURY, V17, P643, DOI 10.1080/0269905031000107133; Baker WB, 2014, BIOMED OPT EXPRESS, V5, P4053, DOI 10.1364/BOE.5.004053; Bennett S, 2016, SHAKESPEAR INT YEARB, V16, P1; Benning SD, 2003, PSYCHOL ASSESSMENT, V15, P340, DOI 10.1037/1040-3590.15.3.340; Berg JM, 2015, PSYCHOL ASSESSMENT, V27, P1494, DOI 10.1037/pas0000129; Blair RJR, 2009, PSYCHOL MED, V39, P543, DOI 10.1017/S0033291708003991; Bresin K, 2014, J ABNORM PSYCHOL, V123, P634, DOI 10.1037/a0037229; Brinkley CA, 2004, CLIN PSYCHOL-SCI PR, V11, P69, DOI 10.1093/clipsy/bph054; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Burnham KP., 2002, MODEL SELECTION MULT; Carlson SR, 2010, BIOL PSYCHOL, V85, P318, DOI 10.1016/j.biopsycho.2010.08.002; Carlson SR, 2009, PSYCHOPHYSIOLOGY, V46, P100, DOI 10.1111/j.1469-8986.2008.00756.x; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Claes L, 2009, J PERS DISORD, V23, P477, DOI 10.1521/pedi.2009.23.5.477; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Contreras-Rodriguez O, 2015, BIOL PSYCHIAT, V78, P647, DOI 10.1016/j.biopsych.2014.03.007; Cope LM, 2012, PSYCHIAT RES-NEUROIM, V204, P91, DOI 10.1016/j.pscychresns.2012.10.004; CORKUM PV, 1993, J CHILD PSYCHOL PSYC, V34, P1217, DOI 10.1111/j.1469-7610.1993.tb01784.x; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Gao Y, 2010, BEHAV SCI LAW, V28, P194, DOI 10.1002/bsl.924; Glenn AL, 2009, MOL PSYCHIATR, V14, P909, DOI 10.1038/mp.2009.76; Hiatt K.D., 2006, HDB PSYCHOPATHY, P334; Ishikawa SS, 2001, J ABNORM PSYCHOL, V110, P423, DOI 10.1037/0021-843X.110.3.423; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Kiehl KA, 1999, BIOL PSYCHIAT, V45, P1498, DOI 10.1016/S0006-3223(98)00193-0; Kiehl KA, 2006, J ABNORM PSYCHOL, V115, P443, DOI 10.1037/0021-843X.115.3.443; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Korponay C, 2017, SOC COGN AFFECT NEUR, V12, P1169, DOI 10.1093/scan/nsx042; Lee TMC, 2008, MOL PSYCHIATR, V13, P655, DOI 10.1038/mp.2008.46; Li T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3567085; Li XB, 2012, J AM ACAD CHILD PSY, V51, P1197, DOI 10.1016/j.jaac.2012.08.013; Lilienfeld S. O., 2005, SOC INFLUENCE, V61, P97; Lozier LM, 2014, JAMA PSYCHIAT, V71, P627, DOI 10.1001/jamapsychiatry.2013.4540; MacCoon D. G., 2004, HDB SELF REGULATION, P422; Maes JHR, 2013, PSYCHIAT RES, V210, P1265, DOI 10.1016/j.psychres.2013.09.028; Manzanero S., 2017, J CONCUSSION, DOI [10.1177/2059700217726874, DOI 10.1177/2059700217726874]; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nakagawa S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0213; Neumann C. S., 2006, HDB PSYCHOPATHY, P58; Newman JP, 2010, BIOL PSYCHIAT, V67, P66, DOI 10.1016/j.biopsych.2009.07.035; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patrick CJ., 2009, HDB NEUROSCIENCE BEH, P1110, DOI [10.1002/9780470478509.neubb002057, DOI 10.1002/9780470478509.NEUBB002057]; Philippi CL, 2015, J NEUROSCI, V35, P6068, DOI 10.1523/JNEUROSCI.5010-14.2015; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Poythress NG, 1998, PSYCHOL ASSESSMENT, V10, P426, DOI 10.1037/1040-3590.10.4.426; R Core Team, 2019, R LANG ENV STAT COMP; RAINE A, 1988, PSYCHOPHYSIOLOGY, V25, P30, DOI 10.1111/j.1469-8986.1988.tb00954.x; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Salekin RT, 2017, J CHILD PSYCHOL PSYC, V58, P1180, DOI 10.1111/jcpp.12738; Salekin RT, 2016, PERSONAL DISORD, V7, P180, DOI 10.1037/per0000150; Sandoval AMR, 2000, J PERS ASSESS, V74, P262, DOI 10.1207/S15327752JPA7402_7; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sebastian CL, 2012, ARCH GEN PSYCHIAT, V69, P814, DOI 10.1001/archgenpsychiatry.2011.2070; Sharan T., 2016, THESIS; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Strangman GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066319; Tong YJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00313; Tong YJ, 2013, NEUROIMAGE, V76, P202, DOI 10.1016/j.neuroimage.2013.03.019; Tong YJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.106004; Uzieblo K, 2010, ASSESSMENT, V17, P334, DOI 10.1177/1073191109356544; Vossel S, 2006, NEUROIMAGE, V32, P1257, DOI 10.1016/j.neuroimage.2006.05.019; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Weidacker K, 2016, CLIN NEUROPHYSIOL, V127, P3102, DOI 10.1016/j.clinph.2016.05.274; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wu ZY, 2018, CNS NEUROSCI THER, V24, P539, DOI 10.1111/cns.12811; Xia SG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00162; Yang Y, 2009, MOL PSYCHIATR, V14, P561, DOI 10.1038/mp.2009.12; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yildirim BO, 2015, AGGRESS VIOLENT BEH, V24, P9, DOI 10.1016/j.avb.2015.05.001; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	78	2	2	1	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0882-2689	1573-3505		J PSYCHOPATHOL BEHAV	J. Psychopathol. Behav. Assess.	DEC	2020	42	4					627	636		10.1007/s10862-020-09808-5		MAY 2020	10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	OD4CW	WOS:000534520100001					2022-02-06	
J	Comstock, RD; Arakkal, AT; Pierpoint, LA; Fields, SK				Comstock, R. Dawn; Arakkal, Alan T.; Pierpoint, Lauren A.; Fields, Sarah K.			Are high school girls' lacrosse players at increased risk of concussion because they are not allowed to wear the same helmet boys' lacrosse players are required to wear?	INJURY EPIDEMIOLOGY			English	Article						Concussion; Lacrosse; Gender; Attributable risk; Attributable risk percent; Surveillance; Prevention	SURVEILLANCE DESCRIPTIVE EPIDEMIOLOGY; WOMENS LACROSSE; PROTECTIVE EYEWEAR; EYE INJURIES; SAFETY HELMETS; HEAD-INJURIES; 1ST DECADE; COMPENSATION; SKIERS; SNOWBOARDERS	BackgroundBoys' lacrosse (LAX), a full contact sport allowing body and stick checking, mandates hard shell helmets with full face masks. Girls' LAX, which prohibits body checking and whose sphere rule is supposed to prevent stick checking to the head, allows optional flexible headgear with/without integrated eye protection. Whether the required boys' LAX helmets should also be mandated in girls' LAX has been debated.MethodsIn this retrospective cohort study we used LAX concussion data from a national high school sports-related injury surveillance study to determine if girls' LAX players were at increased risk of concussion from stick or ball contact due to differences in helmet regulations by calculating the attributable risk and attributable risk percent (AR%) for concussion resulting from ball or stick impacts.ResultsFrom 2008-09 through 2018-19, boys' LAX players sustained 614 concussions during 1,318,278 athletic exposures (AEs) (4.66 per 10,000 AEs) and girls' LAX players sustained 384 concussions during 983,291 AEs (3.91 per 10,000 AEs). For boys, athlete-athlete contact was the most common mechanism of concussion accounting for 66.4% of all concussions, while stick or ball contact accounted for 23.5%. For girls, stick or ball contact accounted for 72.7% of all concussions, while athlete-athlete contact accounted for 19.8%. Concussion rates from stick or ball contact were significantly higher in girls vs. boys (RR=2.60, 95% CI 2.12-3.18). The attributable risk associated with playing girls' vs. boys' LAX for concussion resulting from stick or ball contact was 1.75 concussions per 10,000 AEs (95% CI 1.37-2.12) and the AR% was 61.5% (95% CI 52.9-68.5). An estimated 44.7% of all girls' LAX concussions could have been prevented if girls' LAX players wore the helmet mandated in boys' LAX.ConclusionsGirls' LAX players who are allowed, but not required, to wear a flexible headgear are at increased risk of concussions from stick or ball impacts compared to boys' LAX players, who are required to wear a hard shell helmet with full face mask. Additional research is needed to determine if there are any defendable arguments to continue justifying restricting girls' LAX players access to this effective piece of protective equipment.	[Comstock, R. Dawn] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, 13001 E 17th Pl,Mail Stop B119,Fitzsimons Bldg, Aurora, CO 80045 USA; [Arakkal, Alan T.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; [Pierpoint, Lauren A.] Steadman Philippon Res Inst, Vail, CO USA; [Fields, Sarah K.] Univ Colorado, Dept Commun, Denver, CO 80202 USA		Comstock, RD (corresponding author), Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, 13001 E 17th Pl,Mail Stop B119,Fitzsimons Bldg, Aurora, CO 80045 USA.	dawn.comstock@cuanschutz.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01, R49/CE002106-01]; National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; DonJoy Orthotics; EyeBlack	Funding for the High School Reporting Information Online (High School RIO) was provided in part by the Centers for Disease Control and Prevention (grants R49/CE000674-01 R49/CE001172-01, and R49/CE002106-01) as well as research funding support from the National Federation of State High School Associations, the National Operating Committee on Standards for Athletic Equipment, DonJoy Orthotics, and EyeBlack.	Acabchuk Rebecca L, 2017, Concussion, V2, pCNC39, DOI 10.2217/cnc-2017-0005; [Anonymous], WOM LACR HEADG FAQS; [Anonymous], 2015, F313715 ASTM; [Anonymous], RULES; Brunner F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132002; Bull A, 2016, STRATEGIES, V29, P20, DOI [10.1080/08924562.2016.1231097, DOI 10.1080/08924562.2016.1231097]; Caswell SV, 2017, AM J SPORT MED, V45, P3374, DOI 10.1177/0363546517724754; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick R, 2007, J ATHL TRAINING, V42, P262; Foss KDB, 2018, CLIN J SPORT MED, V28, P406, DOI 10.1097/JSM.0000000000000458; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Harmer PA, 1993, SPORT HLTH, V11, P14; Kelley C., 2018, UNDERSTANDING WOMENS; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kriz PK, 2015, PEDIATRICS, V136, P521, DOI 10.1542/peds.2015-0216; Kriz PK, 2012, PEDIATRICS, V130, P1069, DOI 10.1542/peds.2012-1492; LAPIDUS CS, 1992, J TRAUMA, V32, P555, DOI 10.1097/00005373-199205000-00003; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Lombardi NJ, 2016, ORTHOPEDICS, V39, pE944, DOI 10.3928/01477447-20160623-10; LUND AK, 1986, ACCIDENT ANAL PREV, V18, P367, DOI 10.1016/0001-4575(86)90010-2; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McGuine T, 2020, BRIT J SPORT MED, V54, P408, DOI 10.1136/bjsports-2018-100238; McKinney D, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.12.018; Miele LM, 2017, PSYCHOL TODAY; NFHS (National Federation of State High School Associations), 2019, HIGH SCH PART SURV A; NFHS (National Federation of State High School Associations), 2018, RUL CHANG AFF RISK 1; NFHS (National Federation of State High School Associations), 2019, SOFT HEADG NONH SPOR; Otago L, 2007, Int J Inj Contr Saf Promot, V14, P259, DOI 10.1080/17457300701602381; Ouellet JV, 2011, TRAFFIC INJ PREV, V12, P71, DOI 10.1080/15389588.2010.529974; Pennington B., 2016, NY TIMES; Peterson E, 2013, CANCER CAUSE CONTROL, V24, P2013, DOI 10.1007/s10552-013-0278-x; Pierpoint LA, 2019, J ATHL TRAINING, V54, P42, DOI 10.4085/1062-6050-201-17; Pierpoint LA, 2019, J ATHL TRAINING, V54, P30, DOI 10.4085/1062-6050-200-17; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rodowicz KA, 2015, ANN BIOMED ENG, V43, P949, DOI 10.1007/s10439-014-1154-x; Ruedl G, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173107; Ruedl G, 2012, ACCIDENT ANAL PREV, V48, P292, DOI 10.1016/j.aap.2012.01.031; Scott MD, 2007, INJURY PREV, V13, P173, DOI 10.1136/ip.2006.014142; Warner K, 2018, J ATHL TRAINING, V53, P1049, DOI 10.4085/1062-6050-312-17; Washington RL, 2004, PEDIATRICS, V113, P619; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914	43	2	2	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	MAY 18	2020	7	1							18	10.1186/s40621-020-00242-5			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	TD5KF	WOS:000669365000001	32418542	gold, Green Published			2022-02-06	
J	Pueringer, J; Cohn, JE; Othman, S; Shokri, T; Ducic, Y; Sokoya, M				Pueringer, John; Cohn, Jason E.; Othman, Sammy; Shokri, Tom; Ducic, Yadranko; Sokoya, Mofiyinfolu			Tennis-related adult maxillofacial trauma injuries	PHYSICIAN AND SPORTSMEDICINE			English	Article						Tennis; maxillofacial trauma; facial trauma craniofacial trauma; sports trauma; NEISS	EMERGENCY-DEPARTMENTS; ICE HOCKEY; SPORTS; FRACTURES; PREVENTION; MECHANISM; ETIOLOGY	Objectives: Tennis participation continues to increase amongst adults across the United States. The purpose of this study was to analyze trends in adult tennis-related facial injury epidemiology, demographics, diagnoses, and locations of injury. Materials and methods: The National Electronic Injury Surveillance System was evaluated for tennis-related facial injuries in adults from 2009 through 2018. Number of injuries were extrapolated, and data were analyzed for age, sex, specific injury diagnoses, locations, and discharge disposition. Descriptive statistics were used to present and describe variables of interest. Chi-squared testing (chi 2) was performed to compare categorical variables. Results: During the study period, 342 tennis-related facial trauma ED visits were analyzed. Lacerations were the most common injury (45%), followed by contusions or abrasions (33.3%), concussions (11.7%), and fractures (8.5%). The most common sites of injury were the face (47.4%) and head (27.2%) regions. Males accounted for 62.0% of injuries, while females accounted for the remaining 38.0%. Patients between 34-65 years-old accounted for 47.7% of all injuries, and athletes over 65 years-old had the highest rate of fractures (10.1%). Conclusions: Facial trauma incurred secondary to tennis may follow patient-specific patterns. The incidence of tennis-related facial trauma is smaller compared to other sports, but the severity of such injuries remain a danger. Facial protection and enforcement in tennis is virtually absent, and these findings strengthen the need to educate athletes, families, and physicians on injury awareness and prevention.	[Pueringer, John] Philadelphia Coll Osteopath Med, Philadelphia, PA USA; [Cohn, Jason E.] Philadelphia Coll Osteopath Med, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA USA; [Othman, Sammy] Drexel Univ, Coll Med, 2900 West Queen Lane, Philadelphia, PA 19129 USA; [Shokri, Tom] Penn State Hershey Med Ctr, Dept Otolaryngol Head & Neck Surg, Hershey, PA USA; [Ducic, Yadranko] Otolaryngol & Facial Plast Surg Associates, Dept Otolaryngol Head & Neck Surg, Ft Worth, TX USA; [Sokoya, Mofiyinfolu] Univ Arizona, Coll Med, Dept Otolaryngol Head & Neck Surg, Tucson, AZ USA		Othman, S (corresponding author), Drexel Univ, Coll Med, 2900 West Queen Lane, Philadelphia, PA 19129 USA.	sothman13@gmail.com		Othman, Sammy/0000-0002-8814-1048			Bobian MR, 2016, ANN OTO RHINOL LARYN, V125, P992, DOI 10.1177/0003489416668195; Boffano P, 2014, BRIT J ORAL MAX SURG, V52, P901, DOI 10.1016/j.bjoms.2014.08.007; Boskey AL, 2010, J DENT RES, V89, P1333, DOI 10.1177/0022034510377791; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Carniol ET, 2015, OTOLARYNG HEAD NECK, V153, P957, DOI 10.1177/0194599815602668; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Diamond G R, 1982, Clin Sports Med, V1, P469; Exadaktylos AK, 2004, BRIT J SPORT MED, V38, P750, DOI 10.1136/bjsm.2003.008581; Fatovich DM, 2013, J TRAUMA ACUTE CARE, V74, P647, DOI 10.1097/TA.0b013e3182788065; Fraser MA, 2017, J ATHL TRAINING, V52, P698, DOI 10.4085/1062-6050-52.3.10; Gandy JR, 2016, LARYNGOSCOPE, V126, P1054, DOI 10.1002/lary.25584; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; Humphrey JA, 2019, OPEN ACCESS J SPORTS, V10, P81, DOI 10.2147/OAJSM.S198500; Hwang K, 2014, J CRANIOFAC SURG, V25, pE267, DOI 10.1097/SCS.0000000000000630; International Tennis Association, 2019, ITF GLOB TENN REP 20; Jacobson NA, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113517860; Kim SY, 2016, BRIT J ORAL MAX SURG, V54, P936, DOI 10.1016/j.bjoms.2016.06.024; Lawrence LA, 2015, LARYNGOSCOPE, V125, P589, DOI 10.1002/lary.24893; Mello MJ, 2009, ACAD EMERG MED, V16, P243, DOI 10.1111/j.1553-2712.2009.00357.x; Miller BL, 2011, OTOLARYNG HEAD NECK, V144, P883, DOI 10.1177/0194599810396790; Murphy C, 2015, J CRANIOFAC SURG, V26, P2120, DOI 10.1097/SCS.0000000000002109; Othman S, 2019, CRANIOMAX TRAUM REC, V12, P266, DOI 10.1055/s-0039-1679930; Parashar Atul, 2013, Indian J Plast Surg, V46, P221, DOI 10.4103/0970-0358.118597; Plawecki A, 2017, JAMA FACIAL PLAST SU, V19, P453, DOI 10.1001/jamafacial.2017.0332; Pluim BM, 2006, BRIT J SPORT MED, V40, P415, DOI 10.1136/bjsm.2005.023184; Rodriguez JO, 2003, AM FAM PHYSICIAN, V67, P1481; Ruslin M, 2016, J CRANIOFAC SURG, V27, pE91, DOI 10.1097/SCS.0000000000002242; STOCK JG, 1991, AM FAM PHYSICIAN, V44, P515; Tennis Industry Association, 2019, 2019 TIA TENN PART R; VINGER PF, 1978, JAMA-J AM MED ASSOC, V239, P2575, DOI 10.1001/jama.239.24.2575; Viozzi CF, 2017, CLIN SPORT MED, V36, P355, DOI 10.1016/j.csm.2016.11.007	31	2	2	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	JAN 2	2021	49	1					64	67		10.1080/00913847.2020.1768451		MAY 2020	4	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	PZ5KF	WOS:000535119900001	32400246				2022-02-06	
J	Tsitsopoulos, PP; Marklund, N; Rostami, E; Enblad, P; Hillered, L				Tsitsopoulos, P. P.; Marklund, N.; Rostami, E.; Enblad, P.; Hillered, L.			Association of the bleeding time test with aspects of traumatic brain injury in patients with alcohol use disorder	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Injury severity; Alcohol use disorder; Hemostasis; Platelets; IVY bleeding time test; Outcome	HEAD TRAUMA; COMPUTED-TOMOGRAPHY; PLATELET-FUNCTION; COAGULOPATHY; COAGULATION; BLOOD; GUIDELINES; MODERATE; SCALE; COMA	Background-aim Traumatic brain injury (TBI) and alcohol use disorder (AUD) can occur concomitantly and be associated with coagulopathy that influences TBI outcome. The use of bleeding time tests in TBI management is controversial. We hypothesized that in TBI patients with AUD, a prolonged bleeding time is associated with more severe injury and poor outcome. Material and methods Moderate and severe TBI patients with evidence of AUD were examined with bleeding time according to IVY bleeding time on admission during neurointensive care. Baseline clinical and radiological characteristics were recorded. A standardized IVY bleeding time test was determined by staff trained in the procedure. Bleeding time test results were divided into normal (<= 600 s), prolonged (> 600 s), and markedly prolonged (>= 900 s). Normal platelet count (PLT) was defined as > 150,000/mu L. This cohort was compared with another group of TBI patients without evidence of AUD. Results Fifty-two patients with TBI and AUD were identified, and 121 TBI patients without any history of AUD were used as controls. PLT was low in 44.2% and bleeding time was prolonged in 69.2% of patients. Bleeding time values negatively correlated with PLT (p < 0.05). TBI patients with markedly prolonged values (>= 900 s) had significantly increased hematoma size, and more frequently required intracranial pressure measurement and mechanical ventilation compared with those with bleeding times < 900 s (p < 0.05). Most patients (88%) with low platelet count had prolonged bleeding time. No difference in 6-month outcome between the bleeding time groups was observed (p > 0.05). Subjects with TBI and no evidence for AUD had lower bleeding time values and higher platelet count compared with those with TBI and history of AUD (p < 0.05). Conclusions Although differences in the bleeding time values between TBI cohorts exist and prolonged values may be seen even in patients with normal platelet count, the bleeding test is a marker of primary hemostasis and platelet function with low specificity. However, it may provide an additional assessment in the interpretation of the overall status of TBI patients with AUD. Therefore, the bleeding time test should only be used in combination with the patient's bleeding history and careful assessment of other hematologic parameters.	[Tsitsopoulos, P. P.; Marklund, N.; Rostami, E.; Enblad, P.; Hillered, L.] Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden; [Marklund, N.] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Neurosurg, Lund, Sweden		Tsitsopoulos, PP (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden.	ptsitsopoulos@auth.gr			Uppsala University; Uppsala University Hospital; Selander Foundation	Open Access funding provided by Uppsala University. The study was supported by Uppsala University Hospital and the Selander Foundation.	Ballard HS, 1997, ALCOHOL HEALTH RES W, V21, P42; BUCHANAN GR, 1989, AM J CLIN PATHOL, V91, P45, DOI 10.1093/ajcp/91.1.45; COWAN DH, 1980, SEMIN HEMATOL, V17, P137; DECATERINA R, 1994, BLOOD, V84, P3363; DeRossi SS, 1996, J ORAL MAXIL SURG, V54, P1119, DOI 10.1016/S0278-2391(96)90173-1; DUARTE APT, 1995, THROMB RES, V78, P107, DOI 10.1016/0049-3848(95)00039-9; Duke WW, 1910, J AMER MED ASSOC, V55, P1185, DOI 10.1001/jama.1910.04330140029009; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; ELMER O, 1984, HAEMOSTASIS, V14, P223; GEORGE JN, 1991, NEW ENGL J MED, V324, P27, DOI 10.1056/NEJM199101033240106; GILES C, 1981, BRIT J HAEMATOL, V48, P31; Greenberg EM, 2013, CRIT CARE NURS CLIN, V25, P427, DOI 10.1016/j.ccell.2013.08.003; Guidelines on platelet function testing, 1988, J CLIN PATHOL, V41, P1322, DOI DOI 10.1136/jcp.41.12.1322; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Harrison P, 2005, BLOOD REV, V19, P111, DOI 10.1016/j.blre.2004.05.002; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hoeltke LB, 2017, COMPLETE TXB PHLEBOT; Howard BM, 2014, J TRAUMA ACUTE CARE, V77, P865, DOI 10.1097/TA.0000000000000357; Ivy AC, 1935, SURG GYNECOL OBSTET, V60, P781; Ivy AC, 1941, J LAB CLIN MED, V70, P642; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; JALAN R, 1994, GASTROINTEST ENDOSC, V40, P599, DOI 10.1016/S0016-5107(94)70261-6; KELLY DF, 1995, J NEUROTRAUM, V12, P883, DOI 10.1089/neu.1995.12.883; KOSTER T, 1989, AM J CLIN PATHOL, V92, P315, DOI 10.1093/ajcp/92.3.315; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; LIND SE, 1991, BLOOD, V77, P2547; Liumbruno GM, 2011, BLOOD TRANSFUS-ITALY, V9, P19, DOI 10.2450/2010.0074-10; Longstaff C, 2018, J THROMB HAEMOST, V16, P652, DOI 10.1111/jth.13957; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Maleki A, 2014, ARYA ATHEROSCLER, V10, P199; Marklund N, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00540; Mukamal KJ, 2001, CIRCULATION, V104, P1367, DOI 10.1161/hc3701.096067; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nyholm L, 2017, UPSALA J MED SCI, V122, P177, DOI 10.1080/03009734.2017.1319440; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Peterson P, 1998, ARCH SURG-CHICAGO, V133, P134, DOI 10.1001/archsurg.133.2.134; Ridefelt P, 2001, Lakartidningen, V98, P3922; RODGERS RPC, 1990, SEMIN THROMB HEMOST, V16, P1, DOI 10.1055/s-2007-1002658; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Salem Raneem O, 2005, Am J Clin Pathol, V123 Suppl, pS96; Schreiber MA, 2004, CRIT CARE CLIN, V20, P101, DOI 10.1016/S0749-0704(03)00095-2; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; TEASDALE G, 1974, LANCET, V2, P81; Teitel JM, 2000, CLIN LAB HAEMATOL, V22, P9, DOI 10.1046/j.1365-2257.2000.00002.x; Tran HA, 2013, MED J AUSTRALIA, V198, P198, DOI 10.5694/mja12.10614; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Watson HG, 2008, SEMIN THROMB HEMOST, V34, P97, DOI 10.1055/s-2008-1066028; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; Wiegele M, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2352-6; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zetterberg Eva, 2013, Lakartidningen, V110, P1276; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	57	2	2	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2020	162	7					1597	1606		10.1007/s00701-020-04373-y		MAY 2020	10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LY2HG	WOS:000533830700001	32424564	Green Published, hybrid			2022-02-06	
J	Li, XM; Yang, YF; Ma, ZF; Gao, S; Ning, Y; Zhao, L; He, ZY; Luo, XQ				Li, Xiaomin; Yang, Yafeng; Ma, Zheng Feei; Gao, Shan; Ning, Yuan; Zhao, Ling; He, Zhangya; Luo, Xiaoqin			Enteral combined with parenteral nutrition improves clinical outcomes in patients with traumatic brain injury	NUTRITIONAL NEUROSCIENCE			English	Article; Early Access						Traumatic brain injury; enteral nutrition; parenteral nutrition; Glasgow coma score	SUPPORT; GUIDELINES; MULTICENTER; MANAGEMENT; SCORE	Objective: To investigate the effect of nutritional support on nutritional status and clinical outcomes of patients with traumatic brain injury (TBI). Methods: Sixty-one patients with TBI from the intensive care unit and neurosurgery of Xianyang Central Hospital from 2017 to 2019 were retrospectively included. General and clinical data of the study subjects were collected. The control group (n = 28) received parenteral nutrition alone, and the observation group (n = 33) received parenteral nutrition combined with enteral nutrition. The general conditions and biochemical indicators of both groups of patients were divided into two groups of <= 8 and >= 9 for stratified analysis to compare the nutritional support status and infection complications during hospitalization Occurrence, ICU length of stay, total length of stay, total cost of stay, and prognostic indicators of the patients were analyzed and compared. Results: There were no significant differences in biochemical indicators between both groups of patients when they were discharged. Among patients with GCS <= 8 points, the incidence of lung infection in the observer was significantly higher than that in the control group (P < 0.001), but the incidence of intracranial infection, stress ulcers, and diarrhea was not statistically different from that in the control group (P = 0.739). No significant differences were observed in hospitalization time and hospitalization costs between both groups (P = 0.306 and P = 0.079, respectively). The observation group was significantly better than the control group in GSC score and long-term quality of life score (P = 0.042 and P = 0.025, respectively). When GCS was >= 9 points, there was no statistical difference in the incidence of lung infections and intracranial infections between both groups of patients (P = 0.800 and P = 0.127, respectively). The observation group was significantly higher than the control group in terms of length of hospital stay, nasal feeding time and hospitalization costs (P < 0.001, P < 0.001 and P = 0.006, respectively). The observation group was significantly better than the control group in GSC score and long-term quality of life score (P = 0.001 and P = 0.015, respectively). There was no significant difference in the incidence of pulmonary infection and intracranial infection between both groups of patients (P = 0.800 and P = 0.127, respectively). Conclusion: Enteral nutrition combined with parenteral nutrition intervention has a positive effect on the clinical prognosis of TBI patients.	[Li, Xiaomin; He, Zhangya; Luo, Xiaoqin] Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Nutr & Food Safety, Xian 710061, Peoples R China; [Li, Xiaomin; Yang, Yafeng; Gao, Shan; Ning, Yuan; Zhao, Ling] Xianyang Cent Hosp, Dept Clin Nutr, Xianyang, Peoples R China; [Ma, Zheng Feei] Xian Jiaotong Liverpool Univ, Dept Hlth & Environm Sci, Suzhou, Peoples R China		Luo, XQ (corresponding author), Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Nutr & Food Safety, Xian 710061, Peoples R China.	luoxiaoqin2012@mail.xjtu.edu.cn	Zheng Feei, FHEA ANutr FRSPH/B-1225-2015	Zheng Feei, FHEA ANutr FRSPH/0000-0002-7276-2229	Xianyang Central Hospital Research Innovation Fund; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [xjj2017186]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81874263]	This work was supported by the Xianyang Central Hospital Research Innovation Fund (2017) and the Fundamental Research Funds for the Central Universities [grant number xjj2017186], the National Natural Science Foundation of China [grant number 81874263].	ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis, 1999, AM J HLTH SYST PHARM, V56, P347, DOI DOI 10.1093/AJHP/56.4.347; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bernicker E, 1998, JAMA-J AM MED ASSOC, V280, P1368, DOI 10.1001/jama.280.15.1368; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Briain DO, 2018, NEUROCRIT CARE, V29, P443, DOI 10.1007/s12028-018-0553-5; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Charles EJ, 2014, AM J CLIN NUTR, V100, P1337, DOI 10.3945/ajcn.114.088609; Chiang YH, 2012, J NEUROTRAUM, V29, P75, DOI 10.1089/neu.2011.1801; Chourdakis M, 2011, HIPPOKRATIA, V15, P288; Doig GS, 2013, JAMA-J AM MED ASSOC, V309, P2130, DOI 10.1001/jama.2013.5124; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; Harvey SE, 2014, NEW ENGL J MED, V371, P1673, DOI 10.1056/NEJMoa1409860; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Jianfeng S., 2013, MODERN PREVENTIVE ME; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Liao JM, 2015, NEW ENGL J MED, V373, P1279, DOI 10.1056/NEJMc1506108; Lin FL, 2015, J INT TRANSL MED, V3, P278; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Marik PE, 2010, CRIT CARE MED, V38, P2222, DOI 10.1097/CCM.0b013e3181f17adf; Oertel MF, 2009, J CLIN NEUROSCI, V16, P1161, DOI 10.1016/j.jocn.2008.11.013; Sorensen J, 2008, CLIN NUTR, V27, P340, DOI 10.1016/j.clnu.2008.03.012; Souter MJ, 2012, ESSENTIALS OF NEUROSURGICAL ANESTHESIA & CRITICAL CARE: STRATEGIES FOR PREVENTION, EARLY DETECTION, AND SUCCESSFUL MANAGEMENT OF PERIOPERATIVE COMPLICATIONS, P777, DOI 10.1007/978-0-387-09562-2_80; Tao X, 2010, SHANDONG MED J, P224; Taylor BE, 2016, CRIT CARE MED, V44, P390, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; TEASDALE G, 1974, LANCET, V2, P81; Vieira LV, 2018, METAB BRAIN DIS, V33, P1755, DOI 10.1007/s11011-018-0287-2; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Zilberberg MD, 2010, CLIN INFECT DIS, V51, pS131, DOI 10.1086/653062	29	2	2	3	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1028-415X	1476-8305		NUTR NEUROSCI	Nutr. Neurosci.												10.1080/1028415X.2020.1765114		MAY 2020	7	Neurosciences; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Nutrition & Dietetics	LT3NL	WOS:000536977800001	32431234				2022-02-06	
J	Wright, KL; Hopkins, RO; Robertson, FE; Bigler, ED; Taylor, HG; Rubin, KH; Vannatta, K; Stancin, T; Yeates, KO				Wright, Kacie L.; Hopkins, Ramona O.; Robertson, Frank E.; Bigler, Erin D.; Taylor, H. Gerry; Rubin, Kenneth H.; Vannatta, Kathryn; Stancin, Terry; Yeates, Keith Owen			Assessment of White Matter Integrity after Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						FreeSurfer; NeuroQuant; pediatric; traumatic brain injury; white matter	MAGNETIC-RESONANCE; PROCESSING SPEED; HIPPOCAMPAL VOLUME; HYPERINTENSITIES; RELIABILITY; CHILDREN; SEGMENTATION; FREESURFER; DIFFUSION; LESIONS	White matter (WM) abnormalities, such as atrophy and hyperintensities (WMH), can be accessed via magnetic resonance imaging (MRI) after pediatric traumatic brain injury (TBI). Several methods are available to classify WM abnormalities (i.e., total WM volumes and WMHs), but automated and manual volumes and clinical ratings have yet to be compared in pediatric TBI. In addition, WM integrity has been associated reliably with processing speed. Consequently, methods of assessing WM integrity should relate to processing speed to have clinical application. This study had two goals: (1) to compare Scheltens rating scale, manual tracing, FreeSurfer, and NeuroQuant(R) methods of assessing WM abnormalities, and (2) to relate WM methods to processing speed scores. We report findings from the Social Outcomes of Brain Injury in Kids (SOBIK) study, a multi-center study of 60 children with chronic TBI (65% male) from ages 8-13. Scheltens WMH ratings had good to excellent agreement with WMH volumes for both NeuroQuant (ICC = 0.62; r = 0.29, p = 0.005) and manual tracing (ICC = 0.82; r = 0.50, p = 0.000). NeuroQuant WMH volumes did not correlate with manually traced WMH volumes (r = 0.12, p = 0.21) and had poor agreement (ICC = 0.24). NeuroQuant and FreeSurfer total WM volumes correlated (r = 0.38, p = 0.004) and had fair agreement (ICC = 0.52). The WMH assessment methods, both ratings and volumes, were associated with processing speed scores. In contrast, total WM volume was not related to processing speed. Measures of WMH may hold clinical utility for predicting cognitive functioning after pediatric TBI.	[Wright, Kacie L.; Hopkins, Ramona O.; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, 22 KMBL, Provo, UT 84093 USA; [Hopkins, Ramona O.; Robertson, Frank E.; Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84093 USA; [Taylor, H. Gerry; Vannatta, Kathryn] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Taylor, H. Gerry; Vannatta, Kathryn] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH USA; [Rubin, Kenneth H.] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Stancin, Terry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Stancin, Terry] Rainbow Babies & Childrens Hosp, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Hopkins, RO (corresponding author), Brigham Young Univ, Dept Psychol, 22 KMBL, Provo, UT 84093 USA.; Hopkins, RO (corresponding author), Brigham Young Univ, Dept Neurosci, 1022 KMBL, Provo, UT 84093 USA.	mona_hopkins@byu.edu	Yeates, Keith/AAJ-4223-2020		National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5R01HD048946, 3R01HD04894605S1]; Brigham Young University	Supported by the National Institute of Child Health and Human Development (Grant Nos. 5R01HD048946 and 3R01HD04894605S1) and college grant funds from Brigham Young University.	Alam A, 2010, Med J Armed Forces India, V66, P374, DOI 10.1016/S0377-1237(10)80022-X; Albright J., 2016, IMPORTANCE QUANTITAT; Ambarki K, 2011, AM J NEURORADIOL, V32, P408, DOI 10.3174/ajnr.A2275; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Azab M, 2015, AM J NEURORADIOL, V36, P1400, DOI 10.3174/ajnr.A4313; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Bigler ED, 2016, J CHILD NEUROL, V31, P1302, DOI 10.1177/0883073816654143; Bigler E, 2015, NEUROPSYCHOL REV, V25, P224, DOI 10.1007/s11065-015-9290-0; Bigler ED, 2015, BRAIN INJURY, V29, P1062, DOI 10.3109/02699052.2015.1011234; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2013, NEUROREHABILITATION, V32, P707, DOI 10.3233/NRE-130896; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brewer JB, 2009, AM J NEURORADIOL, V30, P578, DOI 10.3174/ajnr.A1402; Caligiuri ME, 2015, NEUROINFORMATICS, V13, P261, DOI 10.1007/s12021-015-9260-y; Capizzano AA, 2004, J NEUROL NEUROSUR PS, V75, P822, DOI 10.1136/jnnp.2003.019273; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Eisenmenger LB, 2016, J PEDIATR NEURORADIO, V5, P13, DOI 10.1055/s-0036-1584243; Eritaia J, 2000, MAGN RESON MED, V44, P973, DOI 10.1002/1522-2594(200012)44:6<973::AID-MRM21>3.0.CO;2-H; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Foegler T., 2018, CORTECHS LABS ANNOUN; Genc S, 2017, J NEUROTRAUM, V34, P798, DOI 10.1089/neu.2016.4584; Gorman S, 2016, NEUROPSYCHOLOGY, V30, P263, DOI 10.1037/neu0000214; Gouw AA, 2008, CEREBROVASC DIS, V25, P247, DOI 10.1159/000113863; Grimm O, 2015, J NEUROSCI METH, V253, P254, DOI 10.1016/j.jneumeth.2015.05.024; Harrison S., 2017, NEW VERSION NEUROQUA; Hernandez MDV, 2017, NEURORADIOLOGY, V59, P951, DOI 10.1007/s00234-017-1892-1; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kochunov P, 2010, NEUROIMAGE, V49, P1190, DOI 10.1016/j.neuroimage.2009.09.052; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kourtidou P, 2013, J HEAD TRAUMA REHAB, V28, P433, DOI 10.1097/HTR.0b013e3182585d06; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lisanti C, 2007, AM J ROENTGENOL, V188, P716, DOI 10.2214/AJR.05.0003; Luo W., 2017, NEUROLOGY, V88; Lyden H, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00398; McCarthy CS, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00379; Murphy S, 2016, J PEDIATR NEURORADIO, V5, P2, DOI 10.1055/s-0036-1584226; Neema M, 2009, AM J NEURORADIOL, V30, P911, DOI 10.3174/ajnr.A1514; Ochs AL, 2015, J NEUROIMAGING, V25, P721, DOI 10.1111/jon.12229; Papp KV, 2014, AGING NEUROPSYCHOL C, V21, P197, DOI 10.1080/13825585.2013.795513; Prigatano GP, 2008, CLIN NEUROPSYCHOL, V22, P603, DOI 10.1080/13854040701440501; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Reid MW, 2017, J NEUROIMAGING, V27, P365, DOI 10.1111/jon.12431; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Schoemaker D, 2016, NEUROIMAGE, V129, P1, DOI 10.1016/j.neuroimage.2016.01.038; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Shultz EL, 2016, NEUROPSYCHOLOGY, V30, P830, DOI 10.1037/neu0000288; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Stuckey SL, 2007, AM J ROENTGENOL, V189, P913, DOI 10.2214/AJR.07.2424; van den Heuvel DMJ, 2006, J NEUROL NEUROSUR PS, V77, P149, DOI 10.1136/jnnp.2005.070193; Vannorsdall TD, 2009, ARCH CLIN NEUROPSYCH, V24, P209, DOI 10.1093/arclin/acp037; Wang YB, 2012, NEUROIMAGE, V60, P2379, DOI 10.1016/j.neuroimage.2012.02.034; Wechsler D., 2003, PSYCHOL CORPORATION; Wenger E, 2014, HUM BRAIN MAPP, V35, P4236, DOI 10.1002/hbm.22473; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Wu MJ, 2006, PSYCHIAT RES-NEUROIM, V148, P133, DOI 10.1016/j.pscychresns.2006.09.003; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Zhan W, 2009, NEUROIMAGE, V47, pT58, DOI 10.1016/j.neuroimage.2009.02.004; ZIMMERMAN RD, 1986, AM J ROENTGENOL, V146, P443, DOI 10.2214/ajr.146.3.443; 2017, WOODHEAD PUBL SER EN, P00001	72	2	2	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2020	37	20					2188	2197		10.1089/neu.2019.6691		MAY 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	OA4HP	WOS:000533216200001	32253971	Green Published			2022-02-06	
J	McCarron, RH; Gracey, F; Bateman, A				McCarron, Robyn Henrietta; Gracey, Fergus; Bateman, Andrew			Detecting mental health problems after paediatric acquired brain injury: A pilot Rasch analysis of the strengths and difficulties questionnaire	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Acquired Brain injury; Rasch analysis; Construct validity; Mental health; Psychosocial	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ANXIETY DISORDERS; PSYCHIATRIC-DISORDERS; SOMATIC SYMPTOMS; CHILDREN; ADOLESCENTS; CHILDHOOD; INTERVENTIONS; INFORMATION; PREVALENCE	The parent-reported Strengths and Difficulties Questionnaire (SDQ-P) is commonly used to assess for mental health problems, but its psychometric properties have not been studied in the paediatric Acquired Brain Injury (ABI) population. This study investigated the properties of the SDQ-P and its subscales in this population using Rasch analysis. One hundred and forty-three SDQ-Ps and 123 Impact Supplements were analyzed. Sixty-nine percent of SDQ-Ps were completed by female carers, 59% of young people were male, and 58% had Traumatic Brain Injury (TBI). In this population the SDQ-P Total Difficulties Scale and the Conduct Problems subscale showed questionable construct validity. The individual subscales and Impact Supplement did not meet the criteria for reliability. Two items had disordered thresholds. The individual subscales showed mistargeting and 13-24% person misfit. Two items were significantly underdiscriminating. There was differential item functioning with age and time post-injury, and local dependence between subscale items. The Total Difficulties scale was multidimensional. The most easily endorsed items were in keeping with common symptoms of brain injury. These findings suggest the SDQ-P in its current form may not be a reliable and valid assessment measure for mental health difficulties in the paediatric ABI population and requires further investigation.	[McCarron, Robyn Henrietta; Gracey, Fergus] Cambridgeshire & Peterborough NHS Fdn Trust CPFT, Cambridge Ctr Paediat Neuropsychol Rehabil, Cambridge, England; [McCarron, Robyn Henrietta; Bateman, Andrew] Univ Cambridge, Dept Psychiat, Cambridge, England; [Gracey, Fergus] Natl Inst Hlth Res NIHR, Collaborat Leadership Appl Hlth Res & Care CLAHRC, Cambridge, England; [Gracey, Fergus] Univ East Anglia, Dept Clin Psychol, Norwich, Norfolk, England; [Bateman, Andrew] Univ Essex, Sch Hlth & Social Care, Colchester, Essex, England		McCarron, RH (corresponding author), Cambridge Ctr Paediat Neuropsychol Rehabil CCPNR, Brookside Clin, 18D Trumpington Rd, Cambridge CB2 8AH, England.	robyn.dudley@cantab.net	McCarron, Robyn/AAZ-3977-2021	McCarron, Robyn/0000-0002-9878-0345; Gracey, Fergus/0000-0002-1416-7894; Bateman, Andrew/0000-0002-2547-5921	Addenbrookes' Charitable Trust, Cambridge University Hospitals [9980]	This work was supported by Addenbrookes' Charitable Trust, Cambridge University Hospitals [grant number 9980].	Anderson V, 2017, J NEUROTRAUM, V34, P2261, DOI 10.1089/neu.2016.4692; Andersson K, 2016, BRAIN INJURY, V30, P829, DOI 10.3109/02699052.2016.1146963; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Andrich D., 2009, RUMM2030 RASCH UNIDI; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bateman A, 2009, NEUROPSYCHOL REHABIL, V19, P941, DOI 10.1080/09602010903021170; Brooks BL, 2019, J NEUROTRAUM, V36, P679, DOI 10.1089/neu.2018.5792; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Ewing-Cobbs L, 2013, J INT NEUROPSYCH SOC, V19, P497, DOI 10.1017/S1355617713000210; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Goodman A, 2012, BRIT J PSYCHIAT, V200, P426, DOI 10.1192/bjp.bp.111.104380; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hambleton RK., 1991, FUNDAMENTALS ITEM RE; Hobart J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13120; Honeyman Cheryl, 2007, Paediatr Nurs, V19, P38; Huebner ARS, 2018, PM&R, V10, P462, DOI 10.1016/j.pmrj.2017.10.004; Hung AH, 2017, J DEV BEHAV PEDIATR, V38, P49, DOI 10.1097/DBP.0000000000000366; Kersten P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021551; Kersten P, 2016, INT J BEHAV DEV, V40, P64, DOI 10.1177/0165025415570647; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Kristensen H, 2014, EUR CHILD ADOLES PSY, V23, P795, DOI 10.1007/s00787-013-0512-9; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Masi G, 2000, PSYCHIATRY, V63, P140, DOI 10.1080/00332747.2000.11024905; MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2015, J PEDIATR REHAB MED, V8, P345, DOI 10.3233/PRM-150352; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; McCarron R, 2017, CLIN NEUROPSYCHIATR, V14, P195; McCarron RH, 2019, J INT NEUROPSYCH SOC, V25, P403, DOI 10.1017/S1355617719000213; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Membride Heather, 2016, Br J Nurs, V25, P552, DOI 10.12968/bjon.2016.25.10.552; NHS England, 2013, 2013 2014 NHS STAND; Ornstein TJ, 2013, J NEUROPSYCHOL, V7, P1, DOI 10.1111/j.1748-6653.2012.02027.x; Pastore V, 2018, BRAIN INJURY, V32, P1011, DOI 10.1080/02699052.2018.1469041; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Rasch Georg, 1960, STUDIES MATHEMATICAL; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Simblett SK, 2015, BRIT J CLIN PSYCHOL, V54, P249, DOI 10.1111/bjc.12070; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Smith RM, 2003, J APPL MEAS, V4, P198; Soo C, 2014, BRAIN INJURY, V28, P906, DOI 10.3109/02699052.2014.888762; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Wright B. D., 1995, RASCH MEASUREMENT T, V9, P430; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	57	2	2	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	AUG 9	2021	31	7					1048	1068		10.1080/09602011.2020.1760111		MAY 2020	21	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	SS3KN	WOS:000533761500001	32401169	Green Accepted			2022-02-06	
J	Clark, JM; Hoshizaki, TB; Annaidh, AN; Gilchrist, MD				Clark, J. Michio; Hoshizaki, T. Blaine; Annaidh, Aisling Ni; Gilchrist, Michael D.			Equestrian Helmet Standards: Do They Represent Real-World Accident Conditions?	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Head impact biomechanics; Concussion; Oblique impacts; Finite element modeling	BRAIN DEFORMATION METRICS; AMERICAN FOOTBALL HELMETS; VIDEO ANALYSIS; HEAD; INJURY; PREDICTORS; IMPACTS; MODEL; RECONSTRUCTION; CONCUSSION	The use of helmets in equestrian sports has reduced the occurrence of traumatic brain injuries although, despite improvements to helmets, concussion remains a common injury. Currently, equestrian helmets are designed to pass certification standards involving a linear drop test to a rigid surface, while most concussions in equestrian sports result from oblique impacts to a compliant surface. The purpose of this study was to: (1) Compare the head kinematics and brain tissue response of the current equestrian helmet standard (EN1) and proposed standard EN13087-11 (EN2) to those associated with reconstructions of real-world equestrian concussion accidents. (2) Design a test protocol that would reflect the real-world conditions associated with concussion in equestrian sports. (3) To assess the protective capacity of an equestrian helmet using the flat turf and 45 degrees turf proposed test protocols. Results for reconstructions of real-world concussions were obtained from a previous study (Clark et al. in J. Sci. Med. Sport 23:222-236, 2020). Using one jockey helmet model, impact tests were conducted according to the EN1 and EN2 protocols. Additionally, helmeted and unhelmeted tests were conducted at 5.9 and 6.0 m/s on to flat turf and 45 degrees turf anvils for front, front-boss and rear-boss impact locations. The results demonstrated EN1 and EN2 both had higher magnitude accelerations and shorter duration impacts than reconstructed real-world concussive impacts. Impacts to turf anvils, on the other hand, produced similar head kinematics compared to the reconstructed real-world concussive impacts. Additionally, this study demonstrated that helmeted impacts significantly decreased rotational kinematics and brain tissue response below what is associated with unhelmeted impacts for oblique falls. However, the head kinematics and brain tissue response associated with these helmeted falls were consistent with concussion, suggesting that scope exists to improve the capacity of equestrian helmets to protect against concussion.	[Clark, J. Michio; Annaidh, Aisling Ni; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Clark, J. Michio] Vector Sci Inc, Golden, CO 80403 USA; [Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	michael.gilchrist@ucd.ie	Ni Annaidh, Aisling/ABF-8938-2021	Ni Annaidh, Aisling/0000-0002-9929-4541	European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie Grant [642662]	This research received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie Grant Agreement No. 642662. Helmets were supplied by Charles Owen.	Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; [Anonymous], 1997, 1078 EN BRIT STAND I; [Anonymous], 2007, 1077 EN; [Anonymous], 2016, 1384 EN; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; Bandak FA, 1994, SAE T, P1708; Bland ML, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040019; Bourdet N, 2012, P I MECH ENG P-J SPO, V226, P282, DOI 10.1177/1754337112442326; Clark J A, 2019, THESIS; Clark JM, 2020, J TEST EVAL, V48, P2185, DOI 10.1520/JTE20190513; Clark JM, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4045403; Clark JM, 2020, J SCI MED SPORT, V23, P222, DOI 10.1016/j.jsams.2019.10.006; Clark JM, 2017, COMPUT METHOD BIOMEC, V20, P1299, DOI 10.1080/10255842.2017.1341977; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Clark JM, 2016, ISBS C TSUKUBA JAPAN, V1, P395; Connor TA, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0193-0; Cui L, 2009, MATER DESIGN, V30, P3414, DOI 10.1016/j.matdes.2009.03.044; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBL D; Forero Rueda M. A., 2007, STARSS C LOUGHB; Forero Rueda M. A., 2010, INJURY, V41, P533, DOI DOI 10.1016/j.injury.2009.05.009; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Halldin P, 2001, INT J CRASHWORTHINES, V6, P53, DOI 10.1533/cras.2001.0162; Halldin P, 2015, TC158WG11 CEN; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S., 2001, IRCOBI C ISL MAN UK; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McLeod D. G., 1974, 741193 SAE; MILLS NJ, 1989, INJURY, V20, P189, DOI 10.1016/0020-1383(89)90108-3; Nahum A, 1977, 21 STAPP CAR CRASH C; Oeur RA, 2019, INT J CRASHWORTHINES, V24, P326, DOI 10.1080/13588265.2018.1441617; Pang TY, 2011, INT J CRASHWORTHINES, V16, P297, DOI 10.1080/13588265.2011.559799; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Pioneer Network, 2011, TOOLS CHANGE, V1, P1, DOI DOI 10.3923/ajpnft.2011.1.22; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2017, SPORTS ENG, V20, P111, DOI 10.1007/s12283-016-0219-5; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Ruan J, 1994, THESIS; Rueda MAF, 2009, MATER DESIGN, V30, P3405, DOI 10.1016/j.matdes.2009.03.037; Snell M, 2015, USE MOTORCYCLES OTHE; Trosseille X, 1992, SAE TECHNICAL PAPER; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; Van Lierde C, 2005, THESIS; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Yoganandan Narayan, 2008, Biomed Sci Instrum, V44, P256; Yu Z., 2009, BIOM SCI ENG C; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	65	2	2	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	AUG	2020	48	8					2247	2267		10.1007/s10439-020-02531-y		MAY 2020	21	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	MV0EJ	WOS:000532116500001	32399843				2022-02-06	
J	Ware, AL; Goodrich-Hunsaker, NJ; Lebel, C; Shukla, A; Wilde, EA; Abildskov, TJ; Bigler, ED; Cohen, DM; Mihalov, LK; Bacevice, A; Bangert, BA; Taylor, HG; Yeates, KO				Ware, Ashley L.; Goodrich-Hunsaker, Naomi J.; Lebel, Catherine; Shukla, Ayushi; Wilde, Elisabeth A.; Abildskov, Tracy J.; Bigler, Erin D.; Cohen, Daniel M.; Mihalov, Leslie K.; Bacevice, Ann; Bangert, Barbara A.; Taylor, H. Gerry; Yeates, Keith Owen			Post-Acute Cortical Thickness in Children with Mild Traumatic Brain Injury versus Orthopedic Injury	JOURNAL OF NEUROTRAUMA			English	Article						cortical thickness; mild TBI; orthopedic injury; pediatric TBI; structural MRI	COMMON DATA ELEMENTS; MOTION; RECOMMENDATIONS; MRI; CONCUSSION; COLLEGIATE; SYMPTOMS; QUALITY; RISK	Studies of brain morphometry may illuminate the effects of pediatric mild traumatic brain injury (TBI; e.g., concussion). However, no published studies have examined cortical thickness in the early injury phases of pediatric mild TBI using an appropriate comparison group. The current study used an automated approach (i.e., FreeSurfer) to determine whether cortical thickness differed in children following a mild TBI or a mild orthopedic injury (OI), and to examine whether post-acute cortical thickness predicted post-acute and chronic post-concussive symptoms (PCS). Children ages 8.00-16.99 years with mild TBI (n = 136) or OI (n = 70) were recruited at emergency department visits to two children's hospitals, during which parents rated children's pre-injury symptoms retrospectively. Children completed a post-acute (3-24 days post-injury) assessment, which included a 3 Tesla MRI, and 3- and 6-month post-injury assessments. Parents and children rated PCS at each assessment. Cortical thickness was estimated using FreeSurfer. Linear mixed effects and multi-variable negative binomial regression models were used to test study aims, with false discovery rate (FDR) correction for multiple comparisons. Groups differed significantly on left parietal cortical thickness (TBI > OI) after FDR correction. Cortical thickness also varied by brain subregion and age, but not sex. Groups differed significantly on PCS post-acutely (TBI > OI), but not at 3 or 6 months. Right frontal thickness was positively related to post-acute PCS in both groups. Right cingulum thickness predicted chronic PCS in the OI group only. Results highlight the complexity of predicting outcomes of pediatric mild TBI from post-acute neuroimaging biomarkers.	[Ware, Ashley L.; Yeates, Keith Owen] Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Ware, Ashley L.; Lebel, Catherine; Shukla, Ayushi; Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Lebel, Catherine; Shukla, Ayushi] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Goodrich-Hunsaker, Naomi J.; Wilde, Elisabeth A.; Abildskov, Tracy J.; Bigler, Erin D.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Goodrich-Hunsaker, Naomi J.; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Cohen, Daniel M.; Mihalov, Leslie K.; Taylor, H. Gerry] Ohio State Univ, Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH 43210 USA; [Cohen, Daniel M.; Mihalov, Leslie K.; Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Bacevice, Ann; Bangert, Barbara A.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA		Ware, AL (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	ashley.ware@ucalgary.ca	Yeates, Keith/AAJ-4223-2020		National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Predicting Outcomes in Children with Mild Traumatic Brain Injury [1R01HD076885]	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Predicting Outcomes in Children with Mild Traumatic Brain Injury, 1R01HD076885.	Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Afacan O, 2016, PEDIATR RADIOL, V46, P1728, DOI 10.1007/s00247-016-3677-9; Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Backhausen LL, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00558; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2015, BRAIN NEUROTRAUMA MO, P1; Bigler ED, 2018, INT J PSYCHOPHYSIOL, V132, P99, DOI 10.1016/j.ijpsycho.2018.07.474; Bigler ED, 2015, BRAIN INJURY, V29, P1062, DOI 10.3109/02699052.2015.1011234; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Blumenthal JD, 2002, NEUROIMAGE, V16, P89, DOI 10.1006/nimg.2002.1076; Brown TT, 2012, CURR BIOL, V22, P1693, DOI 10.1016/j.cub.2012.07.002; Brown TT, 2010, NEUROIMAGE, V53, P139, DOI 10.1016/j.neuroimage.2010.06.017; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Ducharme S, 2016, NEUROIMAGE, V125, P267, DOI 10.1016/j.neuroimage.2015.10.010; Duhaime AC, 2012, J NEUROTRAUM, V29, P629, DOI 10.1089/neu.2011.1927; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Focke NK, 2011, NEUROIMAGE, V56, P1164, DOI 10.1016/j.neuroimage.2011.02.029; Giedd JN, 2015, NEUROPSYCHOPHARMACOL, V40, P43, DOI 10.1038/npp.2014.236; Gilchrist J., 2011, MMWR-MORBID MORTAL W, V60, P1337; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Goodrich-Hunsaker NJ, 2018, J NEUROSCI RES, V96, P626, DOI 10.1002/jnr.24142; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Hubbard CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156545; Jernigan TL, 2016, DEV COGN NEUROS-NETH, V18, P2, DOI 10.1016/j.dcn.2015.07.008; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Kuznetsova A., 2017, J STAT SOFTWARE, V82; Lee LC, 2008, RES DEV DISABIL, V29, P247, DOI 10.1016/j.ridd.2007.05.002; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; Littmann A, 2006, ACAD RADIOL, V13, P1055, DOI 10.1016/j.acra.2006.05.001; LODER RT, 1995, J PEDIATR ORTHOPED, V15, P41, DOI 10.1097/01241398-199501000-00010; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Mayer AR, 2020, NEUROLOGY, V94, pE241, DOI 10.1212/WNL.0000000000008488; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; Newsome MR, 2018, BRAIN INJURY, V32, P1236, DOI 10.1080/02699052.2018.1494853; Ozer K, 2010, J PEDIATR ORTHOPED, V30, P324, DOI 10.1097/BPO.0b013e3181d8fa8c; Rauch SL, 2005, BIOL PSYCHIAT, V57, P1261, DOI 10.1016/j.biopsych.2005.02.014; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Song, 2009, INSIGHT J, V2, P1; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; STEVENS G, 1985, SOC SCI RES, V14, P142, DOI 10.1016/0049-089X(85)90008-0; TEASDALE G, 1974, LANCET, V2, P81; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; Uslu M, 2007, CLIN ORTHOP RELAT R, P192, DOI 10.1097/BLO.0b013e31805002da; Vovk U, 2007, IEEE T MED IMAGING, V26, P405, DOI 10.1109/TMI.2006.891486; Walhovd KB, 2017, CEREB CORTEX, V27, P1472, DOI 10.1093/cercor/bhv301; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Ware AL, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102106; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Wilde EA, 2018, BRAIN INJURY, V32, P1266, DOI 10.1080/02699052.2018.1494855; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhou DM, 2015, NEUROIMAGE, V104, P138, DOI 10.1016/j.neuroimage.2014.10.005	67	2	2	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2020	37	17					1892	1901		10.1089/neu.2019.6850		MAY 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	NK7JF	WOS:000532326500001	32178577	Green Published			2022-02-06	
J	Monseau, AJ; Balcik, BJ; Roberts, L; Andrews, R; Sharon, MJ				Monseau, Aaron J.; Balcik, Brenden J.; Roberts, Luke; Andrews, Reed; Sharon, Melinda J.			Initially concealed concussion lowers in-game performance of NCAA Division I football players: a case series	PHYSICIAN AND SPORTSMEDICINE			English	Article						Concussion; effects; football; reporting; disclosing	EXTREMITY MUSCULOSKELETAL INJURY; NON-DISCLOSURE; COLLEGIATE; SYMPTOMS; HOCKEY; TIME; RISK	Objectives: Many athletes conceal concussion symptoms to continue to play. If athletes and coaches knew that performance drops significantly after a concussion, in turn hurting the team, athletes may be more prone to report concussion symptoms. The objective of our research was to report three cases that support this performance decline after an undisclosed concussion. Methods: This is a case series of three NCAA Division I football players who did not immediately report their concussions. The play in which the concussion occurred was identified via video review then the players' pre and post-injury performance grades, as scored by their position coaches, were recorded. Additional data regarding their performance in other games and their concussion assessments were also recorded. Results: Three injuries were identified and reviewed. Player 1 had a pre-injury performance score of 76/100 with a post-injury score of 47/100. This was a drop of 29 points for a decrease in his in-game performance by 38%. Player 2 had a pre-injury score of 100/100 with a post-injury score of 60/100. This was a drop of 40 points or a 40% decrease in his in-game performance. Player 3 had a pre-injury score of 67/100 and a post-injury score of 43/100 for a drop of 24 points or a 36% decrease in his in-game performance. Conclusions: We reported three college football players who suffered concussions but did not immediately disclose their symptoms. Each had a marked decrease in performance grades after their concussion. If the performance effect of a concussion can be quantified, athletes and coaches may begin to change their mind-set that a concussion can be 'played through.' This case series should serve as a first step in quantifying concussion effects on performance.	[Monseau, Aaron J.; Balcik, Brenden J.] West Virginia Univ, Sch Med, Dept Emergency Med, 1 Med Ctr Dr, Morgantown, WV 26506 USA; [Roberts, Luke; Andrews, Reed] West Virginia Univ, Sch Med, Morgantown, WV 26506 USA; [Sharon, Melinda J.] Marshall Univ, Sch Med, Morgantown, WV USA		Monseau, AJ (corresponding author), West Virginia Univ, Sch Med, Dept Emergency Med, 1 Med Ctr Dr, Morgantown, WV 26506 USA.	amonseau@hsc.wvu.edu					Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Baugh CM, 2019, J NEUROTRAUM, V36, P2065, DOI 10.1089/neu.2018.6161; Beverly EA, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0818-2; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2019, J ATHL TRAINING, V54, P527, DOI 10.4085/1062-6050-200-18; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Craig DI, 2020, RES SPORTS MED, V28, P181, DOI 10.1080/15438627.2019.1586706; Craig DI, 2019, ATHL TRAIN SPORTS HL, DOI [10.3928/19425864-20190322-01, DOI 10.3928/19425864-20190322-01]; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Howell DR, 2019, J SCI MED SPORT, V22, P521, DOI 10.1016/j.jsams.2018.11.014; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2020, J CLIN SPORT PSYCHOL, V14, P41, DOI 10.1123/jcsp.2017-0036; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kuhn AW, 2016, AM J SPORT MED, V44, P2152, DOI 10.1177/0363546516638327; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mathiasen R, 2018, J NEUROTRAUM, V35, P691, DOI 10.1089/neu.2017.5072; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Milroy JJ, 2018, J CLIN SPORT PSYCHOL, V12, P268, DOI 10.1123/jcsp.2017-0029; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Tjong VK, 2017, JAAOS GLOB RES REV, V1, DOI 10.5435/JAAOSGlobal-D-17-00070; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Van Pelt KL, 2019, J ATHL TRAINING, V54, P534, DOI 10.4085/1062-6050-218-18; Yengo-Kahn AM, 2016, PHYSICIAN SPORTSMED, V44, P297, DOI 10.1080/00913847.2016.1200956; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2018, J SURG ORTHOP ADV, V27, P187	35	2	2	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	JAN 2	2021	49	1					51	56		10.1080/00913847.2020.1763145		MAY 2020	6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	PZ5KF	WOS:000534886400001	32345080				2022-02-06	
J	Liao, JY; Yang, HH; Yu, JS; Liang, XW; Chen, ZY				Liao, Jianyi; Yang, Huihui; Yu, Jinsui; Liang, Xiaowen; Chen, Zhiyi			Progress in the Application of Ultrasound Elastography for Brain Diseases	JOURNAL OF ULTRASOUND IN MEDICINE			English	Article						brain; shear wave elastography; ultrasound elastography	SHEAR-WAVE ELASTOGRAPHY; 1 BASIC PRINCIPLES; CLINICAL-USE; WFUMB GUIDELINES; NEONATAL BRAIN; EFSUMB GUIDELINES; IMAGE QUALITY; INJURY; RECOMMENDATIONS; ELASTICITY	Ultrasound (US) can be used to evaluate the brain structure and nervous system damage. Patients with neurologic symptoms need rapid, noninvasive imaging with high spatial resolution and tissue contrast. Magnetic resonance imaging is currently the most sensitive and specific imaging method for evaluating neuropathologic conditions. This approach does present some challenges, such as the need to transport patients who may be seriously ill to the magnetic resonance imaging suite and the need for patients to remain for a considerable time. Cranial US provides a very valuable imaging method for clinicians, which can make a rapid diagnosis and evaluation without ionizing radiation. The main disadvantage of cranial US is its low sensitivity and specificity for subtle/early lesions. In recent years, with the rapid development of anatomic and functional US technology, the practicability of US diagnosis and intervention has been greatly improved. Ultrasound elastography may have the potential to improve the sensitivity and specificity of various cranial nerve conditions. Ultrasound elastography has received considerable critical attention, and an increasing number of studies have recognized its critical role in evaluating brain diseases. At present, US elastography has been applied to the evaluation of traumatic brain injury, ischemic stroke, intraoperative brain tumors, and hypoxic ischemic encephalopathy. The latest animal experiments and human clinical trial developments in the applications of US elastography for brain diseases are summarized in this review.	[Liao, Jianyi; Yang, Huihui; Yu, Jinsui; Liang, Xiaowen; Chen, Zhiyi] Guangzhou Med Univ, Affiliated Hosp 3, Dept Ultrasound Med, Lab Ultrasound Mol Imaging, 63 Duobao Rd, Guangzhou 510150, Peoples R China		Chen, ZY (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Dept Ultrasound Med, Lab Ultrasound Mol Imaging, 63 Duobao Rd, Guangzhou 510150, Peoples R China.	zhiyi_chen@gzhmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81971621, 81671707]; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2019A1515012212]; Major Research Projects of Universities in Guangdong Province [2019KZDZX1032]; Research Fund for Lin He's Academician Workstation of New Medicine and Clinical Translation, Scientific and Technological Livelihood Projects of Liwan District [201904003]; Youth Foundation of the Third Affiliated Hospital of Guangzhou Medical University [2017Q10]	This work was supported by the Research Projects of National Natural Science Foundation of China (No. 81971621, No. 81671707), the Natural Science Foundation of Guangdong Province (No. 2019A1515012212), Major Research Projects of Universities in Guangdong Province (2019KZDZX1032), the Research Fund for Lin He's Academician Workstation of New Medicine and Clinical Translation, Scientific and Technological Livelihood Projects of Liwan District (201904003) and the Youth Foundation of the Third Affiliated Hospital of Guangzhou Medical University (grant 2017Q10).	Albayrak E, 2018, J ULTRAS MED, V37, P959, DOI 10.1002/jum.14366; Bailey C, 2017, J NEUROIMAGING, V27, P437, DOI 10.1111/jon.12443; Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Barr RG, 2017, ULTRASOUND MED BIOL, V43, P27, DOI 10.1016/j.ultrasmedbio.2016.06.020; Bhatia KSS, 2012, EUR RADIOL, V22, P2397, DOI 10.1007/s00330-012-2495-1; Chandrasekhar R, 2006, ULTRASOUND MED BIOL, V32, P847, DOI 10.1016/j.ultrasmedbio.2006.02.1407; Chauvet D, 2016, ULTRASCHALL MED, V37, P584, DOI 10.1055/s-0034-1399152; Chen XL, 2009, CHIN J MED ULTRASOUN, V6, P14; Cho SH, 2010, ULTRASOUND MED BIOL, V36, P202, DOI 10.1016/j.ultrasmedbio.2009.10.009; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cosgrove D, 2013, ULTRASCHALL MED, V34, P238, DOI 10.1055/s-0033-1335375; Cosgrove D, 2017, ULTRASOUND MED BIOL, V43, P4, DOI 10.1016/j.ultrasmedbio.2016.06.022; Demene C, 2014, J CEREBR BLOOD F MET, V34, P1009, DOI 10.1038/jcbfm.2014.49; Eilander HJ, 2013, J PEDIATR REHAB MED, V6, P73, DOI 10.3233/PRM-130241; Ertl M, 2018, ULTRASOUND MED BIOL, V44, P78, DOI 10.1016/j.ultrasmedbio.2017.08.1885; Ferraioli G, 2015, ULTRASOUND MED BIOL, V41, P1161, DOI 10.1016/j.ultrasmedbio.2015.03.007; Fisher M, 2018, CIRCULATION, V137, P103, DOI 10.1161/CIRCULATIONAHA.117.032903; Franchi-Abella S, 2017, ULTRASOUND MED BIOL, V43, P2402, DOI 10.1016/j.ultrasmedbio.2017.06.008; Garra BS, 2015, ABDOM IMAGING, V40, P680, DOI 10.1007/s00261-014-0305-8; Guan B, 2017, DIAGN INTERV IMAG, V98, P469, DOI 10.1016/j.diii.2016.12.001; Havre RF, 2008, ULTRASOUND MED BIOL, V34, P1638, DOI 10.1016/j.ultrasmedbio.2008.03.009; Hu ZW, 2015, ULTRASOUND MED BIOL, V41, P1530, DOI 10.1016/j.ultrasmedbio.2015.02.005; Hwang M, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2609; Hwang M, 2018, J NEUROIMAGING, V28, P150, DOI 10.1111/jon.12492; Kim HG, 2017, J ULTRAS MED, V36, P1313, DOI 10.7863/ultra.16.06079; Lea CL, 2017, ARCH DIS CHILD-FETAL, V102, pF176, DOI 10.1136/archdischild-2016-311949; Li CT, 2016, ULTRASOUND MED BIOL, V42, P1551, DOI 10.1016/j.ultrasmedbio.2016.02.018; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mace E, 2011, IEEE T MED IMAGING, V30, P550, DOI 10.1109/TMI.2010.2079940; Martin A, 2012, J CEREBR BLOOD F MET, V32, P1496, DOI 10.1038/jcbfm.2012.49; Mei ZR, 2017, METAB BRAIN DIS, V32, P1861, DOI 10.1007/s11011-017-0075-4; Montaldo G, 2009, IEEE T ULTRASON FERR, V56, P489, DOI 10.1109/TUFFC.2009.1067; Mumoli N, 2007, NEW ENGL J MED, V357, P2203; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nowicki A, 2016, J ULTRASON, V16, P113, DOI 10.15557/JoU.2016.0013; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Ozturk A, 2018, ABDOM RADIOL, V43, P773, DOI 10.1007/s00261-018-1475-6; Plaisier A, 2015, ARCH DIS CHILD-FETAL, V100, pF293, DOI 10.1136/archdischild-2014-306129; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Sadigh G, 2013, EUR RADIOL, V23, P1006, DOI 10.1007/s00330-012-2682-0; Scholz M, 2005, J ULTRAS MED, V24, P985, DOI 10.7863/jum.2005.24.7.985; Shiina T, 2015, ULTRASOUND MED BIOL, V41, P1126, DOI 10.1016/j.ultrasmedbio.2015.03.009; Sigrist RMS, 2017, THERANOSTICS, V7, P1303, DOI 10.7150/thno.18650; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; Su Y, 2015, CLIN EXP OBSTET GYN, V42, P797; Toms DA, 2006, J ULTRAS MED, V25, P560; Treece G, 2011, INTERFACE FOCUS, V1, P540, DOI 10.1098/rsfs.2011.0011; Wang SD, 2015, INT J CLIN EXP PATHO, V8, P12177; Xu ZNS, 2014, J ULTRAS MED, V33, P1763, DOI 10.7863/ultra.33.10.1763; Xu ZNS, 2013, J ULTRAS MED, V32, P485, DOI 10.7863/jum.2013.32.3.485; Zeng BD, 2016, J ULTRAS MED, V35, P253, DOI 10.7863/ultra.15.03076; Zhou W, 2015, INT J CLIN EXP MED, V8, P16445	53	2	2	7	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4297	1550-9613		J ULTRAS MED	J. Ultrasound Med.	NOV	2020	39	11					2093	2104		10.1002/jum.15317		MAY 2020	12	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	OD4TW	WOS:000531667700001	32385862				2022-02-06	
J	Xu, LJ; Ye, WS				Xu, Lujie; Ye, Wensong			Radial neck fracture or Monteggia equivalent lesion: delayed radial head subluxation in an adolescent and review of literature	BMC MUSCULOSKELETAL DISORDERS			English	Article						Monteggia fracture; Monteggia equivalent lesion; Radial neck fracture; Radiocapitellar dislocation; Adolescent; Children	ANTERIOR DISLOCATION; REDUCTION; CHILDREN; DISPLACEMENT; OSTEOTOMY; ULNA	Background Monteggia equivalent lesion represents a series of combined elbow and forearm injuries that resemble typical Monteggia fracture either in presentation or mechanism. The term has gradually evolved since its introduction, as sporadic case reports continued to complement it. The aim of this study was to present a furthermore type of that lesion which no previous study had reported and arouse pediatric orthopedists' additional awareness of it. Case presentation A 11-year-old girl, whose injury pattern initially appeared to be a mild radial neck fracture with undisplaced proximal ulnar fracture, and without radial head dislocation, was treated with closed reduction and long-arm splint immobilization. Acceptable results were acquired at first-week follow-up, yet dramatic changes turned up 2 weeks later when the dislocated radial head was found. A further reduction to the fracture and joint site only resulted in a subluxated and incongruous radiocapitellar joint on the three-dimensional computed tomography (3D-CT). Then a definitive operation was performed, which involved a Boyd incision, correction of radial head tilting, opening wedge osteotomy of the proximal ulna and proper fixation respectively. And acceptable results were achieved 1 year later. Conclusions This case, with occult proximal ulna fracture, angulated radial neck fracture, subsequent radiocapitellar dislocation, and articular incongruity, was deemed as a rare Monteggia type-one equivalent fracture-dislocation variant rather than an ordinary radial neck fracture and it facilitates further understanding and management of the Monteggia fracture.	[Xu, Lujie; Ye, Wensong] Zhejiang Univ, Childrens Hosp, Dept Orthopaed, Sch Med, 14th Floor,Inpatient Bldg,3333 Binsheng Rd, Hangzhou, Zhejiang, Peoples R China		Xu, LJ (corresponding author), Zhejiang Univ, Childrens Hosp, Dept Orthopaed, Sch Med, 14th Floor,Inpatient Bldg,3333 Binsheng Rd, Hangzhou, Zhejiang, Peoples R China.	xulujie@zju.edu.cn					Bado J L, 1967, Clin Orthop Relat Res, V50, P71; BOYD HB, 1969, CLIN ORTHOP RELAT R, P94; Ceroni D, 2010, J PEDIATR ORTHOPED, V30, P649, DOI 10.1097/BPO.0b013e3181ec95e0; Clark TR, 2017, J PEDIATR ORTHOP B, V26, P36, DOI 10.1097/BPB.0000000000000362; Exner GU, 2001, J BONE JOINT SURG BR, V83B, P547, DOI 10.1302/0301-620X.83B4.11103; FAHMY NRM, 1981, INJURY, V12, P399, DOI 10.1016/0020-1383(81)90011-5; Faundez AA, 2003, J BONE JOINT SURG BR, V85B, P584, DOI 10.1302/0301-620X.85B4.13204; Heinrich SD, 2007, CLIN ORTHOP RELAT R, P258, DOI 10.1097/BLO.0b013e31804b20fa; HIRAYAMA T, 1987, J BONE JOINT SURG BR, V69, P639, DOI 10.1302/0301-620X.69B4.3611173; JEFFERY CC, 1950, J BONE JOINT SURG BR, V32, P314, DOI 10.1302/0301-620X.32B3.314; KAMALI M, 1974, J BONE JOINT SURG AM, VA 56, P841, DOI 10.2106/00004623-197456040-00026; Kay R M, 1998, Am J Orthop (Belle Mead NJ), V27, P606; Kim E, 2012, J SHOULDER ELB SURG, V21, P1644, DOI 10.1016/j.jse.2011.12.006; Kim YS, 2014, J PEDIATR ORTHOP B, V23, P383, DOI 10.1097/BPB.0000000000000061; LETTS M, 1985, J BONE JOINT SURG BR, V67, P724, DOI 10.1302/0301-620X.67B5.4055869; Metaizeau JP, 2005, INJURY, V36, pA75, DOI 10.1016/j.injury.2004.12.016; Monteggia GB, 1814, I CHRURGICHE; OLNEY BW, 1989, J PEDIATR ORTHOPED, V9, P219; Peter VK, 2002, EMERG MED J, V19, P88, DOI 10.1136/emj.19.1.88; Reina N, 2012, J PEDIATR ORTHOP B, V21, P532, DOI 10.1097/BPB.0b013e32834d4e06; ROKITO SE, 1995, J ORTHOP TRAUMA, V9, P259, DOI 10.1097/00005131-199506000-00013; Ruchelsman DE, 2005, J ORTHOP TRAUMA, V19, P425; Sirois ZJ, 2018, J AM ACAD ORTHOP SUR; SOIN B, 1995, INJURY, V26, P407, DOI 10.1016/0020-1383(95)00046-C; Sur Yoo Joon, 2010, J Orthop Trauma, V24, pe12, DOI 10.1097/BOT.0b013e3181a5e441; TIBONE JE, 1981, J BONE JOINT SURG AM, V63, P100, DOI 10.2106/00004623-198163010-00013; TOMPKINS DG, 1971, J BONE JOINT SURG AM, VA 53, P1109, DOI 10.2106/00004623-197153060-00007; Weisman DS, 1999, J PEDIATR ORTHOPED, V19, P523, DOI 10.1097/00004694-199907000-00020; WRIGHT PR, 1963, J BONE JOINT SURG BR, V45, P727, DOI 10.1302/0301-620X.45B4.727; Zrig M, 2011, ARCH ORTHOP TRAUM SU, V131, P973, DOI 10.1007/s00402-010-1253-6	30	2	2	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2474		BMC MUSCULOSKEL DIS	BMC Musculoskelet. Disord.	MAY 6	2020	21	1							282	10.1186/s12891-020-03315-0			7	Orthopedics; Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rheumatology	LO3MR	WOS:000533533200001	32375718	Green Published, gold			2022-02-06	
J	Kjerulff, JL; Seidenfaden, SC; Juul, N; Moller, MF; Munster, AMB; Botker, MT				Kjerulff, Julie Linding; Seidenfaden, Sophie-Charlott; Juul, Niels; Moller, Mette Fogh; Munster, Anna-Marie Bloch; Botker, Morten Thingemann			Influence of Simulated Pre-Hospital Transport, Time to Analysis, and Storage Temperature on S100 Calcium-Binding Protein B Values	JOURNAL OF NEUROTRAUMA			English	Article						biomarker S100B; traumatic brain injury; validity	TRAUMATIC BRAIN-INJURY; SCANDINAVIAN GUIDELINES; SERUM S100B; UTILITY; MILD	According to in-hospital guidelines, the biomarker, S100 calcium-binding protein B (S100B), is used to rule out intracranial lesions in mild-moderate traumatic brain injury (TBI). It is currently investigated whether S100B is applicable in a pre-hospital setting. The aim was to compare S100B values and hemolysis index in blood samples drawn and stored under simulated pre-hospital conditions to standardized blood samples. Thirty patients undergoing craniotomy at Department of Neurosurgery, Aarhus University Hospital (Aarhus, Denmark) each had six blood samples drawn. Two samples, drawn in in-hospital standardized Beckton Dickinson tubes and pre-hospital Monovette tubes, respectively, were stored as references at 21 degrees C for 30 min. Two samples were stored at 15 degrees C and 29 degrees C, respectively, one sample was stored at prolonged time (60 min), and one sample was transported for 30 min before centrifugation. S100B values were compared by equivalence test with a pre-defined equivalence margin of +/- 8.5%. There was no clinically relevant difference between samples stored in different tubes, at various temperatures, or time to analysis compared to reference samples. Transported samples had an 11.5% (90% confidence interval [CI], 6.55; 16.61) higher median S100B value and a 430% (95% CI, 279.6; 661.4) higher median hemolysis index compared to reference samples. Three of 30 (10%) patients had an S100B value above guideline cutoff in the transported sample, which was not found in reference samples (false positive). There were no false negatives. In conclusion, S100B values were not influenced by different tubes, temperatures, and time to analysis. Transported samples had higher median S100B values and hemolysis, icterus, and lipemia index compared to reference samples.	[Kjerulff, Julie Linding; Seidenfaden, Sophie-Charlott; Botker, Morten Thingemann] Cent Denmark Reg, Res & Dev, Prehosp Emergency Med Serv, Olof Palmes Alle 34,2nd Floor, DK-8200 Aarhus N, Denmark; [Juul, Niels] Cent Denmark Reg, Aarhus Univ Hosp, Sect North, Dept Anesthesiol, Aarhus, Denmark; [Moller, Mette Fogh] Cent Denmark Reg, Dept Clin Biochem, Reg Hosp Herning, Herning, Denmark; [Munster, Anna-Marie Bloch] Esbjerg Southern Denmark Reg, Dept Clin Biochem, Esbjerg, Denmark		Kjerulff, JL (corresponding author), Cent Denmark Reg, Res & Dev, Prehosp Emergency Med Serv, Olof Palmes Alle 34,2nd Floor, DK-8200 Aarhus N, Denmark.	julkje@rm.dk		Munster, Anna-Marie Bloch/0000-0002-3398-3977			Ananthaharan A, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0193-2; Beaudeux JL, 2000, CLIN CHEM, V46, P989; de Vries J, 2003, MINIM INVAS NEUROSUR, V46, P33, DOI 10.1055/s-2003-37963; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Eskesen V., 2014, UGESKRIFT LAEGER, V176; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P247, DOI 10.1007/978-3-211-98811-4_46; Minkkinen M, 2019, J NEUROTRAUM, V36, P2904, DOI 10.1089/neu.2018.6351; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Raabe A, 2003, CLIN CHEM LAB MED, V41, P700, DOI 10.1515/CCLM.2003.106; Region Hospital Herning  Central Denmark Region, 2018, AN GUID S100B; Syeda T, 2013, JCPSP-J COLL PHYSICI, V23, P112, DOI 02.2013/JCPSP.112115; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772	14	2	2	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2020	37	17					1864	1869		10.1089/neu.2019.6907		MAY 2020	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NK7JF	WOS:000530254400001	32204643	Green Submitted			2022-02-06	
J	Ratliff, WA; Qubty, D; Delic, V; Pick, CG; Citron, BA				Ratliff, Whitney A.; Qubty, Doaa; Delic, Vedad; Pick, Chaim G.; Citron, Bruce A.			Repetitive Mild Traumatic Brain Injury and Transcription Factor Modulation	JOURNAL OF NEUROTRAUMA			English	Article						mild TBI; mouse models; pioglitazone; tBHQ; transcription factors	COGNITIVE DEFICITS; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE DAMAGE; EXPRESSION; RECOVERY; IMPAIRMENTS; HIPPOCAMPUS; ACTIVATOR; SEQUELAE; PATHWAY	The worldwide incidence of traumatic brain injury (TBI) is similar to 0.5% per year and the frequency is significantly higher among military personnel and athletes. Repetitive TBIs are associated with military and athletic activities, and typically involve more severe consequences. The majority of TBIs are mild; however, these still can result in long-term cognitive deficits, and there is currently no effective treatment. tert-Butylhydroquinone (tBHQ) and pioglitazone can activate the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and peroxisome proliferator-activated receptor-gamma (PPAR-gamma) transcription factors, respectively, and each has been shown to be neuroprotective in various model systems. We examined behavioral and gene expression changes after repetitive mild TBI followed by simultaneous treatment with both factors. We used a repetitive closed head injury of mice involving five injuries with a 1-week interval between each TBI. We found that memory performance was significantly reduced by the injuries, unless the TBIs were followed by the tBHQ and pioglitazone administrations. Certain genes; for example, growth hormone and osteopontin, were downregulated by the injury, and this was reversed by the treatment, whereas other genes; for example, a tumor necrosis factor receptor, were upregulated by the injury and restored if the post-injury treatment was administered. Analysis of gene expression levels affected by the injury and/or the treatment point to potential mechanisms that could be exploited therapeutically.	[Ratliff, Whitney A.; Citron, Bruce A.] Bay Pines VA Healthcare Syst, Res & Dev, Mol Biol Lab, Bay Pines, FL USA; [Qubty, Doaa; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, Tel Aviv, Israel; [Delic, Vedad; Citron, Bruce A.] VA New Jersey Hlth Care Syst, Res & Dev, Mol Biol Lab, Bldg 16,Room 16-176 385 Tremont Ave, E Orange, NJ 07018 USA; [Citron, Bruce A.] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA		Citron, BA (corresponding author), VA New Jersey Hlth Care Syst, Res & Dev, Mol Biol Lab, Bldg 16,Room 16-176 385 Tremont Ave, E Orange, NJ 07018 USA.	bruce.citron@va.gov			Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development)US Department of Veterans Affairs [I01RX001520]; Assistant Secretary of Defense for Health Affairs through the Congressionally Directed Gulf War Illness Research Program [W81XWH-16-1-0626]; Florida Department of Health James and Esther King Biomedical Research Program [4KB14]; Bay Pines Foundation; Veterans Bio-Medical Research Institute; Ari and Regine Aprijaskis Fund at Tel-Aviv University; Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases in Tel-Aviv University, Tel-Aviv, Israel	This study was supported by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development [I01RX001520]), the Assistant Secretary of Defense for Health Affairs through the Congressionally Directed Gulf War Illness Research Program (W81XWH-16-1-0626), the Florida Department of Health James and Esther King Biomedical Research Program (4KB14), The Bay Pines Foundation, and the Veterans Bio-Medical Research Institute. This research was supported in part by the Ari and Regine Aprijaskis Fund at Tel-Aviv University and the Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases in Tel-Aviv University, Tel-Aviv, Israel.	Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Bhowmick S, 2019, J MOL MED, V97, P1627, DOI 10.1007/s00109-019-01851-4; Chan JL, 2014, EXP NEUROL, V261, P757, DOI 10.1016/j.expneurol.2014.08.015; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Faul M, 2010, TRAUMATIC BRAIN INJU; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Jullienne A, 2020, J NEUROSCI RES, V98, P141, DOI 10.1002/jnr.24405; Kreber LA, 2016, J NEUROTRAUM, V33, P1607, DOI 10.1089/neu.2015.4127; Liu M, 2017, J NEUROTRAUM, V34, P414, DOI 10.1089/neu.2015.4361; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Pilipovic K, 2015, PROG NEURO-PSYCHOPH, V59, P8, DOI 10.1016/j.pnpbp.2015.01.003; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rabenstein M, 2016, J NEUROIMMUNOL, V299, P130, DOI 10.1016/j.jneuroim.2016.09.009; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rowe RK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1200-y; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Saykally JN, 2018, J NEUROTRAUM, V35, P139, DOI 10.1089/neu.2017.5070; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; van Velthoven CTJ, 2011, STROKE, V42, P2294, DOI 10.1161/STROKEAHA.110.608315; Zhang WQ, 2018, MED SCI MONITOR, V24, P1588, DOI 10.12659/MSM.905700; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	40	2	2	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2020	37	17					1910	1917		10.1089/neu.2020.7005		MAY 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NK7JF	WOS:000530259700001	32292111	Bronze			2022-02-06	
J	L'Ecuyer-Giguere, F; Greffou, S; Tabet, S; Frenette, LC; Tinawi, S; Feyz, M; de Guise, E				L'Ecuyer-Giguere, Fanny; Greffou, Selma; Tabet, Sabrina; Frenette, Lucie C.; Tinawi, Simon; Feyz, Mitra; de Guise, Elaine			Visual memory performance following mild traumatic brain injury and its relationship with intellectual functioning	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Concussion; mild traumatic brain injury; Rey Complex Figure Test; visual memory; intelligence	COMPLEX FIGURE TEST; CONCUSSION SYMPTOMS QUESTIONNAIRE; HEAD-INJURY; RECOGNITION MEMORY; COGNITIVE SEQUELAE; DIGIT SPAN; DEFICITS; PATIENT; DAMAGE; CT	To compare the visual memory performance of uncomplicated and complicated mild TBI (mTBI) groups with that of a control group on the Rey Complex Figure Test (RCFT). We also aimed to explore the influence of factors such as age, gender, education, occupation, and intellectual functioning on visual memory in individuals with mTBI. The RCFT and the Wechsler Abbreviated Scale of Intelligence (WASI-II) were administered to 138 participants (90 uncomplicated mTBI patients, 19 complicated mTBI patients, and 29 controls). The mTBI patients demonstrated significantly lower scores than control participants on both immediate and delayed RCFT recall conditions, with performance in the low average and borderline range. However, there was no difference in performance between the two mTBI groups on the recall conditions. In addition, no significant differences were observed across the three groups on the recognition condition. The WASI-II Performance and Verbal IQ scales explained most of the variance in the immediate and delayed RCFT recall conditions but were not associated with performance on the recognition condition. In contrast with the recognition processes involved in visual memory, recall processes seem to be more vulnerable following mTBI and both verbal and performance IQ seem to be related to visual memory performance.	[L'Ecuyer-Giguere, Fanny; Tabet, Sabrina; Frenette, Lucie C.; de Guise, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [L'Ecuyer-Giguere, Fanny; Tabet, Sabrina; Frenette, Lucie C.; de Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ H2H 2N8, Canada; [Greffou, Selma] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Tinawi, Simon; Feyz, Mitra] McGill Univ, Hlth Ctr, Montreal Gen Hosp, Montreal, PQ, Canada; [de Guise, Elaine] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada		de Guise, E (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.; de Guise, E (corresponding author), Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ H2H 2N8, Canada.	elainedeguise@hotmail.ca	Frenette, Lucie C./C-9579-2017		Research Institute of the McGill University Health Center [2668]	We thank the Research Institute of the McGill University Health Center for their support [Grant 2668].	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; ARDILA A, 1989, BRAIN COGNITION, V11, P147, DOI 10.1016/0278-2626(89)90015-8; Ardila A, 1991, CLIN NEUROPSYCHOL, V5, P371, DOI [10.1080/13854049108404104, DOI 10.1080/13854049108404104]; Ashton VL, 2005, J CLIN EXP NEUROPSYC, V27, P55, DOI 10.1080/138033990513636; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; Bastin C, 2004, NEUROCASE, V10, P330, DOI 10.1080/13554790490507650; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bolzenius JD, 2015, APPL NEUROPSYCH-ADUL, V22, P79, DOI 10.1080/23279095.2013.845823; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Carlesimo GA, 1997, CORTEX, V33, P131, DOI 10.1016/S0010-9452(97)80009-3; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CASSIDY JD, 2014, ARCH PHYS MED REHAB, V95, P132; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan J., 2005, PROBLEMATIC SUBSTANC; De Guise E., 2012, ISRN REHABIL, V2012, P1, DOI [10.5402/2012/534856, DOI 10.5402/2012/534856]; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Everitt B, 2002, CAMBRIDGE DICT STAT; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Fujii DE, 2000, CLIN NEUROPSYCHOL, V14, P551, DOI 10.1076/clin.14.4.551.7206; Gaines KD, 2016, APPL NEUROPSYCH-ADUL, V23, P115, DOI 10.1080/23279095.2015.1012762; Gallagher C, 2007, BRIT J CLIN PSYCHOL, V46, P35, DOI 10.1348/014466506X106047; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hart R. P., 1994, NEUROPSYCHOLOGY, V8, P325, DOI [10.1037/0894-4105.8.3.325, DOI 10.1037/0894-4105.8.3.325]; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kixmiller JS, 2000, J CLIN EXP NEUROPSYC, V22, P198, DOI 10.1076/1380-3395(200004)22:2;1-1;FT198; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Leh SE, 2017, J NEUROTRAUM, V34, P1402, DOI 10.1089/neu.2016.4591; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Mayes AR, 2002, HIPPOCAMPUS, V12, P325, DOI 10.1002/hipo.1111; Meyers J. E., 1995, CLIN NEUROPSYCHOL, V9, P63, DOI [10.1080/13854049508402059, DOI 10.1080/13854049508402059]; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; National Institute, 2005, TRENDS DRUG AB; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schwarz L, 2009, CLIN NEUROPSYCHOL, V23, P255, DOI 10.1080/13854040802220034; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tombaugh T.N., 1996, TEST MEMORY MALINGER; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wechsler D., 2008, WECHSLER ADULT INTEL	66	2	3	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAY 3	2020	27	3					219	231		10.1080/23279095.2018.1528263			13	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	KZ9HS	WOS:000523570900002	30646771				2022-02-06	
J	Abdelwahab, MA; Spataro, EA; Elkholy, NA; El-Degwi, A; Most, SP				Abdelwahab, Mohamed A.; Spataro, Emily A.; Elkholy, Noha A.; El-Degwi, Ahmed; Most, Sam P.			Biportal transparotid dissection in the retromandibular approach for condylar fracture osteosynthesis: Efficacy of a novel technique	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Condylar fracture; Retromandibular; Biportal; Transparotid	MANDIBULAR CONDYLE; INTERNAL-FIXATION; SURGICAL APPROACH; OPEN REDUCTION; COMPLICATIONS; NECK	Objective: Facial nerve injury is a primary complication of open surgical manage- ment of condylar fractures. A new modification of the retromandibular transparotid approach, the "biportal transparotid dissection" (BTD), was developed to reduce these injuries in acci- dental nerve exposure. Design: Prospective cohort study. Setting: Tertiary referral center. Methods: Patients managed by retromandibular transparotid approach for condylar fractures at Department of Otolaryngology- Head and Neck Surgery, Mansoura University were included between November 2015 and August 2019 with exclusion of cases managed endoscopically or by a closed approach. Three groups were identified: Group A included patients undergoing the BTD technique, which entails transparotid dissection above and below exposed nerve branches and minimal nerve retraction; Group B included patients undergoing traditional dissection and nerve retraction away from the surgical field; and Group C included patients with unidentified facial nerve branches. The function of facial nerve branches was documented postoperatively. Results: Fifty-seven fractures were included in the study. Facial nerve branches' injury occurred in 13 cases (22.8%): two (of ten) in Group A (20%), seven (of ten) in Group B (70%) and four (of 37) in Group C (10.81%). Compared to patients with non-exposed branches, Groups A and B were found to have 2.06 (p = 0.447) and 19.25 (p = 0.001) greater odds of nerve injury, respectively. The results showed significant faster nerve recovery in the BTD group compared to traditional dissection (mean 5 versus 9 weeks) ( p = 0.015). Conclusion and relevance: Although avoiding facial nerve exposure minimizes injury the most, BTD approach reduces exposed nerve injury compared to the traditional method. (c) 2019 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Abdelwahab, Mohamed A.; Most, Sam P.] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Div Facial Plast & Reconstruct Surg, 801 Welch Rd, Stanford, CA 94305 USA; [Abdelwahab, Mohamed A.; Elkholy, Noha A.; El-Degwi, Ahmed] Mansoura Univ, Fac Med, Dept Otolaryngol Head & Neck Surg, 35516 El Gomhoreya St, Mansoura, Egypt; [Spataro, Emily A.] Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Div Facial Plast & Reconstruct Surg, 1020 N Mason Rd,Ste 205, St Louis, MO 63141 USA		Abdelwahab, MA (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Div Facial Plast & Reconstruct Surg, 801 Welch Rd, Stanford, CA 94305 USA.	m.wahab.plasty@gmail.com	Abdelwahab, Mohamed/AAE-4040-2019	Abdelwahab, Mohamed/0000-0002-2588-8355			Al-Moraissi EA, 2018, J CRANIO MAXILL SURG, V46, P398, DOI 10.1016/j.jcms.2017.10.024; Bhutia O, 2014, BRIT J ORAL MAX SURG, V52, P236, DOI 10.1016/j.bjoms.2013.12.002; Bindra S, 2010, J MAXILLOFAC ORAL SU, V9, P355, DOI 10.1007/s12663-010-0133-5; Bouchard C, 2014, J ORAL MAXIL SURG, V72, P370, DOI 10.1016/j.joms.2013.08.014; Choi KY, 2012, ARCH PLAST SURG-APS, V39, P291, DOI 10.5999/aps.2012.39.4.291; Derfoufi L, 2011, J CRANIOFAC SURG, V22, P1448, DOI 10.1097/SCS.0b013e31821d1814; Girotto R, 2012, J CRANIO MAXILL SURG, V40, P78, DOI 10.1016/j.jcms.2011.01.009; Hou J, 2014, OR SURG OR MED OR PA, V117, P283, DOI 10.1016/j.oooo.2013.11.491; Kanno T, 2014, INT J ORAL MAX SURG, V43, P177, DOI 10.1016/j.ijom.2013.08.008; Kim BK, 2012, J CRANIOFAC SURG, V23, P712, DOI 10.1097/SCS.0b013e31824dbb35; Manisali M, 2003, INT J ORAL MAX SURG, V32, P253, DOI 10.1054/ijom.2002.0270; Meeran NA, 2012, ARCH ORAL SCI RES, V2, P31; Neff A, 2014, CRANIOMAX TRAUM REC, V7, pS44, DOI 10.1055/s-0034-1389559; Nogami S, 2012, J CRANIOFAC SURG, V23, P1815, DOI 10.1097/SCS.0b013e3182710393; Rozeboom A, 2018, J CRANIO MAXILLOFAC; Salgarelli AC, 2013, INT J ORAL MAX SURG, V42, P464, DOI 10.1016/j.ijom.2012.12.012; SPIESSL B, 1972, RECONSTRUCTION SURGERY AND TRAUMATOLOGY, V13, P124	17	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	MAY	2020	73	5					927	933		10.1016/j.bjps.2019.11.044			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	ME8IY	WOS:000544897700017	31959498				2022-02-06	
J	Bernard, CO; McKinlay, A; Krieser, D; Ponsford, JL				Bernard, Coco O.; McKinlay, Audrey; Krieser, David; Ponsford, Jennie L.			Postconcussive Symptoms Following Mild TBI and Extracranial Injury: What Are the Contributing Factors?	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Mild traumatic brain injury; Postconcussive symptoms; Children; Outcomes; Concussion; Paediatric	TRAUMATIC BRAIN-INJURY; POST-CONCUSSIVE SYMPTOMS; COMPLAINT BASE RATES; HEAD-INJURY; PSYCHOSOCIAL OUTCOMES; CHILDREN; PREDICTORS; ADOLESCENTS; CHILDHOOD; PRESCHOOL	Objectives: Whether mild traumatic brain injury (mTBI) sustained by children results in persistent or recurrent symptoms, over and above those experienced by children who solely sustain mild extracranial injuries, remains debated. The current prospective longitudinal case-controlled study aimed to examine the relative influence of injury and noninjury factors on symptoms in preschool and primary school-aged children who sustained an mTBI or mild extracranial injury at least 8 month earlier. Methods: Participants were 64 parents of children (31 mTBI, 33 trauma controls) who sustained injury between ages 2 and 12, whose postconcussive symptoms across the first 3-month postinjury have been previously described. The current study assessed postconcussive symptoms at 8 or more months postinjury (M = 24.3, SD = 8.4) and examined a range of injury and noninjury predictive factors. Results: At or beyond 8-month postinjury, symptom numbers in the mTBI group were comparable with those of the group who sustained mild extracranial injury. Educational attainment of parents (below or above high-school attainment level) was the only predictor of symptoms at follow-up, with preexisting learning difficulties approaching significance as a predictor. Conclusions: While our earlier study found that mTBI was associated with symptoms at 3-month postinjury, follow-up at more than 8 months showed mTBI no longer predicted symptom reporting. While mTBI contributes significantly to the presence of symptoms in the first few months postinjury, researchers and healthcare practitioners in this field need to consider the potential impact of noninjury factors on persistent or recurrent symptoms after mTBI.	[Bernard, Coco O.; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3800, Australia; [McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Krieser, David] Sunshine Hosp, Emergency Dept, Melbourne, Vic 3021, Australia		Bernard, CO (corresponding author), Monash Univ, Sch Psychol Sci, Melbourne, Vic 3800, Australia.	coco.bernard@monash.edu	Krieser, David/AAA-1370-2021	Krieser, David/0000-0002-7173-6993	Jack Brockoff foundation; Dr Coco Bernard's Doctoral Research fund	The authors would like to acknowledge the time contribution of participants and their parents who were involved in this study. This research work was partially supported by a grant awarded to Professor Jennie Ponsford and Dr Audrey McKinlay from the Jack Brockoff foundation, and from Dr Coco Bernard's Doctoral Research fund.	Abidin R., 1983, PARENTAL STRESS INDE; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V., 1997, J INT NEUROPSYCH SOC, V3, P553; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; [Anonymous], 2014, CANCER DISCOV, V4, pOF5, DOI DOI 10.1227/NEU.0000000000000505; [Anonymous], 2010, MED CHANNEL, V16, P94, DOI DOI 10.1017/S1355617709991007; [Anonymous], 2013, ANN WYOMING, V27, P14, DOI DOI 10.1175/JAS-D-12-062.1.J.CART0N; [Anonymous], 2012, GLOBE REV INT ETUDES, VXV, P13, DOI DOI 10.3109/17518423.2011.625558; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bernard C, 2017, BRAIN INJURY, V31, P1414, DOI 10.1080/02699052.2017.1350999; Bernard CO, 2017, J HEAD TRAUMA REHAB, V32, P413, DOI 10.1097/HTR.0000000000000298; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Bracken B.A., 2004, CLIN ASSESSMENT BEHA; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; GIBBONS RD, 1993, ARCH GEN PSYCHIAT, V50, P739; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Goodlin-Jones BL, 2008, J DEV BEHAV PEDIATR, V29, P82, DOI 10.1097/DBP.0b013e318163c39a; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Hosmer DW, 2013, WILEY SER PROBAB ST, P269; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2017, CHILD NEUROPSYCHOL, V23, P273, DOI 10.1080/09297049.2015.1130219; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; Medicines and Healthcare products Regulatory Agency (UK), 2018, YELLOW CARD IT DRUG, V11, P7, DOI DOI 10.3233/PRM-160424; Meisenberg G, 2008, PERS INDIV DIFFER, V44, P1539, DOI 10.1016/j.paid.2008.01.010; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 1999, NEUROPSYCHOL REHABIL, V9, P517, DOI 10.1080/096020199389563; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Risen SR, 2017, PM&R, V9, P874, DOI 10.1016/j.pmrj.2016.12.005; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; StataCorp, 2013, STATA STAT SOFTW REL; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Thomas DG, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P73, DOI 10.1007/978-0-387-89545-1_6; Melo JRT, 2010, ARQ NEURO-PSIQUIAT, V68, P381, DOI 10.1590/S0004-282X2010000300010; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; 2000, REPORTS INT ARBITRAL, V23, P1	75	2	2	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2020	26	5					451	463	PII S1355617719001279	10.1017/S1355617719001279			13	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	LJ6YI	WOS:000530308000001	31822313				2022-02-06	
J	Carpenter, S; Lininger, M; Craig, D				Carpenter, Samantha; Lininger, Monica; Craig, Debbie			INTRAPERSONAL FACTORS AFFECTING CONCUSSION REPORTING BEHAVIORS ACCORDING TO THE THEORY OF PLANNED BEHAVIOR IN HIGH SCHOOL FOOTBALL PLAYERS	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						adolescents; head injury; intentions; self-efficacy; sports	KNOWLEDGE; EDUCATION; IMPACT	Background: The diagnosis of a sports-related concussion (SRC) relies heavily on self-report from the athlete; therefore, the true percentage of those sustaining an SRC is not readily known. Concussed athletes are at higher risk for permanent or more catastrophic injury, especially without a diagnosis. Limited research has been done to determine the factors associated with concussion reporting behaviors in high school athletes. Purpose: To determine the intrapersonal factors affecting concussion reporting behavior in high school athletes based on the Theory of Planned Behavior (TPB). Study Design: Cross-sectional design. Methods: A convenience sample of 40 high school football players (age: 15.6 +/- 1.0 years) who played during the fall 2017 season and had not been diagnosed with a sports-related concussion two weeks prior to data collection completed a previously validated questionnaire. Of these, 58% were underclassmen and 65% were skill players. An ordinal regression was used to analyze the association between the intention to report and four variables (attitudes of reporting, reporting self-efficacy, symptoms and behavior, subjective norms, and concussion knowledge). Before data collection, it was hypothesized that these factors could be used to form a model to determine the athletes' intention to report, which can then be related to their reporting behavior. Results: Self-efficacy was the only TPB variable significantly associated with reporting intention. Conclusion: Reporting self-efficacy was significantly associated with intention to report, where participants with a high self-efficacy score were 3.15 times more likely to report an SRC than those with a lower score. Freshmen athletes had higher reporting intentions than juniors, and participants that identified as 'white' had higher intentions than those who identified as 'other'. Concussion knowledge, subjective norms, attitudes of reporting, and symptoms and behavior were not significantly associated with intention to report.	[Carpenter, Samantha; Lininger, Monica; Craig, Debbie] No Arizona Univ, POB 15094, Flagstaff, AZ 86011 USA		Lininger, M (corresponding author), No Arizona Univ, POB 15094, Flagstaff, AZ 86011 USA.	monica.lininger@nau.edu					Ajzen I, 2013, J APPL SOC PSYCHOL, V43, P155, DOI 10.1111/j.1559-1816.2012.00989.x; Hunt TN., 2015, ATHLETIC TRAIN ED J, V10, P65, DOI [10.4085/100165, DOI 10.4085/100165]; Kroshus E., 2014, J ADOLESCENT HEALTH, V54, pe2; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Roland N, 2018, J COLL STUD RETENT-R, V20, P215, DOI 10.1177/1521025116656632; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543	11	2	2	0	4	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	MAY	2020	15	3					374	379		10.26603/ijspt20200374			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	MC4KP	WOS:000543258200004	32566373				2022-02-06	
J	Corrigan, JD; Zheng, TY; Pinto, SM; Bogner, J; Kean, J; Niemeier, JP; Guerrier, TP; Haaland, B; Horn, SD				Corrigan, John D.; Zheng, Tianyu; Pinto, Shanti M.; Bogner, Jennifer; Kean, Jacob; Niemeier, Janet P.; Guerrier, Tami P.; Haaland, Benjamin; Horn, Susan D.			Effect of Preexisting and Co-Occurring Comorbid Conditions on Recovery in the 5 Years After Rehabilitation for Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						comorbidities; function; medical conditions; outcomes; rehabilitation; traumatic brain injury	MODEL SYSTEMS; INPATIENT REHABILITATION; NATIONAL INSTITUTE; LONGITUDINAL DESCRIPTION; OUTCOMES; DISABILITY; SEVERITY; OLDER; INDIVIDUALS; ASSOCIATION	Objective: To determine the relationship between comorbid health conditions and the trajectory of functional recovery 5 years following traumatic brain injury (TBI) rehabilitation. Setting: Two acute rehabilitation facilities. Participants: A total of 407 patients with primary diagnosis of TBI. Design: Prospective, observational. Main Measures: Functional Independence Measure Cognitive and Motor scores. Results: Female gender was negatively associated with the trajectory of motor recovery (P < .001). TBI severity was negatively associated with both motor and cognitive recovery and interacted with time after injury (both Ps < .0001). Hypertension was negatively associated with both motor (P < .0001) and cognitive (P = .0121) recovery, although this relationship diminished over time for motor function (P = .0447). Cardiac conditions were negatively associated with motor recovery (P = .0204), and rate of cognitive recovery was more rapid for patients with cardiac conditions (P = .0088). Depressed patients recovered cognitive function more quickly than those who were not depressed (P = .0196). Diabetes was negatively associated with motor function (P = .0088). Drug/alcohol use was positively associated with motor function (P = .0036). Conclusions: Injury severity remains an important predictor of long-term recovery; however, certain comorbid medical conditions are negatively associated with functional abilities over the first 5 years after injury. Patients being discharged from TBI rehabilitation with comorbid cardiac, hypertensive, diabetic, and/or depressive conditions may benefit from early and ongoing clinical surveillance.	[Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Columbus, OH 43210 USA; [Zheng, Tianyu; Kean, Jacob; Haaland, Benjamin; Horn, Susan D.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Pinto, Shanti M.; Niemeier, Janet P.; Guerrier, Tami P.] Carolinas Rehabil, Charlotte, NC USA		Corrigan, JD (corresponding author), Ohio State Univ, Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA.	corrigan.1@osu.edu			National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institutes of Health, National Institute on Disability and Rehabilitation Research [H133A080023]; National Institutes of Health, National Institute on Disability Independent Living and Rehabilitation Research [90DP0040, 90DP0084, CHC001]	Funding for this study came from the National Institutes of Health, National Center for Medical Rehabilitation Research (grant 1R01HD050439-01), the National Institute on Disability and Rehabilitation Research (grant H133A080023), and the National Institute on Disability Independent Living and Rehabilitation Research (grants 90DP0040 to Ohio State University and 90DP0084 subaward CHC001 to Carolinas Rehabilitation).	AVERILL RF, 1992, HEALTH SERV RES, V27, P587; Clemmer TP, 1999, CRIT CARE MED, V27, P1768, DOI 10.1097/00003246-199909000-00011; Coronado VG, 2011, 3 FED INT C TRAUM BR; Corrigan JD, 2012, CTR DIS CONTR PREV I; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; Dams-O'Connor K, 2020, J HEAD TRAUMA REHAB, V35, P127, DOI 10.1097/HTR.0000000000000484; Deckers K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184244; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Dijkers MP, 2013, ARCH PHYS MED REHAB, V94, pS61, DOI 10.1016/j.apmr.2012.11.048; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gardizi E, 2014, ARCH PHYS MED REHAB, V95, P2396, DOI 10.1016/j.apmr.2014.06.004; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hammond F, 2019, J HEAD TRAUMA REHABI, DOI 10.1097/HTR.0000000000000459; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2002, J PEDIATR-US, V141, P496, DOI 10.1067/mpd.2002.126925; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Horn SD, 2013, ARCH PHYS MED REHAB, V94, pS75, DOI 10.1016/j.apmr.2012.10.036; Jimenez-Balado J, 2019, HYPERTENSION, V73, P342, DOI 10.1161/HYPERTENSIONAHA.118.12090; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P754, DOI 10.1001/jama.2011.1170; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Lecours A, 2012, J HEAD TRAUMA REHAB, V27, P379, DOI 10.1097/HTR.0b013e31823b2385; Muthen BO, 1997, PSYCHOL METHODS, V2, P371, DOI 10.1037/1082-989X.2.4.371; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2478, DOI 10.1016/j.apmr.2013.06.019; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Scholten AC, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0127-3; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Wenger NK, 2018, J AM COLL CARDIOL, V71, P1797, DOI 10.1016/j.jacc.2018.02.033; Whiteneck GG, 2013, ARCH PHYS MED REHAB, V94, pS67, DOI 10.1016/j.apmr.2012.12.022; Willson D F, 2000, Pediatr Crit Care Med, V1, P127, DOI 10.1097/00130478-200010000-00007; World Health Organization, 1993, INT STAT CLASS DIS R	38	2	2	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2020	35	3			SI		E288	E298		10.1097/HTR.0000000000000521			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LP4ZM	WOS:000534327200012	31479076				2022-02-06	
J	Dobryakova, E; Genova, H; Schneider, V; Chiaravalloti, ND; Spirou, A; Wylie, GR; DeLuca, J				Dobryakova, Ekaterina; Genova, Helen; Schneider, Veronica; Chiaravalloti, Nancy D.; Spirou, Angela; Wylie, Glenn R.; DeLuca, John			Reward presentation reduces on-task fatigue in traumatic brain injury	CORTEX			English	Article						Cognitive fatigue; Striatum; Functional MRI; Motivation; Reward	STRIATAL DOPAMINE RELEASE; MENTAL FATIGUE; COGNITIVE FATIGUE; MULTIPLE-SCLEROSIS; POSTSTROKE FATIGUE; MILD; FMRI; ACTIVATION; MOTIVATION; RESPONSES	While cognitive fatigue is experienced by up to 80% of individuals with traumatic brain injury (TBI), little is known about its neural underpinnings. We previously hypothesized that presentation of rewarding outcomes leads to cognitive fatigue reduction and activation of the striatum, a brain region shown to be associated with cognitive fatigue in clinical populations and processing of rewarding outcomes. We have demonstrated this in individuals with multiple sclerosis. Here, we tested this hypothesis in individuals with TBI. Twenty-one individuals with TBI and 24 healthy participants underwent functional magnetic resonance imaging. Participants performed a task during which they were presented with 1) the Outcome condition where they were exposed to monetary rewards, and 2) the No Outcome condition that served as the control condition and was not associated with monetary rewards. In accordance with our hypothesis, results showed that attainment of rewarding outcomes leads to cognitive fatigue reduction in individuals with TBI, as well as activation of the striatum. Specifically, we observed a significant group by condition interaction on fatigue scores driven by the TBI group reporting lower levels of fatigue after the Outcome condition. fMRI data revealed a significant main-effect of condition in regions previously implicated in outcome processing, while a significant group by condition interaction was observed in the left ventral striatum as revealed by a priori region of interest analysis. Results suggest that a salient motivator can significantly reduce fatigue and that outcome presentation leads to increased activation of the ventral striatum in TBI. These findings can inform the development of future non-pharmacological cognitive fatigue treatment methods and contribute to the growing body of evidence showing the association between cognitive fatigue and the striatum. (C) 2020 Elsevier Ltd. All rights reserved.	[Dobryakova, Ekaterina; Schneider, Veronica; Chiaravalloti, Nancy D.; Spirou, Angela; DeLuca, John] Kessler Fdn, Ctr Traumat Brain Injury Res, E Hanover, NJ USA; [Dobryakova, Ekaterina; Genova, Helen; Chiaravalloti, Nancy D.; Wylie, Glenn R.; DeLuca, John] Rutgers New Jersey Med Sch Newark, Dept Phys Med & Rehabil, Newark, NJ USA; [Genova, Helen; Chiaravalloti, Nancy D.; DeLuca, John] Kessler Fdn, Ctr Neuropsychol & Neurosci Res, West Orange, NJ USA; [Wylie, Glenn R.] Kessler Fdn, Rocco Ortenzio Neuroimaging Ctr, West Orange, NJ USA		Dobryakova, E (corresponding author), Kessler Fdn, 120 Eagle Rock Ave, E Hanover, NJ 07936 USA.	edobryakova@kesslerfoundation.org; hgenova@kesslerfoundation.org; vschneider@kesslerfoundation.org; nchiaravalloti@kesslerfoundation.org; aspirou@kesslerfoundation.org; gwylie@kesslerfoudnation.org; jdeluca@kesslerfoundation.org	Dobryakova, Ekaterina/ABD-2853-2021	Dobryakova, Ekaterina/0000-0002-6005-2115	National Institute for Independent Living, Disability and Rehabilitation [90SF00090100]	This work was supported by the National Institute for Independent Living, Disability and Rehabilitation (Award#90SF00090100), awarded to EkaterinaDobryakova, PhD.	Bales James W, 2010, Open Drug Discov J, V2, P119; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barsevick A, 2010, QUAL LIFE RES, V19, P1419, DOI 10.1007/s11136-010-9757-7; Boecker R., 2014, PLOS ONE, V9; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Braver TS, 2014, COGN AFFECT BEHAV NE, V14, P443, DOI 10.3758/s13415-014-0300-0; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Clark AL, 2017, BRAIN IMAGING BEHAV, V11, P1548, DOI 10.1007/s11682-016-9594-6; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Damasceno A, 2016, MULT SCLER J, V22, P822, DOI 10.1177/1352458515599451; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dobryakova E, 2018, MULT SCLER J, V24, P1174, DOI 10.1177/1352458517717087; Dobryakova E, 2017, NEUROIMAGE, V147, P330, DOI 10.1016/j.neuroimage.2016.12.029; Dobryakova E, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00052; Dobryakova E, 2013, COGN AFFECT BEHAV NE, V13, P725, DOI 10.3758/s13415-013-0182-6; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Farah MJ, 2018, NAT REV NEUROSCI, V19, P428, DOI 10.1038/s41583-018-0023-2; Flachenecker P, 2002, MULT SCLER J, V8, P523, DOI 10.1191/1352458502ms839oa; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friedman JH, 2011, EXPERT OPIN PHARMACO, V12, P1999, DOI 10.1517/14656566.2011.587120; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griffiths KR, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00101; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Ingles JL, 1999, ARCH PHYS MED REHAB, V80, P173, DOI 10.1016/S0003-9993(99)90116-8; Iverson G, 2007, BRAIN INJURY MED PRI; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johansson B, 2017, NEUROPSYCHOL REHABIL, V27, P1047, DOI 10.1080/09602011.2017.1292921; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kluger BM, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101730; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kurniawan IT, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00081; Luking KR, 2014, DEV COGN NEUROS-NETH, V9, P82, DOI 10.1016/j.dcn.2014.01.005; Malhotra PA, 2013, J NEUROL NEUROSUR PS, V84, P366, DOI 10.1136/jnnp-2012-303169; Milyavskaya M., 2017, NEUROPSYCHOLOGY, V123, P159; Muller T, 2019, NEUROPSYCHOLOGIA, V123, P141, DOI 10.1016/j.neuropsychologia.2018.04.030; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; Pappata S, 2002, NEUROIMAGE, V16, P1015, DOI 10.1006/nimg.2002.1121; Pardini M, 2010, BEHAV NEUROSCI, V124, P329, DOI 10.1037/a0019585; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Ryan NP, 2016, CORTEX, V83, P222, DOI 10.1016/j.cortex.2016.07.020; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, P116, DOI 10.1097/HTR.0000000000000019; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Siciliano M., 2018, MOVEMENT DISORDERS, V1-12; Siegel JS, 2014, HUM BRAIN MAPP, V35, P1981, DOI 10.1002/hbm.22307; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Tang WK, 2013, J NEUROL SCI, V324, P131, DOI 10.1016/j.jns.2012.10.022; Tang WK, 2010, J NEUROL, V257, P178, DOI 10.1007/s00415-009-5284-2; Tate D. F., 2016, J NEUROL, V33, P113; Tricomi E, 2008, NEUROIMAGE, V41, P1154, DOI 10.1016/j.neuroimage.2008.02.066; Tricomi E, 2006, J COGNITIVE NEUROSCI, V18, P1029, DOI 10.1162/jocn.2006.18.6.1029; Tricomi E, 2017, ADV MOTIV A, V19, P175, DOI 10.1108/S0749-742320160000019015; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wanger AK, 2009, J NEUROCHEM, V110, P801, DOI 10.1111/j.1471-4159.2009.06155.x; Weiland BJ, 2014, PSYCHIAT RES-NEUROIM, V223, P244, DOI 10.1016/j.pscychresns.2014.05.015; Westbrook A, 2015, COGN AFFECT BEHAV NE, V15, P395, DOI 10.3758/s13415-015-0334-y; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Zgaljardic DJ, 2014, BRAIN INJURY, V28, P389, DOI 10.3109/02699052.2014.884242; Zink CF, 2003, J NEUROSCI, V23, P8092	70	2	2	2	3	ELSEVIER MASSON, CORP OFF	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	MAY	2020	126						16	25		10.1016/j.cortex.2020.01.003			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	LE8VE	WOS:000527003400002	32062140				2022-02-06	
J	Elbin, RJ; D'Amico, NR; McCarthy, M; Womble, MN; O'Connor, S; Schatz, P				Elbin, R. J.; D'Amico, Nathan R.; McCarthy, Matthew; Womble, Melissa N.; O'Connor, Sydne; Schatz, Philip			How Do ImPACT Quick Test Scores Compare with ImPACT Online Scores in Non-Concussed Adolescent Athletes?	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Computerized neurocognitive testing; Concussion; Sport	TEST-RETEST RELIABILITY; HIGH-SCHOOL; COMPUTER; VERSION	Objective: To compare neurocognitive scores between the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) Quick Test (QT) and Online Versions in non-concussed high school athletes. Methods: A sample of 47 high school athletes completed the ImPACT Online Version pre-season and the ImPACT QT approximately 3 months later. Paired sample t-tests and Pearson's correlations examined differences and relationships between the ImPACT batteries. Results: The ImPACT QT scores were significantly higher for performance on the Three Letters: Average Counted (p < .001, d = .88), Three Letters: Average Counted Correctly (p < .001, d = .80), and Symbol Match: Correct RT Visible (p < .001, d = .72), and Symbol Match: Correct RT Hidden (p = .002, d = .50) subtests. There were significant relationships for Three Letters: Average Counted (r = .85, p < .001), Three Letters: Average Counted Correctly (r = .82, p < .001), and Symbol Match: Total Correct Hidden (r = .40, p = .006) subtests. Conclusions: Post-injury evaluation data using ImPACT QT should be compared to normative referenced data, and not to pre-season data from the ImPACT Online Version.	[Elbin, R. J.; D'Amico, Nathan R.; McCarthy, Matthew] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AK 72701 USA; [Womble, Melissa N.] Inova Sports Med, Inova Med Grp, Dept Orthopaed & Sports Med, Concuss Program, Fairfax, VA USA; [O'Connor, Sydne; Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA		Elbin, RJ (corresponding author), Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AK 72701 USA.	rjelbin@uark.edu					[Anonymous], 2017, IMPACT QUICK TEST AD; Byun YS, 2018, ANN OCCUP ENVIRON ME, V30, DOI 10.1186/s40557-018-0264-6; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Forlines C., 2007, COMP HUM INT C SAN J; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kong XJ, 2018, APPL MEAS EDUC, V31, P17, DOI 10.1080/08957347.2017.1391261; MacInnes WJ, 2001, BEHAV RES METH INS C, V33, P174, DOI 10.3758/BF03195363; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKinney CJ, 1999, BEHAV RES METH INS C, V31, P129, DOI 10.3758/BF03207703; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Schatz P, 2015, ASSESSMENT, V22, P405, DOI 10.1177/1073191114566622; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	15	2	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2020	35	3			SI		326	331		10.1093/arclin/acz072			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN7WL	WOS:000568997800010	32044991				2022-02-06	
J	Elkbuli, A; Smith, Z; Shaikh, S; Hai, S; McKenney, M; Boneva, D				Elkbuli, Adel; Smith, Zachary; Shaikh, Saamia; Hai, Shaikh; McKenney, Mark; Boneva, Dessy			Mild and Moderate Traumatic Brain Injury and Gender-Based Critical Care Outcomes	WORLD JOURNAL OF SURGERY			English	Article							SEX; BLUNT; RISK	Background Traumatic brain injury (TBI) is a major contributor to death and complications. Previous studies have identified gender disparities among trauma patients. This study aims to examine the association between gender and outcomes in TBI patients. Study design and methods Review of our trauma registry: Patients were classified into groups according to their gender. Demographics extracted from the registry included age, injury severity score (ISS), Glasgow Coma Score (GCS), head abbreviated injury score (AIS), and the presence of an epidural hematoma (EDH). The primary outcome was mortality; secondary outcomes included ICU length of stay (ICU-LOS), craniotomy rate, ventilator-associated pneumonia (VAP), and readmission rates. Significance was defined as p < 0.05. Results Nine hundred and thirty-five patients with TBI were studied: 62.1% (n = 581) were male and 37.9% (n = 354) were female. There were no differences in GCS, ISS, and head AIS. Males were younger [53 (IQR 30-77) vs. 76 (IQR 49.25-84), p < 0.05] and were more likely to have an EDH (9.6% vs. 4.8%, p = 0.007). Males also had a longer median ICU-LOS [4 days (IQR 2-8) vs. 3 days (IQR 0-5), p < 0.05] and were significantly more likely to require a craniotomy (44.6% vs. 19.2%, p < 0.001). In addition, males were more likely to develop VAP (4.1% vs. 0.8%, p = 0.004). Predicted survival (79.2% vs. 72.9%) and actual mortality rates (4.5% vs. 4.5%) were similar in both genders (p > 0.05). Conclusion In the context of our study, male patients with TBI were significantly younger, were more likely to sustain an EDH, and were also more likely to require a craniotomy, but mortality rates between both genders were similar. The male gender was also associated with a significantly increased ICU-LOS and VAP.	[Elkbuli, Adel; Smith, Zachary; Shaikh, Saamia; Hai, Shaikh; McKenney, Mark; Boneva, Dessy] Kendall Reg Med Ctr, Dept Surg, 11750 Bird Rd, Miami, FL 33175 USA; [McKenney, Mark; Boneva, Dessy] Univ S Florida, Tampa, FL 33620 USA		Elkbuli, A (corresponding author), Kendall Reg Med Ctr, Dept Surg, 11750 Bird Rd, Miami, FL 33175 USA.	Adel.Elkbuli@hcahealthcare.com	Elkbuli, Adel/AAK-7374-2021	Elkbuli, Adel/0000-0001-7730-617X			Berndtson AE, 2016, J TRAUMA ACUTE CARE, V81, P493, DOI 10.1097/TA.0000000000001157; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brain Trauma Foundation, 2016, GUID MAN SEV TRAUM B; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Centers for Disease Control and Prevention, 2019, SURV TBI REL EM DEP; Coleman JR, 2019, J AM COLL SURGEONS, V228, P760, DOI 10.1016/j.jamcollsurg.2019.01.009; Croce MA, 2002, J TRAUMA, V53, P889, DOI 10.1097/00005373-200211000-00013; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Einarsen CE, 2018, WORLD NEUROSURG, V114, pE1199, DOI 10.1016/j.wneu.2018.03.176; Engler-Chiurazzi EB, 2017, PROG NEUROBIOL, V157, P188, DOI 10.1016/j.pneurobio.2015.12.008; Forbes EE, 2010, BRAIN COGNITION, V72, P66, DOI 10.1016/j.bandc.2009.10.007; George RL, 2003, SHOCK, V19, P28, DOI 10.1097/00024382-200301000-00006; Kluen LM, 2017, PSYCHONEUROENDOCRINO, V84, P181, DOI 10.1016/j.psyneuen.2017.07.240; Liu T, 2015, AM J SURG, V210, P911, DOI 10.1016/j.amjsurg.2015.03.021; Marcolini Evie G, 2019, Anesthesiol Clin, V37, P107, DOI 10.1016/j.anclin.2018.09.007; Napolitano LM, 2001, J TRAUMA, V50, P274, DOI 10.1097/00005373-200102000-00013; Oppelt K, 2018, BRAIN INJURY, V32, P1500, DOI 10.1080/02699052.2018.1499963; Peters Matthew E, 2018, Concussion, V3, pCNC56, DOI 10.2217/cnc-2018-0001; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Sharpe JP, 2014, J TRAUMA ACUTE CARE, V77, P161, DOI 10.1097/TA.0000000000000251; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; The Committee on Trauma American College of Surgeons, 2018, ADV TRAUM LIF SUPP; Weniger M, 2016, SHOCK, V46, P4, DOI 10.1097/SHK.0000000000000670	23	2	2	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	MAY	2020	44	5					1492	1497		10.1007/s00268-020-05381-w			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	KY8OY	WOS:000522837000019	31965278				2022-02-06	
J	Fan, MC; Li, SF; Sun, P; Bai, GT; Wang, N; Han, C; Sun, J; Li, Y; Li, HT				Fan, Ming-chao; Li, Shi-fang; Sun, Peng; Bai, Guang-tao; Wang, Nian; Han, Chao; Sun, Jian; Li, Yang; Li, Huan-ting			Early Intensive Rehabilitation for Patients with Traumatic Brain Injury: A Prospective Pilot Trial	WORLD NEUROSURGERY			English	Article						Barthel Index; Fugl-Meyer Assessment; Glasgow Outcome Scale; Rehabilitation management; Traumatic brain injury	EARLY-ONSET; RECOVERY; STIMULATION; IMPROVE; STROKE	OBJECTIVE: To investigate the effects of early intensive rehabilitation management on the recovery of motor function and activities of daily living in patients with moderate traumatic brain injury. METHODS: Eighty-seven patients (age range, 18-65 years) with traumatic brain injury that met the enrollment criteria were randomly divided into 2 groups. Group 1 received early and high-intensity rehabilitation management (from 7 days after injury, 7 d/wk, 4 times/d, 1 h/session) for 4 weeks; group 2 received ordinary rehabilitation (from 14 days after injury, 5 d/wk, 2 times/d, 1 h/session) for 4 weeks. The Fugl-Meyer Assessment (FMA, motor function) and Barthel Index (BI) were used to assess the daily living functional state before treatment, 3 months after injury, and 6 months after injury. The Glasgow Coma Scale (GCS) was used to assess outcomes 6 months after injury. RESULTS: Three months after rehabilitation, the FMA (motor function) score was significantly higher in the early intensive intervention group versus the control group (59.83 +/- 11.87 vs. 44.56 +/- 8.32, respectively; P < 0.05); no significant between-group differences were found in the GCS score or BI score (P> 0.05). Six months after rehabilitation, the FMA score and BI score were significantly higher in the early intensive intervention group versus the control group (FMA: 73.18 +/- 16.55 vs. 57.86 +/- 10.67, P < 0.01; BI: 87.17 +/- 13.85 vs. 60.68 +/- 11.98, P < 0.01, respectively). The GCS score was higher in the early intensive intervention group versus the control group (4.24 +/- 0.91 vs. 3.43 +/- 0.88, P < 0.05, respectively) 6 months after injury. CONCLUSIONS: Early intensive rehabilitation management might be more beneficial for neurologic function and activities of daily living in patients with moderate traumatic brain injury.	[Fan, Ming-chao; Li, Shi-fang; Sun, Peng; Li, Huan-ting] Qingdao Univ, Affiliated Hosp, Dept Neurosurg, Qingdao, Peoples R China; [Fan, Ming-chao; Wang, Nian; Sun, Jian; Li, Yang] Qingdao Univ, Affiliated Hosp, Neurosurg Intens Care Unit, Qingdao, Peoples R China; [Bai, Guang-tao; Han, Chao] Qingdao Univ, Affiliated Hosp, Dept Rehabil Med, Qingdao, Peoples R China		Li, HT (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Neurosurg, Qingdao, Peoples R China.	fanmcqd@163.com	Li, Shi-fang/AAX-1508-2021	Li, Shi-fang/0000-0002-2602-7506; Fan, Ming-chao/0000-0003-2946-5816			Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Bartolo M, 2016, EUR J PHYS REHAB MED, V52, P90; Elliott L, 2005, NEUROPSYCHOL REHABIL, V15, P480, DOI 10.1080/09602010443000506; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gruner ML, 2000, BRAIN INJURY, V14, P585; Han C, 2013, CLIN REHABIL, V27, P75, DOI 10.1177/0269215512447223; Kreitzer N, 2019, J HEAD TRAUMA REHAB, V34, pE66, DOI 10.1097/HTR.0000000000000477; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Mattson MP, 2000, CELL TISSUE RES, V301, P173, DOI 10.1007/s004419900154; Self M, 2013, ADAPT PHYS ACT Q, V30, P20, DOI 10.1123/apaq.30.1.20; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Solvsten CAE, 2017, J MOL NEUROSCI, V62, P142, DOI 10.1007/s12031-017-0918-9; Steiner Emanuel, 2016, J Trauma Manag Outcomes, V10, P5, DOI 10.1186/s13032-016-0035-8; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Traversa R, 1997, STROKE, V28, P110, DOI 10.1161/01.STR.28.1.110; von Wild KRH, 2006, ACTA NEUROCHIR SUPPL, V99, P3; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	21	2	2	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2020	137						E183	E188		10.1016/j.wneu.2020.01.113			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LN1TU	WOS:000532728700004	32001397				2022-02-06	
J	Frank, D; Melamed, I; Gruenbaum, BF; Grinshpun, J; Kuts, R; Shvartsur, R; Azab, AN; Assadi, MH; Vinokur, M; Boyko, M				Frank, Dmitry; Melamed, Igor; Gruenbaum, Benjamin F.; Grinshpun, Julia; Kuts, Ruslan; Shvartsur, Rachel; Azab, Abed N.; Assadi, Mohamad H.; Vinokur, Max; Boyko, Matthew			Induction of Diffuse Axonal Brain Injury in Rats Based on Rotational Acceleration	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 159; Diffuse axonal injury (DAI); traumatic brain injury (TBI); rotational acceleration; rat model; white matter; stretch injury	CONTROLLED CORTICAL IMPACT; LATERAL HEAD ROTATION; BETA-APP; MODELS; MARKER; DAMAGE	Traumatic brain injury (TBI) is a major cause of death and disability. Diffuse axonal injury (DAI) is the predominant mechanism of injury in a large percentage of TBI patients requiring hospitalization. DAI involves widespread axonal damage from shaking, rotation or blast injury, leading to rapid axonal stretch injury and secondary axonal changes that are associated with a long-lasting impact on functional recovery. Historically, experimental models of DAI without focal injury have been difficult to design. Here we validate a simple, reproducible and reliable rodent model of DAI that causes widespread white matter damage without skull fractures or contusions.	[Frank, Dmitry; Grinshpun, Julia; Kuts, Ruslan; Vinokur, Max; Boyko, Matthew] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Div Anesthesia & Crit Care, Beer Sheva, Israel; [Frank, Dmitry; Melamed, Igor; Grinshpun, Julia; Kuts, Ruslan; Vinokur, Max; Boyko, Matthew] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Melamed, Igor] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Neurosurg, Beer Sheva, Israel; [Gruenbaum, Benjamin F.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06520 USA; [Shvartsur, Rachel; Azab, Abed N.] Ben Gurion Univ Negev, Fac Hlth Sci, Recanati Sch Community Hlth Profess, Beer Sheva, Israel; [Assadi, Mohamad H.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, Beer Sheva, Israel		Boyko, M (corresponding author), Ben Gurion Univ Negev, Soroka Univ Med Ctr, Div Anesthesia & Crit Care, Beer Sheva, Israel.; Boyko, M (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel.	matthewboykoresearch@gmail.com	Boyko, Matthew/AAC-7341-2021	Boyko, Matthew/0000-0003-3116-1643; Shvartsur, Rachel/0000-0003-0049-9633	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM086287] Funding Source: Medline		ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Boyko M, 2019, BIOL PROCED ONLINE, V21, DOI 10.1186/s12575-019-0097-x; Boyko M, 2013, BRAIN RES, V1491, P109, DOI 10.1016/j.brainres.2012.10.061; Bullock Ross, 1993, Journal of Emergency Medicine, V11, P23; Faul M, 2010, TRAUMATIC BRAIN INJU; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; He XS, 2010, ACTA NEUROL BELG, V110, P49; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Marehbian J, 2017, NEUROCRIT CARE, V27, P430, DOI 10.1007/s12028-017-0408-5; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Nyanzu M, 2017, INT J MED SCI, V14, P494, DOI 10.7150/ijms.18075; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Peterson AB, 2019, SURVEILLANCE REPORT; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Reichard RR, 2003, J NEUROTRAUM, V20, P347, DOI 10.1089/089771503765172309; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Slazinski T, 1994, J Neurosci Nurs, V26, P151; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Su E, 2015, FRONT NEUROSCI, V57, P41; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wilkinson AE, 1999, ACTA NEUROPATHOL, V98, P197, DOI 10.1007/s004010051069; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zlotnik A, 2012, J NEUROSURG ANESTH, V24, P30, DOI 10.1097/ANA.0b013e318232deaa	40	2	2	2	5	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	MAY	2020		159							e61198	10.3791/61198			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MH0FM	WOS:000546406600161	32449735	Green Accepted			2022-02-06	
J	Honore, T; Salga, M; Grelier, A; Denormandie, P; Genet, G; Labib, A; Bonan, I; Genet, F				Honore, Thibaud; Salga, Marjorie; Grelier, Amandine; Denormandie, Philippe; Genet, Guillaume; Labib, Alain; Bonan, Isabelle; Genet, Francois			EFFECTIVENESS OF RADIOTHERAPY TO PREVENT RECURRENCE OF HETEROTOPIC OSSIFICATION IN PATIENTS WITH SPINAL CORD INJURY AND TRAUMATIC HEAD INJURY: A RETROSPECTIVE CASE-CONTROLLED STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						heterotopic ossification; radiotherapy; recurrence; spinal cord injury; traumatic brain injury; excision	RADIATION-THERAPY; BRAIN-INJURY; BONE; HIP; PROPHYLAXIS; RESECTION; RISK; EXCISION	Objective: To evaluate recurrence and early postoperative complications (sepsis) following surgical excision combined with radiotherapy for troublesome hip heterotopic ossification in patients with spinal cord injury and traumatic brain injury. Design: Retrospective case-control study. Setting: Data relating to patients with spinal cord injury or traumatic brain injury who underwent surgical excision of hip heterotopic ossification were retrieved from the BANKHO database. Case patients underwent excision + radiotherapy, and controls underwent excision only. Control patients were matched to case patients according to sex and age (+/- 4 years). Participants: Data from 19 case patients and 76 controls were analysed. @ Main outcome measure: The primary end-point was recurrence of heterotopic ossification. Secondary end-points were postoperative complications and, more specifically, sepsis that required surgical revision. Results: There was no difference between the odds ratios (OR) for recurrence for each group (OR case group = 0.63, OR spinal cord injury subgroup = 0.45 and OR head injury subgroup = 1.04). The rate of sepsis requiring surgical revision was significantly higher in the case group (p < 0.05). Conclusion: Based on the results of this case-control study, we suggest that radiotherapy should not be combined with surgery in patients with troublesome hip heterotopic ossification undergoing excision. Radiotherapy does not appear to prevent recurrence and, moreover, it is associated with an increased risk of postoperative sepsis.	[Honore, Thibaud; Salga, Marjorie; Grelier, Amandine; Genet, Guillaume; Genet, Francois] Univ Versailles St Quentin En Yvelines, INSERM, U1179, Montigny Le Bretonneux, France; [Denormandie, Philippe] Hop Raymond Poincare, Orthoped Surg Dept, Garches, France; [Labib, Alain] Rene Huguenin Hosp, Radiotherapy Dept, St Cloud, France; [Bonan, Isabelle] Univ Rennes 1, Pontchaillou Hosp, U1228, Dept Phys & Rehabil Med, Rennes, France		Honore, T (corresponding author), Univ Versailles St Quentin En Yvelines, INSERM, U1179, UFR Sci Sante Simone Veil, F-78170 Montigny Le Bretonneux, France.	docteurhonore.thibaud@gmail.fr					Almangour W, 2016, ANN PHYS REHABIL MED, V59, P263, DOI 10.1016/j.rehab.2016.03.009; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; Banovac K, 2004, SPINAL CORD, V42, P707, DOI 10.1038/sj.sc.3101628; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; BRESLOW N, 1982, ANNU REV PUBL HEALTH, V3, P29, DOI 10.1146/annurev.pu.03.050182.000333; Burd TA, 2003, J BONE JOINT SURG BR, V85B, P700, DOI 10.1302/0301-620X.85B5.13970; Cadieux CL, 2016, MED DOSIM, V41, P212, DOI 10.1016/j.meddos.2016.02.001; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Cipriano C, 2009, ORTHOPEDICS, V32; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Gacon G, 1977, REV CHIR ORTHOP REPA, V64, P375; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Gatin L, 2017, ORTHOP TRAUMATOL-SUR, V103, P357, DOI 10.1016/j.otsr.2017.02.001; Genet F, 2015, SPINAL CORD, V53, P340, DOI 10.1038/sc.2015.20; Genet F, 2009, J BONE JOINT SURG BR, V91B, P1493, DOI 10.1302/0301-620X.91B11.22305; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023129; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Jang SH, 2000, YONSEI MED J, V41, P536, DOI 10.3349/ymj.2000.41.4.536; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; KIM JH, 1978, RADIOLOGY, V129, P501, DOI 10.1148/129.2.501; Koelbl O, 2003, STRAHLENTHER ONKOL, V179, P767, DOI 10.1007/s00066-003-1088-y; Krauss H, 2015, SPINAL CORD, V53, P345, DOI 10.1038/sc.2014.186; Lee CH, 2016, ANN REHABIL MED-ARM, V40, P1135, DOI 10.5535/arm.2016.40.6.1135; Meiners T, 1997, SPINAL CORD, V35, P443, DOI 10.1038/sj.sc.3100415; Milakovic M, 2015, RADIOTHER ONCOL, V116, P4, DOI 10.1016/j.radonc.2015.05.022; Mourad WF, 2012, PRACT RADIAT ONCOL, V2, pE1, DOI [10.1016/j.prro.2011.11.003, 10.1016/j.prro.2011.06.005]; Museler AC, 2017, SPINAL CORD, V55, P244, DOI 10.1038/sc.2016.112; Oertel S, 2008, STRAHLENTHER ONKOL, V184, P212, DOI 10.1007/s00066-008-1757-y; Roos DE, 2015, RADIOTHER ONCOL, V116, P1, DOI 10.1016/j.radonc.2015.07.005; Sautter-Bihl ML, 2001, STRAHLENTHER ONKOL, V177, P200, DOI 10.1007/PL00002399; Sautter-Bihl ML, 2000, SPINAL CORD, V38, P33, DOI 10.1038/sj.sc.3100847; SCHAEFFER MA, 1995, ARCH PHYS MED REHAB, V76, P284, DOI 10.1016/S0003-9993(95)80617-2; Seegenschmiedt MH, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150080; SEEGENSCHMIEDT MH, 1994, INT J RADIAT ONCOL, V30, P63; Seegenschmiedt MH, 1997, INT J RADIAT ONCOL, V39, P161, DOI 10.1016/S0360-3016(97)00285-X; STOVER SL, 1976, J BONE JOINT SURG AM, V58, P683, DOI 10.2106/00004623-197658050-00019; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628	42	2	2	0	0	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2020	52	5							UNSP jrm00066	10.2340/16501977-2692			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	LY9PC	WOS:000540859000011	32421202	Green Published, gold			2022-02-06	
J	Iverson, GL; Karr, JE; Terry, DP; Garcia-Barrera, MA; Holdnack, JA; Ivins, BJ; Silverberg, ND				Iverson, Grant L.; Karr, Justin E.; Terry, Douglas P.; Garcia-Barrera, Mauricio A.; Holdnack, James A.; Ivins, Brian J.; Silverberg, Noah D.			Developing an Executive Functioning Composite Score for Research and Clinical Trials	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Executive functions; Assessment; Norms/normative studies	TRAUMATIC BRAIN-INJURY; MULTIVARIATE BASE RATES; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; NEUROPSYCHOLOGICAL IMPAIRMENT; FRONTOTEMPORAL DEMENTIA; MEMORY SCORES; FRONTAL LOBES; DOUBLE-BLIND; EFFICACY	Objective: Executive functioning encompasses interactive cognitive processes such as planning, organization, set-shifting, inhibition, self-monitoring, working memory, and initiating and sustaining motor and mental activity. Researchers therefore typically assess executive functioning with multiple tests, each yielding multiple scores. A single composite score of executive functioning, which summarizes deficits across a battery of tests, would be useful in research and clinical trials. This study examines multiple candidate composite scores of executive functioning using tests from the Delis-Kaplan Executive Function System (D-KEFS). Method: Participants were 875 adults between the ages of 20 and 89 years from the D-KEFS standardization sample. Seven Total Achievement scores were used from three tests (i.e., Trail Making, Verbal Fluency, and Color-Word Interference) to form eight composite scores that were compared based on their psychometric properties and association with intelligence (IQ). Results: The distributions of most composite scores were mildly to severely skewed, and some had a pronounced ceiling effect. The composite scores all showed a medium positive correlation with IQ. The composite scores were highly intercorrelated in the total sample and in four IQ subgroups (i.e., IQ <89, 90-99, 100-109, 110+), with some being so highly correlated that they appear redundant. Conclusions: This study is part of a larger research program developing a cognition endpoint for research and clinical trials with sound psychometric properties and utility across discrepant test batteries. Future research is needed to examine the reliability and ecological validity of these composite scores.	[Iverson, Grant L.; Karr, Justin E.; Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Spaulding Res Inst, Boston, MA 02129 USA; [Iverson, Grant L.; Karr, Justin E.; Terry, Douglas P.] A Red Sox Fdn, Home Base, Boston, MA 02129 USA; [Iverson, Grant L.; Karr, Justin E.; Terry, Douglas P.] Massachusetts Gen Hosp Program, Boston, MA 02129 USA; [Garcia-Barrera, Mauricio A.] Univ Victoria, Dept Psychol, Victoria, BC V8W 2Y2, Canada; [Ivins, Brian J.] Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC V5Z 2G9, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Rehabil Res Program, Vancouver, BC V5Z 2G9, Canada		Iverson, GL (corresponding author), Harvard Med Sch, Ctr Hlth & Rehabil, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu	Garcia-Barrera, Mauricio A./AAO-9757-2021	Garcia-Barrera, Mauricio A./0000-0002-4302-4964	TBI Endpoints Development Initiative [W81XWH-14-2-0176]	This work was funded as part of the TBI Endpoints Development Initiative with a grant entitled Development and Validation of a Cognition Endpoint for Traumatic Brain Injury Clinical Trials (subaward from W81XWH-14-2-0176).	Almenieir N, 2017, J NUCL MED TECHNOL, V45, P247, DOI 10.2967/jnmt.116.182212; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; [Anonymous], 1999, WECHSLER ABBREVIATED; Antony JM, 2017, TRANSL NEUROSCI, V8, P87, DOI 10.1515/tnsci-2017-0014; Ardila A, 2018, ARCH CLIN NEUROPSYCH, V33, P379, DOI 10.1093/arclin/acx066; Aron AR, 2008, CURR DIR PSYCHOL SCI, V17, P124, DOI 10.1111/j.1467-8721.2008.00561.x; Baron IS, 2004, CHILD NEUROPSYCHOL, V10, P147, DOI 10.1080/09297040490911140; Biederman J, 2011, EUR NEUROPSYCHOPHARM, V21, P508, DOI 10.1016/j.euroneuro.2010.11.005; Binder JC, 2016, PSYCHOL AGING, V31, P390, DOI 10.1037/pag0000081; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Brooks BL, 2008, J INT NEUROPSYCH SOC, V14, P463, DOI 10.1017/S1355617708080521; Brooks BL, 2007, J INT NEUROPSYCH SOC, V13, P490, DOI 10.1017/D1355617707070531; Brooks BL, 2013, PRACT RESOUR MENT, P75, DOI 10.1016/B978-0-12-386934-0.00002-X; Brooks BL, 2009, DEMENT GERIATR COGN, V27, P439, DOI 10.1159/000215390; Burnham SC, 2015, J ALZHEIMERS DIS, V46, P1079, DOI 10.3233/JAD-143015; Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034; Butowski N, 2012, CURR OPIN NEUROL, V25, P780, DOI 10.1097/WCO.0b013e328359b45e; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Collette F, 2005, HUM BRAIN MAPP, V25, P409, DOI 10.1002/hbm.20118; Cook NE, 2019, CHILD NEUROPSYCHOL, V25, P836, DOI 10.1080/09297049.2018.1543389; Crawford JR, 2011, PSYCHOL ASSESSMENT, V23, P888, DOI 10.1037/a0023712; Cysique L. A., 2015, BMCNEUROLOGY, V15, P1; DAWES RM, 1979, AM PSYCHOL, V34, P571, DOI 10.1037/0003-066X.34.7.571; Decloedt EH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005401; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delucchi KL, 2004, AM J PSYCHIAT, V161, P1159, DOI 10.1176/appi.ajp.161.7.1159; Dickinson T, 2017, J AFFECT DISORDERS, V218, P407, DOI 10.1016/j.jad.2017.04.010; Donohue Michael C, 2017, Alzheimers Dement (N Y), V3, P123, DOI 10.1016/j.trci.2016.12.001; Duggan E. C., 2015, HDB INTELLIGENCE EVO, P435, DOI DOI 10.1007/978-1-4939-1562-0_27; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Han SD, 2017, NEUROPSYCHOL REV, V27, P305, DOI 10.1007/s11065-017-9345-5; Harvey PD, 2003, INT J GERIATR PSYCH, V18, P820, DOI 10.1002/gps.929; Hill B. D., 2012, HORIZONS NEUROSCIENC, V7, P159; Hill BD, 2013, ARCH CLIN NEUROPSYCH, V28, P640, DOI 10.1093/arclin/act045; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Iverson GL, 2020, ARCH CLIN NEUROPSYCH, V35, P56, DOI 10.1093/arclin/acz021; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Karr JE, 2019, ARCH CLIN NEUROPSYCH, V34, P381, DOI 10.1093/arclin/acy043; Karr JE, 2018, PSYCHOL BULL, V144, P1147, DOI 10.1037/bul0000160; Karr JE, 2018, CLIN NEUROPSYCHOL, V32, P42, DOI 10.1080/13854046.2017.1334828; Karr JE, 2017, ARCH CLIN NEUROPSYCH, V32, P297, DOI 10.1093/arclin/acw105; KENDLER KS, 1994, ARCH GEN PSYCHIAT, V51, P456; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Langbaum JB, 2014, ALZHEIMERS DEMENT, V10, P666, DOI 10.1016/j.jalz.2014.02.002; Latzman RD, 2010, ASSESSMENT, V17, P172, DOI 10.1177/1073191109356254; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Mahableshwarkar AR, 2015, NEUROPSYCHOPHARMACOL, V40, P2025, DOI 10.1038/npp.2015.52; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McIntyre RS, 2017, J CLIN PSYCHIAT, V78, P115, DOI 10.4088/JCP.16m10744; McIntyre RS, 2014, INT J NEUROPSYCHOPH, V17, P1557, DOI 10.1017/S1461145714000546; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; O'Hearn K, 2008, DEV PSYCHOPATHOL, V20, P1103, DOI 10.1017/S0954579408000527; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Poulin V, 2012, TOP STROKE REHABIL, V19, P158, DOI 10.1310/tsr1902-158; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Robertson KR, 2016, AIDS, V30, P2315, DOI 10.1097/QAD.0000000000001189; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Rostamian S, 2015, NEUROLOGY, V85, P783, DOI 10.1212/WNL.0000000000001895; Shunk AW., 2006, APPL NEUROPSYCHOLOGY, V13, P275, DOI [DOI 10.1207/S15324826AN1304_9, DOI 10.1207/S15324826AN1304_]; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Susanto TAK, 2015, J ALZHEIMERS DIS, V45, P253, DOI 10.3233/JAD-142451; Swanson J, 2005, CAN J SCH PSYCHOL, V20, P117, DOI 10.1177/0829573506295469; Vandemeulebroecke M, 2017, CPT-PHARMACOMET SYST, V6, P635, DOI 10.1002/psp4.12219; Vardy JL, 2015, J CLIN ONCOL, V33, P4085, DOI 10.1200/JCO.2015.63.0905; Vellas B, 2015, J Prev Alzheimers Dis, V2, P128; Zinn S, 2007, ARCH PHYS MED REHAB, V88, P173, DOI 10.1016/j.apmr.2006.11.015	78	2	2	1	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2020	35	3			SI		312	325		10.1093/arclin/acz070			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN7WL	WOS:000568997800009	31965141	Bronze			2022-02-06	
J	Jeffries, KK; Girouard, TJ; Tandy, RD; Radzak, KN				Jeffries, Kori K.; Girouard, Tedd J.; Tandy, Richard D.; Radzak, Kara N.			Concussion-Prevention Strategies Used in National Collegiate Athletic Association Divisions I and II Women's Soccer	JOURNAL OF ATHLETIC TRAINING			English	Article						headgear; mouthguards; cervical strengthening; mild traumatic brain injury; athletic trainers	STATES HIGH-SCHOOL; NECK STRENGTH; HEAD ACCELERATION; MUSCLE STRENGTH; SEX-DIFFERENCES; IMPACT; SPORTS; RISK; INTERVENTIONS; MOUTHGUARDS	Context: Whereas much attention has been paid to identifying mechanisms for decreasing concussion rates in women's soccer players, which strategies are currently being used is unknown. In addition, athletic trainers' (ATs') knowledge and beliefs about the efficacy of concussion-prevention practices have not been studied. Objectives: To evaluate the concussion-prevention strategies being used in National Collegiate Athletic Association Division I and Division II women's soccer and identify the beliefs of certified ATs regarding mechanisms for preventing concussion. Design: Cross-sectional study. Setting: Online survey. Patients or other participants: A total of 223 women's soccer team ATs employed at Division I or II universities. Main outcome measure(s): A survey instrument of structured questions and open-ended, follow-up questions was developed to identify the use of cervical-strengthening programs, headgear, and other techniques for preventing concussion. Questions also addressed ATs' beliefs regarding the effectiveness of cervical strengthening, headgear, and mouthguards in concussion prevention. Data were collected via questionnaire in Qualtrics survey software. Descriptive statistics of frequencies and percentages were calculated for close-ended questions. Open-ended questions were evaluated for common themes, which were then reported by response frequency. Results: Cervical strengthening or stability for concussion prevention was reported by 38 (17.12%) respondents; 153 (69.86%) ATs believed that cervical strengthening would aid in concussion prevention. Seventy-eight (35.49%) reported that their players wore headgear. Nineteen (8.76%) believed that soccer headgear prevented concussions; 45 (20.74%) believed that mouthguards prevented concussions. Education in proper soccer technique was reported by 151 (69.59%) respondents. Fourteen (0.06%) respondents cited nutritional strategies for concussion prevention. Conclusions: Although ATs believed that cervical strengthening could help prevent concussions, few had implemented this strategy. However, the ATs whose teams used headgear outnumbered those who believed that headgear was an effective prevention strategy. Based on our findings, we saw a disconnect among the current use of concussion-prevention strategies, ATs' beliefs, and the available evidence.	[Jeffries, Kori K.; Girouard, Tedd J.; Tandy, Richard D.; Radzak, Kara N.] Univ Nevada, 4505 South Maryland Pkwy, Las Vegas, NV 89154 USA; [Jeffries, Kori K.] Orthoped & Sports Med Inst Las Vegas, Las Vegas, NV USA		Radzak, KN (corresponding author), Univ Nevada, 4505 South Maryland Pkwy, Las Vegas, NV 89154 USA.	Kara.radzak@unlv.edu		Girouard, Tedd/0000-0003-3996-5291			Balas E A, 2000, Yearb Med Inform, P65; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eckner JT, 2018, AM J PHYS MED REHAB, V97, P292, DOI 10.1097/PHM.0000000000000843; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gultekin R, 2016, INJURY, V47, P516, DOI 10.1016/j.injury.2015.10.011; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Kelly G S, 1998, Altern Med Rev, V3, P114; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Leppanen M, 2014, SPORTS MED, V44, P473, DOI 10.1007/s40279-013-0136-8; Lloyd JD, 2017, DENT TRAUMATOL, V33, P421, DOI 10.1111/edt.12375; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; McGuine T, 2020, BRIT J SPORT MED, V54, P408, DOI 10.1136/bjsports-2018-100238; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Ruxton CHS, 2004, J HUM NUTR DIET, V17, P449, DOI [10.1111/j.1365-277X.2004.00552.x, 10.1111/j.1365-277X.2007.00770.x]; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Waltzman D, 2019, J SAFETY RES, V68, P157, DOI 10.1016/j.jsr.2018.11.005	32	2	2	1	7	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY	2020	55	5					469	474		10.4085/1062-6050-142-19			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NK4YN	WOS:000566738600004	32216659	Green Published, gold			2022-02-06	
J	Jiang, HT; Hao, GS; Zhang, R; Pang, Q				Jiang, Haitao; Hao, Guangshan; Zhang, Rui; Pang, Qi			Determinants affecting the prognosis of decompressive craniectomy for traumatic brain injury	PAKISTAN JOURNAL OF MEDICAL SCIENCES			English	Article						Decompressive craniectomy; Traumatic brain injury; Age; D-dimer; Hypernatremia; Post-traumatic hydrocephalus	MORTALITY; HYPERNATREMIA; PREDICT	Objective: This research was designed to investigate the prognostic determinants of patients with traumatic brain injury (TBI) undergoing decompressive craniectomy (DC). Methods: The present study was a retrospective single center research including a total of 112 patients undergoing DC for TBI in Liaocheng People's Hospital between January 2017 and December 2018. The results were measured by Extended Glasgow Outcome Sale (GOSE). The prognostic determinants were identified by univariate and binary logistic regression analysis between the deaths and survivors or favorable and unfavorable outcomes. Results: At the six-month follow-up, the mortality was 45.5% including 37 (33.0%) patients died within 30 days. The independent prognostic factors of 30-day mortality were age (p=0.033), D-dimer level at admission (p=0.032) and postoperative hypernatremia (p=0.014). Seventy five patients survived more than 30 days after DC, among which 27 (36.0%) patients had unfavorable prognosis (GOSE 1-4) and 48 (64.0%) patients presented favorable prognosis (GOSE 5-8). After 30 days from DC, the occurrence of post-traumatic hydrocephalus(PTH) (p= 0.008) was associated with unfavorable prognosis. Conclusions: Although DC is an effective treatment for TBI patients, the mortality and morbidity risk remain high. A combination of age, D-dimer level at admission and postoperative hypernatremia may be a good prognostic factor for 30-day mortality. Developing an accurate therapy strategy to prevent and control PTH may be beneficial to the 6-month prognosis for TBI patients undergoing DC.	[Jiang, Haitao; Zhang, Rui; Pang, Qi] Shandong Univ, Shandong Prov Hosp, Dept Neurosurg, 324 Jingwuweiqi Rd, Jinan 250012, Peoples R China; [Jiang, Haitao; Hao, Guangshan] Liaocheng Peoples Hosp, Dept Neurosurg, 67 Dongchangxi Rd, Liaocheng 252000, Shandong, Peoples R China		Pang, Q (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Neurosurg, 324 Jingwuweiqi Rd, Jinan 250012, Peoples R China.	qi_pang@sina.cn		Pang, Qi/0000-0001-8333-5647			Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Hayakawa M, 2016, SHOCK, V45, P308, DOI 10.1097/SHK.0000000000000542; Honeybul S, 2017, J CLIN NEUROSCI, V43, P11, DOI 10.1016/j.jocn.2017.04.032; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Khalili Hosseinali, 2017, Bull Emerg Trauma, V5, P190; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Mollayeva T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018626; Moskowitz E, 2018, AM SURGEON, V84, P1314; Muzevic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010193.pub2; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Nasi D, 2018, WORLD NEUROSURG, V116, pE543, DOI 10.1016/j.wneu.2018.05.028; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Vedantam A, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17418; Yao S, 2017, WORLD NEUROSURG, V101, P528, DOI 10.1016/j.wneu.2017.02.072; Zhou JK, 2019, WORLD NEUROSURG, V123, pE141, DOI 10.1016/j.wneu.2018.11.095	22	2	2	1	1	PROFESSIONAL MEDICAL PUBLICATIONS	SADDAR	PANORAMA CENTRE, RM 522, 5TH FLOOR, BLDG 2, RAJA GHAZANFAR ALI RD, PO BOX 8766, SADDAR, KARACHI 00000, PAKISTAN	1682-024X			PAK J MED SCI	Pak. J. Med. Sci.	MAY-JUN	2020	36	4					770	775		10.12669/pjms.36.4.2045			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MW9OA	WOS:000557359300035	32494272	gold, Green Published			2022-02-06	
J	Kirkwood, MW; Crossland, MM; Howell, DR; Wilson, JC; Peterson, RL				Kirkwood, Michael W.; Crossland, Maria M.; Howell, David R.; Wilson, Julie C.; Peterson, Robin L.			A Longitudinal Investigation of Symptom Recovery following Concussion in Youth Soccer	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; POSTCONCUSSIVE SYMPTOMS; HIGH-SCHOOL; CHILDREN; AGREEMENT; PLAYERS; PARENTS	Objective To prospectively evaluate symptom outcomes after youth soccer-related concussion. Study design Using a prospective cohort design, we enrolled male and female competitive soccer players age 8-17 years into 3 groups: concussed (n = 23), matched control (n = 23), and orthopedic injury (n = 24). Postconcussive symptoms were monitored serially via both athlete and parent report at days 1-2, 4, 7, 10, 30, and 90. Results Repeated-measures analyses revealed a significant time by group interaction (F [12, 402] = 19.91, P<.001). In the initial days postinjury, the concussed group reported greater symptoms than the comparison groups, with more symptoms reported by athletes on average than parents. By 10 days, concussed athletes did not differ from the matched controls by either rater's report, but they did differ from the orthopedic injury group by parent report. At 30 days, no differences were apparent among groups. At 30 days, 100% of concussed youth and 91% of parents rated symptoms as back to preinjury levels using reliable change indices. At 30 days, 86% of athletes had been cleared to return to full game play. Conclusions The natural clinical history of concussion symptoms in youth competitive soccer players was similar to that seen in older athletes, with resolution in days to a few weeks. Additional study will be required to investigate which factors best predict symptom outcomes for individual athletes and how symptom report relates to performance-based outcome measures and underlying neurophysiologic recovery.	[Kirkwood, Michael W.; Peterson, Robin L.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.; Crossland, Maria M.; Peterson, Robin L.] Childrens Hosp Colorado, Dept Rehabil Med, Aurora, CO 80045 USA; [Howell, David R.; Wilson, Julie C.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Howell, David R.; Wilson, Julie C.] Childrens Hosp Colorado, Sports Med Ctr, Orthoped Inst, Aurora, CO 80045 USA; [Wilson, Julie C.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA		Kirkwood, MW (corresponding author), Childrens Hosp Colorado, Dept Rehabil Med, Concuss Program, B285,13123 E 16th Ave, Aurora, CO 80045 USA.	Michael.Kirkwood@childrenscolorado.org			Children's Hospital Colorado Department of Rehabilitation Medicine	Supported by funding from the Children's Hospital Colorado Department of Rehabilitation Medicine. The authors declare no conflicts of interest.	Asarnow RF, 1995, TRAUMATIC HEAD INJUR, pxv 299; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Moser RS, 2018, ARCH CLIN NEUROPSYCH, V33, P417, DOI 10.1093/arclin/acx070; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Rowhani-Rahbar A, 2016, J NEUROTRAUM, V33, P784, DOI 10.1089/neu.2015.4100; Smith NA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0346; Sports and Fitness Industry Association, 2018, 2018 SPORTS FITN LEI; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	36	2	2	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	MAY	2020	220						207	+		10.1016/j.jpeds.2020.01.068			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	LR9BV	WOS:000535991500039	32147217				2022-02-06	
J	Lepard, JR; Walters, BC				Lepard, Jacob R.; Walters, Beverly C.			A Bibliometric Analysis of Neurosurgical Practice Guidelines	NEUROSURGERY			English	Article; Proceedings Paper	34th Annual J. Garber Galbraith Scientific Session	OCT 06, 2017	Birmingham, AL			Neurosurgical guidelines; Bibliometrics; Dissemination; H-index; Citation metrics	TRAUMATIC BRAIN-INJURY; NORMAL-PRESSURE HYDROCEPHALUS; HIGHLY CITED PUBLICATIONS; SPINAL-CORD-INJURY; FUNCTIONAL NEUROSURGERY; NEUROLOGICAL SURGEONS; AMERICAN SOCIETY; MANAGEMENT; METHYLPREDNISOLONE; STIMULATION	BACKGROUND: In the last 20 yr, the rate of neurosurgical guideline publication has increased. However, despite the higher volume and increasing emphasis on quality there remains no reliable means of measuring the overall impact of clinical practice guidelines (CPGs). OBJECTIVE: To utilize citation analysis to evaluate the dispersion of neurosurgical CPGs. METHODS: A list of neurosurgical guidelines was compiled by performing electronic searches using the Scopus (Elsevier, Amsterdam, Netherlands) and National Guideline Clearinghouse databases. The Scopus database was queried to obtain current publication and citation data for all included documents and categorized based upon recognized neurosurgical specialties. The h-index, R-index, h(2)-index, i10-index, and dissemination index (D-Index) were manually calculated for each subspecialty. RESULTS: After applying screening criteria the search yielded 372 neurosurgical CPGs, which were included for bibliometric analysis. The overall calculated h-index for neurosurgery was 56. When broken down by subspecialty trauma/critical care had the highest value at 35, followed by spine and peripheral nerve at 30, cerebrovascular at 28, tumor at 16, pediatrics at 14, miscellaneous at 11, and functional/stereotactic/pain at 6. Cerebrovascular neurosurgery was noted to have the highest D-Index at 3.4. CONCLUSION: A comprehensive framework is useful for guideline impact analysis. Bibliometric data provides a novel and adequate means of evaluating the successful dissemination of neurosurgical guidelines. There remains a paucity of data regarding implementation and clinical outcomes of individual guidelines.	[Lepard, Jacob R.; Walters, Beverly C.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA		Lepard, JR (corresponding author), 510 20th St South,FOT 1008, Birmingham, AL 35233 USA.	Jlepard@uabmc.edu			University of Alabama at BirminghamWomen's Leadership Council	This study was completed while Jacob R. Lepard, MD was a Wilson Family Clinical Scholar supported by the University of Alabama at BirminghamWomen's Leadership Council. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS28; Alonso S, 2009, J INFORMETR, V3, P273, DOI 10.1016/j.joi.2009.04.001; [Anonymous], 1987, PEDIATRICS, V80, P298; [Anonymous], 2018, ADVOCACY NEWS GUIDEL; Baird RA, 2013, NEUROLOGY, V80, P1424, DOI 10.1212/WNL.0b013e31828c2f3e; Brolliar SM, 2016, J NEUROTRAUM, V33, P1554, DOI 10.1089/neu.2015.4183; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Ducis K, 2016, WORLD NEUROSURG, V90, P322, DOI 10.1016/j.wneu.2016.02.044; Freda PU, 2011, J CLIN ENDOCR METAB, V96, P894, DOI 10.1210/jc.2010-1048; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Groff MW, 2014, J NEUROSURG-SPINE, V21, P1, DOI 10.3171/2014.4.SPINE14190; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Hadley M, 2002, NEUROSURGERY, V50, pS58; HADLEY MN, 2002, NEUROSURGERY S, V50, pS6; Hamani C, 2014, NEUROSURGERY, V75, P327, DOI 10.1227/NEU.0000000000000499; Hinds Ii Sidney R, 2016, US Army Med Dep J, P97; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hurlbert RJ, 2008, CAN J NEUROL SCI, V35, P41, DOI 10.1017/S031716710000754X; Hurlbert RJ, 2002, CAN J NEUROL SCI, V29, P236, DOI 10.1017/S0317167100002006; Ishikawa M, 2008, NEUROL MED-CHIR, V48, pS1, DOI 10.2176/nmc.48.S1; Jin BH, 2007, CHINESE SCI BULL, V52, P855, DOI 10.1007/s11434-007-0145-9; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kesinger MR, 2014, INJURY, V45, P1350, DOI 10.1016/j.injury.2014.04.037; Khan Nickalus R, 2015, World Neurosurg, V83, P403, DOI 10.1016/j.wneu.2014.12.005; Khan NR, 2013, CHILD NERV SYST, V29, P2215, DOI 10.1007/s00381-013-2293-3; Khormi YH, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0140-1; Kosmulski M., 2006, ISSI NEWSLETTER, V2, P4; Lipsman N, 2012, STEREOT FUNCT NEUROS, V90, P201, DOI 10.1159/000337170; Mori E, 2012, NEUROL MED-CHIR, V52, P775, DOI 10.2176/nmc.52.775; Nuttin B, 2014, J NEUROL NEUROSUR PS, V85, P1003, DOI 10.1136/jnnp-2013-306580; Ponce FA, 2010, J NEUROSURG, V112, P223, DOI 10.3171/2009.12.JNS091599; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Sweet JA, 2015, NEUROSURGERY, V77, P332, DOI 10.1227/NEU.0000000000000872; Tarapore PE, 2016, J NEUROTRAUM, V33, P2026, DOI 10.1089/neu.2015.4114; Taylor DR, 2015, J NEUROSURG, V123, P547, DOI 10.3171/2014.10.JNS141025; Tsao MN, 2012, PRACT RADIAT ONCOL, V2, P210, DOI 10.1016/j.prro.2011.12.004; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f; Wilcox MA, 2013, CHILD NERV SYST, V29, P2201, DOI 10.1007/s00381-013-2228-z	46	2	2	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAY	2020	86	5					605	614		10.1093/neuros/nyz240			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	LU0BX	WOS:000537429900024	31264698				2022-02-06	
J	Nabasny, A; Myrga, JM; Juengst, SB				Nabasny, Andrew; Myrga, John M.; Juengst, Shannon B.			Neurobehavioral Symptoms by Gender and Experience of Nightmares After Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						brain injury; gender; nightmares; substance abuse; impulsivity	POSTTRAUMATIC-STRESS-DISORDER; SEX-DIFFERENCES; SLEEP; HEALTH; COMORBIDITY; PREVALENCE; OUTCOMES	Purpose/Objective: The purpose of this study is to assess how neurobehavioral symptoms following traumatic brain injury (TBI) may differ based on gender and the experience of nightmares. Research Method/Design: This cross-sectional study of community-dwelling adults >= 3 months post-TBI (n = 110) assessed differences in neurobehavioral symptoms between women (n = 41) and men (n = 69) by experience of nightmares. Outcome measures included the Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, and Behavioral Assessment Screening 'fool subscales for negative affect, substance abuse, executive functioning, fatigue, impulsivity, and maladaptive coping. Results: N = 22 participants (n = 7 women. n = 15 men) experienced nightmares at least "sometimes" over the past 2 weeks. Nightmares were associated with more substance abuse, negative affect, fatigue, maladaptive coping, depressive symptoms, and anxiety symptoms (ps < .02). Women reported more negative affect, maladaptive coping, depressive symptoms, and anxiety symptoms (ps < .05) than men. Men experiencing nightmares reported more substance use than men without nightmares (p = .036). a difference not seen in women (p = .233). Women experiencing nightmares reported more impulsivity than women without nightmares (p = .028), a difference not seen in men (p = .559). Conclusions/Implications: Nightmares, post-TBI, are associated with more neurobehavioral symptoms. However, symptom patterns associated with nightmares may differ by gender. Nightmares may be a symptom of, or contribute to. sleep disruptions post-TBI or may indicate other conditions, like posttraumatic stress disorder. Future research should examine gender differences in neurobehavioral symptoms post-TBI in the context of nightmares and/or sleep disorders.	[Nabasny, Andrew] Univ Texas Southwestern Med Ctr Dallas, Sch Hlth Profess, Dept Hlth Care Sci, Dallas, TX 75390 USA; [Nabasny, Andrew; Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Myrga, John M.] Univ Pittsburgh, Dept Urol, Sch Med, Pittsburgh, PA 15260 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Sch Hlth Profess, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Sch Hlth Profess, Dept Rehabil Counseling, Dallas, TX 75390 USA		Juengst, SB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	shannon.juengst@utsouthwestern.edu		Juengst, Shannon/0000-0003-4709-545X; Nabasny, Andrew/0000-0002-7368-8729	University of Pittsburgh Medical Center Rehabilitation Institute Pilot Program [01140]	This study was supported in part by grants from the University of Pittsburgh Medical Center Rehabilitation Institute Pilot Program (01140). This article represents a secondary analysis from a larger study ("Factor Structure of the Behavioral Assessment Screening Tool (BAST) in Traumatic Brain Injury"). The results of this analysis were reported as a poster at the 2018 American Congress for Rehabilitation Medicine Annual Conference in Dallas, Texas ("Gender Differences in Behavioral and Emotional Symptoms by Experience of Nightmares after Traumatic Brain Injury").	Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bishop TM, 2020, SLEEP MED, V66, P264, DOI 10.1016/j.sleep.2019.07.016; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Christiansen D.M., 2012, POSTTRAUMATIC STRESS, P113, DOI DOI 10.5772/28363; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fattore L, 2016, ADDICT BIOL, V21, P1043, DOI 10.1111/adb.12381; Gujar N, 2011, CEREB CORTEX, V21, P115, DOI 10.1093/cercor/bhq064; Husky MM, 2018, COMPR PSYCHIAT, V84, P75, DOI 10.1016/j.comppsych.2018.04.007; Jacobs E, 2011, J NEUROSCI, V31, P5286, DOI 10.1523/JNEUROSCI.6394-10.2011; Juengst SB, 2020, DISABIL REHABIL, V42, P255, DOI 10.1080/09638288.2018.1496487; Juengst SB, 2019, DISABIL REHABIL, V41, P1200, DOI 10.1080/09638288.2017.1423403; Juengst SB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01210; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Levin R, 2007, PSYCHOL BULL, V133, P482, DOI 10.1037/0033-2909.133.3.482; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Martinez-Martin P, 2012, J NEUROL, V259, P1639, DOI 10.1007/s00415-011-6392-3; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Nadorff MR, 2011, SLEEP, V34, P93, DOI 10.1093/sleep/34.1.93; Sandman N, 2015, SLEEP, V38, P507, DOI 10.5665/sleep.4560; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Segev S, 2018, J TRAUMA STRESS, V31, P64, DOI 10.1002/jts.22250; Simor P, 2012, EUR ARCH PSY CLIN N, V262, P687, DOI 10.1007/s00406-012-0318-7; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Weber M, 2013, J SLEEP DISORD THER, V2, P110, DOI DOI 10.4172/2167-0277.1000110; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	32	2	2	0	5	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2020	65	2					186	191		10.1037/rep0000320			6	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	LL4FM	WOS:000531511800009	32250133				2022-02-06	
J	Ozga-Hess, JE; Whirtley, C; O'Hearn, C; Pechacek, K; Vonder Haar, C				Ozga-Hess, Jenny E.; Whirtley, Cory; O'Hearn, Christopher; Pechacek, Kristen; Vonder Haar, Cole			Unilateral parietal brain injury increases risk-taking on a rat gambling task	EXPERIMENTAL NEUROLOGY			English	Article						Decision-making; Impulsivity; Executive function; Controlled cortical impact	DISADVANTAGEOUS DECISION-MAKING; CORTICAL IMPACT INJURY; PREFRONTAL CORTEX; DOPAMINE; IMPULSIVITY; DYSFUNCTION; DISEASE; DISCRIMINATION; SENSITIVITY; PERFORMANCE	Traumatic brain injury (TBI) affects millions of individuals every year. Many of these injuries lead to lasting effects, particularly impairments in domains broadly classified as executive functions, such as impulse control and decision-making. While these impairments have been historically associated with frontal brain damage, other injuries such as concussion or parietal injury also contribute to similar dysfunction. However, it is unknown whether animal models of TBI would replicate these broad effects that are observed in human patients. In the current study, we delivered a unilateral parietal controlled cortical impact injury and assessed the performance of rats on a motoric task (rotarod) and a test of decision-making and impulsivity (rodent gambling task). TBI rats demonstrated significant motor impairments on the rotarod task; however, this did not extend to difficulties inhibiting motor actions (impulsivity). In addition, TBI caused chronic alterations to risk-based decision-making, extending out to 12 weeks post-injury. Specifically, rats with TBI preferred the riskiest, and most suboptimal option over all others. The current data suggest that models of unilateral TBI are sufficient for replicating some aspects of executive dysfunction (risky decision-making), while others are limited to frontal damage (impulsivity). These models may be used to develop therapeutics targeted at the chronic post-injury period when these symptoms often manifest in patients, a critically understudied area in preclinical TBI research.	[Ozga-Hess, Jenny E.; Whirtley, Cory; O'Hearn, Christopher; Pechacek, Kristen; Vonder Haar, Cole] West Virginia Univ, Dept Psychol, Injury & Recovery Lab, Morgantown, WV 26505 USA; [Vonder Haar, Cole] West Virginia Univ, Dept Neurosci, Morgantown, WV 26505 USA		Vonder Haar, C (corresponding author), West Virginia Univ, Dept Psychol, POB 6040,53 Campus Dr, Morgantown, WV 26505 USA.	cole.vonderhaar@mail.wvu.edu		Vonder Haar, Cole/0000-0001-7949-2068; Toegel, Cory/0000-0002-9050-8398	National Institute of Health (NIGMS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20-GM109098]; National Institute of Health (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS110905]	We would like to thank the Injury and Recovery Laboratory members who contributed to the behavioral testing of animals in this project. This work was funded by the National Institutes of Health (NIGMS P20-GM109098; NINDS R01-NS110905).	Arulsamy A, 2019, BEHAV BRAIN RES, V368, P80, DOI 10.1016/j.bbr.2019.111912; Baarendse PJJ, 2013, PSYCHOPHARMACOLOGY, V225, P719, DOI 10.1007/s00213-012-2857-z; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barrus MM, 2015, J PSYCHIATR NEUROSCI, V40, P108, DOI 10.1503/jpn.140045; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Boyle PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067376; Brevers D, 2013, J GAMBL STUD, V29, P119, DOI 10.1007/s10899-012-9292-2; CARLI M, 1983, BEHAV BRAIN RES, V9, P361, DOI 10.1016/0166-4328(83)90138-9; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Cotrena C, 2014, BRAIN INJURY, V28, P1070, DOI 10.3109/02699052.2014.896943; Diaz-Arrastia R., 2014, TRAUMATIC BRAIN INJU, P183; Dixon MR, 2005, BEHAV INTERVENT, V20, P101, DOI 10.1002/bin.173; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Fellows LK, 2007, ANN NY ACAD SCI, V1121, P421, DOI 10.1196/annals.1401.023; Gansler DA, 2011, ARCH CLIN NEUROPSYCH, V26, P706, DOI 10.1093/arclin/acr082; Ghalaenovi H, 2018, BRAIN INJURY, V32, P1050, DOI 10.1080/02699052.2018.1476733; Haar CV, 2019, EXP NEUROL, V317, P87, DOI 10.1016/j.expneurol.2019.02.012; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Haar CV, 2012, RESTOR NEUROL NEUROS, V30, P291, DOI 10.3233/RNN-2012-110196; Hamilton KR, 2012, AM J DRUG ALCOHOL AB, V38, P30, DOI 10.3109/00952990.2011.643978; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hammond FM, 2018, J NEUROTRAUM, V35, P2298, DOI 10.1089/neu.2018.5767; Huang EYK, 2014, BEHAV BRAIN RES, V267, P156, DOI 10.1016/j.bbr.2014.03.033; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lan YL, 2019, AM J TRANSL RES, V11, P2616; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; MacPherson SE, 2009, CLIN NEUROPSYCHOL, V23, P510, DOI 10.1080/13854040802396586; Martens KM, 2019, J NEUROTRAUM, V36, P2827, DOI 10.1089/neu.2019.6470; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; Moor E, 2006, EXP GERONTOL, V41, P303, DOI 10.1016/j.exger.2005.12.006; Moreno-Lopez L, 2017, EUR NEUROPSYCHOPHARM, V27, P159, DOI 10.1016/j.euroneuro.2016.12.002; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Ozga JE, 2018, BEHAV PHARMACOL, V29, P617, DOI 10.1097/FBP.0000000000000430; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P166, DOI 10.1176/appi.neuropsych.22.2.166; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Schlund MW, 2000, BRAIN INJURY, V14, P573, DOI 10.1080/026990500120475; SEMCHUK KM, 1993, NEUROLOGY, V43, P1173, DOI 10.1212/WNL.43.6.1173; Sevy S, 2007, SCHIZOPHR RES, V92, P74, DOI 10.1016/j.schres.2007.01.005; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shaver TK, 2019, BRAIN RES, V1704, P103, DOI 10.1016/j.brainres.2018.10.004; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Vonder Haar C, 2014, J NEUROTRAUM, V31, P1711, DOI 10.1089/neu.2014.3459; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Xiao L, 2013, J CLIN EXP NEUROPSYC, V35, P518, DOI 10.1080/13803395.2013.789484; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Zeeb FD, 2009, NEUROPSYCHOPHARMACOL, V34, P2329, DOI 10.1038/npp.2009.62; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	61	2	2	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2020	327								113217	10.1016/j.expneurol.2020.113217			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KX8RA	WOS:000522140800008	32014440	Green Accepted			2022-02-06	
J	Petranovich, CL; Smith-Paine, J; Wade, SL; Yeates, KO; Taylor, HG; Stancin, T; Kurowski, BG				Petranovich, Christine L.; Smith-Paine, Julia; Wade, Shari L.; Yeates, Keith Owen; Taylor, H. Gerry; Stancin, Terry; Kurowski, Brad G.			From Early Childhood to Adolescence: Lessons About Traumatic Brain Injury From the Ohio Head Injury Outcomes Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						early childhood; longitudinal; long-term outcome; traumatic brain injury	CATECHOL-O-METHYLTRANSFERASE; LONG-TERM; YOUNG-CHILDREN; EXECUTIVE FUNCTION; FAMILY ENVIRONMENT; DIFFERENTIAL SUSCEPTIBILITY; ACADEMIC-ACHIEVEMENT; COGNITIVE FUNCTION; APOLIPOPROTEIN E4; BEHAVIOR PROBLEMS	Objective: The Ohio Head Injury Outcomes study was a 12-year longitudinal study of early childhood traumatic brain injury (TBI). This article reviewed the findings pertaining to caregiver and family functioning and child cognition, behavior, social competence, emotional functioning, and academics. We further considered individual and social-environmental influences on recovery and interventions. Setting: Recruitment was completed at 3 children's hospitals and 1 general hospital. Participants: Children aged 3 to 7 years at the time of injury with complicated mild to moderate and severe TBI or orthopedic injury requiring hospitalization were included. Design: A concurrent cohort/prospective research design was used. A baseline assessment was completed shortly after the injury. Follow-up assessments were completed at 6, 12, and 18 months and at an average of 38 and 82 months postinjury. Main Measures: At baseline, parents/guardians completed retrospective ratings of their child's behavioral, emotional, and social functioning preinjury. At the subsequent assessments, ratings reflected current functioning. Information about current family and caregiver functioning was collected at each time point and cognitive testing was completed at selected time points. Results and Conclusions: Recovery after TBI is complex, varies over time, and involves injury-related and premorbid influences, cognition, genetics, and caregiver and family functioning. A sizable number of children with TBI have persisting unmet clinical needs.	[Petranovich, Christine L.] Childrens Hosp Colorado, Dept Rehabil Med, 13123 East 16th Ave, Aurora, CO 80045 USA; [Petranovich, Christine L.] Univ Colorado Denver, Sch Med, Aurora, CO USA; [Smith-Paine, Julia] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Yeates, Keith Owen] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Taylor, H. Gerry] Ohio State Univ, Nationwide Childrens Hosp, Biobehav Hlth Ctr, Columbus, OH 43210 USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil, Cincinnati, OH USA		Petranovich, CL (corresponding author), Childrens Hosp Colorado, Dept Rehabil Med, 13123 East 16th Ave, Aurora, CO 80045 USA.	cpetranovich@gmail.com	Yeates, Keith/AAJ-4223-2020		NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729, K02 HD44099]; USPHS NIHUnited States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA [M01 RR 08084]; State of Ohio Emergency Medical Services; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077-04]; Rehabilitation Medicine Scientist Training Program (RMSTP) [K-12 HD001097-16]	The research reported here was supported by grant R01 HD42729 from NICHD, in part by USPHS NIH grant M01 RR 08084, and by Trauma Research grants from the State of Ohio Emergency Medical Services, all to Dr Wade. The project described was also supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through grant 8 UL1 TR000077-04. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr Yeates received support from career development grant K02 HD44099 from NICHD. Dr Kurowski was supported by the Rehabilitation Medicine Scientist Training Program (RMSTP) K-12 HD001097-16.	Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Aguilar JM, 2020, DISABIL REHABIL, V42, P2383, DOI 10.1080/09638288.2019.1594397; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; [Anonymous], 1999, WECHSLER ABBREVIATED; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Bendikas EA, 2011, REHABIL PSYCHOL, V56, P374, DOI 10.1037/a0025634; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bookheimer S, 2009, ANNU REV CLIN PSYCHO, V5, P343, DOI 10.1146/annurev.clinpsy.032408.153625; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Carrow-Woolfolk E ., 1999, COMPREHENSIVE ASSESS; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Culbertson WC., 2001, TOWER LONDON DREXEL; Delis DC., 2001, DELIS KAPLAN EXECUTI; Derogatis L. R., 1994, USE PSYCHOL TESTING, P217; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Durber CM, 2017, NEUROPSYCHOLOGY, V31, P499, DOI 10.1037/neu0000351; Durish CL, 2018, J INT NEUROPSYCH SOC, V24, P11, DOI 10.1017/S1355617717000595; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Fairbanks JM, 2013, REHABIL PSYCHOL, V167, P156; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Hodges K, 1999, USE PSYCHOL TESTING; Hung AH, 2017, J DEV BEHAV PEDIATR, V38, P49, DOI 10.1097/DBP.0000000000000366; Huston T.L., 1979, SOCIAL EXCHANGE DEV, P168, DOI [DOI 10.1016/B978-0-12-143550-9.50011-2, 10.1016/B978-0-12-143550-9.50011-2]; Ihle A, 2012, NEUROPSYCHOLOGY, V26, P267, DOI 10.1037/a0026769; Kadotani H, 2001, JAMA-J AM MED ASSOC, V285, P2888, DOI 10.1001/jama.285.22.2888; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Karver CL, 2014, CHILD NEUROPSYCHOL, V20, P343, DOI 10.1080/09297049.2013.796918; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Kurowski BG, 2017, J NEUROTRAUM, V34, P2280, DOI 10.1089/neu.2016.4856; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000162; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Mahley RW, 2016, J MOL MED, V94, P739, DOI 10.1007/s00109-016-1427-y; Manegot S, 2012, CHILD NEUROPSYCHOL, V8, P271; Manly T, 1999, TEA CH TEST EVERYDAY; Mannisto PT, 1999, PHARMACOL REV, V51, P593; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Merrell KM., 2002, HOME COMMUNITY SOCIA; MOOS RH, 1988, SOC SCI MED, V27, P999, DOI 10.1016/0277-9536(88)90291-2; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Narad ME, 2019, J DEV BEHAV PEDIATR, V40, P451, DOI 10.1097/DBP.0000000000000681; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Narad ME, 2017, J PEDIATR PSYCHOL, V42, P304, DOI 10.1093/jpepsy/jsw079; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; Papoutsis J, 2014, DEV NEUROPSYCHOL, V39, P638, DOI 10.1080/87565641.2014.979926; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Psychological Corporation, 2003, WECHSLER INTELLIGENC; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; Rosema S, 2015, J NEUROTRAUM, V32, P976, DOI 10.1089/neu.2014.3567; Schorr E, 2020, DISABIL REHABIL, V42, P2437, DOI 10.1080/09638288.2019.1602676; Schwartz D, 2000, DEV PSYCHOL, V36, P646, DOI [10.1037/0012-1649.36.5.646, 10.1037//0012-1649.36.5.646]; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Smith-Paine J, 2018, J NEUROTRAUM, V35, P2796, DOI 10.1089/neu.2017.5388; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Stancin T, 2010, J DEV BEHAV PEDIATR, V31, P317, DOI 10.1097/DBP.0b013e3181dbaf32; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P1132, DOI 10.1017/S1355617711001202; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; Treble-Barna A, 2016, DEV PSYCHOL, V52, P1777, DOI 10.1037/dev0000208; Treble-Barna A, 2016, J INT NEUROPSYCH SOC, V22, P859, DOI 10.1017/S1355617716000631; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2010, NEUROREHABILITATION, V27, P63, DOI 10.3233/NRE-2010-0581; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 2016, J HEAD TRAUMA REHAB, V129, P198; Walz NC, 2012, J NEUROPSYCHOL, V6, P143, DOI 10.1111/j.1748-6653.2011.02020.x; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Wechsler D, 1987, MANUAL WECHSLER MEMO; Woodcock R. W., 2001, WOODCOCKJOHNSON 3 TE; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	101	2	2	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2020	35	3			SI		226	239		10.1097/HTR.0000000000000555			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LP4ZM	WOS:000534327200007	31996606	Green Accepted			2022-02-06	
J	Plourde, V; Rohr, CS; Virani, S; Bray, S; Yeates, KO; Brooks, BL				Plourde, Vickie; Rohr, Christiane S.; Virani, Shane; Bray, Signe; Yeates, Keith Owen; Brooks, Brian L.			Default mode network functional connectivity after multiple concussions in children and adolescents	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Default mode network; Neuroimaging; Childhood; Adolescence; Long term	TRAUMATIC BRAIN-INJURY; MILD; INTEGRATION; INFERENCE; RECOVERY	The default mode network (DMN), a set of brain regions, has been shown to be affected post-concussion. Objective: This cross-sectional study aims to elucidate if children and adolescents with multiple concussions demonstrate long-term alterations in DMN functional connectivity (FC). Method: Participants (N = 57, 27 girls and 30 boys; 8-19 years old, M age = 14.7, SD = 2.8) were divided into three groups (orthopedic injury [OI] n = 20; one concussion n = 16; multiple concussions n = 21, M = 3.2 concussions, SD = 1.7) and seen on average 31.6 months post-injury (range 4.3-130.7 months; SD = 19.4). They underwent a resting-state functional magnetic resonance imaging scan. Parents completed the ADHD rating scale-5 for children and adolescents. Children and parents completed the post-concussion symptom inventory (PCSI). Results: Anterior and posterior DMN components were extracted from the fMRI data for each participant using FSL's MELODIC and dual regression. We tested for pairwise group differences within each DMN component in FSL's Randomize (5000 permutations) using threshold-free cluster enhancement to estimate cluster activation, controlling for age, sex, and symptoms of inattention. FC of the anterior DMN was significantly reduced in the group with multiple concussions compared to the two other groups, whereas there were no significant group differences on FC of the posterior DMN. There were no significant associations between DMN FC and PCSI scores. Conclusions. These results suggest reduced FC in the anteriorDMNin youth with multiple concussions, but no linear association with post-concussive symptoms.	[Plourde, Vickie] Univ Moncton, Sch Psychol, Moncton, NB, Canada; [Plourde, Vickie] Univ Alberta, Fac St Jean, Edmonton, AB, Canada; [Rohr, Christiane S.; Bray, Signe] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Rohr, Christiane S.; Bray, Signe] Univ Calgary, Child & Adolescent Imaging Res Program, Calgary, AB, Canada; [Rohr, Christiane S.; Virani, Shane; Bray, Signe; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Res Inst, Alberta Childrens Hosp, Calgary, AB, Canada; [Rohr, Christiane S.; Bray, Signe] Hotchkiss Brain Inst, Calgary, AB, Canada; [Virani, Shane] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada		Plourde, V (corresponding author), Univ Moncton, 68 Notre Dame du Sacre Coeur St, Moncton, NB E1A 3H6, Canada.	vickie.plourde@umoncton.ca	Yeates, Keith/AAJ-4223-2020	Plourde, Vickie/0000-0002-0098-5431	Shaikh Family Research Award; Alberta Children's Hospital Research Institute; Ronald and Irene Ward Chair in Pediatric Brain Injury; Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary AwardCanadian Institutes of Health Research (CIHR); Alberta Children's Hospital Research Institute (University of Calgary); Integrated Concussion Research Program (University of Calgary); Alberta Innovates-Health Solutions	This study was funded by the Shaikh Family Research Award, an endowment held by the Alberta Children's Hospital Foundation and granted to Brian Brooks by the Alberta Children's Hospital Research Institute. Additional support was provided from the Ronald and Irene Ward Chair in Pediatric Brain Injury (awarded to Keith Yeates). Brian Brooks acknowledges salary funding from the Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary Award. Vickie Plourde acknowledges fellowship funding from the Alberta Children's Hospital Research Institute (University of Calgary), the Integrated Concussion Research Program (University of Calgary), and Alberta Innovates-Health Solutions. Keith Yeates acknowledges funding from the Ronald and Irene Ward Chair in Pediatric Brain Injury.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Brooks BL, 2019, BRAIN INJURY, V33, P233, DOI 10.1080/02699052.2018.1540798; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Chen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144963; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Dunkley BT, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00280; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; Murdaugh DL, 2018, J INT NEUROPSYCH SOC, V24, P781, DOI 10.1017/S1355617718000413; Murphy K, 2017, NEUROIMAGE, V154, P169, DOI 10.1016/j.neuroimage.2016.11.052; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Parkes L, 2018, NEUROIMAGE, V171, P415, DOI 10.1016/j.neuroimage.2017.12.073; Power JD, 2018, P NATL ACAD SCI USA, V115, pE2105, DOI 10.1073/pnas.1720985115; Qiu MG, 2011, BRAIN TOPOGR, V24, P243, DOI 10.1007/s10548-010-0168-4; Reid, 2016, ADHD RATING SCALE 5; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Rohr CS, 2019, NEUROPSYCHOLOGIA, V127, P84, DOI 10.1016/j.neuropsychologia.2019.02.011; Rohr CS, 2018, DEV COGN NEUROS-NETH, V30, P200, DOI 10.1016/j.dcn.2018.03.007; Rohr CS, 2017, CEREB CORTEX, V27, P4350, DOI 10.1093/cercor/bhw236; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sato JR, 2016, J CHILD PSYCHOL PSYC, V57, P55, DOI 10.1111/jcpp.12444; Schmidt J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3406; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	52	2	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2020	35	3			SI		302	311		10.1093/arclin/acz073			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN7WL	WOS:000568997800008		Bronze, Green Published			2022-02-06	
J	Proctor, SP; Maule, AL; Heaton, KJ; Cadarette, BS; Guerriere, KI; Haven, CC; Taylor, KM; Scarpaci, MM; Ospina, M; Calafat, AM				Proctor, Susan P.; Maule, Alexis L.; Heaton, Kristin J.; Cadarette, Bruce S.; Guerriere, Katelyn, I; Haven, Caitlin C.; Taylor, Kathryn M.; Scarpaci, Matthew M.; Ospina, Maria; Calafat, Antonia M.			Permethrin exposure from wearing fabric-treated military uniforms in high heat conditions under varying wear-time scenarios	JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY			English	Article						Permethrin; Urinary biomarkers; Absorbed dose; Heat; Military; Pesticides	NEUROPSYCHOLOGICAL ASSESSMENT METRICS; TRAUMATIC BRAIN-INJURY; BATTLE DRESS UNIFORMS; PYRETHROID INSECTICIDES; METABOLITES; POPULATION; HEALTH	This study examined the effect of high-temperature conditions and uniform wear time durations (expeditionary, 33 h continuous wear; garrison, 3 days, 8 h/day wear) on permethrin exposure, assessed by urinary permethrin biomarkers, from wearing post-tailored, factory-treated military uniforms. Four group study sessions took place over separate 11-day periods, involving 33 male Soldiers. Group 1 (n = 10) and Group 2 (n = 8) participants wore a study-issued permethrin-treated Army uniform under high heat environment (35 degrees C, 40% relative humidity (rh)) and expeditionary and garrison wear-time conditions, respectively. For comparison, Group 3 (n = 7) and Group 4 (n = 8) participants wore study-issued permethrin-treated uniforms in cooler ambient conditions under operational and garrison wear-time conditions, respectively. Urinary biomarkers of permethrin (3-phenoxybenzoic acid, and the sum of cis- and trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid) were significantly higher under high temperature compared to ambient conditions, regardless of wear-time situations (Group 1 vs. Group 3; Group 2 vs. Group 4; p < 0.001, for both). Under high-temperature conditions, expeditionary (continuous) compared to garrison wear-time resulted in significantly (p < 0.001) higher urinary biomarker concentrations (Group 1 vs. Group 2). Differences related to wear-time under the ambient conditions (Group 3 vs. Group 4) were not statistically significant. Findings suggest that wearing permethrin-treated clothing in heat conditions results in higher internal dose of permethrin above that observed under ambient conditions.	[Proctor, Susan P.; Maule, Alexis L.; Heaton, Kristin J.; Cadarette, Bruce S.; Guerriere, Katelyn, I; Haven, Caitlin C.; Taylor, Kathryn M.; Scarpaci, Matthew M.] US Army, Environm Med Res Inst, Mil Performance Div, Natick, MA 01760 USA; [Proctor, Susan P.] VA Boston Healthcare Syst, Res Serv, 180 South Huntington Ave, Boston, MA 02130 USA; [Proctor, Susan P.; Heaton, Kristin J.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, 715 Albany St, Boston, MA 02118 USA; [Maule, Alexis L.; Scarpaci, Matthew M.] Henry M Jackson Fdn Adv Mil Med, 6720 ARockledge Dr,Suite 100, Bethesda, MD USA; [Ospina, Maria; Calafat, Antonia M.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Lab Sci, 4770 Buford Hwy, Atlanta, GA USA		Proctor, SP (corresponding author), US Army, Environm Med Res Inst, Mil Performance Div, Natick, MA 01760 USA.; Proctor, SP (corresponding author), VA Boston Healthcare Syst, Res Serv, 180 South Huntington Ave, Boston, MA 02130 USA.; Proctor, SP (corresponding author), Boston Univ, Sch Publ Hlth, Dept Environm Hlth, 715 Albany St, Boston, MA 02118 USA.	susan.p.proctor.civ@mail.mil			Intramural CDC HHS [CC999999] Funding Source: Medline		Abou-Donia MB, 2004, PHARMACOL BIOCHEM BE, V77, P253, DOI 10.1016/j.pbb.2003.10.018; AFPMB [Armed Forces Pest Management Board], 2015, TECHN GUID 36 PERS P; [Anonymous], 2009, DORIOT CLIMATIC CHAM; Appel KE, 2008, INT J HYG ENVIR HEAL, V211, P88, DOI 10.1016/j.ijheh.2007.10.005; Barr DB, 2010, ENVIRON HEALTH PERSP, V118, P742, DOI 10.1289/ehp.0901275; Baty International, 2010, HARP SKINF CAL HSB B; Center for Disease Control and Prevention (CDC) Division of Nutrition Physical Activity and Obesity National Center for Chronic Disease Prevention and Health Promotion, 2017, BMI AD; Center for the Study of Human Operator Performance (C-SHOP), 2007, ANAM4 SOFTW US MAN; Centers for Disease Control and Prevention, 2009, 4 NAT REP HUM EXP EN, V1; Davis MD, 2013, J CHROMATOGR B, V929, P18, DOI 10.1016/j.jchromb.2013.04.005; FAO/WHO, 1999, M FAO PAN EXP PEST R; Gordon CJ, 2003, ENVIRON RES, V92, P1, DOI 10.1016/S0013-9351(02)00008-7; Health Canada, 2013, 2 REP HUM BIOM ENV C; Heil DP, 2006, RES Q EXERCISE SPORT, V77, P64, DOI 10.5641/027013606X13080769703920; Heudorf U, 2001, ENVIRON HEALTH PERSP, V109, P213, DOI 10.2307/3434687; Hornung R. W., 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [DOI 10.1080/1047322X.1990.10389587, 10.1080/1047322X.1990.10389587]; Ix JH, 2011, CLIN J AM SOC NEPHRO, V6, P184, DOI 10.2215/CJN.05030610; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Kazis LE, 1999, GLOBAL ENTREPRENEURS; Kegel P, 2014, OCCUP ENVIRON MED, V71, P112, DOI 10.1136/oemed-2012-101279; Macedo PA, 2007, J TOXICOL ENV HEAL A, V70, P1758, DOI 10.1080/15287390701459049; Matthews CG., 1964, INSTRUCTION MANUAL A; Maule AL, URINARY CONCENTRATIO; National Research Council, 1994, HLTH EFF PERM IMPR A; Proctor SP, 1998, INT J EPIDEMIOL, V27, P1000, DOI 10.1093/ije/27.6.1000; Proctor SP, 2018, TOXICOL LETT, V299, P210, DOI 10.1016/j.toxlet.2018.10.001; Proctor SP, 2014, J EXPO SCI ENV EPID, V24, P572, DOI 10.1038/jes.2013.65; Proctor SP, 2011, NEUROTOXICOLOGY, V32, P799, DOI 10.1016/j.neuro.2011.06.010; Riederer AM, 2008, ENVIRON HEALTH PERSP, V116, P1015, DOI 10.1289/ehp.11082; Riviere JE, 2002, TOXICOL LETT, V135, P61, DOI 10.1016/S0378-4274(02)00239-4; Roebuck-Spencer TM, 2008, MIL PSYCHOL, V20, P187, DOI 10.1080/08995600802118825; Rossbach B, 2014, TOXICOL LETT, V231, P147, DOI 10.1016/j.toxlet.2014.10.017; Rossbach B, 2010, TOXICOL LETT, V192, P50, DOI 10.1016/j.toxlet.2009.06.863; Stewart AL, 1992, MEASURING FUNCTIONIN; Strauss E, 2006, COMPENDIUM NEUROPYSC; TBMED 507, 2003, TBMED TECHN B MED, P5; Trunnelle KJ, 2014, ENVIRON SCI TECHNOL, V48, P1931, DOI 10.1021/es403661a; United States Army Public Health Center (USAPHC), 2018, DOD INS REP SYST; United States Army Public Health Center (USAPHC), 2018, 2017 HLTH FORC REP; United States Environmental Protection Agency (EPA), 2002, PERM; United States Environmental Protection Agency (EPA), 2009, REG EL DEC RED PERM; United States Environmental Protection Agency (EPA), REP TREAT CLOTH; VIJVERBERG HPM, 1990, CRIT REV TOXICOL, V21, P105, DOI 10.3109/10408449009089875; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289	45	2	2	2	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1559-0631	1559-064X		J EXPO SCI ENV EPID	J. Expo. Sci. Environ. Epidemiol.	MAY	2020	30	3					525	536		10.1038/s41370-019-0120-y			12	Environmental Sciences; Public, Environmental & Occupational Health; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Toxicology	LG6SZ	WOS:000528229600012	30728486	Green Accepted			2022-02-06	
J	Raab, CA; Peak, AS; Knoderer, C				Raab, Courtney A.; Peak, Amy Sutton; Knoderer, Chad			Half of Purposeful Baseline Sandbaggers Undetected by ImPACT's Embedded Invalidity Indicators	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Sandbagging; Brain concussion; ImPACT; Baseline; Malingering	PERFORMANCE; CONCUSSION	Objective: The main objectives of this study were to determine how accurately the embedded invalidity indicators (EIIs) identify purposeful underperformers on the baseline Immediate Post-concussion Assessment and Cognitive Test (ImPACT); and to assess the effectiveness of each individual EII. Methods: A randomized controlled trial was conducted in which all participants completed a baseline ImPACT assessment. Participants were randomized into a control or purposeful underperformance (sandbagging) group. The primary outcomes measured were the number of participants identified as invalid (via any EII), as well as the ability of each individual EII to detect purposeful sandbagging. Additionally, participants mean raw composite scores and percentiles were evaluated. Results: Seventy-seven participants completed the study (control n = 37, sandbag n = 40.) None of the participants in the control group, and 50% of the purposeful sandbaggers were identified as invalid via the current EIIs. Of the five EIIs, three were unable to identify more than 15% of purposeful sandbaggers. The best performing EIIs were Word Memory and Three Letters, identifying 40% and 35% of purposeful sandbaggers, respectively. Sixty- five percent of the purposeful sandbaggers had at least one composite score <= 1st percentile. Using a composite score <= 1st percentile as potential marker of invalidity would have accurately identified more purposeful sandbaggers than all existing EIIs combined. Conclusion: Half of purposeful sandbaggers were not identified by ImPACT's current EIIs. Multiple EIIs were only able to identify <15% of purposeful underperformers, suggesting that reevaluation and/or recalibration of EII cutoffs may be appropriate.	[Raab, Courtney A.; Peak, Amy Sutton; Knoderer, Chad] Butler Univ, Dept Hlth Sci, Indianapolis, IN 46208 USA		Raab, CA (corresponding author), Indiana Univ, Sch Med Northwest, 3400 Broadway Ave, Gary, IN 46408 USA.	coraab@iu.edu			Butler University Holcomb Awards Committee; Butler Summer Research Institute	This work was supported by a grant from the Butler University Holcomb Awards Committee and the Butler Summer Research Institute. Neither author has any affiliation with the manufacturer of ImPACT or any other neuropsychological test manufacturer.	Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; [Anonymous], 2016, IMPACT ADM INTERPRET; Cassidy D., 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097699, DOI 10.1136/BJSPORTS-2017-097699]; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; ImPACT Application. Inc., 2016, IMPACT; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Szabo AJ, 2013, J ATHL TRAINING, V48, P851, DOI 10.4085/1062-6050-48.6.20; Walton SR, 2018, MED SCI SPORT EXER, V50, P1377, DOI 10.1249/MSS.0000000000001592	9	2	2	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2020	35	3			SI		283	290		10.1093/arclin/acz001			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN7WL	WOS:000568997800006	30957141	Bronze			2022-02-06	
J	Roy, R; Pattnaik, S; Sivagurunathan, S; Chidambaram, S				Roy, Rupa; Pattnaik, Sambhavi; Sivagurunathan, Suganya; Chidambaram, Subbulakshmi			Small ncRNA binding protein, PIWI: A potential molecular bridge between blood brain barrier and neuropathological conditions	MEDICAL HYPOTHESES			English	Article							PREFRONTAL CORTEX; EPH RECEPTORS; RNAS; IDENTIFICATION; MORPHOGENESIS; ANGIOGENESIS; ACTIVATION; EXPRESSION; JUNCTIONS; PATHOLOGY	The blood brain barrier (BBB) is a neuroprotective layer that maintains the homeostasis of central nervous system and provides an appropriate environment for neurons to execute their functions. The fundamental role of the dynamic semi-permeable BBB is selective and stringent transport of molecules from circulating blood and surrounding extracellular matrix across brain. Disruption of BBB has critical implications that can lead to various neuropathological disorders (NPDs) namely multiple sclerosis, Alzheimer's disease, epilepsy, traumatic brain injuries and neuropsychiatric disorders, etc. Therapeutic management of NPDs is still a daunting challenge in the field of neuromedicine and there is a great need for identifying novel drug targets and biomarkers. Recently, noncoding RNAs (ncRNA) have emerged as promising prognostic markers in NPDs. Piwi interacting RNAs (piRNA), a family of short noncoding RNAs which in association with PIWI-like proteins have shown to regulate neuronal function and memory formation. In addition, piRNAs are differentially expressed in Alzheimer's brain tissues and studies also revealed the association of denovo mutations in PIWI genes with autism. Moreover, the role of PIWI-like proteins in neuronal long-term potentiation and neurite outgrowth is now evident, confirming their importance in normal physiology of the brain. Notably, we have reported the significance of PIWI-like proteins in the maintenance of Blood Retinal Barrier (BRB) and its potential role in diseases like diabetic retinopathy through modulation of tight junction proteins. Further studies in hydra and cancer cells confirmed the important function of PIWI-like proteins in the organization of tight junctions. Interestingly, we also observed that loss of PIWI-like proteins affected the activity of Ephrin receptors which have an established functional link to tight junction assembly. Collectively, the evidences profoundly support the novel concept that piRNAs/PIWI-like proteins may have a potential role on the governance of BBB by altering the tight junctions through Ephrin effectors, commotion of which could be the preceding event to various NPDs. Here, we propose PIWI-like proteins and associated piRNAs as potential restorative drug targets for combating neuropathological conditions.	[Roy, Rupa; Pattnaik, Sambhavi; Chidambaram, Subbulakshmi] Pondicherry Univ, Dept Biochem & Mol Biol, Pondicherry, India; [Sivagurunathan, Suganya] Vis Res Fdn, RS Mehta Jain Dept Biochem & Cell Biol, KBIRVO, Chennai, Tamil Nadu, India		Chidambaram, S (corresponding author), Pondicherry Univ, Dept Biochem & Mol Biol, Pondicherry, India.	csubbulakshmi@gmail.com		Sivagurunathan, Suganya/0000-0002-9778-5400	Department of Biotechnology under the project DBT-Neurobiology Taskforce [BT/PR5055/MED/30/761/2012]; Indian Council of Medical Research (ICMR)Indian Council of Medical Research (ICMR) [5/4/6/1/OPH/2015-NCD-II]; Department of Science and Technology (DST)Department of Science & Technology (India) [SR/WOS-A/LS-388/2018]; University Grants Commission, New DelhiUniversity Grants Commission, India	We acknowledge the financial assistance provided by Department of Biotechnology under the project DBT-Neurobiology Taskforce - "BT/PR5055/MED/30/761/2012" and Indian Council of Medical Research (ICMR) project NO. 5/4/6/1/OPH/2015-NCD-II. The funding body is not involved in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. RR thanks the Department of Science and Technology (DST) for the Women Scientist Scheme-A fellowship under the project NO. SR/WOS-A/LS-388/2018. CS thanks the support from University Grants Commission, New Delhi for the award of Assistant Professorship under its Faculty Recharge Program (UGC-FRP).	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Arnau-Soler A, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-018-0360-y; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Barquilla A, 2015, ANNU REV PHARMACOL, V55, P465, DOI 10.1146/annurev-pharmtox-011112-140226; Barton WA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009142; Bauer H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/402593; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Cox DN, 2000, DEVELOPMENT, V127, P503; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Esposito P, 2001, BRAIN RES, V888, P117, DOI 10.1016/S0006-8993(00)03026-2; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fiorentino M, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0110-z; Gerlai R, 1999, J NEUROSCI, V19, P9538; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gosselin RD, 2009, NEUROSCIENCE, V159, P915, DOI 10.1016/j.neuroscience.2008.10.018; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Henaoui IS, 2017, DIABETOLOGIA, V60, P1977, DOI 10.1007/s00125-017-4368-2; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Jiang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11765; Jones BC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13856; Kealy J, 2020, NEUROSCI LETT, V726, DOI 10.1016/j.neulet.2018.06.033; Lecuyer MA, 2016, BBA-MOL BASIS DIS, V1862, P472, DOI 10.1016/j.bbadis.2015.10.004; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; Lee HS, 2009, FEBS J, V276, P4622, DOI 10.1111/j.1742-4658.2009.07174.x; Leighton LJ, 2019, NEUROBIOL LEARN MEM, V161, P202, DOI 10.1016/j.nlm.2019.04.002; Leng X, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0886-0; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Malik VA, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00127; Mani SR, 2014, DEV BIOL, V385, P340, DOI 10.1016/j.ydbio.2013.10.017; Martinez VD, 2015, SCI REP-UK, V5, DOI 10.1038/srep10423; Menard C, 2017, NAT NEUROSCI, V20, P1752, DOI 10.1038/s41593-017-0010-3; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Najjar S, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00083; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Nandi S, 2016, P NATL ACAD SCI USA, V113, P12697, DOI 10.1073/pnas.1609287113; Navarro A, 2015, ONCOTARGET, V6, P31544, DOI 10.18632/oncotarget.3003; Nishiura K, 2017, ONCOTARGET, V8, P93382, DOI 10.18632/oncotarget.21850; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290, DOI 10.1073/pnas.95.22.13290; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Ponnusamy M, 2017, EUR J CELL BIOL, V96, P746, DOI 10.1016/j.ejcb.2017.09.004; Qu XH, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0666-y; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Rizzo A, 2016, RIV ITAL FILOS ANAL, V7; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Salim S, 2012, ADV PROTEIN CHEM STR, V88, P1, DOI 10.1016/B978-0-12-398314-5.00001-5; Santha P, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00088; Seipel K, 2004, INT J DEV BIOL, V48, P1, DOI 10.1387/ijdb.15005568; Serlin Y, 2015, SEMIN CELL DEV BIOL, V38, P2, DOI 10.1016/j.semcdb.2015.01.002; Shalev Hadar, 2009, Cardiovasc Psychiatry Neurol, V2009, P278531, DOI 10.1155/2009/278531; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Sivagurunathan S, 2018, BIORXIV, DOI DOI 10.1101/305144.; Sivagurunathan S, 2018, EXP EYE RES, V177, P191, DOI 10.1016/j.exer.2018.08.018; Sivagurunathan S, 2017, CELL MOL BIOL LETT, V22, DOI 10.1186/s11658-017-0048-y; Sivagurunathan S, 2017, MOL CELL BIOCHEM, V427, P145, DOI 10.1007/s11010-016-2906-8; Srivastava M, 2014, CURR BIOL, V24, P1107, DOI 10.1016/j.cub.2014.03.042; Sun HQ, 2010, J BIOL CHEM, V285, P4243, DOI 10.1074/jbc.M109.079533; Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200; Varghese M, 2017, ACTA NEUROPATHOL, V134, P537, DOI 10.1007/s00401-017-1736-4; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Zhang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06502-7; Zhang RX, 2016, NEUROPSYCHOPHARMACOL, V41, P2541, DOI 10.1038/npp.2016.58; Zhou N, 2011, MICROVASC RES, V82, P113, DOI 10.1016/j.mvr.2011.06.005	77	2	2	3	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	MAY	2020	138								109609	10.1016/j.mehy.2020.109609			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	LA0JA	WOS:000523642300023	32070788				2022-02-06	
J	Santana, JA; Martinie, R; Gomez, J				Santana, Jonathan A.; Martinie, Rebecca; Gomez, Jorge			Improving Concussion Management by Including Driving Recommendations for Adolescents with Concussions: A Quality Improvement Project	PEDIATRIC QUALITY & SAFETY			English	Article							TRAUMATIC BRAIN-INJURY; DRIVERS	Introduction: Motor vehicle collisions are the leading cause of death in adolescents. A concussion is a common injury sustained by adolescents and may impair their driving abilities during the acute phase of recovery. Healthcare providers do not consistently perform counseling of adolescents regarding driving after a concussion. This quality improvement project's goal was to increase the incidence of primary care sports medicine physicians providing driving recommendations to 75% of adolescents who suffered from concussions. Methods: Between August 2017 to August 2018, a "smart phrase" implemented in the electronic health record system reminded providers during office visits to provide driving recommendations to patients 15 years old and older who presented to the sports medicine clinic for evaluation of concussion. Performing monthly retrospective chart reviews determined the frequency of patients who received driving recommendations during the initial visit. Results: We achieved the goal of providing driving recommendations to 75% of concussed patients by the second month. This progress was maintained through the remainder of the year, except for 1 month (December). Forty-three percent of patients with concussions evaluated met inclusion criteria, and of those, 48% were actively driving before their concussion. The most common medical reason for restricting driving was vestibular or ocular dysfunction. Conclusion: This quality improvement project showed that providing driving instructions to concussion patients by implementing a smart phrase into the electronic health record system was impactful and sustainable.	[Santana, Jonathan A.; Gomez, Jorge] Baylor Coll Med, Dept Pediat, Sect Adolescent & Sports Med, Houston, TX 77030 USA; [Martinie, Rebecca] Texas Childrens Urgent Care, Houston, TX USA		Santana, JA (corresponding author), Texas Childrens Hosp The Woodlands, 175801-45 South,4th Floor, The Woodlands, TX 77384 USA.	jonathan.santana@bcm.edu					Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Asif IM, 2013, CLIN J SPORT MED, V23, P439, DOI 10.1097/JSM.0b013e31829610cc; Baker A, 2015, ACCIDENT ANAL PREV, V79, P50, DOI 10.1016/j.aap.2015.03.014; Bernstein JPK, 2018, PM&R, V10, P1153, DOI 10.1016/j.pmrj.2018.05.008; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Center for Disease Control and Prevention, 2019, FAT INJ DAT; Christensen J, 2019, CURR SPORT MED REP, V18, P17, DOI 10.1249/JSR.0000000000000558; Foss RD, 2000, JAMA-J AM MED ASSOC, V283, P1617, DOI 10.1001/jama.283.12.1617; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Lucas JA, 2019, BRIT J SPORT MED, V53, P495, DOI 10.1136/bjsports-2018-099118; MacDonald J, 2018, J PEDIATR-US, V194, P177, DOI 10.1016/j.jpeds.2017.10.032; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; National Center for Statistics and Analysis, 2019, 812753 DOT HS NAT CT; Preece MHW, 2013, BRAIN INJURY, V27, P83, DOI 10.3109/02699052.2012.722260; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Romer D, 2014, J ADOLESCENT HEALTH, V54, pS6, DOI 10.1016/j.jadohealth.2013.10.202; Schmidt JD, 2017, J NEUROTRAUM, V34, P1571, DOI 10.1089/neu.2016.4668; Stuart Emily A, 2016, Pediatr Qual Saf, V1, pe006, DOI 10.1097/pq9.0000000000000006; Taylor MJ, 2014, BMJ QUAL SAF, V23, P290, DOI 10.1136/bmjqs-2013-001862; Varkey P, 2007, MAYO CLIN PROC, V82, P735, DOI 10.4065/82.6.735	25	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA		2472-0054		PEDIATR QUAL SAF	Pediatr. Qual. Saf.	MAY-JUN	2020	5	3							e307	10.1097/pq9.0000000000000307			6	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	WR0BX	WOS:000714176000017	32656470	gold, Green Published			2022-02-06	
J	Stokes, W; Runnalls, K; Choynowki, J; St Pierre, M; Anaya, M; Statton, MA; Celnik, PA; Cantarero, G				Stokes, William; Runnalls, Keith; Choynowki, Jake; St Pierre, Maria; Anaya, Manuel; Statton, Matthew A.; Celnik, Pablo A.; Cantarero, Gabriela			Altered corticomotor latencies but normal motor neuroplasticity in concussed athletes	JOURNAL OF NEUROPHYSIOLOGY			English	Article						concussion; corticomotor; motor vertex; neurophysiology; neuroplasticity	DIRECT-CURRENT STIMULATION; GABA(B) RECEPTOR AGONIST; CORTICAL EXCITABILITY; PLASTICITY; CORTEX; RELIABILITY; INSTRUMENT; MODULATION; RESPONSES; VALIDITY	Persistent cognitive, affective, and motor symptoms have been associated with sports-related concussions including several neurophysiological changes in the primary motor cortex. In particular, previous research has provided some evidence of altered latencies of the corticomotor pathway and altered motor neuroplasticity. However, to date, no studies have assessed these neurophysiological metrics in a common group of athletes across different phases of injury and recovery. In this study corticomotor latencies and neuroplasticity were assessed in collegiate athletes with or without a history of prior concussion across two different phases of injury: either in an acute state of concussion (within 2 wk of injury) or in a chronic state of concussion (more than 1 yr after injury). Corticomotor latencies were determined by measuring the motor evoked potential (MEP) onset time, and motor neuroplasticity was assessed by measuring MEP amplitudes following application of anodal transcranial direct current stimulation (tDCS) over the primary motor cortex (M1). We found that concussed athletes had slower corticomotor latencies than nonconcussed athletes, and corticomotor latency was also positively correlated with the number of prior concussions. In contrast, there was no evidence of altered motor neuroplasticity in athletes regardless of concussion history. These findings suggest concussions may lead to permanent changes in the corticospinal tract that are exacerbated by repeated injury. NEW & NOTEWORTHY We are the first to assess corticomotor latencies and motor neuroplasticity in a common group of collegiate athletes across different phases of injury and recovery. We found that the number of concussions an individual sustains negatively impacts corticomotor latencies with a higher number of prior concussions correlating positively with longer latencies. Our findings indicate that concussions may lead to permanent changes in the corticospinal tract that are exacerbated by repeated injury.	[Stokes, William; Runnalls, Keith; Anaya, Manuel; Celnik, Pablo A.; Cantarero, Gabriela] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Choynowki, Jake; St Pierre, Maria] Walter Reed Army Inst Res, Silver Spring, MD USA; [Statton, Matthew A.] Kennedy Krieger Inst, Baltimore, MD USA		Cantarero, G (corresponding author), Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Human Brain Physiol & Stimulat Lab, 707 N Broadway,Rm G-04C, Baltimore, MD 21205 USA.	gcantar1@jhmi.edu		Statton, Matthew/0000-0001-5733-0615	National Institute of Child Health and Human Development GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD073147 04]; Military Operational Medicine Research Program (MOMPR) of the U.S. Army Medical Research and Materiel Command Grant [MOMRP18650]	This work was supported by National Institute of Child Health and Human Development Grant R01 HD073147 04 (to W. Stokes, M. Anaya, M. A. Statton, P. A. Celnik, and G. Cantarero) and Military Operational Medicine Research Program (MOMPR) of the U.S. Army Medical Research and Materiel Command Grant MOMRP18650 (to G. Cantarero, J. Choynowki, and M. St. Pierre).	BRITTON TC, 1991, ELECTROEN CLIN NEURO, V81, P186, DOI 10.1016/0168-5597(91)90071-5; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantarero G, 2013, J NEUROSCI, V33, P4634, DOI 10.1523/JNEUROSCI.4706-12.2013; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; Erdemoglu AK, 2013, ACTA NEUROL SCAND, V128, P351, DOI 10.1111/ane.12131; Faul M, 2010, TRAUMATIC BRAIN INJU; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim HJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1372946; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McDonnell MN, 2007, EXP BRAIN RES, V180, P181, DOI 10.1007/s00221-006-0849-0; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McNamara RK, 1996, PHARMACOL BIOCHEM BE, V53, P303, DOI 10.1016/0091-3057(95)02025-X; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Schretlen DJ, 2009, CLIN NEUROPSYCHOL, V23, P926, DOI 10.1080/13854040802603684; Seeger TA, 2017, BRAIN STIMUL, V10, P305, DOI 10.1016/j.brs.2016.11.011; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Stewart WF, 1999, CEPHALALGIA, V19, P107, DOI 10.1046/j.1468-2982.1999.019002107.x; Suppa A, 2017, CLIN NEUROPHYSIOL, V128, P2140, DOI 10.1016/j.clinph.2017.08.003; Tluczek A, 2009, J NURS MEAS, V17, P19, DOI 10.1891/1061-3749.17.1.19; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Zhang J., 2016, TRANSLATIONAL RES TR	38	2	2	1	3	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	MAY	2020	123	5					1600	1605		10.1152/jn.00774.2019			6	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Physiology	LK8HW	WOS:000531101900003	32073936	Green Published			2022-02-06	
J	Swan, AA; Nelson, JT; Pogoda, TK; Akin, FW; Riska, KM; Hall, CD; Amuan, ME; Yaffe, K; Pugh, MJ				Swan, Alicia A.; Nelson, Jeremy T.; Pogoda, Terri K.; Akin, Faith W.; Riska, Kristal M.; Hall, Courtney D.; Amuan, Megan E.; Yaffe, Kristine; Pugh, Mary Jo		Chronic Effects Neurotrauma Consor	Association of Traumatic Brain Injury With Vestibular Dysfunction and Dizziness in Post-9/11 Veterans	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; dizziness; prevalence; traumatic; vestibular diseases; veteran health; veterans	NOISE EXPOSURE; IRAQI FREEDOM; CLINICAL-OUTCOMES; HEARING-LOSS; SYMPTOMS; PREVALENCE; COMMUNITY; IMPACT; BLAST; COMORBIDITY	Objective: To describe the prevalence and impact of vestibular dysfunction and nonspecific dizziness diagnoses and explore their associations with traumatic brain injury (TBI) severity, mechanism, and postconcussive comorbidities among post-9/11 veterans. Setting: Administrative medical record data from the US Departments of Defense and Veterans Affairs (VA). Participants: Post-9/11 veterans with at least 3 years of VA care. Design: Cross-sectional, retrospective, observational study. Main Measures: International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for TBI, vestibular dysfunction, dizziness, and other commonly associated postconcussive conditions; Neurobehavioral Symptom Inventory. Results: Of the 570 248 post-9/11 veterans in this sample, 0.45% had a diagnosis of vestibular dysfunction and 2.57% had nonspecific dizziness. Those with either condition were more likely to have evidence of TBI (57.11% vs 28.51%) and reported more disruption from neurobehavioral symptoms. Blast and nonblast injuries were associated with greater symptom disruption, particularly in combination. Conclusions: There was a consistent, significant association between TBI and vestibular dysfunction or nonspecific dizziness, after controlling for sociodemographic factors, injury mechanism, and comorbid conditions. Given that most deployed post-9/11 veterans report blast and/or nonblast injuries, the need for prompt identification and management of these conditions and symptoms is clear.	[Swan, Alicia A.] Univ Texas San Antonio, San Antonio, TX USA; [Nelson, Jeremy T.] Def Hlth Agcy, Dept Def Hearing, Ctr Excellence, San Antonio, TX USA; [Nelson, Jeremy T.] Ho Chunk Inc, Alexandria, VA USA; [Nelson, Jeremy T.] Indiana Univ, Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN USA; [Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Akin, Faith W.; Hall, Courtney D.] James H Quillen VA Med Ctr, Mountain Home, TN USA; [Akin, Faith W.] East Tennessee State Univ, Dept Audiol & Speech Language Pathol, Johnson City, TN USA; [Hall, Courtney D.] East Tennessee State Univ, Dept Phys Therapy, Johnson City, TN USA; [Riska, Kristal M.] Duke Univ, Dept Surg, Div Head & Neck Surg & Commun Sci, Durham, NC USA; [Amuan, Megan E.] Edith Nourse Rogers VA Med Ctr, Ctr Hlth Care Org & Implementat Res, Bedford, MA USA; [Yaffe, Kristine] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Sch Med, Dept Epidemiol, San Francisco, CA 94143 USA; [Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr IDEAS, Salt Lake City, UT USA; [Pugh, Mary Jo] Univ Utah, Dept Internal Med, 30 N 1900 E, Salt Lake City, UT 84132 USA		Pugh, MJ (corresponding author), Univ Utah, Dept Internal Med, 30 N 1900 E, Salt Lake City, UT 84132 USA.	maryjo.pugh@hsc.utah.edu	Swan, Alicia A/O-3536-2018	Swan, Alicia A/0000-0003-2412-0499	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, VA Salt Lake CityUS Department of Veterans Affairs	This material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, VA Salt Lake City, and the Joint Trauma System.	Agrawal Y, 2009, ARCH INTERN MED, V169, P938, DOI 10.1001/archinternmed.2009.66; Akdogan O, 2009, AURIS NASUS LARYNX, V36, P2, DOI 10.1016/j.anl.2008.03.003; Akin FW, 2012, EAR HEARING, V33, P458, DOI 10.1097/AUD.0b013e3182498c5f; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bird JC, 1998, BRIT J GEN PRACT, V48, P1828; Bronstein AM, 2010, J NEUROL, V257, P183, DOI 10.1007/s00415-009-5287-z; Bureau of Labor Statistics, 2018, EMPL SIT VET 2017; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Colombo B, 2017, NEUROL SCI, V38, pS107, DOI 10.1007/s10072-017-2882-0; Cruickshanks KJ, 2010, HEARING RES, V264, P3, DOI 10.1016/j.heares.2009.10.008; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Eapen BC, 2013, CURR PHYS MED REHABI, V1, P151, DOI DOI 10.1007/S40141-013-0023-0; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hsu WC, 2008, ARCH OTOLARYNGOL, V134, P1099, DOI 10.1001/archotol.134.10.1099; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Koo JW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008224; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Military Health System and the Defense Health Agency, 2016, SURV CAS DEF 13 NEUR; Moeller JJ, 2008, CAN J NEUROL SCI, V35, P335, DOI 10.1017/S0317167100008921; Murdin L, 2015, OTOL NEUROTOL, V36, P387, DOI 10.1097/MAO.0000000000000691; Nelson JT, 2017, HEARING RES, V349, P13, DOI 10.1016/j.heares.2016.10.005; Neuhauser HK, 2006, NEUROLOGY, V67, P1028, DOI 10.1212/01.wnl.0000237539.09942.06; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Selim Alfredo J, 2004, J Ambul Care Manage, V27, P281; Smith JE, 2019, J ROY ARMY MED CORPS, V165, P57, DOI 10.1136/jramc-2018-001058; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Swan AA, 2017, HEARING RES, V349, P4, DOI 10.1016/j.heares.2017.01.013; Swan AA, 2018, BRAIN INJURY, V32, P1197, DOI 10.1080/02699052.2018.1495340; Tamber AL, 2009, SCAND J PUBLIC HEALT, V37, P613, DOI 10.1177/1403494809105026; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tseng CC, 2013, EUR ARCH OTO-RHINO-L, V270, P2021, DOI 10.1007/s00405-012-2270-6; U.S. Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; US Defense Centers of Excellence, 2010, DEP DEF COD GUID TRA; Wang YP, 2007, OTOLARYNG HEAD NECK, V137, P607, DOI 10.1016/j.otohns.2007.05.005; WICKENS T. D., 1989, MULTIWAY CONTINGENCY; Wu CC, 2009, INT J AUDIOL, V48, P655, DOI 10.1080/14992020903012481; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131	47	2	2	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2020	35	3			SI		E253	E265		10.1097/HTR.0000000000000513			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LP4ZM	WOS:000534327200008	31569144				2022-02-06	
J	Tabor, J; Wright, DK; Christensen, J; Zamani, A; Collins, R; Shultz, SR; Mychasiuk, R				Tabor, Jason; Wright, David K.; Christensen, Jennaya; Zamani, Akram; Collins, Reid; Shultz, Sandy R.; Mychasiuk, Richelle			Examining the Effects of Anabolic-Androgenic Steroids on Repetitive Mild Traumatic Brain Injury (RmTBI) Outcomes in Adolescent Rats	BRAIN SCIENCES			English	Article						concussion; advanced MRI; diffusion; mRNA; development	BINDING PROTEIN OVEREXPRESSION; PREFRONTAL CORTEX; TELOMERE LENGTH; AMYGDALA; MODEL; CONCUSSION; MEMORY; BDNF; PATHOPHYSIOLOGY; ABNORMALITIES	Background: Repetitive mild traumatic brain injury (RmTBI) is increasingly common in adolescents. Anabolic-androgenic steroid (AAS) consumption among younger professional athletes is a significant risk factor for impaired neurodevelopment. Given the increased rates and overlapping symptomology of RmTBI and AAS use, we sought to investigate the behavioural and neuropathological outcomes associated with the AAS Metandienone (Met) and RmTBI on rats. Methods: Rats received either Met or placebo and were then administered RmTBIs or sham injuries, followed by a behavioural test battery. Post-mortem MRI was conducted to examine markers of brain integrity and qRT-PCR assessed mRNA expression of markers for neurodevelopment, neuroinflammation, stress responses, and repair processes. Results: Although AAS and RmTBI did not produce cumulative deficits, AAS use was associated with detrimental outcomes including changes to depression, aggression, and memory; prefrontal cortex (PFC) atrophy and amygdala (AMYG) enlargement; damaged white matter integrity in the corpus callosum; and altered mRNA expression in the PFC and AMYG. RmTBI affected general activity and contributed to PFC atrophy. Conclusions: Findings corroborate previous results indicating that RmTBI negatively impacts neurodevelopment but also demonstrates that AAS results in significant neuropathological insult to the developing brain.	[Tabor, Jason; Christensen, Jennaya; Collins, Reid; Mychasiuk, Richelle] Univ Calgary, Alberta Childrens Hosp, Hotchkiss Brain Inst, Dept Psychol,Res Inst, Calgary, AB T2N 1N4, Canada; [Wright, David K.; Christensen, Jennaya; Zamani, Akram; Shultz, Sandy R.; Mychasiuk, Richelle] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia		Mychasiuk, R (corresponding author), Univ Calgary, Alberta Childrens Hosp, Hotchkiss Brain Inst, Dept Psychol,Res Inst, Calgary, AB T2N 1N4, Canada.; Mychasiuk, R (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia.	jbtabor@ucalgary.ca; david.wright@monash.edu; jennaya.christensen@monash.edu; akram.zamani@monash.edu; reid.collins@ucalgary.ca; sandy.shultz@monash.edu; Richelle.mychasiuk@monash.edu		Mychasiuk, Richelle/0000-0001-5291-5083; Shultz, Sandy/0000-0002-2525-8775; Wright, David/0000-0002-7535-8651	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [PJT-153051]; Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [1304881]	This study was supported by the Canadian Institutes of Health Research (CIHR) grant number: PJT-153051 and Natural Sciences and Engineering Research Council of Canada (NSERC) grant number: 1304881.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Aikey JL, 2002, HORM BEHAV, V42, P448, DOI 10.1006/hbeh.2002.1838; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bahrke MS, 2000, SPORTS MED, V29, P397, DOI 10.2165/00007256-200029060-00003; Basaria S, 2001, J CLIN ENDOCR METAB, V86, P5108, DOI 10.1210/jc.86.11.5108; Bjornebekk A, 2017, BIOL PSYCHIAT, V82, P294, DOI 10.1016/j.biopsych.2016.06.017; Christophidis LJ, 2009, GROWTH HORM IGF RES, V19, P497, DOI 10.1016/j.ghir.2009.05.001; Clark AS, 2003, NEUROSCI BIOBEHAV R, V27, P413, DOI 10.1016/S0149-7634(03)00064-2; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033; Derntl B, 2009, PSYCHONEUROENDOCRINO, V34, P687, DOI 10.1016/j.psyneuen.2008.11.007; Epstein DJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.581; Farrell SF, 2004, HORM BEHAV, V46, P193, DOI 10.1016/j.yhbeh.2004.03.012; Frodl T, 2002, BIOL PSYCHIAT, V51, P708, DOI 10.1016/S0006-3223(01)01359-2; Germanakis I, 2013, FOOD CHEM TOXICOL, V61, P101, DOI 10.1016/j.fct.2013.03.018; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Goetz SMM, 2014, BIOL PSYCHIAT, V76, P324, DOI 10.1016/j.biopsych.2014.01.016; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hall RCW, 2005, PSYCHOSOMATICS, V46, P285, DOI 10.1176/appi.psy.46.4.285; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Heldt SA, 2014, J NEUROSCI, V34, P2444, DOI 10.1523/JNEUROSCI.4085-12.2014; JAROW JP, 1990, AM J SPORT MED, V18, P429, DOI 10.1177/036354659001800417; Jasnow AM, 2005, BEHAV NEUROSCI, V119, P1125, DOI 10.1037/0735-7044.119.4.1125; Johnson RT, 2012, J COMP NEUROL, V520, P2531, DOI 10.1002/cne.23061; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Kaufman MJ, 2015, DRUG ALCOHOL DEPEN, V152, P47, DOI 10.1016/j.drugalcdep.2015.04.023; Kikinis Z, 2017, BRAIN INJURY, V31, P1376, DOI 10.1080/02699052.2017.1318450; Kolb B., 2004, BEHAV LAB RAT HDB TE; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kota LN, 2015, J NEUROPSYCH CLIN N, V27, pE92, DOI 10.1176/appi.neuropsych.13100240; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; LINDZEY G, 1961, NATURE, V191, P474, DOI 10.1038/191474a0; Lithgow K, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0247-1; Lowe MJ, 2006, NEUROIMAGE, V32, P1127, DOI 10.1016/j.neuroimage.2006.04.208; Meinhardt UJ, 2006, CLIN ENDOCRINOL, V65, P413, DOI 10.1111/j.1365-2265.2006.02676.x; Melloni RH, 1997, PHYSIOL BEHAV, V61, P359, DOI 10.1016/S0031-9384(96)00373-3; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MINKIN DM, 1993, PHARMACOL BIOCHEM BE, V44, P959, DOI 10.1016/0091-3057(93)90031-N; Morrison TR, 2015, HORM BEHAV, V69, P132, DOI 10.1016/j.yhbeh.2015.01.009; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; Odagaki Y, 2001, BRAIN RES, V898, P224, DOI 10.1016/S0006-8993(01)02188-6; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; Pope HG, 2014, AM J ADDICTION, V23, P371, DOI 10.1111/j.1521-0391.2013.12118.x; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; RF Silva F., 2013, CURR PSYCHOPHARMACOL, V2, P247, DOI [10.2174/22115560113026660007, DOI 10.2174/22115560113026660007]; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Sagoe D, 2014, ANN EPIDEMIOL, V24, P383, DOI 10.1016/j.annepidem.2014.01.009; Salberg S, 2018, J NEUROTRAUM, V35, P1895, DOI 10.1089/neu.2018.5744; Seitz J, 2017, PSYCHIAT RES-NEUROIM, V260, P1, DOI 10.1016/j.pscychresns.2016.12.003; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Smith JP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00121; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Steidle C, 2003, J CLIN ENDOCR METAB, V88, P2673, DOI 10.1210/jc.2002-021058; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001; Wallace TL, 2004, BIOL PSYCHIAT, V56, P151, DOI 10.1016/j.biopsych.2004.04.010; Wohleb ES, 2014, J NEUROSCI, V34, P2583, DOI 10.1523/JNEUROSCI.3723-13.2014; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zilles K., 1985, CORTEX RAT STEREOTAX, VVI, P1	73	2	2	1	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	MAY	2020	10	5							258	10.3390/brainsci10050258			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LZ2CN	WOS:000541036100056	32354109	Green Published, gold			2022-02-06	
J	Voormolen, DC; Zeldovich, M; Haagsma, JA; Polinder, S; Friedrich, S; Maas, AIR; Wilson, L; Steyerberg, EW; Covic, A; Andelic, N; Plass, AM; Wu, YJ; Asendorf, T; von Steinbuechel, N				Voormolen, Daphne C.; Zeldovich, Marina; Haagsma, Juanita A.; Polinder, Suzanne; Friedrich, Sarah; Maas, Andrew I. R.; Wilson, Lindsay; Steyerberg, Ewout W.; Covic, Amra; Andelic, Nada; Plass, Anne Marie; Wu, Yi-Jhen; Asendorf, Thomas; von Steinbuechel, Nicole		CENTER-TBI Participants	Outcomes After Complicated and Uncomplicated Mild Traumatic Brain Injury at Three- and Six-Months Post-Injury: Results from the CENTER-TBI Study	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury; outcome; generic and disease-specific health-related quality of life; complicated mild traumatic brain injury; functional outcome	QUALITY-OF-LIFE; MODERATE HEAD-INJURY; HEALTH; VALIDITY; QOLIBRI; PACKAGE; SCALE; PHQ-9; CARE	The objective of this study was to provide a comprehensive examination of the relation of complicated and uncomplicated mild traumatic brain injury (mTBI) with multidimensional outcomes at three- and six-months after TBI. We analyzed data from the Collaborative European NeuroTrauma Effectiveness Research (CENTER-TBI) research project. Patients after mTBI (Glasgow Coma scale (GCS) score of 13-15) enrolled in the study were differentiated into two groups based on computed tomography (CT) findings: complicated mTBI (presence of any traumatic intracranial injury on first CT) and uncomplicated mTBI (absence of any traumatic intracranial injury on first CT). Multidimensional outcomes were assessed using seven instruments measuring generic and disease-specific health-related quality of life (HRQoL) (SF-36 and QOLIBRI), functional outcome (GOSE), and psycho-social domains including symptoms of post-traumatic stress disorder (PTSD) (PCL-5), depression (PHQ-9), and anxiety (GAD-7). Data were analyzed using a multivariate repeated measures approach (MANOVA-RM), which inspected mTBI groups at three- and six-months post injury. Patients after complicated mTBI had significantly lower GOSE scores, reported lower physical and mental component summary scores based on the SF-36 version 2, and showed significantly lower HRQoL measured by QOLIBRI compared to those after uncomplicated mTBI. There was no difference between mTBI groups when looking at psychological outcomes, however, a slight improvement in PTSD symptoms and depression was observed for the entire sample from three to six months. Patients after complicated mTBI reported lower generic and disease specific HRQoL and worse functional outcome compared to individuals after uncomplicated mTBI at three and six months. Both groups showed a tendency to improve from three to six months after TBI. The complicated mTBI group included more patients with an impaired long-term outcome than the uncomplicated group. Nevertheless, patients, clinicians, researchers, and decisions-makers in health care should take account of the short and long-term impact on outcome for patients after both uncomplicated and complicated mTBI.	[Voormolen, Daphne C.; Haagsma, Juanita A.; Polinder, Suzanne; Steyerberg, Ewout W.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Zeldovich, Marina; Covic, Amra; Plass, Anne Marie; Wu, Yi-Jhen; von Steinbuechel, Nicole] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany; [Haagsma, Juanita A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Emergency Med, NL-3000 CA Rotterdam, Netherlands; [Friedrich, Sarah; Asendorf, Thomas] Univ Med Ctr Gottingen, Dept Med Stat, D-37073 Gottingen, Germany; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, B-2650 Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Dept Neurosurg, B-2650 Edegem, Belgium; [Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling FK9 4LJ, Scotland; [Steyerberg, Ewout W.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, NL-2333 ZC Leiden, Netherlands; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0450 Oslo, Norway; [Andelic, Nada] Univ Oslo, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, N-0373 Oslo, Norway		Voormolen, DC (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands.; Zeldovich, M (corresponding author), Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany.	d.voormolen@erasmusmc.nl; marina.zeldovich@med.uni-goettingen.de; j.haagsma@erasmusmc.nl; s.polinder@erasmusmc.nl; sarah.friedrich@med.uni-goettingen.de; Andrew.Maas@uza.be; l.wilson@stir.ac.uk; e.steyerberg@erasmusmc.nl; amra.covic@med.uni-goettingen.de; nandelic@online.no; annemarie.plass@med.uni-goettingen.de; yi-jhen.wu@med.uni-goettingen.de; thomas.asendorf@med.uni-goettingen.de; nvsteinbuechel@med.uni-goettingen.de	Wilson, Lindsay/A-3659-2009; Friedrich, Sarah/AAF-9038-2020; Castano-Leon, Ana M/ABF-6322-2020	Wilson, Lindsay/0000-0003-4113-2328; Friedrich, Sarah/0000-0003-0291-4378; Castano-Leon, Ana M/0000-0002-7918-5049; Radoi, Andreea/0000-0002-0677-3544	European Union 7th Framework program (EC grant) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Neurotrauma Sciences (USA)	CENTER-TBI was supported by the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA), from Integra LifeSciences Corporation (USA) and from Neurotrauma Sciences (USA).	Abouleish AE, 2015, ASA NEWSLETTER, V79, P38; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Friedrich S., 2020, MANOVA RM RESAMPLING; Friedrich S, 2019, R J, V11, P380; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jackson CH, 2011, J STAT SOFTW, V38, P1; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Karr JE, 2020, BRAIN INJURY, V34, P26, DOI 10.1080/02699052.2019.1669825; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; R Core Team, 2019, R LANG ENV STAT COMP; Shinn E, 2014, J AM COLL SURGEONS, V219, pE144, DOI 10.1016/j.jamcollsurg.2014.07.775; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Turner-Bowker, 2007, USERS MANUAL SF 36V2; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Veeramuthu V, 2017, WORLD NEUROSURG, V97, P416, DOI 10.1016/j.wneu.2016.10.041; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	47	2	2	2	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	MAY	2020	9	5							1525	10.3390/jcm9051525			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LY0OO	WOS:000540223800282	32443573	Green Published, gold			2022-02-06	
J	Walton, SR; Broshek, DK; Freeman, JR; Hertel, J; Meyer, JP; Erdman, NK; Resch, JE				Walton, Samuel R.; Broshek, Donna K.; Freeman, Jason R.; Hertel, Jay; Meyer, J. Patrick; Erdman, Nicholas K.; Resch, Jacob E.			Institutionally Based ImPACT Test (R) Normative Values May Differ from Manufacturer-Provided Normative Values	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Normative data; Baseline testing; Neuropsychological assessment	TEST-RETEST RELIABILITY; SPORT-RELATED CONCUSSION; NEUROPSYCHOLOGICAL ASSESSMENT; ATHLETIC TRAINERS; MANAGEMENT; LINE	Objective: The necessity for pre-injury baseline computerized neurocognitive assessments versus comparing post-concussion outcomes to manufacturer-provided normative data is unclear. Manufacturer-provided norms may not be equivalent to institution-specific norms, which poses risks for misclassifying the presence of impairment when comparing individual post-concussion performance to manufacturer-provided norms. The objective of this cohort study was to compare institutionally derived normative data to manufacturer-provided normative values provided by ImPACT (R) Applications, Incorporated. Method: National Collegiate Athletic Association Division 1 university student athletes (n = 952; aged 19.2 +/- 1.4 years, 42.5% female) from one university participated in this study by completing pre-injury baseline Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) assessments. Participants were separated into 4 groups based on ImPACT's age and gender norms: males <= 18 years old (n = 186), females <= 18 years old (n = 165), males >= 19 years old (n = 361) or females >= 19 years old (n = 240). Comparisons were made between manufacturer-provided norms and institutionally derived normative data for each of ImPACT's clinical composite scores: Verbal (VEM) and Visual (VIM) Memory, Visual Motor Speed (VMS), and Reaction Time (RT). Outcome scores were compared for all groups using a Chi-squared goodness of fit analysis. Results: Institutionally derived normative data indicated above average performance for VEM, VIM, and VMS, and slightly below average performance for RT compared to the manufacturer-provided data (chi(2) >= 20.867; p < 0.001). Conclusions Differences between manufacturer- and institution-based normative value distributions were observed. This has implications for an increased risk of misclassifying impairment following a concussion in lieu of comparison to baseline assessment and therefore supports the need to utilize baseline testing when feasible, or otherwise compare to institutionally derived norms rather than manufacturer-provided norms.	[Walton, Samuel R.; Hertel, Jay; Erdman, Nicholas K.; Resch, Jacob E.] Univ Virginia, Dept Kinesiol, 210 Emmet St S, Charlottesville, VA 22903 USA; [Walton, Samuel R.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Broshek, Donna K.] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22903 USA; [Freeman, Jason R.] Univ Virginia, Sports Psychol, Dept Athlet, Charlottesville, VA 22903 USA; [Meyer, J. Patrick] Univ Virginia, Dept Leadership Fdn & Policy, Charlottesville, VA 22903 USA; [Meyer, J. Patrick] Northwest Evaluat Assoc, Portland, OR 97209 USA		Walton, SR (corresponding author), Univ Virginia, Dept Kinesiol, 210 Emmet St S, Charlottesville, VA 22903 USA.	swaltonatc@gmail.com	Broshek, Donna/ABA-4208-2021; Erdman, Nicholas/ABA-4554-2020	Broshek, Donna/0000-0002-7175-7815; Erdman, Nicholas/0000-0001-8109-7585; Walton, Samuel/0000-0003-2647-5701			Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Brett BL, 2016, ARCH CLIN NEUROPSYCH, V31, P904, DOI 10.1093/arclin/acw055; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown CN, 2007, J ATHL TRAINING, V42, P515; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Cohen J., 2013, STAT POWER ANAL BEHA; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Cramer H., 1946, MATH METHODS STAT; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Henry LC, 2015, APPL NEUROPSYCH-CHIL, V4, P266, DOI 10.1080/21622965.2014.911094; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Lovell M. R, 2004, IMPACT VERSION 2 0 C; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Rabinowitz AR, 2015, DEV NEUROPSYCHOL, V40, P29, DOI 10.1080/87565641.2014.1001066; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Walton S. R., 2018, MED SCI SPORTS EXERC	31	2	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2020	35	3			SI		275	282		10.1093/arclin/acz068			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN7WL	WOS:000568997800005	31711107	Bronze			2022-02-06	
J	Zhang, M; Parikh, B; Dirlikov, B; Cage, T; Lee, M; Singh, H				Zhang, Michael; Parikh, Bhavya; Dirlikov, Ben; Cage, Tene; Lee, Marco; Singh, Harminder			Elevated risk of venous thromboembolism among post-traumatic brain injury patients requiring pharmaceutical immobilization	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Barbiturates; Deep venous thrombosis; Intracranial pressure; Neuromuscular blockade; Traumatic brain injury; Pulmonary embolism; Venous thromboembolism	DEEP-VEIN THROMBOSIS; PROPHYLAXIS; GUIDELINES	Traumatic brain injury (TBI) patients are known to have a high rate of venous thromboembolism (VTE), and additional neuromuscular blockade or barbiturate coma therapy has the theoretical risk of exacerbating baseline hemostasis and elevating the incidence of thromboembolic events. We conducted a single-institution retrospective review of patients surviving severe TBI, as determined by need for intracranial pressure (ICP) monitoring, who further required paralytics or barbiturate therapy to maintain ICP control. Patients were administered VTE prophylaxis as clinically appropriate. Predictors for VTE were subsequently determined with univariate and logistic multivariate regression analyses. The main cohort includes 144 patients, 34 of whom received pharmaceutical immobilization for ICP control. Mean ISS and GCS at intake were 31.9 and 5.2, respectively. Among those receiving vs not-receiving paralytics and/or barbiturate therapy, there was a statistical difference of 12/34 (35.3%) vs 18/110 (16.4%, p = 0.0280) in VTE events, at a mean time greater than two weeks from the time of trauma. Multivariate logistics regression indicated 3.2 times increased odds of developing a VTE (log odds = 1.17, p = 0.023). No pediatric patients were positive for an event (0/12 vs 7/22, p = 0.0356), and infections were only documented among those with VTE (0/22 vs 4/12, p = 0.0107). Overall, paralytics and barbiturate therapy were correlated with a higher incidence of VTE among TBI patients. Although the need for ICP control will outweigh an increase in thromboembolic risk, there is value for increased surveillance and screening during the prolonged inpatient stay of these patients. (C) 2020 Elsevier Ltd. All rights reserved.	[Zhang, Michael; Cage, Tene; Lee, Marco; Singh, Harminder] Stanford Univ, Dept Neurosurg, Sch Med, 300 Pasteur Dr, Palo Alto, CA 94305 USA; [Parikh, Bhavya] Meharry Med Coll, Sch Med, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA; [Parikh, Bhavya; Dirlikov, Ben; Cage, Tene; Lee, Marco; Singh, Harminder] Santa Clara Valley Med Ctr, Dept Neurosurg, 751 S Bascom Ave, San Jose, CA 95128 USA		Singh, H (corresponding author), Stanford Univ, Sch Med, 300 Pasteur Dr, Palo Alto, CA 94304 USA.	harman@stanford.edu		Zhang, Michael/0000-0002-7067-0689	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32 CA009695] Funding Source: Medline		Allen CJ, 2016, J PEDIATR SURG, V51, P168, DOI 10.1016/j.jpedsurg.2015.10.033; Boddi M, 2010, J THROMB HAEMOST, V8, P121, DOI 10.1111/j.1538-7836.2009.03664.x; Booth K, 2016, J TRAUMA NURS, V23, P284, DOI 10.1097/JTN.0000000000000234; Brandt MM, 2007, AM J SURG, V193, P383; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; Cipolle MD, 2002, J TRAUMA, V52, P453, DOI 10.1097/00005373-200203000-00007; Dengler BA, 2016, NEUROCRIT CARE, V25, P215, DOI 10.1007/s12028-016-0280-8; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Dickerson JC, 2020, J NEUROSURG, V132, P1589, DOI 10.3171/2018.12.JNS182800; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; Hanson SJ, 2010, J TRAUMA, V68, P52, DOI 10.1097/TA.0b013e3181a74652; KAUFMAN HH, 1983, ANGIOLOGY, V34, P627, DOI 10.1177/000331978303401001; Kory PD, 2011, CHEST, V139, P538, DOI 10.1378/chest.10-1479; Malato A, 2015, BLOOD TRANSFUS-ITALY, V13, P559, DOI 10.2450/2015.0277-14; Malinoski D, 2013, INJURY, V44, P80, DOI 10.1016/j.injury.2011.10.006; Medcalf RL, 2015, BLOOD, V125, P2457, DOI 10.1182/blood-2015-02-629808; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P1, DOI 10.1016/S0003-9993(96)90210-5; Minet C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1003-9; Murray MJ, 2016, CRIT CARE MED, V44, P2079, DOI 10.1097/CCM.0000000000002027; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Garcia JP, 2018, J EMERG MED, V54, P656, DOI 10.1016/j.jemermed.2017.12.020; Sumislawski JJ, 2018, J TRAUMA ACUTE CARE, V85, P907, DOI 10.1097/TA.0000000000002048; Valle EJ, 2014, J TRAUMA ACUTE CARE, V77, P243, DOI 10.1097/TA.0000000000000307; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V77, P238, DOI 10.1097/TA.0000000000000294; Viarasilpa T, 2020, J INTENSIVE CARE MED, V35, P1226, DOI 10.1177/0885066619841547	28	2	2	2	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2020	75						66	70		10.1016/j.jocn.2020.03.028			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LG7IU	WOS:000528270700013	32245600	Green Accepted			2022-02-06	
J	Aita, SL; Borgogna, NC; Aita, LJ; Ogden, ML; Hill, BD				Aita, Stephen L.; Borgogna, Nicholas C.; Aita, Lilah J.; Ogden, Melissa L.; Hill, Benjamin D.			Comparison of Clinical Psychologist and Physician Beliefs and Practices Concerning Malingering: Results from a Mixed Methods Study	PSYCHOLOGICAL INJURY & LAW			English	Article						Malingering; Effort; Validity; Survey; Medicine; Psychology	BASE RATES; SYMPTOM EXAGGERATION; PAIN; DISABILITY; CHALLENGES; SIGNS; MANAGEMENT; DIAGNOSIS; ISSUES	Malingering, or intentional feigning of impairment for an external incentive, has been the topic of extensive psychological research in recent decades. The emphasis on symptom validity assessment in training, practice, and research in clinical psychology is not echoed across other health professions. While past surveys of clinical psychologists revealed positive beliefs and attitudes toward validity assessment, much less is known about physicians in this area, particularly in regard to how they identify suspected malingering. To address this gap, we surveyed a sample of demographically similar clinical psychologists (n = 57) and physicians (n = 54) regarding their beliefs and practices about malingering. Unique to this study was the use of a mixed survey and mixed methods approach to analyzing quantitative and qualitative data. Broadly, survey findings indicated that more clinical psychologists reported documenting malingering in their careers compared with physicians (65.0% vs. 33.0%). Consistently, more clinical psychologists endorsed "always" or "often" being able to recognize malingering compared with physicians (73.7% vs. 22.2%). Clinical psychologists indicated that they ask patients or evaluees about potential external incentives (e.g., current involvement in litigation) much more often than physicians (70.0% vs. 16.0%). On average, clinical psychologists estimated higher base rates of malingering in six high-risk malingering diagnostic categories compared with physicians, with greatest estimation difference noted for mild traumatic brain injury (19.9% vs. 5.9%). Qualitative examination of respondent data generally converged with quantitative findings and provided additional insights to how conceptualizations of malingering differ across healthcare disciplines. Implications for practice and study limitations are discussed.	[Aita, Stephen L.; Borgogna, Nicholas C.; Aita, Lilah J.; Hill, Benjamin D.] Univ S Alabama, Dept Psychol, 75 South Univ Blvd, Mobile, AL 36688 USA; [Aita, Stephen L.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA; [Ogden, Melissa L.] Univ S Alabama, Dept Neurol, Mobile, AL USA		Aita, SL (corresponding author), Univ S Alabama, Dept Psychol, 75 South Univ Blvd, Mobile, AL 36688 USA.; Aita, SL (corresponding author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	sla1521@jagmail.southalabama.edu					American Psychological Association, 2016, 2015 APA SURV PSYCH; American Psychological Association, 2018, DEM US PSYCH WORKF F; Aronoff Gerald M, 2007, Pain Pract, V7, P178, DOI 10.1111/j.1533-2500.2007.00126.x; Association of American Medical Colleges, 2018, 2018 PHYS SPEC DAT R; Bass Christopher, 2019, Pract Neurol, V19, P96, DOI 10.1136/practneurol-2018-001950; Bass C, 2014, LANCET, V383, P1422, DOI 10.1016/S0140-6736(13)62186-8; Bender SD, 2018, CLIN ASSESSMENT MALI, P122; Bender SD, 2018, CLIN ASSESSMENT MALI, P42; Bond CF, 2006, PERS SOC PSYCHOL REV, V10, P214, DOI 10.1207/s15327957pspr1003_2; BURGOON M, 1994, J LANG SOC PSYCHOL, V13, P443, DOI 10.1177/0261927X94134005; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2015, J HEAD TRAUMA REHAB, V30, P228, DOI 10.1097/HTR.0000000000000110; Carroll S, 1995, COSTS EXCESSIVE MED; Chafetz M, 2013, ARCH CLIN NEUROPSYCH, V28, P633, DOI 10.1093/arclin/act038; Childs RA, 2002, J PERS ASSESS, V78, P130, DOI 10.1207/S15327752JPA7801_08; Christensen, 2017, ED RES QUANTITATIVE; Cohen J., 2013, STAT POWER ANAL BEHA; Dandachi-FitzGerald B, 2013, ARCH CLIN NEUROPSYCH, V28, P771, DOI 10.1093/arclin/act073; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Fishbain DA, 2004, CLIN J PAIN, V20, P399, DOI 10.1097/00002508-200411000-00004; Granacher RP, 2018, CLIN ASSESSMENT MALI, P243; Guriel Jennifer, 2003, Clin Psychol Rev, V23, P881; Harrison AG, 2010, APPL NEUROPSYCHOL, V17, P135, DOI 10.1080/09084281003715642; Hartwig M, 2006, LAW HUMAN BEHAV, V30, P603, DOI 10.1007/s10979-006-9053-9; Hill BD, 2018, APPL NEUROPSYCH-ADUL, V25, P312, DOI 10.1080/23279095.2018.1458502; Horner MD, 2014, CLIN NEUROPSYCHOL, V28, P703, DOI 10.1080/13854046.2014.925143; Iancu Iulian, 2003, Med Law, V22, P373; Jackson JC, 2011, J TRAUMA STRESS, V24, P609, DOI 10.1002/jts.20688; Jung B, 2007, PAIN MED, V8, P433, DOI 10.1111/j.1526-4637.2007.00315.x; Kanaan RA, 2011, J NEUROL NEUROSUR PS, V82, P961, DOI 10.1136/jnnp.2010.233114; Kokcu AT, 2017, J ROY ARMY MED CORPS, V163, P119, DOI 10.1136/jramc-2015-000591; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; LEAVITT F, 1986, PAIN, V25, P357, DOI 10.1016/0304-3959(86)90239-3; LeesHaley PR, 1997, J CLIN PSYCHOL, V53, P745, DOI 10.1002/(SICI)1097-4679(199711)53:7<745::AID-JCLP13>3.3.CO;2-7; LoPiccolo CJ, 1999, ANN MED, V31, P166, DOI 10.3109/07853899909115975; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Martelli MF, 2002, PAIN MANAGEMENT PRAC; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Mayou R, 2002, BRIT MED J, V325, P265, DOI 10.1136/bmj.325.7358.265; McDermott BE, 2007, PSYCHIAT CLIN N AM, V30, P645, DOI 10.1016/j.psc.2007.07.007; Mendelson G, 2004, CLIN J PAIN, V20, P423, DOI 10.1097/00002508-200411000-00007; Mihura JL, 2017, J PERS ASSESS, V99, P153, DOI 10.1080/00223891.2016.1201978; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moon M. A, 2017, CLIN NEUROLOGY NEWS; Musso MW, 2014, J ATTEN DISORD, V18, P186, DOI 10.1177/1087054712441970; NPSYCH, NEUR DISC LIST EL MA; Passik SD, 2007, PAIN MED, V8, P442, DOI 10.1111/j.1526-4637.2007.00338.x; Pella RD, 2012, ARCH CLIN NEUROPSYCH, V27, P45, DOI 10.1093/arclin/acr090; PRIDMORE S, 2004, AUSTRALAS PSYCHIATRY, V12, P134, DOI DOI 10.1080/j.1039-8562.2004.02085.x; Reinhard MA, 2011, J PERS SOC PSYCHOL, V101, P467, DOI 10.1037/a0023726; Resnick PJ, 2018, CLIN ASSESSMENT MALI, P98; Rogers R, 1998, LAW HUMAN BEHAV, V22, P353, DOI 10.1023/A:1025714808591; Rogers R., 2018, CLIN ASSESSMENT MALI, P3; Rosen J, 2004, AM J PSYCHIAT, V161, P1909, DOI 10.1176/appi.ajp.161.10.1909; Rosenthal R., 1991, METAANALYTIC PROCEDU, DOI 10.4135/9781412984997; Ruff RM, 2016, PSYCHOL INJ LAW, V9, P143, DOI 10.1007/s12207-016-9259-1; Samuel R.Z., 2005, PRIMARY PSYCHIAT, V12, P60; Schoonenboom J, 2017, KOLNER Z SOZIOL SOZ, V69, P107, DOI 10.1007/s11577-017-0454-1; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Simpson S. A., 2017, MALINGERING DISORDER, P1; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Stone J, 2009, BRAIN, V132, P2878, DOI 10.1093/brain/awp220; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Sullivan M, 2005, J PAIN, V6, P2, DOI 10.1016/j.jpain.2004.10.006; Swanson LM, 2010, FAM PRACT, V27, P487, DOI 10.1093/fampra/cmq051; Swiergosz AM, 2017, EPLASTY, V17; Vrij A, 2011, CURR DIR PSYCHOL SCI, V20, P28, DOI 10.1177/0963721410391245; WADDELL G, 1980, SPINE, V5, P117, DOI 10.1097/00007632-198003000-00005; Warner R. M., 2013, APPL STAT BIVARIATE; World Health Organization W, 2018, INT CLASSIFICATION D; Wygant DB, 2017, SPINE J, V17, P505, DOI 10.1016/j.spinee.2016.10.018; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4	74	2	2	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	SEP	2020	13	3					246	260		10.1007/s12207-020-09374-x		APR 2020	15	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	NH9OT	WOS:000529598000001					2022-02-06	
J	Curtis, L; ter Avest, E; Griggs, J; Wiliams, J; Lyon, RM				Curtis, L.; ter Avest, E.; Griggs, J.; Wiliams, J.; Lyon, R. M.			The ticking clock: does actively making an enhanced care team aware of the passage of time improve pre-hospital scene time following traumatic incidents?	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Trauma; HEMS; Scene time; Prompting timer	OF-HOSPITAL TIME; GOLDEN HOUR; INTUBATION; MORTALITY; PERCEPTION; INTERVALS; SHOCK	Introduction Pre-hospital enhanced care teams like Helicopter Emergency Medical Services (HEMS) are often dispatched to major trauma patients, including patients with traumatic brain injuries and those with major haemorrhage. For these patients, minimizing the time to definitive care is vital. The aim of this study was to determine whether increased awareness of elapsed on scene time produces a relevant time performance improvement for major trauma patients attended by HEMS, and weather introducing such a timer was feasible and acceptable to clinicians. Methods We performed a prospective cohort study of all single casualty traumatic incidents attended by Air Ambulance Kent Surrey Sussex (AAKSS) between 15 October 2016 and 23 May 2017 to test if introduction of a prompting scene timer within the service resulted in a reduction in pre-hospital scene times. Results The majority of the patients attended were male (74%) and sustained blunt trauma (92%). Overall, median scene time was 25.5 [IQR16.3] minutes before introduction of the scene timer and 23.0 [11.0] minutes after introduction, p = 0.13). Scene times for patients with a GCS < 8 and for patients requiring prehospital anaesthesia were significantly lower after introduction of the timer (28 [IQR 14] vs 25 [1], p = 0.017 and 34 [IQR 13] vs 28 [IQR11] minutes, p = 0.007 respectively). The majority of clinicians felt the timer made them more aware of passing time (91%) but that this had not made a difference to scene time (62%) or their practice (57%). Conclusion Audible scene timers may have the potential to reduce pre-hospital scene time for certain single casualty trauma patients treated by a HEMS team, particularly for those patients needing pre-hospital anaesthesia. Regular use of on-scene timers may improve outcomes by reducing time to definitive care for certain subgroups of trauma patients.	[Curtis, L.; ter Avest, E.; Griggs, J.; Lyon, R. M.] Redhill Airfield, Redhill Aerodrome, Air Ambulance Kent Surrey & Sussex, Redhill RH1 5YP, Surrey, England; [ter Avest, E.] Univ Groningen Hosp, Dept Emergency Med, Groningen, Netherlands; [Wiliams, J.; Lyon, R. M.] Univ Surrey, Sch Hlth Sci, Guildford, Surrey, England; [Wiliams, J.] South East Coast Ambulance Serv NHS Fdn Trust, Crawley, England		Curtis, L (corresponding author), Redhill Airfield, Redhill Aerodrome, Air Ambulance Kent Surrey & Sussex, Redhill RH1 5YP, Surrey, England.	LeighC@aakss.org.uk	Williams, Julia/AAQ-8655-2021	Williams, Julia/0000-0003-0796-5465	South East Coast Ambulance Service NHS Foundation Trust and Kent, Surrey & Sussex Air Ambulance Trust	No external funding was received for this study. Internal support was provided by South East Coast Ambulance Service NHS Foundation Trust and Kent, Surrey & Sussex Air Ambulance Trust.	[Anonymous], 2010, MAJ TRAUM CAR ENGL; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; CAMPBELL JP, 1995, ANN EMERG MED, V26, P590, DOI 10.1016/S0196-0644(95)70009-9; Carr BG, 2008, PREHOSP EMERG CARE, V12, P327, DOI 10.1080/10903120802096928; Cemalovic N, 2016, EMERG MED AUSTRALAS, V28, P295, DOI 10.1111/1742-6723.12575; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; FEERO S, 1995, AM J EMERG MED, V13, P133, DOI 10.1016/0735-6757(95)90078-0; Funder KS, 2011, EMERG MED J, V28, P797, DOI 10.1136/emj.2010.097535; Goodacre SW, 1997, J ACCID EMERG MED, V14, P283; Grosjean V, 1999, ERGONOMICS, V42, P1443, DOI 10.1080/001401399184802; Kidher E, 2012, INJURY, V43, P1386, DOI 10.1016/j.injury.2011.04.014; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; McCoy CE, 2013, ANN EMERG MED, V61, P167, DOI 10.1016/j.annemergmed.2012.08.026; Newgard CD, 2015, ANN EMERG MED, V66, P30, DOI 10.1016/j.annemergmed.2014.12.004; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Osterwalder Joseph J, 2002, Prehosp Disaster Med, V17, P75; Rosini J, 2013, CRIT CARE MED, V41, DOI 10.1097/01.ccm.0000439595.25402.74; Sampalis JS, 1997, J TRAUMA, V43, P608, DOI 10.1097/00005373-199710000-00008; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Trevisanuto D, 2016, J PEDIATR-US, V177, P103, DOI 10.1016/j.jpeds.2016.07.003; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; van der Velden MWA, 2008, EMERG MED J, V25, P444, DOI 10.1136/emj.2007.052662; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wyen H, 2013, EMERG MED J, V30, P1048, DOI 10.1136/emermed-2012-201962; Yeguiayan JM, 2011, CRIT CARE, V15, DOI 10.1186/cc9982	27	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	APR 29	2020	28	1							31	10.1186/s13049-020-00726-9			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LJ9VC	WOS:000530507200001	32349796	Green Published, gold			2022-02-06	
J	Tokshilykova, AB; Sarkulova, ZN; Kabdrakhmanova, GB; Utepkaliyeva, AP; Tleuova, AS; Satenov, ZK				Tokshilykova, Ainur B.; Sarkulova, Zhanslu N.; Kabdrakhmanova, Gulnar B.; Utepkaliyeva, Aigul P.; Tleuova, Arzikhiya S.; Satenov, Zhusupbek K.			Neuron-Specific Markers and their Correlation with Neurological Scales in Patients with Acute Neuropathologies	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Acute neuropathologies; Neuromarkers; Integral scales; Sensitivity; Specificity; Prognosis; Survival	TRAUMATIC BRAIN-INJURY; PROGNOSTIC VALUE; ACUTE STROKE; HEAD TRAUMA; ENOLASE; PROTEIN; S100B; BIOMARKERS; DAMAGE; EPIDEMIOLOGY	In predicting outcomes in patients with acute brain injury, current practice focuses special attention on neuron-specific proteins that reliably reflect the severity of the lesion. Further studies of molecular markers and their specificity and sensitivity could contribute to broadening the understanding of pathophysiological, diagnostic, and prognostic methods, which is vital to reducing the mortality and disability associated with these critical conditions. The purpose of this study was to assess the biomarkers of brain lesions and their correlative relations with the integral Glasgow Coma Scale (GCS) and National Institutes of Health Stroke Scale (NIHSS) in predicting severity and treatment outcomes in patients with acute neuropathologies. Ninety patients were examined, including those with traumatic brain lesions (16.6%, n = 15), hemorrhagic stroke (52.2%, n = 47), and ischemic stroke (31.1%, n = 28). Patients were classified into two groups according to the outcome of the disease: those who survived (group I, 57.8%, n = 52) and those who died (group II, 42.2%, n = 38). In comparison with the survivors, the group of patients who died demonstrated an initial increase in neuron-specific enolase (NSE) by 1.23 and S100 by 6.45 times, and in dynamics by 1.5 and 7.4 times. A significant correlation with NIHSS and GCS was determined for NSE (r = 0.1149; P = 0.3073 and r = -0.0758; P = 0.5011) and for S100 (r = 0.3243; P = 0.0031 and r = -0.2661; P = 0.0163). The receiver operating characteristic (ROC) curves were 0.828 for S100 and 0.712 for NSE. The degree of sensitivity and specificity of the markers was studied. Increased levels of S100 and NSE correlated with NIHSS and GCS, with sensitivity of 80.77 and 63.46% and specificity of 42.11 and 73.68%, respectively, and were predictive of adverse disease outcome. The survival analysis showed that early detection of these biomarkers enables the timely prognostication of the progression of secondary brain injury and aids in implementing treatment.	[Tokshilykova, Ainur B.; Sarkulova, Zhanslu N.; Kabdrakhmanova, Gulnar B.; Utepkaliyeva, Aigul P.; Tleuova, Arzikhiya S.; Satenov, Zhusupbek K.] West Kazakhstan Med Univ, Aktobe, Kazakhstan		Tokshilykova, AB (corresponding author), West Kazakhstan Med Univ, Aktobe, Kazakhstan.	tokshilykova@yandex.ru	Utepkaliyeva, Aigul/E-3050-2018	Utepkaliyeva, Aigul/0000-0002-3230-0433			Abboud T, 2017, WORLD NEUROSURG, V108, P669, DOI 10.1016/j.wneu.2017.09.074; Akshulakov SK, 2018, NAT CTR NEUROSURG JS, V1, P31; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Aslan G, 2012, NEUROSURG REV, V31, P439; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; David A, 2017, DIAGN INTERV IMAG, V98, P551, DOI 10.1016/j.diii.2017.03.010; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; El-Maraghi S, 2013, EGYPT J CRIT CARE ME, V1, P25, DOI 10.1016/j.ejccm.2012.12.002; Goldstein JN, 2008, NEUROCRIT CARE, V9, P277, DOI 10.1007/s12028-008-9049-z; Gonzalez-Garcia S, 2012, CLIN BIOCHEM, V45, P1302, DOI 10.1016/j.clinbiochem.2012.07.094; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Haupt WF, 2016, J NEUROPHYSIOL, V115, P1273, DOI 10.1152/jn.01012.2015; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Li R, 2017, CHINESE NEUROSURGICA, V3, P24, DOI [10.1186/s41016-017-0089-0, DOI 10.1186/S41016-017-0089-0, DOI 10.1186/s41016-017-0089-0]; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Lu KL, 2015, J NEUROL SCI, V359, P202, DOI 10.1016/j.jns.2015.10.034; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Naeimi ZS, 2006, BRAIN INJURY, V20, P463, DOI 10.1080/02699050600664418; Ng GJL, 2017, NEUROCHEM INT, V107, P11, DOI 10.1016/j.neuint.2017.01.005; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Selakovic V, 2005, J CLIN NEUROSCI, V12, P542, DOI 10.1016/j.jocn.2004.07.019; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Vijayan M, 2016, BBA-MOL BASIS DIS, V1862, P1984, DOI 10.1016/j.bbadis.2016.08.003; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Woertgen C, 2002, ACT NEUR S, V81, P205; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006	32	2	3	4	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	AUG	2020	70	8					1267	1273		10.1007/s12031-020-01536-5		APR 2020	7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	MJ2FR	WOS:000529597500001	32350763				2022-02-06	
J	MacGregor, AJ; Zouris, JM; Watrous, JR; McCabe, CT; Dougherty, AL; Galarneau, MR; Fraser, JJ				MacGregor, Andrew J.; Zouris, James M.; Watrous, Jessica R.; McCabe, Cameron T.; Dougherty, Amber L.; Galarneau, Michael R.; Fraser, John J.			Multimorbidity and quality of life after blast-related injury among US military personnel: a cluster analysis of retrospective data	BMC PUBLIC HEALTH			English	Article						Blast injury; Combat; Deployment; Military; Multimorbidity; Quality of life	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; WELL-BEING SCALE; QWB-SA; ADMINISTERED VERSION; MULTISYMPTOM ILLNESS; SEVERITY SCORE; HEALTH; VETERANS; PAIN	BackgroundBlast injury emerged as a primary source of morbidity among US military personnel during the recent conflicts in Iraq and Afghanistan, and led to an array of adverse health outcomes. Multimorbidity, or the presence of two or more medical conditions in an individual, can complicate treatment strategies. To date, there is minimal research on the impact of multimorbidity on long-term patient-reported outcomes. We aimed to define multimorbidity patterns in a population of blast-injured military personnel, and to examine these patterns in relation to long-term quality of life (QOL).MethodsA total of 1972 US military personnel who sustained a blast-related injury during military operations in Iraq and Afghanistan were identified from clinical records. Electronic health databases were used to identify medical diagnoses within the first year postinjury, and QOL was measured with a web-based assessment. Hierarchical cluster analysis methods using Ward's minimum variance were employed to identify clusters with related medical diagnosis categories. Duncan's multiple range test was used to group clusters into domains by QOL.ResultsFive distinct clusters were identified and grouped into three QOL domains. The lowest QOL domain contained one cluster with a clinical triad reflecting musculoskeletal pain, concussion, and mental health morbidity. The middle QOL domain had two clusters, one with concussion/anxiety predominating and the other with polytrauma. The highest QOL domain had two clusters with little multimorbidity aside from musculoskeletal pain.ConclusionsThe present study described blast-related injury profiles with varying QOL levels that may indicate the need for integrated health services. Implications exist for current multidisciplinary care of wounded active duty and veteran service members, and future research should determine whether multimorbidity denotes distinct post-blast injury syndromes.	[MacGregor, Andrew J.; Zouris, James M.; Watrous, Jessica R.; McCabe, Cameron T.; Dougherty, Amber L.; Galarneau, Michael R.] Naval Hlth Res Ctr, Med Modeling Simulat & Miss Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA; [Watrous, Jessica R.; McCabe, Cameron T.; Dougherty, Amber L.] Leidos Inc, 140 Sylvester Rd, San Diego, CA 92106 USA; [Fraser, John J.] Naval Hlth Res Ctr, Warfighter Performance Dept, 140 Sylvester Rd, San Diego, CA 92106 USA		MacGregor, AJ (corresponding author), Naval Hlth Res Ctr, Med Modeling Simulat & Miss Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	andrewmacgregor@protonmail.com	Fraser, John J./H-6714-2016	Fraser, John J./0000-0001-9697-3795; MacGregor, Andrew/0000-0003-1020-7390; McCabe, Cameron/0000-0001-8395-9142	US Navy Bureau of Medicine and Surgery [60808]	This study was funded by the US Navy Bureau of Medicine and Surgery under work unit no. 60808. The funder had no role in the study design, data collection, analysis, or interpretation, or writing of this manuscript.	ALDENDERFER M. S., 1984, SAGE U PAPER SERIES, V07-044; Andresen EM, 1998, MED CARE, V36, P1349, DOI 10.1097/00005650-199809000-00007; [Anonymous], 2009, GULF WAR HLTH LONG T, V7; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brodke DJ, 2016, J AM ACAD ORTHOP SUR, V24, P744, DOI 10.5435/JAAOS-D-15-00404; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Commission on Professional Hospital Activities:, 1977, INT CLASSIFICATION D; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Corsonello A, 2017, GERIATR GERONTOL INT, V17, P1770, DOI 10.1111/ggi.13054; Crofford Leslie J, 2015, Trans Am Clin Climatol Assoc, V126, P167; Davis S, 2006, MIL MED, V171, P220, DOI 10.7205/MILMED.171.3.220; de Regloix SB, 2017, J ROY ARMY MED CORPS, V163, P333, DOI 10.1136/jramc-2016-000733; Dougherty AL, 2013, J REHABIL RES DEV, V50, P893, DOI 10.1682/JRRD.2012.02.0024; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Dougherty AL, 2009, INJURY, V40, P772, DOI 10.1016/j.injury.2009.02.014; Engel Charles C Jr, 2004, J Am Acad Psychoanal Dyn Psychiatry, V32, P321, DOI 10.1521/jaap.32.2.321.35275; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Fraser JJ., 2020, CARDIOPULM PHYS THER, V31, P22, DOI 10.1097/CPT.0000000000000129; Frosch DL, 2004, ARTHRIT RHEUM-ARTHR, V51, P28, DOI 10.1002/art.20071; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Greer N, 2016, PREVALENCE EPIDEMIOL; Gwini SM, 2016, J OCCUP ENVIRON MED, V58, P659, DOI 10.1097/JOM.0000000000000755; Hoffman K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103082; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Hyams KC, 1996, ANN INTERN MED, V125, P398, DOI 10.7326/0003-4819-125-5-199609010-00007; Institute of Medicine [IOM], 2013, GULF WAR HLTH TREATM; Jones E, 2001, BRIT J PSYCHIAT, V178, P242, DOI 10.1192/bjp.178.3.242; Joseph AR, 2018, AM J EPIDEMIOL, V187, P7, DOI 10.1093/aje/kwx199; Kanesarajah J, 2018, MATURITAS, V109, P53, DOI 10.1016/j.maturitas.2017.12.004; Kaplan RM, 1997, PSYCHOL HEALTH, V12, P783, DOI 10.1080/08870449708406739; Le QA, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-59; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; MacGregor AJ, 2013, INJURY, V44, P1458, DOI 10.1016/j.injury.2012.10.009; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Mamczak Christiaan N, 2012, J Surg Orthop Adv, V21, P8; Mancino MJ, 2006, J NERV MENT DIS, V194, P877, DOI 10.1097/01.nmd.0000244686.79689.21; McAndrew LM, 2016, J REHABIL RES DEV, V53, P59, DOI 10.1682/JRRD.2014.10.0255; Nathan ML, 2013, MIL MED, V178, P126, DOI 10.7205/MILMED-D-12-00467; Newcomer SR, 2011, AM J MANAG CARE, V17, pE324; Northwood M, 2018, J ADV NURS, V74, P45, DOI 10.1111/jan.13408; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Pyne JM, 2003, J AFFECT DISORDERS, V76, P237, DOI 10.1016/S0165-0327(03)00106-X; Rosen PN, 2005, J CATARACT REFR SURG, V31, P369, DOI 10.1016/j.jcrs.2004.04.043; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Sang CN, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-016-0601-9; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sieber WJ, 2000, HEADACHE, V40, P662, DOI 10.1046/j.1526-4610.2000.040008662.x; Sieber WJ., 2008, QUALITY WELL BEING S; Smith M, 2018, TRAUMA, V20, P108, DOI 10.1177/1460408617728536; Songer TJ, 2000, AM J PREV MED, V18, P33, DOI 10.1016/S0749-3797(00)00107-0; Spooner SP, 2014, MIL MED, V179, P1319, DOI 10.7205/MILMED-D-14-00191; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Tanielian T, 2008, MG720CCF RAND CORP, DOI [10.7249/MG720, DOI 10.7249/MG720]; Taylor VH, 2017, CAN J DIABETES, V41, P448, DOI 10.1016/j.jcjd.2017.04.004; Teyhen DS, 2018, J ORTHOP SPORT PHYS, V48, P749, DOI 10.2519/jospt.2018.7979; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Watrous JR, 2018, MIL MED, DOI [10.1093/milmed/usy243, DOI 10.1093/MILMED/USY243.EPUB]; Woodruff SI, 2018, QUAL LIFE RES, V27, P1393, DOI 10.1007/s11136-018-1806-7; World Health Organization, 2007, INT CLASS FUNCT DIS	69	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2458		BMC PUBLIC HEALTH	BMC Public Health	APR 28	2020	20	1								10.1186/s12889-020-08696-4			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	LL0ZM	WOS:000531285300014	32345277	gold, Green Published			2022-02-06	
J	Irgens, I; Hoff, JM; Jelnes, R; Alexander, M; Stanghelle, JK; Thoresen, M; Rekand, T				Irgens, Ingebjorg; Hoff, Jana M.; Jelnes, Rolf; Alexander, Marcalee; Stanghelle, Johan K.; Thoresen, Magne; Rekand, Tiina			Spinal cord injury and development of pressure injury during acute rehabilitation in Norway: a national retrospective cross-sectional study	SPINAL CORD			English	Article							RISK-FACTORS; ULCERS; PREDICTORS	Study design A national, retrospective, cross-sectional study. Objectives To analyze the prevalence of pressure injury (PI), and characteristics associated with PI development in the hospitalized population of persons with a newly acquired spinal cord injury (SCI) between 2004 and 2014. Setting All three specialized Spinal Cord Units in Norway. Methods Demographic data related to prevalence and potential risk factors were retrieved from the electronic medical record (EMR). Statistical analyses were performed, using IBM SPSS Statistics, version 23. Results We identified 1012 individuals with a new SCI. Mean age at injury was 48 years (SD 19). The period prevalence of PI was 16% (95% CI = 0.14-0.19), and identified PI associations were complete SCI (OR = 0.1), being injured abroad (OR = 2.4), bowel (OR = 13), and bladder (OR = 9.2) dysfunction; comorbidities like diabetes mellitus 1 (OR = 7.9), diagnosed depression (OR = 3.8), ventilator support (OR = 3.0), drug abuse (OR = 3.0), and concurrent traumatic brain injury (OR = 1.7). Individuals in the age group of 15-29 years had higher odds of PI compared with middle-aged individuals (45-59 years). Conclusion PI is a serious complication after SCI. The association between depression or comorbidity and PI occurrence should be investigated more thoroughly. We recommend implementation of a simple follow-up program regarding observation and prevention of PI. Increased awareness of factors that could contribute to PI will help to focus on better prevention and early recognition of PI. This will contribute to more optimal rehabilitation.	[Irgens, Ingebjorg; Stanghelle, Johan K.] Sunnaas Rehabil Hosp, Bjornemyrveien 11, N-1450 Nesoddtangen, Norway; [Irgens, Ingebjorg; Stanghelle, Johan K.] Univ Oslo, Inst Clin Med, POB 1171, N-0318 Oslo, Norway; [Hoff, Jana M.; Rekand, Tiina] Haukeland Hosp, Dept Neurol, Spinal Cord Unit, Jonas Lies Vei 71, N-5053 Bergen, Norway; [Hoff, Jana M.] VID Specialized Univ, Fac Hlth, N-5021 Bergen, Norway; [Jelnes, Rolf] Hosp Snderjylland, Med Ctr, Kresten Philipsens Vej 15, DK-6200 Aabenraa, Denmark; [Alexander, Marcalee] Telerehabil Int Birmingham, Birmingham, AL 35242 USA; [Alexander, Marcalee] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Sch Med, 1670 Univ Blvd, Birmingham, AL 35233 USA; [Alexander, Marcalee] Harvard Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 25 Shattuck St, Boston, MA 02115 USA; [Thoresen, Magne] Univ Oslo, Dept Biostat, POB 1122, N-0318 Oslo, Norway; [Rekand, Tiina] Univ Gothenburg, Sahlgrenska Acad, Box 100, S-40530 Gothenburg, Sweden; [Rekand, Tiina] Univ Gothenburg, Inst Neurosci & Physiol, Box 100, S-40530 Gothenburg, Sweden		Irgens, I (corresponding author), Sunnaas Rehabil Hosp, Bjornemyrveien 11, N-1450 Nesoddtangen, Norway.; Irgens, I (corresponding author), Univ Oslo, Inst Clin Med, POB 1171, N-0318 Oslo, Norway.	Ingebjorg.irgens@sunnaas.no	Rekand, Tiina/A-6201-2008	Rekand, Tiina/0000-0002-2506-9501; Thoresen, Magne/0000-0003-1511-5938	DAM Foundation	The first author is funded by the DAM Foundation. Name and contact information for the trial founder: Linda Asheim, e-mail;linda.aasheim@nhf.no.The DAM foundation has no influence on the trial protocol or the results.	Apostolopoulou E, 2014, HLTH SCI J, V8, P333, DOI DOI 10.7475/KJAN.2015.27.3.347; Ash D, 2002, J CLIN NURS, V11, P470, DOI 10.1046/j.1365-2702.2002.00603.x; Baumgarten M, 2006, J GERONTOL A-BIOL, V61, P749, DOI 10.1093/gerona/61.7.749; Beeckman D, 2017, J TISSUE VIABILITY, V26, P47, DOI 10.1016/j.jtv.2016.02.004; Bhattacharya S, 2015, INDIAN J PLAST SURG, V48, P4, DOI 10.4103/0970-0358.155260; Biering-Sorensen F, 2017, SPINAL CORD, V55, P759, DOI 10.1038/sc.2017.59; Bredesen IM, 2015, INT J NURS STUD, V52, P149, DOI 10.1016/j.ijnurstu.2014.07.005; Brienza D, 2018, SPINAL CORD, V56, P28, DOI 10.1038/sc.2017.96; Chen D, 1999, ARCH PHYS MED REHAB, V80, P1397, DOI 10.1016/S0003-9993(99)90250-2; Coleman S, 2013, INT J NURS STUD, V50, P974, DOI 10.1016/j.ijnurstu.2012.11.019; Curry K, 1992, J Neurosci Nurs, V24, P185; Eslami V, 2012, SPINAL CORD, V50, P899, DOI 10.1038/sc.2012.75; Frankel H, 2007, AM SURGEON, V73, P1215; Greenhalgh DG, 2003, CLIN PLAST SURG, V30, P37, DOI 10.1016/S0094-1298(02)00066-4; Grigorian A, 2018, J AM COLL CLIN WOUND, V9, P24; Hagen EM, 2010, SPINAL CORD, V48, P313, DOI 10.1038/sc.2009.133; Halvorsen A, 2019, SPINAL CORD, V57, P324, DOI 10.1038/s41393-018-0223-7; Halvorsen A, 2019, SPINAL CORD, V57, P331, DOI 10.1038/s41393-018-0225-5; Halvorsen A, 2018, NORWEGIAN SCI REGIST; Irgens I, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3185-y; Kang H, 2013, KOREAN J ANESTHESIOL, V64, P402, DOI 10.4097/kjae.2013.64.5.402; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kottner J, 2011, INT J NURS STUD, V48, P1339, DOI 10.1016/j.ijnurstu.2011.04.011; MAWSON AR, 1988, AM J PHYS MED REHAB, V67, P123, DOI 10.1097/00002060-198806000-00007; National Kidney Foundation, 2015, DIAB MAJ RISK FACT K; Regan MA, 2014, PRESSURE ULCERS FOLL; Salzberg CA, 1999, WOUNDS, V11, P45; Saunders LL, 2012, ARCH PHYS MED REHAB, V93, P972, DOI 10.1016/j.apmr.2012.02.004; Scovil CY, 2019, ARCH PHYS MED REHAB, V100, P327, DOI 10.1016/j.apmr.2018.07.444; Sheerin F, 2005, J Wound Care, V14, P112; Smith BM, 2008, AM J PHYS MED REHAB, V87, P750, DOI 10.1097/PHM.0b013e3181837a50; Strom V, 2017, AM J PHYS MED REHAB, V96, pS99, DOI 10.1097/PHM.0000000000000572; Tate DG, 2004, ARCH PHYS MED REHAB, V85, P1837, DOI 10.1016/j.apmr.2004.02.022; Taylor C, 2019, DIFFERENCE TYPE 1 TY; The National Regional Ethical Committee (REC), 2014 684 REK NORD; van der Wielen H, 2016, SPINAL CORD, V54, P726, DOI 10.1038/sc.2015.239; Verschueren JHM, 2011, SPINAL CORD, V49, P106, DOI 10.1038/sc.2010.66	37	2	2	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	OCT	2020	58	10					1069	1079		10.1038/s41393-020-0465-z		APR 2020	11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NV3RR	WOS:000529121400001	32341478	Green Accepted, Green Submitted			2022-02-06	
J	Post, A; Dawson, L; Hoshizaki, TB; Gilchrist, MD; Cusimano, MD				Post, Andrew; Dawson, Lauren; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Cusimano, Michael D.			Development of a test method for adult ice hockey helmet evaluation	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Ice hockey; concussion; standard; test methods	SYSTEMATIC VIDEO ANALYSIS; TRAUMATIC BRAIN-INJURIES; ACCIDENT RECONSTRUCTION; INTRACRANIAL-PRESSURE; DYNAMIC-RESPONSE; LEAGUE NHL; HEAD; CONCUSSION; ACCELERATION; BIOMECHANICS	Ice hockey helmet standards have primarily been developed to reduce risk of traumatic brain injury (TBI). While severe TBI has become a rare event in ice hockey, concussion, a type of mild TBI, remains a common head injury. Concussions, in ice hockey result from a number of head impact events including, collisions, stick impacts, puck impacts, falls into the boards, impacts to the glass, and falls to the ice. Helmet testing methods need to represent the impact events creating concussions in ice hockey. The purpose of this research was to develop a helmet test protocol and performance metric for concussive impacts in ice hockey. A protocol using concussion impact parameters from published literature was created that used monorail and linear impactors to impact a helmeted Hybrid III headform. The linear and rotational acceleration time curves were then used to calculate brain tissue strain using the University College Brain Trauma Model. The proposed test protocols created kinematic responses that were representative of levels associated with concussion in ice hockey. Rotational velocity and rotational acceleration were both identified as useful performance metrics representing levels of risk for concussion.	[Post, Andrew; Cusimano, Michael D.] St Michaels Hosp, Toronto, ON, Canada; [Post, Andrew; Dawson, Lauren; Hoshizaki, T. Blaine] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Post, Andrew; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), St Michaels Hosp, Toronto, ON, Canada.; Post, A (corresponding author), Univ Ottawa, Human Kinet, Ottawa, ON, Canada.; Post, A (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.	apost@uottawa.ca		Cusimano, Michael/0000-0002-9989-0650; Post, Andrew/0000-0002-5960-5552	Canadian Standards Association	Funding for this research was provided by the Canadian Standards Association.	Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Canadian Standards Accociation CSA, 2015, IC HOCK HELM; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Cournoyer J, 2019, J ATHL TRAINING, V54, P765, DOI 10.4085/1062-6050-253-18; de Grau S, 2020, P I MECH ENG P-J SPO, V234, P98, DOI 10.1177/1754337119871866; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBL D; Foreman S., 2011, 23 INT SOC BIOM C BR; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Gennarelli TA, 1972, 720970 SAE; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Ho J, 2008, GENERATION PATIENT S; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Madsen DP, 2008, EUR J ORTHODONT, V30, P532, DOI 10.1093/ejo/cjn031; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Oeur A., 2018, EFFECT RECONSTRUCTED; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Pauelsen M, 2017, CLIN J SPORT MED, V27, P283, DOI 10.1097/JSM.0000000000000347; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Post A., 2019, 42 CAN MED BIOL ENG; Post A, 2019, COMPUT METHOD BIOMEC, V22, P713, DOI 10.1080/10255842.2019.1588255; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2017, J NEUROSURG-PEDIATR, V19, P641, DOI 10.3171/2016.11.PEDS16383; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Rousseau P., 2014, ANAL CONCUSSION METR; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Yang J, 2011, COMPUTATIONAL BIOMEC; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	61	2	2	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	AUG 17	2020	23	11					690	702		10.1080/10255842.2020.1758680		APR 2020	13	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	NB4ZB	WOS:000532020700001	32343185				2022-02-06	
J	Bergfeldt, U; Stromberg, J; Ramstrom, T; Kulbacka-Ortiz, K; Reinholdt, C				Bergfeldt, Ulla; Stromberg, Joakim; Ramstrom, Therese; Kulbacka-Ortiz, Katarzyna; Reinholdt, Carina			Functional outcomes of spasticity-reducing surgery and rehabilitation at 1-year follow-up in 30 patients	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Article						Spasticity; hand surgery; rehabilitation; motor function; pain; range of motion	UPPER EXTREMITY SPASTICITY; TOXIN TYPE-A; BOTULINUM TOXIN; DOUBLE-BLIND; RELIABILITY; INJURY; STROKE; MUSCLE; GRIP	The effects of spasticity-reducing surgery in the upper extremity were assessed in a prospective observational study of 30 consecutive patients with stroke (n = 13), incomplete spinal cord injury (n = 9), traumatic brain injury (n = 5), cerebral palsy (n = 2), and degenerative central nervous system disease (n = 1). Surgery, which included lengthening of tendons and release of muscles, was followed by early rehabilitation at three intensity levels depending on the patients' specific needs and conditions. At 12 months follow-up there were significant improvements in all outcome measures with the following mean values: spasticity decreased by 1.4 points (Modified Ashworth Scale, 0-5), visual analogue pain score by 1.3 points, and both Canadian Occupational Performance Measures increased (performance by 3.4 and satisfaction by 3.6), and most measures of joint position or mobility improved. Hand surgery combined with early and comprehensive rehabilitation improves function, activity and patients' satisfaction in patients with disabling spasticity with improvement lasting for at least 1 year.	[Bergfeldt, Ulla; Stromberg, Joakim; Ramstrom, Therese; Kulbacka-Ortiz, Katarzyna; Reinholdt, Carina] Univ Gothenburg, Ctr Adv Reconstruct Extrem, Gothenburg, Sweden		Bergfeldt, U (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Ctr Adv Reconstruct Extrem,Sahlgrenska Univ Hosp, Gothenburg, Sweden.	ullabergfeldt2@gmail.com	Stromberg, Joakim/ABB-4475-2021	Ramstrom, Therese/0000-0003-0893-6615	Promobilia Foundation	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: this work was supported by the Promobilia Foundation by a grant to Carina Reinholdt.	Akporehwe N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5572; BECHTOL CO, 1954, J BONE JOINT SURG AM, V36-A, P820, DOI 10.2106/00004623-195436040-00013; Bell Kathleen, 2016, Arch Phys Med Rehabil, V97, P179, DOI 10.1016/j.apmr.2015.05.010; Bergfeldt U, 2006, J REHABIL MED, V38, P166, DOI 10.1080/16501970500415348; Bhakta BB, 2000, J NEUROL NEUROSUR PS, V69, P217, DOI 10.1136/jnnp.69.2.217; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Cambridge-Keeling CA., 2002, REHABILITATION HAND, V5th ed., P169; Freeman RT, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5633; Friden J, 2010, J HAND SURG-AM, V35A, P1473, DOI 10.1016/j.jhsa.2010.06.003; Gschwind CR, 2019, J HAND SURG-EUR VOL, V44, P898, DOI 10.1177/1753193419866595; Kinnear BZ, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-29; Lance J.W., 1980, SPASTICITY DISORDERE, P185; Law M, 1990, Can J Occup Ther, V57, P82; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; MCCORMACK HM, 1988, PSYCHOL MED, V18, P1007, DOI 10.1017/S0033291700009934; Nair KPS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4737; Pierson SH, 1996, ARCH PHYS MED REHAB, V77, P717, DOI 10.1016/S0003-9993(96)90015-5; Reinholdt C, 2013, THESIS SURG RESTORAT; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; Skold C, 1999, ARCH PHYS MED REHAB, V80, P1548, DOI 10.1016/S0003-9993(99)90329-5; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Tang JB, 2016, J HAND SURG-EUR VOL, V41, P365, DOI 10.1177/1753193416641590; Tranchida GV, 2020, J HAND SURG-EUR VOL, V45, P34, DOI 10.1177/1753193419878973; Tsiampa VA, 2012, J PLAST SURG HAND SU, V46, P262, DOI 10.3109/2000656X.2012.684097; Turner-Stokes L, 2002, CLIN MED, V2, P128, DOI 10.7861/clinmedicine.2-2-128; Wangdell J, 2018, J HAND SURG-EUR VOL, V43, P613, DOI 10.1177/1753193418758852; Wangdell J, 2016, ARCH PHYS MED REHAB, V97, pS117, DOI 10.1016/j.apmr.2015.09.025; Wichers MJ, 2005, DISABIL REHABIL, V27, P583, DOI 10.1080/09638280400018445; WUOLLE KS, 1994, J HAND SURG-AM, V19A, P209, DOI 10.1016/0363-5023(94)90008-6; Yablon SA, 1996, NEUROLOGY, V47, P939, DOI 10.1212/WNL.47.4.939	30	2	2	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	OCT	2020	45	8					807	812	1753193420918743	10.1177/1753193420918743		APR 2020	6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	NV7PC	WOS:000534043900001	32338191				2022-02-06	
J	Ke, X; Yang, M; Luo, JM; Zhang, Y; Chen, XY				Ke, Xin; Yang, Ming; Luo, Jin-Ming; Zhang, Yu; Chen, Xiao-Yu			The role of serum Dickkopf-1 in predicting 30-day death in severe traumatic brain injury	BRAIN AND BEHAVIOR			English	Article						Dickkopf-1; humans; mortality; risk factors; severity; traumatic brain injury	WNT PATHWAY; CIRCULATING DICKKOPF-1; NEGATIVE MODULATOR; CONTRIBUTES; INDUCTION; INHIBITION; INFARCTION; FAMILY; CT	Objective Dickkopf-1 (DKK-1), an inhibitor of the canonical/-catenin cascade of the Wnt pathway, was upregulated in brain tissues of hemorrhagic stroke rats, and its rising circulating levels were associated with poor prognosis of acute ischemic stroke patients. We attempted to ascertain the relationship between serum DKK-1 levels and 30-day death after severe traumatic brain injury (sTBI). Materials and methods Serum DKK-1 levels were gauged in a total of 94 sTBI patients and 94 healthy controls. Trauma severity was assessed using Glasgow Coma Scale (GCS) and Rotterdam classification based on head computerized tomography scan. Prognostic variable was 30-day death. Results Compared with controls, serum DKK-1 levels were substantially elevated in patients (median value, 3.7 versus 1.0 ng/ml). Area under receiver operating characteristic curve was 0.802 (95% confidence interval (CI), 0.708-0.877) for predicting 30-day death. Adjusted logistic regression showed that serum DKK-1 levels above 3.7 ng/ml remained as an independent marker of 30-day death (odds ratio, 8.573; 95% CI, 1.386-53.020) and overall survival (hazard ratio, 7.322; 95% CI, 1.320-40.622). An intimate correlation existed between DKK-1 levels and GCS scores (r = -.649) in addition to Rotterdam classification (r = .664). Conclusions High serum levels of DKK-1 are closely associated with increasing severity and rising short-term mortality of sTBI.	[Ke, Xin; Luo, Jin-Ming; Zhang, Yu; Chen, Xiao-Yu] Taizhou First Peoples Hosp, Dept Crit Med, 218 Hengjie Rd, Taizhou 318020, Zhejiang, Peoples R China; [Yang, Ming] Taizhou First Peoples Hosp, Dept Neurosurg, Taizhou, Peoples R China		Luo, JM (corresponding author), Taizhou First Peoples Hosp, Dept Crit Med, 218 Hengjie Rd, Taizhou 318020, Zhejiang, Peoples R China.	ljm3572603679@163.com					Albanna EAM, 2016, J MATERN-FETAL NEO M, V29, P2171, DOI 10.3109/14767058.2015.1077807; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Cappuccio I, 2005, J NEUROSCI, V25, P2647, DOI 10.1523/JNEUROSCI.5230-04.2005; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Dun YY, 2012, NEUROSCI LETT, V525, P83, DOI 10.1016/j.neulet.2012.07.030; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Fujimoto K, 2016, J NEUROSURG, V124, P1640, DOI 10.3171/2015.4.JNS142760; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; He XW, 2016, ATHEROSCLEROSIS, V253, P22, DOI 10.1016/j.atherosclerosis.2016.08.003; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Li ZH, 2017, J MOL NEUROSCI, V61, P279, DOI 10.1007/s12031-017-0883-3; Mastroiacovo F, 2009, J CEREBR BLOOD F MET, V29, P264, DOI 10.1038/jcbfm.2008.111; Matrisciano F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016447; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Moors M, 2012, TOXICOL SCI, V125, P488, DOI 10.1093/toxsci/kfr304; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nik Amir, 2018, Bull Emerg Trauma, V6, P141, DOI 10.29252/beat-060208; Ostermann RC, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0975-y; Castrillon JLP, 2010, INT J CARDIOL, V145, P164, DOI 10.1016/j.ijcard.2009.07.025; Scott EL, 2013, STEROIDS, V78, P624, DOI 10.1016/j.steroids.2012.11.004; Seifert-Held T, 2011, ATHEROSCLEROSIS, V218, P233, DOI 10.1016/j.atherosclerosis.2011.05.015; Ueland T, 2009, ARTERIOSCL THROM VAS, V29, P1228, DOI 10.1161/ATVBAHA.109.189761; Zhu ZB, 2019, ARTERIOSCL THROM VAS, V39, P285, DOI 10.1161/ATVBAHA.118.311960	27	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	JUN	2020	10	6							e01589	10.1002/brb3.1589		APR 2020	8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	MH8ZZ	WOS:000527852900001	32324340	Green Published, gold			2022-02-06	
J	Lubner, RJ; Knoll, RM; Trakimas, DR; Bartholomew, RA; Lee, DJ; Walters, B; Nadol, JB; Remenschneider, AK; Kozin, ED				Lubner, Rory J.; Knoll, Renata M.; Trakimas, Danielle R.; Bartholomew, Ryan A.; Lee, Daniel J.; Walters, Brad; Nadol, Joseph B., Jr.; Remenschneider, Aaron K.; Kozin, Elliott D.			Long-term cochlear implantation outcomes in patients following head injury	LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY			English	Article						cochlear implant; cochlear implantation; head injury; temporal bone fracture	TEMPORAL BONE-FRACTURES; SENSORINEURAL HEARING-LOSS; TRAUMATIC BRAIN-INJURY; UNILATERAL DEAFNESS; BINAURAL HEARING; REHABILITATION	Objective In cases of a severe to profound sensorineural hearing loss following head injury, the cochlear implant (CI) is the primary option for auditory rehabilitation. Few studies, however, have investigated long-term CI outcomes in patients following head trauma, including those without temporal bone fracture (TBF). Herein, the aim of this study is to examine CI outcomes following cases of head injury with and without TBF. Methods Audiometric outcomes of patients who received a CI due to a head injury resulting in severe to profound hearing loss at two tertiary care hospitals were analyzed. Patients were divided into those who received a CI in a fractured temporal bone (group A, n = 11 patients corresponding to 15 ears) and those who received a CI in a non-fractured temporal bone (group B, n = 8 patients corresponding to nine ears). Primary outcomes included duration of deafness prior to CI and postoperative consonant-nucleus-constant whole word (CNC) scores. Results Nineteen patients (84% male), corresponding to 24 CIs, were identified. Fifteen CI were performed on ears with TBF (group A), and nine CI were performed on ears without TBF (group B). No patients had an enlarged vestibular aqueduct (EVA). The mean duration of deafness was 5.7 and 11.3 years in group A and group B, respectively. The mean duration of CI follow-up (CI experience) was 6.5 years in group A and 2.1 years in group B. The overall mean postoperative CNC score for all subjects was 68.6% (+/- 21.2%, n = 19 with CNC testing). There was no difference in CNC score between group A and group B (69.8% and 66% respectively, P = .639). Conclusion The study is among the largest series examining long-term outcomes of CI after head injury. CI is an effective method for auditory rehabilitation in patients after head injury. Level of evidence IV.	[Lubner, Rory J.; Knoll, Renata M.; Trakimas, Danielle R.; Bartholomew, Ryan A.; Lee, Daniel J.; Nadol, Joseph B., Jr.; Remenschneider, Aaron K.; Kozin, Elliott D.] Massachusetts Eye & Ear, Dept Otolaryngol, Boston, MA USA; [Lubner, Rory J.; Knoll, Renata M.; Trakimas, Danielle R.; Bartholomew, Ryan A.; Lee, Daniel J.; Nadol, Joseph B., Jr.; Remenschneider, Aaron K.; Kozin, Elliott D.] Harvard Med Sch, Dept Otolaryngol, Boston, MA 02115 USA; [Lubner, Rory J.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Trakimas, Danielle R.] Johns Hopkins Med Sch, Dept Otolaryngol, Baltimore, MD USA; [Walters, Brad] Univ Mississippi, Med Ctr, Dept Otolaryngol, Jackson, MS 39216 USA; [Remenschneider, Aaron K.] Univ Massachusetts, Med Ctr, Dept Otolaryngol, Worcester, MA USA		Remenschneider, AK; Kozin, ED (corresponding author), 243 Charles St, Boston, MA 02114 USA.	aaron_remenschneider@meei.harvard.edu; elliott_kozin@meei.harvard.edu		Lubner, Rory/0000-0001-9884-2799; Bartholomew, Ryan/0000-0002-8310-3544; Remenschneider, Aaron/0000-0003-0989-6264; Trakimas, Danielle/0000-0003-1974-1880	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01 DC016365] Funding Source: Medline		Arndt S, 2011, OTOL NEUROTOL, V32, P39, DOI 10.1097/MAO.0b013e3181fcf271; Bishop CE, 2010, LARYNGOSCOPE, V120, P552, DOI 10.1002/lary.20735; Brunner H, 1940, LARYNGOSCOPE, V50, P921; Camilleri AE, 1999, J LARYNGOL OTOL, V113, P454, DOI 10.1017/S0022215100144202; CANNON CR, 1983, ARCH OTOLARYNGOL, V109, P285; Ceranic BJ, 1998, J NEUROL NEUROSUR PS, V65, P523, DOI 10.1136/jnnp.65.4.523; Chen JX, 2018, AM J OTOLARYNG, V39, P338, DOI 10.1016/j.amjoto.2018.01.018; Chen ZN, 2012, CHINESE MED J-PEKING, V125, P4160, DOI 10.3760/cma.j.issn.0366-6999.2012.22.050; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; Chung Jae Ho, 2011, Am J Otolaryngol, V32, P256, DOI 10.1016/j.amjoto.2010.03.002; Clark G M, 1988, Acta Otolaryngol Suppl, V448, P1; Corrales CE, 2010, OTOL NEUROTOL, V31, P1508, DOI 10.1097/MAO.0b013e3181f0c848; de Heyning PV, 2008, ANN OTO RHINOL LARYN, V117, P645, DOI 10.1177/000348940811700903; Emerson LP, 2011, INDIAN J OTOLARYNGOL, V63, P45, DOI 10.1007/s12070-011-0117-x; Espahbodi M, 2015, AM J OTOLARYNG, V36, P578, DOI 10.1016/j.amjoto.2015.04.003; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; Faul M, 2010, TRAUMATIC BRAIN INJU; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Firszt JB, 2012, OTOL NEUROTOL, V33, P1339, DOI 10.1097/MAO.0b013e318268d52d; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; Food and Drug Administration, 2019, MED EL COCHL IMPL SY; FREDRICKSON JM, 1963, ARCHIV OTOLARYNGOL, V78, P770; GREEN JD, 1991, OTOLARYNG HEAD NECK, V104, P320, DOI 10.1177/019459989110400306; Greenberg SL, 2011, OTOL NEUROTOL, V32, P48, DOI 10.1097/MAO.0b013e3181ff73fd; Hagr Abdulrahman, 2011, J Otolaryngol Head Neck Surg, V40, P281; Hartrampf R., 1995, Annals of Otology Rhinology and Laryngology, V104, P416; HEALY GB, 1982, NEW ENGL J MED, V306, P1029, DOI 10.1056/NEJM198204293061705; IACOVOU E, 2011, J SURG CASE REP JUL; Ishai R, 2018, OTOLARYNG HEAD NECK, V159, P526, DOI 10.1177/0194599818769861; Jeon Eun-Sun, 2014, Korean J Audiol, V18, P148, DOI 10.7874/kja.2014.18.3.148; Kamakura T, 2016, HEARING RES, V339, P132, DOI 10.1016/j.heares.2016.06.015; Karch Stephanie J, 2016, US Army Med Dep J, P52; Kerman M, 2002, NEUROSURG QUART, V12, P23, DOI 10.1097/00013414-200203000-00003; Kerr A, 1968, Acta Otolaryngol, V65, P586, DOI 10.3109/00016486809121002; Khwaja S, 2012, OTOL NEUROTOL, V33, P1328, DOI 10.1097/MAO.0b013e3182659d19; LEVINE SC, 1989, AM J OTOL, V10, P477; LINTHICUM FH, 1991, AM J OTOL, V12, P245; Maillot O, 2017, J NEURORADIOLOGY, V44, P333, DOI 10.1016/j.neurad.2017.04.001; Medina M, 2014, OTOL NEUROTOL, V35, P260, DOI 10.1097/MAO.0000000000000235; MORGAN WE, 1994, LARYNGOSCOPE, V104, P426; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; NADOL JB, 1989, ANN OTO RHINOL LARYN, V98, P411, DOI 10.1177/000348948909800602; NAGERIS B, 1995, AM J EMERG MED, V13, P211, DOI 10.1016/0735-6757(95)90096-9; Nosan DK, 1997, OTOLARYNG HEAD NECK, V117, P67, DOI 10.1016/S0194-5998(97)70209-2; OTTE J, 1978, LARYNGOSCOPE, V88, P1231; Plontke SK, 2013, EUR ARCH OTO-RHINO-L, V270, P1757, DOI 10.1007/s00405-013-2350-2; Punte Andrea Kleine, 2011, Cochlear Implants Int, V12 Suppl 1, pS26, DOI 10.1179/146701011X13001035752336; Saraiya PV, 2009, EMERG RADIOL, V16, P255, DOI 10.1007/s10140-008-0777-3; SCHUKNECHT HF, 1950, ANN OTO RHINOL LARYN, V59, P331, DOI 10.1177/000348945005900203; Serin GM, 2010, AM J OTOLARYNG, V31, P350, DOI 10.1016/j.amjoto.2009.04.008; Shin JH, 2008, CLIN EXP OTORHINOLAR, V1, P171, DOI 10.3342/ceo.2008.1.3.171; Simons JP, 2005, OTOLARYNG HEAD NECK, V132, P809, DOI 10.1016/j.otohns.2004.06.711; Trakimas DR, 2019, OTOL NEUROTOL, V40, pE14, DOI 10.1097/MAO.0000000000002057; Vankoevering K, 2014, J TRAUMA TREAT, V3; Vermeire K, 2012, ORL J OTO-RHINO-LARY, V74, P52, DOI 10.1159/000335931; Vermeire K, 2009, AUDIOL NEURO-OTOL, V14, P163, DOI 10.1159/000171478; Virapongse CSB, 1987, RADIOLOGY DIAGNOSIS; Vlastarakos PV, 2014, EUR ARCH OTO-RHINO-L, V271, P2119, DOI 10.1007/s00405-013-2746-z; Voss O., 1936, CHIRURG SCHADELBASIS; Wittmaack K., 1932, ARCH F OHRENH, V131, P59; Zanetti D, 2010, INT J AUDIOL, V49, P788, DOI 10.3109/14992027.2010.497170; Zucker J J, 1989, Ophthalmic Plast Reconstr Surg, V5, P247, DOI 10.1097/00002341-198912000-00004; [No title captured]; [No title captured]	64	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2378-8038			LARYNGOSCOPE INVEST	Laryngoscope Investig. Otol.	JUN	2020	5	3					485	496		10.1002/lio2.378		APR 2020	12	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	MB2ZE	WOS:000527019500001	32596492	gold, Green Published			2022-02-06	
J	Howland, J; Campbell, J; Brown, L; Torres, A; Olshaker, J; Pearson, R; Hess, C				Howland, Jonathan; Campbell, Julia; Brown, Linda; Torres, Alcy; Olshaker, Jonathan; Pearson, Richard; Hess, Courtney			Perceptions of implementation of Massachusetts sports concussion regulations: results of a survey of athletic directors	INJURY EPIDEMIOLOGY			English	Article						Concussion; Mild traumatic brain injury; Athletic directors; Youth sports legislation		BackgroundIn 2011 the Massachusetts Department of Public Health issued regulations pursuant to 2010 Massachusetts youth sports concussion legislation that provided policies and procedures for persons engaged in the prevention, training, management, and return-to-activity for students who sustain head injury during interscholastic athletics, including Athletic Directors (ADs).MethodsA survey instrument was developed with participation from injury prevention experts at the Boston University School of Medicine, the Massachusetts Department of Public Health, and ADs. An electronic survey was sent to all AD members of the Massachusetts Interscholastic Athletic Association to assess their perceptions of implementation of the sports concussion law.ResultsResponse rate was 75% (260/346). The mean rating on a 0-10 scale (10 being "very important") on importance of the law for student safety was 9.24, and the mean rating of the law's impact on workload was 5.54. Perceived impact on workload varied as a function of whether or not the school also employed an athletic trainer (t=2.24, p=0.03). Most respondents (88%) reported that their school had a concussion management team, and 74% reported that they were informed "always" (31%) or "often" (43%) when a student-athlete experienced a head injury in a venue other than extracurricular sports. Most respondents (95%) endorsed that "all" or "most" school nurses were "very knowledgeable" about the law and regulations. Approximately half of all respondents endorsed that "all" or "most" teachers and guidance counselors were "very knowledgeable" about the law and regulations; 76% endorsed that "all" or "most" of students' physicians were "very knowledgeable" about the law and regulations; 59% endorsed that "all" or "most" parents were "very knowledgeable" about the law and regulations. Sixty-six percent endorsed that student-athletes with concussion "often" (10%) or "sometimes" (56%) misrepresent their symptoms to accelerate return-to-play; and, 70% perceived that student-athletes with concussion "often" (15%) or "sometimes" (55%) misrepresent their symptoms to avoid academics.ConclusionsADs perceive the sports concussion legislation as very important to student safety and positively assess implementation of the law and associated regulations. More effort is needed to increase understanding of the law among stakeholders including teachers, parents, and physicians.	[Howland, Jonathan; Campbell, Julia; Torres, Alcy; Olshaker, Jonathan] Boston Univ, Sch Med, Boston, MA 02215 USA; [Howland, Jonathan; Campbell, Julia; Torres, Alcy; Olshaker, Jonathan] Boston Univ, Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Howland, Jonathan; Campbell, Julia; Torres, Alcy; Olshaker, Jonathan] Boston Med Ctr, Injury Prevent Ctr, Boston, MA USA; [Brown, Linda] Massachusetts Dept Publ Hlth, Boston, MA USA; [Pearson, Richard] Massachusetts Interscholast Athlet Assoc, Franklin, MA USA; [Hess, Courtney] Univ Massachusetts, Sch Psychol, Dept Counseling, Amherst, MA 01003 USA		Campbell, J (corresponding author), Boston Univ, Sch Med, Boston, MA 02215 USA.; Campbell, J (corresponding author), Boston Univ, Med Ctr, Dept Emergency Med, Boston, MA 02215 USA.; Campbell, J (corresponding author), Boston Med Ctr, Injury Prevent Ctr, Boston, MA USA.	Julia.campbell@bmc.org			Massachusetts Department of Public Health through Centers for Disease Control and Prevention [NU17CE924835]	This research was made possible through funding from the Massachusetts Department of Public Health through Centers for Disease Control and Prevention grant NU17CE924835. The thoughts and opinions in this report do not necessarily reflect the opinions of the Massachusetts Department of Public Health.U	Brown L, 2015, INJ PREV, V21; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Centers for Disease Control and Prevention, 2019, TBI GET FACTS TRAUM; Centers for Disease Control and Prevention, 2019, SYMPT TRAUM BRAIN IN; Doucette ML, 2016, J LAW MED ETHICS, V44, P503, DOI 10.1177/1073110516667946; Flaherty MR, 2016, J PEDIAT, DOI [10.1016/jpeds.2016.08.025, DOI 10.1016/JPEDS.2016.08.025]; Hackman H, 2020, J SCH NURS, V36, P265, DOI 10.1177/1059840518818709; Hardesty W, 2019, J EMERG MED, V56, P571, DOI 10.1016/j.jemermed.2019.01.001; Howland J, 2018, J SCH NURS, V34, P344, DOI 10.1177/1059840517702697; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Massachusetts Department of Public Health, 2017, HLTH RISK BEH MASS Y, P67; Massachusetts Department of Public Health, 2018, RET SCH CONC 2018 BO; Sarmiento K, 2019, MORB MORTAL WKLY REP; Thompson LL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2151	14	2	2	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	APR 20	2020	7	1							13	10.1186/s40621-020-00240-7			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	TD5JT	WOS:000669363800001	32307023	Green Published, gold			2022-02-06	
J	Carnahan, JL; Judge, KS; Daggy, JK; Slaven, JE; Coleman, N; Fortier, EL; Suelzer, C; Fowler, NR				Carnahan, Jennifer L.; Judge, Katherine S.; Daggy, Joanne K.; Slaven, James E.; Coleman, Nicki; Fortier, Emily L.; Suelzer, Christopher; Fowler, Nicole R.			Supporting caregivers of veterans with Alzheimer's disease and traumatic brain injury: study protocol for a randomized controlled trial	TRIALS			English	Article						Alzheimer's disease; Dementia; Traumatic brain injury; Quality of life; Veterans; Caregivers; Collaborative care	QUALITY-OF-LIFE; PRIMARY-CARE; COLLABORATIVE CARE; DEMENTIA CARE; OLDER-ADULTS; TRAINING-PROGRAM; MEDICAL HOME; QOL-AD; PREVALENCE; DEPRESSION	BackgroundPatients with Alzheimer's disease and related dementias (ADRD) and traumatic brain injury (TBI) and their caregivers require cognitive and behavioral symptom management, interdisciplinary care, support for caregivers, and seamless care coordination between providers. Caring for someone with ADRD or TBI is associated with higher rates of psychological morbidity and burden, social isolation, financial hardship, and deterioration of physical health. Tremendous need exists for primary care-based interventions that concurrently address the care needs of dyads and aim to improve care and outcomes for both individuals with ADRD and TBI and their family caregivers.MethodsThe Aging Brain Care Acquiring New Skills While Enhancing Remaining Strengths (ABC ANSWERS) study is a randomized controlled trial that tests the effectiveness of an intervention based on two evidence-based programs that have been developed for and previously tested in populations with ADRD, TBI, stroke, and late-life depression and/or who have survived an intensive care unit stay. This study includes 200 dyads comprised of a veteran with a diagnosis of ADRD or TBI and the veteran's primary informal caregiver. Dyads are randomized to receive the ABC ANSWERS intervention or routine Veterans Health Administration (VHA) primary care with a standardized educational and resource information packet. Data collection occurs at baseline and three follow-up time points (3months, 6months, and 12months). The primary outcome is caregiver quality of life (QoL). A secondary measure for the caregiver is caregiver burden. Secondary measures for both the veteran and caregiver include symptoms of depression and anxiety.DiscussionThe ABC ANSWERS intervention integrates common features of an evidence-based collaborative care model for brain health while concurrently attending to the implementation barriers of delivering care and skills to dyads. We hypothesize that caregivers in dyads randomized to the ABC ANSWERS program will experience higher levels of QoL and lower levels of depression, anxiety, dyadic strain, and caregiver burden at 12months than those receiving usual VHA primary care.Trial registrationClinicalTrials.gov, NCT03397667. Registered on 12 January 2018.	[Carnahan, Jennifer L.; Fowler, Nicole R.] Indiana Univ Sch Med, Dept Med, 1101 West 10th St, Indianapolis, IN 46202 USA; [Carnahan, Jennifer L.; Fowler, Nicole R.] Div Gen Internal Med & Geriatr, Indianapolis, IN 46202 USA; [Carnahan, Jennifer L.; Coleman, Nicki; Fortier, Emily L.; Fowler, Nicole R.] Indiana Univ, Regenstrief Inst, Ctr Aging Res, Indianapolis, IN 46202 USA; [Judge, Katherine S.] Cleveland State Univ, Coll Sci & Hlth Profess, Dept Psychol, 1836 Euclid Ave, Cleveland, OH 44115 USA; [Daggy, Joanne K.; Slaven, James E.] Indiana Univ Sch Med, Dept Biostat, 410 West 10th St,Suite 3000, Indianapolis, IN 46202 USA; [Suelzer, Christopher] Richard L Roudebush VA Med Ctr Res Serv, 1481 West 10th St, Indianapolis, IN 46202 USA		Fowler, NR (corresponding author), Indiana Univ Sch Med, Dept Med, 1101 West 10th St, Indianapolis, IN 46202 USA.; Fowler, NR (corresponding author), Div Gen Internal Med & Geriatr, Indianapolis, IN 46202 USA.; Fowler, NR (corresponding author), Indiana Univ, Regenstrief Inst, Ctr Aging Res, Indianapolis, IN 46202 USA.	flowern@iupui.edu	Janson, Patrick/AAC-7581-2022		Department of DefenseUnited States Department of Defense [W81XWH-17-1-0574]; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Awards [KL2TR002530, UL1TR002529]	This study is funded by the Department of Defense under award W81XWH-17-1-0574. JLC reports receiving support from grants KL2TR002530 (A. Carroll, principal investigator) and UL1TR002529 (A. Shekhar, principal investigator) from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Awards. The funders have not played a role in the design, conduct, or analysis of the study.	Alzheimer's Association, 2017, ALZH DIS FACTS FIG; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; [Anonymous], 1992, SERV US IMP ELD INF; Austrom MG, 2004, GERONTOLOGIST, V44, P548, DOI 10.1093/geront/44.4.548; Bakas T, 1999, NURS RES, V48, P250, DOI 10.1097/00006199-199909000-00005; Bakas Tamilyn, 2004, J Neurosci Nurs, V36, P95; Bakas Tamilyn, 2002, Top Stroke Rehabil, V9, P34; Bass DM, 2012, AM J GERIAT PSYCHIAT, V20, P239, DOI 10.1097/JGP.0b013e31824108ca; Bass DM, 1996, J GERONTOL B-PSYCHOL, V51, pS121, DOI 10.1093/geronb/51B.3.S121; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Black BS, 2013, J AM GERIATR SOC, V61, P2087, DOI 10.1111/jgs.12549; BOUSTANI MA, 2008, AGING HLTH, V4, P311, DOI [DOI 10.2217/1745509X.4.3.311, 10.2217/1745509XA3.311]; Boustani MA, 2011, AGING MENT HEALTH, V15, P13, DOI 10.1080/13607863.2010.496445; Bradford A, 2009, ALZ DIS ASSOC DIS, V23, P306, DOI 10.1097/WAD.0b013e3181a6bebc; BRENNAN PF, 1995, NURS RES, V44, P166; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; BRODATY H, 1989, BMJ-BRIT MED J, V299, P1375, DOI 10.1136/bmj.299.6712.1375; Brodaty Henry, 2009, Dialogues Clin Neurosci, V11, P217; Buckwalter KC, 1999, ARCH PSYCHIAT NURS, V13, P80, DOI 10.1016/S0883-9417(99)80024-7; Callahan CM, 2011, AGING MENT HEALTH, V15, P5, DOI 10.1080/13607861003801052; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Carey P J, 1991, Oncol Nurs Forum, V18, P1341; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Cottingham AH, 2014, J AM GERIATR SOC, V62, P1364, DOI 10.1111/jgs.12886; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eapen Blessen C, 2015, Semin Neurol, V35, pe1, DOI 10.1055/s-0035-1549094; Frame A., 2013, EGEMS GENERATING EVI, V1, P1; French DD, 2014, HEALTH AFFAIR, V33, P613, DOI 10.1377/hlthaff.2013.1221; Garand L, 2005, INT J GERIATR PSYCH, V20, P512, DOI 10.1002/gps.1318; Gates NJ, 2014, J ALZHEIMERS DIS, V42, pS551, DOI 10.3233/JAD-141302; Gilbert M, 2014, INT PSYCHOGERIATR, V26, P1593, DOI 10.1017/S1041610214000842; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Judge KS, 2013, GERONTOLOGIST, V53, P280, DOI 10.1093/geront/gns076; Judge KS, 2010, GERONTOLOGIST, V50, P294, DOI 10.1093/geront/gnp162; Judge KS, 2010, GERONTOLOGIST, V50, P408, DOI 10.1093/geront/gnp138; Khan BA, 2015, AM J NURS, V115, P24, DOI 10.1097/01.NAJ.0000461807.42226.3e; Krestar ML, 2012, J EMPIR RES HUM RES, V7, P70, DOI 10.1525/jer.2012.7.2.70; LaMantia MA, 2015, J AM GERIATR SOC, V63, P1209, DOI 10.1111/jgs.13447; Little R. J., 2019, STAT ANAL MISSING DA, V793; Logsdon R. G., 1999, J MENTAL HLTH AGING, V5, P21, DOI DOI 10.1037/T00930-000; Logsdon RG, 2002, PSYCHOSOM MED, V64, P510, DOI 10.1097/00006842-200205000-00016; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Martire L M, 2002, CNS Spectr, V7, P791; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; Monahan PO, 2014, CLIN INTERV AGING, V9, P2123, DOI 10.2147/CIA.S64140; Monahan PO, 2012, CLIN INTERV AGING, V7, P143, DOI 10.2147/CIA.S30663; OBERST MT, 1989, CANCER NURS, V12, P209; Oberst MT, 1990, RES NURS HLTH, V13, P3; Odenheimer G, 2013, NEUROLOGY, V81, P1545, DOI 10.1212/WNL.0b013e3182a956bf; Ory MG, 1999, GERONTOLOGIST, V39, P177, DOI 10.1093/geront/39.2.177; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosland AM, 2013, AM J MANAG CARE, V19, pE263; Schulz R, 2004, JAMA-J AM MED ASSOC, V292, P961, DOI 10.1001/jama.292.8.961; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Sibener L, 2014, ALZHEIMERS DEMENT, V10, pS105, DOI 10.1016/j.jalz.2014.04.011; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Thorgrimsen L, 2003, ALZ DIS ASSOC DIS, V17, P201, DOI 10.1097/00002093-200310000-00002; Truzzi Annibal, 2013, Dement. neuropsychol., V7, P286, DOI 10.1590/S1980-57642013DN70300009; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wolak-Thierry A, 2015, AGING MENT HEALTH, V19, P274, DOI 10.1080/13607863.2014.927822; Yano EM, 2014, J GEN INTERN MED, V29, P547, DOI 10.1007/s11606-014-2835-8; Zhao QF, 2016, J AFFECT DISORDERS, V190, P264, DOI 10.1016/j.jad.2015.09.069	71	2	2	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	APR 19	2020	21	1								10.1186/s13063-020-4199-1			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	LI0XX	WOS:000529211000001	32306982	Green Published, gold			2022-02-06	
J	Plancikova, D; Leitgeb, J; Brazinova, A; Melichova, J; Sivco, P; Nemcovska, E; Pekarcikova, J; Majdan, M				Plancikova, Dominika; Leitgeb, Johannes; Brazinova, Alexandra; Melichova, Juliana; Sivco, Patrik; Nemcovska, Eva; Pekarcikova, Jarmila; Majdan, Marek			Characteristics and outcome of severe traumatic brain injuries based on occupational status	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Outcome; Occupational status; Epidemiology	SOCIOECONOMIC-STATUS; DETERMINANTS; PREVENTION; AUSTRIA	Purpose The association of TBI with socioeconomic characteristics of patients has not been studied extensively. The objective of this study was to analyse the differences in injury characteristics and outcome in TBI patients based on their occupational status. Methods Data on patients from 13 centres based in Austria, Croatia, Slovakia, Bosnia and Herzegovina, and Macedonia were included in the analysis. Demographic characteristics, injury characteristics, treatment and outcome at various post-injury stages were compared according to occupational status. Logistic regression was used to adjust for the effect of co-variates. ICU mortality, hospital mortality, 6 months mortality, and outcome at 6 months were used as dependent variables. Results Overall, 886 patients were analysed with a mean age of 45.5 years. High-level falls were most prevalent in the blue-collar group (19%), most low-level falls occurred in the retired group. Traffic accidents were most common in students. The injuries were most severe in the blue-collar group and students. Highest mortalities and unfavourable outcomes were in the retired, students and white-collar workers had the best outcomes. Compared to retired patients, all groups had higher odds of favourable outcome at 6 months after adjusting for co-variates-OR from 2.2 (95% CI 1.1-4.6) for entrepreneurs to 3.6 (95% CI 1.8-7.2) for the blue-collar group. Conclusion Our paper provides clues pertaining specifically to variations in patterns and outcomes of TBI according to occupational status which can inform prevention and planning of services and can serve to plan priorities for further research.	[Plancikova, Dominika; Melichova, Juliana; Sivco, Patrik; Nemcovska, Eva; Pekarcikova, Jarmila; Majdan, Marek] Trnava Univ, Inst Global Hlth & Epidemiol, Fac Hlth Sci & Social Work, Dept Publ Hlth, Hornopotocna 23, Trnava 91843, Slovakia; [Leitgeb, Johannes] Med Univ Vienna, Dept Orthoped & Trauma Surg, Vienna, Austria; [Leitgeb, Johannes; Brazinova, Alexandra; Majdan, Marek] Int Neurotrauma Res Org, Vienna, Austria; [Brazinova, Alexandra] Comenius Univ, Fac Med, Bratislava, Slovakia		Majdan, M (corresponding author), Trnava Univ, Inst Global Hlth & Epidemiol, Fac Hlth Sci & Social Work, Dept Publ Hlth, Hornopotocna 23, Trnava 91843, Slovakia.; Majdan, M (corresponding author), Int Neurotrauma Res Org, Vienna, Austria.	mmajdan@truni.sk	Brazinova, Alexandra/C-4265-2016; Pekarcikova, Jarmila/ABC-5131-2020	Brazinova, Alexandra/0000-0003-0625-256X; Sivco, Patrik/0000-0002-3663-326X	Austrian Ministry of Health; Austrian Worker's Compensation Board [FK 11/2008, FK 11/2010]; AUVA [FK 09/13]; Trnava University [9/TU/2019, 14/TU/2019, 12/TU/2019]	Professor Walter Mauritz was a founder and president of the International Neurotrauma Research Organisation in Vienna and he devoted his life to improve the outcomes and lives of patients after TBI. He was the principal investigator of the studies leading to the data used in this manuscript. He passed away in may 2015. We would like to dedicate this paper to his memory. We would like to ackowledge the work of Professor Martin Rusnak, co-founder of the International Neurotrauma Research Organisation for his work in managing the studies leading to the data used in this publication. We would like to acknowledge the members of the "Austrian Working Group on Improvement of Early TBI Care" for their work in the design of the study and collection of data used for analyses in this paper. The project was funded jointly by the Austrian Ministry of Health (Contract Oct. 15, 2008) and by the Austrian Worker's Compensation Board (AUVA; FK 11/2008 and FK 11/2010). Data analysis was supported by a grant from AUVA (FK 09/13). INRO was supported by an annual grant from Mrs. Ala Auersperg-Isham and Mr. Ralph Isham and by small donations from various sources. The work of Patrik Sivco on this paper was partly funded by an institutional grant from the Trnava University (Grant Number: 14/TU/2019). The work of Dominika Plancikova on this paper was partly funded by an institutional grant from the Trnava University (Grant Number: 12/TU/2019). The work of Juliana Melichova on this paper was partly funded by an institutional grant from the Trnava University (Grant Number: 9/TU/2019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amram O, 2015, INT J ENV RES PUB HE, V12, P15594, DOI 10.3390/ijerph121215009; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Gilbride Susan J, 2006, BMC Pediatr, V6, P30, DOI 10.1186/1471-2431-6-30; Haines KL, 2019, J SURG RES, V235, P131, DOI 10.1016/j.jss.2018.09.072; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kruithof N, 2017, INJURY, V48, P578, DOI 10.1016/j.injury.2017.01.013; Laflamme L, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/819687; Lahelma E, 2004, J EPIDEMIOL COMMUN H, V58, P327, DOI 10.1136/jech.2003.011148; Loberg JA, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012606; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mackenbach J, 2006, HLTH INEQUALITIES EU; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Majdan M, 2015, CENT EUR J PUBL HEAL, V23, P142; Majdan M, 2014, J NEUROTRAUM, V31, P1046, DOI 10.1089/neu.2013.3200; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; McHale P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210226; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Moore L, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0949-2; Potter BK, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-132; RCoreTeam, 2019, R A LANGUAGE AND ENV; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Sato N, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021621; Simpson K, 2005, J EPIDEMIOL COMMUN H, V59, P1072, DOI 10.1136/jech.2005.036723; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Zuckerman SL, 2017, J NEUROSURG-PEDIATR, V19, P652, DOI 10.3171/2017.1.PEDS16611	27	2	2	2	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	DEC	2021	47	6			SI		2035	2041		10.1007/s00068-020-01372-7		APR 2020	7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XE8ZQ	WOS:000527515300001	32306121	hybrid, Green Published			2022-02-06	
J	Fuller, CW; Taylor, A				Fuller, Colin W.; Taylor, Aileen			Ten-season epidemiological study of match injuries in men's international rugby sevens	JOURNAL OF SPORTS SCIENCES			English	Article						Sevens World Series; incidence; severity; burden; risk	RISK; DEMANDS; FATIGUE; LEVEL	The aim of this study was to describe the incidence, nature and causes of match injuries in men's international rugby sevens and to compare these to values for international rugby fifteens. The study comprised a 10-season, whole population, prospective study of the Sevens World Series. Over the ten seasons, the overall incidence of injury was 122.4 (95% CI = 116.3 to 128.9) injuries/1000 player-match-hours and the mean severity of injury was 43.0 (95% CI = 40.3 to 45.7) days-absence. There was an increasing trend in the incidence of injury over the ten-season period (slope = 5.3 injuries/1000 player-hours/season, R-2 = 0.68, p = 0.003) but no trend in the mean severity of injury (slope = 0.02 days/season, R-2 < 0.01, p = 0.971). Head/face (15.7%), knee (15.6%), ankle (15.4%) and shoulder/clavicle (11.9%) were the most common injury locations and ligament sprain (30.5%), muscle strain (16.4%), concussion (12.6%) and haematoma/bruise (10.6%) the most common types of injury sustained. Being-tackled (33.1%), tackling (23.4%), running (16.1%) and collisions (12.4%) were the most common events leading to injury. These results indicate that the burden of injury in international rugby sevens is two to three times higher than that reported for international rugby fifteens.	[Fuller, Colin W.] Colin Fuller Consultancy Ltd, Sutton, Bonington, England; [Fuller, Colin W.; Taylor, Aileen] World Rugby, Dublin, Ireland		Fuller, CW (corresponding author), Colin Fuller Consultancy Ltd, Sutton, Bonington, England.	ColinFullerConsultancy@gmail.com			World Rugby	This work was supported by World Rugby.	Best JP, 2005, BRIT J SPORT MED, V39, P812, DOI 10.1136/bjsm.2004.016402; Chavel B, 2010, TRANSP RES RECORD, P49, DOI 10.3141/2152-06; Drawer S, 2002, BRIT J SPORT MED, V36, P446, DOI 10.1136/bjsm.36.6.446; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; Fuller CW, 2007, CLIN J SPORT MED, V17, P177, DOI 10.1097/JSM.0b013e31803220b3; Fuller CW, 2007, CLIN J SPORT MED, V17, P182, DOI 10.1097/JSM.0b013e31805930b0; Fuller CW, 2019, SPORTS MED, V49, P621, DOI 10.1007/s40279-019-01083-z; Fuller CW, 2018, CLIN J SPORT MED, V28, P377, DOI 10.1097/JSM.0000000000000510; Fuller CW, 2018, J SCI MED SPORT, V21, P553, DOI 10.1016/j.jsams.2017.10.019; Fuller CW, 2018, SPORTS MED, V48, P1597, DOI 10.1007/s40279-018-0913-5; Fuller CW, 2017, BRIT J SPORT MED, V51, P1272, DOI 10.1136/bjsports-2016-097301; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Fuller CW, 2016, BRIT J SPORT MED, V50, P682, DOI 10.1136/bjsports-2016-096043; Fuller CW, 2015, BRIT J SPORT MED, V49, P458, DOI 10.1136/bjsports-2014-094369; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Fuller CW, 2010, CLIN J SPORT MED, V20, P179, DOI 10.1097/JSM.0b013e3181df1eea; Henderson MJ, 2018, KINESIOLOGY, V50, P49; Hendricks S, 2020, EUR J SPORT SCI, V20, P868, DOI 10.1080/17461391.2019.1675764; Higham DG, 2012, J SCI MED SPORT, V15, P277, DOI 10.1016/j.jsams.2011.11.256; Kruyt N, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00676; Quarrie K, 2020, SPORTS MED, V50, P227, DOI 10.1007/s40279-019-01177-8; Ross A, 2015, J SPORT SCI, V33, P1035, DOI 10.1080/02640414.2014.979858; Sterne, 2003, ESSENTIAL MED STAT; Toohey LA, 2019, AM J SPORT MED, V47, P1302, DOI 10.1177/0363546518825380; West DJ, 2014, J SCI MED SPORT, V17, P688, DOI 10.1016/j.jsams.2013.11.003; World Rugby, 2020, PLAYER WELF WORLD RU	26	2	2	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.	JUL 17	2020	38	14					1595	1604		10.1080/02640414.2020.1752059		APR 2020	10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	MY5EF	WOS:000526504400001	32286146				2022-02-06	
J	O'Hara, K; Campbell, J; Torres, A; Olshaker, J; Howland, J				O'Hara, Kathleen; Campbell, Julia; Torres, Alcy; Olshaker, Jonathan; Howland, Jonathan			Evaluation of Implementation of Massachusetts Sports Concussion Regulations: Results of Focus Groups with Athletic Directors	CUREUS			English	Article						concussion; mild traumatic brain injury; student athletes; athletic directors; focus groups		In 2018, the Massachusetts Department of Public Health (MDPH) conducted focus groups with athletic directors (ADs) from Massachusetts middle and high schools to assess the implementation of legislated regulations relative to the management of concussion (mild traumatic brain injuries; mTBI) among students engaged in extracurricular sports. Two tape-recorded focus groups were conducted with a facilitator. Lists of themes were synthesized by investigators. Overall, participating ADs expressed that the law and accompanying regulations were necessary and important for protecting student athletes, despite some burdensome aspects of implementation. Emerging themes included support for the law, some implementation problems, impact on workload, and recommendations for improving mandated procedures. ADs assume an important role in the management of middle and high school students' mTBI when given the authority to do so through legislation and regulation. Nonetheless, challenges to the daily application of legislated protocols exist and should continue to be evaluated.	[O'Hara, Kathleen; Campbell, Julia; Olshaker, Jonathan; Howland, Jonathan] Boston Med Ctr, Emergency Med, Boston, MA 02118 USA; [Torres, Alcy] Boston Univ, Sch Med, Pediat Neurol, Boston, MA 02118 USA		Campbell, J (corresponding author), Boston Med Ctr, Emergency Med, Boston, MA 02118 USA.	jkcampbe@bu.edu					[Anonymous], 2019, TRAUMATIC BRAIN INJU; [Anonymous], 2019, SUMMARY MATRIX STATE; [Anonymous], 2014, HEAD INJURIES CONCUS, V105; [Anonymous], 2018, RETURNING SCH CONCUS; Brown L, 2015, INJURY PREV, V21, pA5; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Doucette ML, 2016, J LAW MED ETHICS, V44, P503, DOI 10.1177/1073110516667946; Hackman H, 2020, J SCH NURS, V36, P265, DOI 10.1177/1059840518818709; Hardesty W, 2019, J EMERG MED, V56, P571, DOI 10.1016/j.jemermed.2019.01.001; Howland J, 2018, J SCH NURS, V34, P344, DOI 10.1177/1059840517702697; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2	11	2	2	0	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	APR 16	2020	12	4							e7691	10.7759/cureus.7691			11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	LD5EI	WOS:000526051700008	32431970	Green Published, gold			2022-02-06	
J	Vasterling, JJ; Aslan, M; Proctor, SP; Ko, J; Leviyah, X; Concato, J				Vasterling, Jennifer J.; Aslan, Mihaela; Proctor, Susan P.; Ko, John; Leviyah, Xenia; Concato, John			Long-term negative emotional outcomes of warzone TBI	CLINICAL NEUROPSYCHOLOGIST			English	Article						Depression; anxiety; stress; military; head injury	TRAUMATIC BRAIN-INJURY; ANXIETY STRESS SCALES; POSTTRAUMATIC-STRESS; POSTCONCUSSIVE SYMPTOMS; PSYCHIATRIC SEQUELAE; COGNITIVE DEFICITS; MILD; DEPRESSION; PREDICTORS; DEPLOYMENT	Objective: Many veterans of the Iraq and Afghanistan Wars have experienced traumatic brain injury (TBI). Although prior work has examined associations between TBI and development of psychiatric syndromes, less is known about associations between TBI and component emotions constituting these syndromes, especially in the long term. The purpose of this study was to examine the long-term emotional consequences of deployment-related TBI. Methods: As part of VA Cooperative Studies Program #566, we assessed a sample of n = 456 US Army soldiers prior to an index deployment to Iraq, and again an average of 8.3 years (SD = 2.4 years) after their deployment for a long-term follow-up assessment. In this report, we used adjusted regression analyses to examine the relationship of deployment TBI to depression, anxiety, and stress symptom severity measured at the long-term follow-up assessment. A structured interview was used to determine TBI history; the Depression, Anxiety, and Stress Scale, 21-item version (DASS-21) was used to determine emotional status at the follow-up evaluation. Results: Warzone TBI events, particularly when greater than mild in severity, were independently associated with depression, anxiety, and stress severity at long-term follow-up, even after taking into account variance attributable to pre-deployment emotional distress and war-zone stress. Post-hoc analyses did not detect independent associations of either number of events or injury mechanism with outcomes. Conclusions: These findings highlight the potentially enduring and multi-faceted emotional effects of deployment TBI, underscoring the need for early assessment of negative affectivity in warzone veterans reporting TBI.	[Vasterling, Jennifer J.] VA Boston Healthcare Syst, Psychol Serv, Boston, MA 02130 USA; [Vasterling, Jennifer J.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Vasterling, Jennifer J.; Leviyah, Xenia] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Aslan, Mihaela; Ko, John] Clin Epidemiol Res Ctr, VA Cooperat Studies Program, West Haven, CT USA; [Aslan, Mihaela; Concato, John] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Proctor, Susan P.] US Army, Environm Med Res Inst, Natick, MA USA; [Proctor, Susan P.] VA Boston Healthcare Syst, Res Serv, Boston, MA USA; [Concato, John] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA		Vasterling, JJ (corresponding author), VA Boston Healthcare Syst, Psychol Serv, Boston, MA 02130 USA.	jennifer.vasterling@va.gov			Department of Veterans Affairs (VA) Cooperative Studies ProgramUS Department of Veterans Affairs [566]; US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD 17-03-0020]; VA Clinical Sciences Research and Development	The study described in this manuscript was supported by the Department of Veterans Affairs (VA) Cooperative Studies Program #566. Support for previous collection of archived data used in this study's longitudinal analyses was provided by the US Army Medical Research and Materiel Command (DAMD 17-03-0020) and VA Clinical Sciences Research and Development.	Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; Arciniegas, 2000, Curr Treat Options Neurol, V2, P169; Aslan M, 2013, J INVEST MED, V61, P569, DOI [10.231/JIM.0b013e31828407ff, 10.2310/JIM.0b013e31828407ff]; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Church HR, 2019, NEUROREHABILITATION, V44, P333, DOI 10.3233/NRE-182631; Ciarleglio MM, 2018, BEHAV THER, V49, P653, DOI 10.1016/j.beth.2018.01.002; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Defense and Veterans Brain Injury Center, 2019, DOD WORLDW NUMB TBI; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Kazis L., 1999, HLTH STATUS OUTCOMES; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Ma HP, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/4364592; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; McNair DM, 1971, PROFILE MOOD STATES; Newsome MR, 2013, J INT NEUROPSYCH SOC, V19, P911, DOI 10.1017/S1355617713000817; O'Donnell ML, 2016, J CLIN PSYCHIAT, V77, pE473, DOI 10.4088/JCP.14m09721; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Randall D, 2017, J HEAD TRAUMA REHAB, V32, P134, DOI 10.1097/HTR.0000000000000250; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Shields C, 2016, NEUROPSYCHOL REHABIL, V26, P410, DOI 10.1080/09602011.2015.1037772; Smith D. H., 2006, BCMJ, V48, P510; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Swan AA, 2018, BRAIN INJURY, V32, P1637, DOI 10.1080/02699052.2018.1518539; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Vasterling JJ, 2016, AM J EPIDEMIOL, V184, P796, DOI 10.1093/aje/kww151; Vasterling JJ, 2015, MIL MED, V180, P524, DOI 10.7205/MILMED-D-14-00468; Vasterling JJ, 2006, MIL MED, V171, P253, DOI 10.7205/MILMED.171.3.253; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662; Yumul JN, 2016, PM&R, V8, P1097, DOI 10.1016/j.pmrj.2016.05.005; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	50	2	2	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 22	2020	34	6			SI		1088	1104		10.1080/13854046.2020.1749935		APR 2020	17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	MV0HS	WOS:000527150800001	32301397	Green Published			2022-02-06	
J	Arakkal, AT; Baron, AE; Lamb, MM; Fields, SK; Comstock, RD				Arakkal, Alan T.; Baron, Anna E.; Lamb, Molly M.; Fields, Sarah K.; Comstock, R. Dawn			Evaluating the effectiveness of traumatic brain injury state laws among high school athletes	INJURY EPIDEMIOLOGY			English	Article						Injury; Concussion; Traumatic brain injury; Traumatic brain injury laws; Profile likelihood approach; Public health	SPORT-RELATED CONCUSSION; FOOTBALL PLAYERS; LYSTEDT LAW; KNOWLEDGE; CHILDREN; DECLINE	Background: Traumatic brain injury legislation varies across states. A comprehensive nationwide evaluation of state traumatic brain injury laws is vital given growing populations of high school athletes. This study evaluates the effectiveness of traumatic brain injury laws by examining longitudinal trends in incident and recurrent concussion rates and determines if state level variations in legislation's language affected the observed trends. Methods: In this retrospective ecological study of a large national sample of US high schools from 2005/06 through 2017/18, piecewise regression models along with a profile likelihood approach were utilized to examine longitudinal trends in incident and recurrent concussion rates. Results: Overall incident concussion rates increased by an additional 1.85%/standardized month (STDM) (95% confidence interval (CI): 1.14, 2.56%) prior to law passage and decreased by an additional 1.08%/ STDM (95%CI: -1.43, -0.72%) after law passage. Similar trends were observed for overall recurrent concussion rates. Among states that specified the category of healthcare provider for return to play clearance, post-law recurrent concussion rates decreased on average by an additional 1.59%/STDM (95%CI: -3.42, 0.22%) compared to states that did not specify the category of healthcare provider. Conclusions: The passage of state level traumatic brain injury laws was associated with an increase in overall incident and recurrent concussion rates prior to law passage and a decrease in rates after law passage. Although not statistically significant, states with traumatic brain injury laws specifying the category of healthcare provider for return to play clearance had a greater rate of decline in post-law recurrent concussion rates compared to states not specifying the category of healthcare provider. The findings suggest that state traumatic brain injury laws may benefit from specifying the category of healthcare provider allowed to provide return to play clearance, if they do not already include such language.	[Arakkal, Alan T.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, 145 N Riverside Dr 100 CPHB, Iowa City, IA 52242 USA; [Baron, Anna E.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Anschutz Med Campus, Aurora, CO USA; [Lamb, Molly M.; Comstock, R. Dawn] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Anschutz Med Campus, Aurora, CO USA; [Fields, Sarah K.] Univ Colorado, Dept Commun, Denver, CO 80202 USA		Arakkal, AT (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Epidemiol, 145 N Riverside Dr 100 CPHB, Iowa City, IA 52242 USA.	alan-arakkal@uiowa.edu		Lamb, Molly/0000-0002-2331-2555	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01, R49/CE002106-01]	This work was supported in part by the Centers for Disease Control and Prevention (grant No. R49/CE000674-01, R49/CE001172-01, and R49/CE002106-01). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the Centers for Disease Control and Prevention.	Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Centers for Disease Control and Prevention, 2018, TRAUM BRAIN INJ CONC; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2019, HEADS; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Comstock RD, 2018, CONVENIENCE SAMPLE S; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Graham R, 2014, BOARD CHILDREN YOUTH; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hall CB, 2000, STAT MED, V19, P1555, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1555::AID-SIM445>3.0.CO;2-3; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harvey H., 2017, YOUTH SPORTS TRAUMAT; High School RIO, 2018, REP INF ONL; Itriyeva Khalida, 2017, Int J Adolesc Med Health, V31, DOI 10.1515/ijamh-2017-0070; Kerr ZY, 2021, CLIN J SPORT MED, V31, pE21, DOI 10.1097/JSM.0000000000000697; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mackenzie B, 2015, PEDIATR EMERG CARE, V31, P25, DOI 10.1097/PEC.0000000000000325; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; National Federation of State High School Associations, 2018, 2017-18 High School Athletics Participation Survey; O'Kane JW, 2014, PHYSICIAN SPORTSMED, V42, P39, DOI 10.3810/psm.2014.09.2074; Schwarz A., 2019, NY TIMES; STASINOPOULOS DM, 1992, COMPUT STAT DATA AN, V13, P461, DOI 10.1016/0167-9473(92)90119-Z; TISHLER A, 1981, J AM STAT ASSOC, V76, P980, DOI 10.2307/2287599; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	32	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	APR 13	2020	7	1							12	10.1186/s40621-020-00241-6			11	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	TD5JM	WOS:000669363100001	32279659	gold, Green Published			2022-02-06	
J	Han, LM; Ding, CS; Guo, YD; Wang, Y; Ding, YJ				Han, Leiming; Ding, Chensen; Guo, Yadong; Wang, Yong; Ding, Yanjun			Sensitively detecting mTBI biomarker S100B by using peptide-modified ratiometric fluorescent C/AuNCs nanoprobe	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						mTBI; Ratiometric fluorescent nanoprobe; Early diagnosis; Forensic practice	TRAUMATIC BRAIN-INJURY; GOLD NANOCLUSTERS; CARBON-DOTS; MILD; PROTEIN; ASSAY	Mild traumatic brain injury (mTBI) has become a tough nut in forensic science because of its minor damages but serious consequences. Utilizing biomarkers to diagnose mTBI has become a promising approach due to various shortcomings of traditional diagnostic methods. In this work, we developed a peptide-modified ratiometric fluorescent nanoprobe based on carbon dots (CDs) and gold nanoclusters (AuNCs) for the measurements of a pivotal biomarker S100B protein in the early diagnosis of mTBI. It has been found that florescence intensity of AuNCs at 580 nm was decreased as report signal while the florescence intensity of CDs was unchanged as reference signal in this sensing system when the surface modified peptide bind tightly with calcium-activated S100B. Under the optimized conditions, S100B concentration ranging from 0.03 to 1 mu g/mL was successfully determined within 30 min, and the detection limit of 0.01 mu g/mL was acquired through the standard rule (S/N = 3). Moreover, the detection of S100B in spiked blood samples were conducted with satisfactory recoveries. The as-prepared ratiometric fluorescent nanoprobe was proved to be a time-saving, convenient, and sensitive strategy, and it showed great prospects in the early diagnosis of mTBI in forensic practice.	[Han, Leiming; Guo, Yadong; Wang, Yong; Ding, Yanjun] Cent South Univ, Sch Basic Med Sci, Dept Forens Sci, Changsha 410013, Hunan, Peoples R China; [Ding, Chensen] Univ Luxembourg, Inst Computat Engn, 6 Ave Fonte, L-4364 Esch Sur Alzette, Luxembourg		Ding, YJ (corresponding author), Cent South Univ, Sch Basic Med Sci, Dept Forens Sci, Changsha 410013, Hunan, Peoples R China.	dingyanjun@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772025]	This study was funded by the National Natural Science Foundation of China (81772025).	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Antonio M, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8040200; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Celikbilek A, 2014, NEUROSCI LETT, V558, P53, DOI 10.1016/j.neulet.2013.10.067; Cevik S, 2019, CLIN NEUROL NEUROSUR, V183, DOI 10.1016/j.clineuro.2019.105380; Charpentier TH, 2010, J MOL BIOL, V396, P1227, DOI 10.1016/j.jmb.2009.12.057; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Dickens AM, 2018, J NEUROTRAUM, V35, P2673, DOI 10.1089/neu.2017.5272; Ding YJ, 2017, ANAL BIOANAL CHEM, V409, P7027, DOI 10.1007/s00216-017-0650-x; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Inman KG, 2002, J MOL BIOL, V324, P1003, DOI 10.1016/S0022-2836(02)01152-X; Jensen JL, 2015, ACTA CRYSTALLOGR D, V71, P1176, DOI 10.1107/S1399004715004216; Kim C, 2015, NANOSCALE, V7, P17820, DOI 10.1039/c5nr05608j; Kirov II, 2018, NEUROIMAG CLIN N AM, V28, P91, DOI 10.1016/j.nic.2017.09.007; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Lecca D, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104528; Li HM, 2017, ANAL BIOANAL CHEM, V409, P6655, DOI 10.1007/s00216-017-0621-2; Liu W, 2018, SENSOR ACTUAT B-CHEM, V262, P810, DOI 10.1016/j.snb.2018.01.222; Liu YM, 2014, J CHROMATOGR A, V1340, P128, DOI 10.1016/j.chroma.2014.03.011; Lu HZ, 2017, BIOSENS BIOELECTRON, V92, P147, DOI 10.1016/j.bios.2017.02.013; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Oris C, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0037; Pavan S, 2012, ANAL BIOANAL CHEM, V402, P3055, DOI 10.1007/s00216-011-5589-8; Plantier D, 2011, ANN PHYS REHABIL MED, V100; Raj V, 2010, ANAL CHIM ACTA, V662, P186, DOI 10.1016/j.aca.2010.01.007; Sadeghi AS, 2018, BIOSENS BIOELECTRON, V118, P137, DOI 10.1016/j.bios.2018.07.045; Shangguan JF, 2016, ANAL CHEM, V88, P7837, DOI 10.1021/acs.analchem.6b01932; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Song W, 2015, BIOSENS BIOELECTRON, V64, P234, DOI 10.1016/j.bios.2014.08.082; Wang H, 2018, ANAL BIOANAL CHEM, V410, P4379, DOI 10.1007/s00216-018-1091-x; Wang XY, 2014, ELECTROCHEM COMMUN, V39, P12, DOI 10.1016/j.elecom.2013.12.003; Woischneck D, 2017, CLIN RADIOL, V72, DOI 10.1016/j.crad.2016.11.011; Wu XQ, 2015, SENSOR ACTUAT B-CHEM, V211, P507, DOI 10.1016/j.snb.2015.01.115; Yu MZ, 2017, BIOSENS BIOELECTRON, V95, P41, DOI 10.1016/j.bios.2017.03.065; Zhang LY, 2016, ACS APPL MATER INTER, V8, P6646, DOI 10.1021/acsami.5b12084; Zhang M, 2012, ANALYST, V137, P601, DOI 10.1039/c1an15909g; Zou GZ, 2017, ANAL CHEM, V89, P13024, DOI 10.1021/acs.analchem.7b04188	39	2	2	5	23	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	JUN	2020	412	15			SI		3695	3702		10.1007/s00216-020-02613-9		APR 2020	8	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	LN2SS	WOS:000525165600001	32279166				2022-02-06	
J	Paraiso, HC; Wang, XQ; Kuo, PC; Furnas, D; Scofield, BA; Chang, FL; Yen, JH; Yu, IC				Paraiso, Hallel C.; Wang, Xueqian; Kuo, Ping-Chang; Furnas, Destin; Scofield, Barbara A.; Chang, Fen-Lei; Yen, Jui-Hung; Yu, I-Chen			Isolation of Mouse Cerebral Microvasculature for Molecular and Single-Cell Analysis	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						blood-brain barrier; endothelial cells; brain capillaries; single-cell isolation; microvasculature damage	BLOOD-BRAIN-BARRIER; AMYLOID-BETA; P-GLYCOPROTEIN; TRANSPORTER; DISRUPTION; CLEARANCE; PERICYTES; PATHWAYS	Brain microvasculature forms a specialized structure, the blood-brain barrier (BBB), to maintain homeostasis and integrity of the central nervous system (CNS). The BBB dysfunction is emerging as a critical contributor to multiple neurological disorders, including stroke, traumatic brain injury, autoimmune multiple sclerosis, and neurodegenerative diseases. The brain microvasculature exhibits highly cellular and regional heterogeneity to accommodate dynamic changes of microenvironment during homeostasis and diseases. Thus, investigating the underlying mechanisms that contribute to molecular or cellular changes of the BBB is a significant challenge. Here, we describe an optimized protocol to purify microvessels from the mouse cerebral cortex using mechanical homogenization and density-gradient centrifugation, while maintaining the structural integrity and functional activity of the BBB. We show that the isolated microvessel fragments consist of BBB cell populations, including endothelial cells, astrocyte end-feet, pericytes, as well as tight junction proteins that seal endothelial cells. Furthermore, we describe the procedures to generate single-cell suspensions from isolated microvessel fragments. We demonstrate that cells in the single-cell suspensions are highly viable and suitable for single-cell RNA-sequencing analysis. This protocol does not require transgenic mice and cell sorting equipment to isolate fluorescence-labeled endothelial cells. The optimized procedures can be applied to different disease models to generate viable cells for single-cell analysis to uncover transcriptional or epigenetic landscapes of BBB component cells.	[Paraiso, Hallel C.; Yu, I-Chen] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Ft Wayne, IN 46805 USA; [Wang, Xueqian] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Ft Wayne, IN USA; [Kuo, Ping-Chang; Furnas, Destin; Scofield, Barbara A.; Yen, Jui-Hung] Indiana Univ Sch Med, Dept Microbiol & Immunol, Ft Wayne, IN USA; [Chang, Fen-Lei] Indiana Univ Sch Med, Dept Neurol, Ft Wayne, IN USA		Yu, IC (corresponding author), Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Ft Wayne, IN 46805 USA.	ivoyu@iu.edu	Yen, Jui-Hung/AAV-3455-2020; Kuo, Ping-Chang/AAR-8920-2021	Yen, Jui-Hung Jimmy/0000-0002-7325-9756; Yu, I-Chen/0000-0001-5270-9888	Indiana Clinical and Translational Sciences Institute - NIH, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [UL1TR002529]; Indiana Clinical and Translation Sciences Award; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS102449]	This project was supported, in part, with support from the Indiana Clinical and Translational Sciences Institute, funded in part by Grant Number UL1TR002529 from the NIH, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. The Indiana Clinical and Translation Sciences Award was to I-CY. J-HY was supported by NIH R01NS102449.	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; BAHARY N, 1990, P NATL ACAD SCI USA, V87, P8642, DOI 10.1073/pnas.87.21.8642; Bauer B, 2008, J CEREBR BLOOD F MET, V28, P1222, DOI 10.1038/jcbfm.2008.16; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Camassa LMA, 2015, GLIA, V63, P2073, DOI 10.1002/glia.22878; Cembrowski MS, 2019, J NEUROSCI METH, V326, DOI 10.1016/j.jneumeth.2019.108353; Cope EC, 2018, J NEUROSCI, V38, P8889, DOI 10.1523/JNEUROSCI.0789-18.2018; Crouch EE, 2018, NAT PROTOC, V13, P738, DOI 10.1038/nprot.2017.158; Czupalla CJ, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3092; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Erion JR, 2014, J NEUROSCI, V34, P2618, DOI 10.1523/JNEUROSCI.4200-13.2014; Faraco G, 2019, NATURE, V574, P686, DOI 10.1038/s41586-019-1688-z; Ortiz GG, 2014, ARCH MED RES, V45, P687, DOI 10.1016/j.arcmed.2014.11.013; Guo SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052665; Hartz AMS, 2004, MOL PHARMACOL, V66, P387, DOI 10.1124/mol.104.001503; Hartz AMS, 2018, JOVE-J VIS EXP, DOI 10.3791/57346; Hartz AMS, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00186; Hartz AMS, 2012, STROKE, V43, P514, DOI 10.1161/STROKEAHA.111.627562; Hartz AMS, 2010, MOL PHARMACOL, V77, P715, DOI 10.1124/mol.109.061754; Hui T, 2018, STEM CELL REP, V11, P578, DOI 10.1016/j.stemcr.2018.07.003; Jung B, 2018, J CEREBR BLOOD F MET, V38, P456, DOI 10.1177/0271678X17697720; Kalluri AS, 2019, CIRCULATION, V140, P147, DOI 10.1161/CIRCULATIONAHA.118.038362; Kassner A, 2015, STROKE, V46, P3310, DOI 10.1161/STROKEAHA.115.008861; Lalonde S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1749-5; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Miller DS, 2000, MOL PHARMACOL, V58, P1357, DOI 10.1124/mol.58.6.1357; Munji RN, 2019, NAT NEUROSCI, V22, P1892, DOI 10.1038/s41593-019-0497-x; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Niedowicz DM, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-64; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Park L, 2011, P NATL ACAD SCI USA, V108, P5063, DOI 10.1073/pnas.1015413108; Sabbagh MF, 2018, ELIFE, V7, DOI 10.7554/eLife.36187; Saliba AE, 2014, NUCLEIC ACIDS RES, V42, P8845, DOI 10.1093/nar/gku555; Stranahan AM, 2016, J CEREBR BLOOD F MET, V36, P2108, DOI 10.1177/0271678X16642233; Sweeney MD, 2018, NAT NEUROSCI, V21, P1318, DOI 10.1038/s41593-018-0234-x; Wang XQ, 2014, J NEUROSCI, V34, P8585, DOI 10.1523/JNEUROSCI.2935-13.2014; Wang XQ, 2010, MOL PHARMACOL, V78, P376, DOI 10.1124/mol.110.063685; Yousef H, 2019, NAT MED, V25, P988, DOI 10.1038/s41591-019-0440-4; Yousef H, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3091; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	43	2	2	3	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	APR 9	2020	14								84	10.3389/fncel.2020.00084			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LJ4LF	WOS:000530137100001	32327974	Green Published, gold			2022-02-06	
J	Pinggera, D; Luger, M; Burgler, I; Bauer, M; Thome, C; Petr, O				Pinggera, Daniel; Luger, Markus; Buergler, Iris; Bauer, Marlies; Thome, Claudius; Petr, Ondra			Safety of Early MRI Examinations in Severe TBI: A Test Battery for Proper Patient Selection	FRONTIERS IN NEUROLOGY			English	Article						intrahospital transport; early magnetic resonance imaging; severe traumatic brain injury; intensive care management; critical ill patients	TRAUMATIC BRAIN-INJURY; INTRAHOSPITAL TRANSPORT; PROGNOSTIC VALUE; SECONDARY INSULTS; MANAGEMENT; MODERATE	Introduction: Early magnetic resonance imaging (MRI) provides important information for management and prognosis in patients with severe traumatic brain injury (sTBI). Yet, optimal timing of MRI remains unknown. The aim of our study was to evaluate the safety of early MRI and to identify a method for appropriate patient selection to minimize adverse events related to the intrahospital transport (IHT) and the MRI examination. Methods: Twenty-six patients with sTBI [mean Glasgow Coma Scale (GCS) 6, range 3-8] admitted to our neurosurgical ICU from 03/2015 to 12/2017 and receiving at least one MRI within the first 14 days after initial traumatic event were prospectively included in the study. The following requirements were fulfilled for at least 4 h prior to anticipated MRI: MAP > 70 mmHg, aPCO(2) 30-40 mmHg, stable ICP < 25 mmHg. All relevant cardiopulmonary and cerebral parameters and medication were recorded. The following MRI sequences were performed: DWI, FLAIR, 3D T2-space, 3D T1 MPRAGE, 3D SWI, 3D TOF, pASL, and H-1/P-31-MRS. Results: Four females and 22 males (aged 23-78 years, mean 46.4 years) with a median GCS on admission of 5 (range 3-8) were analyzed. In total, 40 IHTs were performed within the first 14 days (mean 6 days, range 1-14 days). Mean pre-MRI ICP was 14.1 mmHg (range 3-32 mmHg). The mean post-MRI ICP was 14.3 mmHg (range 3-29 mmHg), decreasing to a mean ICP of 13.2 mmHg after 1 h (range 3-29 mmHg). There were no significant differences in ICP measurements before and after MRI (p = 0.30). MAP remained stable with no significant changes during the entire IHT and MRI. No other adverse events were observed as well. Conclusion: Early MRI in acute severe TBI is feasible and safe. Yet, careful patient selection with prior adequate testing of cardiopulmonary and cerebral parameters is crucial to minimize transport- or examination-related morbidity.	[Pinggera, Daniel; Buergler, Iris; Bauer, Marlies; Thome, Claudius; Petr, Ondra] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria; [Luger, Markus] Med Univ Innsbruck, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria		Petr, O (corresponding author), Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria.	ondra.petr@yahoo.com	Bauer, Marlies/ABC-2537-2021	Bauer, Marlies/0000-0002-2338-8349			ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Bergman LM, 2017, CRIT CARE MED, V45, pE1043, DOI 10.1097/CCM.0000000000002653; Berkow LC, 2016, CURR OPIN ANESTHESIO, V29, P563, DOI 10.1097/ACO.0000000000000366; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chaikittisilpa N, 2017, NEUROCRIT CARE, V26, P196, DOI 10.1007/s12028-016-0308-0; Cuschieri J, 2012, ANN SURG, V255, P993, DOI 10.1097/SLA.0b013e31824f1ebc; Fanara B, 2010, CRIT CARE, V14, DOI 10.1186/cc9018; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; Humble SS, 2018, J TRAUMA ACUTE CARE, V85, P155, DOI 10.1097/TA.0000000000001852; Kleffmann J, 2016, NEUROCRIT CARE, V25, P440, DOI 10.1007/s12028-016-0274-6; Lawrence TP, 2017, NEUROSCI LETT, V655, P143, DOI 10.1016/j.neulet.2017.06.046; Manolakaki D, 2009, J TRAUMA, V66, P1008, DOI 10.1097/TA.0b013e31819adba2; Martin M, 2017, NEUROCRIT CARE, V26, P87, DOI 10.1007/s12028-016-0291-5; Newcombe VFJ, 2008, J NEUROSURG, V109, P159, DOI 10.3171/JNS/2008/109/7/0159; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; O'Phelan KH, 2018, J NEUROTRAUM, V35, P739, DOI 10.1089/neu.2016.4944; Picetti E, 2013, NEUROCRIT CARE, V18, P298, DOI 10.1007/s12028-012-9802-1; Schwebel C, 2013, CRIT CARE MED, V41, P1919, DOI 10.1097/CCM.0b013e31828a3bbd; Shakir A, 2016, J NEUROIMAGING, V26, P103, DOI 10.1111/jon.12286; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Stevens RD, 2014, CURR OPIN CRIT CARE, V20, P168, DOI 10.1097/MCC.0000000000000069; TOBIN JR, 1992, BRIT J ANAESTH, V69, P482, DOI 10.1093/bja/69.5.482; WEG JG, 1989, CHEST, V96, P631, DOI 10.1378/chest.96.3.631; Yang A, 2018, J NEUROTRAUM, V35, P308, DOI 10.1089/neu.2017.5335	25	2	2	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 7	2020	11								219	10.3389/fneur.2020.00219			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LH5WG	WOS:000528854700001	32373042	Green Published, gold			2022-02-06	
J	Azar, A; Bhagavathula, KB; Hogan, J; Ouellet, S; Satapathy, S; Dennison, CR				Azar, Austin; Bhagavathula, Kapil Bharadwaj; Hogan, James; Ouellet, Simon; Satapathy, Sikhanda; Dennison, Christopher R.			Protective Headgear Attenuates Forces on the Inner Table and Pressure in the Brain Parenchyma During Blast and Impact: An Experimental Study Using a Simulant-Based Surrogate Model of the Human Head	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						injury biomechanics; helmet; traumatic brain injury; blast; impact; surrogate model	POSSIBLE DAMAGE MECHANISM; OPERATION IRAQI FREEDOM; INDUCED OCULAR TRAUMA; MILITARY PERSONNEL; INJURY; EXPOSURE; SHOCK; RATS; WAVE; PATHOPHYSIOLOGY	Military personnel sustain head and brain injuries as a result of ballistic, blast, and blunt impact threats. Combat helmets are meant to protect the heads of these personnel during injury events. Studies show peak kinematics and kinetics are attenuated using protective headgear during impacts; however, there is limited experimental biomechanical literature that examines whether or not helmets mitigate peak mechanics delivered to the head and brain during blast. While the mechanical links between blast and brain injury are not universally agreed upon, one hypothesis is that blast energy can be transmitted through the head and into the brain. These transmissions can lead to rapid skull flexure and elevated pressures in the cranial vault, and, therefore, may be relevant in determining injury likelihood. Therefore, it could be argued that assessing a helmet for the ability to mitigate mechanics may be an appropriate paradigm for assessing the potential protective benefits of helmets against blast. In this work, we use a surrogate model of the head and brain to assess whether or not helmets and eye protection can alter mechanical measures during both head-level face-on blast and high forehead blunt impact events. Measurements near the forehead suggest head protection can attenuate brain parenchyma pressures by as much as 49% during blast and 52% during impact, and forces on the inner table of the skull by as much as 80% during blast and 84% during impact, relative to an unprotected head.	[Azar, Austin; Dennison, Christopher R.] Univ Alberta, Dept Mech Engn, Biomed Instrumentat Lab, Edmonton, AB T6G 1H9, Canada; [Bhagavathula, Kapil Bharadwaj; Hogan, James] Univ Alberta, Dept Mech Engn, Edmonton, AB T6G 1H9, Canada; [Ouellet, Simon] Def R&D Valcartier Res Ctr, Weap Effects & Protect Sect, Quebec City, PQ G3J 1X5, Canada; [Satapathy, Sikhanda] US Army Res Labs, Impact Phys Branch, Aberdeen, MD 21005 USA		Dennison, CR (corresponding author), Univ Alberta, Dept Mech Engn, Biomed Instrumentat Lab, Edmonton, AB T6G 1H9, Canada.	aazar@ualberta.ca; bhagavat@ualberta.ca; jdhogan@ualberta.ca; Simon.Ouellet@drdc-rddc.gc.ca; sikhanda.s.satapathy.civ@mail.mil; cdenniso@ualberta.ca			Army Research Laboratories [W911NF-16-2-0083]; Canada Foundation for Innovation (John R Evans Leaders Fund - High speed camera system for imaging the mechanics of Impact); Natural Sciences and Engineering Research Council (Canada)Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 018-04253]	Army Research Laboratories (W911NF-16-2-0083; Funder ID: 10.13039/100006754).; Canada Foundation for Innovation (John R Evans Leaders Fund - High speed camera system for imaging the mechanics of Impact) (Funder ID: 10.13039/501100001805).; Natural Sciences and Engineering Research Council (Canada) (Grant No. RGPIN 018-04253; Funder ID: 10.13039/501100000038).	21st Century Solutions Ltd, 1997, AN DIG HUM 3D BOD AN; Alphonse Vanessa D, 2015, Biomed Sci Instrum, V51, P143; [Anonymous], 2009, DESIGN WEEK, V24, P14; [Anonymous], 2018, LANCET ONCOL, V19, pe581; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2009, MEDIEN ZEIT, V24, P41; [Anonymous], 2013, NATSIONALNA BEZPEKA, V1, P15; BACKMAN ME, 1978, INT J ENG SCI, V16, P1, DOI 10.1016/0020-7225(78)90002-2; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Belmont PJ, 2010, J TRAUMA, V68, P204, DOI 10.1097/TA.0b013e3181bdcf95; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Butz RC, 2015, J BIOMECH, V48, P3816, DOI 10.1016/j.jbiomech.2015.09.032; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Choi Chul-Hee, 2012, Korean J Audiol, V16, P103, DOI 10.7874/kja.2012.16.3.103; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; CLEMEDSON CJ, 1956, AM J PHYSIOL, V184, P119, DOI 10.1152/ajplegacy.1955.184.1.119; Committee on Gulf War and Health, 2014, LONG TERM EFF BLAST, V3; Committee on Review of Test Protocols Used by the DoD to Test Combat Helmets and Board on Army Science and Technology, 2014, REV DEP DEF TEST PRO; Damhuis RAM, 2012, EUR RESPIR J, V40, P185, DOI 10.1183/09031936.00153611; de Klerk A, 2011, ENERG ENVIRON SCI, V4, P1177, DOI 10.1039/c0ee00692k; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; European Commission, 2009, OFF J EUR UNION L, VL15, P1; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Herbst B., 1998, 16 INT TECHN C ENH S; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Jones N, 2014, OCCUP ENVIRON MED, V71, P466, DOI 10.1136/oemed-2013-101903; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Knowles BM, 2017, ANN BIOMED ENG, V45, P2146, DOI 10.1007/s10439-017-1848-y; Knowles BM, 2017, J BIOMECH, V59, P59, DOI 10.1016/j.jbiomech.2017.05.016; Leonardi AD, 2013, ANN BIOMED ENG, V41, P2488, DOI 10.1007/s10439-013-0850-2; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Liu X.H., 2018, J ELECTROCHEM SOC, V165, pC145; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; MCELHANEY JH, 1995, J NEUROTRAUM, V12, P669, DOI 10.1089/neu.1995.12.669; McIntosh AS, 2003, BRIT J SPORT MED, V37, P325, DOI 10.1136/bjsm.37.4.325; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakatsuka Austin S, 2014, Hawaii J Med Public Health, V73, P256; Nelson N. W., 2015, BRAIN NEUROTRAUMA MO; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Office of Justice Programs, 2017, ACT NIJ STAND COMP T; OJEU L161/9, 2015, OFF J EUR UNION, V161, P9; Ouellet S, 2018, SHOCK WAVES, V28, P19, DOI 10.1007/s00193-017-0771-3; Ouellet S., 2014, DRDCRDDC2014P113; Ouellet S., 2012, DEV BIOFIDELIC HEAD; Ouellet S., 2012, P PERS ARM SYST S, P1; Ouellet S., 2014, PERS ARM SYST S PASS; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Raymond D, 2009, J BIOMECH, V42, P2479, DOI 10.1016/j.jbiomech.2009.07.018; SAE (Society of Automotive Engineers), 1995, J2111 SAE; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sances A Jr, 2001, Biomed Sci Instrum, V37, P423; SHUPAK A, 1993, ARCH OTOLARYNGOL, V119, P1362; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Standards Council of Canada, 2008, CANCSAZ262602 STAND; Stemper BD, 2014, PROG NEUROL SURG, V28, P14, DOI 10.1159/000358748; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Underwood J. L., 1981, TECHNOLOGY ASSESSMEN; Wallace D, 2012, J MIL VETERANS HEALT, V20, P10; Wang HCH, 2014, MIL MED, V179, P34, DOI 10.7205/MILMED-D-13-00504; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Williams ST, 2017, MIL MED, V182, P226, DOI 10.7205/MILMED-D-16-00042; Xydakis MS, 2015, NEUROLOGY, V84, P1559, DOI 10.1212/WNL.0000000000001475	78	2	2	1	6	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	APR 1	2020	142	4								10.1115/1.4044926			18	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	LB8WO	WOS:000524911400009	31539422	Bronze			2022-02-06	
J	Barlow, KM; Girgulis, KA; Goldstein, G; Crowe, EG; Vo, MK; Su, P; Esser, MJ; Dewey, D; Kirk, VG				Barlow, Karen M.; Girgulis, Katherine A.; Goldstein, Genevieve; Crowe, Erica G.; Vo, Mai K.; Su, Peter; Esser, Michael J.; Dewey, Deborah; Kirk, Valerie G.			Sleep Parameters and Overnight Urinary Melatonin Production in Children With Persistent Post-concussion Symptoms	PEDIATRIC NEUROLOGY			English	Article						Actigraphy; Traumatic brain injury; Sleep; Recovery; Concussion; Melatonin	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; POSTCONCUSSION SYNDROME; PSYCHIATRIC-DISORDERS; DISTURBANCES; ADOLESCENTS; ACTIGRAPHY; VALIDATION; DIFFICULTIES; PATTERNS	Background: Sleep disturbance is common after a mild traumatic brain injury (mTBI) in children, yet its biology is poorly understood. We aimed to explore sleep-related problems (SRPs), sleep-activity patterns, and endogenous melatonin production in children with different recovery trajectories following mTBI. We hypothesized that children with delayed recovery would have more SRPs and abnormal sleep-activity patterns, which would correlate with lower overnight melatonin production. Methods: In this prospective controlled cohort study, we enrolled 83 children with persistent symptoms, 26 children who had clinically recovered following mTBI, and 25 healthy controls. SRPs were evaluated using the sleep subscale of the Post-Concussion Symptom Inventory. Sleep actigraphy was performed for five to seven days at 37 (S.D. 7) days post-injury. Health-related quality of life and mood disturbance was assessed using the Child Health Questionnaire and the Behavior Assessment System for Children, respectively. Endogenous melatonin production was assessed using overnight urine collection. Results: The groups were similar in age (13.9 [S.D. 2.6] years) and sex (52% female). Regression analysis demonstrated increased SRP in the symptomatic group (9.0; 95% confidence interval: 7.6,11.1) compared with the recovered group (1.6; 95% confidence interval: 1.0, 2.4) and controls (2.0; 95% confidence intervals: 1.2, 3.2). Actigraphy parameters and urinary melatonin levels were not significantly different between groups. Neither SRPs nor actigraphy parameters correlated with anxiety and depression scores. Conclusions: Although children with persistent post-concussion symptoms reported more SRPs, this was not related to actigraphy sleep parameters or melatonin production. Further research is warranted to understand the pathophysiology of post-traumatic sleep disturbance. (C) 2019 Elsevier Inc. All rights reserved.	[Barlow, Karen M.; Esser, Michael J.; Dewey, Deborah; Kirk, Valerie G.] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Barlow, Karen M.; Esser, Michael J.; Dewey, Deborah; Kirk, Valerie G.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Barlow, Karen M.; Su, Peter] Univ Queensland, Fac Med, Childrens Hlth Res Ctr, St Lucia, Qld, Australia; [Girgulis, Katherine A.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Girgulis, Katherine A.; Goldstein, Genevieve; Crowe, Erica G.; Vo, Mai K.] Alberta Childrens Prov Gen Hosp, Sect Pediat, Calgary, AB, Canada; [Dewey, Deborah] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada		Barlow, KM (corresponding author), Univ Queensland, Dept Paediat, Ctr Childrens Hlth Res, Brisbane, Qld 4070, Australia.; Barlow, KM (corresponding author), Univ Queensland, Dept Clin Neurosci, Ctr Childrens Hlth Res, Brisbane, Qld 4070, Australia.	k.barlow@uq.edu.au	Barlow, Karen/I-6492-2019	Barlow, Karen/0000-0003-2612-8507; Dewey, Deborah/0000-0002-1323-5832; Goldstein, Genevieve/0000-0002-0898-920X	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [293375]; Faculty of Medicine, University of Calgary; Markin Undergraduate Student Research Program, University of Calgary	None of the authors report competing financial interests. This study was funded by Canadian Institutes of Health Research (grant number: 293375) and Faculty of Medicine, University of Calgary and the Markin Undergraduate Student Research Program, University of Calgary. These funding sources had no role in the design of this study and did not have any role during its execution, analyses, interpretation of the data, or decision to submit results.	Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; Alfano CA, 2009, DEPRESS ANXIETY, V26, P503, DOI 10.1002/da.20443; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Barclay NL, 2014, CURR TOP BEHAV NEURO, V16, P337, DOI 10.1007/7854_2013_239; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; Botchway EN, 2019, J HEAD TRAUMA REHAB, V34, P241, DOI 10.1097/HTR.0000000000000446; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brown EA, 2016, J PEDIATR PSYCHOL, V41, P244, DOI 10.1093/jpepsy/jsv090; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Cellini N, 2013, CHRONOBIOL INT, V30, P691, DOI 10.3109/07420528.2013.782312; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chaput JP, 2016, APPL PHYSIOL NUTR ME, V41, pS266, DOI 10.1139/apnm-2015-0627; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Grima NA, 2017, CURR OPIN PULM MED, V23, P493, DOI 10.1097/MCP.0000000000000429; Kanady JC, 2011, J SLEEP RES, V20, P214, DOI 10.1111/j.1365-2869.2010.00858.x; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Klante G, 1997, J PINEAL RES, V23, P191, DOI 10.1111/j.1600-079X.1997.tb00354.x; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Kuczynski Wojciech, 2016, Pneumonol Alergol Pol, V84, P302, DOI 10.5603/PiAP.2016.0038; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Landgraf JM, 1996, CHILD HLTH QUESTIONN; Landry-Roy C, 2018, J INT NEUROPSYCH SOC, V24, P769, DOI 10.1017/S1355617718000401; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Mantua J, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx062; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Meltzer LJ, 2016, SLEEP, V39, P1219, DOI 10.5665/sleep.5836; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Mollayeva T, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0800-z; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; MORRISON DN, 1992, J AM ACAD CHILD PSY, V31, P94, DOI 10.1097/00004583-199201000-00014; Mrazik M, 2016, ARCH CLIN NEUROPSYCH, V31, P297, DOI 10.1093/arclin/acw013; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Prause W, 2003, WIEN KLIN WOCHENSCHR, V115, P326, DOI 10.1007/BF03041484; Raat H, 2007, QUAL LIFE RES, V16, P675, DOI 10.1007/s11136-006-9157-1; Raikes AC, 2019, SLEEP MED, V54, P62, DOI 10.1016/j.sleep.2018.09.018; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Short MA, 2013, NAT SCI SLEEP, V5, P23, DOI 10.2147/NSS.S38369; Sullivan KA, 2020, DISABIL REHABIL, V42, P2243, DOI 10.1080/09638288.2018.1558292; Sumpter RE, 2013, J INT NEUROPSYCH SOC, V19, P829, DOI 10.1017/S1355617713000465; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Tham SW, 2019, BRAIN INJURY, V33, P1413, DOI 10.1080/02699052.2019.1643921; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Tomfohr-Madsen L, 2020, J HEAD TRAUMA REHAB, V35, pE103, DOI 10.1097/HTR.0000000000000504; Vallieres A, 2003, SLEEP, V26, P902, DOI 10.1093/sleep/26.7.902; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3	62	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	APR	2020	105						27	34		10.1016/j.pediatrneurol.2019.11.006			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	KW1RA	WOS:000520947400005	32029332				2022-02-06	
J	Bastian, NE; Heaton, LJ; Capote, RT; Wan, Q; Riedy, CA; Ramsay, DS				Bastian, Neal E.; Heaton, Lisa J.; Capote, Raquel T.; Wan, Qing; Riedy, Christine A.; Ramsay, Douglas S.			Mouthguards during orthodontic treatment: Perspectives of orthodontists and a survey of orthodontic patients playing school-sponsored basketball and football	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							PROTECTIVE EQUIPMENT; DENTAL INJURIES; PREVENTION; SPORTS; CONCUSSIONS; KNOWLEDGE; ATTITUDES; COMFORT; CUSTOM; TRAUMA	Introduction: The objectives of this research were to identify the beliefs and practices of orthodontists about mouthguard use in orthodontic patients and to survey orthodontic patients currently playing school-sponsored basketball and/or football about mouthguards. Methods: Fifteen orthodontists were interviewed about mouthguard use in their patients. Patients (aged 11-18 years) playing organized school basketball (n = 53) or football (n = 22) from 13 of those 15 orthodontic practices participated in an online survey about mouthguards. Results: Approximately half of the orthodontists interviewed had initiated discussions about mouthguards with their patients. Although boil-and-bite mouthguards were recommended most often by orthodontists with only a single orthodontist recommending a stock type, stock was the most commonly used type (football [59%], basketball [50%]) followed by boil-and-bite (football [27%], basketball [35%]). Only 2 of the 75 patients surveyed (<3%) reported using a custom mouthguard. All football players reported using a mouthguard, as mandated by this sport. Basketball does not mandate mouthguard use, and only 38% of basketball players reported wearing one. Players who used mouthguards cited forgetting as the most frequent reason for not always using one. A greater percentage of football (91%) than basketball (32%) players reported that their coach recommended a mouthguard (P <0.001). Conclusions: Orthodontists differ in how they approach mouthguard use by their patients, which likely reflects a lack of evidence-based guidelines. The beliefs, recommendations, and practices of orthodontists concerning mouthguard use and the use of mouthguards by orthodontic patients are discussed. Research directions to improve mouthguard use are suggested.	[Bastian, Neal E.; Capote, Raquel T.; Wan, Qing; Ramsay, Douglas S.] Univ Washington, Dept Orthodont, Seattle, WA 98195 USA; [Heaton, Lisa J.; Ramsay, Douglas S.] Univ Washington, Dept Oral Hlth Sci, Box 357475, Seattle, WA 98195 USA; [Riedy, Christine A.] Harvard Univ, Dept Oral Hlth Policy & Epidemiol, Boston, MA 02115 USA		Ramsay, DS (corresponding author), Univ Washington, Dept Oral Hlth Sci, Box 357475, Seattle, WA 98195 USA.	ramsay@uw.edu			University of Washington Orthodontic Alumni AssociationUniversity of Washington	This research was supported by the University of Washington Orthodontic Alumni Association.	[Anonymous], 2017, EP 21 BUS ORTH; Badel T., 2007, KINESIOL, V39, P97; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Berg R, 1998, J AM DENT ASSOC, V129, P1425, DOI 10.14219/jada.archive.1998.0077; BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141, DOI 10.1177/004912418101000205; Bussell MA, 2014, J ORTHOD, V41, P141, DOI 10.1179/1465313313Y.0000000082; Capote R., 2015, THESIS; Chandler N P, 1987, Br J Sports Med, V21, P27; Chapman P J, 1990, Br J Sports Med, V24, P156; Collins CL, 2015, J PRIM PREV, V36, P323, DOI 10.1007/s10935-015-0402-7; Cornwell H, 2003, DENT TRAUMATOL, V19, P193, DOI 10.1034/j.1600-9657.2003.00202.x; DAVIS GT, 1984, AUST DENT J, V29, P217, DOI 10.1111/j.1834-7819.1984.tb06059.x; DEYOUNG AK, 1994, J AM DENT ASSOC, V125, P1112, DOI 10.14219/jada.archive.1994.0121; Gawlak D, 2015, DENT TRAUMATOL, V31, P113, DOI 10.1111/edt.12132; Glendor U, 2009, DENT TRAUMATOL, V25, P19, DOI 10.1111/j.1600-9657.2008.00694.x; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kang Yunlong, 2014, Oral Health Dent Manag, V13, P243; Khodaee M, 2011, RES SPORTS MED, V19, P129, DOI 10.1080/15438627.2011.556907; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Lieger O, 2006, DENT TRAUMATOL, V22, P1, DOI 10.1111/j.1600-9657.2006.00328.x; Love Robert M., 1998, New Zealand Dental Journal, V94, P146; Maestrello Christopher L., 1999, Pediatric Dentistry, V21, P340; MAESTRELLODEMOYA MG, 1989, J DENT CHILD, V56, P36; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; Noy C, 2008, INT J SOC RES METHOD, V11, P327, DOI 10.1080/13645570701401305; Petti S, 2015, DENT TRAUMATOL, V31, P1, DOI 10.1111/edt.12126; Pribble JM, 2004, INJURY PREV, V10, P159, DOI 10.1136/ip.2003.004754; Salam S, 2008, J ORTHOD, V35, P270, DOI 10.1179/14653120722779; Sigurdsson A, 2013, J ENDODONT, V39, pS88, DOI 10.1016/j.joen.2012.11.035; Takeda T, 2005, DENT TRAUMATOL, V21, P134, DOI 10.1111/j.1600-9657.2005.00320.x; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Truman BI, 2002, AM J PREV MED, V23, P21, DOI 10.1016/S0749-3797(02)00449-X; Tuna EB, 2014, SPORTS MED, V44, P777, DOI 10.1007/s40279-014-0167-9; Viano DC, 2012, ANN BIOMED ENG, V40, P47, DOI 10.1007/s10439-011-0399-x; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; ZERMAN N, 1993, ENDOD DENT TRAUMATOL, V9, P61; 2006, J AM DENT ASSOC, V137, P1712	43	2	2	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406	1097-6752		AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	APR	2020	157	4					516	+		10.1016/j.ajodo.2019.04.034			12	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	KY5SE	WOS:000522631500017	32241358	Green Accepted			2022-02-06	
J	Bazarian, JJ; Raukar, N; Devera, G; Ellis, J; Feden, J; Gemme, SR; Hafner, J; Mannix, R; Papa, L; Wright, DW; Auerbach, P				Bazarian, Jeffrey J.; Raukar, Neha; Devera, Gemmie; Ellis, James; Feden, Jeffrey; Gemme, Seth R.; Hafner, John; Mannix, Rebekah; Papa, Linda; Wright, David W.; Auerbach, Paul			Recommendations for the Emergency Department Prevention of Sport-Related Concussion	ANNALS OF EMERGENCY MEDICINE			English	Article							MILD-TRAUMATIC-BRAIN; C-SPINE RULE; DELAYED INTRACRANIAL HEMORRHAGE; CHRONIC POSTTRAUMATIC HEADACHES; MINOR HEAD-INJURY; DISCHARGE INSTRUCTIONS; COMPUTED-TOMOGRAPHY; EARLY INTERVENTION; CERVICAL-SPINE; CHILDREN	Sport-related concussion refers to the subset of concussive injuries occurring duringsport activities. Similar to concussion from nonsport mechanisms, sport-related concussion is associated with significant morbidity, including migrainous headaches, disruption in normal daily activities, and long-term depression and cognitive deficits. Unlike nonsport concussions, sport-related concussion may be uniquely amenable to prevention efforts to mitigate these problems. The emergency department (ED) visit for sport-related concussion represents an opportunity to reduce morbidity by timely diagnosis and management using best practices, and through education and counseling to prevent a subsequent sport-related concussion. This article provides recommendations to reduce sport-related concussion disability through primary, secondary, and tertiary preventive strategies enacted during the ED visit. Although many recommendations have a solid evidence base, several research gaps remain. The overarching goal of improving sport-related concussion outcome through enactment of ED-based prevention strategies needs to be explicitly studied.	[Bazarian, Jeffrey J.; Devera, Gemmie] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY 14627 USA; [Raukar, Neha] Mayo Clin, Dept Emergency Med, Rochester, MN USA; [Ellis, James] Univ South Carolina, Sch Med, Dept Emergency Med, Greenville, SC USA; [Feden, Jeffrey] Brown Univ, Dept Emergency Med, Providence, RI 02912 USA; [Feden, Jeffrey] Brown Univ, Dept Sports Med, Providence, RI 02912 USA; [Gemme, Seth R.] Baystate Med Ctr, Dept Emergency Med, Springfield, MA USA; [Hafner, John] Univ Illinois, Coll Med, Dept Emergency Med, Peoria, IL 61656 USA; [Mannix, Rebekah] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA; [Papa, Linda] Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL USA; [Wright, David W.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Auerbach, Paul] Stanford Univ, Dept Emergency Med, Palo Alto, CA 94304 USA		Bazarian, JJ (corresponding author), Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY 14627 USA.	jeff_bazarian@urmc.rochester.edu			BrainScope LLC; Harvard Catalyst Football Players Health Study; One Mind Foundation; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; Banyan Biomarker	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org).Dr Bazarian reports research support from Banyan Biomarker and BrainScope LLC, and personal fees from Abbott Pharmaceuticals and Q30 Innovations. Dr Mannix reports research support from Harvard Catalyst Football Players Health Study. Dr Papa reports being unpaid scientific consultant for Banyan Biomarkers. Dr Wright reports research support from One Mind Foundation and the Centers for Disease Control and Prevention.	Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; American Academy of Neurology, 2013, UPD EV MAN CONC SPOR; Ashbaugh A, 2016, CURR SPORT MED REP, V15, P16, DOI 10.1249/JSR.0000000000000219; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bell JM, 2017, J SAFETY RES, V62, P253, DOI 10.1016/j.jsr.2017.04.002; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Bin Zahid A, 2019, CLIN J SPORT MED, DOI [10.1097/JSM.0000000000000, DOI 10.1097/JSM.0000000000000.]; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Brooks TM, 2017, PEDIATR EMERG CARE, V33, P553, DOI 10.1097/PEC.0000000000000797; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, WHAT EXP CONC PART C; Chan C, 2018, ARCH PHYSMED REHABIL, V99, P121; Chan S, 2015, AM J EMERG MED, V33, P635, DOI 10.1016/j.ajem.2015.01.053; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Christensen J, 2019, CURR SPORT MED REP, V18, P17, DOI 10.1249/JSR.0000000000000558; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Corwin DJ, 2018, BRAIN INJURY, V32, P794, DOI 10.1080/02699052.2018.1458150; Corwin DJ, 2018, AM J EMERG MED, DOI [10.1016/j.ajem2018.09.008., DOI 10.1016/J.AJEM2018.09.008]; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; De Maio VJ, 2014, PEDIATR EMERG CARE, V30, P20, DOI 10.1097/PEC.0000000000000058; Defense Centers of Excellence, 2013, CLIN REC NEUR FOLL M; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Department of Veterans Affairs and Department of Defense, 2016, CLIN PRACT GUID MAN; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Food and Drug Administration, MED DEV ASS HEAD INJ; Friedman BW, 2017, AM J EMERG MED, V36, P285, DOI DOI 10.1016/j.ajem.2017.10.034; GAWEL MJ, 1993, HEADACHE, V33, P96, DOI 10.1111/j.1526-4610.1993.hed3302096.x; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Hilton MP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003162.pub3; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Howell DR, 2018, J CHILD NEUROL, V33, P794, DOI 10.1177/0883073818789320; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Hunt AW, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1664-3; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kennedy RE, 2006, J HEAD TRAUMA REHAB, V21, P260, DOI 10.1097/00001199-200605000-00006; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lane AD, 2017, J EMERG MED, V52, P690, DOI 10.1016/j.jemermed.2016.12.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Michaleff ZA, 2012, CAN MED ASSOC J, V184, pE867, DOI 10.1503/cmaj.120675; Nance ML, 2016, BRAIN INJURY, V30, P184, DOI 10.3109/02699052.2015.1075591; National Clinical Guideline Centre. National Institute for Health and Clinical Excellence: Guidance, 2014, HEAD INJ TRIAG ASS I; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Perron AD, 2001, ACAD EMERG MED, V8, P296, DOI 10.1111/j.1553-2712.2001.tb01312.x; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sarsfield MJ, 2013, PEDIATR EMERG CARE, V29, P884, DOI 10.1097/PEC.0b013e31829ec0d9; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schroeder SA, 2005, JAMA-J AM MED ASSOC, V294, P482, DOI 10.1001/jama.294.4.482; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Skora W, 2018, ANN AGR ENV MED, V25, P665, DOI 10.26444/aaem/81138; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Stiell IG, 2003, NEW ENGL J MED, V349, P2510, DOI 10.1056/NEJMoa031375; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Sufrinko AM, 2017, J PEDIATR-US, V185, P167, DOI 10.1016/j.jpeds.2017.02.072; Swap Clifford, 2016, Perm J, V20, P14, DOI 10.7812/TPP/15-095; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Thompson EM, 2014, J NEUROSURG-PEDIATR, V13, P636, DOI 10.3171/2014.2.PEDS13567; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Upchurch C, 2015, CLIN J SPORT MED, V25, P297, DOI 10.1097/JSM.0000000000000123; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	111	2	2	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	APR	2020	75	4					471	482		10.1016/j.annemergmed.2019.05.032			12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	KW6NN	WOS:000521281600005	31326205				2022-02-06	
J	Carballo-Cuello, C; de Jesus, O; Fernandez-de Thomas, RJ; Garcia, M; Vigo-Prieto, J; de Jesus-Espinosa, A				Carballo-Cuello, Cesar; de Jesus, Orlando; Fernandez-de Thomas, Ricardo J.; Garcia, Maria; Vigo-Prieto, Juan; de Jesus-Espinosa, Aixa			Posttraumatic Hydrocephalus in Pediatric Patients After Decompressive Craniectomy	WORLD NEUROSURGERY			English	Article						Decompressive craniectomy; Hydrocephalus; Pediatric; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; COMPLICATIONS; OUTCOMES; CHILDREN	OBJECTIVE: The risk for developing posttraumatic hydrocephalus (PTH) is higher when patients undergo decompressive craniectomy as part of their treatment. The purpose of this study is to determine the prevalence of PTH after decompressive craniectomy in pediatric patients and determine associated risk factors that may lead to PTH. METHODS: A retrospective analysis was conducted by searching the Puerto Rico neurologic surgery database from 2010 to 2019. All pediatric patients (1-18 years old) at the University Pediatric Hospital of the Puerto Rico Medical Center who had traumatic brain injury and had a decompressive craniectomy were included in the study. Data were reviewed to determine if time to decompressive craniectomy, side of decompressive craniectomy, gender, mechanism of trauma, amount of subarachnoid hemorrhage, and time to cranioplasty were risk factors for the development of PTH. RESULTS: Incidence of PTH after decompressive craniectomy was 21%. Neither gender, side of decompressive craniectomy, mechanism of trauma, amount of subarachnoid hemorrhage, time from trauma to decompressive craniectomy, nor cranioplasty intervention had statistical significance for developing PTH. Time from decompressive craniectomy to cranioplasty was significant for development of PTH. CONCLUSIONS: Longer time to cranioplasty was associated with an increased likelihood of PTH. We recommend performing cranioplasty as soon as possible to reduce hydrocephalus development.	[Carballo-Cuello, Cesar; de Jesus, Orlando; Fernandez-de Thomas, Ricardo J.; Garcia, Maria; Vigo-Prieto, Juan; de Jesus-Espinosa, Aixa] Univ Puerto Rico, Sch Med, Sect Neurosurg, Med Sci Campus, San Juan, PR 00936 USA		de Jesus, O (corresponding author), Univ Puerto Rico, Sch Med, Sect Neurosurg, Med Sci Campus, San Juan, PR 00936 USA.	drodejesus@aol.com		Fernandez-de Thomas, Ricardo J./0000-0002-5210-8748			Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Bonow RH, 2018, NEUROSURGERY, V83, P732, DOI 10.1093/neuros/nyx470; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Di GF, 2018, WORLD NEUROSURG, V116, pE406, DOI 10.1016/j.wneu.2018.04.216; Fattahian Reza, 2018, Med Arch, V72, P214, DOI 10.5455/medarh.2018.72.214-219; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Morris GF, 1997, CLIN NEUROL NEURO S1, V99, pS16; Nasi D, 2018, ACTA NEUROCHIR, V160, P1691, DOI 10.1007/s00701-018-3639-0; Pechmann A, 2015, NEUROPEDIATRICS, V46, P5, DOI 10.1055/s-0034-1393707; Rumalla K, 2018, PEDIATR NEUROL, V80, P70, DOI 10.1016/j.pediatrneurol.2017.11.015; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37	15	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2020	136						E690	E694		10.1016/j.wneu.2020.01.153			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KW0BN	WOS:000520838600073	32006735				2022-02-06	
J	Cinotti, R; Pelosi, P; Schultz, MJ; Aikaterini, I; Alvarez, P; Badenes, R; Mc Credie, V; Elbuzidi, AS; Elhadi, M; Godoy, DA; Gurjar, M; Haenggi, M; Kaye, C; Mijangos-Mendez, JC; Piagnerelli, M; Piracchio, R; Reza, ST; Stevens, RD; Yoshitoyo, U; Asehnoune, K				Cinotti, Raphael; Pelosi, Paolo; Schultz, Marcus J.; Aikaterini, Ioakeimidou; Alvarez, Pablo; Badenes, Rafael; Mc Credie, Victoria; Elbuzidi, Abdurrahmaan Suei; Elhadi, Muhammed; Agustin Godoy, Daniel; Gurjar, Mohan; Haenggi, Matthias; Kaye, Callum; Cesar Mijangos-Mendez, Julio; Piagnerelli, Michael; Piracchio, Romain; Reza, Syed Tariq; Stevens, Robert D.; Yoshitoyo, Ueno; Asehnoune, Karim		ENIO Study Grp	Extubation strategies in neuro-intensive care unit patients and associations with outcomes: the ENIO multicentre international observational study	ANNALS OF TRANSLATIONAL MEDICINE			English	Article						Weaning; ventilator liberation; extubation; tracheostomy; brain injury; traumatic brain injury; subarachnoid haemorrhage; intra-cranial haemorrhage	RISK-FACTORS; PREDICTION; FAILURE; MANAGEMENT; SCORE	Background: Prolonged invasive ventilation is common in patients with severe brain injury. Information on optimal management of extubation and on the use of tracheostomy in these patients is scarce. International guidelines regarding the ventilator liberation and tracheostomy are currently lacking. Methods: The aim of `Extubation strategies in Neuro-Intensive care unit patients and associations with Outcomes' (ENIO) study is to describe current management of weaning from invasive ventilation, focusing on decisions on timing of tracheal extubation and tracheostomy in intensive care unit (ICU) patients with brain injury. We conducted a prospective, international, multi-centre observational study enrolling patients with various types of brain injury, including trauma, stroke, and subarachnoid haemorrhage, with an initial Glasgow Coma Score equal or less than 12, and a duration of invasive ventilation longer than 24 hours from ICU admission. ENIO is expected to include at least 1,500 patients worldwide. The primary endpoint of the ENIO study is extubation success in the 48 hours following endotracheal tube removal. The primary objective is to validate a score predictive of extubation success. To accomplish this, the study population will be randomly divided to a development cohort (2/3 of the included patients) and a validation cohort (the remaining 1/3). Secondary objectives are: to determine the incidence of extubation success rate according to various time-frames (within 96 hours, >96 hours after extubation); to validate (existing) prediction scores for successful extubation according to various time-frames and definitions (i.e., tracheostomy as extubation failure); and to describe the current practices of extubation and tracheostomy, and their associations. Discussion: ENIO will be the largest prospective observational study of ventilator liberation and tracheostomy practices in patients with severe brain injury undergoing invasive mechanical ventilation, providing a validated predictive score of successful extubation.	[Cinotti, Raphael] Univ Hosp Nantes, Dept Anaesthesia & Crit Care, Hop Guillaume & Rene Laennec, St Herblain, France; [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Pelosi, Paolo] San Martino Policlin Hosp IRCCS Oncol & Neurosci, Anesthesia & Intens Care, Genoa, Italy; [Schultz, Marcus J.] Univ Amsterdam, Location AMC, Med Ctr, Amsterdam, Netherlands; [Schultz, Marcus J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand; [Schultz, Marcus J.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Aikaterini, Ioakeimidou] Gen Hosp Athens, Dept Intens Care Unit, Athens, Greece; [Alvarez, Pablo] Maciel Hosp, Intens Care Unit, Montevideo, Uruguay; [Badenes, Rafael] Univ Valencia, Dept Anesthesiol & Surg Trauma Intens Care, Hiospital Clin, Valencia, Spain; [Badenes, Rafael] Univ Valencia, Dept Surg, Valencia, Spain; [Mc Credie, Victoria] Univ Toronto, Dept Med, Interdept Div Crit Care Med, Toronto, ON, Canada; [Mc Credie, Victoria] Univ Hlth Network, Dept Med, Div Crit Care Med, Toronto, ON, Canada; [Elbuzidi, Abdurrahmaan Suei] Hamad Gen Hosp, Dept Med, Med Intens Unit, Hamad Med Corp, Doha, Qatar; [Elhadi, Muhammed] Univ Tripoli, Fac Med, Tripoli, Libya; [Agustin Godoy, Daniel] Hosp San Juan Bautista, Neurointens Care Unit, Sanatorio Pasteur, Catamarca, Argentina; [Gurjar, Mohan] Sanjay Gandhi Postgrad Inst Med Sci SGPGIMS, Dept Crit Care Med, Lucknow, Uttar Pradesh, India; [Haenggi, Matthias] Univ Bern, Univ Hosp, Dept Intens Care Med, Inselspital, Bern, Switzerland; [Kaye, Callum] NHS Grampian, Aberdeen, Scotland; [Cesar Mijangos-Mendez, Julio] Hosp Civil Guadalajara Fray Antonio Alcalde, Intens Care Unit, Guadalajara, Jalisco, Mexico; [Cesar Mijangos-Mendez, Julio] Univ Guadalajara, Ctr Univ Ciencias Salud, Dept Clin Med, Div Disciplinas Clin, Guadalajara, Jalisco, Mexico; [Piagnerelli, Michael] Univ Libre Bruxelles, CHU Charleroi, Charleroi, Belgium; [Piracchio, Romain] UCSF, Dept Anesthesia & Perioperat Care, San Francisco, CA USA; [Reza, Syed Tariq] Dhaka Med Coll, Intens Care Unit, Dhaka, Bangladesh; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Yoshitoyo, Ueno] Tokushima Univ Hosp, Emergency & Crit Care Med, Tokushima, Japan; [Asehnoune, Karim] Univ Hosp Nantes, Dept Anaesthesia & Crit Care, Hotel Dieu, Nantes, France		Asehnoune, K (corresponding author), Hop Hotel Dieu, Dept Anesthesia & Crit Care, 1 Pl Alexis Ricordeau, F-44093 Nantes 9, France.	karim.asehnoune@chu-nantes.fr	Elhadi, Muhammed/AAU-5641-2020; Haenggi, Matthias/A-8073-2008; Schultz, Marcus/AAB-6379-2021	Elhadi, Muhammed/0000-0001-6406-4212; Haenggi, Matthias/0000-0001-5845-031X; Schultz, Marcus/0000-0003-3969-7792; Kaye, Callum/0000-0002-6904-7048; Badenes, Rafael/0000-0001-7017-0150; Mijangos-Mendez, Julio Cesar/0000-0002-9640-3036	University Hospital of Nantes, France	This work was supported by the University Hospital of Nantes, France for the elaboration of the e-CRF. There is no other funding regarding screening of patients, promotion of the study and inclusion of patients. All the process is based upon local resources only.	Asehnoune K, 2017, ANESTHESIOLOGY, V127, P338, DOI 10.1097/ALN.0000000000001725; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; European Medicines Agency, GUID GOOD CLIN PRACT; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Godet T, 2017, ANESTHESIOLOGY, V126, P104, DOI 10.1097/ALN.0000000000001379; Harell Jr FE, 2001, REGRESSION MODELING; Jaber S, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2150-6; McCredie VA, 2017, ANN AM THORAC SOC, V14, P85, DOI 10.1513/AnnalsATS.201608-620OC; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Miltiades AN, 2017, CRIT CARE MED, V45, P835, DOI 10.1097/CCM.0000000000002327; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Roquilly A, 2015, CLIN INFECT DIS, V60, P64, DOI 10.1093/cid/ciu740; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ruan SY, 2017, AM J RESP CRIT CARE, V196, P792, DOI 10.1164/rccm.201610-2153LE; Thille AW, 2015, CRIT CARE MED, V43, P613, DOI 10.1097/CCM.0000000000000748; Thille AW, 2011, CRIT CARE MED, V39, P2612, DOI 10.1097/CCM.0b013e3182282a5a; Tibshirani R, 2012, J R STAT SOC B, V74, P245, DOI 10.1111/j.1467-9868.2011.01004.x	19	2	2	2	4	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2305-5839	2305-5847		ANN TRANSL MED	ANN. TRANSL. MED.	APR	2020	8	7							503	10.21037/atm.2020.03.160			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	LF4KU	WOS:000527389200085	32395547	Green Published, gold			2022-02-06	
J	Dugan, EA; Bennett, C; Tamames, I; Dietrich, WD; King, CS; Prasad, A; Rajguru, SM				Dugan, Elizabeth A.; Bennett, Cassie; Tamames, Ilmar; Dietrich, W. Dalton; King, Curtis S.; Prasad, Abhishek; Rajguru, Suhrud M.			Therapeutic hypothermia reduces cortical inflammation associated with utah array implants	JOURNAL OF NEURAL ENGINEERING			English	Article						therapeutic hypothermia; Utah arrays; microelectrodes; neuroprotection; brain computer interface; neuroprosthesis; inflammation	TRAUMATIC BRAIN-INJURY; TRANSIENT CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; NF-KAPPA-B; MILD HYPOTHERMIA; MATRIX METALLOPROTEINASES; NEUTROPHIL INFILTRATION; SYSTEMIC HYPOTHERMIA; POSTISCHEMIC HYPOTHERMIA; EXPERIMENTAL STROKE	Objective. Neuroprosthetics hold tremendous promise to restore function through brain-computer interfaced devices. However, clinical applications of implantable microelectrodes remain limited given the challenges of maintaining neuronal signals for extended periods of time and with multiple biological mechanisms negatively affecting electrode performance. Acute and chronic inflammation, oxidative stress, and blood brain barrier disruption contribute to inconsistent electrode performance. We hypothesized that therapeutic hypothermia (TH) applied at the microelectrode insertion site will positively modulate both inflammatory and apoptotic pathways, promoting neuroprotection and improved performance in the long-term. Approach. A custom device and thermoelectric system were designed to deliver controlled TH locally to the cortical implant site at the time of microelectrode array insertion and immediately following surgery. The TH paradigm was derived from in vivo cortical temperature measurements and finite element modeling of temperature distribution profiles in the cortex. Male Sprague-Dawley rats were implanted with non-functional Utah microelectrodes arrays (UMEA) consisting of 4 x 4 grid of 1.5 mm long parylene-coated silicon shanks. In one group, TH was applied to the implant site for two hours following the UMEA implantation, while the other group was implanted under normothermic conditions without treatment. At 48 h, 72 h, 7 d and 14 d post-implantation, mRNA expression levels for genes associated with inflammation and apoptosis were compared between normothermic and hypothermia-treated groups. Main results. The custom system delivered controlled TH to the cortical implant site and the numerical models confirmed that the temperature decrease was confined locally. Furthermore, a one-time application of TH post UMEA insertion significantly reduced the acute inflammatory response with a reduction in the expression of inflammatory regulating cytokines and chemokines. Significance. This work provides evidence that acutely applied hypothermia is effective in significantly reducing acute inflammation post intracortical electrode implantation.	[Dugan, Elizabeth A.; Bennett, Cassie; Tamames, Ilmar; Prasad, Abhishek; Rajguru, Suhrud M.] Univ Miami, Dept Biomed Engn, Coral Gables, FL 33124 USA; [Dietrich, W. Dalton] Univ Miami, Miami Project Cure Paralysis, Coral Gables, FL 33124 USA; [King, Curtis S.] Lucent Med Syst, Kirkland, WA USA; [Rajguru, Suhrud M.] Univ Miami, Dept Otolaryngol, Coral Gables, FL 33124 USA		Prasad, A (corresponding author), Univ Miami, Dept Biomed Engn, Coral Gables, FL 33124 USA.	a.prasad@miami.edu; s.rajguru@miami.edu		Rajguru, Suhrud/0000-0001-5953-8516	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1DP2EB022357, R01DC01379801A1]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002736]; Miami Clinical and Translational Science Institute; Wallace H Coulter Center for Translational Research Neural Engineering SEED Grants	This work was supported by NIH R01DC01379801A1, NIH 1DP2EB022357, a pilot award from National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002736, Miami Clinical and Translational Science Institute, and the Wallace H Coulter Center for Translational Research Neural Engineering SEED Grants. The authors sincerely thank Drs Florian Solzbacher and Rohit Sharma at the University of Utah for providing the non-functional Utah microelectrode arrays for this study.	Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Alva N, 2004, J THERM BIOL, V29, P259, DOI 10.1016/j.jtherbio.2004.04.001; Alva N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/957054; Barrese JC, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066014; BELCH JJF, 1992, SCOT MED J, V37, P67, DOI 10.1177/003693309203700301; Bennett C, 2019, BIOMATERIALS, V188, P144, DOI 10.1016/j.biomaterials.2018.09.040; Bennett C, 2018, BIOMATERIALS, V164, P1, DOI 10.1016/j.biomaterials.2018.02.036; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Brandman DM, 2017, IEEE T NEUR SYS REH, V25, P1687, DOI 10.1109/TNSRE.2017.2677443; Butte A J, 2001, Pac Symp Biocomput, P6; Cappuccino A, 2010, SPINE, V35, pE57, DOI 10.1097/BRS.0b013e3181b9dc28; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Choi CH, 2012, INT J PEDIATR OTORHI, V76, P544, DOI 10.1016/j.ijporl.2012.01.013; Choi JS, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/846716; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cooper D J, 2017, PROPHYLACTIC HYPOTHE; Deng H, 2003, STROKE, V34, P2495, DOI 10.1161/01.STR.0000091269.67384.E7; DEXTER F, 1994, ANN THORAC SURG, V57, P1171, DOI 10.1016/0003-4975(94)91350-1; Diao CG, 2003, ANN BIOMED ENG, V31, P346, DOI 10.1114/1.1554924; Dietrich W Dalton, 2017, Brain Circ, V3, P186, DOI 10.4103/bc.bc_28_17; Dietrich WD, 2011, NEUROTHERAPEUTICS, V8, P229, DOI 10.1007/s13311-011-0035-3; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Fairchild KD, 2005, AM J PHYSIOL-CELL PH, V289, pC1114, DOI 10.1152/ajpcell.00152.2005; Gamen S, 1998, CELL DEATH DIFFER, V5, P241, DOI 10.1038/sj.cdd.4400344; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Gilja V, 2015, NAT MED, V21, P1142, DOI 10.1038/nm.3953; Hall ED, 1997, NEUROSURG CLIN N AM, V8, P195; Han HS, 2002, J NEUROSCI, V22, P3921, DOI 10.1523/JNEUROSCI.22-10-03921.2002; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hata R, 1999, METAB BRAIN DIS, V14, P117, DOI 10.1023/A:1020709814456; Hermann John K., 2018, Critical Reviews in Biomedical Engineering, V46, P341, DOI 10.1615/CritRevBiomedEng.2018027166; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Homer ML, 2013, ANNU REV BIOMED ENG, V15, P383, DOI 10.1146/annurev-bioeng-071910-124640; Huggins CE, 2008, J MOL CELL CARDIOL, V44, P270, DOI 10.1016/j.yjmcc.2007.11.020; Inamasu J, 2003, J NEUROL SCI, V209, P55, DOI 10.1016/S0022-510X(02)00463-X; Inamasu J, 2002, ANN EMERG MED, V40, P220, DOI 10.1067/mem.2002.123697; Inamasu J, 2000, ACT NEUR S, V76, P525; Jiang J, 2017, RANDOMIZED CONTROLLE; Justicia C, 2003, J CEREBR BLOOD F MET, V23, P1430, DOI 10.1097/01.WCB.0000090680.07515.C8; Kawai N, 2000, STROKE, V31, P1982, DOI 10.1161/01.STR.31.8.1982; Keller E, 2009, J NEUROSCI METH, V178, P345, DOI 10.1016/j.jneumeth.2008.12.030; Kim S, 2007, IEEE T NEUR SYS REH, V15, P493, DOI 10.1109/TNSRE.2007.908429; Lawrence MS, 1996, J NEUROSCI, V16, P486; Lee JE, 2005, J NEUROSURG, V103, P289, DOI 10.3171/jns.2005.103.2.0289; Lee SM, 2009, J CEREBR BLOOD F MET, V29, P1589, DOI 10.1038/jcbfm.2009.81; Levi AD, 2010, NEUROSURGERY, V66, P670, DOI 10.1227/01.NEU.0000367557.77973.5F; Liu YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170682; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo TP, 2009, J COMP NEUROL, V514, P433, DOI 10.1002/cne.22014; Maekawa T, 2012, THERAPEUTIC HYPOTHER; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; McManus T, 2004, J NEUROCHEM, V91, P327, DOI 10.1111/j.1471-4159.2004.02711.x; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; Mirzaie M, 2018, INT J MOL CELL MED, V7, P8, DOI 10.22088/IJMCM.BUMS.7.1.8; Nagel S, 2008, BRAIN RES, V1188, P198, DOI 10.1016/j.brainres.2007.10.052; Nakashima K, 1996, STROKE, V27, P913, DOI 10.1161/01.STR.27.5.913; Oh SH, 2000, ACTA OTO-LARYNGOL, V120, P146; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Perez E, 2019, OTOL NEUROTOL, V40, P1167, DOI 10.1097/MAO.0000000000002373; Polderman KH, 2006, CRIT CARE, V10, DOI 10.1186/cc5023; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Prasad Abhishek, 2014, Front Neuroeng, V7, P2, DOI 10.3389/fneng.2014.00002; Prasad A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056015; Purdy PD, 2013, AM J NEURORADIOL, V34, P252, DOI 10.3174/ajnr.A3175; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; ROKKAS CK, 1995, J THORAC CARDIOV SUR, V110, P27, DOI 10.1016/S0022-5223(05)80006-6; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Smith KD, 2011, P I MECH ENG H, V225, P533, DOI 10.1177/0954411911400156; Tamames I, 2018, EAR HEARING, V39, P712, DOI 10.1097/AUD.0000000000000529; Tamames I, 2016, HEARING RES, V339, P32, DOI 10.1016/j.heares.2016.05.015; Toyoda T, 1996, NEUROSURGERY, V39, P1200, DOI 10.1097/00006123-199612000-00024; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Tzen YT, 2013, J SPINAL CORD MED, V36, P357, DOI 10.1179/2045772312Y.0000000085; Wagner S, 2003, BRAIN RES, V984, P63, DOI 10.1016/S0006-8993(03)03088-9; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; Wang YJ, 2007, EUR J APPL PHYSIOL, V101, P31, DOI 10.1007/s00421-007-0451-6; Yin L, 2019, MED BIOL ENG COMPUT, V57, P1313, DOI 10.1007/s11517-019-01962-7; Zhang H, 2010, NEUROL RES, V32, P384, DOI 10.1179/016164110X12670144526228; Zhang HZ, 2015, OTOL NEUROTOL, V36, P1157, DOI 10.1097/MAO.0000000000000787; Zhang ZJ, 2001, MOL BRAIN RES, V95, P75, DOI 10.1016/S0169-328X(01)00247-9	86	2	2	0	8	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	APR	2020	17	2							026035	10.1088/1741-2552/ab85d2			12	Engineering, Biomedical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	LL1MC	WOS:000531318200001	32240985	Green Accepted			2022-02-06	
J	Golderman, V; Gofrit, SG; Maggio, N; Gera, O; Gerasimov, A; Laks, D; Chapman, J; Shavit-Stein, E				Golderman, Valery; Gofrit, Shany G.; Maggio, Nicola; Gera, Orna; Gerasimov, Alexandra; Laks, Dar; Chapman, Joab; Shavit-Stein, Efrat			A Novel Highly Sensitive Method for Measuring Inflammatory Neural-Derived APC Activity in Glial Cell Lines, Mouse Brain and Human CSF	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						activated protein C (APC); protease-activated receptor 1 (PAR1); endothelial protein C receptor (EPCR); thrombin	ACTIVATED PROTEIN-C; THROMBIN; NEUROINFLAMMATION; NEUROGENESIS; CYTOKINES	Background: Neural inflammation is linked to coagulation. Low levels of thrombin have a neuroprotective effect, mediated by activated protein C (APC). We describe a sensitive novel method for the measurement of APC activity at the low concentrations found in neural tissue. Methods: APC activity was measured using a fluorogenic substrate, Pyr-Pro-Arg-AMC, cleaved preferentially by APC. Selectivity was assessed using specific inhibitors and activators. APC levels were measured in human plasma, in glia cell lines, in mice brain slices following mild traumatic brain injury (mTBI) and systemic lipopolysaccharide (LPS) injection, and in cerebrospinal fluid (CSF) taken from viral meningoencephalitis patients and controls. Results: Selectivity required apixaban and alpha-naphthylsulphonylglycyl-4-amidinophenylalanine piperidine (NAPAP). APC levels were easily measurable in plasma and were significantly increased by Protac and CaCl2. APC activity was significantly higher in the microglial compared to astrocytic cell line and specifically lowered by LPS. Brain APC levels were higher in posterior regions and increased by mTBI and LPS. Highly elevated APC activity was measured in viral meningoencephalitis patients CSF. Conclusions: This method is selective and sensitive for the measurement of APC activity that significantly changes during inflammation in cell lines, animal models and human CSF.	[Golderman, Valery; Maggio, Nicola; Chapman, Joab; Shavit-Stein, Efrat] Tel Aviv Univ, Sackler Fac Med, Dept Neurol, IL-6997801 Tel Aviv, Israel; [Gofrit, Shany G.; Maggio, Nicola; Gera, Orna; Gerasimov, Alexandra; Laks, Dar; Chapman, Joab; Shavit-Stein, Efrat] Chaim Sheba Med Ctr, Dept Neurol, IL-5266202 Ramat Gan, Israel; [Maggio, Nicola] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, IL-5266202 Ramat Gan, Israel; [Maggio, Nicola; Chapman, Joab] Tel Aviv Univ, Sagol Sch Neurosci, IL-6997801 Tel Aviv, Israel; [Gera, Orna] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, IL-6997801 Tel Aviv, Israel; [Chapman, Joab] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-6997801 Tel Aviv, Israel; [Chapman, Joab] Tel Aviv Univ, Sackler Fac Med, Robert & Martha Harden Chair Mental & Neurol Dis, IL-6997801 Tel Aviv, Israel		Shavit-Stein, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Neurol, IL-6997801 Tel Aviv, Israel.; Shavit-Stein, E (corresponding author), Chaim Sheba Med Ctr, Dept Neurol, IL-5266202 Ramat Gan, Israel.	efrat.shavit.stein@gmail.com	Chapman, Joab/E-4598-2010	Gofrit, Shany/0000-0001-6104-606X; Shavit-Stein, Efrat/0000-0003-3373-8397	Israeli Ministry of Economy and Industry, Kamin grant [56338]	This research was funded by the Israeli Ministry of Economy and Industry, Kamin grant No. 56338 for novel molecules for the treatment of neuroinflammatory diseases.	Asmat A, 2018, PROTEIN PEPTIDE LETT, V25, P643, DOI 10.2174/0929866525666180619101218; Beilin O, 2001, NEUROREPORT, V12, P2347, DOI 10.1097/00001756-200108080-00013; Ben Shimon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188524; Bushi D, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00138; Bushi D, 2013, J MOL NEUROSCI, V51, P844, DOI 10.1007/s12031-013-0072-y; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Das U, 2014, ARCH MED SCI, V10, P325, DOI 10.5114/aoms.2014.42586; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Ebrahimi S, 2017, J CELL PHYSIOL, V232, P482, DOI 10.1002/jcp.25501; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Esmon CT, 2006, SEMIN THROMB HEMOST, V32, P49, DOI 10.1055/s-2006-939554; Esmon CT, 2014, THROMB HAEMOSTASIS, V111, P625, DOI 10.1160/TH13-09-0730; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Fernandez JA, 2003, BLOOD CELL MOL DIS, V30, P271, DOI 10.1016/S1079-9796(03)00034-2; Festoff BW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00059; Galland F, 2019, NEUROCHEM INT, V131, DOI 10.1016/j.neuint.2019.104538; Gera O, 2016, NEUROSCIENCE, V339, P587, DOI 10.1016/j.neuroscience.2016.10.034; Gould TW, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007948; GRUBER A, 1992, BLOOD, V79, P2340; Guo H, 2004, NEURON, V41, P563, DOI 10.1016/S0896-6273(04)00019-4; Guo H, 2013, J NEUROSCI, V33, P6181, DOI 10.1523/JNEUROSCI.4491-12.2013; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Kore RA, 2014, BIOCHEM BIOPH RES CO, V453, P326, DOI 10.1016/j.bbrc.2014.09.068; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Maggio N, 2014, HIPPOCAMPUS, V24, P1030, DOI 10.1002/hipo.22288; Mahajan-Thakur S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/831059; McClintock D, 2008, CRIT CARE, V12, DOI 10.1186/cc6846; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Oto J, 2020, CLIN CHIM ACTA, V502, P227, DOI 10.1016/j.cca.2019.11.005; Paolicelli RC, 2019, NEUROSCIENCE, V405, P148, DOI 10.1016/j.neuroscience.2018.04.003; Sarangi PP, 2010, BRIT J HAEMATOL, V148, P817, DOI 10.1111/j.1365-2141.2009.08020.x; Shavit-Stein E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01087; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; Stein ES, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/7692182; Stein ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep07912; Tan YL, 2020, MOL PSYCHIATR, V25, P351, DOI 10.1038/s41380-019-0609-8; Thiyagarajan M, 2008, J NEUROSCI, V28, P12788, DOI 10.1523/JNEUROSCI.3485-08.2008; Timmerman R, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00242; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	40	2	2	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	APR	2020	21	7							2422	10.3390/ijms21072422			13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	LR3DN	WOS:000535574200164	32244492	gold, Green Published			2022-02-06	
J	Gorman, E; Frangos, S; DiMaggio, C; Bukur, M; Klein, M; Pachter, HL; Berry, C				Gorman, Elizabeth; Frangos, Spiros; DiMaggio, Charles; Bukur, Marko; Klein, Michael; Pachter, H. Leon; Berry, Cherisse			Is trauma center designation associated with disparities in discharge to rehabilitation centers among elderly patients with Traumatic Brain Injury?	AMERICAN JOURNAL OF SURGERY			English	Article						Disparities; TBI; Rehabilitation	OUTCOMES; AGE; INSURANCE	Background: We sought to evaluate the role of trauma center designation in the association of race and insurance status with disposition to rehabilitation centers among elderly patients with Traumatic Brain Injury (TBI). Methods: The National Trauma Data Bank (2014-2015) was used to identify elderly (age >= 65) patients with isolated moderate to severe blunt TBI who survived to discharge. Race, insurance status, and outcomes were stratified by trauma center designation and compared. Results: 3,292 patients met the inclusion criteria. Black patients were 1.5 times less likely (AOR 0.64, p = 0.01) and Latino patients were 1.7 times less likely (AOR 0.58, p = 0 0.007) to be discharged to rehabilitation centers as compared with White patients. Asian patients at Level I hospitals were more likely to be discharged to rehabilitation centers if they had private vs. non-private insurance (42.9% versus 12.7%, p = 0.01). Conclusion: Black and Latino patients were less likely to be discharged to rehabilitation centers compared to White patients. The etiology of these disparities deserves further study. (C) 2020 Elsevier Inc. All rights reserved.	[Gorman, Elizabeth; Frangos, Spiros; DiMaggio, Charles; Bukur, Marko; Klein, Michael; Pachter, H. Leon; Berry, Cherisse] NYU, NYC Hlth & Hosp Bellevue, Dept Surg, Sch Med, 462 First Ave, New York, NY 10016 USA		Gorman, E (corresponding author), NYU, NYC Hlth & Hosp Bellevue, Dept Surg, Sch Med, 462 First Ave, New York, NY 10016 USA.	Elizabeth.Warnack@nyulangone.org; Spiros.Frangos@nyulangone.org; Charles.DiMaggio@nyulangone.org; Marko.Bukur@nyulangone.org; Michael.Klein@nyulangone.org; Leon.Pachter@nyulangone.org; Cherisse.Berry@nyulangone.org	Berry, Cherisse/AAO-5701-2020	Bukur, Marko/0000-0002-1850-7147; DiMaggio, Charles/0000-0003-2356-6659; Frangos, Spiros/0000-0003-2860-8969			Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; [Anonymous], 1998, NIH Consens Statement, V16, P1; Banks Shawn E, 2013, Anesthesiol Clin, V31, P127, DOI 10.1016/j.anclin.2012.11.004; Budnick HC, 2017, J SURG RES, V215, P231, DOI 10.1016/j.jss.2017.03.062; Frankenfield D, 2000, J TRAUMA, V48, P49, DOI 10.1097/00005373-200001000-00009; Friedland D, 2013, CLASSIFICATION TRAUM; Gowing R, 2007, CAN J SURG, V50, P437; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Llompart-Pou Juan Antonio, 2017, World J Crit Care Med, V6, P99, DOI 10.5492/wjccm.v6.i2.99; Mas MF, 2017, PHYS MED REH CLIN N, V28, P829, DOI 10.1016/j.pmr.2017.06.014; McMahon DJ, 1996, WORLD J SURG, V20, P1113, DOI 10.1007/s002689900170; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Oshima K, 2018, EMERG MED INT, V2018, DOI 10.1155/2018/2137658; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; Schiraldi M, 2015, J NEUROL SURG PART A, V76, P224, DOI 10.1055/s-0034-1543958; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wilson J A, 1987, Brain Inj, V1, P183, DOI 10.3109/02699058709034456; Yap SGM, 2008, J HEAD TRAUMA REHAB, V23, P158, DOI 10.1097/01.HTR.0000319932.15085.fe; ZIETLOW SP, 1994, J TRAUMA, V37, P985, DOI 10.1097/00005373-199412000-00020	22	2	2	0	1	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	APR	2020	219	4					587	591		10.1016/j.amjsurg.2020.02.026			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	LD1PB	WOS:000525802700011	32178839				2022-02-06	
J	Gupta, S; Kaafarani, HMA; Fagenholz, PJ; Tabrizi, M; Rosenthal, M; El Hechi, MW; Velmahos, GC				Gupta, Sanjay; Kaafarani, Haytham M. A.; Fagenholz, Peter J.; Tabrizi, Myriam; Rosenthal, Martin; El Hechi, Majed W.; Velmahos, George C.			Mild traumatic brain injuries with minor intracranial hemorrhage: Can they Be safely managed in the community? - A cohort study	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Minor traumatic brain injury; Minor CT scan findings; Transfer	MINIMAL HEAD-INJURY; COMPUTED-TOMOGRAPHY; CARE; CT; UTILITY; SCANS	Background: Patients with mild traumatic brain injury (mTBI) are frequently transferred to level 1 trauma centers (L1TC) if they have minor findings on a computerized tomographic scan of the head due to the absence of continuous neurosurgical coverage in community hospitals (CH). We hypothesized that such patients can be safely managed at community hospitals with a qualified Trauma team. Methods: This is a multicentered Retrospective Cohort Study. Patients with mild Traumatic Brain Injury (defined as Glasgow Coma Scale [GCS] 13-15 at presentation) and with minor findings on head Computerized Tomography (CT) presenting at a L1TC or 4 Community Hospitals between March 1st, 2012 and February 28th, 2014 were included. All these community hospitals are Level III Trauma center with a well-organized trauma team. Minor CT findings were defined as 1) epidural hematoma < 2 mm; 2) subarachnoid hemorrhage < 2 mm; 3) subdural hematoma < 4 mm; 4) intraparenchymal hemorrhage < 5 mm; 5) minor pneumocephalus; or 6) linear or minimally depressed skull fracture. Our primary end point was the need for TBI specific interventions in 3 groups of patients: 1) direct admission to the L1TC (L1TC group), 2) those admitted at one of the 4 CH (CH group), and 3) those transferred from CH to L1TC (TRANSFER group). TBI-specific interventions were defined as intracranial pressure monitor (ICP) placement, hyperosmolar therapy, or neurosurgical operation. Our secondary aim was to demonstrate that these patients can be safely managed in Community Hospitals with qualified Trauma teams. We also sought to identify the clinical outcomes in these three groups of patients in terms of mortality and complications. Results: A total of 191 patients were included - 39 CH, 64 L1TC and 88 TRANSFER. There was no difference among the groups in terms of TBI-specific interventions: one TRANSFER, four L1TC, and no CH patients required hyperosmolar therapy (p = 0.277). None of the patients required placement of an intracranial pressure monitoring device (ICP) or a neurosurgical operation and complications and mortality rates were similar among the groups. Conclusions: Patients with mild TBI and minor findings on head CT can be safely managed at CH with qualified Trauma Teams.	[Gupta, Sanjay; Kaafarani, Haytham M. A.; Fagenholz, Peter J.; Tabrizi, Myriam; Rosenthal, Martin; El Hechi, Majed W.; Velmahos, George C.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA		Gupta, S (corresponding author), Massachusetts Gen Hosp, Div Trauma Emergency Surg Surg Crit Care, Dept Surg, 165 Cambridge St,Suite 810, Boston, MA 02114 USA.	sgupta18@mgh.harvard.edu; hkaafarani@partners.org; pfagenholz@partners.org; mtabrizi@partners.org; mgrosenthal@mgh.harvard.edu; melhechi@mgh.harvard.edu; gvelmahos@partners.org					AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Agha R, 2019, INT J SURG, V72, P156, DOI 10.1016/j.ijsu.2019.11.002; Anandalwar SP, 2016, J NEUROSURG, V125, P667, DOI 10.3171/2015.9.JNS151379; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Frieden T.R., 2015, REPORT C TRAUMATIC B, P1; Huynh T, 2006, AM SURGEON, V72, P1162; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Joseph B, 2015, ANN SURG, V262, P440, DOI 10.1097/SLA.0000000000001418; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Lewis Paul R, 2017, J Trauma Acute Care Surg, V82, P776, DOI 10.1097/TA.0000000000001388; Overton TL, 2014, AM J SURG, V208, P806, DOI 10.1016/j.amjsurg.2014.02.012; Sharma S, 2014, J AM COLL SURGEONS, V218, P51, DOI 10.1016/j.jamcollsurg.2013.10.005; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d	21	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	APR	2020	76						88	92		10.1016/j.ijsu.2020.02.016			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	KY5YP	WOS:000522649400031	32081713				2022-02-06	
J	Heydari, F; Golban, M; Majidinejad, S				Heydari, Farhad; Golban, Mohammad; Majidinejad, Saeed			Traumatic Brain Injury in Older Adults Presenting to the Emergency Department: Epidemiology, Outcomes and Risk Factors Predicting the Prognosis	ADVANCED JOURNAL OF EMERGENCY MEDICINE			English	Article						Aged; Brain Injuries, Traumatic; Epidemiology; Emergency Department; Geriatrics; Outcome	SCALE SCORE	Introduction: The continuing-to-grow number of older adults with traumatic brain injury (TBI) presenting to emergency departments (EDs) and hospitals necessitates the investigation of TBI in these patients. Objective: The present study was conducted to investigate the epidemiology of TBI and the factors affecting intracranial lesions and patient outcomes in older adults. Method: The present retrospective cross-sectional study was performed between March 2016 and March 2018. The study population comprised all TBI patients with a minimum age of 60 years presenting to the ED. The eligible candidates consisted of patients presenting to the ED within 24 hours of the occurrence of traumas and requiring head CT scan as part of their examination. The patients' baseline information was also recorded. Results: A total of 306 older adult patients with a mean age of 70.61 +/- 8.63 years, of whom 67.6% were male, underwent CT scan for TBI during the study period. Falls were the major cause of head injuries, and intracranial lesions were observed in 22.9% (n=70) of the patients. Subdural hematoma (SDH) was observed as the most prevalent injury in 27.6% of the patients, 22.9% (n=16) were transferred to the operating room, and 7.5% (n=23) died. Moreover, the severity of trauma was significantly different between the two genders (P=0.029). Midline shift, SDH, subarachnoid hemorrhage (SAH) and moderate-to-severe head injuries were also significantly associated with poor outcomes (P<0.05). Conclusion: Death from TBIs was more likely in the patients with SDH, SAH and midline shift or in those with an initial Glasgow coma scale (GCS) of below 13. These predictions are clinically relevant, and can help improve the management of older adults with TBI.	[Heydari, Farhad; Golban, Mohammad; Majidinejad, Saeed] Isfahan Univ Med Sci, Sch Med, Dept Emergency Med, Esfahan, Iran		Majidinejad, S (corresponding author), Isfahan Univ Med Sci, Sch Med, Dept Emergency Med, Esfahan, Iran.	saeedmajidinejad@yahoo.com	Heydari, Farhad/A-6355-2018	Heydari, Farhad/0000-0002-6296-0045	Isfahan University of Medical Sciences, Iran [296118]	The present study was supported by Isfahan University of Medical Sciences, Iran (No.296118).	Abdulle AE, 2018, J HEAD TRAUMA REHAB, V33, pE59, DOI 10.1097/HTR.0000000000000368; Alizadeh Khoeii M, 2013, IRANIAN J DIABETES M, V13, P74; Altman J., 2015, ACAD EMERG MED, V22, pS255; Asadian L., 2015, J MAZANDARAN U MED S, V24, P207; Crandall M, 2011, ARCH SURG-CHICAGO, V146, P442, DOI 10.1001/archsurg.2011.34; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Farzaneh E, 2017, EMERG MED INT, V2017, DOI 10.1155/2017/1439486; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Hadinejad Z, 2017, SALMAND, V12, P372, DOI 10.21859/sija.12.3.372; Hamrah Hadid, 2018, Bull Emerg Trauma, V6, P54, DOI 10.29252/beat-060108.; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Hsiao KY, 2008, EMERG MED J, V25, P670, DOI 10.1136/emj.2007.053405; Kasmaei VM, 2015, EMERGENCY, V3, P141; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Masoumi Babak, 2017, Open Access Maced J Med Sci, V5, P319, DOI 10.3889/oamjms.2017.071; Miller KJ, 2005, J NEUROSURG, V103, P239, DOI 10.3171/jns.2005.103.2.0239; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Nishijima DK, 2017, ANN EMERG MED, V70, P127, DOI 10.1016/j.annemergmed.2016.12.018; Onwuchekwa R. C., 2018, Journal of Medicine in the Tropics, V20, P24, DOI 10.4103/jomt.jomt_28_17; Ostermann RC, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0975-y; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Yousef zade Chabok S, 2008, J GUILAN U MED SCI, V16, P112; Zeng X, 2012, CURR GERIATR REP, V1, P167, DOI 10.1007/s13670-012-0018-1	27	2	2	0	1	TEHRAN UNIV MEDICAL SCIENCES	TEHRAN	CTR ELECTR RES PROVISION & J IMPROVEMENT, #7, POURSINA AVE, QODS AVE, PO 1417653911, TEHRAN, 11498, IRAN		2588-400X		ADV J EMERG MED	Adv. J. Emerg. Med.	APR	2020	4	2							e19	10.22114/ajem.v0i0.170			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	MH7KQ	WOS:000546903600004	32322787				2022-02-06	
J	Heymann, EP				Heymann, Eric P.			Tranexamic acid in traumatic intracranial bleeding: recognizing the limit of results (of the CRASH-3 trial)	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article							BRAIN-INJURY; HEMORRHAGE		[Heymann, Eric P.] Neuchatel Cantonal Hosp, Dept Emergency Med, Maladiere 45, CH-2000 Neuchatel, Switzerland		Heymann, EP (corresponding author), Neuchatel Cantonal Hosp, Dept Emergency Med, Maladiere 45, CH-2000 Neuchatel, Switzerland.	eric.heymann@doctors.org.uk					Gayet-Ageron A, 2018, LANCET, V391, P125, DOI 10.1016/S0140-6736(17)32455-8; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Medcalf RL, 2015, BLOOD, V125, P2457, DOI 10.1182/blood-2015-02-629808; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sprigg N, 2018, LANCET, V391, P2107, DOI 10.1016/S0140-6736(18)31033-X; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023	11	2	2	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	APR	2020	27	2					83	84		10.1097/MEJ.0000000000000657			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LH6IT	WOS:000528887500004	31855889				2022-02-06	
J	Hu, Z; Gajavelli, S; Spurlock, MS; Mahavadi, A; Quesada, LS; Gajavelli, GR; Andreoni, CB; Di, L; Janecki, J; Lee, SW; Rivera, KN; Shear, DA; Bullock, RM				Hu, Zhen; Gajavelli, Shyam; Spurlock, Markus S.; Mahavadi, Anil; Quesada, Liz S.; Gajavelli, Ganesh R.; Andreoni, Cody B.; Di, Long; Janecki, Julia; Lee, Stephanie W.; Rivera, Karla N.; Shear, Deborah A.; Bullock, Ross M.			Human neural stem cell transplant location-dependent neuroprotection and motor deficit amelioration in rats with penetrating traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Meeting of the Society-of-Neuroscience	NOV 13, 2017	Washington, DC	Soc Neuroscience		Traumatic; brain injury; neural stem cells; transplantation; neuroprotection; rat	MICROGLIAL ACTIVATION; STEM/PROGENITOR CELLS; COGNITIVE DEFICITS; MODEL; MORTALITY; EFFICACY; DAMAGE; HEAD; SITE	BACKGROUND Penetrating traumatic brain injury induces chronic inflammation that drives persistent tissue loss long after injury. Absence of endogenous reparative neurogenesis and effective neuroprotective therapies render injury-induced disability an unmet need. Cell replacement via neural stem cell transplantation could potentially rebuild the tissue and alleviate penetrating traumatic brain injury disability. The optimal transplant location remains to be determined. METHODS To test if subacute human neural stem cell (hNSC) transplant location influences engraftment, lesion expansion, and motor deficits, rats (n = 10/group) were randomized to the following four groups (uninjured and three injured): group 1 (Gr1), uninjured with cell transplants (sham+hNSCs), 1-week postunilateral penetrating traumatic brain injury, after establishing motor deficit; group 2 (Gr2), treated with vehicle (media, no cells); group 3 (Gr3), hNSCs transplanted into lesion core (intra); and group 4 (Gr4), hNSCs transplanted into tissue surrounding the lesion (peri). All animals were immunosuppressed for 12 weeks and euthanized following motor assessment. RESULTS In Gr2, penetrating traumatic brain injury effect manifests as porencephalic cyst, 22.53 +/- 2.87 (% of intact hemisphere), withpvalue of <0.0001 compared with uninjured Gr1. Group 3 lesion volume at 17.44 +/- 2.11 did not differ significantly from Gr2 (p= 0.36), while Gr4 value, 9.17 +/- 1.53, differed significantly (p= 0.0001). Engraftment and neuronal differentiation were significantly lower in the uninjured Gr1 (p< 0.05), compared with injured groups. However, there were no differences between Gr3 and Gr4. Significant increase in cortical tissue sparing (p= 0.03), including motor cortex (p= 0.005) was observed in Gr4 but not Gr3. Presence of transplant within lesion or in penumbra attenuated motor deficit development (p< 0.05) compared with Gr2. CONCLUSION In aggregate, injury milieu supports transplanted cell proliferation and differentiation independent of location. Unexpectedly, cortical sparing is transplant location dependent. Thus, apart from cell replacement and transplant mediated deficit amelioration, transplant location-dependent neuroprotection may be key to delaying onset or preventing development of injury-induced disability.	[Hu, Zhen] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Hu, Zhen; Gajavelli, Shyam; Spurlock, Markus S.; Mahavadi, Anil; Quesada, Liz S.; Gajavelli, Ganesh R.; Andreoni, Cody B.; Di, Long; Janecki, Julia; Lee, Stephanie W.; Rivera, Karla N.; Bullock, Ross M.] Univ Miami, Miami Project Cure Paralysis, 1095 NW 14th Terrace, Miami, FL 33136 USA; [Shear, Deborah A.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Branch Brain Trauma Neuroprotect & Nemorestorat, Silver Spring, MD USA		Gajavelli, S (corresponding author), Univ Miami, Miami Project Cure Paralysis, 1095 NW 14th Terrace, Miami, FL 33136 USA.	shyam@miami.edu		Gajavelli, Shyam/0000-0002-5947-6973	U.S. Department of DefenseUnited States Department of Defense [W81XWH-162-0008, BA150111 CDMRP JPC-6]	We thank Dr. Thomas G Hazel, and Dr. Karl K Johe, Neuralstem, Inc. for the hNSCs (GFP labeled NSI-566 RSC), technical help from Dr Hyun-Joo Park for CalLesion, Student volunteer Isa Ciocca and Ms. Jare of The University ofMiami Writing Center for checking themanuscript for grammar. This research is funded by the U.S. Department of Defense W81XWH-162-0008, BA150111 CDMRP JPC-6, and approved by United State Army Medical Research and Material Command, Combat Casualty Care Research Program, Fort Detrick, MD.	Ahmed AI, 2012, J NEUROTRAUM, V29, P828, DOI 10.1089/neu.2011.1923; Ahmed AI, 2016, J ROY ARMY MED CORPS, V162, P98, DOI 10.1136/jramc-2015-000475; Alunni A, 2016, DEVELOPMENT, V143, P741, DOI 10.1242/dev.122796; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; Chang J, 2015, EXP NEUROL, V273, P225, DOI 10.1016/j.expneurol.2015.08.020; Chesnut R M, 1995, New Horiz, V3, P366; Clervius H, 2019, NEURAL REGEN RES, V14, P1699, DOI 10.4103/1673-5374.255620; Cramer SC, 2014, INT J STROKE, V9, P321, DOI 10.1111/ijs.12260; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Dehghani F, 2010, NEUROPATH APPL NEURO, V36, P598, DOI 10.1111/j.1365-2990.2010.01104.x; Deng-Bryant Y, 2015, RESTOR NEUROL NEUROS, V33, P189, DOI 10.3233/RNN-140455; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dixon KJ, 2015, J NEUROTRAUM, V32, P753, DOI 10.1089/neu.2014.3390; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Fackler ML, 1996, ANN EMERG MED, V28, P194, DOI 10.1016/S0196-0644(96)70062-8; Gao JL, 2016, CELL TRANSPLANT, V25, P1863, DOI 10.3727/096368916X691150; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Lee SW, 2018, J NEUROTRAUM, V35, P1681, DOI 10.1089/neu.2017.5530; Lu P., 2014, JOVE-J VIS EXP, V89, DOI DOI 10.3791/50641; Mazzeo AT, 2018, J NEUROSURG SCI, V141, P459; Moreno-Jimenez EP, 2019, NAT MED, V25, P554, DOI 10.1038/s41591-019-0375-9; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Park HJ, 2013, J NEUROSCI METH, V213, P76, DOI 10.1016/j.jneumeth.2012.12.010; Peruzzotti-Jametti L, 2018, CELL STEM CELL, V22, P355, DOI 10.1016/j.stem.2018.01.020; Piltti KM, 2013, STEM CELL TRANSL MED, V2, P204, DOI 10.5966/sctm.2012-0110; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Regasa LE, 2018, J HEAD TRAUMA REHAB, V33, P123, DOI 10.1097/HTR.0000000000000380; Sapsford W, 2003, J R Army Med Corps, V149, P5; Scott G, 2017, BRAIN; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Skardelly M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00318; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Smith EJ, 2012, STEM CELLS, V30, P785, DOI 10.1002/stem.1024; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Spurlock MS, 2017, J NEUROTRAUM, V34, P1981, DOI 10.1089/neu.2016.4602; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; WEISSMAN MN, 1984, SURG NEUROL, V21, P347, DOI 10.1016/0090-3019(84)90112-5; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Wright AK, 2008, BRAIN RES, V1216, P78, DOI 10.1016/j.brainres.2008.04.020; Zafonte RD, 1997, BRAIN INJURY, V11, P403; Zhang GZ, 2019, STEM CELL TRANSL MED, V8, P999, DOI 10.1002/sctm.18-0220; Zibara K, 2019, NEUROPHARMACOLOGY, V145, P177, DOI 10.1016/j.neuropharm.2018.09.032	49	2	2	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2020	88	4					477	485		10.1097/TA.0000000000002510			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	NE5PN	WOS:000562653100003	31626023	Green Published, hybrid			2022-02-06	
J	Imai, T; Sugiyama, T; Iwata, S; Nakamura, S; Shimazawa, M; Hara, H				Imai, Takahiko; Sugiyama, Tomoki; Iwata, Sena; Nakamura, Shinsuke; Shimazawa, Masamitsu; Hara, Hideaki			Levetiracetam, an Antiepileptic Drug has Neuroprotective Effects on Intracranial Hemorrhage Injury	NEUROSCIENCE			English	Article						brain edema; caspase; intracranial hemorrhage; levetiracetam; neuron	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; CEREBRAL-HEMORRHAGE; EXPRESSION; EPIDEMIOLOGY; MODEL	Intracranial hemorrhage (ICH) is a devastating disease that induces hematoma formation with poor neuronal outcome. Levetiracetam (LEV) has been approval for epilepsy seizures. In a previous study, LEV exerted protective effects on cerebral ischemia models; however, the detail effects and the influence of LEV on ICH are still unknown. The aim of this study was to investigate whether oral administration of LEV (50 or 150 mg/kg) has protective effects on ICH injury using both in vivo and in vitro experiments. In in vivo experiments, we utilized ICH models induced by autologous blood (bICH) or collagenase (cICH) injection. Moreover, we established a neuronal injury model using SYSH5Y human neuroblastoma cell lines. In the bICH model, frequently oral administration of LEV attenuated both cerebral edema and neurological deficits. In addition, the expression levels of phosphorylation-extracellular signal related kinase (ERK) 1/2 and cleaved caspase-7 were increased after ICH, and LEV suppressed such alterations. In in vitro experiments, hematoma releasing factors, such as hemoglobin (Hb) and hemin, induced neuronal cell death, and LEV treatment attenuated neuronal injury in a dose-dependent manner. In the cICH model, neurological deficits induced by extensive hematoma formation were attenuated by LEV without affecting hematoma volume. Taken together, these findings suggested that LEV has protective effect on neurons after ICH injury. Therefore, LEV may not only be an efficacious therapeutic agent for seizures, but also for post-hemorrhagic stroke brain injury. (C) 2020 IBRO. Published by Elsevier Ltd. All rights reserved.	[Imai, Takahiko; Sugiyama, Tomoki; Iwata, Sena; Nakamura, Shinsuke; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Mol Pharmacol, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan		Hara, H (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Mol Pharmacol, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	hidehara@gifu-pu.ac.jp	Imai, Takahiko/ABF-6143-2020	Imai, Takahiko/0000-0002-4422-2946			Abdel-Wahab BA, 2015, PHARMACOL BIOCHEM BE, V135, P105, DOI 10.1016/j.pbb.2015.05.020; Ando S, 2019, NEUROCHEM RES; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Block L, 2013, NEUROSCIENCE, V250, P536, DOI 10.1016/j.neuroscience.2013.07.033; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Calikoglu Cagatay, 2015, Med Sci Monit, V21, P813, DOI 10.12659/MSM.893887; Chen SP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1140-6; Chu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066051; Cuomo O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080852; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Deng SX, 2018, J MOL NEUROSCI, V66, P639, DOI 10.1007/s12031-018-1206-z; Erbas O, 2016, ENVIRON TOXICOL PHAR, V42, P226, DOI 10.1016/j.etap.2016.02.005; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Hansson E, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1361-8; Huertas Gonzalez N, 2019, NEUROLOGIA; Ikram MA, 2012, CURR ATHEROSCLER REP, V14, P300, DOI 10.1007/s11883-012-0252-1; Imai T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42370-z; Iwata S, 2018, BRAIN RES, V1698, P130, DOI 10.1016/j.brainres.2018.08.009; Jin HB, 2016, MED SCI MONITOR, V22, P678, DOI 10.12659/MSM.897201; Lee JS, 2018, MOL MED REP, V18, P3898, DOI 10.3892/mmr.2018.9377; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Lu B, 2017, MOL MED REP, V16, P3387, DOI 10.3892/mmr.2017.6995; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; McDaniel WF, 2007, PSYCHOL REP, V100, P164, DOI 10.2466/PR0.100.1.164-166; Min H, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0305-z; Nikolian VC, 2018, J TRAUMA ACUTE CARE, V84, P459, DOI 10.1097/TA.0000000000001765; Niu JP, 2017, INT J IMMUNOPATH PH, V30, P413, DOI 10.1177/0394632017742224; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Scimemi A, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/7301623; Sendrowski K, 2011, FOLIA HISTOCHEM CYTO, V49, P148, DOI 10.5603/FHC.2011.0021; Siaw-Debrah F, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5135429; Sugiyama T, 2018, BRAIN RES, V1701, P137, DOI 10.1016/j.brainres.2018.08.021; Takagi T, 2017, J CEREBR BLOOD F MET, V37, P123, DOI 10.1177/0271678X15621499; Wilkinson DA, 2018, NEUROPHARMACOLOGY, V134, P240, DOI 10.1016/j.neuropharm.2017.09.033; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xu MY, 2019, STROKE VASC NEUROL, V4, P48, DOI 10.1136/svn-2018-000175; Yan BC, 2018, NEUROSCI LETT, V662, P84, DOI 10.1016/j.neulet.2017.10.010; Zhang Y, 2016, MOL NEUROBIOL, V53, P5480, DOI 10.1007/s12035-015-9467-9; Zhu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097423; Ziai WC, 2013, STROKE, V44, pS74, DOI 10.1161/STROKEAHA.111.000662; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	43	2	3	1	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 1	2020	431						25	33		10.1016/j.neuroscience.2020.01.036			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KW0JX	WOS:000520860500003	32058064				2022-02-06	
J	Keenan, HT; Clark, AE; Holubkov, R; Cox, CS; Patel, RP; Moore, KR; Ewing-Cobbs, L				Keenan, Heather T.; Clark, Amy E.; Holubkov, Richard; Cox, Charles S.; Patel, Rajan P.; Moore, Kevin R.; Ewing-Cobbs, Linda			Latent Class Analysis to Classify Injury Severity in Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						LCA; outcomes; pediatric; TBI	GLASGOW COMA SCALE; EXECUTIVE FUNCTION; CHILDREN; MORTALITY; RECOVERY; SCORES; STRATIFICATION; CLASSIFICATION; PREDICTORS; DISABILITY	Heterogeneity of injury severity among children with traumatic brain injury (TBI) classified by the Glasgow Coma Scale (GCS) makes comparisons across research cohorts, enrollment in clinical trials, and clinical predictions of outcomes difficult. The present study uses latent class analysis (LCA) to distinguish severity subgroups from a prospective cohort of 433 children 2.5-15 years of age with TBI who were recruited from two level 1 pediatric trauma centers. Indicator variables available within 48 h post-injury including emergency department (ED) GCS, hospital motor GCS, Abbreviated Injury Score (AIS), Rotterdam Score, hypotension in the ED, and pre-hospital loss of consciousness, intubation, seizures, and sedation were evaluated to define subgroups. To understand whether latent class subgroups were predictive of clinically meaningful outcomes, the Pediatric Injury Functional Outcome Scale (PIFOS) at 6 and 12 months, and the Behavior Rating Inventory of Executive Function at 12 months, were compared across subgroups. Then, outcomes were examined by GCS (primary) and AIS (secondary) classification alone to assess whether LCA provided improved outcome prediction. LCA identified four distinct increasing severity subgroups (1-4). Unlike GCS classification, mean outcome differences on PIFOS at 6 months showed decreasing function across classes. PIFOS differences relative to the lowest latent class (LC1) were: LC2 2.27 (0.83, 3.72), LC3 3.99 (1.88, 6.10), and LC4 11.2 (7.04, 15.4). Differences in 12 month outcomes were seen between the most and least severely injured groups. Differences in outcomes in relation to AIS were restricted to the most and less severely injured at both time points. This study distinguished four latent classes that are clinically meaningful, distinguished a more homogenous severe injury group, and separated children by 6-month functional outcomes better than GCS alone. Systematic reporting of these variables would allow comparisons across research cohorts, potentially improve clinical predictions, and increase sensitivity to treatment effects in clinical trials.	[Keenan, Heather T.; Clark, Amy E.; Holubkov, Richard] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Cox, Charles S.] Univ Texas Med Sch Houston, Dept Pediat Surg, Houston, TX USA; [Patel, Rajan P.] Univ Texas Houston, Dept Diagnost & Intervent Radiol, Div Neuroradiol, McGovern Med Sch, Houston, TX USA; [Moore, Kevin R.] Primary Childrens Med Ctr, Dept Med Imaging, Salt Lake City, UT USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Houston, TX 77030 USA		Keenan, HT (corresponding author), Dept Pediat, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu			Centers for Disease Control (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01/CE002188]; National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [K24HD072984]	This study was supported by The Centers for Disease Control (CDC) under Cooperative Agreement U01/CE002188. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC. This study was supported also by the National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) grant number K24HD072984. Neither the NICHD or the CDC played a role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Davis KC, 2016, J HEAD TRAUMA REHAB, V31, pE39, DOI 10.1097/HTR.0000000000000159; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Fortune PM, 2010, PEDIATR CRIT CARE ME, V11, P339, DOI 10.1097/PCC.0b013e3181c014ab; Gennarelli TA., 2008, ABBREVIATED INJURY S; Gioa GA, 2000, BEHAV RATING INVENTO; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gomez D, 2017, J AM COLL SURGEONS, V225, P755, DOI 10.1016/j.jamcollsurg.2017.08.020; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Hubbard ME, 2019, BRAIN INJURY, V33, P643, DOI 10.1080/02699052.2019.1566966; Isquith PK, 2004, DEV NEUROPSYCHOL, V26, P403, DOI 10.1207/s15326942dn2601_3; JENNETT B, 1975, LANCET, V1, P480; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Kisala PA, 2019, HEALTH PSYCHOL, V38, P435, DOI 10.1037/hea0000685; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Kongsted Alice, 2017, J Physiother, V63, P55, DOI 10.1016/j.jphys.2016.05.018; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Murphy S, 2017, J NEUROTRAUM, V34, P2220, DOI 10.1089/neu.2016.4793; Muthen B., 2017, MPLUS USERS GUIDE; REILLY PL, 1988, CHILD NERV SYST, V4, P30; RINDSKOPF D, 1986, STAT MED, V5, P21, DOI 10.1002/sim.4780050105; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rivara FP, 2011, HEALTH SERV RES, V46, P964, DOI 10.1111/j.1475-6773.2010.01236.x; Rogers S, 2017, J NURSING ED PRACTIC, V7, P23, DOI [10.5430/jnep. v7n11p23, DOI 10.5430/JNEP.V7N11P23]; Runyan DK, 1998, PEDIATRICS, V101, P12, DOI 10.1542/peds.101.1.12; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; TEASDALE G, 1974, LANCET, V2, P81; United Medical Education, 2019, PALS ALG 2019; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wilkinson AA, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0925-6; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	41	2	2	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2020	37	13					1512	1520		10.1089/neu.2019.6874		APR 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ME4JC	WOS:000522970400001	32103698	Green Published			2022-02-06	
J	Klinzing, S; Hilty, MP; Bechtel-Grosch, U; Schuepbach, RA; Buhler, P; Brandi, G				Klinzing, Stephanie; Hilty, Matthias P.; Bechtel-Grosch, Ursina; Schuepbach, Reto Andreas; Buehler, Philipp; Brandi, Giovanna			Dynamic optic nerve sheath diameter changes upon moderate hyperventilation in patients with traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; TBI; Hyperventilation; Intracranial pressure; ICP; Optic nerve ultrasound; ONUS; Optic nerve sheath diameter; ONSD; Point of care ultrasound; POCUS	INTRACRANIAL-PRESSURE; CARBON-DIOXIDE; HYPERTENSION; ULTRASOUND	Background: Sonographic assessment of optical nerve sheath diameter (ONSD) has the potential for non-invasive monitoring of intracranial pressure (ICP). Hyperventilation (HV) -induced hypocapnia is used in the management of patients with traumatic brain injury (TBI) to reduce ICP. This study investigates, whether sonography is a reliable tool to detect dynamic changes in ONSD. Methods: This prospective single center trial included patients with TBI and neuromonitoring within 36 h after injury. Data collection and ONSD measurements were performed at baseline and during moderate HV for 50 min. Patients not suffering from TBI were recruited as control group. Results: Ten patients with TBI (70% males, mean age 35 +/- 14 years) with a median of first GCS of 5.9 and ten control patients (40% males, mean age 45 +/- 16 years) without presumed intracranial hypertension were included. During HV, ICP decreased significantly (p < .0001) in the TBI group. An ONSD response was found for HV (p = .05). Conclusion: We observed a dynamic decrease of ONSD during moderate HV. This suggests a potential use of serial ONSD measurements when applying HV in cases of suspected intracranial hypertension. (C) 2020 Elsevier Inc. All rights reserved.	[Klinzing, Stephanie; Hilty, Matthias P.; Bechtel-Grosch, Ursina; Schuepbach, Reto Andreas; Buehler, Philipp; Brandi, Giovanna] Univ Hosp Zurich, Inst Intens Care Med, Ramistr 100, CH-8091 Zurich, Switzerland		Klinzing, S (corresponding author), Univ Hosp Zurich, Inst Intens Care Med, Ramistr 100, CH-8091 Zurich, Switzerland.	Stephanie.klinzing@usz.ch; Matthias.hilty@usz.ch; Ursina.bechtel-grosch@usz.ch; Reto.schuepbach@usz.ch; Philipp.buehler@usz.ch; Giovanna.brandi@usz.ch	Schuepbach, Reto/AAO-6360-2020; Hilty, Matthias Peter/I-7883-2017; Schuepbach, Reto A/J-9737-2012	Schuepbach, Reto/0000-0002-7058-4377; Hilty, Matthias Peter/0000-0002-2765-881X; Schuepbach, Reto A/0000-0002-7058-4377; Buehler, Philipp Karl/0000-0003-4690-9896			Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bauerle J, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-187; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brandi G, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2304-6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; del Saz-Saucedo P, 2016, J NEUROL SCI, V361, P122, DOI 10.1016/j.jns.2015.12.032; Dinsmore M, 2017, ANAESTHESIA, V72, P618, DOI 10.1111/anae.13784; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Helmke K, 1996, PEDIATR RADIOL, V26, P706, DOI 10.1007/BF01383384; Jeon JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183170; Khan Marium Naveed, 2017, Surg Neurol Int, V8, P51, DOI 10.4103/sni.sni_403_16; Kim JY, 2014, KOREAN J ANESTHESIOL, V67, P240, DOI 10.4097/kjae.2014.67.4.240; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MC S, 2017, PLOTROC TOOL PLOTT R; Moretti R, 2009, J NEUROSURG ANESTH, V21, P16, DOI 10.1097/ANA.0b013e318185996a; Munch E, 1998, ACTA NEUROCHIR, V140, P1113, DOI 10.1007/s007010050224; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Robba C, 2018, INTENS CARE MED, V44, P1284, DOI 10.1007/s00134-018-5305-7; Robba C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002356; Seo H, 2013, TRANSPL P, V45, P2272, DOI 10.1016/j.transproceed.2012.12.032; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Team RDC, 2011, LANG ENV STAT COMP L; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	27	2	2	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2020	56						229	235		10.1016/j.jcrc.2020.01.008			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2RN	WOS:000519555700037	31982696				2022-02-06	
J	Liu, Y; Wang, J; Cheng, G; Zhang, LM; Zhang, JN				Liu Yi; Wang Juan; Cheng Gang; Zhang Leiming; Zhang Jianning			Seawater Immersion Aggravates Early Mitochondrial Dysfunction and Increases Neuronal Apoptosis After Traumatic Brain Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Seawater immersion; Mitochondria; Apoptosis; Neuronal damage	MECHANICAL STRETCH; DEATH	Traumatic brain injury (TBI) is a major cause of death and disability in naval warfare. Due to the unique physiochemical properties of seawater, immersion in it exacerbates TBI and induces severe neural damage and complications. However, the characteristics and underlying mechanisms of seawater-immersed TBI remain unclear. Mitochondrial dysfunction is a major cause of TBI-associated brain damage because it leads to oxidative stress, decrease in energy production, and apoptosis. Thus, the present study aimed to further elucidate the current understanding of the pathology of seawater-immersed TBI, particularly the role of mitochondrial dysfunction, using a well-defined rat model of fluid percussion injury and a stretch injury model comprising cultured neurons. The biochemical and pathological markers of brain-related and neuronal injuries were evaluated. Histological analysis suggested that seawater immersion enhanced brain tissue injury and induced a significant increase in apoptosis in rats with TBI. Additionally, lactate dehydrogenase release occurred earlier and at higher levels in stretched neurons at 24 h after seawater immersion, which was consistent with more severe morphological changes and enhanced apoptosis. Furthermore, seawater immersion induced more rapid decreases in mitochondrial membrane potential, adenosine triphosphate (ATP) content, and H+-ATPase activity in the cortices of TBI rats. In addition, the immunochemical results revealed that seawater immersion further attenuated mitochondrial function in neurons exposed to stretch injury. The increases in neuronal damage and apoptosis triggered by seawater immersion were positively correlated with mitochondrial dysfunction in both in vivo and in vitro models. Thus, the present findings strengthen the current understanding of seawater-immersed TBI. Moreover, because seawater immersion aggravates mitochondrial dysfunction and contributes to post-traumatic neuronal cell death, it is important to consider mitochondria as a therapeutic target for seawater-immersed TBI.	[Liu Yi; Wang Juan; Cheng Gang; Zhang Leiming; Zhang Jianning] Second Mil Med Univ, Gen Navy Hosp PLA, Dept Neurosurg, 6 Fucheng Rd, Beijing 100048, Peoples R China		Zhang, JN (corresponding author), Second Mil Med Univ, Gen Navy Hosp PLA, Dept Neurosurg, 6 Fucheng Rd, Beijing 100048, Peoples R China.	liuyi20053@163.com; 13520041949@163.com; 18601960641@126.com; zhangjn2019@163.com; zhangleiming187@163.com		Zhang, Jianning/0000-0001-6607-3227	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372128]	We thank Prof. Fan Ming for expert technical assistance. This work was supported by the grants: National Natural Science Foundation of China (Grant No. 81372128).	Arandarcikaite O, 2015, NEUROSCI LETT, V586, P65, DOI 10.1016/j.neulet.2014.09.012; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Du LN, 2016, J NEUROTRAUM, V33, P1913, DOI 10.1089/neu.2015.4342; Glass TF, 2002, NEUROSCI LETT, V328, P133, DOI 10.1016/S0304-3940(02)00510-4; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hu XH, 2010, RESPIRATION, V79, P490, DOI 10.1159/000264664; Iannacone JM, 2009, ANAL CHEM, V81, P5433, DOI 10.1021/ac9005843; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; Kilbaugh TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130927; Kirkland RA, 2007, J NEUROSCI, V27, P11315, DOI 10.1523/JNEUROSCI.3590-07.2007; Kirkman E, 2014, BRIT J ANAESTH, V113, P266, DOI 10.1093/bja/aeu232; Lamade AM, 2019, NEUROPHARMACOLOGY, V145, P209, DOI 10.1016/j.neuropharm.2018.07.014; Langhammer CG, 2010, CYTOM PART A, V77A, P1160, DOI 10.1002/cyto.a.20954; Lu Song-min, 2006, Chin J Traumatol, V9, P38; Ma J, 2017, BURNS, V43, P1011, DOI 10.1016/j.burns.2017.01.028; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Pan MH, 2007, J DERMATOL, V34, P683, DOI 10.1111/j.1346-8138.2007.00359.x; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Wang F, 2014, NEUROTOXICOLOGY, V41, P54, DOI 10.1016/j.neuro.2014.01.002; Wang HF, 2015, EXP THER MED, V9, P1153, DOI 10.3892/etm.2015.2281; Wei LF, 2016, TURK NEUROSURG, V26, P384, DOI 10.5137/1019-5149.JTN.8265-13.1; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wu HJ, 2015, CELL MOL NEUROBIOL, V35, P85, DOI 10.1007/s10571-014-0116-z; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yokobori S, 2014, CNS NEUROL DISORD-DR, V13, P606, DOI 10.2174/187152731304140702112805; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Yu SS, 2016, NEUROSCI LETT, V628, P24, DOI 10.1016/j.neulet.2016.06.012; Zhang TY, 2018, CELL MOL NEUROBIOL, V38, P1413, DOI 10.1007/s10571-018-0608-3	37	2	2	2	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	APR	2020	40	3					447	457		10.1007/s10571-019-00747-8			11	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	NR2OX	WOS:000571403300001	31667702				2022-02-06	
J	Losurdo, M; Davidsson, J; Skold, MK				Losurdo, Michela; Davidsson, Johan; Skold, Mattias K.			Diffuse Axonal Injury in the Rat Brain: Axonal Injury and Oligodendrocyte Activity Following Rotational Injury	BRAIN SCIENCES			English	Article						diffuse axonal injury; traumatic brain injury; myelin degradation; oligodendrocyte progenitor cell; olig2	AMYLOID PRECURSOR PROTEIN; CHONDROITIN-SULFATE PROTEOGLYCAN; GLIAL PROGENITOR CELLS; WHITE-MATTER; SUBVENTRICULAR ZONE; MONOCLONAL-ANTIBODY; NEURONAL INJURY; STRESS-RESPONSE; HEAD TRAUMA; BETA-APP	Traumatic brain injury (TBI) commonly results in primary diffuse axonal injury (DAI) and associated secondary injuries that evolve through a cascade of pathological mechanisms. We aim at assessing how myelin and oligodendrocytes react to head angular-acceleration-induced TBI in a previously described model. This model induces axonal injuries visible by amyloid precursor protein (APP) expression, predominantly in the corpus callosum and its borders. Brain tissue from a total of 27 adult rats was collected at 24 h, 72 h and 7 d post-injury. Coronal sections were prepared for immunohistochemistry and RNAscope(R) to investigate DAI and myelin changes (APP, MBP, Rip), oligodendrocyte lineage cell loss (Olig2), oligodendrocyte progenitor cells (OPCs) (NG2, PDGFRa) and neuronal stress (HSP70, ATF3). Oligodendrocytes and OPCs numbers (expressed as percentage of positive cells out of total number of cells) were measured in areas with high APP expression. Results showed non-statistically significant trends with a decrease in oligodendrocyte lineage cells and an increase in OPCs. Levels of myelination were mostly unaltered, although Rip expression differed significantly between sham and injured animals in the frontal brain. Neuronal stress markers were induced at the dorsal cortex and habenular nuclei. We conclude that rotational injury induces DAI and neuronal stress in specific areas. We noticed indications of oligodendrocyte death and regeneration without statistically significant changes at the timepoints measured, despite indications of axonal injuries and neuronal stress. This might suggest that oligodendrocytes are robust enough to withstand this kind of trauma, knowledge important for the understanding of thresholds for cell injury and post-traumatic recovery potential.	[Losurdo, Michela; Skold, Mattias K.] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Losurdo, Michela] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Davidsson, Johan] Chalmers Univ Technol, Dept Mech & Maritime Sci, S-41296 Gothenburg, Sweden; [Skold, Mattias K.] Uppsala Univ, Sect Neurosurg, Dept Neurosci, S-75185 Uppsala, Sweden		Losurdo, M (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.; Losurdo, M (corresponding author), Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy.	michela.losurdo01@universitadipavia.it; johan.davidsson@chalmers.se; mattias.skold@ki.se	Davidsson, Johan/A-3229-2016	Davidsson, Johan/0000-0002-1717-1514	Swedish Armed Forces RD	This work was supported by the Swedish Armed Forces R&D.	[Anonymous], US IMAGEJ AN RNASCOP; Antona-Makoshi J, 2015, TRAFFIC INJ PREV, V16, pS91, DOI 10.1080/15389588.2015.1021416; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Baumgartner D., 2009, P 2009 IRCOBI C YORK; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Bergles DE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020453; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Caprariello AV, 2012, ANN NEUROL, V72, P395, DOI 10.1002/ana.23606; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chen K, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01417; Chen MZ, 1998, J NEUROTRAUM, V15, P171, DOI 10.1089/neu.1998.15.171; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Conti AC, 1998, J NEUROSCI, V18, P5663; Davidsson J., 2013, P JSAE ANN C YOK JAP; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; DeGracia DJ, 2007, NEUROL RES, V29, P356, DOI 10.1179/016164107X204666; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; El Waly B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00145; Fernandez-Castaneda A, 2016, BRAIN BEHAV IMMUN, V57, P1, DOI 10.1016/j.bbi.2016.01.005; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2017, RESTOR NEUROL NEUROS, V35, P251, DOI 10.3233/RNN-160675; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; FRIEDMAN B, 1989, GLIA, V2, P380, DOI 10.1002/glia.440020510; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Goldman SA, 2015, DEVELOPMENT, V142, P3983, DOI 10.1242/dev.126409; Gupta R, 2005, J ORTHOP RES, V23, P1232, DOI 10.1016/j.orthres.2004.12.010; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Lambri M, 2001, CLIN NEUROPATHOL, V20, P263; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Li HD, 2004, DEV BIOL, V271, P225, DOI 10.1016/j.ydbio.2004.02.028; Li P, 2017, NEURAL REGEN RES, V12, P1843, DOI 10.4103/1673-5374.219045; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lotocki G, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2010.0011; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Merrill JE, 1999, NEUROPATH APPL NEURO, V25, P435; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mierzwa AJ, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551782; Moransard M, 2011, BRAIN, V134, P1315, DOI 10.1093/brain/awr070; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nascimento D, 2011, NEUROSIGNALS, V19, P210, DOI 10.1159/000330195; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nishiyama A, 2002, J NEUROCYTOL, V31, P437, DOI 10.1023/A:1025783412651; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rajdev S, 2000, TOXICOL PATHOL, V28, P105, DOI 10.1177/019262330002800113; Rao MS, 1997, DEV BIOL, V188, P48, DOI 10.1006/dbio.1997.8597; Riise J, 2011, J ANAT, V218, P277, DOI 10.1111/j.1469-7580.2010.01333.x; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Scheller A, 2017, NEUROCHEM RES, V42, P2479, DOI 10.1007/s11064-017-2343-4; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Tehse J, 2019, EUR J NEUROSCI, V49, P1157, DOI 10.1111/ejn.14307; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang HC, 2010, J NEUROTRAUM, V27, P707, DOI 10.1089/neu.2009.1071; Watanabe M, 2002, J NEUROSCI RES, V69, P826, DOI 10.1002/jnr.10338; Watanabe M, 2006, J NEUROSCI RES, V84, P525, DOI 10.1002/jnr.20950; Wegner M, 2001, MICROSC RES TECHNIQ, V52, P746, DOI 10.1002/jemt.1059; Wong AW, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00766	100	2	2	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	APR	2020	10	4							229	10.3390/brainsci10040229			27	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP4EO	WOS:000534271500017	32290212	Green Submitted, Green Published, gold			2022-02-06	
J	Lu, BC; Zeng, FY; Xing, W; Liang, L; Huo, JB; Tan, CR; Zhu, LX; Liu, ZZ				Lu, Bichao; Zeng, Fanyong; Xing, Wen; Liang, Lin; Huo, Jianbo; Tan, Chianru; Zhu, Lingxiang; Liu, Zhizhong			Decreased mitochondrial DNA copy number in children with cerebral palsy quantified by droplet digital PCR	CLINICA CHIMICA ACTA			English	Article						Mitochondrial DNA copy number; Droplet digital PCR; Cerebral palsy; Mitochondria] dysfunction	PERIPHERAL-BLOOD CELLS; BRAIN; INFLAMMATION; MAINTENANCE; DEFICIENCY; MUTATIONS; SYSTEM; DAMAGE	Background Mitochondrial DNA copy number is a potential biomarker for mitochondrial dysfunction and is involved in a variety of disease states including autism, neurodegenerative diseases and traumatic brain injury, but few studies on mitochondrial DNA copy number in cerebral palsy have been reported. Therefore, this study aims to investigate the role of mitochondrial DNA copy number in children with cerebral palsy. Methods: A total of 104 children with cerebral palsy and 78 typically developing children were enrolled in this study. All children with cerebral palsy were diagnosed according to clinical criteria and furtherly divided into clinical subtypes. Mitochondrial DNA copy number was quantified by droplet digital PCR. Results: We observed a significant reduction in mitochondrial DNA copy number from children with cerebral palsy comparing to healthy controls (216.76 +/- 71.39 vs 359.66 +/- 72.78, p < 0.001). An upward trend in mitochondrial DNA copy number alteration with the increase of age was found in healthy controls rather than in children with cerebral palsy. In addition, the mitochondrial DNA copy number in children with spastic hemiplegia was higher than that in children with spastic quadriplegia (152.27 +/- 49.78 vs 90.64 +/- 21.55, p = 0.001). Conclusions: Our results suggest that on the basis of accurate quantification by droplet digital PCR, the declined mitochondrial DNA copy number probably has certain implications for mitochondrial dysfunction in children with cerebral palsy, which provides a new clue for the investigation on the molecular mechanism and clinical characteristics of cerebral palsy.	[Lu, Bichao; Xing, Wen; Liang, Lin; Huo, Jianbo; Liu, Zhizhong] Beijing Boai Hosp, China Rehabil Res Ctr, Dept Clin Lab, 10 Jiaomen North Rd, Beijing 100068, Peoples R China; [Zeng, Fanyong] Beijing Boai Hosp, China Rehabil Res Ctr, Dept Children Rehabil, 10 Jiaomen North Rd, Beijing 100068, Peoples R China; [Tan, Chianru] Tsinghua Univ, Sch Med, Dept Biomed Engn, 30 Shuangqing Rd, Beijing 100084, Peoples R China; [Zhu, Lingxiang] Natl Res Inst Family Planning, 12 Da Huisi Rd, Beijing 100081, Peoples R China		Liu, ZZ (corresponding author), Beijing Boai Hosp, China Rehabil Res Ctr, Dept Clin Lab, 10 Jiaomen North Rd, Beijing 100068, Peoples R China.	zhulingxiang@nrifp.org.cn; lzzlab@126.com					Aden U, 2010, BRAIN BEHAV IMMUN, V24, P747, DOI 10.1016/j.bbi.2009.10.010; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Aycicek A, 2006, BRAIN RES BULL, V69, P666, DOI 10.1016/j.brainresbull.2006.03.014; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Chen S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0432-y; Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8; Decraene C, 2018, CLIN CHEM, V64, P317, DOI 10.1373/clinchem.2017.272518; Ellenberg JH, 2013, DEV MED CHILD NEUROL, V55, P210, DOI 10.1111/dmcn.12016; Fazzini F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33684-5; Fleiss B, 2012, LANCET NEUROL, V11, P556, DOI 10.1016/S1474-4422(12)70058-3; FRYER A, 1994, ARCH DIS CHILD, V71, P419, DOI 10.1136/adc.71.5.419; Gucuyener K, 1998, J INHERIT METAB DIS, V21, P173, DOI 10.1023/A:1005304015278; Hemminki K, 2007, PAEDIATR PERINAT EP, V21, P235, DOI 10.1111/j.1365-3016.2007.00798.x; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Huang J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003323; Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625; Kilbaugh TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130927; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Lawson RD, 2003, HAND CLIN, V19, P547, DOI 10.1016/S0749-0712(03)00040-4; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee RW, 2014, NEUROMOL MED, V16, P821, DOI 10.1007/s12017-014-8331-9; Limongelli G, 2012, FUTUR CARDIOL, V8, P71, DOI [10.2217/fca.11.79, 10.2217/FCA.11.79]; Lin CY, 2010, ANN NEUROL, V68, P204, DOI 10.1002/ana.22049; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; Ma ZA, 2012, EXP DIABETES RES, DOI 10.1155/2012/703538; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Marin-Garcia J, 1999, PEDIATRICS, V103, P456, DOI 10.1542/peds.103.2.456; Memon Ashfaque A, 2017, Biomol Detect Quantif, V13, P32, DOI 10.1016/j.bdq.2017.08.001; Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9; Mordekar SR, 2004, J PAEDIATR CHILD H, V40, P714, DOI 10.1111/j.1440-1754.2004.00518.x; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nelson KB, 2004, LANCET NEUROL, V3, P150, DOI 10.1016/S1474-4422(04)00679-9; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; Novak I, 2012, PEDIATRICS, V130, pE1285, DOI 10.1542/peds.2012-0924; O'Hara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119; Palmeira C., 2014, MITOCHONDRIAL REGULA, P1; Pearson TS, 2019, MOVEMENT DISORD, V34, P625, DOI 10.1002/mds.27655; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Pohjoismaki JLO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010426; POULTON J, 1994, HUM MOL GENET, V3, P1763, DOI 10.1093/hmg/3.10.1763; Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reddy PH, 2008, NEUROMOL MED, V10, P291, DOI 10.1007/s12017-008-8044-z; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Rosenbaum PL, 2008, DEV MED CHILD NEUROL, V50, P249, DOI 10.1111/j.1469-8749.2008.02045.x; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Smith LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040686; Sotgia F, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-62; Sukhov A, 2012, J MATERN-FETAL NEO M, V25, P53, DOI 10.3109/14767058.2011.564689; Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T; Wang F, 2018, ANAL CHEM, V90, P8919, DOI 10.1021/acs.analchem.8b01096; Wei W, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0404-6; Wu YW, 2003, JAMA-J AM MED ASSOC, V290, P2677, DOI 10.1001/jama.290.20.2677; Xia C.Y., 2017, CHIN MED J; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514	58	2	2	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	APR	2020	503						122	127		10.1016/j.cca.2020.01.018			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	KU4CJ	WOS:000519657200014	31978410				2022-02-06	
J	Menardi, A; Bertagnoni, G; Sartori, G; Pastore, M; Mondini, S				Menardi, Arianna; Bertagnoni, Giannettore; Sartori, Giuseppe; Pastore, Massimiliano; Mondini, Sara			Past Life Experiences and Neurological Recovery: The Role of Cognitive Reserve in the Rehabilitation of Severe Post-Anoxic Encephalopathy and Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Cognitive reserve; Brain reserve; Traumatic brain injury; Post-anoxic encephalopathy; Functional recovery; Rehabilitation	DEMENTIA; COMA	Objective: Patients with an equivalent clinical background may show unexpected interindividual differences in their outcome. The cognitive reserve (CR) model has been proposed to account for such discrepancies, but its role after acquired severe injuries is still being debated. We hypothesize that inappropriate investigative methods might have been used when dealing with severe patients, which have very likely reduced the possibility of observing meaningful influences in recovery from severe traumas. Methods: To overcome this issue, the potential neuroprotective role of CR was investigated, considering a wider spectrum of clinical symptoms ranging from low-level brain stem functions necessary for life to more complex motor and cognitive skills. In the present study, data from 50 severe patients, 20 suffering from post-anoxic encephalopathy (PAE) and 30 with traumatic brain injury (TBI), were collected and retrospectively analyzed. Results: We found that CR, diagnosis, time of hospitalization, and their interaction had an effect on the clinical indexes. When the predictive power of CR was investigated by means of two machine learning classifier algorithms, CR, together with age, emerged as the strongest factor in discriminating between patients who reached or did not reach successful recovery. Conclusions: Overall, the present study highlights a possible role of CR in shaping the recovery of severe patients suffering from either PAE or TBI. The practical implications underlying the need to routinely considered CR in the clinical practice are discussed.	[Menardi, Arianna] Univ Padua, Padova Neurosci Ctr, Dept Neurosci, Via Giuseppe Orus, I-35131 Padua, PD, Italy; [Bertagnoni, Giannettore] San Bortolo Hosp, Div Phys & Rehabil Med, Viale Ferdinando Rodolfi 37, I-36100 Vicenza, VI, Italy; [Sartori, Giuseppe] Univ Padua, Dept Gen Psychol, Via Venezia 8, I-35131 Padua, PD, Italy; [Sartori, Giuseppe; Mondini, Sara] Univ Padua, Human Inspired Res Ctr, Via Luzzatti 4, I-35122 Padua, PD, Italy; [Pastore, Massimiliano] Univ Padua, Dept Dev & Social Psychol, Via Venezia 8, I-35131 Padua, PD, Italy; [Mondini, Sara] Univ Padua, FISPPA Dept, Via Venezia 14, I-35131 Padua, PD, Italy		Mondini, S (corresponding author), Univ Padua, FISPPA Dept, Via Venezia 14, I-35131 Padua, PD, Italy.	sara.mondini@unipd.it		Kaouachi, Nouha/0000-0003-3042-8238; Menardi, Arianna/0000-0003-4385-6848			[Anonymous], 1908, CURRENT LIT      MAR, V44, P295; [Anonymous], 2003, S AFRICA J J CLIN FO, V10, P153; Auer R.N., 1997, GREENFIELDS NEUROPAT, P263, DOI 10.1201/b13319; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cabeza R, 2018, NAT REV NEUROSCI, V19, P701, DOI 10.1038/s41583-018-0068-2; Devita M, 2020, AGING CLIN EXP RES, V32, P1179, DOI 10.1007/s40520-019-01285-5; Facal D, 2019, INT J GERIATR PSYCH, V34, P941, DOI 10.1002/gps.5090; Fortune DG, 2016, INT J REHABIL RES, V39, P234, DOI 10.1097/MRR.0000000000000175; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hagen C., 1972, LEVELS COGNITIVE FUN; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Jones RN, 2011, J INT NEUROPSYCH SOC, V17, P593, DOI 10.1017/S1355617710001748; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Landwehr N, 2005, MACH LEARN, V59, P161, DOI 10.1007/s10994-005-0466-3; Landwehr N, 2003, LECT NOTES ARTIF INT, V2837, P241; Le Carret Nicolas, 2005, Brain Cogn, V57, P120; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; MAHONEY F I, 1965, Md State Med J, V14, P61; Nucci Massimo, 2012, Aging Clin Exp Res, V24, P218, DOI 10.3275/7800; Nunnari D, 2014, NEUROL SCI, V35, P1513, DOI 10.1007/s10072-014-1897-z; Poletti M, 2011, PARKINSONISM RELAT D, V17, P579, DOI 10.1016/j.parkreldis.2011.03.013; R Development Core Team, 2012, R LANG ENV STAT COMP; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P1467, DOI 10.1001/archneur.65.11.1467; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Snowdon DA, 2003, ANN INTERN MED, V139, P450, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00014; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Sumowski JF, 2009, J CLIN EXP NEUROPSYC, V31, P913, DOI 10.1080/13803390902740643; TEASDALE G, 1974, LANCET, V2, P81; Tucker-Drob EA, 2009, DEV PSYCHOL, V45, P431, DOI 10.1037/a0014012; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; WHITLOCK J A JR, 1992, Brain Injury, V6, P447, DOI 10.3109/02699059209008140; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Witten IH, 2016, DATA MINING PRACTICA	45	2	2	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2020	26	4					394	406	PII S1355617719001231	10.1017/S1355617719001231			13	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	LB9JS	WOS:000524945600005	31727184				2022-02-06	
J	Pavlov, O				Pavlov, Orlin			Rapid evacuation of chronic subdural hematoma - A possible traumatic brain injury (TBI)	MEDICAL HYPOTHESES			English	Article							HYPERPERFUSION SYNDROME	The chronic subdural hematoma is an entity, which affects mainly the elderly patients. According to literature, the complication rate was up to 22,7%, including recurrence of hematoma, worsening of the neurological status, postoperative delirium, etc. Treating of a chronic subdural hematoma could be conservative and operative, including twist drill craniostomy, single or multiple burr hole drainage, and craniotomy. In the patients who underwent a decompression of the hematoma a postoperative hyperperfusion syndrome could be observed, according to literature up to 51,4%. This syndrome is associated risk of postoperative delirium and neurological deterioration. The hyperperfusion syndrome is also observed in traumatic brain injury. A rapid decompression of a subdural hematoma leads to a brain shifting to the skull bones and thus a traumatic brain injury due to decompression. The development of the hyperperfusion syndrome could be related to the decompression of the subdural hematoma in a rapid fashion.	[Pavlov, Orlin] Klinikum Fulda, Dept Neurosurg, Pacellialle 2, D-36043 Hessen, Germany		Pavlov, O (corresponding author), Klinikum Fulda, Dept Neurosurg, Pacellialle 2, D-36043 Hessen, Germany.	orlinpavlov88@gmail.com	Pavlov, Orlin/AAD-7219-2019	Pavlov, Orlin/0000-0002-6963-3426			Ducruet AF, 2015, NEUROSURG REV, V38, P771, DOI 10.1007/s10143-015-0644-0; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; Grover S, 2012, WORLD J PSYCHIATR, V2, P58, DOI 10.5498/wjp.v2.i4.58; Ogasawara K, 2000, SURG NEUROL, V54, P155, DOI 10.1016/S0090-3019(00)00281-0; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Rovlias Aristedis, 2015, Surg Neurol Int, V6, P127, DOI 10.4103/2152-7806.161788; Sharma P, 2019, WORLD NEUROSURG, V126, P694, DOI 10.1016/j.wneu.2019.02.116; Yadav Yad R, 2016, Asian J Neurosurg, V11, P330; Zhang J, 2016, TRANSLATIONAL RES TR	9	2	2	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	APR	2020	137								109539	10.1016/j.mehy.2019.109539			2	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	KW4CF	WOS:000521112300021	31952019				2022-02-06	
J	Peterson, JG; Tjong, VK; Terry, MA; Saltzman, MD; Gryzlo, SM; Sheth, U				Peterson, Joshua G.; Tjong, Vehniah K.; Terry, Michael A.; Saltzman, Matthew D.; Gryzlo, Stephen M.; Sheth, Ujash			Concussion Incidence and Impact on Player Performance in Major League Baseball Players Before and After a Standardized Concussion Protocol	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						traumatic brain injury; head injury; batting; pitching	TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE PERFORMANCE; BATTING PERFORMANCE; RELIABILITY; VALIDITY; SCAT3; NHL	Background: Sports-related concussions have garnered significant attention in recent years because of the negative effects they can have on a player's cognitive health and performance. In response to this growing concern, Major League Baseball (MLB) introduced a standardized concussion protocol during the 2011-2012 season. Purpose/Hypothesis: The purpose of this study was to compare the reported incidence of concussions and the subsequent performance of MLB players before and after the introduction of the standardized concussion protocol. We hypothesized that the introduction of the standardized concussion protocol would not have an impact on player performance postconcussion. Study Design: Cohort study; Level of evidence, 3. Methods: Players who suffered a concussion between 2001 and 2018 were identified from the MLB transactions page. Incidence and player performance were compared before and after the introduction of the standardized concussion protocol. Player performance was evaluated using traditional data and sabermetric data, which are advanced statistics used in conjunction with standard statistics to better compare players and teams. Player averages were calculated and compared using paired t tests for 30 days before and after concussion, 1 year before and after concussion, and career before and after concussion. Averages were also compared before and after the institution of the standardized concussion protocol using independent-measures t tests. Results: There were a total of 114 players who suffered 142 concussions, with 77% of those occurring after the introduction of the concussion protocol (32 before, 110 after). The average time missed because of concussion significantly decreased from 33.7 days (range, 10-122 days) to 18.9 days (range, 6-111 days) after the concussion protocol (P = .0005). There was no difference in player performance (including batting average, on-base percentage, and slugging for batters; earned run average, fielding-independent pitching, and walks plus hits per inning pitched for pitchers) after concussion at any time point (30 days, 1 year, or career) when comparing these statistics before versus after the MLB concussion protocol. However, batter performance was significantly poorer 1 year after concussion and over the remainder of the players' careers (P < .05). Conclusion: The number of reported concussions increased after the introduction of the MLB concussion protocol. However, players spent significantly less time on the disabled list without any adverse effect on player performance. Despite these changes, long-term batting performance was significantly poorer after concussion.	[Peterson, Joshua G.; Tjong, Vehniah K.; Terry, Michael A.; Saltzman, Matthew D.; Gryzlo, Stephen M.; Sheth, Ujash] Northwestern Univ, Dept Orthopaed Surg, Chicago, IL 60611 USA		Peterson, JG (corresponding author), 259 East Erie,13th Floor, Chicago, IL 60611 USA.	joshua.peterson@northwestern.edu					Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Bell M, MAJOR LEAGUE BASEBAL; Berry A, MAJOR LEAGUE BASEBAL; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Chow BH, 2019, OPEN ACCESS J SPORTS, V10, P41, DOI 10.2147/OAJSM.S192338; Christensen J, STARTRIBUNE; Clair M, CUT4 MLB; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eckersley CP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198316; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Green G, 2017, BRIT J SPORT MED, V51, pA64; Green GA, 2015, AM J SPORT MED, V43, P1118, DOI 10.1177/0363546514568089; Green GA, 2021, CLIN J SPORT MED, V31, pE1, DOI 10.1097/JSM.0000000000000679; Gregory S, TIME; Halem DR, 2017, 2017 2021 BASIC AGRE; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Hutchinson MR., 2014, ANN ORTHOP RHEUMATOL, V2, P1022; Janda DH, 2003, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000057789.10364.e3; Jiang JJ, 2014, AM J SPORT MED, V42, P880, DOI 10.1177/0363546513519072; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lucas P, ESPN            0419; Major League Baseball, MAJ LEAG BAS MAJ LEA; Major League Baseball, MLB APPR PADD CAP PI; Major League Baseball. MLB, MLBPA AD EXP RUL 7 1; Manderino LM, 2018, ARCH CLIN NEUROPSYCH, V33, P596, DOI 10.1093/arclin/acx102; Moss A, LOCKED ON YANKEES; Navarro SM, 2018, J NEUROTRAUM, V35, P2391, DOI 10.1089/neu.2017.5611; Perry D, CBS SPORTS DIGITAL; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Ramkumar PN, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118814238; Register-Mihalik JK, 2017, NEUROL CLIN, V35, P387, DOI 10.1016/j.ncl.2017.03.009; Sabesan VJ, 2018, OPEN ACCESS J SPORTS, V9, P253, DOI 10.2147/OAJSM.S157433; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X	37	2	2	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	APR	2020	8	4							2325967120913020	10.1177/2325967120913020			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	LH1SP	WOS:000528569400001	32313811	Green Published, gold			2022-02-06	
J	Phung, D; Nguyen, H; Chu, CD; Sadler, R; Luong, AM; Nguyen, HT; Pham, TC; Huang, CR				Phung, Dung; Nguyen, Ha Trong; Chu, Cordia; Sadler, Ross; Luong, Anh Mai; Nguyen, Huyen Thi; Pham, Tuan Cong; Huang, Cunrui			Impacts of helmet law on the changes in potential years of life lost due to traffic injury: a multiple-province evaluation in Vietnam	INJURY PREVENTION			English	Article						helmet; regulation; traumatic brain injury; burden of disease; process; impact evaluation	MOTORCYCLE INJURIES; A6 MORTALITY; UNIVERSAL; BURDEN; RIDERS; GUIDE	Introduction This study aimed to evaluate the impact of the helmet law on the changes in potential years of life lost (PYLL) due to traffic mortality and to examine modification effects of socioeconomic factors on the impacts in Vietnam. Methods We applied an interrupted time series design using the Bayesian framework to estimate the impact of the law at the provincial level. Then, we used random effects meta-analysis to estimate the impact of the law at the country level and to examine the modification effects of socioeconomic factors. Results The results indicate that the impacts varied among the provinces. These impacts could be classified by four main groups comprising positive impact, and positive impact without sustainability, possible positive impact, negative or inconsistent impact. For the country-level impact, the results reveal a significantly consistent change in monthly PYLLs at the level of 18 per 100 000 persons, and the post-trend was stable without significant change. The results of meta-regression show that 1 unit increase in the population density (persons/km(2)), migration rate (%) and income (x1000 dong) are non-significantly associated with increases of PYLLs at 1.3, 27 and 27 per 100 000 person-months, respectively, whereas 1% increase in literacy associated with a decrease of PYLL at 44 per 100 000 person-months. Discussion Further studies should be warranted to provide a comprehensive evaluation of the law implementation, including its acceptability, adoption, appropriateness, feasibility, cost-effectiveness and sustainability.	[Phung, Dung; Huang, Cunrui] Sun Yat Sen Univ, Sch Publ Hlth, Hlth Management & Policy, Guangzhou, Peoples R China; [Phung, Dung; Chu, Cordia; Sadler, Ross; Pham, Tuan Cong] Griffith Univ, Sch Med, Brisbane, Qld, Australia; [Nguyen, Ha Trong] George Inst Global Hlth, Injury Div, Sydney, NSW, Australia; [Luong, Anh Mai; Nguyen, Huyen Thi] Minist Hlth, Vietnam Hlth Environm Management Agcy, Hanoi, Vietnam		Phung, D (corresponding author), Griffith Univ, Sch Med, Gold Coast Campus, Southport, Qld 4215, Australia.; Huang, CR (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510080, Peoples R China.	d.phung@griffith.edu.au; huangcr@mail.sysu.edu.cn	Phung, Dung/ABC-9218-2021; Huang, Cunrui/ABI-3312-2020	Phung, Dung/0000-0002-1615-3234; Pham, Cong Tuan/0000-0002-1662-2483; Chu, Cordia/0000-0002-3683-5638	Sun Yat-Sen University, China	DP was supported by the research fellowship from Sun Yat-Sen University, China.	Araujo M, 2017, INT J INJ CONTROL SA, V24, P406, DOI 10.1080/17457300.2016.1224901; Bernstein J, 2016, IOP EXPAND PHYS, P1, DOI 10.1088/978-0-7503-1308-7; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Chliaoutakis JE, 2000, ACCIDENT ANAL PREV, V32, P815, DOI 10.1016/S0001-4575(00)00006-3; Craft G, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121486; Dalal Koustuv, 2013, Int J Prev Med, V4, P1442; Enserink M, 2014, SCIENCE, V345, P1261, DOI 10.1126/science.345.6202.1261; General Statistics Office of Vietnam, 2009 VIETN POP HOUS; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Nguyen H, 2013, INJURY PREV, V19, P79, DOI 10.1136/injuryprev-2011-040293; Haqverdi MQ, 2015, ACCIDENT ANAL PREV, V85, P102, DOI 10.1016/j.aap.2015.09.007; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ichikawa M, 2003, ACCIDENT ANAL PREV, V35, P183, DOI 10.1016/S0001-4575(01)00102-6; Ivers RQ, 2014, J ORTHOP TRAUMA, V28, pS50, DOI 10.1097/BOT.0000000000000098; LC L, 2009, GLOBAL HLTH ACTION, V6; Lee JM, 2018, ACCIDENT ANAL PREV, V111, P173, DOI 10.1016/j.aap.2017.11.042; Ministry of Transport, 2013, NUMB TRANSP REG; Ngo AD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-561; Ha NT, 2018, TRAFFIC INJ PREV, V19, P75, DOI 10.1080/15389588.2017.1322203; Olson Z, 2016, INJURY PREV, V22, P233, DOI 10.1136/injuryprev-2015-041650; Papadakaki M, 2013, TRANSPORT RES F-TRAF, V18, P189, DOI 10.1016/j.trf.2013.01.002; Peng YA, 2017, AM J PREV MED, V52, P820, DOI 10.1016/j.amepre.2016.11.030; Pervin A, 2009, B WORLD HEALTH ORGAN, V87, P369, DOI 10.2471/BLT.08.057109; Russo BJ, 2017, TRAFFIC INJ PREV, V18, P95, DOI 10.1080/15389588.2016.1168925; Solagberu BA, 2006, INJURY PREV, V12, P266, DOI 10.1136/ip.2005.011221; Stevenson M, 2015, ASIA-PAC J PUBLIC HE, V27, P733, DOI 10.1177/1010539515602742; Stevenson MR, 2012, INJURY PREV, V18, P360, DOI 10.1136/injuryprev-2011-040261; Urie Y, 2016, TRAFFIC INJ PREV, V17, P686, DOI 10.1080/15389588.2016.1146823; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WHO, 2004, WORLD REPORT ROAD TR; World Health Organization, 2013, GLOB STAT REP ROAD S	31	2	2	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	APR	2020	26	2					109	115		10.1136/injuryprev-2018-043088			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	KZ7QD	WOS:000523453000004	30837327	Green Published			2022-02-06	
J	Reza-Zaldivar, EE; Sandoval-Avila, S; Gutierrez-Mercado, YK; Vazquez-Mendez, E; Canales-Aguirre, AA; Esquivel-Solis, H; Gomez-Pinedo, U; Marquez-Aguirre, AL				Reza-Zaldivar, E. E.; Sandoval-Avila, S.; Gutierrez-Mercado, Y. K.; Vazquez-Mendez, E.; Canales-Aguirre, A. A.; Esquivel-Solis, H.; Gomez-Pinedo, U.; Marquez-Aguirre, A. L.			Human recombinant erythropoietin reduces sensorimotor dysfunction and cognitive impairment in rat models of chronic kidney disease	NEUROLOGIA			Spanish	Article						Chronic kidney disease; Sensorimotor function; Cognitive impairment; Erythropoietin	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; NEUROLOGICAL COMPLICATIONS; FUNCTIONAL RECOVERY; RENAL-FAILURE; BLOOD-FLOW; ANEMIA; NEUROPROTECTION; ACTIVATION; MECHANISMS	Introduction: Chronic kidney disease (CKD) can cause anaemia and neurological disorders. Recombinant human erythropoietin (rHuEPO) is used to manage anaemia in CKD. However, there is little evidence on the effects of rHuEPO on behaviour and cognitive function in CKD. This study aimed to evaluate the impact of rHuEPO in sensorimotor and cognitive functions in a CKD model. Methods: Male Wistar rats were randomly assigned to 4 groups: control and CKD, with and without rHuEPO treatment (1050 IU per kg body weight, once weekly for 4 weeks). The Morris water maze, open field, and adhesive removal tests were performed simultaneously to kidney damage induction and treatment. Markers of anaemia and renal function were measured at the end of the study. Results: Treatment with rHuEPO reduced kidney damage and corrected anaemia in rats with CKD. We observed reduced sensorimotor dysfunction in animals with CKD and treated with rHuEPO. These rats also completed the water maze test in a shorter time than the control groups. Conclusions: rHuEPO reduces kidney damage, corrects anemia, and reduces sensorimotor and cognitive dysfunction in animals with CKD. (C) 2017 Sociedad Espanola de Neurologia. Published by Elsevier Espana, S.L.U.	[Reza-Zaldivar, E. E.; Sandoval-Avila, S.; Gutierrez-Mercado, Y. K.; Vazquez-Mendez, E.; Canales-Aguirre, A. A.; Esquivel-Solis, H.; Marquez-Aguirre, A. L.] Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Biotecnol Mod & Farmaceut, Guadalajara, Jalisco, Mexico; [Canales-Aguirre, A. A.; Esquivel-Solis, H.; Marquez-Aguirre, A. L.] Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Unidad Evaluac Preclin, Guadalajara, Jalisco, Mexico; [Gomez-Pinedo, U.] Univ Complutense, Hosp Clin San Carlos, Dept Neurol, Lab Neurociencias,IdISSC, Madrid, Spain		Marquez-Aguirre, AL (corresponding author), Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Biotecnol Mod & Farmaceut, Guadalajara, Jalisco, Mexico.; Marquez-Aguirre, AL (corresponding author), Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Unidad Evaluac Preclin, Guadalajara, Jalisco, Mexico.	amarquez@ciatej.mx	Esquivel-Solis, Hugo/I-8327-2017; Marquez-Aguirre, Ana Laura/AAC-5346-2022; , ulises.gomez-pinedo/C-3414-2016; Canales-Aguirre, Alejandro/D-8864-2015; Canales-Aguirre, Alejandro Arturo/F-8164-2016	Marquez-Aguirre, Ana Laura/0000-0001-5662-9076; , ulises.gomez-pinedo/0000-0003-3097-5557; Canales-Aguirre, Alejandro/0000-0003-0918-788X; Canales-Aguirre, Alejandro Arturo/0000-0003-0918-788X			Ali BH, 2014, PHYSIOL RES, V63, P351, DOI 10.33549/physiolres.932685; Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Arcasoy MO, 2010, HAEMATOL-HEMATOL J, V95, P1803, DOI 10.3324/haematol.2010.030213; Arnold R, 2016, JRSM CARDIOVASC DIS, V5, DOI 10.1177/2048004016677687; Arnold R, 2013, CLIN NEUROPHYSIOL, V124, P2079, DOI 10.1016/j.clinph.2013.04.012; Ballesta JJ, 2012, EXP NEUROL, V236, P28, DOI 10.1016/j.expneurol.2012.03.020; Bonomini M, 2016, AM J KIDNEY DIS, V67, P133, DOI 10.1053/j.ajkd.2015.06.030; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Chandanathil MI, 2015, COGN NEURODYNAMICS, V9, P201, DOI 10.1007/s11571-014-9315-z; Coldewey SM, 2013, KIDNEY INT, V84, P482, DOI 10.1038/ki.2013.118; Diwan V, 2013, J PHARMACOL TOX MET, V68, P197, DOI 10.1016/j.vascn.2013.05.006; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fan X, 2011, PEDIATR RES, P6956; Franco ECS, 2012, NEUROSCI RES, V73, P122, DOI 10.1016/j.neures.2012.03.006; Fujisaki K, 2014, NEPHROL DIAL TRANSPL, V29, P529, DOI 10.1093/ndt/gft327; Gould TD, MOOD ANXIETY RELATED; Grimm G, 1990, KIDNEY INT, V38, P480; Hong CH, 2013, NEUROLOGY, V81, P528, DOI 10.1212/WNL.0b013e31829e701d; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Karthick N., 2015, J BIOEQUIVALENCE BIO, V7, P74; Krishnan AV, 2009, NAT REV NEUROL, V5, P542, DOI 10.1038/nrneurol.2009.138; Kristensen PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059672; Kristensen PL, 2009, DIABETES RES CLIN PR, V85, P75, DOI 10.1016/j.diabres.2009.01.008; Kurtz P, 2010, NEUROCRIT CARE, V13, P10, DOI 10.1007/s12028-010-9357-y; Kuwabara Y, 2002, KIDNEY INT, V61, P564, DOI 10.1046/j.1523-1755.2002.00142.x; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lund A, 2014, EUR J CLIN INVEST, V44, P1230, DOI 10.1111/eci.12357; MARSH JT, 1991, KIDNEY INT, V39, P155, DOI 10.1038/ki.1991.20; MATHEW RJ, 1985, KIDNEY INT, V28, P64, DOI 10.1038/ki.1985.119; Mazumder MK, 2016, LIFE SCI, V161, P27, DOI 10.1016/j.lfs.2016.07.020; Miranda AS, 2017, CLIN SCI, V131, P1093, DOI 10.1042/CS20160927; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; Nangaku M, 2013, KIDNEY INT, V84, P427, DOI 10.1038/ki.2013.140; National Guideline C, 2012, KDIGO CLIN PRACT GUI; Nguyen AQ, 2014, EXP BIOL MED, V239, P1461, DOI 10.1177/1535370214523703; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; PHILIPS FS, 1952, J PHARMACOL EXP THER, V104, P20; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; Renzi MJ, 2002, MOL BRAIN RES, V104, P86, DOI 10.1016/S0169-328X(02)00323-6; Rivera -Valdes JJ, 2017, CYTOTHERAPY, V19, pS776; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sadamoto Y, 1998, BIOCHEM BIOPH RES CO, V253, P26, DOI 10.1006/bbrc.1998.9748; SIASSI F, 1977, AM J PHYSIOL, V232, pE526, DOI 10.1152/ajpendo.1977.232.5.E526; Singh Narinder P, 2006, Hemodial Int, V10, P267, DOI 10.1111/j.1542-4758.2006.00107.x; Tothova L, 2015, PHYSIOL BEHAV, V138, P133, DOI 10.1016/j.physbeh.2014.10.027; van der Kooij MA, 2008, BRAIN RES REV, V59, P22, DOI 10.1016/j.brainresrev.2008.04.007; Wang RL, 2017, NEUROL RES, V39, P545, DOI 10.1080/01616412.2017.1316904; Watanabe K, 2014, NEUROTOXICOLOGY, V44, P184, DOI 10.1016/j.neuro.2014.06.014; Yoo SJ, 2016, CNS NEUROL DISORD-DR, V15, P927, DOI 10.2174/1871527315666160813223329; Zhu LH, 2017, NEUROSCI LETT, V650, P12, DOI 10.1016/j.neulet.2017.03.024	52	2	2	0	1	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0213-4853	1578-1968		NEUROLOGIA	Neurologia	APR	2020	35	3					147	154		10.1016/j.nrl.2017.07.016			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW8SC	WOS:000539412700001	29132915	gold			2022-02-06	
J	Rodier, SG; Kim, M; Moore, S; Frangos, SG; Tandon, M; Klein, MJ; Berry, CD; Huang, PP; Dimaggio, CJ; Bukur, M				Rodier, Simon G.; Kim, Mirhee; Moore, Samantha; Frangos, Spiros G.; Tandon, Manish; Klein, Michael J.; Berry, Cherisse D.; Huang, Paul P.; Dimaggio, Charles J.; Bukur, Marko			Early Anti-Xa Assay-Guided Low Molecular Weight Heparin Chemoprophylaxis Is Safe in Adult Patients with Acute Traumatic Brain Injury	AMERICAN SURGEON			English	Article; Proceedings Paper	105th Annual Scientific Clinical Congress of the American-College-of-Surgeons / 5th Annual Sessions of the Owen-H-Wangensteen-Scientific-Forum	OCT 27-31, 2019	San Francisco, CA	Amer Coll Surg, Owen H Wangensteen Sci Forum			VENOUS THROMBOEMBOLISM PROPHYLAXIS; UNFRACTIONATED HEPARIN; ENOXAPARIN PROPHYLAXIS; PULMONARY-EMBOLISM; ANTICOAGULATION	This study evaluated the safety of early anti-factor Xa assay-guided enoxaparin dosing for chemoprophylaxis in patients with TBI. We hypothesized that assay-guided chemoprophylaxis would be comparable in the risk of intracranial hemorrhage (ICH) progression to fixed dosing. An observational analysis of adult patients with blunt traumatic brain injury (TBI) was performed at a Level I trauma center from August 2016 to September 2017. Patients in the assay-guided group were treated with an initial enoxaparin dose of 0.5 mg/kg, with peak anti-factor Xa activity measured four hours after the third dose. Prophylactic range was defined as 0.2 to 0.5 IU/mL with a dose adjustment of +/- 10 mg based on the assay result. The assay-guided group was compared with historical fixed-dose controls and to a TBI cohort from the most recent Trauma Quality Improvement Project dataset. Of 179 patients included in the study, 85 were in the assay-guided group and 94 were in the fixed-dose group. Compared with the fixed- dose group, the assay-guided group had a lower Glasgow Coma Score and higher Injury Severity Score. The proportion of severe (Abbreviated Injury Score, head >= 3) TBI, ICH progression, and venous thromboembolism rates were similar between all groups. The assay-guided and fixed-dose groups had chemoprophylaxis initiated earlier than the Trauma Quality Improvement Project group. The assay-guided group had the highest percentage of low molecular weight heparin use. Early initiation of enoxaparin anti-factor Xa assay-guided venous thromboembolism chemoprophylaxis has a comparable risk of ICH progression to fixed dosing in patients with TBI. These findings should be validated prospectively in a multicenter study.	[Rodier, Simon G.; Kim, Mirhee; Moore, Samantha; Frangos, Spiros G.; Tandon, Manish; Klein, Michael J.; Berry, Cherisse D.; Dimaggio, Charles J.; Bukur, Marko] NYU, Sch Med, Dept Surg, New York, NY USA; [Moore, Samantha] St Johns Univ, Coll Pharm & Hlth Sci, Queens, NY USA; [Huang, Paul P.] NYC Hlth & Hosp Bellevue, Dept Neurosurg, New York, NY USA		Rodier, SG (corresponding author), Bellevue Hosp Ctr, Dept Surg, NBV 15 South 5-14,462 First Ave, New York, NY 10016 USA.	simon.rodier@nyulangone.org	Berry, Cherisse/AAO-5701-2020	Frangos, Spiros/0000-0003-2860-8969; Klein, Michael/0000-0003-0072-3690; Huang, Paul/0000-0003-0563-921X; DiMaggio, Charles/0000-0003-2356-6659; Bukur, Marko/0000-0002-1850-7147			Benjamin E, 2017, ANN SURG, V266, P463, DOI 10.1097/SLA.0000000000002359; Berndtson AE, 2016, J TRAUMA ACUTE CARE, V81, P1095, DOI 10.1097/TA.0000000000001142; Bickford A, 2013, AM J SURG, V206, P847, DOI 10.1016/j.amjsurg.2013.07.020; Byrne JP, 2017, J TRAUMA ACUTE CARE, V82, P252, DOI 10.1097/TA.0000000000001321; Costantini TW, 2013, J TRAUMA ACUTE CARE, V74, P128, DOI 10.1097/TA.0b013e3182788fa7; Cryer H, 2015, ACS TQIP BEST PRACTI; DeMuro JP, 2013, J BLOOD DISORD TRANS, V4, P2; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Frisoli FA, 2017, NEUROSURGERY, V81, P1016, DOI 10.1093/neuros/nyx164; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Jacobs BN, 2017, J TRAUMA ACUTE CARE, V83, P151, DOI 10.1097/TA.0000000000001494; KAUFMAN HH, 1983, ANGIOLOGY, V34, P627, DOI 10.1177/000331978303401001; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; LEHR R, 1992, STAT MED, V11, P1099, DOI 10.1002/sim.4780110811; Ludwig KP, 2011, ANN PHARMACOTHER, V45, P1356, DOI [10.1345/aph.1Q313, 10.1345/aph.1P371]; Margulies D, 2013, AM J SURG, V206, P851; Galan LAM, 2016, J TRAUMA ACUTE CARE, V81, P567, DOI 10.1097/TA.0000000000001134; Mohseni Shahin, 2012, J Emerg Trauma Shock, V5, P11, DOI 10.4103/0974-2700.93102; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Ronning P, 2019, J NEUROSURG, V131, P1896, DOI 10.3171/2018.7.JNS18270; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Singer GA, 2016, J TRAUMA ACUTE CARE, V81, P1101, DOI 10.1097/TA.0000000000001193; Van Belle G., 2008, STAT RULES THUMB, V2nd ed.	27	2	3	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	APR	2020	86	4					369	376					8	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	LK1ZZ	WOS:000530658800034	32391762				2022-02-06	
J	Runyon, LM; Bacon, CEW; Neil, ER; Eberman, LE				Runyon, Lacey M.; Bacon, Cailee E. Welch; Neil, Elizabeth R.; Eberman, Lindsey E.			Understanding the Athletic Trainer's Role in the Return-to-Learn Process at National Collegiate Athletic Association Division II and III Institutions	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion management; academic accommodations; collaborative practice	CONCUSSION; MANAGEMENT; PERCEPTIONS; RECOVERY; SCHOOL	Context: Postconcussion, student-athletes should return to the classroom using a gradual, stepwise process to ensure that symptoms are not exacerbated by cognitive activities. The National Collegiate Athletic Association (NCAA) has mandated that its affiliated institutions develop return-to-learn (RTL) policies to support the return to the classroom. Objective: To investigate athletic trainers' (ATs') perceptions of their role in the RTL policy development and implementation at NCAA Division II and III institutions. Design: Qualitative study. Setting: Individual phone interviews. Patients or Other Participants: Fifteen ATs (age = 40 +/- 11 years, clinical practice experience = 16 +/- 9 years, employment term = 9 +/- 9 years) representing NCAA Division II (n = 6) or III (n = 9) institutions. Data Collection and Analysis: Interviews were transcribed verbatim and checked for accuracy by the principal investigator. A 2-member data-analysis team independently coded a portion of the transcripts and then met to discuss the codebook. The codebook was applied to the remaining transcripts, confirmed, and externally reviewed. Results: Five themes emerged: (1) approach, (2) collaborative practice, (3) patient advocacy, (4) institutional autonomy, and (5) barriers. Policies must allow for an individualized, evidence-based approach through facilitated, active communication among members of the RTL team and the student-athlete. Collaborative practice was described as key to successful policy implementation and should include interprofessional collaboration beyond health care providers (eg, educating academicians about the purpose of RTL). The RTL process was triggered by a specific member of the RTL team, usually a medical doctor or the head AT. Participants noted that the purpose of the RTL policy was to advocate for the student-athlete's successful postconcussion outcomes. Conclusions: For the development and implementation of a successful RTL policy, strong communication and interprofessional practice must extend beyond health care professionals. Members of the health care team must establish a network with academic partners to develop a policy that is appropriate for the institution's available resources and the needs of its student-athletes.	[Runyon, Lacey M.] Carroll Univ, Dept Human Movement Sci, Waukesha, WI USA; [Runyon, Lacey M.; Neil, Elizabeth R.; Eberman, Lindsey E.] Indiana State Univ, Dept Appl Med & Rehabil, Neuromech Intervent & Continuing Educ Res NICER L, Terre Haute, IN 47809 USA; [Bacon, Cailee E. Welch] AT Still Univ, Dept Interdisciplinary Hlth Sci, Mesa, AZ 85206 USA		Neil, ER (corresponding author), Indiana State Univ, Dept Appl Med & Rehabil, 530 North 5th St, Terre Haute, IN 47809 USA.	eneil@sycamores.indstate.edu					[Anonymous], NAT COLL ATHL ASS; Bacon CEW, 2017, J ATHL TRAINING, V52, P937, DOI 10.4085/1062-6050-52.7.02; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Breitbach A. P., 2015, ATHL TRAIN ED J, V10, DOI [10.4085/1002170, DOI 10.4085/1002170]; Bridges Diane R, 2011, Med Educ Online, V16, DOI 10.3402/meo.v16i0.6035; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckley TA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702606; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Creswell J.W ., 2007, QUAL INQ; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Gilbert John H V, 2010, J Allied Health, V39 Suppl 1, P196; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Institute of Medicine, 2003, HLTH PROFESSIONS ED; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; National Athletic Trainers' Association, 2011, ATHL TRAIN ED COMP; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Pitney William A, 2002, J Athl Train, V37, pS168; Sauers ADL, 2017, J ATHL TRAINING, V52, P1070, DOI 10.4085/1062-6050-52.10.15; Walker SE, 2016, J ATHL TRAINING, V51, P601, DOI 10.4085/1062-6050-51.9.12; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	25	2	2	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	APR	2020	55	4					365	375		10.4085/1062-6050-116-19			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	LF3FB	WOS:000527305600006	32053405	Green Published, gold			2022-02-06	
J	Sang, RC; Vawda, Y; Greenspoon, D; Reed, N; Hunt, AW				Sang, Robyn Chen; Vawda, Yasira; Greenspoon, Dayna; Reed, Nick; Hunt, Anne W.			An innovative approach to measuring youth concussion recovery: Occupational performance	BRITISH JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Paediatric; youth; concussion; recovery; occupational performance; occupational therapy	TRAUMATIC BRAIN-INJURY; ACTIVE REHABILITATION; CHILDREN; SYMPTOMS; BENEFITS	Introduction Concussion is a common injury in youth. Studies report that active rehabilitation interventions reduce symptoms in these youth. There is no literature that addresses its impact on occupational performance. The purpose of this study was to identify: (a) occupational performance issues experienced by these youth; (b) changes in occupational performance and satisfaction following participation in a 6-week active rehabilitation intervention; and (c) the relationship between changes in occupational performance and symptoms. Method As part of a larger prospective repeated measures study, measures of occupational performance (Canadian Occupational Performance Measure) and self-reported symptoms (Post-Concussion Symptom Inventory) were collected pre and post intervention. Paired t-test, Spearman correlation, and descriptive analyses were conducted. Results Youth (9-18 years; n = 52) reported a range of occupational performance issues in self-care, productivity, and leisure domains. The most frequently reported occupational performance issues were sport (32.70%) and school (31.75%) activities. Positive changes were found in both performance and satisfaction of occupational performance issues post intervention (p<.001). Correlation analysis revealed that as symptoms decreased, occupational performance improved (r(s) = -.359, p = .020). Conclusion Using a measure of occupational performance may provide meaningful insight into the functional recovery of concussion, and can help identify targeted functional approaches to paediatric concussion management.	[Sang, Robyn Chen; Vawda, Yasira; Reed, Nick; Hunt, Anne W.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Greenspoon, Dayna; Reed, Nick; Hunt, Anne W.] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada		Hunt, AW (corresponding author), Holland Bloorview Kids Rehabil Hosp, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	ahunt@hollandbloorview.ca		Chen Sang, Robyn/0000-0002-1339-741X			Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Carswell Anne, 2004, Can J Occup Ther, V71, P210; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Dykeman B, 2003, J INSTRUCTIONAL PSYC, P225; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hunt A, 2016, BMC HEALTH SERV RES, V16, P1; Hunt AW, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2019.027995; IBM, 2017, IBM SSPS STAT; Imhoff Sarah, 2016, J Sports Med (Hindawi Publ Corp), V2016, P5127374, DOI 10.1155/2016/5127374; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lawrence DW, 2018, PLOS ONE, V13, P1; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; McColl M. A., 2006, RES CANADIAN OCCUPAT; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDougall J, 2009, DISABIL REHABIL, V31, P1362, DOI 10.1080/09638280802572973; MENTO AJ, 1992, J APPL PSYCHOL, V77, P395, DOI 10.1037/0021-9010.77.4.395; Missiuna C, 2010, PHYS OCCUP THER PEDI, V30, P205, DOI 10.3109/01942631003761554; Oien I, 2010, CHILD CARE HLTH DEV, V36, P558, DOI 10.1111/j.1365-2214.2009.01038.x; Ontario Neurotrauma Foundation, 2013, GUID CONC MILD TRAUM; Ostensjo S, 2008, DEV NEUROREHABIL, V11, P252, DOI 10.1080/17518420802525500; Paniccia MJ, 2017, CAN J OCCUP THER, V84, P111, DOI 10.1177/0008417416688302; Pollock N, 1998, CANADIAN OCCUPATIONA; Portney LG, 2015, FDN CLIN RES APPL PR; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Reed NI, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5094; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	34	2	2	0	9	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0308-0226	1477-6006		BRIT J OCCUP THER	Br. J. Occup. Ther.	APR	2020	83	4					220	227		10.1177/0308022619851415			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	KZ1PW	WOS:000523042700003					2022-02-06	
J	Tang, W; Fang, F; Ke, L; Huang, Z; Li, H; Yin, Y; Wang, J; Wang, GC; Wei, LY; Ou, Y; Wang, YZ				Tang, Wei; Fang, Fei; Ke, Liu; Huang, Zhi; Li, Hui; Yin, Ying; Wang, Jun; Wang, Guocheng; Wei, Liyu; Ou, Yun; Wang, Yazhou			Aligned Biofunctional Electrospun PLGA-LysoGM1 Scaffold for Traumatic Brain Injury Repair	ACS BIOMATERIALS SCIENCE & ENGINEERING			English	Article						traumatic brain injury; monosialotetrahexosylganglioside; poly (lactic-co-glycolic acid); electrospun scaffold; aligned nanofibers	GM1 GANGLIOSIDE; N-CADHERIN; CELLS; APOPTOSIS; TRANSPLANTATION; INHIBITION; ACTIVATION; NEURONS; BDNF	Due to poor regenerative capabilities of the brain, a treatment for traumatic brain injury (TBI) presents a serious challenge to modern medicine. Biofunctional scaffolds that can support neuronal growth, guide neurite elongation, and re-establish impaired brain tissues are urgently needed. To this end, we developed an aligned biofunctional scaffold (aPLGA-LysoGM1), in which poly (lactic-co-glycolic acid) (PLGA) was functionalized with sphingolipid ceramide N-deacylase (SCDase)-hydrolyzed monosialotetrahexosylganglioside (LysoGM1) and electrospinning was used to form an aligned fibrous network. As a ganglioside of neuronal membranes, the functionalized LysoGM1 endows the scaffold with unique biological properties favoring the growth of neuron and regeneration of injured brain tissues. Moreover, we found that the aligned PLGA-LysoGM1 fibers acted as a topographical cue to guide neurite extension, which is critical for organizing the formation of synaptic networks (neural networks). Systematic in vitro studies demonstrated that the aligned biofunctional scaffold promotes neuronal viability, neurite outgrowth, and synapse formation and also protects neurons from pressure-related injury. Additionally, in a rat TBI model, we demonstrated that the implantation of aPLGA-LysoGM1 scaffold supported recovery from brain injury, as more endogenous neurons were found to migrate and infiltrate into the defect zone compared with alternative scaffold. These results suggest that the aligned biofunctional aPLGA-LysoGM1 scaffold represents a promising therapeutic strategy for brain tissue regeneration following TBI.	[Tang, Wei; Li, Hui; Wei, Liyu; Ou, Yun] Chinese Acad Sci, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen 518055, Peoples R China; [Wang, Yazhou] Chongqing Univ, Coll Bioengn, Sch Med, Chongqing 400044, Peoples R China; [Fang, Fei; Huang, Zhi; Yin, Ying; Wang, Jun; Wang, Yazhou] Chongqing Univ, Coll Bioengn, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China; [Ke, Liu; Wang, Guocheng] Chinese Acad Sci, Inst Biomed & Biotechnol, Shenzhen Inst Adv Technol, Shenzhen 518055, Peoples R China; [Ou, Yun] Hunan Univ Sci & Technol, Hunan Prov Key Lab Hlth Maintenance Mech Equipmen, Xiangtan 411201, Peoples R China		Tang, W (corresponding author), Chinese Acad Sci, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen 518055, Peoples R China.; Wang, YZ (corresponding author), Chongqing Univ, Coll Bioengn, Sch Med, Chongqing 400044, Peoples R China.; Wang, YZ (corresponding author), Chongqing Univ, Coll Bioengn, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China.	wei.tang1@siat.ac.cn; yazhou_wang@cqu.edu.cn	wang, yazhou/B-9019-2011; Wang, Guocheng/P-7551-2014	Wang, Guocheng/0000-0002-8235-4472; fang, fei/0000-0002-9079-1330	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31700835]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2019CDYGZD002]; Shenzhen Science and Technology Research Funding [JCYJ20170413161800287, JCYJ20170818160503855, JCYJ20170307165752275]; Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (Chongqing University, Ministry of Education) [CQj(LBST-2019-008)]	The authors would like to acknowledge funding support from the National Natural Science Foundation of China (No. 31700835), the Fundamental Research Funds for the Central Universities (2019CDYGZD002), Shenzhen Science and Technology Research Funding (Nos. JCYJ20170413161800287, JCYJ20170818160503855,JCYJ20170307165752275,), and Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (Chongqing University, Ministry of Education, No. CQj(LBST-2019-008).	ATASHI JR, 1992, NEURON, V8, P831, DOI 10.1016/0896-6273(92)90197-L; Aureli M, 2016, MOL NEUROBIOL, V53, P1824, DOI 10.1007/s12035-015-9136-z; Baiguera S, 2014, BIOMATERIALS, V35, P1205, DOI 10.1016/j.biomaterials.2013.10.060; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Boscher C, 2012, J BIOL CHEM, V287, P32940, DOI 10.1074/jbc.M112.353334; Brailovskaya IV, 2014, J EVOL BIOCHEM PHYS+, V50, P174, DOI 10.1134/S0022093014020100; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bruses JL, 2006, MOL NEUROBIOL, V33, P237, DOI 10.1385/MN:33:3:237; Chiricozzi E, 2019, MOL NEUROBIOL, V56, P6673, DOI 10.1007/s12035-019-1556-8; Dasgupta R, 2018, P NATL ACAD SCI USA, V115, P5756, DOI 10.1073/pnas.1722320115; Fei J, 2019, NEURAL REGEN RES, V14, P673, DOI 10.4103/1673-5374.247471; Feng YK, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8020013; Flannery R. J., 2012, FRONTIERS NEUROSCIEN, V4, P1; Frohlich M, 2016, INT J DEV NEUROSCI, V48, P9, DOI 10.1016/j.ijdevneu.2015.10.004; Garner J, 2015, INT J PHARMACEUT, V495, P87, DOI 10.1016/j.ijpharm.2015.08.063; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guo TW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27275-7; Guo TW, 2017, CURR PHARM DESIGN, V23, P2161, DOI 10.2174/1381612822666161027113200; Hansen SM, 2008, CELL MOL LIFE SCI, V65, P3809, DOI 10.1007/s00018-008-8290-0; Hong MH, 2018, ACS BIOMATER SCI ENG, V4, P576, DOI 10.1021/acsbiomaterials.7b00801; Huang FT, 2015, J LIPID RES, V56, P1836, DOI 10.1194/jlr.D061176; Jayakumar AR, 2018, NEUROCHEM RES, V43, P397, DOI 10.1007/s11064-017-2434-2; Lackington WA, 2019, J CONTROL RELEASE, V304, P51, DOI 10.1016/j.jconrel.2019.05.001; Ledeen RW, 2015, TRENDS BIOCHEM SCI, V40, P407, DOI 10.1016/j.tibs.2015.04.005; Maclean FL, 2017, ACS BIOMATER SCI ENG, V3, P2542, DOI 10.1021/acsbiomaterials.7b00524; Mai WX, 2017, NAT MED, V23, P1342, DOI 10.1038/nm.4418; Negah SS, 2019, ACTA BIOMATER, V92, P132, DOI 10.1016/j.actbio.2019.05.010; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Sun BB, 2016, J BIOMED NANOTECHNOL, V12, P1987, DOI 10.1166/jbn.2016.2299; Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111; Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3; Tsai YT, 2016, NEUROCHEM RES, V41, P107, DOI 10.1007/s11064-015-1742-7; Wang Q., 2016, GENET MOL RES, V15, P1; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wieringa PA, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201701164; Wu GS, 2005, J NEUROSCI, V25, P11014, DOI 10.1523/JNEUROSCI.3635-05.2005; Xu DY, 2015, PAK J PHARM SCI, V28, P701; Zhang YP, 2016, ACS BIOMATER SCI ENG, V2, P2018, DOI 10.1021/acsbiomaterials.6b00436	41	2	2	5	36	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2373-9878			ACS BIOMATER SCI ENG	ACS Biomater. Sci. Eng.	APR	2020	6	4					2209	2218		10.1021/acsbiomaterials.9b01636			10	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	LD9AU	WOS:000526319100035	33455302				2022-02-06	
J	Traeger, J; Hoffman, B; Misencik, J; Hoffer, A; Makii, J				Traeger, Jessica; Hoffman, Brian; Misencik, Jennifer; Hoffer, Alan; Makii, Jason			Pharmacologic Treatment of Neurobehavioral Sequelae Following Traumatic Brain Injury	CRITICAL CARE NURSING QUARTERLY			English	Article						amantadine; neurobehavioral; neurostimulants; neurotransmitters; selective serotonin reuptake inhibitors; traumatic brain injury	DIFFUSE AXONAL INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EXCESSIVE DAYTIME SLEEPINESS; RANDOMIZED CONTROLLED-TRIAL; OPEN-LABEL; AMANTADINE HYDROCHLORIDE; COGNITIVE DEFICITS; L-DOPA/CARBIDOPA; RATING-SCALE; BLOOD-FLOW	Traumatic brain injury (TBI) is a leading cause of disability in the United States. With decreasing mortality rates, a higher number of patients are impacted by long-term neuropsychiatric sequelae, such as cognitive deficits, depression, anxiety, and sleep-wake disorders. These sequelae are primarily driven by the disruption of key neurotransmitter homeostasis including dopamine, norepinephrine, serotonin, and acetylcholine. Neurostimulants are centrally acting medications used to assist in restoring these neurotransmitter abnormalities and are pharmacologic options to ameliorate symptoms in post-TBI patients. Examples of neurostimulants include amantadine, selective serotonin reuptake inhibitors, tricyclic antidepressants, central stimulants (ie, methylphenidate), modafinil, and donepezil. Large, well-powered studies have not been performed to validate their use in patients with TBI, leaving uncertainty for these agents' place in therapy. Current practice is driven by consideration of patient-specific factors to select the most appropriate agent. This review provides clinicians with a summary of the available literature on neurostimulants following TBI to guide appropriate usage to help improve patients' symptoms and optimize safety.	[Traeger, Jessica; Hoffman, Brian; Misencik, Jennifer; Makii, Jason] Univ Hosp Cleveland, Dept Pharm Serv, Med Ctr, 11100 Euclid Ave,Mather B400, Cleveland, OH 44106 USA; [Hoffer, Alan] Univ Hosp Cleveland, Med Ctr, Dept Neurol Surg, Cleveland, OH 44106 USA; [Hoffer, Alan] Case Western Reserve Univ, Sch Med, Cleveland, OH USA		Traeger, J (corresponding author), Univ Hosp Cleveland, Dept Pharm Serv, Med Ctr, 11100 Euclid Ave,Mather B400, Cleveland, OH 44106 USA.	Jessica.Traeger2@UHhospitals.org					Aigner Thomas G., 1995, Current Opinion in Neurobiology, V5, P155, DOI 10.1016/0959-4388(95)80021-2; [Anonymous], 2017, DEXTR PACK INS; [Anonymous], 2014, DON PACK INS; [Anonymous], 2018, MOD PACK INS; [Anonymous], 2019, RIT RIT SR METH PACK; [Anonymous], 2018, ARM PACK INS; [Anonymous], 2000, AM PACK INS; [Anonymous], 2019, LISD PACK INS; [Anonymous], 2019, RIV TARTR RIV PACK I; [Anonymous], 2018, SERTR PACK INS; [Anonymous], 2019, AM HYDR PACK INS; [Anonymous], 2019, CIT PACK INS; [Anonymous], 2014, DES PACK INS; [Anonymous], 2017, BROM PACK INS; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Bales James W, 2010, Open Drug Discov J, V2, P119; Batejat DM, 1999, AVIAT SPACE ENVIR MD, V70, P493; Bayley MT, 2018, J HEAD TRAUMA REHAB, V33, P296, DOI 10.1097/HTR.0000000000000428; Beusterien KM, 1999, SLEEP, V22, P757, DOI 10.1093/sleep/22.6.757; Blokland A, 1995, BRAIN RES REV, V21, P285, DOI 10.1016/0165-0173(95)00016-X; Bonnet U, 2002, CNS DRUG REV, V8, P283; Bourgeois JA, 2002, J NEUROPSYCH CLIN N, V14, P463, DOI 10.1176/appi.neuropsych.14.4.463; BROWN C, 1989, J CLIN PHARMACOL, V29, P529, DOI 10.1002/j.1552-4604.1989.tb03376.x; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Bullock R., 1997, TRAUMA CARE, V7, P16; Bush G, 2008, ARCH GEN PSYCHIAT, V65, P102, DOI 10.1001/archgenpsychiatry.2007.16; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Campbell KA, 2018, BRAIN INJURY, V32, P972, DOI 10.1080/02699052.2018.1468574; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2013, TRAUM BRAIN INJ US E; Chen JJ, 2007, PHARMACOTHERAPY, V27, p161S, DOI 10.1592/phco.27.12part2.161S; Cooper WO, 2011, NEW ENGL J MED, V365, P1896, DOI 10.1056/NEJMoa1110212; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Elovic E, 2000, J HEAD TRAUMA REHAB, V15, P1068, DOI 10.1097/00001199-200008000-00009; Faul M, 2010, TRAUMATIC BRAIN INJU; Feighner JP, 1999, J CLIN PSYCHIAT, V60, P4; Foster M, 2008, J NEUROPSYCH CLIN N, V20, P106, DOI 10.1176/jnp.2008.20.1.106; Gerrard Paul, 2007, Neuropsychiatr Dis Treat, V3, P349; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hammond FM, 2017, J HEAD TRAUMA REHAB, V32, P308, DOI 10.1097/HTR.0000000000000342; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Hart T, 2018, J NEUROSCI RES, V96, P702, DOI 10.1002/jnr.24102; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337, DOI 10.2190/KQ48-XT0L-2H14-5UMV; Huang CH, 2016, CURR NEUROPHARMACOL, V14, P272, DOI 10.2174/1570159X13666150514233033; Hughes S, 2005, BRAIN INJURY, V19, P1197, DOI 10.1080/02699050500309296; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Jorge RE, 2016, JAMA PSYCHIAT, V73, P1041, DOI 10.1001/jamapsychiatry.2016.2189; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Kanetani Kouichi, 2003, Journal of Nippon Medical School, V70, P313; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; Kim YW, 2009, CLIN NEUROPHARMACOL, V32, P63, DOI 10.1097/WNF.0b013e31816f1bc1; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Menn SJ, 2014, J CLIN SLEEP MED, V10, P1181, DOI 10.5664/jcsm.4196; Meythaler JM, 2001, BRAIN INJURY, V15, P321, DOI 10.1080/026990501750111274; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; Munakomi S, 2017, CHIN J TRAUMATOL, V20, P84, DOI 10.1016/j.cjtee.2016.04.009; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; Newburn G, 1999, BRAIN INJURY, V13, P637; Pangman VC, 2000, APPL NURS RES, V13, P209, DOI 10.1053/apnr.2000.9231; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; Rapoport MJ, 2010, J CLIN PSYCHIAT, V71, P1125, DOI 10.4088/JCP.09m05086blu; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Salter KL, 2016, J HEAD TRAUMA REHAB, V31, pE21, DOI 10.1097/HTR.0000000000000193; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; Sarter M, 1997, BRAIN RES REV, V23, P28, DOI 10.1016/S0165-0173(96)00009-4; Schneider WN, 1999, BRAIN INJURY, V13, P863; Sharp R, 2015, OCCUP MED-OXFORD, V65, P340, DOI 10.1093/occmed/kqv043; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silverberg ND, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2076-9; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Stelmaschuk S, 2015, J TRAUMA NURS, V22, P194, DOI 10.1097/JTN.0000000000000138; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Sugden SG, 2006, NEUROREHABILITATION, V21, P3; Taverni JP, 1998, BRAIN INJURY, V12, P77; Teitelman E, 2001, AM J PSYCHIAT, V158, P1341, DOI 10.1176/ajp.158.8.1341; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Tramontana MG, 2014, BRAIN INJURY, V28, P1461, DOI 10.3109/02699052.2014.930179; Trovato M, 2006, BRAIN INJURY, V20, P339, DOI 10.1080/02699050500487811; Ugoya SO, 2010, CLIN NEUROPHARMACOL, V33, P279, DOI 10.1097/WNF.0b013e3182011070; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; Whitlock JA, 1999, J HEAD TRAUMA REHAB, V14, P424, DOI 10.1097/00001199-199908000-00010; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; Yue JK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080093; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; Zhang WT, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006960; 2003, J NEUROPSYCH CLIN N, V15, P383	112	2	2	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0887-9303	1550-5111		CRIT CARE NURS Q	Crit. Care Nurs. Q.	APR-JUN	2020	43	2			SI		172	190		10.1097/CNQ.0000000000000301			19	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	LG1HB	WOS:000527859800006	32084061				2022-02-06	
J	Zdziarski-Horodyski, L; Vasilopoulos, T; Horodyski, M; Hagen, JE; Sadasivan, KS; Sharififar, S; Patrick, M; Guenther, R; Vincent, HK				Zdziarski-Horodyski, Laura; Vasilopoulos, Terrie; Horodyski, MaryBeth; Hagen, Jennifer E.; Sadasivan, Kalia S.; Sharififar, Sharareh; Patrick, Matthew; Guenther, Robert; Vincent, Heather K.			Can an Integrative Care Approach Improve Physical Function Trajectories after Orthopaedic Trauma? A Randomized Controlled Trial	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							PSYCHOMETRIC PROPERTIES; PSYCHOLOGICAL DISTRESS; COPING STRATEGIES; MULTIPLE TRAUMA; MENTAL-HEALTH; TAMPA SCALE; OUTCOMES; DISABILITY; DEPRESSION; PAIN	Background Orthopaedic trauma patients frequently experience mobility impairment, fear-related issues, self-care difficulties, and work-related disability [12, 13]. Recovery from trauma-related injuries is dependent upon injury severity as well as psychosocial factors [2, 5]. However, traditional treatments do not integrate psychosocial and early mobilization to promote improved function, and they fail to provide a satisfying patient experience. Questions/purposes We sought to determine (1) whether an early psychosocial intervention (integrative care with movement) among patients with orthopaedic trauma improved objective physical function outcomes during recovery compared with usual care, and (2) whether an integrative care approach with orthopaedic trauma patients improved patient-reported physical function outcomes during recovery compared with usual care. Methods Between November 2015 and February 2017, 1133 patients were admitted to one hospital as orthopaedic trauma alerts to the care of the three orthopaedic trauma surgeons involved in the study. Patients with severe or multiple orthopaedic trauma requiring one or more surgical procedures were identified by our orthopaedic trauma surgeons and approached by study staff for enrollment in the study. Patients were between 18 years and 85 years of age. We excluded individuals outside of the age range; those with diagnosis of a traumatic brain injury [28]; those who were unable to communicate effectively (for example, at a level where self-report measures could not be answered completely); patients currently using psychotropic medications; or those who had psychotic, suicidal, or homicidal ideations at time of study enrollment. A total of 112 orthopaedic trauma patients were randomized to treatment groups (integrative and usual care), with 13 withdrawn (n = 99; 58% men; mean age 44 years +/- 17 years). Data was collected at the following time points: baseline (acute hospitalization), 6 weeks, 3 months, 6 months, and at 1 year. By 1-year follow-up, we had a 75% loss to follow-up. Because our data showed no difference in the trajectories of these outcomes during the first few months of recovery, it is highly unlikely that any differences would appear months after 6 months. Therefore, analyses are presented for the 6-month follow-up time window. Integrative care consisted of usual trauma care plus additional resources, connections to services, as well as psychosocial and movement strategies to help patients recover. Physical function was measured objectively (handgrip strength, active joint ROM, and Lower Extremity Gain Scale) and subjectively (Patient-Reported Outcomes Measurement Information System-Physical Function [PROMIS (R)-PF] and Tampa Scale of Kinesiophobia). Higher values for hand grip, Lower Extremity Gain Scale (score range 0-27), and PROMIS (R)-PF (population norm = 50) are indicative of higher functional ability. Lower Tampa Scale of Kinesiophobia (score range 11-44) scores indicate less fear of movement. Trajectories of these measures were determined across time points. Results We found no differences at 6 months follow-up between usual care and integrative care in terms of handgrip strength (right handgrip strength beta = -0.0792 [95% confidence interval -0.292 to 0.133]; p = 0.46; left handgrip strength beta = -0.133 [95% CI -0.384 to 0.119]; p = 0.30), or Lower Extremity Gain Scale score (beta = -0.0303 [95% CI -0.191 to 0.131]; p = 0.71). The only differences between usual care and integrative care in active ROM achieved by final follow-up within the involved extremity was noted in elbow flexion, with usual care group 20 degrees +/- 10 degrees less than integrative care (t [27] = -2.06; p = 0.05). Patients treated with usual care and integrative care showed the same Tampa Scale of Kinesiophobia score trajectories (beta = 0.0155 [95% CI -0.123 to 0.154]; p = 0.83). Conclusion Our early psychosocial intervention did not change the trajectory of physical function recovery compared with usual care. Although this specific intervention did not alter recovery trajectories, these interventions should not be abandoned because the greatest gains in function occur early in recovery after trauma, which is the key time in transition to home. More work is needed to identify ways to capitalize on improvements earlier within the recovery process to facilitate functional gains and combat psychosocial barriers to recovery.	[Zdziarski-Horodyski, Laura; Vasilopoulos, Terrie; Horodyski, MaryBeth; Hagen, Jennifer E.; Sadasivan, Kalia S.; Sharififar, Sharareh; Patrick, Matthew; Vincent, Heather K.] Univ Florida, Dept Orthopaed & Rehabil, Gainesville, FL USA; [Zdziarski-Horodyski, Laura] Univ Utah, Dept Orthopaed & Sports Med, Salt Lake City, UT USA; [Vasilopoulos, Terrie] Univ Florida, Dept Anesthesia, Gainesville, FL USA; [Guenther, Robert] Univ Florida, Dept Clin Psychol, Gainesville, FL 32611 USA		Zdziarski-Horodyski, L (corresponding author), Univ Utah Hlth, Dept Orthopaed, Sports Med, 590 Wakara Way, Salt Lake City, UT 84108 USA.	Laura.zdziarski@hsc.utah.edu	Vincent, Heather/ABH-4566-2020	Vasilopoulos, Terrie/0000-0002-8066-2703	National Athletic Trainers' Association Research & Education Foundation; W. Martin Smith Interdisciplinary Patient Quality and Safety Award (IPQSA); Foundation for Physical Medicine and Rehabilitation (PMR)	The institution of one or more of the authors (LZH, HKV, KSS, MBH) has received, during the study period, funding from the National Athletic Trainers' Association Research & Education Foundation, W. Martin Smith Interdisciplinary Patient Quality and Safety Award (IPQSA), and Foundation for Physical Medicine and Rehabilitation (PM&R).	*AM TRAUM SOC, TRAUM CTR LEV EXPL A; Archer KR, 2015, CLIN ORTHOP RELAT R, V473, P3519, DOI 10.1007/s11999-015-4504-6; Archer KR, 2012, J TRAUMA ACUTE CARE, V72, P473, DOI 10.1097/TA.0b013e3182245ece; Arnetz J, 2004, ADV PHYSIOTHER, V6, P50, DOI DOI 10.1080/14038190310017147; Ayers DC, 2013, J BONE JOINT SURG AM, V95, DOI 10.2106/JBJS.L.00799; Beloosesky Y, 2010, DISABIL REHABIL, V32, P367, DOI 10.3109/09638280903168499; Browne AL, 2013, DISABIL REHABIL, V35, P1149, DOI 10.3109/09638288.2012.721047; Browner BD, 1999, SURG CLIN N AM, V79, P1431, DOI 10.1016/S0039-6109(05)70086-4; Castillo RC, 2013, J TRAUMA ACUTE CARE, V74, P1534, DOI 10.1097/TA.0b013e3182921606; Coronado RA, 2018, CLIN REHABIL, V32, P287, DOI 10.1177/0269215517728562; Dettori Joseph R, 2011, Evid Based Spine Care J, V2, P7, DOI 10.1055/s-0030-1267080; Giummarra MJ, 2017, PAIN REP, V2, DOI 10.1097/PR9.0000000000000622; Giummarra MJ, 2017, J OCCUP REHABIL, V27, P173, DOI 10.1007/s10926-016-9642-5; Goudie S, 2018, CLIN ORTHOP RELAT R, V476, P832, DOI 10.1007/s11999.0000000000000095; Hapidou EG, 2012, PHYSIOTHER CAN, V64, P235, DOI 10.3138/ptc.2011-10; Hoppenfeld S., 2000, TREATMENT REHABILITA; Hung M, 2014, J ORTHOP TRAUMA, V28, P439, DOI 10.1097/BOT.0000000000000059; Hung M, 2013, CLIN ORTHOP RELAT R, V471, P3466, DOI 10.1007/s11999-013-3097-1; Kamel HK, 2003, J GERONTOL A-BIOL, V58, P1042; Kim JK, 2014, CLIN ORTHOP RELAT R, V472, P2536, DOI 10.1007/s11999-014-3666-y; McCarthy ML, 2003, J BONE JOINT SURG AM, V85A, P1689, DOI 10.2106/00004623-200309000-00006; Mecklenburg G, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9667; Nota SPFT, 2015, INJURY, V46, P207, DOI 10.1016/j.injury.2014.06.012; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Potter MQ, 2015, CLIN ORTHOP RELAT R, V473, P3501, DOI 10.1007/s11999-015-4513-5; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Roh YH, 2015, CLIN ORTHOP RELAT R, V473, P3484, DOI 10.1007/s11999-015-4269-y; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Soberg HL, 2015, J TRAUMA ACUTE CARE, V78, P628, DOI 10.1097/TA.0000000000000541; Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050; Spielberger CD., 1970, STATE TRAIT ANXIETY; Steel JL, 2011, INJURY, V42, P288, DOI 10.1016/j.injury.2010.11.045; Sutherland AG, 2011, J ORTHOP TRAUMA, V25, P228, DOI 10.1097/BOT.0b013e3181ee40a9; Tan AL, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0217-y; Vincent HK, 2015, PM&R, V7, P978, DOI 10.1016/j.pmrj.2015.03.007; Vranceanu AM, 2015, INJURY, V46, P552, DOI 10.1016/j.injury.2014.11.001; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048; Woby SR, 2005, PAIN, V117, P137, DOI 10.1016/j.pain.2005.05.029; Zdziarski-Horodyski L, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2430-5; Zelle BA, 2015, J ORTHOP TRAUMA, V29, P510, DOI 10.1097/BOT.0000000000000346; Zimmerman S, 2006, ARCH PHYS MED REHAB, V87, P430, DOI 10.1016/j.apmr.2005.10.026; [No title captured]	42	2	2	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	APR	2020	478	4					792	804		10.1097/CORR.0000000000001140			13	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Surgery	LD7WN	WOS:000526239700022	32032087	hybrid, Green Published			2022-02-06	
J	van Vuuren, H; Welman, K; Kraak, W				van Vuuren, Hanno; Welman, Karen; Kraak, Wilbur			Concussion knowledge and attitudes amongst community club rugby stakeholders	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article						Club level; concussion knowledge; head injuries; mild traumatic brain injury; rugby union	HEAD-INJURIES; EDUCATION; EPIDEMIOLOGY; PREVENTION; PROGRAM; SPORTS; IMPACT; ELITE	Due to the nature of rugby, concussions are a frequent occurrence and can go undetected by different stakeholders. Knowledge regarding identification of symptoms, management and prevention of re-injury is crucial for the welfare of players. The aim of the study was to determine the concussion knowledge and attitudes among different community club rugby stakeholders. The study gathered quantitative information by utilizing the Rosenbaum Concussion Knowledge and Attitude Survey-Student Version (RoCKAS-ST). Of all the participants (N = 434), medical staff (79 +/- 10%) provided the highest Concussion Knowledge Index scores followed by referees (78 +/- 8%) and players (67 +/- 13%). The stakeholders scored 76% overall for Concussion Attitude Index. Across the scenarios the different participants believed to have safer attitudes compared to that of others within their team. Statistical differences were found between stakeholders when asked if concussion is less important than other injuries, as players, coaches and administrative staff all indicated an unsafe response in contrast to that of referees (p < 0.01). Players indicated an unsafe attitude towards returning to play, while symptomatic as a result of a concussion whereas coaches indicated a safer response (p < 0.01). Only two out of eight legitimate symptoms, headaches and dizziness, were correctly identified by 80% or more of participants, which warrants concern that identification of symptoms could be lacking on this level. Investigating the knowledge and attitudes of concussion at community club rugby level could identify which areas are to be further targeted by the South African Rugby Union.	[van Vuuren, Hanno; Kraak, Wilbur] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Sports Sci, Stellenbosch, South Africa; [Welman, Karen] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Sports Sci, Movement Lab, Stellenbosch, South Africa		Kraak, W (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Dept Sports Sci, Stellenbosch, South Africa.	kjw@sun.ac.za	Kraak, Wilbur/O-7992-2014	Kraak, Wilbur/0000-0002-8233-2839			Basson J, 2019, S AFR J RES SPORT PH, V41, P1; Chapman EB, 2018, CLIN J SPORT MED, V28, P117, DOI 10.1097/JSM.0000000000000421; Chinn NR, 2013, COMMUNITY COLL J RES, V37, P409, DOI 10.1080/10668926.2012.710127; Clacy A, 2017, APPL ERGON, P30143; Clacy A, 2015, PROCEDIA MANUF, V3, P1173, DOI 10.1016/j.promfg.2015.07.195; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; Eagles ME, 2016, CAN J NEUROL SCI, V43, P659, DOI 10.1017/cjn.2016.263; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; Griffin S., 2015, CONCUSSION KNO UNPUB; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Kaux JF, 2015, SPORTS, V3, P21, DOI 10.3390/sports3010021; King D., 2010, NZ J SPORTS MED, V37, P52; Kraak W J, 2018, SA J. Sports Med., V30, P1, DOI 10.17159/2078-516x/2018/v30i1a4404; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Mathema P, 2016, CLIN J SPORT MED, V26, P320, DOI 10.1097/JSM.0000000000000256; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2008, S AFR J SPORTS MED, V21, P36; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; O'Connell E, 2016, IRISH J MED SCI, V185, P521, DOI 10.1007/s11845-015-1313-6; Olutende M, 2019, EUR J PUBLIC HLTH ST, V1, P25; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Roberts SP, 2017, AM J SPORT MED, V45, P480, DOI 10.1177/0363546516668296; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Saunders EA, 2013, ATHLETIC TRAINING SP, V5, P11, DOI DOI 10.3928/19425864-20121217-02; Tator CH, 2012, J CLIN SPORT PSYCHOL, V6, P293, DOI 10.1123/jcsp.6.3.293; Viljoen C T, 2017, SA J. Sports Med., V29, P1, DOI 10.17159/2078-516x/2017/v29i0a1942; Walker SP, 2015, SA J. Sports Med., V27, P50, DOI 10.7196/SAJSM.536; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009	32	2	2	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.	JUN	2020	15	3					297	305	1747954120913175	10.1177/1747954120913175		MAR 2020	9	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	LP8LQ	WOS:000523000500001					2022-02-06	
J	Mikkonen, ED; Skrifvars, MB; Reinikainen, M; Bendel, S; Laitio, R; Hoppu, S; Ala-Kokko, T; Karppinen, A; Raj, R				Mikkonen, Era D.; Skrifvars, Markus B.; Reinikainen, Matti; Bendel, Stepani; Laitio, Ruut; Hoppu, Sanna; Ala-Kokko, Tero; Karppinen, Atte; Raj, Rahul			Posttraumatic epilepsy in intensive care unit-treated pediatric traumatic brain injury patients	EPILEPSIA			English	Article						epilepsy; intensive care unit; pediatric; traumatic brain injury	QUALITY-OF-LIFE; RISK-FACTORS; CHILDREN; SEIZURES; OUTCOMES; MULTICENTER; ADOLESCENTS; MODELS; COHORT; TBI	Objective Posttraumatic epilepsy (PTE) is a well-described complication of traumatic brain injury (TBI). The majority of the available data regarding PTE stem from the adult population. Our aim was to identify the clinical and radiological risk factors associated with PTE in a pediatric TBI population treated in an intensive care unit (ICU). Methods We used the Finnish Intensive Care Consortium database to identify pediatric (<18 years) TBI patients treated in four academic university hospital ICUs in Finland between 2003 and 2013. Our primary outcome was the development of PTE, defined as the need for oral antiepileptic medication in patients alive at 6 months. We assessed the risk factors associated with PTE using multivariable logistic regression modeling. Results Of the 290 patients included in the study, 59 (20%) developed PTE. Median age was 15 years (interquartile range [IQR] 13-17), and 80% had an admission Glasgow Coma Scale (GCS) score <= 12. Major risk factors for developing PTE were age (adjusted odds ratio [OR] 1.08, 95% confidence interval [CI] 1.00-1.16), obliterated suprasellar cisterns (OR 6.53, 95% CI 1.95-21.81), and an admission GCS score of 9-12 in comparison to a GCS score of 13-15 (OR 2.88, 95% CI 1.24-6.69). Significance We showed that PTE is a common long-term complication after ICU-treated pediatric TBI. Higher age, moderate injury severity, obliterated suprasellar cisterns, seizures during ICU stay, and surgical treatment are associated with an increased risk of PTE. Further studies are needed to identify strategies to decrease the risk of PTE.	[Mikkonen, Era D.] Helsinki Univ Hosp, Dept Anesthesiol Intens Care & Pain Med, Helsinki, Finland; [Mikkonen, Era D.; Skrifvars, Markus B.; Karppinen, Atte; Raj, Rahul] Univ Helsinki, Helsinki, Finland; [Mikkonen, Era D.; Skrifvars, Markus B.] Helsinki Univ Hosp, Dept Emergency Care & Serv, Helsinki, Finland; [Reinikainen, Matti; Bendel, Stepani] Kuopio Univ Hosp, Dept Anaesthesiol & Intens Care, Kuopio, Finland; [Reinikainen, Matti; Bendel, Stepani] Univ Eastern Finland, Kuopio, Finland; [Laitio, Ruut] Turku Univ Hosp, Dept Intens Care, Turku, Finland; [Laitio, Ruut] Univ Turku, Turku, Finland; [Hoppu, Sanna] Tampere Univ Hosp, Dept Intens Care, Emergency Med Serv, Tampere, Finland; [Hoppu, Sanna] Tampere Univ, Tampere, Finland; [Ala-Kokko, Tero] Univ Oulu, Oulu Univ Hosp, Med Res Ctr Oulu MRC, Res Grp Anesthesiol Surg & Intens Care Med,Div In, Oulu, Finland; [Karppinen, Atte; Raj, Rahul] Helsinki Univ Hosp, Dept Neurosurg, Helsinki, Finland		Mikkonen, ED (corresponding author), Hollandargatan 31, S-11359 Stockholm, Sweden.	era.mikkonen@helsinki.fi	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591; Mikkonen, Era Daniel/0000-0003-1379-0235; Karppinen, Atte/0000-0003-0788-3662	Medicinska Understodsforeningen Liv och Halsa; Finska Lakaresallskapet	Medicinska Understodsforeningen Liv och Halsa; Finska Lakaresallskapet	Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Appenteng R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201550; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bar-Klein G, 2014, ANN NEUROL, V75, P864, DOI 10.1002/ana.24147; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cianchetti C, 2015, SEIZURE-EUR J EPILEP, V24, P93, DOI 10.1016/j.seizure.2014.09.003; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Ikonomidou C, 2010, EPILEPSY RES, V88, P11, DOI 10.1016/j.eplepsyres.2009.09.019; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Keret A, 2018, SEIZURE-EUR J EPILEP, V58, P29, DOI 10.1016/j.seizure.2018.03.018; Keret A, 2017, J NEUROSURG-PEDIATR, V20, P64, DOI 10.3171/2017.2.PEDS16585; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Marsh ED, 2006, EPILEPSIA, V47, P1999, DOI 10.1111/j.1528-1167.2006.00894.x; Mikkonen ED, 2019, J NEUROSURG-PEDIATR, V24, P330, DOI 10.3171/2019.4.PEDS1983; Pechmann A, 2015, NEUROPEDIATRICS, V46, P5, DOI 10.1055/s-0034-1393707; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petridis AK, 2012, CLINICS PRACT, V2, P164, DOI 10.4081/cp.2012.e66; Reinikainen M, 2012, ACTA ANAESTH SCAND, V56, P1114, DOI 10.1111/j.1399-6576.2012.02669.x; Ronen Gabriel M, 2003, Health Qual Life Outcomes, V1, P36, DOI 10.1186/1477-7525-1-36; Rumalla K, 2018, J NEUROSURG-PEDIATR, V22, P684, DOI 10.3171/2018.6.PEDS1813; Saarinen MM, 2016, EPILEPSY BEHAV, V58, P81, DOI 10.1016/j.yebeh.2016.02.040; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; Young AMH, 2016, J NEUROSURG-PEDIATR, V18, P558, DOI 10.3171/2016.5.PEDS15427	35	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	APR	2020	61	4					693	701		10.1111/epi.16483		MAR 2020	9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LG3UX	WOS:000521806400001	32221978	Green Published, hybrid			2022-02-06	
J	Shao, J; Meng, L; Yang, ZB; Yu, PP; Song, L; Gao, Y; Gong, M; Meng, CL; Shi, HH				Shao, Juan; Meng, Li; Yang, Zhenbang; Yu, Panpan; Song, Li; Gao, Yuan; Gong, Miao; Meng, Cuili; Shi, Haishui			Xenon produces rapid antidepressant- and anxiolytic-like effects in lipopolysaccharide-induced depression mice model	NEUROREPORT			English	Article						depression; inflammation; rapid-acting antidepressant; stress; xenon	ADULT HIPPOCAMPAL NEUROGENESIS; STRESS-INDUCED DEPRESSION; TRAUMATIC BRAIN-INJURY; BEHAVIOR; PROTECTS; NEURONS; PATHWAY	Onset delay of current antidepressants is always the most significant limitation for the treatment of depression. More attention has been given to the glutamate acid system for developing fast-onset antidepressants. Xenon, acting as a well-known N-methyl-D-aspartate receptors antagonist, has been widely used clinically as anesthetics and was reported to exert antidepressant-like effects in rats under normal condition. The robust and rapid-acting antidepressant- and anxiolytic-like activities of xenon through the use of depression rodent model are still elusive. By using lipopolysaccharide-induced depression mice models, the present study aimed to evaluate the fast-acting antidepressant-like effects of xenon pretreatment. Behavioral tests, mainly including open-field test, novelty-suppressed feeding test, sucrose preference test, tail suspension test, and forced swimming test, were conducted respectively. Our results showed that both xenon gas and xenon-rich saline pretreatment intraperitoneally produced significant antidepressant- and anxiolytic-like activities in mice under normal condition. Further, xenon gas pretreatment (intraperitoneally) rapidly blocked lipopolysaccharide-induced depression- and anxiety-like behaviors of mice. These findings provide direct evidence that xenon could produce fast-onset antidepressant- and anxiolytic-like activities, which highlights the possibility to develop xenon as a promising fast-acting drug for treatment of depression, anxiety, and even other stress-related diseases.	[Shao, Juan] Hebei Med Univ, Dept Senile Dis, Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Shao, Juan; Meng, Li; Yang, Zhenbang; Song, Li; Gao, Yuan; Gong, Miao; Shi, Haishui] HeBMU, Inst Med & Hlth Sci, Neurosci Res Ctr, Shijiazhuang, Hebei, Peoples R China; [Yu, Panpan] Hebei Med Univ, Dept State Assets & Lab Adm, Shijiazhuang, Hebei, Peoples R China; [Meng, Cuili] Xingtai Med Coll, Sch Basic Med, Dept Biochem, 618 Gangtie Rd, Xingtai 054000, Peoples R China		Meng, CL (corresponding author), Xingtai Med Coll, Sch Basic Med, Dept Biochem, 618 Gangtie Rd, Xingtai 054000, Peoples R China.	mclant@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771462]; Excellent Youth Foundation of Hebei Province, China [H2018206119, SLRC2019047]; Medicine Research Foundation from Heath and Family Planning Commission of Hebei Province, China [20170643]	This study was partly financed by the National Natural Science Foundation of China (81771462), Excellent Youth Foundation of Hebei Province, China (H2018206119 and SLRC2019047); Medicine Research Foundation from Heath and Family Planning Commission of Hebei Province, China (20170643). We thank Dr Tyler W. Lebaron from Molecular Hydrogen Foundation (United States) for his help on manuscript revision.	Bennett S, 2014, MATURITAS, V79, P184, DOI 10.1016/j.maturitas.2014.05.009; Bonnet U, 2015, J PSYCHOACTIVE DRUGS, V47, P276, DOI 10.1080/02791072.2015.1072653; Campos-Pires R, 2018, J NEUROTRAUM, V35, P1037, DOI 10.1089/neu.2017.5360; Chen K, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9371602; Dandekar MP, 2018, PROG NEURO-PSYCHOPH, V86, P140, DOI 10.1016/j.pnpbp.2018.03.011; De Deken J, 2016, CRIT CARE MED, V44, pE886, DOI 10.1097/CCM.0000000000001717; Dobrovolsky A, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1237-1; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Gao Q, 2016, NEUROSCI LETT, V633, P33, DOI 10.1016/j.neulet.2016.08.062; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Iniguez SD, 2018, BIOL PSYCHIAT, V83, P9, DOI 10.1016/j.biopsych.2017.07.014; Kavalaii ET, 2012, AM J PSYCHIAT, V169, P1150, DOI 10.1176/appi.ajp.2012.12040531; Kempermann G, 2003, BIOL PSYCHIAT, V54, P499, DOI 10.1016/S0006-3223(03)00319-6; Klegerman ME, 2017, RAPID COMMUN MASS SP, V31, P1, DOI 10.1002/rcm.7749; Lavaur J, 2017, J NEUROCHEM, V142, P14, DOI 10.1111/jnc.14041; Li SX, 2018, MOL PSYCHIATR, V23, P597, DOI 10.1038/mp.2017.85; Liu RJ, 2017, NEUROPSYCHOPHARMACOL, V42, P1231, DOI 10.1038/npp.2016.202; Liu YZ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00316; Logan RW, 2015, BIOL PSYCHIAT, V78, P249, DOI 10.1016/j.biopsych.2015.01.011; Naughton M, J AFFECT DISORD, V156, P24; Oh DR, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00604; Petzelt C, 2003, LIFE SCI, V72, P1909, DOI 10.1016/S0024-3205(02)02439-6; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Shi HS, 2012, NEUROPSYCHOPHARMACOL, V37, P2671, DOI 10.1038/npp.2012.131; Vizcaychipi MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026394; Walker AK, 2019, MOL PSYCHIATR, V24, P1523, DOI 10.1038/s41380-018-0076-7; Wang QZ, 2017, PROG NEURO-PSYCHOPH, V77, P99, DOI 10.1016/j.pnpbp.2017.04.008; Wray NH, 2019, MOL PSYCHIATR, V24, P1833, DOI 10.1038/s41380-018-0083-8; Wu SH, 2016, BEHAV BRAIN RES, V301, P55, DOI 10.1016/j.bbr.2015.12.030; Yin S, 2019, BEHAV BRAIN RES, V356, P288, DOI 10.1016/j.bbr.2018.08.037; Zhao H, 2013, AM J TRANSPLANT, V13, P2006, DOI 10.1111/ajt.12293; Zhou SZ, 2018, NEUROCHEM RES, V43, P869, DOI 10.1007/s11064-018-2490-2	34	2	2	4	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	MAR 25	2020	31	5					387	393		10.1097/WNR.0000000000001415			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LH7AW	WOS:000528938800004	32106142				2022-02-06	
J	Zinovkina, LA; Galivondzhyan, MK; Prikhodko, AS; Galkin, II; Zinovkin, RA				Zinovkina, Ludmila A.; Galivondzhyan, Mina K.; Prikhodko, Anastasia S.; Galkin, Ivan I.; Zinovkin, Roman A.			Mitochondria-targeted triphenylphosphonium-based compounds do not affect estrogen receptor alpha	PEERJ			English	Article						Triphenylphosphonium; Targeting mitochondria; Estrogen	TRAUMATIC BRAIN-INJURY; CANCER; PLASTOQUINONE; SKQ1; NEUROPROTECTION; DERIVATIVES; APOPTOSIS; CELLS; ACID	Background. Targeting negatively charged mitochondria is often achieved using triphenylphosphonium (TPP) cations. These cationic vehicles may possess biological activity, and a docking study indicates that TPP-moieties may act as modulators of signaling through the estrogen receptor alpha (ER alpha). Moreover, in vivo and in vitro experiments revealed the estrogen-like effects of TPP-based compounds. Here, we tested the hypothesis that TPP-based compounds regulate the activity of ER alpha. Methods. We used ER alpha-positive and ER alpha-negative human breast adenocarcinoma cell lines (MCF-7 and MDA-MB-231, respectively). Cell proliferation was measured using a resazurin cell growth assay and a real-time cell analyzer assay. Cell cycle progression was analyzed using flow cytometry. Real-time PCR was used to assess mRNA expression of endogenous estrogen-responsive genes. Luciferase activity was measured to evaluate transcription driven by estrogen-responsive promoters in cells transfected with an estrogen response element (ERE)(3)-luciferase expression vector. Results. The TPP-based molecules SkQ1 and C12TPP, as well as the rhodamine-based SkQR1, did not increase the proliferation or alter the cell cycle progression of MCF-7 cells. In contrast, 17 beta estradiol increased the proliferation of MCF-7 cells and the proportion of cells in the S/G2/M-phases of the cell cycle. TPP-based compounds did not affect the induction of transcription of an ERE-luciferase expression vector in vitro, and SkQ1 did not alter the levels of expression of estrogen-dependent genes encoding GREB1, TFF1, COX6, and IGFBP4. Conclusion. TPP-based compounds do not possess properties typical of ER alpha agonists.	[Zinovkina, Ludmila A.; Galivondzhyan, Mina K.] Lomonosov Moscow State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Zinovkina, Ludmila A.; Prikhodko, Anastasia S.; Zinovkin, Roman A.] Moscow MV Lomonosov State Univ, Inst Mitoengn, Moscow, Russia; [Prikhodko, Anastasia S.; Galkin, Ivan I.; Zinovkin, Roman A.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Zinovkin, Roman A.] Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow, Russia		Zinovkin, RA (corresponding author), Moscow MV Lomonosov State Univ, Inst Mitoengn, Moscow, Russia.; Zinovkin, RA (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.; Zinovkin, RA (corresponding author), Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow, Russia.	roman.zinovkin@gmail.com	Zinovkin, Roman/J-2500-2013; Prikhodko, Anastasia/AAD-1867-2019; Galivondzhyan, Alina/U-4380-2017	Zinovkin, Roman/0000-0001-5337-4346; Galivondzhyan, Alina/0000-0002-8078-441X; Galkin, Ivan/0000-0002-9025-3794			Aleshin VA, 2015, CELLS-BASEL, V4, P427, DOI 10.3390/cells4030427; Andreev-Andrievskiy AA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8703645; Anisimov VN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1329, DOI 10.1134/S0006297908120055; Antonenko YN, 2011, J BIOL CHEM, V286, P17831, DOI 10.1074/jbc.M110.212837; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Chistyakov VA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1382, DOI 10.1134/S0006297912120061; Davis Susan R., 2002, P345; Feniouk Boris A, 2017, Curr Aging Sci, V10, P41; Galkin II, 2014, BIOCHEMISTRY-MOSCOW+, V79, P124, DOI 10.1134/S0006297914020059; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Kovats S, 2015, CELL IMMUNOL, V294, P63, DOI 10.1016/j.cellimm.2015.01.018; Maioli E, 2009, BIOL PROCED ONLINE, V11, P227, DOI 10.1007/s12575-009-9020-1; Manskikh VN, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1136, DOI 10.1134/S0006297914100162; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Molloy EJ, 2003, BLOOD, V102, P2653, DOI 10.1182/blood-2003-02-0649; Pedram A, 2006, MOL BIOL CELL, V17, P2125, DOI 10.1091/mbc.E05-11-1013; Radde BN, 2016, J CELL BIOCHEM, V117, P2521, DOI 10.1002/jcb.25544; Rodriguez-Cuenca S, 2010, FREE RADICAL BIO MED, V48, P161, DOI 10.1016/j.freeradbiomed.2009.10.039; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Salisbury JP, 2009, BIOINFORMATION, V3, P303, DOI 10.6026/97320630003303; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Silachev DN, 2015, MOLECULES, V20, P14487, DOI 10.3390/molecules200814487; Vollmer G, 2003, ENDOCR-RELAT CANCER, V10, P23, DOI 10.1677/erc.0.0100023; Vorobjeva N, 2017, EUR J CELL BIOL, V96, P254, DOI 10.1016/j.ejcb.2017.03.003; Yamaga R, 2013, HORM CANCER-US, V4, P222, DOI 10.1007/s12672-013-0140-3; Yasar P, 2017, REPROD MED BIOL, V16, P4, DOI 10.1002/rmb2.12006; Zhou J, 2018, AM J TRANSL RES, V10, P1887; Zielonka J, 2017, CHEM REV, V117, P10043, DOI 10.1021/acs.chemrev.7b00042; Zinovkin RA, 2019, CURR MOL PHARMACOL, V12, P202, DOI 10.2174/1874467212666181127151059; Zinovkin RA, 2014, AGING-US, V6, P661, DOI 10.18632/aging.100685	30	2	2	0	1	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	MAR 25	2020	8								e8803	10.7717/peerj.8803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX7HH	WOS:000522047800005	32257641	Green Published, gold			2022-02-06	
J	Downing, M; Hicks, A; Braaf, S; Myles, D; Gabbe, B; Cameron, P; Ameratunga, S; Ponsford, J				Downing, Marina; Hicks, Amelia; Braaf, Sandra; Myles, Dan; Gabbe, Belinda; Cameron, Peter; Ameratunga, Shanthi; Ponsford, Jennie			Factors facilitating recovery following severe traumatic brain injury: A qualitative study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Qualitative; Positive factors; Outcome; Recovery	1ST 5 YEARS; EXPERIENCE; LIFE; ADJUSTMENT; RETURN; DEPRESSION; MODERATE; OUTCOMES; THERAPY; PEOPLE	Given the significant impact of severe traumatic brain injury (TBI), understanding factors influencing recovery is critical to inform prognostication and treatment planning. Previous research has focussed primarily on factors negatively associated with outcome, with less focus on factors facilitating the recovery process. The current qualitative study examined positive factors identified for recovery by individuals who had sustained severe TBI three years earlier. Semi-structured interviews were conducted with nine participants with TBI and 16 close-others. Participants were asked to identify factors about themselves (or the injured individual), those around them, and the care they received that they felt were positive for recovery. Using reflexive thematic analysis, three themes were identified as positive for recovery after a TBI. Having a support network included social supports such as family and friends, and receiving other funded/non-funded assistance towards improving independence and participation. Being positive and engaged included being able to participate, being positive, using compensatory strategies, and becoming fit, healthy and happy. Getting good care included patients perceiving they had a comprehensive and good quality hospital experience, and access to multidisciplinary outpatient services. A focus on enhancing these positive environmental, personal and service factors in service provision may enhance outcomes following severe TBI.	[Downing, Marina; Hicks, Amelia; Ponsford, Jennie] Monash Univ, MERRC, Clayton, Vic, Australia; [Downing, Marina; Hicks, Amelia; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia; [Downing, Marina; Hicks, Amelia; Myles, Dan; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia; [Braaf, Sandra; Myles, Dan; Gabbe, Belinda; Cameron, Peter] Monash Univ, Sch Publ Hlth & Prevent Med, Clayton, Vic, Australia; [Gabbe, Belinda] Swansea Univ, Swansea Univ Med Sch, Hlth Data Res UK, Swansea, W Glam, Wales; [Cameron, Peter] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Ameratunga, Shanthi] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland, New Zealand		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Hicks, Amelia/AAQ-7743-2020; Downing, Marina/AAX-2380-2020; Myles, Dan/H-2257-2018; Ponsford, Jennie/H-8341-2014	Downing, Marina/0000-0002-3126-6632; Myles, Dan/0000-0002-0378-7027; Hicks, Amelia/0000-0002-1152-0576; Ponsford, Jennie/0000-0003-0430-125X	Australian Government's National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [GNT1061786]; Department of Health, State Government of Victoria and Transport Accident Commission; Future Fellowship from the Australian Research CouncilAustralian Research Council; NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia	This project was funded by the Australian Government's National Health and Medical Research Council [grant number GNT1061786]. The Victorian State Trauma Registry (VSTR) is funded by the Department of Health, State Government of Victoria and Transport Accident Commission. BG was supported by a Future Fellowship from the Australian Research Council and PC by a NHMRC Practitioner Fellowship.	Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Braaf S, 2019, BRAIN INJURY, V33, P574, DOI 10.1080/02699052.2019.1566835; Braaf S, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2971-7; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Douglas JM, 2018, BRAIN IMPAIR, V19, P258, DOI 10.1017/BrImp.2018.17; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Eliacin J, 2018, BRAIN INJURY, V32, P1510, DOI 10.1080/02699052.2018.1499964; Forslund MV, 2017, BRAIN INJURY, V31, P329, DOI 10.1080/02699052.2016.1255778; Fraas MR, 2009, AM J SPEECH-LANG PAT, V18, P315, DOI 10.1044/1058-0360(2009/08-0008); Gabbe BJ, 2015, INJURY PREV, V21, P348, DOI 10.1136/injuryprev-2014-041336; Glintborg C, 2018, BRAIN IMPAIR, V19, P215, DOI 10.1017/BrImp.2017.14; Glintborg C, 2016, NEUROREHABILITATION, V38, P99, DOI 10.3233/NRE-161301; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Jones KF, 2018, BRAIN INJURY, V32, P1612, DOI 10.1080/02699052.2018.1511066; Karlovits T, 1999, BRAIN INJURY, V13, P845; Kellezi B, 2015, INJURY, V46, P564, DOI 10.1016/j.injury.2014.11.035; King PR, 2018, REHABIL PSYCHOL, V63, P121, DOI 10.1037/rep0000165; Knox L, 2018, BRAIN INJURY, V32, P1000, DOI 10.1080/02699052.2018.1468924; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lexell EM, 2013, BRAIN INJURY, V27, P529, DOI 10.3109/02699052.2013.765598; Libeson L, 2020, NEUROPSYCHOL REHABIL, V30, P412, DOI 10.1080/09602011.2018.1470987; Maggio MG, 2018, APPL NURS RES, V41, P11, DOI 10.1016/j.apnr.2018.03.005; McPherson K, 2018, J HEAD TRAUMA REHAB, V33, pE44, DOI 10.1097/HTR.0000000000000321; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; Pais C, 2019, NEUROPSYCHOL REHABIL, V29, P625, DOI 10.1080/09602011.2017.1313745; Pais-Hrit C, 2020, NEUROPSYCHOL REHABIL, V30, P1205, DOI 10.1080/09602011.2019.1569536; Piccenna L, 2016, BRAIN INJURY, V30, P241, DOI 10.3109/02699052.2015.1113569; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Powell T, 2012, DISABIL REHABIL, V34, P1461, DOI 10.3109/09638288.2011.644384; Rabinowitz AR, 2018, APPL NEUROPSYCH-ADUL, V25, P295, DOI 10.1080/23279095.2018.1458514; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ruddle Jean Jean, 2011, SOCIAL CARE NEURODIS, V2, P200, DOI [10.1108/20420911111188452, DOI 10.1108/20420911111188452]; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Seagly KS, 2018, BRAIN INJURY, V32, P78, DOI 10.1080/02699052.2017.1374467; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; Sigurdardottir S, 2020, NEUROPSYCHOL REHABIL, V30, P281, DOI 10.1080/09602011.2018.1462719; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Strandberg T, 2009, SOC WORK HEALTH CARE, V48, P276, DOI 10.1080/00981380802599240; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Whiting D, 2020, NEUROPSYCHOL REHABIL, V30, P1348, DOI 10.1080/09602011.2019.1583582	56	2	2	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL 3	2021	31	6					889	913		10.1080/09602011.2020.1744453		MAR 2020	25	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	SB4HE	WOS:000524210500001	32200692				2022-02-06	
J	Koncan, D; Gilchrist, M; Vassilyadi, M; Hoshizaki, TB				Koncan, David; Gilchrist, Michael; Vassilyadi, Michael; Hoshizaki, Thomas B.			Simulated brain strains resulting from falls differ between concussive events of young children and adults	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Concussion; brain injury; impact kinematics; finite element modelling	FINITE-ELEMENT MODELS; HEAD-INJURY; PREDICTORS; ADOLESCENTS; IMPACTS; SPORTS; WHITE	Compared to adults, it has been documented that children are at elevated risk for concussion, repeated concussions, and experience longer recovery times. What is unknown, is whether the developing brain may be injured at differing strain levels. This study examined peak and cumulative brain strain from 20 cases of concussion in both young children and adults using physical reconstructions and finite element modelling of the brain response to impacts. The child group showed lower impact kinematics as well as strain metrics. Results suggest children may suffer concussive injuries with lower brain strains compared to adults.	[Koncan, David; Hoshizaki, Thomas B.] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Vassilyadi, Michael] Univ Ottawa, Childrens Hosp Eastern Ontario Res Inst, Fac Med, Ottawa, ON, Canada		Koncan, D (corresponding author), Univ Ottawa, Human Kinet, Ottawa, ON, Canada.	dkonc074@uottawa.ca			Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	The authors would like to acknowledge the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research for supporting this research, as well as the Pediatric Emergency Research Canada (PERC) Concussion team for their work in collecting patient data.	Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Dawson L, 2016, THESIS; Donelly BR, 1983, 27 STAPP CAR CRASH C; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kendall M., 2016, THESIS; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koncan D, 2017, IRCOBIC 2017 ANTW BE; Koncan D, 2019, P I MECH ENG P-J SPO, V233, P277, DOI 10.1177/1754337118822940; Roman PAL, 2015, NUTR HOSP, V32, P1683, DOI 10.3305/nh.2015.32.4.9486; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meyers MC, 2007, SPORTS MED, V37, P485, DOI 10.2165/00007256-200737060-00003; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Oeur RA, 2019, INT J CRASHWORTHINES, V24, P326, DOI 10.1080/13588265.2018.1441617; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Post A, 2017, J NEUROSURG-PEDIATR, V19, P641, DOI 10.3171/2016.11.PEDS16383; Prange M T, 2000, Stapp Car Crash J, V44, P205; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Sparrey CJ, 2009, J NEUROTRAUM, V26, P585, DOI 10.1089/neu.2008.0654; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Walsh ES, 2018, ASTM INT F08 S MECH; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhou Z, 2016, COMPUT METH PROG BIO, V131, P13, DOI 10.1016/j.cmpb.2016.04.013	43	2	2	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	JUL 3	2020	23	9					500	509		10.1080/10255842.2020.1741555		MAR 2020	10	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	MN6UR	WOS:000524100600001	32207335				2022-02-06	
J	Odgaard, L; Aadal, L; Eskildsen, M; Poulsen, I				Odgaard, Lene; Aadal, Lena; Eskildsen, Marianne; Poulsen, Ingrid			Using clinical quality databases to monitor the quality of fundamental care: Example with weight status after severe traumatic brain injury	JOURNAL OF CLINICAL NURSING			English	Article						body weight changes; complications; fundamentals of care; prevalence; quality of health care; rehabilitation	BODY-MASS INDEX; ADULT PATIENTS; OBESITY; REHABILITATION; INTERVENTIONS; NUTRITION; MODERATE; OUTCOMES	Aims and objectives To determine weight status and risk of overweight up to 1 year after severe traumatic brain injury (TBI) as basis for defining nursing-sensitive indicators of fundamental nutritional nursing care in a clinical quality database. Background Patients' nutritional needs are recognised as fundamental care during hospitalisation, but less attention has been given to nutritional status after discharge. Design Nationwide cohort study. The STROBE checklist was used to ensure reporting quality. Methods Data were retrieved from the Danish Head Trauma Database, a clinical quality database aiming at improving the quality of neurorehabilitation. Individuals aged >= 15 years with severe TBI 2011-2015 (N = 424) were included. Normal weight, underweight and overweight were described according to the body mass index (BMI) at admission to subacute rehabilitation, at discharge and at 1 year postinjury. The probability of transition between weight groups from admission to 1 year postinjury was calculated. Multivariable binominal regression analyses compared risk of overweight between age groups. Results The prevalence of underweight decreased from 13% at admission to 6% and 3% at discharge and 1 year postinjury, respectively. The prevalence of overweight was stable at 26%-27% at admission and discharge and increased to 44% at 1 year postinjury. Of the individuals not overweight at admission, 28% became overweight by 1 year postinjury. Overweight was significantly more prevalent in older compared to younger individuals. The risk of becoming overweight among those not overweight at admission did not differ between age groups. Conclusion Underweight individuals achieved normal weight during inpatient rehabilitation. By 1 year postinjury, individuals were increasingly overweight. Relevance to clinical practice Weight status has potential as nursing-sensitive indicators that may be included in clinical quality databases to inform the organisational and policy level on the state of fundamental nutritional nursing care. The inclusion emphasise requested responsibilities of nursing care. This facilitates health economic attention and influences nursing professional execution.	[Odgaard, Lene; Aadal, Lena] Aarhus Univ, Hammel Neurorehabil Ctr, Aarhus, Denmark; [Odgaard, Lene; Aadal, Lena] Aarhus Univ, Univ Res Clin, Aarhus, Denmark; [Eskildsen, Marianne; Poulsen, Ingrid] Copenhagen Univ Hosp, Rigshosp, Res Unit Brain Injury Rehabil RUBRIC, Dept Neurorehabil,TBI, Copenhagen, Denmark; [Poulsen, Ingrid] Aarhus Univ, Sect Nursing Sci, Hlth, Aarhus, Denmark		Odgaard, L (corresponding author), Hammel Neurorehabil Ctr, Voldbyvej 14, DK-8450 Hammel, Denmark.; Odgaard, L (corresponding author), Univ Res Clin, Voldbyvej 14, DK-8450 Hammel, Denmark.	lene.odgaard@midt.rm.dk	aadal, lena/U-9172-2017	aadal, lena/0000-0001-7365-3916; Odgaard, Lene/0000-0002-9830-3282; Poulsen, ingrid/0000-0002-0342-017X			Aadal L, 2015, J NEUROSCI NURS, V47, P85, DOI 10.1097/JNN.0000000000000121; Beck M, 2019, NURS OPEN, V6, P626, DOI 10.1002/nop2.246; Beck M, 2016, J CLIN NURS, V25, P1614, DOI 10.1111/jocn.13161; Cederholm T, 2017, CLIN NUTR, V36, P49, DOI 10.1016/j.clnu.2016.09.004; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Costello LAS, 2014, INJURY, V45, P1834, DOI 10.1016/j.injury.2014.06.004; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; Dreer LE, 2018, J HEAD TRAUMA REHAB, V33, P246, DOI 10.1097/HTR.0000000000000408; Duraski SA, 2014, REHABIL NURS, V39, P140, DOI 10.1002/rnj.138; Feo R, 2018, J CLIN NURS, V27, P2285, DOI 10.1111/jocn.14247; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Francis R, 2013, REPORT MIDSTAFFORDSH; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Garling P, 2008, SPECIAL COMMISSION I; Holst M, 2017, NUTRITION, V34, P14, DOI 10.1016/j.nut.2016.05.011; Jefferies D, 2011, J CLIN NURS, V20, P317, DOI 10.1111/j.1365-2702.2010.03502.x; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Le D, 2015, AM J PHYS MED REHAB, V94, P627, DOI 10.1097/PHM.0000000000000222; National Board of Health, 2018, DANSK SUNDH NAT SUND; Odgaard L, 2018, J NEUROSCI NURS, V50, P149, DOI 10.1097/JNN.0000000000000365; Odgaard L, 2015, CLIN EPIDEMIOL, V7, P225, DOI 10.2147/CLEP.S78141; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perry L, 2013, WORLDV EVID-BASED NU, V10, P17, DOI 10.1111/j.1741-6787.2012.00255.x; Pokorny Marie E, 2009, Home Healthc Nurse, V27, P43, DOI 10.1097/01.NHH.0000343785.96475.0c; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Richards DA, 2018, J CLIN NURS, V27, P2179, DOI 10.1111/jocn.14150; RKKP, 2019, RKKP ENGL; Robstad N, 2018, J CLIN NURS, V27, P386, DOI 10.1111/jocn.13937; Stratton RJ, 2004, BRIT J NUTR, V92, P799, DOI 10.1079/BJN20041258; World Health Organization, 2019, OBESITY; World Health Organization, 2017, GLOB HLTH OBS DAT RE; World Health Organization. WHO, 2019, NUTRITION	33	2	2	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	JUN	2020	29	11-12			SI		2031	2038		10.1111/jocn.15233		MAR 2020	8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	LO2DE	WOS:000522716900001	32129517				2022-02-06	
J	Iverson, GL; Jones, PJ; Karr, JE; Maxwell, B; Zafonte, R; Berkner, PD; McNally, RJ				Iverson, Grant L.; Jones, Payton J.; Karr, Justin E.; Maxwell, Bruce; Zafonte, Ross; Berkner, Paul D.; McNally, Richard J.			Architecture of Physical, Cognitive, and Emotional Symptoms at Preseason Baseline in Adolescent Student Athletes With a History of Mental Health Problems	FRONTIERS IN NEUROLOGY			English	Article						child; adolescent; concussion; mental health; sports	SPORTS-RELATED CONCUSSION; NETWORK ANALYSIS; DEPRESSION; VALIDITY	Objective: Pre-injury mental health problems are associated with greater symptom reporting following sport-related concussion. We applied a statistical and psychometric approach known as network analysis to examine the interrelationships among symptoms at baseline in adolescent student athletes with a history of mental health problems. Design: Cross-sectional study. Setting: High schools in Maine, USA. Participants: A cohort of 44,527 adolescent student athletes completed baseline preseason testing with ImPACT (R) between 2009 and 2015, and those with a history of mental health problems reporting at least one symptom were included (N = 2,412; 14-18 years-old, 60.1% girls). Independent Variables: Self-reported history of treatment for a psychiatric condition. Main Outcome Measures: Physical, cognitive, and emotional symptoms from the Post-Concussion Symptom Scale. Results: Student athletes reported high frequencies of emotional symptoms (nervousness: boys = 46.6%, girls = 58.3%; irritability: boys = 37.9%, girls = 46.9%; sadness: boys = 38.7%, girls = 53.2%), sleep/arousal-related symptoms (trouble falling asleep: boys = 50.4%, girls = 55.1%; sleeping less than usual: boys = 43.8%, girls = 45.2%; and fatigue: boys = 40.3%, girls = 45.2%), headaches (boys = 27.5%, girls = 41.8%), and inattention (boys = 47.8%, girls = 46.9%) before the start of the season. Although uncommonly endorsed, dizziness was the most central symptom (i.e., the symptom with the highest aggregate connectedness with different symptoms in the network), followed by feeling more emotional and feeling slowed down. Dizziness was related to physical and somatic symptoms (e.g., balance, headache, nausea, numbness/tingling) whereas increased emotionality was related to sadness, nervousness, and irritability. Feeling slowed down was connected to cognitive (e.g., fogginess, forgetfulness), and sensory symptoms (e.g., numbness/tingling, light sensitivity). There were no gender differences in the symptom network structure. Conclusions: We examined the interconnections between symptoms reported by student athletes with mental health problems at preseason baseline, identifying how physical, cognitive, and emotional symptoms interact and potentially reinforce each other in the absence of injury. These findings are a step toward informing more precise interventions for this subgroup of athletes if they are slow to recover following concussion.	[Iverson, Grant L.; Karr, Justin E.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.; Karr, Justin E.] Spaulding Rehabil Hosp, Boston, MA 02129 USA; [Iverson, Grant L.; Karr, Justin E.] Spaulding Res Inst, Boston, MA 02129 USA; [Iverson, Grant L.; Karr, Justin E.; Zafonte, Ross] Home Base, Boston, MA 02129 USA; [Iverson, Grant L.; Karr, Justin E.; Zafonte, Ross] Red Sox Fdn, Boston, MA 02215 USA; [Iverson, Grant L.; Karr, Justin E.; Zafonte, Ross] Massachusetts Gen Hosp Program, Boston, MA 02114 USA; [Iverson, Grant L.; Karr, Justin E.] MassGen Hosp Children, Sport Concuss Program, Boston, MA 02114 USA; [Jones, Payton J.; McNally, Richard J.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Karr, Justin E.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Maxwell, Bruce] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Zafonte, Ross] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Zafonte, Ross] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Zafonte, Ross] Harvard Med Sch, Boston, MA 02115 USA; [Berkner, Paul D.] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA		Iverson, GL (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Iverson, GL (corresponding author), Spaulding Rehabil Hosp, Boston, MA 02129 USA.; Iverson, GL (corresponding author), Spaulding Res Inst, Boston, MA 02129 USA.; Iverson, GL (corresponding author), Home Base, Boston, MA 02129 USA.; Iverson, GL (corresponding author), Red Sox Fdn, Boston, MA 02215 USA.; Iverson, GL (corresponding author), Massachusetts Gen Hosp Program, Boston, MA 02114 USA.; Iverson, GL (corresponding author), MassGen Hosp Children, Sport Concuss Program, Boston, MA 02114 USA.	giverson@mgh.harvard.edu			National Football League	This study was funded in part by the National Football League for a program of research entitled The Spectrum of Concussion: Predictors of Clinical Recovery, Treatment and Rehabilitation, and Possible Long-Term Effects (Iverson, PI). GI acknowledges unrestricted philanthropic support from ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, Boston Bolts, Heinz Family Foundation, and Spaulding Research Institute.	Beard C, 2016, PSYCHOL MED, V46, P3359, DOI 10.1017/S0033291716002300; Borsboom D, 2016, PSYCHOL MED, V46, P1567, DOI 10.1017/S0033291715001944; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Cramer AOJ, 2012, PSYCHOL MED, V42, P957, DOI 10.1017/S003329171100211X; Cramer AOJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167490; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Curtiss J, 2016, J AFFECT DISORDERS, V199, P99, DOI 10.1016/j.jad.2016.04.007; Dalege J, 2017, SOC PSYCHOL PERS SCI, V8, P528, DOI 10.1177/1948550617709827; Epskamp S, 2018, PSYCHOL METHODS, V23, P617, DOI 10.1037/met0000167; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Fried EI, 2017, SOC PSYCH PSYCH EPID, V52, P1, DOI 10.1007/s00127-016-1319-z; Fried EI, 2016, J AFFECT DISORDERS, V189, P314, DOI 10.1016/j.jad.2015.09.005; Friedman J., 2014, GRAPHICAL LASSO ESTI; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; ImPACT Applications Inc, 2011, IMM POSTC ASS COGN T; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jones PJ, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01742; Jones PJ, 2018, NETWORKTOOLS TOOLS I, DOI [10.1155/2018/8268436, DOI 10.1155/2018/8268436]; Jones PJ, 2019, NETWORK MODEL TREES, DOI [10.31219/osf.io/ha4cw, DOI 10.31219/OSF.IO/HA4CW]; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Levinson CA, 2018, INT J EAT DISORDER, V51, P693, DOI 10.1002/eat.22890; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Mair P, 2016, MULTIVAR BEHAV RES, V51, P772, DOI 10.1080/00273171.2016.1235966; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; R CORE DEVELOPMENT TEAM, 2012, R LANG ENV STAT COMP; Robinaugh DJ, 2016, J ABNORM PSYCHOL, V125, P747, DOI 10.1037/abn0000181; Terluin B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155205; van Borkulo C.D., 2017, PHYSIOLOGY, V34, P38569, DOI [10.13140/RG.2.2.29455.38569, DOI 10.13140/RG.2.2.29455.38569]; van Borkulo C, 2015, JAMA PSYCHIAT, V72, P1219, DOI 10.1001/jamapsychiatry.2015.2079; van Loo HM, 2018, J AFFECT DISORDERS, V227, P313, DOI 10.1016/j.jad.2017.10.038; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	41	2	2	1	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 20	2020	11								175	10.3389/fneur.2020.00175			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KZ7KV	WOS:000523438100001	32265822	gold, Green Published			2022-02-06	
J	Rawlins, MLW; Snedden, TR; Kay, MC; Mcleod, TV; Bacon, CEW				Rawlins, Michelle L.; Snedden, Traci R.; Kay, Melissa C.; Mcleod, Tamara; Bacon, Cailee E.			School nurses' perceptions of concussion management for secondary school student-athletes	BRAIN INJURY			English	Article						School health care; policy; mild traumatic brain injury; multidisciplinary health care	SPORT-RELATED CONCUSSION; STATEMENT; KNOWLEDGE; RETURN	Background: School nurses play a vital role in concussion management at the secondary school level, often being the only on-site healthcare provider during school hours. However, little is known regarding how they perceive their role in the concussion management process. The purpose of this study was to explore school nurses' perceptions and satisfaction with concussion management in the secondary school setting using a qualitative approach. Methods: Twenty-two school nurses employed within a United States secondary school setting completed individual, semi-structured phone interviews. Data were analyzed using a consensual qualitative research approach. Results: Four overall themes emerged. This manuscript focuses on one specific theme: school nurse perceptions and satisfaction regarding concussion management. Subthemes included: school nurses' overall perception and satisfaction with current concussion management procedures, interactions with other involved personnel, concussion assessment tools, school nurses' perceived role, current concussion management policies, concussion education, and school nurse continuing education specific to concussion. Conclusions: School nurses were generally positive regarding concussion management within their setting and were satisfied with their roles overall. However, participants identified a number of areas that require further attention to ensure an evidence-based, consistent team approach to concussion management to support best student outcomes and continuity of care.	[Rawlins, Michelle L.; Mcleod, Tamara; Bacon, Cailee E.] AT Still Univ, Dept Interdisciplinary Hlth Sci, Mesa, AZ 85206 USA; [Snedden, Traci R.] Univ Wisconsin, Sch Nursing, Madison, WI USA; [Kay, Melissa C.] Univ Southern Mississippi, Sch Hlth Profess, Hattiesburg, MS 39406 USA; [Mcleod, Tamara; Bacon, Cailee E.] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ 85206 USA		Bacon, CEW (corresponding author), AT Still Univ, Dept Interdisciplinary Hlth Sci, Mesa, AZ 85206 USA.	cwelch@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Snedden, Traci/0000-0002-1550-2340	A.T. Still University Strategic Research Fund	Financial support for this investigation was provided by the A.T. Still University Strategic Research Fund.	[Anonymous], 2016, RZECZPOSPOLITA, V97, pA14, DOI DOI 10.1016/J.APMR.2016.09.077; Bacon CEW, 2018, SAGE OPEN NURS, V4, DOI 10.1177/2377960818798437; Bacon CEW, 2017, J INTERPROF CARE, V31, P725, DOI 10.1080/13561820.2017.1345873; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Diaz Anne L, 2013, NASN Sch Nurse, V28, P110; Elliott R., 1989, ENTERING CIRCLE HERM, P165; Giorgi A., 1985, PHENOMENOLOGY PSYCHO, P8; Glaser B, 1967, DISCOVERY GROUNDED T; Haider Mohammad N, 2017, Concussion, V2, pCNC40, DOI 10.2217/cnc-2017-0001; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Hill CE, 2005, J COUNS PSYCHOL, V52, P196, DOI 10.1037/0022-0167.52.2.196; Hill CE, 1997, COUNS PSYCHOL, V25, P517, DOI 10.1177/0011000097254001; Johnson I, 2018, J CONTIN EDUC NURS, V49, P451, DOI 10.3928/00220124-20180918-04; Kasamatsu T. M., 2016, ATHLETIC TRAINING SP, V8, P112, DOI DOI 10.3928/19425864-20160225-01; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; McAvoy K, GET SCH CONCUSSIONS; McAvoy K, 2012, REAP BENEFITS GOOD C; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Olympia RP, 2016, CLIN J SPORT MED, V26, P115, DOI 10.1097/JSM.0000000000000208; Piebes SK, 2009, J SCH NURS, V25, P270, DOI 10.1177/1059840509339782; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Sarmiento K, 2018, BRAIN INJURY, V32, P889, DOI 10.1080/02699052.2018.1466197; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Weber ML, 2018, J SCH NURS, P1; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475	34	2	2	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 15	2020	34	5					665	672		10.1080/02699052.2020.1739334		MAR 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LB9LL	WOS:000520584500001	32183537				2022-02-06	
J	Van Ierssel, J; Sveistrup, H; Marshall, S; Graham, I				Van Ierssel, Jacquie; Sveistrup, Heidi; Marshall, Shawn; Graham, Ian			The concussion recovery questionnaire (CORE-Q): conceptual model development and item generation of a concussion-specific measure of functional status	BRAIN INJURY			English	Article						Conceptual Model; concussion; functioning; patient-reported outcome measure	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SYMPTOMS QUESTIONNAIRE; ENVIRONMENTAL-FACTORS; PARTICIPATION; INSTRUMENTS; DISABILITY; TASK	Introduction: Defining and measuring limitations in functional status post-concussion has been challenging, as generic measures do not accurately reflect issues most relevant to adults with persistent post-concussion symptoms. Purpose: To develop a new concussion-specific measure of functional status for use in clinical practice and intervention trials. Method: We developed a conceptual model of functioning based on concepts identified from a previous qualitative study with persons with concussion and clinicians. An initial set of questionnaire items was generated from the concepts, codes, and conceptual model. Items were refined using cognitive interviews elicit feedback on their relevance and acceptability. Results: We developed an initial set of 145 items categorized by concepts that were reduced to 50. Our final item set resulted in the COncussion REcovery Questionnaire, which contains a total of 53 items split into 3 separate scales: the Post-Concussion Functional Scale, Concussion Modifiers Scale, and Global Functional Recovery Scale. Conclusion: The new Concussion Recovery Questionnaire is a self-reported measure of functional status for monitoring outcomes in clinical practice and in clinical intervention trials following concussion. Further studies are necessary to provide evidence of the measure's psychometric properties and to determine the questionnaire's ability to facilitate clinical decision-making.	[Van Ierssel, Jacquie] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Sveistrup, Heidi] Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada; [Sveistrup, Heidi] Bruyere, Res Inst, Ottawa, ON, Canada; [Marshall, Shawn] Ottawa Hosp, Ottawa Hosp Res Inst, Div Phys Med & Rehabil, Ottawa, ON, Canada; [Marshall, Shawn] Univ Ottawa, Fac Med, Sch Med, Ottawa, ON, Canada; [Graham, Ian] Ottawa Hosp Res Inst, Ctr Practice Changing Res, Ottawa, ON, Canada; [Graham, Ian] Univ Ottawa, Fac Med, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Graham, Ian] Univ Ottawa, Fac Hlth Sci, Sch Nursing, Ottawa, ON, Canada		Van Ierssel, J (corresponding author), Childrens Hosp Eastern Ontario, 401 Smyth Rd, Ottawa, ON K1H 5B2, Canada.	jminn044@uottawa.ca	Graham, Ian D./ABD-5259-2021	Graham, Ian D./0000-0002-3669-1216; van Ierssel, Jacqueline/0000-0001-5519-8526	CIHRCanadian Institutes of Health Research (CIHR) [FDN143237] Funding Source: Medline		Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; American Educational Research Association, 2014, AM PSYCH ASS NC M E; Brod M, 2009, QUAL LIFE RES, V18, P1263, DOI 10.1007/s11136-009-9540-9; Cieza A, 2005, QUAL LIFE RES, V14, P1225, DOI 10.1007/s11136-004-4773-0; de Guise E, 2016, APPL NEUROPSYCH-ADUL, V23, P213, DOI 10.1080/23279095.2015.1038747; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Eliyahu L, 2016, ACAD EMERG MED, V23, P531, DOI 10.1111/acem.12924; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; Grady KL, 2015, J HEART LUNG TRANSPL, V34, P1292, DOI 10.1016/j.healun.2015.04.003; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Jacobson CJ, 2015, J PAIN, V16, P1243, DOI 10.1016/j.jpain.2015.08.007; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; LEIDY NK, 1994, NURS RES, V43, P196; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mallinson T, 2010, ARCH PHYS MED REHAB, V91, pS29, DOI 10.1016/j.apmr.2010.04.027; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Noreau L, 2010, ARCH PHYS MED REHAB, V91, pS44, DOI 10.1016/j.apmr.2009.10.037; Okochi Jiro, 2005, Health Qual Life Outcomes, V3, P46, DOI 10.1186/1477-7525-3-46; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Patrick DL, 2011, VALUE HEALTH, V14, P978, DOI 10.1016/j.jval.2011.06.013; Peterson CH, 2017, MEAS EVAL COUNS DEV, V50, P217, DOI 10.1080/07481756.2017.1339564; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Streiner D.L., 2015, HLTH MEASUREMENT SCA, V5th ed.; Thigpen CA, 2018, AM J SPORT MED, V46, P3480, DOI 10.1177/0363546518807924; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; van Ierssel J, 2018, QUAL LIFE RES, V27, P3071, DOI 10.1007/s11136-018-1939-8; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; WebFX, 2018, READ TEST TOOL; Willis GB, 2005, COGNITIVE INTERVIEWI, P335; World Health Organization, 2007, INT CLASS FUNCT DIS	35	2	2	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 15	2020	34	5					619	629		10.1080/02699052.2020.1725840		MAR 2020	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LB9LL	WOS:000520154400001	32174175				2022-02-06	
J	Yamakawa, GR; Eyolfson, E; Weerawardhena, H; Mychasiuk, R				Yamakawa, Glenn R.; Eyolfson, Eric; Weerawardhena, Himanthri; Mychasiuk, Richelle			Administration of diphenyl diselenide (PhSe)(2) following repetitive mild traumatic brain injury exacerbates anxiety-like symptomology in a rat model	BEHAVIOURAL BRAIN RESEARCH			English	Article						Concussion; Rat; Animal model; Anxiety; Selenium	DEPRESSIVE-LIKE BEHAVIOR; SUPPLEMENTED DIET; ANTIDEPRESSANT-LIKE; OXIDATIVE STRESS; MEMORY DEFICITS; GENE-EXPRESSION; INVOLVEMENT; SELENIUM; EBSELEN; MICE	Approximately 10-15 % of people that sustain mild traumatic brain injury (mTBI) develop post-concussive syndrome (PCS). PCS is a complex array of symptoms that can result in physical, cognitive and emotional impairments. Following mTBI, there are also complex changes in the oxidative stress system and engagement of the inflammatory system, within the brain. Diphenyl diselenide (PhSe)(2) is an organoselenium compound which can play a role in anti-oxidant and anti-inflammatory activities. (PhSe)(2) also has many interesting properties including anti-anxiety, anti-depressant and anti-nociception effects. We sought to determine if treatment with (PhSe)(2) following repetitive mTBI could have mitigating effects on PCS. To investigate this, we induced mTBI or sham injuries using our lateral impact device in adolescent male and female Sprague Dawley rats and an hour later injected rats with vehicle, 10 mg/kg or 25 mg/kg (PhSe)(2) i.p. Next, we conducted a behavioral assessment designed to assess PCS and then euthanized the animals to examine changes in gene expression and telomere length. (PhSe)(2) decreased the time to cross the beam, distance travelled and time spent in the centre of the open field, time spent in the open arms of the elevated plus maze, the time investigating both objects in the novel context mismatch and time immobile in the forced swim. This anxiety-like symptomology resolved spontaneously between 10 and 12 days after the third mTBI. We found (PhSe)(2) groups showed increased levels of TNF alpha and longer telomeres. We also found higher levels of GPX1 in the injured animals. Our results show that (PhSe)(2) exacerbates anxiety-like symptomology in contrast to previous findings.	[Yamakawa, Glenn R.; Mychasiuk, Richelle] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; [Yamakawa, Glenn R.; Eyolfson, Eric; Weerawardhena, Himanthri; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yamakawa, Glenn R.; Eyolfson, Eric; Weerawardhena, Himanthri; Mychasiuk, Richelle] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yamakawa, Glenn R.; Eyolfson, Eric; Weerawardhena, Himanthri; Mychasiuk, Richelle] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada		Yamakawa, GR (corresponding author), Monash Univ, Dept Neurosci, Melbourne, Vic, Australia.	glenn.yamakawa@monash.edu		Yamakawa, Glenn/0000-0003-3079-6532; Eyolfson, Eric/0000-0002-2201-5444	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [PJT-153051]; Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [1304881]	This study was supported by Canadian Institutes of Health Research (CIHR) grant number: PJT-153051 and Natural Sciences and Engineering Research Council of Canada (NSERC) grant number: 1304881.	Almeida AA, 2018, PEDIATR CLIN N AM, V65, P1151, DOI 10.1016/j.pcl.2018.07.006; Andrade AK, 2019, PHARMACOL BIOCHEM BE, V180, P60, DOI 10.1016/j.pbb.2019.03.006; Anyan J, 2018, NEUROPSYCHOPHARMACOL, V43, P931, DOI 10.1038/npp.2017.260; Barbosa NV, 2017, METALLOMICS, V9, P1703, DOI 10.1039/c7mt00083a; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Bruning CA, 2012, NEUROCHEM RES, V37, P2249, DOI 10.1007/s11064-012-0853-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cechella JL, 2014, PHYSIOL BEHAV, V135, P125, DOI 10.1016/j.physbeh.2014.06.006; Cechella JL, 2014, AGE, V36, DOI 10.1007/s11357-014-9666-8; CHU FF, 1990, NUCLEIC ACIDS RES, V18, P1531, DOI 10.1093/nar/18.6.1531; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Da Rocha JT, 2013, BIOL TRACE ELEM RES, V154, P372, DOI 10.1007/s12011-013-9736-2; da Rocha JT, 2012, PSYCHOPHARMACOLOGY, V222, P709, DOI 10.1007/s00213-012-2675-3; DAWSON DA, 1995, NEUROSCI LETT, V185, P65, DOI 10.1016/0304-3940(94)11226-9; de Freitas AS, 2011, NEUROSCI LETT, V503, P1, DOI 10.1016/j.neulet.2011.07.050; Dobrachinski F, 2014, NEUROTOX RES, V26, P317, DOI 10.1007/s12640-014-9463-2; Dyck ACF, 2018, DEV NEUROREHABIL, V21, P475, DOI 10.1080/17518423.2018.1460878; Ghisleni G, 2008, PROG NEURO-PSYCHOPH, V32, P1508, DOI 10.1016/j.pnpbp.2008.05.008; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Hall CS, 1941, PSYCHOL BULL, V38, P909, DOI 10.1037/h0056232; Hayes JP, 2018, GENES BRAIN BEHAV, V17, P107, DOI 10.1111/gbb.12403; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Howell DR, 2019, CLIN J SPORT MED, V29, P391, DOI 10.1097/JSM.0000000000000629; Jacques-Silva MC, 2001, PHARMACOL TOXICOL, V88, P119, DOI 10.1034/j.1600-0773.2001.d01-92.x; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kolb B, 2019, BRAIN CIRC, V5, P1, DOI 10.4103/bc.bc_29_18; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Leite MR, 2015, CYTOKINE, V71, P119, DOI 10.1016/j.cyto.2014.09.006; Lewis MD, 2016, J AM COLL NUTR, V35, P469, DOI 10.1080/07315724.2016.1150796; Luchese C, 2012, INFLAMM RES, V61, P1117, DOI 10.1007/s00011-012-0504-0; Maciel EN, 2003, B ENVIRON CONTAM TOX, V70, P470, DOI 10.1007/s00128-003-0010-8; Meotti FC, 2003, TOXICOL LETT, V143, P9, DOI 10.1016/S0378-4274(03)00090-0; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Dias GRM, 2014, NEUROENDOCRINOLOGY, V100, P45, DOI 10.1159/000365515; Dias GRM, 2014, PHYSIOL BEHAV, V124, P116, DOI 10.1016/j.physbeh.2013.10.036; Dias GRM, 2012, INT J DEV NEUROSCI, V30, P83, DOI 10.1016/j.ijdevneu.2011.12.011; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Nogueira CW, 2010, J BRAZIL CHEM SOC, V21, P2055, DOI 10.1590/S0103-50532010001100006; Nogueira CW, 2003, INFLAMM RES, V52, P56, DOI 10.1007/s000110300001; Ogawa A, 1999, CEREBROVASC DIS, V9, P112, DOI 10.1159/000015908; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Ribeiro MCP, 2013, CHEM-BIOL INTERACT, V204, P191, DOI 10.1016/j.cbi.2013.05.008; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prigol M, 2012, BIOL TRACE ELEM RES, V150, P272, DOI 10.1007/s12011-012-9464-z; Prigol M, 2010, ARCH TOXICOL, V84, P373, DOI 10.1007/s00204-009-0507-y; Prigol M, 2009, TOXICOL LETT, V189, P35, DOI 10.1016/j.toxlet.2009.04.026; Rosa SG, 2016, PHYSIOL BEHAV, V155, P1, DOI 10.1016/j.physbeh.2015.11.038; Salberg S, 2018, J NEUROTRAUM, V35, P1895, DOI 10.1089/neu.2018.5744; Salberg S, 2017, NEUROSCIENCE, V365, P146, DOI 10.1016/j.neuroscience.2017.09.053; Sampaio TB, 2017, EUR J PHARMACOL, V795, P28, DOI 10.1016/j.ejphar.2016.11.054; Savegnago L, 2008, PHARMACOL BIOCHEM BE, V88, P418, DOI 10.1016/j.pbb.2007.09.015; Schallert T, 2002, PHARM CEREBRAL ISCHE; Scheffler P, 2019, INT J PEDIATR OTORHI, V121, P6, DOI 10.1016/j.ijporl.2019.02.036; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Trojian TH, 2011, CURR SPORT MED REP, V10, P180, DOI 10.1249/JSR.0b013e31822458d5; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12; Yamakawa GR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187218; Yamakawa GR, 2017, EXP NEUROL, V295, P55, DOI 10.1016/j.expneurol.2017.06.001	65	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 16	2020	382								112472	10.1016/j.bbr.2020.112472			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	LD5IO	WOS:000526063300002	31926213				2022-02-06	
J	Beadle, EJ; Ownsworth, T; Fleming, J; Shum, DHK				Beadle, Elizabeth Jane; Ownsworth, Tamara; Fleming, Jennifer; Shum, David H. K.			Personality characteristics and cognitive appraisals associated with self-discrepancy after severe traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Self-concept; Personality; Cognitive appraisal	SOCIAL-DESIRABILITY; HEAD-INJURY; REHABILITATION; RUMINATION; IDENTITY; OPTIMISM; ESTEEM; REFLECTION; NARRATIVES; DISORDERS	Although changes to self-identity or self-discrepancy are common after severe traumatic brain injury (TBI), the mechanisms underlying these changes are poorly understood. This study aimed to examine the influence of personality characteristics and cognitive appraisals on self-discrepancy. Participants were 51 adults (74% male) with severe TBI (Mage = 36.22 years;SD = 12.65) who were on average 34 months (SD = 40.29) post-injury. They completed self-report measures of personality style (optimism and defensiveness), cognitive appraisals (threat appraisals, rumination and reflection and perceived coping resources), and self-discrepancy (Head Injury Semantic Differential Scale - III). Correlation analyses identified that higher levels of optimism, defensiveness and perceived coping resources were significantly associated with more positive self-discrepancy (r = .29-.47,p < .05), whereas higher threat appraisals and rumination were significantly related to more negative self- discrepancy (r = -.50-.57,p < .001). After controlling for personality characteristics, cognitive appraisals significantly accounted for self-discrepancy (R(2)change = .15). Moreover, rumination significantly mediated the relationship between optimism and self-discrepancy. In summary, cognitive appraisals were found to be related to self-discrepancy, independent of personality characteristics. Rumination in particular may be an important target of psychological intervention for individuals experiencing negative self-discrepancy.	[Beadle, Elizabeth Jane; Ownsworth, Tamara; Shum, David H. K.] Griffith Univ, Sch Appl Psychol, Menzies Hlth Inst Queensland, Mt Gravatt, Qld, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; [Shum, David H. K.] Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, CAS Key Lab Mental Hlth, Beijing, Peoples R China		Beadle, EJ (corresponding author), Griffith Univ, Sch Appl Psychol, Menzies Hlth Inst Queensland, Mt Gravatt, Qld, Australia.	e.beadle@griffith.edu.au	Ownsworth, Tamara/ABB-6961-2021; Shum, David H. K./A-3914-2008	Ownsworth, Tamara/0000-0003-1835-7094; Shum, David H. K./0000-0002-4810-9262; Fleming, Jennifer/0000-0002-5603-2410	Centre for Research Excellence in Brain Recovery [CRE: 1023043]	Dr Beadle received a PhD scholarship funded by the Centre for Research Excellence in Brain Recovery [CRE: 1023043].	Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Ashworth F, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P327; Beadle EJ, 2018, J HEAD TRAUMA REHAB, V33, pE42, DOI 10.1097/HTR.0000000000000360; Beadle EJ, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000158; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Dwan T, 2017, INT PSYCHOGERIATR, V29, P1157, DOI 10.1017/S1041610217000382; Ellis-Hill CS, 2000, CLIN REHABIL, V14, P279, DOI 10.1191/026921500671231410; EVANS RG, 1979, J PERS ASSESS, V43, P406, DOI 10.1207/s15327752jpa4304_13; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Fitts WH., 1996, TENNESSEE SELF CONCE; Folkman S, 2000, PSYCHO-ONCOL, V9, P11, DOI 10.1002/(SICI)1099-1611(200001/02)9:1<11::AID-PON424>3.0.CO;2-Z; Folkman S., 1984, STRESS; Gisi TM, 2000, INT J NEUROSCI, V105, P121, DOI 10.3109/00207450009003271; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Gracey F., 2012, THE SOCIAL CURE, P273; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hayes A.F., 2012, PROCESS VERSATILE CO; Jokela M, 2014, PSYCHOL MED, V44, P2629, DOI 10.1017/S0033291714000257; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Klonoff P. S., 2010, PSYCHOTHERAPY BRAIN; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Loo R, 2000, J SOC PSYCHOL, V140, P628, DOI 10.1080/00224540009600503; Luyckx K, 2007, PERS INDIV DIFFER, V43, P1099, DOI 10.1016/j.paid.2007.03.003; MALIA K, 1995, BRAIN INJURY, V9, P697, DOI 10.3109/02699059509008226; Man DWK, 2003, BRAIN INJURY, V17, P775, DOI 10.1080/0269905031000088577; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T., 2017, NEUROPSYCHOLOGICAL R; Ownsworth T., 2005, NEUROPSYCHOANALYSIS, V7, P83; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Ownsworth T, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00096; Ownsworth T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-369; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Papageorgiou C, 2001, COGN BEHAV PRACT, V8, P160, DOI 10.1016/S1077-7229(01)80021-3; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Ramanathan DM, 2011, BRAIN INJURY, V25, P328, DOI 10.3109/02699052.2011.554336; Reddy A, 2017, NEUROPSYCHOL REHABIL, V27, P1103, DOI 10.1080/09602011.2015.1114499; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Riley GA, 2010, NEUROPSYCHOL REHABIL, V20, P869, DOI 10.1080/09602011.2010.503041; Rosenberg M., 1965, SOC ADOLESCENT SELF; Rush BK, 2006, REHABIL PSYCHOL, V51, P257, DOI 10.1037/0090-5550.51.3.257; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Shields C, 2016, NEUROPSYCHOL REHABIL, V26, P410, DOI 10.1080/09602011.2015.1037772; Spector PE, 2006, ORGAN RES METHODS, V9, P221, DOI 10.1177/1094428105284955; Stone J, 2004, J NEUROL NEUROSUR PS, V75, P1708, DOI 10.1136/jnnp.2004.037887; Takano K, 2009, BEHAV RES THER, V47, P260, DOI 10.1016/j.brat.2008.12.008; Trapnell PD, 1999, J PERS SOC PSYCHOL, V76, P284, DOI 10.1037/0022-3514.76.2.284; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; van der Velden AM, 2015, CLIN PSYCHOL REV, V37, P26, DOI 10.1016/j.cpr.2015.02.001; van Mierlo ML, 2015, ARCH PHYS MED REHAB, V96, P1064, DOI 10.1016/j.apmr.2015.01.022; Vickery CD, 2006, REHABIL PSYCHOL, V51, P30, DOI 10.1037/0090-5550.51.1.30; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x	70	2	2	2	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 15	2020	30	3					393	411		10.1080/09602011.2018.1469416			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MB2FW	WOS:000542421300002	29742965				2022-02-06	
J	Markovic, G; Bartfai, A; Ekholm, J; Nilsson, C; Schult, ML; Lofgren, M				Markovic, Gabriela; Bartfai, Aniko; Ekholm, Jan; Nilsson, Charlotte; Schult, Marie-Louise; Lofgren, Monika			Daily management of attention dysfunction two-four years after brain injury and early cognitive rehabilitation with attention process training: a qualitative study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Acquired brain injury; Cognitive rehabilitation; Attention dysfunction; Attention process training; Grounded theory	SELF-AWARENESS; SUBJECTIVE EXPERIENCE; FOLLOW-UP; DEFICITS; PEOPLE; STROKE; PARENT	The evaluation of intensive cognitive training is usually based on neuropsychological tests and questionnaires. A study of the subjective experience of cognitive training would provide another type of valuable information concerning the effects of rehabilitation. We used grounded theory methods to explore the experience and management of attention dysfunction in daily life two-four years after brain injury. Data were collected by in-depth interviews of 14 adults with moderate-to-mild attention dysfunction after stroke or traumatic brain injury, and working part time or full time at the time of the interviews. The group received 20 hours of attention process training within the context of multidisciplinary rehabilitation early after brain injury. Data were analysed by open coding with constant comparison. The management of attention dysfunction was described by the informants as a dynamic process where strategies are continuously refined and flexibly adjusted as awareness and metacognitive knowledge increases. This process is regulated by situation-dependent factors. Attention process training might provide a suitable starting point for the identification of problem areas, improved specific goalsetting and stimulated self-training. The model describes the dynamic nature of the process, the ongoing struggle, self-training and search for feedback.	[Markovic, Gabriela; Bartfai, Aniko; Ekholm, Jan; Schult, Marie-Louise; Lofgren, Monika] Karolinska Inst, Danderyd Univ Hosp, Dept Clin Sci, Stockholm, Sweden; [Markovic, Gabriela; Bartfai, Aniko; Nilsson, Charlotte; Schult, Marie-Louise; Lofgren, Monika] Danderyd Hosp, Dept Rehabil Med, Stockholm, Sweden		Markovic, G (corresponding author), Karolinska Inst, Danderyd Univ Hosp, Dept Clin Sci, Div Rehabil Med, SE-18288 Stockholm, Sweden.	gabriela.markovic@sll.se			Stiftelsen Promobilia [15077, 14125]; Stockholm County CouncilStockholm County Council [LS 1311-1460]; Department of Rehabilitation Medicine, Danderyd Hospital; Strokeforbundet	The study was supported by Stiftelsen Promobilia [grant numbers 15077 and 14125], the Stockholm County Council [grant number LS 1311-1460], the Department of Rehabilitation Medicine, Danderyd Hospital, and Strokeforbundet.	Audulv A, 2014, CHRONIC ILLN, V10, P192, DOI 10.1177/1742395313516133; Audulv A, 2016, J ADV NURS, V72, P2629, DOI 10.1111/jan.13037; Audulv A, 2010, PATIENT EDUC COUNS, V81, P94, DOI 10.1016/j.pec.2009.12.007; Bandura A, 2003, J APPL PSYCHOL, V88, P87, DOI 10.1037/0021-9010.88.1.87; Barker-Collo SL, 2010, TOP STROKE REHABIL, V17, P463, DOI 10.1310/tsr1706-463; Bartfai A, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-102; Ben-Yishay Y, 2000, REHABIL PSYCHOL, V45, P112, DOI 10.1037/0090-5550.45.2.112; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Charmaz K., 2003, HDB SOCIAL STUDIES H, P277; Chen CK, 2018, DEMENTIA-LONDON, V17, P61, DOI 10.1177/1471301216632963; Cicerone KD, 2012, ARCH PHYS MED REHAB, V93, P188, DOI 10.1016/j.apmr.2011.12.003; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Corbin J., 2012, BASICS QUALITATIVE R, V3rd; Dahlgren L, 2007, QUALITATIVE METHODOL; Difrancesco S, 2012, APHASIOLOGY, V26, P1317, DOI 10.1080/02687038.2012.705815; Edwards AR, 2014, BRAIN INJURY, V28, P1700, DOI 10.3109/02699052.2014.947633; Engle JA, 2011, J POPUL THER CLIN PH, V18, pE17; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P324, DOI 10.1006/ccog.2000.0449; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming J., 1995, BRIT J OCCUPATIONAL, V58, P55, DOI [https://doi.org/10.1177/030802269505800204, DOI 10.1177/030802269505800204]; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Haskins M. E., 2013, COGNITIVE REHABILITA; KAUFMAN SR, 1988, QUALITATIVE GERONTOL, P82; Lampinen J., 2003, SCANDINAVIAN J OCCUP, V10, P147, DOI DOI 10.1080/11038120310016580; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lexell J., 2012, Annals of Physical and Rehabilitation Medicine, V55, P577, DOI 10.1016/j.rehab.2012.08.006; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Loetscher T., COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002842, DOI 10.1002/14651858.CD002842]; Lundqvist A, 2010, BRAIN INJURY, V24, P823, DOI 10.3109/02699051003724986; Markovic G, 2017, BRAIN INJURY, V31, P9, DOI 10.1080/02699052.2016.1206213; McEwen SE, 2010, DISABIL REHABIL, V32, P540, DOI 10.3109/09638280903180189; Nilsson C, 2011, DISABIL REHABIL, V33, P969, DOI 10.3109/09638288.2010.528141; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Persson HC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181006; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Prigatano GP, 2011, TOP STROKE REHABIL, V18, P30, DOI 10.1310/tsr1801-30; Rath JF, 2011, REHABIL PSYCHOL, V56, P320, DOI 10.1037/a0025817; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Schacter D. L., 1991, AWARENESS DEFICIT BR, P258; Schunn CD, 2001, MEM COGNITION, V29, P254, DOI 10.3758/BF03194919; Shimamura AP, 2000, CONSCIOUS COGN, V9, P313, DOI 10.1006/ccog.2000.0450; Smeets SMJ, 2017, NEUROPSYCHOL REHABIL, V27, P116, DOI 10.1080/09602011.2015.1077144; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Turner BJ, 2008, AUST OCCUP THER J, V55, P96, DOI 10.1111/j.1440-1630.2007.00660.x; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Waters HS, 2006, ATTACH HUM DEV, V8, P185, DOI 10.1080/14616730600856016; Wilson BA, 2002, NEUROREHAB NEURAL RE, V16, P207, DOI 10.1177/0888439002016002003; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]	62	2	2	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 15	2020	30	3					523	544		10.1080/09602011.2018.1482770			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MB2FW	WOS:000542421300008	29947254	hybrid			2022-02-06	
J	Cohen, D; Bhushan, B; Hanks, R; Yoon, DP; Johnstone, B; Hunt, I				Cohen, Daniel; Bhushan, Braj; Hanks, Robin; Yoon, Dong Pil; Johnstone, Brick; Hunt, Issac			The right parietal lobe, sense of self, and empathy: cross-cultural, ethnic, and religious considerations	MENTAL HEALTH RELIGION & CULTURE			English	Article						Empathy; right parietal lobe; TBI; self; ethnicity; culture; religion	CEREBRAL-BLOOD-FLOW; PERSPECTIVE-TAKING; NEUROPSYCHOLOGICAL FOUNDATION; COGNITIVE FLEXIBILITY; BIOLOGICAL AFFECTS; NEURAL MECHANISMS; SOCIAL-BEHAVIOR; BRAIN; SELFLESSNESS; LESIONS	This study extends previous research where empathy associated with increased right parietal lobe (RPL) "self-orientation" and left hemisphere (LH) "other-orientation" by investigating different cultural (India, US), ethnic (African American, Caucasian, South Asian), and religious (Christian, Hindu, Muslim) groupings. Participants included 108 individuals with traumatic brain injury (TBI) and explored correlations between empathy and neuropsychological measures. Measures included neuropsychological indices of cerebral functional integrity (RPL, left frontal, left temporal) and self-report measures of affective and cognitive empathy. Pearson correlations showed increased RPL functioning positively and significantly associated with increased cognitive empathy for total, India, US, Christian, Muslim, African American, and South Asian samples. LH indices associated positively with both affective and cognitive empathy for US, Caucasian, and Christian participants. Contrary to hypotheses, indices of RPL functioning significantly but negatively associated with affective empathy for Indian, Muslim, and South Asian samples, possibly reflecting different conceptualisations of "self" in individualistic versus collectivist societies.	[Cohen, Daniel] Univ Missouri, Dept Religious Studies Arts & Sci 221, Columbia, MO 65211 USA; [Bhushan, Braj] Indian Inst Technol Kanpur, Dept Humanities & Social Sci, Kanpur, Uttar Pradesh, India; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Yoon, Dong Pil; Hunt, Issac] Univ Missouri, Sch Social Work, Columbia, MO USA; [Johnstone, Brick] Ft Belvoir Community Hosp, Intrepid Spirit Ctr, Ft Belvoir, VA USA		Cohen, D (corresponding author), Univ Missouri, Dept Religious Studies Arts & Sci 221, Columbia, MO 65211 USA.	cohenda@missouri.edu	Bhushan, Braj/B-1173-2008				Adams, 2009, NEUROPSYCHOLOGICAL A, P66; Barrett JL, 1996, COGNITIVE PSYCHOL, V31, P219, DOI 10.1006/cogp.1996.0017; Batson CD, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P3; BENTON A, 1975, NEUROLOGY, V25, P907, DOI 10.1212/WNL.25.10.907; Benton A., 1983, JUDGEMENT LINE ORIEN; Bird G, 2014, NEUROSCI BIOBEHAV R, V47, P520, DOI 10.1016/j.neubiorev.2014.09.021; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Blakemore SJ, 2003, CURR OPIN NEUROBIOL, V13, P219, DOI 10.1016/S0959-4388(03)00043-6; Blanke O, 2005, NEUROSCIENTIST, V11, P16, DOI 10.1177/1073858404270885; Bloom Paul., 2016, EMPATHY CASE RATIONA; Breen N, 2000, MIND LANG, V15, P74, DOI 10.1111/1468-0017.00124; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Buck R, 2002, PSYCHOL REV, V109, P739, DOI 10.1037//0033-295X.109.4.739; Cassels TG, 2010, J COGN CULT, V10, P309, DOI 10.1163/156853710X531203; Chiao JY, 2009, HUM BRAIN MAPP, V30, P2813, DOI 10.1002/hbm.20707; Cozolino L., 2006, NEUROSCIENCE HUMAN R; Crescentini C, 2015, NEUROPSYCHOLOGIA, V70, P71, DOI 10.1016/j.neuropsychologia.2015.02.016; Crescentini C, 2014, CORTEX, V54, P1, DOI 10.1016/j.cortex.2014.01.023; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Greck M, 2012, NEUROIMAGE, V59, P2871, DOI 10.1016/j.neuroimage.2011.09.052; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2009, MORAL BRAIN: ESSAYS ON THE EVOLUTIONARY AND NEUROSCIENTIFIC ASPECTS OF MORALITY, P109, DOI 10.1007/978-1-4020-6287-2_5; Delis DC., 2001, DELIS KAPLAN EXECUTI, P1; Devue C, 2011, CONSCIOUS COGN, V20, P40, DOI 10.1016/j.concog.2010.09.007; EISENBERG N, 1990, MOTIV EMOTION, V14, P131, DOI 10.1007/BF00991640; Feinberg T., 2005, LOST SELF PATHOLOGIE; Feinberg T. E., 2011, CONSCIOUSNESS COGNIT, V20; Fuller Torrey E., 2017, EVOLVING BRAINS EMER; Giordano A., 2014, J PROFESSIONAL COUNS, V41, P53, DOI DOI 10.1080/15566382.2014.12033938; Grant I., 2009, NEUROPSYCHOLOGICAL A; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; GRATTAN LM, 1994, NEUROPSY NEUROPSY BE, V7, P251; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Gray JR, 2002, PSYCHOL REV, V109, P729, DOI 10.1037//0033-295X.109.4.729; Gries P, 2012, J SCI STUD RELIG, V51, P623, DOI 10.1111/j.1468-5906.2012.01683.x; Hoffman, 1984, EMOTIONS COGNITION B; HOFFMAN M.L., 2000, EMPATHY MORAL DEV IM; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; Johnstone B., 2019, NEUROSCIENCE SPIRITU; Johnstone B., 1995, APPL NEUROPSYCHOL, V2, DOI [10.1207/s15324826an0201_4, DOI 10.1207/S15324826AN0201_4]; Johnstone B, 2017, MENT HEALTH RELIG CU, V20, P175, DOI 10.1080/13674676.2017.1333090; Johnstone B, 2016, INT J PSYCHOL RELIG, V26, P287, DOI 10.1080/10508619.2015.1118328; Johnstone B, 2016, J RELIG HEALTH, V55, P572, DOI 10.1007/s10943-015-0170-y; Johnstone B, 2015, RELIG BRAIN BEHAV, V5, P24, DOI 10.1080/2153599X.2014.880069; Johnstone B, 2015, NEUROPSYCHOLOGY, V29, P463, DOI 10.1037/neu0000155; Johnstone B, 2012, INT J PSYCHOL RELIG, V22, P267, DOI 10.1080/10508619.2012.657524; Johnstone B, 2008, ZYGON, V43, P861, DOI 10.1111/j.1467-9744.2008.00964.x; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lee KH, 2012, SOC COGN AFFECT NEUR, V7, P521, DOI 10.1093/scan/nsp001; Leigh R, 2013, BRAIN, V136, P2539, DOI 10.1093/brain/awt177; Levine R., 2016, STRANGER MIRROR SCI; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liew SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016901; Lindeman M, 2016, INT J PSYCHOL RELIG, V26, P185, DOI 10.1080/10508619.2015.1091695; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Ma-Kellams C, 2012, PERS SOC PSYCHOL B, V38, P933, DOI 10.1177/0146167212440291; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; MEADOR KJ, 1993, J CLIN EXP NEUROPSYC, V15, P832, DOI 10.1080/01688639308402599; Merriam-Webster Inc., 1995, MERRIAM WEBSTERS MED; Newberg A, 2003, PERCEPT MOTOR SKILL, V97, P625, DOI 10.2466/PMS.97.5.625-630; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Newberg A, 1997, J NUCL MED, V38, P77; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Penner L. A., 1995, ADV PERSONALITY ASSE, V10, P147, DOI DOI 10.4324/9781315806228; Prodan CI, 2001, NEUROPSY NEUROPSY BE, V14, P206; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Rankin KP, 2005, COGN BEHAV NEUROL, V18, P28, DOI 10.1097/01.wnn.0000152225.05377.ab; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Schjoedt U, 2009, METH THEORY STUD REL, V21, P310, DOI 10.1163/157006809X460347; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2014, CURR BIOL, V24, pR875, DOI 10.1016/j.cub.2014.06.054; SINHA JBP, 1982, DYNAM PSYCHIAT, V15, P148; Soto JA, 2009, EMOTION, V9, P874, DOI 10.1037/a0017399; Sui J, 2009, SOC NEUROSCI, V4, P402, DOI 10.1080/17470910802674825; Tranel D., 2002, HDB MEMORY DISORDERS; Tranel D, 2009, J CLIN EXP NEUROPSYC, V31, P219, DOI 10.1080/13803390802317542; TRIANDIS HC, 1989, PSYCHOL REV, V96, P506, DOI 10.1037/0033-295X.96.3.506; Wechsler D., 1997, WECHSLER MEMORY SCAL; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085; Zhu Y, 2002, SCI CHINA SER C, V45, P120, DOI 10.1360/02yc9014; Zhu Y, 2007, NEUROIMAGE, V34, P1310, DOI 10.1016/j.neuroimage.2006.08.047; Zuo X., 2013, CULTURE BRAIN, V1, P1, DOI DOI 10.1007/s40167-013-0002-4s	93	2	2	2	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1367-4676	1469-9737		MENT HEALTH RELIG CU	Ment. Health Relig. Cult.	MAY 27	2020	23	5					375	397		10.1080/13674676.2020.1725454		MAR 2020	23	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	NT6CH	WOS:000558538200001					2022-02-06	
J	Mu, J; Weng, JQ; Yang, CX; Guan, T; Deng, L; Li, MY; Zhang, GH; Kong, JM				Mu, Jiao; Weng, Jiequn; Yang, Chaoxian; Guan, Teng; Deng, Li; Li, Meiyu; Zhang, Guohui; Kong, Jiming			Necrostatin-1 prevents the proapoptotic protein Bcl-2/adenovirus E1B 19-kDa interacting protein 3 from integration into mitochondria	JOURNAL OF NEUROCHEMISTRY			English	Article						BNIP3; mitochondria; necroptosis; Necrostatin-1; neuron	FOCAL CEREBRAL-ISCHEMIA; BNIP3 UP-REGULATION; CELL-DEATH; ENDONUCLEASE-G; NEURONAL DEATH; AXONAL INJURY; TRANSLOCATION; INHIBITOR; HYPOXIA; AIF	Necrostatin-1 (Nec-1) has previously been shown to protect neurons from death in traumatic and ischemic brain injuries. This study tests the hypothesis that Nec-1 protects neural cells against traumatic and ischemic brain injuries through inhibition of the Bcl-2/adenovirus E1B 19-kDa interacting protein 3 (BNIP3). We have used biochemical and morphological techniques to determine the inhibition of Nec-1 on BNIP3-induced cell death and to identify its mechanism of action in in vivo and in vitro models of neurodegeneration. Here we show that Nec-1 significantly increased neuronal viability following prolonged exposure to hypoxia in vitro, and attenuated myelin damage and neuronal death in traumatic brain injury and cerebral ischemia in Sprague-Dawley rats. Nec-1 alleviated traumatic brain injury-induced up-regulation of BNIP3 in mature oligodendrocytes. In isolated mitochondria, Nec-1 prevented BNIP3 from integrating into mitochondria by modifying its binding sites on the mitochondria. Consequently, Nec-1 robustly inhibited BNIP3-induced collapse of mitochondrial membrane potential and reduced the opening probability of mitochondrial permeability transition pores. Nec-1 also preserved mitochondrial ultrastructure and suppressed BNIP3-induced nuclear translocation of apoptosis-inducing factor. In conclusion, Nec-1 protects neurons and oligodendrocytes against traumatic and ischemic brain injuries by targeting the BNIP3-induced cell death pathway, and is a novel inhibitor for BNIP3.	[Mu, Jiao; Li, Meiyu; Zhang, Guohui; Kong, Jiming] Hebei North Univ, Dept Forens Med, Zhangjiakou, Peoples R China; [Mu, Jiao; Weng, Jiequn; Yang, Chaoxian; Guan, Teng; Deng, Li; Kong, Jiming] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, 745 Bannatyne, Winnipeg, MB R3E 0J9, Canada; [Yang, Chaoxian; Deng, Li; Kong, Jiming] Southwest Med Univ, Preclin Med Res Ctr, Dept Neurobiol, Luzhou, Peoples R China		Kong, JM (corresponding author), Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, 745 Bannatyne, Winnipeg, MB R3E 0J9, Canada.	jiming.kong@umanitoba.ca		Kong, Jiming/0000-0002-2859-9831	Brain Canada/ALS Canada [45278]; Hebei Natural Science FoundationNatural Science Foundation of Hebei Province [H2017405021]; Joint Research Project of Luzhou Municipal Government and Southwest Medical University [2018LZXNYD-ZK35]	Brain Canada/ALS Canada, Grant/Award Number: 45278; Hebei Natural Science Foundation, Grant/Award Number: H2017405021; Joint Research Project of Luzhou Municipal Government and Southwest Medical University, Grant/Award Number: 2018LZXNYD-ZK35	Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Chang P, 2014, J MOL NEUROSCI, V52, P242, DOI 10.1007/s12031-013-0132-3; Chavez-Valdez R, 2012, NEUROSCIENCE, V219, P192, DOI 10.1016/j.neuroscience.2012.05.002; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen R, 2018, INT J MOL MED, V41, P2565, DOI 10.3892/ijmm.2018.3466; Chen YZ, 2018, NEUROSCIENCE, V371, P229, DOI 10.1016/j.neuroscience.2017.12.007; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2013, CELL DEATH DIFFER, V20, P366, DOI 10.1038/cdd.2012.133; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Lee BI, 2005, NEUROSCI LETT, V386, P23, DOI 10.1016/j.neulet.2005.05.058; Li CR, 2013, J NEUROCHEM, V127, P426, DOI 10.1111/jnc.12314; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lim SY, 2007, CARDIOVASC DRUG THER, V21, P467, DOI 10.1007/s10557-007-6067-6; Luan YG, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00285; Mu J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00217; Mu J, 2015, INT J CLIN EXP PATHO, V8, P4388; Prabhakaran K, 2007, NEUROSCIENCE, V150, P159, DOI 10.1016/j.neuroscience.2007.07.033; Qi YM, 2012, J CELL BIOL, V198, P103, DOI 10.1083/jcb.201111063; Rajapakse N, 2001, BRAIN RES PROTOC, V8, P176, DOI 10.1016/S1385-299X(01)00108-8; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Wang Y, 2015, NEUROSCIENCE, V289, P224, DOI 10.1016/j.neuroscience.2014.12.061; Wang Y, 2014, NEUROSCIENCE, V266, P91, DOI 10.1016/j.neuroscience.2014.02.007; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Xu XS, 2007, J NEUROCHEM, V103, P2004, DOI 10.1111/j.1471-4159.2007.04884.x; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113642; Zhang ZF, 2007, STROKE, V38, P1606, DOI 10.1161/STROKEAHA.106.475129; Zhao ST, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-113; Zhu S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.94	31	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAR	2021	156	6					929	942		10.1111/jnc.14993		MAR 2020	14	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	RG9BF	WOS:000563134300001	32112403				2022-02-06	
J	Muhla, F; Clanche, F; Duclos, K; Meyer, P; Maiaux, S; Colnat-Coulbois, S; Gauchard, GC				Muhla, Frederic; Clanche, Fabien; Duclos, Karine; Meyer, Philippe; Maiaux, Severine; Colnat-Coulbois, Sophie; Gauchard, Gerome C.			Impact of using immersive virtual reality over time and steps in the Timed Up and Go test in elderly people	PLOS ONE			English	Article							CENTER-OF-MASS; WALKING; FALLS; BALANCE; HEAD; LOCOMOTION; PREDICTOR; INJURIES; MOBILITY; BEHAVIOR	Today, falls constitute a substantial health problem, especially in the elderly, and the diagnostic tests used by clinicians present often a low sensitivity and specificity. This is the case for the Timed Up and Go test which lacks contextualization with regard to everyday life limiting the relevance of its diagnosis. Virtual reality enables the creation of immersive, reproducible and secure environments, close to situations encountered in daily life, and as such could improve falling risk assessment. This study aims to evaluate the effect of immersive virtual reality by wearing a virtual reality headset with a non-disturbing virtual environment compared to real world on the Timed Up and Go test completion. Thirty-one elders (73.7 +/- 9 years old) volunteered to participate in the study and the mean times and number of steps to complete a Timed Up and Go were compared in two conditions: actual-world clinical and virtual reality conditions. The results showed that the mean completion times and most of the mean number of steps of the Timed Up and Go in virtual reality condition were significantly different to those in clinical condition. These results suggest that there is a virtual reality effect and this effect is significantly correlated to the time taken to complete the Timed Up and Go. This information will be of interest to quantify the potential part of virtual reality effect on the motor control, measured in a virtual task using virtual controlled disturbances.	[Muhla, Frederic; Clanche, Fabien; Duclos, Karine; Gauchard, Gerome C.] Univ Lorraine, Fac Sport Sci, UFR STAPS, Villers Les Nancy, France; [Muhla, Frederic; Clanche, Fabien; Duclos, Karine; Gauchard, Gerome C.] Univ Lorraine, Fac Med, Dev Adaptat & Handicap, EA 3450,DevAH, Vandoeuvre Les Nancy, France; [Meyer, Philippe; Maiaux, Severine] OHS Ctr Florentin, Nancy, France; [Colnat-Coulbois, Sophie] CHU Nancy, CHRU Nancy Neurochirurg, Nancy, France		Gauchard, GC (corresponding author), Univ Lorraine, Fac Sport Sci, UFR STAPS, Villers Les Nancy, France.; Gauchard, GC (corresponding author), Univ Lorraine, Fac Med, Dev Adaptat & Handicap, EA 3450,DevAH, Vandoeuvre Les Nancy, France.	gerome.gauchard@univ-lorraine.fr		MUHLA, Frederic/0000-0003-4448-3027			[Anonymous], 2015, INSERM; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bouvier P., 2009, THESIS; Centre technique d'appui et de formation des Centres d'examens de sante, 2009, APPR COMP DIFF TESTS; Chihara T, 2018, APPL ERGON, V68, P204, DOI 10.1016/j.apergo.2017.11.016; DARGENTMOLINA P, 1995, REV EPIDEMIOL SANTE, V43, P72; Dunlap P, 2012, GAIT POSTURE, V35, P92, DOI 10.1016/j.gaitpost.2011.08.013; FERRANDEZ AM, 1990, EXP AGING RES, V16, P79, DOI 10.1080/07340669008251531; Fuchs P., 2016, CASQUES REALITE PRIM; Fuchs P, 2003, TRAITE PRIME RE PRIM; Gage WH, 2003, EXP BRAIN RES, V150, P385, DOI 10.1007/s00221-003-1468-7; HAS, 2012, REF CONC EV RISQ CHU; Ito K, 2019, LECT NOTES COMPUT SC, V11574, P450, DOI 10.1007/978-3-030-21607-8_35; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Kingma H, 2011, J VESTIBUL RES-EQUIL, V21, P117, DOI 10.3233/VES-2011-0397; Knight JF, 2007, HUM FACTORS, V49, P797, DOI 10.1518/001872007X230172; Lee J, 2013, PM&R, V5, P609, DOI 10.1016/j.pmrj.2013.04.001; Legters K, 2002, PHYS THER, V82, P264, DOI 10.1093/ptj/82.3.264; Leon C, 2014, COMPORTEMENTS SANTE; Li KZH, 2001, PSYCHOL SCI, V12, P230, DOI 10.1111/1467-9280.00341; Lord SR, 1996, AGE AGEING, V25, P292, DOI 10.1093/ageing/25.4.292; LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2; Mohr C, 2003, BEHAV NEUROSCI, V117, P1448, DOI 10.1037/0735-7044.117.6.1448; MORSE JM, 1989, CAN J AGING, V8, P366, DOI 10.1017/S0714980800008576; Paquette MR, 2008, EXP BRAIN RES, V190, P1, DOI 10.1007/s00221-008-1448-z; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Ricard C., 2007, Bulletin Epidemiologique Hebdomadaire, P322; Richard JB, 2013, REV EPIDEMIOL SANTE, V61, P205, DOI 10.1016/j.respe.2012.10.007; Rose T, 2018, APPL ERGON, V69, P153, DOI 10.1016/j.apergo.2018.01.009; Schubert T, 2001, PRESENCE-VIRTUAL AUG, V10, P266, DOI 10.1162/105474601300343603; Socie te Francaise de Documentation et de Recherche en Me decine Ge ne rale (SFDRMG), 2005, PREV CHUT ACC CHEZ P; Steed A, 1996, P IEEE VIRT REAL ANN, P163, DOI 10.1109/VRAIS.1996.490524; Taylor MJD, 2007, LATERALITY, V12, P50, DOI 10.1080/13576500600892745; Thigpen MT, 2000, PHYS THER, V80, P1174, DOI 10.1093/ptj/80.12.1174; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Vellas BJ, 1997, J AM GERIATR SOC, V45, P735, DOI 10.1111/j.1532-5415.1997.tb01479.x; WINTER DA, 1990, PHYS THER, V70, P340, DOI 10.1093/ptj/70.6.340; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Woollacott MH, 1997, PHYS THER, V77, P646, DOI 10.1093/ptj/77.6.646; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Yan Y, 2019, ADV INTELL SYST, V777, P239, DOI 10.1007/978-3-319-94706-8_27	45	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2020	15	3							e0229594	10.1371/journal.pone.0229594			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9AU	WOS:000535290100009	32168361	Green Published, gold			2022-02-06	
J	Olaoye, OA; Soeker, SM; Rhoda, A				Olaoye, Olumide Ayoola; Soeker, Shaheed Moghammad; Rhoda, Anthea			The development of a return to work intervention programme for stroke survivor (SReTWIP): a Delphi survey	BMC NEUROLOGY			English	Article						Stroke; Vocational rehabilitation; Return to work; Intervention; Programme; Cerebrovascular accident	EARLY VOCATIONAL-REHABILITATION; FACILITATORS; BARRIERS; CARE	BackgroundEven though clearly defined pathways for vocational re-entry are well recognized for conditions such as mental health, musculoskeletal dysfunction (MSD) and traumatic brain injury (TBI), none has been identified for stroke. There has been a lack of consensus regarding such clear pathways to vocational re-entry and the essential contents of return to work (RTW) interventions for stroke survivors. As part of a larger study aimed to design a RTW programme for stroke survivors, this study describes the concluding process through which Stroke Return to Work Intervention Programme (SReTWIP) was developed.MethodsExperts in the field of neurorehabilitation and vocational rehabilitation (VR) from 6 countries participated in this 3-round Delphi survey via e-mail. Concept mapping was used to triangulate findings from the Delphi with previous phases of the larger study. Content thematic analysis was conducted on qualitative data while descriptive statistic was used to analyze quantitative data.ResultsFifteen experts with a mean age and mean duration of practice of 44.739.48years and 18.26 +/- 8.71years respectively participated in this study. The developed RTW programme (SReTWIP) is a 12week programme that consisted of four interconnected phases of intervention viz.: an assessment phase, clinic-based work and non-work specific intervention phase, a work test placement phase and a client full participation in worker role phase. The experts agreed on a set of implementation strategies that included the use of interdisciplinary team, the tailoring of intervention to meet stroke survivor's need, as well as the use of case management approach.Conclusion p id=Par The SReTWIP is the first step in developing a VR pathway that can ultimately enhance the RTW rates and quick resumption of the worker role of stroke survivors. The stroke survivor can move along the different phases of the SReTWIP after achieving competency in a preceding phase. Future work will include a feasibility study with other key stakeholders involved in RTW such as employers, informal caregivers and stroke survivors before its implementation.	[Olaoye, Olumide Ayoola; Soeker, Shaheed Moghammad] Univ Western Cape, Fac Community & Hlth Sci, Dept Occupat Therapy, Cape Town, South Africa; [Olaoye, Olumide Ayoola] Obafemi Awolowo Univ, Dept Rehabil Med, Coll Hlth Sci, Ife, Nigeria; [Rhoda, Anthea] Univ Western Cape, Fac Community & Hlth Sci, Dept Physiotherapy, Cape Town, South Africa		Olaoye, OA (corresponding author), Univ Western Cape, Fac Community & Hlth Sci, Dept Occupat Therapy, Cape Town, South Africa.; Olaoye, OA (corresponding author), Obafemi Awolowo Univ, Dept Rehabil Med, Coll Hlth Sci, Ife, Nigeria.	mideolaoye@gmail.com			University of the Western Cape (UWC), Writing Fellowship Bursary; World Bank Robert S. McNamara Doctoral Fellowship; Nigerian Tertiary Education Trust fund (TETFund)	The writing of the manuscript was supported by the University of the Western Cape (UWC), Writing Fellowship Bursary. Research fellowship of OA was supported by the World Bank Robert S. McNamara Doctoral Fellowship. Financial support for the doctoral programme of OA was provided by the Nigerian Tertiary Education Trust fund (TETFund).	Alanko T, 2019, DISABIL REHABIL, V41, P2280, DOI 10.1080/09638288.2018.1463398; Arksey H., 2005, INT J SOC RES METHOD, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Cancelliere C, 2013, HDB WORK DISABILITY, P303; Clarke DJ, 2013, PROG NEUROL PSYCHIAT, V17, P5, DOI 10.1002/pnp.288; Clarke DJ, 2015, J MULTIDISCIP HEALTH, V8, P433, DOI 10.2147/JMDH.S68764; Clarke DJ, 2010, J INTERPROF CARE, V24, P285, DOI 10.3109/13561820903163645; Culler KH, 2011, TOP STROKE REHABIL, V18, P325, DOI 10.1310/tsr1804-325; DeJong G, 2004, ARCH PHYS MED REHAB, V85, P678, DOI 10.1016/j.apmr.2003.06.033; Delbecq A.L., 1975, GROUP TECHNIQUES PRO; Escorpizo R, 2010, J OCCUP REHABIL, V20, P502, DOI 10.1007/s10926-010-9241-9; Feigin VL, 2019, INT J STROKE, V14, P223, DOI 10.1177/1747493019832996; Fernandez M.E, 2016, PLANNING HLTH PROMOT; Finger ME, 2012, DISABIL REHABIL, V34, P429, DOI 10.3109/09638288.2011.608145; Harris R, 2013, INTERPROFESSIONAL TE; Hartigan I., 2012, BR J NEUROSCI NURS, V8, P65, DOI [10.12968/bjnn.2012.8.2.65, DOI 10.12968/BJNN.2012.8.2.65]; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Katan M, 2018, SEMIN NEUROL, V38, P208, DOI 10.1055/s-0038-1649503; Krupa T, 2015, HDB VOCATIONAL REHAB, P335; Levack WMM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009727.pub2; Lloyd Anna, 2018, JBI Database System Rev Implement Rep, V16, P1418, DOI 10.11124/JBISRIR-2017-003499; McCallin AM, 2009, NZ J PHYSIOTHER, V37, P62; [National Clinical Guideline for Stroke Physicians RCo], 2012, INTERCOLLEGIATE STRO; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Olaoye OA, 2019, J VOCAT REHABIL; Olaoye OA, 2019, HONG KONG J OCCUP TH; Plant S, 2018, CLIN REHABIL, V32, P263, DOI 10.1177/0269215517719485; Reeves J, 2010, PROFESSIONAL LEARNING AS RELATIONAL PRACTICE, P1, DOI 10.1007/978-90-481-8739-3_1; Rosewilliam S, 2011, CLIN REHABIL, V25, P501, DOI 10.1177/0269215510394467; Salkind NJ., 2010, ENCY RES DESIGN; Schwarz B, 2018, J OCCUP REHABIL, V28, P28, DOI 10.1007/s10926-017-9713-2; Soeker MS, 2012, WORK, V43, P313, DOI 10.3233/WOR-2012-1412; Solovieva TI, 2011, DISABIL HEALTH J, V4, P39, DOI 10.1016/j.dhjo.2010.03.001; Strauss A., 2008, BASICS QUALITATIVE R, DOI 10.1080/13504620500081384.; Sugavanam T, 2013, DISABIL REHABIL, V35, P177, DOI 10.3109/09638288.2012.690501; van Beurden KM, 2012, J OCCUP REHABIL, V22, P127, DOI 10.1007/s10926-011-9314-4; van Velzen JM, 2015, J VOCAT REHABIL, V42, P31, DOI 10.3233/JVR-140725; van Velzen JM, 2016, DISABIL REHABIL, V38, P62, DOI 10.3109/09638288.2015.1017057	37	2	2	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	MAR 13	2020	20	1								10.1186/s12883-020-01668-6			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KW5PK	WOS:000521217000001	32169033	Green Published, gold, Green Submitted			2022-02-06	
J	London, AS; Wilmoth, JM; Oliver, WJ; Hausauer, JA				London, Andrew S.; Wilmoth, Janet M.; Oliver, William J.; Hausauer, Jessica A.			The Influence of Military Service Experiences on Current and Daily Drinking	SUBSTANCE USE & MISUSE			English	Article						Military; veteran; alcohol; mental health; traumatic brain injury; self-medication	NATIONAL EPIDEMIOLOGIC SURVEY; ALCOHOL-RELATED PROBLEMS; MENTAL-HEALTH PROBLEMS; SELF-MEDICATION; SUBSTANCE USE; COMBAT EXPOSURE; HEAVY DRINKING; VETERANS; DUTY; VA	Background: An extensive public health literature associates military service with increased alcohol consumption and problematic drinking. However, few well-controlled population-based studies compare alcohol use among nonveterans and veterans with diverse military service experiences, and no such study examines everyday drinking. Methods: We use population-representative data from the 2010 and 2011 Behavioral Risk Factor Surveillance System and distinguish four groups of men: nonveterans; non-combat veterans without a psychiatric disorder (PD) or traumatic brain injury (TBI); combat veterans without a PD or TBI; and veterans (non-combat and combat combined) with a PD and/or TBI. We estimate hierarchical multivariate logistic regression models of current drinking (N = 21,947) and daily drinking (among current drinkers; N = 11,491). Results from supplemental analyses are discussed. Results: Relative to nonveterans, non-combat veterans with no PD or TBI and veterans with a PD and/or TBI, respectively, but not combat veterans with no PD or TBI, are more likely to be current drinkers. Among current drinkers, non-combat and combat veterans with no PD or TBI, respectively, are less likely than nonveterans to be daily drinkers. Conversely, among current drinkers, veterans with a PD and/or TBI are more likely to be daily drinkers than nonveterans, non-combat veterans with no PD or TBI, and combat veterans with no PD or TBI. Conclusion: We document heterogeneous and countervailing influences of military service experiences on current and daily drinking. Results indicate that harmful military service experience may be associated with an increased risk of current, moderate daily drinking, which may represent a form of self-medication.	[London, Andrew S.; Wilmoth, Janet M.] Syracuse Univ, Aging Studies Inst, Syracuse, NY USA; [Oliver, William J.; Hausauer, Jessica A.] Syracuse Univ, Maxwell Sch Citizenship & Publ Affairs, Dept Sociol, Syracuse, NY USA		London, AS (corresponding author), Syracuse Univ, Maxwell Sch Citizenship & Publ Affairs, Dept Sociol, Maxwell Deans Off, 200 Eggers Hall, Syracuse, NY 13244 USA.	anlondon@maxwell.syr.edu					Adams RS, 2013, SUBST USE MISUSE, V48, P821, DOI 10.3109/10826084.2013.797995; Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; Ames GM, 2007, J STUD ALCOHOL DRUGS, V68, P336, DOI 10.15288/jsad.2007.68.336; Ames Genevieve M, 2002, Prev Sci, V3, P135, DOI 10.1023/A:1015435401380; Armed Forces Health Surveillance Center, 2007, MED SURVEILLANCE MON, V14, P2; Belkin Aaron, 2012, BRING ME MEN MILITAR; Bohnert ASB, 2012, MIL MED, V177, P198, DOI 10.7205/MILMED-D-11-00270; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; BOSCARINO J, 1980, INT J SOC PSYCHIATR, V27, P204, DOI 10.1177/002076408102700307; Bray RM., 2003, 2002 DEP DEFENSE SUR; Bray RM., 2009, 2008 DEP DEFENSE SUR; Bray RM, 2007, ADDICTION, V102, P1092, DOI 10.1111/j.1360-0443.2007.01841.x; Bray RM, 2013, SUBST USE MISUSE, V48, P799, DOI 10.3109/10826084.2013.796990; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; BROSS ID, 1987, AM J EPIDEMIOL, V126, P1042, DOI 10.1093/oxfordjournals.aje.a114743; COCKERHAM WC, 2000, HDB MED SOCIOLOGY, V0005, P00159; Department of Defense, 2011, DOD INSTR 1015 10 MI; Foran HM, 2011, J CONSULT CLIN PSYCH, V79, P521, DOI 10.1037/a0024110; Gabe J., 2013, KEY CONCEPTS MED SOC, P53; GOLDBERG J, 1990, AM J PUBLIC HEALTH, V80, P570, DOI 10.2105/AJPH.80.5.570; Goodell H. E., 2018, J PREVENTIVE MED, V3, P1, DOI [10.21767/2572-5483.100028, DOI 10.21767/2572-5483.100028]; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Heltemes KJ, 2014, ADDICT BEHAV, V39, P392, DOI 10.1016/j.addbeh.2013.06.001; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hooper R, 2008, ADDICT BEHAV, V33, P1067, DOI 10.1016/j.addbeh.2008.03.010; Howren MB, 2012, APPL RES QUAL LIFE, V7, P83, DOI 10.1007/s11482-011-9147-5; Ingraham, 1984, BOYS BARRACKS OBSERV; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jakupcak M, 2010, ADDICT BEHAV, V35, P840, DOI 10.1016/j.addbeh.2010.03.023; Judd SE, 2011, INT J ENV RES PUB HE, V8, P1601, DOI 10.3390/ijerph8051601; Kanny D, 2018, AM J PREV MED, V54, P486, DOI 10.1016/j.amepre.2017.12.021; Landes SD, 2018, POPUL RES POLICY REV, V37, P517, DOI 10.1007/s11113-018-9468-2; Lazareck S, 2012, J CLIN PSYCHIAT, V73, pE588, DOI 10.4088/JCP.11m07345; Leeies M, 2010, DEPRESS ANXIETY, V27, P731, DOI 10.1002/da.20677; LONDON AS, 2014, J SOCIOL SOC WELFARE, V41, P49; Mansell D, 2006, J AMBUL CARE MANAG, V29, P61, DOI 10.1097/00004479-200601000-00007; Mattiko MJ, 2011, ADDICT BEHAV, V36, P608, DOI 10.1016/j.addbeh.2011.01.023; McDevitt-Murphy ME, 2015, ADDICT RES THEORY, V23, P148, DOI 10.3109/16066359.2014.949696; McKinney WP, 1997, PUBLIC HEALTH REP, V112, P212; Miech RA, 2013, SUBST USE MISUSE, V48, P837, DOI 10.3109/10826084.2013.800120; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Moore RS, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-17; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Nelson KM, 2007, PUBLIC HEALTH REP, V122, P93, DOI 10.1177/003335490712200113; Ramchand R, 2011, MIL PSYCHOL, V23, P6, DOI 10.1080/08995605.2011.534407; RANDALL M, 1987, MED CARE, V25, P1099, DOI 10.1097/00005650-198711000-00008; RICHARDS MS, 1989, AM J PUBLIC HEALTH, V79, P1011, DOI 10.2105/AJPH.79.8.1011; Robinson J, 2009, J ANXIETY DISORD, V23, P38, DOI 10.1016/j.janxdis.2008.03.013; Smith LL, 2017, J HEALTH CARE POOR U, V28, P113, DOI 10.1353/hpu.2017.0056; Spera C, 2011, J STUD ALCOHOL DRUGS, V72, P5, DOI 10.15288/jsad.2011.72.5; Stahre MA, 2009, AM J PREV MED, V36, P208, DOI 10.1016/j.amepre.2008.10.017; Substance Abuse and Mental Health Services Administration, 2001, DHHS PUBLICATION, VSMA 01 3549; Substance Abuse and Mental Health Services Administration, 2001, NHSDA H, VH-13; Substance Abuse and Mental Health Services Administration, 2005, ALC US ALC REL RISK; Teachman J, 2015, ARMED FORCES SOC, V41, P460, DOI 10.1177/0095327X14543848; Turner S, 2018, DEPRESS ANXIETY, V35, P851, DOI 10.1002/da.22771; Verges A, 2018, ALCOHOL CLIN EXP RES, V42, P1674, DOI 10.1111/acer.13812; Walton JL, 2018, AM J ADDICTION, V27, P23, DOI 10.1111/ajad.12658; Weg MWV, 2012, AM J ADDICTION, V21, P31, DOI 10.1111/j.1521-0391.2011.00191.x; Weil ZM, 2018, ALCOHOL RES-CURR REV, V39, P171; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Wilmoth JM., 2013, LIFE COURSE PERSPECT, P1, DOI [10.4324/9780203079744, DOI 10.4324/9780203079744]; Wolf D.A., 2013, LIFE COURSE PERSPECT, P254	63	2	2	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1082-6084	1532-2491		SUBST USE MISUSE	Subst. Use Misuse	MAY 1	2020	55	8					1288	1299		10.1080/10826084.2020.1735438		MAR 2020	12	Substance Abuse; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry; Psychology	LK6TW	WOS:000519723400001	32167849	Green Submitted			2022-02-06	
J	Allen, A; Grigorian, A; Christian, A; Schubl, SD; Barrios, C; Lekawa, M; Borazjani, B; Joe, V; Nahmias, J				Allen, Angela; Grigorian, Areg; Christian, Ashton; Schubl, Sebastian D.; Barrios, Cristobal, Jr.; Lekawa, Michael; Borazjani, Borris; Joe, Victor; Nahmias, Jeffry			Intracranial pressure monitors associated with increased venous thromboembolism in severe traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Intracranial pressure monitor; Venous thromboembolism; Prophylaxis	MOLECULAR-WEIGHT-HEPARIN; PROPHYLAXIS; MANAGEMENT; SAFETY	Background Utilization of intracranial pressure monitors (ICPMs) has not been consistently shown to improve mortality in patients with severe traumatic brain injury (TBI). A single-center analysis concluded that venous thromboembolism (VTE) chemoprophylaxis (CP) posed no significant bleeding risk in patients following ICPM implementation; however, there is still debate about the optimal use and timing of CP in patients with ICPMs for fear of worsening intracranial hemorrhage. We hypothesized that ICPM use is associated with increased time to VTE CP and thus increased VTE in patients with severe TBI. Methods A retrospective analysis of the Trauma Quality Improvement Program (2010-2016) was performed to compare severe TBI patients with and without ICPMs. A multivariable logistic regression analysis was completed. Results From 35,673 patients with severe TBI, 12,487 (35%) had an ICPM. Those with ICPMs had a higher rate of VTE CP (64.3% vs. 49.4%, p < 0.001) but a longer median time to CP initiation (5 vs. 4 days, p < 0.001) as well as a longer hospital length of stay (LOS) (18 vs. 9 days, p < 0.001) compared to those without ICPMs. After adjusting for covariates, ICPM use was found to be associated with a higher risk of VTE (9.2% vs 4.3%, OR = 1.75, CI = 1.42-2.15, p < 0.001). Conclusions Compared to patients without ICPMs, those with ICPMs had a longer delay to initiation of CP leading to an increase in VTE. In addition, there was a nearly two-fold higher associated risk for VTE in patients with ICPMs even when controlling for known VTE risk factors. Improved adherence to initiation of CP in the setting of ICPMs may help decrease the associated risk of VTE with ICPMs.	[Allen, Angela; Grigorian, Areg; Christian, Ashton; Schubl, Sebastian D.; Barrios, Cristobal, Jr.; Lekawa, Michael; Borazjani, Borris; Joe, Victor; Nahmias, Jeffry] Univ Calif Irvine, Dept Surg, 101 City Dr, S Orange, CA 92868 USA		Allen, A (corresponding author), Univ Calif Irvine, Dept Surg, 101 City Dr, S Orange, CA 92868 USA.	Allenam2@uci.edu; agrigori@uci.edu; ashtonbc@uci.edu; sschubl@uci.edu; cbarrios@uci.edu; melekawa@hs.uci.edu; bhborazj@uci.edu; vcjoe@uci.edu; jnahmias1@yahoo.com	Nahmias, Jeffry/ABA-1850-2020	Nahmias, Jeffry/0000-0003-0094-571X			ACS TQIP, 2015, BEST PRACT MAN TRAUM; Benjamin E, 2017, ANN SURG, V266, P463, DOI 10.1097/SLA.0000000000002359; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2013, NEW ENGL J MED, V369, P2465, DOI 10.1056/NEJMx130056; DeGrauw X, 2018, EPILEPSY RES, V146, P41, DOI 10.1016/j.eplepsyres.2018.07.012; Dengler BA, 2016, NEUROCRIT CARE, V25, P215, DOI 10.1007/s12028-016-0280-8; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Fried HI, 2016, NEUROCRIT CARE, V24, P61, DOI 10.1007/s12028-015-0224-8; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Hachem LD, 2018, CLIN NEUROL NEUROSUR, V175, P68, DOI 10.1016/j.clineuro.2018.09.032; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Jacobs BN, 2017, J TRAUMA ACUTE CARE, V83, P151, DOI 10.1097/TA.0000000000001494; Jamjoom AAB, 2013, J NEUROTRAUM, V30, P503, DOI 10.1089/neu.2012.2584; Kostic Aleksandar, 2011, Med Pregl, V64, P461; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450	20	2	2	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2021	47	5			SI		1483	1490		10.1007/s00068-020-01336-x		MAR 2020	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UW8UR	WOS:000532913900002	32157341	Bronze, Green Submitted, Green Published			2022-02-06	
J	Fong, DHC; Cohen, A; Boughton, P; Raftos, P; Herrera, JE; Simons, NG; Putrino, D				Fong, Daryl H. C.; Cohen, Adrian; Boughton, Philip; Raftos, Paul; Herrera, Joseph E.; Simons, Neil G.; Putrino, David			Steady-State Visual-Evoked Potentials as a Biomarker for Concussion: A Pilot Study	FRONTIERS IN NEUROSCIENCE			English	Article						concussion; sport; electroencephalography; SSVEP; football	BRAIN; DIAGNOSIS; FOOTBALL	A variety of assessment tools are currently available to help clinicians assess Sports Related Concussion (SRC). Currently, the most widely available tools are neither objective nor portable, and are therefore not ideal for assessment at the site and time of a suspected injury. A portable system was developed to deliver a measurement of the steady-state visual-evoked potential (SSVEP). This system involved a smartphone housed in a Google Cardboard frame, which delivered a 15-Hz flicker visual stimulus while an electroencephalography (EEG) headset recorded EEG signals. Sixty-five rugby union players were tested during their regular season and were stratified into healthy, concussed, and recovered groups based on clinical examination. Their SSVEP response was quantified into a signal-to-noise ratio (SNR). The SNRs of players in each study group were summarized. Additionally, the SNRs of individual players who had baseline, post-injury, and post-recovery readings were analyzed. Sixty-five participants completed a baseline evaluation to measure their SSVEP. Twelve of these participants sustained a medically diagnosed concussion and completed SSVEP re-testing within 72 h. Eight concussed players received follow-up SSVEP testing after recovery. Concussed participants had a lower SNR [2.20 (2.04-2.38)] when compared to their baseline [4.54 (3.79-5.10)]. When clinically recovered, participant SNR was not significantly different to their baseline [4.82 (4.13-5.18)]. The baseline SNRs of the players who experienced a concussion during the season were not different to those of players who did not experience a concussion [4.80 (4.07-5.68)]. This is the first study to identify differences in SSVEP responses in male amateur rugby union players with and without concussion. It is also the first SSVEP demonstration for concussion evaluation at point-of-care. SSVEPs are significantly attenuated in the presence of concussion in these male athletes. Individuals returned to their baseline SSVEP following clinical recovery from the concussive injury. The use of SSVEPs has the potential to be a supplemental aid for the assessment and management of concussion.	[Fong, Daryl H. C.; Boughton, Philip] Univ Sydney, Fac Engn & Informat Technol, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW, Australia; [Cohen, Adrian] Univ Sydney, Sydney Med Sch, Save Sight Inst, Sydney, NSW, Australia; [Raftos, Paul] Randwick Dist Rugby Union Football Club, Sydney, NSW, Australia; [Herrera, Joseph E.; Putrino, David] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Simons, Neil G.] Univ Sydney, Northern Clin Sch, Sydney, NSW, Australia		Fong, DHC (corresponding author), Univ Sydney, Fac Engn & Informat Technol, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW, Australia.	dfon4556@uni.sydney.edu.au					Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Bey T, 2009, WEST J EMERG MED, V10, P6; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Dreyer AM, 2015, J NEUROSCI METH, V241, P1, DOI 10.1016/j.jneumeth.2014.12.004; Drislane FW., 2007, CLIN NEUROPHYSIOL, P461, DOI [10.1007/978-1-59745-271-7_25, DOI 10.1007/978-1-59745-271-7_25]; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Galloway N, 1990, BRIT J OPHTHALMOL, V74, P255, DOI DOI 10.1136/BJO.74.4.255-A; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Graham R., 2014, SPORTS RELATED CONCU, P336; Handy TC, 2005, EVENT RELATED POTENT; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Kothari R, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/9852194; Kus R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077536; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Liu Y., 2012, 2012 IEEE INT C VIRT; Luck S. J., 2011, OXFORD HDB EVENT REL; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; Norcia AM, 2015, J VISION, V15, DOI 10.1167/15.6.4; Partridge B, 2015, NEUROETHICS-NETH, V8, P39, DOI 10.1007/s12152-014-9217-0; Peterson DJ, 2014, NEUROPSYCHOLOGIA, V63, P145, DOI 10.1016/j.neuropsychologia.2014.08.020; Phurailatpam J., 2014, J MED SOC, V28, P140; Poltavski D, 2017, OPTOMETRY VISION SCI, V94, P742, DOI 10.1097/OPX.0000000000001094; Ragan BG, 2009, ATHLETIC TRAIN SPORT, V1, P180; Rugby Australia, 2018, CONC PROC; Semyon M, 2014, CONCUSSIONS ATHLETIC; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; Yadav NK, 2015, BRAIN INJURY, V29, P352, DOI 10.3109/02699052.2014.979229	34	2	2	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAR 10	2020	14								171	10.3389/fnins.2020.00171			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LC0ZS	WOS:000525059300001	32210749	gold, Green Published			2022-02-06	
J	Garcia, GGP; Lavieri, MS; Jiang, RW; McCrea, MA; McAllister, TW; Broglio, SP				Garcia, Gian-Gabriel P.; Lavieri, Mariel S.; Jiang, Ruiwei; McCrea, Michael A.; McAllister, Thomas W.; Broglio, Steven P.			Data-driven stochastic optimization approaches to determine decision thresholds for risk estimation models	IISE TRANSACTIONS			English	Article						Data-driven optimization; stochastic programming; distributionally robust optimization; quantile estimation; diagnosis decisions; risk estimation models	CONCUSSION ASSESSMENT; SCREENING STRATEGIES; RECURRENT CONCUSSION; COLORECTAL-CANCER; DIAGNOSTIC-TESTS; HIGH-SCHOOL; CARE; GUIDELINES; PROGNOSIS; INFORMATION	The increasing availability of data has popularized risk estimation models in many industries, especially healthcare. However, properly utilizing these models for accurate diagnosis decisions remains challenging. Our research aims to determine when a risk estimation model provides sufficient evidence to make a positive or negative diagnosis, or if the model is inconclusive. We formulate the Two-Threshold Problem (TTP) as a stochastic program which maximizes sensitivity and specificity while constraining false-positive and false-negative rates. We characterize the optimal solutions to TTP as either two-threshold or one-threshold and show that its optimal solution can be derived from a related linear program (TTP*). We also derive utility-based and multi-class classification frameworks for which our analytical results apply. We solve TTP* using data-driven methods: quantile estimation (TTP*-Q) and distributionally robust optimization (TTP*-DR). Through simulation, we characterize the feasibility, optimality, and computational burden of TTP*-Q and TTP*-DR and compare TTP*-Q to an optimized single threshold. Finally, we apply TTP* to concussion assessment data and find that it achieves greater accuracy at lower misclassification rates compared with traditional approaches. This data-driven framework can provide valuable decision support to clinicians by identifying "easy" cases which can be diagnosed immediately and "hard" cases which may require further evaluation before diagnosing.	[Garcia, Gian-Gabriel P.; Lavieri, Mariel S.; Jiang, Ruiwei] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Res, Milwaukee, WI 53226 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA		Garcia, GGP (corresponding author), Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA.	garciagg@umich.edu		Garcia, Gian-Gabriel/0000-0001-9315-0195	National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [DGE 1256260]; National Science FoundationNational Science Foundation (NSF) [CMMI-1662774]; Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium; National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE 1256260. This work has also been supported by National Science Foundation under Grant no. CMMI-1662774. This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the author(s) and are not necessarily endorsed by the Department of Defense (DHP funds).	Ahsen ME, 2019, INFORM SYST RES, V30, P97, DOI 10.1287/isre.2018.0789; Alagoz O., 2011, WILEY ENCY OPERATION; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS99, DOI 10.2337/dc16-S016; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; ANDERSON KM, 1991, BIOMETRICS, V47, P281, DOI 10.2307/2532512; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Ayer T, 2016, MANAGE SCI, V62, P1339, DOI 10.1287/mnsc.2015.2180; Ayer T, 2012, OPER RES, V60, P1019, DOI 10.1287/opre.1110.1019; Ayvaci MUS, 2012, M&SOM-MANUF SERV OP, V14, P600, DOI 10.1287/msom.1110.0371; Ayvaci MUS, 2017, PROD OPER MANAG, V26, P1333, DOI 10.1111/poms.12679; Barnett CL, 2017, MED DECIS MAKING, V37, P815, DOI 10.1177/0272989X17696996; Bayati M, 2018, STAT METHODS MED RES, V27, P2312, DOI 10.1177/0962280216680242; Bertsimas D, 2018, HEALTH CARE MANAG SC, V21, P105, DOI 10.1007/s10729-016-9381-3; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; de Vries C. G., 1997, J EMPIR FINANC, V4, P241, DOI DOI 10.1016/S0927-5398(97)00008-X; Degeling K, 2017, EXPERT REV PHARM OUT, V17, P17, DOI 10.1080/14737167.2017.1273110; DENEEF P, 1993, MED DECIS MAKING, V13, P126, DOI 10.1177/0272989X9301300206; Deo S, 2015, M&SOM-MANUF SERV OP, V17, P191, DOI 10.1287/msom.2014.0512; Deo S, 2015, OPER RES, V63, P287, DOI 10.1287/opre.2015.1353; Ebell M, 2010, MED DECIS MAKING, V30, P712, DOI 10.1177/0272989X10386232; El-Amine H, 2018, OPER RES, V66, P1, DOI 10.1287/opre.2017.1658; Erenay FS, 2014, M&SOM-MANUF SERV OP, V16, P381, DOI 10.1287/msom.2014.0484; Esfahani PM, 2018, MATH PROGRAM, V171, P115, DOI 10.1007/s10107-017-1172-1; Felder S, 2014, MED DECIS MAKING, V34, P33, DOI 10.1177/0272989X13493969; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; GLASZIOU P, 1986, MED DECIS MAKING, V6, P161, DOI 10.1177/0272989X8600600306; Godbole S, 2004, LECT NOTES ARTIF INT, V3056, P22; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P; Gunes ED, 2015, PROD OPER MANAG, V24, P1, DOI 10.1111/poms.12206; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; HARRELL FE, 1982, BIOMETRIKA, V69, P635; HARTZ A, 1986, MED DECIS MAKING, V6, P145, DOI 10.1177/0272989X8600600303; Helm JE, 2015, OPER RES, V63, P979, DOI 10.1287/opre.2015.1405; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Jacobson SH, 2016, PREV MED, V88, P33, DOI 10.1016/j.ypmed.2016.03.018; Jonasson JO, 2017, OPER RES, V65, P1479, DOI 10.1287/opre.2017.1646; Jund J, 2005, MED DECIS MAKING, V25, P406, DOI 10.1177/0272989X05276855; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lee E, 2015, HEALTH CARE MANAG SC, V18, P363, DOI 10.1007/s10729-014-9304-0; Li Y, 2014, EUR J OPER RES, V238, P313, DOI 10.1016/j.ejor.2014.03.004; Maillart LM, 2008, OPER RES, V56, P1411, DOI 10.1287/opre.1080.0614; MANGASARIAN OL, 1995, OPER RES, V43, P570, DOI 10.1287/opre.43.4.570; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01034; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McGregor M, 2006, PHARMACOECONOMICS, V24, P947, DOI 10.2165/00019053-200624100-00002; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mclay LA, 2010, HEALTH CARE MANAG SC, V13, P294, DOI 10.1007/s10729-010-9131-x; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 1997, MED DECIS MAKING, V17, P447, DOI 10.1177/0272989X9701700410; NEASE RF, 1989, MED DECIS MAKING, V9, P91, DOI 10.1177/0272989X8900900204; Nord E, 2009, VALUE HEALTH, V12, pS10, DOI 10.1111/j.1524-4733.2009.00516.x; Odetola FO, 2016, ANN AM THORAC SOC, V13, P671, DOI 10.1513/AnnalsATS.201507-401OC; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; PAUKER SG, 1975, NEW ENGL J MED, V293, P229, DOI 10.1056/NEJM197507312930505; Peck JS, 2012, ACAD EMERG MED, V19, pE1045, DOI 10.1111/j.1553-2712.2012.01435.x; Perk J, 2012, INT J BEHAV MED, V19, P403, DOI 10.1007/s12529-012-9242-5; Pierskalla W. P., 1994, HDB OPERATIONS RES M, V6, P469, DOI [10.1016/S0927- 0507(05)80094-5., DOI 10.1016/S0927-0507(05)80094-5]; Read J, 2011, MACH LEARN, V85, P333, DOI 10.1007/s10994-011-5256-5; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Schell GJ, 2014, OPHTHALMOLOGY, V121, P1539, DOI 10.1016/j.ophtha.2014.02.021; Shapiro A, 2009, LECT STOCHASTIC PROG; Shapiro DE, 1999, STAT METHODS MED RES, V8, P113, DOI 10.1191/096228099666928387; Sheppard JW, 2005, IEEE T INSTRUM MEAS, V54, P1003, DOI 10.1109/TIM.2005.847351; Si B, 2017, IISE T HEALTHC SYST, V4, P248; SOMOZA E, 1992, MED DECIS MAKING, V12, P179, DOI 10.1177/0272989X9201200303; Tejada JJ, 2015, IIE TRANS, V47, P600, DOI 10.1080/0740817X.2014.959671; Teng Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1975-z; Tschandl P, 2019, LANCET ONCOL, V20, P938, DOI 10.1016/S1470-2045(19)30333-X; van Giessen A, 2018, J CLIN EPIDEMIOL, V94, P122, DOI 10.1016/j.jclinepi.2017.09.020; VERMONT J, 1991, COMPUT METH PROG BIO, V35, P141, DOI 10.1016/0169-2607(91)90072-2; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; Weise K, 2006, RADIAT PROT DOSIM, V121, P52, DOI 10.1093/rpd/ncl095; Xue Y, 2019, ARTIF INTELL MED, V95, P27, DOI 10.1016/j.artmed.2018.08.004; Yang Y, 2013, MANAGE SCI, V59, P782, DOI 10.1287/mnsc.1120.1587; Yao YY, 2016, EUR J OPER RES, V251, P904, DOI 10.1016/j.ejor.2015.08.053; Yao YY, 2010, INFORM SCIENCES, V180, P341, DOI 10.1016/j.ins.2009.09.021; Zhang JY, 2012, M&SOM-MANUF SERV OP, V14, P529, DOI 10.1287/msom.1120.0388; Zhang M. L., 2010, KDD 10, P999, DOI DOI 10.1145/1835804.1835930; Zhang ML, 2018, FRONT COMPUT SCI-CHI, V12, P191, DOI 10.1007/s11704-017-7031-7; Zhu YK, 2016, MED DECIS MAKING, V36, P973, DOI 10.1177/0272989X15618658; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265; Zufferey D, 2015, COMPUT BIOL MED, V65, P34, DOI 10.1016/j.compbiomed.2015.07.017	95	2	2	3	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2472-5854	2472-5862		IISE TRANS	IISE Trans.	OCT 2	2020	52	10					1098	1121		10.1080/24725854.2020.1725254		MAR 2020	24	Engineering, Industrial; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Operations Research & Management Science	MR4NR	WOS:000519870700001					2022-02-06	
J	Kornblith, E; Abrams, G; Chen, AJW; Burciaga, J; D'Esposito, M; Novakovic-Agopian, T				Kornblith, Erica; Abrams, Gary; Chen, Anthony J. -W.; Burciaga, Joaquin; D'Esposito, Mark; Novakovic-Agopian, Tatjana			Impact of baseline neurocognitive functioning on outcomes following rehabilitation of executive function training for veterans with history of traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Executive function; rehabilitation; traumatic brain injury	COGNITIVE REHABILITATION; BEHAVIOR; PREDICTORS; DEPLOYMENT; VALIDITY; WAR	Traumatic brain injury (TBI) is common among Veterans, and sequelae frequently include deficits in attention and executive function and problems with emotional regulation. Although rehabilitation has been shown to be effective, it is not clear how patient characteristics such as baseline cognitive status may impact response to rehabilitation in this sample. Explore the relationship between baseline neuropsychological status and postintervention functional outcomes in Veterans with chronic TBI. Thirty-three Veterans with chronic mild-severe TBI completed a neuropsychological evaluation, a functional assessment of executive function (EF), and measures of emotional and everyday functioning pre- and post-EF training or control training. Performance on baseline neuropsychological measures was used to cluster participants. Participants' performance at baseline and postintervention assessments was compared by cluster using multivariate analyses of variance (MANOVAs). Cognitive Difficulty (CD; n = 19) and Cognitively Normal (CN; n = 14) clusters were identified. CD was characterized by z <= -.75 on neuropsychological measures of overall attention/EF, working memory, and memory. CD participants performed worse on functional EF assessment and endorsed more PTSD symptoms and community integration problems, at baseline. CD participants improved post-EF training, but not control training, on neuropsychological and functional measures. CN participants did not show statistically significant improvement. For Veterans with chronic TBI, cognitive assessment can aid in identifying functional impairment and assist treatment planning. Cognitive rehabilitation training appears to be a beneficial treatment option for TBI patients with cognitive, emotional, and daily living difficulties.	[Kornblith, Erica; Burciaga, Joaquin] SFVA Med Ctr, San Francisco, CA USA; [Abrams, Gary] Univ Calif San Francisco, SFVA Med Ctr, Neurol Serv, San Francisco, CA 94143 USA; [Chen, Anthony J. -W.] Univ Calif San Francisco, VA Northern Calif Hlth Care Syst, San Francisco, CA 94143 USA; [D'Esposito, Mark] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Novakovic-Agopian, Tatjana] Univ Calif San Francisco, SFVA Med Ctr, San Francisco, CA 94143 USA		Kornblith, E; Novakovic-Agopian, T (corresponding author), 4150 Clement St, San Francisco, CA 94121 USA.	erica.kornblith@va.gov; tatjana.novakovic-agopian@va.gov		KORNBLITH, ERICA/0000-0002-2802-7454	Department of Veterans Affairs Rehabilitation Research & Development Service Merit Review Awards (VANCHCS Project) [B7467I, VA 1IO1RX001111-01A1]; VA Office of Academic Affiliation Interprofessional TBI/Polytrauma Rehabilitation Research Fellowship	This material is based upon work supported by the Department of Veterans Affairs Rehabilitation Research & Development Service Merit Review Awards (VANCHCS Project #B7467I and VA 1IO1RX001111-01A1) and the VA Office of Academic Affiliation Interprofessional TBI/Polytrauma Rehabilitation Research Fellowship.	Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; Bajo A, 2002, BRAIN INJURY, V16, P385, DOI 10.1080/02699050110119826; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cattran C, 2011, J CLIN EXP NEUROPSYC, V33, P672, DOI 10.1080/13803395.2010.550603; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Delis DC., 2001, DELIS KAPLAN EXECUTI; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Heaton R. K., 2004, REVISED COMPREHENSIV; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IBM CorpReleased, 2015, IBM SPSS STAT WIND V; Ivins BJ, 2006, NEUROEPIDEMIOLOGY, V27, P154, DOI 10.1159/000096127; Kelland DZ, 1996, ARCH CLIN NEUROPSYCH, V11, P339, DOI 10.1016/0887-6177(95)00032-1; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Makowski D, 2015, GERIATR PSYCHOL NEUR, V13, P301, DOI 10.1684/pnv.2015.0561; Malec J., 2005, MAYO PORTLAND ADAPTA; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; McNair P. M., 1981, POMS MANUAL 2; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Nezu AM., 1989, PROBLEM SOLVING THER; Novakovic-Agopian T., 2011, GOAL ORIENTED ATTENT; Novakovic-Agopian T, 2018, J NEUROTRAUM, V35, P2784, DOI 10.1089/neu.2017.5529; Novakovic-Agopian T, 2014, J HEAD TRAUMA REHAB, V29, P136, DOI 10.1097/HTR.0b013e3182691b15; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Reiber GE, 2010, J REHABIL RES DEV, V47, P275, DOI 10.1682/JRRD.2010.01.0009; Robertson LJ, 1996, BRIT J OCCUPATIONAL, V59, P178; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Schweizer TA, 2008, NEUROREHAB NEURAL RE, V22, P72, DOI 10.1177/1545968307305303; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Stuss DT, 1988, CLIN NEUROPSYCHOL, V2, P246, DOI [DOI 10.1080/13854048808520107, 10.1080/13854048808520107]; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Turner G. R., GOAL ORIENTED UNPUB; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Veterans Affairs/Department of Defense, 2016, CLIN PRACT GUID MAN; Weathers F.W., 1994, PTSD CHECKLIST MILIT; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	62	2	2	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 3	2020	27	2					108	120		10.1080/23279095.2018.1490738			13	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	KS3JZ	WOS:000518208000002	30295554				2022-02-06	
J	Silver, IA; Nedelec, JL				Silver, Ian A.; Nedelec, Joseph L.			Traumatic brain injury and adverse psychological effects: Examining a potential pathway to aggressive offending	AGGRESSIVE BEHAVIOR			English	Article						adverse psychological effects; aggressive offending; traumatic brain injury	JUVENILE-OFFENDERS; VIOLENCE; ANXIETY; DEPRESSION; SYMPTOMS; PREVALENCE; DISORDER; STRESS; DELINQUENCY; ADOLESCENCE	Contemporary scholarship has demonstrated an association between traumatic brain injury (TBI) during adolescence and aggressive offending. Research, however, has yet to identify any mechanisms linking TBI to subsequent aggressive offending. Consequently, the current study hypothesized that adverse psychological effects is one such pathway. The current study used the Pathways to Desistance data set (n = 416) to examine the pathway of TBI to aggressive offending through adverse psychological effects. The findings of the structural equation model supported the hypothesized association. Specifically, increased exposure to TBI was indirectly associated with aggressive offending through adverse psychological effects. An additional supplemental analysis illustrated that a direct link between TBI and aggressive offending did not exist for the analytical sample. The findings suggested that the neurological disruptions commonly associated with TBI could result in direct increases in negative psychological outcomes and indirect increases in subsequent negative behavioral outcomes.	[Silver, Ian A.] Univ Cincinnati, Correct Inst, Cincinnati, OH 45221 USA; [Nedelec, Joseph L.] Univ Cincinnati, Dept Criminal Justice, Cincinnati, OH USA		Silver, IA (corresponding author), Univ Cincinnati, Correct Inst, Cincinnati, OH 45221 USA.	Ian.Silver@uc.edu		Silver, Ian/0000-0001-8233-4378	Office of Juvenile Justice and Delinquency Prevention [2007-MU-FX-0002]; National Institute of Justice [2008-IJ-CX-0023]; John D. and Catherine T. MacArthur Foundation; William T. Grant Foundation; Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF); William Penn Foundation; Center for Disease Control; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA019697]; Pennsylvania Commission on Crime and Delinquency; Arizona Governor's Justice Commission	The project described was supported by funds from the following: Office of Juvenile Justice and Delinquency Prevention (2007-MU-FX-0002), National Institute of Justice (2008-IJ-CX-0023), John D. and Catherine T. MacArthur Foundation, William T. Grant Foundation, Robert Wood Johnson Foundation, William Penn Foundation, Center for Disease Control, National Institute on Drug Abuse (R01DA019697), Pennsylvania Commission on Crime and Delinquency, and the Arizona Governor's Justice Commission. The content of the article is the sole responsibility of the authors and does not necessarily represent the official views of these agencies. We are grateful for their support, and any errors or omissions are ours alone. The current study did not receive any support from these grants.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bandura A, 1996, J PERS SOC PSYCHOL, V71, P364, DOI 10.1037/0022-3514.71.2.364; Beaver KM, 2017, CRIME DELINQUENCY, V63, P708, DOI 10.1177/0011128715573617; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Birkley EL, 2015, CLIN PSYCHOL REV, V37, P40, DOI 10.1016/j.cpr.2015.01.002; Bollen KA., 1990, SOCIOL METHODOL, V20, P115, DOI DOI 10.2307/271084; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Byrne B.M., 2016, STRUCTURAL EQUATION, V3rd; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Chitsabesan P, 2015, J HEAD TRAUMA REHAB, V30, P106, DOI 10.1097/HTR.0000000000000129; Darrell-Berry H, 2016, SCHIZOPHR RES, V172, P169, DOI 10.1016/j.schres.2016.02.009; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Douglas KS, 2009, PSYCHOL BULL, V135, P679, DOI 10.1037/a0016311; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Forth A. E., 2003, HARE PSYCHOPATHY CHE; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Goodwin RD, 2004, AM J PSYCHIAT, V161, P88, DOI 10.1176/appi.ajp.161.1.88; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; GRAY JA, 1987, J RES PERS, V21, P493, DOI 10.1016/0092-6566(87)90036-5; Hodgins S, 2011, J FORENSIC PSYCHI PS, V22, P669, DOI 10.1080/14789949.2011.617539; Hosseini SH, 2012, IRAN RED CRESCENT ME, V14, P345; Howard R, 2015, BORDER PERS DIS EMOT, V2, DOI 10.1186/s40479-015-0033-x; HUIZINGA D, 1991, J CRIM LAW CRIM, V82, P83, DOI 10.2307/1143790; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Kline RB., 2011, PRINCIPLES PRACTICE, V3; Kofler MJ, 2011, J CONSULT CLIN PSYCH, V79, P458, DOI 10.1037/a0024108; Kotov R, 2017, J ABNORM PSYCHOL, V126, P454, DOI 10.1037/abn0000258; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McIsaac Kathryn E, 2016, CMAJ Open, V4, pE746, DOI 10.9778/cmajo.20160072; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McLaughlin KA, 2014, J ABNORM PSYCHOL, V123, P13, DOI 10.1037/a0035358; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mulvey Edward P, 2004, Youth Violence Juv Justice, V2, P213, DOI 10.1177/1541204004265864; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Paternoster R, 1997, J QUANT CRIMINOL, V13, P231, DOI 10.1007/BF02221092; Patrick ME, 2016, ADDICT BEHAV, V58, P110, DOI 10.1016/j.addbeh.2016.02.025; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Raposa EB, 2016, CLIN PSYCHOL SCI, V4, P691, DOI 10.1177/2167702615611073; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Russell TD, 2016, PERS INDIV DIFFER, V99, P340, DOI 10.1016/j.paid.2016.05.029; Rydon-Grange M, 2015, CNS SPECTRUMS, V20, P463, DOI 10.1017/S109285291500053X; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schubert Carol A, 2004, Youth Violence Juv Justice, V2, P237, DOI 10.1177/1541204004265875; Schwartz JA, 2021, JUSTICE Q, V38, P196, DOI 10.1080/07418825.2019.1599044; Schwartz JA, 2019, CURR OPIN PSYCHOL, V27, P67, DOI 10.1016/j.copsyc.2018.09.006; Schwartz JA, 2017, J RES CRIME DELINQ, V54, P869, DOI 10.1177/0022427817710287; Selner-O'Hagan MB, 1998, J CHILD PSYCHOL PSYC, V39, P215, DOI 10.1017/S002196309700187X; Silver IA, 2020, BRAIN INJURY, V34, P375, DOI 10.1080/02699052.2020.1723166; Sobel ME., 1982, SOCIOLOGICAL METHODO, V13, P290, DOI DOI 10.2307/270723; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; Stoddard SA, 2011, PEDIATRICS, V127, P1074, DOI 10.1542/peds.2010-2453; Van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd ed.; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Veeh CA, 2018, PSYCHOL CRIME LAW, V24, P1016, DOI 10.1080/1068316X.2018.1497632; WEINBERGER DA, 1990, J PERS, V58, P381, DOI 10.1111/j.1467-6494.1990.tb00235.x; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613	65	2	2	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0096-140X	1098-2337		AGGRESSIVE BEHAV	Aggressive Behav.	MAY	2020	46	3					254	265		10.1002/ab.21886		MAR 2020	12	Behavioral Sciences; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychology	KZ7YB	WOS:000517622000001	32124999				2022-02-06	
J	Uccella, L; Bongetta, D; Fumagalli, L; Raffa, G; Zoia, C				Uccella, Laura; Bongetta, Daniele; Fumagalli, Luca; Raffa, Giovanni; Zoia, Cesare			Acute alcohol intoxication as a confounding factor for mild traumatic brain injury	NEUROLOGICAL SCIENCES			English	Article						Adult brain injury; Alcohol and drug abuse; CT scanning; Alcohol; Head trauma		Background Acute alcohol intoxication is universally considered a risk factor for traumatic brain injury (TBI), therefore an indication for head CT scan. There is no evidence in the literature for this attitude. Aim of this study is to assess the need for head CT scan in acutely alcohol-intoxicated subjects with mTBI and the role of Glasgow coma scale (GCS) score in this kind of patients. Methods We retrospectively analyzed all 3358 consecutive patients presenting to our department in Switzerland, with TBI as chief complaint between January 2014 and January 2018. Results Alcohol was a statistically significant factor for presentation with a GCS score lower than 15. As for bleedings in mild TBI patients, the results were somewhat contradictory with GCS 15 patients showing a higher percentage of hemorrhages than GCS 14 patients. By dividing alcohol-intoxicated subjects into groups per blood alcohol concentration, the higher was the alcohol level, the lower the GCS score. Conclusions We can affirm that GCS score is underestimated in acutely intoxicated head trauma patients. In this kind of patient, alcohol is a confounding factor and mild TBI could be safely managed by watchful waiting.	[Uccella, Laura; Fumagalli, Luca] Osped Civico, Surg & Emergency Dept, Lugano, Switzerland; [Bongetta, Daniele] ASST Fatebenefratelli Sacco, Dept Neurosurg, Milan, Italy; [Raffa, Giovanni] Univ Messina, BIOMORF Dept, Div Neurosurg, Messina, Italy; [Zoia, Cesare] Fdn IRCCS Policlin San Matteo, Neurosurg Dept, Pavia, Italy		Zoia, C (corresponding author), Fdn IRCCS Policlin San Matteo, Neurosurg Dept, Pavia, Italy.	gioiaoffice@gmail.com	uccella, laura/ABD-2621-2021; Zoia, Cesare/B-8463-2015; Zoia, Cesare/ABE-5286-2020; Raffa, Giovanni/K-7972-2016	uccella, laura/0000-0002-5401-8703; Zoia, Cesare/0000-0001-7304-6120; Zoia, Cesare/0000-0001-7304-6120; Raffa, Giovanni/0000-0001-8623-4964			Anandalwar SP, 2016, J NEUROSURG, V125, P667, DOI 10.3171/2015.9.JNS151379; [Anonymous], 2014, NICE GUIDELINES HEAD; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Granata RT, 2017, AM J EMERG MED, V35, P51, DOI 10.1016/j.ajem.2016.09.069; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; JURKOVICH GJ, 1992, ANN EMERG MED, V21, P704, DOI 10.1016/S0196-0644(05)82783-0; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Shaw BA, 2011, J AGING HEALTH, V23, P207, DOI 10.1177/0898264310381276; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vonghia L, 2008, EUR J INTERN MED, V19, P561, DOI 10.1016/j.ejim.2007.06.033; Yost DA, 2002, POSTGRAD MED, V112, P14, DOI 10.3810/pgm.2002.12.1361	15	2	2	0	1	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	AUG	2020	41	8					2127	2134		10.1007/s10072-020-04313-9		MAR 2020	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MN9HP	WOS:000518063600004	32125539				2022-02-06	
J	Sterpka, A; Yang, J; Strobel, M; Zhou, YX; Pauplis, C; Chen, XM				Sterpka, Ashley; Yang, Juan; Strobel, Matthew; Zhou, Yuxin; Pauplis, Connor; Chen, Xuanmao			Diverged morphology changes of astrocytic and neuronal primary cilia under reactive insults	MOLECULAR BRAIN			English	Article						Primary cilia; Astrocytes; Arl13b; AC3; Traumatic brain injury; Epilepsy	LINEAGE SPECIFICITY; GTPASE ARL13B; MOUSE-BRAIN; CELL-CYCLE; SEIZURES; MICE; LOCALIZATION; ASTROGLIOSIS; TRAFFICKING; CENTROSOMES	Primary cilia are centriole-derived sensory organelles that are present in most mammalian cells, including astrocytes and neurons. Evidence is emerging that astrocyte and neuronal primary cilia demonstrate a dichotomy in the mature mouse brain. However, it is unknown how astrocytic and neuronal primary cilia change their morphology and ciliary proteins when exposed to reactive insults including epilepsy and traumatic brain injury. We used a double transgenic mouse strain (Arl13b-mCherry; Centrin2-GFP), in which we found spontaneous seizures, and a cortical injury model to examine the morphological changes of astrocytic and neuronal primary cilia under reactive conditions. Transgenic overexpression of Arl13b drastically increases the length of astrocytic and neuronal primary cilia in the hippocampus, as well as the cilia lengths of cultured astrocytes and neurons. Spontaneous seizures shorten Arl13b-positive astrocytic cilia and AC3-positive neuronal cilia in the hippocampus. In a cortical injury model, Arl13b is not detectable in primary cilia, but Arl13b protein relocates to the cell body and has robust expression in the proximity of injured tissues. In contrast, the number of AC3-positive cilia near injured tissues remains unchanged, but their lengths become shorter. These results on astrocytic cilia implicate Arl13b in regulating astrocyte proliferation and tissue regeneration, while the shortening of AC3-positive cilia suggests adaptive changes of neuronal primary cilia under excitotoxicity.	[Sterpka, Ashley; Yang, Juan; Strobel, Matthew; Zhou, Yuxin; Pauplis, Connor; Chen, Xuanmao] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Coll Life Sci & Agr, 389 Rudman Hall,46 Coll Rd, Durham, NH 03824 USA		Chen, XM (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Coll Life Sci & Agr, 389 Rudman Hall,46 Coll Rd, Durham, NH 03824 USA.	Xuanmao.Chen@unh.edu		Chen, Xuanmao/0000-0002-0057-8510	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21MH105746, K01AG054729, P20GM113131-7006]; Cole Neuroscience and Behavioral Faculty Research Awards; UNH Summer TA Research Fellowships	This study was supported by National Institutes of Health Grants R21MH105746, K01AG054729, and P20GM113131-7006 to X.C.; Cole Neuroscience and Behavioral Faculty Research Awards to X.C.; and UNH Summer TA Research Fellowships to A.S., J.Y., M.S., and Y.Z.	Alvarez-Satta M, 2018, THER ADV MED ONCOL, V10, DOI 10.1177/1758835918801169; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Anvarian Z, 2019, NAT REV NEPHROL, V15, P199, DOI 10.1038/s41581-019-0116-9; Babu D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130052; BALASINGAM V, 1994, J NEUROSCI, V14, P846; Bangs FK, 2015, NAT CELL BIOL, V17, P113, DOI 10.1038/ncb3091; Bay SN, 2018, P NATL ACAD SCI USA, V115, P1570, DOI 10.1073/pnas.1706977115; Bernet A, 2018, HUM REPROD, V33, P1829, DOI 10.1093/humrep/dey276; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Bose A, 2019, J BIOSCI, V44; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Chen XM, 2016, BIOL PSYCHIAT, V80, P836, DOI 10.1016/j.biopsych.2015.12.012; Chen XM, 2012, J NEUROSCI, V32, P15769, DOI 10.1523/JNEUROSCI.2180-12.2012; Chen XM, 2010, NEUROPHARMACOLOGY, V58, P1045, DOI 10.1016/j.neuropharm.2010.01.011; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Delaval B, 2011, CELL CYCLE, V10, P3964, DOI 10.4161/cc.10.22.18150; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Farrell JS, 2017, ADV NEUROBIOL, V15, P317, DOI 10.1007/978-3-319-57193-5_12; Ge WP, 2016, NEUROSCIENCE, V323, P3, DOI 10.1016/j.neuroscience.2015.08.057; Goelz MF, 1998, LAB ANIM SCI, V48, P34; Guadiana SM, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00127; Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024; Heussler HS, 2002, ARCH DIS CHILD, V86, P293, DOI 10.1136/adc.86.4.293; Higginbotham H, 2012, DEV CELL, V23, P925, DOI 10.1016/j.devcel.2012.09.019; Jakel S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00024; Kasaharaa K, 2014, ACTA MED OKAYAMA, V68, P317; Kim YK, 2013, ACTA HISTOCHEM, V115, P789, DOI 10.1016/j.acthis.2013.03.005; Kirschen Gregory W, 2017, Front Biol (Beijing), V12, P124, DOI 10.1007/s11515-017-1447-1; Koemeter-Cox AI, 2014, P NATL ACAD SCI USA, V111, P10335, DOI 10.1073/pnas.1403286111; Kohnken RA, 2016, COMPARATIVE MED, V66, P105; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Li KY, 2019, AGING DIS, V10, P664, DOI 10.14336/AD.2018.0720; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Loskutov YV, 2018, ONCOGENE, V37, P1457, DOI 10.1038/s41388-017-0049-3; Malicki JJ, 2017, TRENDS CELL BIOL, V27, P126, DOI 10.1016/j.tcb.2016.08.002; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Mariani L, 2016, STOR DONNE, P13; MIYAKE T, 1988, BRAIN RES, V451, P133, DOI 10.1016/0006-8993(88)90757-3; Mullee LI, 2016, CHROMOSOME RES, V24, P35, DOI 10.1007/s10577-015-9503-7; Myster DL, 2000, CURR BIOL, V10, pR302, DOI 10.1016/S0960-9822(00)00435-8; Nozaki S, 2017, J CELL SCI, V130, P563, DOI 10.1242/jcs.197004; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Pal K, 2015, DEV NEUROBIOL, V75, P337, DOI 10.1002/dneu.22193; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Phelan KD, 2015, EPILEPSY RES, V117, P90, DOI 10.1016/j.eplepsyres.2015.09.008; Phua SC, 2019, CELL, V178, P261, DOI 10.1016/j.cell.2019.06.015; Qiu Liyan, 2016, Int J Physiol Pathophysiol Pharmacol, V8, P95; Rossi AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078516; Reyes RC, 2012, ASN NEURO, V4, P33, DOI 10.1042/AN20110059; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roy K, 2017, J BIOL CHEM, V292, P17703, DOI 10.1074/jbc.M117.792937; Schiweck J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00261; Schou KB, 2015, EMBO REP, V16, P1099, DOI 10.15252/embr.201540530; Silva-Fernandes A, 2010, SCAND J LAB ANIM SCI, V37, P213; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sterpka A, 2018, PHARMACOL RES, V137, P114, DOI 10.1016/j.phrs.2018.10.002; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Vaisse C, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028217; Valente EM, 2014, NAT REV NEUROL, V10, P27, DOI 10.1038/nrneurol.2013.247; Van Erum J, 2019, EPILEPSY BEHAV, V95, P51, DOI 10.1016/j.yebeh.2019.02.029; Veland IR, 2014, BIOSCIENCE, V64, P1115, DOI 10.1093/biosci/biu179; Wang HJ, 2018, INT J IMMUNOPATH PH, V31, DOI 10.1177/2058738418801406; Wang WJ, 2011, J CELL BIOL, V193, P727, DOI 10.1083/jcb.201101109; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Ying GX, 2014, J NEUROSCI, V34, P6377, DOI 10.1523/JNEUROSCI.0067-14.2014; Zhang SQ, 2017, EXP THER MED, V14, P1905, DOI 10.3892/etm.2017.4760	78	2	2	2	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1756-6606		MOL BRAIN	Mol. Brain	MAR 2	2020	13	1							28	10.1186/s13041-020-00571-y			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KW3NI	WOS:000521073300001	32122360	Green Published, gold			2022-02-06	
J	Williamson, T; Ryser, MD; Abdelgadir, J; Lemmon, M; Barks, MC; Zakare, R; Ubel, PA				Williamson, Theresa; Ryser, Marc D.; Abdelgadir, Jihad; Lemmon, Monica; Barks, Mary Carol; Zakare, Rasheedat; Ubel, Peter A.			Surgical decision making in the setting of severe traumatic brain injury: A survey of neurosurgeons	PLOS ONE			English	Article							DECOMPRESSIVE CRANIECTOMY; PROGNOSTIC MODELS; VALIDATION; RECOVERY	Background Surgical decision-making in severe traumatic brain injury (TBI) is complex. Neurosurgeons weigh risks and benefits of interventions that have the potential to both maximize the chance of recovery and prolong suffering. Inaccurate prognostication can lead to over- or underestimation of outcomes and influence treatment recommendations. Objective To evaluate the impact of evidence-based risk estimates on neurosurgeon treatment recommendations and prognostic beliefs in severe TBI. Methods In a survey-based randomized experiment, a total of 139 neurosurgeons were presented with two hypothetical patient with severe TBI and subdural hematoma; the intervention group received additional evidence-based risk estimates for each patient. The main outcome was neurosurgeon treatment recommendation of non-surgical management. Secondary outcomes included prediction of functional recovery at six months. Results In the first patient scenario, 22% of neurosurgeons recommended non-surgical management and provision of evidence-based risk estimates increased the propensity to recommend non-surgical treatment (odds ratio [OR]: 2.81, 95% CI: 1.21-6.98; p = 0.02). Neurosurgeon prognostic beliefs of 6-month functional recovery were variable in both control (median 20%, IQR: 10%-40%) and intervention (30% IQR: 10%-50%) groups and neurosurgeons were less likely to recommend non-surgical management when they believed prognosis was favorable (odds ratio [OR] per percentage point increase in 6-month functional recovery: 0.97, 95% confidence interval [CI]: 0.95-0.99). The results for the second patient scenario were qualitatively similar. Conclusions Our findings show that the provision of evidence-based risk predictions can influence neurosurgeon treatment recommendations and prognostication, but the effect is modest and there remains large variability in neurosurgeon prognostication.	[Williamson, Theresa; Abdelgadir, Jihad] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27708 USA; [Ryser, Marc D.] Duke Univ, Dept Populat Hlth Sci, Med Ctr, Durham, NC USA; [Ryser, Marc D.; Zakare, Rasheedat; Ubel, Peter A.] Duke Univ, Duke Sch Med, Durham, NC USA; [Ryser, Marc D.] Duke Univ, Dept Math, Durham, NC USA; [Lemmon, Monica] Duke Univ, Dept Pediat, Med Ctr, Durham, NC USA; [Lemmon, Monica] Duke Margolis Ctr Hlth Policy, Durham, NC USA; [Barks, Mary Carol; Ubel, Peter A.] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA		Williamson, T (corresponding author), Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27708 USA.	theresa.williamson@duke.edu		Barks, Mary/0000-0002-3060-5524; williamson, theresa/0000-0002-5036-8597			BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Collaborators M.C.T., 2008, ONLINE 1; Corso P, 2015, INJURY PREV, V21, P432, DOI [10.1136/injuryprev-2015-041862, 10.1136/ip.2005.010983rep]; Finkelstein EA., 2007, J EPIDEMIOL COMMUNIT, V61, P926, DOI DOI 10.1136/JECH.2007.059717; Giacino J.P., 2018, NEUROLOGY; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; Kwok A., 2011, INTENSITY VARIATION, V15; Letsinger J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183552; Lilley E., 2017, JAMA SURG; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCFARLAND SG, 1981, PUBLIC OPIN QUART, V45, P208, DOI 10.1086/268651; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Souter M., 2015, NEUROCRITICAL CARE; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wabi R, 2018, J NEUROSURG, P1	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0228947	10.1371/journal.pone.0228947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8JT	WOS:000535245300012	32119677	Green Published, gold			2022-02-06	
J	Andelic, N; Forslund, MV; Perrin, PB; Sigurdardottir, S; Lu, J; Howe, EI; Sveen, U; Rasmussen, MS; Soberg, HL; Roe, C				Andelic, Nada; Forslund, Marit, V; Perrin, Paul B.; Sigurdardottir, Solrun; Lu, Juan; Howe, Emilie, I; Sveen, Unni; Rasmussen, Mari S.; Soberg, Helene L.; Roe, Cecilie			LONG-TERM FOLLOW-UP OF USE OF THERAPY SERVICES FOR PATIENTS WITH MODERATE-TO-SEVERE TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; rehabilitation; health services; longitudinal study; physical therapy; occupational therapy; speech therapy	1ST 5 YEARS; HEALTH-CARE; MULTIPLE INJURIES; REHABILITATION; TRAJECTORIES; DISABILITY; OUTCOMES; NEEDS	Objectives: To examine the probabilities and base-line predictors of the use of physical therapy, occupational therapy and speech therapy over a period of 10 years after traumatic brain injury. Design: Longitudinal prospective follow-up at 1, 2, and 10 years after traumatic brain injury. Participants: A total of 97 patients with moderate-to-severe traumatic brain injury recruited from Oslo University Hospital, Norway, during acute hospital admission in 2005-2007. Methods: Socio-demographics and injury characteristics were recorded at baseline. Use of physical therapy, occupational therapy and speech therapy were recorded at follow-ups. Hierarchical linear modelling was applied to examine service use probabilities across the 4 time-points. Results: Service use decreased substantially over time, with physical therapy being the main service utilized at the 10-year follow-up (physical therapy 16%, occupational therapy 1%, speech therapy 3%). Use of services was related to severity of injury (CT head severity scores and post-traumatic amnesia), female sex, and pre-injury employment. In addition, in this sample, time since injury was associated with use of occupational therapy and speech therapy. Conclusion: This study presents a novel model for the long-term probability of use of physical therapy, occupational therapy and speech therapy following traumatic brain injury. The use of services was much lower than the expected problem profile of severe traumatic brain injuries, suggesting an insufficient long-term provision of traditional traumatic brain injury rehabilitation services.	[Andelic, Nada; Forslund, Marit, V; Howe, Emilie, I; Sveen, Unni; Rasmussen, Mari S.; Soberg, Helene L.; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Andelic, Nada; Howe, Emilie, I; Rasmussen, Mari S.; Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Sigurdardottir, Solrun] Oslo Univ Hosp, Ctr Rare Disorders, Oslo, Norway; [Lu, Juan] Virginia Commonwealth Univ, Div Epidemiol, Dept Family Med & Populat Hlth, Richmond, VA USA; [Sveen, Unni; Soberg, Helene L.] Oslo Metropolitan Univ, Fac Hlth Sci, Oslo, Norway		Forslund, MV (corresponding author), Oslo Univ Hosp Ulleval, Dept Phys Med & Rehabil, Kirkeveien 166, Oslo 0450, Norway.	mavfor@ous-hf.no		Lu, Juan/0000-0002-5389-7603	Department of Physical Medicine and Rehabilitation, Oslo University Hospital; Institute of Health and Society; CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo	The authors would like to thank the patients for their participation. Special thanks to Nini Hammergren for assistance with patient registrations during the first 2 years post-injury, and Tone Jerstad, neuroradiologist, for the CT assessments. This study was funded by the Department of Physical Medicine and Rehabilitation, Oslo University Hospital, and by The Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo.	Andelic N, 2015, J NEUROL, V262, P523, DOI 10.1007/s00415-014-7595-1; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Callender L, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0828-z; Cnossen MC, 2017, J REHABIL MED, V49, P395, DOI 10.2340/16501977-2216; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; Desiron HAM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-615; Eliacin J, 2018, BRAIN INJURY, V32, P1510, DOI 10.1080/02699052.2018.1499964; Forslund MV, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00219; Forslund MV, 2017, BRAIN INJURY, V31, P329, DOI 10.1080/02699052.2016.1255778; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Hart T, 2019, ARCH PHYS MED REHAB, V100, P987, DOI 10.1016/j.apmr.2018.11.018; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Howe EI, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01051; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Kjeldsberg M, 2013, SCAND J PRIM HEALTH, V31, P36, DOI 10.3109/02813432.2012.751697; Laursen B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001521; Lu J, 2018, J NEUROTRAUM, V35, P1596, DOI 10.1089/neu.2017.5299; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Phillips VL, 2004, J HEAD TRAUMA REHAB, V19, P217, DOI 10.1097/00001199-200405000-00003; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Putman K, 2009, J REHABIL MED, V41, P646, DOI 10.2340/16501977-0385; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Stenberg M, 2013, J REHABIL MED, V45, P792, DOI 10.2340/16501977-1200; Ta'eed G, 2015, NEUROPSYCHOL REHABIL, V25, P841, DOI 10.1080/09602011.2014.990043; TEASDALE G, 1974, LANCET, V2, P81; Toor GK, 2016, ARCH PHYS MED REHAB, V97, pS54, DOI 10.1016/j.apmr.2015.02.010; Tverdal CB, 2018, J REHABIL MED, V50, P505, DOI 10.2340/16501977-2332; Uniform Data System for Medical Rehabilitation, 1996, GUID UN DAT SET MED; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X	39	2	2	0	1	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAR	2020	52	3							jrm00034	10.2340/16501977-2662			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	LK8GT	WOS:000531099000012	32179933	Green Published, gold			2022-02-06	
J	Arca, KN; Starling, AJ; Acierno, MD; Demaerschalk, BM; Marks, L; O'Carroll, CB				Arca, Karissa N.; Starling, Amaal J.; Acierno, Marie D.; Demaerschalk, Bart M.; Marks, Lisa; O'Carroll, Cumara B.			Is King-Devick Testing, Compared With Other Sideline Screening Tests, Superior for the Assessment of Sports-related Concussion? A Critically Appraised Topic	NEUROLOGIST			English	Article						concussion; mild traumatic brain injury; sideline; King-Devick test; evidence-based medicine; critically appraised topic	AMATEUR RUGBY UNION; AUTONOMIC DYSFUNCTION; NEUROLOGIC FUNCTION; YOUTH FOOTBALL; BASE-LINE; TOOL; LEAGUE; RISK	Background: Concussion affects almost 4 million individuals annually. There are many sideline screening tools available to assist in the detection of sports-related concussion. The King-Devick (K-D) test in association with Mayo Clinic utilizes rapid number naming to test saccadic eye movements in order to screen for concussion. An ideal screening tool for concussion would correctly identify all athletes with active concussion. The accuracy of K-D testing compared with other sideline screening tools is undetermined. Objective: To critically assess current evidence regarding the utility of K-D testing as a sideline screening tool for acute concussion and compare K-D testing to other sideline concussion assessments. Methods: The objective was addressed through the development of a critically appraised topic that included a clinical scenario, structured question, literature search strategy, critical appraisal, assessment of results, evidence summary, commentary, and bottom-line conclusions. Participants included consultant and resident neurologists, a medical librarian, clinical epidemiologists, and content experts in the field of concussion neurology and neuro-ophthalmology. Results: A recent meta-analysis was selected for critical appraisal. Cohorts analyzing athletes with sports-related concussion were selected, and utilized K-D testing as the main baseline and sideline assessment of concussion. K-D testing was found to have a high sensitivity and specificity for detecting concussion when there was worsening from baseline. Conclusion: K-D testing has high sensitivity and specificity for detecting sideline concussion. Compared with other sideline screening tools that do not include vision testing, it has greater accuracy. Screening for concussion is optimized when multiple testing modalities are used in conjunction.	[Arca, Karissa N.; Starling, Amaal J.; Demaerschalk, Bart M.; O'Carroll, Cumara B.] Mayo Clin, Dept Neurol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA; [Acierno, Marie D.] Mayo Clin, Dept Ophthalmol, Scottsdale, AZ USA; [Marks, Lisa] Mayo Clin, Dept Lib Serv, Scottsdale, AZ USA		Arca, KN (corresponding author), Mayo Clin, Dept Neurol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	arca.karissa@mayo.edu			Migraine Research Funding; Mayo Clinic	A.J.S.: Consulting fees: Alder, Amgen, eNeura, Eli Lilly & Company, Impel, Lundbeck, Novartis. Research America, and Medscape. Research funding: Migraine Research Funding, and Mayo Clinic Intramural funding.	American Academy of Neurology, SPORTS CONC RES; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 2012, MILITARY ACUTE CONCU; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; Dhawan PS, 2017, NEUROL-CLIN PRACT, V7, P464, DOI 10.1212/CPJ.0000000000000381; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Duenas M, 2014, SURG NEUROL INT, V5, P91, DOI DOI 10.4103/2152-7806.134364; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Galetta K, 2016, CONCUSSION, V1, P1; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; La Fountaine MF, 2018, INT J PSYCHOPHYSIOL, V132, P155, DOI 10.1016/j.ijpsycho.2017.11.016; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; Middleton K, 2010, CLIN J SPORT MED, V20, P491, DOI 10.1097/JSM.0b013e3181fac088; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Vargas BB, 2017, NEUROLOGY, V88, P1580, DOI 10.1212/WNL.0000000000003841	35	2	2	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1074-7931			NEUROLOGIST	Neurologist	MAR	2020	25	2					33	37		10.1097/NRL.0000000000000268			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LB2ZL	WOS:000524506800005	32132498				2022-02-06	
J	Avola, D; Cinque, L; Pannone, D				Avola, Danilo; Cinque, Luigi; Pannone, Daniele			Design of a 3D Platform for Immersive Neurocognitive Rehabilitation	INFORMATION			English	Article						neurocognitive rehabilitation; immersive serious games; human-computer interaction		In recent years, advancements in human-computer interaction (HCI) have enabled the development of versatile immersive devices, including Head-Mounted Displays (HMDs). These devices are usually used for entertainment activities as video-gaming or augmented/virtual reality applications for tourist or learning purposes. Actually, HMDs, together with the design of ad-hoc exercises, can also be used to support rehabilitation tasks, including neurocognitive rehabilitation due to strokes, traumatic brain injuries, or brain surgeries. In this paper, a tool for immersive neurocognitive rehabilitation is presented. The tool allows therapists to create and set 3D rooms to simulate home environments in which patients can perform tasks of their everyday life (e.g., find a key, set a table, do numerical exercises). The tool allows therapists to implement the different exercises on the basis of a random mechanism by which different parameters (e.g., objects position, task complexity) can change over time, thus stimulating the problem-solving skills of patients. The latter aspect plays a key role in neurocognitive rehabilitation. Experiments obtained on 35 real patients and comparative evaluations, conducted by five therapists, of the proposed tool with respect to the traditional neurocognitive rehabilitation methods highlight remarkable results in terms of motivation, acceptance, and usability as well as recovery of lost skills.	[Avola, Danilo; Cinque, Luigi; Pannone, Daniele] Sapienza Univ, Dept Comp Sci, I-00198 Rome, Italy; [Avola, Danilo; Cinque, Luigi; Pannone, Daniele] Sapienza Univ, Comp Vis Lab VisionLab, I-00198 Rome, Italy; [Avola, Danilo] Sapienza Univ, Dept Commun & Social Res, I-00198 Rome, Italy		Avola, D; Cinque, L; Pannone, D (corresponding author), Sapienza Univ, Dept Comp Sci, I-00198 Rome, Italy.; Avola, D; Cinque, L; Pannone, D (corresponding author), Sapienza Univ, Comp Vis Lab VisionLab, I-00198 Rome, Italy.; Avola, D (corresponding author), Sapienza Univ, Dept Commun & Social Res, I-00198 Rome, Italy.	avola@di.uniroma1.it; cinque@di.uniroma1.it; pannone@di.uniroma1.it	Pannone, Daniele/ABD-2058-2021		MIUR under grant "Departments of Excellence 2018-2022" of the Department of Computer Science of Sapienza University	This work was supported in part by the MIUR under grant "Departments of Excellence 2018-2022" of the Department of Computer Science of Sapienza University.	Arunnehru J, 2018, PROCEDIA COMPUT SCI, V133, P471, DOI 10.1016/j.procs.2018.07.059; Avola D, 2018, INTEL SYST REF LIBR, V145, P7, DOI 10.1007/978-3-319-73891-8_2; Avola D., 2009, P IADIS INT C WWW IN, P400; Avola D., 2017, P 2017 14 IEEE INT C, P1; Avola D, 2008, LECT NOTES BUS INF P, V5, P405; Avola D, 2019, LECT NOTES COMPUT SC, V11679, P470, DOI 10.1007/978-3-030-29891-3_41; Avola D, 2020, MULTIMED TOOLS APPL, V79, P4463, DOI 10.1007/s11042-019-7196-1; Avola D, 2019, MULTIMED TOOLS APPL, V78, P5919, DOI 10.1007/s11042-018-6875-7; Avola D, 2020, IEEE T SYST MAN CY-S, V50, P2139, DOI 10.1109/TSMC.2018.2804766; Avola D, 2019, J BIOMED INFORM, V89, P81, DOI 10.1016/j.jbi.2018.11.012; Avola D, 2018, MULTIMED TOOLS APPL, V77, P24955, DOI 10.1007/s11042-018-5730-1; Avola D, 2017, PATTERN RECOGN LETT, V100, P110, DOI 10.1016/j.patrec.2017.10.029; Avola D, 2017, PATTERN RECOGN LETT, V96, P96, DOI 10.1016/j.patrec.2016.10.015; Avola D, 2014, LECT NOTES COMPUT SC, V8641, P363, DOI 10.1007/978-3-319-09994-1_36; Avola D, 2013, LECT NOTES COMPUT SC, V8158, P465, DOI 10.1007/978-3-642-41190-8_50; Avola D, 2013, COMPUT METH PROG BIO, V110, P490, DOI 10.1016/j.cmpb.2013.01.009; Baba M, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19071676; Chemuturi R., P 3 AUGM HUM INT C M, P1, DOI [10.1145/2160125.2160128, DOI 10.1145/2160125.2160128]; Chiu LC, 2013, IEEE T IMAGE PROCESS, V22, P3158, DOI 10.1109/TIP.2013.2259841; de Graaf MMA, 2019, HUM-COMPUT INTERACT, V34, P115, DOI 10.1080/07370024.2017.1312406; Faria AL, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0204-z; Ghariba B, 2019, INFORMATION, V10, DOI 10.3390/info10080257; Kim KJ, 2015, J PHYS THER SCI, V27, P3097, DOI 10.1589/jpts.27.3097; Kim N G, 1999, IEEE Trans Rehabil Eng, V7, P482, DOI 10.1109/86.808952; Li Y, 2019, NAT MACH INTELL, V1, P36, DOI 10.1038/s42256-018-0010-3; Lin WY, 2017, IEEE T IMAGE PROCESS, V26, P2438, DOI 10.1109/TIP.2017.2683063; Manera V., 2016, FRONT AGING NEUROSCI, V7, P1; Martinel N, 2015, LECT NOTES COMPUT SC, V9280, P609, DOI 10.1007/978-3-319-23234-8_56; Ouellet E, 2018, J NEUROSCI METH, V303, P126, DOI 10.1016/j.jneumeth.2018.03.010; Pessoa TM, 2014, COMPUT HUM BEHAV, V31, P384, DOI 10.1016/j.chb.2013.10.025; Placidi G, 2013, COMPUT BIOL MED, V43, P1927, DOI 10.1016/j.compbiomed.2013.08.026; Ramirez-Alonso G, 2017, PATTERN RECOGN LETT, V96, P34, DOI 10.1016/j.patrec.2017.01.011; Schnack A, 2019, FOOD RES INT, V117, P40, DOI 10.1016/j.foodres.2018.01.028; Shapi'i A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/493562; Thomas JS, 2016, JMIR SERIOUS GAMES, V4, DOI 10.2196/games.6476; Torner J, 2019, IEEE T NEUR SYS REH, V27, P1511, DOI 10.1109/TNSRE.2019.2926786; van den Berg ME, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00424; Yi Y, 2020, SIGNAL PROCESS-IMAGE, V80, DOI 10.1016/j.image.2019.115640; Zhou L, 2008, COMMUN ACM, V51, P119, DOI 10.1145/1378727.1389972	39	2	2	2	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2078-2489		INFORMATION	Information	MAR	2020	11	3							134	10.3390/info11030134			19	Computer Science, Information Systems	Emerging Sources Citation Index (ESCI)	Computer Science	LB0DS	WOS:000524309400011		gold			2022-02-06	
J	Bowman, TG; Singe, SM; Lacy, AMP; Register-Mihalik, JK				Bowman, Thomas G.; Singe, Stephanie Mazerolle; Lacy, Alicia M. Pike; Register-Mihalik, Johna K.			Challenges Faced by Collegiate Athletic Trainers, Part II: Treating Concussed Student-Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						organizational conflict; conflict of interest; mild traumatic brain injury	FOOTBALL PLAYERS; SCHOOL; KNOWLEDGE; RETURN; SPORTS; MANAGEMENT; EDUCATION; LEARN; BEHAVIORS; SYMPTOMS	Context: Conflict between athletic trainers (ATs) and other stakeholders can occur because of competing interests over medical decisions regarding concussion. However, we are unaware of any studies specifically exploring these situations across various collegiate athletic affiliations. Objective: To investigate the challenges faced by ATs when treating concussed student-athletes. Design: Qualitative study. Setting: Online questionnaire. Patients or Other Participants: A total of 434 ATs (267 women, 166 men, 1 missing data; age = 27.73 +/- 3.24 years, experience = 5.17 +/- 2.67 years) completed the questionnaire (response rate = 14.47%). Our participants represented multiple employment settings within intercollegiate athletics. Data Collection and Analysis: We sent an online questionnaire to 3000 ATs working in the collegiate and university setting across the United States. A survey expert verified face, content, and construct validity of the questionnaire in 2 rounds of review, and 3 ATs completed a content-validity tool before we finalized the survey. We analyzed the qualitative data using a general inductive approach and ensured trustworthiness through multiple-analyst triangulation and peer review. Results: When we examined the responses from our participants regarding their work with student-athletes who had sustained concussions, we found 2 major themes, each with subthemes. First, educational efforts appeared to be only modestly effective because of a lack of honesty, noncompliant actions, and coach interference. Second, return to learn was challenging because of a lack of communication among stakeholders, athletes being anxious about needing accommodations, and difficulty convincing faculty to provide reasonable accommodations. Conclusions: Based on our findings, we recommend continued efforts to improve the culture surrounding concussion in collegiate athletes. Athletic trainers should include key stakeholders such as coaches, student-athletes, parents, faculty, and other educational administrators in their educational efforts to improve the policies and culture surrounding concussion treatment.	[Bowman, Thomas G.] Univ Lynchburg, Dept Athlet Training, Lynchburg, VA USA; [Singe, Stephanie Mazerolle; Lacy, Alicia M. Pike] Univ Connecticut, Dept Kinesiol, Storrs, CT USA; [Register-Mihalik, Johna K.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Lacy, Alicia M. Pike] AT Still Univ, 5850 East Still Circle, Mesa, AZ 85206 USA		Lacy, AMP (corresponding author), AT Still Univ, 5850 East Still Circle, Mesa, AZ 85206 USA.	alicialacy@atsu.edu	Bowman, Tom/AAU-6473-2020				Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bacon CEW, 2018, INT J ATHL THER TRAI, V23, P33, DOI 10.1123/ijatt.2017-0043; Baker CS, 2018, INT J ATHL THER TRAI, V23, P150, DOI 10.1123/ijatt.2016-0110; Baker JG, 2014, INT J CLIN PRACT, V68, P1286, DOI 10.1111/ijcp.12517; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Celorrio-Navarro M, 2019, J NEUROTRAUM, V36, pA2; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Courson R, 2014, J ATHL TRAINING, V49, P128, DOI 10.4085/1062-6050-49.1.06; Faure C, 2011, SPORT J, V14, P1; Gioia GA, 2010, J INT NEUROPSYCH SOC, V16, P178; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hwang V, 2014, J TRAUMA ACUTE CARE, V77, P117, DOI 10.1097/TA.0000000000000275; Irvine A, 2017, CAN FAM PHYSICIAN, V63, P859; Kroshus E, 2017, HEALTH COMMUN, V32, P963, DOI 10.1080/10410236.2016.1196417; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Lacy Alicia M Pike, 2020, J Athl Train, V55, P303, DOI 10.4085/1062-6050-84-19; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; Naftel KG, 2014, SOUTH MED J, V107, P418, DOI 10.14423/SMJ.0000000000000136; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; The National Collegiate Athletic Association, 2014, 2014 15 NCAA SPORTS, V25th; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	33	2	2	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR	2020	55	3					312	318		10.4085/1062-6050-85-19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	KX2RC	WOS:000521726900012	31986101	Green Published, gold			2022-02-06	
J	Brunner, M; Palmer, S; Togher, L; Dann, S; Hemsley, B				Brunner, Melissa; Palmer, Stuart; Togher, Leanne; Dann, Stephen; Hemsley, Bronwyn			"If I knew what I was doing on Twitter then I would use it more": Twitter experiences and networks of people with traumatic brain injury (TBI)	BRAIN IMPAIRMENT			English	Article						Twitter; social networks; traumatic brain injury; cognitive-communication; disability; communication disability; rehabilitation	SOCIAL MEDIA; COMMUNICATION; REHABILITATION; HEALTH; ADULTS	Aim: of this study was to examine the Twitter experiences and networks of six adults with cognitive-communication disability after a traumatic brain injury (TBI). Method: Using mixed methods, the study integrated: (a) quantitative analysis of Twitter networks using computational and manual coding of tweets; and (b) narrative analysis of in-depth interviews. Results: Diverse experiences were evident, with two experienced and four novice users of the platform. However, all reported feeling connected and included, and identified both positive and negative experiences in their use of Twitter. Developing a supportive network facilitated higher frequency of tweets and increased feelings of enjoyment and connectedness. All expressed a desire to continue using or learning to use Twitter but novices lacked support from rehabilitation professionals or experienced Twitter users, and relied instead on a "trial and error" approach. Conclusion: Proactive integration of Twitter use during rehabilitation after TBI is warranted to support safe, enjoyable, and meaningful use.	[Brunner, Melissa; Hemsley, Bronwyn] UTS, Grad Sch Hlth, Speech Pathol, Ultimo, NSW, Australia; [Palmer, Stuart] Univ Melbourne, Melbourne Ctr Study Higher Educ, Melbourne, Vic, Australia; [Togher, Leanne] Univ Sydney, Fac Hlth Sci, Speech Pathol, Sydney, NSW, Australia; [Dann, Stephen] Australian Natl Univ, Coll Business & Econ, Canberra, ACT, Australia		Brunner, M (corresponding author), UTS, Grad Sch Hlth, Speech Pathol, Ultimo, NSW, Australia.	melissa.brunner@uts.edu.au	; Hemsley, Bronwyn/A-7427-2010	Brunner, Melissa/0000-0001-6823-5189; Hemsley, Bronwyn/0000-0002-6255-3140; Togher, Leanne/0000-0002-4518-6748	University of Newcastle; University of SydneyUniversity of Sydney; University of Technology Sydney	The authors would like to acknowledge and thank the participants for their time and for sharing their experiences, Dr Lucy Bryant for acting as an independent consensus coder in data analysis, and the University of Newcastle, the University of Sydney, and the University of Technology Sydney for administration of funding and support in the conduction of this study.	Australian Securities and Investments Commission, 2015, 429 AUSTR SEC INV CO; Baker-Sparr C, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000305; Bell KR, 2008, AM J PHYS MED REHAB, V87, P330, DOI 10.1097/PHM.0b013e318168d092; Brandtzaeg Petter Bae, 2011, International Journal of Web Based Communities, V7, P28, DOI 10.1504/IJWBC.2011.038124; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brunner M., 2019, HAW INT C SYST SCI 2; Brunner M, 2019, INT J LANG COMM DIS, V54, P221, DOI 10.1111/1460-6984.12405; Brunner M, 2018, BRAIN INJURY, V32, P49, DOI 10.1080/02699052.2017.1403047; Brunner M, 2017, BRAIN INJURY, V31, P1028, DOI 10.1080/02699052.2017.1292429; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Bruns A, 2013, INT J SOC RES METHOD, V16, P91, DOI 10.1080/13645579.2012.756095; Burns A., 2014, TWITTER SOC, P15; Cacioppo JT, 2014, SOC PERSONAL PSYCHOL, V8, P58, DOI 10.1111/spc3.12087; Caron J, 2016, AUGMENT ALTERN COMM, V32, P25, DOI 10.3109/07434618.2015.1052887; Cassidy E., 2018, DRUNK HIST HIGHLIGHT; College of Audiologists and Speech-Language Pathologists of Ontario, 2015, PREF PRACT GUID COGN; Creswell JW., 2014, RES DESIGN QUALITATI, V4; Dann S., 2015, MAXIMIZING COMMERCE, P313; Douglas JM, 2017, BRAIN IMPAIR, V18, P321, DOI 10.1017/BrImp.2017.20; Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Gabbert E., 2018, IS COMPASSION FATIGU; Goasduff L., 2011, GARTNER SURVEY HIGHL; Hemsley B., 2017, C P 50 HAW INT C SYS; Hemsley B, 2018, INT J SPEECH-LANG PA, V20, P50, DOI 10.1080/17549507.2017.1413137; Hemsley B, 2017, AUGMENT ALTERN COMM, V33, P14, DOI 10.1080/07434618.2016.1273386; Hemsley B, 2015, DISABIL REHABIL, V37, P1531, DOI 10.3109/09638288.2015.1045990; Hemsley B, 2014, DEV NEUROREHABIL, V17, P84, DOI 10.3109/17518423.2013.861529; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; Malinen S, 2015, COMPUT HUM BEHAV, V46, P228, DOI 10.1016/j.chb.2015.01.004; Marwick AE, 2011, NEW MEDIA SOC, V13, P114, DOI 10.1177/1461444810365313; McDonald S, 2019, BRAIN IMAGING BEHAV, V13, P819, DOI 10.1007/s11682-018-9906-0; McPhail G, 2017, NEW ZEAL J EDUC STUD, V52, P285, DOI 10.1007/s40841-017-0087-y; Murthy D., 2017, SAGE HDB SOCIAL MEDI; Naslund JA, 2016, EPIDEMIOL PSYCH SCI, V25, P113, DOI 10.1017/S2045796015001067; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Omnicore, 2019, TWITTER NUMBERS STAT; Palmer S, 2014, J MARK HIGH EDUC, V24, P257, DOI 10.1080/08841241.2014.907220; Paterson HL, 2017, AUGMENT ALTERN COMM, V33, P23, DOI 10.1080/07434618.2016.1275789; Patton M., 2015, QUALITATIVE RES EVAL, V4; Ponsford J., 2017, NEUROBEHAVIOURAL DIS, P178; PWD Australia [PWDAustralia], 2018, FOLL CULTUREISINCLUS; Rice P., 1999, QUALITATIVE RES METH; Riessman K. C., 2008, NARRATIVE METHODS HU; Schellinger S., 2015, PUBLIC PERCEPTIONS T; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; The Gephi Consortium, 2012, GEPH VERS 0 8 2 1; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tracy S.J., 2013, QUALITATIVE RES METH; Trevisan F, 2017, PUBLIC RELAT INQ, V6, P191, DOI 10.1177/2046147X17697785; Turkstra LS, 2019, NEUROPSYCHOL REHABIL, V29, P789, DOI 10.1080/09602011.2017.1333012; Twitter, 2017, TWEET UPD SEPT 26 20; Twitter, 2018, GET TWEET TIM; Workewych AM, 2017, SAGE OPEN MED, V5, DOI 10.1177/2050312117720057; Yadron D, 2016, GUARDIAN; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Ziebland S, 2012, MILBANK Q, V90, P219, DOI 10.1111/j.1468-0009.2012.00662.x	58	2	2	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAR	2020	21	1					1	18	PII S1443964619000123	10.1017/BrImp.2019.12			18	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	OB2QS	WOS:000578318900001		Green Submitted			2022-02-06	
